,DRUG_ID,DRUG_NAME,DISEASES,PHASE
0,D00ABE,ALD-301,Ischemia , Phase 2
1,D00ABE,ALD-301,Peripheral arterial disease , Phase 2
2,D00ABO,KW-2449,Acute myeloid leukaemia , Phase 1
3,D00ABW,Opterone,Hormone deficiency , Discontinued in Phase 1
4,D00ACC,ND1251,Depression , Discontinued in Phase 1
5,D00ACH,HMR-4004,Bacterial infection , Terminated
6,D00ACP,Anti-HER-2 mab-FcgR2- FcgR4 fusion proteins,Solid tumour/cancer , Investigative
7,D00ADV,THF carbapenems,Gram-positive bacterial infection , Terminated
8,D00AEQ,Hydroxyprogesterone,Solid tumour/cancer , Approved
9,D00AES,Dicopp,Recurrent glioblastoma , Phase 2
10,D00AEV,Oxothiazolidine carboxylate,Human immunodeficiency virus infection , Approved
11,D00AHT,PRAME antigen-specific cancer immunotherapeutic,Non-small-cell lung cancer , Phase 2
12,D00AHT,PRAME antigen-specific cancer immunotherapeutic,Metastatic melanoma , Phase 1
13,D00AHT,PRAME antigen-specific cancer immunotherapeutic,Melanoma , Phase 1
14,D00AHV,SKL-PD,Central nervous system disease , Investigative
15,D00AIS,AP-11014,Solid tumour/cancer , Investigative
16,D00AIZ,SND-159,Mycobacterium infection , Investigative
17,D00AJI,PF-4480682,Neuropathic pain , Discontinued in Phase 2
18,D00AJS,AIK11,Non-insulin dependent diabetes , Investigative
19,D00AKL,Immunose FLU,Influenza virus infection , Phase 2
20,D00AKQ,O-desulfated heparin,Chronic obstructive pulmonary disease , Phase 2
21,D00AKR,AMG 479,Breast cancer , Phase 2
22,D00AKV,F-351,Liver disease , Phase 2
23,D00AKY,SK&F-S-106203,Asthma , Discontinued in Phase 2
24,D00ALE,H1N1 pandemic influenza vaccine,Influenza virus infection , Approved
25,D00ALJ,Placental expanded stem cell therapy,Peripheral vascular disease , Phase 2
26,D00AMQ,Ethanol,Cystitis , Approved
27,D00AMQ,Ethanol,Chronic pain , Approved
28,D00ANG,Erythropoietin-transfected autologous cell therapy,Anemia , Phase 1/2
29,D00AOJ,Docosanol,Herpes simplex virus infection , Approved
30,D00AQP,Ribavirin + interferon alfa-2a,Middle East Respiratory Syndrome (MERS) , Investigative
31,D00AQV,COTI-4A,Small-cell lung cancer , Investigative
32,D00AQY,IDDB-41331,Obesity , Preclinical
33,D00ARN,Tyloxapol,Cystic fibrosis , Terminated
34,D00ARS,MER-3001,Type-1 diabetes , Phase 2
35,D00ARS,MER-3001,Type-2 diabetes , Phase 2
36,D00ASJ,Typherix,Salmonella infection , Approved
37,D00ASX,PJ-015,Hyperlipidaemia , Investigative
38,D00AUC,(99M)-TC-CPI,Diagnostic imaging , Phase 2
39,D00AUM,AQU-010,Neuropathic pain , Investigative
40,D00AUX,MSDC-0602,Type-2 diabetes , Phase 2
41,D00AUZ,Thiolated chitosan nanoparticle theophylline,Inflammation , Investigative
42,D00AVG,GX-110E,Hepatitis B virus infection , Investigative
43,D00AVH,VEN100,Bacterial infection , Phase 2
44,D00AWA,WIN-63759,Emphysema , Terminated
45,D00AWT,Propericiazine,Psychiatric disorder , Approved
46,D00AXG,SMT-14224,Non-insulin dependent diabetes , Investigative
47,D00AXJ,Miconazole,Fungal infection , Approved
48,D00AXT,MDC-922,Solid tumour/cancer , Investigative
49,D00AXZ,CAP-22,Diabetic angiopathy , Investigative
50,D00AYA,BMS-188797,Solid tumour/cancer , Phase 2
51,D00AYW,HMS5552,Type-2 diabetes , Phase 1
52,D00BBB,MetPril,Hypertension , Investigative
53,D00BCG,Goserelin,Breast cancer , Approved
54,D00BCP,Chlorpropamide,Non-insulin dependent diabetes , Approved
55,D00BCS,INT-0015/2008,Panic disorder , Investigative
56,D00BCZ,XGP-610,Reperfusion injury , Investigative
57,D00BDC,Morniflumate,Otitis media , Approved
58,D00BHL,EC20,Ovarian cancer , Phase 3
59,D00BIY,CGP-48369,Hypertension , Discontinued in Phase 1
60,D00BJV,BMS-986207,Solid tumour/cancer , Phase 1/2
61,D00BKV,SB 418790,Type-2 diabetes , Discontinued in Phase 1
62,D00BLL,Fesoterodine fumarate,Overactive bladder , Approved
63,D00BLS,AZD0284,Plaque psoriasis , Phase 1
64,D00BMF,MK-4827,Ovarian cancer , Phase 3
65,D00BMF,MK-4827,Breast cancer , Phase 2
66,D00BMF,MK-4827,Ewing sarcoma , Phase 1
67,D00BMM,Dismutase mimetics,Solid tumour/cancer , Investigative
68,D00BND,BF-1,Cluster headache , Phase 1
69,D00BND,BF-1,Migraine , Phase 1
70,D00BOY,CP-18770,Non-hodgkin lymphoma , Phase 2
71,D00BPE,AVE-1642,Breast cancer , Discontinued in Phase 2
72,D00BPH,COVA322,Psoriasis vulgaris , Phase 1/2a
73,D00BTW,UC-781,Human immunodeficiency virus infection , Phase 1
74,D00BTZ,CT-003230,Cognitive impairment , Investigative
75,D00BUO,MM-141,Solid tumour/cancer , Phase 2
76,D00BUO,MM-141,Pancreatic cancer , Phase 2
77,D00BUR,ICA-17043,Alzheimer disease , Phase 2
78,D00BUR,ICA-17043,Constitutional neutropenia , Discontinued in Phase 2
79,D00BVB,Men Quad TT,Neisseria meningitis infection , Phase 3
80,D00BVF,IP-889,Osteoarthritis , Discontinued in Phase 3
81,D00BVJ,NHS-IL 12,Solid tumour/cancer , Phase 1
82,D00BVS,Tanezumab,Neuropathic pain , Phase 3
83,D00BVS,Tanezumab,Chronic low back pain , Phase 3
84,D00BVS,Tanezumab,Pain , Phase 3
85,D00BVS,Tanezumab,Osteoarthritis , Phase 3
86,D00BVS,Tanezumab,Cancer related pain , Phase 3
87,D00BWF,AGN-XX/YY,Fibromyalgia , Phase 2
88,D00BWF,AGN-XX/YY,Diabetic nephropathy , Phase 2
89,D00BXK,Pyrazole derivative 39,Obesity , Patented
90,D00BXZ,M-402,Solid tumour/cancer , Investigative
91,D00BYM,Volasertib,Acute myeloid leukaemia , Phase 3
92,D00BZJ,Trumenba,Meningitis , Approved
93,D00BZO,HL-035,Syndrome X , Investigative
94,D00BZS,Gimatecan,Breast cancer , Phase 2
95,D00BZZ,PF-4603629,Type-2 diabetes , Phase 1
96,D00CBP,DTPw-HBV/Hib,Hepatitis B virus infection , Phase 3
97,D00CBY,CEL-021,Interstitial cystitis , Investigative
98,D00CCI,Benoxaprofen,Inflammation , Withdrawn from market
99,D00CED,HG-1097,Solid tumour/cancer , Investigative
100,D00CEE,Tetraxim,Bordetella pertussis infection , Approved
101,D00CEG,D-43787,Allergy , Terminated
102,D00CEI,CM-2501,Poison intoxication , Preclinical
103,D00CFB,Zeniplatin,Melanoma , Discontinued in Phase 2
104,D00CFU,RO-4840700,Schizophrenia , Investigative
105,D00CGH,RO-23-7553,Prostate disease , Phase 1
106,D00CGU,IMS,Inflammatory bowel disease , Discontinued in Phase 1
107,D00CGX,DV-1179,Autoimmune disease , Phase 1
108,D00CGX,DV-1179,Systemic lupus erythematosus , Discontinued in Phase 1
109,D00CIF,EMD-503982,Thrombosis , Discontinued in Phase 1
110,D00CIT,Regavirumab,Cytomegalovirus infection , Discontinued in Preregistration
111,D00CLC,SLV-338,Cardiovascular disease , Phase 1
112,D00CLM,NIP-004,Thrombocytopenia , Phase 1
113,D00CMA,VVZ-172,Pain , Investigative
114,D00CMC,BP-9906,Solid tumour/cancer , Investigative
115,D00CMV,ABT-102,Chronic pain , Phase 1
116,D00COH,Biaryl mannoside derivative 24,Crohn disease , Patented
117,D00COH,Biaryl mannoside derivative 24,Ulcerative colitis , Patented
118,D00COH,Biaryl mannoside derivative 24,Urinary tract infection , Patented
119,D00COJ,Inclisiran,Hypercholesterolaemia , Phase 3
120,D00CPQ,RemoSynch,Pulmonary arterial hypertension , Phase 2
121,D00CQI,Indatuximab ravtansine,Multiple myeloma , Phase 2
122,D00CQL,N-8295,Influenza virus infection , Phase 1
123,D00CQQ,TGFK09SD,Hypoactive sexual desire dysfunction , Phase 2
124,D00CQW,TNP-351,Solid tumour/cancer , Discontinued in Phase 2
125,D00CRQ,Phenylate derivative 1,Solid tumour/cancer , Patented
126,D00CRQ,Phenylate derivative 1,Infectious disease , Patented
127,D00CRQ,Phenylate derivative 1,Human immunodeficiency virus infection , Patented
128,D00CRQ,Phenylate derivative 1,Hepatitis , Patented
129,D00CSA,LFF-269,Hypertension , Phase 2
130,D00CSQ,Triclosan,Malaria , Approved
131,D00CSQ,Triclosan,Trypanosomiasis , Investigative
132,D00CSQ,Triclosan,Infection of P. falciparum , Investigative
133,D00CTS,Lubiprostone,Chronic idiopathic constipation , Approved
134,D00CTZ,MEDI9929,Asthma , Phase 2
135,D00CVJ,Neu-P11,Insomnia , Phase 2
136,D00CVJ,Neu-P11,Alzheimer disease , Phase 2
137,D00CVJ,Neu-P11,Dementia , Phase 2
138,D00CVT,TD-6301,Overactive bladder , Discontinued in Phase 1
139,D00CZT,Solanezumab,Alzheimer disease , Phase 3
140,D00DAE,Carboxyamidotriazole orotate,Glioblastoma multiforme , Phase 2
141,D00DAU,LCP-3301,Autoimmune diabetes , Terminated
142,D00DBE,CI-1018,Asthma , Discontinued in Phase 2
143,D00DBH,NPS 1776,Epilepsy , Discontinued in Phase 2
144,D00DBO,Pipamperone,Insomnia , Phase 1/2
145,D00DBU,SA-IGIV,Staphylococcus infection , Discontinued in Phase 2
146,D00DCY,OraTest,Oral cancer , Approved
147,D00DDR,G3139 + Thalidomide,Multiple myeloma , Investigative
148,D00DEF,Lisdexamfetamine,Attention deficit hyperactivity disorder , Approved
149,D00DFP,KBP-5074,Hypertension , Phase 1/2
150,D00DHM,SDZ-208911,Psychotic disorder , Investigative
151,D00DHT,Mammalian sterile 20-like kinase 1 gene eluting stent,Artery stenosis , Investigative
152,D00DIB,Anti-CD33,Acute myeloid leukaemia , Phase 1
153,D00DIM,Monohydroxyethylrutoside,Cardiovascular disease , Phase 1
154,D00DJC,CJX-1,Solid tumour/cancer , Investigative
155,D00DKK,Isotretinoin,Acne vulgaris , Approved
156,D00DPJ,Amezinium,Hypotension , Approved
157,D00DPP,CYCLOPLATAM,Solid tumour/cancer , Phase 2
158,D00DQX,Motesanib,Non-small-cell lung cancer , Discontinued in Phase 3
159,D00DRA,KA-20X,Gastrointestinal cancer , Investigative
160,D00DRL,MK-2461,Alzheimer disease , Phase 1/2
161,D00DSD,GLI-5021,Cerebrovascular ischaemia , Terminated
162,D00DSG,PF-05313261,Inflammation , Investigative
163,D00DSN,Sepcidin,Sepsis , Investigative
164,D00DSV,Polynoma-1,Melanoma , Phase 2
165,D00DTP,ZP-006,Pharyngitis , Investigative
166,D00DXC,Macrocycle derivative 13,Cell proliferative disorder , Patented
167,D00DXH,LYS-6KAKT1,Solid tumour/cancer , Phase 1
168,D00DYI,Benzothiazole analog 1,Albinism , Patented
169,D00DYI,Benzothiazole analog 1,Ephelides , Patented
170,D00DYI,Benzothiazole analog 1,Menkes disease , Patented
171,D00DYI,Benzothiazole analog 1,Senile lentigines , Patented
172,D00DYI,Benzothiazole analog 1,Melasma , Patented
173,D00DYK,Lunacalcipol,Psoriasis vulgaris , Phase 2
174,D00DYN,Botulinum neurotoxin vaccine,Botulism , Phase 1
175,D00DZN,Beclamide,Psychiatric disorder , Approved
176,D00EBH,ICI-170809,Anxiety disorder , Discontinued in Phase 2
177,D00ECB,CD-349,Hypertension , Discontinued in Phase 2
178,D00ECO,SIB-1553A,Alzheimer disease , Discontinued in Phase 2
179,D00EEL,Gaboxadol,Insomnia , Approved
180,D00EEP,E-3309,Helicobacter infection , Discontinued in Phase 1
181,D00EFD,C-21191,Anxiety disorder , Investigative
182,D00EFO,Interferon alpha-2b,Hepatitis C virus infection , Phase 2
183,D00EGN,ETX-9101,Asthma , Phase 2
184,D00EGU,PACAP38,Nerve injury , Phase 1
185,D00EGV,Monoamine derivative 2,Albinism , Patented
186,D00EGV,Monoamine derivative 2,Ephelides , Patented
187,D00EGV,Monoamine derivative 2,Menkes disease , Patented
188,D00EGV,Monoamine derivative 2,Senile lentigines , Patented
189,D00EGV,Monoamine derivative 2,Melasma , Patented
190,D00EHX,TT-301,Alzheimer disease , Phase 1
191,D00EIB,Ha-1a,Sepsis , Approved
192,D00EIB,Ha-1a,Congestive heart failure , Approved
193,D00EIB,Ha-1a,Atrial fibrillation , Approved
194,D00EIL,CG-103065,Solid tumour/cancer , Investigative
195,D00EJP,GSK2339345,Cough , Phase 2
196,D00EKM,Virapt,Human immunodeficiency virus infection , Investigative
197,D00EMB,GSK-1247446A,Influenza virus infection , Phase 2
198,D00EML,Q-Vax,Coxiella infection , Terminated
199,D00ENU,CAB-101,Autoimmune diabetes , Investigative
200,D00ENY,L-Glutamic Acid,Schizophrenia , Approved
201,D00EPS,PMID18163548C4,Reperfusion injury , Clinical trial
202,D00EPS,PMID18163548C4,Myocardial ischemia , Clinical trial
203,D00EPT,E7850,Solid tumour/cancer , Phase 2
204,D00EQD,PN-277,Cerebrovascular ischaemia , Investigative
205,D00EQL,Tazemetostat,Follicular lymphoma , Approved
206,D00EQL,Tazemetostat,Malignant rhabdoid tumour , Phase 2
207,D00EQL,Tazemetostat,Brain and central nervous system tumour , Phase 2
208,D00EQL,Tazemetostat,Mesothelioma , Phase 2
209,D00EQL,Tazemetostat,Solid tumour/cancer , Phase 2
210,D00EQL,Tazemetostat,Diffuse large B-cell lymphoma , Phase 1/2
211,D00EQL,Tazemetostat,Synovial sarcoma , Phase 1
212,D00EQY,KTN3379,Solid tumour/cancer , Phase 1
213,D00ERV,Gallopamil,Asthma , Phase 2
214,D00ERV,Gallopamil,Hypertension , Discontinued in Phase 1
215,D00ESH,DCVax-Liver,Liver cancer , Phase 1/2
216,D00ETS,Hexobarbital,Anaesthesia , Approved
217,D00EUL,PMID28270021-Compound-WO2016054807Example82,Pruritus , Patented
218,D00EUL,PMID28270021-Compound-WO2016054807Example82,Solid tumour/cancer , Patented
219,D00EUL,PMID28270021-Compound-WO2016054807Example82,Chronic pain , Patented
220,D00EUL,PMID28270021-Compound-WO2016054807Example82,Neuropathic pain , Patented
221,D00EUL,PMID28270021-Compound-WO2016054807Example82,Thymic cancer , Patented
222,D00EVP,Simenepag isopropyl,Ocular hypertension , Phase 2
223,D00EWR,Fidarestat,Diabetic complication , Phase 3
224,D00EXZ,PB-357,Solid tumour/cancer , Phase 1
225,D00EYC,F-7TG,Hemophilia , Phase 1
226,D00EYF,PEGylated insulin,Diabetic complication , Investigative
227,D00EZE,Panamesine,Psychotic disorder , Discontinued in Phase 2
228,D00EZO,TC-2216,Mood disorder , Phase 1
229,D00FAW,CL-508,Vomiting , Investigative
230,D00FBC,KHK-6188,Neuropathic pain , Phase 2
231,D00FBM,LP-2307,Solid tumour/cancer , Discontinued in Phase 2
232,D00FCW,ViaScint,Cardiovascular disease , Discontinued in Preregistration
233,D00FDD,INT-0020,Insomnia , Phase 1
234,D00FEA,GRL-0036A,Human immunodeficiency virus-1 infection , Investigative
235,D00FGO,Melphalan,Multiple myeloma , Approved
236,D00FGO,Melphalan,Intrahepatic cholangiocarcinoma , Phase 3
237,D00FGR,Miltefosine,Leishmaniasis , Approved
238,D00FGR,Miltefosine,Visceral leishmaniasis , Phase 2
239,D00FGV,Carbinoxamine,Vasomotor/allergic rhinitis , Approved
240,D00FGW,Anthrax transdermal vaccine,Anthrax , Phase 1
241,D00FGY,PF-755616,Rheumatoid arthritis , Discontinued in Phase 1
242,D00FHI,Zabiciprilat,Hypertension , Discontinued in Phase 2
243,D00FHR,MGCD-0103,Solid tumour/cancer , Phase 2
244,D00FHR,MGCD-0103,Non-small-cell lung cancer , Phase 2
245,D00FHR,MGCD-0103,Diffuse large B-cell lymphoma , Phase 1/2
246,D00FHR,MGCD-0103,Melanoma , Phase 1
247,D00FIO,Anti-CD20-CAR-transduced T cells,leukaemia , Phase 1/2
248,D00FIO,Anti-CD20-CAR-transduced T cells,Lymphoma , Phase 1/2
249,D00FIV,Leukotoxin,Autoimmune diabetes , Investigative
250,D00FIX,Agalsidase beta,Fabry disease , Approved
251,D00FJC,Nuvanil,Pain , Discontinued in Phase 2
252,D00FJH,N-acylpiperidine ether derivative 4,Pruritus , Patented
253,D00FJH,N-acylpiperidine ether derivative 4,Solid tumour/cancer , Patented
254,D00FJH,N-acylpiperidine ether derivative 4,Chronic pain , Patented
255,D00FJH,N-acylpiperidine ether derivative 4,Neuropathic pain , Patented
256,D00FJH,N-acylpiperidine ether derivative 4,Thymic cancer , Patented
257,D00FJQ,Leucine + metformin,Type-2 diabetes , Phase 2
258,D00FJS,KRH-2731,Human immunodeficiency virus infection , Terminated
259,D00FMK,SDZ-LAV-694,Actinic keratosis , Phase 1
260,D00FMQ,FX-300,Inflammation , Investigative
261,D00FMV,Putrescine,Burn and burn infection , Discontinued in Phase 2
262,D00FMW,TIM ETEC vaccine,Diarrhea , Phase 2
263,D00FOR,NBI-80649,Parkinson disease , Investigative
264,D00FQP,LAGATIDE,Diarrhea , Discontinued in Phase 2
265,D00FRX,CTA-056,leukaemia , Investigative
266,D00FRY,BILD-1351,Herpes simplex virus infection , Terminated
267,D00FSB,BIIB095,Pain , Phase 1
268,D00FSS,SPD-452,Epilepsy , Terminated
269,D00FSV,Phytonadione,Bleeding disorder , Approved
270,D00FSV,Phytonadione,Vitamin K deficiency , Approved
271,D00FUD,HRA-081025,Contraception , Investigative
272,D00FWB,L-163017,Hypertension , Terminated
273,D00FXQ,IG-CN-023,Neuropathic pain , Investigative
274,D00FYF,NVP-DPP728,Type-2 diabetes , Discontinued in Phase 2
275,D00FYP,PG-36,Cytomegalovirus infection , Terminated
276,D00FZA,ALD-805,Solid tumour/cancer , Investigative
277,D00FZH,Nest mesenchymal stem cells,Coronavirus Disease 2019 (COVID-19) , Phase 1
278,D00FZZ,PEG-FGF-21,Type-2 diabetes , Phase 2
279,D00GAM,Beclanorsen,leukaemia , Phase 1/2
280,D00GAV,AR-2474,Bacterial infection , Terminated
281,D00GBG,Resp syncytial virus ig,Respiratory syncytial virus infection , Approved
282,D00GBZ,CEQ-508,Familial adenomatous polyposis , Phase 1/2
283,D00GCA,MK-7288,Excessive daytime sleepiness , Phase 1
284,D00GDN,ML-03,Chronic obstructive pulmonary disease , Terminated
285,D00GEG,Ralfinamide,Neuropathic pain , Phase 3
286,D00GES,JD-5037,Diabetic complication , Preclinical
287,D00GES,JD-5037,Obesity , Preclinical
288,D00GFU,BTma22,Autoimmune diabetes , Investigative
289,D00GFV,Leridistim,Immune System disease , Phase 2
290,D00GHG,VAX-102,Influenza A virus infection , Phase 2
291,D00GIR,DAC-060,Keratosis , Phase 2
292,D00GJK,Depigoid birch pollen extract vaccine,Allergic conjunctivitis , Phase 2
293,D00GKH,HG-1179,Solid tumour/cancer , Investigative
294,D00GLQ,2LM20-4,Autoimmune diabetes , Investigative
295,D00GLW,OM-294-DP,Solid tumour/cancer , Investigative
296,D00GNI,REGN-727,Familial hypercholesterolemia , Approved
297,D00GNI,REGN-727,Hypercholesterolaemia , Approved
298,D00GNJ,Linaclotide,Irritable bowel syndrome , Approved
299,D00GNK,LY293111,Pancreatic cancer , Discontinued in Phase 2
300,D00GNN,P53 mdm-2-binding domain peptides,Solid tumour/cancer , Investigative
301,D00GOH,HepeX-B,Hepatitis virus infection , Phase 2
302,D00GOS,Clocortolone,Rosacea , Approved
303,D00GOV,Nivolumab,Melanoma , Approved
304,D00GOV,Nivolumab,Non-small-cell lung cancer , Approved
305,D00GOV,Nivolumab,Malignant pleural mesothelioma , Phase 3
306,D00GOV,Nivolumab,Multiple myeloma , Phase 3
307,D00GOV,Nivolumab,Small-cell lung cancer , Phase 3
308,D00GOV,Nivolumab,Esophageal cancer , Phase 3
309,D00GOV,Nivolumab,Gastric adenocarcinoma , Phase 3
310,D00GOV,Nivolumab,Recurrent glioblastoma , Phase 3
311,D00GOV,Nivolumab,Central nervous system lymphoma , Phase 2
312,D00GOV,Nivolumab,Diffuse large B-cell lymphoma , Phase 2
313,D00GOV,Nivolumab,Follicular lymphoma , Phase 2
314,D00GOV,Nivolumab,Prostate cancer , Phase 2
315,D00GOV,Nivolumab,Ovarian cancer , Phase 1/2
316,D00GOV,Nivolumab,Pancreatic cancer , Phase 1/2
317,D00GOV,Nivolumab,Triple negative breast cancer , Phase 1/2
318,D00GOV,Nivolumab,Chronic myelogenous leukaemia , Phase 1
319,D00GOV,Nivolumab,Renal cell carcinoma , Application submitted
320,D00GPQ,PF-03084014,Desmoid tumour , Phase 3
321,D00GPQ,PF-03084014,Alzheimer disease , Phase 2
322,D00GPQ,PF-03084014,Solid tumour/cancer , Phase 2
323,D00GPY,OMP-18R5,Solid tumour/cancer , Phase 1
324,D00GXL,PBT-2,Alzheimer disease , Phase 2
325,D00GXL,PBT-2,Huntington disease , Phase 2
326,D00GZW,ONO-2506,Stroke , Phase 2/3
327,D00GZW,ONO-2506,Type-2 diabetes , Terminated
328,D00GZY,AT1001,Autoimmune diabetes , Phase 3
329,D00HAN,IM23,Acute myeloid leukaemia , Phase 1
330,D00HAP,Dapagliflozin/metformin,Type-2 diabetes , Phase 3
331,D00HBE,AZD0914,Neisseria gonorrhoeae infection , Phase 3
332,D00HBE,AZD0914,Bacterial infection , Phase 2
333,D00HBF,CAB-103,Solid tumour/cancer , Investigative
334,D00HBR,AIKO-150,Opioid dependence , Phase 1
335,D00HCQ,Capecitabine,Colorectal cancer , Approved
336,D00HCQ,Capecitabine,Breast cancer , Phase 3
337,D00HDB,AC-105,Spinal cord injury , Phase 2
338,D00HDC,MCP-204,Bladder disease , Investigative
339,D00HDH,Molecule 22,Alzheimer disease , Investigative
340,D00HDK,PGX-5188,Bipolar disorder , Preclinical
341,D00HDU,Moexipril,Hypertension , Approved
342,D00HDZ,Wharton's Jelly-Mesenchymal Stem Cells,Coronavirus Disease 2019 (COVID-19) , Phase 1
343,D00HEA,Transcobalamin (vitamin B12) receptor-targeting mabTCR23-saporin conjugate,Solid tumour/cancer , Investigative
344,D00HEN,"Rotavirus vaccine, Lanzhou Institute of Biological Products",Rotavirus infection (Diarrhoea) , Approved
345,D00HFD,E-6080,Asthma , Discontinued in Phase 2
346,D00HGB,Niflumic Acid,Rheumatoid arthritis , Approved
347,D00HGF,ERYTHRITOL,Neurological disorder , Phase 2/3
348,D00HGY,Insulin B chain vaccine,Type-1 diabetes , Phase 1
349,D00HGY,Insulin B chain vaccine,Insulin-dependent diabetes , Phase 1
350,D00HHP,CP-111905,Bacterial infection , Terminated
351,D00HHS,Pseudoephedrine,Nasal congestion , Approved
352,D00HHU,AFO-18,Human immunodeficiency virus-1 infection , Phase 1
353,D00HIC,Pseudomonas aeruginosa vaccine,Pseudomonas infection , Discontinued in Phase 1
354,D00HMQ,Ormaplatin,leukaemia , Discontinued in Phase 1
355,D00HMZ,TV1-Kidney-1,Renal cell carcinoma , Phase 2
356,D00HNB,Clodronate,Hypercalcaemia , Approved
357,D00HNK,RHb1.1,Anemia , Terminated
358,D00HNQ,TDI-0051,Motor neurone disease , Investigative
359,D00HPD,Moxetumomab pasudotox,Hairy cell leukaemia , Approved
360,D00HPD,Moxetumomab pasudotox,Haematological malignancy , Phase 1
361,D00HPK,Naftifine,Dermatomycosis , Approved
362,D00HPX,ON-04,Breast cancer , Investigative
363,D00HQB,TX-MSD,Multiple sclerosis , Investigative
364,D00HQE,Ty800,Infectious disease , Phase 2
365,D00HSK,Algenpantucel-L,Pancreatic cancer , Phase 3
366,D00HTO,Apomine,Osteopetrosis , Phase 2
367,D00HTT,XE-9,Transplant rejection , Terminated
368,D00HTY,PGF2alpha,Solid tumour/cancer , Clinical trial
369,D00HUZ,NDDP,Solid tumour/cancer , Phase 2
370,D00HWO,Cyclacillin,Bacterial infection , Approved
371,D00HYD,CDT-fenofibrate,Hyperlipidaemia , Phase 1
372,D00HYF,H5N1 influenza vaccine,Influenza virus infection , Phase 3
373,D00HYK,AFN-1252,Staphylococcus infection , Phase 2
374,D00HZA,YPEG-Somatropin,Growth hormone deficiency , Phase 1
375,D00HZO,GS-497C,Lung cancer , Investigative
376,D00HZV,Trimipramine,Major depressive disorder , Approved
377,D00IAH,Hemiacidrin,Urolithiasis , Approved
378,D00IBN,Piroxicam,Pain , Approved
379,D00ICD,SH-529,Peripheral vascular disease , Phase 2
380,D00ICM,Naltiazem hydrochloride,Angina pectoris , Terminated
381,D00ICY,FP-187,Autoimmune diabetes , Phase 2
382,D00IDP,Emdogain,Solid tumour/cancer , Approved
383,D00IDR,Phenylalanine hydroxylase,Autoimmune diabetes , Phase 2
384,D00IDV,CRTX-070,Allergic rhinitis , Investigative
385,D00IEB,DRL-21994,Lipid metabolism disorder , Investigative
386,D00IFH,INO-1400,Breast cancer , Phase 1
387,D00IFH,INO-1400,Solid tumour/cancer , Phase 1
388,D00IFQ,MVT-1075,Pancreatic cancer , Phase 1
389,D00IFQ,MVT-1075,Solid tumour/cancer , Phase 1
390,D00IFR,AZD1208,Solid tumour/cancer , Phase 1
391,D00IJM,EPI-A0001,Friedreich's ataxia , Phase 2
392,D00IJQ,Zatosetron maleate,Anxiety disorder , Phase 3
393,D00IKH,Hexylcarbamoyl fluorouracil,Solid tumour/cancer , Withdrawn from market
394,D00IKI,PF-04895162,Epilepsy , Phase 1
395,D00INM,Occlusin,Liver cancer , Preclinical
396,D00IOS,CYT-017-IL17Qb,Multiple sclerosis , Terminated
397,D00IPW,CGP-47969A,Autoimmune diabetes , Terminated
398,D00IQH,RQ-00000007 (oral),Pain , Phase 2
399,D00IQV,Homspera,Influenza virus infection , Investigative
400,D00IRU,E-5842,Schizophrenia , Terminated
401,D00ISN,MT-1303,Multiple sclerosis , Phase 2
402,D00ISN,MT-1303,Crohn disease , Phase 2
403,D00ITC,PRT4445,Bleeding disorder , Phase 3
404,D00ITG,Clinafloxacin,Pneumonia , Terminated
405,D00IUD,K-832,Rheumatoid arthritis , Phase 2
406,D00IUG,Levobunolol,Open-angle glaucoma , Approved
407,D00IVF,Murepavadin,Ventilator-associated pneumonia , Phase 3
408,D00IVN,Navicixizumab,Colorectal cancer , Phase 1
409,D00IVN,Navicixizumab,Fallopian tube cancer , Phase 1
410,D00IVN,Navicixizumab,Metastatic colorectal cancer , Phase 1
411,D00IVN,Navicixizumab,Ovarian cancer , Phase 1
412,D00IVN,Navicixizumab,Peritoneal cavity cancer , Phase 1
413,D00IWE,RP-6000,Major depressive disorder , Investigative
414,D00IWL,PolyHeme,Blood forming organ disorder , Phase 3
415,D00IXM,DR-3001,Urinary incontinence , Phase 3
416,D00IXN,GS-6637,Substance use disorder , Phase 1
417,D00IYB,Maraciclatide,Breast cancer , Phase 2
418,D00IYM,AEZS-127,Solid tumour/cancer , Preclinical
419,D00IZD,DVC1-0101,Arteriosclerosis , Phase 2
420,D00IZW,BM-13.1188,Diabetic complication , Terminated
421,D00IZY,DCN01,Ocular infection , Phase 2
422,D00JAU,Irbesartan,Hypertension , Approved
423,D00JBM,UR-5908,Chronic obstructive pulmonary disease , Investigative
424,D00JCA,NewGam,Immune System disease , Phase 3
425,D00JCB,CD19/CD22 CAR T cells,Acute lymphoblastic leukaemia , Phase 1
426,D00JDJ,AX-024,Multiple sclerosis , Phase 1
427,D00JDL,MGD006,Acute myeloid lymphoma , Phase 1
428,D00JDL,MGD006,Acute lymphoblastic leukaemia , Phase 1
429,D00JDP,AMX-213,Cachexia , Investigative
430,D00JED,AN-2898,Atopic dermatitis , Phase 2
431,D00JFE,ARN-810,Breast cancer , Phase 2
432,D00JFN,MDC-917,Solid tumour/cancer , Investigative
433,D00JGL,D-4476,Chronic lymphocytic leukaemia , Preclinical
434,D00JIV,PF-4989216,Solid tumour/cancer , Investigative
435,D00JIX,IKH-25,Solid tumour/cancer , Investigative
436,D00JJG,RAP101,Human immunodeficiency virus infection , Phase 2
437,D00JJW,RH 1,Discovery agent , Phase 1
438,D00JJZ,LaViv,Multiple sclerosis , Phase 3
439,D00JKJ,HS-P1,Pancreatic cancer , Investigative
440,D00JME,SMT-14400,Allergy , Investigative
441,D00JMG,HRA-081035,Contraception , Investigative
442,D00JMY,AMP-224,Solid tumour/cancer , Phase 1
443,D00JMY,AMP-224,Colorectal cancer , Phase 1
444,D00JNL,Tenilsetam,Alzheimer disease , Terminated
445,D00JNT,HCV-086,Hepatitis virus infection , Discontinued in Phase 1
446,D00JQA,Benzimidazole derivative 3,Albinism , Patented
447,D00JQA,Benzimidazole derivative 3,Ephelides , Patented
448,D00JQA,Benzimidazole derivative 3,Menkes disease , Patented
449,D00JQA,Benzimidazole derivative 3,Senile lentigines , Patented
450,D00JQA,Benzimidazole derivative 3,Melasma , Patented
451,D00JQE,BAY-60-5521,Arteriosclerosis , Phase 1
452,D00JQQ,RX-465,Sarcoma , Terminated
453,D00JRA,Asenapine,Schizophrenia , Approved
454,D00JRD,PGF2ALPHA-IE,Glaucoma/ocular hypertension , Phase 3
455,D00JRS,Lopinavir,Human immunodeficiency virus infection , Approved
456,D00JRS,Lopinavir,Severe acute respiratory syndrome (SARS) , Preclinical
457,D00JRS,Lopinavir,Middle East Respiratory Syndrome (MERS) , Preclinical
458,D00JSG,Fluoratec,Attention deficit hyperactivity disorder , Terminated
459,D00JVC,ATB-429,Inflammatory bowel disease , Investigative
460,D00JVR,Azelastine,Allergic conjunctivitis , Approved
461,D00JWL,LEX-028,Inflammation , Terminated
462,D00JWN,Allogeneic human dental pulp stem cells,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
463,D00JXV,INCB-10820,Inflammation , Investigative
464,D00JZD,GSK2321138A,Influenza virus infection , Phase 3
465,D00JZS,Anti-FGFR1 mab program,Solid tumour/cancer , Investigative
466,D00JZX,EP-012637,Asthma , Terminated
467,D00KCR,Enkastim-iv,Solid tumour/cancer , Investigative
468,D00KDQ,Anti-CEA CAR-T cells,Colorectal cancer , Phase 1
469,D00KDQ,Anti-CEA CAR-T cells,Gastric adenocarcinoma , Phase 1
470,D00KDQ,Anti-CEA CAR-T cells,Pancreatic cancer , Phase 1
471,D00KDQ,Anti-CEA CAR-T cells,Peritoneal metastasis , Phase 1
472,D00KEF,Org-2766,Cognitive impairment , Discontinued in Phase 3
473,D00KFB,Dextromethorphan Polistirex,Dry cough , Approved
474,D00KGB,Abagovomab,Ovarian cancer , Phase 2/3
475,D00KGI,IVN-201,Allergy , Phase 1
476,D00KHD,TAK-128,Diabetic neuropathy , Phase 2
477,D00KHI,Anti-PSMA CAR-T cell therapy,Solid tumour/cancer , Phase 1
478,D00KHM,Pimozide,Schizophrenia , Approved
479,D00KIE,Ensaculin hydrochloride,Parkinson disease , Phase 2
480,D00KIU,MKC-242844,Lymphoma , Investigative
481,D00KJO,MUT-056399,Methicillin-resistant staphylococci infection , Preclinical
482,D00KKD,PMID26651364-Compound-5,Crohn disease , Patented
483,D00KKD,PMID26651364-Compound-5,Ulcerative colitis , Patented
484,D00KKD,PMID26651364-Compound-5,Urinary tract infection , Patented
485,D00KLH,KR-6346,Stomach ulcer , Terminated
486,D00KLP,Immune globulin + albumin,Alzheimer disease , Phase 3
487,D00KMI,CEP-37309,leukaemia , Investigative
488,D00KML,SYN004,Solid tumour/cancer , Phase 1
489,D00KMQ,OI362GT,Type-1/2 diabetes , Phase 1
490,D00KNI,BI-853520,Solid tumour/cancer , Phase 1
491,D00KOV,Monatepil maleate,Angina pectoris , Discontinued in Preregistration
492,D00KQN,PEGylated pitrakinra,Asthma , Phase 2
493,D00KQN,PEGylated pitrakinra,Allergy , Investigative
494,D00KQT,FR-129169,Arteriosclerosis , Terminated
495,D00KRE,Olsalazine,Ulcerative colitis , Approved
496,D00KRT,Indocyanine green,Gastrointestinal disease , Approved
497,D00KSU,MT-274,Bacterial infection , Investigative
498,D00KTN,PMID25666693-Compound-121,Osteoarthritis pain , Patented
499,D00KTN,PMID25666693-Compound-121,Cancer related pain , Patented
500,D00KTN,PMID25666693-Compound-121,Neuropathic pain , Patented
501,D00KTN,PMID25666693-Compound-121,Inflammatory pain , Patented
502,D00KTV,Salirasib,Lung cancer , Phase 2
503,D00KTV,Salirasib,Non-small-cell lung cancer , Discontinued in Phase 2
504,D00KTV,Salirasib,Pancreatic cancer , Discontinued in Phase 1/2
505,D00KUD,ADL 10-0101,Pain , Discontinued in Phase 2
506,D00KVE,Cutamesine,Major depressive disorder , Preclinical
507,D00KVO,Albendazole,Worm infection , Approved
508,D00KVX,LP-261,Solid tumour/cancer , Phase 1
509,D00KWA,Recainam,Heart arrhythmia , Terminated
510,D00KWF,PYN-9,Ileus , Preclinical
511,D00KXO,Ciraparantag,"Harmful effects of drugs, medicaments or biological substances ", Phase 2
512,D00KXQ,LF-13-0491c,Arteriosclerosis , Terminated
513,D00LAA,VA-118020,Respiratory disease , Investigative
514,D00LBD,Metazosin,Cardiac disease , Discontinued in Phase 3
515,D00LCT,Symakalim,Hypertension , Discontinued in Phase 1
516,D00LDI,UPA-targeted oncolytic Sendai virus,Solid tumour/cancer , Investigative
517,D00LFB,Ritodrine,Premature labour , Approved
518,D00LGA,NN-8226,Psoriasis vulgaris , Phase 2
519,D00LGR,TP-0903,Chronic lymphocytic leukaemia , Phase 1/2
520,D00LGR,TP-0903,Solid tumour/cancer , Phase 1
521,D00LHF,GS-9219,Solid tumour/cancer , Phase 1/2
522,D00LHI,BAY 794980,Discovery agent , Phase 2
523,D00LJF,INT0001/2004,Hypertension , Phase 2
524,D00LLI,Candistat-G,Candidiasis , Discontinued in Phase 2
525,D00LMA,Heteroaryl-carboxamide derivative 4,Solid tumour/cancer , Patented
526,D00LMA,Heteroaryl-carboxamide derivative 4,Metastatic cancer , Patented
527,D00LMR,AP-006,Pulmonary disease , Investigative
528,D00LMY,RO-5212651,Non-insulin dependent diabetes , Investigative
529,D00LNW,Selinexor,Multiple myeloma , Phase 3
530,D00LNW,Selinexor,Liposarcoma , Phase 3
531,D00LNW,Selinexor,Neuroendocrine cancer , Phase 3
532,D00LNW,Selinexor,Solid tumour/cancer , Phase 2
533,D00LNW,Selinexor,Diffuse large B-cell lymphoma , Phase 2
534,D00LNW,Selinexor,Acute myeloid leukaemia , Phase 2
535,D00LNW,Selinexor,Recurrent glioblastoma , Phase 2
536,D00LOB,RWJ-671818,Thrombosis , Phase 1
537,D00LPZ,Vapill,Diabetic complication , Investigative
538,D00LRP,PRS-080,Anaemia , Phase 1/2
539,D00LSD,SERX-1,Non-insulin dependent diabetes , Investigative
540,D00LSI,Vidofludimus,Inflammatory bowel disease , Phase 2
541,D00LSI,Vidofludimus,Rheumatoid arthritis , Phase 2
542,D00LSQ,PMID26815044-Compound-126,Albinism , Patented
543,D00LSQ,PMID26815044-Compound-126,Ephelides , Patented
544,D00LSQ,PMID26815044-Compound-126,Menkes disease , Patented
545,D00LSQ,PMID26815044-Compound-126,Senile lentigines , Patented
546,D00LSQ,PMID26815044-Compound-126,Melasma , Patented
547,D00LSW,VA-111913,Dysmenorrhea , Phase 2
548,D00LVA,Dianicline,Tobacco dependence , Discontinued in Phase 3
549,D00LWD,AF-3473,Neuropathic pain , Investigative
550,D00LWF,P-1075,Hypertension , Discontinued in Phase 2
551,D00LWR,BVT-A,Acromegaly , Preclinical
552,D00LWS,Ataprost,Asthma , Discontinued in Phase 3
553,D00LWX,Promegapoietin,Bone marrow transplantation , Terminated
554,D00LXB,Panaecin,Lung infection , Investigative
555,D00LXD,Omega interferon,Hepatitis C virus infection , Discontinued in Phase 2
556,D00LYE,GC-003,Neutropenia , Investigative
557,D00LYW,BW-1003C87,Cerebrovascular ischaemia , Terminated
558,D00LZM,CP1,Cough , Investigative
559,D00LZO,CZC-19091,Inflammation , Investigative
560,D00LZY,AA-184,Kidney injury , Investigative
561,D00MAM,AMG-JAK2-01,Myeloproliferative syndrome , Investigative
562,D00MAN,GRC-6211,Asthma , Phase 1
563,D00MBR,Iratumumab,Lymphoma , Phase 2
564,D00MBY,AAD-2004,Alzheimer disease , Phase 1
565,D00MCA,BB-PTH 1-84,Osteoporosis , Investigative
566,D00MCY,REC2615,Female sexual arousal dysfunction , Investigative
567,D00MDP,Prinomastat,Lung cancer , Approved
568,D00MDP,Prinomastat,Brain cancer , Discontinued in Phase 3
569,D00MET,Recombinant uteroglobin,Metastatic malignant neoplasm , Investigative
570,D00MEV,Sch-45752,Asthma , Terminated
571,D00MFA,Aspartame,Poison intoxication , Investigative
572,D00MFY,GPI-3000,Cerebrovascular ischaemia , Terminated
573,D00MGO,PMID28270021-Compound-WO2016054807Example1,Pruritus , Patented
574,D00MGO,PMID28270021-Compound-WO2016054807Example1,Solid tumour/cancer , Patented
575,D00MGO,PMID28270021-Compound-WO2016054807Example1,Chronic pain , Patented
576,D00MGO,PMID28270021-Compound-WO2016054807Example1,Neuropathic pain , Patented
577,D00MGO,PMID28270021-Compound-WO2016054807Example1,Thymic cancer , Patented
578,D00MHP,SR-2640,Asthma , Phase 2
579,D00MIF,JTP-4761,Hypertension , Terminated
580,D00MIN,Propylthiouracil,Hyperthyroidism , Approved
581,D00MIX,CP-114271,Obesity , Preclinical
582,D00MJI,Emactuzumab,Solid tumour/cancer , Phase 1
583,D00MLJ,Pyrazole derivative 61,Solid tumour/cancer , Patented
584,D00MLJ,Pyrazole derivative 61,Metastatic cancer , Patented
585,D00MLQ,Protosufloxacin,Bacterial infection , Terminated
586,D00MLW,Triheptanoin,Long-chain fatty acid oxidation disorder , Approved
587,D00MLW,Triheptanoin,Genetic epileptic syndromes with variable age of onset , Phase 3
588,D00MLX,Abacavir/dolutegravir/lamivudine,Human immunodeficiency virus infection , Phase 3
589,D00MMV,Enoticumab,Solid tumour/cancer , Discontinued in Phase 1
590,D00MNG,HIV gp41 vaccine,Human immunodeficiency virus infection , Phase 1
591,D00MPX,JX-1395,Solid tumour/cancer , Investigative
592,D00MQS,PD-165167,Schizophrenia , Preclinical
593,D00MRH,MDPTQ,leukaemia , Investigative
594,D00MSP,FR-149581,Hypertension , Terminated
595,D00MTG,SAR279356,Serious infection , Phase 2
596,D00MUC,CD19 CAR-T cells,Acute lymphoblastic leukaemia , Phase 1
597,D00MVK,Ro-48-8391,Bacterial infection , Terminated
598,D00MWE,UX-004,Lysosomal storage disease , Investigative
599,D00MXN,MK-3207,Migraine , Phase 2
600,D00MYQ,Protriptyline,Depression , Approved
601,D00MYT,Thiopental,Anaesthesia , Approved
602,D00MYW,NS-018,Myelofibrosis , Phase 1/2
603,D00MZC,LTX-100,Infectious disease , Investigative
604,D00MZK,FK-788,Hypertension , Phase 2
605,D00NAX,Promazine,Psychomotor agitation , Approved
606,D00NBF,GM06,Amyotrophic lateral sclerosis , Phase 2
607,D00NBJ,Remetinostat,Basal cell carcinoma , Phase 2
608,D00NBJ,Remetinostat,Cutaneous T-cell lymphoma , Phase 2
609,D00NBW,ONCOS-102,Colorectal cancer , Phase 1/2
610,D00NBW,ONCOS-102,Ovarian cancer , Phase 1/2
611,D00NBW,ONCOS-102,Melanoma , Phase 1
612,D00NBW,ONCOS-102,Solid tumour/cancer , Phase 1
613,D00NEL,BI-754091,Solid tumour/cancer , Phase 1
614,D00NEL,BI-754091,Advanced malignancy , Phase 1
615,D00NGN,Sabeluzole,Cerebrovascular ischaemia , Discontinued in Phase 3
616,D00NIV,ATYR-1920,Genetic disease , Investigative
617,D00NJE,SFc,Autoimmune diabetes , Investigative
618,D00NJJ,Mezlocillin,Urinary tract infection , Approved
619,D00NJL,Clofoctol,Bronchitis , Approved
620,D00NKB,Triamterene,Congestive heart failure , Approved
621,D00NKB,Triamterene,Edema , Approved
622,D00NKB,Triamterene,Hypertension , Approved
623,D00NNC,Etidronic acid,Paget's disease , Approved
624,D00NNI,ASP-3652,Overactive bladder , Phase 2
625,D00NOL,MK-0536,Human immunodeficiency virus infection , Investigative
626,D00NOP,OBP-401,Solid tumour/cancer , Preclinical
627,D00NOY,BetaRx,Type-1 diabetes , Investigative
628,D00NPE,MMP-408,Chronic obstructive pulmonary disease , Investigative
629,D00NPO,ABT-199,Chronic lymphocytic leukaemia , Phase 3
630,D00NPP,Zanamivir,Influenza virus infection , Approved
631,D00NPT,Minodronate,Osteoporosis , Approved
632,D00NSD,XL-820,Solid tumour/cancer , Phase 2
633,D00NSM,CM-GLP-1,Brain injury , Discontinued in Phase 1/2
634,D00NTR,Histoplasmin,Histoplasma infection , Approved
635,D00NTW,BIBR-363,Hypertension , Discontinued in Phase 2
636,D00NUG,Olokizumab,Rheumatoid arthritis , Phase 3
637,D00NUO,IDP-122,Plaque psoriasis , Application submitted
638,D00NVM,SNS-595,Acute myeloid leukaemia , Phase 3
639,D00NVM,SNS-595,Ovarian cancer , Phase 2
640,D00NVO,Flezelastine,Asthma , Phase 2
641,D00NVX,Forasartan,Hypertension , Approved
642,D00NWT,GR-213487,Cystic fibrosis , Discontinued in Phase 2
643,D00NWV,Ypeginterferon alfa-2a,Hepatitis B virus infection , Phase 3
644,D00NXM,GSK-2251052,Urinary tract infection , Phase 2
645,D00NXT,Xmab 5871,Autoimmune diabetes , Phase 2
646,D00NXT,Xmab 5871,IgG4 related disease , Phase 2
647,D00NXT,Xmab 5871,Systemic lupus erythematosus , Phase 2
648,D00NXT,Xmab 5871,Rheumatoid arthritis , Phase 1/2
649,D00NYJ,Varlitinib,Metastatic biliary tract neoplasms , Phase 2/3
650,D00NYJ,Varlitinib,Breast cancer , Phase 1/2
651,D00NYL,AAV2/8-CBA-hSMN1,Spinal muscular atrophy , Investigative
652,D00NZL,LY2603618,Pancreatic cancer , Phase 2
653,D00OAB,APX-007,Bone metastases , Investigative
654,D00OAU,GW-328267,Allergic rhinitis , Phase 1
655,D00OAY,Lenampicillin hci,Bacterial infection , Approved
656,D00OCB,CCT-018159,Solid tumour/cancer , Preclinical
657,D00ODY,PMID25666693-Compound-95,Osteoarthritis pain , Patented
658,D00ODY,PMID25666693-Compound-95,Cancer related pain , Patented
659,D00ODY,PMID25666693-Compound-95,Neuropathic pain , Patented
660,D00ODY,PMID25666693-Compound-95,Inflammatory pain , Patented
661,D00OEG,RhTPO,Idiopathic thrombocytopenic purpura , Discontinued in Phase 3
662,D00OFV,Asperlicin,Gastrointestinal disease , Investigative
663,D00OGX,Anapsos,Atopic dermatitis , Approved
664,D00OHP,PRO-GR-300,Fibrosis , Investigative
665,D00OJL,QBP1 mimetics,Huntington disease , Investigative
666,D00OKK,PC4708,Bacterial infection , Investigative
667,D00OLY,PMID25666693-Compound-149,Osteoarthritis pain , Patented
668,D00OLY,PMID25666693-Compound-149,Cancer related pain , Patented
669,D00OLY,PMID25666693-Compound-149,Neuropathic pain , Patented
670,D00OLY,PMID25666693-Compound-149,Inflammatory pain , Patented
671,D00OMJ,SJ-BRV,Obesity , Investigative
672,D00ONE,CWF-0710,Asthma , Investigative
673,D00OON,CAB-AXL-ADC,Solid tumour/cancer , Phase 1/2
674,D00OOZ,E-7107,Solid tumour/cancer , Phase 1
675,D00OPX,Fostamatinib disodium,Thrombocytopenia , Phase 3
676,D00ORZ,BMS-824393,Hepatitis C virus infection , Phase 2
677,D00OTH,P-979,Inflammation , Investigative
678,D00OTL,Vernakalant,Atrial fibrillation , Phase 3
679,D00OTM,LY3022855,Solid tumour/cancer , Phase 1
680,D00OTQ,Proximab,Inflammatory bowel disease , Investigative
681,D00OTT,ISIS 1570,Lleum inflammation , Approved
682,D00OVC,EVT-201,Insomnia , Phase 2
683,D00OVE,PF-06650808,Solid tumour/cancer , Phase 1
684,D00OVU,Suvorexant,Insomnia , Approved
685,D00OWU,RBP-8000,Cocaine addiction , Phase 2
686,D00OXP,Bb21217,Multiple myeloma , Phase 1
687,D00OYC,Motolimid,Ovarian cancer , Phase 2
688,D00OYQ,Imisopasem manganese,Pain , Phase 2
689,D00OZC,THX-TS01,Tourette syndrome , Phase 3
690,D00PBI,SUVN-501,Neurological disorder , Investigative
691,D00PBS,Allogeneic NK cells,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
692,D00PBX,GDC-0199,Chronic lymphocytic leukaemia , Approved
693,D00PBX,GDC-0199,Solid tumour/cancer , Approved
694,D00PDG,CORT-108297,Weight gain , Discontinued in Phase 1/2
695,D00PDQ,Kuzbanian,Solid tumour/cancer , Investigative
696,D00PEH,Eltrombopag,Thrombocytopenia , Approved
697,D00PEH,Eltrombopag,Idiopathic thrombocytopenic purpura , Phase 3
698,D00PEN,MGD007,Colorectal cancer , Phase 1/2
699,D00PEN,MGD007,Metastatic colorectal cancer , Phase 1
700,D00PFW,AZD4818,Chronic obstructive pulmonary disease , Discontinued in Phase 2
701,D00PGA,ALS-AAV9,Motor neurone disease , Investigative
702,D00PGF,RV-1088,Asthma , Investigative
703,D00PHK,Carboxylic acid derivative 1,Neoplasm , Patented
704,D00PHK,Carboxylic acid derivative 1,Angiogenesis disorder , Patented
705,D00PIE,Banoxantrone,Acute lymphoblastic leukaemia , Discontinued in Phase 1
706,D00PJJ,FK-614,Type-2 diabetes , Phase 2
707,D00PJK,SRI-21009,Solid tumour/cancer , Investigative
708,D00PJY,Prosorba,Breast cancer , Approved
709,D00PLV,Nitroprusside,Hypertension , Approved
710,D00PLX,MystiLol,Glaucoma/ocular hypertension , Investigative
711,D00PMA,CL-246738,Immune System disease , Discontinued in Phase 2
712,D00PMB,VGX-3100,Cervical Intraepithelial neoplasia , Phase 3
713,D00PMB,VGX-3100,Dysplasia , Phase 3
714,D00PMB,VGX-3100,Human papillomavirus infection , Phase 2
715,D00PMB,VGX-3100,Vulvar squamous intraepithelial lesion , Phase 2
716,D00PMB,VGX-3100,Vulvar intraepithelial neoplasia , Phase 2
717,D00PNU,TGN-1412,Autoimmune diabetes , Discontinued in Phase 1
718,D00POS,DL-017,Hypertension , Phase 1
719,D00PPV,Siderophore-conjugated monocarbams,Bacterial infection , Terminated
720,D00PQS,NE-2,Pain , Investigative
721,D00PRI,Edetate calcium disodium,Toxicity , Approved
722,D00PSG,NOX-100,Hypotension , Phase 2
723,D00PTZ,Dasiprotimut-T,Lymphoma , Phase 3
724,D00PUT,BT-016,Rheumatoid arthritis , Phase 2
725,D00PXQ,Fananserin,Schizophrenia , Terminated
726,D00PYP,NBI-37582,Depression , Terminated
727,D00PYP,NBI-37582,Anxiety disorder , Terminated
728,D00PZH,AC-187,Type-2 diabetes , Terminated
729,D00PZK,APD-405,Vomiting , Discontinued in Phase 2
730,D00QAQ,Terpenoid schweinfurthins,Solid tumour/cancer , Investigative
731,D00QAX,PF-708093,Bacterial infection , Preclinical
732,D00QBV,DD7,Acute respiratory distress syndrome , Investigative
733,D00QBV,DD7,Myocardial reperfusion injury , Investigative
734,D00QBV,DD7,Sepsis , Investigative
735,D00QCB,SRI-62-834,Solid tumour/cancer , Discontinued in Phase 2
736,D00QCV,MG-401,Solid tumour/cancer , Investigative
737,D00QCX,SCP-123,Pain , Investigative
738,D00QDJ,Trametinib,Metastatic melanoma , Approved
739,D00QDJ,Trametinib,Severe acute respiratory syndrome (SARS) , Investigative
740,D00QDJ,Trametinib,Middle East Respiratory Syndrome (MERS) , Investigative
741,D00QEP,Inotuzumab ozogamicin,Acute lymphocytic leukaemia , Approved
742,D00QEP,Inotuzumab ozogamicin,Acute lymphoblastic leukaemia , Approved
743,D00QET,Montelukast,Asthma , Approved
744,D00QEZ,PMID25666693-Compound-60,Osteoarthritis pain , Patented
745,D00QEZ,PMID25666693-Compound-60,Cancer related pain , Patented
746,D00QEZ,PMID25666693-Compound-60,Neuropathic pain , Patented
747,D00QEZ,PMID25666693-Compound-60,Inflammatory pain , Patented
748,D00QFV,GR-DD1,Liver cancer , Investigative
749,D00QFY,YM533,Chronic renal failure , Discontinued in Phase 3
750,D00QGB,O-2442,Cocaine addiction , Investigative
751,D00QGV,Human interferon alpha oral,Hepatitis C virus infection , Phase 2
752,D00QHT,AK-295,Cerebral infarction , Terminated
753,D00QIJ,Huntingtin gene antisense,Huntington disease , Preclinical
754,D00QIK,PS-519,Ischemia-reperfusion injury , Terminated
755,D00QJL,Influvac TC,Influenza virus infection , Phase 3
756,D00QKI,SCH-527123,Inflammatory bowel disease , Phase 2
757,D00QKI,SCH-527123,Ulcerative colitis , Phase 2
758,D00QKI,SCH-527123,Chronic obstructive pulmonary disease , Phase 2
759,D00QKI,SCH-527123,Solid tumour/cancer , Phase 1
760,D00QKL,T2c-003,Diabetic neuropathy , Phase 1/2
761,D00QKS,BMS-954561,Diabetic neuropathy , Phase 2
762,D00QLG,Lovaxin M,Melanoma , Investigative
763,D00QNW,Laropiprant/niacin/ simvastatin combination,Hyperlipidaemia , Phase 3
764,D00QOF,ORG-13011,Psychotic disorder , Phase 2
765,D00QOF,ORG-13011,Anxiety disorder , Phase 2
766,D00QOF,ORG-13011,Major depressive disorder , Application submitted
767,D00QOG,F-2833,Arteriosclerosis , Terminated
768,D00QOH,OCT-SG815,Arthritis , Investigative
769,D00QOJ,99mTc-RP-128,Diagnostic imaging , Phase 2
770,D00QTA,A-058,Hepatitis C virus infection , Investigative
771,D00QTL,MDDR 184045,Mycobacterium infection , Investigative
772,D00QTU,TH-1320,Solid tumour/cancer , Investigative
773,D00QUJ,AM-3005,Gram-positive bacterial infection , Investigative
774,D00QUZ,TTP-814,Diabetic complication , Phase 1/2
775,D00QVT,ATN-161,Renal cell carcinoma , Phase 2
776,D00QVY,Resorcinol compound 23,Albinism , Patented
777,D00QVY,Resorcinol compound 23,Ephelides , Patented
778,D00QVY,Resorcinol compound 23,Menkes disease , Patented
779,D00QVY,Resorcinol compound 23,Senile lentigines , Patented
780,D00QVY,Resorcinol compound 23,Melasma , Patented
781,D00QWK,CLL1-specific gene-engineered T cells,Acute myeloid leukaemia , Phase 1/2
782,D00QWU,BMS-779788,Arteriosclerosis , Phase 1
783,D00QXB,WT1 peptide vaccine,leukaemia , Phase 2
784,D00QXV,BMS-181101,Mood disorder , Discontinued in Phase 2
785,D00QZJ,Growth hormone,Growth hormone deficiency , Investigative
786,D00RAM,Bone Marrow-Derived Mesenchymal Stem Cells,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
787,D00RCI,Teduglutide,Short bowel syndrome , Approved
788,D00RDI,OPN-401,Inflammation , Investigative
789,D00RDO,PMID26651364-Compound-116,Crohn disease , Patented
790,D00RDO,PMID26651364-Compound-116,Ulcerative colitis , Patented
791,D00RDO,PMID26651364-Compound-116,Urinary tract infection , Patented
792,D00RFZ,PSI-6130,Hepatitis C virus infection , Terminated
793,D00RGF,GCC-4401,Thrombosis , Phase 1
794,D00RGX,RG7876,Solid tumour/cancer , Phase 1
795,D00RIB,RG-201,Acquired immune deficiency syndrome , Discontinued in Phase 1
796,D00RIK,B7/CD28 costimulatory proteins,Autoimmune diabetes , Investigative
797,D00RJA,VX-148,Psoriasis vulgaris , Patented
798,D00RJB,Rilopirox,Fungal infection , Phase 2
799,D00RJE,Pancopride,Nausea , Phase 3
800,D00RJJ,Ganirelix,Ovulation dysfunction , Approved
801,D00RMC,BIBX-1382,Chronic lymphocytic leukaemia , Phase 1
802,D00RMD,FK-960,Cognitive impairment , Discontinued in Phase 2
803,D00RNB,IQB-9302,Pain , Phase 1
804,D00ROR,CYNK-001 cells,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
805,D00ROV,FK-041,Bacterial infection , Discontinued in Phase 1
806,D00ROY,Adjustable basal insulin,Diabetic complication , Phase 1
807,D00RPV,EPB-200,Virus infection , Investigative
808,D00RQQ,ASP-1120,Pain , Investigative
809,D00RQW,Biaryl mannoside derivative 8,Crohn disease , Patented
810,D00RQW,Biaryl mannoside derivative 8,Ulcerative colitis , Patented
811,D00RQW,Biaryl mannoside derivative 8,Urinary tract infection , Patented
812,D00RRU,BIIB037,Alzheimer disease , Phase 3
813,D00RSK,GW-406381,Neuropathic pain , Discontinued in Phase 3
814,D00RSK,GW-406381,Osteoarthritis , Discontinued in Phase 3
815,D00RTC,Vicinium,Bladder cancer , Phase 3
816,D00RTU,227Th-rituximab,Solid tumour/cancer , Investigative
817,D00RWQ,CX157,Mood disorder , Phase 2
818,D00RWU,FT-301,Muscle wasting disease , Investigative
819,D00RWW,Fexinidazole,Trypanosomiasis , Phase 2/3
820,D00RXR,AC-253,Hypertension , Discontinued in Phase 1
821,D00RYA,SB-1578,Solid tumour/cancer , Phase 1
822,D00RYU,IPH-2102,Acute myeloid leukaemia , Phase 2
823,D00RZA,EPB-500,Hepatitis C virus infection , Investigative
824,D00SBD,Recoflavone,Inflammatory bowel disease , Phase 2
825,D00SBN,Perhexiline,Angina pectoris , Approved
826,D00SBU,PF614,Chronic pain , Phase 1
827,D00SBX,ZL006,Fear-related disorder , Investigative
828,D00SEB,Enalapril,Hypertension , Approved
829,D00SFN,TUCARESOL,Immune System disease , Phase 2
830,D00SFY,BI-44847,Type-2 diabetes , Phase 1
831,D00SGD,Pentacel,Bordetella pertussis infection , Approved
832,D00SHQ,Bromperidol,Schizophrenia , Approved
833,D00SHS,Human hemoglobin,Blood transfusion , Phase 3
834,D00SIA,ARQ-171,Solid tumour/cancer , Phase 1
835,D00SIR,CS-461,Bacterial infection , Terminated
836,D00SIZ,RG6180,Metastatic melanoma , Phase 2
837,D00SIZ,RG6180,Solid tumour/cancer , Phase 1
838,D00SJE,Secobarbital,Intractable insomnia , Approved
839,D00SJN,HLL1-Fab-A3B3,Solid tumour/cancer , Investigative
840,D00SJX,NK-110,Muscle wasting disease , Investigative
841,D00SKM,TT12,Cervical cancer , Phase 1
842,D00SKM,TT12,Oropharyngeal cancer , Phase 1
843,D00SKS,GS-8374,Human immunodeficiency virus infection , Investigative
844,D00SLY,Umeclidinium,Chronic obstructive pulmonary disease , Approved
845,D00SMC,PAN-22,Hepatocellular carcinoma , Investigative
846,D00SML,NMHSS1-1,Glioblastoma multiforme , Investigative
847,D00SMU,Lenti-D,Adrenoleukodystrophy , Phase 3
848,D00SNY,TDI-0057,Motor neurone disease , Investigative
849,D00SOZ,DE-117,Glaucoma/ocular hypertension , Phase 3
850,D00SPK,E-4021,Cardiovascular disease , Discontinued in Phase 2
851,D00SQN,HBI-8000,Solid tumour/cancer , Registered
852,D00SQN,HBI-8000,Non-small-cell lung cancer , Registered
853,D00SQN,HBI-8000,Melanoma , Phase 1/2
854,D00SQN,HBI-8000,Merkel cell carcinoma , Phase 1/2
855,D00SQN,HBI-8000,Renal cell carcinoma , Phase 1/2
856,D00SRE,HPMPA prodrugs,Cytomegalovirus infection , Investigative
857,D00SSZ,OBP-801,Solid tumour/cancer , Phase 1
858,D00STJ,Enocitabine,Solid tumour/cancer , Approved
859,D00STL,Nilotinib,Chronic myelogenous leukaemia , Approved
860,D00STZ,Mam-05.200,Immune System disease , Investigative
861,D00SUK,Tonapofylline,Acute and chronic heart failure , Phase 2
862,D00SVK,PMID25684022-Compound-WO2011137219 37(4-6),Solid tumour/cancer , Patented
863,D00SVK,PMID25684022-Compound-WO2011137219 37(4-6),Metastatic cancer , Patented
864,D00SVP,PF-4455242,Bipolar disorder , Phase 1
865,D00SVU,Y-25130,Nausea and vomiting , Approved
866,D00SWN,MS-806,Diabetic complication , Investigative
867,D00SWQ,Mitoglitazone,Type-2 diabetes , Phase 2
868,D00SWQ,Mitoglitazone,Alzheimer disease , Phase 2
869,D00SYV,GSK2618960,Multiple sclerosis , Phase 1
870,D00SYV,GSK2618960,Sjogren syndrome , Phase 1
871,D00TAP,Helivax,Helicobacter infection , Discontinued in Phase 1
872,D00TBD,PHA-665752,Solid tumour/cancer , Investigative
873,D00TBI,Imidazole derivative 7,Obesity , Patented
874,D00TBJ,PF-271836,Female sexual arousal dysfunction , Investigative
875,D00TBS,SPIRU-211,Constipation , Investigative
876,D00TCM,Yellow fever vaccine,Yellow fever virus infection , Approved
877,D00TED,JNJ-54728518,Type-2 diabetes , Phase 1
878,D00TEN,TV-1390,Multiple sclerosis , Preclinical
879,D00TGR,"Citric acid, magnesium oxide, sodium picosulfate",Crohn disease , Approved
880,D00THA,QLT-091001,Restless legs syndrome , Phase 2
881,D00THA,QLT-091001,Leber congenital amaurosis , Phase 1
882,D00THA,QLT-091001,Retinitis pigmentosa , Phase 1
883,D00THG,DE-105,Corneal disease , Phase 2
884,D00THJ,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 3",Skin disease , Patented
885,D00THJ,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 3",Muscular wasting , Patented
886,D00TIG,RG3806,Acromegaly , Preregistration
887,D00TJV,RP-3120,Respiratory tract inflammation , Investigative
888,D00TJX,Albinterferon alfa-2b,Hepatitis C virus infection , Phase 3
889,D00TKC,NCP-004,Diabetic complication , Terminated
890,D00TLD,RIG-200,Hypertension , Discontinued in Phase 1
891,D00TLM,PRUVANSERIN,Sleep-wake disorder , Phase 2
892,D00TLN,Cyproheptadine,Rhinitis , Approved
893,D00TLP,Simeprevir,Chronic HCV-1 infection , Approved
894,D00TMK,Dengvaxia,Dengue fever , Phase 2
895,D00TMQ,Azetidine-1-carboxamide derivative 3,Obesity , Patented
896,D00TNC,S-8510,Cognitive impairment , Discontinued in Phase 2
897,D00TNZ,Enadenotucirev,Solid tumour/cancer , Phase 1
898,D00TPC,MAT-401,Aspergillosis , Investigative
899,D00TPI,Nalidixic Acid + Ampicillin,Typhoid fever , Investigative
900,D00TPQ,VT-384,Inflammation , Investigative
901,D00TPW,FST-201,Otitis externa , Phase 3
902,D00TQN,JTK-003,Hepatitis C virus infection , Discontinued in Phase 2
903,D00TRL,REV-598,Carcinoid syndrome , Terminated
904,D00TRV,Besifloxacin,Ocular inflammation , Approved
905,D00TTS,Human chorionic gonadotropin,Heart disease , Terminated
906,D00TUP,Vitreosolve,Diabetic retinopathy , Phase 3
907,D00TUR,LY2495655,Disuse muscle atrophy , Phase 2
908,D00TVI,SR-58894A,Gastrointestinal disease , Terminated
909,D00TXL,AAV2-hFIX16,Factor IX deficiency , Phase 1
910,D00TYI,TG-3030,Nicotine dependence , Investigative
911,D00TYP,KIN-4064,Solid tumour/cancer , Investigative
912,D00TYR,Anti-tubulin agents,Solid tumour/cancer , Investigative
913,D00UAE,Bavituximab,Non-small-cell lung cancer , Phase 3
914,D00UAE,Bavituximab,Asthma , Phase 2
915,D00UAE,Bavituximab,Recurrent glioblastoma , Phase 2
916,D00UAE,Bavituximab,Hepatocellular carcinoma , Phase 2
917,D00UBK,L-159689,Hypertension , Terminated
918,D00UBX,TNX-355,Human immunodeficiency virus infection , Phase 3
919,D00UCC,ABT-518,Solid tumour/cancer , Discontinued in Phase 1
920,D00UCW,CEREBROCRAST,Nerve injury , Discontinued in Phase 1
921,D00UDP,Terameprocol,Solid tumour/cancer , Phase 2
922,D00UEC,ASP3662,Alzheimer disease , Phase 1
923,D00UEG,LY288513,Anxiety disorder , Terminated
924,D00UEQ,Etomoxir,Heart failure , Terminated
925,D00UET,SAR-407899,Diabetic nephropathy , Phase 2
926,D00UET,SAR-407899,Microvascular angina , Phase 2
927,D00UFZ,AMG 745,Muscle atrophy , Phase 2
928,D00UGC,HSC660,Alopecia , Phase 1/2
929,D00UGX,Cenplacel-L,Rheumatoid arthritis , Phase 2
930,D00UGY,Natural killer cells,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
931,D00UHK,KI-0905,Asthma , Investigative
932,D00UJF,Dextran,Thrombosis , Approved
933,D00UKN,Mesenchymal stromal cells,Coronavirus Disease 2019 (COVID-19) , Phase 2
934,D00ULY,KAI-9803/ BMS-875944,Reperfusion injury , Phase 2
935,D00UMJ,NM-007-LENK,Pain , Investigative
936,D00UNK,Coltuximab ravtansine,Diffuse large B-cell lymphoma , Phase 2
937,D00UNK,Coltuximab ravtansine,Non-hodgkin lymphoma , Phase 2
938,D00UOQ,PAT-SC1,Gastric adenocarcinoma , Phase 1/2
939,D00UOR,Desirudin,Deep vein thrombosis , Approved
940,D00UOZ,MEDI-491,Virus infection , Discontinued in Phase 1
941,D00UPU,RPR-107836,Anxiety disorder , Investigative
942,D00UQF,GW4064,Hepatic fibrosis , Preclinical
943,D00UQW,RG7741,Lymphoma , Phase 1
944,D00UQW,RG7741,Solid tumour/cancer , Phase 1
945,D00URZ,LG-740,leukaemia , Phase 2
946,D00USF,Trazodone,Depression , Approved
947,D00USS,Cholera vaccine,Vibrio cholerae infection , Approved
948,D00USX,CEFMATILEN HYDROCHLORIDE HYDRATE,Bacterial infection , Discontinued in Phase 3
949,D00UTD,Nedaplatin,Non-small-cell lung cancer , Approved
950,D00UUL,N8-GP,Factor VIII deficiency , Phase 3
951,D00UVA,Carfilzomib,Multiple myeloma , Approved
952,D00UVA,Carfilzomib,Small-cell lung cancer , Phase 1/2
953,D00UVU,Lipoteichoic acid,Solid tumour/cancer , Phase 1/2
954,D00UWY,RT-001,Acne vulgaris , Phase 2
955,D00UWY,RT-001,Friedreich's ataxia , Phase 1/2
956,D00UXT,Acetrizoate Sodium,Radiographic contrast medium , Approved
957,D00UYB,Anti-DLL-4 mab,Solid tumour/cancer , Investigative
958,D00UYE,Meperidine,Pain , Approved
959,D00UYR,IMC-1,Fibromyalgia , Phase 2
960,D00UZR,Palbociclib,Breast cancer , Approved
961,D00UZR,Palbociclib,Solid tumour/cancer , Phase 2
962,D00UZR,Palbociclib,Schizophrenia , Terminated
963,D00VAJ,ORBOFIBAN,Angina pectoris , Discontinued in Phase 3
964,D00VAJ,ORBOFIBAN,Cardiovascular disease , Discontinued in Phase 3
965,D00VBT,ZK 304709,Advanced solid tumour , Discontinued in Phase 1
966,D00VCH,F-98214,Major depressive disorder , Investigative
967,D00VCZ,HGT-2610,Leukodystrophy , Investigative
968,D00VFE,Saralasin Acetate,Hypertension , Approved
969,D00VFH,PXS-25,Fibrosis , Phase 1
970,D00VFM,RWJ-49968,Fungal infection , Investigative
971,D00VGP,XGP-215,Solid tumour/cancer , Investigative
972,D00VJC,Peg. Adrenomedullin,Lung disease , Phase 1
973,D00VKK,VPI-2690B,Diabetic nephropathy , Phase 2
974,D00VLF,HCV/MF59,Hepatitis C virus infection , Discontinued in Phase 1/2
975,D00VMA,Vatreptacog alfa (activated),Bleeding disorder , Phase 3
976,D00VMY,P-3378,Solid tumour/cancer , Investigative
977,D00VNH,ZK-200775,Coronary artery disease , Phase 1
978,D00VOE,Myoblast cell transplantation,Myocardial infarction , Phase 1
979,D00VOF,TNF-PEG-20,Solid tumour/cancer , Investigative
980,D00VPT,SB222200,Schizoaffective disorder , Preclinical
981,D00VPT,SB222200,Schizophrenia , Preclinical
982,D00VPU,SLV-323,Gastric motility disorder , Discontinued in Phase 1
983,D00VPU,SLV-323,Chemotherapy-induced nausea , Discontinued in Phase 1
984,D00VPU,SLV-323,Irritable bowel syndrome , Discontinued in Phase 1
985,D00VPV,TAK-013,Uterine fibroids , Discontinued in Phase 2
986,D00VQI,SQ-30741,Thrombosis , Discontinued in Phase 2
987,D00VQT,99mTc-EC-DG,Solid tumour/cancer , Phase 3
988,D00VSQ,E-1455,Schizophrenia , Investigative
989,D00VUG,FF21101,Solid tumour/cancer , Phase 2
990,D00VUL,Phenazopyridine,Pain , Approved
991,D00VUN,TRX-818,Solid tumour/cancer , Phase 1
992,D00VXZ,YT-1006,Neuropathic pain , Investigative
993,D00VZF,Merbarone,Pancreatic cancer , Discontinued in Phase 2
994,D00VZZ,Allopregnanolone,Postpartum depression , Approved
995,D00VZZ,Allopregnanolone,Depression , Approved
996,D00VZZ,Allopregnanolone,Status epilepticus seizure , Phase 3
997,D00VZZ,Allopregnanolone,Essential tremor or related tremors , Phase 2
998,D00WAM,Hydroflumethiazide,Congestive heart failure , Approved
999,D00WBN,ALV-003,Coeliac disease , Phase 2
1000,D00WCT,EVP-1001-1,Heart disease , Phase 2
1001,D00WCX,Bezafibrate,Hyperlipidaemia , Approved
1002,D00WDM,BST-204,Solid tumour/cancer , Investigative
1003,D00WDY,BMS-903452,Type-2 diabetes , Phase 1
1004,D00WEL,ABS-401,Amnesia , Terminated
1005,D00WEP,BLX-155,Deep vein thrombosis , Investigative
1006,D00WHC,MB-03966,Epileptic seizures , Investigative
1007,D00WHL,Juvidex,Sarcoidosis , Phase 2
1008,D00WJC,DCDS0780A,Non-hodgkin lymphoma , Phase 1
1009,D00WJE,SUN-1334H,Allergic rhinitis , Discontinued in Phase 2
1010,D00WKL,PSX-4206,Pulmonary disease , Investigative
1011,D00WME,Conatumumab,Colorectal cancer , Phase 2
1012,D00WME,Conatumumab,Pain , Discontinued in Phase 2
1013,D00WMJ,CMC-001,Liver cancer , Phase 2
1014,D00WMK,Relvar/Breo,Chronic obstructive pulmonary disease , Approved
1015,D00WOT,CDP-850,Solid tumour/cancer , Discontinued in Phase 2
1016,D00WOX,Human retinal pigment epithelial cell therapy,Macular degeneration , Phase 1/2
1017,D00WPT,ACV-1,Neuropathic pain , Phase 1
1018,D00WPU,Sazetidine-A,Major depressive disorder , Investigative
1019,D00WUC,Histidase-PEG-20,Solid tumour/cancer , Investigative
1020,D00WUF,Pregabalin,Chronic obstructive pulmonary disease , Approved
1021,D00WVI,AS-1907417,Non-insulin dependent diabetes , Investigative
1022,D00WVW,YM443,Functional dyspepsia , Approved
1023,D00WWU,SMP-028,Asthma , Discontinued in Phase 1
1024,D00WYV,V-3526,Encephalitis virus infection , Terminated
1025,D00WZK,BC-3781 intravenous,Bacterial infection , Phase 2
1026,D00XBC,GSK-2239633,Asthma , Phase 1
1027,D00XBH,MNLP-462a,Solid tumour/cancer , Preclinical
1028,D00XCX,DIFLOMOTECAN,Solid tumour/cancer , Phase 2
1029,D00XDN,Pyrazole derivative 40,Obesity , Patented
1030,D00XEM,Beta-cyclodextrin conjugate derivative 3,Crohn disease , Patented
1031,D00XEM,Beta-cyclodextrin conjugate derivative 3,Ulcerative colitis , Patented
1032,D00XEM,Beta-cyclodextrin conjugate derivative 3,Urinary tract infection , Patented
1033,D00XEU,GSK-923295,Solid tumour/cancer , Terminated
1034,D00XEX,MN-201,Solid tumour/cancer , Phase 1
1035,D00XFT,Pyrazole derivative 53,Obesity , Patented
1036,D00XFY,ISIS 2922 + foscarnet 3' -azido-3'-deoxythymidine 2'-3'-dideoxycytidine,Virus infection , Investigative
1037,D00XHD,Balofloxacin,Gram-positive bacterial infection , Approved
1038,D00XIP,MVA-BN Brachyury,Solid tumour/cancer , Phase 1
1039,D00XKB,AZ-4217,Rheumatoid arthritis , Clinical trial
1040,D00XKE,PMID26651364-Compound-109,Crohn disease , Patented
1041,D00XKE,PMID26651364-Compound-109,Ulcerative colitis , Patented
1042,D00XKE,PMID26651364-Compound-109,Urinary tract infection , Patented
1043,D00XLE,PF-4764793,Respiratory disease , Phase 1
1044,D00XMZ,Drug 1940029,Acne vulgaris , Phase 1
1045,D00XNC,CAT-2200,Rheumatoid arthritis , Investigative
1046,D00XND,PMA-511R,Autoimmune diabetes , Investigative
1047,D00XNW,AL-54478,Ocular hypertension , Phase 2
1048,D00XPA,L-759274,Depression , Discontinued in Phase 3
1049,D00XPA,L-759274,Mood disorder , Discontinued in Phase 3
1050,D00XPC,Halobetasol Propionate,Inflammation , Approved
1051,D00XPZ,ELB-WE-007,Central nervous system disease , Investigative
1052,D00XQK,HRC-102,Reperfusion injury , Terminated
1053,D00XQO,MANOALIDE,Arthritis , Phase 2
1054,D00XRI,TJN-220,Hypertension , Terminated
1055,D00XRK,BMS-182193,Human immunodeficiency virus infection , Terminated
1056,D00XSP,S-35678,Cognitive impairment , Investigative
1057,D00XSQ,PGL-1001,Female infertility , Investigative
1058,D00XTS,CR-3834,Hypertension , Terminated
1059,D00XUN,Etidronate Disodium,Osteoporosis , Approved
1060,D00XVE,BR6819,Heart failure , Phase 1
1061,D00XVL,ITI-214,Parkinson disease , Phase 1/2
1062,D00XVL,ITI-214,Schizophrenia , Phase 1
1063,D00XVL,ITI-214,Complete androgen insensitivity syndrome , Phase 1
1064,D00XVL,ITI-214,Immune dysregulation , Phase 1
1065,D00XWB,F-15845,Angina pectoris , Phase 1
1066,D00XWD,Tegaserod,Irritable bowel syndrome , Approved
1067,D00XWD,Tegaserod,Gastro-oesophageal reflux , Withdrawn from market
1068,D00XWD,Tegaserod,Dyspepsia , Withdrawn from market
1069,D00XWF,RBX2660,C. difficile infection , Phase 3
1070,D00XXZ,N-acylpiperidine ether derivative 1,Pruritus , Patented
1071,D00XXZ,N-acylpiperidine ether derivative 1,Solid tumour/cancer , Patented
1072,D00XXZ,N-acylpiperidine ether derivative 1,Chronic pain , Patented
1073,D00XXZ,N-acylpiperidine ether derivative 1,Neuropathic pain , Patented
1074,D00XXZ,N-acylpiperidine ether derivative 1,Thymic cancer , Patented
1075,D00XZP,UR-7198,Hypertension , Discontinued in Phase 1
1076,D00XZY,ORC-Vax,Vibrio cholerae infection , Approved
1077,D00YAH,E2730,Epilepsy , Phase 1
1078,D00YAS,Q-102,Human immunodeficiency virus infection , Investigative
1079,D00YBW,OXY-111A,Cardiovascular disease , Phase 1/2
1080,D00YBZ,OC-10X,Macular degeneration , Phase 1
1081,D00YBZ,OC-10X,Proliferative diabetic retinopathy , Phase 1
1082,D00YCO,Pulvomycin,Bacterial infection , Investigative
1083,D00YDN,CXR-1002,Solid tumour/cancer , Phase 1
1084,D00YEO,NZ-1002,Lysosomal storage disease , Terminated
1085,D00YER,HM-78136B,Solid tumour/cancer , Phase 2
1086,D00YER,HM-78136B,HER2-positive breast cancer , Phase 2
1087,D00YER,HM-78136B,Non-small-cell lung cancer , Phase 2
1088,D00YEV,BAICALEIN,Influenza virus infection , Phase 2
1089,D00YFP,RG7697,Type-2 diabetes , Discontinued in Phase 2
1090,D00YGA,SB-219994,Diabetic complication , Terminated
1091,D00YJD,SEL-103,Alzheimer disease , Investigative
1092,D00YJI,EOS-013,Retinitis pigmentosa , Investigative
1093,D00YLF,Serpacwa,Poison intoxication , Approved
1094,D00YLM,TRAXOPRODIL MESYLATE,Neurological disorder , Phase 2
1095,D00YLW,Dolasetron,Nausea , Approved
1096,D00YMM,SAR-215500,Bacterial infection , Investigative
1097,D00YMN,AIKO-152,Opioid dependence , Investigative
1098,D00YNJ,XB-387,Non-small-cell lung cancer , Investigative
1099,D00YNK,MGN-7455,Ischemic heart disease , Investigative
1100,D00YNY,VPC-94075,Vascular disease , Investigative
1101,D00YOV,MT-110,Solid tumour/cancer , Phase 1
1102,D00YOW,LM-1376,Asthma , Terminated
1103,D00YPR,CP-547632,Solid tumour/cancer , Phase 2
1104,D00YPR,CP-547632,Ovarian cancer , Phase 2
1105,D00YPR,CP-547632,Non-small-cell lung cancer , Phase 2
1106,D00YQI,TRC105,Hemangiosarcoma , Phase 3
1107,D00YQI,TRC105,Angiosarcoma , Phase 3
1108,D00YQI,TRC105,Ovarian cancer , Phase 2
1109,D00YQI,TRC105,Macular degeneration , Phase 2
1110,D00YQI,TRC105,Peritoneal cancer , Phase 2
1111,D00YQI,TRC105,Fallopian tube cancer , Phase 2
1112,D00YQI,TRC105,Soft tissue sarcoma , Phase 2
1113,D00YQI,TRC105,Gestational trophoblastic neoplasia , Phase 2
1114,D00YQI,TRC105,Hepatocellular carcinoma , Phase 2
1115,D00YQI,TRC105,Renal cell carcinoma , Phase 2
1116,D00YQI,TRC105,Recurrent glioblastoma , Phase 2
1117,D00YQI,TRC105,Breast cancer , Phase 1
1118,D00YQI,TRC105,Lung cancer , Phase 1
1119,D00YQZ,L-702958,Cardiac arrhythmias , Terminated
1120,D00YRF,UCB-1277763,Inflammation , Investigative
1121,D00YRS,PMID26815044-Compound-H,Albinism , Patented
1122,D00YRS,PMID26815044-Compound-H,Ephelides , Patented
1123,D00YRS,PMID26815044-Compound-H,Menkes disease , Patented
1124,D00YRS,PMID26815044-Compound-H,Senile lentigines , Patented
1125,D00YRS,PMID26815044-Compound-H,Melasma , Patented
1126,D00YSJ,Tecadenoson,Cardiac arrhythmias , Discontinued in Phase 3
1127,D00YSJ,Tecadenoson,Atrial fibrillation , Discontinued in Phase 3
1128,D00YTQ,BMS-345541,Arthritis , Investigative
1129,D00YTS,AVP-13546,Autoimmune disease , Investigative
1130,D00YTX,OG-19,Dementia , Investigative
1131,D00YUB,NT-3,Constipation , Discontinued in Phase 2
1132,D00YUP,LT-3001,Ischemic stroke , Phase 1
1133,D00YUQ,CART-19 T cells,Multiple myeloma , Phase 1
1134,D00YVF,Exenatide,Type-2 diabetes , Approved
1135,D00YVF,Exenatide,Cardiovascular disease , Phase 3
1136,D00YWH,Anti-MRSA,Fungal infection , Terminated
1137,D00YWL,BMS-936557,Immune System disease , Phase 2
1138,D00YWP,Nandrolone,Osteoporosis , Approved
1139,D00YXA,PMID25666693-Compound-2,Osteoarthritis pain , Patented
1140,D00YXA,PMID25666693-Compound-2,Cancer related pain , Patented
1141,D00YXA,PMID25666693-Compound-2,Neuropathic pain , Patented
1142,D00YXA,PMID25666693-Compound-2,Inflammatory pain , Patented
1143,D00YXG,Anti-mesothelin CAR transduced PBL,Cervical cancer , Phase 1/2
1144,D00YXG,Anti-mesothelin CAR transduced PBL,Lung cancer , Phase 1/2
1145,D00YXG,Anti-mesothelin CAR transduced PBL,Mesothelioma , Phase 1/2
1146,D00YXG,Anti-mesothelin CAR transduced PBL,Ovarian cancer , Phase 1/2
1147,D00YXG,Anti-mesothelin CAR transduced PBL,Pancreatic cancer , Phase 1/2
1148,D00YXR,Foxy-5,Breast cancer , Investigative
1149,D00YXU,CCX-025,Crohn disease , Phase 1
1150,D00YZA,Thiotepa,Breast cancer , Approved
1151,D00YZD,Dolutegravir,Human immunodeficiency virus infection , Approved
1152,D00YZP,EBS-A42,Bacterial infection , Discontinued in Phase 1
1153,D00ZBQ,TL-1892,Solid tumour/cancer , Investigative
1154,D00ZBZ,OGX-427 + Paclitaxel,Lung cancer , Investigative
1155,D00ZBZ,OGX-427 + Paclitaxel,Prostate cancer , Investigative
1156,D00ZBZ,OGX-427 + Paclitaxel,Bladder cancer , Investigative
1157,D00ZBZ,OGX-427 + Paclitaxel,Ovarian cancer , Investigative
1158,D00ZBZ,OGX-427 + Paclitaxel,Breast cancer , Investigative
1159,D00ZCN,Caspofungin,Fungal infection , Approved
1160,D00ZCT,Fostemsavir,Human immunodeficiency virus infection , Approved
1161,D00ZDO,SELA-070,Tobacco dependence , Phase 1
1162,D00ZEG,Umespirone,Anxiety disorder , Phase 1
1163,D00ZEN,Seasonal influenza vaccine,Influenza virus infection , Phase 3
1164,D00ZFC,WilVent,Pulmonary disease , Investigative
1165,D00ZFP,Estrone,Menopausal and postmenopausal disorder , Approved
1166,D00ZFQ,H2N3 MO 2003/AA,Influenza virus infection , Phase 1
1167,D00ZGA,Casopitant,Chemotherapy-induced nausea , Withdrawn from market
1168,D00ZGE,Oncopurge,Solid tumour/cancer , Discontinued in Phase 2
1169,D00ZGF,DA-6886,Irritable bowel syndrome , Phase 1
1170,D00ZGT,MMR vaccine,Rubella prophylaxis , Phase 3
1171,D00ZGT,MMR vaccine,Mumps virus infection , Phase 3
1172,D00ZGT,MMR vaccine,Measles , Phase 3
1173,D00ZHM,Autologous adipose-derived stem cells,Anal fistula , Phase 2
1174,D00ZHR,Salmonella typhimurium A1-R,Solid tumour/cancer , Investigative
1175,D00ZKC,CS-92,Acquired immune deficiency syndrome , Discontinued in Phase 2
1176,D00ZLC,NeuroCell-PD,Parkinson disease , Phase 2
1177,D00ZMN,Fluorofenidone,Fibrosis , Investigative
1178,D00ZMU,P28 cell penetrating peptide,Solid tumour/cancer , Phase 1
1179,D00ZMU,P28 cell penetrating peptide,Central nervous system disease , Phase 1
1180,D00ZNP,HMR-1426,Obesity , Discontinued in Phase 2
1181,D00ZNS,CDE-5110,Inflammation , Terminated
1182,D00ZOF,Sodium lactate,Acidosis , Approved
1183,D00ZPR,Neucardin,Heart failure , Phase 3
1184,D00ZPR,Neucardin,Chronic heart failure , Phase 2
1185,D00ZPT,BI-11634,Thrombosis , Phase 1
1186,D00ZRO,Cyclic compound 3,Solid tumour/cancer , Patented
1187,D00ZRO,Cyclic compound 3,Infectious disease , Patented
1188,D00ZRO,Cyclic compound 3,Human immunodeficiency virus infection , Patented
1189,D00ZRO,Cyclic compound 3,Hepatitis , Patented
1190,D00ZRS,TARP peptide vaccines,Prostate cancer , Phase 1
1191,D00ZTD,OZ277,Malaria , Approved
1192,D00ZUU,ONO-5334,Osteoporosis , Discontinued in Phase 2
1193,D00ZVM,BAY1129980,Solid tumour/cancer , Phase 1
1194,D00ZVS,Condoliase,Herniation disk , Phase 3
1195,D00ZWE,AT-007,Autoimmune diabetes , Investigative
1196,D00ZWG,NS-638,Cerebrovascular ischaemia , Terminated
1197,D00ZXR,Heteroaryl-carboxamide derivative 3,Solid tumour/cancer , Patented
1198,D00ZXR,Heteroaryl-carboxamide derivative 3,Metastatic cancer , Patented
1199,D00ZZB,Oxaborole,Leishmania infection , Investigative
1200,D00ZZH,BK-218,Bacterial infection , Terminated
1201,D01AAH,CAR-T cells targeting CD22,Non-hodgkin lymphoma , Phase 2
1202,D01ACE,BF/PC-13,Dermatitis , Investigative
1203,D01ADH,Evitar,Wound healing , Phase 2
1204,D01ADL,Roledumab,Anemia , Phase 2/3
1205,D01AEF,3F8,Solid tumour/cancer , Phase 2
1206,D01AET,MPC-150-IM,Heart failure , Phase 3
1207,D01AFG,RG7414,Non-small-cell lung cancer , Discontinued in Phase 2
1208,D01AFG,RG7414,Colorectal cancer , Discontinued in Phase 2
1209,D01AHI,Dance-501,Type-1 diabetes , Phase 2
1210,D01AHI,Dance-501,Type-2 diabetes , Phase 2
1211,D01AHO,Abarelix,Prostate cancer , Approved
1212,D01AIM,HBsAG-HBIG complex,Hepatitis B virus infection , Phase 3
1213,D01AIN,Fezakinumab,Psoriasis vulgaris , Phase 2
1214,D01AJM,YP-009,Solid tumour/cancer , Terminated
1215,D01AJY,Baclofen,Multiple sclerosis , Approved
1216,D01AJY,Baclofen,Fragile X syndrome , Phase 3
1217,D01AKK,ALXN1101,Molybdenum cofactor deficiency , Phase 2/3
1218,D01AKU,MCP-201,Pain , Phase 1
1219,D01ALJ,BV-6481,Mycobacterium infection , Investigative
1220,D01ALP,MBC-31,Osteoporosis , Investigative
1221,D01ANE,"EB-1,2,3 mab",leukaemia , Investigative
1222,D01AQT,Terconazole,Candidiasis , Approved
1223,D01ARG,DB-900,Type-2 diabetes , Investigative
1224,D01ARU,DST-2970,Prostate cancer , Phase 1
1225,D01ASM,NPC-15199,Inflammation , Phase 2
1226,D01ATS,LEO-90110,Psoriasis vulgaris , Investigative
1227,D01AUL,L-697639,Human immunodeficiency virus infection , Discontinued in Phase 1
1228,D01AVF,SAR-106881,Peripheral arterial disease , Investigative
1229,D01AXB,Duloxetine,Depression , Approved
1230,D01AXK,Antibodie derivative 10,Neoplasm , Patented
1231,D01AXK,Antibodie derivative 10,Angiogenesis disorder , Patented
1232,D01AXT,NP-50301,Eye disorder , Discontinued in Phase 2
1233,D01AYF,ND-1.1,Influenza virus infection , Phase 1
1234,D01AYJ,Terbinafine,Fungal infection , Approved
1235,D01AYJ,Terbinafine,Onychomycosis , Phase 2
1236,D01AYP,Bromo benzyl ether derivative 1,Solid tumour/cancer , Patented
1237,D01AYP,Bromo benzyl ether derivative 1,Infectious disease , Patented
1238,D01AYP,Bromo benzyl ether derivative 1,Human immunodeficiency virus infection , Patented
1239,D01AYP,Bromo benzyl ether derivative 1,Hepatitis , Patented
1240,D01AYX,AZD3293,Alzheimer disease , Phase 2/3
1241,D01AZG,Risperidone,Schizophrenia , Approved
1242,D01AZP,BNC-105,Mesothelioma , Phase 2
1243,D01BAU,SPN-812,Attention deficit hyperactivity disorder , Phase 2
1244,D01BBB,VM-1500,Human immunodeficiency virus infection , Phase 2/3
1245,D01BBR,Dezinamide,Epileptic seizures , Discontinued in Phase 2
1246,D01BDY,Axomadol,Back pain , Phase 2
1247,D01BEX,PRS-060,Asthma , Investigative
1248,D01BFA,BIK-381,Retinitis pigmentosa , Investigative
1249,D01BGU,UX-002,Lysosomal storage disease , Investigative
1250,D01BHC,BTA-929,Influenza virus infection , Investigative
1251,D01BIQ,Human embryonic stem cell-derived motor neuron progenitors,Neuromuscular disease , Investigative
1252,D01BJK,Mimovax,Alzheimer disease , Investigative
1253,D01BJO,GABA mimetics,Neuropathic pain , Investigative
1254,D01BJS,HL-028,Asthma , Investigative
1255,D01BOD,Pro-Islet,Diabetic complication , Investigative
1256,D01BOE,44-Bu,Heart arrhythmia , Investigative
1257,D01BPF,Avitriptan,Migraine , Discontinued in Phase 3
1258,D01BPP,EC0225,Solid tumour/cancer , Phase 1
1259,D01BQC,Cefonicid,Bacterial infection , Approved
1260,D01BQJ,TCV-295,Hypertension , Terminated
1261,D01BQK,Carbamide peroxide,Ear disease , Approved
1262,D01BRD,SGN-CD123A,Acute myeloid leukaemia , Phase 1
1263,D01BRX,IMM-252,Human immunodeficiency virus infection , Investigative
1264,D01BUS,CA9-ADC,Solid tumour/cancer , Discontinued in Phase 1
1265,D01BUT,LXT-101,Prostate cancer , Investigative
1266,D01BVI,V-101,Erythema , Phase 2
1267,D01BWJ,Tyrophostins,Solid tumour/cancer , Investigative
1268,D01BYB,Adenosine triphosphate,Malnutrition , Approved
1269,D01BYB,Adenosine triphosphate,Heart disease , Phase 2
1270,D01BYB,Adenosine triphosphate,Bradycardia , Discontinued in Phase 2
1271,D01BZP,"Tuberculosis therapy, Ithemba",Mycobacterium infection , Investigative
1272,D01BZR,IC-041,Cognitive impairment , Investigative
1273,D01CAH,Mesenchymal stem cells,Epidermolysis bullosa , Approved
1274,D01CAH,Mesenchymal stem cells,Coronavirus Disease 2019 (COVID-19) , Phase 2
1275,D01CAJ,AZD-3342,Chronic obstructive pulmonary disease , Discontinued in Phase 1
1276,D01CBE,Ygalo,Multiple myeloma , Phase 2
1277,D01CBG,SRP-5051,Duchenne dystrophy , Phase 2
1278,D01CBK,OSE2101,Breast cancer , Phase 3
1279,D01CBK,OSE2101,Non-small-cell lung cancer , Phase 3
1280,D01CBU,FG-020318,Solid tumour/cancer , Investigative
1281,D01CBV,C-5997,Rheumatoid arthritis , Discontinued in Phase 1
1282,D01CDE,BIMU-1,Cognitive impairment , Phase 1
1283,D01CEG,P-1736,Diabetic complication , Phase 2
1284,D01CEQ,CER-227185,Acute myeloid leukaemia , Discontinued in Phase 1/2
1285,D01CFL,Benzothiazoline derivative 1,Albinism , Patented
1286,D01CFL,Benzothiazoline derivative 1,Ephelides , Patented
1287,D01CFL,Benzothiazoline derivative 1,Menkes disease , Patented
1288,D01CFL,Benzothiazoline derivative 1,Senile lentigines , Patented
1289,D01CFL,Benzothiazoline derivative 1,Melasma , Patented
1290,D01CFQ,LB-2.1,Fungal infection , Investigative
1291,D01CGV,LY-2599506,Diabetic complication , Phase 2
1292,D01CHD,RG6061,Solid tumour/cancer , Investigative
1293,D01CHI,VR315,Asthma , Approved
1294,D01CIB,SAR164653,Diabetic complication , Phase 1
1295,D01CIN,STF-62247,Renal cell carcinoma , Investigative
1296,D01CJB,Novovac-M1,Melanoma , Terminated
1297,D01CJY,FR-146687,Prostate disease , Phase 2
1298,D01CKY,Ecabet sodium,Ulcer , Approved
1299,D01CKY,Ecabet sodium,Xerophthalmia , Phase 2
1300,D01CLK,CHGN111,Skin infection , Investigative
1301,D01CNB,E6201,Psoriasis vulgaris , Phase 2
1302,D01CND,PMID26651364-Compound-114,Crohn disease , Patented
1303,D01CND,PMID26651364-Compound-114,Ulcerative colitis , Patented
1304,D01CND,PMID26651364-Compound-114,Urinary tract infection , Patented
1305,D01CNV,PL-611,Diabetic complication , Terminated
1306,D01COH,ZP-010,Bronchitis , Investigative
1307,D01CON,IGIV3I Grifols,Parkinson disease , Phase 3
1308,D01CQJ,KLS-HPV,Cervical cancer , Investigative
1309,D01CRB,L-Tyrosine,Malnutrition , Approved
1310,D01CTR,Plasminogen,Congenital plasminogen activator inhibitor type 1 deficiency , Phase 2/3
1311,D01CTR,Plasminogen,Hypoplasminogenemia , Phase 2/3
1312,D01CUC,BCMA CAR T cells,Multiple myeloma , Phase 1/2
1313,D01CUO,TTI-621,Melanoma , Phase 1
1314,D01CUO,TTI-621,Merkel cell carcinoma , Phase 1
1315,D01CUO,TTI-621,Mycosis fungoides , Phase 1
1316,D01CUO,TTI-621,Squamous cell carcinoma , Phase 1
1317,D01CUO,TTI-621,Haematological malignancy , Phase 1
1318,D01CUO,TTI-621,Solid tumour/cancer , Phase 1
1319,D01CXJ,PAC-113,Oral candidiasis , Phase 2
1320,D01CXW,MEDI0680,Solid tumour/cancer , Phase 1
1321,D01CYA,Bendamustine hydrochloride,leukaemia , Approved
1322,D01CYK,ME1100,Bacterial pneumonia , Phase 1
1323,D01CYT,ELND-002,Autoimmune diabetes , Phase 1
1324,D01CYW,PK-236,Parkinson disease , Investigative
1325,D01CZH,Chanllergen,Allergy , Approved
1326,D01DAD,CJ-13610,Asthma , Discontinued in Phase 2
1327,D01DAW,Bifeprunox,Schizophrenia , Discontinued in Phase 3
1328,D01DBF,APIT,Solid tumour/cancer , Investigative
1329,D01DBQ,Teniposide,Acute lymphoblastic leukaemia , Approved
1330,D01DCJ,GRNOPC-1,Spinal cord injury , Phase 1
1331,D01DDN,SCH-900271,Ischemic stroke , Phase 2
1332,D01DGN,Ethiodized oil,Lymphatic disease , Approved
1333,D01DGZ,ABBV-2222,Cystic fibrosis , Phase 2
1334,D01DIM,CLL442,Cutaneous squamous cell carcinoma , Phase 1/2
1335,D01DIM,CLL442,Squamous cell carcinoma , Phase 1/2
1336,D01DJA,TSK-204,Autoimmune diabetes , Terminated
1337,D01DJI,PHY-906,Hepatocellular carcinoma , Phase 2
1338,D01DLT,Encapsulated live cells converting ifosfamide,Pancreatic cancer , Phase 2
1339,D01DMT,Dendrogenin A,Solid tumour/cancer , Investigative
1340,D01DNH,PMID25666693-Compound-150,Osteoarthritis pain , Patented
1341,D01DNH,PMID25666693-Compound-150,Cancer related pain , Patented
1342,D01DNH,PMID25666693-Compound-150,Neuropathic pain , Patented
1343,D01DNH,PMID25666693-Compound-150,Inflammatory pain , Patented
1344,D01DOY,GR-127607,Migraine , Discontinued in Phase 1
1345,D01DPC,Ribavirin + interferon alfa-2b,Middle East Respiratory Syndrome (MERS) , Investigative
1346,D01DPD,KW-6055,Inflammation , Discontinued in Phase 1
1347,D01DQI,Parvovirus H-1,Glioblastoma multiforme , Investigative
1348,D01DQR,AIR-Epinephrine,Allergy , Discontinued in Phase 1
1349,D01DRE,SOM-0002,Solid tumour/cancer , Investigative
1350,D01DRL,RGH-2721,Psychotic disorder , Terminated
1351,D01DSP,Cephapirin,Sepsis , Approved
1352,D01DTO,AOB102,Eczema , Phase 2
1353,D01DTQ,PXS-2076,Rheumatoid arthritis , Terminated
1354,D01DVR,NT-001,Neuropathic pain , Investigative
1355,D01DVX,DPC-333,Rheumatoid arthritis , Terminated
1356,D01DVX,DPC-333,Inflammatory bowel disease , Terminated
1357,D01DXI,PF-06290510,Staphylococcus infection , Phase 2
1358,D01DXI,PF-06290510,Major depressive disorder , Phase 2
1359,D01EAG,MDDR 287569,Urinary incontinence , Investigative
1360,D01EBJ,4991W93,Migraine , Discontinued in Phase 2
1361,D01ECN,MVA-BN DF,Flavivirus infection , Preclinical
1362,D01EDJ,CSE-1034,Nosocomial infection , Phase 3
1363,D01EDO,GW-250495,Asthma , Discontinued in Phase 1
1364,D01EDS,SL-65.1498,Anxiety disorder , Discontinued in Phase 2
1365,D01EFO,CGP-53716,Solid tumour/cancer , Terminated
1366,D01EHI,Live attenuated H1N1 pandemic influenza vaccine,Influenza virus infection , Approved
1367,D01EJG,RG6100,Alzheimer disease , Phase 2
1368,D01EJJ,JTE-051,Plaque psoriasis , Phase 2
1369,D01EJJ,JTE-051,Allergy , Phase 1
1370,D01EKN,RAV-12,Solid tumour/cancer , Phase 2
1371,D01EKQ,"Ferrous Citrate, Fe-59",Iron deficiency , Approved
1372,D01ELU,VSN-16R,Muscle spasm , Phase 2
1373,D01EMD,Ovarian dendritic cell-based vaccine,Peritoneal cancer , Phase 1/2
1374,D01EMD,Ovarian dendritic cell-based vaccine,Ovarian cancer , Phase 1/2
1375,D01EPO,ABIO 09-01,Anxiety disorder , Investigative
1376,D01EPP,EL-715,Osteoporosis , Terminated
1377,D01EQG,Azapropazone,Inflammation , Withdrawn from market
1378,D01ERE,ASP4345,Cognitive impairment , Phase 2
1379,D01ESB,YM-992,Depression , Discontinued in Phase 2
1380,D01ESC,BBT-009,Anemia , Investigative
1381,D01ESJ,Luzindole,Sleep-wake disorder , Terminated
1382,D01EUF,BMS 275291,Kaposi sarcoma , Discontinued in Phase 3
1383,D01EUF,BMS 275291,Prostate cancer , Discontinued in Phase 3
1384,D01EUF,BMS 275291,Non-small-cell lung cancer , Discontinued in Phase 3
1385,D01EUO,Ragweed extract,Allergic rhinitis , Phase 3
1386,D01EVP,Resorcinol compound 17,Albinism , Patented
1387,D01EVP,Resorcinol compound 17,Ephelides , Patented
1388,D01EVP,Resorcinol compound 17,Menkes disease , Patented
1389,D01EVP,Resorcinol compound 17,Senile lentigines , Patented
1390,D01EVP,Resorcinol compound 17,Melasma , Patented
1391,D01EWC,CR-2991,Hypertension , Terminated
1392,D01EXG,AMG 224,Multiple myeloma , Phase 1
1393,D01EXL,RNF43-721,Colorectal cancer , Phase 2
1394,D01EXY,BN-AO-014,Atrophy , Preclinical
1395,D01EYI,Umbilical Cord Mesenchymal Stem Cells,Coronavirus Disease 2019 (COVID-19) , Phase 2
1396,D01EYM,BB-2275,Human immunodeficiency virus infection , Terminated
1397,D01EYR,ImmunoVEX-timelan,Melanoma , Phase 1/2
1398,D01EZA,EC-8042,Solid tumour/cancer , Investigative
1399,D01EZY,JTP-2724,Hypertension , Terminated
1400,D01FBO,H5N1 influenza vaccine,Influenza virus infection , Phase 1/2
1401,D01FBP,Vanutide cridificar,Alzheimer disease , Phase 2
1402,D01FBS,ALF-5755,Liver failure , Phase 2
1403,D01FCK,Teglicar,Diabetic complication , Discontinued in Phase 2
1404,D01FCY,Engineered hnCD16 iNK Cell,Coronavirus Disease 2019 (COVID-19) , Phase 1
1405,D01FDL,Dabelotine,Cognitive impairment , Phase 3
1406,D01FDN,NAL-GLU,Prostate cancer , Phase 2/3
1407,D01FEC,Rusalatide acetate,Diabetic foot ulcer , Discontinued in Phase 2
1408,D01FFA,(+-)-tetrahydropalmatine,Anxiety disorder , Approved
1409,D01FFA,(+-)-tetrahydropalmatine,Irritability , Approved
1410,D01FFA,(+-)-tetrahydropalmatine,Analgesia , Approved
1411,D01FFC,OPB-51602,Solid tumour/cancer , Phase 1
1412,D01FFG,Antistasin,Attention deficit hyperactivity disorder , Phase 2
1413,D01FGR,Diphenhydramine,Meniere disease , Approved
1414,D01FHL,AGN-150998,Macular degeneration , Phase 2
1415,D01FJA,UC-2024,Premenstrual syndrome , Investigative
1416,D01FJN,BAY-1006451,Arteriosclerosis , Investigative
1417,D01FJT,Bucillamine,Immune System disease , Approved
1418,D01FLN,LX-2932,Autoimmune diabetes , Terminated
1419,D01FME,HNK-20,Respiratory syncytial virus infection , Terminated
1420,D01FQR,Ocaperidone,Schizoaffective disorder , Phase 2
1421,D01FQR,Ocaperidone,Schizophrenia , Phase 2
1422,D01FQR,Ocaperidone,Idiopathic pulmonary fibrosis , Phase 2
1423,D01FQR,Ocaperidone,Type-2 diabetes , Phase 2
1424,D01FQR,Ocaperidone,Pancreatic cancer , Phase 2
1425,D01FQR,Ocaperidone,Diabetic nephropathy , Phase 1b
1426,D01FQV,Dichloroacetate sodium,Pulmonary hypertension , Phase 1
1427,D01FRK,LA-N8,Factor VIII deficiency , Investigative
1428,D01FRP,APC-0013,Solid tumour/cancer , Investigative
1429,D01FSX,REGN5093,Non-small-cell lung cancer , Phase 1
1430,D01FTK,PN-403,Alzheimer disease , Investigative
1431,D01FTU,EQ-317,Hepatitis C virus infection , Investigative
1432,D01FUB,AZD8529,Schizophrenia , Discontinued in Phase 2
1433,D01FUC,Exatecan,Solid tumour/cancer , Phase 3
1434,D01FUL,Balapiravir,Hepatitis C virus infection , Phase 1
1435,D01FWE,Certiva,Bordetella pertussis infection , Approved
1436,D01FWR,MPL-containing Pollinex allergy desensitization vaccine,Melanoma , Preregistration
1437,D01FXD,SCH-351591,Chronic obstructive pulmonary disease , Discontinued in Phase 1
1438,D01FYA,PU-H71,Solid tumour/cancer , Phase 1
1439,D01FYA,PU-H71,Breast cancer , Phase 1
1440,D01FYA,PU-H71,Myelofibrosis , Phase 1
1441,D01FYX,Andes-1537,Solid tumour/cancer , Phase 1
1442,D01FZX,LEO 22811,Psoriasis vulgaris , Phase 2
1443,D01FZZ,GDC0310,Chronic pain , Phase 1
1444,D01GAG,PV-921,Solid tumour/cancer , Investigative
1445,D01GAZ,123I-DRM-106,Alzheimer disease , Investigative
1446,D01GBV,CDD-190,Alzheimer disease , Investigative
1447,D01GBY,Desloratadine,Allergic rhinitis , Approved
1448,D01GCT,AZM-090,Diabetic complication , Terminated
1449,D01GCY,NNC-26-0762,Growth hormone deficiency , Terminated
1450,D01GDB,Tat Oyi-Cys22,Human immunodeficiency virus infection , Investigative
1451,D01GDH,XR-9051,Solid tumour/cancer , Discontinued in Phase 1
1452,D01GDO,Cytoporins,Respiratory tract infection , Preclinical
1453,D01GEB,ROXINDOLE,Psychotic disorder , Phase 2
1454,D01GEK,PMID25666693-Compound-133,Osteoarthritis pain , Patented
1455,D01GEK,PMID25666693-Compound-133,Cancer related pain , Patented
1456,D01GEK,PMID25666693-Compound-133,Neuropathic pain , Patented
1457,D01GEK,PMID25666693-Compound-133,Inflammatory pain , Patented
1458,D01GEO,Telomestatin,Multiple myeloma , Investigative
1459,D01GFU,ADCON(R),Wound healing , Discontinued in Phase 3
1460,D01GFX,OSI-906,Solid tumour/cancer , Phase 3
1461,D01GGB,SL-301,Solid tumour/cancer , Investigative
1462,D01GHV,RANBEZOLID HYDROCHLORIDE,Bacterial infection , Preclinical
1463,D01GIF,BM-113,Asthma , Discontinued in Phase 1
1464,D01GIG,RepliVec,Solid tumour/cancer , Investigative
1465,D01GIW,S3,Infectious disease , Investigative
1466,D01GNW,NGN-9076,Parkinson disease , Investigative
1467,D01GOY,AV-GBM-1,Glioblastoma of brain , Phase 2
1468,D01GPA,Gepon,Human immunodeficiency virus infection , Approved
1469,D01GQD,EZN-3042,Solid tumour/cancer , Phase 1
1470,D01GQO,"Mesenchymal stem cell therapy, ischemic-tolerant stem cells",Acute myocardial infarction , Phase 1
1471,D01GSA,C-0334578,Hepatitis virus infection , Investigative
1472,D01GSE,E-10030,Macular degeneration , Phase 2
1473,D01GTB,ZD-2767,Solid tumour/cancer , Discontinued in Phase 1
1474,D01GTC,TAK-041,XY disorder of sex development due to androgen resistance , Phase 1
1475,D01GUS,Udenafil,Erectile dysfunction , Approved
1476,D01GVC,GP-3269,Convulsion , Phase 1
1477,D01GVM,Lemuteporfin,Acne vulgaris , Phase 2
1478,D01GXB,Combinations SAR245409 / MSC1936369B SAR245408/SAR256212,Solid tumour/cancer , Phase 1
1479,D01GXL,REP8839,Bacterial infection , Phase 1
1480,D01GYK,Succimer,Metal intoxication , Approved
1481,D01GYT,Fosfomycin,Bacterial infection , Approved
1482,D01HAT,CD19.CAR-aNKT cells,B-cell small lymphocytic lymphoma , Phase 1
1483,D01HAT,CD19.CAR-aNKT cells,Chronic lymphocytic leukaemia , Phase 1
1484,D01HAT,CD19.CAR-aNKT cells,Myeloid leukaemia , Phase 1
1485,D01HAT,CD19.CAR-aNKT cells,Non-hodgkin lymphoma , Phase 1
1486,D01HBE,RHIZOXIN,Breast cancer , Discontinued in Phase 2
1487,D01HBG,Apadoline,Pain , Phase 2
1488,D01HDP,SLV 306,Acute decompensated heart failure , Phase 2
1489,D01HED,PMID25666693-Compound-158,Osteoarthritis pain , Patented
1490,D01HED,PMID25666693-Compound-158,Cancer related pain , Patented
1491,D01HED,PMID25666693-Compound-158,Neuropathic pain , Patented
1492,D01HED,PMID25666693-Compound-158,Inflammatory pain , Patented
1493,D01HEN,HBDt.Fc,Solid tumour/cancer , Investigative
1494,D01HFP,HL-160,Solid tumour/cancer , Investigative
1495,D01HGI,TGSC01AA(4),Anxiety disorder , Investigative
1496,D01HGT,Anti-CD22,Haematological malignancy , Phase 1
1497,D01HHD,Fovepta,Infectious disease , Phase 3
1498,D01HHH,CHR-4125,Solid tumour/cancer , Investigative
1499,D01HHJ,HTU-PA,Cerebrovascular ischaemia , Phase 1/2
1500,D01HJQ,Aminoazetidine derivative 1,Obesity , Patented
1501,D01HKL,ABT-335,Dyslipidemia , Approved
1502,D01HKZ,TSR-011,Non-small-cell lung cancer , Phase 1/2
1503,D01HLF,ATI-0810,Solid tumour/cancer , Investigative
1504,D01HLO,PF-05190457,Type-2 diabetes , Phase 1
1505,D01HNL,Allantoin,Vulnerary , Approved
1506,D01HOI,MT-503,Solid tumour/cancer , Investigative
1507,D01HOL,Autologous idiotypic cancer vaccine,Lymphoma , Phase 1
1508,D01HOT,X-072-NAB,Chronic obstructive pulmonary disease , Investigative
1509,D01HPI,DLX-0110,Neuropathic pain , Terminated
1510,D01HPP,ECFCs,Cardiovascular disease , Investigative
1511,D01HPY,Melphalan flufenamide,Multiple myeloma , Approved
1512,D01HPY,Melphalan flufenamide,Ovarian cancer , Phase 1/2
1513,D01HPY,Melphalan flufenamide,Plasma cell myeloma , Phase 1/2
1514,D01HQJ,Dialyzable leukocyte cells,Coronavirus Disease 2019 (COVID-19) , Phase 2
1515,D01HQQ,Bone morphogenetic protein-4,Glioblastoma multiforme , Investigative
1516,D01HQU,AK107,Solid tumour/cancer , Phase 1
1517,D01HRJ,JEBIK V,Japanese encephalitis virus infection , Approved
1518,D01HRR,Domitroban,Thrombosis , Discontinued in Preregistration
1519,D01HRU,SBR-759,Hypophosphatasia , Phase 3
1520,D01HSA,HG-1154,Cardiovascular disease , Investigative
1521,D01HTH,Aptiganel HCl,Ischemic stroke , Investigative
1522,D01HTJ,FG-65155,Reperfusion injury , Investigative
1523,D01HTL,Vinorelbine,Solid tumour/cancer , Approved
1524,D01HTS,MIP-1231,Solid tumour/cancer , Investigative
1525,D01HVC,MTD-102,Solid tumour/cancer , Investigative
1526,D01HVE,ICI-D-1542,Cardiovascular disease , Terminated
1527,D01HVM,99mTc-DI-DD3B6/22-80B3,Glioblastoma multiforme , Phase 2
1528,D01HVR,SAV-001,Human immunodeficiency virus-1 infection , Phase 1
1529,D01HVT,Ribociclib Succinate,Hormone receptor positive and HER2-negative advanced or metastatic breast cancer , Approved
1530,D01HVT,Ribociclib Succinate,Breast cancer , Approved
1531,D01HVZ,TD-8954,Gastrointestinal disease , Phase 2
1532,D01HVZ,TD-8954,Alzheimer disease , Phase 1/2
1533,D01HWK,AA-10044,Diabetic complication , Investigative
1534,D01HXA,AUS-131,Hot flushes , Phase 2
1535,D01HXA,AUS-131,Alzheimer disease , Phase 1/2
1536,D01HXN,TRL-382,Neuropathic pain , Investigative
1537,D01HYQ,IONIS-GCCRRX,Type-2 diabetes , Phase 2
1538,D01HZQ,VP-102,Molluscum contagiosum infection , Phase 3
1539,D01HZQ,VP-102,Common wart , Phase 2
1540,D01IBO,BCX-1470,Bleeding disorder , Discontinued in Phase 1
1541,D01ICI,Remdesivir,Coronavirus Disease 2019 (COVID-19) , Approved
1542,D01ICI,Remdesivir,Ebola virus infection , Phase 1
1543,D01ICU,Conjugated estrogens b,Hormone replacement therapy , Approved
1544,D01ICY,AVE-0657,Cheyne-stokes respiration , Phase 2
1545,D01IDE,E-5324,Hyperlipidaemia , Discontinued in Phase 2
1546,D01IDQ,IPH-1101,Lymphoma , Discontinued in Phase 2
1547,D01IDW,SKI-O-703,Rheumatoid arthritis , Phase 1
1548,D01IED,BVD-523,Melanoma , Phase 2
1549,D01IED,BVD-523,Solid tumour/cancer , Phase 1/2
1550,D01IED,BVD-523,Pancreatic cancer , Phase 1
1551,D01IEM,Pneumovax 23,Otitis media , Approved
1552,D01IGH,SERA5-targeted malaria vaccine,Malaria , Phase 1
1553,D01IGZ,Napabucasin,Pancreatic cancer , Phase 3
1554,D01IGZ,Napabucasin,Colorectal cancer , Phase 3
1555,D01IGZ,Napabucasin,Solid tumour/cancer , Phase 3
1556,D01IGZ,Napabucasin,Advanced malignancy , Phase 1/2
1557,D01IGZ,Napabucasin,Gastrointestinal cancer , Phase 1/2
1558,D01IGZ,Napabucasin,Hepatocellular carcinoma , Phase 1/2
1559,D01IGZ,Napabucasin,Recurring respiratory infection , Phase 1/2
1560,D01IGZ,Napabucasin,Recurrent glioblastoma , Phase 1/2
1561,D01IGZ,Napabucasin,Haematological malignancy , Phase 1
1562,D01IHR,AC-1202,Memory loss , Phase 2
1563,D01IHV,AD-0027,Solid tumour/cancer , Investigative
1564,D01IJJ,MV-NIS,Head and neck cancer , Phase 2
1565,D01IJJ,MV-NIS,Non-small-cell lung cancer , Phase 2
1566,D01IJJ,MV-NIS,Bladder cancer , Phase 1
1567,D01IJJ,MV-NIS,Medulloblastoma , Phase 1
1568,D01IJJ,MV-NIS,Urothelial carcinoma , Phase 1
1569,D01IJL,FR-182877,Solid tumour/cancer , Terminated
1570,D01IJM,LY3164530,Advanced cancer , Phase 1
1571,D01IJM,LY3164530,Solid tumour/cancer , Phase 1
1572,D01IKM,HB-adipose-derived mesenchymal stem cells,Coronavirus Disease 2019 (COVID-19) , Phase 2
1573,D01ILA,GNbAC-1,Multiple sclerosis , Phase 2
1574,D01ILJ,Celvapan,Influenza virus infection , Approved
1575,D01ILP,CNT0-3157,Asthma , Phase 1
1576,D01IMN,VLA15-101,Lyme disease , Phase 1
1577,D01IPI,Gemopatrilat,Hypotension , Discontinued in Phase 2
1578,D01IPT,AGS-v,Virus infection , Phase 1
1579,D01IRG,"Bictegravir, emtricitabine and tenofovir alafenamide",Human immunodeficiency virus infection , Approved
1580,D01IRW,Bermoprofen,Inflammation , Discontinued in Preregistration
1581,D01ISE,Bimakalim,Angina pectoris , Phase 2
1582,D01ITB,TV1001sr,Diabetic neuropathy , Phase 2
1583,D01ITB,TV1001sr,Peripheral arterial disease , Phase 2
1584,D01IUD,PRT-20,Duchenne dystrophy , Investigative
1585,D01IUS,Mapracorat,Ocular disease , Phase 3
1586,D01IVE,Lobeline,Substance use disorder , Phase 2
1587,D01IWJ,Fluticasone furoate/ fluticasone propionate,Asthma , Phase 3
1588,D01IWS,Inulin,Measure kidney function , Approved
1589,D01IXD,Finafloxacin,Urinary tract infection , Approved
1590,D01IYQ,TAK-201,Allergy , Discontinued in Phase 2
1591,D01IZE,Recombinant botulinum toxin vaccine,Yersinia infection , Phase 2
1592,D01JCT,CD19-CAR T Cells,Acute lymphoblastic leukaemia , Clinical trial
1593,D01JEI,F-50003,Parainfluenza virus infection , Terminated
1594,D01JEO,Brevenal,Cystic fibrosis , Investigative
1595,D01JEU,Memantine,Alzheimer disease , Approved
1596,D01JFM,AC-170,Allergic conjunctivitis , Phase 3
1597,D01JFT,Dipivefrin,Chronic open-angle glaucoma , Approved
1598,D01JGE,Netupitant/palonosetron,Chemotherapy-induced nausea , Phase 3
1599,D01JGG,Sodelglitazar,Hyperlipidaemia , Discontinued in Phase 2
1600,D01JGV,Ajmalicine,Circulatory disorder , Approved
1601,D01JHN,CR-3124,Substance use disorder , Terminated
1602,D01JIA,L-glutamine,Short bowel syndrome , Approved
1603,D01JIO,ZK-91587,Cardiovascular disease , Phase 2
1604,D01JKV,MK-8266,Essential hypertension , Phase 1
1605,D01JLH,RESP-3000,Cardiovascular disease , Investigative
1606,D01JLO,Tat-NR2B9c,Cerebrovascular ischaemia , Phase 3
1607,D01JLO,Tat-NR2B9c,Stroke , Phase 3
1608,D01JMC,Lorcaserin,Obesity , Approved
1609,D01JMC,Lorcaserin,Drug abuse , Phase 1
1610,D01JMX,INS-1,Metabolic disorder , Phase 2
1611,D01JNE,Lexibulin,Glioblastoma multiforme , Phase 2
1612,D01JOA,D-1927,Solid tumour/cancer , Discontinued in Phase 1
1613,D01JOJ,RX-77368,Dementia , Discontinued in Phase 2
1614,D01JPA,TRC102,Mesothelioma , Phase 2
1615,D01JPA,TRC102,Recurrent glioblastoma , Phase 2
1616,D01JPA,TRC102,Solid tumour/cancer , Phase 1
1617,D01JPJ,PTC-725,Hepatitis C virus infection , Investigative
1618,D01JQJ,Iodinated glycerol,Asthma , Approved
1619,D01JRF,SPD-453,Epilepsy , Terminated
1620,D01JSG,SBL-109,Escherichia coli infection , Investigative
1621,D01JSI,PF-06863135,Multiple myeloma , Phase 1
1622,D01JSO,VM-505,Breast cancer , Investigative
1623,D01JTL,KM-023,Human immunodeficiency virus infection , Phase 1
1624,D01JTW,PEV3A,Malaria , Phase 2
1625,D01JUF,Phentolamine,Dermal necrosis , Approved
1626,D01JWH,SAN-134,Osteoporosis , Phase 1
1627,D01JYT,INT-0022,Psychotic disorder , Phase 1
1628,D01KCE,BLB-750,Influenza virus infection , Registered
1629,D01KDM,GTP-004,Myasthenia gravis , Phase 1
1630,D01KER,ARX-8203,Pain , Investigative
1631,D01KGP,"IPL 550,260",Inflammation , Phase 1
1632,D01KHH,Cyclobenzaprine,Depression , Approved
1633,D01KHW,CZEN-002,Fungal infection , Phase 2
1634,D01KHX,Rilmakalim,Chronic obstructive pulmonary disease , Discontinued in Phase 1
1635,D01KIC,ORV-116E,Type-2 diabetes , Phase 3
1636,D01KIS,CGP-53437,Human immunodeficiency virus infection , Discontinued in Phase 1
1637,D01KIU,PRE-084,Aging skin , Terminated
1638,D01KIY,EPI-0031,Age-related macular degeneration , Investigative
1639,D01KJM,KST-401,Solid tumour/cancer , Investigative
1640,D01KJZ,Pyrazole derivative 4,Obesity , Patented
1641,D01KKB,PW-2101,Angina pectoris , Discontinued in Preregistration
1642,D01KKE,GW876008,Irritable bowel syndrome , Discontinued in Phase 2
1643,D01KKI,SGN-CD33A,Acute myeloid leukaemia , Phase 1/2
1644,D01KKM,House dust mite allergy vaccine,Allergic rhinitis , Terminated
1645,D01KKQ,Raltitrexed,Rectal adenocarcinoma , Approved
1646,D01KMR,Neramexane,Cancer related pain , Phase 2
1647,D01KMW,BMS-830216,Obesity , Phase 1
1648,D01KMY,MK-8342,Contraception , Phase 2
1649,D01KNA,Diamyd,Type-1 diabetes , Phase 3
1650,D01KNO,CTA1-3M2e-DD,Influenza virus infection , Investigative
1651,D01KNY,LCB-2183,Asthma , Phase 2
1652,D01KOA,Selpercatinib,Non-small-cell lung cancer , Approved
1653,D01KOA,Selpercatinib,Thyroid cancer , Approved
1654,D01KOA,Selpercatinib,Colon cancer , Phase 1/2
1655,D01KPS,IP-112,Solid tumour/cancer , Preregistration
1656,D01KPV,Fexofenadine,Allergic rhinitis , Approved
1657,D01KQA,Nalbuphine,Pain , Approved
1658,D01KQA,Nalbuphine,Prurigo nodularis , Phase 2/3
1659,D01KQA,Nalbuphine,Uremic pruritus , Phase 2/3
1660,D01KQW,ID-93/GLA-SE,Tuberculosis , Phase 2
1661,D01KRQ,EMC-0901,Diabetic complication , Investigative
1662,D01KSL,REGN3048 + REGN3051 mabs,Middle East Respiratory Syndrome (MERS) , Discontinued in Phase 1
1663,D01KSO,Synthetic peptide,Solid tumour/cancer , Investigative
1664,D01KTG,HDM201,Haematological malignancy , Phase 1
1665,D01KTG,HDM201,Liposarcoma , Phase 1
1666,D01KTG,HDM201,Solid tumour/cancer , Phase 1
1667,D01KTN,Cefcapene pivoxil,Bacterial infection , Approved
1668,D01KWB,AD-313,Chronic obstructive pulmonary disease , Terminated
1669,D01KWJ,VX-150,Neuropathic pain , Phase 2
1670,D01KWK,Hydroxychloroquine + azithromycin + ivermectin ,Coronavirus Disease 2019 (COVID-19) , Phase 1
1671,D01KXE,Influenza vaccine,Influenza virus infection , Phase 1
1672,D01KYG,INA-115E,Cytomegalovirus infection , Investigative
1673,D01KYP,APL-130277,Epilepsy , Phase 3
1674,D01KZC,Minopafant,Sepsis , Discontinued in Phase 2
1675,D01KZV,MIQ-004,Brain cancer , Investigative
1676,D01LAC,MOFEGILINE,Cognitive impairment , Discontinued in Phase 3
1677,D01LAP,ISIS 2922 + Ganciclovir,Virus infection , Investigative
1678,D01LAX,Poloxafuse-R,Ischemia , Investigative
1679,D01LBD,Haw-AD-14,Alzheimer disease , Investigative
1680,D01LBI,LIV-1205,Solid tumour/cancer , Investigative
1681,D01LCC,PF-4217903,Solid tumour/cancer , Phase 1
1682,D01LEO,LJJ-10,Solid tumour/cancer , Investigative
1683,D01LES,MEGF0444A,Non-small-cell lung cancer , Phase 2
1684,D01LES,MEGF0444A,Metastatic colorectal cancer , Phase 2
1685,D01LFA,ARX-201,Growth failure , Discontinued in Phase 2
1686,D01LFC,Mutant ras vaccine,Solid tumour/cancer , Phase 2
1687,D01LFH,Curmucin,Solid tumour/cancer , Phase 1
1688,D01LFN,S. mutans Replacement Therapy,Infectious disease , Phase 1
1689,D01LFQ,DWP-438,Solid tumour/cancer , Investigative
1690,D01LGQ,PMID25666693-Compound-103,Osteoarthritis pain , Patented
1691,D01LGQ,PMID25666693-Compound-103,Cancer related pain , Patented
1692,D01LGQ,PMID25666693-Compound-103,Neuropathic pain , Patented
1693,D01LGQ,PMID25666693-Compound-103,Inflammatory pain , Patented
1694,D01LMM,BLY719,Solid tumour/cancer , Phase 1
1695,D01LNG,Balicatib,Osteoporosis , Discontinued in Phase 2
1696,D01LNP,Samarium-153-DOTMP,Bone cancer , Investigative
1697,D01LOE,LY2963016,Type-1/2 diabetes , Phase 3
1698,D01LPK,MGX-006,Vomiting , Discontinued in Preregistration
1699,D01LPX,Linotroban,Thrombosis , Discontinued in Phase 2
1700,D01LQC,P45,Alopecia , Discontinued in Phase 2
1701,D01LQZ,TG-4023,Solid tumour/cancer , Discontinued in Phase 1
1702,D01LRH,Sibopirdine,Alzheimer disease , Terminated
1703,D01LRM,SBC-014,Neutropenia , Phase 2
1704,D01LSB,MEMP1972A,Allergic rhinitis , Phase 2
1705,D01LSB,MEMP1972A,Asthma , Phase 2
1706,D01LSY,Atovaquone + azithromycin,Coronavirus Disease 2019 (COVID-19) , Phase 2
1707,D01LUH,SP-30,Hepatitis C virus infection , Investigative
1708,D01LUS,Mesoglycan,Cerebrovascular disease , Approved
1709,D01LVE,CPI-0610,Myelofibrosis , Phase 3
1710,D01LVE,CPI-0610,Acute myeloid leukaemia , Phase 1/2
1711,D01LVE,CPI-0610,Myelodysplastic neoplasm , Phase 1/2
1712,D01LVE,CPI-0610,Myeloproliferative neoplasm , Phase 1/2
1713,D01LVM,PMA-BB10,Solid tumour/cancer , Investigative
1714,D01LWE,EGFRvIII CAR T cells,Glioblastoma multiforme , Phase 1
1715,D01LWE,EGFRvIII CAR T cells,Recurrent glioblastoma , Phase 1
1716,D01LWO,TM-601,Solid tumour/cancer , Phase 2
1717,D01LXD,Semagacestat,Parkinson disease , Phase 3
1718,D01LXG,KC-11425,Asthma , Terminated
1719,D01LXZ,DWJ-206,Stomach ulcer , Investigative
1720,D01LYX,Eptastigmine,Cognitive impairment , Phase 3
1721,D01LZB,Anti-HM1.24,Multiple myeloma , Investigative
1722,D01LZC,SDZ-GLI-328,Genetic disease , Terminated
1723,D01MAU,AZD-1446,Alzheimer disease , Phase 2
1724,D01MBM,LPO-1010DR,Diabetic retinopathy , Investigative
1725,D01MBV,SB-207266A,Irritable bowel syndrome , Phase 2
1726,D01MCB,HTERT plasmid DNA cancer vaccine,Solid tumour/cancer , Phase 1
1727,D01MDH,Conjugated stigmines,Central nervous system disease , Investigative
1728,D01MDT,Tizanidine,Spasm , Approved
1729,D01MDX,TRBC1,Anaplastic large cell lymphoma , Phase 1/2
1730,D01MDX,TRBC1,Angioimmunoblastic T-cell Lymphoma , Phase 1/2
1731,D01MDX,TRBC1,Non-hodgkin lymphoma , Phase 1/2
1732,D01MDX,TRBC1,Peripheral T-cell lymphoma , Phase 1/2
1733,D01MFA,Infusible platelet membrane,Bleeding disorder , Discontinued in Phase 2
1734,D01MFG,Cholera EPVaccine,Vibrio cholerae infection , Investigative
1735,D01MFK,DFU,Pain , Investigative
1736,D01MGA,Alatrofloxacin mesylate,Bacterial infection , Approved
1737,D01MGV,WC-3048,Female sexual arousal dysfunction , Phase 3
1738,D01MHI,Coluracetam,Alzheimer disease , Phase 2
1739,D01MHL,T-2307,Mycoses , Phase 1
1740,D01MHT,BBT-046,Solid tumour/cancer , Investigative
1741,D01MIP,SU5614,Airway inflammation , Terminated
1742,D01MJT,MGN-2677,Artery stenosis , Investigative
1743,D01MKD,Phenylalanine derivative 1,Glioma , Patented
1744,D01MMB,Extrothyroxine,Hyperlipoproteinemia , Approved
1745,D01MMG,BBT-015,Neutropenia , Investigative
1746,D01MML,MLN9708,Amyloidosis , Approved
1747,D01MML,MLN9708,Multiple myeloma , Approved
1748,D01MND,EU-C-001,Brain injury , Investigative
1749,D01MNK,BS-194,Solid tumour/cancer , Investigative
1750,D01MNV,HER-2VAX,Breast cancer , Discontinued in Phase 1
1751,D01MPE,S-2150,Angina pectoris , Phase 2
1752,D01MPX,PC-190723,Bacterial infection , Investigative
1753,D01MQH,Vepalimomab,Asthma , Discontinued in Phase 1/2
1754,D01MQP,SECTA belomycin,Solid tumour/cancer , Phase 1/2
1755,D01MSB,Hydroxychloroquine + azithromycin + tocilizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
1756,D01MSJ,Veronate,Bacterial infection , Discontinued in Phase 3
1757,D01MSP,PMID30107136-Compound-Example3,Solid tumour/cancer , Patented
1758,D01MSP,PMID30107136-Compound-Example3,Infectious disease , Patented
1759,D01MSP,PMID30107136-Compound-Example3,Human immunodeficiency virus infection , Patented
1760,D01MSP,PMID30107136-Compound-Example3,Hepatitis , Patented
1761,D01MSZ,RM-4865,Hepatitis B virus infection , Investigative
1762,D01MTY,Mefloquine + azithromycin,Coronavirus Disease 2019 (COVID-19) , Phase 2
1763,D01MUR,Brinzolamide,Open-angle glaucoma , Approved
1764,D01MUW,Antineoplaston AS2-1,Glioblastoma multiforme , Phase 2
1765,D01MVK,CV-787,Prostate cancer , Discontinued in Phase 2
1766,D01MVO,ARG201,Diffuse systemic sclerosis , Phase 2
1767,D01MVO,ARG201,Systemic sclerosis , Phase 2
1768,D01MWF,GTx-878,Prostate hyperplasia , Investigative
1769,D01MXG,GLP-1 receptor PAM,Non-insulin dependent diabetes , Investigative
1770,D01MXK,2PX,Pain , Phase 3
1771,D01MXV,Etilefrine,Cardiovascular disease , Withdrawn from market
1772,D01MYJ,WT-4869,leukaemia , Phase 1/2
1773,D01MYN,LY-2523199,Type-2 diabetes , Discontinued in Phase 2
1774,D01MZJ,LR3001,Myeloid leukaemia , Phase 2
1775,D01MZT,FGFR2-ADC,Solid tumour/cancer , Preclinical
1776,D01NAM,ELB-139,Anxiety disorder , Discontinued in Phase 2
1777,D01NAP,MM-151,Solid tumour/cancer , Phase 1
1778,D01NBX,RS-2135,Heart arrhythmia , Terminated
1779,D01NCC,Factor-VIIa-XTEN,Hemophilia , Investigative
1780,D01NCH,Lufironil,Liver cirrhosis , Phase 2
1781,D01NCS,TOL-463,Bacterial vaginosis , Phase 2
1782,D01NCS,TOL-463,Vaginal disease , Phase 1
1783,D01NDF,AVN 101,Anxiety disorder , Phase 2
1784,D01NDF,AVN 101,Alzheimer disease , Phase 2
1785,D01NDF,AVN 101,Cognitive impairment , Phase 2
1786,D01NDN,SNG-8006,Osteoporosis , Investigative
1787,D01NEC,GSK2141795,Lymphoma , Phase 2
1788,D01NEC,GSK2141795,Colorectal cancer , Phase 2
1789,D01NFK,FP-1069,Autoimmune diabetes , Investigative
1790,D01NGB,ADC-1001,Inflammation , Investigative
1791,D01NGH,Multi-envelope HIV vaccine,Human immunodeficiency virus infection , Phase 1
1792,D01NGT,RG-7185,Asthma , Discontinued in Phase 1
1793,D01NIR,Radotinib,leukaemia , Phase 3
1794,D01NJE,ED45,Acute respiratory distress syndrome , Investigative
1795,D01NJE,ED45,Myocardial reperfusion injury , Investigative
1796,D01NJE,ED45,Sepsis , Investigative
1797,D01NJI,Mepyramine maleate,Headache , Approved
1798,D01NJI,Mepyramine maleate,Allergy , Approved
1799,D01NJT,Esreboxetine,Fibromyalgia , Discontinued in Phase 2
1800,D01NJW,PMID26815044-Compound-31,Albinism , Patented
1801,D01NJW,PMID26815044-Compound-31,Ephelides , Patented
1802,D01NJW,PMID26815044-Compound-31,Menkes disease , Patented
1803,D01NJW,PMID26815044-Compound-31,Senile lentigines , Patented
1804,D01NJW,PMID26815044-Compound-31,Melasma , Patented
1805,D01NKF,LY-1-100,Melanoma , Investigative
1806,D01NKS,Mefloquine + azithromycin +  tocilizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
1807,D01NKW,P2B-001,Parkinson disease , Phase 3
1808,D01NLB,Ziconotide,Pain , Approved
1809,D01NLB,Ziconotide,Traumatic brain injury , Phase 1/2
1810,D01NMN,ALORACETAM,Cognitive impairment , Discontinued in Phase 2
1811,D01NNL,Phosphonate,leukaemia , Terminated
1812,D01NOI,IPH-1201,Hepatitis C virus infection , Investigative
1813,D01NPK,PTH-CBD,Osteoporosis , Investigative
1814,D01NQM,Lasmiditan,Migraine , Approved
1815,D01NSM,TST-10088,Solid tumour/cancer , Phase 1
1816,D01NTH,Ruthenium-based complexes,Solid tumour/cancer , Phase 2
1817,D01NTO,Meningitis B,Neisseria meningitis infection , Approved
1818,D01NTQ,SAR127963,Traumatic brain injury , Phase 1
1819,D01NTR,NTF-1836,Mycobacterium infection , Investigative
1820,D01NTX,Mifamurtide,Solid tumour/cancer , Approved
1821,D01NUG,GSK870086,Asthma , Discontinued in Phase 2
1822,D01NUR,ASTX660,Lymphoma , Phase 2
1823,D01NUR,ASTX660,Solid tumour/cancer , Phase 2
1824,D01NWV,Granexin gel,Diabetic foot ulcer , Phase 3
1825,D01NWV,Granexin gel,Radiation syndrome , Phase 3
1826,D01NWV,Granexin gel,Keloidal surgical scar , Phase 2
1827,D01NXF,Mydicar,Heart failure , Phase 2
1828,D01NXX,SAR-126119,Cerebrovascular ischaemia , Phase 1
1829,D01NYQ,Drug 2696274,Metachromatic leukodystrophy , Phase 2
1830,D01NZH,ABBV-323,Crohn disease , Phase 1
1831,D01NZT,Prohibitin-TP-01,Prostate cancer , Phase 1
1832,D01OBM,MEDl-559,Respiratory syncytial virus infection , Phase 1/2
1833,D01ODC,TA-106,Asthma , Investigative
1834,D01ODT,Sophorolipid isoforms,Solid tumour/cancer , Investigative
1835,D01ODU,BAY-35-3377,Otitis media , Phase 3
1836,D01OFY,LAS-31180,Heart failure , Terminated
1837,D01OGL,Technetium Tc-99m Red Blood Cell Kit,Radioactive tracer , Approved
1838,D01OGV,POL-6014,Cystic fibrosis , Phase 1
1839,D01OGV,POL-6014,Chronic obstructive pulmonary disease , Investigative
1840,D01OHD,AMXT-1501,Head and neck cancer , Investigative
1841,D01OIL,Gadobenate Dimeglumine,Schizophrenia , Approved
1842,D01OIR,AYX-1,Pain , Phase 2
1843,D01OKS,Axokine,Obesity , Discontinued in Phase 3
1844,D01OLO,AS602868,Multiple myeloma , Discontinued in Phase 1
1845,D01OML,IoGen,Pain , Discontinued in Phase 3
1846,D01OMM,DeltaFLU-LAIV,Influenza virus infection , Phase 2
1847,D01OMO,AdHSV-2,Herpes simplex virus infection , Investigative
1848,D01OMY,BHT-3034,Myasthenia gravis , Investigative
1849,D01OOQ,FP-253-GDEPT,Prostate cancer , Phase 1
1850,D01OPV,Selenomethionine Se-75,Diagnostic imaging , Approved
1851,D01OQQ,PMID30107136-Compound-Example50,Solid tumour/cancer , Patented
1852,D01OQQ,PMID30107136-Compound-Example50,Infectious disease , Patented
1853,D01OQQ,PMID30107136-Compound-Example50,Human immunodeficiency virus infection , Patented
1854,D01OQQ,PMID30107136-Compound-Example50,Hepatitis , Patented
1855,D01ORM,Mitonafide,Solid tumour/cancer , Discontinued in Phase 2
1856,D01OSN,Riferminogene pecaplasmid,Critical limb ischemia , Discontinued in Phase 3
1857,D01OUA,TJN-598,Glomerulonephritis , Terminated
1858,D01OUE,Betazole,Gastric secretory disorder , Approved
1859,D01OVV,OVI-117,Solid tumour/cancer , Investigative
1860,D01OWB,Immune globulin,Alzheimer disease , Approved
1861,D01OWB,Immune globulin,Immune System disease , Approved
1862,D01OWB,Immune globulin,Virus infection , Approved
1863,D01OWB,Immune globulin,Immunodeficiency , Approved
1864,D01OWB,Immune globulin,Bone marrow transplantation , Approved
1865,D01OWB,Immune globulin,Nervous system paraneoplastic or autoimmune disorders , Phase 3
1866,D01OWB,Immune globulin,Pediatric cancer , Phase 2
1867,D01OWB,Immune globulin,Bacillus anthracis infection , Phase 1
1868,D01OWJ,TG-1024,Solid tumour/cancer , Discontinued in Phase 1
1869,D01OXH,ASP-7035,Nocturia , Phase 2
1870,D01OXI,DTI-015,Liver cancer , Approved
1871,D01OXI,DTI-015,Brain cancer , Approved
1872,D01OYR,AZD-9343,Gastroesophageal reflux disease , Discontinued in Phase 1
1873,D01OYS,Cyclolignan picropodophyllin,Colorectal cancer , Phase 1
1874,D01OYX,N-acetylcysteine + fuzhenghuayu,Coronavirus Disease 2019 (COVID-19) , Phase 2
1875,D01PAR,Vitamin,Vitamin deficiency , Approved
1876,D01PBW,CB-839,Breast cancer , Phase 2
1877,D01PBW,CB-839,Renal cell carcinoma , Phase 2
1878,D01PBW,CB-839,Solid tumour/cancer , Phase 2
1879,D01PBW,CB-839,leukaemia , Phase 1
1880,D01PBX,Biphenyl mannoside derivative 6,Crohn disease , Patented
1881,D01PBX,Biphenyl mannoside derivative 6,Ulcerative colitis , Patented
1882,D01PBX,Biphenyl mannoside derivative 6,Urinary tract infection , Patented
1883,D01PCB,VALERGEN-DS,Asthma , Phase 2
1884,D01PCE,BCH-2687,Pain , Discontinued in Phase 2
1885,D01PFX,TDI-0065,Motor neurone disease , Investigative
1886,D01PGJ,PDM-08,Solid tumour/cancer , Phase 1
1887,D01PGR,SAR245409,Solid tumour/cancer , Phase 2
1888,D01PHK,PCL-016,Acne vulgaris , Phase 2
1889,D01PIL,Remoxipride,Schizophrenia , Withdrawn from market
1890,D01PJR,Tocainide,Ventricular arrhythmias , Approved
1891,D01PJZ,Cyclic peptidomimetic derivative 1,Solid tumour/cancer , Patented
1892,D01PJZ,Cyclic peptidomimetic derivative 1,Infectious disease , Patented
1893,D01PJZ,Cyclic peptidomimetic derivative 1,Human immunodeficiency virus infection , Patented
1894,D01PJZ,Cyclic peptidomimetic derivative 1,Hepatitis , Patented
1895,D01PKG,Fenofibrate/ simvastatin,Hyperlipidaemia , Phase 3
1896,D01PLH,7U85,Solid tumour/cancer , Discontinued in Phase 1
1897,D01PLJ,PMID25666693-Compound-58,Osteoarthritis pain , Patented
1898,D01PLJ,PMID25666693-Compound-58,Cancer related pain , Patented
1899,D01PLJ,PMID25666693-Compound-58,Neuropathic pain , Patented
1900,D01PLJ,PMID25666693-Compound-58,Inflammatory pain , Patented
1901,D01PLN,Cefalotin,Bacterial infection , Approved
1902,D01PLR,PF-04171327,Rheumatoid arthritis , Phase 2
1903,D01PNR,Gastrin 17C diphtheria toxoid conjugate,Pancreatic cancer , Investigative
1904,D01PQK,Ruxolitinib + simvastatin,Coronavirus Disease 2019 (COVID-19) , Phase 2
1905,D01PQM,Vaccinia immune globulin,Vaccination , Approved
1906,D01PRH,APX-009,Solid tumour/cancer , Investigative
1907,D01PSI,AM-3301,Allergic rhinitis , Discontinued in Phase 2
1908,D01PSY,SIG-005,Parkinson disease , Investigative
1909,D01PTS,VG-101,Menopause symptom , Phase 1/2
1910,D01PVV,KD3010,Obesity , Phase 1
1911,D01PVV,KD3010,Metabolic disorder , Phase 1
1912,D01PXH,NAM-NK cells + IL-2,Multiple myeloma , Phase 1
1913,D01PXH,NAM-NK cells + IL-2,Non-hodgkin lymphoma , Phase 1
1914,D01PYH,PANFLUVAC,Influenza virus infection , Phase 1
1915,D01PZD,Romiplostim,Thrombocytopenia , Approved
1916,D01PZD,Romiplostim,Multiple myeloma , Phase 2
1917,D01PZD,Romiplostim,Myelodysplastic syndrome , Phase 2
1918,D01PZJ,BDNA-002,Influenza virus infection , Investigative
1919,D01QAR,LY-221068,Arthritis , Terminated
1920,D01QCY,OBP-AI1,Hepatitis C virus infection , Investigative
1921,D01QGX,Lurasidone hydrochloride,Schizophrenia , Approved
1922,D01QIA,BL-1872,Pain , Terminated
1923,D01QIN,Atorvastatin,Cardiovascular disease , Approved
1924,D01QIV,Prostaview,Prostate cancer , Investigative
1925,D01QIX,Drug 2696275,Wiskott-Aldrich syndrome , Phase 2
1926,D01QKD,ATL-1101,Psoriatic disorder , Preclinical
1927,D01QKR,ALNESPIRONE,Anxiety disorder , Discontinued in Phase 2
1928,D01QKZ,ABT-413,Solid tumour/cancer , Phase 1
1929,D01QLH,Amyl nitrite,Angina pectoris , Approved
1930,D01QLM,AAB-002,Alzheimer disease , Phase 0
1931,D01QLP,Tarextumab,Pancreatic cancer , Phase 2
1932,D01QLP,Tarextumab,Small-cell lung cancer , Phase 2
1933,D01QMC,LAI338,Type-1 diabetes , Phase 2
1934,D01QMK,Denintuzumab mafodotin,Diffuse large B-cell lymphoma , Phase 2
1935,D01QML,Carphenazine,Insomnia , Approved
1936,D01QML,Carphenazine,Schizophrenia , Withdrawn from market
1937,D01QNJ,KD-501,Alzheimer disease , Investigative
1938,D01QNO,LM-13765,Hyperlipidaemia , Investigative
1939,D01QNR,PIM447,Myelofibrosis , Phase 1
1940,D01QQC,Hematopoietic stem cell gene therapy,Wiskott-Aldrich syndrome , Phase 1/2
1941,D01QQM,LAMIFIBAN,Angina pectoris , Discontinued in Phase 3
1942,D01QRF,IKS-04,Solid tumour/cancer , Investigative
1943,D01QRG,RPR 200765A,Rheumatoid arthritis , Terminated
1944,D01QSG,VTP-27999,Hypertension , Phase 1
1945,D01QSO,Buparlisib,Breast cancer , Phase 3
1946,D01QTD,GT-038,Retinitis pigmentosa , Investigative
1947,D01QTJ,XEN901,Epilepsy , Phase 1
1948,D01QUF,GW-3600,Asthma , Terminated
1949,D01QUS,Calcipotriol,Psoriasis vulgaris , Approved
1950,D01QWS,GM-CT-01,Solid tumour/cancer , Phase 1
1951,D01QWT,Ramucirumab,Hepatocellular carcinoma , Phase 3
1952,D01QWT,Ramucirumab,Non-small-cell lung cancer , Phase 3
1953,D01QWT,Ramucirumab,Bladder cancer , Phase 3
1954,D01QXS,RX-0201N,Solid tumour/cancer , Investigative
1955,D01QXW,CSL-324,Inflammation , Investigative
1956,D01QXY,B7-2/GM-CSF,Dementia , Phase 1
1957,D01QXY,B7-2/GM-CSF,Schizophrenia , Phase 1
1958,D01QXY,B7-2/GM-CSF,Dyslipidemia , Phase 1
1959,D01QXY,B7-2/GM-CSF,Solid tumour/cancer , Phase 1
1960,D01QYA,Diamine derivative 1,Albinism , Patented
1961,D01QYA,Diamine derivative 1,Ephelides , Patented
1962,D01QYA,Diamine derivative 1,Menkes disease , Patented
1963,D01QYA,Diamine derivative 1,Senile lentigines , Patented
1964,D01QYA,Diamine derivative 1,Melasma , Patented
1965,D01QYQ,ATL-844,Asthma , Investigative
1966,D01RAE,Sonepiprazole,Schizophrenia , Terminated
1967,D01RAN,LA-419,Cardiovascular disease , Phase 2
1968,D01RBK,Nisin,Bacillus anthracis infection , Terminated
1969,D01RBP,RE-024,Neurodegenerative disorder , Phase 3
1970,D01RBR,SGS742,Schizophrenia , Phase 2
1971,D01RCC,BMS-186318,Human immunodeficiency virus-1 infection , Terminated
1972,D01RCM,TAK-114,Ulcerative colitis , Phase 1
1973,D01RDR,AB569,Pseudomonas infection , Phase 1
1974,D01REE,DA-3031,Neutropenia , Phase 3
1975,D01REJ,VBY- 891,Autoimmune diabetes , Phase 1
1976,D01RFF,Etoxazole,Pest attack , Investigative
1977,D01RFI,Ro-24-0238,Sepsis , Terminated
1978,D01RHK,PMID26651364-Compound-5d,Crohn disease , Patented
1979,D01RHK,PMID26651364-Compound-5d,Ulcerative colitis , Patented
1980,D01RHK,PMID26651364-Compound-5d,Urinary tract infection , Patented
1981,D01RIT,Pyrazole derivative 20,Obesity , Patented
1982,D01RKQ,SDZ-280-446,Solid tumour/cancer , Terminated
1983,D01RKY,VAG-624,Acne vulgaris , Discontinued in Phase 1
1984,D01RLA,CYC-4068,Solid tumour/cancer , Investigative
1985,D01RLG,RTU-007,Diabetic cataract , Approved
1986,D01RLS,Allostrome,Arthropathy , Phase 1/2
1987,D01RLU,EG-016,Peripheral vascular disease , Discontinued in Phase 1/2
1988,D01RNF,ZG-451,Solid tumour/cancer , Investigative
1989,D01RNL,Lintuzumab,leukaemia , Discontinued in Phase 2
1990,D01RNV,AMT-011,Blood forming organ disorder , Phase 3
1991,D01RQN,DS-1971,Pain , Phase 1
1992,D01RQP,IGN002,Non-hodgkin lymphoma , Phase 1
1993,D01RQV,Eculizumab,Age-related macular degeneration , Approved
1994,D01RRF,STA-5312,Solid tumour/cancer , Phase 1
1995,D01RSK,CDP-146,Chronic obstructive pulmonary disease , Investigative
1996,D01RSW,Orazamide orotate,Solid tumour/cancer , Investigative
1997,D01RTO,Polyhydroxy benzamide derivative 4,Albinism , Patented
1998,D01RTO,Polyhydroxy benzamide derivative 4,Ephelides , Patented
1999,D01RTO,Polyhydroxy benzamide derivative 4,Menkes disease , Patented
2000,D01RTO,Polyhydroxy benzamide derivative 4,Senile lentigines , Patented
2001,D01RTO,Polyhydroxy benzamide derivative 4,Melasma , Patented
2002,D01RUK,PMID25666693-Compound-104,Osteoarthritis pain , Patented
2003,D01RUK,PMID25666693-Compound-104,Cancer related pain , Patented
2004,D01RUK,PMID25666693-Compound-104,Neuropathic pain , Patented
2005,D01RUK,PMID25666693-Compound-104,Inflammatory pain , Patented
2006,D01RVA,ADR-851,Nausea and vomiting , Phase 1
2007,D01RVS,AZD5985,Chronic obstructive pulmonary disease , Discontinued in Phase 1
2008,D01RXW,Vaniprevir,Hepatitis C virus infection , Phase 2
2009,D01RYJ,OP-02,Solid tumour/cancer , Investigative
2010,D01SAD,TT-115,Coagulation defect , Investigative
2011,D01SAK,TL-14077,Brain injury , Investigative
2012,D01SAT,Bevantolol,Hypertension , Approved
2013,D01SAV,Oshadi D,Solid tumour/cancer , Phase 2
2014,D01SAY,Sipuleucel-T,Prostate cancer , Approved
2015,D01SAY,Sipuleucel-T,Human immunodeficiency virus-1 infection , Phase 3
2016,D01SBC,TSRI-265,Solid tumour/cancer , Investigative
2017,D01SBP,Co-152791,Epilepsy , Terminated
2018,D01SCR,NPB-001-056,Chronic myelogenous leukaemia , Phase 1/2
2019,D01SEO,ICI-181037,Heart arrhythmia , Terminated
2020,D01SFN,IC9-GD2-CD28-OX40,Neuroblastoma , Phase 1
2021,D01SGK,Opicapone,Parkinson disease , Approved
2022,D01SGM,FK-906,Hypertension , Discontinued in Phase 2
2023,D01SHJ,E7046,Rectal adenocarcinoma , Phase 1
2024,D01SHZ,Rucaparib,Ovarian cancer , Approved
2025,D01SIB,MK-6349,Non-insulin dependent diabetes , Phase 1
2026,D01SJC,Transdur-sufentanil,Pain , Discontinued in Phase 2
2027,D01SJS,AXL-1717,Solid tumour/cancer , Phase 2
2028,D01SJT,PF-562271,Solid tumour/cancer , Phase 1
2029,D01SKR,Lamivudine /maraviroc/zidovudine fixed-dose combination,Human immunodeficiency virus infection , Phase 2
2030,D01SKT,IONIS-SOD111RX,Amyotrophic lateral sclerosis , Phase 2
2031,D01SNU,P-BCMA-ALL01,Multiple myeloma , Preclinical
2032,D01SNV,Recombinant human nerve growth factor,Neurotrophic keratitis , Phase 2
2033,D01SNZ,VTS-270,Niemann-pick disease , Phase 3
2034,D01SPD,BAY-85-3934,Anemia , Phase 2
2035,D01SPI,CGRP,Asthma , Discontinued in Phase 2
2036,D01SPJ,Litenimod,Glioblastoma multiforme , Phase 1
2037,D01SPW,VR647,Asthma , Phase 3
2038,D01SQI,POT-4,Macular degeneration , Phase 2
2039,D01SQP,HM-61713B,Solid tumour/cancer , Investigative
2040,D01SRB,AAV2-hRPE65v2,Ocular disease , Phase 3
2041,D01SSK,MTRN-2696,Solid tumour/cancer , Phase 1
2042,D01SSL,AT-027,Solid tumour/cancer , Investigative
2043,D01STB,Ramipril,Congestive heart failure , Approved
2044,D01SUF,GP-1200,Ulcerative colitis , Investigative
2045,D01SUL,JNJ-10397049,Insomnia , Investigative
2046,D01SUO,EBC-46,Solid tumour/cancer , Investigative
2047,D01SUY,BRU-83-92,Human immunodeficiency virus-1 infection , Investigative
2048,D01SVG,KA-10X,Solid tumour/cancer , Investigative
2049,D01SVO,EIDD-1931,Coronavirus Disease 2019 (COVID-19) , Investigative
2050,D01SWJ,AVP-13748,Autoimmune disease , Investigative
2051,D01SWK,Rafabegron,Type-2 diabetes , Discontinued in Phase 2
2052,D01SXE,F-18 T808,Alzheimer disease , Investigative
2053,D01SXG,ThermoStem,Metabolic disorder , Investigative
2054,D01SXH,CD20-CAR-T Cells,B-cell lymphoma , Phase 1
2055,D01SXY,NVB-302,Clostridium infection , Phase 1
2056,D01SXY,NVB-302,C. difficile infection , Phase 1
2057,D01SYU,Turofexorate isopropyl,Hyperlipidaemia , Phase 1
2058,D01SZA,MR-1817,Pain , Phase 1
2059,D01TAQ,NLP-44,Acne vulgaris , Investigative
2060,D01TBJ,CMX-2043,Myocardial reperfusion injury , Phase 2
2061,D01TBJ,CMX-2043,Cardiac disease , Phase 2
2062,D01TBL,HRGP,Solid tumour/cancer , Investigative
2063,D01TBN,Ezlopitant,Irritable bowel syndrome , Discontinued in Phase 2
2064,D01TBN,Ezlopitant,Vomiting , Discontinued in Phase 2
2065,D01TBN,Ezlopitant,Pain , Investigative
2066,D01TCM,CEE-03-320,Substance use disorder , Terminated
2067,D01TDY,Unacylated ghrelin,Type-1 diabetes , Phase 1
2068,D01TEA,DSC-127,Diabetic foot ulcer , Phase 3
2069,D01TGH,PF-572778,Generalized anxiety disorder , Terminated
2070,D01THN,JTT-654,Type-2 diabetes , Phase 2
2071,D01THX,Factor viii,Hemophilia , Approved
2072,D01TIN,R-1458,Non-insulin dependent diabetes , Terminated
2073,D01TJM,CTCE-9908,Sarcoma , Phase 1/2
2074,D01TJV,K-103-PA,Pain , Investigative
2075,D01TJY,GLPG-0187,Bone metastases , Phase 1
2076,D01TLV,EVT 401,Rheumatoid arthritis , Phase 1
2077,D01TMF,Latrodectus antivenin,Poison intoxication , Approved
2078,D01TMK,GX-G6,Diabetic complication , Investigative
2079,D01TMQ,Bupropion+naltrexone,Obesity , Phase 3
2080,D01TMW,Tradjeta,Type-2 diabetes , Phase 2
2081,D01TNK,CAR-T cells targeting EpCAM,Metastatic cancer , Phase 1
2082,D01TNK,CAR-T cells targeting EpCAM,Gastric adenocarcinoma , Phase 1
2083,D01TNW,Dapagliflozin,Type-2 diabetes , Approved
2084,D01TPU,AWD-160-275,Cardiovascular disease , Terminated
2085,D01TQR,Nonoxynol-9,Contraception , Approved
2086,D01TRU,NFTA-105,Cardiovascular disease , Investigative
2087,D01TSI,Ergotamine,Headache , Approved
2088,D01TVQ,Ibritumomab,Non-hodgkin lymphoma , Approved
2089,D01TVQ,Ibritumomab,Mantle cell lymphoma , Phase 2
2090,D01TVR,Tagatose,Cardiovascular disease , Discontinued in Phase 3
2091,D01TVT,FAS-115,Obesity , Investigative
2092,D01TWG,Rozanolixizumab,Myasthenia gravis , Phase 2
2093,D01TYB,Basulin,Diabetic complication , Discontinued in Phase 1
2094,D01UAD,PTX-022,Flavivirus infection , Phase 2
2095,D01UAM,Human and mouse gp100 DNA plasmid vaccines,Solid tumour/cancer , Phase 1
2096,D01UAU,CTP-543,Asthma , Phase 2
2097,D01UBV,DXL-1215,Endometriosis , Investigative
2098,D01UBX,Aclarubicin,Acute myeloid leukaemia , Approved
2099,D01UBY,JNJ-41443532,Type-2 diabetes , Phase 2
2100,D01UDR,Ro-25-0993,Bacterial infection , Terminated
2101,D01UDS,CNV-2197944,Pain , Phase 2
2102,D01UFK,ATX-MS-1467,Multiple sclerosis , Phase 2
2103,D01UFN,Falecalcitrol,Hyperparathyroidism , Approved
2104,D01UFZ,REL-1017,Neuropathic pain , Phase 1
2105,D01UGG,Sabarubicin,Solid tumour/cancer , Phase 2
2106,D01UHA,MIS-416,Autoimmune diabetes , Phase 2
2107,D01UHA,MIS-416,Bacillus anthracis infection , Investigative
2108,D01UHU,Pyriplatin,Solid tumour/cancer , Investigative
2109,D01UJK,AVE0897,Type-2 diabetes , Phase 1
2110,D01UJS,Rebelex,Acute myeloid leukaemia , Investigative
2111,D01UKK,PF-06760805,Streptococcus infection , Phase 2
2112,D01ULX,CC-0651,Solid tumour/cancer , Investigative
2113,D01UMT,Ro 31-7453,Solid tumour/cancer , Phase 2
2114,D01UNF,BAL-0019764,Gram-positive bacterial infection , Preclinical
2115,D01UNS,Thalidomide + hormones,Coronavirus Disease 2019 (COVID-19) , Phase 2
2116,D01UPT,FA-70,Major depressive disorder , Investigative
2117,D01UTL,Desipramine,Attention deficit hyperactivity disorder , Approved
2118,D01UTL,Desipramine,Depression , Approved
2119,D01UUD,Pitolisant,Excessive daytime sleepiness , Approved
2120,D01UUD,Pitolisant,Schizophrenia , Phase 3
2121,D01UUF,Rh-GDNF,Central nervous system disease , Investigative
2122,D01UUW,Trecetilide fumarate,Cardiac arrhythmias , Investigative
2123,D01UXC,Atenolol,Hypertension , Approved
2124,D01UXJ,Resminostat,Hepatocellular carcinoma , Phase 2
2125,D01UXP,LASSBio-294,Hypertension , Investigative
2126,D01UXW,Morphine-6-glucuronide,Pain , Phase 3
2127,D01UYA,MEDI1341,Parkinson disease , Phase 1
2128,D01UZH,IQP-0528,Human immunodeficiency virus infection , Investigative
2129,D01VAA,ACR-125,Keratosis , Investigative
2130,D01VAB,Alprenolol,Hypertension , Withdrawn from market
2131,D01VAP,YM-430,Hypertension , Phase 2
2132,D01VCB,ACH-2928,Hepatitis C virus infection , Discontinued in Phase 1
2133,D01VCE,Gadomelitol,Cardiovascular disease , Investigative
2134,D01VCW,MEN-10690,Human immunodeficiency virus-1 infection , Terminated
2135,D01VDI,AVI-5126,Coronary artery disease , Phase 2
2136,D01VEJ,Elapegademase,Adenosine deaminase defciency , Approved
2137,D01VEJ,Elapegademase,Immunodeficiency , Phase 3
2138,D01VEV,Cannabinoids,Schizophrenia , Investigative
2139,D01VFQ,CGEN-855,Inflammation , Investigative
2140,D01VHJ,Nitazoxanide,Diarrhea , Approved
2141,D01VHJ,Nitazoxanide,Coronavirus Disease 2019 (COVID-19) , Phase 3
2142,D01VJN,Olanzapine/fluoxetine combination,Depression , Approved
2143,D01VLT,ASP8232,Diabetic macular edema , Phase 2
2144,D01VLT,ASP8232,Diabetic nephropathy , Phase 1
2145,D01VMA,ITX-4520,Hepatitis C virus infection , Investigative
2146,D01VMO,Flutrimazole,Fungal infection , Approved
2147,D01VMZ,ARI-3037MO,Cardiovascular disease , Phase 2
2148,D01VMZ,ARI-3037MO,Hypertriglyceridemia , Phase 2
2149,D01VMZ,ARI-3037MO,Dyslipidemia , Phase 2
2150,D01VNL,JM-1232(-),Anaesthesia , Investigative
2151,D01VNQ,AEM-18,Familial hypercholesterolemia , Investigative
2152,D01VNT,COL-003,Myelodysplastic syndrome , Preregistration
2153,D01VOJ,RTI-4229-982,Neurological disorder , Investigative
2154,D01VPK,FK-453,Renal failure , Discontinued in Phase 2
2155,D01VPR,BBR-3438,Gastric adenocarcinoma , Discontinued in Phase 2
2156,D01VQA,VAL BRO 03,Psoriatic arthritis , Phase 3
2157,D01VQM,CHR-5154,Inflammation , Phase 1
2158,D01VRQ,BAY-1902607,Cough , Phase 2
2159,D01VSK,TR-14531,Asthma , Discontinued in Phase 1
2160,D01VSR,Hepatitis C immune globulin,Hepatitis C virus infection , Phase 3
2161,D01VTT,P-coumaric acid derivative 6,Albinism , Patented
2162,D01VTT,P-coumaric acid derivative 6,Ephelides , Patented
2163,D01VTT,P-coumaric acid derivative 6,Menkes disease , Patented
2164,D01VTT,P-coumaric acid derivative 6,Senile lentigines , Patented
2165,D01VTT,P-coumaric acid derivative 6,Melasma , Patented
2166,D01VUE,BMS-182874,Hypertension , Terminated
2167,D01VVL,PF-04523655,Diabetic macular edema , Phase 2
2168,D01VWB,IL-2/gene-modified lymphocytes,Ovarian cancer , Phase 1/2
2169,D01VWD,HTI-101,Obesity , Phase 2
2170,D01VWR,S-15261,Diabetic complication , Discontinued in Phase 2
2171,D01VZQ,LG-723,Melanoma , Investigative
2172,D01WBD,Mibampator,Alzheimer disease , Phase 2
2173,D01WBT,DYN-15,Blindness , Investigative
2174,D01WCL,SLV 354,Schizophrenia , Phase 1
2175,D01WCW,KPPF-1,Ulcerative colitis , Investigative
2176,D01WFI,VG-FLU,Influenza virus infection , Investigative
2177,D01WHC,Leuvectin,Melanoma , Phase 2
2178,D01WJL,Aminosalicylic Acid,Pulmonary and extrapulmonary tuberculosis , Approved
2179,D01WJL,Aminosalicylic Acid,Inflammatory bowel disease , Approved
2180,D01WJM,D-26344,Solid tumour/cancer , Terminated
2181,D01WKE,Semapimod,Inflammatory bowel disease , Phase 2
2182,D01WKE,Semapimod,Autoimmune diabetes , Phase 2
2183,D01WKZ,Citarinostat,Multiple myeloma , Phase 1
2184,D01WLB,Lu-AA39959,Bipolar disorder , Phase 2
2185,D01WLC,Metolazone,Edema , Approved
2186,D01WLC,Metolazone,Hypertension , Approved
2187,D01WLE,MC-1101,Diabetic retinopathy , Phase 2/3
2188,D01WMI,SP-1031C,Solid tumour/cancer , Investigative
2189,D01WMJ,Copper,Contraception , Approved
2190,D01WMO,Tularemia vaccine,Tularemia , Phase 1
2191,D01WMW,RG7232,Dyslipidemia , Investigative
2192,D01WOD,PF-4064900,Bacterial infection , Discontinued in Phase 1
2193,D01WQL,MPC-9528,Solid tumour/cancer , Investigative
2194,D01WQO,BIRT 2584,Psoriasis vulgaris , Discontinued in Phase 2
2195,D01WQQ,ABT-981,Osteoarthritis , Phase 2
2196,D01WSL,NPB-1,Non-insulin dependent diabetes , Investigative
2197,D01WTV,HDL-200,Attention deficit hyperactivity disorder , Phase 3
2198,D01WUA,Treprostinil,Pulmonary arterial hypertension , Approved
2199,D01WVJ,BIO-306,Migraine , Preclinical
2200,D01WWD,KPS-0373,Parkinson disease , Phase 3
2201,D01WWN,Pyrazole derivative 57,Obesity , Patented
2202,D01WXU,ZK-205367,Coronary artery disease , Phase 2/3
2203,D01WYO,Hydroxychloroquine + nitazoxanide,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
2204,D01WYT,ASP3550,Prostate cancer , Phase 3
2205,D01WYV,Angiostatin/paclitaxel/carboplatin,Lung cancer , Investigative
2206,D01WZG,Creatine ALS-08,Motor neurone disease , Phase 3
2207,D01WZL,AVE-8112,Parkinson disease , Phase 1
2208,D01XAE,PRX-12239,Neurological disorder , Investigative
2209,D01XAJ,CSL-425,Influenza virus infection , Approved
2210,D01XAR,AP-521,Anxiety disorder , Discontinued in Phase 2
2211,D01XBA,Raloxifene,Osteoporosis , Approved
2212,D01XCL,Veratrum Viride Root,High blood pressure , Approved
2213,D01XDL,Idarubicin,Acute myeloid leukaemia , Approved
2214,D01XDO,VSSP,Solid tumour/cancer , Phase 1/2
2215,D01XEC,Botulinum toxin recombinant vaccine,Botulism , Preclinical
2216,D01XEO,Debio-0824,Psoriasis vulgaris , Phase 1b/2a
2217,D01XEO,Debio-0824,Psoriatic arthritis , Phase 1
2218,D01XEQ,R348,Psoriasis vulgaris , Terminated
2219,D01XFZ,GPD-1116,Asthma , Phase 2
2220,D01XGX,JTP-4819,Cognitive impairment , Discontinued in Phase 2
2221,D01XHG,DENBUFYLLINE,Cognitive impairment , Phase 3
2222,D01XHU,AN-207,Solid tumour/cancer , Investigative
2223,D01XIF,Ivermectin + nitazoxanide,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
2224,D01XIK,Antimalarials,Malaria , Investigative
2225,D01XLM,Piperazine,Enterobiasis , Approved
2226,D01XLM,Piperazine,Ascariasis , Approved
2227,D01XMC,VTB-38543,Atopic dermatitis , Phase 2
2228,D01XMP,TG-D,Bone disease , Investigative
2229,D01XMS,ENT-103,Pain , Terminated
2230,D01XNB,Omeprazole,Gastroesophageal reflux disease , Approved
2231,D01XOD,Alpidem,Anxiety disorder , Approved
2232,D01XPG,CAN-296,Fungal infection , Terminated
2233,D01XPY,L-citrulline,Acute lung injury , Phase 3
2234,D01XQQ,TT-30,Autoimmune diabetes , Phase 1
2235,D01XRP,Simethicone,Dyspepsia , Approved
2236,D01XTN,Epaxal,Hepatitis A virus infection , Approved
2237,D01XUE,Tedatioxetine,Major depressive disorder , Phase 1
2238,D01XUE,Tedatioxetine,Generalized anxiety disorder , Phase 1
2239,D01XUG,ASP6432,Lower urinary tract symptom , Discontinued in Phase 1
2240,D01XVF,Sirukumab,Rheumatoid arthritis , Phase 3
2241,D01XVF,Sirukumab,Cutaneous lupus erythematosus , Phase 3
2242,D01XVF,Sirukumab,Giant cell arteritis , Phase 3
2243,D01XVF,Sirukumab,Major depressive disorder , Phase 2
2244,D01XVK,Pyrazoline derivative 2,Obesity , Patented
2245,D01XVX,CC-220,Sarcoidosis , Phase 2
2246,D01XVX,CC-220,Systemic lupus erythematosus , Phase 2
2247,D01XVX,CC-220,Multiple myeloma , Phase 1
2248,D01XWG,Daunorubicin,Acute myeloid leukaemia , Approved
2249,D01XWG,Daunorubicin,Kaposi sarcoma , Approved
2250,D01XWG,Daunorubicin,Solid tumour/cancer , Phase 2
2251,D01XXF,Modified SDF-1,Cardiovascular disease , Investigative
2252,D01XYJ,Zidovudine,Human immunodeficiency virus infection , Approved
2253,D01XYJ,Zidovudine,Virus infection , Investigative
2254,D01XZG,G1T28-1,Solid tumour/cancer , Phase 1
2255,D01YCF,4SCAR-GD2,Tumour , Phase 1/2
2256,D01YCX,YJRN-0904,Hyperlipidaemia , Investigative
2257,D01YDF,Pibutidine,Ulcerative colitis , Discontinued in Phase 3
2258,D01YDH,GSK2981710,Alzheimer disease , Phase 1
2259,D01YFR,DWJ-205,Fungal infection , Investigative
2260,D01YGD,ICO-25,Breast cancer , Phase 2
2261,D01YGF,KF-15570,Asthma , Terminated
2262,D01YGY,UC-1011,Alzheimer disease , Investigative
2263,D01YHL,DasKloster 0039-01,Asbestosis , Investigative
2264,D01YHO,WP-1122,Glioma , Investigative
2265,D01YIF,PAC1,Anaplastic astrocytoma , Phase 1
2266,D01YIF,PAC1,Recurrent glioblastoma , Phase 1
2267,D01YIO,JNJ-10311795,Chronic obstructive pulmonary disease , Phase 2
2268,D01YJR,IVN-birch,Allergic rhinitis , Investigative
2269,D01YKI,ANX-510,Pancreatic cancer , Phase 3
2270,D01YKR,FCR001,Organ transplant rejection , Phase 2
2271,D01YLA,NP-432,Respiratory tract infection , Investigative
2272,D01YLF,PTI-701,Pain , Discontinued in Phase 2
2273,D01YLK,Meningitis ACYW conj.,Meningitis , Phase 1
2274,D01YOC,BMS-181100,Psychotic disorder , Discontinued in Phase 3
2275,D01YQH,GM-CSF,Neurological disorder , Approved
2276,D01YQN,Levamisole Pill + Budesonide+Formoterol inhaler,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
2277,D01YSH,DV-7021,Liver disease , Terminated
2278,D01YSU,AG-PPC709,Respiratory disease , Investigative
2279,D01YTX,CBLC-4H10,Solid tumour/cancer , Investigative
2280,D01YVT,Colesevelam,Hypercholesterolaemia , Approved
2281,D01YVZ,GLYX-13,Major depressive disorder , Phase 3
2282,D01YYP,Margetuximab,HER2-positive breast cancer , Approved
2283,D01YYP,Margetuximab,Gastrointestinal cancer , Phase 2
2284,D01YYP,Margetuximab,Gastric adenocarcinoma , Phase 2
2285,D01YZF,CART-BCMA,Multiple myeloma , Phase 1
2286,D01ZAQ,AZD5363,Triple negative breast cancer , Phase 3
2287,D01ZAQ,AZD5363,Solid tumour/cancer , Phase 2
2288,D01ZBF,E-1224,Fungal infection , Phase 2
2289,D01ZCC,PMID26815044-Compound-118,Albinism , Patented
2290,D01ZCC,PMID26815044-Compound-118,Ephelides , Patented
2291,D01ZCC,PMID26815044-Compound-118,Menkes disease , Patented
2292,D01ZCC,PMID26815044-Compound-118,Senile lentigines , Patented
2293,D01ZCC,PMID26815044-Compound-118,Melasma , Patented
2294,D01ZCL,ACT-N,Brain injury , Preclinical
2295,D01ZDQ,ACH-1095,Hepatitis C virus infection , Investigative
2296,D01ZDR,FR-208419,Dyspepsia , Terminated
2297,D01ZEC,Cefacetrile,Bacterial infection , Approved
2298,D01ZEY,MDL-201112,Colitis , Terminated
2299,D01ZFK,Tuberculosis recombinant vaccine,Tuberculosis , Phase 2
2300,D01ZFM,LNK-3248,Alzheimer disease , Investigative
2301,D01ZGH,JTK-853,Hepatitis C virus infection , Discontinued in Phase 1
2302,D01ZGS,TGN-208,Solid tumour/cancer , Investigative
2303,D01ZHB,Revusiran,Amyloidosis , Phase 3
2304,D01ZHQ,MIM-A2,Glaucoma/ocular hypertension , Investigative
2305,D01ZII,Chlorpromazine,Schizophrenia , Approved
2306,D01ZJB,Autologous bone marrow-derived mesenchymal stem cells,Lateral sclerosis , Phase 1
2307,D01ZJK,Ardeparin,Venous thrombosis , Approved
2308,D01ZJK,Ardeparin,Deep vein thrombosis , Approved
2309,D01ZJK,Ardeparin,Thrombosis , Phase 3
2310,D01ZJK,Ardeparin,Venous thromboembolism , Phase 3
2311,D01ZJM,R-1479,Hepatitis C virus infection , Discontinued in Phase 1
2312,D01ZJP,Lopinavir + ritonavir + hydoxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
2313,D01ZKE,Biaryl mannoside derivative 21,Crohn disease , Patented
2314,D01ZKE,Biaryl mannoside derivative 21,Ulcerative colitis , Patented
2315,D01ZKE,Biaryl mannoside derivative 21,Urinary tract infection , Patented
2316,D01ZLI,CBR-2092,Bacterial infection , Terminated
2317,D01ZLK,APX005M,Melanoma , Phase 2
2318,D01ZLK,APX005M,Solid tumour/cancer , Phase 1
2319,D01ZLK,APX005M,Brain cancer , Phase 1
2320,D01ZLK,APX005M,Chronic lymphocytic leukaemia , Investigative
2321,D01ZLL,Aom-0755,Bacterial infection , Investigative
2322,D01ZLR,PF-05082566,Non-hodgkin lymphoma , Phase 1
2323,D01ZLR,PF-05082566,Solid tumour/cancer , Phase 1
2324,D01ZLU,TAS-120,Cholangiocarcinoma , Phase 3
2325,D01ZLU,TAS-120,Multiple myeloma , Phase 1/2
2326,D01ZLU,TAS-120,Solid tumour/cancer , Phase 1/2
2327,D01ZMR,Calcineurin,T-cell mediated immune dysfunction , Investigative
2328,D01ZMS,PK1,Solid tumour/cancer , Phase 2
2329,D01ZNH,IDAZOXAN HYDROCHLORIDE,Neurological disorder , Phase 3
2330,D01ZNQ,TMC-310911,Human immunodeficiency virus infection , Phase 2
2331,D01ZOB,Terguride,Pulmonary arterial hypertension , Phase 2
2332,D01ZOG,Difluprednate,Ocular pain , Approved
2333,D01ZPK,BA-207,Cardiovascular disease , Investigative
2334,D01ZPT,ACTR087,Non-hodgkin lymphoma , Phase 1
2335,D01ZPY,FMP2.1/AS02A,Malaria , Phase 2
2336,D01ZQE,Metenkefalin + tridecactide,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
2337,D01ZQN,ALD-306,Cardiovascular disease , Investigative
2338,D01ZRI,Axitinib,Renal cell carcinoma , Approved
2339,D01ZSO,Moclobemide,Depression , Approved
2340,D01ZSO,Moclobemide,Skin imperfections , Patented
2341,D01ZSP,AAB-003/PF-05236812,Alzheimer disease , Phase 1
2342,D01ZUA,Coenzyme Q10,Cerebrovascular ischaemia , Phase 4
2343,D01ZUA,Coenzyme Q10,Solid tumour/cancer , Phase 2
2344,D01ZUA,Coenzyme Q10,Squamous cell carcinoma , Phase 2
2345,D01ZUA,Coenzyme Q10,Pancreatic tumour , Phase 2
2346,D01ZUA,Coenzyme Q10,Epidermolysis bullosa , Phase 1
2347,D01ZUA,Coenzyme Q10,Recurrent glioblastoma , Phase 1
2348,D01ZUV,GDC-0425,Lymphoma , Phase 1
2349,D01ZVK,SCD-211,Diabetic complication , Investigative
2350,D01ZWC,RPH-104 + olokizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
2351,D01ZWF,BPI-711001,Hypoglycemia , Investigative
2352,D01ZXW,Lintitript,Obesity , Discontinued in Phase 2
2353,D01ZXW,Lintitript,Pancreatic cancer , Discontinued in Phase 2
2354,D01ZYG,Alemtuzumab,Chronic lymphocytic leukaemia , Approved
2355,D01ZYG,Alemtuzumab,Multiple sclerosis , Approved
2356,D01ZZG,INV-311,Inflammation , Investigative
2357,D02AAD,Biaryl mannoside derivative 31,Crohn disease , Patented
2358,D02AAD,Biaryl mannoside derivative 31,Ulcerative colitis , Patented
2359,D02AAD,Biaryl mannoside derivative 31,Urinary tract infection , Patented
2360,D02AAO,AZD-4877,Acute myeloid leukaemia , Phase 2
2361,D02ABS,BMS-180560,Hypertension , Terminated
2362,D02ADC,SDZ-MKS-492,Asthma , Phase 1
2363,D02ADJ,Apolipoprotein E,Glaucoma/ocular hypertension , Terminated
2364,D02ADM,Silibinin,Hepatic failure , Phase 2/3
2365,D02AEI,BM-13.1196,Diabetic complication , Terminated
2366,D02AEW,Xenon Xe-127,Diagnostic imaging , Approved
2367,D02AIM,Metoprine,Advanced cancer , Phase 2
2368,D02AIN,AZD5718,Coronary artery disease , Phase 2
2369,D02AIZ,BIL010t,Solid tumour/cancer , Phase 1/2
2370,D02AIZ,BIL010t,Alzheimer disease , Phase 1/2
2371,D02ALD,NOLOMIROLE HYDROCHLORIDE,Heart failure , Discontinued in Phase 3
2372,D02ALZ,ONO-3307,Coagulation defect , Phase 2
2373,D02AMG,HGS-1029,Haematological malignancy , Phase 1
2374,D02AMG,HGS-1029,Solid tumour/cancer , Phase 1
2375,D02ANJ,NZ-107,Asthma , Discontinued in Phase 1
2376,D02ANO,LY-2393910,Non-insulin dependent diabetes , Phase 1
2377,D02AOD,HF-0220,Alzheimer disease , Phase 2
2378,D02AQL,AT-003,Solid tumour/cancer , Investigative
2379,D02AQM,VAR-10300,Neurodegenerative disorder , Investigative
2380,D02AQY,Actarit,Immune System disease , Approved
2381,D02ARR,Dehydrocholic acid,Constipation , Approved
2382,D02AUB,Bimosiamose,Atopic dermatitis , Phase 2a
2383,D02AUB,Bimosiamose,Psoriatic disorder , Phase 2a
2384,D02AUB,Bimosiamose,Chronic obstructive pulmonary disease , Phase 2a
2385,D02AUB,Bimosiamose,Asthma , Phase 2
2386,D02AUI,Technetium Tc-99m Mebrofenin Kit,Radioactive tracer , Approved
2387,D02AUY,MERS-five-helix bundle,Middle East Respiratory Syndrome (MERS) , Preclinical
2388,D02AVC,BMS-820132,Type-2 diabetes , Phase 1
2389,D02AWB,MERS-CoV-SDNA vaccine,Middle East Respiratory Syndrome (MERS) , Investigative
2390,D02AWQ,AZD1419,Asthma , Phase 1
2391,D02AXG,Testosterone undecanoate,Hypogonadism , Approved
2392,D02AXS,GSK406725,Epilepsy , Terminated
2393,D02AYL,Pretomanid,Tuberculosis , Approved
2394,D02AYL,Pretomanid,Mycobacterium infection , Phase 3
2395,D02BAA,Patient-derived CD19- and CD22 specific CAR,leukaemia , Phase 1
2396,D02BAA,Patient-derived CD19- and CD22 specific CAR,Lymphoma , Phase 1
2397,D02BAE,Synthetic conjugated estrogen,Vaginal disease , Phase 3
2398,D02BAW,MK-6325,Hepatitis C virus infection , Phase 1
2399,D02BBC,CL-329167,Hypertension , Phase 2
2400,D02BCY,CD19 CART,B-cell lymphoma , Phase 1/2
2401,D02BDL,Dibenzoylmethane,Solid tumour/cancer , Investigative
2402,D02BGL,DHAC,Mesothelioma , Discontinued in Phase 2
2403,D02BGU,Pyrido/pyrrolo-fused pyrimidine derivative 1,Pain , Patented
2404,D02BGZ,AXP-107-17,Radiation syndrome , Investigative
2405,D02BHP,Nacolomab tafenatox,Colorectal cancer , Terminated
2406,D02BHW,IM19 CAR-T,leukaemia , Phase 1/2
2407,D02BIY,DCVax-Direct,Solid tumour/cancer , Phase 1/2
2408,D02BJN,Human liver progenitor cells,Liver cirrhosis , Investigative
2409,D02BLD,Oprozomib,Hodgkin lymphoma , Phase 2
2410,D02BLD,Oprozomib,Haematological malignancy , Phase 1/2
2411,D02BLD,Oprozomib,Multiple myeloma , Phase 1
2412,D02BLD,Oprozomib,Solid tumour/cancer , Preclinical
2413,D02BLO,Oxilan iohexol,Vascular disease , Approved
2414,D02BMJ,ND-601,Mycobacterium infection , Investigative
2415,D02BPX,NGM 282,Type-2 diabetes , Phase 2
2416,D02BPX,NGM 282,Primary biliary cirrhosis , Phase 2
2417,D02BQE,E7820,Solid tumour/cancer , Phase 2
2418,D02BQE,E7820,Colorectal cancer , Phase 2
2419,D02BRJ,Vabicaserin,Psychotic disorder , Phase 2
2420,D02BTZ,Twinrix,Hepatitis B virus infection , Approved
2421,D02BVQ,TGC-9,Solid tumour/cancer , Investigative
2422,D02BVW,FF-10501-01,Acute myeloid leukaemia , Phase 1/2
2423,D02BVW,FF-10501-01,Chronic myelogenous leukaemia , Phase 1/2
2424,D02BVW,FF-10501-01,Myelodysplastic syndrome , Phase 1/2
2425,D02BVW,FF-10501-01,Haematological malignancy , Phase 1/2
2426,D02BWY,JNJ-64041757,Lung cancer , Phase 1/2
2427,D02BWY,JNJ-64041757,Non-small-cell lung cancer , Phase 1
2428,D02BYZ,ASP8273,Non-small-cell lung cancer , Phase 2
2429,D02CAF,NOX-H94,Anemia , Phase 2
2430,D02CBD,J-30,Solid tumour/cancer , Investigative
2431,D02CCA,GSK-172981,Asthma , Investigative
2432,D02CEO,SND-226,Toxoplasmosis , Investigative
2433,D02CFP,Citicoline,Cerebrovascular ischaemia , Approved
2434,D02CFR,GW-559768X,Solid tumour/cancer , Investigative
2435,D02CFV,Solubilized type 1 native bovine collagen,Scleroderma , Phase 2
2436,D02CGC,Sorbinil,Diabetic cataract , Terminated
2437,D02CGY,Bifemelane,Alzheimer disease , Terminated
2438,D02CII,Abaloparatide,Postmenopausal osteoporosis , Approved
2439,D02CJA,CM-2236,Post-traumatic stress disorder , Preclinical
2440,D02CJX,Desoxycorticosterone Acetate,Discovery agent , Approved
2441,D02CKG,Diltiazem + niclosamide,Coronavirus Disease 2019 (COVID-19) , Phase 3
2442,D02CKH,OPI-1002,Acute kidney injury , Phase 2
2443,D02CKO,Anoro,Chronic obstructive pulmonary disease , Approved
2444,D02CKX,Carbimazole,Hyperthyroidism , Approved
2445,D02CLV,AdCh63 AMA1,Malaria , Phase 1/2
2446,D02CND,KI-0901,Solid tumour/cancer , Investigative
2447,D02CNR,Anecortave acetate,Macular degeneration , Approved
2448,D02COS,IdB-1016,Liver disease , Phase 2
2449,D02CPP,Vonoprazan,Helicobacter infection , Approved
2450,D02CPP,Vonoprazan,Gastroesophageal reflux disease , Phase 3
2451,D02CQL,Adyvia,Type-2 diabetes , Discontinued in Phase 2
2452,D02CRM,KI-0907,Obesity , Investigative
2453,D02CTS,Ospemifene,Dyspareunia , Approved
2454,D02CTS,Ospemifene,Postmenopausal vaginal atrophy , Phase 3
2455,D02CTZ,LY433221,Depression , Investigative
2456,D02CUN,NM504,Diabetic complication , Phase 1
2457,D02CUN,NM504,Type-2 diabetes , Phase 0
2458,D02CVF,SynGEM,Respiratory syncytial virus infection , Investigative
2459,D02CWZ,AMBAZONE,Solid tumour/cancer , Investigative
2460,D02CXA,LG-912,Hepatitis C virus infection , Investigative
2461,D02CXZ,PMID26815044-Compound-123,Albinism , Patented
2462,D02CXZ,PMID26815044-Compound-123,Ephelides , Patented
2463,D02CXZ,PMID26815044-Compound-123,Menkes disease , Patented
2464,D02CXZ,PMID26815044-Compound-123,Senile lentigines , Patented
2465,D02CXZ,PMID26815044-Compound-123,Melasma , Patented
2466,D02CYL,MOR-208,Diffuse large B-cell lymphoma , Phase 2/3
2467,D02CYL,MOR-208,Autoimmune diabetes , Phase 2
2468,D02CYL,MOR-208,B-cell chronic lymphocytic leukaemia , Phase 2
2469,D02CYL,MOR-208,Chronic lymphocytic leukaemia , Phase 2
2470,D02CYL,MOR-208,Non-hodgkin lymphoma , Phase 2
2471,D02CYR,Chromic phosphate P 32,Solid tumour/cancer , Approved
2472,D02CZF,Aderbasib,Breast cancer , Phase 1/2
2473,D02CZK,Karenitecin,Lung cancer , Phase 3
2474,D02CZK,Karenitecin,Ovarian cancer , Phase 3
2475,D02DBA,Helicobacter pylori vaccine,Helicobacter infection , Phase 1
2476,D02DEH,GM-602,Alzheimer disease , Phase 2
2477,D02DEH,GM-602,Ischemic stroke , Phase 2
2478,D02DEH,GM-602,Amyotrophic lateral sclerosis , Phase 2
2479,D02DES,Anakinra,Rheumatoid arthritis , Approved
2480,D02DEZ,GALE-301,Ovarian cancer , Phase 2
2481,D02DEZ,GALE-301,Endometrial cancer , Phase 1/2
2482,D02DFJ,Biaryl mannoside derivative 10,Crohn disease , Patented
2483,D02DFJ,Biaryl mannoside derivative 10,Ulcerative colitis , Patented
2484,D02DFJ,Biaryl mannoside derivative 10,Urinary tract infection , Patented
2485,D02DGU,Tretinoin,Acne vulgaris , Approved
2486,D02DGU,Tretinoin,Acute promyelocytic leukaemia , Approved
2487,D02DHU,SKF-81297,Parkinson disease , Terminated
2488,D02DJF,BAX-111,Pain , Preregistration
2489,D02DJG,LY-2189102,Cardiovascular disease , Phase 2
2490,D02DJR,AMG 167,Osteoporosis , Phase 1
2491,D02DJS,Iodoxamate Meglumine,Bile duct disease , Approved
2492,D02DKD,Benzquinamide,Nausea , Approved
2493,D02DLP,VOFOPITANT HYDROCHLORIDE,Vomiting , Phase 2
2494,D02DMQ,Eletriptan,Migraine , Approved
2495,D02DMW,S-1360,Human immunodeficiency virus infection , Phase 2
2496,D02DNA,Cureskin,Sarcoidosis , Approved
2497,D02DOK,SJ-8002,Solid tumour/cancer , Investigative
2498,D02DOZ,ALKS 3831,Schizophrenia , Phase 3
2499,D02DPA,Cimetidine,Acid-reflux disorder , Approved
2500,D02DPP,MTHF,Cognitive impairment , Phase 4
2501,D02DPU,Aniracetam,Cerebrovascular ischaemia , Approved
2502,D02DSD,Sodium Chromate Cr-51,Hemorrhage , Approved
2503,D02DSZ,Temocapril hydrochloride,Cardiovascular disease , Approved
2504,D02DTQ,PF-3893787,Atopic dermatitis , Phase 2
2505,D02DTQ,PF-3893787,Plaque psoriasis , Phase 2
2506,D02DTQ,PF-3893787,Asthma , Phase 1
2507,D02DVB,AGN-191743,Allergy , Discontinued in Phase 1
2508,D02DVK,CV-9201,Non-small-cell lung cancer , Phase 1/2
2509,D02DWK,2-hydroxyoleic acid,Hypertension , Phase 1/2
2510,D02DWM,Amphotericin B,Fungal infection , Approved
2511,D02DWM,Amphotericin B,Mycoses , Investigative
2512,D02DWN,AB-0440a,Bone disease , Investigative
2513,D02DWX,Prostvac-VF,Prostate cancer , Phase 2
2514,D02DXC,SPN-803,Parkinson disease , Phase 1
2515,D02DXV,HAP aniline mustard,Solid tumour/cancer , Investigative
2516,D02DYU,SC-75416,Pain , Phase 2
2517,D02DZI,MGN-8107,Motor neurone disease , Investigative
2518,D02DZK,LY3303560,Alzheimer disease , Phase 1
2519,D02EAS,TBC 11251 (TBC),Pulmonary arterial hypertension , Withdrawn from market
2520,D02ECG,Sodium pyruvate,Asthma , Phase 1/2
2521,D02EEJ,SCY-635,Hepatitis C virus infection , Phase 2
2522,D02EEK,J 591 Lu-177,Prostate cancer , Phase 2
2523,D02EFJ,MDAB-16,Bone disease , Phase 2
2524,D02EGY,Aromatic hydrazine carboxyimidoamide derivative 6,Albinism , Patented
2525,D02EGY,Aromatic hydrazine carboxyimidoamide derivative 6,Ephelides , Patented
2526,D02EGY,Aromatic hydrazine carboxyimidoamide derivative 6,Menkes disease , Patented
2527,D02EGY,Aromatic hydrazine carboxyimidoamide derivative 6,Senile lentigines , Patented
2528,D02EGY,Aromatic hydrazine carboxyimidoamide derivative 6,Melasma , Patented
2529,D02EHE,BI-730357,Plaque psoriasis , Phase 2
2530,D02EHV,Human neutral insulin,Diabetic complication , Approved
2531,D02EKI,Hydroxychloroquine + intravenous famotidine,Coronavirus Disease 2019 (COVID-19) , Phase 3
2532,D02EKO,PMID25666693-Compound-126,Osteoarthritis pain , Patented
2533,D02EKO,PMID25666693-Compound-126,Cancer related pain , Patented
2534,D02EKO,PMID25666693-Compound-126,Neuropathic pain , Patented
2535,D02EKO,PMID25666693-Compound-126,Inflammatory pain , Patented
2536,D02ELN,HM-5016699,Solid tumour/cancer , Investigative
2537,D02ELS,L-alanosine,Brain cancer , Phase 2
2538,D02EMR,Cilomilast,Chronic obstructive pulmonary disease , Discontinued in Phase 3
2539,D02EMR,Cilomilast,Bronchitis , Discontinued in Phase 3
2540,D02EMR,Cilomilast,Emphysema , Discontinued in Phase 3
2541,D02ENG,BVT.2733,Lupus , Phase 3
2542,D02ENG,BVT.2733,Systemic lupus erythematosus , Phase 3
2543,D02ENG,BVT.2733,Myasthenia gravis , Phase 2
2544,D02ENG,BVT.2733,Non-insulin dependent diabetes , Investigative
2545,D02EOH,SGT-53,Pancreatic cancer , Phase 2
2546,D02EOH,SGT-53,Recurrent glioblastoma , Phase 2
2547,D02EOH,SGT-53,Solid tumour/cancer , Phase 1
2548,D02EOR,ABBV-399,Solid tumour/cancer , Phase 1
2549,D02EOS,CVX-241,Solid tumour/cancer , Phase 1
2550,D02EPS,Oralair grasses,Grass pollen hypersensitivity , Approved
2551,D02EPS,Oralair grasses,Allergic conjunctivitis , Approved
2552,D02EPW,Hydroxychloroquine + azithromycin,Coronavirus Disease 2019 (COVID-19) , Phase 3
2553,D02EQX,Hydroxychloroquine + camostat mesylate,Coronavirus Disease 2019 (COVID-19) , Phase 3
2554,D02ERH,EP-2060,Solid tumour/cancer , Terminated
2555,D02ESK,GSK-732461,Human immunodeficiency virus infection , Discontinued in Phase 2
2556,D02ESL,ON-01210.Na,Radiation syndrome , Phase 1
2557,D02ESL,ON-01210.Na,Acute radiation syndrome , Phase 1
2558,D02ESX,Neomedi,Cerebrovascular ischaemia , Investigative
2559,D02ETJ,SIL-43,Solid tumour/cancer , Investigative
2560,D02ETP,SOM-0420,Osteoporosis , Investigative
2561,D02ETU,PMID28270021-Compound-WO2014152663 701,Osteoarthritis pain , Patented
2562,D02ETU,PMID28270021-Compound-WO2014152663 701,Pruritus , Patented
2563,D02ETU,PMID28270021-Compound-WO2014152663 701,Chronic pain , Patented
2564,D02ETU,PMID28270021-Compound-WO2014152663 701,Neuropathic pain , Patented
2565,D02ETU,PMID28270021-Compound-WO2014152663 701,Thymic cancer , Patented
2566,D02ETY,SAR97276,Malaria , Phase 2
2567,D02EVF,Losartan/thioctic acid,Diabetic nephropathy , Phase 2
2568,D02EVL,TDT-077,Postherpetic neuralgia , Investigative
2569,D02EVT,SAR-152954,Sleep-wake disorder , Discontinued in Phase 1
2570,D02EWF,RiVax,Ricin poisoning , Phase 1
2571,D02EXB,Vero cell seasonal influenza vaccine,Influenza virus infection , Phase 3
2572,D02EXZ,Ferric maltol,Iron-deficiency anemia , Approved
2573,D02EXZ,Ferric maltol,Onychomycosis , Phase 3
2574,D02EYG,Linagliptin,Type-2 diabetes , Approved
2575,D02EYZ,GSK2654909A,Virus infection , Phase 1
2576,D02EZM,Fospropofol disodium,Monitored anaesthesia care , Approved
2577,D02FAI,Pbi-shPDX-1 LP,Pancreatic cancer , Investigative
2578,D02FBG,UC-2029,Premenstrual syndrome , Investigative
2579,D02FCQ,Protokylol Hydrochloride,Asthma , Approved
2580,D02FCU,MIV-210,Hepatitis B virus infection , Phase 2
2581,D02FDJ,Ioforminol,Pulmonary embolism , Phase 2
2582,D02FDZ,LCP-AtorFen,Cardiovascular disease , Phase 2/3
2583,D02FEA,FENDILINE,Coronary artery disease , Withdrawn from market
2584,D02FEJ,ODC-0501,Melanoma , Discontinued in Phase 1/2
2585,D02FEM,Natamycin,Conjunctivitis , Approved
2586,D02FEV,S-8921,Hyperlipidaemia , Phase 2
2587,D02FGG,AFM-21,Solid tumour/cancer , Investigative
2588,D02FHP,RX-01-423,Bacterial infection , Preclinical
2589,D02FIC,JB-004/A,Inner ear disease , Phase 2
2590,D02FIJ,FK-224,Asthma , Discontinued in Phase 2
2591,D02FLB,Sodium bicarbonate,Metabolic acidosis , Approved
2592,D02FNJ,AL-309,Central nervous system disease , Investigative
2593,D02FNU,Ipsapirone,Anxiety disorder , Terminated
2594,D02FPT,H5N1 influenza vaccine,Influenza virus infection , Phase 2
2595,D02FTU,Recombinant follicle stimulating hormone,Female infertility , Investigative
2596,D02FTV,INGN-241,Solid tumour/cancer , Phase 2
2597,D02FXK,Botulinum Toxin Type B,Parkinson disease , Approved
2598,D02FXU,Lapaquistat acetate,Hyperlipidaemia , Discontinued in Phase 3
2599,D02FYE,TT-223,Type-1 diabetes , Phase 2
2600,D02FYI,Tozaride,Solid tumour/cancer , Phase 1/2
2601,D02GAC,Clomocycline,Bacterial infection , Approved
2602,D02GDK,Cx-601,Perianal fistula , Phase 3
2603,D02GDN,Berirab,Rabies , Approved
2604,D02GEC,Omalizumab,Asthma , Approved
2605,D02GEC,Omalizumab,Chronic idiopathic urticaria , Phase 2
2606,D02GFZ,Heparin-EGF-like factor,Gastrointestinal disease , Terminated
2607,D02GGG,BLI-1100,Acne vulgaris , Phase 2
2608,D02GIA,BL-7040,Inflammatory bowel disease , Phase 2
2609,D02GIU,Cilastatin,Bacterial infection , Approved
2610,D02GJE,CG-8840,Bladder cancer , Terminated
2611,D02GJZ,Ioflupane i-123,Parkinson disease , Approved
2612,D02GKJ,Monosialoganglioside,Cerebrovascular ischaemia , Approved
2613,D02GLD,MF-101,Hepatitis virus infection , Phase 3
2614,D02GMT,Org-7797,Cardiac arrhythmias , Discontinued in Phase 2
2615,D02GNH,Quinazoline derivative 9,Breast cancer , Phase 1
2616,D02GNL,KMJ-372,Pain , Investigative
2617,D02GOG,BY-963,Myocardial disease , Approved
2618,D02GPG,JNJ-42165279,Anxiety disorder , Phase 2
2619,D02GPG,JNJ-42165279,Social anxiety disorder , Phase 2
2620,D02GRR,Oleclumab,Solid tumour/cancer , Phase 1
2621,D02GSA,RBx10558,Hyperlipidaemia , Discontinued in Phase 2
2622,D02GTN,ZY-15106,Asthma , Phase 2
2623,D02GTT,AR-XYZ,Inflammation , Investigative
2624,D02GTV,Menomune,Virus infection , Approved
2625,D02GTY,Tamibarotene,T-cell leukaemia , Phase 3
2626,D02GTY,Tamibarotene,Alzheimer disease , Phase 2/3
2627,D02GUG,Ajmaline,Atrial fibrillation , Approved
2628,D02GVH,PIRODAVIR,Virus infection , Discontinued in Phase 2
2629,D02GWF,PACTIMIBE,Arteriosclerosis , Phase 2/3
2630,D02GWJ,MCT-125,Fatigue , Phase 2
2631,D02GYD,CDP-845,Solid tumour/cancer , Terminated
2632,D02HBB,AEZS-108,Acute lymphoblastic leukaemia , Phase 3
2633,D02HBI,Bmab-100,Solid tumour/cancer , Investigative
2634,D02HBW,SCH-32615,Pain , Discontinued in Phase 2
2635,D02HCU,WEB-2347,Allergy , Terminated
2636,D02HDG,AQX-1125,Chronic obstructive pulmonary disease , Phase 2
2637,D02HDP,V-1810,Solid tumour/cancer , Investigative
2638,D02HED,Perphenazine,Schizophrenia , Approved
2639,D02HFD,Glutathione,Human immunodeficiency virus infection , Approved
2640,D02HFN,BFCR4350A,Multiple myeloma , Phase 1
2641,D02HHM,SGN-CD19B,Non-hodgkin lymphoma , Phase 1
2642,D02HJR,SID-530,Solid tumour/cancer , Phase 3
2643,D02HKC,MUC1-Poly-ICLC,Colorectal cancer , Phase 2
2644,D02HKL,Suriclone,Anxiety disorder , Discontinued in Preregistration
2645,D02HLL,RQ-00317076,Pain , Discontinued in Phase 2
2646,D02HNF,Radium-223 chloride,Prostate cancer , Approved
2647,D02HNF,Radium-223 chloride,Breast cancer , Phase 2
2648,D02HNG,MK-0752,Alzheimer disease , Phase 2
2649,D02HPF,Biaryl mannoside derivative 9,Crohn disease , Patented
2650,D02HPF,Biaryl mannoside derivative 9,Ulcerative colitis , Patented
2651,D02HPF,Biaryl mannoside derivative 9,Urinary tract infection , Patented
2652,D02HPI,FGI-103-723,Ebola virus infection , Investigative
2653,D02HQR,Anti-HBs human mab,Hepatitis B virus infection , Investigative
2654,D02HRD,KLS-0611,Xerophthalmia , Phase 2
2655,D02HSB,Cabazitaxel,Breast cancer , Approved
2656,D02HSB,Cabazitaxel,Solid tumour/cancer , Phase 2
2657,D02HTD,GS-9451,Chronic HCV-1 infection , Phase 2
2658,D02HUB,Nestorone,Endometriosis , Phase 3
2659,D02HUU,FluPro,Influenza virus infection , Investigative
2660,D02HUW,SAR-548304,Non-alcoholic steatohepatitis , Phase 1
2661,D02HUY,Debio 0827,Chronic pain , Phase 1
2662,D02HVW,Zibotentan,Prostate cancer , Discontinued in Phase 3
2663,D02HWP,CHLOROXINE,Erythema , Approved
2664,D02HWR,PV-1019,Solid tumour/cancer , Investigative
2665,D02HXS,Bufexamac,Dermatitis , Approved
2666,D02HYK,Chondroitin,Cataract , Approved
2667,D02IAR,Nov-038,Inflammation , Investigative
2668,D02IBS,INH-001,Human immunodeficiency virus infection , Investigative
2669,D02IBU,Oritavancin,Bacterial infection , Approved
2670,D02IBU,Oritavancin,Gram-positive bacterial infection , Terminated
2671,D02IBX,"Pyrrolo[2,3-b]pyridine derivative 3",Pruritus , Patented
2672,D02IBX,"Pyrrolo[2,3-b]pyridine derivative 3",Solid tumour/cancer , Patented
2673,D02IBX,"Pyrrolo[2,3-b]pyridine derivative 3",Chronic pain , Patented
2674,D02IBX,"Pyrrolo[2,3-b]pyridine derivative 3",Neuropathic pain , Patented
2675,D02IBX,"Pyrrolo[2,3-b]pyridine derivative 3",Thymic cancer , Patented
2676,D02ICI,VIT-45,Iron-deficiency anemia , Approved
2677,D02IHW,Nepafenac,Osteoarthritis , Approved
2678,D02IIE,Penicillin V Potassium,Bacterial infection , Approved
2679,D02IIL,KOSN1559,Solid tumour/cancer , Investigative
2680,D02IIM,FCX-013,Scleroderma , Phase 1
2681,D02IIW,Faropenem,Gram-positive bacterial infection , Approved
2682,D02IJA,Tau-binding PET tracer,Alzheimer disease , Phase 2
2683,D02IJP,CLX-0900,Hyperlipidaemia , Terminated
2684,D02IKD,HG-1245,Solid tumour/cancer , Investigative
2685,D02IKF,M9831,Solid tumour/cancer , Phase 1
2686,D02IKQ,Hepatitis B DNA vaccine,Hepatitis B virus infection , Phase 1
2687,D02ILI,ZP-G-CSF,Neutropenia , Investigative
2688,D02IND,CBI-006,Solid tumour/cancer , Investigative
2689,D02INX,TD-1211,Opioid-induced constipation , Phase 2
2690,D02INZ,BABIM,Asthma , Terminated
2691,D02IOC,"CP154,526",Depression , Investigative
2692,D02IOH,Alphaprodine,Pain , Approved
2693,D02IPI,CTA-002,Solid tumour/cancer , Terminated
2694,D02IQY,Ergoloid mesylate,Alzheimer disease , Approved
2695,D02IRD,Megesterol acetate,Breast cancer , Approved
2696,D02IRL,IDX375,Hepatitis C virus infection , Discontinued in Phase 2
2697,D02ISP,SKI-2034R,Solid tumour/cancer , Terminated
2698,D02ITL,AV-201,Parkinson disease , Phase 2
2699,D02IUD,Sodium Fluoride F-18,Bone related disease , Approved
2700,D02IUD,Sodium Fluoride F-18,Osteoporosis , Approved
2701,D02IUO,CORT-113083,Weight gain , Investigative
2702,D02IWC,AZD2624,Multiple sclerosis , Phase 2
2703,D02IWC,AZD2624,Schizophrenia , Discontinued in Phase 2
2704,D02IYC,IMP-701,Solid tumour/cancer , Phase 1
2705,D02IZN,ON-123,Solid tumour/cancer , Investigative
2706,D02JAY,Stannsoporfin,Neonatal hyperbilirubinemia , Phase 2
2707,D02JBI,SAL-200,Bacteremia , Phase 2
2708,D02JBI,SAL-200,Staphylococcus infection , Phase 1
2709,D02JDL,Porfimer Sodium,Non-small-cell lung cancer , Approved
2710,D02JDN,IFN-alpha,Hepatitis C virus infection , Phase 2
2711,D02JDN,IFN-alpha,Hepatocellular carcinoma , Phase 2
2712,D02JEW,GSK-2130579A,Acute myeloid leukaemia , Phase 1
2713,D02JFF,ISIS 16518,Solid tumour/cancer , Investigative
2714,D02JGD,SKL-10406,Major depressive disorder , Phase 1
2715,D02JHW,ANG-2864,Solid tumour/cancer , Investigative
2716,D02JIB,Ro-25-2016,Bacterial infection , Terminated
2717,D02JIF,EDP-19,Brain cancer , Investigative
2718,D02JIN,264W94,Hyperlipidaemia , Phase 2
2719,D02JIS,Iobenguane I-123,Neuroendocrine cancer , Approved
2720,D02JKY,TD-9855,Pain , Phase 2
2721,D02JKY,TD-9855,Orthostatic hypotension , Phase 1
2722,D02JMI,SLV-310,Schizophrenia , Discontinued in Phase 2
2723,D02JMU,Tasquinimod,Prostate cancer , Phase 3
2724,D02JMZ,Recombinant human keratinocyte growth factor-2,Wound healing , Phase 1
2725,D02JNC,BCMA CAR-T,Multiple myeloma , Phase 1/2
2726,D02JND,ADC-3680,Allergic rhinitis , Phase 2
2727,D02JNM,Desonide,Atopic dermatitis , Approved
2728,D02JNX,OxycoDex,Pain , Discontinued in Phase 2
2729,D02JNY,BIBN-140,Alzheimer disease , Terminated
2730,D02JOA,Phenylisoserine derivatives SK80,Severe acute respiratory syndrome (SARS) , Preclinical
2731,D02JOH,BMS-708163,Alzheimer disease , Phase 2
2732,D02JOI,EPI-3905,Gastrointestinal disease , Investigative
2733,D02JQB,PMID25666693-Compound-140,Osteoarthritis pain , Patented
2734,D02JQB,PMID25666693-Compound-140,Cancer related pain , Patented
2735,D02JQB,PMID25666693-Compound-140,Neuropathic pain , Patented
2736,D02JQB,PMID25666693-Compound-140,Inflammatory pain , Patented
2737,D02JRD,VT-310,Inflammation , Investigative
2738,D02JRT,111In-imciromab pentetate,Myocardial infarction , Approved
2739,D02JUM,METIAPRIL,Hypotension , Discontinued in Phase 2
2740,D02JVX,Resorcinol compound 7,Albinism , Patented
2741,D02JVX,Resorcinol compound 7,Ephelides , Patented
2742,D02JVX,Resorcinol compound 7,Menkes disease , Patented
2743,D02JVX,Resorcinol compound 7,Senile lentigines , Patented
2744,D02JVX,Resorcinol compound 7,Melasma , Patented
2745,D02JWA,Flomoxef sodium,Bacterial infection , Approved
2746,D02JWN,STNM-01,Pyloric stenosis , Investigative
2747,D02JXG,SB-265610,Asthma , Phase 2
2748,D02JXG,SB-265610,Chronic obstructive pulmonary disease , Discontinued in Phase 1
2749,D02JYA,Raxibacumab,Anthrax , Approved
2750,D02JYT,GSK2654911A,Virus infection , Phase 1
2751,D02JYY,Indium In-111 Oxyquinoline,Diagnostic radiopharmaceutical , Approved
2752,D02JZJ,ETS-6218,Fibromyalgia , Phase 2
2753,D02KAF,GT-2203,Anxiety disorder , Terminated
2754,D02KAU,PF-03882845,Diabetic nephropathy , Terminated
2755,D02KAW,CDP-7657,Systemic lupus erythematosus , Phase 1
2756,D02KBD,Mebutamate,Anxiety disorder , Approved
2757,D02KBE,Ad-OC-hsvTK/valacyclovir,Prostate cancer , Phase 1
2758,D02KBO,Ciprokiren,Hypertension , Terminated
2759,D02KCV,Iothalamate,Arthropathy , Approved
2760,D02KEL,AVO113,Malignant glioma , Phase 2
2761,D02KEW,Levamisole + isoprinosine,Coronavirus Disease 2019 (COVID-19) , Phase 3
2762,D02KEY,SPP-676,Hypertension , Discontinued in Phase 1
2763,D02KFP,Invert sugar,Nutritional deficiency , Approved
2764,D02KIE,Cimetropium bromide,Spasm , Approved
2765,D02KIE,Cimetropium bromide,Gastric motility disorder , Approved
2766,D02KII,Vaqta,Hepatitis A virus infection , Approved
2767,D02KIU,Etonogestrel,Contraception , Approved
2768,D02KJX,Betain anhydrous,Inborn homocystinuria , Approved
2769,D02KKA,MK-1775,Ovarian cancer , Phase 2
2770,D02KKA,MK-1775,Solid tumour/cancer , Phase 1
2771,D02KKQ,BAM-1110,Parkinson disease , Discontinued in Phase 2
2772,D02KLD,BVT-74316,Obesity , Phase 1
2773,D02KLE,P-536,Virus infection , Investigative
2774,D02KLW,DIZOCILPINE,Cerebrovascular ischaemia , Terminated
2775,D02KMG,Milveterol,Asthma , Discontinued in Phase 2
2776,D02KMO,Pinacidil,High blood pressure , Approved
2777,D02KOF,Lomefloxacin,Bacterial infection , Approved
2778,D02KOY,RotaTeq,Rotavirus infection (Diarrhoea) , Approved
2779,D02KPJ,UCART19,Burkitt cell leukaemia , Phase 1
2780,D02KQE,ON-09300,Solid tumour/cancer , Terminated
2781,D02KRI,Epristeride,Hirsutism , Phase 3
2782,D02KRS,Amantadine,Influenza A virus infection , Approved
2783,D02KSP,Tislelizumab,Hodgkin lymphoma , Approved
2784,D02KSP,Tislelizumab,Hepatocellular carcinoma , Phase 3
2785,D02KTA,DER-45-EV,Rosacea , Phase 2
2786,D02KTG,CGEN-25068,Immune System disease , Investigative
2787,D02KUO,Cenegermin,Neurotrophic keratitis , Approved
2788,D02KVT,TUSC2/FUS1 gene therapy,Non-small-cell lung cancer , Phase 1/2
2789,D02KXE,Aom-0811,Premature ejaculation , Investigative
2790,D02KXW,HE3286,Type-2 diabetes , Phase 3
2791,D02KYP,AC-101,Neuropathic pain , Investigative
2792,D02KZI,L-786392,Bacterial infection , Terminated
2793,D02LAP,Oxymera,Obesity , Investigative
2794,D02LBK,ARRY-797,Pain , Phase 2
2795,D02LBK,ARRY-797,Osteoarthritis , Phase 2
2796,D02LBK,ARRY-797,Dilated cardiomyopathy , Phase 2
2797,D02LCI,TA-5493,Inflammation , Discontinued in Phase 1
2798,D02LCL,T-5224,Rheumatoid arthritis , Discontinued in Phase 2
2799,D02LCR,Tiapride,Alcohol dependence , Approved
2800,D02LCR,Tiapride,Neuropathic pain , Phase 1
2801,D02LCT,ARTELINIC ACID,Malaria , Investigative
2802,D02LDN,Magnesium Sulfate,Acute pain , Approved
2803,D02LDV,Thiamine Hydrochloride,Wernicke-Korsakoff Syndrome , Approved
2804,D02LDV,Thiamine Hydrochloride,Thiamine deficiency , Approved
2805,D02LHR,INDORAMIN,Hypertension , Withdrawn from market
2806,D02LIY,Euro-Celtique 2,Pain , Investigative
2807,D02LJR,Methenamine,Urinary tract infection , Approved
2808,D02LJW,Tirbanibulin,Actinic keratosis , Approved
2809,D02LJW,Tirbanibulin,Prostate cancer , Phase 2
2810,D02LMR,Adva-27a,Solid tumour/cancer , Investigative
2811,D02LNU,CART22-65s cells and huCART19 Cells,Acute lymphoblastic leukaemia , Phase 1
2812,D02LOB,JIN-2013,Cardiovascular disease , Investigative
2813,D02LPF,Altretamine,Ovarian cancer , Approved
2814,D02LPY,A-623,Systemic lupus erythematosus , Phase 2/3
2815,D02LQA,TTH 03-001,Pain , Investigative
2816,D02LRQ,Cycrimine,Parkinson disease , Approved
2817,D02LSR,SNK-882,Cognitive impairment , Phase 2
2818,D02LTL,Dermatan sulfate,Deep vein thrombosis , Approved
2819,D02LUP,RN-1005,Sarcoidosis , Terminated
2820,D02LVZ,Darbepoetin alfa,Anemia , Approved
2821,D02LWU,Pralatrexate,Breast cancer , Approved
2822,D02LWU,Pralatrexate,Peripheral T-cell lymphoma , Approved
2823,D02LYH,PMI-004,Diabetic neuropathy , Preclinical
2824,D02LZB,Demecolcine,Solid tumour/cancer , Approved
2825,D02MBM,Mosquirix malaria recombinant vaccine,Parkinson disease , Preregistration
2826,D02MBM,Mosquirix malaria recombinant vaccine,Malaria , Preregistration
2827,D02MBN,SD-6010,Osteoarthritis , Phase 3
2828,D02MBO,EPICOAT cancer vaccine,Solid tumour/cancer , Terminated
2829,D02MFC,62Cu-ATSM,Hypoxia , Phase 1
2830,D02MFK,Affinitak + Cisplatin,Non-small-cell lung cancer , Investigative
2831,D02MGH,Pneumococcal vaccine,Streptococcus infection , Approved
2832,D02MHD,NPC-16570,Allergy , Terminated
2833,D02MHE,CVS-1123,Myocardial infarction , Discontinued in Phase 1
2834,D02MLA,AXP-107-08,Wound healing , Investigative
2835,D02MLN,ChAdOx1 nCoV-19 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
2836,D02MLO,WT1-targeted autologous dendritic cell vaccine,Acute myeloid leukaemia , Phase 2
2837,D02MLW,Ibutilide,Atrial fibrillation , Approved
2838,D02MMF,FP-1097,Urinary incontinence , Phase 2
2839,D02MMG,Pyrimidine derivative 3,Solid tumour/cancer , Patented
2840,D02MMG,Pyrimidine derivative 3,Metastatic cancer , Patented
2841,D02MMP,VX-500,Hepatitis C virus infection , Phase 1
2842,D02MNY,ON-01135,Solid tumour/cancer , Preclinical
2843,D02MPT,MAGE-A3 immunotherapeutic,Type-2 diabetes , Phase 3
2844,D02MPT,MAGE-A3 immunotherapeutic,Non-small-cell lung cancer , Phase 3
2845,D02MPT,MAGE-A3 immunotherapeutic,Melanoma , Phase 3
2846,D02MQL,RWJ-61907,Fungal infection , Investigative
2847,D02MRN,Golotimod,Immune System disease , Phase 2
2848,D02MRN,Golotimod,Inflammation , Discontinued in Phase 2
2849,D02MRX,ONO-4059,B-cell lymphoma , Phase 1
2850,D02MSG,AcVx-25,Acne vulgaris , Phase 2
2851,D02MTK,AT-008,Autoimmune diabetes , Investigative
2852,D02MUA,PF-06439535,Non-small-cell lung cancer , Phase 3
2853,D02MUA,PF-06439535,Solid tumour/cancer , Phase 1
2854,D02MVA,NI-0701,Autoimmune diabetes , Phase 1
2855,D02MVG,AMG-548,Inflammation , Terminated
2856,D02MXT,MK-2894,Inflammation , Investigative
2857,D02MYI,CAR-T Cells targeting PSCA,Pancreatic cancer , Phase 1
2858,D02MZD,AMG 876,Type-2 diabetes , Phase 1
2859,D02MZY,Cefpiramide,Bacterial infection , Approved
2860,D02NBY,LACTIN-V,Urinary tract infection , Phase 2/3
2861,D02NBY,LACTIN-V,Bacterial infection , Phase 2
2862,D02NDC,GSK-2202083A,Hepatitis B virus infection , Phase 2
2863,D02NDP,PMID26651364-Compound-7a,Crohn disease , Patented
2864,D02NDP,PMID26651364-Compound-7a,Ulcerative colitis , Patented
2865,D02NDP,PMID26651364-Compound-7a,Urinary tract infection , Patented
2866,D02NDV,Levovist,Cardiovascular disease , Approved
2867,D02NEH,Ibutamoren,Fibromyalgia , Approved
2868,D02NEZ,IMX-942,Mucositis , Preclinical
2869,D02NFA,A-68828,Kidney disease , Terminated
2870,D02NFE,Anti-CD19 CART Cells,Multiple myeloma , Phase 1
2871,D02NGR,MK-499,Cardiac arrhythmias , Discontinued in Phase 2
2872,D02NHD,Ragaglitazar,Type-1 diabetes , Phase 3
2873,D02NHW,GSK-264220A,Coagulation defect , Clinical trial
2874,D02NHY,PLADD,Colorectal cancer , Phase 1
2875,D02NIP,ITASETRON,Nausea , Phase 1
2876,D02NJA,Fomepizole,Athylene glycol or methanol poisoning , Approved
2877,D02NJE,PEK fusion protein vaccine,Cervical cancer , Phase 1
2878,D02NJK,MDR-03030,Influenza virus infection , Investigative
2879,D02NMG,SLV-332,Irritable bowel syndrome , Preclinical
2880,D02NMJ,Meningococcal B vaccine,Neisseria meningitis infection , Approved
2881,D02NMO,FR-79620,Diabetic complication , Preclinical
2882,D02NMO,FR-79620,Obesity , Preclinical
2883,D02NMO,FR-79620,Eating disorder , Preclinical
2884,D02NMR,SFX-01,Breast cancer , Phase 2
2885,D02NMR,SFX-01,Subarachnoid hemorrhage , Phase 2
2886,D02NNN,CBP-501,Mesothelioma , Phase 1/2
2887,D02NNN,CBP-501,Solid tumour/cancer , Phase 1
2888,D02NNV,VX-745,Rheumatoid arthritis , Phase 2
2889,D02NNV,VX-745,Alzheimer disease , Phase 2
2890,D02NNZ,"1,2,4-triazole derivative 1",Obesity , Patented
2891,D02NOC,Cotara,Recurrent glioblastoma , Phase 2
2892,D02NOC,Cotara,Glioblastoma multiforme , Phase 2
2893,D02NSF,Oxymorphone,Pain , Approved
2894,D02NSS,CART-22 cells,Acute lymphoblastic leukaemia , Phase 1
2895,D02NTO,Tolnaftate,Dermatophytosis , Approved
2896,D02NTO,Tolnaftate,Jock itch , Approved
2897,D02NTS,JNJ-39393406,Depression , Phase 2
2898,D02NTS,JNJ-39393406,Tobacco dependence , Phase 2
2899,D02NTS,JNJ-39393406,Cognitive impairment , Phase 1
2900,D02NUS,MB-314,Solid tumour/cancer , Investigative
2901,D02NUT,KU-60019,Non-small-cell lung cancer , Clinical trial
2902,D02NVF,M-241247,Cerebrovascular ischaemia , Terminated
2903,D02NXM,GSK2110183,leukaemia , Phase 2
2904,D02NXM,GSK2110183,Solid tumour/cancer , Phase 2
2905,D02NXM,GSK2110183,Multiple myeloma , Phase 1
2906,D02NXQ,NXL-105,Bacterial infection , Investigative
2907,D02NXR,S-117957,Neuropathic pain , Phase 1
2908,D02NYA,Anti-Ebola mAb,Ebola virus infection , Phase 1/2
2909,D02NYK,Pifithrin-alpha,Toxicity , Terminated
2910,D02NZF,NZ-17000,Gram-positive bacterial infection , Investigative
2911,D02NZO,Amlodipine/ irbesartan fixed-dose combination,Hypertension , Phase 3
2912,D02OAH,PMID25666693-Compound-5,Osteoarthritis pain , Patented
2913,D02OAH,PMID25666693-Compound-5,Cancer related pain , Patented
2914,D02OAH,PMID25666693-Compound-5,Neuropathic pain , Patented
2915,D02OAH,PMID25666693-Compound-5,Inflammatory pain , Patented
2916,D02OAV,Chloral hydrate,Alcohol dependence , Approved
2917,D02OBU,Valpentin,Pain , Investigative
2918,D02OBW,Aminoazetidine derivative 2,Obesity , Patented
2919,D02OCD,NIBR-785,Multiple sclerosis , Investigative
2920,D02OCF,AZD-8294,Lipid metabolism disorder , Terminated
2921,D02OEP,CWF-07pre03,Diabetic complication , Investigative
2922,D02OGQ,APD,Human immunodeficiency virus-1 infection , Investigative
2923,D02OHR,SC-57666,Rheumatoid arthritis , Discontinued in Phase 1
2924,D02OIP,OP-05,Liver cancer , Investigative
2925,D02OJC,Xaliproden,Juvenile idiopathic arthritis , Phase 3
2926,D02OJC,Xaliproden,Plaque psoriasis , Phase 3
2927,D02OJC,Xaliproden,Lateral sclerosis , Discontinued in Phase 3
2928,D02OJC,Xaliproden,Peripheral sensory neuropathies , Discontinued in Phase 3
2929,D02OJC,Xaliproden,Alzheimer disease , Discontinued in Phase 3
2930,D02OJN,Ru-41740,Recurring respiratory infection , Approved
2931,D02OLJ,N-acylpiperidine ether derivative 7,Pruritus , Patented
2932,D02OLJ,N-acylpiperidine ether derivative 7,Solid tumour/cancer , Patented
2933,D02OLJ,N-acylpiperidine ether derivative 7,Chronic pain , Patented
2934,D02OLJ,N-acylpiperidine ether derivative 7,Neuropathic pain , Patented
2935,D02OLJ,N-acylpiperidine ether derivative 7,Thymic cancer , Patented
2936,D02ONA,AUTO3,Acute lymphoblastic leukaemia , Phase 1/2
2937,D02ONA,AUTO3,Diffuse large B-cell lymphoma , Phase 1/2
2938,D02ONK,Y-20024,Psychotic disorder , Terminated
2939,D02ONR,RG7686,Hepatocellular carcinoma , Phase 2
2940,D02ONT,5-FP,Solid tumour/cancer , Phase 1
2941,D02OOB,PRX-12205,Neurological disorder , Investigative
2942,D02ORJ,H1N1 influenza vaccine,Influenza virus infection , Approved
2943,D02ORS,YKP-GI,Constipation , Phase 2
2944,D02OTH,FR-115427,Cerebrovascular ischaemia , Terminated
2945,D02OTK,CH-4051,Rheumatoid arthritis , Phase 2
2946,D02OYJ,rMERS-CoV-E vaccine,Middle East Respiratory Syndrome (MERS) , Investigative
2947,D02OZE,Digoxin,Heart failure , Approved
2948,D02OZE,Digoxin,Arrhythmia , Approved
2949,D02OZE,Digoxin,Congestive cardiac insufficiency , Approved
2950,D02OZK,Obatoclax,Solid tumour/cancer , Phase 2
2951,D02OZT,DCR-MYC,Hepatocellular carcinoma , Phase 1/2
2952,D02OZY,Metharbital,Epilepsy , Approved
2953,D02PAH,Bendroflumethiazide,High blood pressure , Approved
2954,D02PAJ,UR-9650,Fungal infection , Terminated
2955,D02PAW,TLC-388,Solid tumour/cancer , Phase 2
2956,D02PCR,Spectinomycin,Bacterial infection , Approved
2957,D02PGP,PU3,Solid tumour/cancer , Phase 1
2958,D02PHE,AZD9668,Chronic obstructive pulmonary disease , Phase 2
2959,D02PHE,AZD9668,Bronchiectasis , Phase 2
2960,D02PIH,HO-221,Virus infection , Discontinued in Phase 1
2961,D02PIN,GR-94839,Pain , Terminated
2962,D02PIO,Benralizumab,Asthma , Approved
2963,D02PIO,Benralizumab,Chronic obstructive pulmonary disease , Phase 3
2964,D02PJA,Hydriodic acid iodine-125,Asthma , Approved
2965,D02PKV,Human recombinant factor VIIa,Factor IX deficiency , Investigative
2966,D02PMO,Topotecan,Ovarian cancer , Approved
2967,D02PMO,Topotecan,Solid tumour/cancer , Approved
2968,D02PMO,Topotecan,Small-cell lung cancer , Phase 1
2969,D02PMT,Nagrestipen,Bone marrow transplantation , Phase 1
2970,D02PNH,COL-171,Attention deficit hyperactivity disorder , Preclinical
2971,D02PNP,AGN-214868,Overactive bladder , Phase 2
2972,D02POH,TA-7906,Atopic dermatitis , Phase 2
2973,D02PPN,Methylphenidate,Attention deficit hyperactivity disorder , Approved
2974,D02PPN,Methylphenidate,Traumatic brain injury , Phase 4
2975,D02PQB,ATX-101,Obesity , Phase 3
2976,D02PSS,RG1577,Alzheimer disease , Phase 2
2977,D02PSZ,A-74498,Obesity , Preclinical
2978,D02PTD,IDC-7181,Bacterial infection , Preclinical
2979,D02PTI,AST-005,Psoriasis vulgaris , Phase 1
2980,D02PVS,KUR-213,Wound healing , Investigative
2981,D02PWM,Dyphylline,Acute bronchial asthma , Approved
2982,D02PXP,CIGB-370,Solid tumour/cancer , Investigative
2983,D02PYB,SDZ-GPI-562,Thrombosis , Phase 1
2984,D02PYM,QAK-423,Chronic obstructive pulmonary disease , Phase 1
2985,D02PYN,SR 16234,Breast cancer , Phase 2
2986,D02QAO,IPP-203101,Bacterial infection , Investigative
2987,D02QBJ,TIPLASININ,Thrombosis , Discontinued in Phase 1
2988,D02QBT,AZETIRELIN,Pain , Phase 3
2989,D02QCD,DEXMETHYLPHENIDATE HYDROCHLORIDE,Attention deficit hyperactivity disorder , Approved
2990,D02QCM,Calcitonin Human,Paget's disease , Approved
2991,D02QCM,Calcitonin Human,Postmenopausal osteoporosis , Phase 3
2992,D02QCM,Calcitonin Human,Pain , Phase 3
2993,D02QDQ,QAX-576,Allergic rhinitis , Phase 2
2994,D02QFW,NNZ-2566,Fragile X syndrome , Phase 2
2995,D02QFW,NNZ-2566,Rett syndrome , Phase 2
2996,D02QFW,NNZ-2566,Traumatic brain injury , Phase 2
2997,D02QFW,NNZ-2566,Type-1 diabetes , Phase 2
2998,D02QGM,CGS-26529,Inflammation , Terminated
2999,D02QHJ,Intratect,Immune System disease , Approved
3000,D02QJE,PMID25666693-Compound-23,Osteoarthritis pain , Patented
3001,D02QJE,PMID25666693-Compound-23,Cancer related pain , Patented
3002,D02QJE,PMID25666693-Compound-23,Neuropathic pain , Patented
3003,D02QJE,PMID25666693-Compound-23,Inflammatory pain , Patented
3004,D02QJH,Fluocinolone Acetonide,Inflammation , Approved
3005,D02QLH,PTL-43401,Solid tumour/cancer , Investigative
3006,D02QLQ,SRD-174,Pruritus , Phase 2
3007,D02QMQ,S-3578,Bacterial infection , Discontinued in Phase 1
3008,D02QND,GF-011802-00,Bacterial infection , Investigative
3009,D02QOL,XMetD,Hypoglycemia , Investigative
3010,D02QPR,Manganese Chloride,Overactive bladder , Approved
3011,D02QQB,A-216546,Solid tumour/cancer , Discontinued in Phase 1
3012,D02QQE,NKTR 214,Melanoma , Phase 3
3013,D02QQE,NKTR 214,Sarcoma , Phase 2
3014,D02QQE,NKTR 214,Bladder cancer , Phase 1/2
3015,D02QQE,NKTR 214,Colorectal cancer , Phase 1/2
3016,D02QQE,NKTR 214,Renal cell carcinoma , Phase 1/2
3017,D02QQE,NKTR 214,Solid tumour/cancer , Phase 1/2
3018,D02QQT,Quattvaxem,Bordetella pertussis infection , Approved
3019,D02QQV,ACAM-1000,Virus infection , Phase 3
3020,D02QUB,GM-CT-02,Hepatic fibrosis , Investigative
3021,D02QWJ,EREMOMYCIN,Bacterial infection , Discontinued in Phase 2
3022,D02QWK,SHP647,Ulcerative colitis , Phase 3
3023,D02QWK,SHP647,Crohn disease , Phase 2
3024,D02QXI,ST-04,Osteoarthritis , Investigative
3025,D02QYY,LY01005,Prostate cancer , Phase 1
3026,D02QZL,PNQX,Cerebrovascular ischaemia , Terminated
3027,D02QZR,LY-545694,Neuropathic pain , Phase 2
3028,D02RAI,ABX-PTH,Parathyroid disease , Terminated
3029,D02RAU,KRP-297,Type-2 diabetes , Discontinued in Phase 2
3030,D02RAU,KRP-297,Hyperlipidaemia , Terminated
3031,D02RBB,SUPERVAX,Hepatitis B virus infection , Approved
3032,D02RBQ,NG-2,Diabetic neuropathy , Investigative
3033,D02RBR,Nitazoxanide + ivermectin + chloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
3034,D02RCV,BVF-247,Cardiovascular disease , Terminated
3035,D02RDC,NV.XOD.09,Brain cancer , Investigative
3036,D02RDE,JTV-605,Dysmenorrhea , Terminated
3037,D02RDX,XP-23829,Multiple sclerosis , Phase 2
3038,D02RDX,XP-23829,Plaque psoriasis , Phase 2
3039,D02RED,DCVax-Brain,Brain cancer , Phase 3
3040,D02REJ,JNJ-17216498,Narcolepsy , Phase 2
3041,D02REM,DPI-221,Urinary incontinence , Investigative
3042,D02REO,TDI-0050,Motor neurone disease , Investigative
3043,D02RGZ,MKC-204,Autoimmune diabetes , Investigative
3044,D02RHC,ET190,Haematological malignancy , Phase 1
3045,D02RHU,SF-111,Infectious disease , Investigative
3046,D02RHV,PROXODOLOL,Glaucoma/ocular hypertension , Discontinued in Phase 2
3047,D02RIV,Hydroxystilbamidine Isethionate,Blastomycosis , Approved
3048,D02RJY,PHA-739358,Prostate cancer , Phase 2
3049,D02RKG,MORAb-004,Sarcoma , Phase 2
3050,D02RKG,MORAb-004,Melanoma , Phase 2
3051,D02RKG,MORAb-004,Colorectal cancer , Phase 2
3052,D02RKG,MORAb-004,Merkel cell carcinoma , Phase 2
3053,D02RLS,R-1554,Overactive bladder , Terminated
3054,D02RNJ,SK&F-104662,Bacterial infection , Terminated
3055,D02RNR,LB-100,Astrocytoma , Phase 2
3056,D02RNR,LB-100,Solid tumour/cancer , Phase 1
3057,D02RNS,Oglufanide,Bacterial infection , Phase 3
3058,D02ROU,ASP-1707,Endometriosis , Phase 2
3059,D02RPK,Z 360,Discovery agent , Phase 2
3060,D02RPO,BMS-986249,Solid tumour/cancer , Phase 1
3061,D02RPP,TPI ASM8,Asthma , Phase 2
3062,D02RQT,Tenidap,Rheumatoid arthritis , Phase 3
3063,D02RQU,Pravastatin,Hypercholesterolaemia , Approved
3064,D02RRX,SILTENZEPINE,Stomach disease , Phase 1
3065,D02RSN,Levofloxacin,Bacterial infection , Approved
3066,D02RSY,ADVM-022,Wet age-related macular degeneration , Phase 3
3067,D02RUO,ONO-8815Ly,Miscarriage , Terminated
3068,D02RUZ,A-922500,Lipid metabolism disorder , Investigative
3069,D02RVC,PPI-383,Hepatitis C virus infection , Phase 1
3070,D02RVE,TA-7552,Arteriosclerosis , Discontinued in Phase 2
3071,D02RVN,Selurampanel,Epilepsy , Phase 2
3072,D02RXG,Nalfurafine hcl,Uremic pruritus , Approved
3073,D02RXJ,Ribavirin + lopinavir + ritonavir + interferon beta-1b,Coronavirus Disease 2019 (COVID-19) , Phase 2
3074,D02RYE,AMA-237,Chronic obstructive pulmonary disease , Investigative
3075,D02RZC,ASC-JMX2,Prostate hyperplasia , Investigative
3076,D02RZL,AZD4769,Solid tumour/cancer , Discontinued in Phase 1
3077,D02SAC,Anti-CD123 CAR-T cells,leukaemia , Phase 1
3078,D02SAC,Anti-CD123 CAR-T cells,Lymphoma , Phase 1
3079,D02SAK,2NTX-99,Arteriosclerosis , Investigative
3080,D02SBQ,Urofollitropin,Female infertility , Approved
3081,D02SDC,Inactine,Anemia , Discontinued in Phase 3
3082,D02SDY,NaBen,Schizophrenia , Phase 2/3
3083,D02SES,Peptide analog 2,Solid tumour/cancer , Patented
3084,D02SES,Peptide analog 2,Infectious disease , Patented
3085,D02SES,Peptide analog 2,Human immunodeficiency virus infection , Patented
3086,D02SES,Peptide analog 2,Hepatitis , Patented
3087,D02SEU,PT-107,Sarcoma , Phase 2
3088,D02SEU,PT-107,Non-small-cell lung cancer , Phase 2
3089,D02SGL,PMID26815044-Compound-49,Albinism , Patented
3090,D02SGL,PMID26815044-Compound-49,Ephelides , Patented
3091,D02SGL,PMID26815044-Compound-49,Menkes disease , Patented
3092,D02SGL,PMID26815044-Compound-49,Senile lentigines , Patented
3093,D02SGL,PMID26815044-Compound-49,Melasma , Patented
3094,D02SGT,OM-197-MP-AC,Solid tumour/cancer , Investigative
3095,D02SHI,M8891,Solid tumour/cancer , Phase 1
3096,D02SJB,Imidazopyridazine derivative 8,Pain , Patented
3097,D02SJB,Imidazopyridazine derivative 8,Inflammation , Patented
3098,D02SJG,VT-362,Autoimmune diabetes , Investigative
3099,D02SJN,VBP,Asthma , Investigative
3100,D02SKA,FCE-22716,Hypertension , Discontinued in Phase 2
3101,D02SKQ,PMID29334795-Compound-28,Histamine H3-associated disorder , Patented
3102,D02SLV,CB-1922,Human immunodeficiency virus infection , Investigative
3103,D02SME,INO-4885,Asthma , Phase 1
3104,D02SMV,Herpes simplex virus therapy,Herpes simplex virus infection , Preclinical
3105,D02SNE,NeuGene,Bacillus anthracis infection , Investigative
3106,D02SNJ,SPD602,Anemia , Phase 2
3107,D02SNQ,Pyrazole derivative 8,Obesity , Patented
3108,D02SNY,WF-10,Acquired immune deficiency syndrome , Phase 2
3109,D02SOL,GF-15,Solid tumour/cancer , Investigative
3110,D02SPX,IDX899,Human immunodeficiency virus infection , Phase 2
3111,D02SRB,BPL-001,Cardiovascular disease , Investigative
3112,D02SSR,Methylene blue + vitamin C + N-acetyl cysteine,Coronavirus Disease 2019 (COVID-19) , Phase 1
3113,D02SSV,ALN-RSV02,Respiratory syncytial virus infection , Investigative
3114,D02STG,ONO-4232,Acute heart failure , Phase 1
3115,D02STN,ABIRATERONE,Prostate cancer , Approved
3116,D02SUB,SWT-06101,Fibromyalgia , Phase 1
3117,D02SUP,TT-114,Coagulation defect , Investigative
3118,D02SUR,"L-697,661",Human immunodeficiency virus infection , Phase 2
3119,D02SVQ,HBI-3000,Heart arrhythmia , Phase 2
3120,D02SVQ,HBI-3000,Atrial fibrillation , Phase 1
3121,D02SWB,Grass pollen-derived peptides,Allergic conjunctivitis , Phase 1/2
3122,D02SXZ,S-707106,Type-2 diabetes , Phase 2
3123,D02SYQ,Sm-14,Schistosomiasis , Phase 1
3124,D02SYV,Lenzilumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
3125,D02SYV,Lenzilumab,Chronic myelogenous leukaemia , Phase 1
3126,D02SZF,18F-SMIBR-K5,Solid tumour/cancer , Investigative
3127,D02TAB,CJ-50300,Virus infection , Phase 3
3128,D02TBI,Carbenicillin,Infection of the upper and lower urinary tract , Approved
3129,D02TBU,CIGB-552,Solid tumour/cancer , Investigative
3130,D02TDV,ZK-001,Thrombosis , Phase 1/2
3131,D02TGD,Netoglitazone,Non-alcoholic fatty liver disease , Phase 2
3132,D02TGF,Apolipoprotein E-derived peptides,Bacterial infection , Investigative
3133,D02TGN,XMT-1536,Solid tumour/cancer , Phase 1
3134,D02TGW,GE-20372A,Human immunodeficiency virus infection , Terminated
3135,D02THB,SKF-96067,Peptic ulcer , Discontinued in Phase 3
3136,D02TIK,HP-184,Multiple sclerosis , Phase 2
3137,D02TIY,Monoamine derivative 1,Albinism , Patented
3138,D02TIY,Monoamine derivative 1,Ephelides , Patented
3139,D02TIY,Monoamine derivative 1,Menkes disease , Patented
3140,D02TIY,Monoamine derivative 1,Senile lentigines , Patented
3141,D02TIY,Monoamine derivative 1,Melasma , Patented
3142,D02TJS,Dicumarol,Thrombosis , Approved
3143,D02TJS,Dicumarol,Bleeding disorder , Approved
3144,D02TJT,MK-8109,Ovarian cancer , Phase 3
3145,D02TKX,Sac-0601,Diabetic retinopathy , Investigative
3146,D02TLD,AMT-050,Cholesterol metabolism disorder , Terminated
3147,D02TLO,Ifosfamide,Solid tumour/cancer , Approved
3148,D02TMO,177Lu-AMBA,Breast cancer , Phase 1
3149,D02TNS,TMC-353121,Respiratory syncytial virus infection , Preclinical
3150,D02TNW,VR179,Cystic fibrosis , Phase 2
3151,D02TOI,Tricyclic phytocannabinoid derivative 2,Neuropathic pain , Patented
3152,D02TOK,IL-2 mimetic peptides,Solid tumour/cancer , Investigative
3153,D02TOS,AMSH,Female sexual arousal dysfunction , Investigative
3154,D02TQE,TA-102,Thrombosis , Investigative
3155,D02TQO,Vitamin E,Cardiovascular disease , Approved
3156,D02TSJ,Promethazine + sumatriptan,Migraine , Phase 2
3157,D02TTF,YM-90K,Convulsion , Discontinued in Phase 2
3158,D02TTL,Debio 0932,Solid tumour/cancer , Phase 1
3159,D02TTP,TDI-0015,Motor neurone disease , Investigative
3160,D02TUL,PF-06651600,Alopecia , Phase 2/3
3161,D02TUL,PF-06651600,Asthma , Phase 2
3162,D02TUL,PF-06651600,Crohn disease , Phase 1
3163,D02TVU,HTERT vaccine,Solid tumour/cancer , Phase 1
3164,D02TWR,BIIB080,Alzheimer disease , Phase 1/2
3165,D02TWR,BIIB080,Dementia , Phase 1/2
3166,D02TXV,TRN-157,Chronic obstructive pulmonary disease , Phase 2
3167,D02TYL,HER-801,Neurological disorder , Discontinued in Phase 2
3168,D02TYV,DPS-102,Psoriasis vulgaris , Phase 2
3169,D02TZB,T2 18C3,Type-2 diabetes , Phase 2
3170,D02UAR,DiffGAM,Diarrhea , Discontinued in Phase 2
3171,D02UBC,MEDI6383,Solid tumour/cancer , Phase 1
3172,D02UCW,PA-2794,Bacterial infection , Terminated
3173,D02UDO,PMID26651364-Compound-9d,Crohn disease , Patented
3174,D02UDO,PMID26651364-Compound-9d,Ulcerative colitis , Patented
3175,D02UDO,PMID26651364-Compound-9d,Urinary tract infection , Patented
3176,D02UFG,Metaproterenol Sulfate,Asthma , Approved
3177,D02UFQ,TAK-285,Solid tumour/cancer , Phase 1
3178,D02UGL,TR-Flu,Influenza virus infection , Investigative
3179,D02UIC,SSR-128428,Thrombosis , Phase 1
3180,D02UIE,ZK-91296,Alzheimer disease , Terminated
3181,D02UJD,PD-143188,Psychotic disorder , Phase 2
3182,D02UJG,ISIS-387898,Huntington disease , Investigative
3183,D02UJQ,TM-400,Bone marrow transplantation , Investigative
3184,D02UJS,PMID30107136-Compound-Example49,Solid tumour/cancer , Patented
3185,D02UJS,PMID30107136-Compound-Example49,Infectious disease , Patented
3186,D02UJS,PMID30107136-Compound-Example49,Human immunodeficiency virus infection , Patented
3187,D02UJS,PMID30107136-Compound-Example49,Hepatitis , Patented
3188,D02UKX,CAP1-6D,Pancreatic cancer , Phase 2
3189,D02ULG,CP-4033,Solid tumour/cancer , Investigative
3190,D02ULU,Semaglutide,Type-2 diabetes , Approved
3191,D02UMF,KT6-971,Hypercholesterolaemia , Phase 2
3192,D02UNP,IMA-901,Renal cell carcinoma , Phase 3
3193,D02UOE,Miltirone,Anxiety disorder , Terminated
3194,D02UOZ,NB-001,Multiple sclerosis , Phase 3
3195,D02UPI,AGS-6MF,Solid tumour/cancer , Phase 1
3196,D02UQG,RDEA-436,Solid tumour/cancer , Discontinued in Phase 1
3197,D02UQU,ABS-301,Alzheimer disease , Terminated
3198,D02URD,SAR425899,Diabetic complication , Phase 1
3199,D02URD,SAR425899,Type-2 diabetes , Phase 1
3200,D02URM,Rezafungin,Candidiasis , Phase 3
3201,D02URS,Potassium iodide,Thyrotoxicosis , Approved
3202,D02URX,KamRAB,leukaemia , Phase 2/3
3203,D02USE,Heterocyclic derivative 15,Solid tumour/cancer , Patented
3204,D02USE,Heterocyclic derivative 15,Metastatic cancer , Patented
3205,D02USG,P-2745,Chronic myelogenous leukaemia , Phase 1
3206,D02UVT,Dolutegravir + abacavir sulphate + lamivudine,Human immunodeficiency virus infection , Phase 3
3207,D02UWX,OT-440,Glaucoma/ocular hypertension , Investigative
3208,D02UXK,MBX-3254,Non-insulin dependent diabetes , Investigative
3209,D02UYB,Patisiran,Hereditary amyloidosis , Approved
3210,D02UYB,Patisiran,Amyloidosis , Approved
3211,D02UYB,Patisiran,Amyloid cardiomyopathy , Phase 3
3212,D02UYB,Patisiran,Transthyretin familial amyloid cardiomyopathy , Phase 3
3213,D02UYM,SB414,Atopic dermatitis , Phase 1
3214,D02UYM,SB414,Psoriasis vulgaris , Phase 1
3215,D02VBF,BI-D1870,Chronic lymphocytic leukaemia , Preclinical
3216,D02VBL,EMZ701,Hepatitis B virus infection , Phase 2
3217,D02VCJ,Metrizamide,Central nervous system disease , Approved
3218,D02VCK,FLUPAROXAN,Depression , Discontinued in Phase 3
3219,D02VER,Radavirsen,Influenza virus infection , Phase 1
3220,D02VFB,Miproxifene,Solid tumour/cancer , Discontinued in Phase 3
3221,D02VFC,Cefoxitin,Bacterial infection , Approved
3222,D02VFK,PPRT-152,Major depressive disorder , Terminated
3223,D02VHE,A-72055,Alzheimer disease , Terminated
3224,D02VIF,OLT1177 gel,Pain , Phase 2
3225,D02VIP,SB-267268,Osteoporosis , Discontinued in Phase 1
3226,D02VIT,Arbidol,Virus infection , Approved
3227,D02VJP,Cobicistat,Human immunodeficiency virus infection , Approved
3228,D02VJY,Biricodar,Ovarian cancer , Discontinued in Phase 2
3229,D02VKC,NBQX,Neurological disorder , Phase 1
3230,D02VLT,CholeraGarde cholera vaccine live attenuated,Vibrio cholerae infection , Phase 2
3231,D02VLX,Beractant,Neonatal respiratory distress , Approved
3232,D02VMC,RP-1000,Obesity , Investigative
3233,D02VMJ,TRICLABENDAZOLE,Helminth infection , Approved
3234,D02VNY,Pleodrug,Peripheral neuropathy , Investigative
3235,D02VOJ,RWJ-51204,Anxiety disorder , Preclinical
3236,D02VPS,Anti-FGFR2 humanized mab,Solid tumour/cancer , Investigative
3237,D02VPX,Calcidiol,Vitamin D deficiency , Approved
3238,D02VQU,STF-31,Solid tumour/cancer , Investigative
3239,D02VRN,KT-1,Cardiovascular disease , Investigative
3240,D02VSP,MK-7655,Bacterial infection , Phase 2
3241,D02VTB,BAY1193397,Peripheral arterial disease , Phase 2
3242,D02VUL,AIKO-151,Opioid dependence , Investigative
3243,D02VUX,PF-217830,Schizophrenia , Discontinued in Phase 2
3244,D02VUX,PF-217830,Bipolar disorder , Discontinued in Phase 2
3245,D02VYE,Opdivo + Yervoy,Esophageal cancer , Phase 3
3246,D02VYE,Opdivo + Yervoy,Gastric adenocarcinoma , Phase 3
3247,D02VYE,Opdivo + Yervoy,Head and neck cancer , Phase 3
3248,D02VYE,Opdivo + Yervoy,Urothelial carcinoma , Phase 3
3249,D02VYE,Opdivo + Yervoy,Colorectal cancer , Phase 2
3250,D02VZP,Flesinoxan,Anxiety disorder , Discontinued in Phase 3
3251,D02WAB,Diloxanide,Parasitic infection , Approved
3252,D02WCI,Pirfenidone,Idiopathic pulmonary fibrosis , Approved
3253,D02WDO,MGN-1333,Hepatitis B virus infection , Investigative
3254,D02WEL,VG-106,Solid tumour/cancer , Terminated
3255,D02WEU,ApoCell,Autoimmune diabetes , Phase 1/2
3256,D02WFK,Cycloserine,Tuberculosis , Approved
3257,D02WFK,Cycloserine,Bacterial infection , Approved
3258,D02WFK,Cycloserine,Obsessive compulsive disorder , Phase 2
3259,D02WFN,MK-7622,Alzheimer disease , Phase 2
3260,D02WGD,LOR-220,Bacterial infection , Investigative
3261,D02WGN,YM-114,Nausea , Discontinued in Phase 2
3262,D02WGY,Eprotirome,Cardiovascular disease , Discontinued in Phase 3
3263,D02WHY,Rubidium chloride Rb82,Coronary artery disease , Approved
3264,D02WII,TR-14035,Multiple sclerosis , Discontinued in Phase 1
3265,D02WIW,Dexbrompheniramine,Hay fever , Approved
3266,D02WJB,PMID26815044-Compound-124,Albinism , Patented
3267,D02WJB,PMID26815044-Compound-124,Ephelides , Patented
3268,D02WJB,PMID26815044-Compound-124,Menkes disease , Patented
3269,D02WJB,PMID26815044-Compound-124,Senile lentigines , Patented
3270,D02WJB,PMID26815044-Compound-124,Melasma , Patented
3271,D02WLS,Onyvax-105,Prostate cancer , Phase 1/2
3272,D02WLS,Onyvax-105,Colorectal cancer , Discontinued in Phase 1
3273,D02WMX,CR-6261,Influenza A virus infection , Phase 2
3274,D02WQR,GSK-008A,Gynecological disease , Investigative
3275,D02WQZ,Aprosulate sodium,Coagulation defect , Discontinued in Phase 1
3276,D02WRE,ATS-907,Glaucoma/ocular hypertension , Investigative
3277,D02WRV,OrthoDerm,Musculoskeletal disorder , Phase 2
3278,D02WSB,CRS-207,Pancreatic cancer , Phase 2
3279,D02WSB,CRS-207,Gastric adenocarcinoma , Phase 2
3280,D02WSB,CRS-207,Mesothelioma , Phase 2
3281,D02WSB,CRS-207,Ovarian cancer , Phase 1/2
3282,D02WST,Unfractionated heparin,Thrombosis , Phase 3
3283,D02WSY,CVX-060,Solid tumour/cancer , Phase 1/2
3284,D02WUC,Fenquizone,Hypertension , Approved
3285,D02WUW,PLD-177,Allergic rhinitis , Terminated
3286,D02WVT,E-3810,Solid tumour/cancer , Phase 3
3287,D02WWT,Aryl mannoside derivative 19,Crohn disease , Patented
3288,D02WWT,Aryl mannoside derivative 19,Ulcerative colitis , Patented
3289,D02WWT,Aryl mannoside derivative 19,Urinary tract infection , Patented
3290,D02XAC,MG-1102,Solid tumour/cancer , Phase 1
3291,D02XAS,SGM-1019,Inflammatory bowel disease , Phase 1
3292,D02XBN,ZPL521,Atopic dermatitis , Phase 1/2
3293,D02XBW,Urea,Dermatological disease , Approved
3294,D02XBY,AGS-005,Chronic lymphocytic leukaemia , Discontinued in Phase 1/2
3295,D02XEI,DCVax-Ovarian,Pain , Phase 3
3296,D02XEI,DCVax-Ovarian,Brain cancer , Phase 3
3297,D02XEI,DCVax-Ovarian,Recurrent glioblastoma , Phase 3
3298,D02XEI,DCVax-Ovarian,Ovarian cancer , Phase 1
3299,D02XGC,PF-3864086,Pain , Phase 1
3300,D02XGF,H5N1 influenza vaccine,Influenza virus infection , Registered
3301,D02XHD,KI-0805,Obesity , Discontinued in Phase 3
3302,D02XHV,FluBlok,Influenza virus infection , Approved
3303,D02XIY,Octreotide,Acromegaly , Approved
3304,D02XJI,Emedastine,Allergic conjunctivitis , Approved
3305,D02XJJ,LM11A-31,Alzheimer disease , Phase 1/2
3306,D02XJY,Midodrine,Orthostatic hypotension , Approved
3307,D02XKK,FRM-0962,Alzheimer disease , Phase 2
3308,D02XLI,LY-2979165,Bipolar disorder , Phase 1
3309,D02XMD,BGS-649,Endometriosis , Phase 2
3310,D02XMM,Midaglizole,Asthma , Terminated
3311,D02XNH,C-linked disaccharide biphenyl mannoside derivative 6,Crohn disease , Patented
3312,D02XNH,C-linked disaccharide biphenyl mannoside derivative 6,Ulcerative colitis , Patented
3313,D02XNH,C-linked disaccharide biphenyl mannoside derivative 6,Urinary tract infection , Patented
3314,D02XNJ,CogniXan,Neurological disorder , Investigative
3315,D02XNT,BMS-A,Inflammation , Investigative
3316,D02XNW,VX-680,Solid tumour/cancer , Phase 2
3317,D02XOK,Levomilnacipran,Fibromyalgia , Approved
3318,D02XOM,HX-01,Solid tumour/cancer , Investigative
3319,D02XPI,Hydroxychloroquine + ivermectin,Coronavirus Disease 2019 (COVID-19) , Phase 2
3320,D02XSA,Stiripentol,Dravet syndrome , Approved
3321,D02XSA,Stiripentol,Epilepsy , Approved
3322,D02XSL,GlyT1 PET radiotracers,Schizophrenia , Phase 1
3323,D02XTN,RO5545965,Schizophrenia , Phase 1
3324,D02XTT,LV305,Non-small-cell lung cancer , Phase 1
3325,D02XTT,LV305,Melanoma , Phase 1
3326,D02XTT,LV305,Breast cancer , Phase 1
3327,D02XUC,VF001,Venous leg ulcer , Phase 2
3328,D02XUE,TDI-0106,Motor neurone disease , Investigative
3329,D02XUN,Trivalent seasonal influenza vaccine,Influenza virus infection , Phase 2
3330,D02XUY,AZ-1297442,Pain , Investigative
3331,D02XVC,Phenylate derivative 2,Solid tumour/cancer , Patented
3332,D02XVC,Phenylate derivative 2,Infectious disease , Patented
3333,D02XVC,Phenylate derivative 2,Human immunodeficiency virus infection , Patented
3334,D02XVC,Phenylate derivative 2,Hepatitis , Patented
3335,D02XXF,BMN044,Duchenne dystrophy , Phase 2
3336,D02XXN,Evacetrapib,Cardiovascular disease , Phase 3
3337,D02XXQ,MEDl-557,Respiratory syncytial virus infection , Phase 1
3338,D02XXT,Diphencyprone,Alopecia , Phase 2
3339,D02XXW,Allogeneic/autologous adult mesenchymal stem cell therapy,Ischemic heart disease , Phase 1/2
3340,D02XYA,Astuprotimut-R,Non-small-cell lung cancer , Phase 3
3341,D02XYB,SARIPIDEM,Anxiety disorder , Phase 2
3342,D02XYT,Furopyridine derivative 1,Obesity , Patented
3343,D02XYW,CD19-directed CAR-T cells,leukaemia , Phase 1
3344,D02YAD,Vivia-008,Solid tumour/cancer , Investigative
3345,D02YAQ,GW-974,Breast cancer , Terminated
3346,D02YBD,CAL-401,Candidiasis , Investigative
3347,D02YBP,Mequitamium iodide,Asthma , Discontinued in Phase 2
3348,D02YCH,Icodextrin,Kidney disease , Approved
3349,D02YCL,SB-36131,Diabetic complication , Investigative
3350,D02YEG,VBY-376,Hepatitis C virus infection , Phase 1
3351,D02YEO,NBTXR3,Prostate cancer , Phase 1/2
3352,D02YEY,FPL-62064,Inflammation , Phase 3
3353,D02YIP,AbGn-168,Allergy , Phase 2
3354,D02YIW,"5-(N,N-hexamethylene)-amiloride",Coronavirus infection , Preclinical
3355,D02YIZ,Erythromycin,Bacterial infection , Approved
3356,D02YKI,PF-04995274,Alzheimer disease , Phase 1
3357,D02YNH,CP-809101,Neurological disorder , Investigative
3358,D02YNI,OTX-015,Acute myeloid leukaemia , Phase 1/2
3359,D02YNI,OTX-015,Myelodysplastic syndrome , Phase 1
3360,D02YNI,OTX-015,Solid tumour/cancer , Phase 1
3361,D02YOQ,NUCB-1000,Hepatitis B virus infection , Discontinued in Phase 1
3362,D02YPG,Etomidate,Anaesthesia , Approved
3363,D02YPU,Pyridoxamine,Diabetic nephropathy , Phase 3
3364,D02YPU,Pyridoxamine,Diabetic kidney disease , Phase 3
3365,D02YQB,MenQuadfi,Meningococcal infection , Approved
3366,D02YQJ,B-5354a,Arteriosclerosis , Terminated
3367,D02YRD,4SCAR19 and 4SCAR70,B-cell lymphoma , Phase 1/2
3368,D02YRX,C-0333158,Atopic dermatitis , Investigative
3369,D02YSO,GX-C4,Autoimmune diabetes , Investigative
3370,D02YVM,Zicronapine,Schizophrenia , Phase 3
3371,D02YWD,B27PD,Uveitis , Phase 1/2
3372,D02YWE,EBP-1597,Hepatitis C virus infection , Investigative
3373,D02YWM,BIO-500,Radiation syndrome , Investigative
3374,D02YWV,GR-159897,Anxiety disorder , Terminated
3375,D02YWW,IDM-1,Ovarian cancer , Discontinued in Phase 3
3376,D02YXQ,GT-2016,Alzheimer disease , Terminated
3377,D02YYF,Bretylium,Ventricular fibrillation , Approved
3378,D02YYS,BDNA-001,Hepatitis B virus infection , Investigative
3379,D02YZK,RO-5303253,Hepatitis C virus infection , Phase 1
3380,D02ZAN,SparVax recombinant protective antigen anthrax vaccine,Depression , Phase 2
3381,D02ZAN,SparVax recombinant protective antigen anthrax vaccine,Anthrax , Phase 2
3382,D02ZAT,VGV-S,Sepsis , Investigative
3383,D02ZBW,LC-150444,Type-2 diabetes , Phase 3
3384,D02ZCE,AD-337,Chemotherapy-induced nausea , Phase 1
3385,D02ZCE,AD-337,Myalgia , Phase 1
3386,D02ZCE,AD-337,Fibromyalgia , Phase 1
3387,D02ZCM,Ad26.ENVA.01 HIV-1 recombinant vaccine,Human immunodeficiency virus infection , Phase 1
3388,D02ZEM,OBERADILOL MONOETHYL MALEATE,Hypertension , Discontinued in Phase 2
3389,D02ZGI,Secalciferol,Disorder of calcium metabolism , Approved
3390,D02ZHW,177Lu-DOTA-octreotate,Melanoma , Phase 3
3391,D02ZHW,177Lu-DOTA-octreotate,Neuroendocrine cancer , Phase 3
3392,D02ZJI,Levalbuterol,Asthma , Approved
3393,D02ZKB,WAY-126227,Hypertension , Terminated
3394,D02ZKL,Reglixane,Diabetic complication , Discontinued in Phase 2
3395,D02ZKR,BCX-3408,Plaque psoriasis , Phase 2
3396,D02ZKR,BCX-3408,Gout , Phase 2
3397,D02ZKR,BCX-3408,Autoimmune diabetes , Phase 2
3398,D02ZLM,F-991,Allergic skin disorder , Discontinued in Phase 2
3399,D02ZMB,Urelumab,Solid tumour/cancer , Phase 2
3400,D02ZMB,Urelumab,B-cell non-hodgkin lymphoma , Phase 2
3401,D02ZMB,Urelumab,Melanoma , Phase 2
3402,D02ZMI,AA-29504,Major depressive disorder , Investigative
3403,D02ZNH,TT-310,Solid tumour/cancer , Investigative
3404,D02ZPM,Anpirtoline,Pain , Terminated
3405,D02ZPN,NN-414,Type-1 diabetes , Phase 1
3406,D02ZQN,PMID28270021-Compound-WO2013009582Example16,Pruritus , Patented
3407,D02ZQN,PMID28270021-Compound-WO2013009582Example16,Solid tumour/cancer , Patented
3408,D02ZQN,PMID28270021-Compound-WO2013009582Example16,Chronic pain , Patented
3409,D02ZQN,PMID28270021-Compound-WO2013009582Example16,Neuropathic pain , Patented
3410,D02ZQN,PMID28270021-Compound-WO2013009582Example16,Thymic cancer , Patented
3411,D02ZQS,GSK269962A,Inflammation , Clinical trial
3412,D02ZSU,NS-49,Urinary incontinence , Discontinued in Phase 2
3413,D02ZTJ,Sulfasalazine,Rheumatoid arthritis , Approved
3414,D02ZTJ,Sulfasalazine,Irritable bowel syndrome , Approved
3415,D02ZUG,Atogepant,Migraine , Phase 2/3
3416,D02ZUO,Forodesine,B-cell acute lymphoblastic leukaemia , Phase 1/2
3417,D02ZUO,Forodesine,Cutaneous T-cell lymphoma , Phase 1/2
3418,D02ZUT,TRP6-01,Brain injury , Investigative
3419,D02ZVY,Diphenyl purine derivative 4,Obesity , Patented
3420,D02ZWG,SR-80027A,Thrombosis , Terminated
3421,D02ZWJ,EP-94,Ischemic heart disease , Investigative
3422,D02ZWO,DEF-201,Ebola virus infection , Investigative
3423,D02ZWR,IMO-2134,Allergy , Preclinical
3424,D02ZWR,IMO-2134,Asthma , Preclinical
3425,D02ZXK,TJ003234,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
3426,D02ZXM,Thioguanine,Acute myeloid leukaemia , Approved
3427,D02ZYI,IPP-201007,Allergy , Investigative
3428,D02ZYV,Biaryl mannoside derivative 15,Crohn disease , Patented
3429,D02ZYV,Biaryl mannoside derivative 15,Ulcerative colitis , Patented
3430,D02ZYV,Biaryl mannoside derivative 15,Urinary tract infection , Patented
3431,D02ZZC,NN-8630,Growth hormone deficiency , Phase 2
3432,D02ZZG,LEO 43204,Squamous cell carcinoma , Phase 3
3433,D02ZZG,LEO 43204,Acne vulgaris , Phase 2
3434,D02ZZG,LEO 43204,Actinic keratosis , Phase 2
3435,D02ZZU,DM-CHOC-PEN,Brain cancer , Phase 2
3436,D02ZZU,DM-CHOC-PEN,Brain metastases , Phase 2
3437,D03AAV,ProLindaun,Solid tumour/cancer , Investigative
3438,D03ABH,Deriglidole,Diabetic complication , Discontinued in Phase 2
3439,D03ACE,ASP5094,Rheumatoid arthritis , Phase 1
3440,D03ACT,PRS-211375 iv,Pain , Discontinued in Phase 2
3441,D03AEG,CBI-008,Solid tumour/cancer , Investigative
3442,D03AFF,JNJ-64007957,Multiple myeloma , Phase 2
3443,D03AFX,CM-2397,Pain , Terminated
3444,D03AGK,PF-05251749,Alzheimer disease , Phase 1
3445,D03AJF,SPN-810,Attention deficit hyperactivity disorder , Phase 3
3446,D03AJU,Osilodrostat,Cushing disease , Approved
3447,D03AKH,CER-001,Acute coronary syndrome , Phase 2
3448,D03AKH,CER-001,Cardiovascular disease , Phase 2
3449,D03AKL,ATLIPROFEN METHYL ESTER,Inflammation , Terminated
3450,D03ALS,VA-DIFTET,Clostridium infection , Approved
3451,D03AND,RAF265,Melanoma , Phase 2
3452,D03AOP,DS-8500,Diabetic complication , Phase 2
3453,D03AOP,DS-8500,Type-2 diabetes , Phase 2
3454,D03APL,AS-1403,Breast cancer , Discontinued in Phase 1
3455,D03APM,ABT-110,Chronic pain , Phase 1
3456,D03AQZ,GMB-Vax,Glioblastoma multiforme , Phase 2
3457,D03ATI,ITV-2,Human immunodeficiency virus infection , Investigative
3458,D03AUN,RG1512,Acute coronary syndrome , Discontinued in Phase 2
3459,D03AVA,SNG-8033,leukaemia , Investigative
3460,D03AVS,SR13668,Solid tumour/cancer , Phase 1
3461,D03AXQ,Soluble FePPi,Anemia , Phase 2
3462,D03AYQ,EB-1020,Attention deficit hyperactivity disorder , Phase 2
3463,D03AZB,Neo-1528,Pain , Investigative
3464,D03AZK,Sodium zirconium cyclosilicate,Hyperkalemia , Approved
3465,D03AZR,Berubicin,Solid tumour/cancer , Phase 2
3466,D03AZU,Org-31710,Contraception , Discontinued in Phase 1
3467,D03AZY,PNU-177864,Schizophrenia , Terminated
3468,D03BAC,Revacept,Arteriosclerosis , Phase 2
3469,D03BAY,N-acylpiperidine ether derivative 5,Pruritus , Patented
3470,D03BAY,N-acylpiperidine ether derivative 5,Solid tumour/cancer , Patented
3471,D03BAY,N-acylpiperidine ether derivative 5,Chronic pain , Patented
3472,D03BAY,N-acylpiperidine ether derivative 5,Neuropathic pain , Patented
3473,D03BAY,N-acylpiperidine ether derivative 5,Thymic cancer , Patented
3474,D03BBU,Lucatumumab,Lymphoma , Phase 2
3475,D03BCE,FPT-038,Non-insulin dependent diabetes , Investigative
3476,D03BCV,Macrocycle derivative 6,Solid tumour/cancer , Patented
3477,D03BCV,Macrocycle derivative 6,Infectious disease , Patented
3478,D03BCV,Macrocycle derivative 6,Human immunodeficiency virus infection , Patented
3479,D03BCV,Macrocycle derivative 6,Hepatitis , Patented
3480,D03BDE,QRX-401,Hypercholesterolaemia , Discontinued in Phase 1
3481,D03BDP,Triferic,Iron-deficiency anemia , Approved
3482,D03BFS,SPN-809,Depression , Phase 1
3483,D03BFS,SPN-809,Central nervous system disease , Investigative
3484,D03BFU,Pradaxa,Stroke , Phase 3
3485,D03BGG,ST-1141,Functional bowel disorder , Phase 1
3486,D03BHM,R1507,Graves ophthalmopathy , Phase 2
3487,D03BHO,JTP-2942,Cognitive impairment , Discontinued in Phase 2
3488,D03BHZ,AZD8186,Solid tumour/cancer , Phase 1
3489,D03BIH,DFN-15,Migraine , Phase 3
3490,D03BJX,Botulinum toxin,Solid tumour/cancer , Investigative
3491,D03BKN,MS201408-0005B,Solid tumour/cancer , Phase 1
3492,D03BKV,KML-001,Solid tumour/cancer , Phase 1
3493,D03BLF,Triamcinolone,Allergic rhinitis , Approved
3494,D03BLG,AGS-009,Systemic lupus erythematosus , Phase 1
3495,D03BMR,PRX-1,Parkinson disease , Investigative
3496,D03BND,GFC-001,Leishmania infection , Investigative
3497,D03BNF,IMGN632,Blastic plasmacytoid dendritic cell neoplasm , Phase 1/2
3498,D03BNU,XL-388,Solid tumour/cancer , Preclinical
3499,D03BOZ,RS-130830,Hepatitis C virus infection , Discontinued in Phase 2
3500,D03BPU,Hematological disease agents,Hematologic disease , Investigative
3501,D03BQD,NMS-1,Solid tumour/cancer , Investigative
3502,D03BQP,Rebamipide,Peptic ulcer , Phase 3
3503,D03BRP,Aromatic hydrazine carboxyimidoamide derivative 5,Albinism , Patented
3504,D03BRP,Aromatic hydrazine carboxyimidoamide derivative 5,Ephelides , Patented
3505,D03BRP,Aromatic hydrazine carboxyimidoamide derivative 5,Menkes disease , Patented
3506,D03BRP,Aromatic hydrazine carboxyimidoamide derivative 5,Senile lentigines , Patented
3507,D03BRP,Aromatic hydrazine carboxyimidoamide derivative 5,Melasma , Patented
3508,D03BSK,URC102,Gout , Phase 2
3509,D03BTP,Fosfluridine tidoxil,Keratosis , Terminated
3510,D03BVH,AWD-23-111,Heart arrhythmia , Terminated
3511,D03BVW,V-419,Generalized anxiety disorder , Phase 3
3512,D03BVW,V-419,Poliovirus infection , Application submitted
3513,D03BWQ,ATN-658,Solid tumour/cancer , Investigative
3514,D03BXU,LNK-754,Bladder cancer , Phase 1
3515,D03BYM,BAY1895344,Lymphoma , Phase 1
3516,D03BYM,BAY1895344,Solid tumour/cancer , Phase 1
3517,D03BZN,Sodium taurocholate,Type-2 diabetes , Phase 1/2
3518,D03BZS,MK-8655,Type-2 diabetes , Phase 1
3519,D03BZU,RG7802,Non-small-cell lung cancer , Phase 1/2
3520,D03CAT,Cefteram pivoxil,Bacterial infection , Approved
3521,D03CBU,PHY-626,Solid tumour/cancer , Investigative
3522,D03CCH,SK&F-95601,Peptic ulcer , Terminated
3523,D03CCY,XEL 001HP,Alzheimer disease , Phase 1
3524,D03CDK,ASP-7147,Irritable bowel syndrome , Phase 2
3525,D03CEF,Desvenalfaxine succinate,Fibromyalgia , Approved
3526,D03CFJ,NCX-701,Pain , Discontinued in Phase 2
3527,D03CFR,SEP-226332,Obstructive sleep apnea , Discontinued in Phase 1
3528,D03CGQ,AG-013958,Age-related macular degeneration , Phase 1/2
3529,D03CGS,CHF-3098,Epilepsy , Withdrawn from market
3530,D03CHE,PF-251802,Rheumatoid arthritis , Discontinued in Phase 1
3531,D03CHM,MSC1936369B,Colorectal cancer , Phase 2
3532,D03CHT,Fudosteine,Expectorant , Approved
3533,D03CHT,Fudosteine,Bronchitis , Approved
3534,D03CIN,PTX-007011,Bacterial infection , Terminated
3535,D03CJL,Droperidol,Nausea , Approved
3536,D03CKP,DasKloster 0182-01,Sarcoidosis , Investigative
3537,D03CKX,Cromafiban,Coronary artery disease , Discontinued in Phase 2
3538,D03CLP,Dendritic cell vaccine,Glioblastoma multiforme , Phase 1
3539,D03CMR,TER-16998,Diabetic complication , Terminated
3540,D03CMZ,CAR-T cells targeting EGFRviii,Glioblastoma multiforme , Phase 1
3541,D03CNS,Cyclothiazide,Congestive heart failure , Approved
3542,D03CNT,L-698532,Neurological disorder , Terminated
3543,D03CNV,VMD-30283,Myocardial infarction , Phase 1/2
3544,D03CPM,SLV-334,Brain injury , Phase 2
3545,D03CQE,Gatifloxacin,Respiratory tract infection , Approved
3546,D03CQN,Chk1-A,Solid tumour/cancer , Investigative
3547,D03CTH,Biphenyl mannoside derivative 10,Crohn disease , Patented
3548,D03CTH,Biphenyl mannoside derivative 10,Ulcerative colitis , Patented
3549,D03CTH,Biphenyl mannoside derivative 10,Urinary tract infection , Patented
3550,D03CUF,Furazolidone,Diarrhea , Approved
3551,D03CUS,CS-207,Cardiovascular disease , Terminated
3552,D03CVT,ONC1-13B,Prostate cancer , Phase 1/2
3553,D03CVV,Anisperimus,Immune System disease , Discontinued in Phase 2
3554,D03CWO,ENDG-3020,Pain , Investigative
3555,D03CWX,MEM-1414,Mood disorder , Phase 1
3556,D03CYF,RVX-408,Cardiovascular disease , Investigative
3557,D03CZE,VPZ-758,Raynaud disease , Investigative
3558,D03CZX,PMA-201,Autoimmune diabetes , Investigative
3559,D03DAP,Flecainide,Tachyarrhythmias , Approved
3560,D03DAP,Flecainide,Paroxysmal atrial fibrillation , Phase 1
3561,D03DAP,Flecainide,Atrial fibrillation , Investigative
3562,D03DAY,ITV-1,Human immunodeficiency virus infection , Phase 2
3563,D03DBW,Pretubulysin,Solid tumour/cancer , Investigative
3564,D03DDR,Quinine,Malaria , Approved
3565,D03DEI,Sulfinpyrazone,Gout , Approved
3566,D03DFY,NP-7557,Alzheimer disease , Terminated
3567,D03DHM,CCX507,Ulcerative colitis , Phase 1
3568,D03DHQ,CX-516,Pervasive developmental disorder , Phase 2/3
3569,D03DHQ,CX-516,Schizophrenia , Phase 2/3
3570,D03DIG,Codeine,Pain , Approved
3571,D03DIG,Codeine,Cough , Phase 1
3572,D03DII,Pollen allergen immunotherapy,Seasonal allergic rhinitis , Investigative
3573,D03DJL,Indacaterol,Chronic obstructive pulmonary disease , Approved
3574,D03DJL,Indacaterol,Asthma , Phase 4
3575,D03DJT,Bococizumab,Chronic obstructive pulmonary disease , Phase 3
3576,D03DKR,GALAMUSTINE HYDROCHLORIDE,Solid tumour/cancer , Phase 1
3577,D03DKV,RGB-286638,Haematological malignancy , Phase 1
3578,D03DMB,GSK2894512,Atopic dermatitis , Phase 2
3579,D03DMB,GSK2894512,Plaque psoriasis , Phase 2
3580,D03DMB,GSK2894512,Psoriasis vulgaris , Phase 2
3581,D03DNI,Hepatitis C virus E2 protein vaccines,Hepatitis C virus infection , Terminated
3582,D03DOC,DCC-2909,Metastatic malignant neoplasm , Investigative
3583,D03DOW,SWT-05141,Atopic dermatitis , Investigative
3584,D03DPZ,INK128,Breast cancer , Phase 2
3585,D03DPZ,INK128,Multiple myeloma , Phase 2
3586,D03DQK,PEG-Hb/HS,Shock , Investigative
3587,D03DRR,Noberastine,Asthma , Phase 2
3588,D03DRW,UTIBAPRIL,Hypertension , Discontinued in Phase 2
3589,D03DSB,Trospectomycin,Bacterial infection , Discontinued in Preregistration
3590,D03DSR,Ambroxol,Bronchitis , Approved
3591,D03DSX,SSR411298,Major depressive disorder , Phase 2
3592,D03DTQ,PMX-700,Glioblastoma multiforme , Investigative
3593,D03DTU,BCL-5,Diabetic complication , Investigative
3594,D03DTW,EHT-107,Solid tumour/cancer , Investigative
3595,D03DUH,ACAM-FLU-A,Influenza virus infection , Phase 1
3596,D03DUI,GBR 830,Atopic dermatitis , Phase 2
3597,D03DUY,BMS-833923,Solid tumour/cancer , Phase 1b
3598,D03DVD,Norovirus virus-like particle vaccine,Norovirus infection , Phase 1/2
3599,D03DVJ,Propylhexedrine,Obesity , Approved
3600,D03DVV,NC-1006,Heart arrhythmia , Terminated
3601,D03DWZ,SNP-002,Major depressive disorder , Investigative
3602,D03DXN,Polyestradiol Phosphate,Prostate cancer , Approved
3603,D03DXS,Odapipam,Psychotic disorder , Discontinued in Phase 1
3604,D03DYB,AZD-0275,Rheumatoid arthritis , Terminated
3605,D03DYB,AZD-0275,Chronic obstructive pulmonary disease , Terminated
3606,D03DYT,K252a,Solid tumour/cancer , Investigative
3607,D03DZK,WSBI-19711A,Autoimmune diabetes , Investigative
3608,D03EBK,HIV-specific STAR fusions,Human immunodeficiency virus infection , Investigative
3609,D03EBV,JNS-001,Attention deficit hyperactivity disorder , Phase 3
3610,D03EDD,VN/107-1,Prostate cancer , Investigative
3611,D03EDQ,Vismodegib,Basal cell carcinoma , Approved
3612,D03EDQ,Vismodegib,Primitive neuroectodermal tumour medulloblastoma , Phase 2
3613,D03EEA,PMID25666693-Compound-70,Osteoarthritis pain , Patented
3614,D03EEA,PMID25666693-Compound-70,Cancer related pain , Patented
3615,D03EEA,PMID25666693-Compound-70,Neuropathic pain , Patented
3616,D03EEA,PMID25666693-Compound-70,Inflammatory pain , Patented
3617,D03EEH,Gadodiamide,Central nervous system disease , Approved
3618,D03EER,Thyrotropin,Hypothyroidism , Approved
3619,D03EFD,KT-95,Inflammatory bowel disease , Terminated
3620,D03EHN,Avdoralimab,Coronavirus Disease 2019 (COVID-19) , Phase 2
3621,D03EHR,Lecimibide,Hyperlipidaemia , Terminated
3622,D03EIA,Anti-CD19-CAR T,leukaemia , Phase 1
3623,D03EIA,Anti-CD19-CAR T,Lymphoma , Phase 1
3624,D03EIC,ZD-7349,Multiple sclerosis , Discontinued in Phase 1
3625,D03EIG,C3BS-GQR-1,Myocardial infarction , Investigative
3626,D03EIK,NV.RYM.09,Ocular disease , Investigative
3627,D03ELL,Amisulpride,Schizophrenia , Approved
3628,D03END,Insecticide,Pest attack , Investigative
3629,D03EOF,Meplazumab,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
3630,D03EOT,Borocaptate sodium B 10,Brain cancer , Approved
3631,D03EOZ,IMG-7289,Acute myeloid leukaemia , Phase 2
3632,D03EOZ,IMG-7289,Myelodysplastic syndrome , Phase 2
3633,D03EOZ,IMG-7289,Myelofibrosis , Phase 1/2
3634,D03ERR,H1N1 influenza vaccine,Influenza virus infection , Phase 3
3635,D03ESO,GW-3333,Chronic obstructive pulmonary disease , Preclinical
3636,D03ESU,Anti-SEB mabs,Bacterial infection , Investigative
3637,D03ESW,Cetefloxacin,Bacterial infection , Discontinued in Phase 1
3638,D03EWD,CTAP101,Kidney disease , Preregistration
3639,D03EXK,Povidone-iodine,Bacterial infection , Approved
3640,D03EZB,AR-H047108,Duodenal ulcer , Discontinued in Phase 2
3641,D03EZE,GSK2126458,Lymphoma , Phase 1
3642,D03EZQ,AN-1006,Solid tumour/cancer , Terminated
3643,D03EZR,CMD-003,Lymphoma , Phase 2
3644,D03EZR,CMD-003,Non-hodgkin lymphoma , Phase 2
3645,D03FAP,A-75729,Bacterial infection , Terminated
3646,D03FBV,PF-04950615,Hypercholesterolaemia , Phase 3
3647,D03FCF,Novolimus,Artery stenosis , Approved
3648,D03FDN,PMID26161824-Compound-69,Obesity , Patented
3649,D03FDT,Phenolphthalein,Constipation , Withdrawn from market
3650,D03FEO,Ipecac,Poison intoxication , Approved
3651,D03FEP,Nanofibers,Myocardial infarction , Investigative
3652,D03FFA,HB-AS02V,Hepatitis B virus infection , Phase 3
3653,D03FFL,Chitosan-thiomer,Xerophthalmia , Phase 2
3654,D03FFY,AZD3355,Gastroesophageal reflux disease , Discontinued in Phase 2
3655,D03FGI,Anti-LAG3 mAb,Recurrent glioblastoma , Phase 1
3656,D03FIE,AEZS-126,Solid tumour/cancer , Investigative
3657,D03FIL,Insulin Zinc Susp Recombinant Human,Diabetic complication , Approved
3658,D03FIS,EDP-23,Solid tumour/cancer , Investigative
3659,D03FKQ,Ultrase,Pancreatic malfunction , Approved
3660,D03FLC,Lamotrigine,Bipolar disorder , Approved
3661,D03FLC,Lamotrigine,Epilepsy , Approved
3662,D03FLT,CP-331684,Diabetic complication , Phase 2
3663,D03FNJ,Pipobroman,Refractory chronic myeloid leukaemia , Approved
3664,D03FON,Comvac5,Hepatitis B virus infection , Approved
3665,D03FOP,AMG 319,Myeloid leukaemia , Phase 1
3666,D03FOP,AMG 319,Hematologic tumour , Phase 1
3667,D03FOT,AMD-AAV7,Age-related macular degeneration , Investigative
3668,D03FPA,APP-018,Arteriosclerosis , Discontinued in Phase 1
3669,D03FQY,PMID26815044-Compound-121,Albinism , Patented
3670,D03FQY,PMID26815044-Compound-121,Ephelides , Patented
3671,D03FQY,PMID26815044-Compound-121,Menkes disease , Patented
3672,D03FQY,PMID26815044-Compound-121,Senile lentigines , Patented
3673,D03FQY,PMID26815044-Compound-121,Melasma , Patented
3674,D03FSF,PMID25666693-Compound-73,Osteoarthritis pain , Patented
3675,D03FSF,PMID25666693-Compound-73,Cancer related pain , Patented
3676,D03FSF,PMID25666693-Compound-73,Neuropathic pain , Patented
3677,D03FSF,PMID25666693-Compound-73,Inflammatory pain , Patented
3678,D03FUG,Pegylated carboxyhemoglobin,Sickle-cell disorder , Phase 2
3679,D03FUO,GDC-0834,Rheumatoid arthritis , Terminated
3680,D03FVI,97-139,Cerebrovascular disease , Discontinued in Phase 2
3681,D03FVR,GSK-1827771,Rheumatoid arthritis , Phase 1
3682,D03FVS,Salvicine,Solid tumour/cancer , Phase 2
3683,D03FXM,Protamine,Bleeding disorder , Approved
3684,D03GAI,IR-103,Human immunodeficiency virus infection , Discontinued in Phase 3
3685,D03GAN,A-558693,Neurological disorder , Investigative
3686,D03GAX,TAK-802,Urinary dysfunction , Discontinued in Phase 2
3687,D03GAY,H-409/22,Cardiovascular disease , Discontinued in Phase 2
3688,D03GCJ,Carteolol,Glaucoma/ocular hypertension , Approved
3689,D03GCR,MK-8742,Hepatitis C virus infection , Phase 3
3690,D03GET,Menadione,Vitamin K deficiency , Approved
3691,D03GET,Menadione,Prostate cancer , Phase 2
3692,D03GFC,AZD-7545,Diabetic complication , Terminated
3693,D03GFZ,"Thieno[3,2-c]pyridine-7-carboxamide derivative 2",Solid tumour/cancer , Patented
3694,D03GFZ,"Thieno[3,2-c]pyridine-7-carboxamide derivative 2",Metastatic cancer , Patented
3695,D03GGN,RO-09-4889,Solid tumour/cancer , Phase 1
3696,D03GHR,C-myb,Pain , Investigative
3697,D03GHV,PR1 peptide antigen vaccine,Acute myeloid leukaemia , Phase 3
3698,D03GII,SR-26831,Rheumatoid arthritis , Terminated
3699,D03GIV,SNP-001,Epilepsy , Investigative
3700,D03GKP,FD-891,Solid tumour/cancer , Terminated
3701,D03GLK,Imidazole derivative 1,Obesity , Patented
3702,D03GLL,TSS-HIG,Endotoxic shock , Investigative
3703,D03GLM,BMS-210285,Type-2 diabetes , Terminated
3704,D03GNI,ISOQUINE,Malaria , Phase 1
3705,D03GNR,ANA-975,Immune System disease , Discontinued in Phase 1
3706,D03GOI,Liraglutide,Type-2 diabetes , Approved
3707,D03GOI,Liraglutide,Obesity , Phase 2
3708,D03GOO,Fumaric acid,Multiple sclerosis , Phase 3
3709,D03GOO,Fumaric acid,Pustular palmoplantar psoriasis , Phase 3
3710,D03GOP,Imvamune smallpox vaccine,Virus infection , Approved
3711,D03GOP,Imvamune smallpox vaccine,Smallpox , Phase 3
3712,D03GOP,Imvamune smallpox vaccine,Monkeypox virus infection , Phase 3
3713,D03GPK,DA-9801,Diabetic neuropathy , Phase 2
3714,D03GQC,PD-117596,Bacterial infection , Terminated
3715,D03GQH,B-581,Solid tumour/cancer , Terminated
3716,D03GRD,AX-200,Cardiovascular disease , Phase 2
3717,D03GSN,KVD001,Diabetic macular edema , Phase 2
3718,D03GTO,C-Met/PD-L1 CAR-T Cell,Hepatocellular carcinoma , Phase 1
3719,D03GVC,Methyclothiazide,Edema , Approved
3720,D03GVC,Methyclothiazide,Hypertension , Approved
3721,D03GVG,NP-2,Influenza A virus infection , Phase 2
3722,D03GWV,ZP-002,Inflammation , Investigative
3723,D03GWY,Ciglitazone,Pulmonary fibrosis , Preclinical
3724,D03GXU,WIN-901,Asthma , Phase 2
3725,D03GYK,Laropiprant+niacin,Dyslipidemia , Discontinued in Phase 3
3726,D03HAA,PMID30107136-Compound-Example45,Solid tumour/cancer , Patented
3727,D03HAA,PMID30107136-Compound-Example45,Infectious disease , Patented
3728,D03HAA,PMID30107136-Compound-Example45,Human immunodeficiency virus infection , Patented
3729,D03HAA,PMID30107136-Compound-Example45,Hepatitis , Patented
3730,D03HAW,HemaMax,Myelodysplastic syndrome , Phase 2
3731,D03HCZ,Propoxyphene Hydrochloride,Pain , Approved
3732,D03HDL,MK 8719,Progressive supranuclear palsy , Phase 1
3733,D03HDP,ACEA-1416,Cerebrovascular ischaemia , Terminated
3734,D03HDV,DWP-431,Bone development disorder , Phase 3
3735,D03HFG,Fluvoxamine,Depression , Approved
3736,D03HGP,CTP-conjugated WT1 peptide,Solid tumour/cancer , Investigative
3737,D03HGW,AV-370,Solid tumour/cancer , Investigative
3738,D03HHD,Pyrazoline derivative 4,Obesity , Patented
3739,D03HHG,PMID26651364-Compound-121,Crohn disease , Patented
3740,D03HHG,PMID26651364-Compound-121,Ulcerative colitis , Patented
3741,D03HHG,PMID26651364-Compound-121,Urinary tract infection , Patented
3742,D03HHJ,GSK3174998,Haematological malignancy , Phase 1
3743,D03HHJ,GSK3174998,Solid tumour/cancer , Phase 1
3744,D03HIG,AVX-470,Inflammatory bowel disease , Phase 1
3745,D03HIG,AVX-470,Ulcerative colitis , Phase 1
3746,D03HJK,Zithromax,Syphilis infection , Approved
3747,D03HJZ,AZ-11657312,Inflammation , Investigative
3748,D03HKA,ZFP TF,Pain , Investigative
3749,D03HKR,CDX-0158,Gastrointestinal stromal tumour , Phase 1
3750,D03HKR,CDX-0158,Solid tumour/cancer , Phase 1
3751,D03HKR,CDX-0158,Tumour , Phase 1
3752,D03HLK,PRT-060096,Cardiovascular disease , Investigative
3753,D03HML,CD56-specific gene-engineered T cells,Acute myeloid leukaemia , Phase 1/2
3754,D03HMM,ABS-201,Psychotic disorder , Investigative
3755,D03HOP,HG-1220,Solid tumour/cancer , Investigative
3756,D03HOT,BC-19,Brain disease , Investigative
3757,D03HQE,CRT0066101,Solid tumour/cancer , Investigative
3758,D03HQR,SUN-44,Nervous system disease , Investigative
3759,D03HSA,Actimab-A,Acute myeloid leukaemia , Phase 2
3760,D03HSF,Ro-23-7777,Fungal infection , Terminated
3761,D03HSN,CNTO-1959,Plaque psoriasis , Approved
3762,D03HSN,CNTO-1959,Asthma , Phase 3
3763,D03HSQ,GBR-401,B-cell lymphoma , Investigative
3764,D03HSS,LG-1041,Hunter syndrome , Investigative
3765,D03HTI,HMR-3787,Bacterial infection , Terminated
3766,D03HTZ,LD201t1,Inflammation , Investigative
3767,D03HUX,PCM-075,Acute myeloid leukaemia , Phase 2
3768,D03HUX,PCM-075,Prostate cancer , Phase 2
3769,D03HUX,PCM-075,Solid tumour/cancer , Phase 1
3770,D03HVN,P-1,Atopic dermatitis , Discontinued in Phase 3
3771,D03HVV,Efaproxyn,Lung cancer , Phase 3
3772,D03HXO,NPS-1,Solid tumour/cancer , Investigative
3773,D03HYQ,Ranolazine,Chronic/stable angina , Approved
3774,D03HYQ,Ranolazine,Paroxysmal atrial fibrillation , Phase 2
3775,D03HYX,Mometasone,Skin allergy , Approved
3776,D03IBI,Levotofisopam,Anxiety disorder , Phase 2
3777,D03ICO,AR-709,Bacterial infection , Terminated
3778,D03ICS,NPT-500,Major depressive disorder , Investigative
3779,D03IDK,CEP-18050,Lymphoma , Investigative
3780,D03IDU,Hydrogen peroxide,Infectious disease , Approved
3781,D03IEB,Penecure,Onychomycosis , Investigative
3782,D03IGB,BVT.28949,Glaucoma/ocular hypertension , Phase 2
3783,D03IGH,Darunavir,Human immunodeficiency virus infection , Approved
3784,D03IGH,Darunavir,Human immunodeficiency virus-1 infection , Phase 3
3785,D03IHA,GT 1061,Alzheimer disease , Investigative
3786,D03IHD,Anti-CD22-CAR-transduced T cells,leukaemia , Phase 1/2
3787,D03IHD,Anti-CD22-CAR-transduced T cells,Lymphoma , Phase 1/2
3788,D03IIP,EP-3533,Myocardial infarction , Terminated
3789,D03IJO,GS-9820,Lymphoma , Phase 1
3790,D03IJO,GS-9820,Chronic lymphocytic leukaemia , Phase 1
3791,D03IJZ,Recombinant botulinum toxin,Neurological disorder , Investigative
3792,D03IKT,Paramethasone,Inflammation , Approved
3793,D03IKT,Paramethasone,Diabetic macular edema , Phase 3
3794,D03IKZ,HBP-347,Autoimmune diabetes , Discontinued in Phase 3
3795,D03ILU,D17.4,Myasthenia gravis , Investigative
3796,D03IMU,TNFR1 NAM,Multiple sclerosis , Investigative
3797,D03INC,Triplelastat,Kidney transplant rejection , Investigative
3798,D03ING,Anrukinzumab,Ulcerative colitis , Phase 2
3799,D03ING,Anrukinzumab,Asthma , Phase 2
3800,D03INQ,Laevo-Bambuterol,Asthma , Phase 1
3801,D03IOM,CART-19,Acute lymphoblastic leukaemia , Phase 2/3
3802,D03IQD,PF-06480605,Crohn disease , Phase 1
3803,D03IQH,EDG-006,Major depressive disorder , Investigative
3804,D03IQK,BC-821,Bladder cancer , Investigative
3805,D03IQP,Alpha-Helical lipopeptides LLS,Middle East Respiratory Syndrome (MERS) , Preclinical
3806,D03IRG,PNK-007,Acute myeloid leukaemia , Phase 1
3807,D03IRG,PNK-007,Multiple myeloma , Phase 1
3808,D03ISE,PAFENOLOL,Hypertension , Discontinued in Phase 1
3809,D03ISJ,BMS-863233,Haematological malignancy , Phase 1/2
3810,D03ITZ,Aryl mannoside derivative 4,Crohn disease , Patented
3811,D03ITZ,Aryl mannoside derivative 4,Ulcerative colitis , Patented
3812,D03ITZ,Aryl mannoside derivative 4,Urinary tract infection , Patented
3813,D03IUD,Ceftolozane sulfate,Respiratory tract infection , Phase 4
3814,D03IUY,Estropipate,Hypogonadism , Approved
3815,D03IWT,NT-13317,Neuropathic pain , Investigative
3816,D03IXK,ME-344,Breast cancer , Phase 1/2
3817,D03IXK,ME-344,Solid tumour/cancer , Preclinical
3818,D03JAA,Glycodiazine,Diabetic complication , Approved
3819,D03JAF,Nrti,Human immunodeficiency virus infection , Investigative
3820,D03JBI,PPI-03306,Obstructive sleep apnea , Investigative
3821,D03JCA,MB-11055,Fatty liver disease , Phase 2
3822,D03JCT,M-110101,Seborrhea , Investigative
3823,D03JDA,Nu-3,Diabetic foot ulcer , Phase 1/2
3824,D03JDA,Nu-3,Bacterial infection , Investigative
3825,D03JFJ,PMID26651364-Compound-108,Crohn disease , Patented
3826,D03JFJ,PMID26651364-Compound-108,Ulcerative colitis , Patented
3827,D03JFJ,PMID26651364-Compound-108,Urinary tract infection , Patented
3828,D03JHJ,FK-352,Hypertension , Discontinued in Phase 2
3829,D03JIH,SSR-125180,Obesity , Discontinued in Phase 1
3830,D03JJY,GANTACURIUM CHLORIDE,Anaesthesia , Phase 1/2
3831,D03JLR,PLX51107,Haematological malignancy , Phase 1
3832,D03JLR,PLX51107,Solid tumour/cancer , Phase 1
3833,D03JMF,IKI-1,Solid tumour/cancer , Investigative
3834,D03JMN,AD-177,Psoriasis vulgaris , Terminated
3835,D03JNS,Peanut allergy vaccine,Peanut hypersensitivity , Phase 1
3836,D03JOA,Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes,Acute lymphoblastic leukaemia , Phase 1/2
3837,D03JOA,Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes,Chronic lymphocytic leukaemia , Phase 1/2
3838,D03JOA,Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes,Mantle cell lymphoma , Phase 1/2
3839,D03JOA,Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes,Non-hodgkin lymphoma , Phase 1/2
3840,D03JPH,Isoxicam,Osteoarthritis , Withdrawn from market
3841,D03JQR,RG-7273,Lipid metabolism disorder , Discontinued in Phase 1
3842,D03JRA,Beta-lactam,Neisseria meningitis infection , Investigative
3843,D03JRG,VU0364739,Coagulation defect , Clinical trial
3844,D03JRJ,NTE-122,Arteriosclerosis , Terminated
3845,D03JRL,TDI-0102,Motor neurone disease , Investigative
3846,D03JRO,ADCI,Epileptic seizures , Phase 1
3847,D03JSJ,Mupirocin,Bacterial infection , Approved
3848,D03JSO,ASP-2535,Schizophrenia , Discontinued in Phase 1
3849,D03JSS,Tidembersat,Migraine , Discontinued in Phase 1
3850,D03JTG,Fruquintinib,Solid tumour/cancer , Phase 3
3851,D03JTL,APVO414,Prostate cancer , Phase 1
3852,D03JUF,KRL-104,Generalized anxiety disorder , Phase 1
3853,D03JUM,Pentaxim,Bordetella pertussis infection , Approved
3854,D03JUN,Anti-IL31,Immune System disease , Investigative
3855,D03JWU,REC-01,Acute myocardial infarction , Phase 1
3856,D03JXN,Recombinant anti-IgE Fabs,Asthma , Investigative
3857,D03JXR,NOSO-74,Bacterial infection , Investigative
3858,D03JYD,Tnk-6123,Human immunodeficiency virus infection , Investigative
3859,D03JZC,PF-06263507,Solid tumour/cancer , Phase 1
3860,D03JZD,Neurosolve,Glaucoma/ocular hypertension , Preclinical
3861,D03KAC,XL147,Solid tumour/cancer , Phase 2
3862,D03KAV,Biphenyl mannoside derivative 12,Crohn disease , Patented
3863,D03KAV,Biphenyl mannoside derivative 12,Ulcerative colitis , Patented
3864,D03KAV,Biphenyl mannoside derivative 12,Urinary tract infection , Patented
3865,D03KAY,Darunavir + ritonavir + oseltamivir + hydroxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
3866,D03KDO,Prochymal,Graft-versus-host disease , Phase 3
3867,D03KDO,Prochymal,Crohn disease , Phase 3
3868,D03KDO,Prochymal,Acute radiation syndrome , Phase 3
3869,D03KDO,Prochymal,Heart disease , Phase 3
3870,D03KEK,Artemisinin SP,Malaria , Approved
3871,D03KFJ,TB-102,Bleeding disorder , Investigative
3872,D03KGH,Upamostat,Breast cancer , Phase 2
3873,D03KHN,CLR-1404,Solid tumour/cancer , Phase 2
3874,D03KHO,PF-05175157,Type-2 diabetes , Phase 2
3875,D03KHQ,DNA-Ad,Malaria , Phase 1/2
3876,D03KHX,MC-D11,Norovirus infection , Phase 1/2
3877,D03KIA,Cerivastatin,Hyperlipidaemia , Approved
3878,D03KIA,Cerivastatin,Multiple myeloma , Phase 1/2
3879,D03KIK,AP-300,Bladder cancer , Investigative
3880,D03KIZ,RG7596,Haematological malignancy , Phase 2
3881,D03KJP,Meningococcal CYW vaccine,Neisseria meningitis infection , Terminated
3882,D03KJS,Antalarmin,Depression , Terminated
3883,D03KJU,NV-04,Cardiovascular disease , Phase 1
3884,D03KJV,Ultramorph,Pain , Discontinued in Phase 2
3885,D03KLF,MDX-1203,Solid tumour/cancer , Phase 1
3886,D03KLU,CT-406,Cardiovascular disease , Investigative
3887,D03KNZ,Monoamine derivative 3,Albinism , Patented
3888,D03KNZ,Monoamine derivative 3,Ephelides , Patented
3889,D03KNZ,Monoamine derivative 3,Menkes disease , Patented
3890,D03KNZ,Monoamine derivative 3,Senile lentigines , Patented
3891,D03KNZ,Monoamine derivative 3,Melasma , Patented
3892,D03KOU,XPro-1595,Inflammation , Investigative
3893,D03KOZ,Epalrestat,Diabetic neuropathy , Approved
3894,D03KOZ,Epalrestat,Pain , Investigative
3895,D03KPZ,Ciprofloxacin+dexamethasone,Otitis externa , Approved
3896,D03KPZ,Ciprofloxacin+dexamethasone,Acute otitis media , Approved
3897,D03KQF,Maprotiline,Major depressive disorder , Approved
3898,D03KRF,Superoxide dismutase mimetics,Retinopathy , Investigative
3899,D03KST,KT2-962,Thrombosis , Discontinued in Phase 1
3900,D03KTD,Chromomycin a3,Solid tumour/cancer , Approved
3901,D03KTE,LGD2941,Osteoporosis , Discontinued in Phase 1
3902,D03KTK,TAK-937,Cerebrovascular ischaemia , Discontinued in Phase 1
3903,D03KTU,BMS-561388,Anxiety disorder , Investigative
3904,D03KUB,Deslorelin,Solid tumour/cancer , Approved
3905,D03KVW,MDX-1411,Solid tumour/cancer , Phase 1
3906,D03KVY,BCT303,Hypothyroidism , Phase 2
3907,D03KWN,AZD-6703,Rheumatoid arthritis , Discontinued in Phase 1
3908,D03KWU,VRP-S vaccine,Middle East Respiratory Syndrome (MERS) , Investigative
3909,D03KXY,Doxifluridine,Solid tumour/cancer , Approved
3910,D03KYG,Perindopril,Hypertension , Approved
3911,D03KYI,IMD-1622,Myocardial infarction , Investigative
3912,D03KZM,Tolvaptan,Hyponatraemia , Approved
3913,D03KZM,Tolvaptan,Heart failure , Phase 3
3914,D03LAB,TBC-3711,Hypotension , Phase 2
3915,D03LAI,MSB0010445,Melanoma , Phase 2
3916,D03LAL,RBBX-01,Solid tumour/cancer , Phase 1
3917,D03LAV,MEDI0700,Systemic lupus erythematosus , Phase 1
3918,D03LBD,G-115,Prostate cancer , Investigative
3919,D03LCX,CCX-662,Solid tumour/cancer , Investigative
3920,D03LFA,Allogeneic CART-19,leukaemia , Phase 1
3921,D03LFR,SB-756050,Type-2 diabetes , Discontinued in Phase 2
3922,D03LGG,Zucapsacin,Osteoarthritis , Approved
3923,D03LGX,NI-105,Neurodegenerative disorder , Investigative
3924,D03LGY,Divalproex sodium,Seizure disorder , Approved
3925,D03LIE,PAV-059,Encephalitis virus infection , Investigative
3926,D03LJR,Sirolimus,Organ transplant rejection , Approved
3927,D03LJR,Sirolimus,Multiple myeloma , Approved
3928,D03LJR,Sirolimus,Dutch elm disease , Phase 1/2
3929,D03LKU,Spheramine,Parkinson disease , Phase 2
3930,D03LKV,BMN045,Duchenne dystrophy , Phase 2
3931,D03LLL,PRX-12255,Neurological disorder , Investigative
3932,D03LMK,IB-07A085,Fungal infection , Investigative
3933,D03LNM,TK-112690,Mucositis , Investigative
3934,D03LNN,IDX136,Hepatitis C virus infection , Preclinical
3935,D03LNV,Argotom-VAX,Human immunodeficiency virus infection , Investigative
3936,D03LQC,APD-209,Cachexia , Phase 2
3937,D03LQQ,Alinidine,Angina pectoris , Discontinued in Phase 3
3938,D03LRU,Alvespimycin hydrochloride,Refractory hematologic malignancy , Phase 1
3939,D03LRU,Alvespimycin hydrochloride,Ovarian cancer , Phase 1
3940,D03LSO,SPD-418,Epilepsy , Discontinued in Phase 1
3941,D03LTA,Haemophilus influenzae B vaccine,Haemophilus influenza , Approved
3942,D03LTO,Tigatuzumab,Pancreatic cancer , Phase 2
3943,D03LTO,Tigatuzumab,Ovarian cancer , Phase 2
3944,D03LTO,Tigatuzumab,Liver cancer , Phase 2
3945,D03LTO,Tigatuzumab,Colorectal cancer , Phase 2
3946,D03LTO,Tigatuzumab,Breast cancer , Phase 2
3947,D03LUF,CD137 CAR-T Cell,Acute lymphoblastic leukaemia , Phase 1/2
3948,D03LUF,CD137 CAR-T Cell,B-cell lymphoma , Phase 1/2
3949,D03LUN,Laronidase,Mucopolysaccharidosis , Approved
3950,D03LWG,BGJ398,Cholangiocarcinoma , Phase 3
3951,D03LWG,BGJ398,Solid tumour/cancer , Phase 2
3952,D03LWO,Desirudin Recombinant,Coagulation defect , Approved
3953,D03LXH,GAI-122,Liver disease , Investigative
3954,D03LXJ,KB-2683,Arthritis , Discontinued in Phase 1
3955,D03LZK,APS-3010,Solid tumour/cancer , Investigative
3956,D03MAD,CP-800569,Arteriosclerosis , Discontinued in Phase 1
3957,D03MBU,SC-006,Colorectal cancer , Phase 1
3958,D03MBU,SC-006,Solid tumour/cancer , Phase 1
3959,D03MCV,RB-006,Vascular disease , Discontinued in Phase 3
3960,D03MCV,RB-006,Coronary artery disease , Discontinued in Phase 3
3961,D03MCV,RB-006,Thrombosis , Discontinued in Phase 3
3962,D03MDV,PAT-CSL1,Solid tumour/cancer , Investigative
3963,D03MDW,DS-7309,Diabetic complication , Phase 1
3964,D03MDY,PLX9486,Gastrointestinal stromal tumour , Phase 1/2
3965,D03MDY,PLX9486,Solid tumour/cancer , Phase 1
3966,D03MER,Endogenous human peptide LL-37,Wound healing , Investigative
3967,D03MEU,Pathogen-specific aAPCs vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
3968,D03MFQ,CHF-5074,Alzheimer disease , Phase 2
3969,D03MFQ,CHF-5074,Cognitive impairment , Phase 2
3970,D03MFV,MNLP-18,Virus infection , Preclinical
3971,D03MGL,Tafamidis meglumine,Hereditary amyloidosis , Approved
3972,D03MGL,Tafamidis meglumine,Transthyretin familial amyloid cardiomyopathy , Phase 3
3973,D03MGV,ASP-5034,Non-insulin dependent diabetes , Discontinued in Phase 1
3974,D03MIN,M-0004,Gastroesophageal reflux disease , Phase 1
3975,D03MIP,SPI-256,Human immunodeficiency virus infection , Discontinued in Phase 1
3976,D03MIR,Doxazosin,Hypertension , Approved
3977,D03MKE,Resorcinol compound 15,Albinism , Patented
3978,D03MKE,Resorcinol compound 15,Ephelides , Patented
3979,D03MKE,Resorcinol compound 15,Menkes disease , Patented
3980,D03MKE,Resorcinol compound 15,Senile lentigines , Patented
3981,D03MKE,Resorcinol compound 15,Melasma , Patented
3982,D03MLR,ADE-LAM,Wound healing , Investigative
3983,D03MNN,SKI-758,Ischemia , Approved
3984,D03MNS,ADL-7445,Constipation , Discontinued in Phase 1
3985,D03MSF,Nerenone,Diabetic nephropathy , Phase 2
3986,D03MSN,HD-101,Asthma , Investigative
3987,D03MSV,PB-1023,Type-2 diabetes , Phase 2
3988,D03MTN,Mepolizumab,Severe asthma , Approved
3989,D03MTN,Mepolizumab,Asthma , Phase 2/3
3990,D03MTY,LA22-radioimmunoconjugates,Solid tumour/cancer , Investigative
3991,D03MUM,EDONENTAN HYDRATE,Pulmonary arterial hypertension , Discontinued in Phase 2
3992,D03MUT,Calfactant,Acute lung injury , Approved
3993,D03MWM,Oncolysin B,Bone marrow transplantation , Discontinued in Phase 2
3994,D03MWZ,Syntropin,Dwarfism , Phase 1
3995,D03MXK,AT-406,Squamous head and neck cell carcinom , Phase 3
3996,D03MXK,AT-406,Solid tumour/cancer , Phase 2
3997,D03MXK,AT-406,Lymphoma , Phase 1/2
3998,D03MXK,AT-406,Acute myeloid leukaemia , Phase 1
3999,D03MYO,MGL-3196,Familial hypercholesterolemia , Phase 2
4000,D03MYO,MGL-3196,Hyperlipidaemia , Phase 1
4001,D03MYO,MGL-3196,Hypercholesterolaemia , Phase 1
4002,D03MYX,AM0010,Pancreatic ductal carcinoma , Phase 3
4003,D03MYX,AM0010,Pancreatic cancer , Phase 3
4004,D03MYX,AM0010,Solid tumour/cancer , Phase 1
4005,D03MYX,AM0010,Renal cell carcinoma , Phase 1
4006,D03MYX,AM0010,Non-small-cell lung cancer , Phase 1
4007,D03MZJ,BUCINDOLOL,Atrial fibrillation , Phase 2/3
4008,D03MZJ,BUCINDOLOL,Hypertension , Phase 2
4009,D03MZQ,Sevelamer hydrochloride,Hypophosphatasia , Approved
4010,D03MZU,AHCQ,Asthma , Phase 2
4011,D03NAW,Dulaglutide,Type-2 diabetes , Approved
4012,D03NCL,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3",Albinism , Patented
4013,D03NCL,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3",Ephelides , Patented
4014,D03NCL,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3",Menkes disease , Patented
4015,D03NCL,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3",Senile lentigines , Patented
4016,D03NCL,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 3",Melasma , Patented
4017,D03NDI,KCO-912,Chronic obstructive pulmonary disease , Discontinued in Phase 2
4018,D03NGH,Ramoplanin,Bacterial infection , Phase 3
4019,D03NHS,PCO371,Hypoparathyroidism , Phase 1
4020,D03NHW,Ofloxacin,Bacterial infection , Approved
4021,D03NHZ,Engineered toxin bodies,Solid tumour/cancer , Investigative
4022,D03NIW,B244,Hypertension , Phase 2
4023,D03NJN,PAT-SM5,Solid tumour/cancer , Investigative
4024,D03NJY,SF1126,Head and neck cancer , Phase 2
4025,D03NJY,SF1126,Solid tumour/cancer , Phase 1
4026,D03NJY,SF1126,Hepatocellular carcinoma , Phase 1
4027,D03NLJ,FGI-106,Virus infection , Investigative
4028,D03NLQ,ABT-957,Alzheimer disease , Phase 1
4029,D03NLV,KDT-501,Inflammation , Phase 2
4030,D03NLV,KDT-501,Type-2 diabetes , Phase 2
4031,D03NMM,AM-643,Dermatological disease , Investigative
4032,D03NMQ,131I-CLR-1404,Solid tumour/cancer , Phase 2
4033,D03NOS,Rimiterol,Asthma , Approved
4034,D03NPH,Quazepam,Insomnia , Approved
4035,D03NPI,Idecabtagene vicleucel,Multiple myeloma , Approved
4036,D03NPZ,NNC-22-0031,Psychotic disorder , Terminated
4037,D03NTF,CWP-231,Solid tumour/cancer , Phase 1
4038,D03NTJ,Prolixin decanoate,Schizophrenia , Approved
4039,D03NVS,NC-003,Myalgia , Phase 2
4040,D03NWC,SNG-8023,Breast cancer , Investigative
4041,D03NXS,GKT-04,Angiogenesis disorder , Investigative
4042,D03NZM,T-588,Amyotrophic lateral sclerosis , Discontinued in Phase 2
4043,D03NZV,SC-236,Solid tumour/cancer , Terminated
4044,D03OBV,AS-1405,Solid tumour/cancer , Terminated
4045,D03OCG,FGF-21,Type-2 diabetes , Discontinued in Phase 1/2
4046,D03ODX,IC-84,Multiple sclerosis , Phase 1
4047,D03OFA,Ro-09-1428,Bacterial infection , Terminated
4048,D03OFF,Pioglitazone,Diabetic complication , Approved
4049,D03OFF,Pioglitazone,Type-2 diabetes , Phase 3
4050,D03OFF,Pioglitazone,Obesity , Investigative
4051,D03OFN,NK-314,Solid tumour/cancer , Phase 1
4052,D03OGQ,AZD-7009,Atrial fibrillation , Phase 2
4053,D03OIO,Anti-Mesothelin CAR-T cells,Solid tumour/cancer , Phase 1
4054,D03OIW,Kinetin,Skin photodamage , Approved
4055,D03OKG,FK-739,Hypertension , Discontinued in Phase 2
4056,D03OKS,DC-IL-12 DNA therapeutic,Melanoma , Phase 1
4057,D03OLA,L-745631,Solid tumour/cancer , Terminated
4058,D03OMK,DM-107,Atopic dermatitis , Investigative
4059,D03ONE,BL-6010,Non-insulin dependent diabetes , Investigative
4060,D03ONX,CL-H02,Headache , Investigative
4061,D03ONZ,MCS-18,Autoimmune diabetes , Phase 2
4062,D03OPE,CL-284027,Cardiac disease , Phase 2
4063,D03OPS,HR2P-M2 peptide,Middle East Respiratory Syndrome (MERS) , Preclinical
4064,D03OQI,Tozadenant,Parkinson disease , Phase 3
4065,D03OSE,GVAX,Multiple myeloma , Phase 2
4066,D03OSG,MBX-8025,Obesity , Phase 2/3
4067,D03OSG,MBX-8025,Familial hypercholesterolemia , Phase 2
4068,D03OSG,MBX-8025,Primary biliary cholangitis , Phase 2
4069,D03OSO,HT-61,Staphylococcus infection , Investigative
4070,D03OTH,Belagenpumatucel-L,Small-cell lung cancer , Phase 3
4071,D03OTH,Belagenpumatucel-L,Non-small-cell lung cancer , Phase 3
4072,D03OTX,PSP-D-GITRL,Solid tumour/cancer , Investigative
4073,D03OVA,8-chloro-adenosine,Solid tumour/cancer , Phase 1/2
4074,D03OVN,ReN-003,Retinitis pigmentosa , Phase 1/2
4075,D03OVN,ReN-003,Retinopathy , Investigative
4076,D03OYY,MAR-531,Hypoglycemia , Investigative
4077,D03PBT,DuP-983,Pruritus , Terminated
4078,D03PBW,PG-760564,Rheumatoid arthritis , Phase 2
4079,D03PCJ,MPI-461359,Human immunodeficiency virus infection , Terminated
4080,D03PCP,NCT-400,Major depressive disorder , Investigative
4081,D03PDY,SB-332235,Chronic obstructive pulmonary disease , Discontinued in Phase 1
4082,D03PEF,Hedgehog labelled stem cells,Breast cancer , Investigative
4083,D03PGE,PG-2,Fatigue , Approved
4084,D03PGS,IONIS-TTRRX,Amyloid cardiomyopathy , Phase 3
4085,D03PHU,Tetrazolast meglumine,Asthma , Discontinued in Phase 2
4086,D03PIA,CB-183315,Malignant carcinoid syndrome , Phase 3
4087,D03PIR,Ceftezole,Urinary tract infection , Approved
4088,D03PJP,Trenonacog alfa,Discovery agent , Discontinued in Phase 3
4089,D03PKI,Geldanamycin,Peripheral nerve damage , Discontinued in Phase 2
4090,D03PKI,Geldanamycin,Kidney cancer , Discontinued in Phase 2
4091,D03PKJ,MK-6186,Human immunodeficiency virus infection , Phase 1
4092,D03PLQ,Benzothiazole analog 3,Albinism , Patented
4093,D03PLQ,Benzothiazole analog 3,Ephelides , Patented
4094,D03PLQ,Benzothiazole analog 3,Menkes disease , Patented
4095,D03PLQ,Benzothiazole analog 3,Senile lentigines , Patented
4096,D03PLQ,Benzothiazole analog 3,Melasma , Patented
4097,D03PLR,RemuneX,Human immunodeficiency virus-1 infection , Phase 3
4098,D03PLR,RemuneX,Melanoma , Discontinued in Phase 3
4099,D03PMB,PTI-601,Pain , Investigative
4100,D03POY,ISIS-AR,Prostate cancer , Phase 1
4101,D03PQW,BAY 79-4620,Solid tumour/cancer , Phase 1
4102,D03PRC,K562/GM-CSF,Acute myeloid leukaemia , Phase 2
4103,D03PRM,NST-141,Pruritus , Phase 2
4104,D03PRV,BGC-20-1259,Parkinson disease , Phase 1
4105,D03PSA,"1,2,4-oxadiazole derivative 2",Solid tumour/cancer , Patented
4106,D03PSA,"1,2,4-oxadiazole derivative 2",Infectious disease , Patented
4107,D03PSA,"1,2,4-oxadiazole derivative 2",Human immunodeficiency virus infection , Patented
4108,D03PSA,"1,2,4-oxadiazole derivative 2",Hepatitis , Patented
4109,D03PSP,Panobacumab,Ventilator-associated pneumonia , Phase 2
4110,D03PSP,Panobacumab,Hospital-acquired pneumonia , Phase 2
4111,D03PSP,Panobacumab,Pseudomonas infection , Phase 1/2
4112,D03PTH,Pyrantel,Worm infection , Approved
4113,D03PTZ,BTS-73947,Psychotic disorder , Discontinued in Phase 1
4114,D03PUA,Siltuximab,Idiopathic multicentric Castlemans disease , approved
4115,D03PUA,Siltuximab,Coronavirus Disease 2019 (COVID-19) , Phase 3
4116,D03PUG,Revax-TBE,Flavivirus infection , Investigative
4117,D03PVQ,EDP-420,Bacterial infection , Phase 2
4118,D03PVY,GlycoPEGylated erythropoietin,Solid tumour/cancer , Discontinued in Phase 2
4119,D03PWD,GMI-1271,Acute myeloid leukaemia , Phase 3
4120,D03PWD,GMI-1271,Multiple myeloma , Phase 1
4121,D03PXT,Altastaph,Staphylococcus infection , Phase 2
4122,D03PYA,Cyclohexyl carbamate derivative 3,Albinism , Patented
4123,D03PYA,Cyclohexyl carbamate derivative 3,Ephelides , Patented
4124,D03PYA,Cyclohexyl carbamate derivative 3,Menkes disease , Patented
4125,D03PYA,Cyclohexyl carbamate derivative 3,Senile lentigines , Patented
4126,D03PYA,Cyclohexyl carbamate derivative 3,Melasma , Patented
4127,D03PYD,K-604,Arteriosclerosis , Phase 2
4128,D03PZY,PHER-O2,Bacterial infection , Investigative
4129,D03PZZ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7",Albinism , Patented
4130,D03PZZ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7",Ephelides , Patented
4131,D03PZZ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7",Menkes disease , Patented
4132,D03PZZ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7",Senile lentigines , Patented
4133,D03PZZ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 7",Melasma , Patented
4134,D03QAO,AZD-9742,MRSA infection , Phase 1
4135,D03QAQ,SN429,Thrombosis , Investigative
4136,D03QAS,E-758,Solid tumour/cancer , Investigative
4137,D03QAW,PMID25666693-Compound-61,Osteoarthritis pain , Patented
4138,D03QAW,PMID25666693-Compound-61,Cancer related pain , Patented
4139,D03QAW,PMID25666693-Compound-61,Neuropathic pain , Patented
4140,D03QAW,PMID25666693-Compound-61,Inflammatory pain , Patented
4141,D03QBL,Autologous idiotypic cancer vaccine,Lymphoma , Phase 1
4142,D03QBS,Furazolidinone,Bacterial infection , Approved
4143,D03QBT,Golnerminogene pradenovac,Esophageal cancer , Phase 3
4144,D03QBY,Anavip,Poison intoxication , Phase 3
4145,D03QCW,Interferon alfa-n1,Chronic myelogenous leukaemia , Approved
4146,D03QEB,VGX-1027,Rheumatoid arthritis , Phase 1
4147,D03QEC,ASP4131,Breast cancer , Investigative
4148,D03QEC,ASP4131,Colorectal cancer , Investigative
4149,D03QFN,Patrome,Parkinson disease , Phase 3
4150,D03QFO,SOR-N43,Pain , Investigative
4151,D03QFY,PPLs,Neurodegenerative disorder , Investigative
4152,D03QGB,JNJ-5207852,Narcolepsy , Investigative
4153,D03QGM,Sulpiride,Schizophrenia , Approved
4154,D03QHC,KAF156,Malaria , Phase 2
4155,D03QHM,JNJ-64041809,Prostate cancer , Phase 1
4156,D03QHR,GFC-036,Leishmania infection , Investigative
4157,D03QIE,Bicifadine,Neuropathic pain , Phase 3
4158,D03QIE,Bicifadine,Chronic low back pain , Phase 3
4159,D03QIP,fluciclovine F-18,Prostate cancer , Approved
4160,D03QJA,GSK-812397,Human immunodeficiency virus-1 infection , Investigative
4161,D03QJL,Ibudilast,Castleman's disease , Approved
4162,D03QJL,Ibudilast,Amyotrophic lateral sclerosis , Phase 2
4163,D03QJL,Ibudilast,Alcohol dependence , Phase 2
4164,D03QJL,Ibudilast,Methamphetamine dependence , Phase 2
4165,D03QJL,Ibudilast,Opioid dependence , Phase 2
4166,D03QJL,Ibudilast,Multiple sclerosis , Phase 2
4167,D03QJN,DPC 423,Thrombosis , Discontinued in Phase 1
4168,D03QKW,KUC-7483,Overactive bladder , Phase 1
4169,D03QLG,CEP1347,Asthma , Phase 2/3
4170,D03QMY,IDM-2101,Colorectal cancer , Phase 2
4171,D03QNA,CIGB-845,Central nervous system disease , Investigative
4172,D03QNW,Hextend,Blood transfusion , Approved
4173,D03QQP,BDNA-003,Chlamydia infection , Investigative
4174,D03QRS,Triptorelin,Solid tumour/cancer , Approved
4175,D03QRS,Triptorelin,Prostate cancer , Phase 4
4176,D03QSC,NT-KC-005,Cerebrovascular ischaemia , Investigative
4177,D03QSR,TP-20,Cerebrovascular ischaemia , Terminated
4178,D03QSS,AMX0035,Amyotrophic lateral sclerosis , Phase 2
4179,D03QTB,NSD-551,Brain cancer , Terminated
4180,D03QTM,Oncophage vitespen,Hepatitis B virus infection , Phase 3
4181,D03QTP,CGP-52411,Solid tumour/cancer , Terminated
4182,D03QUJ,PYM-60001,Chronic obstructive pulmonary disease , Investigative
4183,D03QVY,EZN-4482,Solid tumour/cancer , Investigative
4184,D03QWG,Ad-IFN-alpha,Bladder cancer , Phase 1
4185,D03QWO,Dexefaroxan,Parkinson disease , Phase 2
4186,D03QWO,Dexefaroxan,Schizophrenia , Discontinued in Phase 2
4187,D03QWT,Doripenem,Urinary tract infection , Approved
4188,D03QWT,Doripenem,Gram-positive bacterial infection , Phase 3
4189,D03QWZ,PP-099,Myocardial infarction , Phase 2
4190,D03QXD,RXP-470,Arteriosclerosis , Investigative
4191,D03QZB,F-1394,Arteriosclerosis , Discontinued in Phase 1
4192,D03QZJ,CC-122,Solid tumour/cancer , Phase 1
4193,D03QZJ,CC-122,Recurrent glioblastoma , Phase 1
4194,D03QZJ,CC-122,Chronic lymphocytic leukaemia , Phase 1
4195,D03QZJ,CC-122,Diffuse large B-cell lymphoma , Phase 1
4196,D03QZJ,CC-122,Hepatocellular carcinoma , Phase 1
4197,D03QZJ,CC-122,Lymphoma , Phase 1
4198,D03QZJ,CC-122,Multiple myeloma , Phase 1
4199,D03RCB,FGI-101-1A6,Influenza virus infection , Phase 1
4200,D03RCJ,Sodium Succinate,Arthritis , Approved
4201,D03RCP,NM-135,Dermatitis , Discontinued in Phase 2
4202,D03RCV,D2A21,Burn and burn infection , Phase 3
4203,D03RDQ,Gavilimomab,Graft-versus-host disease , Phase 2/3
4204,D03RDS,Labetuzumab govitecan,Colorectal cancer , Phase 2
4205,D03REC,KP-736,Bacterial infection , Discontinued in Phase 2
4206,D03RFK,GTP-200,Solid tumour/cancer , Phase 2
4207,D03RGO,CP-331,Pain , Terminated
4208,D03RHZ,MDL-27192,Epileptic seizures , Phase 2
4209,D03RIO,GSK598809,Drug abuse , Phase 2
4210,D03RIX,Sirukumab,Rheumatoid arthritis , Phase 3
4211,D03RIX,Sirukumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
4212,D03RJZ,Oxeglitazar,Gout , Phase 1
4213,D03RKC,EG-Vac,Solid tumour/cancer , Investigative
4214,D03RLC,MOR-6292,Pain , Investigative
4215,D03RLP,GT160-246,Diarrhea , Phase 3
4216,D03RMN,1069C,Solid tumour/cancer , Phase 1
4217,D03RNX,EPC-K1,Nerve injury , Discontinued in Phase 2
4218,D03ROA,Tr-2,Solid tumour/cancer , Investigative
4219,D03ROX,Betaxolol,Hypertension , Approved
4220,D03RQW,Rostaporfin,Macular degeneration , Phase 3
4221,D03RQW,Rostaporfin,Breast cancer , Phase 2
4222,D03RQW,Rostaporfin,Basal cell carcinoma , Phase 1
4223,D03RQW,Rostaporfin,Solid tumour/cancer , Phase 1
4224,D03RSI,IMMLG-5521,Inflammation , Investigative
4225,D03RSQ,Vivia-007,Solid tumour/cancer , Investigative
4226,D03RTC,BMS-812204,Obesity , Investigative
4227,D03RTK,Trabectedin,Solid tumour/cancer , Approved
4228,D03RTK,Trabectedin,Ovarian cancer , Phase 3
4229,D03RTR,INP-02,HIV-associated dementia , Investigative
4230,D03RTS,Celecoxib,Rheumatoid arthritis , Approved
4231,D03RTS,Celecoxib,Pain , Phase 3
4232,D03RUL,AP5280,Solid tumour/cancer , Discontinued in Phase 1/2
4233,D03RVC,YH-4808,Duodenal ulcer , Phase 2
4234,D03RXE,Biphenyl mannoside derivative 3,Crohn disease , Patented
4235,D03RXE,Biphenyl mannoside derivative 3,Ulcerative colitis , Patented
4236,D03RXE,Biphenyl mannoside derivative 3,Urinary tract infection , Patented
4237,D03RXS,TAK-831,Friedreich's ataxia , Phase 2
4238,D03RXS,TAK-831,Schizophrenia , Phase 1
4239,D03RYJ,REL-1015,Chronic pain , Phase 2
4240,D03RYN,Cytolin,Human immunodeficiency virus infection , Preclinical
4241,D03RYS,VNA-932,Urinary incontinence , Discontinued in Phase 1
4242,D03RZM,Steroid hormone conjugates,Cachexia , Terminated
4243,D03RZU,CNS-5788,Cerebrovascular ischaemia , Terminated
4244,D03RZV,Tolazoline,Pulmonary hypertension , Approved
4245,D03SCP,PNT-200,Solid tumour/cancer , Investigative
4246,D03SDH,Siratiazem,Angina pectoris , Terminated
4247,D03SFN,Elzasonan hydrochloride,Mood disorder , Discontinued in Phase 2
4248,D03SFU,TERTATOLOL,Hypertension , Approved
4249,D03SGF,WBZ-7,Solid tumour/cancer , Investigative
4250,D03SGR,Efalizumab,Psoriasis vulgaris , Approved
4251,D03SGR,Efalizumab,Renal transplantation , Phase 2
4252,D03SHD,Myo-inositol,Alzheimer disease , Phase 2
4253,D03SHI,Ro-5287373,Solid tumour/cancer , Investigative
4254,D03SHM,PMID25666693-Compound-88,Osteoarthritis pain , Patented
4255,D03SHM,PMID25666693-Compound-88,Cancer related pain , Patented
4256,D03SHM,PMID25666693-Compound-88,Neuropathic pain , Patented
4257,D03SHM,PMID25666693-Compound-88,Inflammatory pain , Patented
4258,D03SHP,GSK2849466,Heart failure , Discontinued in Phase 1
4259,D03SIA,OBI-1,Factor VIII deficiency , Phase 3
4260,D03SKC,KRP-104,Type-2 diabetes , Phase 2
4261,D03SKD,Oxycodone,Pain , Approved
4262,D03SKD,Oxycodone,Back pain , Phase 3
4263,D03SKF,SC-124a,Multiple sclerosis , Discontinued in Phase 3
4264,D03SKL,BAY 86-9766,Solid tumour/cancer , Phase 3
4265,D03SKR,Clonidine,Hypertension , Approved
4266,D03SKR,Clonidine,Diabetic neuropathy , Phase 3
4267,D03SLK,SAR292833,Pain , Phase 2
4268,D03SLK,SAR292833,Insulin-dependent diabetes , Investigative
4269,D03SLO,OSU-2S,Solid tumour/cancer , Investigative
4270,D03SMB,2-18F-FE-5-Br-glyburide,Non-insulin dependent diabetes , Investigative
4271,D03SNE,PMID27828716-Compound-BIO-acetoxime,Malignant glioma , Patented
4272,D03SQT,Q203,Coronavirus Disease 2019 (COVID-19) , Phase 2
4273,D03SQT,Q203,Tuberculosis , Phase 1
4274,D03SRY,Estramustine,Prostate cancer , Approved
4275,D03SSE,Mechlorethamine,T-cell lymphoma , Approved
4276,D03SSE,Mechlorethamine,Hodgkin lymphoma , Phase 3
4277,D03SSG,PA-10040,Cardiovascular disease , Investigative
4278,D03SSH,AI-1008,Chronic myelogenous leukaemia , Investigative
4279,D03STA,Darotropium,Chronic obstructive pulmonary disease , Discontinued in Phase 2
4280,D03STV,GSK-2197870A,Hepatitis B virus infection , Phase 2
4281,D03SUQ,Apilimod dimesylate,Non-hodgkin lymphoma , Phase 2
4282,D03SVG,GSK-2189242A,Pneumococcal infection , Phase 2
4283,D03SVX,Aliskiren,Hypertension , Approved
4284,D03SVZ,Yersinia pestis vaccine,Yersinia infection , Terminated
4285,D03SWH,PNU-142633,Migraine , Discontinued in Phase 2
4286,D03SXE,Betamethasone Valerate,Dermatological disease , Approved
4287,D03SXI,INCAGN1949,Solid tumour/cancer , Phase 1/2
4288,D03SXQ,MDX-1140,Solid tumour/cancer , Investigative
4289,D03SXS,LY-2875358,Solid tumour/cancer , Phase 2
4290,D03SYC,LY-GSK-3i,Solid tumour/cancer , Investigative
4291,D03SZK,VXM-01,Solid tumour/cancer , Phase 1
4292,D03SZR,M-carboxycinnamic acid bishydroxamide,Solid tumour/cancer , Preclinical
4293,D03TAP,MCT-275,Insulin-dependent diabetes , Investigative
4294,D03TAT,Weight regulating human endocrine peptide,Obesity , Investigative
4295,D03TAY,VGX-3400,Influenza A virus H5N1 infection , Phase 1
4296,D03TBD,BMS-986148,Solid tumour/cancer , Phase 1
4297,D03TBJ,GRT-6005,Diabetic neuropathy , Phase 3
4298,D03TDB,TMB-358,Human immunodeficiency virus infection , Investigative
4299,D03TDE,AC-4402,Alzheimer disease , Investigative
4300,D03TDK,Sulfonamide derivative 1,Obesity , Patented
4301,D03TDW,Thiopilocarpine,Cognitive impairment , Phase 1
4302,D03TFJ,Benzimidazole,Cytomegalovirus Disease , Investigative
4303,D03TGB,MOD-1002,Obesity , Investigative
4304,D03TGJ,Sorivudine,Virus infection , Approved
4305,D03TIJ,Titanocene dichloride,Solid tumour/cancer , Discontinued in Phase 2
4306,D03TIS,Brentuximab vedotin,Hodgkin lymphoma , Approved
4307,D03TJN,KOS-1803,Solid tumour/cancer , Preclinical
4308,D03TKI,FM-201,Rheumatoid arthritis , Investigative
4309,D03TME,Crotalidae fab,Venom poisoning , Approved
4310,D03TNA,ABT-724,Erectile dysfunction , Discontinued in Phase 2
4311,D03TNG,GCAN 101,Melanoma , Phase 2
4312,D03TOH,AC-0523,Huntington disease , Investigative
4313,D03TPI,TV-1102,Multiple sclerosis , Phase 2
4314,D03TPR,Dextrothyroxine Sodium,High blood cholesterol level , Approved
4315,D03TQB,AU105,Recurrent glioblastoma , Phase 1/2
4316,D03TRO,GRN-529,Major depressive disorder , Investigative
4317,D03TSR,Grass pollen immunotherapy,Allergy , Phase 3
4318,D03TTQ,TRYPAN BLUE,Ophthalmic surgery injury , Approved
4319,D03TTT,AR-00341677,Solid tumour/cancer , Investigative
4320,D03TVE,FGF21-PKE Adnectin,Metabolic disorder , Investigative
4321,D03TVW,Stepronin,Bronchitis , Approved
4322,D03TVY,OTI-030,Knee injuries , Phase 2
4323,D03TWD,PMID30107136-Compound-Example4,Solid tumour/cancer , Patented
4324,D03TWD,PMID30107136-Compound-Example4,Infectious disease , Patented
4325,D03TWD,PMID30107136-Compound-Example4,Human immunodeficiency virus infection , Patented
4326,D03TWD,PMID30107136-Compound-Example4,Hepatitis , Patented
4327,D03TXW,CSP-9222,Solid tumour/cancer , Investigative
4328,D03TXY,PMID28216367-compound-6d,Severe acute respiratory syndrome (SARS) , Preclinical
4329,D03TXY,PMID28216367-compound-6d,Middle East Respiratory Syndrome (MERS) , Preclinical
4330,D03TYI,Aminophylline,Bronchial asthma , Approved
4331,D03TYI,Aminophylline,Asthma , Phase 2
4332,D03TYJ,ATHX-105,Obesity , Phase 2
4333,D03TYT,PF-03800130,Bipolar disorder , Investigative
4334,D03TYY,Nicotine-Q,Tobacco dependence , Phase 2
4335,D03TZG,MGN-9103,Cardiac failure , Investigative
4336,D03UAO,MG-1105,Hepatitis B virus infection , Investigative
4337,D03UBI,VALERGEN-DP,Asthma , Phase 2
4338,D03UBW,Ficlatuzumab,Non-small-cell lung cancer , Phase 2
4339,D03UBW,Ficlatuzumab,Multiple myeloma , Phase 2
4340,D03UBW,Ficlatuzumab,Pancreatic cancer , Phase 2
4341,D03UBW,Ficlatuzumab,Squamous cell carcinoma , Phase 2
4342,D03UBW,Ficlatuzumab,Acute myeloid leukaemia , Phase 1
4343,D03UDF,LOXO-195,Solid tumour/cancer , Phase 1
4344,D03UDW,AI-850,Solid tumour/cancer , Phase 1
4345,D03UEO,Clazakizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
4346,D03UFM,BMS-200980,Myocardial infarction , Discontinued in Preregistration
4347,D03UFQ,Malaria vaccine,Malaria , Approved
4348,D03UHV,ONO-4578,Solid tumour/cancer , Phase 1
4349,D03UIB,TOK-8801,Arthritis , Phase 2
4350,D03UID,RJR-2403,Cognitive impairment , Discontinued in Phase 2
4351,D03UIF,SA-6541,Inflammation , Investigative
4352,D03UIW,Brontictuzumab,Colorectal cancer , Phase 1
4353,D03UKI,Autologous dendritic cell vaccines,Solid tumour/cancer , Phase 1
4354,D03UKJ,Pazopanib + Tyverb/Tykerb,Inflammatory breast cancer , Phase 2
4355,D03UMA,CNT0-0007,Ischemic stroke , Phase 1
4356,D03UNN,L-689560,Neurodegenerative disorder , Terminated
4357,D03UNT,Anti-CD19-CAR vector-transduced T cells,Mantle cell lymphoma , Phase 1/2
4358,D03UNT,Anti-CD19-CAR vector-transduced T cells,B-cell non-hodgkin lymphoma , Phase 1/2
4359,D03UNT,Anti-CD19-CAR vector-transduced T cells,Acute lymphoblastic leukaemia , Clinical trial
4360,D03UNT,Anti-CD19-CAR vector-transduced T cells,B-cell chronic lymphocytic leukaemia , Clinical trial
4361,D03UNT,Anti-CD19-CAR vector-transduced T cells,Diffuse large B-cell lymphoma , Clinical trial
4362,D03UNT,Anti-CD19-CAR vector-transduced T cells,Follicular lymphoma , Clinical trial
4363,D03UNT,Anti-CD19-CAR vector-transduced T cells,Haematopoietic/lymphoid cancer , Clinical trial
4364,D03UNT,Anti-CD19-CAR vector-transduced T cells,Prolymphocytic leukaemia , Clinical trial
4365,D03UOG,P2B-004,Solid tumour/cancer , Investigative
4366,D03UOT,Hydroquinone,Melasma , Approved
4367,D03UQM,Retapamulin,Impetigo , Approved
4368,D03URV,HL-1172,Solid tumour/cancer , Investigative
4369,D03USI,SL-87.0495,Angina pectoris , Discontinued in Phase 2
4370,D03UUL,APN01,Myocardial infarction , Phase 1
4371,D03UUL,APN01,Hypertension , Phase 1
4372,D03UVL,SSR-240612,Rheumatoid arthritis , Phase 2
4373,D03UVS,Gemcitabine,Solid tumour/cancer , Approved
4374,D03UVX,NOPPI,Solid tumour/cancer , Investigative
4375,D03UWE,CAT-1904,Non-insulin dependent diabetes , Investigative
4376,D03UXT,Recombinant house dust mite allergy desensitization injection,Allergy , Terminated
4377,D03UYI,TAK-427,Allergic rhinitis , Discontinued in Phase 2
4378,D03UZC,DS-1150b,Type-2 diabetes , Phase 1
4379,D03UZP,RG7888,Solid tumour/cancer , Phase 2
4380,D03UZP,RG7888,Urothelial carcinoma , Phase 2
4381,D03VAR,Trecovirsen sodium,Human immunodeficiency virus-1 infection , Discontinued in Phase 2
4382,D03VCF,Urtoxazumab,Escherichia coli infection , Discontinued in Phase 2
4383,D03VCJ,NP-01,Type-2 diabetes , Phase 2
4384,D03VDA,PTL-303,Fibrosis , Investigative
4385,D03VDC,Talc,Pleural disease , Approved
4386,D03VDX,CPD-0905,Trypanosomiasis , Investigative
4387,D03VEZ,AD-439,Human immunodeficiency virus infection , Terminated
4388,D03VFL,TOCOTRIENOL,Hyperlipidaemia , Approved
4389,D03VFV,IL1aQb,Arteriosclerosis , Terminated
4390,D03VGD,PACIS,Solid tumour/cancer , Approved
4391,D03VGW,GCR-1087,Type-2 diabetes , Preclinical
4392,D03VGW,GCR-1087,Obesity , Preclinical
4393,D03VHI,HMR-3562,Bacterial infection , Discontinued in Phase 1
4394,D03VLG,DCB-WH1,Diabetic foot ulcer , Phase 2
4395,D03VLH,ColoAd1,Solid tumour/cancer , Phase 1/2
4396,D03VLO,CD1-TB,Mycobacterium infection , Investigative
4397,D03VLS,Lu-AA37096,Anxiety disorder , Discontinued in Phase 1
4398,D03VMW,HepaGam B,Hepatitis B virus infection , Approved
4399,D03VNB,NI-0801,Autoimmune diabetes , Phase 2
4400,D03VNJ,Carperitide,Congestive heart failure , Approved
4401,D03VNX,Pro-urokinase,Thrombin deficiency , Approved
4402,D03VPC,Cilostazol,Intermittent claudication , Approved
4403,D03VPJ,AN0128,Psoriatic disorder , Phase 2
4404,D03VPJ,AN0128,Atopic dermatitis , Phase 2
4405,D03VPM,DPV-001,Non-small-cell lung cancer , Phase 2
4406,D03VPM,DPV-001,Prostate cancer , Phase 1
4407,D03VRX,Albumin Iodinated Serum,Imaging , Approved
4408,D03VTN,TRIMOPROSTIL,Glaucoma/ocular hypertension , Discontinued in Phase 3
4409,D03VUV,Adarotene ester derivative back-up compounds,Solid tumour/cancer , Investigative
4410,D03VWB,MP-157,Hypertension , Phase 1
4411,D03VXG,Insulin Lyspro recombinant,Diabetic complication , Approved
4412,D03VXJ,Hydrochloric acid,Alkalosis , Approved
4413,D03VXP,PMID25666693-Compound-145,Osteoarthritis pain , Patented
4414,D03VXP,PMID25666693-Compound-145,Cancer related pain , Patented
4415,D03VXP,PMID25666693-Compound-145,Neuropathic pain , Patented
4416,D03VXP,PMID25666693-Compound-145,Inflammatory pain , Patented
4417,D03VXQ,"Oxetane 3,3-dicarboxamide compound 1",Virus infection , Patented
4418,D03VYZ,MRX-4,Allergic rhinitis , Phase 2
4419,D03VZH,Ethchlorvynol,Insomnia , Approved
4420,D03WAJ,Heptabarbital,Anaesthesia , Approved
4421,D03WAT,PRC-4016,Dyslipidemia , Phase 2
4422,D03WAT,PRC-4016,Arteriosclerosis , Investigative
4423,D03WAU,Anamorelin,Carbohydrate metabolism disorder , Phase 3
4424,D03WAX,KST-301,Solid tumour/cancer , Investigative
4425,D03WCJ,"4-methyl-4,5-dihydro-1H-pyrazole-3-carboxamide derivative 1",Obesity , Patented
4426,D03WCT,LAS-189913,Multiple sclerosis , Investigative
4427,D03WDN,BI-638683,Solid tumour/cancer , Phase 1
4428,D03WEX,Vortioxetine,Major depressive disorder , Approved
4429,D03WEX,Vortioxetine,Mood disorder , Phase 3
4430,D03WFI,Heteroaryl-carboxamide derivative 9,Solid tumour/cancer , Patented
4431,D03WFI,Heteroaryl-carboxamide derivative 9,Metastatic cancer , Patented
4432,D03WGM,SOM-0888,Malaria , Investigative
4433,D03WHC,Nnrti,Human immunodeficiency virus infection , Investigative
4434,D03WJB,Biphenyl mannoside derivative 25,Crohn disease , Patented
4435,D03WJB,Biphenyl mannoside derivative 25,Ulcerative colitis , Patented
4436,D03WJB,Biphenyl mannoside derivative 25,Urinary tract infection , Patented
4437,D03WLI,Technetium Tc-99m Pentetate Kit,Radioactive tracer , Approved
4438,D03WMK,AC-162352,Obesity , Discontinued in Phase 1
4439,D03WMT,ML-721,Solid tumour/cancer , Investigative
4440,D03WMY,NPC-17731,Asthma , Terminated
4441,D03WMZ,MEDI5884,Coronary artery disease , Phase 2
4442,D03WNG,CORT-125134,Cushing disease , Phase 3
4443,D03WNG,CORT-125134,Solid tumour/cancer , Phase 1/2
4444,D03WNG,CORT-125134,Alcohol dependence , Clinical trial
4445,D03WNN,RG-7010,Motor neurone disease , Phase 1
4446,D03WOG,Evinacumab,Hypercholesterolaemia , Approved
4447,D03WOG,Evinacumab,Elevated C-reactive protein , Phase 2
4448,D03WOG,Evinacumab,Familial hypercholesterolemia , Phase 2
4449,D03WOQ,LY3127804,Solid tumour/cancer , Phase 1
4450,D03WOW,QS-21,Melanoma , Phase 3
4451,D03WPA,Trovafloxacin,Bacterial infection , Approved
4452,D03WPI,NC-190,Solid tumour/cancer , Discontinued in Phase 2
4453,D03WPP,Necitumumab,Colorectal cancer , Approved
4454,D03WQS,BMS-582664,Hepatocellular carcinoma , Phase 3
4455,D03WRJ,Lisofylline,Type-1 diabetes , Phase 2
4456,D03WRN,AVT-02 UE,Skin infection , Discontinued in Phase 2
4457,D03WSE,XomaZyme-Mel,Melanoma , Discontinued in Phase 2
4458,D03WTE,BT-301,Periodontal disease , Investigative
4459,D03WTX,SBC-105,Metabolic disorder , Investigative
4460,D03WUH,YM-099,Hypertension , Terminated
4461,D03WUU,Multivalent (HIVIS 07) DNA vaccine Derma Vax/ZetaJet,Human immunodeficiency virus infection , Preclinical
4462,D03WVP,IBU-PC,Inflammation associated with osteoarthritis , Preclinical
4463,D03WVP,IBU-PC,Pain , Preclinical
4464,D03WWG,Elcatonin,Disorder of calcium metabolism , Approved
4465,D03WWW,Hepcidin,Hemochromatosis , Phase 1
4466,D03WXL,Staphguard,Staphylococcus infection , Investigative
4467,D03WXM,C-linked disaccharide biphenyl mannoside derivative 4,Crohn disease , Patented
4468,D03WXM,C-linked disaccharide biphenyl mannoside derivative 4,Ulcerative colitis , Patented
4469,D03WXM,C-linked disaccharide biphenyl mannoside derivative 4,Urinary tract infection , Patented
4470,D03WYV,TAK-225,Asthma , Terminated
4471,D03WZJ,A33-Ac-225,Colon cancer , Investigative
4472,D03XAO,NVX-108,Recurrent glioblastoma , Phase 2
4473,D03XBB,DX-2400,Solid tumour/cancer , Investigative
4474,D03XBT,Prostatix,Prostate cancer , Investigative
4475,D03XCR,Simotaxel,Solid tumour/cancer , Phase 1
4476,D03XDD,OG-45,Dementia , Investigative
4477,D03XDX,Tarazepide,Gastrointestinal disease , Discontinued in Phase 2
4478,D03XES,Eptazocine hbr,Pain , Approved
4479,D03XET,POD-003,Osteoporosis , Investigative
4480,D03XEV,NDC-1187,Solid tumour/cancer , Investigative
4481,D03XEY,Epstein-barr virus-specific immunotherapy,Nasopharyngeal carcinoma , Phase 2
4482,D03XFH,ACTR-BCMA,Multiple myeloma , Phase 1
4483,D03XHD,A-11259,Bacterial infection , Terminated
4484,D03XHS,ACT-178882,Cardiovascular disease , Phase 1
4485,D03XIH,ABS-103,Bipolar disorder , Terminated
4486,D03XJP,Y-175L,Lupus , Investigative
4487,D03XLO,PEV-8,Influenza virus infection , Investigative
4488,D03XLX,CP-778875,Lipid metabolism disorder , Phase 2
4489,D03XOC,Trilostane,Cushing disease , Approved
4490,D03XRA,GSK2661380,Solid tumour/cancer , Phase 1
4491,D03XRZ,PF-05094037,Solid tumour/cancer , Investigative
4492,D03XSJ,Buclizine,Nausea , Approved
4493,D03XST,MC-207252,Staphylococcus infection , Terminated
4494,D03XSX,CEL-2000,Rheumatoid arthritis , Investigative
4495,D03XTC,Esmolol,Acute supraventricular tachycardia , Approved
4496,D03XTY,APR-246,Ovarian cancer , Phase 2
4497,D03XTY,APR-246,Bladder cancer , Phase 1/2
4498,D03XTY,APR-246,Gastric adenocarcinoma , Phase 1/2
4499,D03XTY,APR-246,Esophageal cancer , Phase 1
4500,D03XTY,APR-246,Myelodysplastic syndrome , Phase 1
4501,D03XTY,APR-246,Solid tumour/cancer , Preclinical
4502,D03XUQ,ABS-212,Pain , Terminated
4503,D03XYW,Fenoprofen,Rheumatoid arthritis , Approved
4504,D03XZP,IL-12 gene therapy,Prostate cancer , Phase 1
4505,D03XZT,Cyclic compound 1,Solid tumour/cancer , Patented
4506,D03XZT,Cyclic compound 1,Infectious disease , Patented
4507,D03XZT,Cyclic compound 1,Human immunodeficiency virus infection , Patented
4508,D03XZT,Cyclic compound 1,Hepatitis , Patented
4509,D03YAA,PMID27215781-Compound-28,Endometriosis , Patented
4510,D03YAS,ONO-AE1-437,Asthma , Phase 2
4511,D03YBJ,DS-8895,Solid tumour/cancer , Phase 1
4512,D03YBQ,DNL151,Parkinson disease , Phase 1
4513,D03YCT,TVX-004,Influenza virus infection , Investigative
4514,D03YEG,REGN-910,Solid tumour/cancer , Phase 1
4515,D03YEM,CD19/CD22 CAR T-Cells,Acute lymphocytic leukaemia , Phase 1
4516,D03YEM,CD19/CD22 CAR T-Cells,B-cell lymphoma , Phase 1
4517,D03YEM,CD19/CD22 CAR T-Cells,B-cell prolymphocytic leukaemia , Phase 1
4518,D03YEM,CD19/CD22 CAR T-Cells,leukaemia , Phase 1
4519,D03YEM,CD19/CD22 CAR T-Cells,Non-hodgkin lymphoma , Phase 1
4520,D03YET,Coal tar,Psoriasis vulgaris , Approved
4521,D03YFL,PMID25666693-Compound-71,Osteoarthritis pain , Patented
4522,D03YFL,PMID25666693-Compound-71,Cancer related pain , Patented
4523,D03YFL,PMID25666693-Compound-71,Neuropathic pain , Patented
4524,D03YFL,PMID25666693-Compound-71,Inflammatory pain , Patented
4525,D03YGL,RHIgM22,Multiple sclerosis , Phase 1
4526,D03YGP,CC-8490,Brain cancer , Phase 1
4527,D03YGR,Cinacalcet,Hyperparathyroidism , Approved
4528,D03YGR,Cinacalcet,Kidney disease , Phase 3
4529,D03YGX,SP-D,Lung inflammation , Investigative
4530,D03YIT,CL-186659,Bacterial infection , Terminated
4531,D03YIU,Danoprevir + ritonavir + interferon,Coronavirus Disease 2019 (COVID-19) , Phase 2
4532,D03YIX,Pneumostem,Respiratory distress syndrome , Phase 2
4533,D03YIX,Pneumostem,Bronchopulmonary dysplasia , Phase 1/2
4534,D03YJC,SKL-NP,Pain , Phase 2
4535,D03YJW,Fus-1 tumor suppressor gene therapy,Non-small-cell lung cancer , Phase 1/2
4536,D03YJZ,SDZ-89-104,Bone marrow transplantation , Terminated
4537,D03YKE,FG-4592,Kidney disease , Phase 3
4538,D03YKE,FG-4592,Anaemia , Phase 3
4539,D03YKO,VT-346,Inflammation , Investigative
4540,D03YKQ,AD-452,Rheumatoid arthritis , Phase 2
4541,D03YLN,CP-67015,Bacterial infection , Terminated
4542,D03YLZ,Thiamphenicol,Bacterial infection , Approved
4543,D03YMD,RP-805,Arteriosclerosis , Investigative
4544,D03YOS,Phenoxodiol,Ovarian cancer , Phase 1/2
4545,D03YPL,RP-70676,Hyperlipidaemia , Terminated
4546,D03YPR,HL-1983,Hepatitis B virus infection , Investigative
4547,D03YSJ,NBI-29,Prostate cancer , Investigative
4548,D03YSL,CAT-1000,Inflammation , Investigative
4549,D03YSQ,SAR-405838,Solid tumour/cancer , Phase 1
4550,D03YVO,Methylnaltrexone bromide,Opioid-induced constipation , Approved
4551,D03YVO,Methylnaltrexone bromide,Obesity , Preclinical
4552,D03YVR,Oxamflatin,Solid tumour/cancer , Terminated
4553,D03YXI,PIKAMILONE,Anxiety disorder , Phase 2
4554,D03YZJ,ALO-02,Pain , Phase 3
4555,D03ZAE,Peg-G-CSF,Solid tumour/cancer , Phase 3
4556,D03ZBL,MMS-255,Multiple sclerosis , Terminated
4557,D03ZBM,NPC-567,Rhinitis , Discontinued in Phase 2
4558,D03ZBN,Olprinone,Heart failure , Approved
4559,D03ZBT,Crizotinib,Non-small-cell lung cancer , Approved
4560,D03ZCG,CMV vaccine,Cytomegalovirus infection , Discontinued in Phase 1
4561,D03ZCH,4SCAR19 and 4SCAR20,B-cell lymphoma , Phase 1/2
4562,D03ZDX,SM-88,Pancreatic cancer , Phase 2/3
4563,D03ZDX,SM-88,Prostate cancer , Phase 2
4564,D03ZFG,Cerulenin,Weight loss , Approved
4565,D03ZFN,Tromethamine,Acidosis , Approved
4566,D03ZGV,Co-60549,Anxiety disorder , Terminated
4567,D03ZHE,MDX-070,Prostate cancer , Discontinued in Phase 2
4568,D03ZHN,SL-65.1708,Cerebrovascular ischaemia , Discontinued in Phase 1
4569,D03ZIK,MT-001,Hypercholesterolaemia , Investigative
4570,D03ZIP,LOAd703,Pancreatic cancer , Phase 1/2
4571,D03ZIS,PERFOSFAMIDE,Solid tumour/cancer , Phase 2
4572,D03ZJK,NNZ-3006,Metabolic disorder , Investigative
4573,D03ZKE,CS-003,Chronic obstructive pulmonary disease , Discontinued in Phase 2
4574,D03ZKM,UX-001,Hereditary inclusion body myositis , Phase 3
4575,D03ZKM,UX-001,Myopathy , Phase 2
4576,D03ZLN,SEL-403,Mesothelioma , Phase 1
4577,D03ZLN,SEL-403,Pancreatic cancer , Phase 1
4578,D03ZLR,Apimostinel,Major depressive disorder , Phase 2
4579,D03ZME,Darinaparsin,Multiple myeloma , Phase 2
4580,D03ZME,Darinaparsin,Liver cancer , Phase 2
4581,D03ZME,Darinaparsin,Hematologic tumour , Phase 2
4582,D03ZME,Darinaparsin,Peripheral T-cell lymphoma , Phase 2
4583,D03ZMK,NTP-6009,Central nervous system disease , Investigative
4584,D03ZMY,AM-220,Wound healing , Investigative
4585,D03ZNK,Tc99-labeled 14F7 humanized mab,Breast cancer , Investigative
4586,D03ZOZ,PMID25666693-Compound-97,Osteoarthritis pain , Patented
4587,D03ZOZ,PMID25666693-Compound-97,Cancer related pain , Patented
4588,D03ZOZ,PMID25666693-Compound-97,Neuropathic pain , Patented
4589,D03ZOZ,PMID25666693-Compound-97,Inflammatory pain , Patented
4590,D03ZPX,PRX-07034,Obesity , Phase 1
4591,D03ZPY,SQ-33351,Hypertension , Terminated
4592,D03ZSA,BMS-986016,Hematologic tumour , Phase 1/2
4593,D03ZSA,BMS-986016,Solid tumour/cancer , Phase 1
4594,D03ZTE,Chenodiol,Cholelithiasis , Approved
4595,D03ZVD,KW-4490,Asthma , Discontinued in Phase 2
4596,D03ZVW,Vapiprost,Cardiovascular disease , Terminated
4597,D03ZWR,APC-300,Prostate cancer , Investigative
4598,D03ZXZ,XL-228,leukaemia , Phase 1
4599,D03ZYQ,Olokizumab,Rheumatoid arthritis , phase 3
4600,D03ZYQ,Olokizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
4601,D03ZYZ,Prophylactic dengue fever vaccine,Flavivirus infection , Phase 2
4602,D03ZZC,Vascugel,Peripheral vascular disease , Phase 1/2
4603,D03ZZH,SLV-313,Schizophrenia , Discontinued in Phase 1
4604,D03ZZK,Fluocinonide,Inflammation , Approved
4605,D03ZZM,DMT310,Acne vulgaris , Phase 2
4606,D03ZZX,123I-MNI-420,Huntington disease , Phase 1
4607,D04AAN,Mesoridazine,Schizophrenia , Approved
4608,D04AAR,XB-513,Cardiac failure , Terminated
4609,D04AAW,Cidofovir,Cytomegalovirus infection , Approved
4610,D04ABS,CPH-102,Solid tumour/cancer , Preclinical
4611,D04ACD,[111In]B3,Solid tumour/cancer , Investigative
4612,D04ACK,Anti-CD30 CAR T cells,Lymphoma , Phase 1/2
4613,D04ACW,Alogliptin/metformin,Type-2 diabetes , Approved
4614,D04AEQ,V81444,Parkinson disease , Phase 1/2
4615,D04AEQ,V81444,Advanced cancer , Phase 1
4616,D04AGG,Favipiravir,Influenza virus infection , Approved
4617,D04AGG,Favipiravir,Coronavirus Disease 2019 (COVID-19) , Phase 3
4618,D04AGM,PRTT-100,Pain , Investigative
4619,D04AHQ,LY3009120,Solid tumour/cancer , Phase 1
4620,D04AHY,HT-2157,Cognitive impairment , Phase 1/2
4621,D04AIB,AZD1772//RDX5791,Chronic kidney disease , Phase 2
4622,D04AIT,B-Lactams,Bacterial infection , Approved
4623,D04AIV,Eteplirsen,Duchenne dystrophy , Approved
4624,D04AKG,SER-287,Ulcerative colitis , Phase 1
4625,D04ALI,FHT-CT4,Asthma , Investigative
4626,D04AMD,ZD-6126,Solid tumour/cancer , Phase 2
4627,D04APR,Tirilazad mesylate,Subarachnoid hemorrhage , Approved
4628,D04APR,Tirilazad mesylate,Cataract , Approved
4629,D04APY,KC-11404,Asthma , Terminated
4630,D04AQH,Sermorelin,Pediatric growth disorder , Approved
4631,D04ARO,PEV-4,Respiratory syncytial virus infection , Investigative
4632,D04ASA,X-083-NAB,Psoriasis vulgaris , Investigative
4633,D04ASH,Leuprorelin acetate,Prostate cancer , Approved
4634,D04ASP,Influenza virus DNA vaccine,Influenza A virus H1N1 infection , Phase 1
4635,D04ATE,AT-009,Solid tumour/cancer , Investigative
4636,D04ATM,Trimegestone,Hormone replacement therapy , Approved
4637,D04ATY,Bulleyaconitine A,Pain , Investigative
4638,D04AUA,MIV-170,Human immunodeficiency virus infection , Terminated
4639,D04AYH,ADE-CRAN,Wound healing , Investigative
4640,D04AYZ,CSL-654,Factor IX deficiency , Phase 3
4641,D04AZM,ARQ 736,Solid tumour/cancer , Phase 1
4642,D04AZT,MEDI1814,Alzheimer disease , Phase 1
4643,D04BBA,Thiazole carboxamide derivative 24,Solid tumour/cancer , Patented
4644,D04BBA,Thiazole carboxamide derivative 24,Metastatic cancer , Patented
4645,D04BBT,Heterocyclic derivative 12,Solid tumour/cancer , Patented
4646,D04BBT,Heterocyclic derivative 12,Metastatic cancer , Patented
4647,D04BCB,Lobeglitazone,Type-2 diabetes , Approved
4648,D04BCW,Ketobemidone,Pain , Approved
4649,D04BEN,Amrubicin,Small-cell lung cancer , Phase 3
4650,D04BFC,CC-292,Chronic lymphocytic leukaemia , Phase 2
4651,D04BFI,LGD-4665,Immune thrombocytopenic purpura , Phase 2
4652,D04BFU,LIDORESTAT,Diabetic complication , Phase 2
4653,D04BFX,IPL-423,Inflammation , Terminated
4654,D04BHS,Recombinant batroxobin,Blood forming organ disorder , Phase 2
4655,D04BHY,KP-27,Solid tumour/cancer , Investigative
4656,D04BIG,SR-90067,Hormone deficiency , Discontinued in Phase 2
4657,D04BIY,NKTR-140,Human immunodeficiency virus infection , Investigative
4658,D04BKO,Etripamil,Cardiovascular disease , Phase 2
4659,D04BKO,Etripamil,Paroxysmal supraventricular tachycardia , Phase 2
4660,D04BKZ,Mangafodipir Trisodium,Magnetic resonance imaging of liver , Approved
4661,D04BLE,A-3309,Lipid metabolism disorder , Phase 3
4662,D04BMR,AL-59640,Xerophthalmia , Investigative
4663,D04BNA,RF1V,Parasitic infection , Phase 2
4664,D04BNB,Lenzilumab,Coronavirus Disease 2019 (COVID-19) , Phase 3
4665,D04BNP,Temazepam,Insomnia , Approved
4666,D04BOK,DiabeCell,Insulin-dependent diabetes , Phase 2
4667,D04BOT,Dalotuzumab,Breast cancer , Phase 2
4668,D04BPS,Naveglitazar,Diabetic complication , Phase 2
4669,D04BQR,Acecainide,Solid tumour/cancer , Discontinued in Phase 3
4670,D04BQV,Isofagomine tartrate,Metabolic disorder , Phase 2
4671,D04BRF,TA-101,Inflammation , Investigative
4672,D04BRW,Five membered heterocyclic benzamide derivative 2,Pruritus , Patented
4673,D04BRW,Five membered heterocyclic benzamide derivative 2,Solid tumour/cancer , Patented
4674,D04BRW,Five membered heterocyclic benzamide derivative 2,Chronic pain , Patented
4675,D04BRW,Five membered heterocyclic benzamide derivative 2,Neuropathic pain , Patented
4676,D04BRW,Five membered heterocyclic benzamide derivative 2,Thymic cancer , Patented
4677,D04BSV,L-377202,Solid tumour/cancer , Phase 1/2
4678,D04BSZ,PD-0204318,Pain , Terminated
4679,D04BUH,Cizolirtine,Neuropathic pain , Phase 2
4680,D04BVL,IM19,Haematological malignancy , Phase 1
4681,D04BVL,IM19,Non-hodgkin lymphoma , Phase 1
4682,D04BVN,PDGF-BB,Diabetic foot ulcer , Phase 3
4683,D04BXA,Pyrazole derivative 32,Obesity , Patented
4684,D04BXH,COTI-001,Acute myeloid leukaemia , Investigative
4685,D04BXJ,ED-1812,Pain , Preclinical
4686,D04BXX,AN-019,Chronic myelogenous leukaemia , Phase 2
4687,D04CBI,Oestradiol valerate and dienogest,Endometriosis , Approved
4688,D04CBI,Oestradiol valerate and dienogest,Contraception , Approved
4689,D04CCK,MT-119,Solid tumour/cancer , Investigative
4690,D04CCX,PMID30107136-Compound-Example14,Solid tumour/cancer , Patented
4691,D04CCX,PMID30107136-Compound-Example14,Infectious disease , Patented
4692,D04CCX,PMID30107136-Compound-Example14,Human immunodeficiency virus infection , Patented
4693,D04CCX,PMID30107136-Compound-Example14,Hepatitis , Patented
4694,D04CDO,TAS-102,Colorectal cancer , Phase 3
4695,D04CEY,PYM-50018,Glaucoma/ocular hypertension , Preclinical
4696,D04CFL,SB 242784,Arterial calcification , Preclinical
4697,D04CFW,Bacampicillin,Bacterial infection , Approved
4698,D04CJE,ATF-936,Osteoporosis , Phase 1
4699,D04CJL,Ferric citrate,Chronic kidney disease , Approved
4700,D04CJN,CTP-298,Human immunodeficiency virus infection , Phase 1
4701,D04CKB,IkT-001,Infectious disease , Investigative
4702,D04CKC,GPC3-CART cells,Hepatocellular carcinoma , Phase 1/2
4703,D04CKG,SPI-2012,Breast cancer , Phase 3
4704,D04CKR,CAL-103-R,Herpes simplex virus infection , Investigative
4705,D04CLH,PMID26048809-compound2,Middle East Respiratory Syndrome (MERS) , Preclinical
4706,D04CLM,YM-758,Angina pectoris , Phase 2
4707,D04CNX,Ro-25-1132,Bacterial infection , Terminated
4708,D04CON,SL-89.0591,Prostate disease , Discontinued in Phase 2
4709,D04CQK,MK-8521,Type-2 diabetes , Phase 2
4710,D04CQV,Cis-urocanic acid,Atopic dermatitis , Phase 2
4711,D04CRL,Glatiramer Acetate,Multiple sclerosis , Approved
4712,D04CRN,Atomoxetine,Attention deficit hyperactivity disorder , Approved
4713,D04CSZ,Menthol,Throat irritation , Approved
4714,D04CTD,SNDX-6352,Solid tumour/cancer , Phase 1
4715,D04CTP,EP-200,Solid tumour/cancer , Investigative
4716,D04CUZ,SRG,Neutropenia , Investigative
4717,D04CWI,Galidesivir,Coronavirus Disease 2019 (COVID-19) , Phase 1
4718,D04CWI,Galidesivir,Severe acute respiratory syndrome (SARS) , Preclinical
4719,D04CWI,Galidesivir,Middle East Respiratory Syndrome (MERS) , Preclinical
4720,D04CWS,Anti-M1 prime,Asthma , Phase 2
4721,D04CXX,GNKG-168,Chronic lymphocytic leukaemia , Phase 1
4722,D04CYD,ONT-10,Solid tumour/cancer , Phase 1
4723,D04DAL,LAS-41001,Rosacea , Discontinued in Preregistration
4724,D04DBA,BAG956,Haematological malignancy , Investigative
4725,D04DDW,MK-49,Pain , Investigative
4726,D04DFJ,Pulmonary insulin,Diabetic complication , Approved
4727,D04DFR,FX005,Melanoma , Phase 2/3
4728,D04DGE,SB-247853,Anxiety disorder , Discontinued in Phase 1
4729,D04DHZ,CART-EGFR,Solid tumour/cancer , Phase 1/2
4730,D04DJN,Dihydrotestosterone,Prostate hyperplasia , Phase 4
4731,D04DJS,"ICI 118,551",Gastric adenocarcinoma , Phase 3
4732,D04DJS,"ICI 118,551",HER2-positive breast cancer , Phase 3
4733,D04DKH,NAFTOPIDIL,Hypertension , Approved
4734,D04DKL,ALT-836,Adult respiratory distress syndrome , Phase 2
4735,D04DLW,NA-1 neuroprotectant,Stroke , Phase 2
4736,D04DMO,FR-194738,Hypercholesterolaemia , Terminated
4737,D04DMQ,Fabesetron,Irritable bowel syndrome , Discontinued in Phase 2
4738,D04DMZ,AVXS-101,Spinal muscular atrophy , Phase 3
4739,D04DNB,Xentuzumab,Breast cancer , Phase 2
4740,D04DNB,Xentuzumab,Prostate cancer , Phase 1/2
4741,D04DNL,ALN-FLU01,Influenza virus infection , Preclinical
4742,D04DQO,ABBV-257,Rheumatoid arthritis , Phase 1
4743,D04DQP,ADRIAC-36,Solid tumour/cancer , Investigative
4744,D04DQT,Ribavirin + interferon beta-1a,Middle East Respiratory Syndrome (MERS) , Investigative
4745,D04DQZ,AZD-2327,Anxiety disorder , Phase 2
4746,D04DSD,TEI-5178,Nephritis , Phase 1
4747,D04DTH,Emapalumab,Primary haemophagocytic lymphohistiocytosis , Approved
4748,D04DTH,Emapalumab,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
4749,D04DUF,Phenylsulfonyl derivative 2,Central nervous system disease , Patented
4750,D04DUG,AAV-GUS,Genetic disease , Terminated
4751,D04DUH,PMI-005,Osteoarthritis , Phase 1
4752,D04DUJ,S-2474,Rheumatoid arthritis , Discontinued in Phase 2
4753,D04DVA,HAp-IFN,Hepatitis C virus infection , Investigative
4754,D04DVF,CHF-1522,Non-insulin dependent diabetes , Terminated
4755,D04DXA,Tofogliflozin,Type-2 diabetes , Approved
4756,D04DXN,Benzoyl peroxide,Acne vulgaris , Approved
4757,D04DYA,SMTP-0,Solid tumour/cancer , Investigative
4758,D04DYC,PF-06463922,Non-small-cell lung cancer , Phase 2
4759,D04DYC,PF-06463922,Solid tumour/cancer , Phase 1/2
4760,D04DYZ,ABT-839,Non-small-cell lung cancer , Terminated
4761,D04DZD,Bidisomide,Heart arrhythmia , Discontinued in Phase 3
4762,D04DZE,BRL 26830A,Obesity , Terminated
4763,D04EAT,MCS-110,Bone metastases , Phase 2
4764,D04EAT,MCS-110,Tenosynovial giant cell tumour , Phase 2
4765,D04EAT,MCS-110,Triple negative breast cancer , Phase 2
4766,D04EAT,MCS-110,Advanced malignancy , Phase 1/2
4767,D04EAT,MCS-110,Breast cancer , Phase 1
4768,D04EAZ,M102.4,Virus infection , Investigative
4769,D04EDM,PMID25684022-Compound-US20120277229 41(1.3),Solid tumour/cancer , Patented
4770,D04EDM,PMID25684022-Compound-US20120277229 41(1.3),Metastatic cancer , Patented
4771,D04EET,West Nile virus vaccine,West nile virus infection , Terminated
4772,D04EFB,OP-03,Melanoma , Investigative
4773,D04EFG,DD-3,Autoimmune diabetes , Investigative
4774,D04EFK,DDP-225,Irritable bowel syndrome , Phase 2
4775,D04EFK,DDP-225,Chronic functional vomiting , Discontinued in Phase 2
4776,D04EGR,1-MNA,Hyperlipidaemia , Phase 2/3
4777,D04EGR,1-MNA,Cardiovascular disease , Phase 2
4778,D04EGX,Cabergoline,Hyperprolactinaemia , Approved
4779,D04EHF,DAV-132,Toxicity , Investigative
4780,D04EIF,LOXORIBINE,Immune System disease , Phase 2
4781,D04EIL,YM-344031,Asthma , Preclinical
4782,D04EIX,AA-102,Breast cancer , Preclinical
4783,D04EJG,SHR-1314,Plaque psoriasis , Phase 1/2
4784,D04ELD,Glassia,Emphysema , Approved
4785,D04ELS,ISCAR,Human immunodeficiency virus infection , Phase 2
4786,D04EMB,IW-1973,Heart failure , Phase 2
4787,D04ENF,"Gene therapy, retinopathy,",Retinopathy , Investigative
4788,D04ENK,TCV-309,Sepsis , Discontinued in Phase 2
4789,D04EOH,APC-003,Solid tumour/cancer , Investigative
4790,D04EON,BAL-101553,Solid tumour/cancer , Phase 1/2
4791,D04EON,BAL-101553,Recurrent glioblastoma , Phase 1
4792,D04EPP,RTL-342m,Optic neuritis , Investigative
4793,D04EPS,ON-24160,Solid tumour/cancer , Investigative
4794,D04EQF,MT-101,Solid tumour/cancer , Investigative
4795,D04EQX,BIIB-098,Multiple sclerosis , Phase 3
4796,D04ERQ,CXD-101,Solid tumour/cancer , Phase 1
4797,D04ESH,PMID30107136-Compound-Example8,Solid tumour/cancer , Patented
4798,D04ESH,PMID30107136-Compound-Example8,Infectious disease , Patented
4799,D04ESH,PMID30107136-Compound-Example8,Human immunodeficiency virus infection , Patented
4800,D04ESH,PMID30107136-Compound-Example8,Hepatitis , Patented
4801,D04ETV,Nemonaxacin,Methicillin-resistant staphylococci infection , Phase 3
4802,D04EVE,VR876,Diffuse large B-cell lymphoma , Phase 3
4803,D04EXW,A-Fizz,Anal fistula , Investigative
4804,D04EXX,KBF-611,Mycobacterium infection , Investigative
4805,D04EYC,Metaraminol,Hypotension , Approved
4806,D04EYG,Ranibizumab,Hereditary hemorrhagic telangiectasia , Approved
4807,D04EZI,Peru-15 pCTB,Diarrhea , Phase 1
4808,D04EZR,SIG-003,Respiratory disease , Investigative
4809,D04FAC,SHEF-1,Age-related macular degeneration , Investigative
4810,D04FAI,SCIO-323,Cerebrovascular ischaemia , Preclinical
4811,D04FBR,Mycophenolate mofetil,Organ transplant rejection , Approved
4812,D04FBR,Mycophenolate mofetil,Pemphigus vulgaris , Phase 3
4813,D04FBR,Mycophenolate mofetil,Immune System disease , Investigative
4814,D04FDN,Palifosfamide,Soft tissue sarcoma , Phase 2
4815,D04FFM,ADXS-HPV,Cervical Intraepithelial neoplasia , Phase 2
4816,D04FFM,ADXS-HPV,Cervical cancer , Phase 2
4817,D04FFY,AMG-8563,Pain , Investigative
4818,D04FGX,EP-302,Breast cancer , Phase 2
4819,D04FGX,EP-302,Solid tumour/cancer , Investigative
4820,D04FHB,R547,Advanced solid tumour , Discontinued in Phase 1
4821,D04FHY,BL-7020,Psoriasis vulgaris , Investigative
4822,D04FIO,Aom-0871,Transplant rejection , Investigative
4823,D04FIP,Cyclodextrin,Osteoarthritis , Phase 4
4824,D04FKX,D-3263,Solid tumour/cancer , Phase 1
4825,D04FMB,XK-469,Solid tumour/cancer , Phase 1
4826,D04FNQ,BIM23A760,Acromegaly , Phase 2
4827,D04FNQ,BIM23A760,Carcinoid syndrome , Phase 2
4828,D04FNQ,BIM23A760,Psoriasis vulgaris , Discontinued in Phase 3
4829,D04FNR,Mitumomab,Melanoma , Phase 3
4830,D04FOP,Ravulizumab,Paroxysmal nocturnal haemoglobinuria , Approved
4831,D04FOP,Ravulizumab,Coronavirus Disease 2019 (COVID-19) , Phase 3
4832,D04FPN,CD19 CAR-T lymphocytes,Acute lymphoblastic leukaemia , Phase 1/2
4833,D04FQD,PH-80,Premenstrual syndrome , Phase 3
4834,D04FRB,CGP-13774,Asthma , Discontinued in Phase 1
4835,D04FRL,PMID25666693-Compound-44,Osteoarthritis pain , Patented
4836,D04FRL,PMID25666693-Compound-44,Cancer related pain , Patented
4837,D04FRL,PMID25666693-Compound-44,Neuropathic pain , Patented
4838,D04FRL,PMID25666693-Compound-44,Inflammatory pain , Patented
4839,D04FRU,LLG783,Intermittent claudication , Phase 2
4840,D04FRU,LLG783,Vascular systems peripheral arterial disorder , Phase 2
4841,D04FSD,TgAAG76,Blindness , Phase 1/2
4842,D04FTB,AR-H049020,Type-1 diabetes , Discontinued in Phase 1
4843,D04FVD,TGBA01AD,Mood disorder , Phase 2
4844,D04FVU,Palonosetron,Nausea , Approved
4845,D04FWP,AMG 157,Asthma , Phase 2
4846,D04FXE,KW-3433,Hypertension , Terminated
4847,D04FXS,Didox,Solid tumour/cancer , Discontinued in Phase 2
4848,D04FXY,SMT-19969,C. difficile infection , Phase 3
4849,D04FYI,H pylori vaccine,Helicobacter infection , Terminated
4850,D04FYL,Contusugene ladenovec,Oral cancer , Phase 3
4851,D04FYL,Contusugene ladenovec,Liver metastasis , Phase 1
4852,D04FYM,Genital herpes therapy,Herpes simplex virus infection , Phase 1
4853,D04FYU,DMP-444,Coronary artery disease , Phase 3
4854,D04FYZ,Plevitrexed (R)-isomer,Gastric adenocarcinoma , Phase 2
4855,D04GAG,GBR 1342,Multiple myeloma , Phase 1
4856,D04GBP,QR-010,Cystic fibrosis , Phase 1/2
4857,D04GBW,IC31 seasonal influenza vaccine,Influenza virus infection , Phase 1
4858,D04GBW,IC31 seasonal influenza vaccine,Influenza A virus infection , Phase 1
4859,D04GCC,N-acylpiperidine ether derivative 6,Pruritus , Patented
4860,D04GCC,N-acylpiperidine ether derivative 6,Solid tumour/cancer , Patented
4861,D04GCC,N-acylpiperidine ether derivative 6,Chronic pain , Patented
4862,D04GCC,N-acylpiperidine ether derivative 6,Neuropathic pain , Patented
4863,D04GCC,N-acylpiperidine ether derivative 6,Thymic cancer , Patented
4864,D04GCH,Bmab-200,Solid tumour/cancer , Investigative
4865,D04GCV,APS-2010,Hepatitis B virus infection , Investigative
4866,D04GDI,NP93-31,Brain injury , Investigative
4867,D04GEI,TAK-448,Prostate cancer , Phase 2
4868,D04GFO,MC-2001,leukaemia , Preclinical
4869,D04GGA,StaphStop,MRSA infection , Investigative
4870,D04GGG,CD123/CLL1 CAR-T Cells,Acute myeloid leukaemia , Phase 2/3
4871,D04GGJ,WST-057,Peripheral neuropathy , Phase 1
4872,D04GGQ,MPC-0767,Solid tumour/cancer , Investigative
4873,D04GIJ,Piperazine urea derivative 4,Inflammation , Patented
4874,D04GIJ,Piperazine urea derivative 4,Solid tumour/cancer , Patented
4875,D04GIO,Anti-CD19 and Anti-CD20 CAR-T Cells,B-cell lymphoma , Phase 1/2
4876,D04GJN,Megestrol,Breast cancer , Approved
4877,D04GJX,ZD-9720,Arteriosclerosis , Terminated
4878,D04GKL,RAXOFELAST,Ischemia , Phase 2
4879,D04GKO,Cilazapril,Congestive heart failure , Approved
4880,D04GKP,AS-902330,Arthropathy , Phase 2
4881,D04GLJ,OCFENTANIL,Pain , Phase 2
4882,D04GMY,TD-5108,Gastroparesis , Phase 2
4883,D04GNG,CC-90011,Non-hodgkin lymphoma , Phase 1
4884,D04GNG,CC-90011,Solid tumour/cancer , Phase 1
4885,D04GNX,SHP615,Seizure disorder , Phase 2
4886,D04GPZ,Hyaluronidase (ovine),Resorption of radiopaque agents , Approved
4887,D04GRB,THRX-198321,Chronic obstructive pulmonary disease , Phase 2
4888,D04GSA,DAU-6285,Vomiting , Terminated
4889,D04GSL,ImmuCyst,Hepatocellular carcinoma , Approved
4890,D04GSV,TRICIRIBINE,Solid tumour/cancer , Phase 1/2
4891,D04GSY,Buserelin acetate,Solid tumour/cancer , Approved
4892,D04GTA,Pegsunercept,Rheumatoid arthritis , Phase 2
4893,D04GTW,ReSX-i,Diabetic complication , Investigative
4894,D04GVN,PF-807925,Arteriosclerosis , Discontinued in Phase 1
4895,D04GWO,Otilimab,Rheumatoid arthritis , Phase 3
4896,D04GWO,Otilimab,Coronavirus Disease 2019 (COVID-19) , Phase 2
4897,D04GWY,Telinavir,Human immunodeficiency virus infection , Discontinued in Phase 2
4898,D04GXS,BL-1893,Solid tumour/cancer , Terminated
4899,D04GYO,Oxiconazole,Tinea pedis , Approved
4900,D04GZA,Gentian violet,Bacterial infection , Approved
4901,D04GZS,Tempol,Spinal cord injury , Phase 2
4902,D04HAA,WL-276,Solid tumour/cancer , Investigative
4903,D04HAF,LY-2624803,Insomnia , Phase 2
4904,D04HBH,AM-3701,Bone metastases , Investigative
4905,D04HBJ,IGFBP 2 variants,Solid tumour/cancer , Investigative
4906,D04HBL,PMID30107136-Compound-Example59,Solid tumour/cancer , Patented
4907,D04HBL,PMID30107136-Compound-Example59,Infectious disease , Patented
4908,D04HBL,PMID30107136-Compound-Example59,Human immunodeficiency virus infection , Patented
4909,D04HBL,PMID30107136-Compound-Example59,Hepatitis , Patented
4910,D04HCS,PMID25666693-Compound-93,Osteoarthritis pain , Patented
4911,D04HCS,PMID25666693-Compound-93,Cancer related pain , Patented
4912,D04HCS,PMID25666693-Compound-93,Neuropathic pain , Patented
4913,D04HCS,PMID25666693-Compound-93,Inflammatory pain , Patented
4914,D04HDZ,GRN163,Multiple myeloma , Phase 1
4915,D04HER,SOM-0999,Multiple sclerosis , Investigative
4916,D04HEW,PMID26815044-Compound-32,Albinism , Patented
4917,D04HEW,PMID26815044-Compound-32,Ephelides , Patented
4918,D04HEW,PMID26815044-Compound-32,Menkes disease , Patented
4919,D04HEW,PMID26815044-Compound-32,Senile lentigines , Patented
4920,D04HEW,PMID26815044-Compound-32,Melasma , Patented
4921,D04HHW,FK-011,Asthma , Discontinued in Phase 2
4922,D04HIS,Varilrix,Varicella zoster virus infection , Approved
4923,D04HIZ,BO-653,Artery stenosis , Discontinued in Phase 2
4924,D04HJE,"AZ-01, PEGylated interferon-beta",Multiple sclerosis , Phase 2
4925,D04HLE,Vitaxin,Solid tumour/cancer , Discontinued in Phase 2
4926,D04HMD,Glyphosate,Malaria , Investigative
4927,D04HMK,Hi8 melanoma vaccine,Melanoma , Phase 2
4928,D04HMM,XP-20925,Migraine , Preclinical
4929,D04HOT,LFG-316,Macular degeneration , Phase 2
4930,D04HQA,FIT-06,Human immunodeficiency virus infection , Phase 2
4931,D04HQC,SB-9200,Hepatitis B virus infection , Phase 2
4932,D04HQJ,AB-103,Necrotizing soft tissue infection , Phase 3
4933,D04HQT,proglumide,Influenza virus infection , Phase 2
4934,D04HSH,IMGN289,Solid tumour/cancer , Phase 1
4935,D04HTL,ABX-0402,Inflammatory bowel disease , Investigative
4936,D04HUC,mRNA-046,Solid tumour/cancer , Investigative
4937,D04HVB,Panomifene,Solid tumour/cancer , Discontinued in Phase 2
4938,D04HWK,IL-7/CD80-expressing allogeneic RCC-26 tumor cell vaccine,Renal cell carcinoma , Phase 1
4939,D04HXB,Meningitec,Bacterial infection , Approved
4940,D04HXP,PN-2XXX,Non-alcoholic steatohepatitis , Investigative
4941,D04HXS,REC-15/3079,Urinary incontinence , Discontinued in Phase 2
4942,D04HYR,XN-05,Solid tumour/cancer , Investigative
4943,D04HZX,CCX-832,Psoriasis vulgaris , Discontinued in Phase 1
4944,D04IAJ,MVA62B,Human immunodeficiency virus infection , Phase 2
4945,D04IBA,Ellipravin,Solid tumour/cancer , Discontinued in Phase 2
4946,D04IBG,Infanrix-DTaP-IPV-Hep B,Hepatitis B virus infection , Approved
4947,D04IBG,Infanrix-DTaP-IPV-Hep B,Bordetella pertussis infection , Approved
4948,D04IBI,ABX-301,Allergy , Investigative
4949,D04ICN,DuP-630,Dermatitis , Terminated
4950,D04IDT,Helicobacter vaccine,Helicobacter infection , Terminated
4951,D04IEM,Nartograstim,Constitutional neutropenia , Approved
4952,D04IFD,GR-ARA1,Solid tumour/cancer , Investigative
4953,D04IFU,GSK835726,Allergic rhinitis , Discontinued in Phase 2
4954,D04IHB,RUTI,Mycobacterium infection , Phase 2
4955,D04IIU,INDISULAM,Lymphoma , Phase 2
4956,D04IJZ,Microplasmin,Eye disorder , Phase 3
4957,D04IKF,18F-LMI-1195,Heart failure , Phase 2
4958,D04IME,SCH-48461,Hyperlipidaemia , Discontinued in Phase 2
4959,D04INP,Pixykine,Human immunodeficiency virus infection , Phase 3
4960,D04IPX,WEHI-0103122,Solid tumour/cancer , Investigative
4961,D04IQH,PF-655,Diabetic macular edema , Phase 2
4962,D04ITO,Rifaximin,Bacterial infection , Approved
4963,D04ITR,PMID26868298-compound-N3,Severe acute respiratory syndrome (SARS) , Preclinical
4964,D04ITR,PMID26868298-compound-N3,Middle East Respiratory Syndrome (MERS) , Preclinical
4965,D04ITR,PMID26868298-compound-N3,Coronavirus Disease 2019 (COVID-19) , Investigative
4966,D04IUB,NT0202,Attention deficit hyperactivity disorder , Phase 3
4967,D04IUQ,SonoRx,Gastrointestinal disease , Approved
4968,D04IUY,APC-001,Solid tumour/cancer , Investigative
4969,D04IWZ,PT2.0,Clostridium infection , Investigative
4970,D04IXD,IPH-2101,Multiple myeloma , Phase 2
4971,D04IXJ,Bimetopyrole,Pain , Investigative
4972,D04IXL,HCV vaccine,Hepatitis virus infection , Phase 1
4973,D04IXL,HCV vaccine,Hepatitis C virus infection , Phase 1
4974,D04JAB,Tcelna,Multiple sclerosis , Phase 2
4975,D04JAQ,FH-AAV8,Familial hypercholesterolemia , Investigative
4976,D04JAT,PF-4427429,Migraine , Phase 1
4977,D04JCD,Six-membered heterocyclic benzamide derivative 6,Pruritus , Patented
4978,D04JCD,Six-membered heterocyclic benzamide derivative 6,Solid tumour/cancer , Patented
4979,D04JCD,Six-membered heterocyclic benzamide derivative 6,Chronic pain , Patented
4980,D04JCD,Six-membered heterocyclic benzamide derivative 6,Neuropathic pain , Patented
4981,D04JCD,Six-membered heterocyclic benzamide derivative 6,Thymic cancer , Patented
4982,D04JCN,Pergolide,Parkinson disease , Approved
4983,D04JCT,AA-204,Kidney disease , Investigative
4984,D04JEE,Propranolol,Migraine , Approved
4985,D04JFB,RX-20001,Ocular disease , Investigative
4986,D04JFG,BMS-986253,Coronavirus Disease 2019 (COVID-19) , Phase 2
4987,D04JFT,KW-5139,Pain , Discontinued in Phase 2
4988,D04JGA,BMS-191095,Angina pectoris , Discontinued in Phase 1
4989,D04JHH,CAR-T cells targeting CD19,leukaemia , Phase 1/2
4990,D04JHH,CAR-T cells targeting CD19,Lymphoma , Phase 1/2
4991,D04JHH,CAR-T cells targeting CD19,Multiple myeloma , Phase 1/2
4992,D04JHN,Hydromorphone,Pain , Approved
4993,D04JHN,Hydromorphone,Chronic pain , Phase 3
4994,D04JIE,SER-201,Solid tumour/cancer , Investigative
4995,D04JIM,UCB-35440,Rhinitis , Phase 2
4996,D04JIS,OG-Cx-833,Huntington disease , Investigative
4997,D04JJE,RP-66153,Asthma , Terminated
4998,D04JKE,Promostem,Solid tumour/cancer , Phase 1/2
4999,D04JKG,TherAtoH,Hearing disorder , Investigative
5000,D04JLW,AWD-72-011,Allergy , Terminated
5001,D04JMG,CEQ-626,Inflammatory bowel disease , Investigative
5002,D04JMI,Plasma derived human butyrylcholinesterase,Neurotoxicity , Phase 1
5003,D04JMQ,Flurithromycin ethylsuccinate,Bacterial infection , Approved
5004,D04JNC,ZL-N-91,Lung inflammation , Investigative
5005,D04JNI,GSK2245840,Chronic obstructive pulmonary disease , Phase 2
5006,D04JNZ,PROSTRATIN,Human immunodeficiency virus infection , Investigative
5007,D04JOE,Placulumab,Sciatica , Phase 1/2
5008,D04JPJ,Lomustine,Brain cancer , Approved
5009,D04JPQ,PSN-101,Diabetic complication , Investigative
5010,D04JQR,LY-367385,Neurological disorder , Terminated
5011,D04JRK,P-1104,Multiple sclerosis , Investigative
5012,D04JSE,MK-7725,Obesity , Investigative
5013,D04JSI,CAR-T cells targeting CD133,Acute myeloid leukaemia , Preclinical
5014,D04JTD,PX-12,Solid tumour/cancer , Phase 2
5015,D04JTX,BI-224436,Human immunodeficiency virus infection , Phase 1
5016,D04JTY,Thiolactomycin,Malaria , Investigative
5017,D04JTY,Thiolactomycin,Urinary tract infection , Investigative
5018,D04JVU,Long-acting IFN-alpha,Solid tumour/cancer , Phase 1/2
5019,D04JVX,AKP-320,Type-2 diabetes , Terminated
5020,D04JYK,GC-1107,Clostridium infection , Phase 3
5021,D04JZD,Polyvalent crotalid antivenin ovine fab,Poison intoxication , Approved
5022,D04JZH,PF-01247324,Pain , Phase 1
5023,D04JZP,Mazapertine succinate,Psychotic disorder , Phase 2
5024,D04KAQ,Pivampicillin,Bacterial infection , Approved
5025,D04KBL,Bevacizumab,Metastatic colorectal cancer , Approved
5026,D04KBL,Bevacizumab,Colorectal cancer , Phase 3
5027,D04KBL,Bevacizumab,Brain metastases , Phase 2
5028,D04KBL,Bevacizumab,Solid tumour/cancer , Phase 1
5029,D04KBL,Bevacizumab,Lung cancer , Phase 1
5030,D04KBL,Bevacizumab,Ovarian cancer , Application submitted
5031,D04KBU,AIR-001,Hypertension , Phase 2
5032,D04KBU,AIR-001,Heart failure , Phase 2
5033,D04KCT,Org-21465,Anaesthesia , Discontinued in Phase 1
5034,D04KEL,EV-086,Fungal infection , Investigative
5035,D04KFR,NVP-SAA164,Pain , Investigative
5036,D04KGB,Anti-IFN-alpha human mabs,Autoimmune diabetes , Investigative
5037,D04KHH,CEFCANEL DALOXATE HYDROCHLORIDE,Bacterial infection , Discontinued in Phase 3
5038,D04KHY,Spiroglumide,Stomach disease , Phase 2
5039,D04KHY,Spiroglumide,Neuropathic pain , Discontinued in Phase 1
5040,D04KIH,Ac-YVAD-FMK,Photocontact dermatitis , Patented
5041,D04KIH,Ac-YVAD-FMK,Irritant contact dermatitis , Patented
5042,D04KIH,Ac-YVAD-FMK,Allergic contact dermatitis , Patented
5043,D04KJO,Formoterol,Asthma , Approved
5044,D04KJT,ABT-333,Hepatitis C virus infection , Phase 1
5045,D04KKE,Diaziquone,Solid tumour/cancer , Discontinued in Phase 3
5046,D04KKX,QX-30002222,Bacterial infection , Investigative
5047,D04KMO,CGP-35348,Epilepsy , Terminated
5048,D04KMP,SUVN-G3031,Cognitive impairment , Phase 3
5049,D04KMQ,GSK3117391,Rheumatoid arthritis , Phase 1
5050,D04KNL,PG-545,Ocular disease , Phase 1
5051,D04KQF,Tubacin,Multiple myeloma , Investigative
5052,D04KRV,Iofolastat I-124,Prostate cancer , Phase 1
5053,D04KTI,LY3127804,Coronavirus Disease 2019 (COVID-19) , Phase 2
5054,D04KTZ,Cloxacillin,Bacterial infection , Approved
5055,D04KUJ,Purine derivative 1,Obesity , Patented
5056,D04KUK,Medium chain triglycerides,Lymphatic disease , Approved
5057,D04KVA,BVI-007,Thrombotic stroke , Phase 1
5058,D04KVA,BVI-007,Myocardial infarction , Phase 1
5059,D04KVQ,BAY-86-9596,Solid tumour/cancer , Phase 1
5060,D04KWH,Des-Arg(9)-[Leu(8)]-BK,Depression , Investigative
5061,D04KWO,MEDl-551,Scleroderma , Phase 1
5062,D04KWY,RTI-336,Cocaine addiction , Phase 1
5063,D04KXF,CEFTRAZONAL BOPENTIL,Bacterial infection , Discontinued in Phase 1
5064,D04KYB,ASCJ-9,Alopecia , Phase 2
5065,D04KYB,ASCJ-9,Acne vulgaris , Phase 2
5066,D04KYY,Allopurinol,Hyperuricaemia , Approved
5067,D04KZH,FluBiovax,Influenza virus infection , Investigative
5068,D04KZN,CTP-354,Pain , Discontinued in Phase 1
5069,D04KZS,PRO-045,Duchenne dystrophy , Phase 1/2
5070,D04KZY,Gilteritinib,Acute myeloid leukaemia , Approved
5071,D04LAQ,Candoxatrilat,Heart failure , Discontinued in Phase 1
5072,D04LBC,Iclaprim,Bacterial infection , Phase 3
5073,D04LBC,Iclaprim,Pneumonia , Phase 2
5074,D04LBC,Iclaprim,Acute bacterial skin infection , Application submitted
5075,D04LBJ,ASOBAMAST,Asthma , Investigative
5076,D04LCQ,Tafluprost,Glaucoma/ocular hypertension , Approved
5077,D04LCX,Vax-SPIRAL,Leptospira infection , Approved
5078,D04LDH,BZ6,Ataxia-telangiectasia , Investigative
5079,D04LDK,TZP-202,Dyspepsia , Preclinical
5080,D04LEH,LTX-03,Pain , Phase 2
5081,D04LEK,GSK729327,Schizophrenia , Discontinued in Phase 1
5082,D04LFG,CGP-25454A,Major depressive disorder , Terminated
5083,D04LFR,SAR404460,Pre-sarcopenia , Phase 1
5084,D04LGK,VRT-750018,Allergy , Investigative
5085,D04LHG,SP-SAP,Cancer related pain , Investigative
5086,D04LHJ,Methscopolamine Bromide,Nausea and vomiting , Approved
5087,D04LIH,AVI-6002,Ebola virus infection , Phase 1
5088,D04LIR,PD-159913,Cerebrovascular ischaemia , Terminated
5089,D04LJB,NP-213,Onychomycosis , Phase 2
5090,D04LKS,Ruxolitinib,High-risk myelofibrosis , Approved
5091,D04LKS,Ruxolitinib,Essential thrombocythemia , Approved
5092,D04LKS,Ruxolitinib,Pancreatic cancer , Phase 3
5093,D04LKS,Ruxolitinib,Atopic dermatitis , Phase 1/2
5094,D04LKS,Ruxolitinib,Vitiligo , Phase 1/2
5095,D04LMJ,MMB-4,Poison intoxication , Investigative
5096,D04LMZ,X-22,Smoking dependence , Phase 2
5097,D04LMZ,X-22,Myocardial infarction , Phase 2
5098,D04LMZ,X-22,Tobacco dependence , Phase 2
5099,D04LOR,BMS-919373,Atrial fibrillation , Phase 2
5100,D04LPZ,SAB-301,Middle East Respiratory Syndrome (MERS) , Discontinued in Phase 1
5101,D04LQN,ELAD,Acute liver failure , Phase 3
5102,D04LQN,ELAD,Heart failure , Phase 2/3
5103,D04LRQ,TDI-0059,Motor neurone disease , Investigative
5104,D04LRU,AHR-16462B,Hypertension , Terminated
5105,D04LSD,ABT-239,Cognitive impairment , Phase 1
5106,D04LSH,SAR101099,Diabetic nephropathy , Discontinued in Phase 1
5107,D04LTF,TLN-4601,Solid tumour/cancer , Phase 2
5108,D04LTO,Steamchol,Gallstone , Investigative
5109,D04LTQ,Buproprion+zonisamide,Obesity , Phase 2
5110,D04LUG,BSP-C801,Gram-positive bacterial infection , Investigative
5111,D04LVK,Ceritinib,Non-small-cell lung cancer , Approved
5112,D04LWT,GSK1440115,Asthma , Phase 1
5113,D04LXB,Captisol-enabled Melphalan,Multiple myeloma , Phase 2
5114,D04LYD,Azosemide,Edema , Approved
5115,D04LZF,NVX-208,Ischemic stroke , Phase 1/2
5116,D04MBK,AGS-67E,Solid tumour/cancer , Phase 1
5117,D04MBK,AGS-67E,Acute myeloid leukaemia , Phase 1
5118,D04MBK,AGS-67E,Malignant lymphatic , Phase 1
5119,D04MBQ,iPSC-derived RPE (autologous),Wet age-related macular degeneration , Phase 1
5120,D04MBS,BMS-182657,Cardiovascular disease , Terminated
5121,D04MCY,BMS 650032,Hepatitis C virus infection , Phase 2
5122,D04MDJ,Cefdaloxime pentexil tosilate,Bacterial infection , Discontinued in Phase 1
5123,D04MDO,HuL2G7,Solid tumour/cancer , Phase 1
5124,D04MEB,Antituberculosis agents,Mycobacterium infection , Investigative
5125,D04MEM,ORMD-1001,Influenza virus infection , Investigative
5126,D04MFQ,Myotubularin,Myotonic dystrophy , Investigative
5127,D04MFW,DL-3,Prostate cancer , Investigative
5128,D04MFY,AJ-3941,Cerebrovascular ischaemia , Terminated
5129,D04MGD,Elpetrigine,Bipolar disorder , Phase 1
5130,D04MGI,PF-821385,Human immunodeficiency virus infection , Preclinical
5131,D04MGU,Technetium (99m Tc) bicisate,Central nervous system disease , Approved
5132,D04MGW,BI-836858,Myelodysplastic syndrome , Phase 2
5133,D04MGW,BI-836858,Acute myeloid leukaemia , Phase 1/2
5134,D04MHP,AZP-2006,Alzheimer disease , Investigative
5135,D04MHV,Heterocyclic derivative 17,Solid tumour/cancer , Patented
5136,D04MHV,Heterocyclic derivative 17,Metastatic cancer , Patented
5137,D04MKJ,Renzapride,Irritable bowel syndrome , Phase 3
5138,D04MLE,GKA-23,Diabetic complication , Investigative
5139,D04MLR,CD123-specific gene-engineered T cells,Acute myeloid leukaemia , Phase 1/2
5140,D04MMJ,ADX-2 series,Schizophrenia , Preclinical
5141,D04MNL,SERM-3339,Osteoporosis , Discontinued in Phase 2
5142,D04MOF,Milveterol+Fluticasone,Chronic obstructive pulmonary disease , Discontinued in Phase 2
5143,D04MOZ,NB3178,Gram-positive bacterial infection , Investigative
5144,D04MPB,Bevirimat,Human immunodeficiency virus infection , Phase 2
5145,D04MPV,Pyrazole derivative 15,Obesity , Patented
5146,D04MRA,BAY-73-7977,Diabetic complication , Discontinued in Phase 1
5147,D04MRG,Stevioside,Sweetener , Approved
5148,D04MRQ,Irsogladine,Metastatic malignant neoplasm , Approved
5149,D04MRX,Chondroitinase,Intervertebral disc displacement , Investigative
5150,D04MSM,Carbamazepine,Epilepsy , Approved
5151,D04MSM,Carbamazepine,Type-1 diabetes , NDA filed
5152,D04MSM,Carbamazepine,Gastric adenocarcinoma , Phase 3
5153,D04MUQ,RiVax + TVax,Ricin poisoning , Phase 1
5154,D04MWJ,Methacholine Chloride,bronchial hyperreactivity , Approved
5155,D04MWJ,Methacholine Chloride,Asthma , Approved
5156,D04MXN,CEP-32496,Solid tumour/cancer , Phase 1/2
5157,D04MXO,BCX-5191,Hepatitis C virus infection , Investigative
5158,D04MXV,VGV-L,Lyme disease , Investigative
5159,D04MYC,NSC-625487,Human immunodeficiency virus infection , Investigative
5160,D04MYG,Fenbunafide,Solid tumour/cancer , Investigative
5161,D04MYO,ABN-912,Asthma , Discontinued in Phase 1
5162,D04MYS,LL-4218,Psoriasis vulgaris , Phase 2
5163,D04MZP,NI-0101,Autoimmune diabetes , Phase 1
5164,D04MZR,Bucelipase alfa,Exocrine pancreatic insufficiency , Phase 3
5165,D04NAQ,Emricasan,Hepatic fibrosis , Phase 2
5166,D04NAQ,Emricasan,Liver cirrhosis , Phase 2
5167,D04NBY,SPVF-2801-10,Solid tumour/cancer , Investigative
5168,D04NCC,PMID28350212-Compound-18,Alzheimer disease , Patented
5169,D04NCJ,BMY-21950,Hyperlipidaemia , Discontinued in Phase 2
5170,D04NCK,Streptokinase,Acute myocardial infarction , Phase 4
5171,D04NCK,Streptokinase,Severe acute respiratory syndrome (SARS) , Discontinued in Phase 3
5172,D04NDK,Oral human gammaglobulin,Juvenile idiopathic arthritis , Phase 2
5173,D04NDK,Oral human gammaglobulin,Clostridium infection , Phase 2
5174,D04NDM,Paromomycin,Intestinal amebiasis , Approved
5175,D04NFB,DMP-963,Human immunodeficiency virus infection , Terminated
5176,D04NHQ,HSV529,Herpes simplex virus infection , Phase 1
5177,D04NIZ,AMG 747,Schizophrenia , Phase 2
5178,D04NJP,TRF-1101,Sickle-cell anaemia , Phase 2
5179,D04NJS,SAR351034,Dyslipidemia , Phase 1
5180,D04NJS,SAR351034,Type-2 diabetes , Phase 1
5181,D04NKJ,Alferon LDO,Severe acute respiratory syndrome (SARS) , Discontinued in Phase 2
5182,D04NMF,DISC-PRO,Herpes simplex virus infection , Discontinued in Phase 1
5183,D04NMJ,PMID25553724-Compound-US2012830453910,Immune System disease , Patented
5184,D04NNJ,ZANOTERONE,Prostate hyperplasia , Phase 3
5185,D04NNK,Recombinant therapeutic proteins,Solid tumour/cancer , Investigative
5186,D04NOE,OTSGC-A24,Colorectal cancer , Phase 1/2
5187,D04NPP,SLX-2101,Raynaud disease , Discontinued in Phase 2
5188,D04NPP,SLX-2101,Hypertension , Discontinued in Phase 2
5189,D04NPP,SLX-2101,Erectile dysfunction , Discontinued in Phase 2
5190,D04NPR,Lu AF35700,Schizophrenia , Phase 3
5191,D04NPX,ZD-1611,Hypotension , Discontinued in Phase 1
5192,D04NQI,Amodiaquine,Malaria , Approved
5193,D04NQZ,V502,Human papillomavirus infection , Phase 1
5194,D04NRB,Cetilistat,Obesity , Phase 3
5195,D04NRB,Cetilistat,Diabetic complication , Phase 3
5196,D04NRP,ALS-2135,Virus infection , Investigative
5197,D04NRV,IMM-101,Solid tumour/cancer , Phase 2
5198,D04NSW,S-12340,Arteriosclerosis , Terminated
5199,D04NTJ,Glisoxepide,Non-insulin dependent diabetes , Approved
5200,D04NVG,Angiotensin (1-7),Coronavirus Disease 2019 (COVID-19) , Phase 2/3
5201,D04NVK,ShRNA molecule silencing DNAPK radiosensitizer,Prostate cancer , Investigative
5202,D04NWP,DRAFLAZINE,Cardiac arrhythmias , Discontinued in Phase 2
5203,D04NWU,ONO-4053,Allergic rhinitis , Phase 2
5204,D04NXG,PMID26651364-Compound-128,Crohn disease , Patented
5205,D04NXG,PMID26651364-Compound-128,Ulcerative colitis , Patented
5206,D04NXG,PMID26651364-Compound-128,Urinary tract infection , Patented
5207,D04NXL,Indibulin,Advanced sarcoma , Phase 2
5208,D04NXQ,Pefloxacin,Gonococcal urethritis , Approved
5209,D04NXR,RO-16-8714,Diabetic complication , Discontinued in Phase 1
5210,D04NYX,AP-15012,Solid tumour/cancer , Investigative
5211,D04OBB,Pheniramine,Hay fever , Approved
5212,D04OBS,ZP-013,Chronic obstructive pulmonary disease , Investigative
5213,D04OCC,Org-9616,Anaesthesia , Discontinued in Phase 2
5214,D04OCO,AC-163954,Obesity , Investigative
5215,D04ODH,Gonadorelin,Hypothalamic hypogonadism , Approved
5216,D04ODO,GSK-256073,Hyperlipidaemia , Phase 2
5217,D04ODQ,447C88,Hyperlipidaemia , Discontinued in Phase 1
5218,D04OFR,MEDI8897,Respiratory syncytial virus infection , Phase 2/3
5219,D04OFY,ABBV-321,Solid tumour/cancer , Phase 1
5220,D04OGH,SEL-068,Smoking dependence , Phase 1
5221,D04OGP,HL-10,Respiratory distress syndrome , Phase 3
5222,D04OGS,LIV-2008,Solid tumour/cancer , Investigative
5223,D04OGZ,D-699126,Solid tumour/cancer , Investigative
5224,D04OIF,TAK-259,Overactive bladder , Discontinued in Phase 1
5225,D04OIG,DSLIM,Solid tumour/cancer , Investigative
5226,D04OJM,Human interleukin-2,Renal cell carcinoma , Phase 2
5227,D04OKJ,Garenoxacin,Endocarditis , Terminated
5228,D04OLK,AST-1306,Solid tumour/cancer , Phase 1
5229,D04OMR,PF-04840082,Osteoporosis , Phase 1
5230,D04ONP,ALBIFYLLINE,Sepsis , Discontinued in Phase 1
5231,D04OOC,FCE-20696,Mycobacterium infection , Terminated
5232,D04OPS,MDT-011,Chronic obstructive pulmonary disease , Investigative
5233,D04OQU,ASP2408,Rheumatoid arthritis , Phase 1
5234,D04ORP,GMK,Melanoma , Phase 3
5235,D04OSA,AZD-3839,Alzheimer disease , Phase 1
5236,D04OSE,Nifedipine,Angina pectoris , Approved
5237,D04OTH,SomaKit-TOC; gallium (68Ga) edotreotide,Neuroendocrine cancer , Phase 2
5238,D04OTY,BFH-772,Psoriasis vulgaris , Phase 2
5239,D04OUP,NNI-AD,Alzheimer disease , Investigative
5240,D04OXD,Netivudine,Virus infection , Phase 3
5241,D04OXG,PMZ-2123,Cerebral oedema in diabetic ketoacidosis , Phase 1
5242,D04OXU,E-2078,Pain , Discontinued in Phase 2
5243,D04OYW,ST-06,Injury , Investigative
5244,D04OZL,Hu3S193,Fallopian tube cancer , Phase 2
5245,D04OZR,TTH 02-001,Neurodegenerative disorder , Investigative
5246,D04PAF,ANA-04,Autoimmune diabetes , Investigative
5247,D04PAN,Perflubron,Contrast imaging , Approved
5248,D04PAU,GSK2245035,Asthma , Phase 2
5249,D04PBH,CONTIGOSIDE B,Thrombosis , Phase 2/3
5250,D04PBS,MC-3001,Lipid metabolism disorder , Preclinical
5251,D04PCT,PMID30107136-Compound-Example12,Solid tumour/cancer , Patented
5252,D04PCT,PMID30107136-Compound-Example12,Infectious disease , Patented
5253,D04PCT,PMID30107136-Compound-Example12,Human immunodeficiency virus infection , Patented
5254,D04PCT,PMID30107136-Compound-Example12,Hepatitis , Patented
5255,D04PDI,CD19-targeted CAR-T cells,leukaemia , Clinical trial
5256,D04PEI,BMS-509744,Inflammation , Investigative
5257,D04PEO,IRT-101,Human immunodeficiency virus infection , Phase 2
5258,D04PER,XEN-402,Osteoarthritis , Phase 2
5259,D04PER,XEN-402,Vasodilatation of extremities , Phase 2
5260,D04PER,XEN-402,Pain , Phase 2
5261,D04PFD,TriMixDC,Melanoma , Investigative
5262,D04PGB,Gpi-1046,Parkinson disease , Terminated
5263,D04PGO,MDL-28133A,Thrombosis , Terminated
5264,D04PHC,Epinephrine,Allergy , Approved
5265,D04PIH,Novaferon,Colorectal cancer , Phase 2
5266,D04PIU,CART-BCMA cells,Multiple myeloma , Phase 1/2
5267,D04PKQ,Conjugated 3-(indolyl)-and 3-(azaindolyl)-4-arylmaleimide compound 1,Gastric adenocarcinoma , Patented
5268,D04PKR,Aviptadil,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
5269,D04PKX,PMID26651364-Compound-125,Crohn disease , Patented
5270,D04PKX,PMID26651364-Compound-125,Ulcerative colitis , Patented
5271,D04PKX,PMID26651364-Compound-125,Urinary tract infection , Patented
5272,D04PLC,FOV1101,Allergic conjunctivitis , Discontinued in Phase 2
5273,D04PLI,SR46349B,Schizophrenia , Phase 3
5274,D04PLI,SR46349B,Primary insomnia , Phase 3
5275,D04PLI,SR46349B,Sleep-wake disorder , Phase 3
5276,D04PMM,AZD1386,Gastroesophageal reflux disease , Discontinued in Phase 2
5277,D04PMM,AZD1386,Esophagus sensitivity , Discontinued in Phase 2
5278,D04PMS,HER2 antigen-specific cancer immunotherapeutic,Breast cancer , Phase 2
5279,D04PPE,VE-04051645,Solid tumour/cancer , Investigative
5280,D04PPK,CER-522,Aortic valve stenosis , Phase 1
5281,D04PSL,FINROZOLE,Prostate disease , Discontinued in Phase 2
5282,D04PUI,BT-062,Multiple myeloma , Phase 2
5283,D04PUO,OPNT001,Eating disorder , Phase 2
5284,D04PVE,PDA-002,Ulcer , Phase 2
5285,D04PVE,PDA-002,Diabetic foot ulcer , Phase 2
5286,D04PVE,PDA-002,Diabetic neuropathy , Phase 2
5287,D04PVE,PDA-002,Peripheral neuropathy , Phase 2
5288,D04PVN,SPI-376,Schizophrenia , Preclinical
5289,D04PWT,DP-b99,Stroke , Phase 3
5290,D04PXS,Amitifadine,Obesity , Phase 3
5291,D04PXS,Amitifadine,Alcohol dependence , Phase 2
5292,D04PXS,Amitifadine,Mood disorder , Phase 2
5293,D04QCY,Antineoplaston-A3,Solid tumour/cancer , Discontinued in Phase 1
5294,D04QFV,SNX-024,Obesity , Terminated
5295,D04QFX,1-TDC,Bacterial infection , Investigative
5296,D04QFY,GTx-027,Solid tumour/cancer , Investigative
5297,D04QHT,EDP-20,Solid tumour/cancer , Investigative
5298,D04QIE,Pemafibrate,Hyperlipidemia , Approved
5299,D04QIE,Pemafibrate,Lipid metabolism disorder , Phase 3
5300,D04QIE,Pemafibrate,Cardiovascular disease , Phase 3
5301,D04QIL,IMP-111,Solid tumour/cancer , Investigative
5302,D04QJD,Valaciclovir,Virus infection , Approved
5303,D04QKU,RG-7090,Fragile X syndrome , Phase 2
5304,D04QLL,hESC-derived RPE (MA09-hRPE),Myopic macular degeneration , Phase 1/2
5305,D04QLL,hESC-derived RPE (MA09-hRPE),Dry age-related macular degeneration , Phase 1/2
5306,D04QLL,hESC-derived RPE (MA09-hRPE),Stargardt disease , Phase 1
5307,D04QLR,Dyclonine,Pain , Approved
5308,D04QNO,Symbicort,Chronic obstructive pulmonary disease , Approved
5309,D04QPA,AST-OPC1,Spinal cord injury , Phase 1/2
5310,D04QPD,FV-100,Varicella zoster virus infection , Phase 3
5311,D04QQZ,AT132,X-linked myotubular myopathy , Phase 1/2
5312,D04QRG,Antineoplaston A-10,Glioblastoma multiforme , Phase 2
5313,D04QRX,Thiazole carboxamide derivative 27,Solid tumour/cancer , Patented
5314,D04QRX,Thiazole carboxamide derivative 27,Metastatic cancer , Patented
5315,D04QSH,DW-167,Hepatocellular carcinoma , Phase 2/3
5316,D04QSJ,R0-93877,Irritable bowel syndrome , Approved
5317,D04QSJ,R0-93877,Constipation , Approved
5318,D04QST,Riboflavin,Acne vulgaris , Approved
5319,D04QUG,A-101,Cardiovascular disease , Phase 2
5320,D04QUX,PF-446687,Female sexual arousal dysfunction , Phase 2
5321,D04QVK,"1,2,4-tri-substituted imidazoline derivative 1",Obesity , Patented
5322,D04QVN,FPL-64170,Psoriasis vulgaris , Discontinued in Phase 2
5323,D04QVZ,DAS181,Coronavirus Disease 2019 (COVID-19) , Phase 3
5324,D04QWE,Levallorphan,Narcotic depression , Approved
5325,D04QWQ,VX-509,Rheumatoid arthritis , Phase 2/3
5326,D04QWV,APX-008,Bone metastases , Investigative
5327,D04QXF,Anti-CD3 monoclonal antibody,Autoimmune diabetes , Phase 3
5328,D04QXG,SR 120819A,Eating disorder , Terminated
5329,D04QXK,KY-62,Leishmania infection , Terminated
5330,D04QXW,ARC-069,Alzheimer disease , Investigative
5331,D04QYS,SNA-120,Plaque psoriasis , Phase 2
5332,D04QYS,SNA-120,Pruritus , Phase 2
5333,D04QZD,Eslicarbazepine,Seizure disorder , Approved
5334,D04QZI,Retosiban,Preterm labour , Phase 3
5335,D04RAT,BIIR-777,Neurological disorder , Preclinical
5336,D04RBY,EX-201,Mucositis , Investigative
5337,D04RCG,MEN-10627,Asthma , Terminated
5338,D04RCT,CHF-3381,Neuropathic pain , Phase 2
5339,D04RCZ,Immunosuppressant synthetic peptide,Autoimmune diabetes , Approved
5340,D04RDT,CEP-431,Alzheimer disease , Terminated
5341,D04RDW,CAR-T cells targeting Lewis-Y,Solid tumour/cancer , Phase 1
5342,D04REV,CDX-1307,Bladder cancer , Phase 2
5343,D04RFE,AnervaX.DB,Insulin-dependent diabetes , Terminated
5344,D04RFX,LFn-p24,Human immunodeficiency virus infection , Phase 1
5345,D04RGA,Dinoprost Tromethamine,Abortion , Approved
5346,D04RHJ,RG7116,Solid tumour/cancer , Phase 1
5347,D04RJM,DW-941,Coronavirus infection , Investigative
5348,D04RKH,APH-0911,Solid tumour/cancer , Investigative
5349,D04RKW,7-methylxanthine,Myopia , Phase 2
5350,D04RLB,HPIV-1 vaccine,Parainfluenza virus infection , Phase 1
5351,D04RLX,Tariquidar,Adrenocortical carcinoma , Discontinued in Phase 2
5352,D04RLY,Vindesine,Acute lymphoblastic leukaemia , Approved
5353,D04RMM,Clazakizumab,Crohn disease , Phase 2
5354,D04RMM,Clazakizumab,Rheumatoid arthritis , Phase 2
5355,D04RMP,Co-111732,Epilepsy , Terminated
5356,D04RNG,CAR-T cells recognizing EpCAM,Melanoma , Phase 1
5357,D04RNG,CAR-T cells recognizing EpCAM,Breast cancer , Phase 1
5358,D04RNN,SUN-101,Chronic obstructive pulmonary disease , Phase 3
5359,D04RRZ,MEDI4736,Solid tumour/cancer , Phase 3
5360,D04RSI,FAS1,Fungal infection , Preclinical
5361,D04RSR,Crolibulin,Solid tumour/cancer , Phase 1/2
5362,D04RSZ,GI-13000,Hepatitis B virus infection , Investigative
5363,D04RUA,WRR-276,Malaria , Investigative
5364,D04RUP,SDZ-NKT-343,Pain , Discontinued in Phase 1
5365,D04RWV,INS1009,Pulmonary arterial hypertension , Phase 1
5366,D04RXX,N-acylpiperidine ether derivative 2,Pruritus , Patented
5367,D04RXX,N-acylpiperidine ether derivative 2,Solid tumour/cancer , Patented
5368,D04RXX,N-acylpiperidine ether derivative 2,Chronic pain , Patented
5369,D04RXX,N-acylpiperidine ether derivative 2,Neuropathic pain , Patented
5370,D04RXX,N-acylpiperidine ether derivative 2,Thymic cancer , Patented
5371,D04RYU,Digitalin,Cardiovascular disease , Approved
5372,D04RZD,"Interferon Alfa-2b, Recombinant",Hairy cell leukaemia , Approved
5373,D04RZE,FluLaval,Influenza virus infection , Approved
5374,D04RZE,FluLaval,Influenza A virus infection , Approved
5375,D04RZZ,A-5021,Virus infection , Discontinued in Phase 2
5376,D04SBH,Zamifenacin,Urinary incontinence , Discontinued in Phase 3
5377,D04SBI,H.P. Acthar Gel,Amyotrophic lateral sclerosis , Phase 2
5378,D04SBW,Hexavalent conjugate vaccine,Bordetella pertussis infection , Phase 1
5379,D04SBX,Temafloxacin,Bacterial infection , Withdrawn from market
5380,D04SDN,RWJ-3981,Gram-positive bacterial infection , Investigative
5381,D04SEJ,IW-9179,Dyspepsia , Phase 2
5382,D04SFH,Medrysone,Eye inflammation , Approved
5383,D04SHH,TC-6499-12,Irritable bowel syndrome , Phase 2
5384,D04SHO,NMI-1182,Inflammation , Terminated
5385,D04SIO,NGD-91-1,Anxiety disorder , Terminated
5386,D04SIU,MCD-386,Alzheimer disease , Phase 1
5387,D04SJT,MB-11040,Autoimmune diabetes , Phase 1
5388,D04SKM,CART-10 cells,Acute lymphoblastic leukaemia , Phase 1
5389,D04SLF,Bevacizumab + Trastuzumab,Breast cancer , Phase 3
5390,D04SNL,Grippol Plus,Influenza virus infection , Phase 3
5391,D04SOA,H1N1 pandemic influenza A vaccine,Influenza virus infection , Approved
5392,D04SOS,BMS-181168,Cognitive impairment , Discontinued in Phase 2
5393,D04SOU,MK-4074,Diabetic complication , Phase 1
5394,D04SPJ,AZD7624,Chronic obstructive pulmonary disease , Phase 2
5395,D04SPK,Seratrodast,Allergic asthma , Discontinued in Phase 3
5396,D04SQJ,EW-A-401,Peripheral vascular disease , Phase 1
5397,D04SQO,DEBIO 1562,B-cell non-hodgkin lymphoma , Phase 2
5398,D04SQO,DEBIO 1562,Diffuse large B-cell lymphoma , Phase 2
5399,D04SRO,GRT-3983Y,Diabetic neuropathy , Phase 2
5400,D04STQ,CBH-11,Hepatitis C virus infection , Terminated
5401,D04SUU,Thymosin,Coronavirus Disease 2019 (COVID-19) , Phase 2
5402,D04SUX,Recombinant birch pollen allergen,Allergic rhinitis , Phase 2
5403,D04SVB,FR-133605,Arthritis , Terminated
5404,D04SWF,FP-1302,Inflammation , Investigative
5405,D04SWT,Anti-CD47 mab,Ischemia , Investigative
5406,D04SXL,APG-115,Prolymphocytic leukaemia , Phase 2
5407,D04SXL,APG-115,Solid tumour/cancer , Phase 1
5408,D04SZA,P-3914,Inflammation , Phase 1
5409,D04SZG,COTI-219,Small-cell lung cancer , Investigative
5410,D04TBC,OZ-439,Malaria , Phase 2
5411,D04TBW,C-Rx,Hepatitis C virus infection , Investigative
5412,D04TCQ,J-775Y,Allergy , Investigative
5413,D04TDQ,Noscapine (narcotine),Cough , Approved
5414,D04TEF,Alpha-1 antitrypsin,Coagulation defect , Phase 2
5415,D04TEF,Alpha-1 antitrypsin,Bacillus anthracis infection , Phase 1/2
5416,D04TFE,CreaVax-HCC,Hepatocellular carcinoma , Phase 3
5417,D04TFL,SGX203,Crohn disease , Phase 2
5418,D04TGF,AZD-2927,Atrial fibrillation , Phase 2
5419,D04TGU,MK-3901,Pain , Investigative
5420,D04THK,AL0-212,Critical limb ischemia , Investigative
5421,D04THU,KP-624,Hyperuricaemia , Investigative
5422,D04TIJ,Namitecan,Solid tumour/cancer , Phase 1
5423,D04TIL,ANA773,Hepatitis C virus infection , Phase 2a
5424,D04TIT,Nowarta110,Plantar wart , Phase 1/2
5425,D04TIU,PMID25666693-Compound-154,Osteoarthritis pain , Patented
5426,D04TIU,PMID25666693-Compound-154,Cancer related pain , Patented
5427,D04TIU,PMID25666693-Compound-154,Neuropathic pain , Patented
5428,D04TIU,PMID25666693-Compound-154,Inflammatory pain , Patented
5429,D04TJL,LAS-41004,Atopic dermatitis , Phase 2
5430,D04TJP,Totrombopag,Thrombocytopenia , Discontinued in Phase 1
5431,D04TKP,L-748415,Osteoporosis , Terminated
5432,D04TKU,H1N1 influenza vaccine,Influenza virus infection , Phase 1
5433,D04TLJ,Soblidotin,Solid tumour/cancer , Phase 2
5434,D04TLQ,Cyclic peptidomimetic derivative 2,Solid tumour/cancer , Patented
5435,D04TLQ,Cyclic peptidomimetic derivative 2,Infectious disease , Patented
5436,D04TLQ,Cyclic peptidomimetic derivative 2,Human immunodeficiency virus infection , Patented
5437,D04TLQ,Cyclic peptidomimetic derivative 2,Hepatitis , Patented
5438,D04TNT,ABT-639,Pain , Phase 2
5439,D04TPF,TDI-0054,Motor neurone disease , Investigative
5440,D04TPQ,Aganepag isopropyl,Glaucoma/ocular hypertension , Phase 2
5441,D04TPS,A-887755,Alzheimer disease , Investigative
5442,D04TPU,RO-5323441,Solid tumour/cancer , Phase 2
5443,D04TQO,Tenapanor,Irritable bowel syndrome , Approved
5444,D04TQO,Tenapanor,Kidney disease , Phase 2
5445,D04TQO,Tenapanor,Constipation , Phase 2
5446,D04TQT,Barusiban,Androgen deficiency , Phase 2
5447,D04TSO,UNBS-1450,Solid tumour/cancer , Phase 1
5448,D04TSV,CI-992,Hypertension , Terminated
5449,D04TUN,HTI-1066,Solid tumour/cancer , Phase 1
5450,D04TXB,Ceplene/Peg-Intron/Rebetol,Hepatitis C virus infection , Investigative
5451,D04TYP,RG7600,Pancreatic cancer , Discontinued in Phase 1
5452,D04TYP,RG7600,Ovarian cancer , Discontinued in Phase 1
5453,D04TZA,PF-04957325,Itching , Investigative
5454,D04TZA,PF-04957325,Inflammation , Investigative
5455,D04TZK,LNK-3186,Alzheimer disease , Investigative
5456,D04TZT,SDZ-280-636,Fungal infection , Terminated
5457,D04UAL,Clovoxamine,Major depressive disorder , Approved
5458,D04UAZ,CTA-091,Hyperparathyroidism , Investigative
5459,D04UBI,AB928,Metastatic colorectal cancer , Phase 1/2
5460,D04UBI,AB928,Solid tumour/cancer , Phase 1
5461,D04UFI,ImMucin,Multiple myeloma , Phase 1/2
5462,D04UFY,UX-003,Lysosomal storage disease , Phase 3
5463,D04UFY,UX-003,Mucopolysaccharidosis , Phase 3
5464,D04UHW,PMID25684022-Compound-WO2008079988,Solid tumour/cancer , Patented
5465,D04UHW,PMID25684022-Compound-WO2008079988,Metastatic cancer , Patented
5466,D04UHX,HumaRAD-HN,Head and neck cancer , Discontinued in Phase 1
5467,D04UKC,Riociguat,Pulmonary arterial hypertension , Approved
5468,D04UKJ,NP-61,Alzheimer disease , Discontinued in Phase 1
5469,D04UKP,Tenatumomab,Glioma , Phase 3
5470,D04UME,BI-144807,Asthma , Phase 2
5471,D04UNO,KUL-7211,Neurogenic bladder dysfunction , Phase 1
5472,D04UNY,Anti-GD2 T-cells (1RG-CART),Neuroblastoma , Phase 1
5473,D04UOJ,PYN-7,Solid tumour/cancer , Preclinical
5474,D04UPJ,DasKloster 0247-01,Pulmonary hypertension , Investigative
5475,D04UPM,KBAB-401,Bacterial infection , Investigative
5476,D04UPW,RWJ-68023,Irritable bowel syndrome , Phase 1
5477,D04UQF,Influvac tC cell culture-derived influenza vaccine,Influenza virus infection , Phase 1
5478,D04UQS,NXD-9062,Alzheimer disease , Investigative
5479,D04URO,Streptokinase,Pulmonary embolism , Approved
5480,D04URZ,AVX-003,Glomerulonephritis , Investigative
5481,D04USC,Ergotidine,Respiratory allergy , Approved
5482,D04USK,H5N1 influenza vaccine,Influenza virus infection , Preclinical
5483,D04UTH,Long-acting erythropoietin conjugate,Anemia , Phase 1
5484,D04UTT,Olodaterol,Chronic obstructive pulmonary disease , Approved
5485,D04UUD,CC-401,Solid tumour/cancer , Phase 2
5486,D04UUH,Lithium Carbonate,Manic depression disorder , Approved
5487,D04UWG,Autologous T-cell therapy,Prostate cancer , Phase 1
5488,D04UWU,Oraxol,Gastric adenocarcinoma , Phase 3
5489,D04UWU,Oraxol,Breast cancer , Phase 3
5490,D04UXX,PD-158771,Schizophrenia , Preclinical
5491,D04UYT,CBLB-612,Radiation syndrome , Investigative
5492,D04UYY,AD5-10,Solid tumour/cancer , Investigative
5493,D04UZN,Pyrimethamine/sulfadoxine,Pneumocystis pneumonia , Approved
5494,D04UZT,Quinestrol,Breast cancer , Approved
5495,D04VAR,GSK-2136773,Colorectal cancer , Investigative
5496,D04VBF,JNJ-38518168,Rheumatoid arthritis , Phase 2
5497,D04VBF,JNJ-38518168,Plaque psoriasis , Phase 2
5498,D04VCF,ADR58,Rheumatoid arthritis , Investigative
5499,D04VCN,Bovactant,Pulmonary disease , Approved
5500,D04VCQ,CART33 cells,Myeloid leukaemia , Phase 1/2
5501,D04VCS,Neocartilage,Pain , Phase 3
5502,D04VDY,L-741671,Vomiting , Terminated
5503,D04VEJ,Lymecycline,Bacterial infection , Approved
5504,D04VFJ,Toremifene,Breast cancer , Approved
5505,D04VFW,SAR-116242,Malaria , Investigative
5506,D04VGR,PMID27998201-Compound-9,Rheumatoid arthritis , Patented
5507,D04VGS,Selenium sulfide,Erythema , Approved
5508,D04VGY,CYT-007-TNFQb,Allergic rhinitis , Discontinued in Phase 1/2
5509,D04VHB,RSV recombinant vaccine,Respiratory syncytial virus infection , Phase 2
5510,D04VHK,CLR-3001,Major depressive disorder , Phase 2
5511,D04VHL,MystiTears,Xerophthalmia , Investigative
5512,D04VHQ,AVI-7012,Junin virus infection , Investigative
5513,D04VHZ,Interferon-alpha 2b,Hairy cell leukaemia , Approved
5514,D04VHZ,Interferon-alpha 2b,Coronavirus Disease 2019 (COVID-19) , Phase 1
5515,D04VIP,4030W92,Pain , Discontinued in Phase 2
5516,D04VIS,Andrographolide,Bacillary dysentery , Approved
5517,D04VJH,ACREOZAST,Asthma , Discontinued in Phase 2
5518,D04VJQ,BVS857,Insulin-resistant disorder , Phase 1
5519,D04VKO,ATON-004,Heavy metal poisoning , Discontinued in Phase 2
5520,D04VKS,Acrisorcin,Fungal infection , Approved
5521,D04VLR,PA-161,Human immunodeficiency virus infection , Preclinical
5522,D04VMG,ELEMENE,Solid tumour/cancer , Phase 1
5523,D04VMM,Encapsulated cancer cells,Solid tumour/cancer , Phase 2
5524,D04VMT,Sotalol,Sinus rhythm disorder , Approved
5525,D04VOE,AS-1402,Breast cancer , Phase 2
5526,D04VOZ,TKM-ApoB,Hypercholesterolaemia , Phase 4
5527,D04VPA,Moricizine,Arrhythmia , Approved
5528,D04VPA,Moricizine,Heart arrhythmia , Withdrawn from market
5529,D04VPP,ATI-1150,Solid tumour/cancer , Investigative
5530,D04VQH,XEN-D0501,Overactive bladder , Phase 2
5531,D04VRB,NeuVax,Breast cancer , Phase 3
5532,D04VRN,MMR,Rubella prophylaxis , Phase 3
5533,D04VRN,MMR,Mumps virus infection , Phase 3
5534,D04VRN,MMR,Measles , Phase 3
5535,D04VSI,Arbidol,Influenza virus infection , Phase 4
5536,D04VSI,Arbidol,Coronavirus Disease 2019 (COVID-19) , Phase 2
5537,D04VSM,CS-8958,Influenza virus infection , Phase 3
5538,D04VTV,SYN-114,Cognitive impairment , Discontinued in Phase 1
5539,D04VUM,CGEN-928,Multiple myeloma , Investigative
5540,D04VUY,RG-7166,Major depressive disorder , Discontinued in Phase 1
5541,D04VVD,TeloB-Vax,Prostate cancer , Phase 1
5542,D04VVL,Malaria next generation vaccine,Malaria , Phase 2
5543,D04VWJ,ARRY-520,Solid tumour/cancer , Phase 2
5544,D04VWJ,ARRY-520,Multiple myeloma , Phase 2
5545,D04VWO,Recombinant soluble CD6,Sepsis , Investigative
5546,D04VXN,Moxalactam Disodium,Bacterial infection , Approved
5547,D04VXS,ENT-102,Pain , Terminated
5548,D04VZS,CTS-21166,Alzheimer disease , Phase 1
5549,D04WBT,Act1,Wound healing , Phase 3
5550,D04WBY,Menotropins,Female infertility , Approved
5551,D04WCA,AVP-7,Solid tumour/cancer , Investigative
5552,D04WCI,PAMAPIMOD,Rheumatoid arthritis , Discontinued in Phase 2
5553,D04WCJ,DV-100,Type-1 diabetes , Phase 2
5554,D04WCO,EPB-415,Hepatitis C virus infection , Investigative
5555,D04WDA,CSL-412,Influenza virus infection , Phase 2
5556,D04WDX,PJ34,Coronavirus infection , Preclinical
5557,D04WFD,Nortriptyline,Depression , Approved
5558,D04WFL,Trastuzumab,Breast cancer , Approved
5559,D04WFL,Trastuzumab,Gastric adenocarcinoma , Application submitted
5560,D04WFL,Trastuzumab,HER2-positive breast cancer , Application submitted
5561,D04WFV,Hepatitis B immune globulin,Hepatitis B virus infection , Approved
5562,D04WHM,G0-203-2c,Pancreatic cancer , Phase 1/2
5563,D04WHM,G0-203-2c,Acute myeloid leukaemia , Phase 1
5564,D04WHX,FP-21399,Human immunodeficiency virus infection , Discontinued in Phase 2
5565,D04WIE,Sirna-027,Exudative age-related macular degeneration , Phase 1/2
5566,D04WIE,Sirna-027,Neovascular age-related macular degeneration , Phase 1
5567,D04WIF,ISIS-GCGR,Diabetic complication , Phase 2
5568,D04WIF,ISIS-GCGR,Type-2 diabetes , Preclinical
5569,D04WIG,CY-1747,Cardiovascular disease , Terminated
5570,D04WJO,Talaporfin,Breast cancer , Approved
5571,D04WLX,AIK-21,Cerebrovascular ischaemia , Investigative
5572,D04WMR,Tepoxalin,Asthma , Phase 2
5573,D04WNA,ART-237,Arthropathy , Investigative
5574,D04WOM,Seractide Acetate,Essential hypertension , Approved
5575,D04WQJ,AMG-181,Crohn disease , Phase 2
5576,D04WQJ,AMG-181,Ulcerative colitis , Phase 2
5577,D04WQT,RG7201,Type-2 diabetes , Phase 3
5578,D04WSK,99mTc-ImmuRAID-LL1,Autoimmune diabetes , Investigative
5579,D04WSL,Cardiotoxin,Solid tumour/cancer , Investigative
5580,D04WTN,Oxabact,Hyperoxaluria , Phase 3
5581,D04WUA,"CP-101,606",Parkinson disease , Phase 2
5582,D04WUA,"CP-101,606",Ischemic stroke , Investigative
5583,D04WVI,M-17 E. Coli,Irritable bowel syndrome , Phase 3
5584,D04WVL,SF-1,Breast cancer , Discontinued in Phase 1/2
5585,D04WVY,SPI-026,Pulmonary arterial hypertension , Phase 2
5586,D04WWG,S-1389,Heart arrhythmia , Terminated
5587,D04WXG,DVC-LVS,Tularemia , Phase 2
5588,D04WYX,Netarsudil,Open-angle glaucoma , Approved
5589,D04WYX,Netarsudil,Glaucoma/ocular hypertension , Phase 2
5590,D04WZK,AZD-2858,Alzheimer disease , Terminated
5591,D04WZL,CART-meso cells,Pancreatic cancer , Clinical trial
5592,D04XAB,Autologous cancer vaccine,Lymphoma , Phase 1
5593,D04XBU,ATL-104,Solid tumour/cancer , Phase 2
5594,D04XCK,OMP-313M32,Solid tumour/cancer , Phase 1
5595,D04XCO,AZD-8848,Allergic rhinitis , Phase 2
5596,D04XDT,Delafloxacin Meglumine,Acute bacterial skin infection , Approved
5597,D04XDT,Delafloxacin Meglumine,Skin infection , Approved
5598,D04XEG,Fenoterol,Asthma , Approved
5599,D04XEO,ChelASE,Retina disorder , Discontinued in Phase 1
5600,D04XEQ,Imetelstat,Myelodysplastic syndrome , Phase 2/3
5601,D04XEQ,Imetelstat,Multiple myeloma , Phase 2
5602,D04XEQ,Imetelstat,Breast cancer , Phase 2
5603,D04XEQ,Imetelstat,Non-small-cell lung cancer , Phase 2
5604,D04XEQ,Imetelstat,Essential thrombocythemia , Phase 2
5605,D04XEQ,Imetelstat,Myelofibrosis , Phase 2
5606,D04XGT,Benznidazole,Chagas disease , Approved
5607,D04XGT,Benznidazole,Trypanosomiasis , Approved
5608,D04XGU,Crestor/TriLipix,Dyslipidemia , Approved
5609,D04XIA,Meningococcus B vaccine,Neisseria meningitis infection , Terminated
5610,D04XIO,Dutogliptin,Type-2 diabetes , Phase 3
5611,D04XIV,Mesenchymal precursor cell,Type-2 diabetes , Phase 2
5612,D04XJE,REM-001,Breast cancer , Phase 2
5613,D04XJG,BKR-013,Type-2 diabetes , Phase 1
5614,D04XJM,R1295,Rheumatoid arthritis , Discontinued in Phase 1
5615,D04XJV,GRC-9332,Lipid metabolism disorder , Investigative
5616,D04XJX,GP-1001,Influenza virus infection , Investigative
5617,D04XLU,Dendritic cell vaccine,Prostate cancer , Preclinical
5618,D04XMJ,LY525327,Migraine , Terminated
5619,D04XMJ,LY525327,Neuropathic pain , Terminated
5620,D04XML,TRI-002,Pain , Investigative
5621,D04XMN,NK-109,Solid tumour/cancer , Terminated
5622,D04XNQ,BioScavenger,Solid tumour/cancer , Phase 1
5623,D04XOX,Malate synthase,Mycobacterium infection , Investigative
5624,D04XPD,DV-0100,Systemic lupus erythematosus , Phase 2
5625,D04XPW,Cocaine,Anaesthesia , Approved
5626,D04XQW,Dornase alfa,Cystic fibrosis , Approved
5627,D04XQW,Dornase alfa,Coronavirus Disease 2019 (COVID-19) , Phase 2
5628,D04XSP,Alpha-fetoprotein cancer vaccine,Hepatocellular carcinoma , Phase 1/2
5629,D04XTK,SRM003,Peripheral vascular disease , Phase 2
5630,D04XUJ,CBT-101,Solid tumour/cancer , Phase 1
5631,D04XUJ,CBT-101,Glaucoma/ocular hypertension , Discontinued in Phase 2
5632,D04XVE,QAX-028,Chronic obstructive pulmonary disease , Phase 2
5633,D04XVJ,LEO-29102,Atopic dermatitis , Phase 2
5634,D04XVN,Trametinib,Melanoma , Approved
5635,D04XVU,GKT-137831,Fibrosis , Phase 2
5636,D04XWX,PS-178990,Muscle atrophy , Phase 1
5637,D04XZE,NS-7,Nerve injury , Phase 2
5638,D04YAJ,SELODENOSON,Cardiac arrhythmias , Phase 2
5639,D04YAK,MPC-2130,Solid tumour/cancer , Phase 1
5640,D04YCE,Pidotimod,Urinary tract infection , Withdrawn from market
5641,D04YCQ,GEN-003,Herpes simplex virus infection , Phase 2
5642,D04YEW,Tarafenacin,Overactive bladder , Phase 2
5643,D04YEY,PS-388023,Ocular disease , Terminated
5644,D04YFA,VAX-161,Influenza A virus infection , Phase 1
5645,D04YGT,VAL-001,Acne vulgaris , Investigative
5646,D04YHG,ErepoXen,Anemia , Phase 3
5647,D04YHJ,Meninge B,Meningitis , Phase 1
5648,D04YHR,Samarium Sm-153 Lexidronam Pentasodium,Cancer related pain , Approved
5649,D04YHW,R-1487,Rheumatoid arthritis , Discontinued in Phase 1
5650,D04YIA,CNVN-202,Non-small-cell lung cancer , Phase 1/2
5651,D04YJN,R411,Asthma , Phase 2
5652,D04YJO,CGS-19480A,Anxiety disorder , Investigative
5653,D04YKM,Microfibrillar collagen hemostat,Bleeding disorder , Approved
5654,D04YKO,Piperidine derivative 2,Inflammation , Patented
5655,D04YKO,Piperidine derivative 2,Solid tumour/cancer , Patented
5656,D04YKQ,NaQuinate,Osteoporosis , Investigative
5657,D04YKY,NT-502,Age-related macular degeneration , Investigative
5658,D04YLQ,AMG 334,Migraine , Phase 2
5659,D04YLU,AZ-599,Pain , Investigative
5660,D04YMH,Lumiracoxib,Knee osteoarthritis , Approved
5661,D04YNI,WY-48989,Rheumatoid arthritis , Terminated
5662,D04YPN,Treosulfan,Melanoma , Approved
5663,D04YPZ,Decapeptide allergy vaccine,Allergy , Discontinued in Phase 2
5664,D04YRD,DTX101,Haemophilia B , Phase 1/2
5665,D04YSC,CD19 CAR T cells,Acute lymphoblastic leukaemia , Phase 2/3
5666,D04YSC,CD19 CAR T cells,B-cell lymphoma , Phase 2/3
5667,D04YSK,Pagibaximab,Enterococcus faecium infection , Phase 2/3
5668,D04YSQ,HepaXen,Hepatitis B virus infection , Investigative
5669,D04YSY,Recombinant NOV,Corneal disease , Investigative
5670,D04YTT,DAV-148,Enterobacteriaceae infection , Investigative
5671,D04YTX,HPy-HP 097,Helicobacter infection , Investigative
5672,D04YWM,Atacicept,Lymphoma , Phase 3
5673,D04YWM,Atacicept,Multiple sclerosis , Phase 2
5674,D04YWM,Atacicept,Rheumatoid arthritis , Phase 2
5675,D04YWM,Atacicept,Systemic lupus erythematosus , Phase 2
5676,D04YWM,Atacicept,Lupus , Phase 2
5677,D04YWS,RAGE-Fc fusion protein,Diabetic complication , Investigative
5678,D04YXL,PEGylated IFN beta 1-a,Type-2 diabetes , Approved
5679,D04YZL,Sodium chloride,Skin burns , Approved
5680,D04YZS,KIT-302,Pain , Application submitted
5681,D04YZS,KIT-302,Osteoarthritis , Application submitted
5682,D04YZS,KIT-302,Hypertension , Application submitted
5683,D04ZAH,Piperacillin,Bacterial infection , Approved
5684,D04ZBA,NVLS/FX-18A,Cardiovascular disease , Investigative
5685,D04ZBT,Icatibant,Hereditary angioedema , Approved
5686,D04ZBU,JTT-302,Lipid metabolism disorder , Phase 2
5687,D04ZCL,VZ-564,Asthma , Terminated
5688,D04ZCZ,GINKOLIDE B,Sepsis , Terminated
5689,D04ZEP,A-849531,Metabolic disorder , Investigative
5690,D04ZFO,WVE-120102,Huntington disease , Phase 1/2
5691,D04ZHJ,TNF alpha kinoid,Autoimmune diabetes , Phase 2
5692,D04ZIJ,Pepstatin,Malaria , Terminated
5693,D04ZIO,NBI-640756,Essential tremor or related tremors , Phase 1
5694,D04ZIZ,DMUC-5754A,Ovarian cancer , Phase 1
5695,D04ZIZ,DMUC-5754A,Peritoneal cancer , Phase 1
5696,D04ZIZ,DMUC-5754A,Fallopian tube cancer , Phase 1
5697,D04ZJG,PI-88,Hepatocellular carcinoma , Phase 3
5698,D04ZJG,PI-88,Prostate cancer , Phase 2
5699,D04ZJP,HSR-113,Nausea and vomiting , Discontinued in Phase 1
5700,D04ZJQ,VN/13-1RA,Dermatological disease , Investigative
5701,D04ZKY,SEP-363856,Schizophrenia , Phase 3
5702,D04ZKY,SEP-363856,Parkinson disease , Phase 2
5703,D04ZKY,SEP-363856,Major depressive disorder , Phase 1
5704,D04ZLC,N-(arylalkyl)-1H-indole-2-sulfonic acid amide derivative 1,Obesity , Patented
5705,D04ZLG,IDEC-151,Rheumatoid arthritis , Discontinued in Phase 2
5706,D04ZLJ,LOSOXANTRONE,Breast cancer , Discontinued in Phase 2
5707,D04ZND,PGL-2001,Endometriosis , Phase 2
5708,D04ZNG,LF-08-0133,Arteriosclerosis , Discontinued in Phase 1
5709,D04ZNL,RG-7234,Type-2 diabetes , Phase 2
5710,D04ZOZ,MS-322,Spasm , Discontinued in Phase 2
5711,D04ZQB,KPT-9274,Non-hodgkin lymphoma , Phase 1
5712,D04ZQB,KPT-9274,Solid tumour/cancer , Phase 1
5713,D04ZQO,TG-2349,Hepatitis C virus infection , Phase 2
5714,D04ZSL,SB-313-xTZ,Glioblastoma multiforme , Phase 1
5715,D04ZSZ,DS-AH-14,Asthma , Investigative
5716,D04ZTA,ANA-5,Alzheimer disease , Investigative
5717,D04ZTY,Voglibose,Diabetic complication , Approved
5718,D04ZUU,AKT-10081,Clostridium infection , Investigative
5719,D04ZVO,ZS-9,Hyperkalemia , Investigative
5720,D04ZWD,EZN-4150,Solid tumour/cancer , Investigative
5721,D04ZWH,"UK-279,276",Stroke , Discontinued in Phase 2
5722,D04ZWQ,Org-25435,Epilepsy , Phase 1
5723,D04ZXP,Dicycloplatin,Prostate cancer , Registered
5724,D04ZYP,Cat-SPIRE,Solid tumour/cancer , Phase 3
5725,D04ZZD,AVP-6,Prostate cancer , Investigative
5726,D04ZZM,Resorcinol compound 21,Albinism , Patented
5727,D04ZZM,Resorcinol compound 21,Ephelides , Patented
5728,D04ZZM,Resorcinol compound 21,Menkes disease , Patented
5729,D04ZZM,Resorcinol compound 21,Senile lentigines , Patented
5730,D04ZZM,Resorcinol compound 21,Melasma , Patented
5731,D04ZZQ,VAS-2870,Cardiovascular disease , Investigative
5732,D04ZZT,AGS-004,Human immunodeficiency virus-1 infection , Phase 2
5733,D04ZZX,Mi-TUMEX,Solid tumour/cancer , Investigative
5734,D05AAD,Isatoribine,Hepatitis C virus infection , Phase 2
5735,D05AAM,BINOSPIRONE MESYLATE,Anxiety disorder , Discontinued in Phase 1
5736,D05AAQ,BCP-1081,Asthma , Investigative
5737,D05AAW,VR-776,Premature ejaculation , Discontinued in Phase 1
5738,D05ACQ,Gallium maltolate,Human immunodeficiency virus infection , Discontinued in Phase 2
5739,D05ADE,RAD-100,Pain , Investigative
5740,D05ADP,R-roscovitine,Non-small-cell lung cancer , Phase 2
5741,D05ADP,R-roscovitine,Solid tumour/cancer , Phase 2
5742,D05ADP,R-roscovitine,Nasopharyngeal carcinoma , Investigative
5743,D05AEE,RG7935,Parkinson disease , Phase 2
5744,D05AFC,Dalfopristin,Bacterial infection , Approved
5745,D05AFP,CY-301,Herpes simplex virus infection , Investigative
5746,D05AFR,Rolitetracycline,Acne vulgaris , Approved
5747,D05AFX,Nefopam,Pain , Approved
5748,D05AHC,NOV-205,Human immunodeficiency virus infection , Phase 2
5749,D05AHE,Methylergonovine,Spontaneous abortion , Approved
5750,D05AHK,INGN-234,Oral cancer , Discontinued in Phase 2
5751,D05AHQ,Epiroprim,Bacterial infection , Terminated
5752,D05AJT,XL019,Solid tumour/cancer , Phase 3
5753,D05AJT,XL019,Polycythemia vera , Phase 1
5754,D05AKH,OnabotulinumtoxinA,Major depressive disorder , Phase 2
5755,D05ALG,RWJ-49815,Fungal infection , Terminated
5756,D05ALG,RWJ-49815,Obesity , Investigative
5757,D05ALG,RWJ-49815,Eating disorder , Investigative
5758,D05ALP,REG1,Acute coronary syndrome , Phase 3
5759,D05AON,LSI-518P,Cardiovascular disease , Terminated
5760,D05APM,ANG-2684,Cerebrovascular ischaemia , Investigative
5761,D05APW,ABT-116,Pain , Investigative
5762,D05AQB,FAS-89B,Obesity , Investigative
5763,D05AQP,ASP-0306,Urinary dysfunction , Discontinued in Phase 1
5764,D05AQT,PMID28270021-Compound-WO2014078408Example1,Pruritus , Patented
5765,D05AQT,PMID28270021-Compound-WO2014078408Example1,Solid tumour/cancer , Patented
5766,D05AQT,PMID28270021-Compound-WO2014078408Example1,Chronic pain , Patented
5767,D05AQT,PMID28270021-Compound-WO2014078408Example1,Neuropathic pain , Patented
5768,D05AQT,PMID28270021-Compound-WO2014078408Example1,Thymic cancer , Patented
5769,D05ARP,Ganciclovir,Virus infection , Approved
5770,D05ASV,VTX-1463,Allergic rhinitis , Phase 1
5771,D05ATD,AVX-502,Influenza virus infection , Phase 1/2
5772,D05ATI,Sodium lauryl sulfate,Constipation , Approved
5773,D05ATQ,MVA HER-2 AutoVac,Breast cancer , Phase 1
5774,D05AVB,DW-1029M,Diabetic nephropathy , Phase 2
5775,D05AVL,JNJ-61178104,Autoimmune disease , Phase 1
5776,D05AWP,Moxidectin ,River blindness , Approved
5777,D05AWP,Moxidectin ,Onchocerciasis , Approved
5778,D05AXS,CRx-189,Inflammatory bowel disease , Terminated
5779,D05AZE,Biphenyl mannoside derivative 30,Crohn disease , Patented
5780,D05AZE,Biphenyl mannoside derivative 30,Ulcerative colitis , Patented
5781,D05AZE,Biphenyl mannoside derivative 30,Urinary tract infection , Patented
5782,D05BAJ,PDR001,Melanoma , Phase 3
5783,D05BAJ,PDR001,Neuroendocrine cancer , Phase 2
5784,D05BAJ,PDR001,Esophageal squamous cell carcinoma , Phase 2
5785,D05BAJ,PDR001,Lymphoma , Phase 1
5786,D05BAJ,PDR001,Solid tumour/cancer , Phase 1
5787,D05BBB,Saratin,Inflammation , Phase 2
5788,D05BBQ,RP-66364,Inflammation , Terminated
5789,D05BCA,MX-4509,Neurological disorder , Discontinued in Phase 1
5790,D05BCF,Clavulanate+Amoxicillin,Infectious disease , Investigative
5791,D05BCU,RQ-00000004,Gastroesophageal reflux disease , Phase 3
5792,D05BDY,PXT-3003,Charcot marie tooth disease , Phase 3
5793,D05BGY,PM184,Colorectal cancer , Phase 2
5794,D05BHF,Masilukast,Asthma , Phase 2
5795,D05BII,Ancrod,Blood forming organ disorder , Phase 3
5796,D05BIJ,RWJ-140998,Gram-positive bacterial infection , Investigative
5797,D05BIN,F-14512,Solid tumour/cancer , Phase 1/2
5798,D05BIT,Maxy-10,Autoimmune diabetes , Terminated
5799,D05BJD,Motexafin gadolinium,Brain cancer , Approved
5800,D05BJD,Motexafin gadolinium,Human immunodeficiency virus infection , Phase 3
5801,D05BKS,Nimotuzumab,Head and neck cancer , Approved
5802,D05BKY,NK-1005,Atrial fibrillation , Investigative
5803,D05BLG,MC-116,Central nervous system disease , Investigative
5804,D05BLN,MGCD516,Solid tumour/cancer , Phase 2/3
5805,D05BLN,MGCD516,Breast cancer , Phase 2
5806,D05BLN,MGCD516,Non-small-cell lung cancer , Phase 1/2
5807,D05BLQ,Neuromed 2,Pain , Investigative
5808,D05BMC,GW-42004,Lipid metabolism disorder , Phase 2
5809,D05BMG,Amphetamine,Attention deficit hyperactivity disorder , Approved
5810,D05BNS,Oral-Vimo-001,Solid tumour/cancer , Phase 1
5811,D05BPC,Tiprelestat,Myocardial infarction , Phase 2
5812,D05BPD,Emepepimut-S,Non-small-cell lung cancer , Phase 2
5813,D05BPO,PF-06801591,Solid tumour/cancer , Phase 1
5814,D05BPO,PF-06801591,Advanced malignancy , Phase 1
5815,D05BPO,PF-06801591,Non-hodgkin lymphoma , Phase 1
5816,D05BQK,Butalbital,Anxiety disorder , Approved
5817,D05BQK,Butalbital,Headache , Approved
5818,D05BRZ,PG-140,Transplant rejection , Investigative
5819,D05BSG,Enkastim-ev,Solid tumour/cancer , Phase 1
5820,D05BTL,PMID26651364-Compound-126c,Crohn disease , Patented
5821,D05BTL,PMID26651364-Compound-126c,Ulcerative colitis , Patented
5822,D05BTL,PMID26651364-Compound-126c,Urinary tract infection , Patented
5823,D05BTM,Maxacalcitol,Disorder of calcium metabolism , Approved
5824,D05BTR,Tallimustine,Solid tumour/cancer , Discontinued in Phase 2
5825,D05BUD,Mannoside derivative 10,Crohn disease , Patented
5826,D05BUD,Mannoside derivative 10,Ulcerative colitis , Patented
5827,D05BUD,Mannoside derivative 10,Urinary tract infection , Patented
5828,D05BWH,PRX-3140,Post-traumatic stress disorder , Phase 2
5829,D05BWH,PRX-3140,Alzheimer disease , Phase 2
5830,D05BWX,CB-2431,Osteoarthritis , Discontinued in Phase 2
5831,D05BWY,CLR-300,Major depressive disorder , Investigative
5832,D05BXO,Brasofensine,Parkinson disease , Phase 2
5833,D05BXY,Talimogene Laherparepvec,Melanoma , Approved
5834,D05BYA,NVP-AUY922,Multiple myeloma , Phase 2
5835,D05BYA,NVP-AUY922,Solid tumour/cancer , Phase 2
5836,D05BYJ,PF-06413367,Asthma , Phase 1
5837,D05BYO,ISIS-SOD1,Motor neurone disease , Phase 1
5838,D05BYO,ISIS-SOD1,Amyotrophic lateral sclerosis , Phase 1
5839,D05BYP,Lupron 3-month depot,Bone marrow transplantation , Phase 2
5840,D05CBJ,PA-799,Colorectal cancer , Phase 1/2
5841,D05CBJ,PA-799,Solid tumour/cancer , Phase 1
5842,D05CBP,PMID26651364-Compound-9a,Crohn disease , Patented
5843,D05CBP,PMID26651364-Compound-9a,Ulcerative colitis , Patented
5844,D05CBP,PMID26651364-Compound-9a,Urinary tract infection , Patented
5845,D05CDF,Doramapimod,Inflammatory bowel disease , Discontinued in Phase 2
5846,D05CDG,R-1164,Osteoporosis , Discontinued in Phase 1
5847,D05CEK,CV 6209,Asthma , Terminated
5848,D05CEO,Brodalumab,Plaque psoriasis , Approved
5849,D05CEO,Brodalumab,Psoriasis vulgaris , Phase 3
5850,D05CEO,Brodalumab,Asthma , Phase 2
5851,D05CEU,Flunarizine,Migraine , Approved
5852,D05CFG,PR104,Acute myeloid leukaemia , Phase 2
5853,D05CFH,AGN-199981,Neuropathic pain , Phase 2
5854,D05CFQ,AMG-191,Inflammation , Phase 1
5855,D05CFV,Dapirolizumab pegol,Systemic lupus erythematosus , Phase 2
5856,D05CGH,Evatak,Solid tumour/cancer , Investigative
5857,D05CGO,XP-28,Muscle fatigue , Phase 3
5858,D05CGX,SPK-FIX,Haemophilia B , Phase 1/2
5859,D05CHI,Rifabutin,Mycobacterium infection , Approved
5860,D05CHI,Rifabutin,Tuberculosis , Approved
5861,D05CHN,Irofulven/Taxotere,Solid tumour/cancer , Phase 1
5862,D05CHR,LBY-135,Solid tumour/cancer , Discontinued in Phase 1
5863,D05CJN,HG-1336,Neurological disorder , Investigative
5864,D05CJU,DLX-105,Osteoarthritis , Phase 2
5865,D05CKF,AJD-101,Type-2 diabetes , Discontinued in Phase 2
5866,D05CKR,Nabumetone,Pain , Approved
5867,D05CMT,COMBO Stent,Coronary artery disease , Clinical trial
5868,D05CMY,Peginterferon lambda-1a,Coronavirus Disease 2019 (COVID-19) , Phase 2
5869,D05CMZ,ONO-2952,Irritable bowel syndrome , Phase 2
5870,D05COE,PMID30107136-Compound-Example52,Solid tumour/cancer , Patented
5871,D05COE,PMID30107136-Compound-Example52,Infectious disease , Patented
5872,D05COE,PMID30107136-Compound-Example52,Human immunodeficiency virus infection , Patented
5873,D05COE,PMID30107136-Compound-Example52,Hepatitis , Patented
5874,D05COG,DU-1777,Hypertension , Terminated
5875,D05CPD,BIOO-2,Solid tumour/cancer , Investigative
5876,D05CPS,Dendritic cell vaccine,Head and neck cancer , Phase 1
5877,D05CPV,Dronedarone,Angina pectoris , Approved
5878,D05CPV,Dronedarone,Atrial fibrillation , Withdrawn from market
5879,D05CQS,NB1011,Breast cancer , Phase 1/2
5880,D05CRG,L-054852,Acromegaly , Investigative
5881,D05CRY,ADCT-502,Solid tumour/cancer , Phase 1
5882,D05CSS,CAR-T cells targeting MucI,Lung cancer , Phase 1/2
5883,D05CSS,CAR-T cells targeting MucI,Glioblastoma multiforme , Phase 1
5884,D05CTQ,CD138 CAR T cells,Multiple myeloma , Phase 1/2
5885,D05CTS,C-202,Epilepsy , Terminated
5886,D05CTY,NV.TLM.10,Insomnia , Investigative
5887,D05CVC,90Y-cG250,Solid tumour/cancer , Phase 1
5888,D05CVH,Hu neutral insulin,Type-1 diabetes , Approved
5889,D05CYX,DAV-121,Toxicity , Investigative
5890,D05DAX,TT-120,Coagulation defect , Investigative
5891,D05DBT,EG-HPV,Human papillomavirus infection , Investigative
5892,D05DBY,Imagabalin,Generalized anxiety disorder , Phase 3
5893,D05DBZ,AGS-8M4,Ovarian cancer , Discontinued in Phase 2
5894,D05DCL,ZYT-1,Lipid metabolism disorder , Phase 1
5895,D05DCX,Genetically modified allogeneic sertoli cells,Brain injury , Investigative
5896,D05DDN,HCV-796,Hepatitis C virus infection , Discontinued in Phase 2
5897,D05DDZ,MV-6401,Artery stenosis , Preclinical
5898,D05DFV,PRO-044,Duchenne dystrophy , Phase 2
5899,D05DKT,CART19 cell,B-cell prolymphocytic leukaemia , Phase 1
5900,D05DNA,FR-183998,Hypertension , Terminated
5901,D05DNH,A-79296,Herpes simplex virus infection , Terminated
5902,D05DON,MILACAINIDE TARTRATE,Cardiac arrhythmias , Discontinued in Phase 2
5903,D05DOY,ING-1,Solid tumour/cancer , Phase 1
5904,D05DPE,BR-05001,Anemia , Investigative
5905,D05DPU,SP-102,Sciatica/lumbar radicular pain , Phase 3
5906,D05DQF,Indole N -acetamide,Hepatovirus infection , Investigative
5907,D05DQR,HDV-interferon,Hepatitis C virus infection , Phase 2
5908,D05DRG,PDC-31,Dysmenorrhea , Investigative
5909,D05DSK,E2101,Spasm , Discontinued in Phase 1
5910,D05DSK,E2101,Cervical dystonia , Discontinued in Phase 1
5911,D05DSS,GI-13020,Hepatitis B virus infection , Phase 1
5912,D05DVP,Zafirlukast,Asthma , Approved
5913,D05DXT,XEN-D0103,Atrial fibrillation , Phase 1
5914,D05DZA,PUR-0110,Inflammation , Phase 2
5915,D05DZJ,TDI-0055,Motor neurone disease , Investigative
5916,D05DZK,Interferon alpha 2a,Hepatitis C virus infection , Phase 3
5917,D05DZR,Elotuzumab,Multiple myeloma , Approved
5918,D05EAJ,ETV-003,Neisseria meningitis infection , Investigative
5919,D05EAM,Pentamidine,Fungal infection , Approved
5920,D05EAM,Pentamidine,Human immunodeficiency virus infection , Withdrawn from market
5921,D05EBY,PCSK9 Adnectin,Cardiovascular disease , Phase 1
5922,D05ECA,LJM716,Breast cancer , Phase 1/2
5923,D05ECK,SKF-110679,Growth hormone deficiency , Phase 2
5924,D05ECQ,RX-10001,Rheumatoid arthritis , Phase 1
5925,D05ECQ,RX-10001,Asthma , Phase 1
5926,D05EEJ,ETRX-101,Anemia , Discontinued in Phase 2
5927,D05EFR,SprayGel,Abdominal surgical procedure , Approved
5928,D05EFR,SprayGel,Pelvic inflammatory disease , Approved
5929,D05EFR,SprayGel,Gastric disease , Approved
5930,D05EHJ,IMOVAX,Poliovirus infection , Approved
5931,D05EHS,MyoDys,Duchenne dystrophy , Phase 1
5932,D05EIT,CVT-E002,Virus infection , Approved
5933,D05EJG,L-Tryptophan,Depression , Approved
5934,D05EKM,FR-121196,Alzheimer disease , Terminated
5935,D05EKO,OvaSave,Autoimmune diabetes , Phase 2
5936,D05ELM,AC-150,Allergic conjunctivitis , Phase 2
5937,D05ELO,"Insulin, porcine",Diabetic complication , Approved
5938,D05ELV,Zinc Chloride,Common cold , Approved
5939,D05ELY,Influenza A virus vaccine H9N2,Influenza A virus H9N2 infection , Phase 2
5940,D05ELZ,IC9/CAR.19/IL15-transduced CB-NK cells,Acute lymphoblastic leukaemia , Phase 1/2
5941,D05ELZ,IC9/CAR.19/IL15-transduced CB-NK cells,Non-hodgkin lymphoma , Phase 1/2
5942,D05EMG,Butylscopolamine,Dysmenorrhea , Approved
5943,D05EMV,GR148672X,Acute lymphoblastic leukaemia , Clinical trial
5944,D05EMW,Long-acting polysialic acid-interferon alpha 2b conjugate,Hepatitis C virus infection , Investigative
5945,D05ENG,AVX701,Colorectal cancer , Phase 1/2
5946,D05ENG,AVX701,Rectosigmoid junction cancer , Phase 1/2
5947,D05ENJ,Fasitibant chloride,Osteoarthritis , Phase 2
5948,D05EOT,CM-PK,Parkinson disease , Investigative
5949,D05EPE,VRC-SRSDNA015-00-VP,Coronavirus infection , Phase 1
5950,D05EPM,Ethotoin,Complex partial seizure , Approved
5951,D05EPU,ZD7114,Diabetic complication , Phase 1
5952,D05EPV,Ozoralizumab,Rheumatoid arthritis , Phase 2
5953,D05EPY,L-693612,Glaucoma/ocular hypertension , Investigative
5954,D05ERA,PXL-01,Sarcoidosis , Phase 2
5955,D05ERT,GV-196771,Migraine , Discontinued in Phase 2
5956,D05ETC,SN-32793,Non-small-cell lung cancer , Phase 1/2
5957,D05EUH,H5N1 influenza virus vaccine,Influenza A virus H5N1 infection , Phase 1/2
5958,D05EUI,DeltaFLU,Influenza virus infection , Phase 2
5959,D05EUR,LJN452,Primary biliary cholangitis , Phase 2
5960,D05EUS,Human microbio modulator,Solid tumour/cancer , Phase 1
5961,D05EVF,Iodine-123-iodophenylpentadecanoic acid,Coronary artery disease , Approved
5962,D05EVI,U-78875,Anxiety disorder , Discontinued in Phase 1
5963,D05EXN,CC-223,Solid tumour/cancer , Phase 1/2
5964,D05EYG,L-745337,Asthma , Terminated
5965,D05FBZ,CPHPC,Parkinson disease , Phase 1/2
5966,D05FCR,GT0918,Coronavirus Disease 2019 (COVID-19) , Phase 3
5967,D05FCR,GT0918,Prostate cancer , Phase 1/2
5968,D05FFR,MGBG,Head and neck cancer , Terminated
5969,D05FGG,Azilsartan,Hypertension , Approved
5970,D05FGN,DFV890,Coronavirus Disease 2019 (COVID-19) , Phase 2
5971,D05FGP,DWP-418,Solid tumour/cancer , Phase 1
5972,D05FHZ,MGD009,Solid tumour/cancer , Phase 1
5973,D05FIJ,GSK2816126,Solid tumour/cancer , Phase 1
5974,D05FKU,ETC-1922159,Solid tumour/cancer , Phase 1
5975,D05FOB,GenFusAb,leukaemia , Investigative
5976,D05FOF,CHS-0214,Ischemic heart disease , Phase 3
5977,D05FOF,CHS-0214,Plaque psoriasis , Phase 3
5978,D05FOF,CHS-0214,Rheumatoid arthritis , Phase 3
5979,D05FPZ,M7824,Solid tumour/cancer , Phase 2
5980,D05FQD,Metaiodobenzylguanidine I-131,Neuroblastoma , Phase 2
5981,D05FQD,Metaiodobenzylguanidine I-131,Neuroendocrine cancer , Phase 2
5982,D05FQD,Metaiodobenzylguanidine I-131,Pheochromocytoma , Application submitted
5983,D05FQF,FLUNOPROST,Nasal congestion , Investigative
5984,D05FRM,ApoVax104-HPV,Cervical cancer , Investigative
5985,D05FRP,Rindopepimut,Glioblastoma multiforme , Phase 3
5986,D05FRP,Rindopepimut,Brain cancer , Phase 3
5987,D05FSK,MSL-143438,Yersinia infection , Investigative
5988,D05FTJ,Mefenamic acid,Dysmenorrhea , Approved
5989,D05FTY,ES-1005,Hypertension , Terminated
5990,D05FUP,CAR-T cells targeting Mesothelin,Cervical cancer , Phase 1/2
5991,D05FUP,CAR-T cells targeting Mesothelin,Lung cancer , Phase 1/2
5992,D05FUU,Pratosartan,Hypertension , Phase 3
5993,D05FVK,RPI-78M,Multiple sclerosis , Phase 1
5994,D05FVK,RPI-78M,Rheumatoid arthritis , Discontinued in Phase 1
5995,D05FVX,CDP-484,Immune System disease , Discontinued in Phase 1/2
5996,D05FWF,Fostrap,Hypophosphatasia , Phase 1
5997,D05FWH,SCH-900776,Solid tumour/cancer , Phase 2
5998,D05FYA,Thioperamide,Cognitive impairment , Terminated
5999,D05FZM,CD19-UCART,Acute lymphoblastic leukaemia , Clinical trial
6000,D05FZM,CD19-UCART,Non-hodgkin lymphoma , Clinical trial
6001,D05GBH,F4co vaccine,Human immunodeficiency virus infection , Phase 2
6002,D05GBR,MVA CSP,Malaria , Investigative
6003,D05GBZ,ABS-205,Neurodegenerative disorder , Terminated
6004,D05GDS,N-(arylalkyl)-1H-indole-2-sulfonic acid amide derivative 2,Obesity , Patented
6005,D05GEF,KRN-5500,Peripheral neuropathy , Phase 2
6006,D05GGD,SYNVISC-ONE,Pain , Phase 4
6007,D05GGP,HEGF,Diabetic foot ulcer , Approved
6008,D05GIO,ICT-037,Solid tumour/cancer , Investigative
6009,D05GJJ,JR-051,Fabry disease , Investigative
6010,D05GJP,LBVH-0101,Bacterial infection , Phase 3
6011,D05GJW,Cladribine,Hairy cell leukaemia , Approved
6012,D05GJW,Cladribine,Multiple sclerosis , Phase 3
6013,D05GJW,Cladribine,Relapsing-remitting multiple sclerosis , Phase 3
6014,D05GKD,Tramadol,Pain , Approved
6015,D05GKN,SBC-106,Lysosomal storage disease , Investigative
6016,D05GKZ,Follistatin,Osteoporosis , Investigative
6017,D05GLT,Norisoboldine,Inflammation , Investigative
6018,D05GMG,NNI-351,Major depressive disorder , Investigative
6019,D05GMT,Pyridinone carboxamide derivative 1,Solid tumour/cancer , Patented
6020,D05GMT,Pyridinone carboxamide derivative 1,Metastatic cancer , Patented
6021,D05GNW,AZD-9164,Chronic obstructive pulmonary disease , Phase 2
6022,D05GOA,Vivia-1615,Solid tumour/cancer , Investigative
6023,D05GOM,S-20928,Sleep-wake disorder , Terminated
6024,D05GPB,Eptacog alfa,Hemophilia , Phase 1
6025,D05GPN,Recombinant human CFH protein,Kidney disease , Investigative
6026,D05GPO,Olopatadine,Allergic conjunctivitis , Approved
6027,D05GPO,Olopatadine,Ocular allergy , Phase 3
6028,D05GQD,CSA-13,Bacterial infection , Preclinical
6029,D05GQH,ADX-88178,Anxiety disorder , Investigative
6030,D05GQL,KNI-102,Human immunodeficiency virus infection , Terminated
6031,D05GQV,RTA-801,Motor neurone disease , Investigative
6032,D05GRY,Nesiritide,Congestive heart failure , Approved
6033,D05GSI,LA-480,Solid tumour/cancer , Investigative
6034,D05GUK,INTOPLICINE,Solid tumour/cancer , Phase 1
6035,D05GVO,PAT-NM-1,Solid tumour/cancer , Investigative
6036,D05GVQ,Muromonab-cd3,Graft-versus-host disease , Approved
6037,D05GVV,Pyrimidine derivative 5,Neurodegenerative disorder , Patented
6038,D05GVV,Pyrimidine derivative 5,Fibrosis , Patented
6039,D05GVV,Pyrimidine derivative 5,Blood vessel proliferative disorder , Patented
6040,D05GXC,Peginterferon lambda alfa-1a,Coronavirus Disease 2019 (COVID-19) , Phase 2
6041,D05GYL,UR-63325,Allergic rhinitis , Phase 2
6042,D05GYU,EP-201,Ovarian cancer , Phase 2
6043,D05GZB,Dupixent,Atopic dermatitis , Phase 3
6044,D05GZD,Rilapladib,Cardiovascular disease , Phase 1
6045,D05GZD,Rilapladib,Arteriosclerosis , Phase 1
6046,D05HAD,DP-4088,Coagulation defect , Phase 1
6047,D05HAJ,Follitropin alfa/lutropin alfa,Infertility , Approved
6048,D05HBZ,E 7974,Ovarian cancer , Phase 1
6049,D05HCO,1954U89,Solid tumour/cancer , Preclinical
6050,D05HDX,GW-501516,Type-1 diabetes , Discontinued in Phase 4
6051,D05HEJ,Beta 1-6 glucan-conjugated trastuzumab,Breast cancer , Investigative
6052,D05HFN,99mTc-tetrofosmin,Breast cancer , Approved
6053,D05HFN,99mTc-tetrofosmin,Radioactive tracer , Approved
6054,D05HFU,TGX-6B4,Thrombosis , Preclinical
6055,D05HFY,Acenocoumarol,Thrombosis , Approved
6056,D05HGL,GW-695634,Human immunodeficiency virus infection , Phase 1
6057,D05HHP,Astenose,Arteriosclerosis , Terminated
6058,D05HHZ,NX-002,Inflammatory bowel disease , Investigative
6059,D05HID,rAAV1.tMCK.human-alpha-sarcoglycan,Discovery agent , Phase 1
6060,D05HIJ,SAR260301,Pten-deficient tumour , Discontinued in Phase 1
6061,D05HIP,Comvac4-HB,Hepatitis B virus infection , Approved
6062,D05HIX,MK-6406,Infectious disease , Phase 1
6063,D05HJO,PD-2024,Insulin-resistant disorder , Investigative
6064,D05HJR,Oncoprex,Non-small-cell lung cancer , Phase 2
6065,D05HJR,Oncoprex,Solid tumour/cancer , Investigative
6066,D05HKB,RS 86,Alzheimer disease , Terminated
6067,D05HKC,PMID26651364-Compound-123,Crohn disease , Patented
6068,D05HKC,PMID26651364-Compound-123,Ulcerative colitis , Patented
6069,D05HKC,PMID26651364-Compound-123,Urinary tract infection , Patented
6070,D05HKG,Pegylated interferon lambda,Coronavirus Disease 2019 (COVID-19) , Phase 2
6071,D05HLC,NVC-727,Conjunctivitis , Investigative
6072,D05HPI,Daptomycin,Bacterial infection , Approved
6073,D05HRW,SKL-NP2,Neuropathic pain , Investigative
6074,D05HSC,Tubocurarine,Anaesthesia , Approved
6075,D05HSC,Tubocurarine,Smoking dependence , Approved
6076,D05HSI,T-0632,Pancreatic malfunction , Discontinued in Phase 1
6077,D05HTS,PLX8394,Solid tumour/cancer , Phase 2
6078,D05HTS,PLX8394,Melanoma , Phase 1/2
6079,D05HUG,OMS-403,Opioid dependence , Phase 2
6080,D05HUG,OMS-403,Nicotine dependence , Phase 2
6081,D05HUQ,BIOVANCE,Wound healing , Phase 4
6082,D05HUZ,TTI-314,Autoimmune diabetes , Investigative
6083,D05HVY,GSK-644784,Neuropathic pain , Discontinued in Phase 2
6084,D05HWN,BIIB-021,Breast cancer , Phase 2
6085,D05HWX,99mTc-depreotide,Melanoma , Approved
6086,D05HXX,Tranexamic Acid,Excessive bleeding , Approved
6087,D05HYC,F-50077,Respiratory syncytial virus infection , Discontinued in Phase 2
6088,D05HYL,YM-022,Gastrointestinal disease , Terminated
6089,D05HYT,IPAZILIDE FUMARATE,Cardiac arrhythmias , Phase 2
6090,D05HZI,"MDL 101,731",Gastric adenocarcinoma , Discontinued in Phase 2
6091,D05HZJ,GPC-3298306,Hepatocellular carcinoma , Phase 2
6092,D05IAN,G3139 + Irinotecan,Metastatic colorectal cancer , Investigative
6093,D05IBA,Shanvac-B,Hepatitis B virus infection , Approved
6094,D05IBP,DFD-09,Rosacea , Application submitted
6095,D05IBV,AR-12432,Ocular disease , Investigative
6096,D05ICS,ProSavin,Parkinson disease , Phase 1/2
6097,D05ICT,ABBV-744,Prostate cancer , Phase 1
6098,D05ICT,ABBV-744,Acute myeloid leukaemia , Phase 1
6099,D05IEN,Epstein Barr-based gene therapy,Solid tumour/cancer , Phase 1
6100,D05IHU,Tetrahydrozoline,Ocular disease , Approved
6101,D05IHZ,VP-20621,Multiple sclerosis , Phase 2
6102,D05IIB,NoroVAXX,Norovirus infection , Investigative
6103,D05IIN,SSR125543,Anxiety disorder , Phase 2
6104,D05IIN,SSR125543,Congenital adrenal hyperplasia , Phase 2
6105,D05IIP,L-651582,Solid tumour/cancer , Phase 3
6106,D05IJM,Recruitin,Autoimmune diabetes , Investigative
6107,D05ILN,Agalsidase alfa,Fabry disease , Approved
6108,D05ILZ,NN8209,Rheumatoid arthritis , Discontinued in Phase 2
6109,D05INV,PEGPH20,Pancreatic cancer , Phase 2
6110,D05INV,PEGPH20,Non-small-cell lung cancer , Phase 2
6111,D05INV,PEGPH20,Gallbladder disease , Phase 1
6112,D05INV,PEGPH20,Gastric adenocarcinoma , Phase 1
6113,D05IPF,Kombiglyze XR/Komboglyze FDC,Diabetic complication , Approved
6114,D05IPO,BTS-79018,Schizophrenia , Terminated
6115,D05IQI,LX9211,Neuropathic pain , Phase 1
6116,D05IQX,Belimumab,Systemic lupus erythematosus , Approved
6117,D05IRT,P276-00,Mantle cell lymphoma , Phase 2
6118,D05IRV,Elesclomol,Acute myeloid leukaemia , Phase 3
6119,D05ISO,Bemarituzumab,Gastric adenocarcinoma , Phase 2
6120,D05ISV,Live attenuated human parainfluenza virus type 2 vaccine,Parainfluenza virus infection , Phase 1
6121,D05ITS,ALN-VEG01,Macular degeneration , Terminated
6122,D05IUQ,Anti-PECAM-1 mab,Solid tumour/cancer , Investigative
6123,D05IVZ,RU-33965,Alzheimer disease , Terminated
6124,D05IWE,Alloferon,Solid tumour/cancer , Approved
6125,D05IYA,MEDI3902,Ventilator-associated pneumonia , Phase 2
6126,D05IYA,MEDI3902,Pseudomonas infection , Phase 1
6127,D05IZC,RGI-1001,Allergy , Investigative
6128,D05IZG,BAY-Z-4305,Human immunodeficiency virus-1 infection , Terminated
6129,D05JAA,ARRY-382,Solid tumour/cancer , Phase 2
6130,D05JAC,Linagliptin,Type 2 diabetes , Approved
6131,D05JAC,Linagliptin,Coronavirus Disease 2019 (COVID-19) , Phase 3
6132,D05JAS,Biphenyl mannoside derivative 5,Crohn disease , Patented
6133,D05JAS,Biphenyl mannoside derivative 5,Ulcerative colitis , Patented
6134,D05JAS,Biphenyl mannoside derivative 5,Urinary tract infection , Patented
6135,D05JBC,N-(2-aminoethyl)-1-aziridine-ethanamine,Severe acute respiratory syndrome (SARS) , Investigative
6136,D05JBP,IPI-194,Solid tumour/cancer , Investigative
6137,D05JCG,CBF-BS2,Rheumatoid arthritis , Discontinued in Phase 2
6138,D05JDR,Ceftibuten,Chronic bronchitis , Approved
6139,D05JEG,BMN-701,Pompe disease , Phase 3
6140,D05JEG,BMN-701,Type 2 glycogen storage disease , Phase 3
6141,D05JEL,Onzeald,Brain metastases , Phase 3
6142,D05JEL,Onzeald,Breast cancer , Phase 3
6143,D05JET,Remacemide,Pain , Phase 3
6144,D05JFA,INTERCEPT,Blood transfusion , Phase 3
6145,D05JFA,INTERCEPT,Infectious disease , Phase 2
6146,D05JFY,Hydralazine hydrochloride/ isosorbide dinitrate,Heart failure , Approved
6147,D05JGR,TBDT,Overactive bladder , Investigative
6148,D05JHB,ArtemiC,Coronavirus Disease 2019 (COVID-19) , Phase 2
6149,D05JHJ,LB-10522,Bacterial infection , Terminated
6150,D05JLG,ACS-6,Respiratory distress syndrome , Investigative
6151,D05JMP,IDR-803,Solid tumour/cancer , Investigative
6152,D05JMW,RGA-1512,leukaemia , Phase 1
6153,D05JNI,Framycetin,Alcoholic cirrhosis of liver , Approved
6154,D05JNI,Framycetin,Acute liver failure , Approved
6155,D05JNI,Framycetin,Bacterial infection , Approved
6156,D05JPJ,ELND-004,Autoimmune diabetes , Phase 1
6157,D05JQD,M-6040,Pain , Investigative
6158,D05JQF,Tipredane,Allergy , Terminated
6159,D05JRG,Antithrombin alfa,Thrombin deficiency , Approved
6160,D05JSU,Edivoxetine,Pediatric attention deficit hyperactivity disorder , Phase 3
6161,D05JSU,Edivoxetine,Major depressive disorder , Phase 3
6162,D05JTJ,IC-50,Bacterial infection , Investigative
6163,D05JXF,YD-501,Obesity , Investigative
6164,D05JXM,PF-3932295,Obesity , Discontinued in Phase 1
6165,D05JXR,SC-52012,Thrombosis , Discontinued in Phase 1
6166,D05KAC,PG-102,Autoimmune diabetes , Phase 2
6167,D05KBP,INO-8875,Glaucoma/ocular hypertension , Phase 1/2
6168,D05KBU,Gabapentin enacarbil,Alcohol dependence , Phase 2
6169,D05KCJ,ANZ-521,Hepatitis C virus infection , Phase 1/2
6170,D05KED,Rocilinostat,Multiple myeloma , Phase 2
6171,D05KED,Rocilinostat,Autoimmune diabetes , Phase 1/2
6172,D05KEZ,Ethyl chloride,Pain , Approved
6173,D05KFA,BL-1832,Pain , Discontinued in Phase 3
6174,D05KFH,CD171 specific CAR T cells expressing EGFRt,Ganglioneuroblastoma , Phase 1
6175,D05KFH,CD171 specific CAR T cells expressing EGFRt,Neuroblastoma , Phase 1
6176,D05KGG,IMA101,Solid tumour/cancer , Phase 1
6177,D05KHN,ICI-169369,Anxiety disorder , Terminated
6178,D05KHP,ABC-3,Fibrosis , Investigative
6179,D05KIV,Ecopipam hydrochloride,Tourette syndrome , Phase 2
6180,D05KKC,CHML,Solid tumour/cancer , Phase 3
6181,D05KKF,NC-2500,Hyperuricaemia , Investigative
6182,D05KKP,PF-06252616,Muscular dystrophy , Phase 2
6183,D05KKP,PF-06252616,Duchenne dystrophy , Phase 2
6184,D05KKV,Dicaffeoylquinic acids,Human immunodeficiency virus infection , Investigative
6185,D05KLQ,HIV vaccines,Human immunodeficiency virus infection , Phase 2
6186,D05KME,ORADUR-ADHD,Attention deficit hyperactivity disorder , Phase 1
6187,D05KNG,ALB-109564(a),Solid tumour/cancer , Phase 1
6188,D05KOA,Prophylactic DNA vaccine,Hepatitis B virus infection , Terminated
6189,D05KON,Felbamate,Epilepsy , Approved
6190,D05KOP,Ii-Key hybrid peptide vaccine,Influenza A virus H1N1 infection , Phase 1
6191,D05KOY,"Stem cell therapy, spinal cord injury",Spinal cord injury , Investigative
6192,D05KQE,MK-287,Sepsis , Discontinued in Phase 2
6193,D05KRC,Emopamil,Cerebrovascular ischaemia , Terminated
6194,D05KRH,CNDO-113,Solid tumour/cancer , Investigative
6195,D05KRS,CT-340,Arthritis , Investigative
6196,D05KSY,LIM-0746,Cholesterol metabolism disorder , Investigative
6197,D05KTK,CJC-1004,Thrombosis , Discontinued in Phase 1
6198,D05KTV,NGD-93-1,Psychotic disorder , Terminated
6199,D05KUP,ERB-257,Sepsis , Phase 1
6200,D05KVC,Paliroden,Parkinson disease , Phase 2
6201,D05KWY,ZD-9063P,Solid tumour/cancer , Terminated
6202,D05KXJ,GSK233705,Chronic obstructive pulmonary disease , Phase 2
6203,D05KZK,SMT-D002,Seborrhea , Approved
6204,D05KZM,Dimesna,Diabetic nephropathy , Phase 3
6205,D05KZM,Dimesna,Lung cancer , Phase 3
6206,D05KZV,VR-461,Fungal infection , Investigative
6207,D05LBH,PMID28621580-Compound-WO2013112959C68,Fibrosis , Patented
6208,D05LBN,TAK-981,Coronavirus Disease 2019 (COVID-19) , Phase 1
6209,D05LBU,Ticlopidine,Stroke , Approved
6210,D05LCN,BMP-7 bone morphogenetic protein,Kidney disease , Phase 4
6211,D05LCX,A-70276,Gastrointestinal disease , Terminated
6212,D05LDK,IPX203,Parkinson disease , Phase 2
6213,D05LDQ,BAY 94-9027,Stroke , Phase 3
6214,D05LDQ,BAY 94-9027,Hemophilia , Phase 3
6215,D05LEO,Fluorouracil,Solid tumour/cancer , Approved
6216,D05LEO,Fluorouracil,Tumour , Investigative
6217,D05LEO,Fluorouracil,Colorectal cancer , Investigative
6218,D05LGX,Fipamezole,Acute myeloid leukaemia , Phase 2
6219,D05LIH,Anti-CD19 CAR-T cells,Acute lymphocytic leukaemia , Phase 1/2
6220,D05LIH,Anti-CD19 CAR-T cells,B-cell prolymphocytic leukaemia , Phase 1/2
6221,D05LIH,Anti-CD19 CAR-T cells,Chronic lymphocytic leukaemia , Phase 1/2
6222,D05LIH,Anti-CD19 CAR-T cells,Diffuse large B-cell lymphoma , Phase 1/2
6223,D05LIH,Anti-CD19 CAR-T cells,Follicular lymphoma , Phase 1/2
6224,D05LIH,Anti-CD19 CAR-T cells,Mantle cell lymphoma , Phase 1/2
6225,D05LKP,Sulfadiazine,Rheumatic fever , Approved
6226,D05LKZ,HPP-607,Solid tumour/cancer , Phase 1
6227,D05LLH,Penciclovir,Recurrent herpes labialis , Approved
6228,D05LLH,Penciclovir,Coronavirus Disease 2019 (COVID-19) , Investigative
6229,D05LLJ,MK-4815,Malaria , Investigative
6230,D05LMC,AMG 595,Glioblastoma multiforme , Phase 1
6231,D05LOB,FP-1201,Acute lung injury , Phase 3
6232,D05LOV,ADV-1002401,Type-2 diabetes , Phase 1
6233,D05LOY,ACH-702,Bacterial infection , Investigative
6234,D05LPP,ABH001,Liver cancer , Phase 3
6235,D05LPW,DA-1229,Type-2 diabetes , Phase 1
6236,D05LQX,BOL-303259-X,Open-angle glaucoma , Approved
6237,D05LQX,BOL-303259-X,Renal cell carcinoma , Phase 3
6238,D05LRD,BMS-933043,Psychiatric disorder , Phase 1
6239,D05LST,Myrcludex B,Hepatitis B virus infection , Investigative
6240,D05LSY,AKP-020,Type-2 diabetes , Discontinued in Phase 2
6241,D05LTJ,ISIS 325568,Type-2 diabetes , Phase 1
6242,D05LTY,Enbrel,Arthritis , Approved
6243,D05LUT,Molecule 23,Malaria , Investigative
6244,D05LVL,AVR-147,Solid tumour/cancer , Preclinical
6245,D05LXC,QA-241,Bacterial infection , Terminated
6246,D05LXH,Beta-interferon,Multiple sclerosis , Investigative
6247,D05LYC,KR-62436,Non-insulin dependent diabetes , Investigative
6248,D05LYX,Glibenclamide,Diabetic complication , Approved
6249,D05LYX,Glibenclamide,Stroke , Phase 3
6250,D05LZG,R-type pyocins,Pseudomonas infection , Investigative
6251,D05MBE,NK-102,Cerebrovascular ischaemia , Investigative
6252,D05MBZ,Tamsulosin,Benign prostatic hyperplasia , Approved
6253,D05MCS,GSK2190915,Asthma , Discontinued in Phase 2
6254,D05MDJ,ORG-34517,Depression , Phase 2
6255,D05MDQ,CG-701338,Solid tumour/cancer , Investigative
6256,D05MEL,PV-705,Diabetic neuropathy , Discontinued in Phase 2
6257,D05MEP,AE-O,Ovarian cancer , Phase 1
6258,D05MEY,Epitinib,Solid tumour/cancer , Investigative
6259,D05MFA,Valacyclovir Hydrochloride,Herpes simplex virus infection , Approved
6260,D05MFG,Spirapril,Hypertension , Approved
6261,D05MFO,MDL-11939,Anxiety disorder , Discontinued in Phase 3
6262,D05MGQ,MDX-1342,leukaemia , Phase 2
6263,D05MHI,AC-607,Ischemic heart disease , Phase 2
6264,D05MIL,Iopentol,Urinary tract disease , Approved
6265,D05MIQ,O-SPC/rBRU vaccine,Shigella infection , Phase 1
6266,D05MJS,PRO22,Atopic dermatitis , Phase 2
6267,D05MKA,Lixisenatide,Type-2 diabetes , Approved
6268,D05MKG,Nalmefene prodrug,Alcohol dependence , Investigative
6269,D05MLX,ONYX-411,Solid tumour/cancer , Terminated
6270,D05MNV,Fosclin,Malaria , Phase 3
6271,D05MNW,Virginiamycin,Bacterial infection , Approved
6272,D05MOZ,G-202,Solid tumour/cancer , Phase 2
6273,D05MOZ,G-202,Adenocarcinoma , Phase 2
6274,D05MPX,Bornaprine,Parkinson disease , Approved
6275,D05MQK,Tadalafil,Erectile dysfunction , Approved
6276,D05MQO,BEA-005,Cytomegalovirus infection , Terminated
6277,D05MRY,Six-membered heterocyclic benzamide derivative 7,Pruritus , Patented
6278,D05MRY,Six-membered heterocyclic benzamide derivative 7,Solid tumour/cancer , Patented
6279,D05MRY,Six-membered heterocyclic benzamide derivative 7,Chronic pain , Patented
6280,D05MRY,Six-membered heterocyclic benzamide derivative 7,Neuropathic pain , Patented
6281,D05MRY,Six-membered heterocyclic benzamide derivative 7,Thymic cancer , Patented
6282,D05MSG,BMS-694153,Migraine , Investigative
6283,D05MSL,DC-756,Bacterial infection , Terminated
6284,D05MSM,CK-37,Solid tumour/cancer , Investigative
6285,D05MUA,NOX 2149,Stress , Investigative
6286,D05MUA,NOX 2149,Pain , Investigative
6287,D05MVA,RGD-891,Thrombosis , Phase 1
6288,D05MVA,RGD-891,Angina pectoris , Discontinued in Phase 2
6289,D05MVX,ATA520,Haematological malignancy , Phase 1
6290,D05MVX,ATA520,Multiple myeloma , Phase 1
6291,D05MWY,RF-1051,Genetic disease , Discontinued in Phase 2
6292,D05MXK,GW-473178,Heart arrhythmia , Discontinued in Phase 1
6293,D05MXL,CHDI-003940246,Huntington disease , Investigative
6294,D05MZI,nusinersen,Spinal muscular atrophy , Approved
6295,D05NBD,MONTIRELIN TETRAHYDRATE,Pain , Discontinued in Preregistration
6296,D05NCT,DPC-1528,Acne vulgaris , Investigative
6297,D05NDN,Alovudine,Breast cancer , Phase 2
6298,D05NDR,Sifalimumab,Renal cell carcinoma , Approved
6299,D05NDR,Sifalimumab,Systemic lupus erythematosus , Phase 2
6300,D05NDY,OAP-189,Type-2 diabetes , Phase 1
6301,D05NEK,N-acetylcysteine,Cystic fibrosis , Approved
6302,D05NEK,N-acetylcysteine,Coronavirus Disease 2019 (COVID-19) , Phase 2
6303,D05NFR,TPX-0005,Solid tumour/cancer , Phase 1/2
6304,D05NHA,Resorcinol compound 20,Albinism , Patented
6305,D05NHA,Resorcinol compound 20,Ephelides , Patented
6306,D05NHA,Resorcinol compound 20,Menkes disease , Patented
6307,D05NHA,Resorcinol compound 20,Senile lentigines , Patented
6308,D05NHA,Resorcinol compound 20,Melasma , Patented
6309,D05NHT,BP-C1,Breast cancer , Phase 1
6310,D05NIO,NP-17,Alzheimer disease , Investigative
6311,D05NIR,ALX-0061,Autoimmune diabetes , Phase 2
6312,D05NIR,ALX-0061,Rheumatoid arthritis , Phase 2
6313,D05NIR,ALX-0061,Systemic lupus erythematosus , Phase 2
6314,D05NJG,PH sensitive micelles,Solid tumour/cancer , Investigative
6315,D05NJI,STX 64,Prostate cancer , Phase 1
6316,D05NJL,ALSE-100,Bone disease , Investigative
6317,D05NLD,ARRY-300,Solid tumour/cancer , Phase 1
6318,D05NLR,Adva-33c,Solid tumour/cancer , Investigative
6319,D05NMJ,Biphasic porcine insulin,Diabetic complication , Approved
6320,D05NMU,DasKloster 0274-01,Pseudomonas infection , Investigative
6321,D05NOS,Triflupromazine,Psychotic disorder , Approved
6322,D05NQR,LyphoDerm,Wound healing , Terminated
6323,D05NRI,Ceronapril,Major depressive disorder , Discontinued in Phase 2
6324,D05NRX,VG-102,Solid tumour/cancer , Investigative
6325,D05NSF,4SC-207,Solid tumour/cancer , Investigative
6326,D05NTQ,PRO-015,Retinitis pigmentosa , Investigative
6327,D05NTY,NPC-18166,Psychotic disorder , Terminated
6328,D05NUH,Hm61713,Lung cancer , Approved
6329,D05NUN,Pyrazole derivative 36,Obesity , Patented
6330,D05NUP,SBS-1000,Diabetic complication , Phase 1
6331,D05NUT,ALS-00T2-0501,Psoriasis vulgaris , Discontinued in Phase 1
6332,D05NWJ,SLV-337,Cardiovascular disease , Phase 2
6333,D05NWM,Pyraclostrobin,Plant grey mould disease , Investigative
6334,D05NYF,HuMax-TF,Solid tumour/cancer , Phase 1/2
6335,D05NYK,BEL-0222,Neuroblastoma , Phase 1/2
6336,D05NYO,Imab-027,Solid tumour/cancer , Phase 1/2
6337,D05NZV,BRL 35135,Diabetic complication , Phase 2
6338,D05OAI,CART-19/22,leukaemia , Phase 1/2
6339,D05OAJ,AW-814141,Inflammation , Investigative
6340,D05OBK,DwLIP-GCGRrx,Diabetic complication , Investigative
6341,D05ODE,CC-90001,Fibrosis , Phase 1
6342,D05ODE,CC-90001,Idiopathic pulmonary fibrosis , Phase 1
6343,D05ODU,Belerofon,Hepatitis C virus infection , Phase 1
6344,D05OEG,E-2001,Cerebrovascular ischaemia , Discontinued in Phase 1
6345,D05OEU,Technetium Tc-99m Succimer Kit,Radioactive tracer , Approved
6346,D05OFO,TC-2696,Pain , Discontinued in Phase 2
6347,D05OFX,Lacosamide,Convulsion , Approved
6348,D05OFX,Lacosamide,Epilepsy , Approved
6349,D05OFX,Lacosamide,Diabetic neuropathy , Phase 3
6350,D05OHY,CAR-T cells targeting EphA2,Malignant glioma , Phase 1/2
6351,D05OIS,Benzyl alcohol,Head and body lice , Approved
6352,D05OIU,PMID27998201-Compound-5,Cirrhosis , Patented
6353,D05OIU,PMID27998201-Compound-5,Chronic obstructive pulmonary disease , Patented
6354,D05OIU,PMID27998201-Compound-5,Psoriasis vulgaris , Patented
6355,D05OIU,PMID27998201-Compound-5,Multiple sclerosis , Patented
6356,D05OIU,PMID27998201-Compound-5,Gastrointestinal disease , Patented
6357,D05OMO,PMID26651364-Compound-11b,Crohn disease , Patented
6358,D05OMO,PMID26651364-Compound-11b,Ulcerative colitis , Patented
6359,D05OMO,PMID26651364-Compound-11b,Urinary tract infection , Patented
6360,D05OMT,MK-8033,Solid tumour/cancer , Phase 1
6361,D05ONA,Cyt-1010,Pain , Phase 1
6362,D05OQJ,Methyprylon,Insomnia , Approved
6363,D05OQX,NCX-4016,Inflammation , Phase 2
6364,D05OQX,NCX-4016,Claudication , Discontinued in Phase 2
6365,D05OQX,NCX-4016,Nephropathy , Discontinued in Phase 2
6366,D05OQX,NCX-4016,Type-2 diabetes , Discontinued in Phase 2
6367,D05ORA,MOR-103,Multiple sclerosis , Phase 1/2
6368,D05ORI,AGI-350,Pulmonary disease , Investigative
6369,D05ORO,Anti-N3pG-Abeta antibody,Alzheimer disease , Phase 1
6370,D05OSR,Human immune globulin,Immunodeficiency , Approved
6371,D05OTD,Heterocyclic derivative 4,Solid tumour/cancer , Patented
6372,D05OTD,Heterocyclic derivative 4,Metastatic cancer , Patented
6373,D05OTL,NW-3509,Schizophrenia , Phase 2
6374,D05OTZ,SMP-986,Overactive bladder , Phase 2
6375,D05OVC,Atipamezole,Male sexual disorder , Discontinued in Phase 2
6376,D05OVR,ALP-242,Cystic fibrosis , Terminated
6377,D05OWB,mab-216,leukaemia , Phase 1
6378,D05OXZ,BIWA 4,Solid tumour/cancer , Phase 1
6379,D05OZG,BTSCAN,Breast cancer , Phase 1
6380,D05OZQ,Efpeglenatide,Type-2 diabetes , Phase 3
6381,D05PCM,PF-04965842,Atopic dermatitis , Phase 3
6382,D05PCM,PF-04965842,Lupus , Phase 2
6383,D05PDJ,SAGE-217b,Major depressive disorder , Phase 2
6384,D05PFE,HC-15,Solid tumour/cancer , Investigative
6385,D05PFS,LTI-291,Parkinson disease , Phase 2
6386,D05PGG,Prostvac,Prostate cancer , Phase 3
6387,D05PGM,AdV-tK,Ankylosing spondylitis , Phase 2
6388,D05PGU,Clostridium difficile toxoid vaccine,Clostridium infection , Phase 3
6389,D05PHH,Gabexate,Pancreatitis , Approved
6390,D05PIX,CG-400549,Bacterial infection , Phase 2
6391,D05PIZ,Levomethadyl Acetate,Opioid dependence , Approved
6392,D05PJJ,NOX 2137a/b,Stress , Investigative
6393,D05PJJ,NOX 2137a/b,Pain , Investigative
6394,D05PKF,SOM-0720,Coagulation defect , Investigative
6395,D05PLH,Carisoprodol,Musculoskeletal disorder , Approved
6396,D05PMU,Dicaffeoyltartaric acids,Human immunodeficiency virus infection , Investigative
6397,D05PQF,ONO-4127,Allergic rhinitis , Discontinued in Phase 1
6398,D05PQW,AZD-5180,Solid tumour/cancer , Preclinical
6399,D05PRV,PerCvax,Hepatitis C virus infection , Phase 1/2
6400,D05PTG,EPD-clofarabine,Solid tumour/cancer , Terminated
6401,D05PTH,MK-8175A,Contraception , Phase 2
6402,D05PTL,NMB-T-BMX-OS01,Solid tumour/cancer , Investigative
6403,D05PTT,ROSMARINIC ACID,Rheumatoid arthritis , Investigative
6404,D05PUD,Aldesleukin,Renal cell carcinoma , Approved
6405,D05PUD,Aldesleukin,Non-hodgkin lymphoma , Phase 2
6406,D05PVW,CX-2007,Attention deficit hyperactivity disorder , Investigative
6407,D05PWA,PNT-600,Solid tumour/cancer , Investigative
6408,D05PWU,PRo antigen cancer vaccine,Prostate cancer , Phase 3
6409,D05PWU,PRo antigen cancer vaccine,Human immunodeficiency virus infection , Phase 3
6410,D05PWX,Sulfatinib,Neuroendocrine cancer , Phase 3
6411,D05PWX,Sulfatinib,Solid tumour/cancer , Phase 1
6412,D05PWZ,Ecromeximab,Melanoma , Discontinued in Phase 2
6413,D05PXA,BTX1503,Acne vulgaris , Phase 2
6414,D05PXL,PL-3394,Congestive heart failure , Phase 2
6415,D05PXL,PL-3394,Heart failure , Phase 2
6416,D05PYB,Elstree-BN,Virus infection , Discontinued in Phase 1/2
6417,D05PZB,AT9283,Solid tumour/cancer , Phase 3
6418,D05PZI,MB-CART20.1,Non-hodgkin lymphoma , Phase 1/2
6419,D05PZN,TRO-19622,Peripheral neuropathy , Phase 2
6420,D05PZZ,DDP-200,Urinary incontinence , Discontinued in Phase 2
6421,D05QAA,PNU-248686A,Solid tumour/cancer , Investigative
6422,D05QBF,Devazepide,Gastrointestinal disease , Investigative
6423,D05QBH,LAS-41003,Eczema , Phase 2
6424,D05QCE,KM-01221,Cardiovascular disease , Investigative
6425,D05QDC,Acitretin,Psoriasis vulgaris , Approved
6426,D05QFA,R-71762,Human immunodeficiency virus-1 infection , Terminated
6427,D05QFO,RLY-106,Cardiovascular disease , Investigative
6428,D05QGH,DXL-625,Chronic lymphocytic leukaemia , Investigative
6429,D05QHL,Sivelestat sodium hydrate,Acute lung injury , Phase 4
6430,D05QHL,Sivelestat sodium hydrate,Community-acquired pneumonia , Phase 2
6431,D05QHO,ACE-527,Escherichia coli infection , Phase 2
6432,D05QHU,CRS-3123,Clostridium infection , Phase 1
6433,D05QIK,CM4620,Coronavirus Disease 2019 (COVID-19) , Phase 2
6434,D05QIM,TA-NIC,Nicotine dependence , Approved
6435,D05QIS,VX-944,Solid tumour/cancer , Phase 2
6436,D05QIU,Embeconazole,Fungal infection , Phase 1
6437,D05QIZ,GTx-822,Ocular disease , Investigative
6438,D05QJT,GW274150,Asthma , Phase 2
6439,D05QKI,LixiLan,Type-2 diabetes , Application submitted
6440,D05QKO,NBI-5788,Multiple sclerosis , Phase 2
6441,D05QKZ,Adipose-derived regenerative cell therapy,Chronic myocardial ischemia , Phase 3
6442,D05QLQ,HIV vaccine,Human immunodeficiency virus infection , Terminated
6443,D05QMG,FR167653,Chronic obstructive pulmonary disease , Discontinued in Phase 1
6444,D05QMJ,RWJ-56423,Asthma , Discontinued in Phase 1
6445,D05QML,PQ-1,Solid tumour/cancer , Investigative
6446,D05QMQ,MLN-0905,Lymphoma , Investigative
6447,D05QNO,Decamethonium,Muscle spasm , Approved
6448,D05QOL,Polatuzumab vedotin,Diffuse large B-cell lymphoma , Approved
6449,D05QOL,Polatuzumab vedotin,Follicular lymphoma , Phase 2
6450,D05QOL,Polatuzumab vedotin,Haematological malignancy , Phase 2
6451,D05QPC,[L/D]-aminopterin,Rheumatoid arthritis , Phase 2
6452,D05QPW,Choline salicylate,Inflammation , Approved
6453,D05QTO,LF-801,Asthma , Terminated
6454,D05QUL,T89,Multiple myeloma , Phase 3
6455,D05QUL,T89,Angina pectoris , Phase 3
6456,D05QXT,BAY-38-1315,Arteriosclerosis , Preclinical
6457,D05QXW,TZ-111,Neurological disorder , Investigative
6458,D05RBF,PMID25666693-Compound-99,Osteoarthritis pain , Patented
6459,D05RBF,PMID25666693-Compound-99,Cancer related pain , Patented
6460,D05RBF,PMID25666693-Compound-99,Neuropathic pain , Patented
6461,D05RBF,PMID25666693-Compound-99,Inflammatory pain , Patented
6462,D05RBH,N9-GP,Factor IX deficiency , Phase 1
6463,D05RBL,CL-184005,Sepsis , Terminated
6464,D05RBO,OPM-3023,Inflammation , Discontinued in Phase 2
6465,D05RCZ,HSV2 DNA vaccine,Genital herpes , Phase 1
6466,D05RDE,TJN-505,Heart arrhythmia , Terminated
6467,D05REB,ZT-1,Parkinson disease , Phase 1
6468,D05REH,Flosulide,Pain , Terminated
6469,D05REL,GR-82334,Vomiting , Terminated
6470,D05RFC,Tumor vascular thrombogen,Solid tumour/cancer , Investigative
6471,D05RFI,QBI-206,Solid tumour/cancer , Investigative
6472,D05RFO,A-928605,Solid tumour/cancer , Investigative
6473,D05RGV,MK-1496,Solid tumour/cancer , Phase 1
6474,D05RHI,Trifluridine,Virus infection , Approved
6475,D05RIM,SPN-808,Anxiety disorder , Phase 1
6476,D05RIY,Perflubutane lipid microsphere-encapsulated,Heart disease , Approved
6477,D05RJG,Schiff base compound 1,Alzheimer disease , Patented
6478,D05RJP,Oblimersen,Multiple myeloma , Phase 3
6479,D05RJP,Oblimersen,Melanoma , Phase 3
6480,D05RKV,Sch-036,Immune System disease , Investigative
6481,D05RLR,1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole,Conjunctival fibrosis , Investigative
6482,D05RMW,ZD-3638,Schizophrenia , Terminated
6483,D05ROI,Dabrafenib,Melanoma , Approved
6484,D05RPN,BMS-488516,Inflammation , Investigative
6485,D05RPT,MER-2101,Asthma , Investigative
6486,D05RQW,Guglipid,Lipoprotein disorder , Approved
6487,D05RQX,Cefaclidine,Bacterial infection , Discontinued in Preregistration
6488,D05RQY,MM-093,Autoimmune diabetes , Phase 2
6489,D05RRA,HQK-1004,Solid tumour/cancer , Phase 2
6490,D05RRU,IL-2/CD40L-expressing leukemia vaccine,Chronic lymphocytic leukaemia , Phase 2
6491,D05RSC,Sofinicline,Attention deficit hyperactivity disorder , Phase 2
6492,D05RSS,PF-03772304,Solid tumour/cancer , Investigative
6493,D05RTB,Anti-Staphylococcus enterotoxin B hyperimmune globulin,Bacterial infection , Investigative
6494,D05RTF,AME-527,Rheumatoid arthritis , Discontinued in Phase 1/2
6495,D05RTV,Superoxide dismutase,Myocardial infarction , Phase 2
6496,D05RTX,RO-1752,Human immunodeficiency virus infection , Investigative
6497,D05RUH,FMX101,Acne vulgaris , Phase 3
6498,D05RUJ,G-1128,Chronic myelogenous leukaemia , Discontinued in Phase 2
6499,D05RUM,Melperone,Alcohol dependence , Withdrawn from market
6500,D05RVA,CFG920,Prostate cancer , Phase 1/2
6501,D05RWL,NSD-788,Anxiety disorder , Phase 1
6502,D05RWN,Lanthanum polystyrene sulfonate,Hypophosphatasia , Investigative
6503,D05RXI,Hydrocortamate,Inflammation , Approved
6504,D05RXW,LAS-41002,Eczema , Phase 2
6505,D05RZE,LY-2623091,Chronic kidney disease , Phase 2
6506,D05RZI,AA-193,Hyperuricaemia , Discontinued in Phase 2
6507,D05RZJ,Recombinant human CC10,Endometriosis , Investigative
6508,D05RZW,YM-934,Angina pectoris , Phase 2
6509,D05SBI,TBC-395,Cardiovascular disease , Terminated
6510,D05SBO,LY2835219,Breast cancer , Approved
6511,D05SBO,LY2835219,Solid tumour/cancer , Phase 3
6512,D05SBR,Piclidenoson,Keratoconjunctivitis sicca , Phase 3
6513,D05SBR,Piclidenoson,Coronavirus Disease 2019 (COVID-19) , Phase 2
6514,D05SCQ,TDI-0079,Motor neurone disease , Investigative
6515,D05SEW,OB-24,Solid tumour/cancer , Investigative
6516,D05SFD,DMP-961,Human immunodeficiency virus infection , Discontinued in Phase 2
6517,D05SGI,BGB-3113,B-cell lymphoma , Phase 1
6518,D05SHK,Nadolol,High blood pressure , Approved
6519,D05SHQ,ASP-2002,Ulcerative colitis , Investigative
6520,D05SJD,DasKloster 0501-01,Scleroderma , Investigative
6521,D05SJK,Bone marrow stem cell therapy,Ischemic heart disease , Phase 1
6522,D05SJW,Gallamine Triethiodide,Stabilize muscle contraction , Approved
6523,D05SJY,WS-CoQ10,Parkinson disease , Investigative
6524,D05SLM,LY-2590443,Migraine , Phase 2
6525,D05SMP,PMID25666693-Compound-116,Osteoarthritis pain , Patented
6526,D05SMP,PMID25666693-Compound-116,Cancer related pain , Patented
6527,D05SMP,PMID25666693-Compound-116,Neuropathic pain , Patented
6528,D05SMP,PMID25666693-Compound-116,Inflammatory pain , Patented
6529,D05SMV,P2B-002,Solid tumour/cancer , Investigative
6530,D05SNX,APT070,Reperfusion injury , Phase 3
6531,D05SOF,SPM-3672,Angina pectoris , Terminated
6532,D05SOH,CTAP-201,Hyperparathyroidism , Phase 1
6533,D05SOW,SX-MTR1,Bladder cancer , Investigative
6534,D05SPL,Monofer,Iron-deficiency anemia , Approved
6535,D05SQU,BIM-64152,Metabolic disorder , Investigative
6536,D05SSC,Dalcetrapib,Hyperlipidaemia , Phase 3
6537,D05SSC,Dalcetrapib,Acute coronary syndrome , Phase 3
6538,D05SSJ,Dotarizine,Migraine , Terminated
6539,D05STL,ARRY-502,Allergic asthma , Phase 2
6540,D05STQ,Pazufloxacin,Conjunctivitis , Phase 3
6541,D05SUA,A-798,Obesity , Terminated
6542,D05SVN,PdB-W433F,Streptococcus infection , Investigative
6543,D05SVQ,C-AFG,Virus infection , Terminated
6544,D05SWL,PMID25666693-Compound-28,Osteoarthritis pain , Patented
6545,D05SWL,PMID25666693-Compound-28,Cancer related pain , Patented
6546,D05SWL,PMID25666693-Compound-28,Neuropathic pain , Patented
6547,D05SWL,PMID25666693-Compound-28,Inflammatory pain , Patented
6548,D05SXB,SMT-D004,Age-related macular degeneration , Investigative
6549,D05SXC,SCR-44001,Solid tumour/cancer , Terminated
6550,D05SXL,PLR-8,Asthma , Terminated
6551,D05SXT,INP-03,Poison intoxication , Investigative
6552,D05SYO,KR-33889,Myocardial infarction , Investigative
6553,D05TBI,DG-770,Diabetic complication , Investigative
6554,D05TBQ,SAR408701,Non-small-cell lung cancer , Phase 3
6555,D05TBQ,SAR408701,Solid tumour/cancer , Phase 1/2
6556,D05TCC,TMX-202,Bladder cancer , Investigative
6557,D05TDJ,TS01,Stroke , Phase 1
6558,D05TDS,Nu-2,Bacterial infection , Investigative
6559,D05TFW,H1N1 HA flu vaccine,Influenza virus infection , Approved
6560,D05TGV,PEG-Infergen,Hepatitis virus infection , Discontinued in Phase 2
6561,D05TIB,Trospium,Spasm , Approved
6562,D05TIB,Trospium,Overactive bladder , Approved
6563,D05TJR,Fluvirin,Influenza virus infection , Approved
6564,D05TKB,GS-9256,Hepatitis C virus infection , Phase 2
6565,D05TKO,Retagliptin,Non-insulin dependent diabetes , Investigative
6566,D05TKW,alpha-ketothiazole analogue 36,Alzheimer disease , Clinical trial
6567,D05TLM,E-5065,Bacterial infection , Discontinued in Phase 1
6568,D05TLP,Carabersat,Epileptic seizures , Phase 2
6569,D05TLQ,ETR-001,Kidney disease , Investigative
6570,D05TLR,Tetramune,Bacterial infection , Withdrawn from market
6571,D05TMA,MAGE-A4 TCR,Solid tumour/cancer , Phase 1
6572,D05TMQ,Aprobarbital,Anaesthesia , Approved
6573,D05TMQ,Aprobarbital,Insomnia , Approved
6574,D05TMW,Methotrexate,Choriocarcinoma , Approved
6575,D05TMW,Methotrexate,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
6576,D05TNY,Generalized glucocorticoid,Adrenal adenoma , Investigative
6577,D05TOJ,Peretinoin,Hepatocellular carcinoma , Phase 3
6578,D05TPA,SP-1062C-O,Colorectal cancer , Investigative
6579,D05TPI,EPICATECHIN,Duchenne dystrophy , Phase 1/2
6580,D05TPI,EPICATECHIN,Friedreich's ataxia , Phase 1/2
6581,D05TQG,Pyrazole derivative 30,Obesity , Patented
6582,D05TRI,GeNOsyl,Pulmonary arterial hypertension , Phase 2
6583,D05TRJ,SB-728-HSPC,Human immunodeficiency virus infection , Phase 1/2
6584,D05TSG,ANB-020,Atopic dermatitis , Phase 2
6585,D05TSJ,LY2784544,Breast cancer , Phase 2
6586,D05TSJ,LY2784544,Myeloproliferative neoplasm , Phase 2
6587,D05TUL,MB-11316,Injury , Phase 2
6588,D05TUQ,MAT-302,Ocular disease , Investigative
6589,D05TUZ,Tasonermin,Solid tumour/cancer , Approved
6590,D05TVI,TD-9594,Overactive bladder , Investigative
6591,D05TVW,DCVax-Head/Neck,Head and neck cancer , Phase 1/2
6592,D05TWD,Autologous VEGF-and angiopoietin-1-expressing endothelial and smooth muscle cell therapy,Cardiovascular disease , Phase 1/2
6593,D05TWD,Autologous VEGF-and angiopoietin-1-expressing endothelial and smooth muscle cell therapy,Peripheral arterial disease , Phase 1/2
6594,D05TXS,BMN-168,Phenylketonuria , Investigative
6595,D05TZJ,Ankinara,Rheumatoid arthritis , Investigative
6596,D05TZJ,Ankinara,Psoriasis vulgaris , Investigative
6597,D05TZJ,Ankinara,Inflammatory bowel disease , Investigative
6598,D05UAA,SX-HIV1,Retrovirus infection , Investigative
6599,D05UAO,J591-Ac-225,Prostate cancer , Investigative
6600,D05UAV,Bis(olanzapine) pamoate monohydrate,Psychotic disorder , Phase 3
6601,D05UBX,Cefmetazole,Bacterial infection , Approved
6602,D05UCM,Sulfonatoporphyrin,Coronavirus Disease 2019 (COVID-19) , Phase 1
6603,D05UCW,MEDI-2338,Chronic obstructive pulmonary disease , Phase 1
6604,D05UDU,YK-3237,Solid tumour/cancer , Investigative
6605,D05UEF,RR-1,Solid tumour/cancer , Investigative
6606,D05UEI,99mTc-besilesomab,Bone metastases , Approved
6607,D05UFG,BIBW 2992,Non-small-cell lung cancer , Approved
6608,D05UFJ,Minnelide 001,Gastrointestinal cancer , Phase 1
6609,D05UFJ,Minnelide 001,Gastric adenocarcinoma , Phase 1
6610,D05UFN,PN-202,Xerophthalmia , Investigative
6611,D05UFP,PEG-SN38,Metastatic colorectal cancer , Phase 2
6612,D05UFP,PEG-SN38,Breast cancer , Phase 2
6613,D05UGH,LEO 124249,Asthma , Phase 2
6614,D05UGH,LEO 124249,Eczema , Phase 2
6615,D05UGJ,XL844,Solid tumour/cancer , Discontinued in Phase 1
6616,D05UGL,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 1",Skin disease , Patented
6617,D05UGL,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 1",Muscular wasting , Patented
6618,D05UHF,Galsulfase,Mucopolysaccharidosis , Approved
6619,D05UHJ,SM-10888,Cognitive impairment , Discontinued in Phase 2
6620,D05UIL,TV-4710,Systemic lupus erythematosus , Discontinued in Phase 2
6621,D05UJF,PBSVax,Human immunodeficiency virus infection , Phase 1
6622,D05UJS,ADVAX,Human immunodeficiency virus infection , Phase 1
6623,D05UJU,MV-2101,Vascular disease , Preclinical
6624,D05UKK,FK-888,Migraine , Discontinued in Phase 2
6625,D05ULR,Sildenafil,Erectile dysfunction , Approved
6626,D05ULR,Sildenafil,Coronavirus Disease 2019 (COVID-19) , Phase 3
6627,D05UMD,R-87366,Human immunodeficiency virus infection , Discontinued in Phase 2
6628,D05UMO,BAY-793,Human immunodeficiency virus infection , Terminated
6629,D05UOU,CD19-CAR-T2 Cells,Acute lymphoblastic leukaemia , Phase 1
6630,D05UPB,CI-972,Rheumatoid arthritis , Discontinued in Phase 1
6631,D05UQD,Omapatrilat,Hypertension , Terminated
6632,D05UQF,NCX-226,Pulmonary fibrosis , Investigative
6633,D05URO,Quinvaxem,Hepatitis B virus infection , Approved
6634,D05URT,MX-7091,Solid tumour/cancer , Terminated
6635,D05USL,KU-55933,Solid tumour/cancer , Investigative
6636,D05USQ,Nintedanib,Idiopathic pulmonary fibrosis , Approved
6637,D05USQ,Nintedanib,Coronavirus Disease 2019 (COVID-19) , Phase 2
6638,D05UTF,SB-41947,Solid tumour/cancer , Investigative
6639,D05UTV,Albuterpenoids,Varicella zoster virus infection , Phase 2
6640,D05UTW,ErythroMax,Hypoxia , Phase 1
6641,D05UVD,Timolol,High blood pressure , Approved
6642,D05UVL,SND-121,Infectious disease , Investigative
6643,D05UXF,Emapunil,Anxiety disorder , Discontinued in Phase 2
6644,D05UXU,INM-176,Alzheimer disease , Phase 3
6645,D05UYQ,Camicinal,Delayed gastric emptying , Phase 2
6646,D05UYQ,Camicinal,Diabetic gastroparesis , Phase 2
6647,D05UYW,Dorzolamide,Open-angle glaucoma , Approved
6648,D05UZO,MIVOBULIN ISETHIONATE,Solid tumour/cancer , Discontinued in Phase 2
6649,D05VAA,Isbufylline,Asthma , Discontinued in Phase 2
6650,D05VAE,Posiphen R-phenserine,Alzheimer disease , Phase 1
6651,D05VEP,DX-2802,Solid tumour/cancer , Preclinical
6652,D05VEU,Coagulin-B,Hemophilia , Discontinued in Phase 1/2
6653,D05VFO,Rh-erythropoietin-alfa,Postoperative inflammation , Approved
6654,D05VFQ,TriTAb,Poison intoxication , Discontinued in Phase 2
6655,D05VFZ,ABP-710,Plaque psoriasis , Phase 1
6656,D05VFZ,ABP-710,Psoriatic arthritis , Phase 1
6657,D05VGL,Tavaborole,Onychomycosis , Approved
6658,D05VGS,ALB-127158(a),Obesity , Terminated
6659,D05VHB,EMP-123,Peanut hypersensitivity , Phase 1
6660,D05VIL,Nalmefene,Opioid dependence , Approved
6661,D05VIN,Imidazole derivative 2,Obesity , Patented
6662,D05VIX,Gemfibrozil,Hyperlipidaemia , Approved
6663,D05VKS,VT-122,Hepatocellular carcinoma , Phase 2
6664,D05VKS,VT-122,Pancreatic cancer , Phase 1
6665,D05VLB,PEGylated recombinant IFN-alpha2b,Solid tumour/cancer , Investigative
6666,D05VLN,Isomazole,Asthma , Terminated
6667,D05VLS,Rofecoxib,Osteoarthritis , Approved
6668,D05VNG,BB-1101,Multiple sclerosis , Terminated
6669,D05VNP,TESTOSTERONE BUCICLATE,Contraception , Phase 1
6670,D05VNS,CD19 and CD22 CAR-T Cells,B-cell lymphoma , Phase 1/2
6671,D05VNS,CD19 and CD22 CAR-T Cells,leukaemia , Phase 1/2
6672,D05VNX,IPC-003,Solid tumour/cancer , Investigative
6673,D05VOP,RAP-160,Psoriasis vulgaris , Preclinical
6674,D05VQD,BMS-183729,Cerebrovascular ischaemia , Terminated
6675,D05VQI,Cyclandelate,Dementia , Approved
6676,D05VSH,REGN3767,Advanced cancer , Phase 1
6677,D05VSH,REGN3767,Solid tumour/cancer , Phase 1
6678,D05VTE,CAI orotate,Age-related macular degeneration , Phase 2
6679,D05VTN,CCX-354,Autoimmune diabetes , Phase 2
6680,D05VTN,CCX-354,Rheumatoid arthritis , Phase 2
6681,D05VUX,BHV-0223,Amyotrophic lateral sclerosis , Phase 1
6682,D05VVT,PEG-PLA-TNP-470,Solid tumour/cancer , Investigative
6683,D05VVX,PTC299,Rheumatoid arthritis , Phase 2
6684,D05VVX,PTC299,Solid tumour/cancer , Phase 2
6685,D05VWK,AXP-107-16,Gynecological disease , Investigative
6686,D05VWX,CGEN-25008,Solid tumour/cancer , Investigative
6687,D05VXF,YSCMA,Haematological malignancy , Phase 1/2
6688,D05VXQ,SRSC-355,Neuropathic pain , Terminated
6689,D05VYJ,SUN-09,Hypertonia , Discontinued in Phase 3
6690,D05VYY,Rapamycin,Lymphangioleiomyomatosis , Approved
6691,D05VYY,Rapamycin,Severe acute respiratory syndrome (SARS) , Investigative
6692,D05VYY,Rapamycin,Middle East Respiratory Syndrome (MERS) , Investigative
6693,D05VZE,Marimastat,Pancreatic cancer , Phase 3
6694,D05VZE,Marimastat,Lung cancer , Discontinued in Phase 3
6695,D05VZJ,J-104132,Pulmonary arterial hypertension , Discontinued in Phase 2
6696,D05WCI,ABT-384,Alzheimer disease , Phase 2
6697,D05WCI,ABT-384,Hepatitis C virus infection , Phase 2
6698,D05WDD,Group B streptococcal vaccine,Bacterial infection , Terminated
6699,D05WDG,Natroba,Sarcoptes scabiei infection , Phase 3
6700,D05WDM,Ro5203280,Nasopharyngeal carcinoma , Investigative
6701,D05WEP,Befloxatone,Major depressive disorder , Discontinued in Phase 3
6702,D05WET,Anti-CD38 CAR-T cells,Multiple myeloma , Phase 1
6703,D05WFF,GNI-102,Hepatitis B virus infection , Discontinued in Phase 1
6704,D05WJF,Defibrotide,Hepatic veno-occlusive disease , Approved
6705,D05WJF,Defibrotide,Coronavirus Disease 2019 (COVID-19) , Phase 2
6706,D05WJQ,Saredutant,Anxiety disorder , Discontinued in Phase 3
6707,D05WJQ,Saredutant,Depression , Discontinued in Phase 3
6708,D05WKQ,LAI287,Type-2 diabetes , Phase 3
6709,D05WKQ,LAI287,Type-1 diabetes , Phase 1
6710,D05WKT,PK-44,Non-insulin dependent diabetes , Investigative
6711,D05WLE,INO-1800,Hepatitis B virus infection , Phase 1
6712,D05WOS,BMS-986226,Solid tumour/cancer , Phase 1
6713,D05WPQ,BW A4C,Arthritis , Terminated
6714,D05WQT,Flanvotumab,Melanoma , Phase 1
6715,D05WRB,Galactofucan sulphate fraction,Human immunodeficiency virus infection , Investigative
6716,D05WSD,NaAPR1M-74,Hookworm infection , Investigative
6717,D05WSP,UK-396082,Thrombosis , Phase 1
6718,D05WTS,Galavit,Autoimmune diabetes , Approved
6719,D05WTT,Remune,Hereditary angioedema , Phase 3
6720,D05WTT,Remune,Human immunodeficiency virus infection , Phase 2
6721,D05WTT,Remune,Human immunodeficiency virus-1 infection , Application submitted
6722,D05WTZ,Galarubicin,Solid tumour/cancer , Discontinued in Phase 2
6723,D05WUN,OTI-020,Myocardial disease , Phase 3
6724,D05WUQ,Omtriptolide,Solid tumour/cancer , Phase 1
6725,D05WUZ,TT-113,Coagulation defect , Investigative
6726,D05WVO,EDP-17,Solid tumour/cancer , Investigative
6727,D05WVU,131i-chtnt,Solid tumour/cancer , Approved
6728,D05WWJ,ALX-5407,Schizophrenia , Phase 1
6729,D05WWX,Biphenyl mannoside derivative 14,Crohn disease , Patented
6730,D05WWX,Biphenyl mannoside derivative 14,Ulcerative colitis , Patented
6731,D05WWX,Biphenyl mannoside derivative 14,Urinary tract infection , Patented
6732,D05WYW,L-373890,Thrombosis , Terminated
6733,D05XAH,Aromatic hydrazine carboxyimidoamide derivative 4,Albinism , Patented
6734,D05XAH,Aromatic hydrazine carboxyimidoamide derivative 4,Ephelides , Patented
6735,D05XAH,Aromatic hydrazine carboxyimidoamide derivative 4,Menkes disease , Patented
6736,D05XAH,Aromatic hydrazine carboxyimidoamide derivative 4,Senile lentigines , Patented
6737,D05XAH,Aromatic hydrazine carboxyimidoamide derivative 4,Melasma , Patented
6738,D05XCZ,VPC-51299,Solid tumour/cancer , Investigative
6739,D05XDZ,LMT-X,Acute myeloid leukaemia , Phase 3
6740,D05XDZ,LMT-X,Alzheimer disease , Phase 3
6741,D05XEA,RP5063,Schizophrenia , Phase 2
6742,D05XEA,RP5063,Alzheimer disease , Phase 1
6743,D05XEA,RP5063,Attention deficit hyperactivity disorder , Phase 1
6744,D05XEA,RP5063,Bipolar disorder , Phase 1
6745,D05XEA,RP5063,Major depressive disorder , Phase 1
6746,D05XEA,RP5063,Parkinson disease , Phase 1
6747,D05XFQ,VLN-244,Colon cancer , Investigative
6748,D05XGH,PMID26651364-Compound-6e,Crohn disease , Patented
6749,D05XGH,PMID26651364-Compound-6e,Ulcerative colitis , Patented
6750,D05XGH,PMID26651364-Compound-6e,Urinary tract infection , Patented
6751,D05XGO,Cariprazine,Bipolar disorder , Approved
6752,D05XIA,SF-22,Autoimmune disease , Preclinical
6753,D05XJW,Resiniferatoxin,Neuropathic pain , Phase 2
6754,D05XJW,Resiniferatoxin,Pain , Phase 1
6755,D05XJW,Resiniferatoxin,Osteoarthritis , Phase 1
6756,D05XJW,Resiniferatoxin,Cancer related pain , Phase 1
6757,D05XKN,APG-101.10,Gout , Investigative
6758,D05XKW,VM-501,Thrombocytopenia , Phase 3
6759,D05XLO,INCB13739,Type-2 diabetes , Phase 2a
6760,D05XLO,INCB13739,Diabetic complication , Phase 2
6761,D05XMY,Acteoside,Nephritis , Terminated
6762,D05XNF,IM21 CART,Multiple myeloma , Phase 1
6763,D05XPZ,JWCAR029,Non-hodgkin lymphoma , Phase 1
6764,D05XQE,Plaunotol,Ulcer , Approved
6765,D05XRZ,HI-6,Poison intoxication , Investigative
6766,D05XSJ,Asfotase alfa,Genetic disease , Approved
6767,D05XTO,ABT-100,Solid tumour/cancer , Terminated
6768,D05XTQ,DELTIBANT,Sepsis , Phase 2
6769,D05XUY,JM216,Solid tumour/cancer , Phase 2
6770,D05XXF,ORMD-0901,Type-2 diabetes , Phase 2
6771,D05XXQ,MLR-1326,Diabetic complication , Investigative
6772,D05XYC,LY-231617,Arthritis , Discontinued in Phase 1
6773,D05XYH,MIC-31,Gastrointestinal ulcer , Investigative
6774,D05XZQ,HepaStem,Liver failure , Phase 2
6775,D05YAD,PMID25656651-Compound-11c,Chronic myeloid leukaemia , Patented
6776,D05YAG,Recombinant human endostatin,Solid tumour/cancer , Approved
6777,D05YAS,Tolafentrine,Chronic obstructive pulmonary disease , Discontinued in Phase 2
6778,D05YBZ,Tolonium chloride,Solid tumour/cancer , Approved
6779,D05YEI,SUN-K0706,Chronic lymphocytic leukaemia , Phase 1
6780,D05YEI,SUN-K0706,Parkinson disease , Phase 1
6781,D05YEL,CH-3697,Asthma , Investigative
6782,D05YES,StaphVAX,Staphylococcus infection , Phase 3
6783,D05YFE,Diphyllin,Osteoporosis , Investigative
6784,D05YFL,AFTVac,Glioblastoma multiforme , Phase 2
6785,D05YHW,Vapaliximab,Inflammation , Terminated
6786,D05YIX,LymphoScan,Lymphoma , Discontinued in Phase 3
6787,D05YLL,FL-386,Hyperlipidaemia , Discontinued in Phase 2
6788,D05YLN,SAR256212,Solid tumour/cancer , Phase 2
6789,D05YLO,Her-2-Bi-armed ATC,Breast cancer , Discontinued in Phase 2
6790,D05YLP,SP-333,Ulcerative colitis , Phase 2
6791,D05YMT,Tricomin,Alopecia , Approved
6792,D05YOT,PPRT-321,Prostate hyperplasia , Terminated
6793,D05YQL,BM-ca,Non-hodgkin lymphoma , Phase 1
6794,D05YQT,LBR-101,Migraine , Phase 1
6795,D05YRG,TDI-0025,Motor neurone disease , Investigative
6796,D05YRP,C4.4a-ADC,Solid tumour/cancer , Phase 1
6797,D05YRV,ETX-6107,Arteriosclerosis , Preclinical
6798,D05YTG,SLx-4090,Hyperlipidaemia , Phase 2
6799,D05YTG,SLx-4090,Dyslipidemia , Phase 2
6800,D05YTG,SLx-4090,Diabetic complication , Phase 2
6801,D05YTN,Saracatinib,Metastatic colorectal cancer , Phase 2
6802,D05YTN,Saracatinib,Middle East Respiratory Syndrome (MERS) , Investigative
6803,D05YUI,Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy,Immunodeficiency , Phase 1/2
6804,D05YUK,FOROPAFANT,Asthma , Discontinued in Phase 3
6805,D05YWJ,IFX-1,Hidradenitis suppurativa , Phase 2
6806,D05YWN,GS-168,Renal cell carcinoma , Investigative
6807,D05YYB,ACE-06X,Metabolic disorder , Investigative
6808,D05YYK,AP-401,Inflammation , Investigative
6809,D05YYP,RG-7599,Ovarian cancer , Phase 2
6810,D05ZAI,Grippol TC,Influenza virus infection , Phase 3
6811,D05ZBV,RTX-240,Acute myeloid leukaemia , Phase 1/2
6812,D05ZBV,RTX-240,Solid tumour/cancer , Phase 1/2
6813,D05ZCQ,DAP-81,Solid tumour/cancer , Preclinical
6814,D05ZCZ,Beifutai,Central nervous system disease , Investigative
6815,D05ZDA,JZAD-IV-22,Narcolepsy , Investigative
6816,D05ZDD,Recombinant human cartilage-derived retinoic acid-sensitive protein depot,Articular cartilage disorder , Phase 2/3
6817,D05ZDJ,THR-18,Asthma , Phase 2
6818,D05ZEW,INO-3510,Influenza A virus H1N1/H5N1 infection , Phase 1
6819,D05ZGQ,Dexchlorpheniramine Maleate,Rhinitis , Approved
6820,D05ZGW,DPI-201-106,Cardiovascular disease , Terminated
6821,D05ZHA,Alilusem,Diuretic vasodilator , Phase 3
6822,D05ZHZ,PMID26651364-Compound-5e,Crohn disease , Patented
6823,D05ZHZ,PMID26651364-Compound-5e,Ulcerative colitis , Patented
6824,D05ZHZ,PMID26651364-Compound-5e,Urinary tract infection , Patented
6825,D05ZIF,DFN-02,Migraine , Phase 3
6826,D05ZIK,Mirtazapine,Depression , Approved
6827,D05ZIS,SM-04690,Osteoarthritis , Phase 2
6828,D05ZIT,EC-400,Macular degeneration , Investigative
6829,D05ZJG,Anisodine,Central and peripheral nervous disease , Approved
6830,D05ZLH,IMP-731,Autoimmune diabetes , Investigative
6831,D05ZLY,AST-008,Solid tumour/cancer , Phase 1
6832,D05ZNA,ESBA-903,Ocular disease , Investigative
6833,D05ZPL,Polidocanol,Reticular veins , Approved
6834,D05ZPL,Polidocanol,Spider veins , Approved
6835,D05ZQC,PRISOTINOL,Cognitive impairment , Discontinued in Phase 2
6836,D05ZQV,NK-611,Solid tumour/cancer , Discontinued in Phase 2
6837,D05ZSB,Ovine corticotropin-releasing hormone,Cushing disease , Approved
6838,D05ZSB,Ovine corticotropin-releasing hormone,Diagnostic imaging , Approved
6839,D05ZSX,NN-8828,Autoimmune diabetes , Phase 1
6840,D05ZTH,Iloprost,Pulmonary arterial hypertension , Approved
6841,D05ZTJ,Anileridine Hydrochloride,Pain , Approved
6842,D05ZVU,ANG-3062,Fibrosis , Investigative
6843,D05ZWG,Senktide,Ischemic stroke , Phase 2
6844,D05ZWG,Senktide,Epilepsy , Phase 2
6845,D05ZWR,PMID25666693-Compound-90,Osteoarthritis pain , Patented
6846,D05ZWR,PMID25666693-Compound-90,Cancer related pain , Patented
6847,D05ZWR,PMID25666693-Compound-90,Neuropathic pain , Patented
6848,D05ZWR,PMID25666693-Compound-90,Inflammatory pain , Patented
6849,D05ZXS,MAXY-G34,Neutropenia , Phase 2
6850,D05ZXZ,BAY 57-1293,Herpes simplex virus infection , Phase 2
6851,D05ZYM,N-Acetyl-D-glucosamine,Autoimmune diabetes , Approved
6852,D06AAG,Anthrax Immune Globulin (AIG),Bacterial infection , Phase 1/2
6853,D06AAP,Ipodate,Graves disease , Approved
6854,D06ABF,Loratadine,Allergy , Approved
6855,D06ABF,Loratadine,Allergic rhinitis , Discontinued in Phase 2
6856,D06ABM,CAB-175,Bacterial infection , Discontinued in Phase 1
6857,D06ACI,BZYX,Neurodegenerative disorder , Investigative
6858,D06ACW,Adenosine monophosphate,Malnutrition , Approved
6859,D06AEB,Iodoquinol,Amoebiasis , Approved
6860,D06AEO,Cyproterone,Prostate cancer , Approved
6861,D06AES,BB-16000,Solid tumour/cancer , Investigative
6862,D06AGD,MK-0963,Prostate disease , Discontinued in Phase 1
6863,D06AGH,Trametinib + dabrafenib,Melanoma , Approved
6864,D06AHQ,Ro-31-8830,Inflammation , Terminated
6865,D06AJL,Antacids,Gastric adenocarcinoma , Approved
6866,D06AKC,IVVS-1001,Breast cancer , Investigative
6867,D06AKJ,FR-111142,Arthritis , Terminated
6868,D06ALB,BCH-2763,Thrombosis , Terminated
6869,D06ALD,Empagliflozin,Type-1 diabetes , Approved
6870,D06ALE,IFX-1,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
6871,D06ALK,Xmab-2513,Lymphoma , Phase 1
6872,D06ANS,CVBT-141H,Coronary artery disease , Phase 2
6873,D06ANS,CVBT-141H,Peripheral arterial disease , Phase 2
6874,D06ANS,CVBT-141H,Coronary heart disease , Phase 2
6875,D06ANT,Grass pollen extract sublingual vaccine,Seasonal allergic rhinitis , Approved
6876,D06APK,Rinfabate,Solid tumour/cancer , Phase 2/3
6877,D06APO,PDC-748,Cough , Phase 2
6878,D06AQI,NN344,Diabetic complication , Discontinued in Phase 1
6879,D06AQJ,TRK-530,Osteoporosis , Phase 2
6880,D06AQP,EC-0531,Solid tumour/cancer , Investigative
6881,D06ARI,NM-001,Respiratory tract infection , Investigative
6882,D06ARV,Anti-IL-23,Inflammation , Phase 3
6883,D06AVN,CS-891B,Alopecia , Discontinued in Phase 2
6884,D06AWA,SCIB-1,Melanoma , Phase 1/2
6885,D06AWD,Anti-D human immunoglobulin,Acquired haemolytic anemia , Approved
6886,D06AWE,Buprenorphine,Pain , Approved
6887,D06AWE,Buprenorphine,Psychiatric disorder , Phase 3
6888,D06AWE,Buprenorphine,Migraine , Phase 2
6889,D06AZH,B-220,Autoimmune diabetes , Terminated
6890,D06BBF,BLV-0801,Solid tumour/cancer , Investigative
6891,D06BBO,Polymerized vaccine,Allergy , Phase 3
6892,D06BBV,XZK-monascus,Hyperlipidaemia , Phase 2
6893,D06BBZ,ZM-224832,Hypertension , Terminated
6894,D06BCB,Vinpocetine,Ischemic stroke , Approved
6895,D06BDE,Remdesivir,Coronavirus Disease 2019 (COVID-19) , Phase 3
6896,D06BDE,Remdesivir,Severe acute respiratory syndrome (SARS) , Investigative
6897,D06BDE,Remdesivir,Middle East Respiratory Syndrome (MERS) , Investigative
6898,D06BDP,OtiVax,Otitis media , Terminated
6899,D06BEP,Chlordiazepoxide,Anxiety disorder , Approved
6900,D06BEX,"Gene therapy, congestive heart failure",Congestive heart failure , Investigative
6901,D06BFH,5-fluoro-1H-indole-2-carboxylic acid,Glioma , Investigative
6902,D06BFH,5-fluoro-1H-indole-2-carboxylic acid,Melanoma , Investigative
6903,D06BFP,CGS-17867A,Alcohol dependence , Terminated
6904,D06BGK,FiloVax,Ebola virus infection , Investigative
6905,D06BGO,Telcyta canfosfamide,Non-hodgkin lymphoma , Phase 3
6906,D06BGO,Telcyta canfosfamide,Mantle cell lymphoma , Phase 3
6907,D06BGO,Telcyta canfosfamide,Diffuse large B-cell lymphoma , Phase 3
6908,D06BGS,AIDSVAX,Human immunodeficiency virus infection , Phase 3
6909,D06BGZ,LY3200882,Solid tumour/cancer , Phase 1
6910,D06BHB,Trastuzumab deruxtecan,HER2-positive breast cancer , Approved
6911,D06BHB,Trastuzumab deruxtecan,Colorectal cancer , Phase 2
6912,D06BHG,Safotibant,Diabetic macular edema , Phase 2
6913,D06BHI,BMS-986089,Duchenne dystrophy , Phase 1/2
6914,D06BHK,ORG-9453,Paralysis , Investigative
6915,D06BHQ,YM-17K,Bacterial infection , Discontinued in Phase 2
6916,D06BIE,PanBlok,Pandemic influenza infection , Phase 2
6917,D06BIE,PanBlok,Influenza virus infection , Phase 1/2
6918,D06BJP,NXB-4221,Bacterial infection , Investigative
6919,D06BKF,PEGylated recombinant EPO,Anemia , Investigative
6920,D06BKH,GR-MD-02,Melanoma , Phase 2
6921,D06BKH,GR-MD-02,Plaque psoriasis , Phase 2
6922,D06BKH,GR-MD-02,Hypertension , Phase 2
6923,D06BKH,GR-MD-02,Non-alcoholic steatohepatitis , Phase 1
6924,D06BKK,NN9748,Type-2 diabetes , Phase 1
6925,D06BLQ,Sofalcone,Ulcer , Approved
6926,D06BMO,BI 1026706,Diabetic macular edema , Phase 2
6927,D06BMO,BI 1026706,Osteoarthritis , Phase 1
6928,D06BPF,R-102557,Fungal infection , Terminated
6929,D06BPG,Nomifensine,Breast cancer , Withdrawn from market
6930,D06BQU,Salicin,Analgesia , Approved
6931,D06BSE,EDI1200,Ectodermal dysplasia , Phase 2
6932,D06BSG,"Thieno[3,2-c]pyridine-7-carboxamide derivative 1",Solid tumour/cancer , Patented
6933,D06BSG,"Thieno[3,2-c]pyridine-7-carboxamide derivative 1",Metastatic cancer , Patented
6934,D06BSV,PMID30107136-Compound-Example46,Solid tumour/cancer , Patented
6935,D06BSV,PMID30107136-Compound-Example46,Infectious disease , Patented
6936,D06BSV,PMID30107136-Compound-Example46,Human immunodeficiency virus infection , Patented
6937,D06BSV,PMID30107136-Compound-Example46,Hepatitis , Patented
6938,D06BTD,4Ab-028,Cytomegalovirus infection , Investigative
6939,D06BTF,Almorexant,Insomnia , Terminated
6940,D06BTF,Almorexant,Sleep-wake disorder , Terminated
6941,D06BUA,Nexopamil,Hypertension , Phase 2
6942,D06BUI,PN-355,Human immunodeficiency virus-1 infection , Discontinued in Phase 1
6943,D06BUS,ST-7,Neutropenia , Investigative
6944,D06BVT,Affitope AD-02,Alzheimer disease , Discontinued in Phase 2
6945,D06BYG,Clostridium butyricum MIYAIRI 588,Bacterial infection , Approved
6946,D06BYS,Imepitoin,Convulsion , Discontinued in Phase 1
6947,D06BYV,Phensuximide,Seizure disorder , Approved
6948,D06CAC,Anidulafungin,Candidiasis , Approved
6949,D06CAC,Anidulafungin,Coronavirus Disease 2019 (COVID-19) , Investigative
6950,D06CAS,Cerliponase Alfa,Tripeptidyl peptidase 1 deficiency , Approved
6951,D06CAS,Cerliponase Alfa,Neuronal ceroid lipofuscinosis , Approved
6952,D06CAV,KiroVAX-004,Solid tumour/cancer , Phase 1/2
6953,D06CCR,Fialuridine,Hepatitis B virus infection , Phase 2
6954,D06CDN,AG-TMB711,Gastric motility disorder , Approved
6955,D06CDO,Chlorphentermine Hydrochloride,Appetite suppressant , Approved
6956,D06CDP,MT-176,Bacterial infection , Investigative
6957,D06CEA,Purine derivative 3,Obesity , Patented
6958,D06CFJ,DC-480,Malaria , Investigative
6959,D06CFT,PP-4001,Cystitis , Phase 2
6960,D06CFZ,ARM-AK-105,Hyperlipidaemia , Investigative
6961,D06CGB,Desogestrel,Contraception , Approved
6962,D06CIE,Amifostine,Mucositis , Approved
6963,D06CIJ,ISIS-CRP,Inflammation , Phase 1
6964,D06CIJ,ISIS-CRP,Cardiovascular disease , Phase 1
6965,D06CIR,Thymosin beta-4,Neurotrophic keratitis , Phase 3
6966,D06CIR,Thymosin beta-4,Alopecia , Phase 2
6967,D06CJN,INCAGN1876,Solid tumour/cancer , Phase 1/2
6968,D06CKX,SB-649868,Insomnia , Phase 2
6969,D06CML,VLF-02,Fungal infection , Investigative
6970,D06CMW,MVA-BN polytope HIV vaccine,Human immunodeficiency virus infection , Discontinued in Phase 1/2
6971,D06CNP,Abiraterone acetate,Prostate cancer , Approved
6972,D06CSK,BCT-194,Psoriasis vulgaris , Phase 1
6973,D06CSR,INP-1750,Diarrhea , Investigative
6974,D06CTD,IN-N01,Brain injury , Investigative
6975,D06CTE,Imiquimod,Skin cancer , Approved
6976,D06CTM,Ferumoxytol,Chronic kidney disease , Approved
6977,D06CVN,EC0489,Solid tumour/cancer , Phase 1
6978,D06CVO,OrM3,Chronic obstructive pulmonary disease , Phase 2b
6979,D06CVT,Tianeptine,Major depressive disorder , Approved
6980,D06CWH,Betamethasone Benzoate,Inflammation , Approved
6981,D06CWM,AZD-7507,Solid tumour/cancer , Investigative
6982,D06CWV,W-205GBA2ED,Bacterial infection , Phase 1
6983,D06CWZ,CAR-CLD18 T cell,Adenocarcinoma , Clinical trial
6984,D06CWZ,CAR-CLD18 T cell,Pancreatic cancer , Clinical trial
6985,D06CXL,Anakinra,Rheumatoid arthritis , Approved
6986,D06CXL,Anakinra,Coronavirus Disease 2019 (COVID-19) , Phase 3
6987,D06CYI,Nitric Oxide,Hypertension , Approved
6988,D06CYI,Nitric Oxide,Coronavirus Disease 2019 (COVID-19) , Phase 2
6989,D06CZJ,Idursulfase,Infertility , Approved
6990,D06CZJ,Idursulfase,Hunter syndrome , Approved
6991,D06CZS,V85546,Inflammation , Discontinued in Phase 1
6992,D06DBJ,REGN-846,Atopic dermatitis , Phase 1/2
6993,D06DCL,LY335979,Acute myeloid leukaemia , Discontinued in Phase 3
6994,D06DET,AE-3763,Chronic obstructive pulmonary disease , Discontinued in Phase 1
6995,D06DFU,TP-023,Anxiety disorder , Preclinical
6996,D06DHB,E7016,Melanoma , Phase 2
6997,D06DKD,QBI-139,Solid tumour/cancer , Phase 1
6998,D06DKU,Amiodarone,Ventricular tachycardia , Approved
6999,D06DKU,Amiodarone,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
7000,D06DLI,MCI-186,Amyotrophic lateral sclerosis , Approved
7001,D06DLN,SHP621,Eosinophilic esophagitis , Phase 2
7002,D06DLO,Ro-24-7341,Bacterial infection , Terminated
7003,D06DLQ,CGP-37849,Neurological disorder , Discontinued in Phase 1
7004,D06DMQ,VX-970,Solid tumour/cancer , Phase 1
7005,D06DMV,ER-21018,Gastrointestinal disease , Investigative
7006,D06DOJ,Seribantumab,Colorectal cancer , Phase 2
7007,D06DOJ,Seribantumab,Head and neck cancer , Phase 2
7008,D06DOJ,Seribantumab,Non-small-cell lung cancer , Phase 2
7009,D06DPJ,HITOPK-032,Nasopharyngeal carcinoma , Investigative
7010,D06DPQ,AIM-101,Asthma , Investigative
7011,D06DPS,PD-170292,Obesity , Preclinical
7012,D06DQF,RO-5095932,Non-insulin dependent diabetes , Phase 1
7013,D06DRU,ELP-10,leukaemia , Investigative
7014,D06DSQ,DPIV/CD26,Acne vulgaris , Phase 2
7015,D06DUO,SSR-182289,Myocardial infarction , Discontinued in Phase 2
7016,D06DUS,PVX-410,Multiple myeloma , Phase 2
7017,D06DUS,PVX-410,Triple negative breast cancer , Phase 2
7018,D06DUS,PVX-410,Solid tumour/cancer , Phase 1
7019,D06DWQ,TOPIXANTRONE HYDROCHLORIDE,Gastric adenocarcinoma , Discontinued in Phase 2
7020,D06DZI,GR-127935,Major depressive disorder , Terminated
7021,D06DZZ,NVX-188,Solid tumour/cancer , Investigative
7022,D06EBJ,CX-02,Solid tumour/cancer , Investigative
7023,D06EBU,ALTU-242,Gout , Investigative
7024,D06ECI,TD-101,Flavivirus infection , Phase 2
7025,D06ECI,TD-101,Pachyonychia , Phase 1
7026,D06ECJ,Verapamil,Hypertension , Approved
7027,D06ECJ,Verapamil,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
7028,D06ECM,HBN-2,Neurological disorder , Investigative
7029,D06EDP,DSP-0565,Epilepsy , Phase 1
7030,D06EDT,ZOPOLRESTAT,Diabetic complication , Discontinued in Phase 2
7031,D06EEL,Miokamycin,Bronchitis , Approved
7032,D06EEM,JD-3000,Malaria , Investigative
7033,D06EFW,RG7304,Solid tumour/cancer , Phase 1
7034,D06EGV,LY2801653,Solid tumour/cancer , Phase 2
7035,D06EGV,LY2801653,Biliary tract cancer , Phase 2
7036,D06EHW,IAI-100,Solid tumour/cancer , Investigative
7037,D06EHX,TAK-935,Dravet syndrome , Phase 2
7038,D06EHX,TAK-935,LennoxGastaut syndrome , Phase 2
7039,D06EHX,TAK-935,Tuberous sclerosis , Phase 2
7040,D06EHX,TAK-935,Glutamate excitotoxity , Phase 1
7041,D06EIC,ASP-015K,Psoriasis vulgaris , Phase 3
7042,D06EIC,ASP-015K,Rheumatoid arthritis , Phase 2
7043,D06EIJ,RFT-5.dgA,Human immunodeficiency virus infection , Phase 2
7044,D06EIM,IPN-200,Flavivirus infection , Investigative
7045,D06EIO,Trimelamol,Solid tumour/cancer , Discontinued in Phase 2
7046,D06EIY,Lm-Malaria,Malaria , Investigative
7047,D06EMM,CERC-301,Major depressive disorder , Phase 2
7048,D06EMQ,AM-112,Bacterial infection , Investigative
7049,D06EMT,Chlormerodrin,Diagnostic imaging , Approved
7050,D06EMW,AZD8566,Rheumatoid arthritis , Discontinued in Phase 1
7051,D06EMW,AZD8566,Chronic obstructive pulmonary disease , Discontinued in Phase 1
7052,D06ENH,Prostacyclin analog,Pulmonary hypertension , Investigative
7053,D06ENM,Oliceridine,Acute pain , Approved
7054,D06ENM,Oliceridine,Thyroid disease , Clinical trial
7055,D06ENR,HG-1096,Immune System disease , Investigative
7056,D06EPF,Plicamycin,Testicular cancer , Approved
7057,D06EPF,Plicamycin,Hypercalcaemia , Approved
7058,D06EPF,Plicamycin,Solid tumour/cancer , Withdrawn from market
7059,D06EPF,Plicamycin,Lung cancer , Investigative
7060,D06EPF,Plicamycin,Ovarian cancer , Investigative
7061,D06EPO,PF-4136309,Hepatitis C virus infection , Phase 2
7062,D06EPP,CNB-001,Brain injury , Investigative
7063,D06EQN,XR-510,Hypertension , Terminated
7064,D06EQP,Aceprometazine,Sleep-wake disorder , Approved
7065,D06ERY,BMS-394136,Arrhythmia , Phase 1
7066,D06ESU,AM-461,Respiratory disease , Phase 1
7067,D06ETI,ABT-263,Myelofibrosis , Phase 3
7068,D06ETI,ABT-263,Relapsed or refractory chronic lymphocytic leukaemia , Phase 2
7069,D06ETI,ABT-263,Solid tumour/cancer , Discontinued in Phase 2
7070,D06EUC,PMX-10098,Fungal infection , Investigative
7071,D06EVZ,Anti-GD2 CART,Neuroblastoma , Phase 2
7072,D06EWO,Gemtuzumab ozogamicin,Acute myeloid leukaemia , Approved
7073,D06EWT,CLR1404-I-124,Glioma , Phase 2
7074,D06EWT,CLR1404-I-124,Non-small-cell lung cancer , Phase 1/2
7075,D06EWT,CLR1404-I-124,Brain cancer , Phase 1/2
7076,D06EWW,Sacrovir,Herpes simplex virus infection , Investigative
7077,D06EXA,SALVINORIN A,Cerebral vasospasm , Phase 1
7078,D06EXI,FGLL,Alzheimer disease , Phase 1
7079,D06EYQ,TDI-0094,Motor neurone disease , Investigative
7080,D06EZI,Capreomycin Sulfate,Tuberculosis , Approved
7081,D06FAA,Metelimumab,Scleroderma , Phase 1/2
7082,D06FBB,Azithromycin/chloroquine,Bacterial infection , Discontinued in Phase 3
7083,D06FCR,CL-277082,Arteriosclerosis , Discontinued in Phase 1
7084,D06FDR,Didanosine,Human immunodeficiency virus infection , Approved
7085,D06FEA,Dinoprostone,Medical abortion , Approved
7086,D06FEQ,WIT-301,Insulin-dependent diabetes , Investigative
7087,D06FER,BMX-010,Atopic dermatitis , Phase 2
7088,D06FER,BMX-010,Plaque psoriasis , Phase 2
7089,D06FES,Doxepin,Depression , Approved
7090,D06FGJ,Protexia,Alzheimer disease , Phase 1
7091,D06FGM,Snake venom antisera,Poison intoxication , Investigative
7092,D06FHQ,BMS-936561,Haematological malignancy , Phase 1
7093,D06FIT,SB-728-T,Human immunodeficiency virus infection , Phase 2
7094,D06FJO,Benzydamine,Chemotherapy or radiotherapy-induced mucositis , Discontinued in Phase 2
7095,D06FKC,Eltoprazine,Attention deficit hyperactivity disorder , Phase 3
7096,D06FKC,Eltoprazine,Non-hodgkin lymphoma , Phase 2
7097,D06FKC,Eltoprazine,Alzheimer disease , Phase 2
7098,D06FKC,Eltoprazine,Dyskinesia , Phase 2
7099,D06FKC,Eltoprazine,Parkinson disease , Phase 2
7100,D06FLP,AMG 811,Systemic lupus erythematosus , Phase 1
7101,D06FLP,AMG 811,Discoid lupus erythematosus , Phase 1
7102,D06FMO,ABP 501,Rheumatoid arthritis , Phase 3
7103,D06FMO,ABP 501,Plaque psoriasis , Application submitted
7104,D06FMY,CGP-70726,Human immunodeficiency virus-1 infection , Terminated
7105,D06FOA,Bone morphogenetic protein-2,Bone injury , Investigative
7106,D06FOF,Imidazole derivative 5,Obesity , Patented
7107,D06FOL,CALDARET HYDRATE,Cardiovascular disease , Phase 2
7108,D06FOU,Trifarotene,Acne vulgaris , Approved
7109,D06FPF,Valortim,Bacterial infection , Phase 1
7110,D06FPQ,Frovatriptan,Migraine , Approved
7111,D06FQS,TGOF02N,Schizophrenia , Phase 2
7112,D06FQU,INCB53914,Advanced malignancy , Phase 1/2
7113,D06FRB,ACH-0137171,Hepatitis C virus infection , Phase 2
7114,D06FSC,NP-118809,Pain , Discontinued in Phase 2
7115,D06FSD,NN-9161,Obesity , Discontinued in Phase 1/2
7116,D06FSV,Onco-D,Solid tumour/cancer , Investigative
7117,D06FTM,RG7221,Colorectal cancer , Phase 2
7118,D06FTM,RG7221,Metastatic colorectal cancer , Phase 2
7119,D06FTW,RP135,Human immunodeficiency virus infection , Terminated
7120,D06FTY,CT-400,Solid tumour/cancer , Investigative
7121,D06FUE,CDX-3379,Squamous cell carcinoma , Phase 2
7122,D06FUE,CDX-3379,Solid tumour/cancer , Phase 1
7123,D06FUM,PMID26815044-Compound-114,Albinism , Patented
7124,D06FUM,PMID26815044-Compound-114,Ephelides , Patented
7125,D06FUM,PMID26815044-Compound-114,Menkes disease , Patented
7126,D06FUM,PMID26815044-Compound-114,Senile lentigines , Patented
7127,D06FUM,PMID26815044-Compound-114,Melasma , Patented
7128,D06FUQ,MIQ-003,Multiple sclerosis , Investigative
7129,D06FVX,Nedocromil sodium,Allergic conjunctivitis , Approved
7130,D06FWC,Fludiazepam,Anxiety disorder , Approved
7131,D06FWG,Oncomer,Solid tumour/cancer , Terminated
7132,D06FYE,Atorvastatin + aspirin + ramipril,Hypertension , Phase 2
7133,D06FZH,MazF gene therapy,Human immunodeficiency virus-1 infection , Phase 1
7134,D06FZX,Antazoline,Nasal congestion , Approved
7135,D06GAM,Fleroxacin,Bacterial infection , Approved
7136,D06GAP,SAR252067,Ulcerative colitis , Phase 1
7137,D06GAP,SAR252067,Crohn disease , Phase 1
7138,D06GAQ,Atu-111,Prostate cancer , Investigative
7139,D06GBQ,Enfuvirtide,Human immunodeficiency virus infection , Approved
7140,D06GCK,Eupatilin,Pancreatitis , Approved
7141,D06GCK,Eupatilin,Chronic diarrhoea , Approved
7142,D06GCO,Gonadoreline-6-d-trp acetate,Solid tumour/cancer , Approved
7143,D06GCP,PSD-506,Overactive bladder , Discontinued in Phase 2
7144,D06GDH,DA-5018,Postherpetic neuralgia , Discontinued in Phase 2
7145,D06GDH,DA-5018,Diabetic neuropathy , Discontinued in Phase 2
7146,D06GDR,VAP-1 monoclonal antibody,Inflammation , Phase 2a
7147,D06GDY,Paroxetine,Depression , Approved
7148,D06GFG,KD-3020,Non-alcoholic fatty liver disease , Preclinical
7149,D06GGL,MSB11022,Plaque psoriasis , Phase 3
7150,D06GGT,MCL-1-specific antisense oligonucleotide + nilotinib (AMN107),Systemic mastocytosis , Investigative
7151,D06GIP,Thymol,Fungal infection , Approved
7152,D06GJT,Alizapride,Vomiting , Approved
7153,D06GKE,GZ402665,Niemann-pick disease , Phase 2/3
7154,D06GKN,Alosetron,Irritable bowel syndrome , Approved
7155,D06GKR,Deferoxamine,Acute iron or aluminum toxicity , Approved
7156,D06GKR,Deferoxamine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
7157,D06GMG,Etoposide,Testicular cancer , Approved
7158,D06GMG,Etoposide,Coronavirus Disease 2019 (COVID-19) , Phase 2
7159,D06GMJ,GSK945237,Bacterial infection , Discontinued in Phase 1
7160,D06GMM,FT-026,Fibrosis , Investigative
7161,D06GNF,TS-022,Atopic dermatitis , Phase 2
7162,D06GOF,IDP-123,Acne vulgaris , Phase 3
7163,D06GOT,"Pyrrolo[2,3-b]pyridine derivative 2",Pruritus , Patented
7164,D06GOT,"Pyrrolo[2,3-b]pyridine derivative 2",Solid tumour/cancer , Patented
7165,D06GOT,"Pyrrolo[2,3-b]pyridine derivative 2",Chronic pain , Patented
7166,D06GOT,"Pyrrolo[2,3-b]pyridine derivative 2",Neuropathic pain , Patented
7167,D06GOT,"Pyrrolo[2,3-b]pyridine derivative 2",Thymic cancer , Patented
7168,D06GRK,ARC029,Alzheimer disease , Phase 3
7169,D06GSA,CMV DNA vaccine,Cytomegalovirus infection , Preclinical
7170,D06GSE,GPI-1337,Neurodegenerative disorder , Terminated
7171,D06GUA,GSK2269557,Asthma , Phase 2
7172,D06GUG,BTT-1023,Psoriasis vulgaris , Phase 2
7173,D06GWF,Valganciclovir,Virus infection , Approved
7174,D06GYJ,PD-01,Parkinson disease , Phase 4
7175,D06GYY,Ifenprodil,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
7176,D06GZW,PEGylated leptin,Obesity , Investigative
7177,D06HBJ,BAY2306001,Thrombosis , Phase 2
7178,D06HBQ,Gliquidone,Diabetic complication , Approved
7179,D06HBT,LT-1951,Coronary artery disease , Phase 1/2
7180,D06HCC,LANEPITANT,Pain , Phase 2
7181,D06HCD,SM-6586,Hypertension , Discontinued in Phase 1
7182,D06HCF,SPD-557,Diabetic gastroparesis , Phase 2
7183,D06HCP,MELARSOPROL,Trypanosomiasis , Approved
7184,D06HFI,L-ornithine phenylacetate,Acute liver failure , Phase 2
7185,D06HGM,LPO-1010CA,Cataract , Investigative
7186,D06HGO,MDY-1001,Gastrointestinal disease , Investigative
7187,D06HGY,RTA-403 analog,Inflammation , Investigative
7188,D06HIO,Istaroxime,Cardiac disease , Discontinued in Phase 2
7189,D06HKB,Lodenosine,Human immunodeficiency virus infection , Discontinued in Phase 2
7190,D06HLY,Pilocarpine,Glaucoma/ocular hypertension , Approved
7191,D06HMN,BAY1251152,Haematological malignancy , Phase 1
7192,D06HMO,CVBT-141B topical,Diabetic foot ulcer , Phase 2
7193,D06HNO,MEDI4920,Sjogren syndrome , Phase 1
7194,D06HNO,MEDI4920,Rheumatoid arthritis , Phase 1
7195,D06HPA,Argidene,Dermatological disease , Discontinued in Preregistration
7196,D06HPP,AGT-182,Hunter syndrome , Phase 1
7197,D06HQG,SPM-5185,Angina pectoris , Terminated
7198,D06HQM,Apo805K1,Psoriasis vulgaris , Phase 2
7199,D06HRD,EUR-1100,Eosinophilic esophagitis , Phase 1/2
7200,D06HRY,SNAP-5089,Heart arrhythmia , Terminated
7201,D06HUF,AM-365,Hepatitis B virus infection , Discontinued in Phase 2
7202,D06HUH,Recombinant human butyrylcholinesterase,Poison intoxication , Investigative
7203,D06HUS,PF-06755347,Chronic inflammatory demyelinating polyneuropathy , Phase 1
7204,D06HWG,Inflexal V,Influenza virus infection , Approved
7205,D06HWU,CHR-4487,Arthritis , Investigative
7206,D06HXC,NPY-1 antagonist,Eating disorder , Investigative
7207,D06HYC,VLI-01B,Solid tumour/cancer , Phase 1
7208,D06HYF,M2698,Solid tumour/cancer , Phase 1
7209,D06HYG,Barucainide,Heart arrhythmia , Terminated
7210,D06HZA,GSK2586184,Systemic lupus erythematosus , Phase 2
7211,D06HZA,GSK2586184,Arthritis , Phase 1
7212,D06HZY,Fructose,Vomiting , Approved
7213,D06IAA,LK-410,Solid tumour/cancer , Terminated
7214,D06IAQ,Ambenonium,Myasthenia gravis , Approved
7215,D06IAR,Adenosine,Paroxysmal supraventricular tachycardia , Approved
7216,D06IBG,MK-3415A,Malaria , Phase 3
7217,D06IBG,MK-3415A,Clostridium infection , Phase 3
7218,D06ICE,Radiolabeled anti-PSMA huJ591 minibodies,Prostate cancer , Investigative
7219,D06ICW,MDI-P,Asthma , Phase 3
7220,D06IDT,Demecarium bromide,Open-angle glaucoma , Approved
7221,D06IEX,Cardiotrophin-1,Acute liver failure , Phase 1
7222,D06IFR,PF-3654764,Allergic rhinitis , Phase 2
7223,D06IGC,ACT-0932,Glioma , Investigative
7224,D06IGE,Factor IX-XTEN,Hemophilia , Investigative
7225,D06IGU,Troleandomycin,Bacterial infection , Approved
7226,D06IGW,Coronary artery disease gene therapy,Coronary artery disease , Phase 1
7227,D06IHW,SCF-I2,Discovery agent , Preclinical
7228,D06IIB,Halcinonide,Skin disease , Approved
7229,D06IJG,Silyman DD,Liver disease , Approved
7230,D06ILL,BMS-986158,Solid tumour/cancer , Phase 1/2
7231,D06IME,CCX-140,Diabetic nephropathy , Phase 2
7232,D06IPN,Sunscreens,Skin cancer , Approved
7233,D06IPV,"Pyrazolo[1,5-a]pyrimidine derivative 2",Obesity , Patented
7234,D06IPZ,MK-3281,Hepatitis C virus infection , Phase 1
7235,D06IQE,H1N1 influenza vaccine,Influenza virus infection , Discontinued in Phase 3
7236,D06IVH,Org-20781,Heart arrhythmia , Terminated
7237,D06IVN,PolongaTab,Poison intoxication , Discontinued in Preregistration
7238,D06IXT,Propyphenazone,Pain , Approved
7239,D06IYV,TAK-810,Prostate cancer , Discontinued in Phase 1
7240,D06IZM,Erythrityl Tetranitrate,Angina pectoris , Approved
7241,D06IZQ,JKB-121,Fatty liver disease , Phase 1/2
7242,D06IZS,XEL-004FP,Pain , Investigative
7243,D06JAL,8H9,Solid tumour/cancer , Phase 1
7244,D06JAL,8H9,Brain cancer , Phase 1
7245,D06JBA,HGS-TR2J,Solid tumour/cancer , Discontinued in Phase 1
7246,D06JBV,SGN LIV1A,Breast cancer , Phase 1
7247,D06JCO,Palomid-529,Alzheimer disease , Phase 1
7248,D06JDK,Perflexane-lipid microsphere,Cardiovascular disease , Approved
7249,D06JDV,K-312,Cardiovascular disease , Phase 1
7250,D06JED,Subcuvia,Immune System disease , Approved
7251,D06JGH,Pyridoxal Phosphate,Malnutrition , Approved
7252,D06JHN,VG-WNV,West nile virus infection , Investigative
7253,D06JHV,Flumatinib,Chronic myelogenous leukaemia , Phase 2
7254,D06JHW,PMID25666693-Compound-37,Osteoarthritis pain , Patented
7255,D06JHW,PMID25666693-Compound-37,Cancer related pain , Patented
7256,D06JHW,PMID25666693-Compound-37,Neuropathic pain , Patented
7257,D06JHW,PMID25666693-Compound-37,Inflammatory pain , Patented
7258,D06JKO,Dust mite allergen extract,Allergic rhinitis , Phase 2
7259,D06JKV,[111In]SRVII23,Prostate cancer , Investigative
7260,D06JLG,AVX-601,Cytomegalovirus infection , Phase 1
7261,D06JLQ,KIN-100,Hepatitis C virus infection , Investigative
7262,D06JLX,Measles vaccine,Measles , Approved
7263,D06JNC,CRD-007,Aortic aneurysm , Phase 2
7264,D06JPB,Ergocalciferol,Hypoparathyroidism , Approved
7265,D06JPY,AZD2995,Alzheimer disease , Phase 1
7266,D06JQM,SPP-800,Hypertension , Investigative
7267,D06JQS,HuM195/rGel,leukaemia , Phase 1
7268,D06JRD,Metamizole,Pain , Withdrawn from market
7269,D06JRD,Metamizole,Fever , Withdrawn from market
7270,D06JTW,FM-VP4,Hyperlipidaemia , Phase 2
7271,D06JTZ,Contepo,Acute bacterial skin infection , Phase 2
7272,D06JUE,NN8555,Crohn disease , Phase 2
7273,D06JUE,NN8555,Rheumatoid arthritis , Discontinued in Phase 2
7274,D06JUR,Rogletimide,Breast cancer , Terminated
7275,D06JVU,A-68552,Obesity , Terminated
7276,D06JVV,ALD-151,Chronic lymphocytic leukaemia , Discontinued in Phase 1
7277,D06JWO,KT-362,Heart arrhythmia , Discontinued in Phase 1
7278,D06KCF,Mavrilimumab,Rheumatoid arthritis , Phase 2
7279,D06KCM,CUV-3,Solid tumour/cancer , Investigative
7280,D06KCU,MLN1202,Multiple sclerosis , Phase 2
7281,D06KCU,MLN1202,Metastatic cancer , Phase 2
7282,D06KCU,MLN1202,Respiratory syncytial virus infection , Terminated
7283,D06KDP,Ganglioside gm1,Thrombin deficiency , Approved
7284,D06KDP,Ganglioside gm1,Cerebrovascular ischaemia , Withdrawn from market
7285,D06KEJ,PV903,Infertility , Discontinued in Phase 1
7286,D06KFR,RP-73163,Arteriosclerosis , Terminated
7287,D06KGC,AEZS-120,Melanoma , Investigative
7288,D06KGI,TG-0054,Macular degeneration , Phase 2
7289,D06KGV,HUMAN CORTICOTROPIN-RELEASING HORMONE,leukaemia , Approved
7290,D06KIJ,AG-858,leukaemia , Phase 2
7291,D06KJG,CLX-0301,Diabetic complication , Terminated
7292,D06KJQ,BI 201335,Hepatitis C virus infection , Phase 3
7293,D06KKL,PulmoXen,Cystic fibrosis , Investigative
7294,D06KKO,PMID26815044-Compound-50,Albinism , Patented
7295,D06KKO,PMID26815044-Compound-50,Ephelides , Patented
7296,D06KKO,PMID26815044-Compound-50,Menkes disease , Patented
7297,D06KKO,PMID26815044-Compound-50,Senile lentigines , Patented
7298,D06KKO,PMID26815044-Compound-50,Melasma , Patented
7299,D06KKS,Cefradine,Bacterial infection , Approved
7300,D06KLJ,STAMP,Dental caries , Phase 3
7301,D06KNE,INCB15050,Human immunodeficiency virus infection , Phase 1
7302,D06KNJ,PB-127,Cardiovascular disease , Phase 3
7303,D06KNK,TDZD-8,Malignant glioma , Patented
7304,D06KOL,Napitane mesilate,Major depressive disorder , Discontinued in Phase 2
7305,D06KOM,DN24-02,Urogenital cancer , Phase 2
7306,D06KOM,DN24-02,Colorectal cancer , Phase 2
7307,D06KOR,SWT-05104,Vitiligo , Investigative
7308,D06KPR,CER-002,Dyslipidemia , Phase 1
7309,D06KPV,CreaVax-RCC,Renal cell carcinoma , Approved
7310,D06KPW,U-103017,Human immunodeficiency virus infection , Discontinued in Phase 1
7311,D06KQG,HER-2-targeting CAR T Cells,Breast cancer , Phase 1/2
7312,D06KQN,TPI-926,Neurological disorder , Phase 2
7313,D06KRZ,MC-4232,Hypertension , Discontinued in Phase 2
7314,D06KSA,TK-115339,Cardiovascular disease , Investigative
7315,D06KSV,Omigapil,Lateral sclerosis , Phase 2
7316,D06KSV,Omigapil,Muscular dystrophy , Phase 1
7317,D06KTF,HL-029,Hyperlipidaemia , Investigative
7318,D06KTJ,TAK-659,Diffuse large B-cell lymphoma , Phase 2
7319,D06KTJ,TAK-659,Haematological malignancy , Phase 1/2
7320,D06KUY,ACH-2684,Hepatitis C virus infection , Phase 1
7321,D06KVU,ABP 215,Non-small-cell lung cancer , Application submitted
7322,D06KWU,DWP-09031,Alzheimer disease , Phase 1
7323,D06KXS,PT-112,Solid tumour/cancer , Phase 1
7324,D06KYN,Arbutamine,Coronary artery disease , Approved
7325,D06KYU,Rycals,Heart failure , Preclinical
7326,D06KZL,AG140699,Melanoma , Phase 2
7327,D06LAN,BlockAide/CR,Human immunodeficiency virus infection , Terminated
7328,D06LAX,PGI-02749,Brain injury , Investigative
7329,D06LBO,Croconazole,Dermatological disease , Approved
7330,D06LBV,E-4767,Bacterial infection , Discontinued in Phase 1
7331,D06LBZ,MVA-BN JEV,Japanese encephalitis virus infection , Preclinical
7332,D06LCB,Thiazole carboxamide derivative 9,Solid tumour/cancer , Patented
7333,D06LCB,Thiazole carboxamide derivative 9,Metastatic cancer , Patented
7334,D06LCS,Legionella pneumophila vaccine,Legionella infection , Terminated
7335,D06LCW,KIN-4044,Non-small-cell lung cancer , Investigative
7336,D06LDC,Palonidipine hydrochloride,Hypertension , Discontinued in Preregistration
7337,D06LDT,Segesterone acetate; ethinyl estradiol,Contraception , Approved
7338,D06LEA,MER-102,Thrombosis , Phase 1
7339,D06LEC,LPD-608,Hypercholesterolaemia , Investigative
7340,D06LEG,Influenza A virus H5N1 vaccine,Influenza virus infection , Phase 3
7341,D06LEJ,Lu-AA44608,Mood disorder , Discontinued in Phase 1
7342,D06LFE,Indomethacin,Rheumatoid arthritis , Approved
7343,D06LFE,Indomethacin,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
7344,D06LFV,NM-702,Angina pectoris , Phase 3
7345,D06LGC,ZD-2486,Angina pectoris , Discontinued in Phase 2
7346,D06LGZ,ET-007,Small-cell lung cancer , Investigative
7347,D06LHE,Inactivated H7N7 influenza vaccine,Influenza virus infection , Phase 1/2
7348,D06LHG,FENBUFEN,Arthritis , Approved
7349,D06LHI,GCH-01,Sepsis , Investigative
7350,D06LHK,2X-111,Brain metastases , Phase 1
7351,D06LHK,2X-111,Recurrent glioblastoma , Phase 1
7352,D06LHU,Iodamide,Contrast medium for intravenous urography , Approved
7353,D06LHU,Iodamide,Brain disease , Withdrawn from market
7354,D06LIQ,Cyclohexyl carbamate derivative 8,Albinism , Patented
7355,D06LIQ,Cyclohexyl carbamate derivative 8,Ephelides , Patented
7356,D06LIQ,Cyclohexyl carbamate derivative 8,Menkes disease , Patented
7357,D06LIQ,Cyclohexyl carbamate derivative 8,Senile lentigines , Patented
7358,D06LIQ,Cyclohexyl carbamate derivative 8,Melasma , Patented
7359,D06LJG,BURKE-104,Verruca vulgaris , Investigative
7360,D06LKA,L2-05,Mycobacterium infection , Investigative
7361,D06LKM,PNU-282987,Schizophrenia , Terminated
7362,D06LKP,OTI-050,Osteoarthritis , Investigative
7363,D06LLS,PMID25684022-Compound-WO2009153313,Solid tumour/cancer , Patented
7364,D06LLS,PMID25684022-Compound-WO2009153313,Metastatic cancer , Patented
7365,D06LMS,P-coumaric acid derivative 4,Albinism , Patented
7366,D06LMS,P-coumaric acid derivative 4,Ephelides , Patented
7367,D06LMS,P-coumaric acid derivative 4,Menkes disease , Patented
7368,D06LMS,P-coumaric acid derivative 4,Senile lentigines , Patented
7369,D06LMS,P-coumaric acid derivative 4,Melasma , Patented
7370,D06LNW,Fidaxomicin,Clostridium difficile associated diarrhea , Approved
7371,D06LOQ,ARZOXIFENE,Breast cancer , Approved
7372,D06LPT,STI-003,Autoimmune disease , Phase 2
7373,D06LQF,131-I-MIP-1095,Prostate cancer , Phase 1
7374,D06LQY,BI-1,Solid tumour/cancer , Phase 2
7375,D06LRG,TRV027,Heart failure , Phase 2
7376,D06LRQ,TKP-1001,Alzheimer disease , Investigative
7377,D06LSZ,PMID25684022-Compound-US20120277229 40(1.2),Solid tumour/cancer , Patented
7378,D06LSZ,PMID25684022-Compound-US20120277229 40(1.2),Metastatic cancer , Patented
7379,D06LUH,ABX-201,Thrombosis , Investigative
7380,D06LUI,Ad-IL-12 DNA therapeutic,Melanoma , Phase 1/2
7381,D06LUI,Ad-IL-12 DNA therapeutic,Recurrent glioblastoma , Phase 1
7382,D06LUZ,GS-5885,Hepatitis C virus infection , Phase 2
7383,D06LVJ,Mam-06.301,Allergy , Phase 2
7384,D06LXP,POL-7080,Bacterial infection , Phase 2
7385,D06LYG,Prilocaine,Pain , Approved
7386,D06LYI,BPX-501,Osteoporosis , Phase 1/2
7387,D06LYI,BPX-501,Immunodeficiency , Phase 1/2
7388,D06LYI,BPX-501,Hematopoietic stem cell transplantation , Phase 1/2
7389,D06LYI,BPX-501,Acute lymphoblastic leukaemia , Phase 1/2
7390,D06LYI,BPX-501,Acute myeloid leukaemia , Phase 1/2
7391,D06LYI,BPX-501,Solid tumour/cancer , Phase 1/2
7392,D06LYS,Prednimustine,Solid tumour/cancer , Approved
7393,D06LYZ,A-841720,Pain , Preclinical
7394,D06MAJ,Mizolastine,Allergic rhinitis , Approved
7395,D06MBR,ACI-636,Alzheimer disease , Investigative
7396,D06MCH,TG-6002,Solid tumour/cancer , Investigative
7397,D06MDT,INV-155,Cerebrovascular ischaemia , Investigative
7398,D06MEC,THA-901,Cancer related pain , Investigative
7399,D06MGW,OrniFlu,Influenza virus infection , Phase 2
7400,D06MHZ,NLG919,Solid tumour/cancer , Phase 1
7401,D06MIQ,MRE-0094,Diabetic foot ulcer , Phase 2
7402,D06MIU,Mycoprex,Fungal infection , Terminated
7403,D06MIW,Pyrazole derivative 37,Obesity , Patented
7404,D06MJP,TNFQb therapeutic vaccines,Crohn disease , Terminated
7405,D06MKG,MBP(75-95),Multiple sclerosis , Phase 1
7406,D06MLA,GET 73,Alcohol dependence , Phase 2
7407,D06MLZ,WAY-123223,Heart arrhythmia , Terminated
7408,D06MMU,LM-CD45,Transplant rejection , Phase 1
7409,D06MMW,ADCON-T/N,Wound healing , Approved
7410,D06MNC,PRS-050,Solid tumour/cancer , Phase 1
7411,D06MNF,Pardoprunox,Parkinson disease , Phase 2
7412,D06MOB,WSB-102,Autoimmune diabetes , Investigative
7413,D06MOY,DM-99,Alzheimer disease , Phase 2
7414,D06MPF,Sch-40120,Pruritus , Terminated
7415,D06MPH,Pyrazole derivative 28,Obesity , Patented
7416,D06MPJ,BD-NP,Hypertension , Investigative
7417,D06MQM,Lumefantrine,Malaria , Approved
7418,D06MQW,GP-1002,Influenza virus infection , Investigative
7419,D06MRR,WilGraf,Autoimmune diabetes , Investigative
7420,D06MRS,NSD-761,Cognitive impairment , Investigative
7421,D06MRT,Acitazanolast,Allergy , Approved
7422,D06MRY,Enteric-coated mycophenolate sodium,Transplant rejection , Approved
7423,D06MTH,KIN-4050,Psoriasis vulgaris , Investigative
7424,D06MTM,S-16276-1,Rheumatoid arthritis , Terminated
7425,D06MUB,SMOi2-17,Solid tumour/cancer , Investigative
7426,D06MUI,A-81988,Hypertension , Terminated
7427,D06MUZ,SDZ-87-469,Coronary artery disease , Terminated
7428,D06MWK,Aimpila,Colorectal cancer , Phase 1
7429,D06MWU,LUF-5833,Ischemia , Investigative
7430,D06MXB,IB-09C190,Angiogenesis disorder , Investigative
7431,D06MXY,BL-1827,Cancer related pain , Discontinued in Phase 1
7432,D06MYP,SK-MS10,Gastritis , Phase 2
7433,D06NAG,Anti-CD137,Solid tumour/cancer , Phase 2
7434,D06NBK,Sodium Iodide I-131 Capsules,Thyroid disease , Approved
7435,D06NDP,CIGB-128,Basal cell carcinoma , Phase 1
7436,D06NEU,CJ-23423,Arthralgia , Discontinued in Phase 2
7437,D06NHK,Sitagliptin + atorvastatin,Cardiovascular disease , Discontinued in Phase 3
7438,D06NIT,PF-4181366,Cognitive impairment , Investigative
7439,D06NJB,AM-802,Lung inflammation , Investigative
7440,D06NKA,IRC-083927,Solid tumour/cancer , Investigative
7441,D06NLP,WTC-01,Solid tumour/cancer , Investigative
7442,D06NMP,CGP-29030A,Pain , Investigative
7443,D06NMY,MDC-1231,Colon cancer , Investigative
7444,D06NMZ,NVP-ADW742,Multiple myeloma , Investigative
7445,D06NND,FPA144,Bladder cancer , Phase 1
7446,D06NND,FPA144,Gastric adenocarcinoma , Phase 1
7447,D06NNQ,VRC-HIVADV014-00-VP,Human immunodeficiency virus infection , Phase 2
7448,D06NNU,NSC-631570,Solid tumour/cancer , Approved
7449,D06NOF,ATI-9242,Schizophrenia , Phase 1
7450,D06NOR,IVL745,Asthma , Discontinued in Phase 2
7451,D06NOU,D-9120,Inflammatory bowel disease , Terminated
7452,D06NPB,GLPG-0259,Rheumatoid arthritis , Discontinued in Phase 2
7453,D06NQA,Plasmid IL-12 immunotherapy,Cutaneous T-cell lymphoma , Phase 1
7454,D06NQH,RG7155,Solid tumour/cancer , Phase 2
7455,D06NQJ,Triproamylin acetate,Diabetic complication , Approved
7456,D06NSA,Thiamylal,Anaesthesia , Approved
7457,D06NSL,PIC-060,Dermatitis , Terminated
7458,D06NSS,Cromoglicate,Asthma , Approved
7459,D06NSS,Cromoglicate,Allergic rhinitis , Terminated
7460,D06NVJ,Nicotinamide,Inflammatory skin condition , Approved
7461,D06NVN,BMS-599793,Human immunodeficiency virus-1 infection , Investigative
7462,D06NXG,PF-04236921,Systemic lupus erythematosus , Phase 2
7463,D06NXG,PF-04236921,Crohn disease , Phase 2
7464,D06NXY,Ethinyl Estradiol,Female hypogonadism , Approved
7465,D06NYA,2-Methoxyestradiol,Pulmonary arterial hypertension , Phase 2
7466,D06OAV,Aminohippurate sodium,Kidney disease , Approved
7467,D06ODM,Talsaclidine fumarate,Alzheimer disease , Discontinued in Phase 2
7468,D06OES,CART-38 cells,Myelodysplastic syndrome , Phase 1
7469,D06OES,CART-38 cells,Acute myeloid leukaemia , Phase 1
7470,D06OFD,BAY-85-8102,Brain disease , Phase 1
7471,D06OFJ,NPI-3304,Gram-positive bacterial infection , Investigative
7472,D06OFS,Rilmenidine,Hypertension , Approved
7473,D06OFZ,LEISH-F1,Leishmania infection , Phase 2
7474,D06OIG,Hib-MenCY-TT vaccine,Meningitis , Phase 3
7475,D06OIV,Tolbutamide,Non-insulin dependent diabetes , Approved
7476,D06OMH,Safflower seed-derived apolipoprotein A1,Cardiovascular disease , Investigative
7477,D06OMK,Tacrolimus,Organ transplant rejection , Approved
7478,D06OMK,Tacrolimus,Ocular allergy , Phase 3
7479,D06OMW,Rasagiline,Parkinson disease , Approved
7480,D06OMW,Rasagiline,Skin cancer , Patented
7481,D06OMW,Rasagiline,Skin imperfections , Patented
7482,D06ONB,AZ505,Solid tumour/cancer , Preclinical
7483,D06OQI,Tilarginine acetate,Myocardial infarction , Phase 3
7484,D06OQI,Tilarginine acetate,Angina pectoris , Discontinued in Phase 2
7485,D06ORI,Ketamine,Anaesthesia , Approved
7486,D06ORI,Ketamine,Coronavirus Disease 2019 (COVID-19) , Phase 2
7487,D06ORU,Butacaine,Pain , Approved
7488,D06OSM,Tandospirone,Anxiety disorder , Approved
7489,D06OUL,Ceforanide,Bacterial infection , Approved
7490,D06OUT,ANG-4011,Fibrosis , Investigative
7491,D06OUW,PBI-220,Bacillus anthracis infection , Investigative
7492,D06OVF,Santalum,Atopic dermatitis , Phase 2
7493,D06OVF,Santalum,Human papillomavirus infection , Phase 2
7494,D06OVF,Santalum,Psoriasis vulgaris , Phase 2
7495,D06OVM,KM-3413,Solid tumour/cancer , Investigative
7496,D06OVY,Cefixime,Bacterial infection , Approved
7497,D06OWF,TBI-301,Hepatitis C virus infection , Investigative
7498,D06OZJ,RWJ-67657,Arthritis , Phase 1
7499,D06OZW,Artemisone,Malaria , Phase 2/3
7500,D06PAW,Z-4105,Alzheimer disease , Terminated
7501,D06PAZ,Encainide,Heart arrhythmia , Withdrawn from market
7502,D06PBH,NN8640,Growth failure , Phase 3
7503,D06PDQ,AOP-200704,Heart arrhythmia , Phase 2
7504,D06PDT,TARP peptide-pulsed autologous dendritic cell vaccine,Prostate cancer , Phase 1
7505,D06PEB,Cinalukast,Asthma , Approved
7506,D06PEW,IT-101,Solid tumour/cancer , Phase 3
7507,D06PFK,TDT-044,Dermatological disease , Investigative
7508,D06PFT,Rhumab Beta7,Ulcerative colitis , Phase 3
7509,D06PGZ,Setrobuvir,Hepatitis C virus infection , Phase 2
7510,D06PHH,Rimacalib,Rheumatoid arthritis , Phase 2
7511,D06PHO,E-3030,Hyperlipidaemia , Discontinued in Phase 1
7512,D06PHS,EVT302,Alzheimer disease , Phase 2
7513,D06PJK,Euro-Celtique 3,Pain , Investigative
7514,D06PKL,BPL-003,Pain , Investigative
7515,D06PKS,ONO-4007,Immune System disease , Discontinued in Phase 2
7516,D06PLP,Resten-MP,Coronary artery disease , Phase 2
7517,D06PNN,Biaryl mannoside derivative 26,Crohn disease , Patented
7518,D06PNN,Biaryl mannoside derivative 26,Ulcerative colitis , Patented
7519,D06PNN,Biaryl mannoside derivative 26,Urinary tract infection , Patented
7520,D06PPL,BIX-01294,Breast cancer , Preclinical
7521,D06PQR,OPC-8490,Cardiovascular disease , Discontinued in Phase 2
7522,D06PQT,Vitamin B1,Vitamin B1 deficiency , Approved
7523,D06PSS,Nateglinide,Diabetic complication , Approved
7524,D06PSU,BAY1143572,Solid tumour/cancer , Phase 1
7525,D06PTA,Levosalbutamol/ipratropium,Chronic obstructive pulmonary disease , Phase 4
7526,D06PTG,ARX788,Breast cancer , Phase 1
7527,D06PTG,ARX788,HER2-positive breast cancer , Phase 1
7528,D06PTT,MS-424,Ischemia , Discontinued in Phase 2
7529,D06PTW,Thiazole carboxamide derivative 12,Solid tumour/cancer , Patented
7530,D06PTW,Thiazole carboxamide derivative 12,Metastatic cancer , Patented
7531,D06PVA,Volociximab,Non-small-cell lung cancer , Phase 2
7532,D06PVN,R-65,Glaucoma/ocular hypertension , Investigative
7533,D06PXT,CF602,Inflammation , Preclinical
7534,D06PYP,JTS-653,Pain , Discontinued in Phase 2
7535,D06PYP,JTS-653,Overactive bladder , Discontinued in Phase 2
7536,D06PZC,SAM-6,Melanoma , Phase 1
7537,D06PZO,ASC-101,Haematological malignancy , Phase 1/2
7538,D06QAJ,PS948115,Respiratory failure , Discontinued in Phase 1
7539,D06QAK,BMN-111,Achondroplasia , Phase 3
7540,D06QBV,BI 894999,Solid tumour/cancer , Phase 1
7541,D06QBX,VDA-1102,Actinic keratosis , Phase 2
7542,D06QBY,INT131,Type-2 diabetes , Phase 2
7543,D06QCC,Cefmenoxime,Bacterial infection , Approved
7544,D06QCE,MTKi-328,Solid tumour/cancer , Investigative
7545,D06QDR,Choline alfoscerate,Amnesia , Approved
7546,D06QEL,FARANOXI,Solid tumour/cancer , Phase 2
7547,D06QEW,CLT-003,Diabetic macular edema , Investigative
7548,D06QGH,Dukoral,Escherichia coli infection , Approved
7549,D06QHT,Risotilide,Heart arrhythmia , Discontinued in Phase 2
7550,D06QIP,AP-022,Glaucoma/ocular hypertension , Investigative
7551,D06QIW,EPO peptide mimetics,Anemia , Investigative
7552,D06QJE,F-992,Urinary incontinence , Terminated
7553,D06QJG,PG-1014491,Bone disease , Investigative
7554,D06QKV,Brodimoprim,Bacterial infection , Approved
7555,D06QMA,MK-5286,Inflammation , Investigative
7556,D06QMV,DWP-450,Glabellar frown line , Application submitted
7557,D06QOA,PSI-938,Hepatitis C virus infection , Phase 1
7558,D06QOC,GX-301,Prostate cancer , Phase 1/2
7559,D06QOD,CT-120,Influenza virus infection , Investigative
7560,D06QOF,R7128,Hepatitis C virus infection , Discontinued in Phase 2
7561,D06QOJ,RS-8359,Major depressive disorder , Discontinued in Phase 2
7562,D06QOK,DW-2282,Solid tumour/cancer , Terminated
7563,D06QOM,TP-101,Bacterial infection , Investigative
7564,D06QPI,NY-ESO-1 tumour vaccine,Lung cancer , Discontinued in Phase 1
7565,D06QQH,T-1210,Allergic conjunctivitis , Phase 2
7566,D06QRW,Lazabemide,Skin imperfections , Patented
7567,D06QRW,Lazabemide,Cognitive impairment , Discontinued in Phase 3
7568,D06QRY,IDN-5390,Solid tumour/cancer , Investigative
7569,D06QSN,Itolizumab,Type-1 diabetes , Phase 3
7570,D06QUY,CO-18,Obesity , Investigative
7571,D06QWM,OI338GT,Type-1/2 diabetes , Phase 2
7572,D06QWM,OI338GT,Type-1 diabetes , Phase 2
7573,D06QWM,OI338GT,Type-2 diabetes , Phase 2
7574,D06QXI,NRX-4204,Diabetic complication , Phase 2
7575,D06QYJ,Anticancer glycosaminoglycans,Solid tumour/cancer , Terminated
7576,D06QYR,PF-4800567,Chronic lymphocytic leukaemia , Preclinical
7577,D06QZL,Lerisetron,Vomiting , Phase 3
7578,D06QZL,Lerisetron,Testicular germ cell tumour , Phase 3
7579,D06QZL,Lerisetron,Nausea , Phase 3
7580,D06RBJ,DIPROTEVERINE HYDROCHLORIDE,Angina pectoris , Phase 3
7581,D06RCB,Diethylcarbamazine,Lymphatic filariasis , Approved
7582,D06RCE,HER2-specific T cells,Recurrent glioblastoma , Phase 1
7583,D06RCS,Besonprodil,Parkinson disease , Discontinued in Phase 1
7584,D06REJ,MX-7065,Solid tumour/cancer , Terminated
7585,D06REO,Befunolol hci,Glaucoma/ocular hypertension , Approved
7586,D06RFG,Estradiol valerate/dienogest,Discovery agent , Approved
7587,D06RGG,Levothyroxine,Hypothyroidism , Approved
7588,D06RGW,PMID25684022-Compound-WO2004087707,Solid tumour/cancer , Patented
7589,D06RGW,PMID25684022-Compound-WO2004087707,Metastatic cancer , Patented
7590,D06RHC,DS-1040,Ischemic stroke , Phase 1
7591,D06RIM,LIM-0705,Insulin-resistant disorder , Phase 2
7592,D06RNK,Hi8 HBV vaccine,Hepatitis virus infection , Phase 2
7593,D06RQD,Anti-GD2 mab,Solid tumour/cancer , Investigative
7594,D06RQU,HC-Toxin,Solid tumour/cancer , Preclinical
7595,D06RRD,Fibrates,Dyslipidemia , Investigative
7596,D06RSE,V935,Solid tumour/cancer , Phase 1
7597,D06RUD,FT-011,Fibrosis , Investigative
7598,D06RUK,Combotox,leukaemia , Phase 1
7599,D06RUL,Bitolterol,Chronic obstructive pulmonary disease , Approved
7600,D06RUL,Bitolterol,Asthma , Withdrawn from market
7601,D06RVQ,Xenon,Brain injury , Phase 3
7602,D06RVY,SIR-1076,Retinopathy , Preclinical
7603,D06RWM,Carmeseal,Duchenne dystrophy , Phase 1
7604,D06RWM,Carmeseal,Fibrosis , Investigative
7605,D06RYG,PRAME-SLP,Melanoma , Investigative
7606,D06RYU,RLP-035,Escherichia coli infection , Investigative
7607,D06RYY,ZD-9379,Cerebrovascular ischaemia , Phase 1
7608,D06RZQ,HG-1091,Immune System disease , Investigative
7609,D06SAT,HZ-166,Neuropathic pain , Investigative
7610,D06SBB,Basiliximab,Organ transplant rejection , Approved
7611,D06SBD,DS-2248,Solid tumour/cancer , Phase 1
7612,D06SBK,Atocalcitol,Psoriasis vulgaris , Discontinued in Phase 2
7613,D06SBL,MM-121,Breast cancer , Phase 2
7614,D06SBL,MM-121,Non-small-cell lung cancer , Phase 2
7615,D06SBS,SSR-504734,Schizophrenia , Preclinical
7616,D06SCK,MB-311,Solid tumour/cancer , Phase 1
7617,D06SCP,VISION 5,Glaucoma/ocular hypertension , Phase 2
7618,D06SCQ,QBM076,Chronic obstructive pulmonary disease , Phase 2
7619,D06SCY,BM-32,Allergic rhinitis , Phase 2
7620,D06SDP,Melanotetan II,Type-2 diabetes , Preclinical
7621,D06SDP,Melanotetan II,Obesity , Preclinical
7622,D06SDP,Melanotetan II,Sexual dysfunction , Preclinical
7623,D06SDQ,UCB0599,Parkinson disease , Phase 1
7624,D06SEA,CX-7000,Solid tumour/cancer , Investigative
7625,D06SEL,NNRTIs,Human immunodeficiency virus infection , Investigative
7626,D06SEY,Etilevodopa,Parkinson disease , Discontinued in Phase 3
7627,D06SFX,Soybean Oil,Bupicavaine toxicity , Approved
7628,D06SHZ,SHP616,Neuromyelitis optica , Phase 1
7629,D06SIG,AR177,Human immunodeficiency virus infection , Terminated
7630,D06SJO,GSK-2282512A,Influenza virus infection , Phase 3
7631,D06SJZ,XB-947,Solid tumour/cancer , Phase 1
7632,D06SMP,SMT-15000,Infectious disease , Investigative
7633,D06SMU,SMT-D003,Glaucoma/ocular hypertension , Investigative
7634,D06SNS,Mirostipen,Breast cancer , Discontinued in Phase 2
7635,D06SNV,MORAb-28,Solid tumour/cancer , Phase 1
7636,D06SRB,Brain-derived neurotrophic factor peptidomimetics,Rett syndrome , Investigative
7637,D06SRX,MDA-19,Neuropathic pain , Investigative
7638,D06SSR,AVP-26452,Hyperlipidaemia , Discontinued in Phase 1
7639,D06STK,Purine derivative 2,Obesity , Patented
7640,D06STX,Thiadiazolyl carboxamide derivative 1,Alzheimer disease , Patented
7641,D06SUS,AZD-3043,Anaesthesia , Phase 1
7642,D06SVC,M-0011,Alpha-mannosidosis , Phase 3
7643,D06SVW,Insulin recombinant,Diabetic complication , Approved
7644,D06SWS,NN-1952,Insulin-dependent diabetes , Phase 1
7645,D06SWT,Aryl mannoside derivative 5,Crohn disease , Patented
7646,D06SWT,Aryl mannoside derivative 5,Ulcerative colitis , Patented
7647,D06SWT,Aryl mannoside derivative 5,Urinary tract infection , Patented
7648,D06SYA,MT-061,Gram-positive bacterial infection , Investigative
7649,D06SYN,Ioflubenzamide (131I),Melanoma , Phase 1
7650,D06SZU,WVE-210201,Duchenne dystrophy , Phase 2/3
7651,D06TAL,Tazofelone,Inflammatory bowel disease , Discontinued in Phase 2
7652,D06TAR,DM-512,Psoriasis vulgaris , Investigative
7653,D06TEO,UCL-1390,Pain , Terminated
7654,D06TEO,UCL-1390,Epilepsy , Terminated
7655,D06TEO,UCL-1390,Eating disorder , Terminated
7656,D06TFE,Technetium Tc-99m Depreotide,Radioactive tracer , Approved
7657,D06TFI,LY2157299,Arteriosclerosis , Phase 2/3
7658,D06TFI,LY2157299,Non-small-cell lung cancer , Phase 2/3
7659,D06TFI,LY2157299,Hepatocellular carcinoma , Phase 2
7660,D06TFI,LY2157299,Glioma , Phase 1/2
7661,D06TFI,LY2157299,Solid tumour/cancer , Phase 1/2
7662,D06TFI,LY2157299,Pancreatic cancer , Phase 1
7663,D06TGE,Taranabant,Obesity , Discontinued in Phase 3
7664,D06TGS,Cx-603,Ischemic stroke , Preclinical
7665,D06THG,DS-1205,Non-small-cell lung cancer , Phase 1
7666,D06THT,INGN-402,Solid tumour/cancer , Terminated
7667,D06TJJ,FLUORESCEIN,Ocular disease , Approved
7668,D06TJQ,CRLX301,Solid tumour/cancer , Phase 1/2
7669,D06TKE,ZD-7288,Angina pectoris , Phase 2
7670,D06TKI,CHR-3996,Lymphoma , Phase 1/2
7671,D06TKI,CHR-3996,Solid tumour/cancer , Phase 1
7672,D06TKR,CART 19,Acute lymphoblastic leukaemia , Phase 2
7673,D06TKR,CART 19,Pancreatic cancer , Preclinical
7674,D06TLK,EPB-600,Hepatitis C virus infection , Investigative
7675,D06TME,MEDI-546,Ovarian cancer , Phase 2
7676,D06TMH,HG-1164,Solid tumour/cancer , Investigative
7677,D06TNG,Polythiazide,Edema , Approved
7678,D06TNG,Polythiazide,Hypertension , Approved
7679,D06TNL,Ethacrynic acid,High blood pressure , Approved
7680,D06TNO,CD19 CAR T-cells,Non-hodgkin lymphoma , Phase 1
7681,D06TOE,Micafungin,Candidiasis , Approved
7682,D06TQD,CMPD-167,Human immunodeficiency virus-1 infection , Investigative
7683,D06TQR,PF-06372865,Chronic pain , Phase 2
7684,D06TQZ,Meticillin,Bacterial infection , Approved
7685,D06TQZ,Meticillin,Neurological disorder , Investigative
7686,D06TTS,LZ-8,Autoimmune diabetes , Terminated
7687,D06TTT,Recombinant Tat protein vaccine,Human immunodeficiency virus infection , Phase 1
7688,D06TVC,Tienoxolol,Hypertension , Discontinued in Phase 2
7689,D06TVG,Inaperisone,Pollakiuria , Discontinued in Preregistration
7690,D06TVU,Q-101,Human immunodeficiency virus infection , Investigative
7691,D06TWA,TB-403,Glioblastoma of brain , Phase 2
7692,D06TWE,CLX-0921,Type-2 diabetes , Phase 1
7693,D06TWS,CAR-T cells targeting CD2,Cervical cancer , Phase 1/2
7694,D06TZT,RIPISARTAN,Hypertension , Discontinued in Phase 2
7695,D06TZZ,CAT 1004,Duchenne dystrophy , Phase 2
7696,D06TZZ,CAT 1004,Type-2 diabetes , Phase 1
7697,D06UAD,HR2P peptide,Middle East Respiratory Syndrome (MERS) , Preclinical
7698,D06UBF,V180,Dengue fever , Phase 1
7699,D06UCV,Z-335,Thrombosis , Discontinued in Phase 2
7700,D06UDG,Valsartan,Hypertension , Approved
7701,D06UDO,Phenindamine,Common cold , Approved
7702,D06UDV,AZD2516,Chronic neuropathic pain , Discontinued in Phase 2
7703,D06UEC,ADXS-HER2,Solid tumour/cancer , Phase 2
7704,D06UEC,ADXS-HER2,Breast cancer , Phase 1/2
7705,D06UEP,GKT-136901,Cardiovascular disease , Investigative
7706,D06UFH,CZ-112,Solid tumour/cancer , Terminated
7707,D06UIS,LY-2828360,Pain , Phase 2
7708,D06UJD,H-102,Hepatocellular carcinoma , Investigative
7709,D06UJO,Rhenex,Solid tumour/cancer , Discontinued in Phase 1
7710,D06UKG,LY-377604,Obesity , Phase 2
7711,D06ULU,Sucralfate,Acne vulgaris , Approved
7712,D06UND,FP-85A,Mycobacterium infection , Phase 1
7713,D06UNI,RBx-10017609,Respiratory disease , Phase 2
7714,D06UNR,Unithiol,Metal intoxication , Approved
7715,D06UNW,IVN-mite,Allergy , Investigative
7716,D06UNY,SB204,Acne vulgaris , Phase 3
7717,D06UOL,PIROTIODECANE,Ophthalmic graves disease , Investigative
7718,D06UOU,MGA271,Metastatic cancer , Phase 1
7719,D06UPS,Rozrolimupab,Anemia , Discontinued in Phase 2
7720,D06UPW,WSS-45,Dengue fever , Investigative
7721,D06URI,ATL101,Influenza virus infection , Phase 2
7722,D06URK,CKD-533,Erectile dysfunction , Investigative
7723,D06URS,Arcitumomab,Breast cancer , Approved
7724,D06URX,CAR-T Cells targeting MUCI,Pancreatic cancer , Phase 1
7725,D06USG,CS-560,Allergic rhinitis , Discontinued in Phase 3
7726,D06UTH,RDEA-684,Gout , Phase 2
7727,D06UTM,Anti-CD19-CAR T cells,B-cell lymphoma , Phase 1
7728,D06UTM,Anti-CD19-CAR T cells,Non-hodgkin lymphoma , Phase 1
7729,D06UUE,AZ-AAV9,Alzheimer disease , Investigative
7730,D06UUU,BLX-1017,Inflammation , Investigative
7731,D06UVD,Bleomycin,Hodgkin lymphoma , Approved
7732,D06UVO,DuP-654,Pruritus , Discontinued in Phase 2
7733,D06UVZ,DPD-207,Bacterial infection , Investigative
7734,D06UWD,Clobutinol,Cough , Withdrawn from market
7735,D06UWF,SOR-C13,Ovarian cancer , Phase 1
7736,D06UWF,SOR-C13,Solid tumour/cancer , Phase 1
7737,D06UWF,SOR-C13,Alzheimer disease , Phase 1
7738,D06UXL,GI-248573,Bladder disease , Terminated
7739,D06UYI,AM103,Cardiovascular disease , Discontinued in Phase 2
7740,D06UZS,VDA-1124,Aortic aneurysm , Investigative
7741,D06VAQ,EUK-189,Skin burns , Phase 1
7742,D06VCC,REGN-421,Solid tumour/cancer , Phase 1
7743,D06VCJ,Fusion toxin protein,Solid tumour/cancer , Investigative
7744,D06VCN,Denagliptin,Type-2 diabetes , Phase 2/3
7745,D06VFF,EGFR antisense DNA,Head and neck cancer , Phase 1/2
7746,D06VFI,PRTT-200,Fibromyalgia , Investigative
7747,D06VFO,Anisodamine,Central and peripheral nervous disease , Approved
7748,D06VFP,SOTB07,Asthma , Phase 3
7749,D06VHG,NSI-189,Major depressive disorder , Phase 2
7750,D06VIZ,NVX-144,Solid tumour/cancer , Investigative
7751,D06VJK,Verpasep caltespen,Cervical Intraepithelial neoplasia , Discontinued in Phase 3
7752,D06VLI,HPPH photodynamic therapy,Solid tumour/cancer , Phase 2
7753,D06VMJ,Melogliptin,Type-2 diabetes , Phase 2
7754,D06VMV,BHF-177,Anxiety disorder , Investigative
7755,D06VNK,Succinic acid,Malnutrition , Approved
7756,D06VOM,NEBO-174,Major depressive disorder , Discontinued in Phase 1
7757,D06VPE,Lu-AA38466,Neurological disorder , Discontinued in Phase 1
7758,D06VPT,TDI-0028,Motor neurone disease , Investigative
7759,D06VRI,Leflunomide,Multiple sclerosis , Approved
7760,D06VRI,Leflunomide,Coronavirus Disease 2019 (COVID-19) , Phase 1
7761,D06VRS,CRB-15,Autoimmune diabetes , Investigative
7762,D06VSD,Captopril,Hypertension , Approved
7763,D06VSD,Captopril,Coronavirus Disease 2019 (COVID-19) , Phase 3
7764,D06VTI,Macrocycle derivative 1,Solid tumour/cancer , Patented
7765,D06VTI,Macrocycle derivative 1,Infectious disease , Patented
7766,D06VTI,Macrocycle derivative 1,Human immunodeficiency virus infection , Patented
7767,D06VTI,Macrocycle derivative 1,Hepatitis , Patented
7768,D06VTL,ZO-Y49,Gynecological disease , Investigative
7769,D06VVH,GSK-2115160A,Influenza virus infection , Phase 1
7770,D06VWA,FR-901469,Fungal infection , Terminated
7771,D06VWL,VA-106483,Nocturia , Phase 2
7772,D06VXE,ALS-2160,Hepatitis C virus infection , Investigative
7773,D06VXY,SB-237376,Arrhythmia , Terminated
7774,D06VYE,Belotecan hydrocholoride,Small-cell lung cancer , Approved
7775,D06VYF,PMID25666693-Compound-3,Osteoarthritis pain , Patented
7776,D06VYF,PMID25666693-Compound-3,Cancer related pain , Patented
7777,D06VYF,PMID25666693-Compound-3,Neuropathic pain , Patented
7778,D06VYF,PMID25666693-Compound-3,Inflammatory pain , Patented
7779,D06VYK,Azithromycin,Bronchitis , Approved
7780,D06VYK,Azithromycin,Coronavirus Disease 2019 (COVID-19) , Phase 3
7781,D06VZN,SPK-843,Fungal infection , Phase 3
7782,D06WAA,CKBP-004,Solid tumour/cancer , Investigative
7783,D06WAM,Oradoxel,Solid tumour/cancer , Phase 1
7784,D06WAN,Benzimidazole and imidazopyridine derivative 1,Solid tumour/cancer , Patented
7785,D06WAN,Benzimidazole and imidazopyridine derivative 1,Metastatic cancer , Patented
7786,D06WBA,SQ-28603,Hypertension , Terminated
7787,D06WBE,ERTIPROTAFIB,Type-2 diabetes , Terminated
7788,D06WCR,JAIVAC-1,Malaria , Phase 1
7789,D06WCW,UCB-1350883,Solid tumour/cancer , Investigative
7790,D06WDT,PF-04094667,Metabolic disorder , Investigative
7791,D06WEB,LAF-389,Solid tumour/cancer , Discontinued in Phase 1
7792,D06WEK,Ammonium chloride,Urinary tract infection , Approved
7793,D06WGK,Q-LAIV,Seasonal influenza infection , Approved
7794,D06WGO,Resorcinol compound 8,Albinism , Patented
7795,D06WGO,Resorcinol compound 8,Ephelides , Patented
7796,D06WGO,Resorcinol compound 8,Menkes disease , Patented
7797,D06WGO,Resorcinol compound 8,Senile lentigines , Patented
7798,D06WGO,Resorcinol compound 8,Melasma , Patented
7799,D06WGQ,Anthrax DNA vaccine,Anthrax , Discontinued in Phase 1
7800,D06WHL,NS-257,Cerebrovascular ischaemia , Terminated
7801,D06WHN,KDT-500,Inflammation , Investigative
7802,D06WHY,AZD-5438,Solid tumour/cancer , Phase 1
7803,D06WJC,GC-24,Hyperthyroidism , Investigative
7804,D06WJI,OPC-28326,Peripheral vascular disease , Discontinued in Phase 2
7805,D06WKA,MD-1100,Constipation , Approved
7806,D06WKA,MD-1100,Irritable bowel syndrome , Phase 2
7807,D06WLG,P53 fusion protein,Liver cancer , Investigative
7808,D06WLY,PN-951,Hematologic disease , Investigative
7809,D06WNQ,TKM-PLK1,Solid tumour/cancer , Phase 1/2
7810,D06WOF,Rova-T,Small-cell lung cancer , Phase 3
7811,D06WOF,Rova-T,Neuroendocrine cancer , Phase 1
7812,D06WOJ,JTH-601,Prostate disease , Discontinued in Phase 2
7813,D06WPM,Coprexa,Neurological disorder , Phase 3
7814,D06WQT,Nolatrexed,Solid tumour/cancer , Phase 3
7815,D06WRF,KD019,Non-small-cell lung cancer , Phase 2
7816,D06WRF,KD019,Polycystic kidney disease , Phase 2
7817,D06WRF,KD019,Brain metastases , Phase 2
7818,D06WRF,KD019,Meningioma metastases , Phase 2
7819,D06WRF,KD019,Recurrent glioblastoma , Phase 2
7820,D06WRJ,Icotinib hydrochloride,Non-small-cell lung cancer , Registered
7821,D06WRY,NFTC-103,Cardiovascular disease , Investigative
7822,D06WSG,AP-005,Ulcerative colitis , Investigative
7823,D06WSQ,AWD-140-190,Epileptic seizures , Discontinued in Phase 1
7824,D06WTI,NRP290,Pain , Investigative
7825,D06WTQ,TD-0714,Heart failure , Phase 1
7826,D06WTZ,Lovastatin,Hypercholesterolaemia , Approved
7827,D06WTZ,Lovastatin,Cardiovascular disease , Phase 3
7828,D06WUK,Carlumab,Pulmonary fibrosis , Phase 2
7829,D06WXJ,Thiazole carboxamide derivative 14,Solid tumour/cancer , Patented
7830,D06WXJ,Thiazole carboxamide derivative 14,Metastatic cancer , Patented
7831,D06WXS,APX-002,Diabetic complication , Investigative
7832,D06WYG,99mTc-MIP-1407,Neuroendocrine cancer , Investigative
7833,D06WZQ,LPO-1010UV,Uveitis , Investigative
7834,D06XAA,RG7667,Cytomegalovirus infection , Phase 2
7835,D06XAE,Drotaverine,Irritable bowel syndrome , Approved
7836,D06XAK,H-216/44,Glaucoma/ocular hypertension , Terminated
7837,D06XAT,BCT-100,Solid tumour/cancer , Phase 1/2
7838,D06XBG,MIP-1267,Solid tumour/cancer , Investigative
7839,D06XBN,ACT-GRO-777,Solid tumour/cancer , Phase 2
7840,D06XCD,PMID27998201-Compound-12,Cancer related pain , Patented
7841,D06XCD,PMID27998201-Compound-12,Bone cancer , Patented
7842,D06XCF,EQ-917,Solid tumour/cancer , Phase 2
7843,D06XCP,AZD5991,Haematological malignancy , Phase 1
7844,D06XDI,QAW-039,Asthma , Phase 3
7845,D06XDJ,Clemizole,Hepatitis C virus infection , Phase 1
7846,D06XDS,GSK-1070806,Type-2 diabetes , Phase 2
7847,D06XEL,DG051,Myocardial infarction , Discontinued in Phase 2
7848,D06XES,Melphalan,Ovarian cancer , Approved
7849,D06XES,Melphalan,Coronavirus Disease 2019 (COVID-19) , Phase 2
7850,D06XFV,Neo-Kidney Augment,Chronic kidney disease , Phase 2
7851,D06XFV,Neo-Kidney Augment,Type-2 diabetes , Phase 1
7852,D06XGB,Tissue Repair Cells (TRCs),Spinal cord injury , Phase 2
7853,D06XGC,BMS-986202,Idiopathic pulmonary fibrosis , Preclinical
7854,D06XGW,Acetylcysteine,Liver disease , Approved
7855,D06XHC,Amcinonide,Inflammation , Approved
7856,D06XIT,ABT-414,Glioblastoma multiforme , Phase 2
7857,D06XIT,ABT-414,Recurrent glioblastoma , Phase 2
7858,D06XIT,ABT-414,Brain cancer , Phase 1
7859,D06XIX,RHuA1AT,Alpha-1 antitrypsin deficiency , Investigative
7860,D06XIZ,HM-2002,Breast cancer , Investigative
7861,D06XJP,APT-222,Thrombosis , Terminated
7862,D06XJQ,SIRS-T,Acne vulgaris , Phase 2
7863,D06XKM,Privigen,Spinal cord injury , Phase 1
7864,D06XLC,BMS-739562,Solid tumour/cancer , Investigative
7865,D06XME,TT-105,Deep vein thrombosis , Investigative
7866,D06XMF,KT&G-101,Atrophy , Phase 3
7867,D06XMU,Testosterone,Osteoporosis , Approved
7868,D06XMU,Testosterone,Hormone deficiency , Phase 2
7869,D06XMU,Testosterone,Male hormonal deficiency , Investigative
7870,D06XMW,DPK-060,Atopic dermatitis , Phase 2
7871,D06XNW,NKP-3752,Solid tumour/cancer , Investigative
7872,D06XOI,BMY-41802,Bacterial infection , Investigative
7873,D06XOT,F18-flutemetamol,Alzheimer disease , Approved
7874,D06XPL,TOCA-511,Glioblastoma multiforme , Phase 2/3
7875,D06XPX,CERE-135,Motor neurone disease , Investigative
7876,D06XRA,LU AA24493,Stroke , Discontinued in Phase 2
7877,D06XRQ,AA-861,Allergy , Terminated
7878,D06XSB,GW-870086-X,Atopic dermatitis , Phase 2
7879,D06XSG,AZD8075,Chronic obstructive pulmonary disease , Discontinued in Phase 1
7880,D06XTA,PMID27998201-Compound-17,Hair loss , Patented
7881,D06XVF,CBT-1,Non-small-cell lung cancer , Phase 3
7882,D06XVF,CBT-1,Solid tumour/cancer , Application submitted
7883,D06XVN,Farletuzumab,Ovarian cancer , Phase 3
7884,D06XVN,Farletuzumab,Non-small-cell lung cancer , Phase 3
7885,D06XVR,BAN2401,Alzheimer disease , Phase 2
7886,D06XVX,RP-5000,Schizophrenia , Phase 2
7887,D06XWB,Huperzine A,Alzheimer disease , Approved
7888,D06XWD,CAR-T Cells targeting HER2,Pancreatic cancer , Phase 1
7889,D06XWQ,Benzothiazine-carboxamide compound 2,Skin inflammation , Patented
7890,D06XXA,AMA-1-Dico,Malaria , Investigative
7891,D06XXD,IG-AI-025,Rheumatoid arthritis , Investigative
7892,D06XXH,Dacomitinib,Non-small-cell lung cancer , Approved
7893,D06XYL,DP-6001,Human immunodeficiency virus infection , Phase 1
7894,D06XZM,GBL-100,Dermatological disease , Discontinued in Phase 1
7895,D06XZR,Pizotyline,Headache , Approved
7896,D06XZW,Troglitazone,Diabetic complication , Approved
7897,D06YAG,ABX-102,Solid tumour/cancer , Investigative
7898,D06YAI,SOM-0004,Bacterial infection , Investigative
7899,D06YAK,MG-3,Malaria , Investigative
7900,D06YCR,Marburg virus DNA vaccine,Marburg virus infection , Phase 1
7901,D06YEE,Prodigiosin,Pancreatic cancer , Investigative
7902,D06YEG,Indirab,Rabies , Approved
7903,D06YEK,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 4",Skin disease , Patented
7904,D06YEK,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 4",Muscular wasting , Patented
7905,D06YFA,Bromocriptine,Parkinson disease , Approved
7906,D06YFO,AD-121,Rheumatoid arthritis , Discontinued in Phase 1/2
7907,D06YFT,1-methyl-L-tryptophan,Solid tumour/cancer , Preclinical
7908,D06YGP,BN-OD-026,Solid tumour/cancer , Preclinical
7909,D06YHL,Cefamandole,Microorganisms infection , Approved
7910,D06YKN,Resorcinol compound 22,Albinism , Patented
7911,D06YKN,Resorcinol compound 22,Ephelides , Patented
7912,D06YKN,Resorcinol compound 22,Menkes disease , Patented
7913,D06YKN,Resorcinol compound 22,Senile lentigines , Patented
7914,D06YKN,Resorcinol compound 22,Melasma , Patented
7915,D06YMT,PLX-ORI3,Solid tumour/cancer , Investigative
7916,D06YNK,TRM-88,Wound healing , Investigative
7917,D06YOD,ZD-7717,Asthma , Terminated
7918,D06YPQ,SPI-452,Human immunodeficiency virus infection , Phase 1
7919,D06YPU,Dexibuprofen,Ankylosing spondylitis , Approved
7920,D06YRR,GSK2254233A,Pneumococcal infection , Phase 2
7921,D06YRR,GSK2254233A,Haemophilus influenza , Phase 2
7922,D06YSK,HuMax-Her2,Solid tumour/cancer , Investigative
7923,D06YSP,AT13387,Melanoma , Phase 1
7924,D06YTE,NOX-D14,Inflammation , Investigative
7925,D06YUM,AZD6423,Suicidal ideation , Phase 1
7926,D06YUR,Oxindole derivative,Malaria , Investigative
7927,D06YWA,BVA-101,Multiple sclerosis , Investigative
7928,D06YWH,YM155,Non-hodgkin lymphoma , Phase 2
7929,D06YWH,YM155,Breast cancer , Phase 2
7930,D06YXD,Taprostene,Thrombosis , Discontinued in Phase 3
7931,D06YYD,Dexlansoprazole,Non-erosive gastro-esophageal reflux disease , Approved
7932,D06YYD,Dexlansoprazole,Erosive esophagitis , Approved
7933,D06YYD,Dexlansoprazole,Peptic ulcer , Approved
7934,D06YYD,Dexlansoprazole,NSAID-associated gastric ulcer , Phase 3
7935,D06YYY,KAR-1880,Dermatitis , Investigative
7936,D06ZAK,CA-50040,Colorectal cancer , Investigative
7937,D06ZAM,MF268,Alzheimer disease , Terminated
7938,D06ZAS,Technetium Tc-99m Ferpentetate Kit,Radioactive tracer , Approved
7939,D06ZAY,Haloprogin,Dermatophytosis , Approved
7940,D06ZAY,Haloprogin,Candidiasis , Approved
7941,D06ZCH,SA-ANP,Hypertension , Investigative
7942,D06ZCP,Ischemic tolerant allogeneic mesenchymal stem cell therapy,Acute myocardial infarction , Phase 2
7943,D06ZEC,Glucagon,Hypoglycemia , Phase 1
7944,D06ZEE,Atovaquone,Fungal infection , Approved
7945,D06ZEO,Vericiguat,Heart failure , Approved
7946,D06ZFV,QPI-1007,Ischemic optic neuropathy , Phase 3
7947,D06ZFV,QPI-1007,Non-arteritic anterior ischemic optic neuropathy , Phase 3
7948,D06ZFV,QPI-1007,Glaucoma/ocular hypertension , Phase 2/3
7949,D06ZHN,Lactermin,Oral mucositis , Phase 1
7950,D06ZHZ,FX-125L,Sarcoidosis , Phase 2
7951,D06ZII,Eszopiclone,Insomnia , Approved
7952,D06ZIL,CTA-001,Solid tumour/cancer , Investigative
7953,D06ZIS,SIG-990,Rosacea , Investigative
7954,D06ZIT,Pegloticase,Gout , Approved
7955,D06ZJD,Melapuldencel-T,Melanoma , Phase 3
7956,D06ZKG,SC-56525,Hypertension , Terminated
7957,D06ZME,RTL-551,Brain injury , Investigative
7958,D06ZNU,"Pyrrolo[2,3-d]pyrimidine derivative 16",Solid tumour/cancer , Patented
7959,D06ZNU,"Pyrrolo[2,3-d]pyrimidine derivative 16",Autoimmune disease , Patented
7960,D06ZPS,Oxyphenbutazone,Arthritis , Approved
7961,D06ZPX,BTL-TML-001,Influenza virus infection , Phase 2
7962,D06ZPX,BTL-TML-001,Herpes simplex labialis , Phase 2
7963,D06ZQK,Nucleozin analog 3061 (FA-2),Influenza virus infection , Investigative
7964,D06ZQL,NP-2 gene therapy,Cancer related pain , Phase 2
7965,D06ZUK,Imipramine,Depression , Approved
7966,D06ZUP,Dirithromycin,Bacterial infection , Approved
7967,D06ZVC,WAY-181187,Anxiety disorder , Discontinued in Phase 1
7968,D06ZVG,AST-120,Poison intoxication , Approved
7969,D06ZVG,AST-120,Irritable bowel syndrome , Approved
7970,D06ZVG,AST-120,Thrombocytopenia , Investigative
7971,D06ZVO,PX-478,Solid tumour/cancer , Phase 1
7972,D06ZVZ,Duvelisib,Follicular lymphoma , Approved
7973,D06ZVZ,Duvelisib,Coronavirus Disease 2019 (COVID-19) , Phase 2
7974,D06ZWG,AVE-5997EF,Psychotic disorder , Discontinued in Phase 1
7975,D06ZWG,AVE-5997EF,Schizophrenia , Terminated
7976,D06ZWL,Amdoxovir,Hepatitis B virus infection , Phase 2
7977,D06ZXF,U3-1565,Solid tumour/cancer , Phase 1
7978,D06ZXH,PHN-131,Pain , Phase 2/3
7979,D06ZXT,N-6547,Inflammatory bowel disease , Investigative
7980,D06ZYC,MLN0415,Arthritis , Discontinued in Phase 1
7981,D06ZYM,Cholestyramine,Diarrhea , Approved
7982,D06ZZL,MEDI-500,Bone marrow transplantation , Terminated
7983,D07AAN,Sodium Iodide I-123,Thyroid disease , Approved
7984,D07ABV,Posaconazole,Aspergillosis , Approved
7985,D07ACL,PNT-2258,Solid tumour/cancer , Phase 2
7986,D07ACL,PNT-2258,Diffuse large B-cell lymphoma , Phase 2
7987,D07ACP,CWF-0902,Migraine , Investigative
7988,D07ACT,Ceftriaxone,Bacterial infection , Approved
7989,D07ACZ,CLR457,Advanced solid tumour , Phase 1/2
7990,D07ADU,AEM-28,Familial hypercholesterolemia , Phase 2
7991,D07ADU,AEM-28,Hyperlipidaemia , Phase 1/2
7992,D07AEO,Isotretinoin,Coronavirus Disease 2019 (COVID-19) , Phase 3
7993,D07AGR,SB-206284A,Cerebrovascular ischaemia , Terminated
7994,D07AHC,LITOXETINE,Mood disorder , Phase 3
7995,D07AHW,Vitamin C,Vitamin C deficiency , Approved
7996,D07AHW,Vitamin C,Urinary tract infection , Phase 2
7997,D07AIE,BAL-2299,Psoriasis vulgaris , Discontinued in Phase 2
7998,D07AJC,HIV MAG pDNA vaccine,Human immunodeficiency virus infection , Phase 1
7999,D07AJO,Bicyclic heteroaryl benzamide derivative 9,Pruritus , Patented
8000,D07AJO,Bicyclic heteroaryl benzamide derivative 9,Solid tumour/cancer , Patented
8001,D07AJO,Bicyclic heteroaryl benzamide derivative 9,Chronic pain , Patented
8002,D07AJO,Bicyclic heteroaryl benzamide derivative 9,Neuropathic pain , Patented
8003,D07AJO,Bicyclic heteroaryl benzamide derivative 9,Thymic cancer , Patented
8004,D07AKD,TOL-101,Multiple sclerosis , Phase 1/2
8005,D07ALX,Sirolimus,Lymphangioleiomyomatosis , Approved
8006,D07ALX,Sirolimus,Coronavirus Disease 2019 (COVID-19) , Phase 2
8007,D07ANO,Synthetic neutrophil inhibitor peptide,Rhinitis , Phase 1
8008,D07AOL,PEITC,Prostate cancer , Phase 2
8009,D07AOO,Rilotumumab,Grade IV malignant glioma , Discontinued in Phase 2
8010,D07AOY,Avarofloxacin,Bacterial pneumonia , Discontinued in Phase 2
8011,D07APS,TRC093,Solid tumour/cancer , Phase 1
8012,D07APX,Neuromed 5,Pain , Investigative
8013,D07ARN,SAR-125844,Solid tumour/cancer , Phase 2
8014,D07ATG,GSK2190914,Asthma , Discontinued in Phase 2
8015,D07AUI,Influenza A virus vaccine H5N1,Influenza A virus H5N1 infection , Phase 2
8016,D07AUI,Influenza A virus vaccine H5N1,Influenza virus infection , Phase 1
8017,D07AUS,KRL-901,Alcohol dependence , Phase 1
8018,D07AVU,PMID28621580-Compound-WO2015089220C70,Retinopathy , Patented
8019,D07AVU,PMID28621580-Compound-WO2015089220C70,Age-related macular degeneration , Patented
8020,D07AVV,Ac-YVAD-cmk,Photocontact dermatitis , Patented
8021,D07AVV,Ac-YVAD-cmk,Irritant contact dermatitis , Patented
8022,D07AVV,Ac-YVAD-cmk,Allergic contact dermatitis , Patented
8023,D07AWM,Segard,Sepsis , Discontinued in Phase 3
8024,D07AYI,CWP232291,Acute myeloid leukaemia , Phase 1/2
8025,D07AYI,CWP232291,Multiple myeloma , Phase 1
8026,D07AYN,Chikungunya virus vaccine,Chikungunya virus infection , Phase 2
8027,D07BAE,SUN-0597,Allergic rhinitis , Investigative
8028,D07BAJ,Clade D HIV vaccine,Human immunodeficiency virus infection , Phase 1
8029,D07BBD,Zona pellucida contraceptive vaccine,Contraception , Terminated
8030,D07BCO,WAY-100635,Eating disorder , Terminated
8031,D07BCT,Tobramycin,Bacterial infection , Approved
8032,D07BCU,Eflornithine + sulindac,Familial adenomatous polyposis , Phase 3
8033,D07BCU,Eflornithine + sulindac,Colon cancer , Phase 3
8034,D07BDW,OC-108,Hemorrhoids , Approved
8035,D07BDY,Tisocalcitate,Psoriasis vulgaris , Discontinued in Phase 2
8036,D07BEE,AnergiX.RA,Rheumatoid arthritis , Discontinued in Phase 2
8037,D07BFP,PMID27215781-Compound-37,Prostate cancer , Patented
8038,D07BGC,GDC-0084,Glioblastoma of brain , Phase 2
8039,D07BIK,VEL-0230,Rheumatoid arthritis , Phase 1
8040,D07BKL,KW-2170,Breast cancer , Discontinued in Phase 2
8041,D07BKR,ARQ 621,Haematological malignancy , Phase 1
8042,D07BLC,AMT-090,Huntington disease , Investigative
8043,D07BNG,RHIgM12B7,Solid tumour/cancer , Phase 1
8044,D07BNL,NV.AT.08,Ocular disease , Investigative
8045,D07BPO,Ingavirin,Influenza virus infection , Approved
8046,D07BPS,Suprofen,Miosis , Approved
8047,D07BQE,Alteplase,Pulmonary embolism , Approved
8048,D07BRZ,LY-517717,Thrombosis , Phase 2
8049,D07BSE,Hyaluronate sodium,Joint lubricant , Approved
8050,D07BSE,Hyaluronate sodium,Enthesopathy , Phase 3
8051,D07BSE,Hyaluronate sodium,Pancytopenia , Investigative
8052,D07BSQ,Progesterone,Premature labour , Approved
8053,D07BSQ,Progesterone,Contraception , Phase 3
8054,D07BUH,F-627,Neutropenia , Phase 2
8055,D07BUO,AZD-3783,Anxiety disorder , Discontinued in Phase 1
8056,D07BVI,Ipilimumab,Melanoma , Approved
8057,D07BWU,PMX-10072,Mycobacterium infection , Investigative
8058,D07BXC,IZONSTERIDE,Hirsutism , Phase 1/2
8059,D07BXE,Daniquidone,Lymphoma , Phase 1
8060,D07BXQ,VR632,Asthma , Approved
8061,D07BYK,Penciclovir,Human immunodeficiency virus infection , Approved
8062,D07BZW,PMID25666693-Compound-85,Osteoarthritis pain , Patented
8063,D07BZW,PMID25666693-Compound-85,Cancer related pain , Patented
8064,D07BZW,PMID25666693-Compound-85,Neuropathic pain , Patented
8065,D07BZW,PMID25666693-Compound-85,Inflammatory pain , Patented
8066,D07CAQ,SAFINGOL,Psoriasis vulgaris , Phase 1
8067,D07CBH,SKL13865,Attention deficit hyperactivity disorder , Phase 1
8068,D07CBY,Cyclin A2,Myocardial infarction , Investigative
8069,D07CCV,MK-0431C,Diabetic complication , Phase 3
8070,D07CEI,Zinc Sulfate,Zinc deficiency , Approved
8071,D07CGH,1D09C3,Solid tumour/cancer , Terminated
8072,D07CGI,M-M-R II,Measles , Approved
8073,D07CIB,CI-1013,Virus infection , Discontinued in Phase 1
8074,D07CIN,(-)-Phenserine,Alzheimer disease , Phase 3
8075,D07CIX,FM-101,Multiple myeloma , Investigative
8076,D07CJN,ST-101,Anxiety disorder , Phase 2
8077,D07CJN,ST-101,Alzheimer disease , Phase 2
8078,D07CLV,GDC-0152,Obesity , Phase 1
8079,D07CLV,GDC-0152,Solid tumour/cancer , Discontinued in Phase 1
8080,D07CMM,Interferon alfa-n3,Human immunodeficiency virus infection , Approved
8081,D07CMN,PD-200390,Insomnia , Phase 2
8082,D07CNF,G-CSF,leukaemia , Investigative
8083,D07CNL,Anisotropine Methylbromide,Peptic ulcer , Approved
8084,D07CNY,Instiladrin,Bladder cancer , Phase 2
8085,D07CPL,Bicyclic heteroaryl benzamide derivative 6,Pruritus , Patented
8086,D07CPL,Bicyclic heteroaryl benzamide derivative 6,Solid tumour/cancer , Patented
8087,D07CPL,Bicyclic heteroaryl benzamide derivative 6,Chronic pain , Patented
8088,D07CPL,Bicyclic heteroaryl benzamide derivative 6,Neuropathic pain , Patented
8089,D07CPL,Bicyclic heteroaryl benzamide derivative 6,Thymic cancer , Patented
8090,D07CPM,GP2013,Chronic lymphocytic leukaemia , Phase 3
8091,D07CPM,GP2013,Diffuse large B-cell lymphoma , Phase 3
8092,D07CPM,GP2013,Follicular lymphoma , Phase 3
8093,D07CPM,GP2013,Rheumatoid arthritis , Phase 2
8094,D07CPU,Rosoxacin,Bacterial infection , Approved
8095,D07CQJ,F-50040,Melanoma , Discontinued in Phase 1
8096,D07CQW,Lomab B,Acute myeloid leukaemia , Phase 2
8097,D07CTM,Carbol-fuchsin,Bacterial infection , Approved
8098,D07CUR,Bb2121,Multiple myeloma , Phase 2
8099,D07CUU,SC-02,Allergy , Investigative
8100,D07CWD,Hydroxyurea,Chronic myelogenous leukaemia , Approved
8101,D07CWH,INCB40093,Lymphoma , Phase 1/2
8102,D07CXM,AVI-7288,Marburg virus infection , Phase 1
8103,D07DAU,Tafluposide,Solid tumour/cancer , Phase 1
8104,D07DBE,Amolimogene,Dysplasia , Phase 2/3
8105,D07DBS,RP-64477,Hyperlipidaemia , Discontinued in Phase 2
8106,D07DCG,Ivosidenib,Acute myeloid leukaemia , Approved
8107,D07DCG,Ivosidenib,Cholangiocarcinoma , Phase 3
8108,D07DCG,Ivosidenib,Haematological malignancy , Phase 1
8109,D07DCX,CDP-855,Autoimmune diabetes , Terminated
8110,D07DDK,HG-1177,Solid tumour/cancer , Investigative
8111,D07DFC,Aromatic hydrazine carboxyimidoamide derivative 1,Albinism , Patented
8112,D07DFC,Aromatic hydrazine carboxyimidoamide derivative 1,Ephelides , Patented
8113,D07DFC,Aromatic hydrazine carboxyimidoamide derivative 1,Menkes disease , Patented
8114,D07DFC,Aromatic hydrazine carboxyimidoamide derivative 1,Senile lentigines , Patented
8115,D07DFC,Aromatic hydrazine carboxyimidoamide derivative 1,Melasma , Patented
8116,D07DGA,Imatinib and nilotinib derivative 2,Cas mediated disorder , Patented
8117,D07DGM,BQ-518,Hypertension , Terminated
8118,D07DGR,SEL-113,Autoimmune diabetes , Investigative
8119,D07DIM,Herbimycin A,Solid tumour/cancer , Approved
8120,D07DIS,MG-1110,Solid tumour/cancer , Investigative
8121,D07DIX,ALO-1567,Glaucoma/ocular hypertension , Phase 1
8122,D07DJP,Avigen Parkinson,Parkinson disease , Phase 1/2
8123,D07DJQ,Emetine,Hepatitis virus infection , Approved
8124,D07DLA,ISF-402,Type-2 diabetes , Phase 1
8125,D07DMY,MK-3475,Melanoma , Approved
8126,D07DNV,ARN-2966,Alzheimer disease , Investigative
8127,D07DPC,IMGN-853,Solid tumour/cancer , Phase 1
8128,D07DPI,Aspirin/ esomeprazole fixed-dose combination,Cardiovascular disease , Approved
8129,D07DPM,HP-011-101,Ulcer , Phase 2
8130,D07DQZ,CN-16,Sepsis , Investigative
8131,D07DRO,SF-106,Retinopathy , Investigative
8132,D07DSK,BSI-302,Solid tumour/cancer , Investigative
8133,D07DSN,BIIB 033,Multiple sclerosis , Phase 2
8134,D07DSQ,Vapreotide acetate,Solid tumour/cancer , Approved
8135,D07DTC,L-97-1 intravenous,Sepsis , Investigative
8136,D07DTM,Cetraxal Otic,Otitis externa , Phase 3
8137,D07DTV,AT7519,Solid tumour/cancer , Phase 1
8138,D07DTZ,VK0612,Type-2 diabetes , Phase 2
8139,D07DUU,Alglucosidase alfa,Pompe disease , Approved
8140,D07DVK,Beclomethasone,Allergic rhinitis , Approved
8141,D07DVK,Beclomethasone,Asthma , Approved
8142,D07DWB,Revascor,Myocardial infarction , Phase 2
8143,D07DWC,SDX-7320,Solid tumour/cancer , Phase 1
8144,D07DWF,ARQ 092,Proteus syndrome , Phase 2
8145,D07DWF,ARQ 092,Solid tumour/cancer , Phase 1
8146,D07DZS,"1,3-bis(1,3-benzothiazol-2-ylthio)acetone",Glioma , Investigative
8147,D07DZS,"1,3-bis(1,3-benzothiazol-2-ylthio)acetone",Melanoma , Investigative
8148,D07DZT,H2TFPC-SGlc,Colon cancer , Investigative
8149,D07EAV,PMID25666693-Compound-41,Osteoarthritis pain , Patented
8150,D07EAV,PMID25666693-Compound-41,Cancer related pain , Patented
8151,D07EAV,PMID25666693-Compound-41,Neuropathic pain , Patented
8152,D07EAV,PMID25666693-Compound-41,Inflammatory pain , Patented
8153,D07EBF,CK-2017357,Amyotrophic lateral sclerosis , Phase 3
8154,D07EBF,CK-2017357,Muscle fatigue , Phase 2
8155,D07EBU,AMG-221,Metabolic disorder , Discontinued in Phase 1
8156,D07EDB,Ozanimod,Multiple sclerosis , Approved
8157,D07EDB,Ozanimod,Ulcerative colitis , Phase 3
8158,D07EDB,Ozanimod,Non-small-cell lung cancer , Phase 3
8159,D07EDB,Ozanimod,Crohn disease , Phase 2
8160,D07EEN,Lixivaptan,Hyponatraemia , Phase 3
8161,D07EEN,Lixivaptan,Skin infection , Phase 2
8162,D07EEN,Lixivaptan,Congestive heart failure , Phase 2
8163,D07EFA,AST-915,Movement disorder , Discontinued in Phase 1/2
8164,D07EFB,LFn-p24-B-C,Human immunodeficiency virus infection , Phase 1
8165,D07EFM,Arecoline,Parkinson disease , Phase 1
8166,D07EGF,PMID25666693-Compound-56,Osteoarthritis pain , Patented
8167,D07EGF,PMID25666693-Compound-56,Cancer related pain , Patented
8168,D07EGF,PMID25666693-Compound-56,Neuropathic pain , Patented
8169,D07EGF,PMID25666693-Compound-56,Inflammatory pain , Patented
8170,D07EGS,CGS-23425,Arteriosclerosis , Terminated
8171,D07EGW,AE-0047,Hypertension , Discontinued in Preregistration
8172,D07EHB,Latrunculin B,Glaucoma/ocular hypertension , Phase 1
8173,D07EHV,LGH-447,Multiple myeloma , Phase 1/2
8174,D07EIJ,EPI-12323,Chronic obstructive pulmonary disease , Discontinued in Phase 2
8175,D07EIQ,Fluvoxamine,Obsessive compulsive disorder , Approved
8176,D07EIQ,Fluvoxamine,Coronavirus Disease 2019 (COVID-19) , Phase 2
8177,D07EJY,AR-12286,Glaucoma/ocular hypertension , Phase 2
8178,D07EKK,PTC596,Fallopian tube cancer , Phase 1
8179,D07EKK,PTC596,Ovarian cancer , Phase 1
8180,D07EKK,PTC596,Peritoneal cavity cancer , Phase 1
8181,D07ELC,ABI-2088,Solid tumour/cancer , Investigative
8182,D07ELT,NOX-700,Type-2 diabetes , Phase 1
8183,D07ENB,NPI-32101,Bacterial infection , Phase 2
8184,D07ENH,IVV-001,Solid tumour/cancer , Investigative
8185,D07EPV,Teneligliptin,Type-2 diabetes , Phase 1
8186,D07EQJ,RG-7594,Solid tumour/cancer , Discontinued in Phase 1
8187,D07ESC,Apremilast,Psoriasis vulgaris , Approved
8188,D07ESH,PF-1913539,Alzheimer disease , Discontinued in Phase 3
8189,D07EUO,Naltrexone,Chronic alcoholism , Approved
8190,D07EUO,Naltrexone,Coronavirus Disease 2019 (COVID-19) , Phase 2
8191,D07EUY,H5N1 influenza vaccine,Human immunodeficiency virus infection , Phase 3
8192,D07EXH,Phloroglucinol,Urinary tract disease , Approved
8193,D07EXV,XEMILOFIBAN,Peripheral vascular disease , Discontinued in Phase 3
8194,D07EXV,XEMILOFIBAN,Cardiovascular disease , Discontinued in Phase 3
8195,D07FBM,ASP1941,Liver disease , Phase 3
8196,D07FCA,BAMLET,Bladder cancer , Investigative
8197,D07FDM,FR-901379,Pneumocystis pneumonia , Terminated
8198,D07FDV,Melaxin,Melanoma , Discontinued in Phase 2
8199,D07FEC,Plecanatide,Irritable bowel syndrome , Approved
8200,D07FEC,Plecanatide,Chronic idiopathic constipation , Approved
8201,D07FEC,Plecanatide,Crohn disease , Phase 3
8202,D07FGA,ZYC101a,Cervical cancer , Phase 2/3
8203,D07FGK,SAR-3419,Non-hodgkin lymphoma , Phase 2
8204,D07FGU,SAR440067,Type-1 diabetes , Phase 1
8205,D07FGU,SAR440067,Type-2 diabetes , Phase 1
8206,D07FGV,LLL-2011,Migraine , Discontinued in Phase 3
8207,D07FHI,Chlamydia vaccine,Chlamydia infection , Terminated
8208,D07FHW,PF-915275,Non-insulin dependent diabetes , Discontinued in Phase 1
8209,D07FHZ,Ro 20-1724,Asthma , Terminated
8210,D07FIC,CYT-6091,Solid tumour/cancer , Phase 1
8211,D07FIF,APH-0701,Prostate cancer , Investigative
8212,D07FIY,PMID25666693-Compound-50,Osteoarthritis pain , Patented
8213,D07FIY,PMID25666693-Compound-50,Cancer related pain , Patented
8214,D07FIY,PMID25666693-Compound-50,Neuropathic pain , Patented
8215,D07FIY,PMID25666693-Compound-50,Inflammatory pain , Patented
8216,D07FJM,BRECANAVIR,Human immunodeficiency virus infection , Discontinued in Phase 2
8217,D07FKQ,Siponimod,Multiple sclerosis , Approved
8218,D07FKQ,Siponimod,Hepatocellular carcinoma , Phase 3
8219,D07FKQ,Siponimod,Rheumatoid arthritis , Phase 2
8220,D07FKX,HMPL-011,Autoimmune diabetes , Phase 1
8221,D07FMW,PMID25684022-Compound-US20130053382 38(5-7),Solid tumour/cancer , Patented
8222,D07FMW,PMID25684022-Compound-US20130053382 38(5-7),Metastatic cancer , Patented
8223,D07FND,Nabi-HB,Hepatitis B virus infection , Approved
8224,D07FNG,AM336,Pain , Discontinued in Phase 2
8225,D07FPJ,MK-4214,Neutropenia , Phase 3
8226,D07FPR,R4996,Neurological disorder , Phase 1
8227,D07FPY,SB-639,Solid tumour/cancer , Phase 1
8228,D07FQL,Diannexin,Myocardial reperfusion injury , Phase 2
8229,D07FQS,ZP-011,Sinusitis , Investigative
8230,D07FRV,Ramipril,Acute heart failure , Approved
8231,D07FRV,Ramipril,Coronavirus Disease 2019 (COVID-19) , Phase 2
8232,D07FTD,Sodium Monofluorophosphate,Glaucoma/ocular hypertension , Approved
8233,D07FUH,LPCN-1087,Cough , Investigative
8234,D07FUJ,Fluorescein Sodium,Diagnostic fluorescein angiography or angioscopy of vasculature , Approved
8235,D07FUO,TA-264,Thrombosis , Investigative
8236,D07FUP,Dupilumab,Atopic dermatitis , Approved
8237,D07FUP,Dupilumab,Asthma , Phase 3
8238,D07FWF,PMID25666693-Compound-117,Osteoarthritis pain , Patented
8239,D07FWF,PMID25666693-Compound-117,Cancer related pain , Patented
8240,D07FWF,PMID25666693-Compound-117,Neuropathic pain , Patented
8241,D07FWF,PMID25666693-Compound-117,Inflammatory pain , Patented
8242,D07FWH,RU-59863,Bacterial infection , Terminated
8243,D07FXF,CP-613,Pancreatic cancer , Phase 2
8244,D07FYK,HuMax-VEGF,Solid tumour/cancer , Investigative
8245,D07FZC,Recombinant vaccine,Allergy , Phase 2
8246,D07FZF,XMT-1522,Breast cancer , Phase 1
8247,D07FZF,XMT-1522,Non-small-cell lung cancer , Phase 1
8248,D07GAA,ACP-001,Growth hormone deficiency , Phase 2
8249,D07GAN,Biaryl mannoside derivative 12,Crohn disease , Patented
8250,D07GAN,Biaryl mannoside derivative 12,Ulcerative colitis , Patented
8251,D07GAN,Biaryl mannoside derivative 12,Urinary tract infection , Patented
8252,D07GCK,ARC-100,Melanoma , Phase 2
8253,D07GCK,ARC-100,Prostate cancer , Phase 2
8254,D07GCK,ARC-100,Breast cancer , Phase 2
8255,D07GDN,Torcetrapib,Hyperlipidaemia , Discontinued in Phase 2
8256,D07GDN,Torcetrapib,Peripheral vascular disease , Discontinued in Phase 2
8257,D07GDR,AMG 282,Asthma , Phase 1
8258,D07GET,ALTU-236,Genetic disease , Investigative
8259,D07GFF,PKI166,Esophageal cancer , Discontinued in Phase 2
8260,D07GFZ,VVZ-138,Arthritis , Investigative
8261,D07GGQ,ND-801,Mycobacterium infection , Investigative
8262,D07GGT,ANT-429,Solid tumour/cancer , Investigative
8263,D07GHA,PLX2853,Acute myeloid leukaemia , Phase 1/2
8264,D07GHA,PLX2853,Solid tumour/cancer , Phase 1/2
8265,D07GHV,PF-05180999,Schizophrenia , Phase 1
8266,D07GIB,AZD5672,Rheumatoid arthritis , Terminated
8267,D07GJH,PMID26161824-Compound-68,Obesity , Patented
8268,D07GJZ,CQA 206-291,Parkinson disease , Phase 3
8269,D07GKS,MAGE-101,Breast cancer , Investigative
8270,D07GLB,PEV-7,Candidiasis , Phase 1
8271,D07GLF,Nemifitide,Major depressive disorder , Discontinued in Phase 2
8272,D07GLX,CNS-1531,Nervous system disease , Terminated
8273,D07GMF,MVA-85A,Mycobacterium infection , Phase 2
8274,D07GNL,GSK-523338,Non-insulin dependent diabetes , Phase 3
8275,D07GNO,KRN-330,Colorectal cancer , Phase 1/2
8276,D07GNP,Iopromide,X-rays imaging , Approved
8277,D07GNR,Vivaglobin,Nervous system disease , Approved
8278,D07GOY,CD59 gene therapy,Age-related macular degeneration , Investigative
8279,D07GQA,ZD-7155,Hypertension , Terminated
8280,D07GRH,Ciclopirox,Fungal infection , Approved
8281,D07GTF,Aipusheng,Japanese encephalitis virus infection , Approved
8282,D07GTW,Fosdenopterin,Molybdenum cofactor deficiency , Approved
8283,D07GTW,Fosdenopterin,Encephalopathy , Phase 2
8284,D07GVE,EDP-14,Allergy , Investigative
8285,D07GVM,JNJ-42491293,Psychiatric disorder , Phase 1
8286,D07GWZ,NT-501 CNTF,Ovarian cancer , Phase 1/2
8287,D07GXR,Ubrogepant,Migraine , Approved
8288,D07GYP,TYT-1,West nile virus infection , Investigative
8289,D07GZG,Endomorphins,Inflammation , Investigative
8290,D07GZL,R-701,Overactive bladder , Discontinued in Phase 1
8291,D07GZZ,Grass allergy vaccine,Allergic rhinitis , Terminated
8292,D07HAD,Telbermin,Diabetic foot ulcer , Discontinued in Phase 2
8293,D07HAR,OMS-302,Pain , Phase 3
8294,D07HBI,ZD-2138,Asthma , Discontinued in Phase 2
8295,D07HBX,Salicyclic acid,Seborrhoeic dermatitis , Approved
8296,D07HCH,LY2812176,Solid tumour/cancer , Phase 1/2
8297,D07HGR,Lisinopril,Hypertension , Approved
8298,D07HJS,Anti-BCMA CAR-T cells,Multiple myeloma , Phase 1
8299,D07HJT,Amidine compound 3,Inflammation , Patented
8300,D07HKV,IMGN-388,Solid tumour/cancer , Phase 1
8301,D07HLS,Anacetrapib,Arteriosclerosis , Phase 3
8302,D07HLS,Anacetrapib,Hyperlipidaemia , Phase 2
8303,D07HLZ,GZ404477,Parkinson disease , Phase 1
8304,D07HOA,Heterocyclic derivative 9,Solid tumour/cancer , Patented
8305,D07HOA,Heterocyclic derivative 9,Metastatic cancer , Patented
8306,D07HOB,Irinotecan,Colorectal cancer , Approved
8307,D07HOF,Picibanil,Carcinoma , Phase 4
8308,D07HOH,MM-398,Pancreatic cancer , Phase 3
8309,D07HOP,Alkyl mannoside derivative 9,Crohn disease , Patented
8310,D07HOP,Alkyl mannoside derivative 9,Ulcerative colitis , Patented
8311,D07HOP,Alkyl mannoside derivative 9,Urinary tract infection , Patented
8312,D07HOT,ALXN1007,Phospholipid syndrome , Phase 2
8313,D07HPH,MEDI5083,Solid tumour/cancer , Phase 1
8314,D07HPJ,AEW-541,Multiple myeloma , Phase 1
8315,D07HQC,Modafinil,Narcolepsy , Approved
8316,D07HQC,Modafinil,Bipolar disorder , Phase 4
8317,D07HQC,Modafinil,Brain injury , Investigative
8318,D07HRU,KRN633,Solid tumour/cancer , Phase 1
8319,D07HRU,KRN633,Glioma , Phase 1
8320,D07HSR,GSK2798745,Heart failure , Phase 2
8321,D07HTX,GL-331,Colorectal cancer , Discontinued in Phase 2
8322,D07HUW,Oregovomab,Ovarian cancer , Phase 3
8323,D07HUW,Oregovomab,Epithelial ovarian cancer , Phase 2
8324,D07HVY,Efavirenz,Human immunodeficiency virus infection , Approved
8325,D07HYR,GCC-1290K,Parkinson disease , Phase 1
8326,D07HZG,PF-00734200,Type-2 diabetes , Phase 2
8327,D07HZP,CNTO888,Solid tumour/cancer , Phase 1
8328,D07HZY,Xylose,Gastrointestinal disease , Approved
8329,D07IBY,STA-9584,Solid tumour/cancer , Investigative
8330,D07IEC,GSK2340273A,Influenza A virus H1N1 infection , Phase 2
8331,D07IEF,Bisacodyl,Constipation , Approved
8332,D07IEM,AMG-8562,Pain , Terminated
8333,D07IEU,MLN2480,Solid tumour/cancer , Phase 2
8334,D07IEU,MLN2480,Melanoma , Phase 1
8335,D07IGC,DSP-8658,Type-2 diabetes , Phase 1
8336,D07IGC,DSP-8658,Alzheimer disease , Phase 1
8337,D07IGE,Glyfoline,Solid tumour/cancer , Terminated
8338,D07IGQ,C-Immune,Hepatitis C virus infection , Investigative
8339,D07IHT,"N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 1",Osteoporosis , Patented
8340,D07IIX,AMELTOLIDE,Epileptic seizures , Discontinued in Phase 1
8341,D07ILQ,Guanfacine extended release,Attention deficit hyperactivity disorder , Approved
8342,D07IMX,BMS-844421,Cardiovascular disease , Discontinued in Phase 1
8343,D07IND,SRD-285,Wound healing , Preclinical
8344,D07INL,SCY-078,Invasive candidiasis , Phase 3
8345,D07INL,SCY-078,Fungal infection , Phase 2
8346,D07INU,LDN-22684,Parkinson disease , Investigative
8347,D07INV,Ethoxzolamide,Glaucoma/ocular hypertension , Approved
8348,D07INV,Ethoxzolamide,Duodenal ulcer , Withdrawn from market
8349,D07IOT,TPI 287,Glioma , Phase 2
8350,D07IOT,TPI 287,Recurrent glioblastoma , Phase 2
8351,D07IOT,TPI 287,Alzheimer disease , Phase 1
8352,D07IOT,TPI 287,Brain metastases , Phase 1
8353,D07IOT,TPI 287,Progressive supranuclear palsy , Phase 1
8354,D07IPB,Valrubicin,Bladder cancer , Approved
8355,D07IPB,Valrubicin,Psoriasis vulgaris , Phase 2
8356,D07IQE,Heterocyclic derivative 10,Solid tumour/cancer , Patented
8357,D07IQE,Heterocyclic derivative 10,Metastatic cancer , Patented
8358,D07IQS,Atazanavir,Human immunodeficiency virus infection , Approved
8359,D07IRF,Prasugrel,Acute coronary syndrome , Approved
8360,D07IRG,Calcium polycarbophil,Irritable bowel syndrome , Approved
8361,D07ISD,AFPep,Breast cancer , Investigative
8362,D07ISE,Interferon alpha,Hepatitis C virus infection , Phase 1/2
8363,D07ISO,VariZIG,Postherpetic neuralgia , Approved
8364,D07ISX,Thalidomide,Multiple myeloma , Approved
8365,D07ISX,Thalidomide,Coronavirus Disease 2019 (COVID-19) , Phase 2
8366,D07ITH,4SCAR19 cells,Acute lymphoblastic leukaemia , Phase 1
8367,D07IVS,Gerilimzumab,Rheumatoid arthritis , Phase 1
8368,D07IXD,P-0654,Arteriosclerosis , Discontinued in Phase 1
8369,D07IYC,TDI-0067,Motor neurone disease , Investigative
8370,D07IYO,Triazavirin,Influenza virus infection , Phase 2
8371,D07IYO,Triazavirin,Coronavirus Disease 2019 (COVID-19) , Investigative
8372,D07IZF,Sch-57790,Alzheimer disease , Terminated
8373,D07IZG,GSK4112,Inflammation , Preclinical
8374,D07IZP,ND-401,Human immunodeficiency virus infection , Investigative
8375,D07IZS,ITE,Solid tumour/cancer , Investigative
8376,D07JAG,Upadacitinib,Rheumatoid arthritis , Approved
8377,D07JAG,Upadacitinib,Psoriatic arthritis , Phase 3
8378,D07JAG,Upadacitinib,Atopic dermatitis , Phase 2
8379,D07JAG,Upadacitinib,Crohn disease , Phase 2
8380,D07JAG,Upadacitinib,Ulcerative colitis , Phase 2
8381,D07JAI,NSC-639829,Solid tumour/cancer , Phase 1
8382,D07JBE,CG-200745,Solid tumour/cancer , Phase 1
8383,D07JCU,PRS-040,Ocular disease , Investigative
8384,D07JDR,LRN-672,Ocular disease , Investigative
8385,D07JEW,Human coagulation factor X,Renal cell carcinoma , BLA submitted
8386,D07JFE,CVT-427,Migraine , Phase 1
8387,D07JFU,CGEN-712,Non-hodgkin lymphoma , Investigative
8388,D07JGH,UR-13756,Inflammation , Investigative
8389,D07JGT,Nalidixic Acid,Urinary tract infection , Approved
8390,D07JHH,Meclocycline,Bacterial infection , Approved
8391,D07JHJ,IGANIDIPINE HYDROCHLORIDE,Glaucoma/ocular hypertension , Discontinued in Phase 1
8392,D07JHK,AMG 151,Type-2 diabetes , Phase 2
8393,D07JHV,Carimune NF,Immune System disease , Approved
8394,D07JIN,FMX103,Rosacea , Phase 3
8395,D07JJC,DPC-684,Human immunodeficiency virus infection , Discontinued in Phase 1
8396,D07JJS,Sulfamethizole,Urinary tract infection , Approved
8397,D07JKA,SEN-1500,Alzheimer disease , Investigative
8398,D07JKY,KP-496,Asthma , Phase 2
8399,D07JLM,Alagebrium chloride,Hypotension , Phase 2/3
8400,D07JMX,XEN-600,Iron overload disease , Investigative
8401,D07JNJ,PMID25666693-Compound-17,Osteoarthritis pain , Patented
8402,D07JNJ,PMID25666693-Compound-17,Cancer related pain , Patented
8403,D07JNJ,PMID25666693-Compound-17,Neuropathic pain , Patented
8404,D07JNJ,PMID25666693-Compound-17,Inflammatory pain , Patented
8405,D07JOS,NS-004,Hypertension , Terminated
8406,D07JOW,XTL-Pseudomonas-mab,Pseudomonas infection , Investigative
8407,D07JPC,Arbekacin,Bacterial infection , Approved
8408,D07JPK,ETX-1153b,MRSA infection , Preclinical
8409,D07JPL,RT-401,Rhinitis , Investigative
8410,D07JQO,SB 249417,Sepsis , Discontinued in Phase 1
8411,D07JRF,Influenza A virus H1N1 vaccine,Familial chylomicronemia syndrome , Phase 3
8412,D07JRL,Epithalon,Ocular inflammation , Phase 1/2
8413,D07JSI,Salicylihalamide A,Solid tumour/cancer , Preclinical
8414,D07JSK,Sulotroban,Asthma , Terminated
8415,D07JSX,IL-2 pDNA,Melanoma , Phase 1
8416,D07JTD,NSC-645809,Breast cancer , Phase 2
8417,D07JTH,MM-Q01,Gastrointestinal disease , Approved
8418,D07JUL,JR-032,Hunter syndrome , Investigative
8419,D07JVL,Diazepam,Epilepsy , Approved
8420,D07JVO,Fosbretabulin,Rheumatoid arthritis , Phase 2
8421,D07JVS,Cephalosporin,Bacterial infection , Approved
8422,D07JVT,GWN323,Lymphoma , Phase 1
8423,D07JVT,GWN323,Solid tumour/cancer , Phase 1
8424,D07JVU,Ciclosporin,Graft-versus-host disease , Approved
8425,D07JVU,Ciclosporin,Severe acute respiratory syndrome (SARS) , Investigative
8426,D07JVU,Ciclosporin,Middle East Respiratory Syndrome (MERS) , Investigative
8427,D07JWO,IL-21,Colorectal cancer , Phase 2
8428,D07JWT,Perazine,Psychotic disorder , Approved
8429,D07JXN,SPP-600,Hypertension , Phase 2
8430,D07JXR,IMD-4852,Thrombosis , Investigative
8431,D07JZF,Netilmicin,Bacterial infection , Approved
8432,D07JZT,LA-EP2006,Neutropenia , Phase 3
8433,D07KAB,AST-VAC1,Acute myeloid leukaemia , Phase 2
8434,D07KAK,OSH-101,Alopecia , Phase 2
8435,D07KAQ,L19-IL-2 fusion protein,Lymphoma , Phase 2
8436,D07KBM,AZD4573,Haematological malignancy , Phase 1
8437,D07KCA,Aryl mannoside derivative 22,Crohn disease , Patented
8438,D07KCA,Aryl mannoside derivative 22,Ulcerative colitis , Patented
8439,D07KCA,Aryl mannoside derivative 22,Urinary tract infection , Patented
8440,D07KDE,Fusafungine,Bacterial infection , Withdrawn from market
8441,D07KDI,AR-42,Multiple myeloma , Phase 1/2
8442,D07KDI,AR-42,Chronic lymphocytic leukaemia , Phase 1/2
8443,D07KEH,AKB-6548,Anaemia , Phase 3
8444,D07KFB,Varespladib methyl,Rheumatoid arthritis , Phase 3
8445,D07KFG,Human prothrombin complex concentrate,Bleeding disorder , Approved
8446,D07KGR,VI-1121,Alzheimer disease , Phase 2
8447,D07KGV,Anti-HCV agent,Hepatitis C virus infection , Investigative
8448,D07KGW,PF-3392455,Hypertension , Discontinued in Phase 1
8449,D07KHH,LAS-34273,Chronic obstructive pulmonary disease , Approved
8450,D07KHR,PSMA-VRP,Prostate cancer , Phase 1
8451,D07KIB,4-fluoroselegiline,Dementia , Investigative
8452,D07KIE,LYC-30937,Plaque psoriasis , Phase 2
8453,D07KIE,LYC-30937,Ulcerative colitis , Phase 2
8454,D07KIJ,INCB3344,Arteriosclerosis , Terminated
8455,D07KJH,LYMErix,Lyme disease , Approved
8456,D07KKQ,Hepatitis A vaccine,Hepatitis A virus infection , Approved
8457,D07KKZ,Ga 68 dotatate,Neuroendocrine cancer , Approved
8458,D07KMA,T-oligos,Solid tumour/cancer , Investigative
8459,D07KMI,ACI-518,Alzheimer disease , Investigative
8460,D07KOR,INOC-002,Solid tumour/cancer , Discontinued in Phase 1
8461,D07KSG,Tamoxifen,Breast cancer , Approved
8462,D07KTA,Ab-01,Inflammation , Phase 2
8463,D07KTP,SCH79687,Central nervous system disease , Investigative
8464,D07KUN,RAD-1901,Breast cancer , Phase 3
8465,D07KVD,ARGX-109,Autoimmune diabetes , Investigative
8466,D07KVL,PMID28270021-Compound-WO2010077680 811,Pruritus , Patented
8467,D07KVL,PMID28270021-Compound-WO2010077680 811,Solid tumour/cancer , Patented
8468,D07KVL,PMID28270021-Compound-WO2010077680 811,Chronic pain , Patented
8469,D07KVL,PMID28270021-Compound-WO2010077680 811,Neuropathic pain , Patented
8470,D07KVL,PMID28270021-Compound-WO2010077680 811,Thymic cancer , Patented
8471,D07KVV,Selinexor,Multiple myeloma , Approved
8472,D07KVV,Selinexor,Coronavirus Disease 2019 (COVID-19) , Phase 2
8473,D07KWN,Isosteviol,Non-insulin dependent diabetes , Phase 2
8474,D07KYK,NK-111,Ischemic heart disease , Investigative
8475,D07KYT,AC220,leukaemia , Phase 3
8476,D07KYT,AC220,Acute myeloid leukaemia , Phase 3
8477,D07KYU,Benactyzine,Depression , Withdrawn from market
8478,D07KYZ,GABA-B receptor PAM,Anxiety disorder , Investigative
8479,D07LAP,BMS-184476,Solid tumour/cancer , Phase 2
8480,D07LBP,RabiCide,Rabies , Investigative
8481,D07LBQ,GSK2398852,Amyloidosis , Phase 1
8482,D07LCA,AMG0714,Rheumatoid arthritis , Phase 2
8483,D07LCF,Naloxegol,Opioid-induced constipation , Approved
8484,D07LCP,Ad5Ag85A,Mycobacterium infection , Phase 1
8485,D07LCY,RVSVIN HIV-1 gag vaccine,Human immunodeficiency virus infection , Phase 1
8486,D07LEW,BIBS-39,Hypertension , Terminated
8487,D07LFJ,BU-32,Solid tumour/cancer , Investigative
8488,D07LGU,MMPT,Solid tumour/cancer , Investigative
8489,D07LJR,CDR-267F018,Diabetic complication , Investigative
8490,D07LLI,Mucin type glycoproteins,Inflammation , Investigative
8491,D07LMO,Drug 2862277,Acute lung injury , Phase 2
8492,D07LPT,EP-7041,Thrombosis , Phase 1
8493,D07LRB,Factor VIII-XTEN,Hemophilia , Investigative
8494,D07LRT,A-425619,Pain , Preclinical
8495,D07LSU,CDRI-S002-333,Thrombosis , Investigative
8496,D07LSV,Recombinant galectin-3,Corneal abrasion , Investigative
8497,D07LUA,PfSPZ-GA1,Plasmodium falciparum malaria , Phase 2
8498,D07LUJ,URSOLIC ACID,Metabolic syndrome x , Phase 2
8499,D07LWK,AVE0118,Obstructive sleep apnea , Phase 1
8500,D07LWL,WIN-34B,Osteoarthritis , Phase 2
8501,D07LWT,FE-202767,Erectile dysfunction , Phase 2
8502,D07LYC,SCYX-7158,Trypanosomiasis , Phase 1
8503,D07LZH,ERB-041,Inflammatory bowel disease , Phase 2
8504,D07MBQ,CNTO-736,Non-insulin dependent diabetes , Investigative
8505,D07MCK,Salicylamide,Pain , Approved
8506,D07MDY,Elsulfavirine,Human immunodeficiency virus infection , Phase 2
8507,D07MED,RG7716,Neovascular age-related macular degeneration , Phase 3
8508,D07MED,RG7716,Choroidal neovascularization , Phase 2
8509,D07MEH,Meglitinides,Type-2 diabetes , Approved
8510,D07MEH,Meglitinides,Psychotic disorder , Phase 4
8511,D07MEL,Amiprilose,Rheumatoid arthritis , Discontinued in Preregistration
8512,D07MEX,CLR-1401,Solid tumour/cancer , Phase 1/2
8513,D07MFY,STX-200,Acute lung injury , Investigative
8514,D07MGA,Hesperetin,High blood cholesterol level , Approved
8515,D07MGC,Talacotuzumab,Acute myeloid leukaemia , Phase 2
8516,D07MHM,PP-405,Solid tumour/cancer , Investigative
8517,D07MKL,ABT-229,Pain , Phase 2
8518,D07MLA,CIGB-200,Human immunodeficiency virus infection , Investigative
8519,D07MLP,APN-601,Pain , Investigative
8520,D07MMC,STP-702,Influenza virus infection , Investigative
8521,D07MME,Dexamethasone palmitate,Choroidal neovascularization , Phase 1/2
8522,D07MNI,PMID25666693-Compound-127,Osteoarthritis pain , Patented
8523,D07MNI,PMID25666693-Compound-127,Cancer related pain , Patented
8524,D07MNI,PMID25666693-Compound-127,Neuropathic pain , Patented
8525,D07MNI,PMID25666693-Compound-127,Inflammatory pain , Patented
8526,D07MNT,P52-/p36- GAP vaccine,Malaria , Phase 1/2
8527,D07MOK,KANAb-071,Autoimmune diabetes , Investigative
8528,D07MON,ONAPRISTONE,Breast cancer , Phase 2
8529,D07MOX,Norepinephrine,Sepsis , Approved
8530,D07MPI,MEDI-0639,Solid tumour/cancer , Phase 1
8531,D07MPJ,A-75925,Virus infection , Discontinued in Phase 2
8532,D07MPL,SNX-5422,Haematological malignancy , Phase 1/2
8533,D07MPL,SNX-5422,Non-small-cell lung cancer , Phase 1/2
8534,D07MPL,SNX-5422,Chronic lymphocytic leukaemia , Phase 1
8535,D07MPL,SNX-5422,Neuroendocrine cancer , Phase 1
8536,D07MQC,PS-1145,Multiple myeloma , Investigative
8537,D07MQY,HIV-LAMP-vax,Human immunodeficiency virus infection , Investigative
8538,D07MSB,Thiazole carboxamide derivative 11,Solid tumour/cancer , Patented
8539,D07MSB,Thiazole carboxamide derivative 11,Metastatic cancer , Patented
8540,D07MSL,TL-1836,Solid tumour/cancer , Investigative
8541,D07MTL,SRSC-371,Epilepsy , Terminated
8542,D07MTT,HP-831-064,Wound healing , Phase 1
8543,D07MUN,Vitamin B6,Vitamin B6 deficiency , Approved
8544,D07MUS,CPA-7,Solid tumour/cancer , Investigative
8545,D07MUT,TDI-0032,Motor neurone disease , Investigative
8546,D07MVE,PD-151832,Parkinson disease , Discontinued in Phase 1/2
8547,D07MVK,Halofantrine,Malaria , Approved
8548,D07MWY,XR-1853,Thrombosis , Terminated
8549,D07MXA,C75,Obesity , Investigative
8550,D07MXF,Zabofloxacin,Pneumonia , Phase 3
8551,D07MZC,Vasoflux,Myocardial infarction , Discontinued in Phase 2
8552,D07NAA,Sulfonylated piperazine derivative 4,Obesity , Patented
8553,D07NAJ,Chloroprocaine,Anaesthesia , Approved
8554,D07NBA,Veltuzumab,Systemic lupus erythematosus , Phase 2
8555,D07NBA,Veltuzumab,Non-hodgkin lymphoma , Phase 2
8556,D07NBA,Veltuzumab,Chronic lymphocytic leukaemia , Phase 2
8557,D07NBA,Veltuzumab,Solid tumour/cancer , Phase 2
8558,D07NBA,Veltuzumab,Thrombocytopenia , Phase 1/2
8559,D07NCC,VTT-201,Prostate cancer , Investigative
8560,D07NCN,Doxofylline,Asthma , Approved
8561,D07NCV,BXT-51072,Cardiovascular disease , Phase 2
8562,D07NDK,WAY-644,Aortic aneurysm , Investigative
8563,D07NEE,AEZS-131,Solid tumour/cancer , Investigative
8564,D07NEI,PMID30280939-Compound-US20179642901,Malaria , Patented
8565,D07NFT,P-2281,Ulcerative colitis , Investigative
8566,D07NFW,BMS-196085,Diabetic complication , Phase 1
8567,D07NGJ,S-23906-1,Solid tumour/cancer , Discontinued in Phase 1
8568,D07NGZ,Insulin-glargine,Diabetic complication , Approved
8569,D07NGZ,Insulin-glargine,Malaria , Phase 3
8570,D07NGZ,Insulin-glargine,Type-1 diabetes , Phase 3
8571,D07NGZ,Insulin-glargine,Type-2 diabetes , Application submitted
8572,D07NHZ,CD19 CAR T cells,Acute lymphoblastic leukaemia , Phase 1/2
8573,D07NHZ,CD19 CAR T cells,B-cell non-hodgkin lymphoma , Phase 1/2
8574,D07NJI,Treximet,Migraine , Approved
8575,D07NJN,Siltuximab,Anemia , Approved
8576,D07NJN,Siltuximab,Multiple myeloma , Phase 2
8577,D07NKJ,AT-001,Coronavirus Disease 2019 (COVID-19) , Phase 2
8578,D07NKZ,VVP-808,Type-2 diabetes , Phase 2
8579,D07NLI,Vismed,Eye disorder , Phase 4
8580,D07NOI,BAY-57-9352,Solid tumour/cancer , Phase 2
8581,D07NOI,BAY-57-9352,Gastric adenocarcinoma , Phase 2
8582,D07NPH,Colostrinin,Alzheimer disease , Approved
8583,D07NPS,Zarnestra,Acute myeloid leukaemia , Phase 3
8584,D07NPS,Zarnestra,Chronic myelogenous leukaemia , Phase 2
8585,D07NPS,Zarnestra,Myelodysplastic syndrome , Phase 2
8586,D07NPS,Zarnestra,Human papillomavirus infection , Phase 2
8587,D07NPS,Zarnestra,Peripheral T-cell lymphoma , Phase 2
8588,D07NPS,Zarnestra,Colorectal cancer , Phase 1/2
8589,D07NPS,Zarnestra,Pancreatic cancer , Phase 1/2
8590,D07NPX,Triiodothyronine,Euthyroid goiter , Approved
8591,D07NPX,Triiodothyronine,Coronavirus Disease 2019 (COVID-19) , Phase 2
8592,D07NSU,Glucosamine,Osteoarthritis , Approved
8593,D07NTC,WCK-771,Bacterial infection , Phase 2
8594,D07NTN,CERM-11956,Angina pectoris , Discontinued in Phase 1
8595,D07NUH,IDX-15971,Human immunodeficiency virus infection , Investigative
8596,D07NUL,PF-06650833,Lupus , Phase 1
8597,D07NUO,JNJ-39588146,Heart failure , Phase 2
8598,D07NUZ,Phospho-aspirins,Solid tumour/cancer , Investigative
8599,D07NVF,WAS gene therapy,Wiskott-Aldrich syndrome , Phase 1/2
8600,D07NVI,CPI-613,Acute myeloid leukaemia , Phase 3
8601,D07NVI,CPI-613,Pancreatic cancer , Phase 3
8602,D07NVI,CPI-613,Myelodysplastic syndrome , Phase 2
8603,D07NVI,CPI-613,B-cell lymphoma , Phase 2
8604,D07NVI,CPI-613,Recurrent adult burkitt lymphoma , Phase 2
8605,D07NVI,CPI-613,Metastatic colorectal cancer , Phase 1
8606,D07NVI,CPI-613,T-cell lymphoma , Phase 1
8607,D07NVU,Midostaurin,Acute myeloid leukaemia , Approved
8608,D07NVU,Midostaurin,Systemic mastocytosis , Approved
8609,D07NVU,Midostaurin,Chronic myelomonocytic leukaemia , Phase 2
8610,D07NVU,Midostaurin,Colorectal cancer , Phase 1
8611,D07NWC,SC-241,Anxiety disorder , Terminated
8612,D07NWZ,CL-301,Neurological disorder , Investigative
8613,D07NYF,MLN-2201,Cerebrovascular ischaemia , Discontinued in Phase 1
8614,D07NZC,AMG 581,Psychotic disorder , Phase 1
8615,D07OAD,GO-203-2c,Acute myeloid leukaemia , Phase 2
8616,D07OAD,GO-203-2c,Solid tumour/cancer , Phase 1/2
8617,D07OAO,IONIS-HTTRX,Huntington disease , Phase 3
8618,D07OBJ,PHX-1766,Hepatitis C virus infection , Phase 1
8619,D07OBK,SL-201,Solid tumour/cancer , Investigative
8620,D07OCC,JSM-10292,Pain , Terminated
8621,D07OCM,Dendritic cell-based immunotherapy,Rheumatoid arthritis , Investigative
8622,D07OCV,HT-0712,Cognitive impairment , Phase 2
8623,D07ODC,VBY- 036,Neuropathic pain , Phase 1
8624,D07OED,BL-5040,Cachexia , Investigative
8625,D07OEY,ZK-118182,Thrombosis , Terminated
8626,D07OFM,GSK525762,Solid tumour/cancer , Phase 1
8627,D07OFM,GSK525762,Haematological malignancy , Phase 1
8628,D07OGR,YM-26734,Rheumatoid arthritis , Terminated
8629,D07OGZ,Darexaban maleate,Acute coronary syndrome , Discontinued in Phase 3
8630,D07OHO,Ampiroxicam,Inflammation , Approved
8631,D07OHT,ABT-450,Hepatitis C virus infection , Phase 2
8632,D07OIO,AZD-2461,Solid tumour/cancer , Phase 1
8633,D07OIX,Iodipamide,Gallbladder disease , Approved
8634,D07OIZ,R-84,Solid tumour/cancer , Investigative
8635,D07OJZ,Capmatinib,Non-small-cell lung cancer , Approved
8636,D07OJZ,Capmatinib,Hepatocellular carcinoma , Phase 2
8637,D07OJZ,Capmatinib,Recurrent glioblastoma , Phase 1
8638,D07OLO,Milacemide,Alzheimer disease , Terminated
8639,D07OMK,RO-48-6791,Anxiety disorder , Discontinued in Phase 2
8640,D07ONP,Phenacemide,Epilepsy , Approved
8641,D07OQJ,GM-CAIX,Renal cell carcinoma , Investigative
8642,D07ORE,TVGV-1 vaccine,Human papillomavirus infection , Phase 2
8643,D07ORO,Solamargine,Solid tumour/cancer , Approved
8644,D07OSS,9cUAB-30,Solid tumour/cancer , Phase 1
8645,D07OTU,NRX-1050,Bipolar disorder , Investigative
8646,D07OTW,WT2725,Solid tumour/cancer , Phase 1
8647,D07OTW,WT2725,Haematological malignancy , Phase 1
8648,D07OUE,AUX-202,Bone metastases , Terminated
8649,D07OVM,Benzothiazine-carboxamide compound 4,Skin inflammation , Patented
8650,D07OXW,FVh1 DNA-based influenza vaccine,Influenza A virus H1N1 infection , Phase 1
8651,D07OYT,NPB-2,Solid tumour/cancer , Investigative
8652,D07OZO,BMP-4,Glioblastoma multiforme , Investigative
8653,D07OZR,TKI258,Renal cell carcinoma , Phase 3
8654,D07OZR,TKI258,Endometrial cancer , Phase 2
8655,D07OZR,TKI258,Triple negative breast cancer , Phase 2
8656,D07PAG,U-97456,Bacterial infection , Terminated
8657,D07PAO,Sulphadoxine,Malaria , Approved
8658,D07PAY,B-956,Solid tumour/cancer , Terminated
8659,D07PBZ,Epoetin alfa,Anemia , Approved
8660,D07PCI,Carboprost Tromethamine,Abortion , Approved
8661,D07PCZ,AR20.5,Pancreatic cancer , Phase 1/2
8662,D07PFG,HL-009,Atopic dermatitis , Phase 2
8663,D07PFU,JNJ-63733657,Alzheimer disease , Phase 1
8664,D07PHS,CXCL8,Psoriasis vulgaris , Investigative
8665,D07PIA,AG-1350,Human immunodeficiency virus infection , Terminated
8666,D07PIH,Pyrazole derivative 60,Obesity , Patented
8667,D07PJR,Cyclic compound 2,Solid tumour/cancer , Patented
8668,D07PJR,Cyclic compound 2,Infectious disease , Patented
8669,D07PJR,Cyclic compound 2,Human immunodeficiency virus infection , Patented
8670,D07PJR,Cyclic compound 2,Hepatitis , Patented
8671,D07PJS,JNJ-68284528,Multiple myeloma , Phase 1/2
8672,D07PLK,WIN-64821,Asthma , Terminated
8673,D07PMG,Afeletecan,Breast cancer , Phase 1
8674,D07PMH,VH-0445 based conjugated therapeutics,Pain , Investigative
8675,D07PML,Ublituximab + umbralisib,Chronic lymphocytic leukaemia , Phase 3
8676,D07PML,Ublituximab + umbralisib,Non-hodgkin lymphoma , Phase 2/3
8677,D07PMP,PKI-402,Solid tumour/cancer , Investigative
8678,D07PMU,111In-OC-125 F(ab1/2)-DTPA,Ovarian cancer , Terminated
8679,D07PNC,Organon,Schizophrenia , Preclinical
8680,D07PND,Diphenyl purine derivative 1,Obesity , Patented
8681,D07PNQ,CD200Fc,Autoimmune diabetes , Investigative
8682,D07PNT,XL999,Advanced malignancy , Phase 1
8683,D07PNX,PMID26815044-Compound-115,Albinism , Patented
8684,D07PNX,PMID26815044-Compound-115,Ephelides , Patented
8685,D07PNX,PMID26815044-Compound-115,Menkes disease , Patented
8686,D07PNX,PMID26815044-Compound-115,Senile lentigines , Patented
8687,D07PNX,PMID26815044-Compound-115,Melasma , Patented
8688,D07POC,Erlotinib,Non-small-cell lung cancer , Approved
8689,D07POC,Erlotinib,Pancreatic cancer , Phase 3
8690,D07POC,Erlotinib,Colon cancer , Phase 2
8691,D07POS,Alkyl mannoside derivative 12,Crohn disease , Patented
8692,D07POS,Alkyl mannoside derivative 12,Ulcerative colitis , Patented
8693,D07POS,Alkyl mannoside derivative 12,Urinary tract infection , Patented
8694,D07POY,Peptagon,Cerebrovascular ischaemia , Investigative
8695,D07PQJ,ARQ-087,Intrahepatic cholangiocarcinoma , Phase 3
8696,D07PQJ,ARQ-087,Cholangiocarcinoma , Phase 2
8697,D07PQJ,ARQ-087,Solid tumour/cancer , Phase 1
8698,D07PRA,UX-005,Lysosomal storage disease , Investigative
8699,D07PRC,BAL-30072,Bacterial infection , Phase 1
8700,D07PRH,DE-098,Rheumatoid arthritis , Phase 2
8701,D07PSJ,Resorcinol compound 24,Albinism , Patented
8702,D07PSJ,Resorcinol compound 24,Ephelides , Patented
8703,D07PSJ,Resorcinol compound 24,Menkes disease , Patented
8704,D07PSJ,Resorcinol compound 24,Senile lentigines , Patented
8705,D07PSJ,Resorcinol compound 24,Melasma , Patented
8706,D07PSL,PLX7486,Pancreatic cancer , Phase 1
8707,D07PSL,PLX7486,Solid tumour/cancer , Phase 1
8708,D07PSP,U-75875,Human immunodeficiency virus infection , Terminated
8709,D07PSX,ABBV-084,Systemic lupus erythematosus , Phase 1
8710,D07PTH,13-cis-retinoic acid,Glioma , Phase 3
8711,D07PTH,13-cis-retinoic acid,Infertility , Phase 2
8712,D07PTH,13-cis-retinoic acid,Azoospermia , Phase 2
8713,D07PUS,DSM1,Malaria , Investigative
8714,D07PVB,Squalamine,Solid tumour/cancer , Phase 3
8715,D07PVB,Squalamine,Diabetic macular edema , Phase 2
8716,D07PVT,NVC-638,Conjunctivitis , Investigative
8717,D07PVX,Aryl mannoside derivative 21,Crohn disease , Patented
8718,D07PVX,Aryl mannoside derivative 21,Ulcerative colitis , Patented
8719,D07PVX,Aryl mannoside derivative 21,Urinary tract infection , Patented
8720,D07PWY,Anti-RON receptor mabs,Solid tumour/cancer , Investigative
8721,D07PXQ,ASP-2151,Herpes simplex virus infection , Phase 3
8722,D07QAA,BRL-46470,Anxiety disorder , Discontinued in Phase 2
8723,D07QAF,BI 207127,Hepatitis C virus infection , Phase 2
8724,D07QAH,Biaryl mannoside derivative 17,Crohn disease , Patented
8725,D07QAH,Biaryl mannoside derivative 17,Ulcerative colitis , Patented
8726,D07QAH,Biaryl mannoside derivative 17,Urinary tract infection , Patented
8727,D07QAK,Xanomeline tartrate,Parkinson disease , Phase 2
8728,D07QAR,Dalbavancin,Bacterial infection , Approved
8729,D07QBJ,HJP-272,Premature labour , Investigative
8730,D07QCA,GDNF-producing adult stem cell therapy,Lateral sclerosis , Phase 2
8731,D07QCE,Azathioprine,Organ transplant rejection , Approved
8732,D07QDT,MA-0211,Duchenne dystrophy , Phase 1
8733,D07QFM,TP10,Myocardial ischemia , Phase 2
8734,D07QFP,Teriflunomide,Hyperlipidaemia , Approved
8735,D07QFP,Teriflunomide,Multiple sclerosis , Approved
8736,D07QFP,Teriflunomide,Rheumatoid arthritis , Phase 3
8737,D07QFP,Teriflunomide,Hepatitis B virus infection , Phase 1
8738,D07QFU,T-607,Solid tumour/cancer , Phase 2
8739,D07QHF,SAR-260093,Type-2 diabetes , Phase 2
8740,D07QIQ,Anti-BCMA-CAR-transduced T cells,leukaemia , Phase 1/2
8741,D07QIQ,Anti-BCMA-CAR-transduced T cells,Lymphoma , Phase 1/2
8742,D07QIQ,Anti-BCMA-CAR-transduced T cells,Multiple myeloma , Phase 1/2
8743,D07QIT,GPX-150D,Breast cancer , Phase 2
8744,D07QIT,GPX-150D,Soft tissue sarcoma , Phase 2
8745,D07QJK,Plitidepsin,Multiple myeloma , Phase 3
8746,D07QJK,Plitidepsin,Angioimmunoblastic T-cell Lymphoma , Phase 2
8747,D07QKK,CHLORIDE,Solid tumour/cancer , Phase 3
8748,D07QKM,HL-1225,Diabetic complication , Discontinued in Phase 2
8749,D07QKN,Terpin hydrate,Cough , Approved
8750,D07QLD,Pyrazole derivative 7,Obesity , Patented
8751,D07QLG,Oxilofrine,Orthostatic hypotension , Approved
8752,D07QNH,SAIT301,Nasopharyngeal carcinoma , Investigative
8753,D07QPM,Potassium Citrate,Kidney stone , Approved
8754,D07QQD,Aescin,Inflammation , Approved
8755,D07QQP,INS-37217,Cystic fibrosis , Phase 2
8756,D07QSA,CP-83101,Arteriosclerosis , Terminated
8757,D07QTB,AF-243,Deafness , Investigative
8758,D07QTG,JNJ-479655,Alzheimer disease , Clinical trial
8759,D07QVY,DBT-066,Dementia , Investigative
8760,D07QWW,NBI-34041,Eating disorder , Phase 1
8761,D07QWZ,AZT-P-DDI,Human immunodeficiency virus infection , Discontinued in Phase 2
8762,D07QXG,EF-27,Radiation syndrome , Terminated
8763,D07QXM,AVI-4020,Virus infection , Phase 1
8764,D07QXU,NS 2359,Cocaine addiction , Phase 2
8765,D07QXU,NS 2359,Attention deficit hyperactivity disorder , Discontinued in Phase 2
8766,D07QXU,NS 2359,Mood disorder , Discontinued in Phase 2
8767,D07QYQ,Chloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
8768,D07QYQ,Chloroquine,Malaria , Withdrawn from market
8769,D07QYQ,Chloroquine,Severe acute respiratory syndrome (SARS) , Investigative
8770,D07QYQ,Chloroquine,Middle East Respiratory Syndrome (MERS) , Investigative
8771,D07QZO,MPS-AAV8,Maroteaux-lamy syndrome , Investigative
8772,D07RAA,PMID26651364-Compound-119,Crohn disease , Patented
8773,D07RAA,PMID26651364-Compound-119,Ulcerative colitis , Patented
8774,D07RAA,PMID26651364-Compound-119,Urinary tract infection , Patented
8775,D07RDQ,LMB-100,Pancreatic cancer , Phase 1/2
8776,D07RDQ,LMB-100,Mesothelioma , Phase 1
8777,D07RDU,IDP-107,Acne vulgaris , Phase 2
8778,D07RGW,Mephenytoin,Epilepsy , Approved
8779,D07RHF,GDC 695,Actinic keratosis , Phase 3
8780,D07RHP,INCB50465,Diffuse large B-cell lymphoma , Phase 2
8781,D07RHP,INCB50465,Follicular lymphoma , Phase 2
8782,D07RHP,INCB50465,Mantle cell lymphoma , Phase 2
8783,D07RHP,INCB50465,Marginal zone lymphoma , Phase 2
8784,D07RIE,BC-PN-02,Nervous system disease , Investigative
8785,D07RIJ,Autologous melanoma cell vaccine,Solid tumour/cancer , Phase 1
8786,D07RJD,Resorcinol compound 2,Albinism , Patented
8787,D07RJD,Resorcinol compound 2,Ephelides , Patented
8788,D07RJD,Resorcinol compound 2,Menkes disease , Patented
8789,D07RJD,Resorcinol compound 2,Senile lentigines , Patented
8790,D07RJD,Resorcinol compound 2,Melasma , Patented
8791,D07RKN,GGTI-2418,Solid tumour/cancer , Phase 1
8792,D07RKO,MRX-6,Contact dermatitis , Phase 2
8793,D07RME,GX-401,Arteriosclerosis , Investigative
8794,D07RMX,ZK-thiazolidinone,Solid tumour/cancer , Preclinical
8795,D07RPB,HT-90B,Anxiety disorder , Terminated
8796,D07RPC,RAP-103,Neuropathic pain , Investigative
8797,D07RPK,NIP-151,Atrial fibrillation , Investigative
8798,D07RPR,Bropirimine,Virus infection , Discontinued in Phase 3
8799,D07RPT,Lentiviral RNAi therapy,Human immunodeficiency virus-1 infection , Phase 1
8800,D07RQA,Alkyl mannoside derivative 8,Crohn disease , Patented
8801,D07RQA,Alkyl mannoside derivative 8,Ulcerative colitis , Patented
8802,D07RQA,Alkyl mannoside derivative 8,Urinary tract infection , Patented
8803,D07RQR,SYN-120,Alzheimer disease , Phase 2
8804,D07RQR,SYN-120,Parkinson disease , Phase 2
8805,D07RRC,BioHib,Haemophilus influenza , Approved
8806,D07RSI,Lipobean,Lipid metabolism disorder , Approved
8807,D07RST,Ibuprofenamine,Osteoarthritis , Phase 2
8808,D07RUC,E-6087,Pain , Discontinued in Phase 1
8809,D07RUD,Progesterone,Amenorrhea , Approved
8810,D07RUD,Progesterone,Coronavirus Disease 2019 (COVID-19) , Phase 1
8811,D07RUH,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14",Albinism , Patented
8812,D07RUH,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14",Ephelides , Patented
8813,D07RUH,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14",Menkes disease , Patented
8814,D07RUH,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14",Senile lentigines , Patented
8815,D07RUH,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 14",Melasma , Patented
8816,D07RUR,HB-1345,Acne vulgaris , Investigative
8817,D07RUV,Terflavoxate,Urinary incontinence , Discontinued in Phase 2
8818,D07RVP,GR-63799X,Asthma , Discontinued in Phase 1
8819,D07RWY,LMI1195,Heart failure , Phase 2
8820,D07RXM,HM-90822,Solid tumour/cancer , Investigative
8821,D07RXX,HG-1051,Immune System disease , Investigative
8822,D07RYI,Etelcalcetide,Secondary hyperparathyroidism , Approved
8823,D07RYI,Etelcalcetide,Myelodysplastic syndrome , Phase 3
8824,D07RYM,PMID25666693-Compound-131,Osteoarthritis pain , Patented
8825,D07RYM,PMID25666693-Compound-131,Cancer related pain , Patented
8826,D07RYM,PMID25666693-Compound-131,Neuropathic pain , Patented
8827,D07RYM,PMID25666693-Compound-131,Inflammatory pain , Patented
8828,D07RYX,Antide,Prostate hyperplasia , Discontinued in Phase 2
8829,D07RZW,AZD9150,Haematological malignancy , Phase 1/2
8830,D07SBP,AZD4831,Heart failure , Phase 1
8831,D07SBX,Anti-HCV peptides,Hepatitis C virus infection , Investigative
8832,D07SCN,KC-11458,Gastric motility disorder , Discontinued in Phase 2
8833,D07SDE,Pranidipine,Angina pectoris , Terminated
8834,D07SDQ,Curcumin,Solid tumour/cancer , Phase 3
8835,D07SDT,HPP-376,Pain , Investigative
8836,D07SEB,BM-17.0505,Diabetic complication , Terminated
8837,D07SEZ,HG-1072,Solid tumour/cancer , Investigative
8838,D07SGB,ABT-299,Sepsis , Discontinued in Phase 1
8839,D07SHZ,COTI-58,Small-cell lung cancer , Investigative
8840,D07SJT,Pantothenic acid,Vitamin deficiency , Approved
8841,D07SKJ,LY3015014,Cardiovascular disease , Phase 2
8842,D07SKN,PF-885706,Gastroesophageal reflux disease , Phase 2
8843,D07SLJ,JCAR024,Breast cancer , Phase 1
8844,D07SLJ,JCAR024,Non-small-cell lung cancer , Phase 1
8845,D07SMH,MK-5172,Hepatitis C virus infection , Phase 2
8846,D07SNG,DF-098,Haemophilus influenza , Approved
8847,D07SNN,STxB-E7,Human papillomavirus infection , Investigative
8848,D07SNO,Dabrafenib + trametinib,Non-small-cell lung cancer , Phase 2
8849,D07SOJ,Adenovirus/Semliki Forest virus hybrid vector delivered IL-12 immunotherapy,Hepatitis B virus infection , Investigative
8850,D07SOO,Methoxyflurane,Anaesthesia , Approved
8851,D07SPG,ARGX-110,Autoimmune diabetes , Phase 1
8852,D07SQT,Ferroportin mab,Anemia , Phase 1
8853,D07SRN,Debio-1036,Autoimmune diabetes , Investigative
8854,D07STB,EG-1962,Subarachnoid hemorrhage , Phase 3
8855,D07STB,EG-1962,Aneurysmal subarachnoid hemorrhage , Phase 3
8856,D07SUG,Busulfan,Myeloproliferative syndrome , Approved
8857,D07SWU,TM30338,Obesity , Discontinued in Phase 2
8858,D07SXG,PRT-061103,Cardiovascular disease , Investigative
8859,D07SXO,AG-041R,Ulcerative colitis , Terminated
8860,D07SYJ,Sulfameter,Bacterial infection , Approved
8861,D07SYN,FX-007,Pain , Preclinical
8862,D07SYO,Stromal stem cell therapy,Liver failure , Phase 1
8863,D07SYY,"Pyrazolo[1,5-a]pyrimidine derivative 3",Obesity , Patented
8864,D07SYZ,RX-0201,Solid tumour/cancer , Phase 2
8865,D07SYZ,RX-0201,Renal cell carcinoma , Phase 2
8866,D07SYZ,RX-0201,Pancreatic cancer , Phase 2
8867,D07SZJ,A-75169,Glaucoma/ocular hypertension , Terminated
8868,D07TAS,CI-959,Asthma , Phase 1
8869,D07TBD,DT-2228,Major depressive disorder , Investigative
8870,D07TBJ,NuThrax,Anthrax , Phase 2
8871,D07TCS,CDP-6038,Rheumatoid arthritis , Phase 2
8872,D07TCV,Anti-CD19 anti-CD20 Bispecific CAR-T,leukaemia , Phase 1
8873,D07TCV,Anti-CD19 anti-CD20 Bispecific CAR-T,Lymphoma , Phase 1
8874,D07TDT,L-733560,Aspergillosis , Terminated
8875,D07TDV,Bendavia,Mitochondrial myopathy , Phase 3
8876,D07TDV,Bendavia,Heart failure , Phase 2
8877,D07TDV,Bendavia,Acute myocardial infarction , Phase 2
8878,D07TEE,"Gene therapy, mucopolysaccharidosis type I",Mucopolysaccharidosis , Investigative
8879,D07TEP,SCH 420814,Parkinson disease , Phase 2
8880,D07TFL,Blosozumab,Osteoporosis , Phase 2
8881,D07TGN,Deslanoside,Heart failure , Approved
8882,D07TGN,Deslanoside,Arrhythmia , Approved
8883,D07TGN,Deslanoside,Congestive cardiac insufficiency , Approved
8884,D07TGY,Indeloxazine,Dementia , Approved
8885,D07THJ,IPH-3102,Solid tumour/cancer , Terminated
8886,D07TIX,TDI-0018,Motor neurone disease , Investigative
8887,D07TJM,PMID30784880-compound-6-5,Severe acute respiratory syndrome (SARS) , Preclinical
8888,D07TJT,Imilecleucel-T,Multiple sclerosis , Phase 2
8889,D07TKZ,BIOD-123,Type-1 diabetes , Phase 2
8890,D07TKZ,BIOD-123,Type-2 diabetes , Phase 2
8891,D07TMJ,EGFRt/19-28z/4-1BBL CAR T cells,Chronic lymphocytic leukaemia , Phase 1
8892,D07TMR,ISIS 23722,Solid tumour/cancer , Phase 3
8893,D07TNU,DACTIMICIN,Bacterial infection , Terminated
8894,D07TOK,Larotrectinib,Solid tumour/cancer , Approved
8895,D07TPL,Ro-40-0655,Colorectal cancer , Investigative
8896,D07TQN,Asimadoline,Diarrhea-predominant irritable bowel syndrome , Phase 3
8897,D07TQN,Asimadoline,Pruritus , Phase 2
8898,D07TQU,FibroStem,Sarcoidosis , Investigative
8899,D07TQV,Lamivudine,Chronic HBV infection , Approved
8900,D07TQV,Lamivudine,Human immunodeficiency virus infection , Approved
8901,D07TQV,Lamivudine,Human immunodeficiency virus-1 infection , Approved
8902,D07TRF,F18-florbetaben,Alzheimer disease , Approved
8903,D07TRP,APTO-253,Solid tumour/cancer , Phase 1
8904,D07TRV,Anthrax vaccine,Bacillus anthracis infection , Discontinued in Phase 1
8905,D07TSS,MSC-100-IV,Crohn disease , Phase 3
8906,D07TSV,Atorvastatin,Hyperlipidemia , Approved
8907,D07TSV,Atorvastatin,Coronavirus Disease 2019 (COVID-19) , Phase 2
8908,D07TTI,AZD-8309,Rheumatoid arthritis , Discontinued in Phase 1
8909,D07TTI,AZD-8309,Chronic obstructive pulmonary disease , Discontinued in Phase 1
8910,D07TUD,PF-2391677,Gastroesophageal reflux disease , Discontinued in Phase 1
8911,D07TUT,ND-07,Inflammation , Investigative
8912,D07TWK,TCN-P,Acute myeloid leukaemia , Phase 1
8913,D07TWN,Tafenoquine,Plasmodium vivax malaria , Approved
8914,D07TWN,Tafenoquine,Malaria , Approved
8915,D07TWZ,TDI-0053,Motor neurone disease , Investigative
8916,D07TXJ,Dextofisopam,Irritable bowel syndrome , Phase 2
8917,D07TYE,GS-9857,Hepatitis C virus infection , Phase 2
8918,D07TYJ,PRO-98498,Asthma , Phase 2
8919,D07TYM,Autologous T-lymphocyte cell therapy,Peripheral vascular disease , Phase 2
8920,D07TYV,BAY1862864,Non-hodgkin lymphoma , Phase 1
8921,D07TZT,A-007,Skin cancer , Phase 2
8922,D07UAJ,CMB-401,Breast cancer , Terminated
8923,D07UAS,PEG arginine deiminase,Hepatocellular carcinoma , Phase 3
8924,D07UAS,PEG arginine deiminase,Acute myeloid leukaemia , Phase 1
8925,D07UBB,ITI-003,Female sexual arousal dysfunction , Investigative
8926,D07UBG,Olmesartan medoxomil,High blood pressure , Approved
8927,D07UBK,AS-1892802,Pain , Investigative
8928,D07UBZ,Thiazoline derivative 2,Albinism , Patented
8929,D07UBZ,Thiazoline derivative 2,Ephelides , Patented
8930,D07UBZ,Thiazoline derivative 2,Menkes disease , Patented
8931,D07UBZ,Thiazoline derivative 2,Senile lentigines , Patented
8932,D07UBZ,Thiazoline derivative 2,Melasma , Patented
8933,D07UDI,HO/04/08,Dermatological disease , Investigative
8934,D07UDO,DNX-3000,Solid tumour/cancer , Investigative
8935,D07UDW,COG-112,Solid tumour/cancer , Investigative
8936,D07UEJ,Empagli ozin,Type-2 diabetes , Investigative
8937,D07UFS,SPI-5557,Deafness , Investigative
8938,D07UGA,Sphingosine-1-phosphate,Acne vulgaris , Phase 1
8939,D07UGI,PPS14 PCMV,Streptococcus infection , Investigative
8940,D07UHS,Fingolimod,Primary progressive multiple sclerosis , Approved
8941,D07UHX,9-AMINOCAMPTOTHECIN,Acquired immune deficiency syndrome , Phase 2
8942,D07UHY,NIK-616,Chronic obstructive pulmonary disease , Terminated
8943,D07UIS,CORT125281,Prostate cancer , Phase 2
8944,D07UJA,DRL-17822,Arteriosclerosis , Phase 2
8945,D07UKF,VBY-129,Autoimmune diabetes , Phase 1
8946,D07UKF,VBY-129,Crohn disease , Phase 1
8947,D07UKF,VBY-129,Neuropathic pain , Phase 1
8948,D07UKJ,Enavatuzumab,Solid tumour/cancer , Phase 1
8949,D07UKT,ALRN-6924,Haematological malignancy , Phase 2
8950,D07UKT,ALRN-6924,Acute myeloid leukaemia , Phase 1
8951,D07UKT,ALRN-6924,Myelodysplastic syndrome , Phase 1
8952,D07UKT,ALRN-6924,Solid tumour/cancer , Phase 1
8953,D07ULK,OX-23,Pain , Terminated
8954,D07ULS,DDG-39,Acquired immune deficiency syndrome , Terminated
8955,D07UNH,Pyridine and pyrimidine derivative 1,Fibrosis , Patented
8956,D07UNH,Pyridine and pyrimidine derivative 1,Pain , Patented
8957,D07UNH,Pyridine and pyrimidine derivative 1,Solid tumour/cancer , Patented
8958,D07UOS,MK-434,Prostate disease , Discontinued in Phase 1
8959,D07UQQ,ACE-536,Myelodysplastic syndrome , Phase 3
8960,D07UQQ,ACE-536,Anemia , Phase 2
8961,D07UQQ,ACE-536,Myelofibrosis , Phase 2
8962,D07UQR,Keyhole limpet hemocyanin,Bladder cancer , Discontinued in Phase 3
8963,D07URD,PRX-102,Fabry disease , Phase 1/2
8964,D07URH,AP-004,Proctitis , Investigative
8965,D07USR,SAVX-1,Central nervous system disease , Investigative
8966,D07USV,MM-302,Breast cancer , Phase 1
8967,D07UTC,QNL-111,Human immunodeficiency virus-1 infection , Investigative
8968,D07UUB,4SC-203,Solid tumour/cancer , Phase 1
8969,D07UWJ,Bromhexine,Sjogren syndrome , Approved
8970,D07UWV,Argatroban,Thrombosis , Approved
8971,D07UXF,AR19,Mental disease , Phase 3
8972,D07UXJ,Aom-0785,Bacterial infection , Investigative
8973,D07UXP,Cinoxacin,Urinary tract infection , Approved
8974,D07UYO,Linezolid,Bacterial infection , Approved
8975,D07UZX,Nerve growth factor conjugated RAP peptide,Neurodegenerative disorder , Investigative
8976,D07UZY,Lpathomab,Solid tumour/cancer , Phase 1
8977,D07VAI,ALZ-801,Alzheimer disease , Phase 2
8978,D07VAQ,MG-1109,Influenza virus infection , Phase 3
8979,D07VBA,Estradiol Valerate,Hormone replacement therapy , Approved
8980,D07VDF,CXCR4 gene disrupted T cells,Human immunodeficiency virus infection , Investigative
8981,D07VDZ,Topiramate,Alcohol dependence , Approved
8982,D07VDZ,Topiramate,Epilepsy , Approved
8983,D07VDZ,Topiramate,Seizure disorder , Investigative
8984,D07VFD,Mirogabalin,Peripheral neuropathy , Registered
8985,D07VFD,Mirogabalin,Fibromyalgia , Phase 3
8986,D07VFD,Mirogabalin,Cancer related pain , Phase 3
8987,D07VFD,Mirogabalin,Cardiovascular disease , Phase 3
8988,D07VFQ,Six-membered heterocyclic benzamide derivative 3,Pruritus , Patented
8989,D07VFQ,Six-membered heterocyclic benzamide derivative 3,Solid tumour/cancer , Patented
8990,D07VFQ,Six-membered heterocyclic benzamide derivative 3,Chronic pain , Patented
8991,D07VFQ,Six-membered heterocyclic benzamide derivative 3,Neuropathic pain , Patented
8992,D07VFQ,Six-membered heterocyclic benzamide derivative 3,Thymic cancer , Patented
8993,D07VHR,Phenylbutazone,Chronic pain , Approved
8994,D07VHS,Isavuconazole,Invasive aspergillosis , Phase 3
8995,D07VHS,Isavuconazole,Invasive candidiasis , Phase 3
8996,D07VHS,Isavuconazole,Candidemia , Phase 3
8997,D07VHU,NIS793,Pancreatic ductal carcinoma , Phase 2
8998,D07VHU,NIS793,Solid tumour/cancer , Phase 1/2
8999,D07VHX,Augmab,Solid tumour/cancer , Investigative
9000,D07VIB,Tecarfarin,Cerebrovascular ischaemia , Phase 3
9001,D07VIB,Tecarfarin,Thrombosis , Phase 3
9002,D07VIK,Arsenic trioxide,Acute lymphoblastic leukaemia , Approved
9003,D07VJI,Hookworm vaccine,Infectious disease , Phase 1
9004,D07VJK,IDN-6384,Solid tumour/cancer , Investigative
9005,D07VKT,Ch14.18 mab,Diabetic foot ulcer , Phase 3
9006,D07VKT,Ch14.18 mab,Neuroblastoma , Phase 3
9007,D07VLY,Doxorubicin,Solid tumour/cancer , Approved
9008,D07VLY,Doxorubicin,Hepatocellular carcinoma , Phase 3
9009,D07VLY,Doxorubicin,Breast cancer , Phase 2
9010,D07VLY,Doxorubicin,Tumour , Investigative
9011,D07VMC,LY-243062,Inflammation , Terminated
9012,D07VNH,Acebilustat,Chronic blistering skin disorder , Phase 1
9013,D07VOF,THA-904,Neuropathic pain , Investigative
9014,D07VPG,BW-773U82,Solid tumour/cancer , Discontinued in Phase 2
9015,D07VQW,Sant7,Multiple myeloma , Investigative
9016,D07VRO,Benzalkonium chloride,Bacterial infection , Approved
9017,D07VRP,EG-Mirotin,Diabetic retinopathy , Investigative
9018,D07VSA,KRX-0403,Solid tumour/cancer , Discontinued in Phase 2
9019,D07VTD,HBV-MF59,Hepatitis B virus infection , Discontinued in Phase 2
9020,D07VUD,ZD-3980,Prostate hyperplasia , Terminated
9021,D07VWP,S-9947,Atrial fibrillation , Investigative
9022,D07VXT,INCB8696,Multiple sclerosis , Discontinued in Phase 1
9023,D07VYO,Recombinant human alkaline phosphatase,Ulcerative colitis , Investigative
9024,D07VYP,FT-2102,Glioma , Phase 1/2
9025,D07VYP,FT-2102,Acute myeloid leukaemia , Phase 1
9026,D07VYP,FT-2102,Myelodysplastic syndrome , Phase 1
9027,D07VZV,N-0861,Cardiac disease , Discontinued in Phase 3
9028,D07WAF,Anti-Fas mabs,Solid tumour/cancer , Investigative
9029,D07WCB,Colchicine,Acute gout flare , Approved
9030,D07WCB,Colchicine,Coronavirus Disease 2019 (COVID-19) , Phase 2
9031,D07WCT,SAR-100842,Fibrosis , Phase 2
9032,D07WCT,SAR-100842,Systemic sclerosis , Phase 2
9033,D07WDS,NNC-14-0189,Epilepsy , Terminated
9034,D07WDW,VR496,Cystic fibrosis , Phase 2
9035,D07WEN,Venglustat,Fabry disease , Phase 2
9036,D07WEN,Venglustat,Parkinson disease , Phase 2
9037,D07WEN,Venglustat,Gaucher disease , Phase 1
9038,D07WEP,Diazoxide,Hypertension , Approved
9039,D07WEV,PMID26868298-compound-5705213,Severe acute respiratory syndrome (SARS) , Preclinical
9040,D07WEV,PMID26868298-compound-5705213,Middle East Respiratory Syndrome (MERS) , Preclinical
9041,D07WFK,Acetohexamide,Diabetic complication , Approved
9042,D07WFQ,VBP 926,Paronychia , Phase 2
9043,D07WGE,C-KAD,Cataract , Phase 2
9044,D07WGN,DP9,Myocardial ischemia , Phase 2
9045,D07WGW,WJ-9708011,Prostate cancer , Investigative
9046,D07WHN,FASORACETAM,Cognitive impairment , Phase 3
9047,D07WHS,"CL-316,243",Obesity , Phase 2
9048,D07WJE,NVC-422,Infectious disease , Phase 2/3
9049,D07WJU,SUVN-911,Major depressive disorder , Phase 1
9050,D07WLI,99mTc-fanolesomab,Appendicitis , Approved
9051,D07WMD,MK-5478,Hypertension , Phase 1
9052,D07WMH,GT102-279,Hypercholesterolaemia , Discontinued in Phase 2
9053,D07WNG,Atrimer,Autoimmune diabetes , Investigative
9054,D07WON,Bronchostat,Bronchitis , Approved
9055,D07WPE,Epothilon,Ovarian cancer , Phase 3
9056,D07WPQ,Oxycodone hydrochloride,Chronic pain , Application submitted
9057,D07WQT,Ivermectin,Onchocerciasis , Approved
9058,D07WQT,Ivermectin,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
9059,D07WRW,LADIRUBICIN,Breast cancer , Phase 2
9060,D07WSR,TS-032,Schizophrenia , Discontinued in Phase 1
9061,D07WTG,Recombinant acidic fibroblast growth factor,Skin burns , Phase 3
9062,D07WTH,UltraCD40L,Systemic lupus erythematosus , Phase 1
9063,D07WUJ,H5N1 influenza vaccine,Human immunodeficiency virus infection , Phase 1
9064,D07WXE,L-alanyl-l-glutamine,Mucositis , Approved
9065,D07WXH,Pandemrix,Influenza virus infection , Approved
9066,D07WXI,Maribavir,Cytomegalovirus infection , Phase 3
9067,D07WXQ,CKD-404,Growth failure , Investigative
9068,D07WYI,SPI-1620,Solid tumour/cancer , Phase 2
9069,D07WYO,JI-3292,Inflammation , Investigative
9070,D07WZH,Cephaloglycin,Bacterial infection , Approved
9071,D07XAX,AEP-924,Major depressive disorder , Terminated
9072,D07XBA,PMID25684022-Compound-US20130053382 36(3-5),Solid tumour/cancer , Patented
9073,D07XBA,PMID25684022-Compound-US20130053382 36(3-5),Metastatic cancer , Patented
9074,D07XBE,Lentinan,Solid tumour/cancer , Approved
9075,D07XBI,AVR118,leukaemia , Phase 2
9076,D07XBZ,ARC-200,Solid tumour/cancer , Investigative
9077,D07XCF,Benfluorex,Hyperlipidaemia , Withdrawn from market
9078,D07XCG,Apligraf,Diabetic foot ulcer , Approved
9079,D07XCQ,MDX-1414,Solid tumour/cancer , Investigative
9080,D07XDQ,Figopitant,Diabetic complication , Phase 1
9081,D07XDS,Tomopenem,Bacterial infection , Discontinued in Phase 2
9082,D07XEV,WPP-201,Diabetic foot ulcer , Phase 1
9083,D07XGH,Pristinamycin,Bacterial infection , Approved
9084,D07XGR,Fenofibrate,High cholesterol level , Approved
9085,D07XGT,AM-577,Pain , Terminated
9086,D07XHJ,TAN-950A,Fungal infection , Terminated
9087,D07XHO,Nafamostat,Pancreatitis , Approved
9088,D07XHO,Nafamostat,Sepsis , Discontinued in Phase 2
9089,D07XJJ,M118,Acute coronary syndrome , Phase 2
9090,D07XJM,Dicyclomine,Functional bowel syndrome , Approved
9091,D07XLA,GM04-001,Influenza virus infection , Investigative
9092,D07XMG,IFN-alpha 2B-XL,Hepatitis virus infection , Discontinued in Phase 2
9093,D07XOV,EFT508,Colorectal cancer , Phase 2
9094,D07XOV,EFT508,Hepatocellular carcinoma , Phase 2
9095,D07XOV,EFT508,Triple negative breast cancer , Phase 2
9096,D07XOV,EFT508,Solid tumour/cancer , Phase 1/2
9097,D07XOV,EFT508,Lymphoma , Phase 1/2
9098,D07XPE,Phenformin,Diabetic complication , Withdrawn from market
9099,D07XPT,Ronacaleret,Osteoporosis , Discontinued in Phase 2
9100,D07XQS,ONC201,Glioma , Phase 2
9101,D07XQS,ONC201,Endometrial cancer , Phase 2
9102,D07XQS,ONC201,Multiple myeloma , Phase 2
9103,D07XQS,ONC201,Neuroendocrine cancer , Phase 2
9104,D07XQS,ONC201,Recurring respiratory infection , Phase 2
9105,D07XQS,ONC201,leukaemia , Phase 1/2
9106,D07XQS,ONC201,Lymphoma , Phase 1/2
9107,D07XQS,ONC201,Solid tumour/cancer , Phase 1
9108,D07XRU,Telmisartan,Hypertension , Approved
9109,D07XRU,Telmisartan,Coronavirus Disease 2019 (COVID-19) , Phase 3
9110,D07XSD,SUN-13333,Inflammation , Investigative
9111,D07XSN,Cytarabine,Acute lymphoblastic leukaemia , Approved
9112,D07XVL,PMID25666693-Compound-119,Osteoarthritis pain , Patented
9113,D07XVL,PMID25666693-Compound-119,Cancer related pain , Patented
9114,D07XVL,PMID25666693-Compound-119,Neuropathic pain , Patented
9115,D07XVL,PMID25666693-Compound-119,Inflammatory pain , Patented
9116,D07XVN,Dexrazoxane,Breast cancer , Approved
9117,D07XVN,Dexrazoxane,Chemoprotection , Approved
9118,D07XVN,Dexrazoxane,Respiratory tract disease , Investigative
9119,D07XVR,Sodium nitroprusside,Hypertension , Approved
9120,D07XXT,DEDN-6526A,Melanoma , Phase 1
9121,D07XYT,Medusa IL-2,Solid tumour/cancer , Phase 1/2
9122,D07XYV,Bambuterol,Asthma , Approved
9123,D07XZR,PMID25666693-Compound-134,Osteoarthritis pain , Patented
9124,D07XZR,PMID25666693-Compound-134,Cancer related pain , Patented
9125,D07XZR,PMID25666693-Compound-134,Neuropathic pain , Patented
9126,D07XZR,PMID25666693-Compound-134,Inflammatory pain , Patented
9127,D07YAC,Anticalin,Alzheimer disease , Investigative
9128,D07YAR,NX-1207,Hepatocellular carcinoma , Phase 3
9129,D07YAR,NX-1207,Prostate cancer , Phase 2
9130,D07YCR,S-16020-2,Solid tumour/cancer , Discontinued in Phase 2
9131,D07YDE,Nitroglycerin,Diabetic foot ulcer , Approved
9132,D07YDE,Nitroglycerin,Angina pectoris , Approved
9133,D07YDO,GTx-186,Solid tumour/cancer , Investigative
9134,D07YEK,NV-52,Inflammatory bowel disease , Phase 1
9135,D07YGH,GSK239512,Dementia , Phase 2
9136,D07YGH,GSK239512,Alzheimer disease , Phase 2
9137,D07YGK,Vilaprisan,Endometriosis , Phase 2
9138,D07YGQ,Anti-MUC1 AR20.5,Pancreatic cancer , Phase 1/2
9139,D07YHM,LY-2456302,Alcohol dependence , Phase 2
9140,D07YHM,LY-2456302,Major depressive disorder , Phase 2
9141,D07YHT,ENRASENTAN,Pulmonary arterial hypertension , Discontinued in Phase 2
9142,D07YHY,CR-2093,Intestine cancer , Discontinued in Phase 1
9143,D07YIX,NmVac4,Meningococcal infection , Phase 1
9144,D07YJK,ShRNA apolipoprotein B100 gene siliencer,Cardiovascular disease , Investigative
9145,D07YKJ,EVT-103,Major depressive disorder , Discontinued in Phase 1
9146,D07YKQ,EPX-100,Dravet syndrome , Phase 1
9147,D07YLK,LE-300,Schizophrenia , Preclinical
9148,D07YLO,SDF-1,Heart failure , Phase 2
9149,D07YLO,SDF-1,Peripheral arterial disease , Phase 2
9150,D07YLV,Ciclesonide,Asthma , Approved
9151,D07YLV,Ciclesonide,Coronavirus Disease 2019 (COVID-19) , Phase 3
9152,D07YMP,TAB001,Advanced malignancy , Phase 1
9153,D07YNC,NCI-4650,Melanoma , Phase 1/2
9154,D07YNH,SAN-61,Alzheimer disease , Terminated
9155,D07YNM,NN8765,Rheumatoid arthritis , Phase 2
9156,D07YOP,JBD-401,Solid tumour/cancer , Investigative
9157,D07YPA,CGEN-920,Inflammation , Investigative
9158,D07YPB,Hu-CART meso cells,Fallopian tube cancer , Phase 1
9159,D07YPB,Hu-CART meso cells,Lung cancer , Phase 1
9160,D07YPB,Hu-CART meso cells,Ovarian cancer , Phase 1
9161,D07YPB,Hu-CART meso cells,Peritoneal mesothelioma , Phase 1
9162,D07YPB,Hu-CART meso cells,Pleural mesothelioma , Phase 1
9163,D07YPP,BreMel/TNF alpha,Breast cancer , Investigative
9164,D07YPV,AbelaDrug200,Head injury , Phase 1/2
9165,D07YPW,Shigamabs,Bacterial infection , Phase 3
9166,D07YPW,Shigamabs,Haemolytic uraemic syndrome , Phase 2
9167,D07YRJ,AERAS-405,Mycobacterium infection , Investigative
9168,D07YRV,AER-002,Chronic obstructive pulmonary disease , Phase 2
9169,D07YRW,ASP7991,Hyperparathyroidism , Phase 2
9170,D07YUH,HybriCell,Melanoma , Approved
9171,D07YUY,MDL-29311,Arteriosclerosis , Terminated
9172,D07YVK,Sumanirole,Parkinson disease , Phase 3
9173,D07YVM,CLX-090700,Diabetic complication , Preclinical
9174,D07YWY,Nafronyl,Cerebrovascular ischaemia , Approved
9175,D07YXD,HL-024,Solid tumour/cancer , Investigative
9176,D07YZK,CAMI-103,Heart failure , Investigative
9177,D07YZQ,Melanoma DNA vaccine,Melanoma , Phase 1
9178,D07ZAH,ACH-1625,Hepatitis C virus infection , Phase 2
9179,D07ZAK,RGX 501,Familial hypercholesterolemia , Phase 1/2
9180,D07ZAO,OVI-123,Acute lymphoblastic leukaemia , Phase 1/2
9181,D07ZBE,Iobitridol,Solid tumour/cancer , Approved
9182,D07ZBO,ADepVac,Alzheimer disease , Investigative
9183,D07ZCK,ZK-93423,Epileptic seizures , Phase 3
9184,D07ZCU,BKT-120,Solid tumour/cancer , Investigative
9185,D07ZDG,EDN-OL1,Alzheimer disease , Investigative
9186,D07ZES,T2CA,Allergic rhinitis , Investigative
9187,D07ZGF,Biothrax,Bacillus anthracis infection , Approved
9188,D07ZHM,ATX-S10,Solid tumour/cancer , Investigative
9189,D07ZHV,CB1954,Solid tumour/cancer , Discontinued in Phase 2
9190,D07ZJC,INOC-005,Solid tumour/cancer , Preclinical
9191,D07ZKE,PMID25684022-Compound-US20120277229 45(1.5),Solid tumour/cancer , Patented
9192,D07ZKE,PMID25684022-Compound-US20120277229 45(1.5),Metastatic cancer , Patented
9193,D07ZKK,131I-81C6,Brain cancer , Terminated
9194,D07ZMG,Thiazole carboxamide derivative 29,Solid tumour/cancer , Patented
9195,D07ZMG,Thiazole carboxamide derivative 29,Metastatic cancer , Patented
9196,D07ZMQ,HD-003,Kidney disease , Phase 2
9197,D07ZNF,IMC-EB10,Acute myeloid leukaemia , Phase 1
9198,D07ZNI,STX-140,Osteoporosis , Phase 2
9199,D07ZQS,Macrocycle derivative 9,Solid tumour/cancer , Patented
9200,D07ZQS,Macrocycle derivative 9,Infectious disease , Patented
9201,D07ZQS,Macrocycle derivative 9,Human immunodeficiency virus infection , Patented
9202,D07ZQS,Macrocycle derivative 9,Hepatitis , Patented
9203,D07ZRI,Technetium Tc-99m Oxidronate Kit,Radioactive tracer , Approved
9204,D07ZSU,Freeze-dried bee venom,Multiple sclerosis , Phase 3
9205,D07ZTB,HG-1068,Solid tumour/cancer , Investigative
9206,D07ZTD,MB-07811,Hyperlipidaemia , Phase 2
9207,D07ZTO,Bethanechol,Urinary retention , Approved
9208,D07ZUW,Nanoemulsion,Molluscum contagiosum infection , Phase 2/3
9209,D07ZUW,Nanoemulsion,Osteoarthritis , Phase 2
9210,D07ZUX,CR-3465,Allergy , Phase 1
9211,D07ZUZ,CK-2127107,Amyotrophic lateral sclerosis , Phase 2
9212,D07ZUZ,CK-2127107,Spinal muscular atrophy , Phase 2
9213,D07ZUZ,CK-2127107,Muscle atrophy , Phase 1
9214,D07ZVO,PT1.2,Staphylococcus infection , Phase 1
9215,D07ZXE,Wetimicin,Infectious disease , Discontinued in Phase 1
9216,D07ZZI,SLV-341,Non-insulin dependent diabetes , Phase 1
9217,D07ZZS,AGS-22ME,Solid tumour/cancer , Phase 1
9218,D07ZZX,MDX-1110,Lung cancer , Investigative
9219,D08AAB,VLX600,Solid tumour/cancer , Phase 1
9220,D08AAV,AZD-3514,Prostate cancer , Phase 1
9221,D08ABQ,Acalabrutinib,leukaemia , Approved
9222,D08ABQ,Acalabrutinib,Coronavirus Disease 2019 (COVID-19) , Phase 2
9223,D08ABX,CAR-T cells targeting CD34,Acute myeloid leukaemia , Preclinical
9224,D08ADK,Glycoferon,Hepatitis C virus infection , Investigative
9225,D08ADX,Clevudine,Hepatitis B , phase 4
9226,D08ADX,Clevudine,Coronavirus Disease 2019 (COVID-19) , Phase 2
9227,D08AFD,NP-252,Hypertension , Discontinued in Phase 1
9228,D08AHH,LHW090,Kidney failure , Phase 2
9229,D08AHH,LHW090,Hypertension , Phase 2
9230,D08AJF,PI-0824,Autoimmune diabetes , Phase 1
9231,D08ALK,Cisatracurium,Muscle spasm , Approved
9232,D08ALQ,RPR-101821,Arteriosclerosis , Terminated
9233,D08AMJ,TK-DLI,Graft-versus-host disease , Preregistration
9234,D08AMQ,SB-234551,Nerve injury , Discontinued in Phase 1
9235,D08ANE,Opdivo nivolumab +Yervoy ipilimumab,Brain and central nervous system tumour , Phase 2
9236,D08ANF,Cerebral EDV,Recurrent glioblastoma , Phase 1
9237,D08ANJ,AP-30663,Atrial fibrillation , Phase 1/2
9238,D08ANZ,Pembrolizumab,Melanoma , Approved
9239,D08ANZ,Pembrolizumab,Hepatocellular carcinoma , Phase 3
9240,D08ANZ,Pembrolizumab,Renal cell carcinoma , Phase 3
9241,D08ANZ,Pembrolizumab,Small-cell lung cancer , Phase 3
9242,D08ANZ,Pembrolizumab,Breast cancer , Phase 3
9243,D08ANZ,Pembrolizumab,Colorectal cancer , Phase 3
9244,D08ANZ,Pembrolizumab,Esophageal cancer , Phase 3
9245,D08ANZ,Pembrolizumab,Solid tumour/cancer , Phase 2
9246,D08ANZ,Pembrolizumab,Ovarian cancer , Phase 2
9247,D08ANZ,Pembrolizumab,Prostate cancer , Phase 2
9248,D08ANZ,Pembrolizumab,Cutaneous squamous cell carcinoma , Phase 2
9249,D08ANZ,Pembrolizumab,Primary mediastinal B-cell lymphoma , Application submitted
9250,D08AOV,INO-1002,Solid tumour/cancer , Investigative
9251,D08AOZ,BMS-986142,Rheumatoid arthritis , Phase 2
9252,D08APZ,NT-100,Implantation failure , Phase 2
9253,D08AWI,PRX-00023,Mood disorder , Discontinued in Phase 2
9254,D08AXM,VALERGENT-BT,Asthma , Investigative
9255,D08BBL,Iomab-B,Bone marrow transplantation , Phase 3
9256,D08BBL,Iomab-B,Acute myeloid leukaemia , Phase 3
9257,D08BBU,GW-42003,Opioid dependence , Phase 2
9258,D08BCU,U-90042,Anxiety disorder , Terminated
9259,D08BDT,Halopredone acetate,Arthritis , Approved
9260,D08BEA,Ipamorelin,Postoperative ileus , Phase 1/2
9261,D08BED,CERE-140,Glaucoma/ocular hypertension , Investigative
9262,D08BEO,Talampanel,Parkinson disease , Phase 2
9263,D08BIH,N-acylpyrrolidine ether derivative 2,Pruritus , Patented
9264,D08BIH,N-acylpyrrolidine ether derivative 2,Solid tumour/cancer , Patented
9265,D08BIH,N-acylpyrrolidine ether derivative 2,Chronic pain , Patented
9266,D08BIH,N-acylpyrrolidine ether derivative 2,Neuropathic pain , Patented
9267,D08BIH,N-acylpyrrolidine ether derivative 2,Thymic cancer , Patented
9268,D08BIJ,IL-1 Monoclonal Antibody,Cardiovascular disease , Phase 1
9269,D08BIN,Munumbicins,Bacterial infection , Terminated
9270,D08BKH,18-Methoxycoronaridine,Drug abuse , Investigative
9271,D08BKM,Porcine isophane insulin,Diabetic complication , Approved
9272,D08BLZ,Aryl mannoside derivative 23,Crohn disease , Patented
9273,D08BLZ,Aryl mannoside derivative 23,Ulcerative colitis , Patented
9274,D08BLZ,Aryl mannoside derivative 23,Urinary tract infection , Patented
9275,D08BMC,Olea europaea-containing vaccine,Allergic conjunctivitis , Phase 3
9276,D08BMO,Resveratrol,Middle East Respiratory Syndrome (MERS) , Preclinical
9277,D08BMV,PEG-hGH,Dwarfism , Phase 2
9278,D08BNB,Biaryl mannoside derivative 5,Crohn disease , Patented
9279,D08BNB,Biaryl mannoside derivative 5,Ulcerative colitis , Patented
9280,D08BNB,Biaryl mannoside derivative 5,Urinary tract infection , Patented
9281,D08BNJ,DTP-HepB-Polio-Hib,Pertussis , Phase 3
9282,D08BNJ,DTP-HepB-Polio-Hib,Tetanus , Phase 3
9283,D08BNJ,DTP-HepB-Polio-Hib,Diphtheria , Phase 3
9284,D08BPD,EC-70124,Solid tumour/cancer , Investigative
9285,D08BPS,JCAR017,Chronic lymphocytic leukaemia , Phase 1/2
9286,D08BPS,JCAR017,leukaemia , Phase 1/2
9287,D08BPS,JCAR017,Mantle cell lymphoma , Phase 1
9288,D08BPS,JCAR017,Non-hodgkin lymphoma , Phase 1
9289,D08BPS,JCAR017,Follicular lymphoma , Phase 1
9290,D08BPS,JCAR017,Primary mediastinal B-cell lymphoma , Phase 1
9291,D08BPS,JCAR017,B-cell non-hodgkin lymphoma , Phase 1
9292,D08BPS,JCAR017,Multiple myeloma , Clinical trial
9293,D08BQJ,Brain dendritic cell-based vaccine,Glioblastoma multiforme , Phase 1/2
9294,D08BTB,protirelin,Central nervous system disease , Approved
9295,D08BTX,X-387,Solid tumour/cancer , Investigative
9296,D08BVM,TTP-355,Diabetic complication , Discontinued in Phase 2
9297,D08BXT,Spermidine,Plaque psoriasis , Phase 3
9298,D08BXT,Spermidine,Rheumatoid arthritis , Phase 3
9299,D08BYJ,WIN-902A,Obesity , Investigative
9300,D08BZZ,Omburtamab I-131,Neuroblastoma , Phase 2/3
9301,D08BZZ,Omburtamab I-131,Small round cell desmoplastic tumour , Phase 1/2
9302,D08CCC,AFP-Scan,Liver cancer , Discontinued in Phase 2
9303,D08CCE,Guaimesal,Inflammation , Approved
9304,D08CCF,IPX-159,Restless legs syndrome , Discontinued in Phase 2
9305,D08CDE,Celgosivir,Dengue fever , Phase 1/2
9306,D08CDI,Lapatinib,Breast cancer , Approved
9307,D08CEA,122-0551 foam,Plaque psoriasis , Phase 3
9308,D08CEU,Recombinant Factor X,Hemophilia , Investigative
9309,D08CGE,Integrin alpha 5/beta 1,Metastatic malignant neoplasm , Investigative
9310,D08CGG,VRC-EBOADV018-00-VP,Ebola virus infection , Phase 1
9311,D08CGU,Bevacizumab + Rituximab,Non-hodgkin lymphoma , Phase 3
9312,D08CGU,Bevacizumab + Rituximab,Lymphoma , Phase 3
9313,D08CJM,Peptide YY 3-36,Obesity , Phase 2
9314,D08CKJ,Fonsartan,Hypertension , Discontinued in Phase 2
9315,D08CLA,PMID25666693-Compound-123,Osteoarthritis pain , Patented
9316,D08CLA,PMID25666693-Compound-123,Cancer related pain , Patented
9317,D08CLA,PMID25666693-Compound-123,Neuropathic pain , Patented
9318,D08CLA,PMID25666693-Compound-123,Inflammatory pain , Patented
9319,D08CLN,Suritozole,Major depressive disorder , Discontinued in Phase 2
9320,D08CMF,Angeloxin,Solid tumour/cancer , Investigative
9321,D08CNP,AC430,leukaemia , Phase 1
9322,D08COR,ARC-520,Hepatitis B virus infection , Phase 2
9323,D08COU,FSH patch,Infertility , Phase 1
9324,D08CPL,MIST-B03,Inflammation , Phase 1
9325,D08CPT,AC 137-164594,Obesity , Discontinued in Phase 2
9326,D08CQE,AVE-9940,Rheumatoid arthritis , Discontinued in Phase 1
9327,D08CQY,Brilacidin,Infectious disease , Phase 2
9328,D08CQY,Brilacidin,Acute bacterial skin infection , Phase 2
9329,D08CRO,PNH-192,Solid tumour/cancer , Investigative
9330,D08CSE,IP-880,Osteoarthritis , Approved
9331,D08CSZ,HMR-3004,Bacterial infection , Discontinued in Phase 2
9332,D08CTT,Dimethindene,Respiratory allergy , Approved
9333,D08CUE,BI-661051,Solid tumour/cancer , Phase 1
9334,D08CVC,Tocofersolan,Vitamin E deficiency , Phase 3
9335,D08CVQ,Mipomersen,Familial hypercholesterolemia , Approved
9336,D08CWX,BVX-20-CD20,Non-hodgkin lymphoma , Investigative
9337,D08CZE,Dihydropyrone,Hepatovirus infection , Investigative
9338,D08CZY,PMID28270021-Compound-WO2016054807Example71,Pruritus , Patented
9339,D08CZY,PMID28270021-Compound-WO2016054807Example71,Solid tumour/cancer , Patented
9340,D08CZY,PMID28270021-Compound-WO2016054807Example71,Chronic pain , Patented
9341,D08CZY,PMID28270021-Compound-WO2016054807Example71,Neuropathic pain , Patented
9342,D08CZY,PMID28270021-Compound-WO2016054807Example71,Thymic cancer , Patented
9343,D08DBE,R-343,Asthma , Discontinued in Phase 2
9344,D08DCP,BI-847325,Solid tumour/cancer , Phase 1
9345,D08DFF,AM-001,Dermatological disease , Phase 2
9346,D08DFF,AM-001,Actinic keratosis , Phase 2
9347,D08DFU,CMX-157,Human immunodeficiency virus infection , Phase 1
9348,D08DFX,Canagliflozin,Type-2 diabetes , Approved
9349,D08DFX,Canagliflozin,Diabetic nephropathy , Phase 3
9350,D08DFX,Canagliflozin,Type-1 diabetes , Phase 2
9351,D08DGC,CPL-7075,Diffuse systemic sclerosis , Phase 3
9352,D08DGC,CPL-7075,Cystic fibrosis , Phase 2
9353,D08DGC,CPL-7075,Rheumatoid arthritis , Phase 2
9354,D08DGC,CPL-7075,Systemic lupus erythematosus , Phase 2
9355,D08DGC,CPL-7075,Systemic sclerosis , Phase 2
9356,D08DGG,SnPP Protoporphyrin,Coronavirus Disease 2019 (COVID-19) , Phase 1
9357,D08DGW,CXL,Methicillin-resistant staphylococci infection , Phase 2
9358,D08DHN,VX-787,Influenza A virus infection , Phase 3
9359,D08DHR,EDP-22,Glaucoma/ocular hypertension , Investigative
9360,D08DIU,LN-144,Melanoma , Phase 2
9361,D08DJE,K-133W,Dysmenorrhea , Investigative
9362,D08DJH,Juvenile chondrocyte grafts,Contraception , Phase 2
9363,D08DJP,AE-298p,Solid tumour/cancer , Investigative
9364,D08DJV,TAK-195,Poliovirus infection , Phase 1
9365,D08DKA,Levcromakalim,Chronic obstructive pulmonary disease , Discontinued in Preregistration
9366,D08DMH,BAY2402234,Myeloid leukaemia , Phase 1
9367,D08DMY,Bria-IMT,Breast cancer , Phase 1/2
9368,D08DNA,PA-517,Autoimmune diabetes , Investigative
9369,D08DOE,ML-04,Myelodysplastic syndrome , Phase 2
9370,D08DOQ,IGN301,Solid tumour/cancer , Discontinued in Phase 1
9371,D08DPN,GSK-625433,Hepatitis C virus infection , Phase 1
9372,D08DPV,PRO-052,Duchenne dystrophy , Investigative
9373,D08DRU,Influenza A virus H5N1 cell culture-based vaccine,Influenza A virus H5N1 infection , Phase 1
9374,D08DSC,BST-1005,Solid tumour/cancer , Preclinical
9375,D08DSF,MEDI-557,Respiratory syncytial virus infection , Phase 1
9376,D08DTD,Biostrophin,Duchenne dystrophy , Phase 1
9377,D08DTR,RHPIV1 84/del/170/942A,Parainfluenza virus infection , Phase 1
9378,D08DUF,GL-0817,Head and neck cancer , Phase 2
9379,D08DUF,GL-0817,Squamous cell carcinoma , Phase 2
9380,D08DUF,GL-0817,Multiple myeloma , Phase 2
9381,D08DUF,GL-0817,Oral cavity squamous cell carcinoma , Phase 2
9382,D08DUY,T-1249,Human immunodeficiency virus infection , Phase 1/2
9383,D08DVE,BI-660848,Neuropathic pain , Phase 1
9384,D08DWC,MSC2015103B,Solid tumour/cancer , Phase 1
9385,D08DWH,Idrapril,Hypertension , Discontinued in Phase 2
9386,D08DWM,Gp100:209-217(210M) peptide vaccine,Melanoma , Phase 2
9387,D08DZO,Malaria DNA vaccine,Malaria , Phase 1/2
9388,D08DZZ,HE2100,Thrombocytopenia , Discontinued in Phase 1
9389,D08EAI,AS-101,Acute myeloid leukaemia , Phase 2
9390,D08EAR,HE2200,Hyperlipidaemia , Investigative
9391,D08EBN,Nitazoxanide,Diarrhea , Approved
9392,D08ECB,LAS-101057,Asthma , Preclinical
9393,D08ECW,Racotumomab,Breast cancer , Phase 2
9394,D08EDE,MIRNA-Rx07,Solid tumour/cancer , Investigative
9395,D08EEM,PV-701,Solid tumour/cancer , Phase 1
9396,D08EEO,Demobesin,Breast cancer , Phase 1
9397,D08EES,XR-5000,Colorectal cancer , Phase 2
9398,D08EEU,Englitazone sodium,Type-2 diabetes , Phase 1
9399,D08EGT,PMID25684022-Compound-WO2008005457,Solid tumour/cancer , Patented
9400,D08EGT,PMID25684022-Compound-WO2008005457,Metastatic cancer , Patented
9401,D08EHL,Macrocycle derivative 2,Solid tumour/cancer , Patented
9402,D08EHL,Macrocycle derivative 2,Infectious disease , Patented
9403,D08EHL,Macrocycle derivative 2,Human immunodeficiency virus infection , Patented
9404,D08EHL,Macrocycle derivative 2,Hepatitis , Patented
9405,D08EIK,LY3016859,Chronic kidney disease , Phase 1/2
9406,D08EIX,T-686,Arteriosclerosis , Terminated
9407,D08ELL,TBE-80E,Encephalitis virus infection , Investigative
9408,D08ELM,RWJ-58259,Artery stenosis , Terminated
9409,D08ENB,GSK1995057,Adult respiratory distress syndrome , Phase 1
9410,D08ENJ,Anti-CGEN-153 mab,Ovarian cancer , Investigative
9411,D08ENK,Insulin Susp Isophane Recombinant Human,Diabetic complication , Approved
9412,D08EOD,Methsuximide,Epileptic seizures , Approved
9413,D08EOW,RG7112,Haematological malignancy , Phase 1
9414,D08EOW,RG7112,Solid tumour/cancer , Discontinued in Phase 1
9415,D08EPK,UBP-551,Neurological disorder , Investigative
9416,D08EQD,FGF401,Hepatocellular carcinoma , Phase 1/2
9417,D08EQD,FGF401,Solid tumour/cancer , Phase 1/2
9418,D08EQQ,LPD-1050,Psoriasis vulgaris , Investigative
9419,D08ESA,CI-966,Convulsion , Phase 1
9420,D08EUS,CGC-11047,Prostate cancer , Phase 2
9421,D08EVF,Anti-Notch-1 mabs,Solid tumour/cancer , Investigative
9422,D08EVM,FR-128998,Thrombocytopenia , Terminated
9423,D08EVN,Tyropanoate sodium,Gallbladder disease , Approved
9424,D08EWE,Plitidepsin,Coronavirus Disease 2019 (COVID-19) , Phase 1
9425,D08EWM,UCB-0942,Epilepsy , Phase 2
9426,D08EWM,UCB-0942,Seizure disorder , Phase 2
9427,D08EYQ,ORE-1001,Diabetic complication , Phase 1/2
9428,D08EYQ,ORE-1001,Type-2 diabetes , Discontinued in Phase 1
9429,D08FAC,CaCP-29,Sepsis , Phase 2
9430,D08FAT,RP-170,Carcinoma , Terminated
9431,D08FDD,HL-4130,Hyperlipidaemia , Investigative
9432,D08FDX,MGCD265,Non-small-cell lung cancer , Phase 2
9433,D08FDX,MGCD265,Solid tumour/cancer , Phase 1
9434,D08FGX,PALOSURAN,Renal failure , Discontinued in Phase 2
9435,D08FHP,BFKB8488A,Type-2 diabetes , Phase 1
9436,D08FHV,NY-008,Hypertension , Terminated
9437,D08FHZ,ATL-313,Arteriosclerosis , Phase 1/2
9438,D08FIB,LY3316531,Psoriasis vulgaris , Phase 1
9439,D08FIX,OTSSP167,Acute lymphoblastic leukaemia , Phase 1
9440,D08FIX,OTSSP167,Acute myeloid leukaemia , Phase 1
9441,D08FIX,OTSSP167,Breast cancer , Phase 1
9442,D08FIX,OTSSP167,Chronic lymphocytic leukaemia , Phase 1
9443,D08FIX,OTSSP167,Myelodysplastic syndrome , Phase 1
9444,D08FIX,OTSSP167,Myeloproliferative neoplasm , Phase 1
9445,D08FJG,EHT/AGN-0002,Neurodegenerative disorder , Investigative
9446,D08FJL,Carbetocin,Postpartum haemorrhage , Approved
9447,D08FKD,Autologous renal cell carcinoma vaccine,Renal cell carcinoma , Phase 2
9448,D08FKH,KLH-2109,Endometriosis , Phase 2
9449,D08FKL,ACHN-975,Pseudomonas infection , Phase 1
9450,D08FKX,SDZ-MAR-327,Psychotic disorder , Phase 2
9451,D08FKX,SDZ-MAR-327,Schizophrenia , Terminated
9452,D08FMK,LY2944876,Diabetic complication , Phase 2
9453,D08FMR,ARC-1905,Macular degeneration , Phase 1
9454,D08FNJ,RO-14,Phlebothrombosis , Phase 1
9455,D08FOX,Piroximone,Cardiac failure , Discontinued in Phase 3
9456,D08FPM,Dhaq diacetate,Solid tumour/cancer , Approved
9457,D08FSD,SER-100,Heart failure , Phase 2
9458,D08FSR,QLT-091382,Sebaceous gland disease , Investigative
9459,D08FTG,Phenindione,Coagulation defect , Approved
9460,D08FTG,Phenindione,Pulmonary embolism , Approved
9461,D08FTP,99mTc-MIP-1404,Prostate cancer , Phase 2
9462,D08FUR,IMU-838,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
9463,D08FVH,4SCAR19/22 T cells,B-cell lymphoma , Phase 1/2
9464,D08FVH,4SCAR19/22 T cells,leukaemia , Phase 1/2
9465,D08FWJ,GSK3377794,Melanoma , Phase 2
9466,D08FWJ,GSK3377794,Merkel cell carcinoma , Phase 2
9467,D08FWJ,GSK3377794,Multiple myeloma , Phase 2
9468,D08FWJ,GSK3377794,Ovarian cancer , Phase 2
9469,D08FWJ,GSK3377794,Synovial sarcoma , Phase 2
9470,D08FWK,Oxypurinol,Heart failure , Phase 2/3
9471,D08FWO,Lixte-1.2,Neurological disorder , Investigative
9472,D08FWW,Gammaplex,Immune System disease , Approved
9473,D08FXE,MD-920,Wound healing , Phase 1
9474,D08FXZ,RP-525,Solid tumour/cancer , Investigative
9475,D08FYH,PF-04776548,Human immunodeficiency virus infection , Phase 1
9476,D08FZT,Corus 1030,Asthma , Discontinued in Phase 2
9477,D08GAH,EV-075,Ebola virus infection , Investigative
9478,D08GBB,Valopicitabine dihydrochloride,Virus infection , Phase 2
9479,D08GBT,SAR-131675,Solid tumour/cancer , Investigative
9480,D08GEX,TriGem,Melanoma , Discontinued in Phase 2
9481,D08GFN,MVA-BN Breast,Prostate cancer , Phase 1
9482,D08GHB,Fluvastatin,Hypercholesterolaemia , Approved
9483,D08GHI,18F-AV-45 dimer,Cerebral amyloid angiopathy , Investigative
9484,D08GHX,TA-104,Osteoporosis , Investigative
9485,D08GIH,NGR-hTNF,Colorectal cancer , Phase 3
9486,D08GIH,NGR-hTNF,Malignant pleural mesothelioma , Phase 3
9487,D08GIM,Elisidepsin,Psoriasis vulgaris , Phase 2
9488,D08GJH,Blonanserin,Schizophrenia , Phase 3
9489,D08GJO,Benorilate,Arthritis , Approved
9490,D08GKD,AZD-2315,Rheumatoid arthritis , Discontinued in Phase 1
9491,D08GKD,AZD-2315,Chronic obstructive pulmonary disease , Discontinued in Phase 1
9492,D08GKU,BriaVax,Breast cancer , Phase 1/2
9493,D08GLH,DBP-118,Vomiting , Investigative
9494,D08GLX,MDT-2004,Pain , Phase 2
9495,D08GNA,SKF-106610,Autoimmune diabetes , Terminated
9496,D08GNX,FPL-14294,Obesity , Preclinical
9497,D08GNY,Lactococcus lactis anti-IL-27,Inflammatory bowel disease , Investigative
9498,D08GOD,Tradipitant,Coronavirus Disease 2019 (COVID-19) , Phase 3
9499,D08GOI,FT596,Lymphoma , Phase 1
9500,D08GQK,WS-75624B,Cardiovascular disease , Terminated
9501,D08GRF,LG-1550,Solid tumour/cancer , Discontinued in Phase 2
9502,D08GRY,DUP 697,Pain , Discontinued in Phase 1
9503,D08GSC,KPE-02001003,Hepatitis C virus infection , Phase 2
9504,D08GSF,Proflavine,Sepsis , Approved
9505,D08GSM,AG-014,Coeliac disease , Investigative
9506,D08GSX,MOR-104,Inflammation , Investigative
9507,D08GUX,TD-4001,Bladder disease , Investigative
9508,D08GUZ,Somatrem,Hormone deficiency , Approved
9509,D08GVB,AMR-001,Heart failure , Phase 2
9510,D08GYO,Procarbazine,Hodgkin lymphoma , Approved
9511,D08GZE,AbGn-107,Pancreatic cancer , Phase 1
9512,D08GZE,AbGn-107,Colorectal cancer , Phase 1
9513,D08GZE,AbGn-107,Gastric adenocarcinoma , Phase 1
9514,D08GZJ,MK-2918,Migraine , Investigative
9515,D08GZX,PF-613322,Chronic obstructive pulmonary disease , Investigative
9516,D08HDD,RP-58802B,Asthma , Terminated
9517,D08HDY,Pivmecillinam,Urinary tract infection , Approved
9518,D08HES,MC-02331,Gram-positive bacterial infection , Terminated
9519,D08HFA,Y-27152,Angina pectoris , Discontinued in Phase 2
9520,D08HFW,TAK-901,Haematological malignancy , Phase 1
9521,D08HGR,LLL-3348,Psoriasis vulgaris , Phase 2
9522,D08HGY,Naronapride,Gastroesophageal reflux disease , Discontinued in Phase 2
9523,D08HHT,Procervix,Human papillomavirus infection , Phase 2
9524,D08HIH,ERB-196,Inflammatory bowel disease , Discontinued in Phase 1
9525,D08HJI,WT2527,Solid tumour/cancer , Investigative
9526,D08HJT,Peplomycin,Breast cancer , Approved
9527,D08HKK,CD10-CART,leukaemia , Phase 1
9528,D08HKT,BEMORADAN,Heart failure , Phase 2
9529,D08HMK,ETC-276,Ischemia , Discontinued in Phase 1
9530,D08HNA,SMT-D001,Hypersalivation , Investigative
9531,D08HOM,ABT-348,Haematological malignancy , Phase 2
9532,D08HPZ,Tocilizumab,Rheumatoid arthritis , Approved
9533,D08HPZ,Tocilizumab,Juvenile idiopathic arthritis , Phase 3
9534,D08HQI,ISIS-EIF4E,Prostate cancer , Phase 2
9535,D08HQI,ISIS-EIF4E,Non-small-cell lung cancer , Phase 2
9536,D08HQI,ISIS-EIF4E,Solid tumour/cancer , Phase 2
9537,D08HQK,Tetracaine,Spinal anesthesia , Approved
9538,D08HQK,Tetracaine,Pain , Phase 2
9539,D08HQT,ZK-005,Wound healing , Investigative
9540,D08HRD,Plasmodium vivax vaccine,Plasmodium vivax malaria , Phase 1/2
9541,D08HRJ,Cyclizine,Nausea , Approved
9542,D08HSS,LY3300054,Solid tumour/cancer , Phase 1
9543,D08HSS,LY3300054,Advanced malignancy , Phase 1
9544,D08HTF,JNJ-1930942,Cognitive impairment , Investigative
9545,D08HUB,ANG-2004,Obesity , Investigative
9546,D08HUC,Isoetharine,Asthma , Approved
9547,D08HVD,NRLU-10,Breast cancer , Discontinued in Phase 1
9548,D08HVE,Dimethyl Sulfoxide,Rheumatoid arthritis , Approved
9549,D08HVG,BAL-8557,Fungal infection , Phase 3
9550,D08HVR,Levodopa,Parkinson disease , Approved
9551,D08HWV,BGB-A317,Hepatocellular carcinoma , Phase 3
9552,D08HWV,BGB-A317,Squamous cell carcinoma , Phase 3
9553,D08HWV,BGB-A317,Solid tumour/cancer , Phase 1
9554,D08HXB,Lopinavir + ritonavir + interferon beta,Middle East Respiratory Syndrome (MERS) , Investigative
9555,D08HXG,PMX-60056,Coagulation defect , Phase 2
9556,D08HZC,Penicillamine,Rheumatoid arthritis , Approved
9557,D08HZL,Trimeprazine,Allergic rhinitis , Approved
9558,D08HZN,ABC-4,Solid tumour/cancer , Investigative
9559,D08IAQ,ARC-AAT,Alpha-1 antitrypsin deficiency , Phase 1
9560,D08IBS,Adenine,Malnutrition , Approved
9561,D08ICT,PMID25666693-Compound-13,Osteoarthritis pain , Patented
9562,D08ICT,PMID25666693-Compound-13,Cancer related pain , Patented
9563,D08ICT,PMID25666693-Compound-13,Neuropathic pain , Patented
9564,D08ICT,PMID25666693-Compound-13,Inflammatory pain , Patented
9565,D08ICX,Tofacitinib,Rheumatoid arthritis , Approved
9566,D08ICX,Tofacitinib,Coronavirus Disease 2019 (COVID-19) , Phase 2
9567,D08IDB,HuA33,Colorectal cancer , Phase 1
9568,D08IDQ,BILA-2157BS,Hypertension , Terminated
9569,D08IFG,Interferon-alpha dimers,Solid tumour/cancer , Investigative
9570,D08IFL,Meclofenamic acid,Ankylosing spondylitis , Approved
9571,D08IFL,Meclofenamic acid,Joint pain , Approved
9572,D08IHF,A-74932,Lung cancer , Terminated
9573,D08IID,TNO155,Solid tumour/cancer , Phase 1
9574,D08IKV,58-1066,Solid tumour/cancer , Investigative
9575,D08IMD,AZD-6495,Solid tumour/cancer , Preclinical
9576,D08IMP,AAV-hAADC gene therapy,Parkinson disease , Phase 1
9577,D08INO,WX-UK1,Solid tumour/cancer , Discontinued in Phase 1/2
9578,D08IRG,BIIB 015,Solid tumour/cancer , Phase 1
9579,D08IRR,Org-10490,Psychotic disorder , Terminated
9580,D08IST,SB-509,Nervous system disease , Phase 2
9581,D08IUW,VLI-03B,Hepatocellular carcinoma , Investigative
9582,D08IVF,BP1001,Acute myeloid leukaemia , Phase 2
9583,D08IWD,Finasteride,Benign prostatic hyperplasia , Approved
9584,D08IXA,BQ788,Acute kidney injury , Phase 3
9585,D08IXA,BQ788,Encephalopathy , Phase 3
9586,D08IXA,BQ788,Myasthenia gravis , Phase 3
9587,D08IXA,BQ788,Neuromyelitis optica , Phase 3
9588,D08IXA,BQ788,Hypertension , Phase 1
9589,D08IYF,GSK-692342,Influenza A virus H1N1 infection , Phase 2
9590,D08JAC,Fenretinide,Macular degeneration , Phase 3
9591,D08JAC,Fenretinide,Lymphoma , Phase 2
9592,D08JAC,Fenretinide,Peripheral T-cell lymphoma , Phase 2
9593,D08JAC,Fenretinide,Solid tumour/cancer , Phase 2
9594,D08JAC,Fenretinide,Tumour , Phase 1
9595,D08JAH,TPM-001,Peritoneal cavity cancer , Investigative
9596,D08JAN,Cipatinib,Solid tumour/cancer , Phase 1
9597,D08JAP,Robalzotan,Anxiety disorder , Discontinued in Phase 2
9598,D08JBL,PF-03446962,Solid tumour/cancer , Phase 2
9599,D08JCA,Silver sulfadiazine,Bacterial infection , Approved
9600,D08JCL,ONO-3805,Prostate disease , Discontinued in Phase 3
9601,D08JEA,AKB-4924,MRSA infection , Investigative
9602,D08JGB,Otlertuzumab,Chronic lymphocytic leukaemia , Phase 2
9603,D08JGB,Otlertuzumab,Peripheral T-cell lymphoma , Phase 2
9604,D08JGE,SonoLysis Prolyse,Cerebral ischemia , Phase 2
9605,D08JHG,ChimeriVax-Dengue,Dengue fever , Phase 2
9606,D08JHY,AVM0703,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
9607,D08JHZ,BLD-2660,Coronavirus Disease 2019 (COVID-19) , Phase 2
9608,D08JIP,Rintatolimod,Human immunodeficiency virus infection , Phase 3
9609,D08JIV,Amlodipine,Hypertension , Approved
9610,D08JKK,RWJ-63556,Arthritis , Terminated
9611,D08JLC,J-607Y,Allergy , Investigative
9612,D08JLH,Spartalizumab,Melanoma , Phase 3
9613,D08JLV,TH-337,Solid tumour/cancer , Investigative
9614,D08JMI,ALN-VSP,Liver cancer , Phase 1
9615,D08JML,Microxine,Pain , Investigative
9616,D08JMO,Iron proteinsuccinylate,Anemia , Approved
9617,D08JNE,RG1578,Major depressive disorder , Discontinued in Phase 2
9618,D08JNG,Malonic acid,Neurodegenerative disorder , Investigative
9619,D08JNI,MEDI5872,Systemic lupus erythematosus , Phase 2
9620,D08JOE,ANA971,Hepatitis virus infection , Discontinued in Phase 1
9621,D08JOY,Avrina,Skin infection , Phase 1/2
9622,D08JPU,G6976,Solid tumour/cancer , Investigative
9623,D08JRT,RhApo2L/TRAIL,Solid tumour/cancer , Discontinued in Phase 1/2
9624,D08JSA,SB208,Onychomycosis , Phase 2
9625,D08JSA,SB208,Tinea pedis , Phase 2
9626,D08JSE,JNJ-42041935,Anemia , Investigative
9627,D08JSQ,DS-3032,Solid tumour/cancer , Phase 1
9628,D08JSQ,DS-3032,Haematological malignancy , Phase 1
9629,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,Acute lymphoblastic leukaemia , Phase 1/2
9630,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,B-cell chronic lymphocytic leukaemia , Phase 1/2
9631,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,Chronic lymphocytic leukaemia , Phase 1/2
9632,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,Diffuse large B-cell lymphoma , Phase 1/2
9633,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,Follicular lymphoma , Phase 1/2
9634,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,Mantle cell lymphoma , Phase 1/2
9635,D08JTI,Anti-CD19/22-CAR vector-transduced T cells,Prolymphocytic leukaemia , Phase 1/2
9636,D08JTN,AFM-20,Solid tumour/cancer , Investigative
9637,D08JTU,R-944,Human immunodeficiency virus infection , Discontinued in Phase 1
9638,D08JUO,CR-4056,Pain , Investigative
9639,D08JVS,NU-206,Gastrointestinal disease , Phase 1
9640,D08JWC,GS-9620,Hepatitis B virus infection , Phase 2
9641,D08JWC,GS-9620,Human immunodeficiency virus infection , Phase 1
9642,D08JWJ,PF-1228305,Pulmonary hypertension , Phase 3
9643,D08JWM,In-111-DAC imaging agent,Solid tumour/cancer , Phase 1
9644,D08JWY,PMID30107136-Compound-Example43,Solid tumour/cancer , Patented
9645,D08JWY,PMID30107136-Compound-Example43,Infectious disease , Patented
9646,D08JWY,PMID30107136-Compound-Example43,Human immunodeficiency virus infection , Patented
9647,D08JWY,PMID30107136-Compound-Example43,Hepatitis , Patented
9648,D08JXR,HG-1202,Solid tumour/cancer , Investigative
9649,D08JXW,INS-117548,Glaucoma/ocular hypertension , Phase 1
9650,D08JYV,PSMA subunit vaccine,Prostate cancer , Phase 1
9651,D08JYW,CZ-ON002,Solid tumour/cancer , Investigative
9652,D08JZS,Mepyramine,Allergy , Approved
9653,D08KAD,CYT-004-MelQbG10,Melanoma , Phase 2
9654,D08KBB,DT-310,Solid tumour/cancer , Investigative
9655,D08KBK,Tedizolid,Skin infection , Approved
9656,D08KCA,Leupeptin,Malaria , Investigative
9657,D08KCJ,ABY-025,Bladder cancer , Phase 1/2
9658,D08KCK,ART621,Psoriasis vulgaris , Phase 1/2
9659,D08KCK,ART621,Rheumatoid arthritis , Phase 1/2
9660,D08KDK,T-2007,Epilepsy , Phase 2
9661,D08KDL,TES-23-NCS,Solid tumour/cancer , Terminated
9662,D08KDP,AS-8112,Vomiting , Terminated
9663,D08KDU,PT-201,Urinary dysfunction , Phase 1
9664,D08KEC,AG-NPN803,Nephritis , Investigative
9665,D08KGY,PRX-302,Prostate cancer , Phase 3
9666,D08KHD,Leonurine,Ischemic heart disease , Investigative
9667,D08KIB,SAR-114137,Pain , Phase 1
9668,D08KMU,Gca-186,Human immunodeficiency virus infection , Clinical trial
9669,D08KNG,VAN-10-4-eluting stent,Artery stenosis , Phase 1
9670,D08KNK,MPL-containing Pollinex allergy desensitization vaccine,Allergy , Preregistration
9671,D08KOD,ISIS 15770,Solid tumour/cancer , Investigative
9672,D08KPA,BZL-101,Breast cancer , Phase 2
9673,D08KQK,PMID31244113-compound-2c,Severe acute respiratory syndrome (SARS) , Preclinical
9674,D08KQK,PMID31244113-compound-2c,Middle East Respiratory Syndrome (MERS) , Preclinical
9675,D08KSU,AP12009,Colorectal cancer , Phase 3
9676,D08KSV,RG6146,Haematological malignancy , Phase 1
9677,D08KSV,RG6146,Solid tumour/cancer , Phase 1
9678,D08KTO,AD04,Alcohol dependence , Phase 2
9679,D08KTO,AD04,Opioid dependence , Phase 1
9680,D08KTQ,CJC-1295,Cachexia , Phase 2
9681,D08KVK,CYT-009-GhrQb,Obesity , Discontinued in Phase 1/2
9682,D08KVZ,Sibutramine,Obesity , Approved
9683,D08KWQ,Sn-117m-DTPA,Bone metastases , Discontinued in Phase 2
9684,D08KWV,NXT-1021,Bacterial infection , Investigative
9685,D08KXC,SGX201,Solid tumour/cancer , Phase 1/2
9686,D08KXE,RP-67580,Pain , Terminated
9687,D08KXO,CCP-020,Epidermolysis bullosa , Phase 3
9688,D08KXX,JBD-411,Malaria , Investigative
9689,D08KYN,INNO-105,Solid tumour/cancer , Phase 1
9690,D08KYQ,Sulopenem,Urinary tract infection , Phase 3
9691,D08KZJ,CAY 10471,Allergy , Investigative
9692,D08KZM,CC49 humanized radioimmunoconjugates,Solid tumour/cancer , Phase 1
9693,D08KZR,BXL-746,Inflammation , Discontinued in Phase 1
9694,D08LAE,LGD-4033,Musculoskeletal disorder , Phase 1
9695,D08LDB,GSK1265744,Human immunodeficiency virus infection , Phase 3
9696,D08LDG,Org-31433,Dementia , Terminated
9697,D08LDS,LUBELUZOLE,Neurological disorder , Discontinued in Preregistration
9698,D08LDV,PA-1050040,Human immunodeficiency virus infection , Discontinued in Phase 1
9699,D08LEY,Lanadelumab,Hereditary angioedema , Approved
9700,D08LFX,MB-300,Breast cancer , Terminated
9701,D08LFZ,Diflunisal,Pain , Approved
9702,D08LHE,Prinoxodan,Cardiac failure , Terminated
9703,D08LIF,Propiram fumarate,Cancer related pain , Discontinued in Phase 3
9704,D08LIU,Amooranin,Autoimmune diabetes , Investigative
9705,D08LJP,Rasburicase,Hyperuricaemia , Approved
9706,D08LJY,MB-312,Solid tumour/cancer , Investigative
9707,D08LLB,Human CD19 targeted T Cells,Follicular lymphoma , Phase 1
9708,D08LLB,Human CD19 targeted T Cells,Diffuse large B-cell lymphoma , Phase 1
9709,D08LLM,NS-8,Urinary incontinence , Phase 1
9710,D08LLR,UK-51656,Cardiovascular disease , Terminated
9711,D08LMS,CG201,Solid tumour/cancer , Phase 2
9712,D08LQD,RESEQUINIL,Epilepsy , Discontinued in Phase 2
9713,D08LQS,ETBX-021,Breast cancer , Phase 1
9714,D08LRU,Disorazol Z-LHRH conjugates,Ovarian cancer , Investigative
9715,D08LRV,BGP-15,Type-2 diabetes , Phase 2
9716,D08LSA,SCY-524,Hepatitis C virus infection , Investigative
9717,D08LTU,Minocycline,Bacterial infection , Approved
9718,D08LTU,Minocycline,Rosacea , Phase 2
9719,D08LUT,ABT-702,Pain , Terminated
9720,D08LVF,Nitecapone,Pain , Discontinued in Phase 2
9721,D08LXJ,Heterologous liver cell therapy,Urea cycle disorder , Phase 2
9722,D08LYB,SB 239063,Pain , Investigative
9723,D08LYZ,VesiGel,Bladder cancer , Phase 2
9724,D08LZI,NS-220,Hyperlipidaemia , Discontinued in Phase 2
9725,D08LZZ,DPO-1,Atrial fibrillation , Investigative
9726,D08MAR,CP-230821,Arteriosclerosis , Terminated
9727,D08MCC,NRX-101,Suicidal ideation , Phase 2
9728,D08MCI,L1Q-001,Influenza virus infection , Phase 1
9729,D08MCL,Recombinant human biglycan,Duchenne dystrophy , Investigative
9730,D08MCO,SPD-703,Otitis media , Terminated
9731,D08MCS,ADS-5102,Dyskinesia , Phase 3
9732,D08MCT,BMS-192548,Obesity , Preclinical
9733,D08MDV,CT-3501,Coronary artery disease , Terminated
9734,D08MDX,ED-001,Hepatitis C virus infection , Terminated
9735,D08MEF,BAY-86-4884,Liver disease , Approved
9736,D08MGU,SLIT TR-03,Lung cancer , Preclinical
9737,D08MHD,E-2609,Alzheimer disease , Phase 3
9738,D08MHM,PF-3758309,Solid tumour/cancer , Phase 1
9739,D08MID,T-115,Solid tumour/cancer , Investigative
9740,D08MIG,RPA-102,Anthrax , Phase 2
9741,D08MJO,CDP323,Rheumatoid arthritis , Phase 2
9742,D08MJO,CDP323,Multiple sclerosis , Phase 2
9743,D08MJX,R-56865,Angina pectoris , Terminated
9744,D08MKR,DT388IL-3,Acute myeloid leukaemia , Phase 1/2
9745,D08MLG,CNI-H0294,Human immunodeficiency virus-1 infection , Terminated
9746,D08MLH,TUG-469,Non-insulin dependent diabetes , Investigative
9747,D08MMP,ENDG-8010,Epilepsy , Investigative
9748,D08MOL,Anti-CMV mabs,Cytomegalovirus infection , Investigative
9749,D08MPA,AMA-76,Glaucoma/ocular hypertension , Phase 2
9750,D08MRN,Hexylcaine,Anaesthesia , Approved
9751,D08MTA,Tetanolic acid,Breast cancer , Investigative
9752,D08MTG,Abafungin,Fungal infection , Discontinued in Phase 3
9753,D08MTN,Glucose analogue,Infection of P. falciparum , Investigative
9754,D08MUX,S33005,Depression , Investigative
9755,D08MVK,GCC-AP0341,Asthma , Terminated
9756,D08MVV,PRX-111,Female infertility , Investigative
9757,D08MVY,R-116712,Pain , Investigative
9758,D08MXB,NCX-125,Glaucoma/ocular hypertension , Investigative
9759,D08MXP,LEE011,Solid tumour/cancer , Phase 3
9760,D08MXP,LEE011,Breast cancer , Phase 3
9761,D08MYF,Bio-Hep-B,Hepatitis B virus infection , Approved
9762,D08MYL,NIM-811,Solid tumour/cancer , Discontinued in Phase 2
9763,D08MYO,LAG-078,Lipid metabolism disorder , Terminated
9764,D08MYW,Human M-SAA3 peptide,Gastrointestinal infection , Investigative
9765,D08NAB,Chymotrypsin,Asthma , Approved
9766,D08NAD,Batabulin,Solid tumour/cancer , Phase 2/3
9767,D08NAI,SAR438584,Respiratory syncytial virus infection , Phase 3
9768,D08NCO,Vanadate,Psoriatic arthritis , Phase 3
9769,D08NCO,Vanadate,Rheumatoid arthritis , Phase 3
9770,D08NCO,Vanadate,Plaque psoriasis , Application submitted
9771,D08NDA,ISIS-HBV,Hepatitis B virus infection , Phase 2
9772,D08NDE,BLZ-945,Amyotrophic lateral sclerosis , Phase 2
9773,D08NDE,BLZ-945,Solid tumour/cancer , Phase 1
9774,D08NEM,BVRS-GamVac vaccine,Middle East Respiratory Syndrome (MERS) , Phase 1/2
9775,D08NES,S-3536,Osteoarthritis , Discontinued in Phase 1
9776,D08NGV,PMID25553724-Compound-US2012820715110,Immune System disease , Patented
9777,D08NHF,SR-11335,Human immunodeficiency virus-1 infection , Terminated
9778,D08NIN,NN-9926,Type-2 diabetes , Phase 1
9779,D08NJE,CR-845,Pain , Phase 2/3
9780,D08NJE,CR-845,Chronic pain , Phase 2
9781,D08NJQ,TJ-8117,Nephritis , Discontinued in Phase 2
9782,D08NLC,Cu64-CNND1-B,Breast cancer , Investigative
9783,D08NLN,Biolimus a9,Artery stenosis , Approved
9784,D08NLN,Biolimus a9,Coronary artery disease , Phase 3
9785,D08NLQ,Licarbazepine,Bipolar disorder , Discontinued in Phase 3
9786,D08NMV,Ixekizumab,Plaque psoriasis , Approved
9787,D08NMV,Ixekizumab,Psoriatic arthritis , Phase 3
9788,D08NNR,Testosterone glucoside,Hypogonadism , Discontinued in Phase 2
9789,D08NNW,Boric acid,Otitis media , Approved
9790,D08NPB,TO-195,Nephritis , Terminated
9791,D08NPG,MBX-2044,Type-2 diabetes , Phase 2
9792,D08NQG,VB2-011,Solid tumour/cancer , Terminated
9793,D08NQZ,Tetracycline,Bacterial infection , Approved
9794,D08NRG,HYP-10,Pain , Investigative
9795,D08NTD,Trappsol Cyclo,Niemann-pick disease , Investigative
9796,D08NTW,Antineoplaston A10 + antineoplaston AS2-2,Glioma , Phase 2
9797,D08NUS,XEL-005OP,Urinary tract disease , Investigative
9798,D08NWC,Peginterferon alfa-2b,Hepatitis C virus infection , Approved
9799,D08NWF,crisaborole,Atopic dermatitis , Approved
9800,D08NWY,ALS-2158,Hepatitis C virus infection , Investigative
9801,D08NXP,ABBV-951,Parkinson disease , Phase 1
9802,D08NXW,GLP-1,Diabetic complication , Phase 3
9803,D08NYL,AGN211745,Choroidal neovascularization , Discontinued in Phase 2
9804,D08NYO,PDGF gene therapy,Diabetic foot ulcer , Investigative
9805,D08NYZ,ASM-024,Asthma , Phase 2
9806,D08NZG,Ifabotuzumab,Acute myeloid leukaemia , Phase 2
9807,D08NZG,Ifabotuzumab,Myelodysplastic syndrome , Phase 2
9808,D08NZG,Ifabotuzumab,Recurrent glioblastoma , Phase 1
9809,D08OAS,Flavimun,Yellow fever virus infection , Discontinued in Preregistration
9810,D08ODH,Atiratecan,Colorectal cancer , Discontinued in Phase 2
9811,D08ODP,CSC-700008,Anxiety disorder , Investigative
9812,D08OES,NiCord,Hematologic tumour , Phase 3
9813,D08OES,NiCord,Sickle-cell anaemia , Phase 1/2
9814,D08OES,NiCord,Acute lymphoblastic leukaemia , Phase 1/2
9815,D08OES,NiCord,Hodgkin lymphoma , Phase 1/2
9816,D08OES,NiCord,Myelodysplastic syndrome , Phase 1/2
9817,D08OGB,YourDex,Autoimmune diabetes , Phase 3
9818,D08OHK,AKP-501,Female infertility , Phase 1
9819,D08OIT,Viroprev,Virus infection , Investigative
9820,D08OJB,Benzoic acid linked peptide analog 4,Albinism , Patented
9821,D08OJB,Benzoic acid linked peptide analog 4,Ephelides , Patented
9822,D08OJB,Benzoic acid linked peptide analog 4,Menkes disease , Patented
9823,D08OJB,Benzoic acid linked peptide analog 4,Senile lentigines , Patented
9824,D08OJB,Benzoic acid linked peptide analog 4,Melasma , Patented
9825,D08OJE,Femoxetine,Major depressive disorder , Discontinued in Phase 3
9826,D08OJF,ICA-105665,Epilepsy , Phase 2
9827,D08OJU,SOU-001,Urinary incontinence , Discontinued in Phase 2
9828,D08OKJ,Iron Dextran,Iron-deficiency anemia , Approved
9829,D08OKW,Metalfullerene,Alopecia , Investigative
9830,D08OLB,CH-5015765,Solid tumour/cancer , Investigative
9831,D08OLR,ART-144,Osteoarthritis , Investigative
9832,D08OLU,AVP-5,Non-hodgkin lymphoma , Investigative
9833,D08OMM,BL-1040,Myocardial infarction , Phase 1/2
9834,D08ONJ,MPC-3100,Solid tumour/cancer , Phase 1
9835,D08OOJ,CB-5083,Multiple myeloma , Phase 1
9836,D08OOJ,CB-5083,Solid tumour/cancer , Phase 1
9837,D08OPS,ATYR 1940,Muscular dystrophy , Phase 1/2
9838,D08OPW,ARRY-575,Solid tumour/cancer , Investigative
9839,D08OPX,4SC-205,Lymphoma , Phase 1
9840,D08OQQ,Lavoltidine,Gastroesophageal reflux disease , Discontinued in Phase 2
9841,D08ORO,OPC-21268,Cardiac disease , Discontinued in Phase 2
9842,D08ORV,AZD-4992,Breast cancer , Discontinued in Phase 1
9843,D08OTE,RO-4995819,Major depressive disorder , Phase 2
9844,D08OUL,EGT-0001474,Type-2 diabetes , Phase 1
9845,D08OUU,Genevx,Angina pectoris , Terminated
9846,D08OUV,CHF-4227,Osteoporosis , Phase 1
9847,D08OVG,CKD-516,Solid tumour/cancer , Phase 1
9848,D08OVR,AMG 357,Autoimmune diabetes , Phase 1
9849,D08OWA,NVC-704,Conjunctivitis , Investigative
9850,D08OWW,SLP-0906,Gram-positive bacterial infection , Investigative
9851,D08OXC,INDUS-82030,Influenza virus infection , Investigative
9852,D08OXD,Mannoside derivative 8,Crohn disease , Patented
9853,D08OXD,Mannoside derivative 8,Ulcerative colitis , Patented
9854,D08OXD,Mannoside derivative 8,Urinary tract infection , Patented
9855,D08OXU,IMO-3100,Psoriasis vulgaris , Phase 2
9856,D08OXU,IMO-3100,Autoimmune diabetes , Phase 1
9857,D08OYF,Ad/PSA,Prostate cancer , Phase 2
9858,D08PAV,CDP-860,Solid tumour/cancer , Discontinued in Phase 2
9859,D08PBB,"L-694,458",Cystic fibrosis , Phase 2
9860,D08PBQ,Pancreas algenpantucel-L,Pancreatic cancer , Phase 3
9861,D08PCE,Oxantel pamoate,Trichuris trichiura infection , Approved
9862,D08PCH,Javelin,Melanoma , Phase 3
9863,D08PCR,CM3.1-AC100,Diabetic complication , Phase 1
9864,D08PFA,Rivoglitazone,Ocular inflammation , Phase 3
9865,D08PGC,Andolast,Rhinitis , Phase 3
9866,D08PHD,DR-5001,Adenovirus infection , Phase 3
9867,D08PIE,Brigatinib,Non-small-cell lung cancer , Approved
9868,D08PIE,Brigatinib,Anaplastic large cell lymphoma , Approved
9869,D08PIJ,JTV-506,Angina pectoris , Discontinued in Phase 2
9870,D08PIK,11C-GSK-215083,Neurodegenerative disorder , Phase 1
9871,D08PIQ,Methylprednisolone,Solid tumour/cancer , Approved
9872,D08PIQ,Methylprednisolone,Spinal cord injury , Investigative
9873,D08PKF,AMI-HS,Liver disease , Discontinued in Phase 1
9874,D08PKG,LY2541546,Osteoporosis , Phase 2
9875,D08PKI,EV-077,Type-2 diabetes , Phase 2
9876,D08PLK,Fremanezumab,Hyperprolactinaemia , Approved
9877,D08PMB,Imeglimin,Type-2 diabetes , Phase 2
9878,D08PMB,Imeglimin,Diabetic complication , Phase 2
9879,D08PMW,BMS-223131,Erectile dysfunction , Phase 2
9880,D08PNQ,Trombodipine,Platelet aggregation disorder , Discontinued in Phase 2
9881,D08PNW,JPH-101,Hypophosphatasia , Investigative
9882,D08POF,ALX-0081,Thrombotic thrombocytopenic purpura , Phase 3
9883,D08POF,ALX-0081,Thrombocytopenia , Phase 2
9884,D08POH,Invaplex 50,Shigella infection , Phase 1/2
9885,D08PRP,IMGX003,Coeliac disease , Phase 2
9886,D08PSC,BI 860585,Solid tumour/cancer , Phase 1
9887,D08PSI,H5N1 influenza vaccine,Influenza virus infection , Phase 2
9888,D08PSU,Lmw heparin,Hematologic disease , Approved
9889,D08PSU,Lmw heparin,Coagulation defect , Approved
9890,D08PSV,CIGB-428,Diabetic neuropathy , Investigative
9891,D08PUW,BAICALIN,Human immunodeficiency virus infection , Terminated
9892,D08PVL,Ibulocydine,Solid tumour/cancer , Investigative
9893,D08PXL,MK-8457,Rheumatoid arthritis , Phase 2
9894,D08PXM,MDX-214,Autoimmune diabetes , Discontinued in Phase 1/2
9895,D08PXR,ABT-761,Asthma , Phase 3
9896,D08PYC,AL-38583,Allergic conjunctivitis , Phase 2
9897,D08PYO,KW-2478,Solid tumour/cancer , Phase 2
9898,D08PYQ,EDL-2000,Diabetic complication , Investigative
9899,D08PZF,Liposomal disintergrin,Solid tumour/cancer , Investigative
9900,D08QAC,Ferumoxides,Liver cancer , Approved
9901,D08QAC,Ferumoxides,Liver disease , Approved
9902,D08QAN,BVRS-GamVac-Combi vaccine,Middle East Respiratory Syndrome (MERS) , Phase 1/2
9903,D08QCJ,Thiabendazole,Helminth infection , Approved
9904,D08QCJ,Thiabendazole,Dutch elm disease , Approved
9905,D08QDB,KSI-4088,Nematode infection , Investigative
9906,D08QDF,Systebryl,Amyloidosis , Phase 1
9907,D08QED,TAK-850,Lymphoma , Phase 2
9908,D08QEF,CEP-37250,Advanced solid tumour , Phase 1
9909,D08QGD,Ammonium lactate,Dermatological disease , Approved
9910,D08QGE,SI-614,Alzheimer disease , Phase 2/3
9911,D08QGT,GDC0941,Non-hodgkin lymphoma , Phase 2
9912,D08QGT,GDC0941,Solid tumour/cancer , Phase 2
9913,D08QGT,GDC0941,Breast cancer , Phase 2
9914,D08QHJ,UPAR-lock,Solid tumour/cancer , Investigative
9915,D08QHS,DG041,Peripheral vascular disease , Discontinued in Phase 2
9916,D08QHX,PRX00933,Diabetic complication , Phase 2
9917,D08QHX,PRX00933,Obesity , Phase 2
9918,D08QIP,Pranlukast,Asthma , Approved
9919,D08QJD,IGN-311,Solid tumour/cancer , Terminated
9920,D08QJS,Carbazochrome salicylate,Bleeding disorder , Approved
9921,D08QKJ,Stanozolol,Hereditary angioedema , Approved
9922,D08QKY,IXS-312,Ocular disease , Investigative
9923,D08QLL,AG-NDT802,Cough , Investigative
9924,D08QLM,Merimepodib,Hepatitis C virus infection , Phase 2b
9925,D08QLM,Merimepodib,Coronavirus Disease 2019 (COVID-19) , Investigative
9926,D08QME,Ethambutol,Pulmonary tuberculosis , Approved
9927,D08QMX,Estradiol,Breast cancer , Approved
9928,D08QPJ,MBI-2401,Gram-positive bacterial infection , Investigative
9929,D08QRE,MB-11319,Allergy , Investigative
9930,D08QRO,BL-6020,Cachexia , Investigative
9931,D08QRT,99mTc-siboroxime,Diagnostic imaging , Investigative
9932,D08QTK,Anti-EGFL7,Non-small-cell lung cancer , Phase 1
9933,D08QTP,BMS-433771,Respiratory syncytial virus infection , Terminated
9934,D08QUC,OT-121,Asthma , Investigative
9935,D08QUV,Amineptine,Major depressive disorder , Withdrawn from market
9936,D08QVM,NU-400,Multiple sclerosis , Investigative
9937,D08QWQ,bimatoprost (free acid form),Alzheimer disease , Clinical trial
9938,D08QXE,HP-161,Solid tumour/cancer , Investigative
9939,D08QYJ,SORETOLIDE,Convulsion , Terminated
9940,D08QYL,ISV-102,Ocular infection , Investigative
9941,D08QYS,Heat shock protein vaccine,Meningococcal infection , Phase 2
9942,D08QYW,CAR-T Cells targeting EpCAM,Colon cancer , Phase 1/2
9943,D08QYW,CAR-T Cells targeting EpCAM,Esophageal cancer , Phase 1/2
9944,D08QYW,CAR-T Cells targeting EpCAM,Gastric adenocarcinoma , Phase 1/2
9945,D08QYW,CAR-T Cells targeting EpCAM,Hepatocellular carcinoma , Phase 1/2
9946,D08QYW,CAR-T Cells targeting EpCAM,Pancreatic cancer , Phase 1/2
9947,D08QYW,CAR-T Cells targeting EpCAM,Prostate cancer , Phase 1/2
9948,D08QZH,Anti-HER2 CAR-T,Colorectal cancer , Phase 1/2
9949,D08QZH,Anti-HER2 CAR-T,Gastric adenocarcinoma , Phase 1/2
9950,D08QZH,Anti-HER2 CAR-T,Glioma , Phase 1/2
9951,D08QZH,Anti-HER2 CAR-T,Lung cancer , Phase 1/2
9952,D08QZH,Anti-HER2 CAR-T,Ovarian cancer , Phase 1/2
9953,D08QZH,Anti-HER2 CAR-T,Pancreatic cancer , Phase 1/2
9954,D08RAK,Japanese cedar pollen allergy sublingual immunotherapy,Allergy , Investigative
9955,D08RBC,Escitalopram,Major depressive disorder , Approved
9956,D08RBS,WX-037,Solid tumour/cancer , Investigative
9957,D08RBV,"Autologous dendritic cell vaccine, St Anna Children's Hospital",Glioblastoma multiforme , Phase 2
9958,D08RBW,LY900014,Type-2 diabetes , Phase 3
9959,D08RBW,LY900014,Type-1 diabetes , Phase 1
9960,D08RCI,CRTX-072,Cough , Investigative
9961,D08RCV,"Pyrido[2,3-d]pyrimidine derivative 2",Obesity , Patented
9962,D08RDB,Polyamine,Breast cancer , Investigative
9963,D08RDC,R-765,Non-insulin dependent diabetes , Terminated
9964,D08RDD,PF-06823859,Rheumatoid arthritis , Phase 2
9965,D08RDD,PF-06823859,Dermatomycosis , Phase 2
9966,D08RDD,PF-06823859,Lupus , Phase 1
9967,D08RDG,PBI-4419,Fibrosis , Investigative
9968,D08RET,PMID30107136-Compound-Example47,Solid tumour/cancer , Patented
9969,D08RET,PMID30107136-Compound-Example47,Infectious disease , Patented
9970,D08RET,PMID30107136-Compound-Example47,Human immunodeficiency virus infection , Patented
9971,D08RET,PMID30107136-Compound-Example47,Hepatitis , Patented
9972,D08RFA,TAK-816,Bacterial infection , Application submitted
9973,D08RFZ,RSV mAb,Respiratory syncytial virus infection , Phase 2/3
9974,D08RGA,AZD6370,Type-2 diabetes , Discontinued in Phase 2
9975,D08RGH,ChAdOx1 MERS001 vaccine,Middle East Respiratory Syndrome (MERS) , Phase 1
9976,D08RHR,Optaflu,Influenza virus infection , Approved
9977,D08RHU,Cissampeline,Skeletal muscle relaxant , Approved
9978,D08RIB,Edetate disodium,Heart arrhythmia , Approved
9979,D08RID,MK-8616,Poison intoxication , Approved
9980,D08RIL,GKT-03,Hypertension , Investigative
9981,D08RJM,SD-101,Hepatitis C virus infection , Phase 3
9982,D08RJM,SD-101,Skin disease , Phase 2
9983,D08RJM,SD-101,Melanoma , Phase 1/2
9984,D08RJM,SD-101,Squamous cell carcinoma , Phase 1/2
9985,D08RJM,SD-101,Squamous head and neck cell carcinom , Phase 1/2
9986,D08RJY,Anti-EGFRvIII CAR transduced PBL,Brain cancer , Phase 1/2
9987,D08RJY,Anti-EGFRvIII CAR transduced PBL,Malignant glioma , Phase 1/2
9988,D08RJY,Anti-EGFRvIII CAR transduced PBL,Recurrent glioblastoma , Phase 1/2
9989,D08RKZ,IN0-3106,Squamous cell carcinoma , Phase 1
9990,D08RMH,APC-2059,Inflammatory bowel disease , Discontinued in Phase 2
9991,D08RMJ,GSK461364,Non-hodgkin lymphoma , Phase 1
9992,D08RMJ,GSK461364,Solid tumour/cancer , Phase 1
9993,D08ROP,Leflunomide,Arthritis , Approved
9994,D08ROP,Leflunomide,Multiple sclerosis , Approved
9995,D08ROQ,S-25585,Eating disorder , Investigative
9996,D08RPV,IDM-4,leukaemia , Discontinued in Phase 1/2
9997,D08RQE,DepoVax,Bordetella pertussis infection , Investigative
9998,D08RSL,Genz-644470,Hypophosphatasia , Phase 2
9999,D08RUN,2-Bromopalmitate,Autoimmune diabetes , Investigative
10000,D08RUW,PD-176931,Human immunodeficiency virus infection , Preclinical
10001,D08RUX,Z-321,Parkinson disease , Discontinued in Phase 1
10002,D08RWO,CAB-ROR2-ADC,Solid tumour/cancer , Phase 1/2
10003,D08RXW,MT-062,Melanoma , Investigative
10004,D08RYN,RQ-00202730,Inflammatory bowel disease , Investigative
10005,D08RZV,HSR-609,Rhinitis , Discontinued in Phase 2
10006,D08SAO,ZN-1014,Hepatitis C virus infection , Investigative
10007,D08SAX,DB-772d,Cardiovascular disease , Phase 1
10008,D08SCL,MK-3697,Insomnia , Phase 2
10009,D08SCQ,Poractant alfa,Respiratory distress syndrome , Approved
10010,D08SDI,House dust mite allergy vaccine,Allergy , Phase 1
10011,D08SEI,Levocabastine,Allergic conjunctivitis , Approved
10012,D08SGE,M7583,Haematological malignancy , Phase 1
10013,D08SHE,SEP-228432,Neuropathic pain , Phase 1
10014,D08SHE,SEP-228432,Depression , Phase 1
10015,D08SHI,SG-1311,Glioblastoma multiforme , Investigative
10016,D08SHM,NB-007,Hepatitis B virus infection , Investigative
10017,D08SIC,BDB001,Solid tumour/cancer , Phase 2
10018,D08SIF,Milatuzumab,Chronic lymphocytic leukaemia , Phase 1/2
10019,D08SIF,Milatuzumab,Systemic lupus erythematosus , Phase 1
10020,D08SIR,CL-314698,Type-2 diabetes , Preclinical
10021,D08SIR,CL-314698,Obesity , Preclinical
10022,D08SIT,NKP-1339,Solid tumour/cancer , Phase 1
10023,D08SJT,Sarilumab,Rheumatoid arthritis , Approved
10024,D08SJT,Sarilumab,Coronavirus Disease 2019 (COVID-19) , Phase 3
10025,D08SJY,MRX34,Liver cancer , Phase 1
10026,D08SJZ,Ibandronate,Osteoporosis , Approved
10027,D08SKH,Methoxsalen,Cutaneous T-cell lymphoma , Approved
10028,D08SKH,Methoxsalen,Psoriasis vulgaris , Approved
10029,D08SMN,POP-1,Solid tumour/cancer , Investigative
10030,D08SNL,JTC-801,Pain , Discontinued in Phase 2
10031,D08SNT,Heteroaryl-carboxamide derivative 2,Solid tumour/cancer , Patented
10032,D08SNT,Heteroaryl-carboxamide derivative 2,Metastatic cancer , Patented
10033,D08SNX,V-11294A,Asthma , Discontinued in Phase 2
10034,D08SOF,Terfenadine,Allergy , Withdrawn from market
10035,D08SPH,Eculizumab,Neuromyelitis optica , Approved
10036,D08SPH,Eculizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
10037,D08SPP,TG-44,Helicobacter infection , Investigative
10038,D08SSO,CNSB-006,Arthralgia , Investigative
10039,D08SSP,Lersivirine,Human immunodeficiency virus infection , Phase 2
10040,D08STA,CAL-203,Respiratory syncytial virus infection , Investigative
10041,D08SUQ,ES-285,Solid tumour/cancer , Discontinued in Phase 1
10042,D08SVH,Tacalcitol,Psoriasis vulgaris , Approved
10043,D08SXS,Polyflu,Influenza virus infection , Investigative
10044,D08SXV,DWP-422,Arthritis , Phase 1
10045,D08SZO,F-12458,Solid tumour/cancer , Investigative
10046,D08SZP,TA-103,Solid tumour/cancer , Investigative
10047,D08TAB,XL-499,Solid tumour/cancer , Preclinical
10048,D08TBK,Opdivo + Yervoynivolumab + ipilimumab,Malignant pleural mesothelioma , Phase 3
10049,D08TBK,Opdivo + Yervoynivolumab + ipilimumab,Small-cell lung cancer , Phase 3
10050,D08TBK,Opdivo + Yervoynivolumab + ipilimumab,Ovarian cancer , Phase 1/2
10051,D08TCU,GT-4001,Alzheimer disease , Terminated
10052,D08TDK,ANA-011,Solid tumour/cancer , Investigative
10053,D08TEJ,Clascoterone,Acne vulgaris , Approved
10054,D08TGG,Insulin transdermal,Type-1/2 diabetes , Phase 1
10055,D08TIA,IC-200214,Cognitive impairment , Investigative
10056,D08TJM,Binodenoson,Hypertension , Phase 3
10057,D08TKV,SKF-97426,Hyperlipidaemia , Discontinued in Phase 2
10058,D08TLI,E-4716,Respiratory disease , Phase 2
10059,D08TNG,RG7775,Acute myeloid leukaemia , Phase 1
10060,D08TPH,TC-5653,Nicotine dependence , Investigative
10061,D08TPS,Epidermal growth factor,Vulnerary , Approved
10062,D08TPS,Epidermal growth factor,Wound healing , Phase 2
10063,D08TQK,NM-9405,Rheumatoid arthritis , Investigative
10064,D08TQP,INX-189,Hepatitis C virus infection , Phase 2
10065,D08TRG,AZD-3241,Parkinson disease , Phase 2
10066,D08TRM,ChAdOx1 MERS002 vaccine,Middle East Respiratory Syndrome (MERS) , Phase 1
10067,D08TRX,CST-101,Solid tumour/cancer , Phase 1
10068,D08TVI,HPP-854,Alzheimer disease , Phase 1
10069,D08TXL,A-796260,Pain , Investigative
10070,D08TYK,GLS-5300 vaccine,Middle East Respiratory Syndrome (MERS) , Phase 1/2
10071,D08TZZ,Oleuropein,Inflammation , Investigative
10072,D08UAT,DPS-151,Psoriasis vulgaris , Investigative
10073,D08UDB,GSK-2263167,Psoriasis vulgaris , Investigative
10074,D08UDE,Peptide-conjugated phosphorodiamidate morpholino oligomers,Bacterial infection , Investigative
10075,D08UDF,PIBAXIZINE,Spasm , Discontinued in Phase 2
10076,D08UDG,MEDI4276,Solid tumour/cancer , Phase 1
10077,D08UDZ,MK-6105,Allergy , Investigative
10078,D08UEC,PMID25666693-Compound-135,Osteoarthritis pain , Patented
10079,D08UEC,PMID25666693-Compound-135,Cancer related pain , Patented
10080,D08UEC,PMID25666693-Compound-135,Neuropathic pain , Patented
10081,D08UEC,PMID25666693-Compound-135,Inflammatory pain , Patented
10082,D08UEJ,Ajinomoto 2,Pain , Investigative
10083,D08UGB,VRX806,Human immunodeficiency virus infection , Phase 2
10084,D08UGJ,Vincamine,Cerebrovascular disease , Approved
10085,D08UGS,JNJ 63723283,Ulcerative colitis , Phase 2
10086,D08UGS,JNJ 63723283,Prostate cancer , Phase 1/2
10087,D08UGS,JNJ 63723283,Solid tumour/cancer , Phase 1/2
10088,D08UGS,JNJ 63723283,Multiple myeloma , Phase 1
10089,D08UGX,LIAROZOLE,Dermatological disease , Phase 2/3
10090,D08UHC,PMA-104R,Solid tumour/cancer , Investigative
10091,D08UHN,Irtemazole,Hyperuricaemia , Discontinued in Phase 2
10092,D08UHV,AMG 780,Solid tumour/cancer , Phase 1
10093,D08UJH,Toca 511 + Toca FC combination,Glioblastoma multiforme , Phase 1/2
10094,D08ULI,Org-4094,Autoimmune diabetes , Terminated
10095,D08UMH,Methylphenobarbital,Anxiety disorder , Approved
10096,D08UMZ,STD-07,Constipation , Phase 1/2
10097,D08UNC,GPC3 targeting CAR-T cells,Hepatocellular carcinoma , Phase 1
10098,D08UNC,GPC3 targeting CAR-T cells,Lung squamous cell carcinoma , Phase 1
10099,D08UNQ,NSD-644,Neurological disorder , Discontinued in Phase 1
10100,D08UOY,Vadimezan,Solid tumour/cancer , Phase 2
10101,D08UQC,Oshadi R,Solid tumour/cancer , Phase 2
10102,D08UQS,MEM-1003,Bipolar disorder , Phase 2a
10103,D08UQS,MEM-1003,Dementia , Phase 2
10104,D08USJ,Neostigmine,Myasthenia gravis , Approved
10105,D08USU,Ticarcillin,Bacterial infection , Approved
10106,D08UUD,R-1663,Coagulation defect , Phase 1
10107,D08UUK,Rostafuroxin,Hypertension , Phase 2
10108,D08UUL,LY2606368,Ovarian cancer , Phase 2
10109,D08UUL,LY2606368,Small-cell lung cancer , Phase 2
10110,D08UUL,LY2606368,Head and neck cancer , Phase 1
10111,D08UUL,LY2606368,Squamous cell anal carcinoma , Phase 1
10112,D08UUL,LY2606368,Solid tumour/cancer , Phase 1
10113,D08UVN,Anti-CEA CAR-T cells,Acute myeloid leukaemia , Phase 1
10114,D08UVZ,E004,Asthma , Phase 3
10115,D08UXQ,FHT-1106,Ischemic heart disease , Investigative
10116,D08UYM,ONO-2333Ms,Anxiety disorder , Phase 2
10117,D08UZA,Chitosan/IL-12,Bladder cancer , Investigative
10118,D08UZD,Viraplex,Solid tumour/cancer , Preclinical
10119,D08UZL,TMPyP4,Multiple myeloma , Investigative
10120,D08UZP,MPL-containing Pollinex allergy desensitization vaccine,Angina pectoris , Phase 3
10121,D08UZP,MPL-containing Pollinex allergy desensitization vaccine,Allergy , Phase 2
10122,D08VAR,APH-0812,Human immunodeficiency virus-1 infection , Phase 2
10123,D08VAR,APH-0812,Human immunodeficiency virus infection , Phase 1
10124,D08VBV,TAP311,Dyslipidemia , Phase 1
10125,D08VDJ,IDN-13389,Solid tumour/cancer , Investigative
10126,D08VDM,AZD4694,Alzheimer disease , Phase 2
10127,D08VDV,PMID30107136-Compound-Example15,Solid tumour/cancer , Patented
10128,D08VDV,PMID30107136-Compound-Example15,Infectious disease , Patented
10129,D08VDV,PMID30107136-Compound-Example15,Human immunodeficiency virus infection , Patented
10130,D08VDV,PMID30107136-Compound-Example15,Hepatitis , Patented
10131,D08VFX,Full-length Factor VIII molecule,Hemophilia , Investigative
10132,D08VGS,Recombinant protein subunit vaccine  (seasonal influenza),Influenza virus infection , Terminated
10133,D08VGT,BMY-30129,Pruritus , Discontinued in Phase 2
10134,D08VHG,RPL-554,Allergic rhinitis , Phase 2
10135,D08VIS,AKB-9778,Peripheral arterial disease , Phase 2
10136,D08VIS,AKB-9778,Diabetic macular edema , Phase 2
10137,D08VJC,PSMA ADC,Prostate cancer , Phase 2
10138,D08VJI,F-14413,Alzheimer disease , Terminated
10139,D08VKQ,INGN-007,Solid tumour/cancer , Terminated
10140,D08VKZ,Edaglitazone,Type-2 diabetes , Terminated
10141,D08VLN,CAT-2000,Lipid metabolism disorder , Investigative
10142,D08VMO,JTT-811,Diabetic complication , Discontinued in Phase 2
10143,D08VMW,MP-529,Solid tumour/cancer , Investigative
10144,D08VRM,RO-0534,Dengue fever , Investigative
10145,D08VRO,Ketanserin,Hypertension , Approved
10146,D08VRQ,EVIRNA,Solid tumour/cancer , Investigative
10147,D08VRX,GHRP-2,Growth hormone deficiency , Approved
10148,D08VSI,Revolade/Promacta,Idiopathic thrombocytopenic purpura , Approved
10149,D08VSI,Revolade/Promacta,Chronic liver disease , Phase 3
10150,D08VSI,Revolade/Promacta,Thrombocytopenia , Phase 2
10151,D08VSQ,BMS-816336,Lipid metabolism disorder , Phase 1
10152,D08VTA,EXP-6803,Hypertension , Terminated
10153,D08VTV,PMID28350212-Compound-7,Herpes simplex virus infection , Patented
10154,D08VUJ,ABT-202,Pain , Discontinued in Phase 1
10155,D08VVI,AR-54,Solid tumour/cancer , Investigative
10156,D08VVR,TY-51924,Myocardial infarction , Phase 2
10157,D08VWF,GSK-932121A,Malaria , Preclinical
10158,D08VWJ,TD-1770,Bladder cancer , Investigative
10159,D08VWK,Vaxchora,Vibrio cholerae infection , Phase 3
10160,D08VWL,BRL-42715,Bacterial infection , Terminated
10161,D08VWM,QUAN-0806,Epilepsy , Investigative
10162,D08VWO,LFF571,Clostridium infection , Phase 2
10163,D08VXD,CGF166,Deafness , Phase 1/2
10164,D08VXL,Molsidomine,Angina pectoris , Approved
10165,D08VXO,Brompheniramine,Allergic rhinitis , Approved
10166,D08VYC,Phosphate,Constipation , Approved
10167,D08VYV,Metoclopramide,Nausea , Approved
10168,D08VZH,ESS,Burn and burn infection , Phase 2
10169,D08WAN,Lu-AF11167,Neurological disorder , Phase 1
10170,D08WBF,BB-3644,Solid tumour/cancer , Terminated
10171,D08WBJ,KOS-2187,Gastroesophageal reflux disease , Phase 1
10172,D08WBJ,KOS-2187,Gastrointestinal disease , Phase 1
10173,D08WCU,BMS-180448,Angina pectoris , Discontinued in Phase 2
10174,D08WCY,Seysara,Acne vulgaris , Application submitted
10175,D08WDH,HXTC-901,Bleeding disorder , Investigative
10176,D08WDP,AM-3840,Autoimmune diabetes , Investigative
10177,D08WDT,"VDA, HIV-1",Human immunodeficiency virus-1 infection , Investigative
10178,D08WFH,DNA-HIV-C/NYVAC-HIV-C,Human immunodeficiency virus infection , Phase 1
10179,D08WGI,AK-2,Virus infection , Investigative
10180,D08WGZ,TS-033,Diabetic complication , Discontinued in Phase 2
10181,D08WHX,AGS-348,Hereditary angioedema , Phase 1
10182,D08WII,Anti-MUC1 CAR T Cells,Breast cancer , Phase 1/2
10183,D08WII,Anti-MUC1 CAR T Cells,Hepatocellular carcinoma , Phase 1/2
10184,D08WII,Anti-MUC1 CAR T Cells,Pancreatic cancer , Phase 1/2
10185,D08WLY,ME-401,Chronic lymphocytic leukaemia , Phase 1
10186,D08WLY,ME-401,Diffuse large B-cell lymphoma , Phase 1
10187,D08WLY,ME-401,Follicular lymphoma , Phase 1
10188,D08WLY,ME-401,Lymphoma , Phase 1
10189,D08WNO,GGF,Congestive heart failure , Phase 1b
10190,D08WOE,MC-3002,Metabolic disorder , Preclinical
10191,D08WOJ,OBE-101,Obesity , Phase 2
10192,D08WOW,LY3039478,T-cell acute lymphoblastic leukaemia , Phase 1/2
10193,D08WOW,LY3039478,Solid tumour/cancer , Phase 1/2
10194,D08WOW,LY3039478,Lymphoma , Phase 1
10195,D08WQH,BI 1361849,Non-small-cell lung cancer , Phase 2
10196,D08WQU,AEB1102,Arginase 1 deficiency , Phase 2
10197,D08WQU,AEB1102,Small-cell lung cancer , Phase 1/2
10198,D08WQU,AEB1102,Acute myeloid leukaemia , Phase 1
10199,D08WQU,AEB1102,Solid tumour/cancer , Phase 1
10200,D08WQU,AEB1102,Myelodysplastic syndrome , Phase 1
10201,D08WSG,AZD-8683,Chronic obstructive pulmonary disease , Phase 2
10202,D08WSW,BRL-32872A,Cardiac arrhythmias , Discontinued in Phase 2
10203,D08WSY,Denosumab,Postmenopausal osteoporosis , Approved
10204,D08WSY,Denosumab,Prostate cancer , Phase 3
10205,D08WSY,Denosumab,Rheumatoid arthritis , Phase 2
10206,D08WTE,Vorsetuzumab mafodotin,Renal cell carcinoma , Discontinued in Phase 1
10207,D08WTW,Pyrazole derivative 12,Obesity , Patented
10208,D08WUF,Influenza DNA vaccine,Influenza virus infection , Phase 1
10209,D08WUK,MVA-MERS-S_DF-1 vaccine,Middle East Respiratory Syndrome (MERS) , Phase 1b
10210,D08WVA,UK-224671,Urinary incontinence , Discontinued in Phase 1
10211,D08WWN,RG7853,Non-small-cell lung cancer , Approved
10212,D08WYH,LY-2228820,Solid tumour/cancer , Phase 1/2
10213,D08WYK,OJP-2028,Hypertension , Phase 2
10214,D08WYM,Nafarelin,Endometriosis , Approved
10215,D08WYO,6F4,Solid tumour/cancer , Investigative
10216,D08WZC,PMID26651364-Compound-48,Crohn disease , Patented
10217,D08WZC,PMID26651364-Compound-48,Ulcerative colitis , Patented
10218,D08WZC,PMID26651364-Compound-48,Urinary tract infection , Patented
10219,D08WZQ,MRG-201,Keloid , Phase 2
10220,D08WZQ,MRG-201,Scleroderma , Phase 1
10221,D08XAC,Nystatin,Fungal infection , Approved
10222,D08XBF,AMEP,Melanoma , Phase 1
10223,D08XDL,KHK2455,Solid tumour/cancer , Phase 1
10224,D08XDO,Glial progenitor cell therapy,Brain injury , Phase 1/2
10225,D08XFA,IL-2 XL,Renal cell carcinoma , Phase 1/2
10226,D08XFJ,NN-1218,Diabetic complication , Phase 1
10227,D08XFJ,NN-1218,Type-1 diabetes , Application submitted
10228,D08XFJ,NN-1218,Type-2 diabetes , Application submitted
10229,D08XFR,AEZS-115,Solid tumour/cancer , Investigative
10230,D08XFV,Flurazepam,Insomnia , Approved
10231,D08XHN,AL-59412C,Ocular hypertension , Phase 2
10232,D08XIF,GSK-0862,Inflammation , Investigative
10233,D08XKL,SPI-014,Hypophosphatasia , Phase 1
10234,D08XKL,SPI-014,Alzheimer disease , Phase 1
10235,D08XLV,Sharon-5000,MRSA infection , Investigative
10236,D08XMM,NicVAX,Nicotine dependence , Phase 3
10237,D08XOF,P-13,Otitis media , Investigative
10238,D08XOT,LY467711,Migraine , Terminated
10239,D08XOT,LY467711,Neuropathic pain , Terminated
10240,D08XOY,ABT-126,Schizophrenia , Phase 2
10241,D08XOY,ABT-126,Alzheimer disease , Phase 2
10242,D08XPI,CMV-specific STAR fusions,Cytomegalovirus infection , Investigative
10243,D08XPN,mab 1-7F9,Multiple myeloma , Phase 2
10244,D08XPW,CYTISINE,Tobacco dependence , Phase 3
10245,D08XQA,RSD-921,Anaesthesia , Discontinued in Phase 2
10246,D08XQV,USL311,Recurring respiratory infection , Phase 1/2
10247,D08XQV,USL311,Solid tumour/cancer , Phase 1/2
10248,D08XRD,SF-108,Glaucoma/ocular hypertension , Investigative
10249,D08XRX,ANGX-3227,Sickle-cell anaemia , Discontinued in Phase 2
10250,D08XUP,GE-37468A,Bacterial infection , Investigative
10251,D08XVR,Baminercept,Rheumatoid arthritis , Phase 2
10252,D08XVU,MVA-BN anthrax,Bacillus anthracis infection , Investigative
10253,D08XWZ,ALX-0646,Migraine , Discontinued in Phase 1
10254,D08XYX,Aprotinin,Bleeding disorder , Approved
10255,D08XZQ,PF-4287881,Respiratory tract infection , Phase 1
10256,D08YAD,Disarmin,Infectious disease , Investigative
10257,D08YAL,PMID25666693-Compound-111,Osteoarthritis pain , Patented
10258,D08YAL,PMID25666693-Compound-111,Cancer related pain , Patented
10259,D08YAL,PMID25666693-Compound-111,Neuropathic pain , Patented
10260,D08YAL,PMID25666693-Compound-111,Inflammatory pain , Patented
10261,D08YCS,TQ-1017,Pain , Investigative
10262,D08YFD,PF-05212372,Asthma , Discontinued in Phase 1
10263,D08YGD,Haempatch,Bleeding disorder , Investigative
10264,D08YGY,MK-6302,Neutropenia , Phase 1
10265,D08YHB,BIIB 023,Rheumatoid arthritis , Phase 2
10266,D08YHE,NKR-2 CAR-T Cells,Myelodysplastic syndrome , Phase 1
10267,D08YHE,NKR-2 CAR-T Cells,Acute myeloid leukaemia , Phase 1
10268,D08YHS,Linopirdine,Cognitive impairment , Phase 3
10269,D08YIN,Dalfampridine,Multiple sclerosis , Approved
10270,D08YJN,BRT-FC-83C,Atopic dermatitis , Phase 2
10271,D08YKD,CLT-011,Ocular disease , Investigative
10272,D08YLC,ONO-01210,Acute radiation syndrome , Phase 1
10273,D08YNC,MU-1140-S,Bacterial infection , Investigative
10274,D08YNI,Somatoprim,Acromegaly , Phase 2
10275,D08YOM,Sulopenem etzadroxil,Bacterial infection , Phase 2
10276,D08YPQ,Thiazole carboxamide derivative 7,Solid tumour/cancer , Patented
10277,D08YPQ,Thiazole carboxamide derivative 7,Metastatic cancer , Patented
10278,D08YPZ,Ammoniated mercury,Psoriasis vulgaris , Approved
10279,D08YQG,Entelon,Lymphatic disease , Investigative
10280,D08YRD,A-717,Diabetic complication , Terminated
10281,D08YRM,Long-acting interferon beta conjugate,Multiple sclerosis , Investigative
10282,D08YRO,Ad VEGF-C,Lymphatic disease , Investigative
10283,D08YSY,VGX-200,Solid tumour/cancer , Investigative
10284,D08YTF,RG6013,Haemophilia A , Phase 3
10285,D08YTQ,M2e influenza vaccine,Influenza virus infection , Phase 1
10286,D08YVP,Vericigiuat,Heart failure , Phase 2
10287,D08YVT,SCH-211803,Parkinson disease , Discontinued in Phase 1
10288,D08YWK,FX-006,Pain , Phase 3
10289,D08YWN,HIV vaccine,Human immunodeficiency virus infection , Phase 1
10290,D08YWY,SCH-900117,Rheumatoid arthritis , Phase 1
10291,D08YXS,CAP-3.2,Solid tumour/cancer , Investigative
10292,D08YYY,Ocinaplon,Generalized anxiety disorder , Discontinued in Phase 3
10293,D08ZAC,ICAR30 T cells,Anaplastic large cell lymphoma , Phase 1
10294,D08ZAC,ICAR30 T cells,Hodgkin lymphoma , Phase 1
10295,D08ZAX,RS-93522,Hypertension , Terminated
10296,D08ZBB,PMID25666693-Compound-84,Osteoarthritis pain , Patented
10297,D08ZBB,PMID25666693-Compound-84,Cancer related pain , Patented
10298,D08ZBB,PMID25666693-Compound-84,Neuropathic pain , Patented
10299,D08ZBB,PMID25666693-Compound-84,Inflammatory pain , Patented
10300,D08ZBT,SDZ-WAG-994,Hypertension , Discontinued in Phase 1
10301,D08ZBU,Cyanocobalamin Co-60,Vitamin B12 deficiency , Approved
10302,D08ZCC,MTC-896,Seborrhea , Phase 2
10303,D08ZCI,ALN-AT3SC,Haemophilia A , Phase 1
10304,D08ZCI,ALN-AT3SC,Haemophilia B , Phase 1
10305,D08ZCW,ZD-8321,Acute lung injury , Discontinued in Phase 2
10306,D08ZDI,Anti-Factor D,Age-related macular degeneration , Phase 1/2
10307,D08ZDM,Nh-125,Solid tumour/cancer , Investigative
10308,D08ZEB,Chlorzoxazone,Acute pain , Approved
10309,D08ZEM,Quinazoline derivative 11,Cirrhosis , Patented
10310,D08ZEM,Quinazoline derivative 11,Chronic obstructive pulmonary disease , Patented
10311,D08ZEM,Quinazoline derivative 11,Psoriasis vulgaris , Patented
10312,D08ZEM,Quinazoline derivative 11,Multiple sclerosis , Patented
10313,D08ZEM,Quinazoline derivative 11,Gastrointestinal disease , Patented
10314,D08ZFC,IGN-312,Solid tumour/cancer , Terminated
10315,D08ZFJ,Colestilan,Diabetic complication , Approved
10316,D08ZGG,P-218,Malaria , Investigative
10317,D08ZHL,FGF-1,Coronary heart disease , Phase 2
10318,D08ZHQ,C4X-301,Cardiovascular disease , Investigative
10319,D08ZIH,CGX-1160,Acute or chronic pain , Terminated
10320,D08ZJJ,H1N1 pandemic influenza vaccine,Influenza virus infection , Phase 3
10321,D08ZJX,LY3076226,Solid tumour/cancer , Phase 1
10322,D08ZKJ,Ontazolast,Asthma , Phase 2
10323,D08ZKN,PG-530742,Myocardial infarction , Discontinued in Phase 2
10324,D08ZKN,PG-530742,Osteoarthritis , Discontinued in Phase 2
10325,D08ZLL,Quick-acting insulin,Diabetic complication , Investigative
10326,D08ZOY,Tecogalan sodium,Solid tumour/cancer , Phase 1
10327,D08ZPO,H-1152,Pulmonary arterial hypertension , Phase 2
10328,D08ZQI,FPA-008,Autoimmune diabetes , Phase 1/2
10329,D08ZQI,FPA-008,Pigmented villonodular synovitis , Phase 1
10330,D08ZQI,FPA-008,Tenosynovial giant cell tumour , Phase 1
10331,D08ZRR,KW-5092,Pain , Phase 1
10332,D08ZRW,Cantide + Cisplatin,Tumour , Investigative
10333,D08ZSQ,Parke-Davis 1,Pain , Investigative
10334,D08ZTH,SLP-1002,Fungal infection , Investigative
10335,D08ZUC,TRK-950,Solid tumour/cancer , Phase 1
10336,D08ZUG,RBT-05,Human immunodeficiency virus infection , Investigative
10337,D08ZVY,Technetium Tc-99m Lidofenin Kit,Radioactive tracer , Approved
10338,D08ZXG,INT-2500,Human immunodeficiency virus infection , Investigative
10339,D08ZXH,AX-208,Parkinson disease , Terminated
10340,D08ZXM,REG2,Venous thrombosis , Phase 1
10341,D08ZXQ,Neublastin,Pain , Phase 2
10342,D08ZYZ,Chikungunya vaccine,Chikungunya virus infection , Phase 2
10343,D08ZZO,NS-696,Epilepsy , Terminated
10344,D08ZZP,EchoGen,Cardiovascular disease , Phase 1/2
10345,D09AAK,Ripretinib,Gastrointestinal stromal tumour , Approved
10346,D09AAK,Ripretinib,Glioma , Phase 1
10347,D09AAK,Ripretinib,Solid tumour/cancer , Phase 1
10348,D09AAK,Ripretinib,Systemic mastocytosis , Phase 1
10349,D09AAM,ICI-164384,Breast cancer , Terminated
10350,D09ACC,CNTO-0007,Cerebrovascular ischaemia , Phase 1
10351,D09ADN,VOXERGOLIDE HYDROCHLORIDE,Depression , Discontinued in Phase 1
10352,D09ADS,Immuncell-LC,Glioblastoma multiforme , Approved
10353,D09ADT,ABT-418,Alzheimer disease , Discontinued in Phase 2
10354,D09AFE,AG-NDP803,Inflammation , Investigative
10355,D09AFI,INCB039110,Malignant neoplasm , Phase 2
10356,D09AFI,INCB039110,Non-small-cell lung cancer , Phase 2
10357,D09AFJ,SR-121787,Thrombosis , Discontinued in Phase 2
10358,D09AFV,GLG-101,Solid tumour/cancer , Investigative
10359,D09AGG,GSK2890457,Obesity , Phase 2
10360,D09AGZ,CEE-04-421,Pain , Terminated
10361,D09AHK,ZYN002-CBD,Seizure disorder , Phase 2
10362,D09AHZ,Celivarone,Ventricular arrhythmias , Phase 2/3
10363,D09AIH,PCUR-101,Prostate cancer , Phase 1
10364,D09AIT,BHT-3201,Type-1 diabetes , Phase 1
10365,D09AJU,TS-111,Depression , Phase 1
10366,D09ALE,Enadoline,Pain , Phase 2
10367,D09ALM,BIIB061,Multiple sclerosis , Phase 1
10368,D09ALR,MM36,Atopic dermatitis , Phase 2
10369,D09AMZ,Enprofylline,Asthma , Approved
10370,D09ANC,"MC-02,479",Bacterial infection , Discontinued in Phase 1
10371,D09ANG,Misoprostol,Medical abortion , Approved
10372,D09AOO,ANAVEX 2-73,Alzheimer disease , Phase 1
10373,D09AOO,ANAVEX 2-73,Infantile spasm , Phase 1
10374,D09AOO,ANAVEX 2-73,Parkinson disease , Phase 1
10375,D09AOO,ANAVEX 2-73,Rett syndrome , Phase 1
10376,D09AOO,ANAVEX 2-73,Cognitive impairment , Phase 1
10377,D09APA,Plasma derived factor VIII PEGylated liposomal,Factor VIII deficiency , Phase 3
10378,D09APB,IDX-189,Hepatitis C virus infection , Phase 1
10379,D09ATR,PF-06804103,Solid tumour/cancer , Phase 1
10380,D09AUP,GW-215864,Rhinitis , Discontinued in Phase 2
10381,D09AVX,WIB-901H,Hyperlipidaemia , Investigative
10382,D09AVZ,E1/E4-deleted adenoviral vector,Ornithine transcarbamylase deficiency , Investigative
10383,D09AWJ,H5N1 influenza vaccine,Human immunodeficiency virus infection , Approved
10384,D09AWM,ODSH,Chronic obstructive pulmonary disease , Phase 2
10385,D09AXQ,CD22-CART,leukaemia , Phase 1
10386,D09AYA,IB-08C175,Graft-versus-host disease , Investigative
10387,D09AYM,MABp1,Colorectal cancer , Phase 3
10388,D09AYM,MABp1,Type-2 diabetes , Phase 2
10389,D09AYM,MABp1,Acne vulgaris , Phase 2
10390,D09AYM,MABp1,Atopic dermatitis , Phase 2
10391,D09AYM,MABp1,Hidradenitis suppurativa , Phase 2
10392,D09AYM,MABp1,Plaque psoriasis , Phase 2
10393,D09AYM,MABp1,Pyoderma gangrenosum , Phase 2
10394,D09AYM,MABp1,Peripheral vascular disease , Phase 2
10395,D09AYQ,PIRITREXIM,Bladder cancer , Phase 2
10396,D09AYS,Antineoplaston-A5,Solid tumour/cancer , Discontinued in Phase 1
10397,D09BAP,KUR-212,Wound healing , Phase 2
10398,D09BBA,TAK-071,Alzheimer disease , Phase 1
10399,D09BBW,Sodium stibogluconate,Solid tumour/cancer , Phase 2
10400,D09BCC,ImmuDyn,Human immunodeficiency virus infection , Terminated
10401,D09BCJ,PMID30124346-Compound-34TABLE4,Attention deficit hyperactivity disorder , Patented
10402,D09BCL,DCB-AD1,Alzheimer disease , Phase 2
10403,D09BDE,PAC-14028,Atopic dermatitis , Phase 2
10404,D09BDH,Rabeximod,Rheumatoid arthritis , Phase 2
10405,D09BDK,SNG-163,Solid tumour/cancer , Investigative
10406,D09BEG,CNS-5161,Neuropathic pain , Phase 2
10407,D09BEJ,AQST-305,Malignant carcinoid syndrome , Phase 1
10408,D09BEO,DBP-192,Anxiety disorder , Investigative
10409,D09BGB,Aryl mannoside derivative 1,Crohn disease , Patented
10410,D09BGB,Aryl mannoside derivative 1,Ulcerative colitis , Patented
10411,D09BGB,Aryl mannoside derivative 1,Urinary tract infection , Patented
10412,D09BHA,LY-353433,Inflammatory bowel disease , Terminated
10413,D09BHB,Tolmetin,Rheumatoid arthritis , Approved
10414,D09BHF,WF-2421,Diabetic complication , Terminated
10415,D09BID,PRO-206,Hepatitis C virus infection , Terminated
10416,D09BIW,99mTc-sestamibi,Breast cancer , Approved
10417,D09BIX,Nexagon,Diabetic foot ulcer , Phase 2
10418,D09BJH,Retroviral MGMT-transduced hematopoietic cells,Anemia , Phase 1
10419,D09BKE,NS398,Endometriosis , Terminated
10420,D09BKY,Bevacizumab + Erlotinib,Metastatic colorectal cancer , Phase 3
10421,D09BKY,Bevacizumab + Erlotinib,Non-small-cell lung cancer , Phase 3
10422,D09BKY,Bevacizumab + Erlotinib,Hepatocellular carcinoma , Phase 2
10423,D09BKY,Bevacizumab + Erlotinib,Hypopharyngeal squamous cell carcinoma , Phase 1/2
10424,D09BLW,TgAAV-CFTR,Cystic fibrosis , Discontinued in Phase 2
10425,D09BNP,Heterocyclic derivative 11,Solid tumour/cancer , Patented
10426,D09BNP,Heterocyclic derivative 11,Metastatic cancer , Patented
10427,D09BNR,Gazyva,Haematological malignancy , Phase 1
10428,D09BNZ,LDE225,Skin cancer , Phase 2
10429,D09BNZ,LDE225,Medulloblastoma , Phase 2
10430,D09BOH,Verubulin,Solid tumour/cancer , Phase 2
10431,D09BOH,Verubulin,Brain metastases , Phase 2
10432,D09BOH,Verubulin,Glioblastoma multiforme , Phase 2
10433,D09BOH,Verubulin,Recurrent glioblastoma , Phase 2
10434,D09BPN,Anatibant,Traumatic brain injury , Phase 2
10435,D09BPT,Anti-CD9 mab,Gastric adenocarcinoma , Investigative
10436,D09BQO,ATD transdermal gel,Contraception , Phase 1
10437,D09BRE,U-78517F,Asthma , Terminated
10438,D09BSI,TDI-0039,Motor neurone disease , Investigative
10439,D09BTK,NCX-1000,Cardiovascular disease , Phase 2
10440,D09BVL,NS-1619,Asthma , Terminated
10441,D09BWC,E-4080,Angina pectoris , Terminated
10442,D09BWG,CAR-T cells targeting CD19,Non-hodgkin lymphoma , Phase 2
10443,D09BXF,CLS003,Plantar wart , Phase 2
10444,D09BXJ,PF-5177624,Solid tumour/cancer , Investigative
10445,D09BZJ,MEHD-7945A,Colorectal cancer , Phase 2
10446,D09BZJ,MEHD-7945A,Solid tumour/cancer , Phase 2
10447,D09BZS,CK-101,Non-small-cell lung cancer , Phase 1/2
10448,D09BZY,Nibentan,Cardiac arrhythmias , Phase 1
10449,D09CAC,U-96988,Human immunodeficiency virus infection , Discontinued in Phase 1
10450,D09CBI,Anti-Her-2 mab,Solid tumour/cancer , Investigative
10451,D09CCZ,Triciribine prodrug,Solid tumour/cancer , Phase 1/2
10452,D09CEJ,CYT003,Asthma , Phase 2
10453,D09CEY,SKL-PSY,Bipolar disorder , Phase 1
10454,D09CFM,DANOFLOXACIN,Bacterial infection , Discontinued in Phase 2
10455,D09CGE,Florbetapir F-18,Diagnostic imaging , Approved
10456,D09CHX,AMR-SIX-1,Obesity , Investigative
10457,D09CIB,BC-22,Major depressive disorder , Investigative
10458,D09CIF,TH-9402,Graft-versus-host disease , Phase 2
10459,D09CIQ,Cadralazine,Hypertension , Approved
10460,D09CJO,CXB-029,Central nervous system disease , Investigative
10461,D09CKF,Licostinel,Neurological disorder , Discontinued in Phase 1
10462,D09CKG,MVA-MERS-S vaccine,Middle East Respiratory Syndrome (MERS) , Discontinued in Phase 1
10463,D09CKT,LY433222,Depression , Investigative
10464,D09CLC,C188-9,Solid tumour/cancer , Phase 1
10465,D09CLG,VRC-SRSDNA015-00-VP vaccine,Severe acute respiratory syndrome (SARS) , Discontinued in Phase 1
10466,D09CLH,Samarium SM-153 lexidronam,Prostate cancer , Phase 2
10467,D09CLX,MDT-006,Constipation , Investigative
10468,D09CMK,R-salbutamol sulphate,Skin infection , Phase 2
10469,D09CNO,Grass pollen allergy vaccine,Seasonal allergic rhinitis , Phase 2/3
10470,D09CNR,KLS-Npk,Parkinson disease , Investigative
10471,D09CNV,EDG-005,Major depressive disorder , Investigative
10472,D09COD,Romurtide,Solid tumour/cancer , Approved
10473,D09CPR,Penicillin V,Bacterial infection , Approved
10474,D09CQB,GPs-0193,Human immunodeficiency virus infection , Discontinued in Phase 1
10475,D09CRQ,RPK-739,Solid tumour/cancer , Terminated
10476,D09CTF,Human recombinant factor VIII,Factor VIII deficiency , Investigative
10477,D09CTH,RP-701,Solid tumour/cancer , Investigative
10478,D09CTY,OPHD-002,Inflammatory bowel disease , Terminated
10479,D09CUR,Trans-sodium crocetinate,Glioblastoma of brain , Phase 3
10480,D09CUR,Trans-sodium crocetinate,Brain metastases , Phase 1
10481,D09CXE,Norovirus bivalent vaccine,Norovirus infection , Phase 1/2
10482,D09CYK,ENDG-3010,Pain , Investigative
10483,D09CZA,Travoprost,Open-angle glaucoma , Approved
10484,D09CZS,DRF-1042,Solid tumour/cancer , Phase 1
10485,D09DAJ,FG-6874,Anemia , Investigative
10486,D09DAQ,ISIS 353512,Cardiovascular disease , Terminated
10487,D09DBR,Micronomicin sulfate,Bacterial infection , Approved
10488,D09DBY,Rilonacept,Arthritis , Approved
10489,D09DBY,Rilonacept,Acute gout flare , Phase 3
10490,D09DDQ,FUB-130,Neurological disorder , Investigative
10491,D09DER,QR-336,Radiation syndrome , Preclinical
10492,D09DEU,HMPL-342,Asthma , Investigative
10493,D09DFB,EFEGATRAN SULFATE HYDRATE,Myocardial infarction , Phase 2
10494,D09DGE,LD-101,Solid tumour/cancer , Investigative
10495,D09DHL,TDI-0090,Motor neurone disease , Investigative
10496,D09DHT,phorbol 12-myristate 13-acetate,Acute myeloid leukaemia , Phase 2
10497,D09DHT,phorbol 12-myristate 13-acetate,Hodgkin lymphoma , Phase 2
10498,D09DHY,Colchicine,Acute gouty arthritis , Approved
10499,D09DIB,RG-4929,Metabolic disorder , Phase 2
10500,D09DIG,Ablukast,Asthma , Discontinued in Phase 3
10501,D09DIQ,CART22 cells expressing anti-CD22 scFv TCRz:41BB,Acute lymphoblastic leukaemia , Phase 1
10502,D09DJC,IRX4204,Prostate cancer , Phase 1
10503,D09DJC,IRX4204,Breast cancer , Phase 1
10504,D09DJC,IRX4204,Pancreatic cancer , Phase 1
10505,D09DJC,IRX4204,Non-small-cell lung cancer , Phase 1
10506,D09DJO,Pafuramidine,Malaria , Phase 3
10507,D09DJS,INV-400,Arteriosclerosis , Investigative
10508,D09DJU,SU-14813,Breast cancer , Discontinued in Phase 2
10509,D09DKY,AEZS-123,Alcohol dependence , Preclinical
10510,D09DLN,L-739749,Solid tumour/cancer , Terminated
10511,D09DLP,Tramiprosate,Alzheimer disease , Phase 3
10512,D09DND,Anti-GD2-CAR engineered T cells,Neuroblastoma , Phase 1
10513,D09DND,Anti-GD2-CAR engineered T cells,Osteosarcoma , Phase 1
10514,D09DND,Anti-GD2-CAR engineered T cells,Sarcoma , Phase 1
10515,D09DRG,NE-100,Schizophrenia , Terminated
10516,D09DRM,NT-1635,Sarcopenia , Investigative
10517,D09DSK,JWH-051,Pain , Investigative
10518,D09DTY,DABO-1047,Human immunodeficiency virus infection , Investigative
10519,D09DUQ,AN-2718,Fungal infection , Phase 1
10520,D09DWL,Zaleplon,Insomnia , Approved
10521,D09DXX,PF-06282999,Acute coronary syndrome , Phase 1
10522,D09DYB,CHDI-00316226,Huntington disease , Investigative
10523,D09DYT,EP-5001,Thrombosis , Discontinued in Phase 2
10524,D09EBJ,MC-02306,Bacterial infection , Terminated
10525,D09EBL,Antegren,Multiple sclerosis , Approved
10526,D09EBS,Oxymetazoline,Eye inflammation , Approved
10527,D09EBS,Oxymetazoline,Nasal congestion , Approved
10528,D09EDA,PRM-151,Macular degeneration , Phase 2
10529,D09EDA,PRM-151,Idiopathic pulmonary fibrosis , Phase 2
10530,D09EDA,PRM-151,Myelofibrosis , Phase 2
10531,D09EDA,PRM-151,Polycythemia vera , Phase 2
10532,D09EDA,PRM-151,Thrombocythemia , Phase 2
10533,D09EDW,Deligoparin sodium,Ulcerative colitis , Discontinued in Phase 3
10534,D09EED,SYM-009,Infectious disease , Investigative
10535,D09EEV,Declopramide,Inflammatory bowel disease , Discontinued in Phase 2
10536,D09EFC,CAP-232,Renal cell carcinoma , Phase 2a
10537,D09EFC,CAP-232,Pain , Phase 2
10538,D09EFW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13",Albinism , Patented
10539,D09EFW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13",Ephelides , Patented
10540,D09EFW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13",Menkes disease , Patented
10541,D09EFW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13",Senile lentigines , Patented
10542,D09EFW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 13",Melasma , Patented
10543,D09EGZ,Chloroquine,Malaria , Approved
10544,D09EHO,ABT-751,Solid tumour/cancer , Phase 2
10545,D09EIQ,Biaryl mannoside derivative 18,Crohn disease , Patented
10546,D09EIQ,Biaryl mannoside derivative 18,Ulcerative colitis , Patented
10547,D09EIQ,Biaryl mannoside derivative 18,Urinary tract infection , Patented
10548,D09EIX,PMID26936077-Compound-13,Type-2 diabetes , Patented
10549,D09EIX,PMID26936077-Compound-13,Metabolic disorder , Patented
10550,D09EIX,PMID26936077-Compound-13,Gastric ulcer , Patented
10551,D09EJC,IRX-03,Neutropenia , Investigative
10552,D09ELC,AVI-7537,Ebola virus infection , Phase 1
10553,D09ELP,Clevidipine butyrate,Hypertension , Approved
10554,D09ELW,Enalkiren,Glaucoma/ocular hypertension , Discontinued in Phase 2
10555,D09EMS,CO-8,Diabetic complication , Investigative
10556,D09ENA,Org-30035,Psychotic disorder , Terminated
10557,D09ENF,PNT-300,Solid tumour/cancer , Investigative
10558,D09ENR,Itarnafloxin,leukaemia , Phase 2
10559,D09ENZ,EPZ-004777,leukaemia , Investigative
10560,D09EOZ,CX-99,Solid tumour/cancer , Investigative
10561,D09EPU,18F-BAY-85-8050,Solid tumour/cancer , Phase 1
10562,D09EPX,MitoLinoleic,Non-alcoholic steatohepatitis , Investigative
10563,D09EQA,SpirH,Human immunodeficiency virus infection , Discontinued in Phase 2
10564,D09EQZ,XN-0502,Solid tumour/cancer , Investigative
10565,D09ESW,Anipamil,Hypertension , Discontinued in Phase 3
10566,D09ETH,E-7050,Head and neck cancer , Phase 1
10567,D09EVP,NNZ-4921,Multiple sclerosis , Investigative
10568,D09EVZ,BMS-488043,Human immunodeficiency virus infection , Discontinued in Phase 2
10569,D09EWK,PRO-053,Duchenne dystrophy , Phase 1/2
10570,D09EXD,Rituximab,Non-hodgkin lymphoma , Approved
10571,D09EXD,Rituximab,Haematological malignancy , Phase 1
10572,D09EXQ,PMID26651364-Compound-8a,Crohn disease , Patented
10573,D09EXQ,PMID26651364-Compound-8a,Ulcerative colitis , Patented
10574,D09EXQ,PMID26651364-Compound-8a,Urinary tract infection , Patented
10575,D09EYJ,IPS cell program,Cardiovascular disease , Investigative
10576,D09EYN,RSV F protein vaccine,Respiratory syncytial virus infection , Phase 3
10577,D09EZU,Myrrhanol A,Inflammation , Investigative
10578,D09FAZ,Azacitidine,Myelodysplastic syndrome , Approved
10579,D09FDN,IMA201,Squamous cell carcinoma , Phase 1
10580,D09FDN,IMA201,Non-small-cell lung cancer , Phase 1
10581,D09FEN,PRO-515,Rheumatoid arthritis , Discontinued in Phase 2
10582,D09FFI,SARS-CoV vaccine,Severe acute respiratory syndrome (SARS) , Discontinued in Phase 1
10583,D09FFS,FT-071,Fibrosis , Investigative
10584,D09FGM,ZP-10719,Mucopolysaccharidosis , Investigative
10585,D09FGV,Recombinant S protein SARS vaccine,Severe acute respiratory syndrome (SARS) , Discontinued in Phase 1
10586,D09FGX,ELACRIDAR,Solid tumour/cancer , Discontinued in Phase 1
10587,D09FHM,Fluzone QIV,Ovarian cancer , Approved
10588,D09FHM,Fluzone QIV,Influenza , Approved
10589,D09FHM,Fluzone QIV,Influenza virus infection , Phase 3
10590,D09FHY,HIV multiantigen vaccine,Human immunodeficiency virus-1 infection , Phase 1
10591,D09FJB,Tolazamide,Diabetic complication , Approved
10592,D09FJH,CFC-240,Bacterial infection , Terminated
10593,D09FKY,GED-0301,Crohn disease , Phase 3
10594,D09FKY,GED-0301,Ulcerative colitis , Phase 2
10595,D09FNI,Nonocog beta pegol,Haemophilia B , Phase 3
10596,D09FOP,MCP-202,Overactive bladder , Phase 1
10597,D09FQB,UR-12460,Thrombosis , Terminated
10598,D09FQP,PMID25684022-Compound-US20120277229 39(1.1),Solid tumour/cancer , Patented
10599,D09FQP,PMID25684022-Compound-US20120277229 39(1.1),Metastatic cancer , Patented
10600,D09FQS,FG-3622,Fungal infection , Preclinical
10601,D09FQW,THVD-201,Overactive bladder , Phase 3
10602,D09FSG,Golimumab,Rheumatoid arthritis , Approved
10603,D09FSG,Golimumab,Inflammatory bowel disease , Phase 2/3
10604,D09FTC,BacTRL-Spike vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
10605,D09FTJ,TTP-054,Type-2 diabetes , Phase 2
10606,D09FWK,E-003,Solid tumour/cancer , Investigative
10607,D09FYW,PF-06743649,Gout , Phase 1
10608,D09FZI,TALTOBULIN,Solid tumour/cancer , Discontinued in Phase 1
10609,D09FZM,BreMel/rGel,Breast cancer , Investigative
10610,D09GAG,DC-159a,Bacterial infection , Discontinued in Phase 1
10611,D09GBM,GD-AAV8,Gaucher disease , Investigative
10612,D09GDD,Regorafenib,Metastatic colorectal cancer , Approved
10613,D09GDY,GNI-103,Hepatitis C virus infection , Discontinued in Phase 1/2
10614,D09GEK,ASP3026,Diffuse large B-cell lymphoma , Phase 1
10615,D09GFL,Trihexyphenidyl,Dystonia , Approved
10616,D09GFL,Trihexyphenidyl,Parkinson disease , Approved
10617,D09GFL,Trihexyphenidyl,Obesity , Investigative
10618,D09GGJ,CVT-124,Autoimmune diabetes , Discontinued in Phase 3
10619,D09GGO,A-252444.0,Inflammation , Terminated
10620,D09GHB,RO-4987655,Solid tumour/cancer , Discontinued in Phase 1
10621,D09GHO,LY-334370,Migraine , Phase 2
10622,D09GIA,SAR391786,Muscle atrophy , Phase 2
10623,D09GIP,QRS-5-005,Sepsis , Terminated
10624,D09GJQ,Tricyclic phytocannabinoid derivative 1,Neuropathic pain , Patented
10625,D09GLS,GSK1614235,Type-2 diabetes , Phase 1
10626,D09GMC,GX-101,Systemic lupus erythematosus , Investigative
10627,D09GME,Covid-19 aAPC vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
10628,D09GMH,Hepatitis B virus vaccine,Hepatitis B virus infection , Approved
10629,D09GOS,Clotrimazole,Fungal infection , Approved
10630,D09GPB,AZD2066,Chronic neuropathic pain , Discontinued in Phase 2
10631,D09GPB,AZD2066,Gastroesophageal reflux disease , Discontinued in Phase 2
10632,D09GPB,AZD2066,Major depressive disorder , Discontinued in Phase 2
10633,D09GPI,FRM-6308,Schizophrenia , Phase 1b
10634,D09GQS,JD-0100,Obesity , Investigative
10635,D09GRB,NNC-90-0270,Alzheimer disease , Terminated
10636,D09GRH,O-Vax,Ovarian cancer , Phase 1/2
10637,D09GRX,Tucatinib,HER2-positive breast cancer , Approved
10638,D09GRX,Tucatinib,Gastric adenocarcinoma , Phase 2/3
10639,D09GSV,FBT-A05,Chronic lymphocytic leukaemia , Phase 1/2
10640,D09GUI,PTL-68001,Solid tumour/cancer , Discontinued in Phase 1
10641,D09GUJ,Omadacycline,Acute bacterial skin infection , Approved
10642,D09GUJ,Omadacycline,Bacterial pneumonia , Approved
10643,D09GUJ,Omadacycline,Bacterial infection , Phase 3
10644,D09GVB,OL-135,Pain , Investigative
10645,D09GVI,VSF-173,Sleep-wake disorder , Phase 2
10646,D09GWA,SARS-CoV-2 rS vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
10647,D09GXF,RB-105,Hypertension , Investigative
10648,D09GYJ,BNT162a1 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
10649,D09GYT,Methoxamine,Hypertension , Approved
10650,D09HAL,JTT-651,Type-2 diabetes , Discontinued in Phase 1
10651,D09HCE,Long-acting FSH conjugate,Female infertility , Investigative
10652,D09HCR,FM-401,Inflammation , Investigative
10653,D09HDR,Deserpidine,Hypertension , Approved
10654,D09HDV,AD-529,Neuropathic pain , Preclinical
10655,D09HEV,GS-9005,Human immunodeficiency virus infection , Discontinued in Phase 1/2
10656,D09HFJ,NM-3,Solid tumour/cancer , Phase 1
10657,D09HFL,GSK2398852 + GSK2315698,Amyloidosis , Phase 2
10658,D09HFS,AFP464,Breast cancer , Phase 2
10659,D09HIC,BF-388,Inflammation , Terminated
10660,D09HJS,BIZELESIN,Skin disease , Phase 1
10661,D09HKX,Cefoselis,Bacterial infection , Approved
10662,D09HNR,Telithromycin,Bacterial infection , Approved
10663,D09HNV,Intedanib,Colorectal cancer , Approved
10664,D09HNV,Intedanib,Idiopathic pulmonary fibrosis , Approved
10665,D09HNV,Intedanib,Non-small-cell lung cancer , Phase 3
10666,D09HNV,Intedanib,Mesothelioma , Phase 3
10667,D09HNV,Intedanib,Ovarian cancer , Phase 2
10668,D09HOJ,NPB-01,Pemphigoid , Phase 3
10669,D09HOW,S-364735,Human immunodeficiency virus infection , Phase 2
10670,D09HRH,Anti-CD133-CAR vector-transduced T cells,Brain cancer , Phase 1
10671,D09HRH,Anti-CD133-CAR vector-transduced T cells,Colorectal cancer , Phase 1
10672,D09HRH,Anti-CD133-CAR vector-transduced T cells,Liver cancer , Phase 1
10673,D09HRH,Anti-CD133-CAR vector-transduced T cells,Ovarian cancer , Phase 1
10674,D09HRH,Anti-CD133-CAR vector-transduced T cells,Pancreatic cancer , Phase 1
10675,D09HRS,GHB-16L2,Influenza virus infection , Phase 1/2
10676,D09HTB,SAR153191,Ankylosing spondylitis , Phase 3
10677,D09HTE,HA20,Lymphoma , Phase 1/2
10678,D09HTS,Lanatoside a,Cardiovascular disease , Approved
10679,D09HUF,UR-60427,Asthma , Investigative
10680,D09HUU,EC1456,Solid tumour/cancer , Phase 1
10681,D09HVD,Ramucirumab,Gastric adenocarcinoma , Approved
10682,D09HVH,NMS-E973,Solid tumour/cancer , Investigative
10683,D09HVL,Bivalirudin,Thrombocytopenia , Approved
10684,D09HVY,Cystatin C,Alzheimer disease , Investigative
10685,D09HYG,NP16,Staphylococcus infection , Investigative
10686,D09HYI,M-2001,Non-insulin dependent diabetes , Investigative
10687,D09IAN,Anti-CD19 Chimeric Antigen Receptor T Cells,leukaemia , Clinical trial
10688,D09ICC,SB220025,Arthritis , Terminated
10689,D09ICH,CD7.CAR/28zeta CAR T cells,B-cell acute lymphoblastic leukaemia , Phase 1
10690,D09ICH,CD7.CAR/28zeta CAR T cells,Cutaneous T-cell lymphoma , Phase 1
10691,D09ICH,CD7.CAR/28zeta CAR T cells,Non-hodgkin lymphoma , Phase 1
10692,D09IEE,Prednicarbate,Inflammation , Approved
10693,D09IFW,Cruentaren,Fungal infection , Preclinical
10694,D09IGF,MG-28,Solid tumour/cancer , Investigative
10695,D09IGR,AZX-100,Asthma , Phase 2
10696,D09IIX,HMAG-1 targeting GRSA,Breast cancer , Investigative
10697,D09IJP,A-71378,Obesity , Preclinical
10698,D09IKZ,AS-1949490,Non-insulin dependent diabetes , Investigative
10699,D09IMN,SAR153192,Solid tumour/cancer , Phase 1
10700,D09IMS,Mequitazine,Allergic rhinitis , Approved
10701,D09IMS,Mequitazine,Respiratory disease , Phase 2
10702,D09IMY,SLP-0905,Enterococcus faecium infection , Investigative
10703,D09INA,HD-148,Solid tumour/cancer , Investigative
10704,D09INF,Laquinamod,Multiple sclerosis , Phase 3
10705,D09INX,DSP-3905,Neuropathic pain , Phase 1
10706,D09IOA,EM-3106B,Insulinoma , Investigative
10707,D09IOF,Troplasminogen alfa,Myocardial infarction , Phase 2
10708,D09IOI,Amoxapine,Major depressive disorder , Approved
10709,D09IPV,Danazol,Menorrhagia , Approved
10710,D09IPV,Danazol,Breast cancer , Phase 2
10711,D09IRN,LU AE58054,Schizophrenia , Phase 3
10712,D09IRQ,Ataluren,Cystic fibrosis , Phase 3
10713,D09IRQ,Ataluren,Dravet syndrome , Phase 2
10714,D09IRQ,Ataluren,Muscular dystrophy , Phase 2
10715,D09IRQ,Ataluren,Aniridia , Phase 1
10716,D09IRQ,Ataluren,Mucopolysaccharidosis , Phase 1
10717,D09IRQ,Ataluren,Duchenne dystrophy , Application submitted
10718,D09ISJ,SOM-0856,Virus infection , Investigative
10719,D09ISS,CZEN-001,Pruritus , Phase 1
10720,D09ITH,Botulism immune globulin,Clostridium infection , Approved
10721,D09IUG,F-3796,Alzheimer disease , Terminated
10722,D09IUR,Midismase,Cerebral infarction , Phase 2
10723,D09IVP,Anti-folate receptor 1 humanized mab,Ovarian cancer , Investigative
10724,D09IYH,Pyrazole derivative 58,Obesity , Patented
10725,D09IYM,AT13148,Solid tumour/cancer , Phase 1
10726,D09IZX,GW-275919,Pain , Discontinued in Phase 2
10727,D09JBP,Paramethadione,Seizure disorder , Approved
10728,D09JBP,Paramethadione,Fetal trimethadione syndrome , Approved
10729,D09JCH,CDNA vaccine,Prostate cancer , Phase 1
10730,D09JDV,PMID26651364-Compound-5a,Crohn disease , Patented
10731,D09JDV,PMID26651364-Compound-5a,Ulcerative colitis , Patented
10732,D09JDV,PMID26651364-Compound-5a,Urinary tract infection , Patented
10733,D09JDX,RCD-2,Fecal incontinence , Preclinical
10734,D09JEJ,CX-4945,Coronavirus infection , Phase 2
10735,D09JEJ,CX-4945,Cholangiocarcinoma , Phase 1/2
10736,D09JEJ,CX-4945,Solid tumour/cancer , Phase 1
10737,D09JES,Sampatrilat,Hypotension , Phase 2
10738,D09JET,NGD 96-3,Insomnia , Investigative
10739,D09JFY,Dutasteride + tamsulosin,Benign prostatic hyperplasia , Phase 3
10740,D09JFY,Dutasteride + tamsulosin,Prostate cancer , Phase 3
10741,D09JGH,EC-145,Solid tumour/cancer , Phase 2
10742,D09JGK,TAK-960,Solid tumour/cancer , Phase 1
10743,D09JJG,MCT-465,Solid tumour/cancer , Investigative
10744,D09JJU,EchiTAb,Poison intoxication , Approved
10745,D09JKN,P-BCMA-101,Multiple myeloma , Phase 1/2
10746,D09JKS,GRASPA,Acute lymphoblastic leukaemia , Phase 3
10747,D09JKS,GRASPA,Pancreatic cancer , Phase 1
10748,D09JLI,Vicriviroc,Human immunodeficiency virus infection , Phase 3
10749,D09JLP,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10",Albinism , Patented
10750,D09JLP,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10",Ephelides , Patented
10751,D09JLP,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10",Menkes disease , Patented
10752,D09JLP,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10",Senile lentigines , Patented
10753,D09JLP,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 10",Melasma , Patented
10754,D09JMW,IHV001,Human immunodeficiency virus infection , Phase 1
10755,D09JNP,MVax,Ovarian cancer , Approved
10756,D09JPT,CB-183872,Hepatitis C virus infection , Investigative
10757,D09JSM,IMC-3C5,Solid tumour/cancer , Phase 1
10758,D09JTE,BIOO-6,Solid tumour/cancer , Investigative
10759,D09JUG,Zileuton,Asthma , Approved
10760,D09JUL,Naltrexone prodrug,Alcohol dependence , Investigative
10761,D09JVK,LY3090106,Sjogren syndrome , Phase 2/3
10762,D09JVK,LY3090106,Rheumatoid arthritis , Phase 1
10763,D09JVV,Physostigmine,Xerostomia , Discontinued in Phase 2
10764,D09JXH,LUM001,Primary biliary cirrhosis , Phase 2
10765,D09JXH,LUM001,Primary biliary cholangitis , Phase 2
10766,D09JXH,LUM001,Primary sclerosing cholangitis , Phase 2
10767,D09JXH,LUM001,Progressive familial intrahepatic cholestasis , Phase 2
10768,D09JXH,LUM001,Structural developmental anomalies of liver , Phase 2
10769,D09JXL,SEGLITIDE,Pain , Discontinued in Phase 2
10770,D09JXM,Phenylpropanolamine,Obesity , Withdrawn from market
10771,D09JYF,Epocarbazolin-A,Asthma , Terminated
10772,D09JYL,Hu5F9-G4,Myelodysplastic syndrome , Phase 3
10773,D09JYL,Hu5F9-G4,Solid tumour/cancer , Phase 1/2
10774,D09JYL,Hu5F9-G4,Colorectal cancer , Phase 1/2
10775,D09JYL,Hu5F9-G4,B-cell non-hodgkin lymphoma , Phase 1/2
10776,D09JYL,Hu5F9-G4,Acute myeloid leukaemia , Phase 1
10777,D09JYY,F-1013,Solid tumour/cancer , Investigative
10778,D09KAK,NOX-F37,Acute and chronic heart failure , Preclinical
10779,D09KDN,Cefazolin,Bacterial infection , Approved
10780,D09KDV,Dihydroxyacetone,Sunburn , Approved
10781,D09KEB,PRT-060318,Thrombosis , Investigative
10782,D09KEW,KPL-716,Atopic dermatitis , Phase 1
10783,D09KEW,KPL-716,Nodular prurigo , Phase 1
10784,D09KGQ,Menadiol sodium diphosphate,Coagulation defect , Approved
10785,D09KGZ,QG-AGC1,Solid tumour/cancer , Terminated
10786,D09KHE,EN3488,Non-muscle invasive bladder cancer , Phase 3
10787,D09KIG,ETX201,Crohn disease , Phase 1
10788,D09KIP,Chondrogel,Pediatric cancer , Discontinued in Phase 3
10789,D09KKD,AZD-3118,Heart arrhythmia , Terminated
10790,D09KKH,Mepartricin,Fungal infection , Approved
10791,D09KLO,AZD-5106,Urinary incontinence , Terminated
10792,D09KLR,Alendronate,Paget's disease , Approved
10793,D09KLR,Alendronate,Osteoporosis , Approved
10794,D09KLX,Cartistem-adipo,Arthropathy , Investigative
10795,D09KMA,Zofroxia,Influenza virus infection , Investigative
10796,D09KNG,RSV-604,Virus infection , Phase 2
10797,D09KRE,Bezlotoxumab,C. difficile infection , Approved
10798,D09KRU,BI-831266,Solid tumour/cancer , Phase 1
10799,D09KRV,Adhexil,Injury , Phase 3
10800,D09KRX,AVR-168,Solid tumour/cancer , Preclinical
10801,D09KSW,3-CLA,Solid tumour/cancer , Investigative
10802,D09KTE,BCL-004,Renal cell carcinoma , Investigative
10803,D09KTI,GS-5816,Chronic HCV-1 infection , Phase 2
10804,D09KTS,Ibrutinib,Mantle cell lymphoma , Approved
10805,D09KTS,Ibrutinib,B-cell non-hodgkin lymphoma , Phase 3
10806,D09KTS,Ibrutinib,Diffuse large B-cell lymphoma , Phase 3
10807,D09KTS,Ibrutinib,Follicular lymphoma , Phase 3
10808,D09KTS,Ibrutinib,Non-hodgkin lymphoma , Phase 3
10809,D09KTS,Ibrutinib,Pancreatic cancer , Phase 3
10810,D09KTS,Ibrutinib,Solid tumour/cancer , Phase 2
10811,D09KUE,NSC-88915,Solid tumour/cancer , Investigative
10812,D09KWN,Anti-MUC1 CAR-T cells,Esophageal cancer , Phase 1/2
10813,D09KWX,Hl-con1,Macular degeneration , Phase 1
10814,D09KXA,PD-131112,Bacterial infection , Discontinued in Phase 1
10815,D09KYB,Pyrimidine derivative 7,Neurodegenerative disorder , Patented
10816,D09KYB,Pyrimidine derivative 7,Fibrosis , Patented
10817,D09KYB,Pyrimidine derivative 7,Blood vessel proliferative disorder , Patented
10818,D09KYR,RP-49356,Hypertension , Phase 2
10819,D09KYZ,V-24343,Type-2 diabetes , Phase 1
10820,D09LBS,Sennoside b,Cardiovascular disease , Approved
10821,D09LDR,Oxazepam,Anxiety disorder , Approved
10822,D09LEB,RG7641,Kidney disease , Discontinued in Phase 1
10823,D09LEN,Pneumococcal 13-valent conjugate vaccine,Streptococcus infection , Approved
10824,D09LEP,Pyrethroids,Pest attack , Phase 2
10825,D09LGV,MT-204,Inflammation , Investigative
10826,D09LHG,YY-162,Attention deficit hyperactivity disorder , Phase 3
10827,D09LIE,ASIbcl vaccine,B-cell lymphoma , Terminated
10828,D09LIZ,KI-0502,Solid tumour/cancer , Phase 3
10829,D09LKR,TS-011,Stroke , Phase 1
10830,D09LKU,NOX-E36,Diabetic complication , Phase 2
10831,D09LLS,Havrix,Hepatitis virus infection , Approved
10832,D09LMQ,Vaginal ring,Human papillomavirus infection , Investigative
10833,D09LMX,Revatropate,Chronic obstructive pulmonary disease , Discontinued in Phase 1
10834,D09LNI,Fluconazole,Fungal infection , Approved
10835,D09LOZ,TTAC-0001,Recurrent glioblastoma , Phase 2
10836,D09LPI,BCG65-E7,Human papillomavirus infection , Discontinued in Phase 3
10837,D09LPI,BCG65-E7,Anal intraepithelial neoplasia , Discontinued in Phase 3
10838,D09LPK,4E2Rcat,Severe acute respiratory syndrome (SARS) , Investigative
10839,D09LPK,4E2Rcat,Coronavirus Disease 2019 (COVID-19) , Investigative
10840,D09LPN,Lepirudin,Thrombocytopenia , Approved
10841,D09LPV,N6022,Asthma , Phase 2
10842,D09LQK,BQ-123,Pulmonary arterial hypertension , Phase 2
10843,D09LQP,RG-14893,Asthma , Terminated
10844,D09LSX,KU-0058948,Ovarian cancer , Approved
10845,D09LSY,EDP-322,Bacterial infection , Phase 1
10846,D09LTC,Non GC-C,Gastrointestinal disease , Investigative
10847,D09LTO,A-76341,Diabetic complication , Investigative
10848,D09LVD,ISIS-APOARx,Coronary artery disease , Phase 1
10849,D09LVK,TDI-0026,Motor neurone disease , Investigative
10850,D09LWP,PMID26651364-Compound-105,Crohn disease , Patented
10851,D09LWP,PMID26651364-Compound-105,Ulcerative colitis , Patented
10852,D09LWP,PMID26651364-Compound-105,Urinary tract infection , Patented
10853,D09LWS,Ezetimibe,Hypercholesterolaemia , Approved
10854,D09LWZ,Mannoside derivative 7,Crohn disease , Patented
10855,D09LWZ,Mannoside derivative 7,Ulcerative colitis , Patented
10856,D09LWZ,Mannoside derivative 7,Urinary tract infection , Patented
10857,D09LZA,CS-4771,Sepsis , Discontinued in Phase 1
10858,D09LZN,ACER-001,Maple-syrup-urine disease , Investigative
10859,D09LZT,Levomepromazine,Psychotic disorder , Approved
10860,D09LZT,Levomepromazine,Bipolar disorder , Approved
10861,D09MAB,Anti-CD5 humanized mab,Solid tumour/cancer , Investigative
10862,D09MAS,FR-901483,Graft-versus-host disease , Discontinued in Phase 1
10863,D09MCG,Amantidine,Influenza virus infection , Approved
10864,D09MCG,Amantidine,Severe acute respiratory syndrome (SARS) , Investigative
10865,D09MED,Toca 511/Toca FC,Glioblastoma multiforme , Phase 3
10866,D09MED,Toca 511/Toca FC,Glioma , Phase 3
10867,D09MED,Toca 511/Toca FC,Lymphoma , Phase 1
10868,D09MED,Toca 511/Toca FC,Solid tumour/cancer , Phase 1
10869,D09MEV,JES-9501,Alzheimer disease , Phase 1
10870,D09MFV,KC-7F2,Solid tumour/cancer , Investigative
10871,D09MGR,Etoricoxib,Rheumatoid arthritis , Approved
10872,D09MHC,CJC-1134-PC,Type-2 diabetes , Phase 3
10873,D09MHN,Ixmyelocel-T,Type-1 diabetes , Phase 3
10874,D09MHN,Ixmyelocel-T,Dilated cardiomyopathy , Phase 3
10875,D09MHN,Ixmyelocel-T,Heart failure , Phase 2
10876,D09MHU,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6",Albinism , Patented
10877,D09MHU,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6",Ephelides , Patented
10878,D09MHU,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6",Menkes disease , Patented
10879,D09MHU,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6",Senile lentigines , Patented
10880,D09MHU,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 6",Melasma , Patented
10881,D09MIN,LCL161,Solid tumour/cancer , Phase 2
10882,D09MIN,LCL161,Multiple myeloma , Phase 2
10883,D09MIN,LCL161,Myelofibrosis , Phase 2
10884,D09MIN,LCL161,Breast cancer , Phase 1
10885,D09MJH,SEA-CD40,Haematological malignancy , Phase 1
10886,D09MJH,SEA-CD40,Lymphoma , Phase 1
10887,D09MJH,SEA-CD40,Solid tumour/cancer , Phase 1
10888,D09MJJ,RP4010,Non-hodgkin lymphoma , Phase 1
10889,D09MJO,HL-004,Arteriosclerosis , Preclinical
10890,D09MKH,TRI-102,Attention deficit hyperactivity disorder , Phase 3
10891,D09MKL,TD-1607,Gram-positive bacterial infection , Phase 1
10892,D09MKQ,AMG 317,Asthma , Discontinued in Phase 1
10893,D09MOD,NNC-252504,Type-2 diabetes , Terminated
10894,D09MON,A-75998,Hormone deficiency , Discontinued in Phase 1
10895,D09MPD,ALX-0651,Haematological malignancy , Phase 1
10896,D09MPN,TDI-0087,Motor neurone disease , Investigative
10897,D09MPO,HLD100,Attention deficit hyperactivity disorder , Phase 2
10898,D09MPU,Astromycin sulfate,Bacterial infection , Approved
10899,D09MPX,SPF66,Malaria , Phase 1
10900,D09MQQ,CDD-0199-J,Alzheimer disease , Preclinical
10901,D09MQU,OGX-225,Prostate cancer , Investigative
10902,D09MQY,CKD-403,Solid tumour/cancer , Investigative
10903,D09MRD,MGN-4220,Fibrosis , Investigative
10904,D09MRL,Pidilizumab,Diffuse large B-cell lymphoma , Phase 2
10905,D09MRY,ACU-0101979,Alzheimer disease , Investigative
10906,D09MSE,JNJ-38224342,Seasonal allergic rhinitis , Phase 1
10907,D09MTC,ADL-5945,Constipation , Discontinued in Phase 2
10908,D09MUS,JBD-201,Fungal infection , Investigative
10909,D09MVZ,mab17-1a,Colorectal cancer , Approved
10910,D09MWJ,Alfuzosin,Benign prostatic hyperplasia , Approved
10911,D09MXE,TCK-1,Inflammation , Investigative
10912,D09MXS,Sorbitol,Constipation , Approved
10913,D09NAF,AV 133,Alzheimer disease , Phase 3
10914,D09NAW,PF-05105679,Pain , Phase 1
10915,D09NBH,ICT-121,Solid tumour/cancer , Phase 1
10916,D09NBH,ICT-121,Recurrent glioblastoma , Phase 1
10917,D09NBM,SB-435495,Arteriosclerosis , Discontinued in Phase 1
10918,D09NCH,AM-230,Osteoarthritis , Investigative
10919,D09NCU,GS-6624,Colorectal cancer , Phase 2
10920,D09NDM,IN-001,Erectile dysfunction , Phase 3
10921,D09NEE,BVT-115959,Pain , Discontinued in Phase 2
10922,D09NEL,CWF-0804,Alzheimer disease , Investigative
10923,D09NFN,Pentetate calcium trisodium,Acute radiation syndrome , Approved
10924,D09NFW,Dendritic cell vaccine,Ovarian cancer , Phase 2
10925,D09NHD,Peptide P21S10,Middle East Respiratory Syndrome (MERS) , Preclinical
10926,D09NHS,PfCS-102,Malaria , Phase 1/2
10927,D09NIA,Chlorthalidone,Edema , Approved
10928,D09NIA,Chlorthalidone,Hypertension , Approved
10929,D09NIB,Epipodophyllotoxin,Solid tumour/cancer , Approved
10930,D09NIY,Trolamine Polypeptide Oleate Condensate,Impacted cerumen , Approved
10931,D09NKX,ANA-246,Hepatitis C virus infection , Terminated
10932,D09NLC,Guar gum,Hypercholesterolaemia , Approved
10933,D09NLK,Minokine,Neurodegenerative disorder , Investigative
10934,D09NMD,Lasofoxifene,Osteoporosis , Approved
10935,D09NMD,Lasofoxifene,Virus infection , Discontinued in Phase 1
10936,D09NNA,Dromostanolone,Mammary tumour , Approved
10937,D09NNH,Dihydroergocristine,Alcohol dependence , Approved
10938,D09NQD,CIGB-55,Rheumatoid arthritis , Investigative
10939,D09NQX,HBV-002,West nile virus infection , Phase 1
10940,D09NST,Afimoxifene,Breast cancer , Phase 2
10941,D09NST,Afimoxifene,Ductal carcinoma , Phase 2
10942,D09NTC,CC-486,Myelodysplastic syndrome , Phase 3
10943,D09NTC,CC-486,Acute myeloid leukaemia , Phase 3
10944,D09NTC,CC-486,Diffuse large B-cell lymphoma , Phase 1
10945,D09NTG,Taurocholic Acid,Type-2 diabetes , Phase 1/2
10946,D09NTM,VR506,Asthma , Approved
10947,D09NUH,4SCAR-FRa,Bladder cancer , Phase 1/2
10948,D09NVR,PRN2246,Multiple sclerosis , Phase 1
10949,D09NVU,ZP-1848,Inflammatory bowel disease , Phase 1
10950,D09NWW,AMG-247,Inflammation , Investigative
10951,D09NXZ,HL-038,Angina pectoris , Investigative
10952,D09NYB,CASTANOSPERMINE,Diabetic complication , Discontinued in Phase 2
10953,D09NYS,Methylene blue,Acquired methemoglobinemia , Approved
10954,D09NYU,Polaprezinc,Ulcer , Approved
10955,D09NYU,Polaprezinc,Helicobacter infection , Approved
10956,D09OAQ,TNP-470,Solid tumour/cancer , Discontinued in Phase 2
10957,D09OBB,Dextromethorphan,Cough , Approved
10958,D09OBF,CMUS-100,Solid tumour/cancer , Investigative
10959,D09OCK,UK-371800,Erectile dysfunction , Phase 1
10960,D09ODU,XL475,Type-2 diabetes , Preclinical
10961,D09OHH,OS-440,Gastric adenocarcinoma , Phase 3
10962,D09OHH,OS-440,Muscle spasm , Application submitted
10963,D09OHP,Indeglitazar,Type-2 diabetes , Discontinued in Phase 2
10964,D09OHR,SY-1365,Solid tumour/cancer , Phase 1
10965,D09OHW,Dendritic cell therapy,Breast cancer , Phase 3
10966,D09OJI,D-0502,Breast cancer , Phase 1
10967,D09OJQ,Methadone,Dry cough , Approved
10968,D09OKV,Amprenavir,Human immunodeficiency virus infection , Approved
10969,D09OKV,Amprenavir,Coronavirus Disease 2019 (COVID-19) , Investigative
10970,D09OKZ,CA4P,Neuroendocrine cancer , Phase 2
10971,D09OKZ,CA4P,Ovarian cancer , Phase 2
10972,D09OLR,Debio-1141,Bladder cancer , Investigative
10973,D09OLZ,Cetrorelix,Ovarian stimulation , Approved
10974,D09OMK,Tarvacin Anti-Viral,Hepatitis virus infection , Phase 1
10975,D09ONL,SAR439794,Allergy , Phase 1
10976,D09OOC,Gp100,Solid tumour/cancer , Phase 3
10977,D09OOQ,TGFK08AA,Generalized anxiety disorder , Phase 2
10978,D09OOV,Polymyxin B Sulfate,Pseudomonas infection , Approved
10979,D09OPH,NPB-3,Allergic rhinitis , Investigative
10980,D09OPS,SN-28049,Solid tumour/cancer , Investigative
10981,D09OQV,N-0923,Parkinson disease , Approved
10982,D09ORU,ZELANDOPAM HYDROCHLORIDE,Hypertension , Discontinued in Phase 2
10983,D09OSC,Anti-EGFRvIII CAR T cells,Glioblastoma multiforme , Phase 1
10984,D09OSM,TGFTX-1,Arteriosclerosis , Investigative
10985,D09OTF,ACEA-1031,Cerebrovascular ischaemia , Terminated
10986,D09OTG,MS-377,Schizophrenia , Terminated
10987,D09OTU,SSR-180575,Rheumatoid arthritis , Phase 2
10988,D09OTX,RG7800,Spinal muscular atrophy , Phase 1/2
10989,D09OUT,NN-818,Brain injury , Preclinical
10990,D09OWC,SKLB-010,Inflammation , Investigative
10991,D09OWI,HDV-insulin,Type-2 diabetes , Phase 2/3
10992,D09OWI,HDV-insulin,Type-1 diabetes , Phase 2
10993,D09OWK,AGN-2979,Psychotic disorder , Phase 2
10994,D09OXR,Diffistat-G,Clostridium infection , Discontinued in Phase 2
10995,D09OZC,Lucanthone,Solid tumour/cancer , Approved
10996,D09PAU,M87o,Human immunodeficiency virus infection , Phase 1/2
10997,D09PCL,JNJ-64565111,Obesity , Phase 2
10998,D09PCL,JNJ-64565111,Type-2 diabetes , Phase 1
10999,D09PDK,F-9TG,Factor IX deficiency , Investigative
11000,D09PEQ,Gentamicine sulfate,Bacterial infection , Approved
11001,D09PEV,Itazigrel,Thrombosis , Terminated
11002,D09PFR,LAMB3-transduced autologous epidermal stem cells,Epidermolysis bullosa , Phase 1
11003,D09PGG,MVI-816,Prostate cancer , Phase 2
11004,D09PGH,PA-508,Cardiovascular disease , Investigative
11005,D09PGL,Capromab,Prostate cancer , Approved
11006,D09PGM,BY-1949,Cognitive impairment , Discontinued in Phase 2
11007,D09PGT,T2c-002,Peripheral arterial disease , Phase 2
11008,D09PHB,Mefenamic,Pain , Approved
11009,D09PIH,NK-1007,Atrial fibrillation , Investigative
11010,D09PJB,ARG301,Rheumatoid arthritis , Phase 1
11011,D09PJX,Tetrabenazine,Hyperkinetic movement disorder , Approved
11012,D09PJX,Tetrabenazine,Huntington disease , Approved
11013,D09PKU,ERBULOZOLE,Solid tumour/cancer , Discontinued in Phase 2
11014,D09PKZ,NM-9308,Age-related macular degeneration , Investigative
11015,D09PLF,Org-30029,Heart failure , Phase 2
11016,D09PLI,Efalith,Acne vulgaris , Approved
11017,D09PLZ,NI-1201,Autoimmune diabetes , Investigative
11018,D09PMV,"Interferon Alfa-2a, Recombinant",Chronic HCV-1 infection , Approved
11019,D09PNS,UGP-281,Obesity , Investigative
11020,D09PNV,KSG-504,Pancreatic malfunction , Investigative
11021,D09PNY,Tropicamide,Mydriasis , Approved
11022,D09POH,AEG-33773,Diabetic neuropathy , Phase 2
11023,D09PON,MRLP-098,Bacterial infection , Investigative
11024,D09POQ,OM-174,Solid tumour/cancer , Phase 1
11025,D09PPF,CNS-1067,Epilepsy , Terminated
11026,D09PPG,Metformin arginine-hemisuccinimide,Type-2 diabetes , Approved
11027,D09PPU,CA-170,Lymphoma , Phase 1
11028,D09PPU,CA-170,Solid tumour/cancer , Phase 1
11029,D09PQP,SGN-70,Autoimmune diabetes , Phase 1
11030,D09PQZ,Acalabrutinib,Mantle cell lymphoma , Approved
11031,D09PQZ,Acalabrutinib,Chronic lymphocytic leukaemia , Phase 3
11032,D09PRN,TROVIRDINE HYDROCHLORIDE,Human immunodeficiency virus infection , Phase 1
11033,D09PRY,CB-28,Aging skin , Terminated
11034,D09PSB,DPC-082,Human immunodeficiency virus infection , Discontinued in Phase 1
11035,D09PSY,ANS-6637,Substance use disorder , Phase 1
11036,D09PSZ,Deferitrin,Iron overload disease , Phase 1/2
11037,D09PTA,HP-290,Parkinson disease , Discontinued in Phase 2
11038,D09PTD,BMS-986168,Progressive supranuclear palsy , Phase 1
11039,D09PTL,SRI-3072,Mycobacterium infection , Terminated
11040,D09PTP,CEP-28122,Solid tumour/cancer , Investigative
11041,D09PTY,V-212,Varicella zoster virus infection , Phase 3
11042,D09PTY,V-212,Zoster , Phase 3
11043,D09PUL,L-Alanine,Glioma , Approved
11044,D09PUL,L-Alanine,Dietary shortage , Approved
11045,D09PVO,Aramchol,Lipid metabolism disorder , Phase 2/3
11046,D09PWS,KI-0902,Gastrointestinal ulcer , Investigative
11047,D09PYD,CGS-25462,Hypertension , Discontinued in Phase 2
11048,D09PYV,AZ-40140,Type-2 diabetes , Phase 2
11049,D09PYV,AZ-40140,Obesity , Phase 2
11050,D09PYZ,MK-3328,Alzheimer disease , Phase 1
11051,D09PZO,Idoxuridine,Herpes simplex virus infection , Approved
11052,D09PZV,ITV-4,Human immunodeficiency virus infection , Investigative
11053,D09PZZ,Lypressin,Amnesia , Approved
11054,D09QAD,CGS-15873A,Psychotic disorder , Phase 2
11055,D09QBG,Cangrelor,Thrombosis , Approved
11056,D09QDP,Clorgyline,Parkinson disease , Approved
11057,D09QDP,Clorgyline,Skin imperfections , Patented
11058,D09QEI,Pentoxifylline,Intermittent claudication , Approved
11059,D09QHP,PS-873266,Inflammation , Phase 1
11060,D09QHU,SD-560,Pulmonary fibrosis , Investigative
11061,D09QIJ,PF-3491165,Arteriosclerosis , Discontinued in Phase 1
11062,D09QKI,PPL-100,Human immunodeficiency virus infection , Phase 1
11063,D09QLR,Dibenzothiazepines,Drug abuse , Investigative
11064,D09QMX,Q-301,Hepatitis C virus infection , Phase 2
11065,D09QMX,Q-301,Atopic dermatitis , Phase 2
11066,D09QOF,EM-2487,Human immunodeficiency virus infection , Terminated
11067,D09QOR,Eniluracil,Hyperlipidaemia , Phase 2
11068,D09QPD,HPP-515,Female sexual arousal dysfunction , Investigative
11069,D09QPE,AP-1189,Atopic dermatitis , Investigative
11070,D09QQE,Crodox,Breast cancer , Investigative
11071,D09QQS,Diazepinone derivative 1,Reflux disease , Patented
11072,D09QQS,Diazepinone derivative 1,Parkinson disease , Patented
11073,D09QRG,BXT-25,Coronavirus Disease 2019 (COVID-19) , Investigative
11074,D09QRI,NX-001,Kidney transplant rejection , Phase 1
11075,D09QRO,CGS-13080,Asthma , Terminated
11076,D09QRS,Chondrocelect,Articular cartilage disorder , Approved
11077,D09QSC,PSMA protein vaccine,Prostate cancer , Phase 1
11078,D09QTS,LC-01,Ocular inflammation , Investigative
11079,D09QUE,MVA-BN HIV Polytope,Human immunodeficiency virus infection , Discontinued in Phase 1/2
11080,D09QUQ,Levobupivacaine,Anaesthesia , Approved
11081,D09QVI,LQB-118,Solid tumour/cancer , Investigative
11082,D09QVR,BMS-986218,Solid tumour/cancer , Phase 1/2
11083,D09QVT,Streptococcus vaccines,Streptococcus infection , Terminated
11084,D09QVU,APH-0703,Alzheimer disease , Phase 1/2
11085,D09QVV,Vincristine,Acute lymphoblastic leukaemia , Approved
11086,D09QWD,CEP-37251,Bone metastases , Phase 1
11087,D09QWK,AMG-327,Inflammation , Investigative
11088,D09QWN,CB4211,Non-alcoholic steatohepatitis , Phase 1
11089,D09QXC,PMID25666693-Compound-79,Osteoarthritis pain , Patented
11090,D09QXC,PMID25666693-Compound-79,Cancer related pain , Patented
11091,D09QXC,PMID25666693-Compound-79,Neuropathic pain , Patented
11092,D09QXC,PMID25666693-Compound-79,Inflammatory pain , Patented
11093,D09QYD,ILS920,Stroke , Phase 1
11094,D09QZB,Resorcinol compound 32,Albinism , Patented
11095,D09QZB,Resorcinol compound 32,Ephelides , Patented
11096,D09QZB,Resorcinol compound 32,Menkes disease , Patented
11097,D09QZB,Resorcinol compound 32,Senile lentigines , Patented
11098,D09QZB,Resorcinol compound 32,Melasma , Patented
11099,D09QZI,Norgestimate,Contraception , Approved
11100,D09QZK,RIG-I adjuvant,Solid tumour/cancer , Investigative
11101,D09QZS,Olaratumab,Soft tissue sarcoma , Approved
11102,D09QZS,Olaratumab,Non-small-cell lung cancer , Phase 1
11103,D09RAB,PRO-300,Mucositis , Investigative
11104,D09RBQ,Zutectra,Hepatitis B virus infection , Approved
11105,D09RDT,GT-3021,Herpes simplex virus infection , Discontinued in Phase 1
11106,D09RED,Prostat,Prostate hyperplasia , Approved
11107,D09RGS,Anti-CD97 mab,Rheumatoid arthritis , Investigative
11108,D09RGW,AZD-3778,Asthma , Discontinued in Phase 2
11109,D09RHQ,Ropivacaine,Anaesthesia , Approved
11110,D09RHS,Arilvax,Yellow fever virus infection , Approved
11111,D09RII,Voxelotor,Sickle-cell disorder , Approved
11112,D09RJA,RELVARTM or BREOTM ELLIPTATM,Asthma , NDA filed
11113,D09RJN,S-17092-1,Cognitive impairment , Phase 1
11114,D09RJN,S-17092-1,Non-small-cell lung cancer , Clinical trial
11115,D09RKU,SCH-1518291,Schizophrenia , Investigative
11116,D09RLQ,CDX-1127,Solid tumour/cancer , Phase 1
11117,D09RLQ,CDX-1127,leukaemia , Phase 1
11118,D09RLQ,CDX-1127,Lymphoma , Phase 1
11119,D09RMS,AMT-070,Liver cirrhosis , Terminated
11120,D09RMU,GPI-0100,Breast cancer , Phase 2
11121,D09RMZ,HibTITER,Pneumococcal infection , Phase 2
11122,D09RND,EZN-4176,Prostate cancer , Phase 1
11123,D09RNI,ESN-YY,Inflammation , Investigative
11124,D09RNP,GSK 679769,Major depressive disorder , Discontinued in Phase 2
11125,D09RNP,GSK 679769,Chemotherapy-induced nausea , Discontinued in Phase 2
11126,D09RNP,GSK 679769,Anxiety disorder , Discontinued in Phase 2
11127,D09RNP,GSK 679769,Incontinence , Discontinued in Phase 2
11128,D09RON,LY-2300559,Migraine , Discontinued in Phase 2
11129,D09RPB,DFD-06,Plaque psoriasis , Phase 3
11130,D09RPP,CAR-GPC3 T cell,Hepatocellular carcinoma , Clinical trial
11131,D09RPU,4'-GALACTOSYLLACTOSE,Hyperlipidaemia , Investigative
11132,D09RRG,BK-4SP,Bordetella pertussis infection , Approved
11133,D09RSN,MediPhage MRPA,Pseudomonas infection , Investigative
11134,D09RSY,Onyvax-P,Prostate cancer , Phase 2
11135,D09RTF,VT-1,Breast cancer , Terminated
11136,D09RTK,Tapet,Solid tumour/cancer , Phase 1
11137,D09RUJ,SX-GLP1,Non-insulin dependent diabetes , Investigative
11138,D09RUO,SGN-CD352A,Multiple myeloma , Phase 1
11139,D09RUW,Iomeprol,Brain disease , Approved
11140,D09RVI,Tegobuvir,Hepatitis C virus infection , Phase 2
11141,D09RXG,EA-230,Bacillus anthracis infection , Phase 2
11142,D09RYU,Tractinostat,Lymphoma , Phase 1/2
11143,D09RYU,Tractinostat,Solid tumour/cancer , Phase 1
11144,D09RZB,BBI-11008,Pain , Investigative
11145,D09RZH,AdRTVP-1,Prostate cancer , Phase 1
11146,D09RZM,E-1101,Bacterial infection , Phase 2
11147,D09SAH,PZ01 CAR-T cells,Acute lymphoblastic leukaemia , Phase 1
11148,D09SAH,PZ01 CAR-T cells,B-cell lymphoma , Phase 1
11149,D09SAU,IMM-160,Hepatocellular carcinoma , Investigative
11150,D09SAV,Dendritic cell PEG fusion cancer vaccine,Kidney cancer , Discontinued in Phase 1/2
11151,D09SBE,Anti-CD7 CAR-T cells,leukaemia , Phase 1
11152,D09SBE,Anti-CD7 CAR-T cells,Lymphoma , Phase 1
11153,D09SBY,Hebervis,Oral mucositis , Investigative
11154,D09SCI,SKF-104351,Rheumatoid arthritis , Terminated
11155,D09SCP,ADXS-PSA,Prostate cancer , Phase 1/2
11156,D09SFH,R-82150,Human immunodeficiency virus infection , Discontinued in Phase 1
11157,D09SFV,LY294002,Neuroblastoma , Phase 1
11158,D09SFX,AGEN1884,Cervical cancer , Phase 1/2
11159,D09SFX,AGEN1884,Solid tumour/cancer , Phase 1
11160,D09SGL,BTP-114,Solid tumour/cancer , Phase 1
11161,D09SGV,Daclatasvir,Hepatitis C virus infection , Approved
11162,D09SHC,ALT-804,Solid tumour/cancer , Investigative
11163,D09SHH,BAX-817,Hemophilia , Phase 3
11164,D09SHL,S. epidermidis vaccine,Skin infection , Phase 1
11165,D09SHX,GM-CSF cancer vaccine,Solid tumour/cancer , Phase 2
11166,D09SIK,Azaribine,Psoriasis vulgaris , Approved
11167,D09SIR,Lonidamine,Benign prostatic hyperplasia , Discontinued in Phase 3
11168,D09SJE,KB002/003,Rheumatoid arthritis , Phase 2
11169,D09SLI,Aryl mannoside derivative 13,Crohn disease , Patented
11170,D09SLI,Aryl mannoside derivative 13,Ulcerative colitis , Patented
11171,D09SLI,Aryl mannoside derivative 13,Urinary tract infection , Patented
11172,D09SLU,LG-101280,Arteriosclerosis , Discontinued in Phase 1
11173,D09SMA,PMID25666693-Compound-128,Osteoarthritis pain , Patented
11174,D09SMA,PMID25666693-Compound-128,Cancer related pain , Patented
11175,D09SMA,PMID25666693-Compound-128,Neuropathic pain , Patented
11176,D09SMA,PMID25666693-Compound-128,Inflammatory pain , Patented
11177,D09SMG,Hepatyrix,Hepatitis A virus infection , Approved
11178,D09SOA,Clonixin,Dysmenorrhea , Approved
11179,D09SOD,RAP-102,Human immunodeficiency virus infection , Investigative
11180,D09SQM,VAY736,Sjogren syndrome , Phase 2
11181,D09SQM,VAY736,Pemphigus vulgaris , Phase 2
11182,D09SQM,VAY736,Rheumatoid arthritis , Phase 2
11183,D09SRR,Unoprostone,Glaucoma/ocular hypertension , Approved
11184,D09SRZ,Recombinant factor IX-Fc,Haemophilia B , Approved
11185,D09SSC,Nipradilol,Angina pectoris , Approved
11186,D09SSY,Foscarnet + Cidofovir,Cytomegalovirus infection , Investigative
11187,D09SVB,SEB-Humab,Staphylococcus infection , Investigative
11188,D09SWM,Epostane,Abortion , Investigative
11189,D09SXJ,NC-0604,Solid tumour/cancer , Investigative
11190,D09SXR,KRH-102053,Solid tumour/cancer , Investigative
11191,D09SYB,J5dLPS/OMP,Sepsis , Phase 1
11192,D09SZY,IQ-DAA,Bacillus anthracis infection , Phase 1
11193,D09TAB,Pexidartinib,Tenosynovial giant cell tumour , Approved
11194,D09TAB,Pexidartinib,Alzheimer disease , Phase 3
11195,D09TAB,Pexidartinib,Pigmented villonodular synovitis , Phase 3
11196,D09TAB,Pexidartinib,Neurofibromatosis type 1 , Phase 1/2
11197,D09TBD,Sulfisoxazole,Urinary tract infection , Approved
11198,D09TBM,PRX-12261,Neurological disorder , Investigative
11199,D09TCY,CDX-1401,Solid tumour/cancer , Phase 2
11200,D09TCY,CDX-1401,Ovarian cancer , Phase 2
11201,D09TDG,NFTB-104,Cardiovascular disease , Investigative
11202,D09TDK,DPN-205-734,Cardiac disease , Investigative
11203,D09TEI,ReN-1869,Pain , Discontinued in Phase 2
11204,D09TFB,TOFIMILAST,Chronic obstructive pulmonary disease , Phase 2
11205,D09TFL,PCI-27483,Pancreatic cancer , Phase 2
11206,D09TGC,MK-1903,Arteriosclerosis , Phase 2
11207,D09TGD,KUR-112,Bone disease , Phase 1
11208,D09TGO,Autologous ET1402L1-CART cells,Hepatocellular carcinoma , Phase 1
11209,D09TGO,Autologous ET1402L1-CART cells,Liver cancer , Phase 1
11210,D09TGO,Autologous ET1402L1-CART cells,Metastatic liver cancer , Phase 1
11211,D09TGT,Atu-027,Solid tumour/cancer , Phase 1
11212,D09TGX,Valspodar,Acute myeloid leukaemia , Discontinued in Phase 3
11213,D09TGZ,Examorelin,Growth hormone deficiency , Discontinued in Phase 2
11214,D09THN,IMGN901,Solid tumour/cancer , Phase 2
11215,D09TIW,SLP-0904,Influenza virus infection , Investigative
11216,D09TJJ,Pamrevlumab,Pancreatic cancer , Phase 3
11217,D09TJJ,Pamrevlumab,Duchenne dystrophy , Phase 2
11218,D09TJV,PGC-lysostaphin,Staphylococcus infection , Investigative
11219,D09TKY,Biaryl mannoside derivative 7,Crohn disease , Patented
11220,D09TKY,Biaryl mannoside derivative 7,Ulcerative colitis , Patented
11221,D09TKY,Biaryl mannoside derivative 7,Urinary tract infection , Patented
11222,D09TLE,Tefinostat,Solid tumour/cancer , Phase 1
11223,D09TLJ,ATOFLUDING,Solid tumour/cancer , Phase 3
11224,D09TLT,BZF961,Hepatitis C virus infection , Phase 1/2
11225,D09TMV,AZD-4619,Lipid metabolism disorder , Discontinued in Phase 1
11226,D09TNR,Ki-23057,Solid tumour/cancer , Investigative
11227,D09TOK,PF-4531083,Pain , Phase 2
11228,D09TOL,RG-7816,Autism spectrum disorder , Phase 1
11229,D09TOS,ST-669,Virus infection , Investigative
11230,D09TPF,Molindone,Schizophrenia , Approved
11231,D09TPW,PF-04475270,Glaucoma/ocular hypertension , Investigative
11232,D09TQI,VT-401,Muscular dystrophy , Investigative
11233,D09TQY,Dusigitumab,Breast cancer , Phase 2
11234,D09TRM,D-5410,Rheumatoid arthritis , Terminated
11235,D09TSD,I-vation,Diabetic retinopathy , Phase 2
11236,D09TSX,CEL-011,Bladder cancer , Investigative
11237,D09TUW,Hepatitis C vaccine,Hepatitis C virus infection , Phase 2
11238,D09TVH,TCH-013,Rheumatoid arthritis , Investigative
11239,D09TXA,HelicoVax,Helicobacter infection , Investigative
11240,D09TXG,CEMADOTIN HYDROCHLORIDE,Solid tumour/cancer , Discontinued in Phase 2
11241,D09TXO,humanin,Alzheimer disease , Preclinical
11242,D09TXU,DT-831j,Thrombosis , Investigative
11243,D09TYS,Loviride,Human immunodeficiency virus infection , Discontinued in Phase 2
11244,D09TYX,GC-501,Influenza virus infection , Approved
11245,D09UAI,TB-402,Atrial fibrillation , Phase 2
11246,D09UAI,TB-402,Venous thromboembolism , Phase 2
11247,D09UCO,BMS-986046,Heart failure , Preclinical
11248,D09UCU,APT3111,Blood forming organ disorder , Investigative
11249,D09UCV,SRW-LAMP-vax,Allergy , Investigative
11250,D09UDL,LTX-315,Solid tumour/cancer , Phase 1
11251,D09UFV,AZD-5423,Chronic obstructive pulmonary disease , Discontinued in Phase 2
11252,D09UFZ,CD38 CAR T cells,Multiple myeloma , Phase 1/2
11253,D09UGG,Zemab,Solid tumour/cancer , Phase 1
11254,D09UGP,RPR-106541,Asthma , Discontinued in Phase 2
11255,D09UHY,SMK-01/03,Ocular disease , Investigative
11256,D09UIM,LXR-0151,Diarrhea , Discontinued in Phase 1
11257,D09UJB,PMID28350212-Compound-19,Alzheimer disease , Patented
11258,D09UKH,XL550,Type-2 diabetes , Phase 1
11259,D09UMN,LEQ-506,Solid tumour/cancer , Phase 1
11260,D09UMP,MN-305,Mood disorder , Phase 2
11261,D09UMR,UV1 + GM-CSF vaccine,Melanoma , Phase 1
11262,D09UQS,LPG-1030I,Inflammatory bowel disease , Investigative
11263,D09URP,DABIS MALEATE,Solid tumour/cancer , Phase 1
11264,D09URT,OCO-1112,Hyperlipidaemia , Discontinued in Phase 2
11265,D09USN,IC-485,Chronic obstructive pulmonary disease , Phase 2
11266,D09UTQ,GC-7101,Stomach ulcer , Investigative
11267,D09UVK,MK-8835A,Type-2 diabetes , Phase 3
11268,D09UVX,PRX-12247,Neurological disorder , Investigative
11269,D09UXE,Fosmidomycin,Malaria , Approved
11270,D09UXI,MGN-5804,Metabolic disorder , Investigative
11271,D09UXP,AZD-1744,Asthma , Discontinued in Phase 1
11272,D09UXU,T1-1081,Macular degeneration , Investigative
11273,D09UZB,Glucopyranoside derivatives,Mycobacterium infection , Investigative
11274,D09UZL,TAK-063,Schizophrenia , Phase 2
11275,D09UZO,Mercaptopurine,Acute lymphoblastic leukaemia , Approved
11276,D09UZO,Mercaptopurine,Crohn disease , Phase 4
11277,D09VAB,BPR1K-0224,Solid tumour/cancer , Investigative
11278,D09VAD,Angiopoietin 2 mAb,Solid tumour/cancer , Phase 1
11279,D09VAS,M281,Autoimmune disease , Phase 1
11280,D09VAZ,TRIENTINE,Inborn error of metabolism , Approved
11281,D09VBC,Carbetapentane,Cough , Approved
11282,D09VBE,Elinogrel,Myocardial infarction , Phase 1
11283,D09VBN,CTX110,Non-hodgkin lymphoma , Phase 1/2
11284,D09VCC,PL-6983,Female sexual arousal dysfunction , Investigative
11285,D09VFA,Live attenuated cholera vaccine,Vibrio cholerae infection , Phase 2
11286,D09VFU,MST-400,Solid tumour/cancer , Investigative
11287,D09VFX,SAR342434,Diabetic complication , Phase 3
11288,D09VFX,SAR342434,Type-1 diabetes , Phase 3
11289,D09VFX,SAR342434,Type-2 diabetes , Phase 3
11290,D09VGC,Milnacipran,Depression , Approved
11291,D09VHA,BDF-9148,Cardiac failure , Terminated
11292,D09VHS,EM-101,Solid tumour/cancer , Investigative
11293,D09VIX,VRC01LS,Human immunodeficiency virus infection , Phase 1
11294,D09VKP,C-Cure,Neuroblastoma , Phase 2/3
11295,D09VKP,C-Cure,Chronic heart failure , Phase 2/3
11296,D09VLQ,VP-50406,Hepatitis C virus infection , Discontinued in Phase 2
11297,D09VMI,Cediranib,Peritoneal cavity cancer , Phase 3
11298,D09VOK,Trientine Hydrochloride,Wilson disease , Approved
11299,D09VOS,ETI-204,Anthrax , Approved
11300,D09VQO,CLR-901,Neurological disorder , Terminated
11301,D09VQW,MCTP-39,Prostate cancer , Investigative
11302,D09VRO,Cyclohexyl carbamate derivative 6,Albinism , Patented
11303,D09VRO,Cyclohexyl carbamate derivative 6,Ephelides , Patented
11304,D09VRO,Cyclohexyl carbamate derivative 6,Menkes disease , Patented
11305,D09VRO,Cyclohexyl carbamate derivative 6,Senile lentigines , Patented
11306,D09VRO,Cyclohexyl carbamate derivative 6,Melasma , Patented
11307,D09VRZ,AZM-131,Obesity , Terminated
11308,D09VSV,PH80-PMD,Migraine , Phase 3
11309,D09VTB,IDX-320,Hepatitis C virus infection , Discontinued in Phase 1/2
11310,D09VWI,BRX-005,Diabetic foot ulcer , Phase 1
11311,D09VWI,BRX-005,Amyotrophic lateral sclerosis , Discontinued in Phase 2
11312,D09VXM,Crofelemer,HIV-associated diarrhoea , Approved
11313,D09VYF,RDEN1delta30,Dengue fever , Phase 2
11314,D09VYS,BXL-1H5,Pain , Investigative
11315,D09VYT,CD19-targeted CAR-T cells,leukaemia , Clinical trial
11316,D09VYT,CD19-targeted CAR-T cells,Lymphoma , Clinical trial
11317,D09VZR,SGI-1252,Solid tumour/cancer , Investigative
11318,D09WAY,OPN-501,Inflammatory bowel disease , Investigative
11319,D09WBQ,DSM2,Malaria , Investigative
11320,D09WCC,MP-0270,Autoimmune diabetes , Investigative
11321,D09WCE,IS-159,Migraine , Discontinued in Phase 2
11322,D09WCM,Spinosad,Head and body lice , Approved
11323,D09WCN,Intetumumab,Prostate cancer , Phase 2
11324,D09WDK,Tbo-Filgrastim,Neutropenia , Approved
11325,D09WEJ,Bromopride,Dyspepsia , Approved
11326,D09WFI,Tetramethylpyrazine,Neurological disorder , Discontinued in Phase 2
11327,D09WFL,MP-12,Rift valley fever , Phase 2
11328,D09WGH,Ropidoxuridine,Solid tumour/cancer , Phase 1
11329,D09WGH,Ropidoxuridine,Gastrointestinal cancer , Phase 1
11330,D09WGU,PEG-VM-501,Thrombocytopenia , Investigative
11331,D09WHM,DU-29894,Psychotic disorder , Discontinued in Phase 1
11332,D09WIM,AviFluCide-I,Influenza virus infection , Investigative
11333,D09WIR,CC-90009,Acute myeloid leukaemia , Phase 1
11334,D09WJT,Toleragens,Autoimmune diabetes , Investigative
11335,D09WKB,Anisindione,Coagulation defect , Approved
11336,D09WKH,Zosyn/Tazocin,Bacterial infection , Approved
11337,D09WKM,BI-836826,Diffuse large B-cell lymphoma , Phase 2
11338,D09WKM,BI-836826,Chronic lymphocytic leukaemia , Phase 1/2
11339,D09WKM,BI-836826,Solid tumour/cancer , Phase 1
11340,D09WKM,BI-836826,Non-hodgkin lymphoma , Phase 1
11341,D09WKT,ARD-412,Premature ejaculation , Investigative
11342,D09WMV,BMS-753951,Arteriosclerosis , Investigative
11343,D09WND,TETRAPLATIN TETRANITRATE,Solid tumour/cancer , Phase 2
11344,D09WNK,Fenfluramine,Dravet syndrome , Phase 3
11345,D09WNK,Fenfluramine,LennoxGastaut syndrome , Phase 3
11346,D09WNK,Fenfluramine,Obesity , Withdrawn from market
11347,D09WNQ,NCTX,Solid tumour/cancer , Investigative
11348,D09WOI,NZ-39000,Autoimmune diabetes , Investigative
11349,D09WOY,SB-559457,Acute myeloid leukaemia , Investigative
11350,D09WPI,GOVX-B11,Human immunodeficiency virus infection , Phase 2
11351,D09WPN,AP22408,Osteoporosis , Terminated
11352,D09WRG,CEP-41750,Rheumatoid arthritis , Phase 3
11353,D09WRI,ELINAFIDE MESILATE,Solid tumour/cancer , Discontinued in Phase 2
11354,D09WSR,PCA062,Breast cancer , Phase 1
11355,D09WSR,PCA062,Esophageal cancer , Phase 1
11356,D09WSR,PCA062,Head and neck cancer , Phase 1
11357,D09WSR,PCA062,Solid tumour/cancer , Phase 1
11358,D09WTQ,RC-8800,Solid tumour/cancer , Discontinued in Phase 1
11359,D09WUY,TP-104,Bacterial infection , Investigative
11360,D09WVR,FX-107,Dengue fever , Preclinical
11361,D09WWB,MenABCWY,Meningococcal infection , Phase 2
11362,D09WXY,CDX-014,Renal cell carcinoma , Phase 1/2
11363,D09WXY,CDX-014,Ovarian cancer , Phase 1
11364,D09WYC,Y-26611,Bacterial infection , Discontinued in Phase 2
11365,D09WYE,NST-001,Tinnitus , Phase 1
11366,D09WYL,GSK-557296,Premature ejaculation , Phase 2
11367,D09WYX,Deflazacort,Duchenne dystrophy , Approved
11368,D09WZG,Anascorp,Poison intoxication , Phase 3
11369,D09WZU,BCI-838,Major depressive disorder , Phase 1
11370,D09WZU,BCI-838,Alzheimer disease , Discontinued in Phase 1
11371,D09WZV,GMA-161,Idiopathic thrombocytopenic purpura , Approved (orphan drug)
11372,D09XCX,PIRINIXIC ACID,Pulmonary fibrosis , Preclinical
11373,D09XDR,Granulosin,Chronic granulomatous disease , Investigative
11374,D09XEM,NGN-9080,Spinal cord injury , Investigative
11375,D09XGB,VER 50589,Breast cancer , Phase 2
11376,D09XGK,Testetrol,Hypogonadism , Investigative
11377,D09XHI,AZD-6538,Gastroesophageal reflux disease , Discontinued in Phase 1
11378,D09XHQ,TA-CD,Cocaine addiction , Phase 2
11379,D09XHU,HER-2 Protein AutoVac,Breast cancer , Phase 2
11380,D09XIZ,JNJ-26481585,Advanced stage follicular lymphoma , Phase 2
11381,D09XIZ,JNJ-26481585,Solid tumour/cancer , Phase 2
11382,D09XJF,EPI 589,Amyotrophic lateral sclerosis , Phase 2
11383,D09XJF,EPI 589,Parkinson disease , Phase 2
11384,D09XKO,KD-101,Metabolic disorder , Phase 1
11385,D09XKT,KI-1003,Eating disorder , Investigative
11386,D09XKW,Castor oil,Constipation , Approved
11387,D09XLS,FR139317,Hypertension , Phase 2
11388,D09XLS,FR139317,Anxiety disorder , Discontinued in Phase 1
11389,D09XLS,FR139317,Depression , Discontinued in Phase 1
11390,D09XMP,SC-114,Autoimmune diabetes , Terminated
11391,D09XMX,SaxaDapa FDC,Diabetic complication , Phase 3
11392,D09XNZ,CT-2408R,Shock , Terminated
11393,D09XOF,NY-ESO-1 vaccine,Solid tumour/cancer , Phase 1
11394,D09XOR,Palladium Pd 103,Melanoma , Approved
11395,D09XPD,GivaRex,Solid tumour/cancer , Investigative
11396,D09XPJ,Micacocidin A,Bacterial infection , Terminated
11397,D09XQF,Isoniazid,Tuberculosis , Approved
11398,D09XQU,Tirapazamine,Alzheimer disease , Phase 3
11399,D09XQU,Tirapazamine,Hepatocellular carcinoma , Phase 2
11400,D09XRD,Comvax,Hepatitis B virus infection , Approved
11401,D09XRQ,HCBE-11,Solid tumour/cancer , Phase 1
11402,D09XSH,Cytoreg,Solid tumour/cancer , Investigative
11403,D09XTN,Emicizumab,Factor VIII deficiency , Approved
11404,D09XUB,Viramidine,Hepatitis C virus infection , Phase 3
11405,D09XUH,GASTRAZOLE,Duodenal ulcer , Phase 3
11406,D09XUI,"1,5-diphenylpyrrolidin-2-one derivative 2",Obesity , Patented
11407,D09XUY,Icofungipen,Fungal infection , Phase 2
11408,D09XVQ,PT-14,Erectile dysfunction , Discontinued in Phase 2
11409,D09XVS,Tc-99m tilmanocept,Melanoma , Approved
11410,D09XWD,Teprenone,Peptic ulcer , Approved
11411,D09XWT,AZP-03,Metabolic disorder , Investigative
11412,D09XXH,VCH-286,Human immunodeficiency virus infection , Phase 1
11413,D09XXW,Co-2-1068,Epilepsy , Terminated
11414,D09XYU,XR-12890,Asthma , Terminated
11415,D09XZB,Gefitinib,Solid tumour/cancer , Approved
11416,D09XZB,Gefitinib,Head and neck cancer , Phase 3
11417,D09XZB,Gefitinib,Urethral cancer , Phase 2
11418,D09XZL,LX-7101,Glaucoma/ocular hypertension , Phase 1/2
11419,D09YAS,CYT-013-IL1bQb,Inflammation , Phase 1
11420,D09YBF,Gamma-tocotrienol,Prostate cancer , Investigative
11421,D09YBZ,CO-12,Mycobacterium infection , Investigative
11422,D09YDM,Camptothecin,Solid tumour/cancer , Phase 3
11423,D09YDO,Quinotolast,Asthma , Phase 3
11424,D09YDQ,STX-107,Autism spectrum disorder , Phase 2
11425,D09YEY,Botulinum toxin type F,Dystonia , Approved
11426,D09YGK,Ultragrivak,Influenza virus infection , Investigative
11427,D09YGZ,OCT-002,Acute hyperammonaemia , Phase 2
11428,D09YHI,SX5,Staphylococcus infection , Investigative
11429,D09YHJ,Ivermectin,Intestinal strongyloidiasis due to nematode parasite , Approved
11430,D09YHL,MKG-02,Diabetic complication , Investigative
11431,D09YJK,BMS-766,Hepatitis C virus infection , Investigative
11432,D09YKI,Polyhydroxy benzamide derivative 1,Albinism , Patented
11433,D09YKI,Polyhydroxy benzamide derivative 1,Ephelides , Patented
11434,D09YKI,Polyhydroxy benzamide derivative 1,Menkes disease , Patented
11435,D09YKI,Polyhydroxy benzamide derivative 1,Senile lentigines , Patented
11436,D09YKI,Polyhydroxy benzamide derivative 1,Melasma , Patented
11437,D09YNJ,IQP-0410,Human immunodeficiency virus-1 infection , Investigative
11438,D09YPJ,SM08502,Solid tumour/cancer , Phase 1
11439,D09YRA,SSTarbaclofen,Fragile X syndrome , Phase 2
11440,D09YRA,SSTarbaclofen,Autism spectrum disorder , Phase 2
11441,D09YTH,CPU-228,Cardiac failure , Investigative
11442,D09YTY,Osutidine,Duodenal ulcer , Discontinued in Phase 3
11443,D09YUH,Anti-HIV peptides,Human immunodeficiency virus infection , Investigative
11444,D09YUK,SS1(dsFv)-PE38,Solid tumour/cancer , Discontinued in Phase 1
11445,D09YUQ,SR-11237,Solid tumour/cancer , Terminated
11446,D09YUS,KRG-3332,Glaucoma/ocular hypertension , Terminated
11447,D09YVQ,Chondrogen,Arthritis , Phase 1/2
11448,D09YVX,Etofenamate,Rheumatoid arthritis , Approved
11449,D09YXN,CAR-T cells targeting Mesothelin,Solid tumour/cancer , Phase 1
11450,D09YXS,GX-E2,Anemia , Investigative
11451,D09YXT,LY3321367,Solid tumour/cancer , Phase 1
11452,D09YYQ,Aponidin,Autoimmune diabetes , Investigative
11453,D09ZAV,RG-8803,Diabetic retinopathy , Terminated
11454,D09ZBJ,RAGE-immunoglobulin fusion protein,Diabetic macular edema , Investigative
11455,D09ZCA,Biphenyl mannoside derivative 24,Crohn disease , Patented
11456,D09ZCA,Biphenyl mannoside derivative 24,Ulcerative colitis , Patented
11457,D09ZCA,Biphenyl mannoside derivative 24,Urinary tract infection , Patented
11458,D09ZCH,HRC-201,Liver cancer , Terminated
11459,D09ZDY,CAR138 T Cells,Immune System disease , Phase 1
11460,D09ZDY,CAR138 T Cells,Multiple myeloma , Phase 1
11461,D09ZFF,HRC-101,Blood transfusion , Terminated
11462,D09ZFJ,AMG 529,Cardiovascular disease , Phase 1
11463,D09ZGK,BCMA-CART,Multiple myeloma , Clinical trial
11464,D09ZHZ,Mecobalamin,Anemia , Approved
11465,D09ZIO,Eptifibatide,Acute cardiac ischemic events , Approved
11466,D09ZIS,Zonisamide,Epilepsy , Approved
11467,D09ZJQ,Seocalcitol,Rickets , Phase 3
11468,D09ZKB,Ad35-GRIN/ENV,Human immunodeficiency virus infection , Phase 1
11469,D09ZKS,HP-228,Postoperative pain , Phase 2
11470,D09ZKU,DISBA-01,Solid tumour/cancer , Investigative
11471,D09ZLZ,RAD-140,Breast cancer , Phase 1
11472,D09ZLZ,RAD-140,Osteoporosis , Investigative
11473,D09ZMV,Votucalis,Allergic rhinitis , Phase 2
11474,D09ZNL,ChronSeal,Fibrosis , Phase 1/2
11475,D09ZNQ,Recombinant L-asparaginase,Acute lymphoblastic leukaemia , Investigative
11476,D09ZNS,Paramyxovirus therapy,Paramyxovirus infection , Investigative
11477,D09ZOQ,Incruse Ellipta,Chronic obstructive pulmonary disease , Approved
11478,D09ZPN,MK-6892,Arteriosclerosis , Investigative
11479,D09ZPX,HSR-6071,Asthma , Discontinued in Phase 1
11480,D09ZQN,Dienestrol,Atrophic vaginitis , Approved
11481,D09ZQX,SL65.0155,Parkinson disease , Discontinued in Phase 2
11482,D09ZRB,PUR0200,Chronic obstructive pulmonary disease , Phase 1
11483,D09ZSC,Everolimus,Advanced/metastatic breast cancer , Approved
11484,D09ZSC,Everolimus,Severe acute respiratory syndrome (SARS) , Investigative
11485,D09ZSC,Everolimus,Middle East Respiratory Syndrome (MERS) , Investigative
11486,D09ZSO,Alefacept,Pain , Approved
11487,D09ZSY,CI-1012,Acquired immune deficiency syndrome , Phase 2
11488,D09ZUM,CR-4892,Pain , Investigative
11489,D09ZVC,Begacestat,Alzheimer disease , Phase 1
11490,D09ZVJ,R-954,Diabetic complication , Investigative
11491,D09ZVR,MDL-43291,Asthma , Terminated
11492,D09ZWH,LX2931,Rheumatoid arthritis , Phase 2
11493,D09ZWH,LX2931,Hereditary acantholytic dermatoses , Phase 2
11494,D09ZWI,KUR-521,Back pain , Investigative
11495,D09ZWU,PMID25666693-Compound-40,Osteoarthritis pain , Patented
11496,D09ZWU,PMID25666693-Compound-40,Cancer related pain , Patented
11497,D09ZWU,PMID25666693-Compound-40,Neuropathic pain , Patented
11498,D09ZWU,PMID25666693-Compound-40,Inflammatory pain , Patented
11499,D09ZXO,Cilengitide,Rheumatoid arthritis , Phase 3
11500,D09ZXR,Eluxadoline,Diarrhea-predominant irritable bowel syndrome , Approved
11501,D09ZYW,P53,Solid tumour/cancer , Discontinued in Phase 2
11502,D09ZZB,EV71 vaccine,Enterovirus infection , Phase 1
11503,D09ZZF,IPH-41XX,Mycoses , Investigative
11504,D09ZZW,VX-759,Hepatitis C virus infection , Phase 2
11505,D0A0BK,Cal-1,Human immunodeficiency virus-1 infection , Phase 1/2
11506,D0A0CC,Viperfav,Poison intoxication , Terminated
11507,D0A0CY,CNDO-109,Solid tumour/cancer , Phase 1/2
11508,D0A0CY,CNDO-109,Acute myeloid leukaemia , Phase 1
11509,D0A0CY,CNDO-109,Myelodysplastic syndrome , Phase 1
11510,D0A0EI,MP-0210,Autoimmune diabetes , Investigative
11511,D0A0FB,ZYOG1,Diabetic complication , Phase 1
11512,D0A0FG,NICANARTINE,Arteriosclerosis , Discontinued in Phase 1
11513,D0A0FI,FHT-401,Rheumatoid arthritis , Investigative
11514,D0A0FL,Bupivacaine,Anaesthesia , Approved
11515,D0A0FL,Bupivacaine,Pain , Phase 2
11516,D0A0GU,E-52862,Coronavirus Disease 2019 (COVID-19) , Investigative
11517,D0A0JH,Nafcillin,Arthritis , Approved
11518,D0A0JM,Carotegrast,Inflammation , Investigative
11519,D0A0MJ,Nerve growth factor,Alzheimer disease , Terminated
11520,D0A0MS,BI 655066,Chronic plaque psoriasis , Phase 3
11521,D0A0MS,BI 655066,Ankylosing spondylitis , Phase 2
11522,D0A0MS,BI 655066,Crohn disease , Phase 2
11523,D0A0MS,BI 655066,Psoriatic arthritis , Phase 2
11524,D0A0MT,KRL-103,Sleep-wake disorder , Phase 2
11525,D0A0MU,FOZIVUDINE TIDOXIL,Human immunodeficiency virus infection , Discontinued in Phase 2
11526,D0A0NZ,LP-02,Ulcerative colitis , Phase 3
11527,D0A0OO,Amprenavir,Human immunodeficiency virus infection , Approved
11528,D0A0QH,Stapuldencel-T,Prostate cancer , Phase 3
11529,D0A0RM,PMID26815044-Compound-51,Albinism , Patented
11530,D0A0RM,PMID26815044-Compound-51,Ephelides , Patented
11531,D0A0RM,PMID26815044-Compound-51,Menkes disease , Patented
11532,D0A0RM,PMID26815044-Compound-51,Senile lentigines , Patented
11533,D0A0RM,PMID26815044-Compound-51,Melasma , Patented
11534,D0A0SI,BAY 85-8501,Bronchiectasis , Phase 2
11535,D0A0SK,HPH-116,Human immunodeficiency virus infection , Phase 2
11536,D0A0SP,Pyrvinium,Worm infection , Approved
11537,D0A0TF,Tc-99m ethylenedicysteine glucosamine,Non-small-cell lung cancer , Phase 2
11538,D0A0TI,TgAAC-09,Human immunodeficiency virus infection , Phase 2
11539,D0A0TS,VesiculoVax,Ebola virus infection , Phase 1
11540,D0A0TT,IONIS-AGT-LRX,Hypertension , Phase 2
11541,D0A0UU,RG7828,Haematological malignancy , Phase 1
11542,D0A0YI,PMID25666693-Compound-34,Osteoarthritis pain , Patented
11543,D0A0YI,PMID25666693-Compound-34,Cancer related pain , Patented
11544,D0A0YI,PMID25666693-Compound-34,Neuropathic pain , Patented
11545,D0A0YI,PMID25666693-Compound-34,Inflammatory pain , Patented
11546,D0A0YQ,CX-8998,Epilepsy , Phase 2
11547,D0A0YQ,CX-8998,Essential tremor or related tremors , Phase 2
11548,D0A0YQ,CX-8998,Parkinson disease , Phase 2
11549,D0A0YZ,PYZD-4409,leukaemia , Investigative
11550,D0A0ZW,ARN-6039,Multiple sclerosis , Phase 1
11551,D0A0ZW,ARN-6039,Psoriasis vulgaris , Phase 1
11552,D0A0ZX,Glutathionarsenoxide,Human immunodeficiency virus infection , Discontinued in Phase 2
11553,D0A0ZY,ALD-901,Pain , Investigative
11554,D0A1AQ,Rosiglitazone + metformin,Diabetic complication , Phase 3
11555,D0A1AQ,Rosiglitazone + metformin,Advanced solid tumour , Phase 1
11556,D0A1AS,Palivizumab,Respiratory syncytial virus infection , Approved
11557,D0A1CB,Cefepime,Bacterial infection , Approved
11558,D0A1DG,KO-947,Solid tumour/cancer , Phase 1
11559,D0A1DH,Nitrendipine,Hypertension , Approved
11560,D0A1DT,ICI-245991,Arteriosclerosis , Investigative
11561,D0A1FB,RPA gene based adenovirus 4 vector vaccine,Anthrax , Phase 1
11562,D0A1FG,MTL-005,Solid tumour/cancer , Investigative
11563,D0A1GJ,CY-9652,Inflammation , Terminated
11564,D0A1GR,CALAA-01,Solid tumour/cancer , Phase 1
11565,D0A1IL,VAL-083,Recurrent glioblastoma , Phase 3
11566,D0A1IL,VAL-083,Recurring respiratory infection , Phase 3
11567,D0A1IL,VAL-083,Grade IV malignant glioma , Phase 1/2
11568,D0A1IL,VAL-083,Acute myeloid leukaemia , Phase 1/2
11569,D0A1KP,SWT-05105,Vitiligo , Investigative
11570,D0A1KR,JTK-652,Hepatitis C virus infection , Discontinued in Phase 1
11571,D0A1KU,PF-3274167,Female sexual arousal dysfunction , Discontinued in Phase 1
11572,D0A1LS,Genz-644282,Solid tumour/cancer , Phase 1
11573,D0A1MK,HL-027,Parkinson disease , Investigative
11574,D0A1MX,Bapineuzumab,Alzheimer disease , Phase 3
11575,D0A1NU,ABT-279,Type-2 diabetes , Discontinued in Phase 1
11576,D0A1PS,PRT-105,Poison intoxication , Phase 1
11577,D0A1PX,Flurbiprofen,Rheumatoid arthritis , Approved
11578,D0A1QC,Heparan sulfate,Angiogenesis disorder , Investigative
11579,D0A1RP,18F-fluorothymidine,Breast cancer , Phase 2
11580,D0A1UL,RQ-00203078,Neuropathic pain , Investigative
11581,D0A1VL,AR-R-1589,Eating disorder , Preclinical
11582,D0A1VL,AR-R-1589,Obesity , Preclinical
11583,D0A1VS,Safflower Oil,Malnutrition , Approved
11584,D0A1WN,PF-03715455,Chronic obstructive pulmonary disease , Phase 2
11585,D0A1WS,ABBV-176,Solid tumour/cancer , Phase 1
11586,D0A1XS,Colfosceril palmitate,Respiratory distress syndrome , Approved
11587,D0A1XU,EVP-6308,Schizophrenia , Phase 1
11588,D0A1YF,ABBV-3067,Cystic fibrosis , Phase 1
11589,D0A2AJ,Arglabin,Solid tumour/cancer , Approved
11590,D0A2BK,KM-391,Autism spectrum disorder , Investigative
11591,D0A2BO,S-110,Acute myeloid leukaemia , Phase 3
11592,D0A2BO,S-110,Chronic myelogenous leukaemia , Phase 3
11593,D0A2BO,S-110,Solid tumour/cancer , Phase 2
11594,D0A2BS,SelG2,Sickle-cell disorder , Phase 2
11595,D0A2CP,Emtricitabine/tenofovir alafenamide,Human immunodeficiency virus-1 infection , Phase 3
11596,D0A2GM,Heparin Calcium,Coagulation defect , Approved
11597,D0A2HR,Silver nitrate,Chlamydia infection , Approved
11598,D0A2HS,T-3.5,Malaria , Investigative
11599,D0A2IH,KU-1257,Duodenal ulcer , Discontinued in Phase 3
11600,D0A2IK,NPS-846,Cerebrovascular ischaemia , Terminated
11601,D0A2KH,TRK-170,Inflammatory bowel disease , Phase 2
11602,D0A2KL,OXS-1550,Non-hodgkin lymphoma , Phase 2
11603,D0A2KL,OXS-1550,B-lineage leukaemia , Phase 1/2
11604,D0A2KL,OXS-1550,B-lineage lymphoma , Phase 1/2
11605,D0A2MA,FR-104,Autoimmune diabetes , Investigative
11606,D0A2NA,PMID27998201-Compound-11,Metastatic cancer , Patented
11607,D0A2NH,IDEC-131,Thrombocytopenia , Discontinued in Phase 1
11608,D0A2OW,Otenzepad,Heart failure , Discontinued in Phase 2
11609,D0A2PA,IMF-001,Solid tumour/cancer , Phase 1
11610,D0A2PY,Pyrazole derivative 35,Obesity , Patented
11611,D0A2RA,TAK-491,Hypertension , Phase 3
11612,D0A2RF,KI-0906,Arthritis , Investigative
11613,D0A2RG,Conjugated estrogens a,Hormone replacement therapy , Approved
11614,D0A2RI,PMID26815044-Compound-127,Albinism , Patented
11615,D0A2RI,PMID26815044-Compound-127,Ephelides , Patented
11616,D0A2RI,PMID26815044-Compound-127,Menkes disease , Patented
11617,D0A2RI,PMID26815044-Compound-127,Senile lentigines , Patented
11618,D0A2RI,PMID26815044-Compound-127,Melasma , Patented
11619,D0A2RX,19-28z T CELLS,Non-hodgkin lymphoma , Phase 1
11620,D0A2TJ,PBOX-15,Solid tumour/cancer , Investigative
11621,D0A2UV,Ustekinumab,Plaque psoriasis , Approved
11622,D0A2UV,Ustekinumab,Psoriasis vulgaris , Phase 3
11623,D0A2UV,Ustekinumab,Inflammatory bowel disease , Phase 2/3
11624,D0A2UV,Ustekinumab,Malaria , Investigative
11625,D0A2VZ,D-3252,Coronavirus infection , Phase 1
11626,D0A2XD,TAK-065,Alzheimer disease , Discontinued in Phase 1
11627,D0A2XV,HL-162,Hyperlipidaemia , Investigative
11628,D0A2XY,AGB101,Cognitive impairment , Phase 2
11629,D0A2ZX,Metronidazole,Amoebiasis , Approved
11630,D0A2ZX,Metronidazole,Crohn disease , Phase 3
11631,D0A2ZX,Metronidazole,Perianal crohn disease , Phase 3
11632,D0A3AB,NCY-118,Sepsis , Terminated
11633,D0A3AJ,4SC-301,Hepatitis C virus infection , Investigative
11634,D0A3CF,MK-1248,Solid tumour/cancer , Phase 1
11635,D0A3CH,GRN-1201,Non-small-cell lung cancer , Phase 2
11636,D0A3CH,GRN-1201,Melanoma , Phase 1
11637,D0A3CH,GRN-1201,Merkel cell carcinoma , Phase 1
11638,D0A3CL,AZD1979,Obesity , Phase 1
11639,D0A3CW,Oleylphosphocholine,Leishmania infection , Investigative
11640,D0A3EA,Mu5B3,Hepatitis C virus infection , Investigative
11641,D0A3ES,OX-51,Pain , Phase 2
11642,D0A3EX,GRC-15300,Pain , Phase 2
11643,D0A3FQ,Rabies vaccine,Rabies , Phase 3
11644,D0A3FZ,Rilimogene galvacirepvec,Prostate cancer , Phase 3
11645,D0A3HB,Propofol,Anaesthesia , Approved
11646,D0A3HF,VE-16084,Rheumatoid arthritis , Terminated
11647,D0A3JJ,Pentacea,Small-cell lung cancer , Phase 2
11648,D0A3MJ,XEN007,Migraine , Phase 1
11649,D0A3MV,AR-A014418,Ovarian cancer , Patented
11650,D0A3NN,Aroplatin,Solid tumour/cancer , Phase 2
11651,D0A3OA,TGX-003,Bone disease , Investigative
11652,D0A3OE,Anti-C-met CAR-T cells,Colorectal cancer , Phase 1/2
11653,D0A3OE,Anti-C-met CAR-T cells,Hepatocellular carcinoma , Phase 1/2
11654,D0A3OE,Anti-C-met CAR-T cells,Ovarian cancer , Phase 1/2
11655,D0A3OE,Anti-C-met CAR-T cells,Renal cell carcinoma , Phase 1/2
11656,D0A3OF,GMC-283,Schizophrenia , Terminated
11657,D0A3OS,FLUINHIBIT,Influenza virus infection , Investigative
11658,D0A3PF,TVX-001,Influenza virus infection , Investigative
11659,D0A3PP,Biphenyl mannoside derivative 4,Crohn disease , Patented
11660,D0A3PP,Biphenyl mannoside derivative 4,Ulcerative colitis , Patented
11661,D0A3PP,Biphenyl mannoside derivative 4,Urinary tract infection , Patented
11662,D0A3RP,Fedratinib,Polycythemia vera , Approved
11663,D0A3RP,Fedratinib,Coronavirus Disease 2019 (COVID-19) , Investigative
11664,D0A3SQ,3-benzofuran-2-yl-2-benzothiazol-2-yl-3-oxo-propanenitrile,Glioma , Investigative
11665,D0A3SQ,3-benzofuran-2-yl-2-benzothiazol-2-yl-3-oxo-propanenitrile,Melanoma , Investigative
11666,D0A3SX,PTHr pepducins,Endocrine disease , Investigative
11667,D0A3VX,Glucocorticoid mimetics,Inflammation , Investigative
11668,D0A3WJ,Relatlimab,Haematological malignancy , Phase 2/3
11669,D0A3WJ,Relatlimab,Melanoma , Phase 2/3
11670,D0A3WJ,Relatlimab,Solid tumour/cancer , Phase 1/2
11671,D0A3WJ,Relatlimab,Recurrent glioblastoma , Phase 1
11672,D0A3WZ,KBRV-201,Respiratory syncytial virus infection , Investigative
11673,D0A3XA,CNS-1169,Schizophrenia , Investigative
11674,D0A3XC,PMID25666693-Compound-25,Osteoarthritis pain , Patented
11675,D0A3XC,PMID25666693-Compound-25,Cancer related pain , Patented
11676,D0A3XC,PMID25666693-Compound-25,Neuropathic pain , Patented
11677,D0A3XC,PMID25666693-Compound-25,Inflammatory pain , Patented
11678,D0A3ZU,Pomalidomide,Systemic sclerosis , Approved
11679,D0A4BR,Aurothioglucose,Arthritis , Withdrawn from market
11680,D0A4DP,LCS 16,Contraception , Phase 3
11681,D0A4DP,LCS 16,Alzheimer disease , Phase 3
11682,D0A4FE,OS-320,Parkinson disease , Phase 3
11683,D0A4FE,OS-320,Dyskinesia , Phase 3
11684,D0A4GQ,Tisotumab vedotin,Solid tumour/cancer , Phase 2
11685,D0A4GQ,Tisotumab vedotin,Ovarian cancer , Phase 2
11686,D0A4HD,Allotrap-2702,Transplant rejection , Discontinued in Phase 2
11687,D0A4IJ,Abacavir,Human immunodeficiency virus infection , Approved
11688,D0A4JB,JDP-202,Hypertension , Investigative
11689,D0A4JI,NanoDisks,Brain injury , Investigative
11690,D0A4JK,Butabarbital,Insomnia , Approved
11691,D0A4KP,Tuberculosis therapeutics,Mycobacterium infection , Investigative
11692,D0A4MI,KPC-34,Solid tumour/cancer , Investigative
11693,D0A4OT,TAMOLARIZINE HYDROCHLORIDE,Cognitive impairment , Discontinued in Phase 2
11694,D0A4PJ,KTE-C19 CAR-T cell therapy,Mantle cell lymphoma , Phase 2
11695,D0A4RF,PMID17935984C1,Pain , Clinical trial
11696,D0A4SU,WinRho SDF,Autoimmune diabetes , Approved
11697,D0A4TU,MEDI-545,Systemic lupus erythematosus , Phase 2
11698,D0A4UC,GS-6615,Ischemic heart disease , Phase 3
11699,D0A4UC,GS-6615,Long QT syndrome , Phase 3
11700,D0A4UW,BAY-86-7548,Solid tumour/cancer , Phase 1
11701,D0A4VI,AZD-2914,Chronic obstructive pulmonary disease , Terminated
11702,D0A4VJ,CYT-500,Prostate cancer , Phase 1
11703,D0A4VW,TP-110,Multiple myeloma , Investigative
11704,D0A4WL,Creaferon,Hepatitis virus infection , Investigative
11705,D0A4XJ,SU5402,Multiple myeloma , Investigative
11706,D0A4XN,PRS-639058,Neuropathic pain , Terminated
11707,D0A4YE,Sulfaphenazole,Bacterial infection , Approved
11708,D0A4YK,PBI-05204,Solid tumour/cancer , Phase 2
11709,D0A4YK,PBI-05204,Pancreatic cancer , Phase 2
11710,D0A4ZZ,OHR/AVR118,Cachexia , Phase 2
11711,D0A5BJ,EndoAngio-GT,Solid tumour/cancer , Preclinical
11712,D0A5BT,Camostat mesylate,Coronavirus Disease 2019 (COVID-19) , Phase 2
11713,D0A5BT,Camostat mesylate,Severe acute respiratory syndrome (SARS) , Investigative
11714,D0A5BT,Camostat mesylate,Middle East Respiratory Syndrome (MERS) , Investigative
11715,D0A5CH,Integrin alpha-V/beta-3 receptor mab,Arteriosclerosis , Investigative
11716,D0A5CL,ABI-200,Gram-positive bacterial infection , Investigative
11717,D0A5CM,Trolamine salicylate,Pain , Approved
11718,D0A5CU,Ro-24-1882,Bacterial infection , Terminated
11719,D0A5CZ,DW-403,Asthma , Investigative
11720,D0A5DJ,Pancrecarb,Pancreatic malfunction , NDA filed
11721,D0A5EF,GW-427353,Urinary incontinence , Phase 2
11722,D0A5EN,AMG-714,Coeliac disease , Phase 2
11723,D0A5EN,AMG-714,Rheumatoid arthritis , Discontinued in Phase 1
11724,D0A5FD,AR30,Mental disease , Phase 2
11725,D0A5FM,Nitric Oxide,Respiratory failure , Approved
11726,D0A5FM,Nitric Oxide,Solid tumour/cancer , Phase 3
11727,D0A5FM,Nitric Oxide,Tinea pedis , Discontinued in Phase 2
11728,D0A5HC,RV-568,Asthma , Phase 2
11729,D0A5IL,18F-NST-ML-10,Stroke , Phase 2
11730,D0A5JP,Iopanoic acid,Vascular disease , Approved
11731,D0A5KF,IPN-120,Influenza virus infection , Investigative
11732,D0A5KO,TD-3633,Bladder cancer , Investigative
11733,D0A5KS,Hemoxin,Anemia , Investigative
11734,D0A5LH,Penicillin G Procaine,Bacterial infection , Approved
11735,D0A5MC,MLN8054,Solid tumour/cancer , Phase 1
11736,D0A5MD,PHA-568487,Cognitive impairment , Preclinical
11737,D0A5MI,LANIQUIDAR,Solid tumour/cancer , Discontinued in Phase 2
11738,D0A5NL,HS-HIV,Human immunodeficiency virus infection , Investigative
11739,D0A5NN,ECO-0501,Enterococcus faecium infection , Investigative
11740,D0A5OG,ReN-002,Insulin-dependent diabetes , Investigative
11741,D0A5OT,Aromatic ethylene derivative 1,Solid tumour/cancer , Patented
11742,D0A5OT,Aromatic ethylene derivative 1,Infectious disease , Patented
11743,D0A5OT,Aromatic ethylene derivative 1,Human immunodeficiency virus infection , Patented
11744,D0A5OT,Aromatic ethylene derivative 1,Hepatitis , Patented
11745,D0A5PM,PPRT-550,Premenstrual syndrome , Terminated
11746,D0A5RD,Radafaxine,Major depressive disorder , Discontinued in Phase 2
11747,D0A5SA,TAK-272,Type-2 diabetes , Phase 2
11748,D0A5SE,Febuxostat,Hyperuricaemia , Approved
11749,D0A5SJ,B-cell lymphoma vaccine,Follicular lymphoma , Preregistration
11750,D0A5SR,Lenapenem hydrochloride hydrate,Bacterial infection , Phase 2
11751,D0A5TM,SGB-1534,Hypotension , Discontinued in Phase 2
11752,D0A5TS,EVT-101,Neuropathic pain , Discontinued in Phase 2
11753,D0A5WQ,MRF-008,Multiple sclerosis , Phase 1
11754,D0A5XN,Sprodiamide,Diagnostic imaging , Phase 1/2
11755,D0A5ZJ,DW-1350,Osteoporosis , Terminated
11756,D0A5ZL,Anti-LINGO,Multiple sclerosis , Phase 2
11757,D0A6AP,Indigotindisulfonate,Bladder disease , Approved
11758,D0A6CC,Depatuxizumab,Glioblastoma of brain , Phase 2
11759,D0A6CC,Depatuxizumab,Solid tumour/cancer , Phase 1
11760,D0A6CQ,Levobetaxolol,Chronic open-angle glaucoma , Approved
11761,D0A6DK,Ruthenium (II) phosphine/picolinate complexes,Mycobacterium infection , Investigative
11762,D0A6DY,ATM AVI,Bacterial infection , Phase 2
11763,D0A6KA,CLL immunotherapeutic vaccine,Chronic lymphocytic leukaemia , Phase 1/2
11764,D0A6KR,Balsalazide,Inflammatory bowel disease , Approved
11765,D0A6LT,PEG-bHb-CO,Cardiovascular disease , Phase 2/3
11766,D0A6LT,PEG-bHb-CO,Cerebral ischemia , Phase 2
11767,D0A6LT,PEG-bHb-CO,Sickle-cell disorder , Phase 2
11768,D0A6MN,SB773812,Schizophrenia , Phase 2
11769,D0A6MS,Parke-Davis 9,Pain , Investigative
11770,D0A6NP,A35566-A,Solid tumour/cancer , Investigative
11771,D0A6NU,Haloperidol,Schizophrenia , Approved
11772,D0A6NU,Haloperidol,Coronavirus Disease 2019 (COVID-19) , Investigative
11773,D0A6OF,BMS-181321,Diagnostic imaging , Investigative
11774,D0A6OJ,TP-102,Bacterial infection , Investigative
11775,D0A6OO,PSI 7851,Hepatitis C virus infection , Investigative
11776,D0A6OS,TAK-379,Type-2 diabetes , Phase 2
11777,D0A6PD,Oralgen Tree Pollen,Allergy , Investigative
11778,D0A6PL,S-14506,Anxiety disorder , Terminated
11779,D0A6QR,TMCB,Coronavirus Disease 2019 (COVID-19) , Investigative
11780,D0A6RI,Meganucleases,Herpes simplex virus infection , Investigative
11781,D0A6RX,Anti-hTfR IgG3-Av,Solid tumour/cancer , Investigative
11782,D0A6SD,CLS008,Psoriasis vulgaris , Application submitted
11783,D0A6UQ,ETX-1153a,MRSA infection , Preclinical
11784,D0A6VA,PVP-ILH,Conjunctivitis , Phase 2
11785,D0A6VD,VS-4718,Solid tumour/cancer , Phase 1
11786,D0A6VE,FIDUXOSIN HYDROCHLORIDE,Prostate disease , Discontinued in Phase 2
11787,D0A6VM,VCL-HB01,Herpes simplex virus infection , Phase 2
11788,D0A6WA,GAM-501,Diabetic foot ulcer , Phase 2
11789,D0A6WQ,AG-4070,Arteriosclerosis , Investigative
11790,D0A6XC,CD19-targeted CART cells,leukaemia , Phase 1
11791,D0A6YN,SUN-C5174,Peripheral vascular disease , Discontinued in Phase 2
11792,D0A7AG,CP51-2705,Solid tumour/cancer , Investigative
11793,D0A7CH,WIP-901,Osteoarthritis , Investigative
11794,D0A7CO,Heparin,Venous thrombosis , Approved
11795,D0A7CO,Heparin,Coronavirus Disease 2019 (COVID-19) , Investigative
11796,D0A7CZ,PTX-007,Bacterial infection , Investigative
11797,D0A7GA,AMT-2003,Hepatocellular carcinoma , Phase 2/3
11798,D0A7GE,Avanz,Allergic rhinitis , Approved
11799,D0A7GH,ATI-2341,Bone marrow transplantation , Investigative
11800,D0A7GI,BPZE-1,Bordetella pertussis infection , Phase 1
11801,D0A7GX,Echovist,Gynecological disease , Approved
11802,D0A7HY,TAT-120,Ischemic heart disease , Investigative
11803,D0A7JH,WY-50295-tromethamine,Asthma , Phase 2
11804,D0A7KI,Abaperidone,Schizophrenia , Phase 1
11805,D0A7LL,PSMA ADC therapeutic,Prostate cancer , Phase 2
11806,D0A7MY,TECFIDERA,Multiple sclerosis , Approved
11807,D0A7NB,Siplizumab,Lymphoma , Phase 2
11808,D0A7NB,Siplizumab,Psoriasis vulgaris , Discontinued in Phase 2
11809,D0A7NI,LIM-5310,Toxicity , Investigative
11810,D0A7NZ,CNTO-6785,Rheumatoid arthritis , Phase 2
11811,D0A7PW,CP-903397,Schizophrenia , Terminated
11812,D0A7QN,Moxisylyte,Erectile dysfunction , Approved
11813,D0A7UK,PDS-0103,Herpes simplex virus infection , Investigative
11814,D0A7UT,PF-04605412,Solid tumour/cancer , Discontinued in Phase 1
11815,D0A7VF,CP-79328,Solid tumour/cancer , Terminated
11816,D0A7WO,NT-501,Ocular inflammation , Phase 2/3
11817,D0A7WO,NT-501,Retinitis pigmentosa , Phase 2/3
11818,D0A7WO,NT-501,Macular telangiectasia type 2 , Phase 2
11819,D0A7WT,Dornase alpha,Cystic fibrosis , Approved
11820,D0A7XQ,ON-044580,Solid tumour/cancer , Investigative
11821,D0A7ZK,Lemborexant,Insomnia , Approved
11822,D0A7ZK,Lemborexant,Alzheimer disease , Phase 2
11823,D0A8AL,PFK-015,Solid tumour/cancer , Investigative
11824,D0A8AU,MSB2311,Solid tumour/cancer , Phase 1
11825,D0A8AU,MSB2311,Advanced malignancy , Phase 1
11826,D0A8BK,MEN-10979,Human immunodeficiency virus-1 infection , Terminated
11827,D0A8CJ,Tiopronin,Cystinuria , Approved
11828,D0A8CJ,Tiopronin,Cystine urolithiasis , Approved
11829,D0A8EG,TAK-591,Hypertension , Discontinued in Phase 1
11830,D0A8ES,EC-0845,Inflammation , Investigative
11831,D0A8FB,Trimethobenzamide,Nausea and vomiting , Approved
11832,D0A8FD,S-18327,Psychotic disorder , Discontinued in Phase 1
11833,D0A8GM,Ublituximab,Chronic lymphocytic leukaemia , Phase 3
11834,D0A8GM,Ublituximab,Multiple sclerosis , Phase 2
11835,D0A8GM,Ublituximab,Lymphoma , Phase 1/2
11836,D0A8GM,Ublituximab,Nodal marginal zone lymphoma , Phase 1/2
11837,D0A8GW,PMID26651364-Compound-9e,Crohn disease , Patented
11838,D0A8GW,PMID26651364-Compound-9e,Ulcerative colitis , Patented
11839,D0A8GW,PMID26651364-Compound-9e,Urinary tract infection , Patented
11840,D0A8HL,DMP-811,Hypertension , Terminated
11841,D0A8HN,Iboctadekin,Ovarian cancer , Phase 1
11842,D0A8HN,Iboctadekin,Non-hodgkin lymphoma , Phase 1
11843,D0A8IE,AM-831,Schizophrenia , Discontinued in Phase 1
11844,D0A8IM,CF-238,Infectious disease , Investigative
11845,D0A8IQ,ATX-MS2,Multiple sclerosis , Investigative
11846,D0A8JB,VAX-125,Influenza A virus infection , Phase 2
11847,D0A8JB,VAX-125,Human immunodeficiency virus infection , Phase 2
11848,D0A8JM,RDP58,Diarrhea , Phase 2
11849,D0A8KQ,GSK2256294,Chronic obstructive pulmonary disease , Phase 1
11850,D0A8KX,M-518101,Psoriasis vulgaris , Phase 3
11851,D0A8KX,M-518101,Plaque psoriasis , Phase 3
11852,D0A8LP,AG2034,Solid tumour/cancer , Phase 1
11853,D0A8LU,PMID25666693-Compound-113,Osteoarthritis pain , Patented
11854,D0A8LU,PMID25666693-Compound-113,Cancer related pain , Patented
11855,D0A8LU,PMID25666693-Compound-113,Neuropathic pain , Patented
11856,D0A8LU,PMID25666693-Compound-113,Inflammatory pain , Patented
11857,D0A8LZ,BCG vaccine,Bladder cancer , Approved
11858,D0A8MH,M-516102,Pruritus , Phase 2
11859,D0A8NN,CT-637,Autoimmune diabetes , Investigative
11860,D0A8NW,PC-1005,Human immunodeficiency virus infection , Phase 1
11861,D0A8PC,Influenza cell culture vaccine,Influenza virus infection , Phase 3
11862,D0A8QM,Lu-AA34893,Anxiety disorder , Phase 2
11863,D0A8RP,INDOPY-1,Human immunodeficiency virus infection , Investigative
11864,D0A8RV,Biaryl mannoside derivative 4,Crohn disease , Patented
11865,D0A8RV,Biaryl mannoside derivative 4,Ulcerative colitis , Patented
11866,D0A8RV,Biaryl mannoside derivative 4,Urinary tract infection , Patented
11867,D0A8RX,Schizophyllan,Solid tumour/cancer , Approved
11868,D0A8TA,Volanesorsen,Hypertriglyceridemia , Approved
11869,D0A8TA,Volanesorsen,Hyperlipoproteinemia , Phase 3
11870,D0A8TA,Volanesorsen,Familial chylomicronemia syndrome , Phase 1
11871,D0A8UJ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9",Albinism , Patented
11872,D0A8UJ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9",Ephelides , Patented
11873,D0A8UJ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9",Menkes disease , Patented
11874,D0A8UJ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9",Senile lentigines , Patented
11875,D0A8UJ,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 9",Melasma , Patented
11876,D0A8UP,PMID15026062C41,Pancreatitis , Clinical trial
11877,D0A8WR,LUpartumab amadotin,Solid tumour/cancer , Phase 1
11878,D0A8XN,Labetalol,Hypertension , Approved
11879,D0A8XY,Altropane,Attention deficit hyperactivity disorder , Approved
11880,D0A8ZD,SR-33805,Angina pectoris , Discontinued in Phase 1
11881,D0A9BI,Hi-8 PrimeBoost therapeutic melanoma vaccine,Melanoma , Phase 2
11882,D0A9BO,PG-120,Autoimmune diabetes , Investigative
11883,D0A9BU,CB-24,Solid tumour/cancer , Phase 1
11884,D0A9CV,INX-3280,Solid tumour/cancer , Discontinued in Phase 2
11885,D0A9CY,Pentisomide,Heart arrhythmia , Discontinued in Phase 2
11886,D0A9GE,FATE-NK100,Acute myeloid leukaemia , Phase 1
11887,D0A9GE,FATE-NK100,Ovarian cancer , Phase 1
11888,D0A9GE,FATE-NK100,Solid tumour/cancer , Phase 1
11889,D0A9GI,ILV-095,Psoriasis vulgaris , Phase 1
11890,D0A9HT,Avastin,Brain metastases , Phase 2
11891,D0A9IY,PF-4447943,Alzheimer disease , Phase 2
11892,D0A9IY,PF-4447943,Sickle-cell disorder , Phase 1
11893,D0A9JA,Anti-CD44 mab,Acute myeloid leukaemia , Investigative
11894,D0A9JW,GPG,Human immunodeficiency virus infection , Discontinued in Phase 1/2
11895,D0A9KF,Calcium carbimide,Alcohol dependence , Approved
11896,D0A9KI,SB-242235,Arthritis , Discontinued in Phase 1
11897,D0A9ML,SelG1,Vaso-occlusive crisis , Phase 2
11898,D0A9NN,Indinavir,Human immunodeficiency virus infection , Approved
11899,D0A9NN,Indinavir,Coronavirus Disease 2019 (COVID-19) , Investigative
11900,D0A9OR,SLV319,Obesity , Discontinued in Phase 2
11901,D0A9OV,TAK165,Solid tumour/cancer , Discontinued in Phase 1
11902,D0A9PD,Lu AF20513,Alzheimer disease , Phase 1
11903,D0A9PN,GDC-0853,Multiple sclerosis , Phase 3
11904,D0A9PN,GDC-0853,Chronic idiopathic urticaria , Phase 2
11905,D0A9PN,GDC-0853,Solid tumour/cancer , Phase 1
11906,D0A9PN,GDC-0853,Autoimmune disease , Phase 1
11907,D0A9PR,JNJ-61187191,Respiratory syncytial virus infection , Phase 1
11908,D0A9PW,AMT-060,Factor IX deficiency , Phase 1/2
11909,D0A9SA,Canfosfamide,Solid tumour/cancer , Phase 3
11910,D0A9TA,MTL-007,Solid tumour/cancer , Investigative
11911,D0A9TR,XT-101,Neuropathic pain , Investigative
11912,D0A9VO,GYKI-52466,Alzheimer disease , Terminated
11913,D0A9WW,FE-999040,Solid tumour/cancer , Investigative
11914,D0A9YA,Dutasteride,Benign prostatic hyperplasia , Approved
11915,D0A9YA,Dutasteride,Prostate cancer , Phase 3
11916,D0A9YZ,APT-102,Cerebral infarction , Investigative
11917,D0A9ZA,NasoVac,Influenza virus infection , Approved
11918,D0A9ZX,Pentamycin,Vulvovaginitis , Approved
11919,D0AA0L,Pancuronium,Anaesthesia , Approved
11920,D0AA2D,Bifonazole,Fungal infection , Approved
11921,D0AA2X,PNT-500,Solid tumour/cancer , Investigative
11922,D0AA5K,ACT-101,Multiple sclerosis , Phase 1
11923,D0AA5K,ACT-101,Myasthenia gravis , Phase 1
11924,D0AA6Z,Rambazole,Psoriasis vulgaris , Phase 2
11925,D0AA6Z,Rambazole,Asthma , Investigative
11926,D0AA8R,Sotirimod,Keratosis , Phase 2
11927,D0AB2G,HL-022,Solid tumour/cancer , Investigative
11928,D0AB4Q,Ispronicline,Alzheimer disease , Discontinued in Phase 2
11929,D0AB4Q,Ispronicline,Schizophrenia , Discontinued in Phase 2
11930,D0AB7G,MCI-826,Asthma , Terminated
11931,D0AC0A,SB-612111,Inflammation , Investigative
11932,D0AC6O,OBP-AI2,Human immunodeficiency virus infection , Investigative
11933,D0AC7C,IPS-01003,Solid tumour/cancer , Investigative
11934,D0AC8L,Proxinium,Squamous cell carcinoma , Phase 1
11935,D0AC8W,RC-3095,Solid tumour/cancer , Phase 2
11936,D0AC9S,CART-19/BCMA,Multiple myeloma , Phase 1/2
11937,D0AD0B,HIV vaccine Ad4-Clade C,Human immunodeficiency virus infection , Phase 1
11938,D0AD3V,PF-06647020,Solid tumour/cancer , Phase 1
11939,D0AD4D,CXL-1020,Acute decompensated heart failure , Phase 2
11940,D0AD4H,Cethrin,Spinal cord injury , Phase 1/2
11941,D0AD4Z,Fasinumab,Neuropathic pain , Phase 3
11942,D0AD4Z,Fasinumab,Chronic low back pain , Phase 3
11943,D0AD4Z,Fasinumab,Pain , Phase 3
11944,D0AD4Z,Fasinumab,Osteoarthritis , Phase 3
11945,D0AD5C,Acarbose,Diabetic complication , Approved
11946,D0AD5C,Acarbose,Cardiovascular disease , Phase 3
11947,D0AD5S,SRP-4053,Duchenne dystrophy , Phase 2
11948,D0AD6P,Danoprevir + ritonavir,Coronavirus Disease 2019 (COVID-19) , Phase 2
11949,D0AD6Z,mab 224G11,Solid tumour/cancer , Investigative
11950,D0AD8L,Vivia-577,Solid tumour/cancer , Investigative
11951,D0AD9Y,Kifunensine,Muscular dystrophy , Terminated
11952,D0AE1X,GS-9411,Pulmonary disease , Phase 1
11953,D0AE3U,SAR-113945,Osteoarthritis , Phase 2
11954,D0AE3X,Brimonidine,Ocular hypertension , Approved
11955,D0AE3X,Brimonidine,Glaucoma/ocular hypertension , Phase 3
11956,D0AE5K,Oxyntomodulin,Type 2 diabetes , Phase 2
11957,D0AE6Q,MBG453,Myelodysplastic syndrome , Phase 3
11958,D0AE6Q,MBG453,Solid tumour/cancer , Phase 1/2
11959,D0AE8D,Benzothiazole analog 4,Albinism , Patented
11960,D0AE8D,Benzothiazole analog 4,Ephelides , Patented
11961,D0AE8D,Benzothiazole analog 4,Menkes disease , Patented
11962,D0AE8D,Benzothiazole analog 4,Senile lentigines , Patented
11963,D0AE8D,Benzothiazole analog 4,Melasma , Patented
11964,D0AF4F,HO-4073,Solid tumour/cancer , Investigative
11965,D0AF5P,RVT-505,Atopic dermatitis , Phase 2
11966,D0AF5P,RVT-505,Psoriasis vulgaris , Phase 2
11967,D0AF6O,Lorlatinib,Non-small-cell lung cancer , Approved
11968,D0AF7D,APL-180,Heart disease , Discontinued in Phase 2
11969,D0AF7N,Fibrimage,Thrombosis , Discontinued in Phase 3
11970,D0AF8E,BXCL101,Neurofibromatosis type 2 , Phase 1/2
11971,D0AF8R,P-216CM,Bacterial infection , Investigative
11972,D0AG2A,"Pyrrolo[2,3-d]pyrimidine derivative 4",Pruritus , Patented
11973,D0AG2A,"Pyrrolo[2,3-d]pyrimidine derivative 4",Solid tumour/cancer , Patented
11974,D0AG2A,"Pyrrolo[2,3-d]pyrimidine derivative 4",Chronic pain , Patented
11975,D0AG2A,"Pyrrolo[2,3-d]pyrimidine derivative 4",Neuropathic pain , Patented
11976,D0AG2A,"Pyrrolo[2,3-d]pyrimidine derivative 4",Thymic cancer , Patented
11977,D0AG4J,IRX-01,Inflammation , Investigative
11978,D0AG6K,MT201,Prostate cancer , Phase 2
11979,D0AG7M,Benzoic acid linked peptide analog 6,Albinism , Patented
11980,D0AG7M,Benzoic acid linked peptide analog 6,Ephelides , Patented
11981,D0AG7M,Benzoic acid linked peptide analog 6,Menkes disease , Patented
11982,D0AG7M,Benzoic acid linked peptide analog 6,Senile lentigines , Patented
11983,D0AG7M,Benzoic acid linked peptide analog 6,Melasma , Patented
11984,D0AG7N,MEDI-575,Glioblastoma multiforme , Phase 2
11985,D0AG8C,GC376,Severe acute respiratory syndrome (SARS) , Preclinical
11986,D0AG8C,GC376,Middle East Respiratory Syndrome (MERS) , Preclinical
11987,D0AG8C,GC376,Coronavirus Disease 2019 (COVID-19) , Investigative
11988,D0AG8L,BMS-986231,Acute decompensated heart failure , Phase 2
11989,D0AG8L,BMS-986231,Acute heart failure , Phase 2
11990,D0AH2V,RM-6427,Cryptosporidium infection , Investigative
11991,D0AH6V,BN-2629,Solid tumour/cancer , Phase 1/2
11992,D0AI3G,HG-1224,Immune System disease , Investigative
11993,D0AI7H,Anti-MUC1 CAR T Cells,Lung cancer , Phase 1/2
11994,D0AI7H,Anti-MUC1 CAR T Cells,Non-small-cell lung cancer , Phase 1/2
11995,D0AI8V,DSP-1200,Depression , Phase 1
11996,D0AJ1V,Silvestrol,Middle East Respiratory Syndrome (MERS) , Investigative
11997,D0AJ3K,Gemcitabine,Non-small cell lung cancer , Approved
11998,D0AJ3K,Gemcitabine,Severe acute respiratory syndrome (SARS) , Preclinical
11999,D0AJ3K,Gemcitabine,Middle East Respiratory Syndrome (MERS) , Preclinical
12000,D0AJ3O,PMID27240464-compound-3f,Severe acute respiratory syndrome (SARS) , Preclinical
12001,D0AJ3O,PMID27240464-compound-3f,Middle East Respiratory Syndrome (MERS) , Preclinical
12002,D0AJ5E,Rifaximin DR,Crohn disease , Phase 3
12003,D0AJ5L,Oxatomide,Hay fever , Approved
12004,D0AJ9V,ZW25,Biliary tract cancer , Phase 2
12005,D0AJ9V,ZW25,Breast cancer , Phase 2
12006,D0AJ9V,ZW25,Oesophagogastric junction cancer , Phase 2
12007,D0AJ9V,ZW25,Ovarian cancer , Phase 1
12008,D0AK0Z,ICT-69,Autoimmune diabetes , Investigative
12009,D0AK2V,AEH-10p,Solid tumour/cancer , Investigative
12010,D0AK2Y,PMID26651364-Compound-7b,Crohn disease , Patented
12011,D0AK2Y,PMID26651364-Compound-7b,Ulcerative colitis , Patented
12012,D0AK2Y,PMID26651364-Compound-7b,Urinary tract infection , Patented
12013,D0AK4H,AMG-429,Solid tumour/cancer , Investigative
12014,D0AK5G,RPAF-AH,Sepsis , Discontinued in Phase 3
12015,D0AK5R,Floctafenine,Arthritis , Withdrawn from market
12016,D0AK6L,Amidine compound 4,Inflammation , Patented
12017,D0AK8E,K-101,Onychomycosis , Investigative
12018,D0AL0S,GSK-1362885,Type-2 diabetes , Discontinued in Phase 1
12019,D0AL2K,Irbesartan,Hypertension , Approved
12020,D0AL2K,Irbesartan,Coronavirus Disease 2019 (COVID-19) , Investigative
12021,D0AL3O,VX-366,Constitutional neutropenia , Discontinued in Phase 2
12022,D0AL8T,Darbufelone,Asthma , Phase 2/3
12023,D0ALN1,CWHM-12,Hepatic fibrosis , Preclinical
12024,D0ALN1,CWHM-12,Pulmonary fibrosis , Preclinical
12025,D0AM0A,Aryl mannoside derivative 15,Crohn disease , Patented
12026,D0AM0A,Aryl mannoside derivative 15,Ulcerative colitis , Patented
12027,D0AM0A,Aryl mannoside derivative 15,Urinary tract infection , Patented
12028,D0AM1D,Diaryl piperazine derivative 2,Obesity , Patented
12029,D0AM1S,CCD-3693,Anxiety disorder , Discontinued in Phase 1
12030,D0AM2D,Heterocyclic derivative 8,Solid tumour/cancer , Patented
12031,D0AM2D,Heterocyclic derivative 8,Metastatic cancer , Patented
12032,D0AM4P,Interferon gamma-n1,Fungal infection , Approved
12033,D0AM4W,Oseltamivir + hydroxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
12034,D0AM6F,ETX-1153c,Clostridium infection , Preclinical
12035,D0AM8W,Zanapezil,Alzheimer disease , Discontinued in Phase 3
12036,D0AN1Y,L-670596,Asthma , Terminated
12037,D0AN3N,SGT-001,Duchenne dystrophy , Phase 1/2
12038,D0AN7B,Melatonin,Insomnia , Approved
12039,D0AN9V,ADC-03,Solid tumour/cancer , Preclinical
12040,D0AO0K,CNT0-5,Inflammation , Phase 1
12041,D0AO5F,JOT101,Friedreich's ataxia , Phase 2
12042,D0AO5H,Trimethoprim,Urinary tract infection , Approved
12043,D0AO6B,Piperacetazine,Schizophrenia , Approved
12044,D0AO8L,NY-ESO-1 T-cell receptor therapy,Solid tumour/cancer , Phase 2
12045,D0AO9Q,SYNT001,Pemphigus vulgaris , Phase 1/2
12046,D0AO9S,Enflurane,Anaesthesia , Approved
12047,D0AP4O,Gem 92,Human immunodeficiency virus-1 infection , Discontinued in Phase 1
12048,D0AP7A,BMS-986258,Solid tumour/cancer , Phase 1
12049,D0AP9E,Trilaciclib,Small-cell lung cancer , Approved
12050,D0AP9E,Trilaciclib,Triple negative breast cancer , Phase 2
12051,D0AP9T,Cefotetan,Bacterial infection , Approved
12052,D0AQ3H,PF-610355,Chronic obstructive pulmonary disease , Discontinued in Phase 2
12053,D0AQ3U,PMID25666693-Compound-153,Osteoarthritis pain , Patented
12054,D0AQ3U,PMID25666693-Compound-153,Cancer related pain , Patented
12055,D0AQ3U,PMID25666693-Compound-153,Neuropathic pain , Patented
12056,D0AQ3U,PMID25666693-Compound-153,Inflammatory pain , Patented
12057,D0AQ8F,ETV-005,Influenza virus infection , Investigative
12058,D0AR0B,ACAM-2000,Virus infection , Approved
12059,D0AR3J,Acocantherin,Heart failure , Approved
12060,D0AR3J,Acocantherin,Atrial fibrillation , Approved
12061,D0AR5N,BMS-824383,Hepatitis C virus infection , Phase 1
12062,D0AR7L,SAR-389644,Allergic rhinitis , Phase 1
12063,D0AR8G,Habeo,Scleroderma , Phase 3
12064,D0AS0V,"5,8-Dihydroxy-1,4-naphthoquinone",Malaria , Investigative
12065,D0AS1Y,Li-Key peptide vaccine,Coronavirus Disease 2019 (COVID-19) , Preclinical
12066,D0AT5Y,Radiolabeled VEGF,Arteriosclerosis , Investigative
12067,D0AT8C,Pegfilgrastim,Malignant solid tumour , Approved
12068,D0AU2T,REGN1979,B-cell non-hodgkin lymphoma , Phase 2
12069,D0AU2T,REGN1979,Solid tumour/cancer , Phase 1
12070,D0AU2T,REGN1979,Chronic lymphocytic leukaemia , Phase 1
12071,D0AU4G,3-amino-5-benzyl-substituted indazole derivative 1,Pruritus , Patented
12072,D0AU4G,3-amino-5-benzyl-substituted indazole derivative 1,Solid tumour/cancer , Patented
12073,D0AU4G,3-amino-5-benzyl-substituted indazole derivative 1,Chronic pain , Patented
12074,D0AU4G,3-amino-5-benzyl-substituted indazole derivative 1,Neuropathic pain , Patented
12075,D0AU4G,3-amino-5-benzyl-substituted indazole derivative 1,Thymic cancer , Patented
12076,D0AV0O,OPC-51803,Urinary incontinence , Discontinued in Phase 1
12077,D0AV3G,Domperidone,Gastrointestinal disease , Approved
12078,D0AW4T,CART-123 cells,Myelodysplastic syndrome , Phase 1
12079,D0AW4T,CART-123 cells,Acute myeloid leukaemia , Phase 1
12080,D0AW5T,PX-866,Solid tumour/cancer , Phase 2
12081,D0AW7H,StromaCel,Heart disease , Investigative
12082,D0AW8E,Tezosentan,Cardiac disease , Phase 3
12083,D0AW9T,ATryn antithrombin,Multiple sclerosis , Approved
12084,D0AX0V,SOM-1033,Chronic obstructive pulmonary disease , Investigative
12085,D0AX1N,OGX-427,Lung cancer , Phase 2
12086,D0AX1N,OGX-427,Prostate cancer , Phase 2
12087,D0AX1N,OGX-427,Bladder cancer , Phase 2
12088,D0AX1N,OGX-427,Ovarian cancer , Phase 2
12089,D0AX1N,OGX-427,Breast cancer , Phase 2
12090,D0AX3M,KW-2581,Breast cancer , Investigative
12091,D0AX4E,Bertosamil,Angina pectoris , Terminated
12092,D0AX4H,GSK3179106,Inflammatory bowel disease , Phase 1
12093,D0AX9N,Biphenyl derivative 4,Histamine H3-associated disorder , Patented
12094,D0AX9S,GW-409544,Hyperlipidaemia , Phase 1
12095,D0AY0H,PMID26651364-Compound-10c,Crohn disease , Patented
12096,D0AY0H,PMID26651364-Compound-10c,Ulcerative colitis , Patented
12097,D0AY0H,PMID26651364-Compound-10c,Urinary tract infection , Patented
12098,D0AY0U,Kadcyla,Breast cancer , Phase 3
12099,D0AY1I,GSK-2315698,Amyloidosis , Phase 1
12100,D0AY6U,MT-003,Pain , Investigative
12101,D0AY7K,Celiprolol hcl,Hypertension , Approved
12102,D0AY7O,Polyinosinic:polycytidylic acid,Middle East Respiratory Syndrome (MERS) , Investigative
12103,D0AY8A,CA-4948,Lymphoma , Phase 1
12104,D0AY8D,NBXT-001+Nobilis inhalation device,Alzheimer disease , Phase 1
12105,D0AY9Q,Hexyl aminolevulinate,Solid tumour/cancer , Approved
12106,D0AY9Q,Hexyl aminolevulinate,Bladder cancer , Phase 2
12107,D0AY9R,Linear DNA vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
12108,D0AZ0T,NP-003,Parkinson disease , Investigative
12109,D0AZ1N,BSK01,Acute myeloid leukaemia , Phase 1/2
12110,D0AZ1N,BSK01,Haematological malignancy , Phase 1/2
12111,D0AZ1N,BSK01,Solid tumour/cancer , Phase 1/2
12112,D0AZ3C,Imatinib,Chronic myelogenous leukaemia , Approved
12113,D0AZ3C,Imatinib,Acute lymphoblastic leukaemia , Approved
12114,D0AZ3C,Imatinib,Intestinal cancer , Phase 3
12115,D0AZ3C,Imatinib,Lung cancer , Phase 2
12116,D0AZ3C,Imatinib,Systemic mastocytosis , Investigative
12117,D0AZ3Y,CTCE-0214,Constitutional neutropenia , Phase 1
12118,D0AZ4S,VT1021,Solid tumour/cancer , Phase 1
12119,D0AZ5O,LHD-4,Solid tumour/cancer , Investigative
12120,D0AZ5V,L-698544,Alzheimer disease , Terminated
12121,D0AZ6M,Linezolid,Bacterial infection , Approved
12122,D0AZ6M,Linezolid,Coronavirus Disease 2019 (COVID-19) , Investigative
12123,D0AZ7F,NLX-E201,Epilepsy , Investigative
12124,D0AZ8Y,Biciromab,Thrombosis , Approved
12125,D0B0AX,HIF-1alpha,Lymphoma , Phase 4
12126,D0B0BE,PR-5-I,Fertility problem , Preregistration
12127,D0B0CP,Chlorprothixene,Psychotic disorder , Approved
12128,D0B0EB,LY-929,Lipid metabolism disorder , Discontinued in Phase 1
12129,D0B0EO,CPG23STEM,Insulin-dependent diabetes , Investigative
12130,D0B0EZ,DWJ-424,Solid tumour/cancer , Investigative
12131,D0B0FK,NasoVAX vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
12132,D0B0FU,Apramycin,Gram-negative bacterial infection , Phase 1
12133,D0B0GC,E-0722,Diabetic cataract , Terminated
12134,D0B0HK,G3139 + G-CSF,Acute leukaemia , Investigative
12135,D0B0LG,Apomab,Solid tumour/cancer , Investigative
12136,D0B0MA,F-2692,Anxiety disorder , Discontinued in Phase 1
12137,D0B0MQ,KP-303,Bipolar disorder , Investigative
12138,D0B0NH,IK-5001,Congestive heart failure , Phase 2
12139,D0B0NQ,LY293558,Pain , Phase 2
12140,D0B0OA,LEO-27847,Kidney disease , Phase 1
12141,D0B0QX,MSC-204,Human immunodeficiency virus infection , Terminated
12142,D0B0RZ,GRL-0667,Severe acute respiratory syndrome (SARS) , Investigative
12143,D0B0SH,Oxtriphylline,Cough , Approved
12144,D0B0TO,L-768277,Hyperthermia , Terminated
12145,D0B0TW,SSJ-183,Malaria , Investigative
12146,D0B0UF,IBI-308,Bronchioalveolar carcinoma , Phase 3
12147,D0B0UN,R7232,Dyslipidemia , Discontinued in Phase 1
12148,D0B0VD,MORAb-022,Autoimmune diabetes , Phase 1
12149,D0B0VD,MORAb-022,Rheumatoid arthritis , Phase 1
12150,D0B0WJ,PMID25666693-Compound-51,Osteoarthritis pain , Patented
12151,D0B0WJ,PMID25666693-Compound-51,Cancer related pain , Patented
12152,D0B0WJ,PMID25666693-Compound-51,Neuropathic pain , Patented
12153,D0B0WJ,PMID25666693-Compound-51,Inflammatory pain , Patented
12154,D0B0WW,Physostigmine/scopolamine,Nicotine dependence , Terminated
12155,D0B0ZR,AF-05,Anxiety disorder , Phase 1
12156,D0B1CJ,Amphiregulin targeting human mabs,Psoriasis vulgaris , Investigative
12157,D0B1CU,CD19 CAR T-cells,Acute lymphoblastic leukaemia , Phase 1
12158,D0B1CU,CD19 CAR T-cells,Recurrent adult burkitt lymphoma , Phase 1
12159,D0B1DA,SAND-5,Glomerulonephritis , Preclinical
12160,D0B1EM,Nateplase,Thrombin deficiency , Approved
12161,D0B1EM,Nateplase,Myocardial infarction , Approved
12162,D0B1EQ,Taspoglutide,Type-1 diabetes , Phase 3
12163,D0B1ET,Streptococcal B conjugated vaccine,Streptococcal B infection , Phase 2
12164,D0B1EV,Cyclopentolate,Examination of eyes or vision , Approved
12165,D0B1FE,SPI-1005,Reperfusion injury , Approved
12166,D0B1GE,KB103,Dystrophic epidermolysis bullosa , Phase 2
12167,D0B1GX,Iferanserin-Ventrus,Hemorrhoids , Discontinued in Phase 3
12168,D0B1HT,Biaryl mannoside derivative 20,Crohn disease , Patented
12169,D0B1HT,Biaryl mannoside derivative 20,Ulcerative colitis , Patented
12170,D0B1HT,Biaryl mannoside derivative 20,Urinary tract infection , Patented
12171,D0B1IC,CR8020,Influenza virus infection , Phase 2
12172,D0B1IC,CR8020,Influenza A virus infection , Investigative
12173,D0B1IP,Etretinate,Keratosis , Approved
12174,D0B1IV,Vancomycin,Methicillin-resistant staphylococci infection , Approved
12175,D0B1IV,Vancomycin,MRSA infection , Investigative
12176,D0B1JE,TVX-005,Influenza virus infection , Investigative
12177,D0B1KA,Radretumab,Haematological malignancy , Phase 2
12178,D0B1KK,AZD0837,Thrombosis , Discontinued in Phase 2
12179,D0B1KK,AZD0837,Nonvalvular atrial fibrillation , Discontinued in Phase 2
12180,D0B1MJ,Dexniguldipine,Solid tumour/cancer , Discontinued in Phase 2
12181,D0B1NA,PVAC,Psoriasis vulgaris , Discontinued in Phase 2
12182,D0B1OH,ASB17061,Atopic dermatitis , Phase 2
12183,D0B1PC,OXECLOSPORIN,Immune System disease , Discontinued in Phase 1
12184,D0B1PD,NPC-16377,Psychotic disorder , Terminated
12185,D0B1PE,Ro 5-4864,Gram-positive bacterial infection , Investigative
12186,D0B1PH,Oxymethalone,Coronavirus Disease 2019 (COVID-19) , Investigative
12187,D0B1PU,CGEN-856,Cardiovascular disease , Investigative
12188,D0B1RM,LP-226A1,Solid tumour/cancer , Investigative
12189,D0B1RX,ZYI-1,Inflammation , Phase 2
12190,D0B1RY,Aom-0977,Obesity , Investigative
12191,D0B1SA,IDC-G103,Herpes simplex virus infection , Investigative
12192,D0B1SG,BMS-813160,Diabetic nephropathy , Phase 2
12193,D0B1SG,BMS-813160,Solid tumour/cancer , Phase 1
12194,D0B1TI,MPSK3169A,Cardiovascular disease , Phase 2
12195,D0B1TI,MPSK3169A,Metabolic disorder , Phase 1
12196,D0B1TL,Her2-targeted autologous T-cell therapy,Glioblastoma multiforme , Phase 2
12197,D0B1TN,VLIM-88,Acute myeloid leukaemia , Investigative
12198,D0B1TT,AdCh63-MSP1,Malaria , Phase 1/2
12199,D0B1TX,PVAXrcPSAv53l,Prostate cancer , Phase 1/2
12200,D0B1UO,LV-SMENP dendritic cells vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
12201,D0B1VQ,GR-133347,Anxiety disorder , Terminated
12202,D0B1VZ,ALG-1001,Diabetic macular edema , Phase 2
12203,D0B1WU,C-101,Muscular dystrophy , Discontinued in Phase 3
12204,D0B2AH,DMP-695/696,Depression , Investigative
12205,D0B2BQ,Icopezil maleate,Cognitive impairment , Discontinued in Phase 2
12206,D0B2BY,TAK-661,Inflammation , Discontinued in Phase 2
12207,D0B2CQ,GR-131663,Anxiety disorder , Terminated
12208,D0B2DP,Triclofos Sodium,Insomnia , Approved
12209,D0B2GI,Glimepiride,Diabetic complication , Approved
12210,D0B2GM,Thiazole carboxamide derivative 20,Solid tumour/cancer , Patented
12211,D0B2GM,Thiazole carboxamide derivative 20,Metastatic cancer , Patented
12212,D0B2HC,GSK-2302032A,Non-small-cell lung cancer , Phase 2
12213,D0B2HE,RypVax,Yersinia infection , Discontinued in Phase 2
12214,D0B2HF,OI287GT,Type-1/2 diabetes , Phase 1
12215,D0B2IB,KBPA-103,Pseudomonas infection , Investigative
12216,D0B2IR,Nemolizumab,Atopic dermatitis , Phase 3
12217,D0B2JL,JWB-1-84-1,Neurological disorder , Investigative
12218,D0B2JZ,K11777,Severe acute respiratory syndrome (SARS) , Preclinical
12219,D0B2JZ,K11777,Middle East Respiratory Syndrome (MERS) , Preclinical
12220,D0B2LC,HP3070,Schizophrenia , Phase 3
12221,D0B2LF,R-253,Solid tumour/cancer , Terminated
12222,D0B2NF,AEB701,Melanoma , Phase 1
12223,D0B2NV,PMID29334795-Compound-22,Neuropathic pain , Patented
12224,D0B2NV,PMID29334795-Compound-22,Alzheimer disease , Patented
12225,D0B2OC,R-sibutramine metabolite,Attention deficit hyperactivity disorder , Discontinued in Phase 2
12226,D0B2OC,R-sibutramine metabolite,Depression , Discontinued in Phase 2
12227,D0B2OL,AA-2379,Inflammation , Discontinued in Phase 2
12228,D0B2OT,Isoflurophate,Glaucoma/ocular hypertension , Approved
12229,D0B2RZ,ADX-71943,Gastroesophageal reflux disease , Preclinical
12230,D0B2SW,ASP-3291,Ulcerative colitis , Phase 2
12231,D0B2UZ,Prochlorperazine,Nausea , Approved
12232,D0B2VS,Benzyl phenyl ether derivative 1,Solid tumour/cancer , Patented
12233,D0B2VS,Benzyl phenyl ether derivative 1,Infectious disease , Patented
12234,D0B2VS,Benzyl phenyl ether derivative 1,Human immunodeficiency virus infection , Patented
12235,D0B2VS,Benzyl phenyl ether derivative 1,Hepatitis , Patented
12236,D0B2WJ,Flufenamic Acid,Dysmenorrhea , Approved
12237,D0B2WK,Ifetroban sodium,Thrombosis , Phase 2
12238,D0B2WQ,Lomeguatrib,Solid tumour/cancer , Discontinued in Phase 2
12239,D0B2WU,CAR-T cells targeting BCMA,Multiple myeloma , Phase 1
12240,D0B2XS,Autologous myoblast cell therapy,Myocardial infarction , Phase 2
12241,D0B2ZM,GB-2542,Solid tumour/cancer , Investigative
12242,D0B2ZZ,Esomeprazole magnesium + Aspirin,Peptic ulcer , Phase 3
12243,D0B3CC,AlloStim,Solid tumour/cancer , Phase 2/3
12244,D0B3CC,AlloStim,Metastatic colorectal cancer , Phase 2
12245,D0B3CT,BE-13793C,Solid tumour/cancer , Terminated
12246,D0B3CU,C-linked disaccharide biphenyl mannoside derivative 5,Crohn disease , Patented
12247,D0B3CU,C-linked disaccharide biphenyl mannoside derivative 5,Ulcerative colitis , Patented
12248,D0B3CU,C-linked disaccharide biphenyl mannoside derivative 5,Urinary tract infection , Patented
12249,D0B3CY,L-692429,Growth hormone deficiency , Discontinued in Phase 1
12250,D0B3DE,AVN-628,Anxiety disorder , Investigative
12251,D0B3DV,KTE-C19,Acute lymphoblastic leukaemia , Phase 1
12252,D0B3DX,Norelin,Prostate cancer , Discontinued in Phase 2
12253,D0B3FV,NVP-LAQ824,Mood disorder , Phase 3
12254,D0B3FV,NVP-LAQ824,leukaemia , Discontinued in Phase 1/2
12255,D0B3FV,NVP-LAQ824,Multiple myeloma , Investigative
12256,D0B3GF,JNJ-26854165,Prostate cancer , Phase 1
12257,D0B3GF,JNJ-26854165,Non-small-cell lung cancer , Phase 1
12258,D0B3GF,JNJ-26854165,Solid tumour/cancer , Phase 1
12259,D0B3HD,Caffeine,Orthostatic hypotension , Approved
12260,D0B3HF,SCRI-huCAR19v1,leukaemia , Phase 1/2
12261,D0B3HF,SCRI-huCAR19v1,Lymphoma , Phase 1/2
12262,D0B3HP,SGC-1061,Alzheimer disease , Phase 1
12263,D0B3IC,Dopropidil,Angina pectoris , Discontinued in Phase 2
12264,D0B3ID,Medi-NK,Lung cancer , Investigative
12265,D0B3IZ,AMPSL,Diabetic complication , Investigative
12266,D0B3KI,YD-101,Arthritis , Investigative
12267,D0B3LP,Ro-16-6028,Anxiety disorder , Discontinued in Phase 3
12268,D0B3MV,SSR-69071,Chronic obstructive pulmonary disease , Terminated
12269,D0B3MX,NBI-6024,Type-1 diabetes , Discontinued in Phase 2
12270,D0B3QM,Metyrosine,Pheochromocytoma , Approved
12271,D0B3RL,R-IFN-1a,Hepatitis C virus infection , Phase 2
12272,D0B3SV,Meningococcal vaccine group B quadrivalent recombinant vaccine,Neisseria meningitis infection , Phase 3
12273,D0B3TA,TD-1414,Impetigo , Phase 2
12274,D0B3UJ,Paliperidone,Schizophrenia , Approved
12275,D0B3UU,Antiviral BMS-1,Influenza virus infection , Investigative
12276,D0B3VR,H5N1 avian influenza vaccine,Influenza virus infection , Approved
12277,D0B3XG,Recombinant von Willebrand factor/recombinant Factor VIII complex,Von willebrand disease , Phase 3
12278,D0B3YK,AZD8601,Cardiovascular disease , Phase 2
12279,D0B3ZC,Claudiximab,Gastric adenocarcinoma , Phase 3
12280,D0B3ZC,Claudiximab,Esophageal cancer , Phase 2
12281,D0B3ZF,ORM-12741,Alzheimer disease , Phase 2
12282,D0B4AB,ACEA-2085,Pain , Terminated
12283,D0B4AH,RECALL-VAX,Alzheimer disease , Investigative
12284,D0B4CD,GSK-2018682,Immune System disease , Phase 1
12285,D0B4CO,NNC-14-0185,Epilepsy , Terminated
12286,D0B4DC,Butenafine,Dermatologic infection , Approved
12287,D0B4DK,ChronVac-B,Hepatitis B virus infection , Investigative
12288,D0B4DL,CRS-100,Liver cancer , Phase 1
12289,D0B4EG,MBX-500,Bacterial infection , Investigative
12290,D0B4ES,Atamestane + Toremifene,Breast cancer , Phase 3
12291,D0B4EV,IPENOXAZONE,Alzheimer disease , Discontinued in Phase 2
12292,D0B4GZ,E6014,Oral mucositis , Discontinued in Phase 3
12293,D0B4IF,Ketoconazole,Fungal infection , Approved
12294,D0B4JL,SERAZAPINE HYDROCHLORIDE,Anxiety disorder , Discontinued in Phase 2
12295,D0B4JQ,Tripelennamine,Hypersensitivity , Approved
12296,D0B4KH,Technetium TC 99M medronate,Bone disease , Approved
12297,D0B4KU,PF-06273340,Pain , Phase 1
12298,D0B4MB,PRT-300,Duchenne dystrophy , Investigative
12299,D0B4ME,CX-1942,Obstructive sleep apnea , Investigative
12300,D0B4MH,Cytorex-EBV,Solid tumour/cancer , Phase 2
12301,D0B4MK,ISIS-STAT3,Solid tumour/cancer , Phase 1/2
12302,D0B4NI,PMID25666693-Compound-77,Osteoarthritis pain , Patented
12303,D0B4NI,PMID25666693-Compound-77,Cancer related pain , Patented
12304,D0B4NI,PMID25666693-Compound-77,Neuropathic pain , Patented
12305,D0B4NI,PMID25666693-Compound-77,Inflammatory pain , Patented
12306,D0B4OF,123I-iometopane,Parkinson disease , Phase 3
12307,D0B4OK,Sym015,Solid tumour/cancer , Phase 1/2
12308,D0B4RU,Pregnenolone,Schizophrenia , Phase 4
12309,D0B4TN,Biperiden,Parkinson disease , Approved
12310,D0B4TT,GSK1004723,Allergic rhinitis , Discontinued in Phase 1
12311,D0B4VH,CDR-134F194,Diabetic complication , IND submitted
12312,D0B4XU,TGP-580,Neurodegenerative disorder , Discontinued in Phase 2
12313,D0B4XX,QR-333,Diabetic neuropathy , Phase 2
12314,D0B4ZQ,SL-90.0571,Epilepsy , Discontinued in Phase 1
12315,D0B5CN,Rh-MBL,Human immunodeficiency virus infection , Investigative
12316,D0B5EB,Ponezumab,Alzheimer disease , Phase 2
12317,D0B5FZ,Cefozopran,Gram-positive bacterial infection , Approved
12318,D0B5GC,Flavonols,Cerebrovascular ischaemia , Investigative
12319,D0B5GS,Vancomycin hydrochloride,Staphylococcus infection , Phase 3
12320,D0B5HA,ISIS-5320,Human immunodeficiency virus infection , Terminated
12321,D0B5HF,BI-135585,Type-2 diabetes , Phase 1
12322,D0B5HS,NLG8189,Melanoma , Phase 2/3
12323,D0B5HS,NLG8189,Pancreatic cancer , Phase 2
12324,D0B5HS,NLG8189,Prostate cancer , Phase 2
12325,D0B5HS,NLG8189,Acute myeloid leukaemia , Phase 1
12326,D0B5HS,NLG8189,Brain cancer , Phase 1
12327,D0B5KE,EB-1053,Osteoporosis , Discontinued in Phase 2
12328,D0B5LF,Ximelegatran,Myocardial infarction , Approved
12329,D0B5LF,Ximelegatran,Asthma , Terminated
12330,D0B5MP,Aciclovir,Virus infection , Approved
12331,D0B5MP,Aciclovir,Herpes simplex virus infection , Phase 3
12332,D0B5PK,TEN010,Advanced solid tumour , Phase 1
12333,D0B5PK,TEN010,Solid tumour/cancer , Phase 1
12334,D0B5PU,BMS-193884,Pulmonary arterial hypertension , Discontinued in Phase 2
12335,D0B5PV,CART-EGFRvIII T cells,Recurrent glioblastoma , Phase 1
12336,D0B5PV,CART-EGFRvIII T cells,Glioma , Clinical trial
12337,D0B5QK,Activated adult marrow stromal cells,Immune System disease , Investigative
12338,D0B5RO,REN-1654,Cognitive impairment , Phase 2
12339,D0B5RU,CS1-CAR T Therapy,Plasma cell myeloma , Phase 1
12340,D0B5RZ,GS-6620,Hepatitis C virus infection , Phase 1
12341,D0B5SC,Silvestrol,Solid tumour/cancer , Investigative
12342,D0B5TM,AMP-110,Autoimmune diabetes , Phase 1
12343,D0B5TO,Onyvax-CR,Colorectal cancer , Discontinued in Phase 1/2
12344,D0B5UH,ALX-0761,Psoriasis vulgaris , Phase 1
12345,D0B5VA,SAN-300,Rheumatoid arthritis , Phase 2
12346,D0B5VV,IDegLira,Type-2 diabetes , Phase 3
12347,D0B6BE,OT-417,Cystic fibrosis , Investigative
12348,D0B6BQ,ZD-6003,Solid tumour/cancer , Terminated
12349,D0B6BW,ZIO-102,Solid tumour/cancer , Investigative
12350,D0B6CC,Trimethaphan,Aneurysm , Approved
12351,D0B6CC,Trimethaphan,Hypertensive emergency , Approved
12352,D0B6DV,CT-10,Solid tumour/cancer , Investigative
12353,D0B6EA,NV-1020,Liver cancer , Phase 1/2
12354,D0B6ER,Ro-31-6930,Hypertension , Discontinued in Phase 1
12355,D0B6EU,AS-35,Asthma , Discontinued in Phase 2
12356,D0B6GJ,TT-62,Virus infection , Discontinued in Phase 2
12357,D0B6GW,Diphtheria-tetanus vaccine,Clostridium infection , Approved
12358,D0B6HE,SKI-2852,Metabolic syndrome x , Investigative
12359,D0B6HS,HRT,Estrogen deficiency , Discontinued in Phase 1
12360,D0B6IZ,R1678,Schizophrenia , Phase 3
12361,D0B6JV,SB-201993,Psoriasis vulgaris , Discontinued in Phase 2
12362,D0B6LP,Neo-Urinary Conduit,Bladder cancer , Phase 1
12363,D0B6LT,OPNT002,Alcohol dependence , Phase 2
12364,D0B6NT,"Pyrazolo[1,5-a]pyrimidine derivative 11",Obesity , Patented
12365,D0B6OG,BBT-007,Neutropenia , Investigative
12366,D0B6PZ,FORMESTANE,Breast cancer , Withdrawn from market
12367,D0B6QO,NPI-1999,Thrombosis , Terminated
12368,D0B6QZ,AVE-2268,Diabetic complication , Phase 2
12369,D0B6RA,LY404039,Schizophrenia , Phase 3
12370,D0B6SO,BRL-44154,Bacterial infection , Discontinued in Phase 1
12371,D0B6TW,Leucovorin Calcium,Solid tumour/cancer , Approved
12372,D0B6VN,TZI-41078,Arthritis , Phase 2
12373,D0B6VQ,D-20450,Inflammation , Terminated
12374,D0B6WN,AVE0675,Asthma , Terminated
12375,D0B6WP,Improved influenza vaccine,Influenza virus infection , Phase 3
12376,D0B6WV,TNFmab,Rheumatoid arthritis , Investigative
12377,D0B6XE,ASP9226,Neuropathic pain , Discontinued in Phase 1
12378,D0B6YB,LE-SN38,Solid tumour/cancer , Phase 2
12379,D0B6YB,LE-SN38,Colorectal cancer , Phase 2
12380,D0B6YR,HuMax-CD32b,B-cell lymphoma , Investigative
12381,D0B6ZI,H5N1 influenza vaccine,Influenza virus infection , Approved
12382,D0B7AB,R-TPR-013,Female infertility , Phase 3
12383,D0B7AF,KLS-Bfr,Osteonecrosis , Investigative
12384,D0B7AH,INT-777,Metabolic disorder , Investigative
12385,D0B7BX,E-6276,Schizophrenia , Terminated
12386,D0B7CH,Phenylbutyrate,Urea cycle disorder , Phase 2
12387,D0B7CZ,Teloxantrone,Solid tumour/cancer , Discontinued in Phase 1
12388,D0B7DW,Hyqvia + Kiovia,Nervous system paraneoplastic or autoimmune disorders , Phase 3
12389,D0B7EB,Etoposide,Solid tumour/cancer , Approved
12390,D0B7EF,MNT-03-01,Fungal infection , Investigative
12391,D0B7GE,OB-28,Solid tumour/cancer , Investigative
12392,D0B7HH,HTERT-VISA-BikDD nanoparticles,Breast cancer , Investigative
12393,D0B7HJ,U-54494A,Epilepsy , Terminated
12394,D0B7HX,Levosemotiadil,Cardiac arrhythmias , Discontinued in Phase 2
12395,D0B7JZ,CuraVac MG,Myasthenia gravis , Investigative
12396,D0B7KF,RG-7152,Asthma , Discontinued in Phase 1
12397,D0B7LK,CY-1503,Hypertension , Phase 2/3
12398,D0B7LU,CX-5461,Solid tumour/cancer , Investigative
12399,D0B7LZ,NDD-094,Alzheimer disease , Phase 2
12400,D0B7MO,PF-06886992,Meningococcal infection , Phase 3
12401,D0B7MU,SYNSORB-Cd,Diarrhea , Discontinued in Phase 3
12402,D0B7ND,UR-8225,Asthma , Terminated
12403,D0B7NG,Chlorpheniramine,Allergic rhinitis , Approved
12404,D0B7OD,Amfepramone,Obesity , Approved
12405,D0B7OD,Amfepramone,Migraine , Approved
12406,D0B7OM,F-15441,Schizophrenia , Preclinical
12407,D0B7OY,CT 327,Psoriasis vulgaris , Phase 2
12408,D0B7OY,CT 327,Plaque psoriasis , Phase 2
12409,D0B7PY,Prostate cancer vaccine,Prostate cancer , Discontinued in Phase 1
12410,D0B7QP,TM30339,Schizophrenia , Discontinued in Phase 2
12411,D0B7QU,AIM-102,Asthma , Phase 2
12412,D0B7SP,GSK163090,Anxiety disorder , Discontinued in Phase 2
12413,D0B7SP,GSK163090,Episode , Discontinued in Phase 2
12414,D0B7SP,GSK163090,Major depressive disorder , Discontinued in Phase 2
12415,D0B7TH,99mTc-biciromab,Thrombosis , Investigative
12416,D0B7TM,BI-137882,Chronic obstructive pulmonary disease , Phase 1
12417,D0B7UD,TP-103,Bacterial infection , Investigative
12418,D0B7VC,Menactra,Neisseria meningitis infection , Approved
12419,D0B7VH,Remoxy ER,Chronic pain , Application submitted
12420,D0B7VK,Tifacogin,Sepsis , Phase 3
12421,D0B7XF,Lymphozene,B-cell lymphoma , Investigative
12422,D0B7YT,Scopolamine,Addictive disorder , Approved
12423,D0B7YT,Scopolamine,Nausea , Approved
12424,D0B8AT,PB28,Coronavirus Disease 2019 (COVID-19) , Investigative
12425,D0B8BY,INdoximod + temozolomide,Brain cancer , Phase 1
12426,D0B8BZ,CD19CART,B-cell lymphoma , Clinical trial
12427,D0B8BZ,CD19CART,leukaemia , Clinical trial
12428,D0B8CK,PF-05335810,Hypercholesterolaemia , Discontinued in Phase 1
12429,D0B8ES,AA-123,Prostate cancer , Investigative
12430,D0B8IN,PSP-D-CD40L,Solid tumour/cancer , Investigative
12431,D0B8IZ,Analog insulin-PH20,Type-1/2 diabetes , Phase 2
12432,D0B8JG,ATI-0409,Infectious disease , Investigative
12433,D0B8JQ,KRP-101,Hyperlipidaemia , Discontinued in Phase 2
12434,D0B8KE,MDX-1204,Solid tumour/cancer , Investigative
12435,D0B8LN,Iotrolan,Radiocontrast agent , Approved
12436,D0B8MB,[99MTC]-CBPAO,Diagnostic imaging , Phase 1
12437,D0B8MS,MEDI-547,Solid tumour/cancer , Phase 1
12438,D0B8MZ,Careram,Rheumatoid arthritis , Approved
12439,D0B8NH,Nanogam,Immune System disease , Approved
12440,D0B8NW,ICA-1,Solid tumour/cancer , Terminated
12441,D0B8OB,PMID25684022-Compound-WO2011137219 36(3-5),Solid tumour/cancer , Patented
12442,D0B8OB,PMID25684022-Compound-WO2011137219 36(3-5),Metastatic cancer , Patented
12443,D0B8QA,RP-66055,Cerebral infarction , Terminated
12444,D0B8QB,Magnesium,Ischemic stroke , Approved
12445,D0B8RJ,AP vaccine,Bordetella pertussis infection , Approved
12446,D0B8RU,Aryl mannoside derivative 14,Crohn disease , Patented
12447,D0B8RU,Aryl mannoside derivative 14,Ulcerative colitis , Patented
12448,D0B8RU,Aryl mannoside derivative 14,Urinary tract infection , Patented
12449,D0B8SC,BOF-4272,Gout , Discontinued in Phase 2
12450,D0B8SV,NADH,Parkinson disease , Approved
12451,D0B8SY,Calcium Gluceptate,Mild hypocalcemia , Approved
12452,D0B8TK,LX-6171,Neurological disorder , Phase 2
12453,D0B8UD,TNX-1800 vaccine,Coronavirus Disease 2019 (COVID-19) , Preclinical
12454,D0B8UJ,Nelarabine,leukaemia , Approved
12455,D0B8UW,AUTO2,Multiple myeloma , Phase 1/2
12456,D0B8WN,Ranitidine,Peptic ulcer , Approved
12457,D0B8WS,Zostavax,Varicella zoster virus infection , Approved
12458,D0B8WU,JTZ-951,Anaemia , Phase 3
12459,D0B8XK,SC-01,Allergy , Investigative
12460,D0B8YZ,ELTANOLONE,Premenstrual syndrome , Discontinued in Phase 3
12461,D0B8ZJ,OMP-336B11,Solid tumour/cancer , Phase 1
12462,D0B8ZP,PD-144418,Coronavirus Disease 2019 (COVID-19) , Investigative
12463,D0B8ZR,NTO-1151,Cervical cancer , Phase 2
12464,D0B9AO,Saprisartan,Hypertension , Approved
12465,D0B9AQ,WYE-130600,Solid tumour/cancer , Investigative
12466,D0B9CA,Tuvirumab,Hepatitis B virus infection , Terminated
12467,D0B9DI,Lu-AE04621,Parkinson disease , Phase 1
12468,D0B9DM,S-555739,Allergy , Phase 2
12469,D0B9EH,Dermolastin,Atopic dermatitis , Discontinued in Phase 2
12470,D0B9EJ,Mitomycin A,Solid tumour/cancer , Approved
12471,D0B9EN,Aleglitazar,Type-2 diabetes , Discontinued in Phase 3
12472,D0B9FW,Idarucizumab,Reversal of the anticoagulant effects of dabigatran , Approved
12473,D0B9GM,Oxibendazole,Pediatric cancer , Discontinued in Phase 3
12474,D0B9HH,MN-8001,Autoimmune diabetes , Investigative
12475,D0B9IV,XEL-002LG,Pain , Investigative
12476,D0B9JO,Telavancin,Staphylococcus infection , Approved
12477,D0B9LM,PMID26651364-Compound-8b,Crohn disease , Patented
12478,D0B9LM,PMID26651364-Compound-8b,Ulcerative colitis , Patented
12479,D0B9LM,PMID26651364-Compound-8b,Urinary tract infection , Patented
12480,D0B9MR,GSK-2256098,Solid tumour/cancer , Phase 1
12481,D0B9MR,GSK-2256098,Pulmonary arterial hypertension , Phase 1
12482,D0B9NA,ICI-192605,Thrombosis , Discontinued in Phase 2
12483,D0B9NU,Avian H5N1 influenza vaccine,Influenza virus infection , Phase 1
12484,D0B9OG,Adipiplon,Sleep-wake disorder , Phase 2
12485,D0B9RD,ALK-001,Age-related macular degeneration , Phase 2
12486,D0B9RD,ALK-001,Stargardt disease , Phase 2
12487,D0B9RF,DW-953,Dyspepsia , Investigative
12488,D0B9RG,Cabotegravir LA + rilpivirine LA combination,Human immunodeficiency virus infection , Phase 3
12489,D0B9SR,SB-273005,Osteoporosis , Discontinued in Phase 1
12490,D0B9TX,Darodipine,Cerebrovascular ischaemia , Terminated
12491,D0B9UB,PB-200a,Fungal infection , Investigative
12492,D0B9XD,SP-1000,Hypercholesterolaemia , Investigative
12493,D0B9XM,Nano-steroid,Rheumatoid arthritis , Investigative
12494,D0B9XW,Betalutin,Non-hodgkin lymphoma , Phase 1/2
12495,D0B9XW,Betalutin,Diffuse large B-cell lymphoma , Phase 1
12496,D0BA0O,Syn-1002,Pain , Preclinical
12497,D0BA1Y,SYL-045001,Ocular inflammation , Phase 2
12498,D0BA5E,ZYDPLA 1,Type-2 diabetes , Phase 1
12499,D0BA5K,Apaxifylline,Cognitive impairment , Phase 2
12500,D0BA6T,Methyldopa,Hypertension , Approved
12501,D0BA7K,Recombinant human relaxin,Scleroderma , Phase 2
12502,D0BA8H,HemoTech,Hematologic disease , Investigative
12503,D0BA8M,LY-295501,Diabetic complication , Phase 2
12504,D0BA9U,Levonorgestrel,Contraception , Approved
12505,D0BB1T,Semparatide,Osteoporosis , Discontinued in Phase 2
12506,D0BB1X,KRP-105,Lipid metabolism disorder , Terminated
12507,D0BB2F,Pyrazole derivative 26,Obesity , Patented
12508,D0BB2V,ABBV-838,Multiple myeloma , Phase 1
12509,D0BB9M,NE-0080,Helicobacter infection , Discontinued in Phase 2
12510,D0BC0F,OSE-300,Parkinson disease , Phase 3
12511,D0BC2E,Hydroxyflutamide,Prostate cancer , Approved
12512,D0BC4Q,Lifibrol,Arteriosclerosis , Discontinued in Phase 2
12513,D0BC6M,ASG-5ME,Prostate cancer , Phase 1
12514,D0BC6M,ASG-5ME,Pancreatic cancer , Phase 1
12515,D0BD0Q,Proglumetacin,Osteoarthritis , Approved
12516,D0BD5J,GSK2838497A,Haemophilus influenza , Phase 2
12517,D0BD6A,GT-1282,Autoimmune diabetes , Investigative
12518,D0BD8D,Cisapride,Gastroesophageal reflux disease , Approved
12519,D0BD8D,Cisapride,Gastrointestinal disease , Investigative
12520,D0BD9K,Gilotrif,Breast cancer , Phase 3
12521,D0BD9K,Gilotrif,Squamous cell carcinoma , Phase 3
12522,D0BD9K,Gilotrif,Glioma , Phase 2
12523,D0BE0Z,Contezolid acefosamil,Acute bacterial skin infection , Phase 2
12524,D0BE1A,R-209130,Schizophrenia , Phase 2
12525,D0BE6M,Anti-Mesothelin CAR-T cells,Gastric adenocarcinoma , Phase 1/2
12526,D0BE6M,Anti-Mesothelin CAR-T cells,Mesothelioma , Phase 1/2
12527,D0BE6M,Anti-Mesothelin CAR-T cells,Pancreatic cancer , Phase 1/2
12528,D0BE8H,INCB62079,Liver cancer , Phase 1/2
12529,D0BF0X,Interferon beta-1a,Multiple sclerosis , Approved
12530,D0BF0X,Interferon beta-1a,Coronavirus Disease 2019 (COVID-19) , Phase 3
12531,D0BF4Z,GSK2981278,Plaque psoriasis , Phase 2
12532,D0BF8G,Pamidronate,Hypercalcaemia , Approved
12533,D0BF8Y,Pelareorep,Non-small-cell lung cancer , Phase 3
12534,D0BF8Y,Pelareorep,Fallopian tube cancer , Phase 2
12535,D0BF8Y,Pelareorep,Ovarian cancer , Phase 2
12536,D0BF8Y,Pelareorep,Peritoneal cavity cancer , Phase 2
12537,D0BF8Y,Pelareorep,Pancreatic cancer , Phase 1/2
12538,D0BF8Y,Pelareorep,Malignant glioma , Phase 1
12539,D0BF8Y,Pelareorep,Colorectal cancer , Phase 1
12540,D0BF8Y,Pelareorep,Glioma , Phase 1
12541,D0BF8Y,Pelareorep,Multiple myeloma , Phase 1
12542,D0BF9K,ABX-IL8,Melanoma , Phase 2
12543,D0BG2L,ABC-7,Solid tumour/cancer , Investigative
12544,D0BG3B,VX-135,Hepatitis C virus infection , Phase 2
12545,D0BG4W,Cupric Sulfate,Pest attack , Approved
12546,D0BG4W,Cupric Sulfate,Fungal infection , Approved
12547,D0BG4W,Cupric Sulfate,Herbicide , Approved
12548,D0BH2M,4SCAR19 and 4SCAR123,B-cell lymphoma , Phase 1/2
12549,D0BH7Z,Girentuximab I-124,Renal cell carcinoma , Phase 2
12550,D0BH8C,MGVWN-1,West nile virus infection , Discontinued in Phase 1/2
12551,D0BH9I,INN-108,Ulcerative colitis , Phase 1
12552,D0BH9I,INN-108,Inflammatory bowel disease , Discontinued in Phase 1/2
12553,D0BI0F,Imidazole derivative 3,Obesity , Patented
12554,D0BI1C,Live attenuated influenza vaccine,Influenza virus infection , Approved
12555,D0BI3K,Omburtamab I-124,Glioma , Phase 1/2
12556,D0BI3N,Cerdulatinib,B-cell lymphoma , Phase 2
12557,D0BI3N,Cerdulatinib,Non-hodgkin lymphoma , Phase 1/2
12558,D0BI3N,Cerdulatinib,Atopic dermatitis , Phase 1
12559,D0BI3N,Cerdulatinib,Vitiligo , Phase 1
12560,D0BI7J,FP-045,Cardiovascular disease , Phase 1
12561,D0BJ0Q,DDD-64558,Trypanosomiasis , Investigative
12562,D0BJ2W,DAS-431,Dementia , Phase 2
12563,D0BJ3B,Soluble CD83,Autoimmune diabetes , Investigative
12564,D0BJ5O,ASP-4178,Non-insulin dependent diabetes , Discontinued in Phase 1
12565,D0BJ7G,WSB-961,Autoimmune diabetes , Investigative
12566,D0BJ7W,GLPG-0492,Cachexia , Preclinical
12567,D0BJ8Q,INO-8000,Hepatitis C virus infection , Phase 1
12568,D0BK1N,Thioguanine,Acute lymphocytic leukaemia , Approved
12569,D0BK1N,Thioguanine,Severe acute respiratory syndrome (SARS) , Preclinical
12570,D0BK1N,Thioguanine,Middle East Respiratory Syndrome (MERS) , Preclinical
12571,D0BK3Z,ProstaRex,Prostate cancer , Investigative
12572,D0BK4X,Cinryze,Hereditary angioedema , Approved
12573,D0BK7D,Autologous dendritic cell-tumor cell fusion vaccine,Gastrointestinal cancer , Phase 1
12574,D0BL0G,TAK-233,Pheumatoid arthritis , Phase 1
12575,D0BL3X,PMID25553724-Compound-US2011799419010,Immune System disease , Patented
12576,D0BL6E,KUR-113,Bone injury , Phase 2
12577,D0BL6W,THA-902,Fibromyalgia , Investigative
12578,D0BM3R,LY-307853,Fungal infection , Terminated
12579,D0BM4T,CaPre,Hypertriglyceridemia , Phase 2
12580,D0BM5G,Tazarotene,Psoriasis vulgaris , Approved
12581,D0BM6S,IPI-493,Gastric adenocarcinoma , Discontinued in Phase 1
12582,D0BM7M,AZD8931,Breast cancer , Phase 2
12583,D0BM8Z,SOM-0633,Fungal infection , Investigative
12584,D0BN4Y,Ebalzotan,Anxiety disorder , Discontinued in Phase 1
12585,D0BN7W,Roclatan,Glaucoma/ocular hypertension , Phase 3
12586,D0BN9R,GelVac H5N1 influenza virus vaccine,Influenza virus infection , Phase 1
12587,D0BN9X,Tirofiban,Acute coronary syndrome , Approved
12588,D0BO0K,INCSHR1210,Bronchioalveolar carcinoma , Phase 3
12589,D0BO0K,INCSHR1210,Esophageal squamous cell carcinoma , Phase 3
12590,D0BO0K,INCSHR1210,Solid tumour/cancer , Phase 1
12591,D0BO1H,PMID28270021-Compound-WO2016054807Example80,Pruritus , Patented
12592,D0BO1H,PMID28270021-Compound-WO2016054807Example80,Solid tumour/cancer , Patented
12593,D0BO1H,PMID28270021-Compound-WO2016054807Example80,Chronic pain , Patented
12594,D0BO1H,PMID28270021-Compound-WO2016054807Example80,Neuropathic pain , Patented
12595,D0BO1H,PMID28270021-Compound-WO2016054807Example80,Thymic cancer , Patented
12596,D0BO6I,EHT-899,Hepatitis B virus infection , Phase 2
12597,D0BO7P,Bictegravir + emtricitabine  +  tenofovir alafenamide,Human immunodeficiency virus-1 infection , Phase 3
12598,D0BO7U,BMX-001,Head and neck cancer , Phase 2
12599,D0BO7U,BMX-001,Glioma , Phase 1/2
12600,D0BOM7,XmAb22841,Solid tumour/cancer , Phase 1
12601,D0BP4Y,Technetium Tc-99m Sodium Pertechnetate Generator,Radioactive tracer , Approved
12602,D0BP6I,PM-102,Bleeding disorder , Investigative
12603,D0BP7C,J-104135,Chronic obstructive pulmonary disease , Investigative
12604,D0BP7W,VBY-106,Hepatitis C virus infection , Investigative
12605,D0BP9C,Etravirine,Human immunodeficiency virus-1 infection , Approved
12606,D0BQ0C,CD19 CAR-T cells,Acute lymphoblastic leukaemia , Phase 1
12607,D0BQ5X,"Diphtheria, tetanus, pertussis, HBV, Haemophilus influenzae vaccine",Hepatitis B virus infection , Discontinued in Phase 3
12608,D0BQ8A,PMID25553724-Compound-US2011796857710,Immune System disease , Patented
12609,D0BQ8M,CY-208243,Pain , Discontinued in Phase 2
12610,D0BQ8Y,Allyl isothiocyanate,Acute or chronic pain , Approved
12611,D0BR0D,MGB-101,Gram-positive bacterial infection , Investigative
12612,D0BR1S,ProscaVax,Prostate cancer , Phase 1
12613,D0BR5W,Alpha-Helical lipopeptides IIS,Middle East Respiratory Syndrome (MERS) , Preclinical
12614,D0BR6D,PMID27998201-Compound-10,Osteoporosis , Patented
12615,D0BR7M,Breceptin,Solid tumour/cancer , Investigative
12616,D0BR8N,BVA-201,Multiple sclerosis , Investigative
12617,D0BR8X,PUL-042,Coronavirus Disease 2019 (COVID-19) , Phase 2
12618,D0BR9C,Biphenyl mannoside derivative 2,Crohn disease , Patented
12619,D0BR9C,Biphenyl mannoside derivative 2,Ulcerative colitis , Patented
12620,D0BR9C,Biphenyl mannoside derivative 2,Urinary tract infection , Patented
12621,D0BS2S,TPU-002,Parkinson disease , Phase 1
12622,D0BS3E,Biphenyl mannoside derivative 21,Crohn disease , Patented
12623,D0BS3E,Biphenyl mannoside derivative 21,Ulcerative colitis , Patented
12624,D0BS3E,Biphenyl mannoside derivative 21,Urinary tract infection , Patented
12625,D0BS5E,AMO-02,Myotonic dystrophy , Phase 2/3
12626,D0BS6B,TP-801,Solid tumour/cancer , Investigative
12627,D0BS6F,JNJ-64400141,Respiratory syncytial virus infection , Phase 1/2
12628,D0BS7T,VALERGEN-BT,Asthma , Phase 2
12629,D0BT0Z,PF-05241328,Pain , Phase 1
12630,D0BT2P,MBP(82-98),Multiple sclerosis , Discontinued in Phase 3
12631,D0BT4P,TDI-0060,Motor neurone disease , Investigative
12632,D0BT6B,CLT-009,Angiogenesis disorder , Investigative
12633,D0BT6G,Plovamer acetate,Multiple sclerosis , Phase 2
12634,D0BT6H,IW-2143,Anxiety disorder , Phase 2
12635,D0BT7R,ASP-4901,Genitourinary disease , Phase 2
12636,D0BU0J,Azanidazole,Parasitic infection , Approved
12637,D0BU5G,BiovaxlD,Cardiovascular disease , Preregistration
12638,D0BU5Z,Argyrin B,Bacterial infection , Terminated
12639,D0BU8L,Celmoleukin,Solid tumour/cancer , Approved
12640,D0BV0U,Lintuzumab Ac-226,leukaemia , Phase 1
12641,D0BV3B,SCH-602539,Arteriosclerosis , Investigative
12642,D0BV3J,Macimorelin,Somatotropin deficiency , Approved
12643,D0BV3J,Macimorelin,Growth hormone deficiency , Approved
12644,D0BW1O,Zanamivir,Influenza virus infection , Approved
12645,D0BW1O,Zanamivir,Severe acute respiratory syndrome (SARS) , Investigative
12646,D0BW2N,GZ402674,Solid tumour/cancer , Phase 1
12647,D0BW3P,Aerovant,Asthma , Phase 2a
12648,D0BW4W,Sutezolid,Tuberculosis , Phase 2
12649,D0BW6F,GS-9876,Cutaneous lupus erythematosus , Phase 2
12650,D0BW6F,GS-9876,Rheumatoid arthritis , Phase 1
12651,D0BW9R,BMS-181184,Fungal infection , Terminated
12652,D0BX0V,Sel-K1,Inflammatory bowel disease , Investigative
12653,D0BX1S,CD-832,Angina pectoris , Terminated
12654,D0BX5L,LZM009,Solid tumour/cancer , Phase 1
12655,D0BX5L,LZM009,Advanced malignancy , Phase 1
12656,D0BX7G,Anti-PrP mabs,Solid tumour/cancer , Investigative
12657,D0BY0Y,227Th-trastuzumab,Solid tumour/cancer , Investigative
12658,D0BY6W,PSMA VRP therapeutic vaccine,Prostate cancer , Phase 1
12659,D0BZ1D,CGX1321,Solid tumour/cancer , Phase 1
12660,D0BZ1L,PS386113,Inflammation , Discontinued in Phase 1
12661,D0BZ1Q,CRx-401,Type-2 diabetes , Discontinued in Phase 2
12662,D0BZ7V,Matuzumab,Gastric adenocarcinoma , Phase 2
12663,D0BZ7W,Tolterodine,Overactive bladder , Approved
12664,D0C0AA,DTS-108,Solid tumour/cancer , Investigative
12665,D0C0AC,GIT27-NO,Solid tumour/cancer , Investigative
12666,D0C0BE,ST-148,Virus infection , Investigative
12667,D0C0CE,Activated recombinant FVII-albumin fusion protein,Hemophilia , Phase 2/3
12668,D0C0CF,CRD-103,Bipolar disorder , Investigative
12669,D0C0DY,Influenza A virus H7N9 vaccine,Influenza A virus infection , Phase 2
12670,D0C0DY,Influenza A virus H7N9 vaccine,Influenza virus infection , Phase 1
12671,D0C0EO,CP-105696,Inflammatory bowel disease , Discontinued in Phase 1
12672,D0C0EV,ChimeriVax-West Nile,Virus infection , Phase 2
12673,D0C0EV,ChimeriVax-West Nile,West nile virus infection , Discontinued in Phase 2
12674,D0C0EX,SDZ-MTH-958,Artery stenosis , Terminated
12675,D0C0FA,FRAX-120,Solid tumour/cancer , Investigative
12676,D0C0FG,NRT-300,Pain , Investigative
12677,D0C0FO,Plant-based oncology candidate,Breast cancer , Investigative
12678,D0C0HF,GM-MD-01,Hepatic fibrosis , Investigative
12679,D0C0JT,Nimesulide,Metastatic colorectal cancer , Terminated
12680,D0C0JT,Nimesulide,Non-small-cell lung cancer , Terminated
12681,D0C0JT,Nimesulide,Non-hodgkin lymphoma , Terminated
12682,D0C0KI,Aminoazetidine derivative 7,Obesity , Patented
12683,D0C0KP,AllerB,Allergy , Phase 2b
12684,D0C0LO,IMGN529,Non-hodgkin lymphoma , Phase 2
12685,D0C0LO,IMGN529,Metastatic non-hodgkin's lymphoma , Phase 1
12686,D0C0ME,RO-26-2853,Solid tumour/cancer , Preclinical
12687,D0C0MN,Irbesartan/ trichlormethiazide fixed-dose combination,Hypertension , Phase 3
12688,D0C0NH,Avastin+/-Tarceva,Non-small-cell lung cancer , Phase 3
12689,D0C0NH,Avastin+/-Tarceva,Nasopharyngeal carcinoma , Investigative
12690,D0C0OB,LOU064,Chronic idiopathic urticaria , Phase 2
12691,D0C0ON,Human embryonic stem cell-derived osteoblasts,Osteoporosis , Investigative
12692,D0C0QK,LIM-0744,Toxicity , Investigative
12693,D0C0QT,PPI-461,Hepatitis C virus infection , Phase 1
12694,D0C0SK,Pyrimethamine,Malaria , Approved
12695,D0C0SX,SCH-900353,Solid tumour/cancer , Phase 1
12696,D0C0SZ,PRT6207,Solid tumour/cancer , Phase 1
12697,D0C0TJ,PBI-230,Intoxication , Investigative
12698,D0C0TU,SI-613,Knee osteoarthritis , Phase 2
12699,D0C0TV,Autologous stem cell-based cancer immunotherapy,Solid tumour/cancer , Phase 1
12700,D0C0WI,PNB-05,Obsessive compulsive disorder , Investigative
12701,D0C0YG,Youerjian,Hantavirus infection , Approved
12702,D0C0ZC,AZ-628,Solid tumour/cancer , Investigative
12703,D0C0ZN,VXA-A1.1,Influenza virus infection , Phase 2
12704,D0C1AY,GW-796406,Hypotension , Phase 1
12705,D0C1BG,Lactitol,Liver disease , Approved
12706,D0C1BL,mab 37.1,Solid tumour/cancer , Investigative
12707,D0C1CU,SUN-9221,Hypertension , Discontinued in Phase 1
12708,D0C1EO,Melanoma vaccine (ALVAC),Melanoma , Discontinued in Phase 2
12709,D0C1GE,Fusolin,Hepatitis B virus infection , Investigative
12710,D0C1IG,CUDC427,Lymphoma , Phase 1
12711,D0C1IG,CUDC427,Solid tumour/cancer , Phase 1
12712,D0C1IW,Ergonovine,Postpartum haemorrhage , Approved
12713,D0C1JP,AEG35156,Solid tumour/cancer , Phase 1/2
12714,D0C1JV,QGC-001,Hypertension , Phase 2
12715,D0C1LF,VLD-01,Diabetic cataract , Investigative
12716,D0C1MB,FR-180102,Helicobacter infection , Terminated
12717,D0C1MZ,PMID25666693-Compound-10,Osteoarthritis pain , Patented
12718,D0C1MZ,PMID25666693-Compound-10,Cancer related pain , Patented
12719,D0C1MZ,PMID25666693-Compound-10,Neuropathic pain , Patented
12720,D0C1MZ,PMID25666693-Compound-10,Inflammatory pain , Patented
12721,D0C1NZ,REGN 3048,Middle East Respiratory Syndrome (MERS) , Discontinued in Phase 1
12722,D0C1OJ,Debio-0930,Metabolic disorder , Investigative
12723,D0C1PY,Potassium Acetate,Kidney stone , Approved
12724,D0C1QB,LOSIGAMONE,Epileptic seizures , Discontinued in Phase 3
12725,D0C1QS,Iprodione,Plant grey mould disease , Approved
12726,D0C1QZ,Choline C-11,Prostate cancer , Approved
12727,D0C1RN,Japanese cedar peptide allergy desensitization agent,Allergy , Investigative
12728,D0C1SF,Griseofulvin,Ringworm infection , Approved
12729,D0C1SI,MK-386,Acne vulgaris , Discontinued in Phase 2
12730,D0C1TJ,HN-10200,Cardiac failure , Discontinued in Phase 2
12731,D0C1TO,EQ-818-1,Solid tumour/cancer , Investigative
12732,D0C1TR,ASP9853,Solid tumour/cancer , Phase 1
12733,D0C1TT,SPI-017,Alzheimer disease , Investigative
12734,D0C1UF,MDX-1100,Crohn disease , Phase 2
12735,D0C1UP,SX-ARPC,Prostate cancer , Investigative
12736,D0C1WH,Letrozole,Hormonally-responsive breast cancer , Approved
12737,D0C1WL,C-2507,Human immunodeficiency virus infection , Phase 1
12738,D0C1WP,SCH-1595241,Solid tumour/cancer , Investigative
12739,D0C1WR,AMG 232,Merkel cell carcinoma , Phase 2
12740,D0C1WR,AMG 232,Solid tumour/cancer , Phase 1/2
12741,D0C1XS,ZIMELIDINE,Major depressive disorder , Withdrawn from market
12742,D0C1XS,ZIMELIDINE,Depression , Withdrawn from market
12743,D0C1ZO,[N-methyl-3H(3)]AZ-10419369,Mood disorder , Phase 1
12744,D0C2AR,Gadocoletic acid,Coronary artery disease , Phase 2
12745,D0C2BP,AG-270,Lymphoma , Phase 1
12746,D0C2BP,AG-270,Solid tumour/cancer , Phase 1
12747,D0C2CH,OGT-719,Liver cancer , Discontinued in Phase 2
12748,D0C2CP,Conjugated-trastuzumab,Solid tumour/cancer , Investigative
12749,D0C2EP,Remikiren,Hypertension , Approved
12750,D0C2FJ,CL-275838,Depression , Phase 2
12751,D0C2GN,SLP-1001,Influenza virus infection , Investigative
12752,D0C2HF,GR-253035,Alzheimer disease , Discontinued in Phase 1
12753,D0C2HG,BYK-324677,Non-insulin dependent diabetes , Phase 1
12754,D0C2HI,PegCNTF,Obesity , Phase 1
12755,D0C2HR,ORG-9273,Paralysis , Discontinued in Phase 2
12756,D0C2IA,DPC-168,Allergic rhinitis , Discontinued in Phase 1
12757,D0C2II,Methazolamide,Glaucoma/ocular hypertension , Approved
12758,D0C2IR,MP-AA-1,Solid tumour/cancer , Investigative
12759,D0C2KF,JNJ-26489112,Epilepsy , Phase 2
12760,D0C2KV,RGLP-1,Type-2 diabetes , Discontinued in Phase 2
12761,D0C2MS,NP-07,Bipolar disorder , Investigative
12762,D0C2NT,NP-G2-044,Solid tumour/cancer , Phase 1
12763,D0C2OR,MIM-D3,Alzheimer disease , Phase 3
12764,D0C2PH,CCT301-59 (targeting ROR2),Renal cell carcinoma , Phase 1/2
12765,D0C2QF,LY-25582,Obesity , Preclinical
12766,D0C2QJ,GR-270773,Sepsis , Discontinued in Phase 2
12767,D0C2UH,V932,Solid tumour/cancer , Phase 1
12768,D0C2WV,DPT-HBV,Hepatitis B virus infection , Approved
12769,D0C2XI,Claritin/Singulair,Allergic rhinitis , Phase 3
12770,D0C2YB,Cefoperazone,Bacterial infection , Approved
12771,D0C2YZ,67Cu-SARTATE,Neuroblastoma , Phase 1/2
12772,D0C2ZI,PSN-842,Obesity , Investigative
12773,D0C2ZL,Ataciguat,Neuropathic pain , Phase 2
12774,D0C3AA,CKD-712,Solid tumour/cancer , Phase 1
12775,D0C3AD,GW-788388,Solid tumour/cancer , Investigative
12776,D0C3AN,SSR-146977,Psychotic disorder , Discontinued in Phase 1
12777,D0C3BA,YM-358,Hypertension , Phase 2
12778,D0C3BS,DU-176b,Atrial fibrillation , Approved
12779,D0C3CF,SDZ-NVI-085,Major depressive disorder , Discontinued in Phase 1
12780,D0C3CZ,Aldoxorubicin,Soft tissue sarcoma , Phase 3
12781,D0C3CZ,Aldoxorubicin,Pancreatic ductal carcinoma , Phase 2
12782,D0C3CZ,Aldoxorubicin,Glioblastoma multiforme , Phase 2
12783,D0C3CZ,Aldoxorubicin,Small-cell lung cancer , Phase 2
12784,D0C3CZ,Aldoxorubicin,Solid tumour/cancer , Phase 2
12785,D0C3DA,CaroRx,Dental caries , Phase 2
12786,D0C3DH,RAAV vaccine,Melanoma , Terminated
12787,D0C3ET,ASB-16165,Psoriasis vulgaris , Investigative
12788,D0C3FK,TA-CD vaccine,Cocaine addiction , Phase 2
12789,D0C3FN,AX-13057,Solid tumour/cancer , Investigative
12790,D0C3GW,TG-1022,Obesity , Investigative
12791,D0C3GZ,STS-T4,Thrombocytopenia , Investigative
12792,D0C3HS,CDP-1050,Heart failure , Discontinued in Phase 1
12793,D0C3JB,MB-102,Acute kidney injury , Phase 2
12794,D0C3JB,MB-102,Acute myeloid leukaemia , Phase 1
12795,D0C3LL,HER1-VSSP vaccine,Solid tumour/cancer , Phase 2
12796,D0C3LM,RAS-111,Sepsis , Terminated
12797,D0C3LP,Prezatide copper acetate,Diabetic foot ulcer , Approved
12798,D0C3LQ,Ulocuplumab,Multiple myeloma , Phase 3
12799,D0C3LQ,Ulocuplumab,Haematological malignancy , Phase 1/2
12800,D0C3MW,MBO7133,Liver cancer , Phase 1/2
12801,D0C3RF,REP-9AC,Hepatitis B virus infection , Preclinical
12802,D0C3RK,N-(phenylpyrazolyl)benzamide derivative 1,Pruritus , Patented
12803,D0C3RK,N-(phenylpyrazolyl)benzamide derivative 1,Solid tumour/cancer , Patented
12804,D0C3RK,N-(phenylpyrazolyl)benzamide derivative 1,Chronic pain , Patented
12805,D0C3RK,N-(phenylpyrazolyl)benzamide derivative 1,Neuropathic pain , Patented
12806,D0C3RK,N-(phenylpyrazolyl)benzamide derivative 1,Thymic cancer , Patented
12807,D0C3RP,TDI-0074,Motor neurone disease , Investigative
12808,D0C3SW,Lesinurad,Hyperuricaemia , Approved
12809,D0C3TE,TEI-9874,Allergy , Terminated
12810,D0C3TI,Resimmune,Cutaneous T-cell lymphoma , Phase 2
12811,D0C3TI,Resimmune,Melanoma , Phase 1/2
12812,D0C3UC,Ladostigil,Alzheimer disease , Phase 2
12813,D0C3VQ,Zadaxin/lamivudine,Hepatitis B virus infection , Phase 2
12814,D0C3WS,EC-301,Diabetic retinopathy , Investigative
12815,D0C3XD,BIO-11006,Chronic obstructive pulmonary disease , Phase 2
12816,D0C3XD,BIO-11006,Non-small-cell lung cancer , Phase 2
12817,D0C3XN,AG-1321002,Fever , Approved
12818,D0C3YN,Heparin low molecular weight,Thrombosis , Phase 3
12819,D0C3YQ,Mesna,Urinary dysfunction , Approved
12820,D0C3ZR,TG100-115,Myocardial infarction , Phase 1/2
12821,D0C3ZR,TG100-115,Angioedema , Phase 1/2
12822,D0C3ZZ,BNC375,Cognitive impairment , Phase 1
12823,D0C4AM,Pramlintide,Type-1/2 diabetes , Approved
12824,D0C4AY,REGN 3051,Middle East Respiratory Syndrome (MERS) , Discontinued in Phase 1
12825,D0C4BD,KH-901,Solid tumour/cancer , Phase 1
12826,D0C4BI,EX-1314,Cachexia , Investigative
12827,D0C4BL,Coxsackievirus A21,Glioblastoma multiforme , Phase 2
12828,D0C4BL,Coxsackievirus A21,Bladder cancer , Phase 1/2
12829,D0C4BL,Coxsackievirus A21,Lung cancer , Phase 1/2
12830,D0C4BL,Coxsackievirus A21,Melanoma , Phase 1/2
12831,D0C4BL,Coxsackievirus A21,Prostate cancer , Phase 1/2
12832,D0C4CJ,SF-105,Infectious disease , Investigative
12833,D0C4DH,Glecaprevir; pibrentasvir,Hepatitis C virus infection , Approved
12834,D0C4DZ,ThermoProfen,Pain , Phase 3
12835,D0C4EQ,ATYR-0030,Immune System disease , Investigative
12836,D0C4FA,BAX-855,Haemophilia A , Phase 3
12837,D0C4FS,DT-200,Duchenne dystrophy , Phase 1
12838,D0C4FT,HEXESTROL,Irregularities , Withdrawn from market
12839,D0C4GN,CD33-CAR-T Cell,Haematopoietic/lymphoid cancer , Phase 1
12840,D0C4GN,CD33-CAR-T Cell,Acute myeloid leukaemia , Phase 1
12841,D0C4GX,GBL-310,Keratosis , Phase 2
12842,D0C4HG,Levosimendan,Congestive heart failure , Approved
12843,D0C4HG,Levosimendan,Heart failure , Phase 4
12844,D0C4HG,Levosimendan,Cardiac output syndrome , Phase 3
12845,D0C4HG,Levosimendan,Pulmonary hypertension , Phase 2
12846,D0C4HZ,PLR-9,Bacterial infection , Terminated
12847,D0C4JI,DK-0141,Acute lung injury , Investigative
12848,D0C4JV,ISC-4,Solid tumour/cancer , Investigative
12849,D0C4JX,QX-314,Pain , Terminated
12850,D0C4KE,MIM-3Aa,Ocular disease , Investigative
12851,D0C4KT,XOMA 052,Type-2 diabetes , Phase 3
12852,D0C4LF,ARRY-162,Melanoma , Approved
12853,D0C4NF,FMP-825,Diabetic complication , Investigative
12854,D0C4NY,Promestriene,Acne vulgaris , Approved
12855,D0C4PB,LY3381916,Solid tumour/cancer , Phase 1
12856,D0C4QN,ROTIGAPTIDE,Cardiac arrhythmias , Phase 2
12857,D0C4RB,Taxol,Solid tumour/cancer , Approved
12858,D0C4RB,Taxol,Breast cancer , Approved
12859,D0C4RB,Taxol,Pancreatic cancer , Phase 3
12860,D0C4RB,Taxol,Gastric adenocarcinoma , Phase 2
12861,D0C4RB,Taxol,Ovarian cancer , Phase 2
12862,D0C4SH,ZK-209614,Conjunctivitis , Investigative
12863,D0C4TB,Pyrazole derivative 22,Obesity , Patented
12864,D0C4UU,TDI-0099,Motor neurone disease , Investigative
12865,D0C4VN,GM3 ganglioside vaccine,Breast cancer , Phase 3
12866,D0C4WC,Disitertide,Macular degeneration , Phase 2
12867,D0C4WY,SP-08,Alzheimer disease , Investigative
12868,D0C4YA,AG-331,Solid tumour/cancer , Discontinued in Phase 1
12869,D0C4YC,Mesalazine,Ulcerative colitis , Approved
12870,D0C4YF,TAN-1518A,Carcinoma , Terminated
12871,D0C4YQ,GSK315234,Rheumatoid arthritis , Phase 2
12872,D0C5CE,Nabiximols,Cancer related pain , Phase 3
12873,D0C5CE,Nabiximols,Muscle spasm , Phase 3
12874,D0C5DM,SC-52150,Vomiting , Terminated
12875,D0C5EG,A-366,Solid tumour/cancer , Preclinical
12876,D0C5FA,Duvortuxizumab,B-cell lymphoma , Phase 1
12877,D0C5FQ,BHT-3009,Multiple sclerosis , Phase 2
12878,D0C5HV,R zileuton,Asthma , Terminated
12879,D0C5IZ,H1N1 vaccine,Influenza virus infection , Phase 1
12880,D0C5JH,Rimantadine,Influenza virus infection , Approved
12881,D0C5JH,Rimantadine,Severe acute respiratory syndrome (SARS) , Investigative
12882,D0C5JQ,JNJ-40346527,Hodgkin lymphoma , Phase 2
12883,D0C5KG,ORG-33628,Contraception , Discontinued in Phase 2
12884,D0C5LI,SL-91.0893,Prostate hyperplasia , Terminated
12885,D0C5LJ,ADC-1013,Solid tumour/cancer , Phase 1
12886,D0C5MT,Rintatolimod,Chronic fatigue syndrome , phase 3
12887,D0C5MT,Rintatolimod,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
12888,D0C5ND,RO-17,Ulcer , Investigative
12889,D0C5NP,AGG-523,Osteoarthritis , Phase 1
12890,D0C5NT,PMID25666693-Compound-114,Osteoarthritis pain , Patented
12891,D0C5NT,PMID25666693-Compound-114,Cancer related pain , Patented
12892,D0C5NT,PMID25666693-Compound-114,Neuropathic pain , Patented
12893,D0C5NT,PMID25666693-Compound-114,Inflammatory pain , Patented
12894,D0C5OF,Ro-44-3949,Bacterial infection , Terminated
12895,D0C5OK,Drug 2838232,Human immunodeficiency virus infection , Phase 1
12896,D0C5PA,Sibenadet,Chronic obstructive pulmonary disease , Discontinued in Phase 3
12897,D0C5SO,RS-PPCC,Coronavirus Disease 2019 (COVID-19) , Investigative
12898,D0C5UE,Ipoxyn,Ischemia , Investigative
12899,D0C5VP,AB-1003,Insomnia , Investigative
12900,D0C5VQ,PRX-321,Solid tumour/cancer , Phase 2
12901,D0C5WE,AGT-2000,Brain cancer , Investigative
12902,D0C5WK,LY-392098,Cognitive impairment , Investigative
12903,D0C5WR,Cobalt chelate complex CTC-96 dermatological,Conjunctivitis , Phase 2
12904,D0C5XC,Clemastine,Allergic rhinitis , Approved
12905,D0C5XF,GSK-1344386B,Arteriosclerosis , Investigative
12906,D0C5YK,NMI-102,Inflammation , Terminated
12907,D0C5YQ,SDZ-62-826,Solid tumour/cancer , Terminated
12908,D0C6BJ,VII-7-B,Anxiety disorder , Investigative
12909,D0C6DT,Esomeprazole,Peptic ulcer , Approved
12910,D0C6DU,TVX-003,Influenza virus infection , Investigative
12911,D0C6DX,CardiALLO,Heart failure , Phase 1
12912,D0C6EA,XZK,Hyperlipidaemia , Phase 2
12913,D0C6FL,SPD-704,Neisseria meningitis infection , Terminated
12914,D0C6GK,EPZ-5676,Acute myeloid leukaemia , Phase 1/2
12915,D0C6GK,EPZ-5676,Acute lymphoblastic leukaemia , Phase 1
12916,D0C6GK,EPZ-5676,Acute lymphocytic leukaemia , Phase 1
12917,D0C6HM,Cebaracetam,Cognitive impairment , Discontinued in Phase 2
12918,D0C6ID,Citatuzumab bogatox,Solid tumour/cancer , Phase 1
12919,D0C6IQ,Stamulumab,Duchenne dystrophy , Phase 1/2
12920,D0C6KK,RT002,Glabellar frown line , Phase 3
12921,D0C6KS,KiroVAX-002,Haematological malignancy , Phase 1/2
12922,D0C6MS,PF-04991532,Diabetic complication , Phase 2
12923,D0C6ND,AIR-insulin,Diabetic complication , Phase 3
12924,D0C6NM,Latanoprost,Open-angle glaucoma , Approved
12925,D0C6NM,Latanoprost,Glaucoma/ocular hypertension , Phase 2
12926,D0C6NM,Latanoprost,Ocular disease , Investigative
12927,D0C6NV,RUT58-60,Bacterial infection , Phase 1/2
12928,D0C6OQ,Alclofenac,Rheumatoid arthritis , Approved
12929,D0C6PL,Sm-p80-VR1020,Schistosomiasis , Investigative
12930,D0C6PS,Muromonab,Organ transplant rejection , Approved
12931,D0C6QG,Manganese Chloride Tetrahydrate,Overactive bladder , Approved
12932,D0C6QQ,Besipirdine,Cognitive impairment , Phase 3
12933,D0C6RD,Ypeginterferon alfa-2b,Hepatitis B virus infection , Phase 2
12934,D0C6RM,BAY1436032,Acute myeloid leukaemia , Phase 1
12935,D0C6RM,BAY1436032,Solid tumour/cancer , Phase 1
12936,D0C6RR,ACTR087 + rituximab,B-cell lymphoma , Phase 1
12937,D0C6TL,Leptin,Alzheimer disease , Investigative
12938,D0C6VK,Lm Prostate,Prostate cancer , Investigative
12939,D0C6VO,StrataGraft,Burn and burn infection , Phase 1/2
12940,D0C6VV,Prolarix,Solid tumour/cancer , Phase 2
12941,D0C6VX,PMID25684022-Compound-WO2010127754,Solid tumour/cancer , Patented
12942,D0C6VX,PMID25684022-Compound-WO2010127754,Metastatic cancer , Patented
12943,D0C6XD,BCL-005,Melanoma , Investigative
12944,D0C6XR,Trimegestone/ethinyl estradiol,Contraception , Phase 3
12945,D0C6YH,ARC-2022,Postherpetic neuralgia , Phase 1/2
12946,D0C6YQ,BCL201,Follicular lymphoma , Phase 1
12947,D0C6YQ,BCL201,Mantle cell lymphoma , Phase 1
12948,D0C6ZS,CpG-10101,Hepatitis C virus infection , Phase 2
12949,D0C6ZX,KW-3357,Coagulation defect , Phase 3
12950,D0C7AA,Ozagrel,Xerophthalmia , Phase 4
12951,D0C7AA,Ozagrel,Chronic obstructive pulmonary disease , Phase 1
12952,D0C7CS,ALN-HPN,Anemia , Investigative
12953,D0C7CV,Atu-134,Lung injury , Investigative
12954,D0C7DY,S. pneumococcal next-generation vaccine,Streptococcus infection , Phase 2
12955,D0C7ET,Tetrodotoxin,Bacterial infection , Approved
12956,D0C7FN,BMY-40062,Bacterial infection , Terminated
12957,D0C7GJ,Long-acting factor VIII,Coagulation defect , Investigative
12958,D0C7JF,Testolactone,Breast cancer , Approved
12959,D0C7JH,TP-9201,Thrombosis , Discontinued in Phase 1
12960,D0C7JT,YM-976,Asthma , Discontinued in Phase 1
12961,D0C7KB,Nova-EPO,Anemia , Investigative
12962,D0C7KK,Zenarestat,Diabetic neuropathy , Terminated
12963,D0C7LA,MAR--99,Asthma , Investigative
12964,D0C7LD,Pemfexy,Mesothelioma , Application submitted
12965,D0C7LD,Pemfexy,Non-small-cell lung cancer , Application submitted
12966,D0C7LF,DACOPAFANT,Sepsis , Discontinued in Phase 1
12967,D0C7NU,(S)-8-Hydroxy palmitic acid,Solid tumour/cancer , Investigative
12968,D0C7OQ,BIWB-1,Melanoma , Discontinued in Phase 2
12969,D0C7OT,CN54gp140-hsp70 conjugate vaccine,Human immunodeficiency virus infection , Phase 1
12970,D0C7QW,XMetS,Non-insulin dependent diabetes , Investigative
12971,D0C7RV,SR12813,Arteriosclerosis , Terminated
12972,D0C7TO,Tr-3,Solid tumour/cancer , Investigative
12973,D0C7UR,AGI-1096,Transplant rejection , Discontinued in Phase 1
12974,D0C7WO,1192U90,Psychotic disorder , Phase 1
12975,D0C7WO,1192U90,Schizophrenia , Terminated
12976,D0C7WP,SB-431542,Pulmonary fibrosis , Preclinical
12977,D0C7XM,P2045,Small-cell lung cancer , Phase 1/2
12978,D0C7XM,P2045,Non-small-cell lung cancer , Phase 1/2
12979,D0C7YE,NKR-2,Haematological malignancy , Phase 1/2
12980,D0C7YE,NKR-2,Solid tumour/cancer , Phase 1/2
12981,D0C7YH,PMX-900,Solid tumour/cancer , Investigative
12982,D0C7ZB,GSK3196165,Rheumatoid arthritis , Phase 2
12983,D0C8AL,Fluoropeptide vaccine,Influenza virus infection , Phase 2
12984,D0C8AP,AG-348,Pyruvate kinase deficiency , Phase 2
12985,D0C8DC,Ki-1769,Hypertension , Terminated
12986,D0C8DD,Losmapimod,Acute coronary syndrome , Phase 3
12987,D0C8EB,PMID26651364-Compound-45,Crohn disease , Patented
12988,D0C8EB,PMID26651364-Compound-45,Ulcerative colitis , Patented
12989,D0C8EB,PMID26651364-Compound-45,Urinary tract infection , Patented
12990,D0C8ES,CBL0102,Hepatocellular carcinoma , Phase 1/2
12991,D0C8EU,Temozolomide,Grade IV astrocytoma , Approved
12992,D0C8FX,Pyrithione Zinc,Seborrhoeic dermatitis , Approved
12993,D0C8HR,Halometasone,Inflammation , Approved
12994,D0C8IF,LY3154207,Parkinson disease , Phase 2
12995,D0C8JW,Muscular dystrophy gene therapy,Duchenne dystrophy , Phase 1
12996,D0C8KF,Resiquimod,Actinic keratosis , Phase 2
12997,D0C8KF,Resiquimod,Cutaneous T-cell lymphoma , Phase 2
12998,D0C8KF,Resiquimod,Herpes simplex virus infection , Phase 1/2
12999,D0C8KP,Santalum album,Psoriasis vulgaris , Phase 2
13000,D0C8KY,SYN-1001,Pain , Phase 1
13001,D0C8LG,CLT-010,Solid tumour/cancer , Investigative
13002,D0C8MG,SELA-212,Gout , Phase 2
13003,D0C8NG,BI 655064,Lupus , Phase 2
13004,D0C8NG,BI 655064,Rheumatoid arthritis , Phase 1
13005,D0C8NG,BI 655064,Thrombocytopenia , Phase 1
13006,D0C8NK,TG-21,Influenza virus infection , Investigative
13007,D0C8PE,JNJ-37822681,Schizophrenia , Phase 2
13008,D0C8PI,Zoniporide hydrochloride,Angina pectoris , Phase 3
13009,D0C8PQ,CVS-3083,Solid tumour/cancer , Terminated
13010,D0C8PW,Albunex,Female infertility , Approved
13011,D0C8QA,KITE-585,Multiple myeloma , Phase 1
13012,D0C8QS,Ragwitek,Allergic rhinitis , Approved
13013,D0C8RH,Cericlamine,Anxiety disorder , Discontinued in Phase 3
13014,D0C8RW,Rec-antihemophilic factor,Hemophilia , Approved
13015,D0C8TD,Thrombin-JMI,Bleeding disorder , Approved
13016,D0C8UN,KT-3799,Carbacephem , Investigative
13017,D0C8VF,Galcanezumab,Hyperprolactinaemia , Approved
13018,D0C8XT,DLO6001,Parkinson disease , Investigative
13019,D0C8ZD,A-71623,Obesity , Terminated
13020,D0C8ZZ,PMID25666693-Compound-12,Osteoarthritis pain , Patented
13021,D0C8ZZ,PMID25666693-Compound-12,Cancer related pain , Patented
13022,D0C8ZZ,PMID25666693-Compound-12,Neuropathic pain , Patented
13023,D0C8ZZ,PMID25666693-Compound-12,Inflammatory pain , Patented
13024,D0C9AQ,MBI 1121,Solid tumour/cancer , Discontinued in Phase 1
13025,D0C9AV,Mical (1),Plaque psoriasis , Phase 2
13026,D0C9DA,Calaspargase pegol,Acute lymphocytic leukaemia , Approved
13027,D0C9DA,Calaspargase pegol,Acute lymphoblastic leukaemia , Phase 3
13028,D0C9DB,424C79,Pain , Investigative
13029,D0C9EE,PAZELLIPTINE TRIHYDROCHLORIDE,Solid tumour/cancer , Discontinued in Phase 2
13030,D0C9EN,AZD5312,Prostate cancer , Phase 2
13031,D0C9ET,Aflibercept,Metastatic colorectal cancer , Approved
13032,D0C9FF,DNK-333,Irritable bowel syndrome , Discontinued in Phase 2
13033,D0C9FN,PMID25666693-Compound-87,Osteoarthritis pain , Patented
13034,D0C9FN,PMID25666693-Compound-87,Cancer related pain , Patented
13035,D0C9FN,PMID25666693-Compound-87,Neuropathic pain , Patented
13036,D0C9FN,PMID25666693-Compound-87,Inflammatory pain , Patented
13037,D0C9HE,Campyvax,Bacterial infection , Discontinued in Phase 2
13038,D0C9IS,P-9808,Porphyria , Phase 2
13039,D0C9IW,Factor viia,Hemophilia , Approved
13040,D0C9JI,Zn-DPA-B,Breast cancer , Investigative
13041,D0C9JJ,AR-12,Lymphoma , Phase 1
13042,D0C9JL,Y-23684,Anxiety disorder , Discontinued in Phase 3
13043,D0C9KQ,Genimune,Autoimmune diabetes , Terminated
13044,D0C9KW,AVN-457,Cognitive impairment , Investigative
13045,D0C9KX,TSD-0014,Prostate cancer , Phase 1
13046,D0C9KY,Pyridobenzimidazole,Fungal infection , Investigative
13047,D0C9LE,YPL-1101,Chronic obstructive pulmonary disease , Investigative
13048,D0C9LQ,LentiGlobin,Beta thalassemia , Phase 3
13049,D0C9LQ,LentiGlobin,Sickle-cell disorder , Phase 1
13050,D0C9MA,ACH-4471,Anaemia , Phase 2
13051,D0C9MA,ACH-4471,Glomerulonephritis , Phase 1
13052,D0C9MJ,Anti-MUC1 CAR-T cells,Colorectal cancer , Phase 1/2
13053,D0C9MJ,Anti-MUC1 CAR-T cells,Gastric adenocarcinoma , Phase 1/2
13054,D0C9MJ,Anti-MUC1 CAR-T cells,Malignant glioma , Phase 1/2
13055,D0C9NJ,STA-5326,Rheumatoid arthritis , Phase 2
13056,D0C9NJ,STA-5326,Crohn disease , Phase 2
13057,D0C9PZ,PT2385,Recurrent glioblastoma , Phase 2
13058,D0C9PZ,PT2385,Von hippel-lindau disease , Phase 2
13059,D0C9PZ,PT2385,Brain cancer , Investigative
13060,D0C9QM,TH-1011,Solid tumour/cancer , Investigative
13061,D0C9RF,CGEN-25007,Autoimmune diabetes , Investigative
13062,D0C9RM,Nano-PGE1,Peripheral arterial disease , Investigative
13063,D0C9RV,SRSS-016,Pain , Terminated
13064,D0C9RZ,BU-4601A,Asthma , Terminated
13065,D0C9SW,Somatropin intranasal rhGH,Growth hormone deficiency , Phase 2
13066,D0C9SY,Vardenafil,Erectile dysfunction , Approved
13067,D0C9TH,ALD-451,Cognitive impairment , Phase 1
13068,D0C9TP,CaspaCIDe donor lymphocyte infusion,Graft-versus-host disease , Phase 2
13069,D0C9WN,MKC-1106-PP,Solid tumour/cancer , Phase 1
13070,D0C9XA,GSK683699,Inflammatory bowel disease , Phase 2
13071,D0C9XJ,Epirubicin,Solid tumour/cancer , Approved
13072,D0CA0P,Certolizumab,Rheumatoid arthritis , Approved
13073,D0CA2S,HYDAMTIQ,Brain ischaemia , Investigative
13074,D0CA3J,GSK568859,Arteriosclerosis , Discontinued in Phase 1
13075,D0CA3M,Anti-meso-CAR T cells,Mesothelin Positive tumour , Phase 1
13076,D0CA6J,Tioconazole,Onychomycosis , Approved
13077,D0CA7B,BDM-I,Fungal infection , Investigative
13078,D0CB2B,Serlopitant,Prurigo nodularis , Phase 3
13079,D0CB2B,Serlopitant,Psoriasis vulgaris , Phase 2
13080,D0CB6N,AVI-6003,Marburg virus infection , Phase 1
13081,D0CB7L,Hepatitis B Hyperimmune,Hepatitis B virus infection , Investigative
13082,D0CB8W,DE-081,Conjunctivitis , Discontinued in Phase 2
13083,D0CB8W,DE-081,Ocular allergy , Terminated
13084,D0CC1Y,VML-262,Psoriasis vulgaris , Discontinued in Phase 2
13085,D0CC3O,APG-232,Solid tumour/cancer , Investigative
13086,D0CC8L,CRILVASTATIN,Hyperlipidaemia , Phase 2
13087,D0CD7Q,Beta-cyclodextrin conjugate derivative 4,Crohn disease , Patented
13088,D0CD7Q,Beta-cyclodextrin conjugate derivative 4,Ulcerative colitis , Patented
13089,D0CD7Q,Beta-cyclodextrin conjugate derivative 4,Urinary tract infection , Patented
13090,D0CE0O,Alisporivir,Duchenne dystrophy , Phase 3
13091,D0CE0Y,Anti-CD19-CAR-T cells,leukaemia , Phase 1/2
13092,D0CE1R,Antibodie derivative 7,Solid tumour/cancer , Patented
13093,D0CE5S,PD-4074,Diabetic complication , Investigative
13094,D0CE6C,LMI070,Spinal muscular atrophy , Phase 3
13095,D0CE6T,Elisartan potassium,Hypertension , Discontinued in Phase 2
13096,D0CE8J,Genaconazole,Fungal infection , Phase 1
13097,D0CE9S,S(377588)-Fc vaccine,Middle East Respiratory Syndrome (MERS) , Investigative
13098,D0CF0Y,Rolapitant,Chemotherapy-induced nausea , Approved
13099,D0CF2Q,Levamisole,Parasitic infection , Approved
13100,D0CF2Q,Levamisole,Colon cancer , Withdrawn from market
13101,D0CF3H,HG-1070,Solid tumour/cancer , Investigative
13102,D0CF3M,Sifuvirtide,Human immunodeficiency virus infection , Phase 3
13103,D0CF8T,Z-521,Hypophosphatasia , Phase 3
13104,D0CF8Y,Pyrazoline derivative 3,Obesity , Patented
13105,D0CG0K,ATI-502,Atopic dermatitis , Phase 2
13106,D0CG0K,ATI-502,Vitiligo , Phase 2
13107,D0CG0N,PRO-140,Human immunodeficiency virus infection , Phase 3
13108,D0CG1A,EBV-CTL,Post-transplant lymphoproliferative disorder , Phase 2
13109,D0CG8N,Tri-substituted urea derivative 2,Pruritus , Patented
13110,D0CG8N,Tri-substituted urea derivative 2,Solid tumour/cancer , Patented
13111,D0CG8N,Tri-substituted urea derivative 2,Chronic pain , Patented
13112,D0CG8N,Tri-substituted urea derivative 2,Neuropathic pain , Patented
13113,D0CG8N,Tri-substituted urea derivative 2,Thymic cancer , Patented
13114,D0CG8S,oxazine 89,Diabetic nephropathy , Clinical trial
13115,D0CG9E,SL-11093,Solid tumour/cancer , Preclinical
13116,D0CH1U,Interleukin-3,Aplastic anemia , Approved
13117,D0CH3F,Resorcinol compound 16,Albinism , Patented
13118,D0CH3F,Resorcinol compound 16,Ephelides , Patented
13119,D0CH3F,Resorcinol compound 16,Menkes disease , Patented
13120,D0CH3F,Resorcinol compound 16,Senile lentigines , Patented
13121,D0CH3F,Resorcinol compound 16,Melasma , Patented
13122,D0CH4A,SBC-102,Enzyme deficiency , Approved
13123,D0CH4T,Lu-02-750,Parkinson disease , Phase 1
13124,D0CH6B,ALZT-OP1,Alzheimer disease , Phase 3
13125,D0CH6Z,BBR 3576,Prostate cancer , Terminated
13126,D0CH7C,Basmisanil,Alzheimer disease , Phase 2
13127,D0CH7C,Basmisanil,Cognitive impairment , Phase 2
13128,D0CH7C,Basmisanil,Complete androgen insensitivity syndrome , Phase 2
13129,D0CH7C,Basmisanil,Immune dysregulation , Phase 2
13130,D0CH8E,Macrocyclic peptide analog 2,Solid tumour/cancer , Patented
13131,D0CH8E,Macrocyclic peptide analog 2,Infectious disease , Patented
13132,D0CH8E,Macrocyclic peptide analog 2,Human immunodeficiency virus infection , Patented
13133,D0CH8E,Macrocyclic peptide analog 2,Hepatitis , Patented
13134,D0CH9G,Pepvax,Cytomegalovirus Disease , Phase 2
13135,D0CI2U,Benzoic acid linked peptide analog 3,Albinism , Patented
13136,D0CI2U,Benzoic acid linked peptide analog 3,Ephelides , Patented
13137,D0CI2U,Benzoic acid linked peptide analog 3,Menkes disease , Patented
13138,D0CI2U,Benzoic acid linked peptide analog 3,Senile lentigines , Patented
13139,D0CI2U,Benzoic acid linked peptide analog 3,Melasma , Patented
13140,D0CI4B,MP-100,Anxiety disorder , Investigative
13141,D0CI4E,Pertuzumab,Breast cancer , Approved
13142,D0CI5O,SPD-474,Parkinson disease , Terminated
13143,D0CI9T,Ceftobiprole,Community-acquired pneumonia , Phase 3
13144,D0CI9T,Ceftobiprole,Skin and skin-structure infection , Phase 3
13145,D0CI9W,GSK-334429,Cognitive impairment , Investigative
13146,D0CJ3R,MS201408-0005C,Solid tumour/cancer , Phase 1
13147,D0CJ7Z,Abicipar pegol,Diabetic macular edema , Phase 2
13148,D0CK2C,ZP-10395,Solid tumour/cancer , Investigative
13149,D0CK3G,Ethinamate,Insomnia , Approved
13150,D0CK5J,SF-116,Glaucoma/ocular hypertension , Investigative
13151,D0CK7F,AOB103,Rosacea , Phase 2
13152,D0CK8H,Indazole derivative 1,Solid tumour/cancer , Patented
13153,D0CK8H,Indazole derivative 1,Metastatic cancer , Patented
13154,D0CL5D,Ragweed allergy vaccine,leukaemia , Phase 1
13155,D0CL9S,Telbivudine,Hepatitis B virus infection , Approved
13156,D0CM3Z,ATON-009,Metal intoxication , Phase 1
13157,D0CM5P,Quinazoline derivative 10,Cirrhosis , Patented
13158,D0CM5P,Quinazoline derivative 10,Chronic obstructive pulmonary disease , Patented
13159,D0CM5P,Quinazoline derivative 10,Psoriasis vulgaris , Patented
13160,D0CM5P,Quinazoline derivative 10,Multiple sclerosis , Patented
13161,D0CN6Q,PMID26651364-Compound-5c,Crohn disease , Patented
13162,D0CN6Q,PMID26651364-Compound-5c,Ulcerative colitis , Patented
13163,D0CN6Q,PMID26651364-Compound-5c,Urinary tract infection , Patented
13164,D0CN7A,PMID26651364-Compound-7c,Crohn disease , Patented
13165,D0CN7A,PMID26651364-Compound-7c,Ulcerative colitis , Patented
13166,D0CN7A,PMID26651364-Compound-7c,Urinary tract infection , Patented
13167,D0CN7I,IMC-CS4,Solid tumour/cancer , Phase 1
13168,D0CN8U,PF-06763809,Plaque psoriasis , Phase 1
13169,D0CN9D,Anetumab ravtansine,Malignant pleural mesothelioma , Phase 2
13170,D0CN9D,Anetumab ravtansine,Mesothelioma , Phase 2
13171,D0CN9D,Anetumab ravtansine,Solid tumour/cancer , Phase 2
13172,D0CN9D,Anetumab ravtansine,Ovarian cancer , Phase 1
13173,D0CN9Q,CP-724714,Lymphoma , Phase 2
13174,D0CO2M,S-9788,Solid tumour/cancer , Discontinued in Phase 2
13175,D0CO2W,AMG 301,Migraine , Phase 2
13176,D0CO2W,AMG 301,Hyperprolactinaemia , Investigative
13177,D0CO3N,esuberaprost,Gout , Phase 3
13178,D0CO3N,esuberaprost,Pulmonary arterial hypertension , Phase 3
13179,D0CO3O,RAP-701,Ovarian cancer , Investigative
13180,D0CO5F,ALLOD-2,Neuropathic pain , Phase 2
13181,D0CO5F,ALLOD-2,Chronic low back pain , Phase 2
13182,D0CO5F,ALLOD-2,Migraine , Phase 2
13183,D0CO6D,AMG 333,Migraine , Phase 1
13184,D0CO9B,Ad-p53,Solid tumour/cancer , Phase 2
13185,D0CO9B,Ad-p53,Colorectal cancer , Phase 1
13186,D0CP3Z,ALS-012117,Virus infection , Investigative
13187,D0CP4E,Clonazepam,Epilepsy , Approved
13188,D0CP4E,Clonazepam,Seizure disorder , Phase 2
13189,D0CP6B,3-(phenoxymethyl) benzylamine derivative 5,Albinism , Patented
13190,D0CP6B,3-(phenoxymethyl) benzylamine derivative 5,Ephelides , Patented
13191,D0CP6B,3-(phenoxymethyl) benzylamine derivative 5,Menkes disease , Patented
13192,D0CP6B,3-(phenoxymethyl) benzylamine derivative 5,Senile lentigines , Patented
13193,D0CP6B,3-(phenoxymethyl) benzylamine derivative 5,Melasma , Patented
13194,D0CP8N,Silmitasertib,Cholangiocarcinoma , phase 1/2
13195,D0CP8N,Silmitasertib,Coronavirus Disease 2019 (COVID-19) , Investigative
13196,D0CQ0Z,Penfluridol,Schizophrenia , Approved
13197,D0CQ1M,Heterocyclic-carboxamide derivative 2,Solid tumour/cancer , Patented
13198,D0CQ1M,Heterocyclic-carboxamide derivative 2,Metastatic cancer , Patented
13199,D0CQ1X,HTERT RNA vaccine,Acute myeloid leukaemia , Phase 2
13200,D0CQ2O,Interferon beta-1b,Multiple sclerosis , Approved
13201,D0CQ2P,SPL-7013,Human immunodeficiency virus infection , Phase 1
13202,D0CQ5A,SKL20540,Complete androgen insensitivity syndrome , Phase 1
13203,D0CQ5A,SKL20540,Immune dysregulation , Phase 1
13204,D0CQ8D,AMR-103,Parkinson disease , Terminated
13205,D0CR0H,PMID25666693-Compound-138,Osteoarthritis pain , Patented
13206,D0CR0H,PMID25666693-Compound-138,Cancer related pain , Patented
13207,D0CR0H,PMID25666693-Compound-138,Neuropathic pain , Patented
13208,D0CR0H,PMID25666693-Compound-138,Inflammatory pain , Patented
13209,D0CR1I,TJ-9,Asthma , Phase 2
13210,D0CR4Z,IPI-940,Pain , Phase 1
13211,D0CR6E,SSYA10-001,Severe acute respiratory syndrome (SARS) , Preclinical
13212,D0CR6E,SSYA10-001,Middle East Respiratory Syndrome (MERS) , Preclinical
13213,D0CR7L,GSK3326595,Breast cancer , Phase 2
13214,D0CR7L,GSK3326595,Non-hodgkin lymphoma , Phase 1
13215,D0CR7L,GSK3326595,Solid tumour/cancer , Phase 1
13216,D0CR8H,SYM-004,Metastatic colorectal cancer , Phase 3
13217,D0CR8H,SYM-004,Head and neck cancer , Phase 2
13218,D0CR8H,SYM-004,Colorectal cancer , Phase 2
13219,D0CR8H,SYM-004,Recurrent glioblastoma , Phase 2
13220,D0CR8H,SYM-004,Non-small-cell lung cancer , Phase 2
13221,D0CR8J,Biphenyl mannoside derivative 26,Crohn disease , Patented
13222,D0CR8J,Biphenyl mannoside derivative 26,Ulcerative colitis , Patented
13223,D0CR8J,Biphenyl mannoside derivative 26,Urinary tract infection , Patented
13224,D0CR9I,CX-5011,Solid tumour/cancer , Investigative
13225,D0CR9L,Daromun,Melanoma , Phase 3
13226,D0CS0D,WAY-121898,Arteriosclerosis , Terminated
13227,D0CS2C,AZD9056,Chronic obstructive pulmonary disease , Phase 2
13228,D0CS2F,Loperamide,Diarrhea , Approved
13229,D0CS2L,DG-1-66,Herpes simplex virus infection , Investigative
13230,D0CS3A,CART-19,B-cell lymphoma , Phase 1
13231,D0CS6N,Benzodiazepine,Anxiety disorder , Investigative
13232,D0CT1S,BB IND-6989,Salmonella infection , Phase 1
13233,D0CT3I,AgaDerm,Dermatomycosis , Investigative
13234,D0CT4D,Brivaracetam,Complex partial seizure , Approved
13235,D0CT4D,Brivaracetam,Epilepsy , Phase 3
13236,D0CT4D,Brivaracetam,Pain , Phase 3
13237,D0CT5O,ALX-101,Atopic dermatitis , Phase 2
13238,D0CT5Z,SLP-0907,Escherichia coli infection , Investigative
13239,D0CT7M,A-6,Macular degeneration , Phase 2
13240,D0CT9C,Cyclophosphamide,Solid tumour/cancer , Approved
13241,D0CT9Y,Clomifene,Female infertility , Approved
13242,D0CU1O,Dolutegravir + rilpivirine,Human immunodeficiency virus infection , Application submitted
13243,D0CU1T,SB2,Plaque psoriasis , Phase 3
13244,D0CU1T,SB2,Ankylosing spondylitis , Application submitted
13245,D0CU1T,SB2,Crohn disease , Application submitted
13246,D0CU1T,SB2,Psoriatic arthritis , Application submitted
13247,D0CU1T,SB2,Ulcerative colitis , Application submitted
13248,D0CU2Q,DHES0815A,Breast cancer , Phase 1
13249,D0CV7Q,ASO-1,Fatty liver disease , Investigative
13250,D0CV7T,Patamostat,Hypotension , Terminated
13251,D0CV7Z,Epothilone B,Solid tumour/cancer , Discontinued in Phase 3
13252,D0CW1J,Pyrrole derivative 5,Obesity , Patented
13253,D0CW1P,Betamethasone,Inflammation , Approved
13254,D0CW2B,ETX-101,Diabetic gastroparesis , Phase 3
13255,D0CW2N,Reolysinpelareorep,Pancreatic cancer , Phase 2
13256,D0CW3B,M-101,Blood transfusion , Investigative
13257,D0CW3U,Kanjinti,Breast cancer , Application submitted
13258,D0CW3U,Kanjinti,Gastric adenocarcinoma , Application submitted
13259,D0CW6S,Monoxanes,Malaria , Investigative
13260,D0CW8S,ABX-1431,Neuropathic pain , Phase 1
13261,D0CW8S,ABX-1431,Tourette syndrome , Phase 1
13262,D0CX1F,Sulfonylated piperazine derivative 1,Obesity , Patented
13263,D0CX2J,R-1315,Alzheimer disease , Terminated
13264,D0CX4C,PMID25666693-Compound-76,Osteoarthritis pain , Patented
13265,D0CX4C,PMID25666693-Compound-76,Cancer related pain , Patented
13266,D0CX4C,PMID25666693-Compound-76,Neuropathic pain , Patented
13267,D0CX4C,PMID25666693-Compound-76,Inflammatory pain , Patented
13268,D0CY1B,CYC116,Solid tumour/cancer , Phase 1
13269,D0CY2Q,CrohnsVax,Crohn disease , Phase 1
13270,D0CY2Z,HuMax-HepC,Hepatitis C virus infection , Terminated
13271,D0CY3A,Idraparinux,Thrombosis , Discontinued in Phase 3
13272,D0CY3F,Aom-0925,Diabetic complication , Investigative
13273,D0CY3U,Five membered heterocyclic benzamide derivative 3,Pruritus , Patented
13274,D0CY3U,Five membered heterocyclic benzamide derivative 3,Solid tumour/cancer , Patented
13275,D0CY3U,Five membered heterocyclic benzamide derivative 3,Chronic pain , Patented
13276,D0CY3U,Five membered heterocyclic benzamide derivative 3,Neuropathic pain , Patented
13277,D0CY3U,Five membered heterocyclic benzamide derivative 3,Thymic cancer , Patented
13278,D0CY4V,Cetamolol,Angina pectoris , Terminated
13279,D0CY9O,ON-128,Solid tumour/cancer , Investigative
13280,D0CZ0D,EF-12,Coronary artery disease , Discontinued in Phase 3
13281,D0CZ1A,IRISQUINONE,Solid tumour/cancer , Phase 3
13282,D0CZ1Q,Desoximetasone,Inflammation , Approved
13283,D0CZ5Z,SPD-465,Attention deficit hyperactivity disorder , Phase 3
13284,D0D0BE,Ornidazole,Amoebiasis , Approved
13285,D0D0BM,Corticotropin-zinc Hydroxide,Ulcerative colitis , Approved
13286,D0D0DH,TLPLDC,Melanoma , Phase 2
13287,D0D0DH,TLPLDC,Ovarian cancer , Phase 1/2
13288,D0D0FB,TV1001,Diabetic angiopathy , Phase 2
13289,D0D0GH,NsG-0202,Alzheimer disease , Phase 1
13290,D0D0GV,Fenhexamid,Plant grey mould disease , Approved
13291,D0D0HB,DCVax,Prostate cancer , Phase 3
13292,D0D0HB,DCVax,Colorectal cancer , Phase 3
13293,D0D0IF,ScFv23/rGel,Breast cancer , Investigative
13294,D0D0JY,WNVax,West nile virus infection , Investigative
13295,D0D0KZ,AV4025,Hepatitis C virus infection , Phase 1
13296,D0D0LD,L-873724,Asthma , Investigative
13297,D0D0LH,NU-100,Multiple sclerosis , Phase 3
13298,D0D0ML,Heterocyclic derivative 6,Solid tumour/cancer , Patented
13299,D0D0ML,Heterocyclic derivative 6,Metastatic cancer , Patented
13300,D0D0NA,KDT-600,Obesity , Investigative
13301,D0D0OC,G-series prophage vaccine,Glioblastoma multiforme , Phase 2
13302,D0D0OR,V520/V526 combination vaccine,Human immunodeficiency virus infection , Phase 1
13303,D0D0OT,GS-4977,Diabetic nephropathy , Phase 2
13304,D0D0PB,AIC-292,Human immunodeficiency virus infection , Phase 1
13305,D0D0QA,AZD6482,Thrombosis , Terminated
13306,D0D0QQ,Velac Gel,Acne vulgaris , Phase 3
13307,D0D0RJ,LED-209,Gram-positive bacterial infection , Investigative
13308,D0D0RW,KMB-17,Enterovirus infection , Phase 3
13309,D0D0SH,GMDP,Infectious disease , Approved
13310,D0D0TQ,AKN-028,Acute myeloid leukaemia , Investigative
13311,D0D0US,OB-14,Osteoporosis , Investigative
13312,D0D0WH,Anti-CD73 mAb,Solid tumour/cancer , Phase 1
13313,D0D0WP,V-0096,Urticaria , Discontinued in Phase 2
13314,D0D0XF,AG-702,Genital herpes , Discontinued in Phase 1/2
13315,D0D0XX,LY-290154,Asthma , Terminated
13316,D0D0XY,ImmuneFx,Solid tumour/cancer , Investigative
13317,D0D0YK,GI-3000,Non-small-cell lung cancer , Investigative
13318,D0D0YM,Amosulalol,Hypertension , Approved
13319,D0D0ZD,Miglitol,Diabetic complication , Approved
13320,D0D1AL,Haloperidol,Schizophrenia , Approved
13321,D0D1BC,Melanocortin-4 Receptor antagonist,Anorexia nervosa cachexia , Investigative
13322,D0D1BR,GS-7340,Hepatitis B virus infection , Approved
13323,D0D1BR,GS-7340,Human immunodeficiency virus infection , Phase 2
13324,D0D1CL,MB07133,Hepatocellular carcinoma , Phase 1/2
13325,D0D1CS,Boceprevir,Coronavirus Disease 2019 (COVID-19) , Investigative
13326,D0D1DI,Arformoterol,Chronic obstructive pulmonary disease , Approved
13327,D0D1DI,Arformoterol,Asthma , Phase 4
13328,D0D1EI,Diphenyl purine derivative 5,Obesity , Patented
13329,D0D1EV,NSC-364432,Solid tumour/cancer , Phase 2
13330,D0D1FC,LY-362884,Type-2 diabetes , Phase 2
13331,D0D1FC,LY-362884,Obesity , Phase 2
13332,D0D1GF,XL880,Squamous head and neck cell carcinom , Phase 2
13333,D0D1GF,XL880,Renal cell carcinoma , Phase 2
13334,D0D1GF,XL880,Gastric adenocarcinoma , Phase 2
13335,D0D1GF,XL880,Breast cancer , Phase 2
13336,D0D1GF,XL880,Solid tumour/cancer , Phase 1
13337,D0D1GV,CNS-1237,Cerebrovascular ischaemia , Terminated
13338,D0D1HA,Cefotaxime,Bacterial infection , Approved
13339,D0D1HH,Carvedilol,Congestive heart failure , Approved
13340,D0D1HH,Carvedilol,Coronavirus Disease 2019 (COVID-19) , Investigative
13341,D0D1HI,Autologous T Cells Expressing MET scFv CAR,Melanoma , Phase 1
13342,D0D1HI,Autologous T Cells Expressing MET scFv CAR,Breast cancer , Phase 0
13343,D0D1HR,TrkB NAM,Neurodegenerative disorder , Investigative
13344,D0D1HS,Ki23819,Solid tumour/cancer , Phase 1
13345,D0D1HW,Anagrelide,Thrombocythemia , Approved
13346,D0D1HW,Anagrelide,Essential thrombocythemia , Phase 2
13347,D0D1IR,HG-1438,Solid tumour/cancer , Investigative
13348,D0D1JP,WR-279396,Leishmania infection , Phase 3
13349,D0D1LG,AZD-5099,Infectious disease , Discontinued in Phase 1
13350,D0D1LS,5-Fluoro-2-deoxycytidine,Solid tumour/cancer , Phase 2
13351,D0D1MA,Oxyphenonium,Visceral spasms , Approved
13352,D0D1OG,Sapanisertib,Breast cancer , Phase 2
13353,D0D1OG,Sapanisertib,Coronavirus Disease 2019 (COVID-19) , Investigative
13354,D0D1PQ,EDP-21,Obesity , Investigative
13355,D0D1RF,ABX-0401,Inflammatory bowel disease , Preclinical
13356,D0D1RM,Botulinum Toxin Type A,Blepharospasm , Approved
13357,D0D1SG,Prednisolone,Solid tumour/cancer , Approved
13358,D0D1SG,Prednisolone,Multiple sclerosis , Phase 3
13359,D0D1TB,CPC-410,Solid tumour/cancer , Investigative
13360,D0D1TS,Isoquinoline derivative 2,Neuropathic pain , Patented
13361,D0D1TX,Recombinant human pro-urokinase,Myocardial infarction , Investigative
13362,D0D1UD,STI-001,Colorectal cancer , Phase 3
13363,D0D1UD,STI-001,Bacterial infection , Investigative
13364,D0D1UQ,Neu-120,Parkinson disease , Phase 1/2
13365,D0D1VJ,SDZ-210-086,Cognitive impairment , Discontinued in Phase 1
13366,D0D1XG,CI-976,Hyperlipidaemia , Discontinued in Phase 2
13367,D0D1XW,PEG-Interferon lambda (IL-29),Virus infection , Phase 1
13368,D0D1YY,IGN-2098,Duodenal ulcer , Discontinued in Phase 2
13369,D0D1ZF,Mavacamten,Obstructive hypertrophic cardiomyopathy , Phase 3
13370,D0D1ZS,CLP-1001,Chronic heart failure , Phase 2
13371,D0D2AR,SOM-0003,Virus infection , Investigative
13372,D0D2CF,PMID25666693-Compound-115,Osteoarthritis pain , Patented
13373,D0D2CF,PMID25666693-Compound-115,Cancer related pain , Patented
13374,D0D2CF,PMID25666693-Compound-115,Neuropathic pain , Patented
13375,D0D2CF,PMID25666693-Compound-115,Inflammatory pain , Patented
13376,D0D2CY,DEX-M74,Myopathy , Phase 1/2
13377,D0D2FZ,Ragweed allergy vaccine sublingual,Lymphoma , Approved
13378,D0D2GW,EHC18,Hepatitis virus infection , Discontinued in Phase 1
13379,D0D2GZ,AL-408,Central nervous system disease , Investigative
13380,D0D2IU,Engerix B,Hepatitis B virus infection , Approved
13381,D0D2JD,TH-0318,Diabetic complication , Terminated
13382,D0D2JW,Polyhydroxy benzamide derivative 3,Albinism , Patented
13383,D0D2JW,Polyhydroxy benzamide derivative 3,Ephelides , Patented
13384,D0D2JW,Polyhydroxy benzamide derivative 3,Menkes disease , Patented
13385,D0D2JW,Polyhydroxy benzamide derivative 3,Senile lentigines , Patented
13386,D0D2JW,Polyhydroxy benzamide derivative 3,Melasma , Patented
13387,D0D2KU,JQ1,Coronavirus Disease 2019 (COVID-19) , Investigative
13388,D0D2LE,Meso-CART,Pancreatic cancer , Phase 1
13389,D0D2LF,YM-116,Solid tumour/cancer , Phase 1
13390,D0D2PD,ABBV-744,Coronavirus Disease 2019 (COVID-19) , Investigative
13391,D0D2PQ,CT-2412,Solid tumour/cancer , Terminated
13392,D0D2QE,PMID26651364-Compound-117b,Crohn disease , Patented
13393,D0D2QE,PMID26651364-Compound-117b,Ulcerative colitis , Patented
13394,D0D2QE,PMID26651364-Compound-117b,Urinary tract infection , Patented
13395,D0D2RN,Aminopterin,leukaemia , Withdrawn from market
13396,D0D2RR,TgBSSL,Pancreatic malfunction , Investigative
13397,D0D2RZ,SDZ-267-489,Arteriosclerosis , Terminated
13398,D0D2SG,99mTc-ciprofloxacin,Infectious disease , Discontinued in Phase 2
13399,D0D2SX,INNO-101,Hepatitis C virus infection , Discontinued in Phase 2
13400,D0D2TN,Rimexolone,Arthritis , Approved
13401,D0D2TT,TV-1106,Growth hormone deficiency , Phase 3
13402,D0D2TZ,CMS-024-02,Solid tumour/cancer , Phase 3
13403,D0D2UA,2-NAP,Gastrointestinal disease , Investigative
13404,D0D2UU,XEL-003FL,Onychomycosis , Investigative
13405,D0D2VS,Exemestane,Hormonally-responsive breast cancer , Approved
13406,D0D2WX,1614235 + 2330672,Type-2 diabetes , Phase 1
13407,D0D2XA,REIC gene therapy,Prostate cancer , Phase 1/2
13408,D0D2XQ,ASN007,Solid tumour/cancer , Phase 1
13409,D0D2YZ,BMTP-11,Prostate cancer , Phase 1
13410,D0D2ZI,SOM-1000,Fungal infection , Investigative
13411,D0D3AI,L-NAME,Hypertension , Phase 2
13412,D0D3BO,SOLPECAINOL HYDROCHLORIDE,Cardiac arrhythmias , Discontinued in Phase 2
13413,D0D3CJ,BYK-191023,Inflammation , Investigative
13414,D0D3DU,Methotrexate Sodium,Solid tumour/cancer , Approved
13415,D0D3FP,Drug 2881078,Heart failure , Phase 1
13416,D0D3HF,TBI-304,Anemia , Investigative
13417,D0D3HM,RG7212,Solid tumour/cancer , Discontinued in Phase 1
13418,D0D3HV,PLR-21,Psychiatric disorder , Terminated
13419,D0D3JQ,Flovagatran,Thrombosis , Discontinued in Phase 2
13420,D0D3KG,RG-7236,Cardiovascular disease , Discontinued in Phase 1
13421,D0D3KS,Orochol,Vibrio cholerae infection , Approved
13422,D0D3KY,SC-106,Rheumatoid arthritis , Discontinued in Phase 2
13423,D0D3LZ,20D75,Melanoma , Investigative
13424,D0D3PB,BAY 60-4552,Heart failure , Discontinued in Phase 2
13425,D0D3PX,SCH 727965,Acute lymphoblastic leukaemia , Discontinued in Phase 3
13426,D0D3QJ,CRTX-067,Cough , Investigative
13427,D0D3QN,CD11301,Cutaneous T-cell lymphoma , Phase 2
13428,D0D3RS,Biaryl compound 1,Solid tumour/cancer , Patented
13429,D0D3RS,Biaryl compound 1,Infectious disease , Patented
13430,D0D3RS,Biaryl compound 1,Human immunodeficiency virus infection , Patented
13431,D0D3RS,Biaryl compound 1,Hepatitis , Patented
13432,D0D3RY,Merozoite surface protein 3 long synthetic peptide vaccine,Malaria , Phase 2
13433,D0D3SW,ABX-103,Solid tumour/cancer , Investigative
13434,D0D3TO,PYN-22,Obesity , Investigative
13435,D0D3TQ,GSK2330811,Systemic sclerosis , Phase 2
13436,D0D3TQ,GSK2330811,Crohn disease , Phase 2
13437,D0D3TU,DWJ-207,Neuropathic pain , Investigative
13438,D0D3TX,EVP-6124,Schizophrenia , Phase 3
13439,D0D3TX,EVP-6124,Alzheimer disease , Phase 3
13440,D0D3UI,ZY01,Diabetic complication , Phase 1
13441,D0D3UI,ZY01,Obesity , Phase 1
13442,D0D3UQ,Streptococcus mutans vaccine,Dental caries , Phase 1
13443,D0D3VT,Dihydrexidine,Psychotic disorder , Phase 1/2
13444,D0D3XM,TAK-137,Psychiatric disorder , Phase 1
13445,D0D3ZP,NBI-42902,Prostate cancer , Discontinued in Phase 1
13446,D0D4AQ,PCI-45292,Autoimmune diabetes , Preclinical
13447,D0D4CX,Pegamotecan,Esophageal cancer , Phase 2
13448,D0D4CY,Sulfapyridine,Dermatitis herpetiformis , Approved
13449,D0D4DY,Tetracel,Bordetella pertussis infection , Discontinued in Preregistration
13450,D0D4HM,Alglucerase,Enzyme deficiency , Approved
13451,D0D4HN,Podofilox,External genital and perianal wart , Approved
13452,D0D4HN,Podofilox,Condyloma , Approved
13453,D0D4HN,Podofilox,Verruca vulgaris , Approved
13454,D0D4HO,GC021109,Alzheimer disease , Phase 1
13455,D0D4IH,Oxitropium bromide,Asthma , Approved
13456,D0D4IL,AMT-021,Acute intermittent hepatic porphyria , Investigative
13457,D0D4JI,SR-31747,Rheumatoid arthritis , Phase 2
13458,D0D4JO,Artesunate,Malaria , Approved
13459,D0D4LP,JVRS-100,leukaemia , Phase 2
13460,D0D4LS,PUR003,Infectious disease , Phase 1/2
13461,D0D4NJ,CYT-005-allQbG10,Allergic rhinitis , Phase 2
13462,D0D4NX,PMID25666693-Compound-108,Osteoarthritis pain , Patented
13463,D0D4NX,PMID25666693-Compound-108,Cancer related pain , Patented
13464,D0D4NX,PMID25666693-Compound-108,Neuropathic pain , Patented
13465,D0D4NX,PMID25666693-Compound-108,Inflammatory pain , Patented
13466,D0D4OL,SC-002,Bacterial infection , Phase 1
13467,D0D4OL,SC-002,Small-cell lung cancer , Phase 1
13468,D0D4OL,SC-002,Solid tumour/cancer , Phase 1
13469,D0D4OS,VM-202,Angina pectoris , Phase 3
13470,D0D4OS,VM-202,Peripheral neuropathy , Phase 3
13471,D0D4OS,VM-202,Diabetic foot ulcer , Phase 3
13472,D0D4OS,VM-202,Peripheral arterial disease , Phase 3
13473,D0D4OS,VM-202,Amyotrophic lateral sclerosis , Phase 2
13474,D0D4PB,Dextropropoxyphene,Pain , Approved
13475,D0D4QL,Benzimidazole 5-carboxamide,Hepatovirus infection , Investigative
13476,D0D4RF,Sapacitabine,Acute myeloid leukaemia , Phase 3
13477,D0D4RF,Sapacitabine,Acute myelogenous leukaemia , Phase 3
13478,D0D4RF,Sapacitabine,Myelodysplastic syndrome , Phase 2
13479,D0D4RF,Sapacitabine,Breast cancer , Phase 2
13480,D0D4RF,Sapacitabine,Ovarian cancer , Phase 2
13481,D0D4RF,Sapacitabine,Pancreatic cancer , Phase 2
13482,D0D4TC,Sym021,Solid tumour/cancer , Phase 1
13483,D0D4TC,Sym021,Advanced malignancy , Phase 1
13484,D0D4TC,Sym021,Lymphoma , Phase 1
13485,D0D4TC,Sym021,Non-hodgkin lymphoma , Phase 1
13486,D0D4UO,DPK-DTSM-02,Solid tumour/cancer , Investigative
13487,D0D4UT,GSK2849330,Solid tumour/cancer , Phase 1
13488,D0D4VH,BM-212,Asthma , Phase 1
13489,D0D4VN,HPV-16 E7 vaccine,Human papillomavirus infection , Phase 2
13490,D0D4VV,LY2874455,Solid tumour/cancer , Phase 2
13491,D0D4WA,PHY-777,Solid tumour/cancer , Investigative
13492,D0D4XF,Daniplestim,Osteoporosis , Terminated
13493,D0D4YZ,PSI-7977,HCV 1-6 infection , Approved
13494,D0D4YZ,PSI-7977,Hepatitis C virus infection , Phase 2
13495,D0D4ZE,JP-8019,Solid tumour/cancer , Investigative
13496,D0D4ZM,ISRAPAFANT,Asthma , Phase 3
13497,D0D4ZN,CAR-T cells targeting BCMA,leukaemia , Phase 1/2
13498,D0D4ZN,CAR-T cells targeting BCMA,Lymphoma , Phase 1/2
13499,D0D4ZN,CAR-T cells targeting BCMA,Multiple myeloma , Phase 1/2
13500,D0D4ZW,EGS-21,Crohn disease , Phase 2
13501,D0D5AV,HPV 16/18 vaccine,Human papillomavirus infection , Phase 3
13502,D0D5BJ,BPX-201,Prostate cancer , Phase 1
13503,D0D5CJ,SDZ-LAP-977,Psoriasis vulgaris , Discontinued in Phase 2
13504,D0D5CQ,NVP-2,Solid tumour/cancer , Preclinical
13505,D0D5CY,Pradefovir,Hepatitis virus infection , Phase 2
13506,D0D5DE,ALPRENOXIME HYDROCHLORIDE,Glaucoma/ocular hypertension , Discontinued in Phase 2
13507,D0D5EJ,Insulin oral sublingual,Type-1 diabetes , Phase 1
13508,D0D5EW,HKI-9924129,Gram-positive bacterial infection , Investigative
13509,D0D5FB,EPO-derived peptide,Diabetic retinopathy , Investigative
13510,D0D5FQ,Agatolimod,Lung cancer , Discontinued in Phase 2
13511,D0D5FR,Organosphosphates,Candidiasis , Phase 2
13512,D0D5FR,Organosphosphates,Propagation of disease by mosquito , Phase 2
13513,D0D5FU,Baricitinib,Rheumatoid arthritis , Approved
13514,D0D5FU,Baricitinib,Coronavirus Disease 2019 (COVID-19) , Phase 3
13515,D0D5GD,Flumazenil,Benzodiazepine overdose , Approved
13516,D0D5GG,Pemoline,Attention deficit hyperactivity disorder , Approved
13517,D0D5IJ,LN-030,Prostate cancer , Terminated
13518,D0D5IS,SYNSORB-Pk,Clostridium infection , Phase 3
13519,D0D5KQ,PU24S,Solid tumour/cancer , Investigative
13520,D0D5LX,NKTT-120,Sickle-cell disorder , Phase 1
13521,D0D5MQ,Pyrazole derivative 27,Obesity , Patented
13522,D0D5MU,V10153,Ischemic stroke , Phase 2
13523,D0D5NI,GBP-1a,Breast cancer , Investigative
13524,D0D5NV,GC-1109,Bacillus anthracis infection , Phase 2
13525,D0D5NZ,H5N1 influenza vaccine,Influenza virus infection , Phase 3
13526,D0D5RH,TAK-442,Thrombosis , Discontinued in Phase 2
13527,D0D5SQ,Candesartan,Hypertension , Approved
13528,D0D5TN,TT-034,Hepatitis C virus infection , Phase 1/2
13529,D0D5VJ,UK-432097,Chronic obstructive pulmonary disease , Phase 2
13530,D0D5XV,APX-E,Asthma , Investigative
13531,D0D5YE,Imidazo quinoline derivative 1,Solid tumour/cancer , Patented
13532,D0D5YE,Imidazo quinoline derivative 1,Metastatic cancer , Patented
13533,D0D5ZJ,Momelotinib,Myelofibrosis , Phase 3
13534,D0D5ZJ,Momelotinib,Polycythemia vera , Phase 2
13535,D0D5ZJ,Momelotinib,Thrombocythemia , Phase 2
13536,D0D5ZR,TRO-40303,Lateral sclerosis , Discontinued in Phase 2
13537,D0D5ZU,QPI-1002,Renal transplantation , Phase 3
13538,D0D5ZU,QPI-1002,Renal artery disease , Phase 1/2
13539,D0D5ZV,CMI-392,Psoriasis vulgaris , Phase 2
13540,D0D5ZX,RG-12915,Nausea , Discontinued in Phase 3
13541,D0D6BT,Parathyroid hormone analog,Osteoporosis , Phase 1
13542,D0D6DB,Phytosel,Solid tumour/cancer , Discontinued in Phase 1
13543,D0D6EK,RDX-002,Hypophosphatasia , Investigative
13544,D0D6EW,Glypromate,Neurological disorder , Discontinued in Phase 2
13545,D0D6GT,Iota-carrageenan,Influenza virus infection , Phase 4
13546,D0D6HS,Mannoside derivative 12,Crohn disease , Patented
13547,D0D6HS,Mannoside derivative 12,Ulcerative colitis , Patented
13548,D0D6HS,Mannoside derivative 12,Urinary tract infection , Patented
13549,D0D6LF,PD-156,Inflammation , Investigative
13550,D0D6MC,HC-030031,Inflammation , Investigative
13551,D0D6MV,PPI-668,Hepatitis C virus infection , Phase 2
13552,D0D6NQ,HEV-239,Hepatitis E virus infection , Approved
13553,D0D6OM,Alkyl mannoside derivative 7,Crohn disease , Patented
13554,D0D6OM,Alkyl mannoside derivative 7,Ulcerative colitis , Patented
13555,D0D6OM,Alkyl mannoside derivative 7,Urinary tract infection , Patented
13556,D0D6OO,NP-500,Type-2 diabetes , Phase 1
13557,D0D6OO,NP-500,Metabolic syndrome x , Phase 1
13558,D0D6PG,MBS-101,Infectious disease , Investigative
13559,D0D6QH,Sci-DaPT-Vac,Bordetella pertussis infection , Approved
13560,D0D6QU,ADCON-L,Wound healing , Approved
13561,D0D6SZ,TROXACITABINE,Solid tumour/cancer , Phase 2
13562,D0D6VE,Pegvisomant,Acromegaly , Approved
13563,D0D6WF,NP-103,Alzheimer disease , Investigative
13564,D0D6XD,MNX-200,Solid tumour/cancer , Investigative
13565,D0D6XH,LY-203725,Solid tumour/cancer , Phase 1
13566,D0D6XS,LD-02GIFRO,Gastroparesis , Phase 2
13567,D0D6XT,H3B-6527,Hepatocellular carcinoma , Phase 1
13568,D0D6ZB,AX-9657,Pulmonary disease , Investigative
13569,D0D6ZK,"15(S)-hydroxyeicosatetraenoic acid (ophthalmic, dry eye), Alcon",Ocular disease , Discontinued in Phase 3
13570,D0D6ZL,HMPL-002,Solid tumour/cancer , Approved
13571,D0D6ZW,BMS-986020,Scleroderma , Phase 2
13572,D0D6ZW,BMS-986020,Psoriasis vulgaris , Phase 1
13573,D0D7AJ,Pyrazoline derivative 11,Obesity , Patented
13574,D0D7AM,MS-1819,Exocrine pancreatic insufficiency , Phase 1/2
13575,D0D7BX,Rivoceranib,Gastric adenocarcinoma , Phase 3
13576,D0D7BX,Rivoceranib,Sarcoma , Phase 2
13577,D0D7BX,Rivoceranib,Solid tumour/cancer , Phase 1
13578,D0D7CH,TAK-828,Crohn disease , Phase 1
13579,D0D7DH,Green soap,Acne vulgaris , Approved
13580,D0D7DU,VLTS-589,Peripheral vascular disease , Phase 2
13581,D0D7EK,TPI-1361-17,Obesity , Investigative
13582,D0D7EL,CHR-3620,Inflammation , Investigative
13583,D0D7EN,Tiamenidine,Hypertension , Approved
13584,D0D7FV,CD19/CD22 Chimeric Antigen Receptor T Cells,Acute lymphoblastic leukaemia , Phase 1
13585,D0D7FV,CD19/CD22 Chimeric Antigen Receptor T Cells,B-cell lymphoma , Phase 1
13586,D0D7FV,CD19/CD22 Chimeric Antigen Receptor T Cells,Mediastinal large B-cell lymphoma , Phase 1
13587,D0D7GE,TAK-029,Thrombosis , Discontinued in Phase 1
13588,D0D7GS,MultiStem,Ischemic stroke , Phase 3
13589,D0D7GS,MultiStem,Spinal cord injury , Phase 2
13590,D0D7GS,MultiStem,Graft-versus-host disease , Phase 2
13591,D0D7GS,MultiStem,AIDS-related lymphoma , Phase 2
13592,D0D7GS,MultiStem,Acute myocardial infarction , Phase 2
13593,D0D7KC,Alvimopan,Gastrointestinal disease , Approved
13594,D0D7KR,CDD-0235-J,Alzheimer disease , Investigative
13595,D0D7KU,SNA-001,Acne vulgaris , Phase 3
13596,D0D7LA,Metformin,Type-2 diabetes , Approved
13597,D0D7LP,RQ-00201894,Gastroesophageal reflux disease , Investigative
13598,D0D7MJ,CNSB-001,Neuropathic pain , Phase 2
13599,D0D7MZ,UniGAM SD,Immune System disease , Approved
13600,D0D7OE,RHAMLET,Solid tumour/cancer , Investigative
13601,D0D7QY,BPL-004,Influenza virus infection , Investigative
13602,D0D7RE,BBI-8000,Solid tumour/cancer , Investigative
13603,D0D7TB,Opipramol,Anxiety disorder , Approved
13604,D0D7TD,Cethromycin,Bacterial infection , Phase 3
13605,D0D7TD,Cethromycin,Pneumonia , Phase 3
13606,D0D7UD,AS-013,Thrombosis , Phase 3
13607,D0D7VO,GK1-399,Diabetic complication , Phase 2
13608,D0D7VO,GK1-399,Type-2 diabetes , Phase 2
13609,D0D7WS,MTL-102,Solid tumour/cancer , Investigative
13610,D0D7XM,NC-4016,Solid tumour/cancer , Phase 1
13611,D0D7XS,GPG-290,Angina pectoris , Investigative
13612,D0D7XW,SINITRODIL,Angina pectoris , Discontinued in Phase 2
13613,D0D7YA,DSP-6952,Constipation , Phase 2
13614,D0D7YF,NT-CC-017,Neurodegenerative disorder , Investigative
13615,D0D7YR,AMPE4L,Diabetic complication , Investigative
13616,D0D7YW,TC-5214,Palmar hyperhidrosis , Phase 2
13617,D0D7ZU,Pyrazole derivative 23,Obesity , Patented
13618,D0D8CE,EVP-0334,Neurodegenerative disorder , Preclinical
13619,D0D8DA,KAG-308,Ulcerative colitis , Investigative
13620,D0D8DD,Sufentanil,Analgesia , Approved
13621,D0D8EY,HLF 1-11,Bacterial infection , Phase 1/2
13622,D0D8EY,HLF 1-11,Bacteremia , Phase 1/2
13623,D0D8EY,HLF 1-11,Candidemia , Phase 1/2
13624,D0D8FN,LY-156735,Anxiety disorder , Phase 2
13625,D0D8GO,MLR-1045,Irritable bowel syndrome , Investigative
13626,D0D8JB,PF-05212384,Solid tumour/cancer , Phase 2
13627,D0D8KI,Ad5-AC6,Cardiac failure , Terminated
13628,D0D8KQ,Jakafi,Essential thrombocythemia , Phase 3
13629,D0D8KU,Ferritarg P,Lymphoma , Phase 1/2
13630,D0D8LK,Parvovirus B19 vaccine,Parvovirus infection , Phase 2
13631,D0D8LP,Phenylsulfonyl derivative 3,Central nervous system disease , Patented
13632,D0D8MD,ZM-230487,Asthma , Terminated
13633,D0D8MG,NOX-A12,Macular degeneration , Phase 1
13634,D0D8MS,NSD-726,Autoimmune diabetes , Investigative
13635,D0D8NG,Sc Veltuzumab,Rheumatoid arthritis , Phase 1
13636,D0D8NG,Sc Veltuzumab,Idiopathic thrombocytopenic purpura , Phase 1
13637,D0D8PF,Thiazole carboxamide derivative 16,Solid tumour/cancer , Patented
13638,D0D8PF,Thiazole carboxamide derivative 16,Metastatic cancer , Patented
13639,D0D8QV,AXS-02,Neuropathic pain , Phase 3
13640,D0D8QV,AXS-02,Chronic low back pain , Phase 3
13641,D0D8QV,AXS-02,Knee osteoarthritis , Phase 3
13642,D0D8RC,Metformin,Type-2 diabetes , Approved
13643,D0D8RC,Metformin,Coronavirus Disease 2019 (COVID-19) , Investigative
13644,D0D8RT,Quattro,Ragweed hypersensitivity allergic disease , Phase 3
13645,D0D8RT,Quattro,Grass pollen hypersensitivity , Phase 3
13646,D0D8SN,ALD-401,Cerebrovascular ischaemia , Phase 2
13647,D0D8SU,NMS-873,Coronavirus Disease 2019 (COVID-19) , Investigative
13648,D0D8TE,FBS-0701,Iron overload disease , Phase 2
13649,D0D8UH,ABIO-08-01,Amnesia , Discontinued in Phase 2
13650,D0D8UM,Afabicin,Acute bacterial skin infection , Phase 2
13651,D0D8VE,Halothane,Anaesthesia , Approved
13652,D0D8VU,LGD-6972,Type-2 diabetes , Phase 2
13653,D0D8VU,LGD-6972,Non-insulin dependent diabetes , Investigative
13654,D0D8XG,AeroLEF,Pain , Phase 2
13655,D0D8ZB,Ioxithalamate,Cardiovascular disease , Approved
13656,D0D8ZK,OBP-301,Liver cancer , Phase 1/2
13657,D0D8ZK,OBP-301,Head and neck cancer , Phase 1/2
13658,D0D8ZK,OBP-301,Breast cancer , Phase 1/2
13659,D0D8ZU,AX-205,Motor neurone disease , Terminated
13660,D0D9AD,YM-750,Hyperlipidaemia , Discontinued in Phase 1
13661,D0D9AH,VX-702,Coronary artery disease , Phase 2a
13662,D0D9AH,VX-702,Rheumatoid arthritis , Phase 2a
13663,D0D9AH,VX-702,Inflammation , Phase 1
13664,D0D9AL,ATON-005,Psychotic disorder , Phase 1
13665,D0D9BL,Anti-CD19 CAR-T cells,B-cell chronic lymphocytic leukaemia , Phase 1/2
13666,D0D9CO,SB-221420-A,Pain , Investigative
13667,D0D9FV,Orphenadrine,Parkinson disease , Approved
13668,D0D9FW,DP-VPA,Bipolar disorder , Approved
13669,D0D9HA,PF-04634817,Diabetic nephropathy , Phase 2
13670,D0D9HW,Tenofovir,Human immunodeficiency virus infection , Approved
13671,D0D9HZ,PF-06438179,Rheumatoid arthritis , Phase 3
13672,D0D9IQ,BGB-290,Ovarian cancer , Phase 2
13673,D0D9IQ,BGB-290,Solid tumour/cancer , Phase 1/2
13674,D0D9IQ,BGB-290,Recurrent glioblastoma , Phase 1
13675,D0D9JB,ALERT,Solid tumour/cancer , Investigative
13676,D0D9JW,Ketorolac,Postoperative inflammation , Approved
13677,D0D9KK,CD4-BFFI,Human immunodeficiency virus-1 infection , Investigative
13678,D0D9KQ,E-6006,Anxiety disorder , Discontinued in Phase 2
13679,D0D9KV,SKL-18287,Non-insulin dependent diabetes , Investigative
13680,D0D9LB,BIBV 308,Peripheral vascular disease , Phase 1
13681,D0D9LJ,Atiprimod,Multiple myeloma , Phase 1/2
13682,D0D9MV,Aryl mannoside derivative 17,Crohn disease , Patented
13683,D0D9MV,Aryl mannoside derivative 17,Ulcerative colitis , Patented
13684,D0D9MV,Aryl mannoside derivative 17,Urinary tract infection , Patented
13685,D0D9NA,Almitrine,Chronic obstructive pulmonary disease , Approved
13686,D0D9NP,Nix-0699,Sickle-cell disorder , Approved
13687,D0D9NY,Bempedoic acid,Familial hypercholesterolemia , Approved
13688,D0D9NY,Bempedoic acid,Cardiovascular disease , Phase 3
13689,D0D9OM,V1A F/U,Infertility , Investigative
13690,D0D9VE,DCCR,Prader-Willi syndrome , Phase 3
13691,D0D9VE,DCCR,Dyslipidemia , Phase 2
13692,D0D9YB,DPX E7,Human papillomavirus infection , Phase 1/2
13693,D0D9YB,DPX E7,Cervical cancer , Phase 1/2
13694,D0D9YU,PLATENSIMYCIN,Bacterial infection , Investigative
13695,D0D9ZB,TAK-583,Diabetic neuropathy , Phase 2/3
13696,D0DA0C,Peniel-3000,Osteoporosis , Investigative
13697,D0DA1U,C7R-GD2.CART cells,Neuroblastoma , Phase 1
13698,D0DA3D,MLR-1130,Atopic dermatitis , Investigative
13699,D0DA3T,Prostate dendritic cell-based vaccine,Prostate cancer , Phase 3
13700,D0DA4B,JNJ-64407564,Multiple myeloma , Phase 1
13701,D0DA5M,C 82,Scleroderma , Phase 1/2
13702,D0DA6N,TEM-8-Fc,Solid tumour/cancer , Investigative
13703,D0DA6X,JNJ-47910382,Hepatitis C virus infection , Phase 1
13704,D0DBS7,GBR1302,Solid tumour/cancer , Phase 1
13705,D0DC0S,Octaplas LG,Thrombosis , Phase 1
13706,D0DC1I,RG-7356,Haematological malignancy , Discontinued in Phase 1
13707,D0DC2P,PMID25684022-Compound-WO2012135799 42(1.4),Solid tumour/cancer , Patented
13708,D0DC2P,PMID25684022-Compound-WO2012135799 42(1.4),Metastatic cancer , Patented
13709,D0DC4O,PMID25666693-Compound-74,Osteoarthritis pain , Patented
13710,D0DC4O,PMID25666693-Compound-74,Cancer related pain , Patented
13711,D0DC4O,PMID25666693-Compound-74,Neuropathic pain , Patented
13712,D0DC4O,PMID25666693-Compound-74,Inflammatory pain , Patented
13713,D0DC6U,Dapivirine,Human immunodeficiency virus infection , Phase 1/2
13714,D0DC7I,PMID25656651-Compound-11b,Chronic myeloid leukaemia , Patented
13715,D0DC8J,CYT-609,Solid tumour/cancer , Phase 1
13716,D0DD0K,Losartan,Hypertension , Approved
13717,D0DD0O,D-21805,Solid tumour/cancer , Terminated
13718,D0DD4N,GEH-120714,Multiple sclerosis , Phase 1
13719,D0DD4P,Cresemba,Invasive aspergillosis , Phase 3
13720,D0DD4P,Cresemba,Haematological malignancy , Phase 1
13721,D0DD8T,VERU-111,Coronavirus Disease 2019 (COVID-19) , Phase 2
13722,D0DD9F,HumaSPECT,Prostate cancer , Phase 3
13723,D0DD9T,HP-05,Fatigue , Investigative
13724,D0DE0C,Diphenyl purine derivative 2,Obesity , Patented
13725,D0DE4U,Erythropoietin beta,Erythropoietic porphyrias , Approved
13726,D0DE5I,PMID25666693-Compound-78,Osteoarthritis pain , Patented
13727,D0DE5I,PMID25666693-Compound-78,Cancer related pain , Patented
13728,D0DE5I,PMID25666693-Compound-78,Neuropathic pain , Patented
13729,D0DE5I,PMID25666693-Compound-78,Inflammatory pain , Patented
13730,D0DE5K,PMID25666693-Compound-42,Osteoarthritis pain , Patented
13731,D0DE5K,PMID25666693-Compound-42,Cancer related pain , Patented
13732,D0DE5K,PMID25666693-Compound-42,Neuropathic pain , Patented
13733,D0DE5K,PMID25666693-Compound-42,Inflammatory pain , Patented
13734,D0DF1R,Ulinastatin,Premature labour , Phase 3
13735,D0DF6B,Azetidine-1-carboxamide derivative 1,Obesity , Patented
13736,D0DF8Y,CTA-192,Hyperparathyroidism , Investigative
13737,D0DF9Z,Attapulgite,Diarrhea , Approved
13738,D0DG0P,Triflupromazine,Schizophrenia , Withdrawn from market
13739,D0DG0P,Triflupromazine,Severe acute respiratory syndrome (SARS) , Investigative
13740,D0DG0P,Triflupromazine,Middle East Respiratory Syndrome (MERS) , Investigative
13741,D0DG0W,ALX-0625,Migraine , Terminated
13742,D0DG6C,Encapsulated transplanted islets,Type-1 diabetes , Phase 1/2
13743,D0DG9F,PP-1420,Obesity , Phase 1/2
13744,D0DG9M,AZD-9139,Gastrointestinal disease , Terminated
13745,D0DH0Y,Aryl mannoside derivative 12,Crohn disease , Patented
13746,D0DH0Y,Aryl mannoside derivative 12,Ulcerative colitis , Patented
13747,D0DH0Y,Aryl mannoside derivative 12,Urinary tract infection , Patented
13748,D0DH1H,CCT-241533,Solid tumour/cancer , Investigative
13749,D0DH5X,Vibegron,Overactive bladder , Approved
13750,D0DI0B,OX 19,Urinary incontinence , Discontinued in Phase 1
13751,D0DI1B,TTP273,Type-2 diabetes , Phase 2
13752,D0DI1R,PMID25666693-Compound-130,Osteoarthritis pain , Patented
13753,D0DI1R,PMID25666693-Compound-130,Cancer related pain , Patented
13754,D0DI1R,PMID25666693-Compound-130,Neuropathic pain , Patented
13755,D0DI1R,PMID25666693-Compound-130,Inflammatory pain , Patented
13756,D0DI1T,Biaryl mannoside derivative 16,Crohn disease , Patented
13757,D0DI1T,Biaryl mannoside derivative 16,Ulcerative colitis , Patented
13758,D0DI1T,Biaryl mannoside derivative 16,Urinary tract infection , Patented
13759,D0DI3E,DHP-218,Hypertension , Terminated
13760,D0DI6L,Sivextro,Acute bacterial skin infection , Phase 3
13761,D0DI6U,Alkyl mannoside derivative 10,Crohn disease , Patented
13762,D0DI6U,Alkyl mannoside derivative 10,Ulcerative colitis , Patented
13763,D0DI6U,Alkyl mannoside derivative 10,Urinary tract infection , Patented
13764,D0DI8J,BMS-275183,Solid tumour/cancer , Phase 2
13765,D0DJ0S,NGM313,Type-2 diabetes , Phase 1
13766,D0DJ1B,Naproxen,Osteoarthritis , Approved
13767,D0DJ1B,Naproxen,Pain , Phase 2
13768,D0DJ1B,Naproxen,Endometriosis , Investigative
13769,D0DJ2H,BION-1301,Multiple myeloma , Phase 1/2
13770,D0DJ4A,Preverex,Artery stenosis , Phase 2
13771,D0DJ5T,Ecomustine,Solid tumour/cancer , Terminated
13772,D0DJ8D,GPI-16552,Cerebrovascular ischaemia , Terminated
13773,D0DJ8S,CART-Muc1 cells,Myelodysplastic syndrome , Phase 1
13774,D0DJ8S,CART-Muc1 cells,Acute myeloid leukaemia , Phase 1
13775,D0DJ9D,Burosumab,X-linked hypophosphataemia , Approved
13776,D0DK2X,GSK-280,Inflammation , Investigative
13777,D0DK5R,Axicabtagene ciloleucel,Diffuse large B-cell lymphoma , Approved
13778,D0DK5R,Axicabtagene ciloleucel,Large B-cell lymphoma , Approved
13779,D0DK5R,Axicabtagene ciloleucel,Mantle cell lymphoma , Phase 2/3
13780,D0DK5R,Axicabtagene ciloleucel,Follicular lymphoma , Phase 2/3
13781,D0DK5R,Axicabtagene ciloleucel,Primary mediastinal B-cell lymphoma , Phase 2/3
13782,D0DK5R,Axicabtagene ciloleucel,Non-hodgkin lymphoma , Phase 2
13783,D0DK5R,Axicabtagene ciloleucel,Acute lymphoblastic leukaemia , Phase 1
13784,D0DK5X,PF-06263276,Psoriasis vulgaris , Phase 1
13785,D0DK8G,Technetium Tc-99m Etidronate Kit,Radioactive tracer , Approved
13786,D0DK8V,Cetirizine,Allergic rhinitis , Approved
13787,D0DK8X,BMS-911543,Myelofibrosis , Phase 2
13788,D0DL2S,MILFASARTAN,Hypertension , Discontinued in Phase 2
13789,D0DL3R,PMID25553724-Compound-US2011801300410,Immune System disease , Patented
13790,D0DL3W,APX-001,Candidemia , Phase 2
13791,D0DL3W,APX-001,Rheumatoid arthritis , Investigative
13792,D0DL7P,Diazepinone derivative 4,Reflux disease , Patented
13793,D0DL7P,Diazepinone derivative 4,Parkinson disease , Patented
13794,D0DL8A,Clarithromycin,Coronavirus Disease 2019 (COVID-19) , Phase 2
13795,D0DM2G,Bis-indolylmaleimide derivative 1,Solid tumour/cancer , Patented
13796,D0DM2G,Bis-indolylmaleimide derivative 1,Metastatic cancer , Patented
13797,D0DM4K,Heat-killed Mycobacterium vaccine,Mycobacterium infection , Investigative
13798,D0DM5A,SIM-6080,Angina pectoris , Terminated
13799,D0DM6I,DAPITANT,Pain , Phase 2
13800,D0DN0W,Niraparib Tosylate,Peritoneal cancer , Approved
13801,D0DN0W,Niraparib Tosylate,Fallopian tube cancer , Approved
13802,D0DN1I,JTT-551,Type-2 diabetes , Terminated
13803,D0DN1V,Dapagliflozin,Coronavirus Disease 2019 (COVID-19) , Phase 3
13804,D0DN3Q,"Pyrazolo[1,5-a]pyridine derivative 1",Pruritus , Patented
13805,D0DN3Q,"Pyrazolo[1,5-a]pyridine derivative 1",Solid tumour/cancer , Patented
13806,D0DN3Q,"Pyrazolo[1,5-a]pyridine derivative 1",Chronic pain , Patented
13807,D0DN3Q,"Pyrazolo[1,5-a]pyridine derivative 1",Neuropathic pain , Patented
13808,D0DN3Q,"Pyrazolo[1,5-a]pyridine derivative 1",Thymic cancer , Patented
13809,D0DN7Y,SER-214,Parkinson disease , Phase 1
13810,D0DO0B,TT-111,Bleeding disorder , Investigative
13811,D0DO5J,MDAM (y-methylene-10-deazaaminopterin),Solid tumour/cancer , Phase 1
13812,D0DO5U,SK-7068,Solid tumour/cancer , Preclinical
13813,D0DO6K,Thiazole carboxamide derivative 23,Solid tumour/cancer , Patented
13814,D0DO6K,Thiazole carboxamide derivative 23,Metastatic cancer , Patented
13815,D0DO8E,CAR-T cells targeting CLL1,leukaemia , Phase 1/2
13816,D0DO8E,CAR-T cells targeting CLL1,Lymphoma , Phase 1/2
13817,D0DO8E,CAR-T cells targeting CLL1,Multiple myeloma , Phase 1/2
13818,D0DP0J,PR-924,T lymphoblastic leukaemia , Phase 1
13819,D0DP1O,CTD-02,Central nervous system disease , Phase 1
13820,D0DP3V,TG-C,Arthritis , Phase 3
13821,D0DP5I,BMS-986205,Melanoma , Phase 3
13822,D0DP5I,BMS-986205,Gastric adenocarcinoma , Phase 2
13823,D0DP5I,BMS-986205,Renal cell carcinoma , Phase 2
13824,D0DP5I,BMS-986205,Advanced cancer , Phase 1
13825,D0DP5I,BMS-986205,Solid tumour/cancer , Phase 1
13826,D0DP6L,Isoflurane,Anaesthesia , Approved
13827,D0DP7T,Human embryonic stem cell-derived vascular progenitors,Solid tumour/cancer , Investigative
13828,D0DP8E,PMID30107136-Compound-Example57,Solid tumour/cancer , Patented
13829,D0DP8E,PMID30107136-Compound-Example57,Infectious disease , Patented
13830,D0DP8E,PMID30107136-Compound-Example57,Human immunodeficiency virus infection , Patented
13831,D0DP8E,PMID30107136-Compound-Example57,Hepatitis , Patented
13832,D0DP8P,BW755C,Inflammation , Terminated
13833,D0DP8U,IKH-02,Solid tumour/cancer , Investigative
13834,D0DP9O,Autologous chondrocyte implantation,Primary biliary cirrhosis , Phase 3
13835,D0DP9O,Autologous chondrocyte implantation,Cartilage disorder , Phase 3
13836,D0DQ2D,RG7625,Autoimmune disease , Phase 2
13837,D0DQ2D,RG7625,Sjogren syndrome , Phase 2
13838,D0DQ2D,RG7625,Coeliac disease , Phase 1
13839,D0DQ2N,SC-72393,Insomnia , Investigative
13840,D0DQ2T,Cu(II)ATSM,Amyotrophic lateral sclerosis , Phase 1/2
13841,D0DQ2T,Cu(II)ATSM,Parkinson disease , Phase 1
13842,D0DQ3H,Opicinumab,Multiple sclerosis , Phase 2
13843,D0DQ5G,"Pyrrolo[3,2-c]pyridine derivative 1",Pruritus , Patented
13844,D0DQ5G,"Pyrrolo[3,2-c]pyridine derivative 1",Solid tumour/cancer , Patented
13845,D0DQ5G,"Pyrrolo[3,2-c]pyridine derivative 1",Chronic pain , Patented
13846,D0DQ5G,"Pyrrolo[3,2-c]pyridine derivative 1",Neuropathic pain , Patented
13847,D0DQ5G,"Pyrrolo[3,2-c]pyridine derivative 1",Thymic cancer , Patented
13848,D0DQ7T,Sporidin-G,Diarrhea , Discontinued in Phase 3
13849,D0DQ7V,Lutetium Lu 177 dotatate,Neuroendocrine cancer , Approved
13850,D0DQ9N,Fibrovax,Solid tumour/cancer , Discontinued in Phase 1
13851,D0DR0P,ARQ 761,Pancreatic cancer , Phase 2
13852,D0DR0P,ARQ 761,Solid tumour/cancer , Phase 1
13853,D0DR3I,S-33516,Arthritis , Terminated
13854,D0DR3T,Ad.hIL-12,Breast cancer , Phase 1
13855,D0DR4O,SRF231,Haematological malignancy , Phase 1
13856,D0DR4O,SRF231,Solid tumour/cancer , Phase 1
13857,D0DR4W,MyoCell SDF-1,Heart failure , Phase 3
13858,D0DR6N,CART-19 cells,Acute lymphoblastic leukaemia , Phase 1
13859,D0DR6Q,"Diphtheria, tetanus, acellular pertussis vaccine",Bordetella pertussis infection , Approved
13860,D0DS1L,AK-20,Non-alcoholic steatohepatitis , Investigative
13861,D0DS2M,PrLL-37,Wound healing , Investigative
13862,D0DS3J,18-MC,Substance use disorder , Phase 1
13863,D0DS4P,CGS-26393,Heart disease , Terminated
13864,D0DS5U,Sodium polystyrene sulfonate,Mineral-electrolyte metabolism disorder , Approved
13865,D0DT1E,Rh-thrombin,Haemorrhage , Approved
13866,D0DT1R,Triapine,Nerve injury , Phase 2
13867,D0DT1Y,WTX-101,Wilson disease , Phase 2
13868,D0DT2P,Nafagrel,Asthma , Discontinued in Phase 2
13869,D0DT2S,TAK-202,Melanoma , Phase 1
13870,D0DT2S,TAK-202,Solid tumour/cancer , Phase 1
13871,D0DT5E,Cephalothin Sodium,Bacterial infection , Approved
13872,D0DT5H,AZD4785,Solid tumour/cancer , Phase 1
13873,D0DT7M,PMID25666693-Compound-124,Osteoarthritis pain , Patented
13874,D0DT7M,PMID25666693-Compound-124,Cancer related pain , Patented
13875,D0DT7M,PMID25666693-Compound-124,Neuropathic pain , Patented
13876,D0DT7M,PMID25666693-Compound-124,Inflammatory pain , Patented
13877,D0DT8Y,MEDI5117,Rheumatoid arthritis , Phase 1
13878,D0DU4T,IC9-CAR19 cells,Acute lymphoblastic leukaemia , Phase 1
13879,D0DU4T,IC9-CAR19 cells,Immune System disease , Phase 1
13880,D0DU4T,IC9-CAR19 cells,Immunoproliferative disorder , Phase 1
13881,D0DU6X,R-41D,Staphylococcus infection , Investigative
13882,D0DU9I,RT-100,Congestive heart failure , Phase 3
13883,D0DV2Q,BMN-190,Neuronal ceroid lipofuscinosis , Phase 2
13884,D0DV3O,Epinastine,Allergic conjunctivitis , Approved
13885,D0DV3T,Epoetin zeta,Anemia , Phase 3
13886,D0DV4J,Beriplast-P,Wound healing , Approved
13887,D0DV6D,Darolutamide,Prostate cancer , Approved
13888,D0DV8K,Dexamethasone,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
13889,D0DV8Z,Elezanumab,Multiple sclerosis , Phase 2
13890,D0DV8Z,Elezanumab,Spinal cord injury , Phase 2
13891,D0DW3Z,PMID26815044-Compound-93,Albinism , Patented
13892,D0DW3Z,PMID26815044-Compound-93,Ephelides , Patented
13893,D0DW3Z,PMID26815044-Compound-93,Menkes disease , Patented
13894,D0DW3Z,PMID26815044-Compound-93,Senile lentigines , Patented
13895,D0DW3Z,PMID26815044-Compound-93,Melasma , Patented
13896,D0DW5P,Schiff base compound 2,Alzheimer disease , Patented
13897,D0DW7A,PMID26651364-Compound-6b,Crohn disease , Patented
13898,D0DW7A,PMID26651364-Compound-6b,Ulcerative colitis , Patented
13899,D0DW7A,PMID26651364-Compound-6b,Urinary tract infection , Patented
13900,D0DX0G,Tergenpumatucel-L + indoximod + chemotherapy,Non-small-cell lung cancer , Phase 1
13901,D0DX1F,Leber's congenital amaurosis gene therapy,Visual disturbance , Phase 1/2
13902,D0DX1F,Leber's congenital amaurosis gene therapy,Leber congenital amaurosis , Phase 1/2
13903,D0DX4J,P1446A-05,Solid tumour/cancer , Phase 1
13904,D0DX6L,SDZ-PSD-958,Psychiatric disorder , Terminated
13905,D0DX7J,Lucinactant,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
13906,D0DX9T,Skin tissue replacement therapy,Skin burns , Phase 1/2
13907,D0DY1N,AMT-080,Duchenne dystrophy , Investigative
13908,D0DY4E,JNJ-17203212,Cough , Investigative
13909,D0DY5R,Bicyclic heteroaryl benzamide derivative 8,Pruritus , Patented
13910,D0DY5R,Bicyclic heteroaryl benzamide derivative 8,Solid tumour/cancer , Patented
13911,D0DY5R,Bicyclic heteroaryl benzamide derivative 8,Chronic pain , Patented
13912,D0DY5R,Bicyclic heteroaryl benzamide derivative 8,Neuropathic pain , Patented
13913,D0DY5R,Bicyclic heteroaryl benzamide derivative 8,Thymic cancer , Patented
13914,D0DY7W,Nebracetam,Parkinson disease , Phase 3
13915,D0DY9I,MERS-CoVS-containing nanoparticle vaccine,Middle East Respiratory Syndrome (MERS) , Investigative
13916,D0DY9K,BAX335,Haemophilia B , Phase 1/2
13917,D0DZ3X,L-Proline,Malnutrition , Approved
13918,D0DZ8U,Tranexamic acid,Coronavirus Disease 2019 (COVID-19) , Phase 2
13919,D0E0AS,(S)-oxybutynin,Urinary incontinence , Phase 2
13920,D0E0AX,AP-611074,Condyloma , Phase 1/2
13921,D0E0BD,Glycerol phenylbutyrate,Hepatic encephalopathy , Approved
13922,D0E0BE,Na-APR-1,Hookworm infection , Phase 1
13923,D0E0CT,Trimebutine,Irritable bowel syndrome , Approved
13924,D0E0DL,ADX40-TB,Mycobacterium infection , Investigative
13925,D0E0DS,Box-5,Melanoma , Investigative
13926,D0E0FY,CTL-102-GDEPT,Head and neck cancer , Discontinued in Phase 2
13927,D0E0GC,LIM-0723,Toxicity , Investigative
13928,D0E0GW,BVT-3498,Metabolic disorder , Terminated
13929,D0E0HE,Hexyl,Radiation syndrome , Phase 3
13930,D0E0IG,TRX-385,Autoimmune diabetes , Investigative
13931,D0E0IK,Adva-R46,Solid tumour/cancer , Investigative
13932,D0E0JF,Pirazolac,Inflammation , Discontinued in Preregistration
13933,D0E0JO,GLPG-1837,Cystic fibrosis , Phase 2
13934,D0E0JV,CDRI-S007-867,Thrombosis , Investigative
13935,D0E0KQ,Pyronaridine,Malaria , Approved
13936,D0E0LQ,Thiothixene,Schizophrenia , Approved
13937,D0E0MU,AstraStim,Solid tumour/cancer , Investigative
13938,D0E0NL,TRX-1,Autoimmune diabetes , Phase 1
13939,D0E0NM,DCC-2036,Chronic myeloid leukaemia , Phase 1/2
13940,D0E0NM,DCC-2036,Acute lymphoblastic leukaemia , Phase 1
13941,D0E0NM,DCC-2036,Breast cancer , Phase 1
13942,D0E0OG,Lorazepam,Anxiety disorder , Approved
13943,D0E0OI,Memex,Alzheimer disease , Investigative
13944,D0E0QS,VM-301,Dermatitis , Discontinued in Phase 2
13945,D0E0RP,CART20,B-cell lymphoma , Phase 1/2
13946,D0E0RY,Melitracen,Major depressive disorder , Approved
13947,D0E0SA,PMID25666693-Compound-110,Osteoarthritis pain , Patented
13948,D0E0SA,PMID25666693-Compound-110,Cancer related pain , Patented
13949,D0E0SA,PMID25666693-Compound-110,Neuropathic pain , Patented
13950,D0E0SA,PMID25666693-Compound-110,Inflammatory pain , Patented
13951,D0E0SH,CART-117 cells,Myelodysplastic syndrome , Phase 1
13952,D0E0SH,CART-117 cells,Acute myeloid leukaemia , Phase 1
13953,D0E0ST,Tisokinase,Acute myocardial infarction , Approved
13954,D0E0SW,Enoximone,Congestive heart failure , Approved
13955,D0E0UC,DSR-17759,Non-insulin dependent diabetes , Investigative
13956,D0E0UN,PC-22,Solid tumour/cancer , Investigative
13957,D0E0WQ,Barbital,Insomnia , Approved
13958,D0E0WU,TRIN-2755,Solid tumour/cancer , Phase 1
13959,D0E0XL,QMF149,Chronic obstructive pulmonary disease , Phase 3
13960,D0E0YW,DS-1062,Non-small-cell lung cancer , Phase 1
13961,D0E1AN,MINT-1526A,Solid tumour/cancer , Phase 1
13962,D0E1AW,GC5101B,Ulcer , Phase 3
13963,D0E1AZ,ISU-201,Autoimmune diabetes , Investigative
13964,D0E1DF,Afrezza,Type-1/2 diabetes , Approved
13965,D0E1FP,Interferon alpha 5,Infectious disease , Phase 1/2
13966,D0E1GC,PMID26651364-Compound-5g,Crohn disease , Patented
13967,D0E1GC,PMID26651364-Compound-5g,Ulcerative colitis , Patented
13968,D0E1GC,PMID26651364-Compound-5g,Urinary tract infection , Patented
13969,D0E1HC,Tezacaftor and ivacaftor,Acute lung injury , Approved
13970,D0E1HF,FFC-14A,Solid tumour/cancer , Phase 1
13971,D0E1HY,GPCR39 pepducins,Diabetic complication , Investigative
13972,D0E1JP,Montelukast,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
13973,D0E1LB,MK-2578,Anemia , Phase 2
13974,D0E1OJ,Xenon Xe-133,Diagnostic imaging , Approved
13975,D0E1RT,ASP7373,H5N1 influenza infection , Phase 2
13976,D0E1SQ,BIBW-22,Solid tumour/cancer , Terminated
13977,D0E1ST,CAR-T cells targeting GD2,Glioma , Phase 1/2
13978,D0E1SV,MIQ-001,Alzheimer disease , Phase 2
13979,D0E1SW,Acetazolamide,Glaucoma/ocular hypertension , Approved
13980,D0E1UY,AC-501,Acute myeloid leukaemia , Investigative
13981,D0E1UZ,CL-283796,Hyperlipidaemia , Discontinued in Phase 2
13982,D0E1VD,OM-89,Rheumatoid arthritis , Approved
13983,D0E1VV,ELOMOTECAN HYDROCHLORIDE,Solid tumour/cancer , Phase 1
13984,D0E1WH,LY-2608204,Type-2 diabetes , Phase 2
13985,D0E1WI,Fentanyl,Analgesia , Approved
13986,D0E1WI,Fentanyl,Pain , Phase 3
13987,D0E1WI,Fentanyl,Cancer related pain , Phase 3
13988,D0E1WI,Fentanyl,Chronic pain , Phase 1
13989,D0E1WY,EFIPLADIB,Asthma , Terminated
13990,D0E1XL,Levetiracetam,Fibromyalgia , Approved
13991,D0E1XL,Levetiracetam,Epilepsy , Approved
13992,D0E1YN,SB-2280,Solid tumour/cancer , Investigative
13993,D0E1ZE,BBB-022,Cerebrovascular ischaemia , Terminated
13994,D0E1ZQ,SWA11-ZZ-PE38,Solid tumour/cancer , Investigative
13995,D0E1ZR,VLD-517,Malaria , Investigative
13996,D0E1ZV,Labetuzumab-SN-38,Solid tumour/cancer , Phase 2
13997,D0E2AF,PMID27998201-Compound-2,Alzheimer disease , Patented
13998,D0E2AJ,P-27A,Malaria , Phase 1
13999,D0E2CO,BMY-22089,Hyperlipidaemia , Terminated
14000,D0E2CQ,RG7160,Metastatic colorectal cancer , Discontinued in Phase 2
14001,D0E2CS,CD19-TCRz-41BB and CD22-TCRz-41BB CAR-T Cells,Haematopoietic/lymphoid cancer , Phase 1/2
14002,D0E2CZ,FS-205-397,Pain , Discontinued in Phase 2
14003,D0E2DL,CDCA1-derived epitope peptide vaccine,Prostate cancer , Phase 1/2
14004,D0E2ED,IdioVax,Lymphoma , Discontinued in Phase 2
14005,D0E2EN,TDI-0048,Motor neurone disease , Investigative
14006,D0E2EY,BLI-1005,Major depressive disorder , Phase 2
14007,D0E2FZ,ICA-69673,Pain , Preclinical
14008,D0E2GH,MVAH5,Influenza virus infection , Investigative
14009,D0E2HS,TAK-021,Enterovirus infection , Phase 1
14010,D0E2IN,LECOZOTAN HYDROCHLORIDE,Cognitive impairment , Phase 2/3
14011,D0E2JN,KB-6806,Chemotherapy-induced nausea , Phase 2
14012,D0E2KT,S-234462,Obesity , Discontinued in Phase 1
14013,D0E2LA,TAS-103,Solid tumour/cancer , Phase 1
14014,D0E2LH,TT-173,Bleeding disorder , Phase 2
14015,D0E2MI,ARH-1029,Helicobacter infection , Investigative
14016,D0E2MJ,Otamixaban,Angina pectoris , Discontinued in Phase 3
14017,D0E2ML,IG-RD-001,Respiratory disease , Approved
14018,D0E2NQ,Depression NCE,Depression , Phase 1
14019,D0E2OU,Quinupristin,Bacterial infection , Approved
14020,D0E2PX,E-4031,Cardiac arrhythmias , Discontinued in Phase 2
14021,D0E2QC,RK-023,Alopecia , Phase 2
14022,D0E2QG,NC-6300,Solid tumour/cancer , Phase 1
14023,D0E2QG,NC-6300,Soft tissue sarcoma , Phase 1
14024,D0E2QN,AZD-1678,Asthma , Preclinical
14025,D0E2RA,AV-7909,Anthrax , Phase 2
14026,D0E2TH,AVX101,Acquired immune deficiency syndrome , Phase 1
14027,D0E2VF,CD19 Redirected Autologous T Cells,Systemic lupus erythematosus , Phase 1
14028,D0E2WE,Mapp-66,Human immunodeficiency virus infection , Investigative
14029,D0E2WF,ORG 34517/34850,Solid tumour/cancer , Phase 2
14030,D0E2WF,ORG 34517/34850,Mood disorder , Phase 2
14031,D0E2YL,UNI-rhIL-11,Thrombocytopenia , Phase 3
14032,D0E2YV,Glial cell line-derived neurotrophic factor protein,Central nervous system disease , Preclinical
14033,D0E2YX,NRD-135S,Pain , Investigative
14034,D0E2ZA,PPC-5650,Pain , Phase 1
14035,D0E2ZX,SGN-CD70A,Non-hodgkin lymphoma , Phase 1
14036,D0E3BH,Ridogrel,Acute myocardial infarction , Approved
14037,D0E3BJ,SLV-311,Gastrointestinal disease , Discontinued in Phase 1
14038,D0E3CX,NDX-1017,Alzheimer disease , Phase 1
14039,D0E3DS,Alkyl mannoside derivative 11,Crohn disease , Patented
14040,D0E3DS,Alkyl mannoside derivative 11,Ulcerative colitis , Patented
14041,D0E3DS,Alkyl mannoside derivative 11,Urinary tract infection , Patented
14042,D0E3EA,AP-02-00,Lipid metabolism disorder , Investigative
14043,D0E3EK,NP-619,Alopecia , Discontinued in Phase 2
14044,D0E3EO,JTT-251,Pulmonary arterial hypertension , Phase 2
14045,D0E3EO,JTT-251,Type-2 diabetes , Phase 1
14046,D0E3EY,Elsamitrucin,Solid tumour/cancer , Phase 2
14047,D0E3FD,Bromazepam,Panic attacks , Approved
14048,D0E3FD,Bromazepam,Anxiety disorder , Approved
14049,D0E3HY,IP10 C8,Psoriasis vulgaris , Phase 2
14050,D0E3JF,Cx-911,Autoimmune diabetes , Investigative
14051,D0E3JL,SL-25.1188,Alzheimer disease , Discontinued in Phase 1
14052,D0E3JP,Prednisone,Coronavirus Disease 2019 (COVID-19) , Investigative
14053,D0E3LP,SEN-196,Huntington disease , Phase 2
14054,D0E3LW,NV-27,Artery stenosis , Terminated
14055,D0E3MA,Polyacrylic acid,Contraception , Phase 2/3
14056,D0E3NZ,L-696229,Human immunodeficiency virus infection , Discontinued in Phase 2
14057,D0E3OF,Warfarin,Atrial fibrillation , Approved
14058,D0E3OF,Warfarin,Thrombosis , Application submitted
14059,D0E3QU,Cytovaxine,Pseudomonas infection , Terminated
14060,D0E3RC,99mTc-sulesomab,Inflammatory bowel disease , Approved
14061,D0E3RW,Cefditoren,Bacterial infection , Approved
14062,D0E3SA,Betafectin,Immune System disease , Discontinued in Phase 3
14063,D0E3SD,AZD-9272,Neuropathic pain , Discontinued in Phase 1
14064,D0E3SF,MCB-3837,Malaria , Approved
14065,D0E3SH,Panobinostat,Multiple myeloma , Approved
14066,D0E3SH,Panobinostat,Type-2 diabetes , Phase 3
14067,D0E3SH,Panobinostat,Primary myelofibrosis , Phase 2
14068,D0E3SX,SCH-1359113,Alzheimer disease , Preclinical
14069,D0E3UW,RG6046,Breast cancer , Investigative
14070,D0E3VF,E coli vaccine,Diarrhea , Discontinued in Phase 1
14071,D0E3WQ,Eterobarb,Seizure disorder , Approved
14072,D0E3XG,Zolasartan,Hypotension , Discontinued in Phase 2
14073,D0E3ZC,Oseltamivir,Influenza virus infection , Approved
14074,D0E3ZC,Oseltamivir,Coronavirus Disease 2019 (COVID-19) , Phase 3
14075,D0E3ZO,AIK33,Dermatitis , Investigative
14076,D0E4DN,SC16LD6.5,Small-cell lung cancer , Phase 1/2
14077,D0E4DO,PTX-111,Human immunodeficiency virus infection , Phase 2
14078,D0E4DW,Phenytoin,Epilepsy , Approved
14079,D0E4EP,Oncolysin M,leukaemia , Discontinued in Phase 1
14080,D0E4EZ,R-1438,Type-2 diabetes , Discontinued in Phase 2
14081,D0E4FG,Mozenavir,Human immunodeficiency virus infection , Discontinued in Phase 2
14082,D0E4FM,Y-700,Gout , Discontinued in Phase 2
14083,D0E4GE,AZD-2551,Chronic obstructive pulmonary disease , Phase 1
14084,D0E4GG,Resatorvid,Sepsis , Phase 3
14085,D0E4HZ,F-12682,Major depressive disorder , Terminated
14086,D0E4IB,PBF509,Non-small-cell lung cancer , Phase 1/2
14087,D0E4JB,TP-834,Bacterial infection , Investigative
14088,D0E4JL,Rotigitine,Parkinson disease , Investigative
14089,D0E4LS,LAG525,Melanoma , Phase 1/2
14090,D0E4LS,LAG525,Renal cell carcinoma , Phase 1/2
14091,D0E4LS,LAG525,Solid tumour/cancer , Phase 1/2
14092,D0E4MB,GDC-9545,Breast cancer , Phase 1
14093,D0E4MT,Influenza A virus H3N2 vaccine,Influenza A virus H3N2 infection , Phase 1
14094,D0E4MX,Myomap,Cardiovascular disease , Terminated
14095,D0E4PN,API-003,Inflammation , Investigative
14096,D0E4PQ,Inno-LC-01,Glioblastoma multiforme , Phase 3
14097,D0E4RG,NCX-4215,Hypertension , Terminated
14098,D0E4RH,DDB-S,Liver disease , Phase 2
14099,D0E4SI,Rv-11,Bacterial infection , Approved
14100,D0E4SX,VP20629,Friedreich's ataxia , Phase 1
14101,D0E4TD,Sharon-3000,Periodontitis , Investigative
14102,D0E4UB,AX-201,Cerebrovascular ischaemia , Terminated
14103,D0E4VQ,Beloranib,Solid tumour/cancer , Phase 3
14104,D0E4VQ,Beloranib,Obesity , Phase 1
14105,D0E4VT,MAHDL01,Hyperlipidaemia , Preclinical
14106,D0E4WF,METHYLTHIOADENOSINE,Multiple sclerosis , Terminated
14107,D0E4WR,Azelaic Acid,Acne vulgaris , Approved
14108,D0E4YR,IN0-3112,Cervical cancer , Phase 1
14109,D0E5BW,[131I]-Metuximab,Liver cancer , Phase 2
14110,D0E5CX,Abloid,Alzheimer disease , Investigative
14111,D0E5DB,Laromustine,Solid tumour/cancer , Phase 3
14112,D0E5DP,Cixutumumab,Non-small-cell lung cancer , Phase 2
14113,D0E5DP,Cixutumumab,Liver cancer , Phase 2
14114,D0E5FA,62Cu-PTSM,Occlusive coronary artery disease , Phase 2
14115,D0E5FF,PT,Autoimmune diabetes , Investigative
14116,D0E5GI,CJ-12255,Eczema , Phase 1
14117,D0E5GO,PMID31955138-compound-16,Middle East Respiratory Syndrome (MERS) , Preclinical
14118,D0E5GY,RO-319790,Rheumatoid arthritis , Terminated
14119,D0E5IP,WHI-P154,Diffuse large B-cell lymphoma , Investigative
14120,D0E5IT,PMA-411R,Autoimmune diabetes , Investigative
14121,D0E5JC,MSX-122,Solid tumour/cancer , Phase 1
14122,D0E5MJ,INCB19602,Type-2 diabetes , Discontinued in Phase 2
14123,D0E5MO,TrkA-XTEN,Pain , Investigative
14124,D0E5NY,AZD-2423,Chronic obstructive pulmonary disease , Phase 2
14125,D0E5QY,MEN-B,Neisseria meningitis infection , Phase 2
14126,D0E5RA,HGT-1111,Metachromatic leukodystrophy , Phase 2
14127,D0E5TH,BTL-TML-HSV,Oral herpes , Phase 2
14128,D0E5TI,Lyme disease vaccine,Lyme disease , Approved
14129,D0E5UK,Fibrin Sealant,Wound healing , Approved
14130,D0E5VO,Vinanterol/fluticasone furoate,Asthma , Phase 3
14131,D0E5VP,KF-66490,Atopic dermatitis , Investigative
14132,D0E5WX,PF-04518600,Solid tumour/cancer , Phase 2
14133,D0E5XA,R763,Haematological malignancy , Phase 1
14134,D0E5YG,AZD1236,Chronic obstructive pulmonary disease , Discontinued in Phase 2
14135,D0E6AF,Radium-223-Dichloride,Prostate cancer , Approved
14136,D0E6AG,CPI-1205,Prostate cancer , Phase 1/2
14137,D0E6AG,CPI-1205,B-cell lymphoma , Phase 1
14138,D0E6AH,Bryostatin-1,Alzheimer disease , Phase 2
14139,D0E6AP,STX,Estrogen deficiency , Investigative
14140,D0E6BB,Plazomicin,Urinary tract infection , Approved
14141,D0E6BB,Plazomicin,Prostate disease , Approved
14142,D0E6BB,Plazomicin,Bronchitis , Approved
14143,D0E6BB,Plazomicin,Pancreatic cancer , Phase 3
14144,D0E6CH,Hydroxypropyl Cellulose,Insufficient tear production , Approved
14145,D0E6DI,T487,Psoriatic disorder , Discontinued in Phase 2
14146,D0E6DI,T487,Inflammation , Discontinued in Phase 1
14147,D0E6EF,BMS-986192,Non-small-cell lung cancer , Clinical trial
14148,D0E6ES,S. flexneri type 2a-rEPA Asucc,Shigella infection , Phase 3
14149,D0E6FO,JTE-607,Sepsis , Discontinued in Phase 2
14150,D0E6FS,Rivaroxaban,Coronavirus Disease 2019 (COVID-19) , Phase 3
14151,D0E6GS,DasKloster 0249-01,Mycobacterium infection , Investigative
14152,D0E6HT,JNJ-63871860,Escherichia coli infection , Phase 2
14153,D0E6JF,CL-329753,Solid tumour/cancer , Terminated
14154,D0E6JY,EDC/IL-4,Insulin-dependent diabetes , Investigative
14155,D0E6KN,GSK2647544,Alzheimer disease , Phase 1
14156,D0E6LC,SPR-210,Diabetic complication , Terminated
14157,D0E6LU,Resorcinol compound 10,Albinism , Patented
14158,D0E6LU,Resorcinol compound 10,Ephelides , Patented
14159,D0E6LU,Resorcinol compound 10,Menkes disease , Patented
14160,D0E6LU,Resorcinol compound 10,Senile lentigines , Patented
14161,D0E6LU,Resorcinol compound 10,Melasma , Patented
14162,D0E6ME,GED-0507-34-Levo,Inflammatory bowel disease , Phase 2
14163,D0E6MW,BN-108,Solid tumour/cancer , Preclinical
14164,D0E6NH,MEDI-570,Systemic lupus erythematosus , Phase 1
14165,D0E6NR,BAY-Y-3118,Bacterial infection , Discontinued in Phase 2
14166,D0E6OA,TERIKALANT,Cardiac arrhythmias , Terminated
14167,D0E6OC,Tranilast,Ocular allergy , Approved
14168,D0E6OJ,Solumedrol,Coronavirus Disease 2019 (COVID-19) , Phase 2
14169,D0E6PF,Vacc-C5,Human immunodeficiency virus infection , Phase 1/2
14170,D0E6QI,MEN-14295,Solid tumour/cancer , Investigative
14171,D0E6QN,Staphylococcus aureus vaccine conjugate pentavalent,Staphylococcus infection , Discontinued in Phase 1/2
14172,D0E6RE,LB-102,Memory loss , Investigative
14173,D0E6RX,ARD-1600,Smoking dependence , Phase 1
14174,D0E6RX,ARD-1600,Tobacco dependence , Phase 1
14175,D0E6RZ,DAV-147,Gram-positive bacterial infection , Investigative
14176,D0E6SB,HQK-1001,Beta thalassemia , Phase 2
14177,D0E6SQ,ATL1102,Multiple sclerosis , Phase 2
14178,D0E6SX,AZD-5069,Asthma , Phase 2
14179,D0E6UA,Deramciclane,Anxiety disorder , Discontinued in Phase 3
14180,D0E6UD,FK-664,Cardiac disease , Discontinued in Phase 2
14181,D0E6UU,AG-SCT101,Hypertension , Phase 3
14182,D0E6UZ,CUDC-907,Acute myelogenous leukaemia , Phase 1/2
14183,D0E6UZ,CUDC-907,Diffuse large B-cell lymphoma , Phase 1
14184,D0E6UZ,CUDC-907,Neuroblastoma , Phase 1
14185,D0E6UZ,CUDC-907,Solid tumour/cancer , Phase 1
14186,D0E6VF,VAX-128,Influenza A virus H1N1 infection , Phase 1
14187,D0E6VL,RWJ-22108,Allergy , Terminated
14188,D0E6VN,NDV-4,Staphylococcus infection , Investigative
14189,D0E6VR,DS-1093,Anemia , Phase 1
14190,D0E6XN,Cedar pollen allergen extract,Allergic rhinitis , Phase 3
14191,D0E6XR,Dasatinib,Chronic myelogenous leukaemia , Approved
14192,D0E6XR,Dasatinib,Multiple myeloma , Phase 2
14193,D0E6YQ,Tacrine,Alzheimer disease , Approved
14194,D0E6ZI,BTM-0512,Vascular disease , Investigative
14195,D0E6ZN,TKA-731,Pain , Phase 2
14196,D0E7AD,Ibalizumab ,Human immunodeficiency virus infection , Approved
14197,D0E7AD,Ibalizumab ,Human immunodeficiency virus-1 infection , Approved
14198,D0E7AK,VK-2809,Hypercholesterolaemia , Phase 2
14199,D0E7AS,SUN-N8075,Cerebral infarction , Phase 1
14200,D0E7BC,GM-CSF-expressing oncolytic adenovirus,Solid tumour/cancer , Terminated
14201,D0E7BP,CP-663427,Solid tumour/cancer , Terminated
14202,D0E7BS,PRX-12266,Neurological disorder , Investigative
14203,D0E7BY,StMN1 Lp,Solid tumour/cancer , Phase 1
14204,D0E7DH,Factor VIII gene therapy,Hemophilia , Phase 1
14205,D0E7FC,STRO-001,B-cell lymphoma , Phase 1
14206,D0E7FC,STRO-001,Multiple myeloma , Phase 1
14207,D0E7FG,SMND-309,Cerebrovascular ischaemia , Investigative
14208,D0E7FM,GTx-758,Prostate cancer , Phase 2
14209,D0E7FS,Adinazolam,Anxiety disorder , Approved
14210,D0E7FT,PMID30124346-Compound-60TABLE5,Parkinson disease , Patented
14211,D0E7FT,PMID30124346-Compound-60TABLE5,Dyskinesia , Patented
14212,D0E7GN,GFC-012,Solid tumour/cancer , Investigative
14213,D0E7IM,OPB-31121,Hepatocellular carcinoma , Phase 1/2
14214,D0E7IZ,MTI-SAM3,Melanoma , Investigative
14215,D0E7MA,ATG002,Diabetic foot ulcer , Phase 1/2
14216,D0E7MV,Capreomycin,Bacterial infection , Approved
14217,D0E7MV,Capreomycin,Mycobacterium infection , Phase 2
14218,D0E7OC,Serelsa,Haematological malignancy , Phase 3
14219,D0E7OL,C-0084,Glioma , Discontinued in Phase 1
14220,D0E7PQ,Vorinostat,Cutaneous T-cell lymphoma , Approved
14221,D0E7PZ,NOX-B11,Obesity , Investigative
14222,D0E7QB,Mirikizumab,Psoriasis vulgaris , Phase 3
14223,D0E7QN,Biapenem,Bacterial infection , Approved
14224,D0E7RC,HER-2/HER-1 vaccine,Solid tumour/cancer , Phase 1
14225,D0E7RQ,SNN-0029,Lateral sclerosis , Phase 1/2
14226,D0E7RV,Aposense probe-cytotoxic agent conjugates,Solid tumour/cancer , Investigative
14227,D0E7TR,TBI-302,Hepatocellular carcinoma , Investigative
14228,D0E7US,Flu (pre-) pandemic,Influenza A virus infection , Approved
14229,D0E7VY,BAY 98-7196,Endometriosis , Phase 2
14230,D0E7WH,KPAX002,Alzheimer disease , Phase 2
14231,D0E7WH,KPAX002,Amyotrophic lateral sclerosis , Clinical trial
14232,D0E7WH,KPAX002,Parkinson disease , Clinical trial
14233,D0E7XM,BAY-2253651,Obstructive sleep apnea , Phase 2
14234,D0E7XO,IMM-255,Influenza virus infection , Investigative
14235,D0E7YQ,TABILAUTIDE,Immune System disease , Discontinued in Phase 2
14236,D0E7ZN,PMID25553724-Compound-US2011000295210,Immune System disease , Patented
14237,D0E7ZU,Deutetrabenazine,Tardive dyskinesia , Approved
14238,D0E7ZU,Deutetrabenazine,Huntington disease , Approved
14239,D0E8AE,Myolimus,Coronary artery disease , Phase 1
14240,D0E8BD,NM-006-MENK,Solid tumour/cancer , Investigative
14241,D0E8CI,Triprolidine,Hay fever , Approved
14242,D0E8CZ,Amibegron,Mood disorder , Discontinued in Phase 3
14243,D0E8CZ,Amibegron,Major depressive disorder , Discontinued in Phase 3
14244,D0E8CZ,Amibegron,Type-2 diabetes , Preclinical
14245,D0E8CZ,Amibegron,Obesity , Preclinical
14246,D0E8DK,COL-1077,Pain , Phase 2
14247,D0E8HA,T-817MA,Alzheimer disease , Phase 2
14248,D0E8HH,Fusion peptide EK1,Severe acute respiratory syndrome (SARS) , Investigative
14249,D0E8HH,Fusion peptide EK1,Middle East Respiratory Syndrome (MERS) , Investigative
14250,D0E8IG,BA-016,Solid tumour/cancer , Investigative
14251,D0E8IQ,DS-8201,Breast cancer , Phase 2
14252,D0E8IQ,DS-8201,Non-small-cell lung cancer , Phase 2
14253,D0E8IQ,DS-8201,Gastric adenocarcinoma , Phase 1
14254,D0E8IT,HBVax,Hepatitis B virus infection , Phase 4
14255,D0E8IZ,Tonabersat,Epilepsy , Phase 2
14256,D0E8JL,ZT-386,Asthma , Terminated
14257,D0E8JO,FO-152,Solid tumour/cancer , Discontinued in Phase 2
14258,D0E8KK,IkT-041,Influenza virus infection , Investigative
14259,D0E8KO,Anti-CD3 activated vaccine-primed lymphocytes,Melanoma , Phase 2
14260,D0E8LA,Saroglitazar,Dyslipidemia , Approved
14261,D0E8LT,Prifinium,Irritable bowel syndrome , Approved
14262,D0E8MW,D-1367,Arthritis , Discontinued in Phase 1
14263,D0E8NJ,ABP 798,B-cell non-hodgkin lymphoma , Phase 3
14264,D0E8NJ,ABP 798,Non-hodgkin lymphoma , Phase 3
14265,D0E8NJ,ABP 798,Rheumatoid arthritis , Phase 3
14266,D0E8NP,Birinapant,Lymphoma , Phase 2
14267,D0E8NP,Birinapant,Solid tumour/cancer , Phase 1/2
14268,D0E8NW,KUR-115,Spinal disease , Investigative
14269,D0E8PG,BGB-3112,Follicular lymphoma , Phase 2
14270,D0E8PR,BAY1163877,Bladder cancer , Phase 2
14271,D0E8PR,BAY1163877,Solid tumour/cancer , Phase 1
14272,D0E8QE,Vesigenurtacel-L,Bladder cancer , Phase 2
14273,D0E8QK,JNJ-26070109,Gastroesophageal reflux disease , Preclinical
14274,D0E8SE,443C81,Asthma , Terminated
14275,D0E8SV,RG7906,Psychiatric disorder , Phase 2
14276,D0E8TK,SPN-802,Bipolar disorder , Phase 1
14277,D0E8UJ,BW-1370U87,Major depressive disorder , Discontinued in Phase 1
14278,D0E8UO,Urokinase,Myocardial infarction , Approved
14279,D0E8UP,PMID25666693-Compound-69,Osteoarthritis pain , Patented
14280,D0E8UP,PMID25666693-Compound-69,Cancer related pain , Patented
14281,D0E8UP,PMID25666693-Compound-69,Neuropathic pain , Patented
14282,D0E8UP,PMID25666693-Compound-69,Inflammatory pain , Patented
14283,D0E8UV,Linetastine,Rhinitis , Discontinued in Phase 2
14284,D0E8VF,IMC-1C11,Solid tumour/cancer , Discontinued in Phase 1
14285,D0E8YH,NCX 1022,Atopic dermatitis , Phase 2
14286,D0E8YS,MOR-206,Solid tumour/cancer , Investigative
14287,D0E8ZL,CD20-CART,leukaemia , Phase 1
14288,D0E8ZY,Vapitadine,Allergic skin disorder , Phase 2
14289,D0E9AF,ALN-TTRsc,Cardiomyopathy , Phase 3
14290,D0E9AZ,Vax-TET,Clostridium infection , Approved
14291,D0E9BF,5-hydroxymethyl-2-furfural,Anemia , Phase 2
14292,D0E9BQ,Anti-Neu5Gc mabs,Solid tumour/cancer , Investigative
14293,D0E9CC,Ombrabulin,Sarcoma , Phase 3
14294,D0E9CD,Isovanillin,Solid tumour/cancer , Approved
14295,D0E9DP,AAV-IGF,Motor neurone disease , Investigative
14296,D0E9EE,SR 144190,Urinary incontinence , Discontinued in Phase 1
14297,D0E9EE,SR 144190,Anxiety disorder , Discontinued in Phase 1
14298,D0E9EE,SR 144190,Acute or chronic pain , Discontinued in Phase 1
14299,D0E9EE,SR 144190,Depression , Discontinued in Phase 1
14300,D0E9GD,Biphenyl mannoside derivative 15,Crohn disease , Patented
14301,D0E9GD,Biphenyl mannoside derivative 15,Ulcerative colitis , Patented
14302,D0E9GD,Biphenyl mannoside derivative 15,Urinary tract infection , Patented
14303,D0E9HQ,R7334,Macular degeneration , Phase 1
14304,D0E9IT,"N,N`-diacetyl-L-cystine",Immune System disease , Discontinued in Phase 2
14305,D0E9JM,Potassium Chloride,Hypokalemia , Approved
14306,D0E9KA,Ingenol mebutate,Actinic keratosis , Approved
14307,D0E9KA,Ingenol mebutate,Melanoma , Phase 3
14308,D0E9KC,AFM-15,Autoimmune diabetes , Investigative
14309,D0E9LH,CDRI-99/411,Malaria , Investigative
14310,D0E9ME,MEDI7247,Haematological malignancy , Phase 1
14311,D0E9MI,FDY-5301,Myocardial infarction , Phase 2
14312,D0E9NJ,PARCETASAL,Inflammation , Investigative
14313,D0E9NU,KRN-23,Hypophosphatasia , Phase 3
14314,D0E9NU,KRN-23,X-linked hypophosphataemia , Phase 3
14315,D0E9OI,DWE-01,Ulcer , Investigative
14316,D0E9PK,MOXONIDINE,Alcohol dependence , Approved
14317,D0E9PT,CK-2289,Cardiac failure , Terminated
14318,D0E9QZ,Copper catalyst-based agent,Overactive bladder , Investigative
14319,D0E9RP,WCK-2349,MRSA infection , Phase 2
14320,D0E9SR,[3H]JNJ 7777120,Inflammation , Investigative
14321,D0E9SZ,SI-657,Alzheimer disease , Phase 3
14322,D0E9TP,Sulodexide,Tinnitus , Approved
14323,D0E9UH,RP1,Solid tumour/cancer , Phase 1/2
14324,D0E9UT,Lopinavir + ritonavir + interferon alpha,Coronavirus Disease 2019 (COVID-19) , Preclinical
14325,D0E9VL,BDD-20617,Parkinson disease , Investigative
14326,D0E9WL,Loracarbef,Bacterial infection , Approved
14327,D0E9WO,Febarbamate,Non-hodgkin lymphoma , Approved
14328,D0E9XG,YM-46A,Phlegmy cough , Discontinued in Phase 2
14329,D0E9XP,Respiratory syncytial virus VLPvaccine,Respiratory syncytial virus infection , Phase 1
14330,D0E9XR,STP705,Basal cell carcinoma , Phase 2
14331,D0E9XR,STP705,Hypertrophic scars , Phase 1/2
14332,D0E9YI,MGMTP140K gene-modified hematopoietic progenitor cells,Neutropenia , Investigative
14333,D0EA7H,LF-7-0165c,Arteriosclerosis , Terminated
14334,D0EA9Y,Biaryl mannoside derivative 14,Crohn disease , Patented
14335,D0EA9Y,Biaryl mannoside derivative 14,Ulcerative colitis , Patented
14336,D0EA9Y,Biaryl mannoside derivative 14,Urinary tract infection , Patented
14337,D0EB0Y,Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1,Pancreatic cancer , Phase 1
14338,D0EB5N,Lefamulin,Community-acquired pneumonia , Approved
14339,D0EB5N,Lefamulin,Acute bacterial skin infection , Phase 2
14340,D0EC1Y,SIG-001,Dermatological disease , Investigative
14341,D0EC2K,SIPATRIGINE,Neurological disorder , Discontinued in Phase 2
14342,D0EC3H,Quinazoline derivative 12,Cirrhosis , Patented
14343,D0EC3H,Quinazoline derivative 12,Chronic obstructive pulmonary disease , Patented
14344,D0EC3H,Quinazoline derivative 12,Psoriasis vulgaris , Patented
14345,D0EC3H,Quinazoline derivative 12,Multiple sclerosis , Patented
14346,D0EC3H,Quinazoline derivative 12,Gastrointestinal disease , Patented
14347,D0EC3Z,PMID25666693-Compound-82,Osteoarthritis pain , Patented
14348,D0EC3Z,PMID25666693-Compound-82,Cancer related pain , Patented
14349,D0EC3Z,PMID25666693-Compound-82,Neuropathic pain , Patented
14350,D0EC3Z,PMID25666693-Compound-82,Inflammatory pain , Patented
14351,D0EC4Z,Six-membered heterocyclic benzamide derivative 4,Pruritus , Patented
14352,D0EC4Z,Six-membered heterocyclic benzamide derivative 4,Solid tumour/cancer , Patented
14353,D0EC4Z,Six-membered heterocyclic benzamide derivative 4,Chronic pain , Patented
14354,D0EC4Z,Six-membered heterocyclic benzamide derivative 4,Neuropathic pain , Patented
14355,D0EC4Z,Six-membered heterocyclic benzamide derivative 4,Thymic cancer , Patented
14356,D0EC5T,Neurox,Neuromuscular disease , Approved
14357,D0EC5X,Gemeprost,Cervical dilation , Withdrawn from market
14358,D0EC6Q,Chlophedianol,Dry cough , Approved
14359,D0EC6Q,Chlophedianol,Anaesthesia , Withdrawn from market
14360,D0ED3R,Clopidogrel,Coronavirus Disease 2019 (COVID-19) , Phase 2
14361,D0ED6E,CAM-2036,Non-insulin dependent diabetes , Investigative
14362,D0ED6O,CSTC1,Alzheimer disease , Phase 2
14363,D0ED7U,Tiagabine,Epilepsy , Approved
14364,D0ED7U,Tiagabine,Anxiety disorder , Phase 2
14365,D0EE3Y,RSV-F,Respiratory syncytial virus infection , Phase 2
14366,D0EE6L,BP-897,Cocaine addiction , Discontinued in Phase 2
14367,D0EE9G,TAK-214,Norovirus infection , Phase 2
14368,D0EF2H,FP-001,Prostate cancer , Phase 3
14369,D0EF7V,Ro-31-4724,Arthritis , Terminated
14370,D0EF9B,DFD-11,Head and body lice , Application submitted
14371,D0EF9I,A-76895,Epilepsy , Terminated
14372,D0EF9Y,VSV-IFN-beta-NIS,Solid tumour/cancer , Phase 1
14373,D0EG1F,GR-199114X,Stomach ulcer , Terminated
14374,D0EG1I,Tofacitinib,Rheumatoid arthritis , Approved
14375,D0EG5A,Retaspimycin,Non-small-cell lung cancer , Discontinued in Phase 2
14376,D0EG5P,Matrix M,Vaccination , Phase 1
14377,D0EH0C,AV-965,Alzheimer disease , Phase 1
14378,D0EH1J,CD19.CAR-T cells,Diffuse large B-cell lymphoma , Phase 1/2
14379,D0EH1J,CD19.CAR-T cells,Follicular lymphoma , Phase 1/2
14380,D0EH1J,CD19.CAR-T cells,Mantle cell lymphoma , Phase 1/2
14381,D0EH2O,BIMG80,Psychotic disorder , Terminated
14382,D0EH2Q,PF-05212366,Adolescent meningitis , Phase 3
14383,D0EH2T,PMID25666693-Compound-118,Osteoarthritis pain , Patented
14384,D0EH2T,PMID25666693-Compound-118,Cancer related pain , Patented
14385,D0EH2T,PMID25666693-Compound-118,Neuropathic pain , Patented
14386,D0EH2T,PMID25666693-Compound-118,Inflammatory pain , Patented
14387,D0EH4P,PMID26815044-Compound-117,Albinism , Patented
14388,D0EH4P,PMID26815044-Compound-117,Ephelides , Patented
14389,D0EH4P,PMID26815044-Compound-117,Menkes disease , Patented
14390,D0EH4P,PMID26815044-Compound-117,Senile lentigines , Patented
14391,D0EH4P,PMID26815044-Compound-117,Melasma , Patented
14392,D0EH9A,Semprana,Migraine , Application submitted
14393,D0EH9Z,Heterocyclic derivative 14,Solid tumour/cancer , Patented
14394,D0EH9Z,Heterocyclic derivative 14,Metastatic cancer , Patented
14395,D0EI1U,DCDT-2980S,Diffuse large B-cell lymphoma , Discontinued in Phase 2
14396,D0EI1U,DCDT-2980S,Non-hodgkin lymphoma , Discontinued in Phase 2
14397,D0EI2V,SAR439459,Solid tumour/cancer , Phase 1
14398,D0EI4B,N-phenyl-pyridine-2-carboxamide derivative 2,Solid tumour/cancer , Patented
14399,D0EI4B,N-phenyl-pyridine-2-carboxamide derivative 2,Infectious disease , Patented
14400,D0EI4B,N-phenyl-pyridine-2-carboxamide derivative 2,Human immunodeficiency virus infection , Patented
14401,D0EI4B,N-phenyl-pyridine-2-carboxamide derivative 2,Hepatitis , Patented
14402,D0EI7H,ThromboMer,Thrombocytopenia , Investigative
14403,D0EJ0O,SC401,Hyperlipoproteinemia , Phase 2
14404,D0EJ3B,AMG 900,Solid tumour/cancer , Phase 1
14405,D0EJ6O,Ciprofibrate,Hyperlipoproteinemia , Approved
14406,D0EJ7U,CPP-115,Tourette syndrome , Phase 2
14407,D0EJ7U,CPP-115,Substance use disorder , Phase 1
14408,D0EJ7U,CPP-115,Infantile spasm , Phase 1
14409,D0EJ8K,GSK-2392102A,Staphylococcus infection , Phase 1
14410,D0EK1C,PHE-377,Pain , Phase 1
14411,D0EK1D,Arteflene,Parasitic infection , Approved
14412,D0EK5H,JCV-specific TCR a chains-CD3zeta fusion protein,Progressive multifocal leukoencephalopathy , Investigative
14413,D0EK6D,FK-838,Hypertension , Discontinued in Phase 2
14414,D0EK9K,Sch-900875,Inflammation , Investigative
14415,D0EL0F,HBV-001-D1,Dengue fever , Phase 1
14416,D0EL2L,VLCA- 04,Clostridium infection , Investigative
14417,D0EL2O,Egualen sodium,Ulcer , Approved
14418,D0EL5Q,JTX-2011,Solid tumour/cancer , Phase 2
14419,D0EL6M,ImmuMax,Immune System disease , Investigative
14420,D0EL9Z,AV0328,Bacterial infection , Phase 1/2
14421,D0EM1D,RO6867461,Diabetic macular edema , Phase 2
14422,D0EM4S,JNJ-39439335,Musculoskeletal pain , Phase 1
14423,D0EM6S,Recombinant viral vector vaccine,Ebola virus infection , Phase 1
14424,D0EN0F,TB-09,Solid tumour/cancer , Investigative
14425,D0EN0G,Histamine Phosphate,Diagnostic imaging , Approved
14426,D0EN0W,Teprotumumab,Graves disease , Approved
14427,D0EN0W,Teprotumumab,Diabetic macular edema , Phase 1
14428,D0EN4G,R-102444,Pancreatitis , Terminated
14429,D0EO2C,LY-2881835,Type-2 diabetes , Phase 1
14430,D0EO3K,ETI-210,Lymphoma , Investigative
14431,D0EO5G,ALKS 6428,Opioid dependence , Phase 3
14432,D0EO6G,Anti-CD19-CAR,Acute lymphoblastic leukaemia , Phase 1
14433,D0EO6G,Anti-CD19-CAR,B-cell lymphoma , Phase 1
14434,D0EO6G,Anti-CD19-CAR,Large cell lymphoma , Phase 1
14435,D0EO6G,Anti-CD19-CAR,leukaemia , Phase 1
14436,D0EO6G,Anti-CD19-CAR,Non-hodgkin lymphoma , Phase 1
14437,D0EO6S,Glaspimod,Constitutional neutropenia , Discontinued in Phase 2
14438,D0EO8F,PMID30124346-Compound-LDT8,Benign prostatic hyperplasia , Patented
14439,D0EO8K,Valsartan,Coronavirus Disease 2019 (COVID-19) , Phase 3
14440,D0EP0C,Spironolactone,Congestive heart failure , Approved
14441,D0EP5O,NS-377,Alzheimer disease , Terminated
14442,D0EP8X,Gamma Hydroxybutyric Acid,Narcolepsy , Approved
14443,D0EP9A,Dinutuximab,Small-cell lung cancer , Phase 2/3
14444,D0EQ1J,S-111,Solid tumour/cancer , Investigative
14445,D0EQ3O,"Pyrazolo[1,5-a]pyrimidine derivative 4",Obesity , Patented
14446,D0EQ3V,Resorcinol compound 4,Albinism , Patented
14447,D0EQ3V,Resorcinol compound 4,Ephelides , Patented
14448,D0EQ3V,Resorcinol compound 4,Menkes disease , Patented
14449,D0EQ3V,Resorcinol compound 4,Senile lentigines , Patented
14450,D0EQ3V,Resorcinol compound 4,Melasma , Patented
14451,D0EQ5W,Sh-28-GST,Schistosomiasis , Phase 3
14452,D0EQ6D,JCARH125,Multiple myeloma , Phase 1/2
14453,D0EQ6D,JCARH125,Chronic lymphocytic leukaemia , Clinical trial
14454,D0EQ6D,JCARH125,Follicular lymphoma , Clinical trial
14455,D0EQ6D,JCARH125,Mantle cell lymphoma , Clinical trial
14456,D0EQ6D,JCARH125,Non-hodgkin lymphoma , Clinical trial
14457,D0EQ6V,Alhydrogel,Hookworm infection , Phase 2
14458,D0EQ9T,JNJ-39220675,Alcohol dependence , Phase 2
14459,D0ER5F,Ad5FGF-4,Angina pectoris , Phase 3
14460,D0ER8I,Ushercell,Bacterial infection , Phase 3
14461,D0ER9I,JNJ-40929837,Asthma , Phase 2
14462,D0ES1Q,Temsirolimus,Renal cell carcinoma , Approved
14463,D0ES6N,SB-030,Peripheral arterial disease , Phase 2
14464,D0ES7H,TV-Brain-1,Recurrent glioblastoma , Phase 2
14465,D0ES9J,BL-4040,Kidney injury , Investigative
14466,D0ES9U,COR-003,Cushing disease , Phase 3
14467,D0ET2S,Epetirimod,Virus infection , Phase 2
14468,D0ET2T,GSK2586881,Acute lung injury , Phase 2
14469,D0ET2T,GSK2586881,Pulmonary arterial hypertension , Phase 1
14470,D0ET5E,"Stem cell therapy, Dry AMD",Macular degeneration , Investigative
14471,D0ET6F,AT-004,Solid tumour/cancer , Investigative
14472,D0ET9M,Biaryl mannoside derivative 30,Crohn disease , Patented
14473,D0ET9M,Biaryl mannoside derivative 30,Ulcerative colitis , Patented
14474,D0ET9M,Biaryl mannoside derivative 30,Urinary tract infection , Patented
14475,D0ET9N,WC-3049,Congestive heart failure , Phase 3
14476,D0ET9U,Pyrazoline derivative 1,Obesity , Patented
14477,D0EU0L,HIE-124,Anaesthesia , Investigative
14478,D0EU1R,GSK-2334470,Solid tumour/cancer , Investigative
14479,D0EU9Z,InterveXin-PCP,Drug abuse , Investigative
14480,D0EV0H,PMID26911565-peptide-P9,Severe acute respiratory syndrome (SARS) , Preclinical
14481,D0EV0H,PMID26911565-peptide-P9,Middle East Respiratory Syndrome (MERS) , Preclinical
14482,D0EV1L,Elsiglutide,Diarrhea , Phase 2
14483,D0EV3G,PMID25666693-Compound-26,Osteoarthritis pain , Patented
14484,D0EV3G,PMID25666693-Compound-26,Cancer related pain , Patented
14485,D0EV3G,PMID25666693-Compound-26,Neuropathic pain , Patented
14486,D0EV3G,PMID25666693-Compound-26,Inflammatory pain , Patented
14487,D0EV4B,CreaVax-PC,Prostate cancer , Phase 1/2
14488,D0EV5O,NGP 555,Alzheimer disease , Phase 1
14489,D0EV6T,Tipranavir,Human immunodeficiency virus infection , Approved
14490,D0EV6U,MFQ,Bacterial infection , Investigative
14491,D0EV8E,Econazole,Tinea versicolor , Approved
14492,D0EV8E,Econazole,Cutaneous candidiasis , Approved
14493,D0EV8E,Econazole,Tinea corporis , Approved
14494,D0EV8E,Econazole,Tinea cruris , Approved
14495,D0EV8E,Econazole,Tinea pedis , Approved
14496,D0EV9B,BTD-001,Narcolepsy , Phase 2
14497,D0EW2D,IMD-4482,Alzheimer disease , Investigative
14498,D0EW3O,Cyclic peptidomimetic derivative 3,Solid tumour/cancer , Patented
14499,D0EW3O,Cyclic peptidomimetic derivative 3,Infectious disease , Patented
14500,D0EW3O,Cyclic peptidomimetic derivative 3,Human immunodeficiency virus infection , Patented
14501,D0EW3O,Cyclic peptidomimetic derivative 3,Hepatitis , Patented
14502,D0EW4L,Abatacept,Rheumatoid arthritis , Approved
14503,D0EW4M,PNB-04,Alzheimer disease , Investigative
14504,D0EW5Y,AlloDerm,Periodontal disease , Approved
14505,D0EW8Y,Thieno-phenanthridin-6-one,Brain ischaemia , Investigative
14506,D0EW9U,[18F]DCFPyL,Prostate cancer , Investigative
14507,D0EX1C,RASV-Sp,Streptococcus infection , Phase 1
14508,D0EY0A,AZD7687,Diabetic complication , Phase 1
14509,D0EY0A,AZD7687,Obesity , Phase 1
14510,D0EY1E,Influsome-Vac,Influenza virus infection , Phase 2
14511,D0EY1Y,CRS-207 + GVAX,Pancreatic cancer , Phase 2
14512,D0EY1Y,CRS-207 + GVAX,Mesothelioma , Phase 1
14513,D0EY3X,KLS-40,Autoimmune diabetes , Investigative
14514,D0EY5A,VLTS-587,Lung cancer , Discontinued in Phase 2
14515,D0EY9S,"1,2,4-oxadiazole derivative 4",Solid tumour/cancer , Patented
14516,D0EY9S,"1,2,4-oxadiazole derivative 4",Infectious disease , Patented
14517,D0EY9S,"1,2,4-oxadiazole derivative 4",Human immunodeficiency virus infection , Patented
14518,D0EY9S,"1,2,4-oxadiazole derivative 4",Hepatitis , Patented
14519,D0EZ0M,TTH 03-002,Neurodegenerative disorder , Investigative
14520,D0EZ5J,Daptacel,Pediatric immunological disease , Approved
14521,D0EZ5Y,KiroVAX-001,Haematological malignancy , Phase 1/2
14522,D0EZ9C,CTLA-4-XTEN,Rheumatoid arthritis , Investigative
14523,D0F0CS,ZARDAVERINE,Chronic obstructive pulmonary disease , Terminated
14524,D0F0EP,Bemetizide,Congestive heart failure , Approved
14525,D0F0ET,T-270,Neuropathic pain , Investigative
14526,D0F0FZ,UNBS-5162,Lymphoma , Phase 1
14527,D0F0ID,Polyoxidonium,Infectious disease , Approved
14528,D0F0JJ,E2012,Alzheimer disease , Phase 1
14529,D0F0JZ,CPG23CARD,Cardiovascular disease , Investigative
14530,D0F0LO,HG-1144,Solid tumour/cancer , Investigative
14531,D0F0MU,BLX-883,Hepatitis C virus infection , Discontinued in Phase 1
14532,D0F0NB,Insulin adjustable basal,Diabetic complication , Phase 1
14533,D0F0NW,Dust mite peptide allergy desensitization,Allergy , Phase 2
14534,D0F0OJ,JTK-656,Human immunodeficiency virus infection , Discontinued in Phase 1
14535,D0F0OK,Sulfametopyrazine,Urinary tract infection , Withdrawn from market
14536,D0F0PG,ZD-6804,Pain , Discontinued in Phase 1
14537,D0F0RR,GSK2592984A,Influenza virus infection , Approved
14538,D0F0TO,Sevoflurane,Coronavirus Disease 2019 (COVID-19) , Phase 3
14539,D0F0TW,SL-910102,Hypertension , Terminated
14540,D0F0UT,ACYLINE,Prostate cancer , Phase 2
14541,D0F0VD,ACHP,Multiple myeloma , Investigative
14542,D0F0VF,Benzoic acid linked peptide analog 2,Albinism , Patented
14543,D0F0VF,Benzoic acid linked peptide analog 2,Ephelides , Patented
14544,D0F0VF,Benzoic acid linked peptide analog 2,Menkes disease , Patented
14545,D0F0VF,Benzoic acid linked peptide analog 2,Senile lentigines , Patented
14546,D0F0VF,Benzoic acid linked peptide analog 2,Melasma , Patented
14547,D0F0VQ,SapC-DOPS,Solid tumour/cancer , Investigative
14548,D0F0VW,Anti-BCMA CAR-T cells,leukaemia , Phase 1
14549,D0F0VW,Anti-BCMA CAR-T cells,Lymphoma , Phase 1
14550,D0F0VY,"Pyrazolo[1,5-a]pyrimidine derivative 5",Obesity , Patented
14551,D0F0YL,SL-25.1039,Urinary incontinence , Discontinued in Phase 2
14552,D0F0YM,MGN-4893,Polycythemia vera , Investigative
14553,D0F0YZ,Pentobarbital,Insomnia , Approved
14554,D0F0ZE,Merimepodib,Breast cancer , Approved
14555,D0F0ZE,Merimepodib,Gastric adenocarcinoma , Phase 3
14556,D0F0ZE,Merimepodib,Head and neck cancer , Phase 2
14557,D0F0ZE,Merimepodib,Hepatitis C virus infection , Patented
14558,D0F0ZE,Merimepodib,Hepatitis virus infection , Discontinued in Phase 2
14559,D0F0ZK,KB-003,Severe asthma , Phase 2
14560,D0F0ZY,Pazopanib HCl,Renal cell carcinoma , Approved
14561,D0F1AX,CB-102930,Bacterial infection , Terminated
14562,D0F1CE,LCQ908,Hepatitis C virus infection , Phase 3
14563,D0F1CE,LCQ908,Familial chylomicronemia syndrome , Phase 3
14564,D0F1CE,LCQ908,Hypertriglyceridemia , Phase 3
14565,D0F1CN,SST-0001,Solid tumour/cancer , Investigative
14566,D0F1DK,Pyridotriazolopyrimidine derivative 1,Obesity , Patented
14567,D0F1DY,Albiglutide,Type-2 diabetes , Approved
14568,D0F1EI,AZD-0303,Thrombosis , Terminated
14569,D0F1EX,Alclometasone,Inflammation , Approved
14570,D0F1FD,Complex heterocyclic compound 1,Inflammation , Patented
14571,D0F1GD,AuroVax,Herpes simplex virus infection , Investigative
14572,D0F1GS,Calcium Acetate,Hypophosphatasia , Approved
14573,D0F1HT,MB-CART19.1,Precursor B-lymphoblastic neoplasm , Phase 2
14574,D0F1JB,Globorix,Hepatitis B virus infection , Discontinued in Preregistration
14575,D0F1JD,Apabetalone,Cardiovascular disease , Phase 3
14576,D0F1JD,Apabetalone,Cardiac events , Phase 3
14577,D0F1JY,LAS-186323,Multiple sclerosis , Phase 1
14578,D0F1KP,PSN821,Type-2 diabetes , Terminated
14579,D0F1LZ,"Acetic Acid, Glacial",infection in the ear canal , Approved
14580,D0F1MU,EML-336,Type-2 diabetes , Discontinued in Phase 2
14581,D0F1OG,Soluble ErbB3 theragnostics,Solid tumour/cancer , Investigative
14582,D0F1OH,CD19CAT-41BBZ CAR T-cells,Acute lymphoblastic leukaemia , Phase 1
14583,D0F1PH,Rimeporide,Myocardial infarction , Investigative
14584,D0F1UL,Dydrogesterone,Menstrual disorder , Approved
14585,D0F1UW,C-Vaxin,Hepatitis C virus infection , Investigative
14586,D0F1UZ,Amitriptyline+ketamine,Neuropathic pain , Phase 3
14587,D0F1UZ,Amitriptyline+ketamine,Diabetic neuropathy , Phase 2
14588,D0F1UZ,Amitriptyline+ketamine,Postherpetic neuralgia , Phase 2
14589,D0F1VQ,ZIFROSILONE,Cognitive impairment , Discontinued in Phase 2
14590,D0F1WD,C-10068,Brain injury , Investigative
14591,D0F1WX,SSR240600,Urinary incontinence , Phase 2
14592,D0F1ZB,LFA-102,Solid tumour/cancer , Phase 1
14593,D0F1ZI,F-16-IL-2 fusion protein,Solid tumour/cancer , Phase 2
14594,D0F2AD,dioscin,Hepatic fibrosis , Preclinical
14595,D0F2AK,Promegestone,Gynecological disease , Approved
14596,D0F2BF,PMID28270021-Compound-WO2010077680 803,Pruritus , Patented
14597,D0F2BF,PMID28270021-Compound-WO2010077680 803,Solid tumour/cancer , Patented
14598,D0F2BF,PMID28270021-Compound-WO2010077680 803,Chronic pain , Patented
14599,D0F2BF,PMID28270021-Compound-WO2010077680 803,Neuropathic pain , Patented
14600,D0F2BF,PMID28270021-Compound-WO2010077680 803,Thymic cancer , Patented
14601,D0F2CH,Mutated growth hormone,Acromegaly , Investigative
14602,D0F2CQ,Fluoroglycoconjugates,Solid tumour/cancer , Investigative
14603,D0F2CW,Almitrine,Coronavirus Disease 2019 (COVID-19) , Phase 3
14604,D0F2DD,KRH-102140,Inflammation , Investigative
14605,D0F2GK,RGI-3010,Insulin-dependent diabetes , Investigative
14606,D0F2HA,ICI-D-8731,Hypertension , Discontinued in Phase 2
14607,D0F2IC,NTx-488,Multiple sclerosis , Discontinued in Phase 2
14608,D0F2IM,MEDI-573,Solid tumour/cancer , Phase 1
14609,D0F2JS,CHR-2797,Acute myeloid leukaemia , Phase 2
14610,D0F2JS,CHR-2797,Myelodysplastic syndrome , Phase 2
14611,D0F2JS,CHR-2797,Inflammation , Terminated
14612,D0F2JY,LY-2334737,Solid tumour/cancer , Phase 1
14613,D0F2KX,Granotapide,Hyperlipidaemia , Phase 2
14614,D0F2KY,TetraMen-T,Neisseria meningitis infection , Phase 2
14615,D0F2ML,MEDETOMIDINE,Pain , Phase 2
14616,D0F2NF,GSK-958108,Premature ejaculation , Phase 1
14617,D0F2NG,HIV vaccine,Human immunodeficiency virus infection , Phase 1
14618,D0F2OG,AFM-19,Allergy , Investigative
14619,D0F2PD,Arimoclomol,Cerebrovascular ischaemia , Phase 2/3
14620,D0F2PD,Arimoclomol,Inclusion body myositis , Phase 2/3
14621,D0F2PO,Pindolol,Hypertension , Approved
14622,D0F2PQ,BL-1050,Human immunodeficiency virus infection , Terminated
14623,D0F2PZ,SUN-E3001,Osteoporosis , Terminated
14624,D0F2QP,CRB-0022,Pain , Investigative
14625,D0F2QS,Mebiphon,Bone metastases , Approved
14626,D0F2RP,VEGF/rGel,Diabetic retinopathy , Investigative
14627,D0F2SA,BPKDi,Solid tumour/cancer , Investigative
14628,D0F2TY,EBV-related Hodgkin's disease vaccine,Hodgkin lymphoma , Terminated
14629,D0F2WN,NAHE-001,Hepatitis C virus infection , Phase 1/2
14630,D0F2WP,Relugolix,Prostate cancer , Approved
14631,D0F2WP,Relugolix,Endometriosis , Phase 3
14632,D0F2XQ,Fludarabine,Haematological malignancy , Approved
14633,D0F2XV,Aztreonam,Bacterial infection , Approved
14634,D0F3BP,PAN-90716-DES,Ocular disease , Investigative
14635,D0F3BY,GW842470X,Atopic dermatitis , Discontinued in Phase 2
14636,D0F3EH,CS-712,Allergic rhinitis , Discontinued in Phase 2
14637,D0F3EO,HS-110,Non-small-cell lung cancer , Phase 2
14638,D0F3FB,S-9977,Cognitive impairment , Discontinued in Phase 2
14639,D0F3FC,GSK-650394,Prostate cancer , Investigative
14640,D0F3FV,mRNA-1440,Influenza virus infection , Phase 1
14641,D0F3GA,Acyclic nucleoside phosphonates,Virus infection , Investigative
14642,D0F3GK,Peniel 1000,Osteoarthritis , Investigative
14643,D0F3GL,Vacc-4x,Human immunodeficiency virus-1 infection , Phase 2
14644,D0F3HA,Cyclohexyl carbamate derivative 2,Albinism , Patented
14645,D0F3HA,Cyclohexyl carbamate derivative 2,Ephelides , Patented
14646,D0F3HA,Cyclohexyl carbamate derivative 2,Menkes disease , Patented
14647,D0F3HA,Cyclohexyl carbamate derivative 2,Senile lentigines , Patented
14648,D0F3HA,Cyclohexyl carbamate derivative 2,Melasma , Patented
14649,D0F3HC,GS-9268,Non-cystic fibrosis bronchiectasis , Phase 3
14650,D0F3HP,PMID25666693-Compound-101,Osteoarthritis pain , Patented
14651,D0F3HP,PMID25666693-Compound-101,Cancer related pain , Patented
14652,D0F3HP,PMID25666693-Compound-101,Neuropathic pain , Patented
14653,D0F3HP,PMID25666693-Compound-101,Inflammatory pain , Patented
14654,D0F3II,COR100140,Inflammation , Preclinical
14655,D0F3IM,IMX-MSP4,Plasmodium vivax malaria , Investigative
14656,D0F3IP,Asasantin,Cerebrovascular ischaemia , Approved
14657,D0F3JA,HL-023,Solid tumour/cancer , Investigative
14658,D0F3JL,RSLV-132,Sjogren syndrome , Phase 2
14659,D0F3JL,RSLV-132,Systemic lupus erythematosus , Phase 2
14660,D0F3JT,Mecasermin,Growth failure , Approved
14661,D0F3KC,Indium-111,Solid tumour/cancer , Phase 2/3
14662,D0F3LS,Insulin determir,Diabetic complication , Approved
14663,D0F3MT,AVX901,Breast cancer , Phase 1/2
14664,D0F3NF,TAS-116,Solid tumour/cancer , Phase 1
14665,D0F3NH,Balaglitazone,Type-1 diabetes , Phase 3
14666,D0F3ON,Adv-005,Lung cancer , Investigative
14667,D0F3PU,Iboctadekin + Doxil,Ovarian cancer , Phase 1
14668,D0F3RQ,BAY 87-2243,Solid tumour/cancer , Phase 1
14669,D0F3SY,Tegafur,Solid tumour/cancer , Approved
14670,D0F3TI,PT-630,Type-2 diabetes , Terminated
14671,D0F3VI,CEL-1000,Solid tumour/cancer , Investigative
14672,D0F3VW,Allergy immunotherapeutic vaccine,Allergy , Phase 1
14673,D0F3WG,Disufenton sodium,Ischemia , Phase 3
14674,D0F3WG,Disufenton sodium,Recurrent glioblastoma , Phase 1
14675,D0F3ZG,RO-5458640,Solid tumour/cancer , Phase 1
14676,D0F470,FP-025,Asthma , Phase 1
14677,D0F4AP,Glycanics,Inflammation , Investigative
14678,D0F4CG,18F-AV-1451,Alzheimer disease , Phase 4
14679,D0F4CT,MRLP-164,Skin infection , Investigative
14680,D0F4DI,PMID25666693-Compound-30,Osteoarthritis pain , Patented
14681,D0F4DI,PMID25666693-Compound-30,Cancer related pain , Patented
14682,D0F4DI,PMID25666693-Compound-30,Neuropathic pain , Patented
14683,D0F4DI,PMID25666693-Compound-30,Inflammatory pain , Patented
14684,D0F4DW,HG-1300,Solid tumour/cancer , Investigative
14685,D0F4FN,68Ga-DOTA-AE-105,Solid tumour/cancer , Investigative
14686,D0F4FV,DX-2300,Chronic obstructive pulmonary disease , Investigative
14687,D0F4GF,MK-8998,Schizophrenia , Phase 2
14688,D0F4GJ,Trifenagrel,Inflammation , Terminated
14689,D0F4HB,Lucinactant,Respiratory distress syndrome , Approved
14690,D0F4IC,AM-250,Spinal cord injury , Investigative
14691,D0F4IF,N-phenyl-pyridine-2-carboxamide derivative 1,Solid tumour/cancer , Patented
14692,D0F4IF,N-phenyl-pyridine-2-carboxamide derivative 1,Infectious disease , Patented
14693,D0F4IF,N-phenyl-pyridine-2-carboxamide derivative 1,Human immunodeficiency virus infection , Patented
14694,D0F4IF,N-phenyl-pyridine-2-carboxamide derivative 1,Hepatitis , Patented
14695,D0F4IG,DS-4574,Asthma , Discontinued in Phase 2
14696,D0F4IM,Adcetris,Hodgkin lymphoma , Phase 3
14697,D0F4IM,Adcetris,Cutaneous T-cell lymphoma , Phase 3
14698,D0F4IM,Adcetris,T-cell leukaemia , Phase 3
14699,D0F4IM,Adcetris,Diffuse large B-cell lymphoma , Phase 2
14700,D0F4IM,Adcetris,Non-hodgkin lymphoma , Phase 2
14701,D0F4JK,CE-224535,Arthralgia , Phase 2/3
14702,D0F4LI,LASSBio-881,Pain , Investigative
14703,D0F4LP,hESC-derived CD15+ISL-1+cardiac progenitors,Heart failure , Phase 1
14704,D0F4MI,TAK-075,Osteoporosis , Investigative
14705,D0F4MK,CyMVectin,Cytomegalovirus infection , Investigative
14706,D0F4NB,PMID30124346-Compound-13TABLE4,Attention deficit hyperactivity disorder , Patented
14707,D0F4NH,VX-222,Hepatitis C virus infection , Phase 2
14708,D0F4NN,CGTG-102,Solid tumour/cancer , Phase 1
14709,D0F4NP,JNJ-17305600,Schizophrenia , Phase 1
14710,D0F4NS,Mozavaptan,Hyponatraemia , Approved
14711,D0F4NW,RO-5428029,Hepatitis C virus infection , Phase 1
14712,D0F4QJ,CR-5790,Osteoarthritis , Investigative
14713,D0F4QO,THE-320,Prostate hyperplasia , Approved
14714,D0F4QV,GSK2696273,Chronic pain , Preregistration
14715,D0F4QV,GSK2696273,Immunodeficiency , Phase 2/3
14716,D0F4RM,MD-2009,Influenza virus infection , Investigative
14717,D0F4RX,OPC-14117,Neurological disorder , Phase 1
14718,D0F4SI,N-9xxx,Vascular disease , Investigative
14719,D0F4SN,KUR-111,Bone disease , Phase 2
14720,D0F4SY,Pridopidine,Huntington disease , Phase 3
14721,D0F4TV,AWD-12-281,Rhinitis , Phase 2
14722,D0F4UI,CPD-VO,Solid tumour/cancer , Investigative
14723,D0F4UM,MG-4101,Solid tumour/cancer , Phase 2
14724,D0F4VK,TB-101,Bleeding disorder , Investigative
14725,D0F4VW,SRX-246,Anxiety disorder , Phase 2
14726,D0F4VW,SRX-246,Post-traumatic stress disorder , Phase 2
14727,D0F4WS,BM-13.1180,Diabetic complication , Terminated
14728,D0F4YX,PMID25666693-Compound-15,Osteoarthritis pain , Patented
14729,D0F4YX,PMID25666693-Compound-15,Cancer related pain , Patented
14730,D0F4YX,PMID25666693-Compound-15,Neuropathic pain , Patented
14731,D0F4YX,PMID25666693-Compound-15,Inflammatory pain , Patented
14732,D0F4ZN,PAMAQUESIDE,Hyperlipidaemia , Phase 3
14733,D0F4ZY,Istradefylline,Parkinson disease , Approved
14734,D0F4ZY,Istradefylline,Substance use disorder , Phase 1
14735,D0F5AB,Rad51,Solid tumour/cancer , Investigative
14736,D0F5AR,Cibinetide,Depression , Phase 2
14737,D0F5AR,Cibinetide,Neuropathic pain , Phase 2
14738,D0F5AR,Cibinetide,Sarcoidosis , Phase 2
14739,D0F5AR,Cibinetide,Diabetic macular edema , Phase 1
14740,D0F5AR,Cibinetide,Peripheral neuropathy , Phase 1
14741,D0F5BL,EXO-230,Diabetic neuropathy , Phase 1/2
14742,D0F5CO,Enloplatin,Chronic lymphocytic leukaemia , Terminated
14743,D0F5DK,TRAIL-R Atrimer,Solid tumour/cancer , Investigative
14744,D0F5DO,Arginine,Growth hormone deficiency , Approved
14745,D0F5GF,AE-08,Melanoma , Phase 1
14746,D0F5HB,Sotrastaurin acetate,Renal transplantation , Phase 2
14747,D0F5IS,NGN-9079,Alzheimer disease , Investigative
14748,D0F5IY,LIRIMILAST,Chronic obstructive pulmonary disease , Phase 2
14749,D0F5JG,AK-1,Solid tumour/cancer , Investigative
14750,D0F5JH,CS-038,Type-2 diabetes , Phase 3
14751,D0F5JR,ONO-1603,Cognitive impairment , Phase 2
14752,D0F5JZ,PLX-4720,Cutaneous melanoma , Phase 1
14753,D0F5KN,99mTc-MIP-1405,Prostate cancer , Phase 1
14754,D0F5LB,Carbon monoxide,Cystic fibrosis , Phase 2
14755,D0F5MT,Fosamprenavir,Human immunodeficiency virus infection , Approved
14756,D0F5NB,CD-581,Atopic dermatitis , Discontinued in Phase 1
14757,D0F5NG,KUR-114,Bone injury , Investigative
14758,D0F5NQ,PMID25666693-Compound-65,Osteoarthritis pain , Patented
14759,D0F5NQ,PMID25666693-Compound-65,Cancer related pain , Patented
14760,D0F5NQ,PMID25666693-Compound-65,Neuropathic pain , Patented
14761,D0F5NQ,PMID25666693-Compound-65,Inflammatory pain , Patented
14762,D0F5OR,Spiramycin,Bacterial infection , Approved
14763,D0F5TD,PMID27841036-Compound-37,Ovarian cancer , Phase 2
14764,D0F5TM,OPI-1100,Solid tumour/cancer , Investigative
14765,D0F5TR,PMID25553724-Compound-US2012832440110,Immune System disease , Patented
14766,D0F5TS,KM-3900,Solid tumour/cancer , Investigative
14767,D0F5UN,SLV320,Heart failure , Phase 2
14768,D0F5UO,KMS-88009,Alzheimer disease , Investigative
14769,D0F5VD,Ezatiostat,Myelodysplastic syndrome , Phase 2
14770,D0F5VX,MNX-100,Solid tumour/cancer , Phase 2
14771,D0F5VX,MNX-100,Medulloblastoma , Phase 2
14772,D0F5WX,GSK768974,Osteoporosis , Phase 2
14773,D0F5ZM,Imidazole salicylate,Inflammation , Approved
14774,D0F5ZZ,Sharon-2000,Dental caries , Investigative
14775,D0F6AB,AR-C-89855,Chronic obstructive pulmonary disease , Terminated
14776,D0F6AJ,Hsp 6/11,Condyloma , Investigative
14777,D0F6CI,R-1437,Prostate hyperplasia , Terminated
14778,D0F6CT,GI 181771,Obesity , Discontinued in Phase 2
14779,D0F6DF,AB-3D3,Ovarian cancer , Investigative
14780,D0F6EO,Amoxicillin,Bacterial infection , Approved
14781,D0F6GR,Clentiazem,Angina pectoris , Terminated
14782,D0F6GU,PF-2400013,Schizophrenia , Discontinued in Phase 1
14783,D0F6GV,Perospirone,Psychotic disorder , Approved
14784,D0F6HW,IPH-4201,Pancreatic cancer , Terminated
14785,D0F6IL,KNW-001,Solid tumour/cancer , Investigative
14786,D0F6JC,GSK1278863,Anaemia , Phase 3
14787,D0F6JC,GSK1278863,Autism spectrum disorder , Phase 2
14788,D0F6JC,GSK1278863,Diabetic foot ulcer , Phase 1
14789,D0F6JI,AR-D-111421,Asthma , Discontinued in Phase 2
14790,D0F6KM,ISIS-APOCIII,Metabolic syndrome x , Phase 1
14791,D0F6KM,ISIS-APOCIII,Atherosclerosis , Phase 1
14792,D0F6KM,ISIS-APOCIII,Hyperlipemia , Phase 1
14793,D0F6KM,ISIS-APOCIII,Inflammation , Phase 1
14794,D0F6OF,NMS-P626,Solid tumour/cancer , Investigative
14795,D0F6QN,SLP-0901,Escherichia coli infection , Investigative
14796,D0F6SS,Ganglioside vaccine,Metastatic sarcoma , Phase 2
14797,D0F6SY,StarGen,Retinitis pigmentosa , Phase 1/2
14798,D0F6TD,SUN N4057,Coronary artery disease , Phase 2
14799,D0F6TN,Mannoside derivative 6,Crohn disease , Patented
14800,D0F6TN,Mannoside derivative 6,Ulcerative colitis , Patented
14801,D0F6TN,Mannoside derivative 6,Urinary tract infection , Patented
14802,D0F6TV,Timcodar dimesilate,Solid tumour/cancer , Phase 1/2
14803,D0F6WV,PD-157695,Schizophrenia , Preclinical
14804,D0F6WW,LU-AA33810,Major depressive disorder , Investigative
14805,D0F6XR,DV-7028,Cardiovascular disease , Terminated
14806,D0F6YK,Implitapide,Hyperlipidaemia , Phase 2
14807,D0F6YM,VBP15,Duchenne dystrophy , Phase 2
14808,D0F6YM,VBP15,Inflammatory bowel disease , Phase 1
14809,D0F6YM,VBP15,Multiple sclerosis , Phase 1
14810,D0F6YM,VBP15,Rheumatoid arthritis , Phase 1
14811,D0F6YW,Sagopilone,Prostate cancer , Phase 2
14812,D0F6YW,Sagopilone,Ovarian cancer , Phase 2
14813,D0F6YW,Sagopilone,Breast cancer , Phase 2
14814,D0F6ZS,Ro-25-6833,Bacterial infection , Terminated
14815,D0F6ZT,GL-0810,Squamous cell carcinoma , Phase 1
14816,D0F7AJ,Ceftolozane/tazobactam,Discovery agent , Approved
14817,D0F7AT,Cryptenamine Acetates,Hypertension , Approved
14818,D0F7BO,Alpha melanotropin,Lung injury , Investigative
14819,D0F7CR,BMS-986178,Solid tumour/cancer , Phase 1/2
14820,D0F7CS,Rotenone,Piscicide , Approved
14821,D0F7EK,MX-6162,Breast cancer , Terminated
14822,D0F7FE,SY-300,Neurological disorder , Investigative
14823,D0F7FM,ASP2409,Organ transplant rejection , Phase 1
14824,D0F7FX,AZD-9684,Thrombosis , Discontinued in Phase 2
14825,D0F7FY,Antimicrobial oral vaccine,Bacterial infection , Phase 1/2
14826,D0F7GX,ACE-011,Anemia , Phase 1
14827,D0F7IG,PH10 nasal spray,Major depressive disorder , Phase 2
14828,D0F7LE,AZD-0902,Rheumatoid arthritis , Terminated
14829,D0F7LE,AZD-0902,Chronic obstructive pulmonary disease , Terminated
14830,D0F7LI,PAN-301-1,Prostate cancer , Phase 1
14831,D0F7NQ,Flumethasone Pivalate,Contact dermatitis , Approved
14832,D0F7NT,349U85.HCL,Cardiovascular disease , Phase 1
14833,D0F7NZ,Guanidine Hydrochloride,Muscle fatigue , Approved
14834,D0F7OY,Recombinant plague F1V vaccine,Yersinia infection , Phase 2
14835,D0F7PZ,PF-232798,Human immunodeficiency virus infection , Phase 2
14836,D0F7QP,StarGen Stargardt's disease gene therapy,Stargardt disease , Phase 1/2
14837,D0F7RU,Anti-TSLP mab,Asthma , Investigative
14838,D0F7SW,MOL-2591,Thrombosis , Terminated
14839,D0F7TR,Autologous skeletal myoblast therapy,Cardiac failure , Phase 2/3
14840,D0F7TV,Torbafylline,Peripheral vascular disease , Terminated
14841,D0F7WQ,HE-2000,Cystic fibrosis , Discontinued in Phase 2
14842,D0F7XN,M-216765,Hypertension , Terminated
14843,D0F7XT,Fluoxetine,Coronavirus Disease 2019 (COVID-19) , Phase 3
14844,D0F7YW,MGN-1703,Colorectal cancer , Phase 3
14845,D0F7YW,MGN-1703,Solid tumour/cancer , Phase 1
14846,D0F7ZH,FXI-AS1,Thrombosis , Investigative
14847,D0F7ZJ,Iseganan,Head and neck cancer , Phase 3
14848,D0F7ZJ,Iseganan,Bacterial infection , Discontinued in Phase 2
14849,D0F7ZR,ARX-424,Multiple sclerosis , Phase 1
14850,D0F8BF,Bicyclic heteroaryl benzamide derivative 2,Pruritus , Patented
14851,D0F8BF,Bicyclic heteroaryl benzamide derivative 2,Solid tumour/cancer , Patented
14852,D0F8BF,Bicyclic heteroaryl benzamide derivative 2,Chronic pain , Patented
14853,D0F8BF,Bicyclic heteroaryl benzamide derivative 2,Neuropathic pain , Patented
14854,D0F8BF,Bicyclic heteroaryl benzamide derivative 2,Thymic cancer , Patented
14855,D0F8BR,XGP-115,Arthritis , Investigative
14856,D0F8BS,YM-796,Cognitive impairment , Discontinued in Phase 2
14857,D0F8CM,Pentosan Polysulfate,Painful bladder syndrome , Approved
14858,D0F8CM,Pentosan Polysulfate,Interstitial cystitis , Approved
14859,D0F8CS,ISF-120,Solid tumour/cancer , Investigative
14860,D0F8EM,Op-1,Tibial nonunions , Approved
14861,D0F8EU,Oralex,Gastrointestinal disease , Discontinued in Phase 2
14862,D0F8GK,LY2886721,Alzheimer disease , Phase 2
14863,D0F8GT,AVI-6006,Dengue fever , Investigative
14864,D0F8HN,DA-8031,Premature ejaculation , Phase 2
14865,D0F8HS,NLX-101,Rett syndrome , Phase 1
14866,D0F8HU,VaxiFlu-S,Influenza virus infection , Approved
14867,D0F8HX,Lactoquinomycin,Haematological malignancy , Investigative
14868,D0F8IO,Cephaloridine,Gram-positive bacterial infection , Withdrawn from market
14869,D0F8JR,Cholecalciferol,Coronavirus Disease 2019 (COVID-19) , Phase 3
14870,D0F8KE,Imidazole benzamide derivative 1,Knee pain , Patented
14871,D0F8KR,RTU-1096,Atopic dermatitis , Investigative
14872,D0F8NE,V-103,Contusion , Investigative
14873,D0F8PG,PMID29334795-Compound-21,Progressive supranuclear palsy , Patented
14874,D0F8PG,PMID29334795-Compound-21,Corticobasal degeneration , Patented
14875,D0F8QM,FR-158999,Thrombosis , Discontinued in Phase 1
14876,D0F8RA,Theophylline,Chronic obstructive pulmonary disease , Approved
14877,D0F8RK,GED-aPC,Cardiovascular disease , Discontinued in Phase 1
14878,D0F8SK,Perfluoropropane gas-filled nanobubbles,Cerebrovascular ischaemia , Phase 1/2
14879,D0F8SW,SNS01-T,Mantle cell lymphoma , Phase 1/2
14880,D0F8SW,SNS01-T,Diffuse large B-cell lymphoma , Phase 1/2
14881,D0F8TB,TSR-033,Solid tumour/cancer , Phase 1
14882,D0F8TS,MPC-9055,Human immunodeficiency virus infection , Discontinued in Phase 1
14883,D0F8UV,Nelipepimut S,Non-hodgkin lymphoma , Phase 3
14884,D0F8UV,Nelipepimut S,Breast cancer , Phase 2
14885,D0F8UV,Nelipepimut S,Gastric adenocarcinoma , Phase 1
14886,D0F8VH,AA-166,Articular cartilage disorder , Investigative
14887,D0F8VM,"Meningococcal vaccine groups A,C,Y,W-135 conjugate",Tourette syndrome , Phase 3
14888,D0F8XI,DS-1442,Dyslipidemia , Discontinued in Phase 1
14889,D0F8XK,ISIS-GCCR,Diabetic complication , Phase 2
14890,D0F8XK,ISIS-GCCR,Type-2 diabetes , Preclinical
14891,D0F8ZD,OPN-302,Inflammation , Investigative
14892,D0F8ZG,GX-G3,Solid tumour/cancer , Phase 1
14893,D0F9AO,BHV-5000,Rett syndrome , Phase 1
14894,D0F9BX,GW-660511,Hypertension , Terminated
14895,D0F9BY,Anidulafungin,Convulsion , Approved
14896,D0F9FR,Oxazolidinones,Gram-positive bacterial infection , Phase 2
14897,D0F9GE,Dipyridamole,Hypertension , Approved
14898,D0F9GL,PMID25553724-Compound-US2011806744710,Immune System disease , Patented
14899,D0F9HK,Strontium-89,Pain , Approved
14900,D0F9IE,MK-5890,Non-small-cell lung cancer , Phase 2
14901,D0F9IE,MK-5890,Solid tumour/cancer , Phase 1
14902,D0F9IK,SMRX-11,Cerebrovascular ischaemia , Investigative
14903,D0F9IS,FR-900482,leukaemia , Terminated
14904,D0F9IX,Samatasvir,Hepatitis C virus infection , Phase 1
14905,D0F9KI,LAS-30538,Hyperinsulinemia , Terminated
14906,D0F9NA,MRC-375,Rheumatoid arthritis , Phase 2
14907,D0F9ND,MGAWN-1,West nile virus infection , Discontinued in Phase 2
14908,D0F9NN,AP-501,Autoimmune diabetes , Investigative
14909,D0F9QH,Abituzumab,Colorectal cancer , Phase 2
14910,D0F9QP,GW-559090,Allergic rhinitis , Discontinued in Phase 2
14911,D0F9SG,Dexfenfluramine,Obesity , Withdrawn from market
14912,D0F9TL,BT-063,Autoimmune diabetes , Phase 1
14913,D0F9VF,Propofol,Coronavirus Disease 2019 (COVID-19) , Investigative
14914,D0F9VH,Tesetaxel,Breast cancer , Phase 3
14915,D0F9VH,Tesetaxel,Prostate cancer , Phase 2
14916,D0F9VH,Tesetaxel,Melanoma , Phase 2
14917,D0F9VH,Tesetaxel,Gastric adenocarcinoma , Phase 2
14918,D0F9VH,Tesetaxel,Bladder cancer , Phase 2
14919,D0F9WF,SINOMENINE,Arthritis , Discontinued in Phase 2
14920,D0F9XG,MEDI2070,Crohn disease , Phase 2
14921,D0F9YJ,Pfs48,Malaria , Investigative
14922,D0F9ZO,Spironolactone,Coronavirus Disease 2019 (COVID-19) , Phase 3
14923,D0FA0A,Apristor,Breast cancer , Phase 2
14924,D0FA2L,"N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 3",Osteoporosis , Patented
14925,D0FA2N,HE-3177,Inflammation , Investigative
14926,D0FA2O,Trioxsalen,Vitiligo , Approved
14927,D0FA3O,Hydrocortisone,Coronavirus Disease 2019 (COVID-19) , Phase 3
14928,D0FA4C,JDP-201,Allergy , Investigative
14929,D0FA4Q,IL1R1 NAM,Gout , Investigative
14930,D0FA5Z,LX-1033,Irritable bowel syndrome , Phase 2
14931,D0FA6S,Altiratinib,Solid tumour/cancer , Phase 1
14932,D0FB1C,BPX-04,Rosacea , Phase 2
14933,D0FB1S,GTx-230,Solid tumour/cancer , Investigative
14934,D0FB4W,CYAD-101,Colorectal cancer , Phase 1
14935,D0FB6T,SYN-987,Bacterial infection , Terminated
14936,D0FC1J,Nifurtimox,Chagas disease , Approved
14937,D0FC1J,Nifurtimox,Trypanosomiasis , Phase 4
14938,D0FC2D,Dec-RVKR-CMK,Middle East Respiratory Syndrome (MERS) , Preclinical
14939,D0FC4R,CVX 096,Type-2 diabetes , Phase 1
14940,D0FC5T,DIAVERIDINE,Bacterial infection , Terminated
14941,D0FC7H,MUC-1 CD40L dendritic cell vaccine,Solid tumour/cancer , Phase 1
14942,D0FC7P,Hepatitis B vaccine 1018-ISS conjugate,Hepatitis B virus infection , Preregistration
14943,D0FC8O,DWP-05195,Neuropathic pain , Phase 2
14944,D0FC8P,Pyrazole derivative 19,Obesity , Patented
14945,D0FD0B,PSN-9301,Diabetic complication , Discontinued in Phase 2
14946,D0FD0H,Aminocaproic Acid,Bleeding disorder , Approved
14947,D0FD0H,Aminocaproic Acid,Postoperative hemorrhage , Approved
14948,D0FD2I,Discodermolide,Immune System disease , Discontinued in Phase 1
14949,D0FD3D,Cripto-1 mabs,Solid tumour/cancer , Investigative
14950,D0FD6D,CEP-11981,Solid tumour/cancer , Phase 1
14951,D0FD6E,Aspoxicillin,Bacterial infection , Approved
14952,D0FD7H,ALT-803,Bladder cancer , Phase 2
14953,D0FD7H,ALT-803,Acute myeloid leukaemia , Phase 2
14954,D0FD7H,ALT-803,Solid tumour/cancer , Phase 1/2
14955,D0FD7H,ALT-803,Non-hodgkin lymphoma , Phase 1/2
14956,D0FD7H,ALT-803,Non-small-cell lung cancer , Phase 1/2
14957,D0FD7H,ALT-803,Human immunodeficiency virus infection , Phase 1
14958,D0FD7H,ALT-803,Pancreatic cancer , Phase 1
14959,D0FD7H,ALT-803,Multiple myeloma , Phase 1
14960,D0FE3P,MIV 150 + zinc acetate,Human immunodeficiency virus infection , Phase 1
14961,D0FE7D,Emibetuzumab,Solid tumour/cancer , Phase 2
14962,D0FE7H,PMID10498202C1,Multiple sclerosis , Clinical trial
14963,D0FE8F,Folic acid,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
14964,D0FF0I,MOD-5014,Bleeding disorder , Phase 2
14965,D0FF0N,TBI-1501,Acute lymphoblastic leukaemia , Phase 1/2
14966,D0FF2G,Sym013,Epithelial ovarian cancer , Phase 1/2
14967,D0FF2G,Sym013,Solid tumour/cancer , Phase 1/2
14968,D0FF2S,RP-G28,Lactose intolerance , Phase 2
14969,D0FF6S,A-803467,Pain , Investigative
14970,D0FF7A,Z-6568,Hypertension , Terminated
14971,D0FG2Z,NC-6004,Bladder cancer , Phase 2
14972,D0FG2Z,NC-6004,Head and neck cancer , Phase 1
14973,D0FG6M,GW642444,Asthma , Approved
14974,D0FG6T,NRP-388,Pain , Terminated
14975,D0FH3X,A-437203,Psychotic disorder , Discontinued in Phase 2
14976,D0FH5N,IW-6118,Inflammation , Phase 2
14977,D0FH7C,Gold sodium thiomalate,Rheumatoid arthritis , Approved
14978,D0FH8R,DB-160,Non-insulin dependent diabetes , Investigative
14979,D0FH9O,SDX-7500,Weight loss , Investigative
14980,D0FI1K,ARX-212,Neurological disorder , Investigative
14981,D0FI1L,CAD-1883,Ataxic disorder , Phase 1/2
14982,D0FI3Q,Biaryl mannoside derivative 13,Crohn disease , Patented
14983,D0FI3Q,Biaryl mannoside derivative 13,Ulcerative colitis , Patented
14984,D0FI3Q,Biaryl mannoside derivative 13,Urinary tract infection , Patented
14985,D0FI5C,MEDI-528,Asthma , Phase 2
14986,D0FJ0W,BAY 1026153,Endometriosis , Phase 1
14987,D0FJ1N,PMID30107136-Compound-Example42,Solid tumour/cancer , Patented
14988,D0FJ1N,PMID30107136-Compound-Example42,Infectious disease , Patented
14989,D0FJ1N,PMID30107136-Compound-Example42,Human immunodeficiency virus infection , Patented
14990,D0FJ1N,PMID30107136-Compound-Example42,Hepatitis , Patented
14991,D0FJ1W,DE-766,Non-small-cell lung cancer , Phase 3
14992,D0FJ1W,DE-766,Gastric adenocarcinoma , Phase 3
14993,D0FJ1W,DE-766,Nasopharyngeal carcinoma , Investigative
14994,D0FJ3P,GW-2592X,Osteoporosis , Preclinical
14995,D0FJ3P,GW-2592X,Bone disease , Investigative
14996,D0FJ4A,Thiazole carboxamide derivative 18,Solid tumour/cancer , Patented
14997,D0FJ4A,Thiazole carboxamide derivative 18,Metastatic cancer , Patented
14998,D0FJ8A,Deferoxamine Mesylate,Acute iron or aluminum toxicity , Approved
14999,D0FJ9I,Cotellic,Melanoma , Phase 3
15000,D0FJ9I,Cotellic,Breast cancer , Phase 2
15001,D0FJ9I,Cotellic,Head and neck cancer , Phase 1
15002,D0FJ9I,Cotellic,Renal cell carcinoma , Phase 1
15003,D0FJ9I,Cotellic,Urothelial carcinoma , Phase 1
15004,D0FJ9I,Cotellic,Solid tumour/cancer , Phase 1
15005,D0FJ9W,KB-004,Haematological malignancy , Phase 1/2
15006,D0FK4P,PMID30107136-Compound-Example48,Solid tumour/cancer , Patented
15007,D0FK4P,PMID30107136-Compound-Example48,Infectious disease , Patented
15008,D0FK4P,PMID30107136-Compound-Example48,Human immunodeficiency virus infection , Patented
15009,D0FK4P,PMID30107136-Compound-Example48,Hepatitis , Patented
15010,D0FK6A,TDI-0068,Motor neurone disease , Investigative
15011,D0FK6N,Peptide analog 5,Solid tumour/cancer , Patented
15012,D0FK6N,Peptide analog 5,Infectious disease , Patented
15013,D0FK6N,Peptide analog 5,Human immunodeficiency virus infection , Patented
15014,D0FK6N,Peptide analog 5,Hepatitis , Patented
15015,D0FK6O,MIN-202,Major depressive disorder , Phase 2
15016,D0FK9H,Ontuxizumab,Melanoma , Phase 2
15017,D0FK9H,Ontuxizumab,Merkel cell carcinoma , Phase 2
15018,D0FK9H,Ontuxizumab,Soft tissue sarcoma , Phase 2
15019,D0FK9H,Ontuxizumab,Colorectal cancer , Phase 1
15020,D0FL0R,ALS-L1023,Obesity , Phase 3
15021,D0FL1E,Resorcinol compound 33,Albinism , Patented
15022,D0FL1E,Resorcinol compound 33,Ephelides , Patented
15023,D0FL1E,Resorcinol compound 33,Menkes disease , Patented
15024,D0FL1E,Resorcinol compound 33,Senile lentigines , Patented
15025,D0FL1E,Resorcinol compound 33,Melasma , Patented
15026,D0FL2K,Cantrixil,Ovarian cancer , Phase 1
15027,D0FL3H,PMID26651364-Compound-6a,Crohn disease , Patented
15028,D0FL3H,PMID26651364-Compound-6a,Ulcerative colitis , Patented
15029,D0FL3H,PMID26651364-Compound-6a,Urinary tract infection , Patented
15030,D0FL4G,DAF-3,Solid tumour/cancer , Investigative
15031,D0FL5S,CART-20 cells,Acute lymphoblastic leukaemia , Phase 1
15032,D0FL5V,Clobetasol,Rosacea , Approved
15033,D0FL5V,Clobetasol,Oral lichen planus , Phase 2
15034,D0FL6C,HL-130,Hypertension , Investigative
15035,D0FL6L,IMA202,Solid tumour/cancer , Phase 1
15036,D0FL6X,DS-8587,Bacterial infection , Discontinued in Phase 1
15037,D0FL8A,PMID28270021-Compound-WO2010077680 481,Pruritus , Patented
15038,D0FL8A,PMID28270021-Compound-WO2010077680 481,Solid tumour/cancer , Patented
15039,D0FL8A,PMID28270021-Compound-WO2010077680 481,Chronic pain , Patented
15040,D0FL8A,PMID28270021-Compound-WO2010077680 481,Neuropathic pain , Patented
15041,D0FL8A,PMID28270021-Compound-WO2010077680 481,Thymic cancer , Patented
15042,D0FM2P,Flunisolide,Allergic rhinitis , Approved
15043,D0FM2W,Defibrotide,Hepatic veno-occlusive disease , Approved
15044,D0FM2W,Defibrotide,Diabetic nephropathy , Phase 3
15045,D0FM4T,EC-0746,Inflammation , Investigative
15046,D0FM5M,IMO-2125,Melanoma , Phase 3
15047,D0FM5M,IMO-2125,Hepatitis C virus infection , Phase 1
15048,D0FM5M,IMO-2125,Solid tumour/cancer , Phase 1
15049,D0FM7Z,BL-1021,Pain , Phase 1
15050,D0FM9V,PMID30107136-Compound-Example60,Solid tumour/cancer , Patented
15051,D0FM9V,PMID30107136-Compound-Example60,Infectious disease , Patented
15052,D0FM9V,PMID30107136-Compound-Example60,Human immunodeficiency virus infection , Patented
15053,D0FM9V,PMID30107136-Compound-Example60,Hepatitis , Patented
15054,D0FN1P,Saviprazole,Peptic ulcer , Terminated
15055,D0FN4K,XToll,Autoimmune diabetes , Phase 1/2
15056,D0FN4T,RM-1929,Head and neck cancer , Phase 2
15057,D0FN6D,NGD-97-1,Alzheimer disease , Discontinued in Phase 2
15058,D0FN7J,Methocarbamol,Musculoskeletal disorder , Approved
15059,D0FN9X,CGEN-671,Solid tumour/cancer , Investigative
15060,D0FO1P,HL-021,Solid tumour/cancer , Investigative
15061,D0FP0D,AZD-6088,Neuropathic pain , Phase 1
15062,D0FP0R,Apaziquone,Non-muscle invasive bladder cancer , Phase 3
15063,D0FP0R,Apaziquone,Bladder cancer , Phase 3
15064,D0FP4R,UR-13870,Autoimmune diabetes , Phase 1
15065,D0FP5B,MK-8962,Fertility problem , Phase 3
15066,D0FP6V,Alpha-Helical lipopeptides IIK,Middle East Respiratory Syndrome (MERS) , Preclinical
15067,D0FP8S,Neugranin,Neutropenia , Preregistration
15068,D0FP9N,P11187,Type-2 diabetes , Phase 1
15069,D0FQ2U,Talabostat,Constitutional neutropenia , Phase 3
15070,D0FQ2U,Talabostat,Solid tumour/cancer , Phase 1
15071,D0FQ3D,Nicotinyl hydroxamic acid derivative 1,Albinism , Patented
15072,D0FQ3D,Nicotinyl hydroxamic acid derivative 1,Ephelides , Patented
15073,D0FQ3D,Nicotinyl hydroxamic acid derivative 1,Menkes disease , Patented
15074,D0FQ3D,Nicotinyl hydroxamic acid derivative 1,Senile lentigines , Patented
15075,D0FQ3D,Nicotinyl hydroxamic acid derivative 1,Melasma , Patented
15076,D0FQ4M,Selenotifen,Asthma , Terminated
15077,D0FQ6O,Etarotene,Psoriasis vulgaris , Discontinued in Phase 3
15078,D0FR1Q,Sulfonylated piperazine derivative 3,Obesity , Patented
15079,D0FR3J,CD19 specific CAR T cells,Acute leukaemia , Phase 1/2
15080,D0FR6I,Cyanocobalamin,Anemia , Approved
15081,D0FR7E,CX1789,Obstructive sleep apnea , Phase 2
15082,D0FR9L,Haem arginate,Porphyria , Approved
15083,D0FS0D,"1,2,3-triazole derivative 2",Obesity , Patented
15084,D0FS0F,CK-301,Solid tumour/cancer , Phase 1
15085,D0FS1B,Micro-dystrophin gene therapy,Duchenne dystrophy , Phase 1
15086,D0FS3H,IDP-126,Acne vulgaris , Phase 2
15087,D0FS9K,MINAMESTANE,Bladder cancer , Terminated
15088,D0FS9V,PMID26651364-Compound-120,Crohn disease , Patented
15089,D0FS9V,PMID26651364-Compound-120,Ulcerative colitis , Patented
15090,D0FS9V,PMID26651364-Compound-120,Urinary tract infection , Patented
15091,D0FT2Z,P1025,Bacterial infection , Discontinued in Phase 1
15092,D0FT3R,Tildrakizumab,Plaque psoriasis , Approved
15093,D0FT4P,Aryl mannoside derivative 3,Crohn disease , Patented
15094,D0FT4P,Aryl mannoside derivative 3,Ulcerative colitis , Patented
15095,D0FT4P,Aryl mannoside derivative 3,Urinary tract infection , Patented
15096,D0FT4R,Sivelestat,Pyoderma gangrenosum , Phase 3
15097,D0FT4R,Sivelestat,Crohn disease , Phase 3
15098,D0FT4R,Sivelestat,Multiple sclerosis , Phase 3
15099,D0FT4R,Sivelestat,Psoriatic arthritis , Phase 3
15100,D0FT4R,Sivelestat,Rheumatoid arthritis , Phase 3
15101,D0FT4R,Sivelestat,Ulcerative colitis , Phase 3
15102,D0FT4R,Sivelestat,Anterior uveitis , Application submitted
15103,D0FT4R,Sivelestat,Axial spondyloarthritis , Application submitted
15104,D0FT5T,CYP2001,Autism spectrum disorder , Phase 1
15105,D0FT7Y,Ammonia,Coronary artery disease , Approved
15106,D0FT8G,PX-12,Pancreatic cancer , Phase 2
15107,D0FT8G,PX-12,Coronavirus Disease 2019 (COVID-19) , Investigative
15108,D0FU0O,XmAb18087,Gastrointestinal stromal tumour , Phase 1
15109,D0FU0O,XmAb18087,Neuroendocrine cancer , Phase 1
15110,D0FU1J,PTG-100,Ulcerative colitis , Phase 1
15111,D0FU5Y,SequestOx,Chronic pain , Application submitted
15112,D0FU8R,Anifrolumab,Systemic lupus erythematosus , Phase 3
15113,D0FV1R,Anti-heparanase mabs,Solid tumour/cancer , Investigative
15114,D0FV3K,AC0010,Non-small-cell lung cancer , Phase 3
15115,D0FV3V,Mepenzolate,Gastrointestinal disease , Approved
15116,D0FV3V,Mepenzolate,Peptic ulcer , Approved
15117,D0FV8P,POL-6326,Human immunodeficiency virus infection , Phase 2
15118,D0FV8P,POL-6326,Breast cancer , Phase 1
15119,D0FW0B,ZP2929,Type-1 diabetes , Phase 1
15120,D0FW0B,ZP2929,Diabetic complication , Preclinical
15121,D0FW0B,ZP2929,Obesity , Preclinical
15122,D0FW2A,LEO 80185,Psoriasis vulgaris , Phase 4
15123,D0FW2A,LEO 80185,Plaque psoriasis , Phase 2
15124,D0FW2B,BAX-930,Thrombotic thrombocytopenic purpura , Phase 1
15125,D0FW2D,NX-101,Dermal neurofibromatoses , Phase 2
15126,D0FW3M,Heterocyclic derivative 18,Solid tumour/cancer , Patented
15127,D0FW3M,Heterocyclic derivative 18,Metastatic cancer , Patented
15128,D0FW8Z,Kybiqo,Hyperlipidaemia , Phase 2
15129,D0FW8Z,Kybiqo,Hypertension , Phase 2
15130,D0FX2Q,Rifamycin,Diarrhea , Approved
15131,D0FX2Q,Rifamycin,Infectious disease , Phase 3
15132,D0FX3P,ISIS 104838,Rheumatoid arthritis , Discontinued in Phase 2
15133,D0FX3P,ISIS 104838,Crohn disease , Discontinued in Phase 2
15134,D0FX3U,Bevacizumab,Metastatic colorectal cancer , Approved
15135,D0FX3U,Bevacizumab,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
15136,D0FX4J,Telenzepine,Chronic obstructive pulmonary disease , Discontinued in Preregistration
15137,D0FX5D,Cx-602,Ischemic stroke , Preclinical
15138,D0FX6P,Dextranomer,Infectious disease , Approved
15139,D0FX8A,Tenecteplase,Myocardial infarction , Approved
15140,D0FX8N,CT1812,Alzheimer disease , Phase 2
15141,D0FY0D,HD-201,Solid tumour/cancer , Phase 1
15142,D0FY1W,Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy,Solid tumour/cancer , Phase 1
15143,D0FY2N,NPRx-30,Neurodegenerative disorder , Investigative
15144,D0FY3O,Rabies immune globulin,Rabies , Approved
15145,D0FY4J,BBI-6000,Psoriasis vulgaris , Phase 1
15146,D0FY4L,SAR438335,Type-2 diabetes , Phase 1
15147,D0FY4M,Echinocandin,Candidiasis , Investigative
15148,D0FY4M,Echinocandin,Fungal infection , Investigative
15149,D0FY5E,TAI-GPC3-CART cells,Hepatocellular carcinoma , Phase 1/2
15150,D0FY6Q,JTK-109,Hepatitis C virus infection , Discontinued in Phase 1
15151,D0FZ1W,BTA-798,Rhinovirus infection , Phase 2
15152,D0FZ1Y,CART30,Non-hodgkin lymphoma , Phase 1/2
15153,D0FZ1Y,CART30,Hodgkin lymphoma , Phase 1/2
15154,D0FZ1Z,Doxorubicin-CEA conjugate,Breast cancer , Terminated
15155,D0FZ4X,MitoPBN,Mitochondrial disease , Investigative
15156,D0FZ5R,"Imidazolidine-2,4-dione derivative 1",Obesity , Patented
15157,D0FZ7Q,NanoPac,Ovarian cancer , Phase 2
15158,D0FZ7Q,NanoPac,Prostate cancer , Phase 2
15159,D0FZ7Q,NanoPac,Actinic keratosis , Phase 2
15160,D0FZ7Q,NanoPac,Skin metastasis , Phase 2
15161,D0FZ8U,Glysopep,Deep vein thrombosis , Investigative
15162,D0FZ9N,TDI-0049,Motor neurone disease , Investigative
15163,D0G0AI,Obizur,Haemophilia A , Approved
15164,D0G0AQ,ADC-1012,Solid tumour/cancer , Investigative
15165,D0G0BJ,VE-821,Solid tumour/cancer , Investigative
15166,D0G0BL,AMG 337,Solid tumour/cancer , Phase 2
15167,D0G0BL,AMG 337,Clear cell sarcoma , Phase 2
15168,D0G0CX,MCC-257,Cognitive impairment , Discontinued in Phase 2
15169,D0G0DZ,Prazosin,Coronavirus Disease 2019 (COVID-19) , Phase 2
15170,D0G0ER,DWJ-208,Cancer related pain , Phase 1
15171,D0G0ER,DWJ-208,Neuropathic pain , Phase 1
15172,D0G0ER,DWJ-208,Pain , Investigative
15173,D0G0FQ,IMA-950,Glioblastoma multiforme , Phase 1
15174,D0G0GI,DMP-696,Anxiety disorder , Terminated
15175,D0G0GP,Carbon dioxide intranasal,Trigeminal neuralgia , Phase 2
15176,D0G0IA,Preflucel,Influenza virus infection , Approved
15177,D0G0IZ,Labradimil,Brain cancer , Discontinued in Phase 2
15178,D0G0KZ,ZP-2571,Solid tumour/cancer , Investigative
15179,D0G0LH,S-312-d,Epilepsy , Discontinued in Phase 2
15180,D0G0MB,MEDI7510,Respiratory syncytial virus infection , Phase 2
15181,D0G0MM,H1N1 influenza vaccine,Influenza virus infection , Approved
15182,D0G0PI,CD38 and BCMA CAR-T Cells,Multiple myeloma , Phase 1/2
15183,D0G0PU,RO-5212054,Solid tumour/cancer , Phase 1
15184,D0G0RT,Carmoterol,Chronic obstructive pulmonary disease , Phase 2
15185,D0G0TS,Meclinertant,Inflammatory bowel disease , Phase 2/3
15186,D0G0TT,RG7410,Psychotic disorder , Phase 1
15187,D0G0UZ,SBP-002,Melanoma , Terminated
15188,D0G0VV,Bafetinib,Bone disease , Phase 2
15189,D0G0XN,UK-156406,Myocardial infarction , Discontinued in Phase 1
15190,D0G0YL,LT-NS001,Ankylosing spondylitis , Phase 2/3
15191,D0G0YZ,UK-356202,Myocardial hypertrophy , Clinical trial
15192,D0G0ZE,TTP-547,Diabetic complication , Phase 1
15193,D0G1AA,AKP-001,Inflammatory bowel disease , Investigative
15194,D0G1AK,UR-12510,Allergy , Investigative
15195,D0G1AQ,KALA-617,Bacterial infection , Investigative
15196,D0G1CB,PRO-105,Spinal muscular atrophy , Investigative
15197,D0G1EA,SLP vaccine,Cervical cancer , Phase 1/2
15198,D0G1EC,Aspirin,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
15199,D0G1EE,ATRINOSITOL,Pain , Discontinued in Phase 2
15200,D0G1EH,AEOL-10150,Multiple sclerosis , Preclinical
15201,D0G1GP,ISIS 2922,Cytomegalovirus infection , Withdrawn from market
15202,D0G1HX,CLBS03,Type-1 diabetes , Phase 2
15203,D0G1IG,F-16-131I,Haematological malignancy , Phase 1/2
15204,D0G1IV,Testogen TDS,Hypogonadism , Phase 2
15205,D0G1JO,Combidex,Solid tumour/cancer , Phase 2
15206,D0G1LP,ALT-802,Solid tumour/cancer , Investigative
15207,D0G1MZ,CY-1787,Allergy , Discontinued in Phase 1
15208,D0G1NW,PF-4308515,Inflammation , Discontinued in Phase 1
15209,D0G1OS,LT-0301,Solid tumour/cancer , Investigative
15210,D0G1OZ,Mephentermine,High blood pressure , Approved
15211,D0G1QL,ET-008,Cervical cancer , Investigative
15212,D0G1RA,Rhodamine-123,Prostate cancer , Discontinued in Phase 1
15213,D0G1RH,NPS-2143,Osteoporosis , Discontinued in Phase 2
15214,D0G1RM,Interferon,Hepatitis C virus infection , Phase 2
15215,D0G1RM,Interferon,Human papillomavirus infection , Investigative
15216,D0G1RT,L-694247,Migraine , Terminated
15217,D0G1SM,AZD-9335,Gastroesophageal reflux disease , Preclinical
15218,D0G1SN,ED1,Acute respiratory distress syndrome , Investigative
15219,D0G1SN,ED1,Myocardial reperfusion injury , Investigative
15220,D0G1SN,ED1,Sepsis , Investigative
15221,D0G1SY,INP-05,Parkinson disease , Investigative
15222,D0G1TX,BA-011,Human immunodeficiency virus infection , Investigative
15223,D0G1TY,CPG 52364,Systemic lupus erythematosus , Phase 1
15224,D0G1VS,UK-78282,Inflammation , Terminated
15225,D0G1VX,BENZYL BENZOATE,Infestations of lice and scabies , Approved
15226,D0G1WC,OC-L vaccine,Fallopian tube cancer , Phase 1
15227,D0G1WL,PITAVASTATIN CALCIUM,Dyslipidemia , Approved
15228,D0G1WM,Influenza A virus H7N1 vaccine,Influenza A virus H7N1 infection , Phase 1
15229,D0G1WR,DasKloster 0014-01,Solid tumour/cancer , Investigative
15230,D0G1WV,Thiophanate-methyl,Plant grey mould disease , Phase 3
15231,D0G1YA,PF-05212377,Alzheimer disease , Phase 2
15232,D0G1YH,ND-201,Mycobacterium infection , Investigative
15233,D0G1YN,DPI-3290,Pain , Discontinued in Phase 2
15234,D0G1YO,GSK1521498,Obesity , Phase 1
15235,D0G1YR,TRI-1144,Human immunodeficiency virus infection , Discontinued in Phase 1
15236,D0G1ZU,EGFR CART,Colorectal cancer , Phase 1/2
15237,D0G2AV,DRH-12,Bacterial infection , Investigative
15238,D0G2CG,AL3818,Alveolar soft part sarcoma , Phase 3
15239,D0G2CG,AL3818,Leiomyosarcoma , Phase 3
15240,D0G2CG,AL3818,Synovial sarcoma , Phase 3
15241,D0G2CG,AL3818,Cervical cancer , Phase 1/2
15242,D0G2CG,AL3818,Endometrial cancer , Phase 1/2
15243,D0G2CG,AL3818,Fallopian tube cancer , Phase 1/2
15244,D0G2CG,AL3818,Ovarian cancer , Phase 1/2
15245,D0G2CG,AL3818,Peritoneal cavity cancer , Phase 1/2
15246,D0G2CL,AG-2024,Arthritis , Terminated
15247,D0G2CQ,WC-3027,Chronic obstructive pulmonary disease , Discontinued in Phase 2
15248,D0G2DR,ANT-G12,Prostate cancer , Investigative
15249,D0G2EP,Amidine compound 6,Inflammation , Patented
15250,D0G2FV,Ultra-rapid insulin,Type-1 diabetes , Phase 2
15251,D0G2FV,Ultra-rapid insulin,Type-2 diabetes , Phase 2
15252,D0G2FY,Anti-CCR5 mabs,Human immunodeficiency virus infection , Investigative
15253,D0G2GR,OP-2507,Hypertension , Discontinued in Phase 2
15254,D0G2GT,SGS-111,Cognitive impairment , Discontinued in Phase 2
15255,D0G2GZ,XGP-120,Arthritis , Investigative
15256,D0G2IC,(S)-FLURBIPROFEN,Myalgia , Preregistration
15257,D0G2IC,(S)-FLURBIPROFEN,Scapulohumeral periarthritis , Preregistration
15258,D0G2IC,(S)-FLURBIPROFEN,Osteoarthritis , Preregistration
15259,D0G2JZ,Bisbenzimide (Hoechst 33258),Solid tumour/cancer , Terminated
15260,D0G2KD,Iophendylate,Spinal cord injury , Approved
15261,D0G2LT,RGH-1756,Schizophrenia , Terminated
15262,D0G2MH,Iodohippurate Sodium,Diagnostic imaging , Approved
15263,D0G2MR,ProstaVac,Prostate hyperplasia , Phase 3
15264,D0G2MW,Icosapent,Thrombin deficiency , Approved
15265,D0G2MW,Icosapent,Hyperglyceridemia , Approved
15266,D0G2MW,Icosapent,Hypertriglyceridemia , Phase 3
15267,D0G2OZ,MORAb-202,Solid tumour/cancer , Phase 1/2
15268,D0G2QH,AEE-788,Solid tumour/cancer , Phase 1/2
15269,D0G2RE,BN 50730,Asthma , Discontinued in Phase 3
15270,D0G2SZ,Piliel,Alopecia , Discontinued in Phase 3
15271,D0G2TA,Rfsh/rhfsh,Infertility , Approved
15272,D0G2UP,DF-152,Mycobacterium infection , Investigative
15273,D0G2UY,HBF-0259,Hepatitis B virus infection , Investigative
15274,D0G2VT,SUN-11031,Anorexia nervosa cachexia , Terminated
15275,D0G2XE,PMX-53,Atopic dermatitis , Phase 2
15276,D0G2XN,S-12968,Hypertension , Discontinued in Phase 3
15277,D0G2XR,TCD-717,Solid tumour/cancer , Phase 1
15278,D0G2ZG,clindamycin phosphate + benzoyl peroxide,Acne vulgaris , Approved
15279,D0G2ZL,Managlinat dialanetil,Type-2 diabetes , Phase 2
15280,D0G2ZX,Vernakalant IV,Atrial fibrillation , Phase 3
15281,D0G3AQ,Prazepam,Anxiety disorder , Approved
15282,D0G3AR,CX-717,Spinal cord injury , Phase 2
15283,D0G3AR,CX-717,Alzheimer disease , Preclinical
15284,D0G3AT,GC813,Middle East Respiratory Syndrome (MERS) , Preclinical
15285,D0G3BK,ZP-2307,Osteoporosis , Investigative
15286,D0G3BN,AE-37,Breast cancer , Phase 2
15287,D0G3BN,AE-37,Prostate cancer , Phase 1
15288,D0G3CO,NHP-229,Gastroesophageal reflux disease , Preclinical
15289,D0G3DC,ASP-1001,Allergic rhinitis , Phase 2/3
15290,D0G3DD,CL-H01,Migraine , Investigative
15291,D0G3DL,Rifampin,Tuberculosis , Approved
15292,D0G3EC,Baquting,Bleeding disorder , Approved
15293,D0G3EU,AMG-139,Crohn disease , Phase 1
15294,D0G3GF,AdPEDR,Exudative age-related macular degeneration , Phase 2
15295,D0G3GR,E7/HSP70 DNA vaccine,Head and neck cancer , Phase 2
15296,D0G3KP,Carbon nanospheres,Allergy , Investigative
15297,D0G3LM,Clomethiazole,Stroke , Phase 3
15298,D0G3MH,PNU-96391A,Substance use disorder , Terminated
15299,D0G3MN,GSK2636771,Solid tumour/cancer , Phase 1
15300,D0G3MN,GSK2636771,Prostate cancer , Phase 1
15301,D0G3OF,V-073,Enterovirus infection , Discontinued in Phase 2
15302,D0G3OI,MK-8237,Allergic asthma , Phase 3
15303,D0G3PI,Alitretinoin,Kaposi sarcoma , Approved
15304,D0G3PK,Fsn-0503,Solid tumour/cancer , Investigative
15305,D0G3QF,Epoxyeicosatrienoic acid mimetics,Pain , Investigative
15306,D0G3RW,Low toxic paclitaxel derivative,Solid tumour/cancer , Investigative
15307,D0G3SH,Ursodeoxycholic acid,Primary biliary cirrhosis , Approved
15308,D0G3TJ,ASKP-1240,Transplant rejection , Phase 2
15309,D0G3UG,HG-1429,Bone disease , Investigative
15310,D0G3UV,PMID25666693-Compound-55,Osteoarthritis pain , Patented
15311,D0G3UV,PMID25666693-Compound-55,Cancer related pain , Patented
15312,D0G3UV,PMID25666693-Compound-55,Neuropathic pain , Patented
15313,D0G3UV,PMID25666693-Compound-55,Inflammatory pain , Patented
15314,D0G3YC,Netupitant,Chemotherapy-induced nausea , Phase 3
15315,D0G3ZN,PF-00614435,Solid tumour/cancer , Investigative
15316,D0G3ZX,Omri-Hep-B,Hepatitis B virus infection , Phase 1
15317,D0G4AE,KNX-Monoclonal204,Alzheimer disease , Investigative
15318,D0G4AJ,AGN-208397,Retina venous occlusion , Phase 1/2
15319,D0G4AL,PA101,Pruritus , Phase 2
15320,D0G4BF,DTaP-HepB prophylactic vaccine,Hepatitis B virus infection , Phase 3
15321,D0G4BI,Efinaconazole,Fungal infection , Approved
15322,D0G4CF,CVT-6883,Asthma , Phase 1
15323,D0G4CY,PA101B,Systemic mastocytosis , Phase 2
15324,D0G4DE,BIA 3-202,Parkinson disease , Phase 2
15325,D0G4DF,AP-1600,Ocular inflammation , Investigative
15326,D0G4ES,Tetrandrine,Sarcoma , Phase 1
15327,D0G4ES,Tetrandrine,Colorectal cancer , Discontinued in Phase 3
15328,D0G4GA,TC-6987,Asthma , Phase 2
15329,D0G4GY,Anti-meso-CAR vector transduced T cells,Endometrial cancer , Phase 1
15330,D0G4GY,Anti-meso-CAR vector transduced T cells,Malignant mesothelioma , Phase 1
15331,D0G4GY,Anti-meso-CAR vector transduced T cells,Ovarian cancer , Phase 1
15332,D0G4GY,Anti-meso-CAR vector transduced T cells,Pancreatic cancer , Phase 1
15333,D0G4GY,Anti-meso-CAR vector transduced T cells,Triple negative breast cancer , Phase 1
15334,D0G4ID,KUR-024,Bone injury , Investigative
15335,D0G4IW,CART-19,Non-hodgkin lymphoma , Phase 2
15336,D0G4IW,CART-19,Acute lymphoblastic leukaemia , Phase 2
15337,D0G4IW,CART-19,Chronic lymphocytic leukaemia , Phase 2
15338,D0G4IW,CART-19,B-cell lymphoma , Phase 1
15339,D0G4IW,CART-19,leukaemia , Phase 1
15340,D0G4IW,CART-19,B-cell chronic lymphocytic leukaemia , Phase 1
15341,D0G4IW,CART-19,Diffuse large B-cell lymphoma , Phase 1
15342,D0G4IW,CART-19,Follicular lymphoma , Phase 1
15343,D0G4IW,CART-19,Haematopoietic/lymphoid cancer , Phase 1
15344,D0G4IW,CART-19,Mantle cell lymphoma , Phase 1
15345,D0G4IW,CART-19,Prolymphocytic leukaemia , Phase 1
15346,D0G4JB,NS-13001,Overactive bladder , Investigative
15347,D0G4JC,ANB-019,Pustular palmoplantar psoriasis , Phase 2
15348,D0G4JI,Pyruvic acid,Malnutrition , Approved
15349,D0G4KD,HS-113,Solid tumour/cancer , Investigative
15350,D0G4KG,Khellin,Asthma , Approved
15351,D0G4MB,ABT-510,Solid tumour/cancer , Phase 2
15352,D0G4OD,Tigecycline,Skin infection , Approved
15353,D0G4OS,SII Rmab,Rabies , Phase 1
15354,D0G4OT,XL784,Diabetic nephropathy , Discontinued in Phase 2
15355,D0G4QL,UNI-rE-4,Type-2 diabetes , Phase 2
15356,D0G4RI,PF-06664178,Solid tumour/cancer , Phase 1
15357,D0G4SO,SUVN-F90101,Pain , Investigative
15358,D0G4XE,Adult stem cell therapy,Stroke , Phase 2
15359,D0G4XE,Adult stem cell therapy,Chronic myocardial ischemia , Phase 2
15360,D0G4YN,177 Lu PSMA-617 targeted radioligand therapy,Prostate cancer , Phase 2
15361,D0G4YR,MT-3995,Diabetic nephropathy , Phase 2
15362,D0G4YT,Liranaftate,Fungal infection , Approved
15363,D0G4YZ,11C-PBR-28,Brain disease , Phase 2
15364,D0G5AG,Mizoribine,Transplant rejection , Approved
15365,D0G5BI,Lamivudine /lopinavir/ritonavir fixed-dose combination,Human immunodeficiency virus-1 infection , Phase 2
15366,D0G5BK,Octafluoropropane perflutren lipid microsphere,Heart disease , Approved
15367,D0G5BL,RG7880,Diabetic foot ulcer , Phase 2
15368,D0G5BL,RG7880,Ulcerative colitis , Phase 1
15369,D0G5CF,Doxercalciferol,Chronic kidney disease , Approved
15370,D0G5CV,Resorcinol compound 1,Albinism , Patented
15371,D0G5CV,Resorcinol compound 1,Ephelides , Patented
15372,D0G5CV,Resorcinol compound 1,Menkes disease , Patented
15373,D0G5CV,Resorcinol compound 1,Senile lentigines , Patented
15374,D0G5CV,Resorcinol compound 1,Melasma , Patented
15375,D0G5DK,ONO-1301,Angina pectoris , Preclinical
15376,D0G5ET,Velaglucerase alfa,Metabolic disorder , Approved
15377,D0G5FR,KST-213,Solid tumour/cancer , Investigative
15378,D0G5GB,MGAH22,Solid tumour/cancer , Phase 2
15379,D0G5GJ,R-68151,Psoriasis vulgaris , Discontinued in Phase 2
15380,D0G5GY,Calcifediol,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
15381,D0G5HI,PF-06678552,Hyperkalemia , Phase 1
15382,D0G5JL,Famotidine,Coronavirus Disease 2019 (COVID-19) , Phase 3
15383,D0G5JW,Erythropoietin,Anemia , Investigative
15384,D0G5LY,SCP-1,Pain , Phase 1
15385,D0G5ME,Telcagepant,Cluster headache , Phase 2
15386,D0G5ME,Telcagepant,Migraine , Phase 2
15387,D0G5ML,Donitriptan,Migraine , Preclinical
15388,D0G5OE,[131I]-BC8,leukaemia , Phase 2
15389,D0G5OV,WAY-255348,Solid tumour/cancer , Investigative
15390,D0G5PF,AFQ056,Fragile X syndrome , Phase 2/3
15391,D0G5QB,Alfentanil,Anaesthesia , Approved
15392,D0G5RQ,AGX-51,Solid tumour/cancer , Investigative
15393,D0G5RT,MC-113,Central nervous system disease , Investigative
15394,D0G5SK,Anti-CD19 CAR T cells,Hodgkin lymphoma , Phase 0
15395,D0G5SU,Paquinimod,Lupus , Phase 2
15396,D0G5TF,Methylene blue,Coronavirus Disease 2019 (COVID-19) , Phase 2
15397,D0G5TU,LESOPITRON DIHYDROCHLORIDE,Mood disorder , Discontinued in Phase 2
15398,D0G5UB,Amlexanox,Respiratory tract inflammation , Approved
15399,D0G5UH,ER-21041,Pain , Investigative
15400,D0G5UW,Saruplase,Thrombosis , Phase 2
15401,D0G5UZ,BVD-CNV,Solid tumour/cancer , Phase 1
15402,D0G5VT,Nazvax-PX,Virus infection , Investigative
15403,D0G5WV,KTE-C19 CAR,Diffuse large B-cell lymphoma , Phase 1/2
15404,D0G5XV,Zanubrutinib,Coronavirus Disease 2019 (COVID-19) , Phase 2
15405,D0G5YR,SAR-566658,Triple negative breast cancer , Phase 2
15406,D0G5YR,SAR-566658,Solid tumour/cancer , Phase 1
15407,D0G5ZE,MDL-28170,Alzheimer disease , Terminated
15408,D0G5ZL,U-93385,Anxiety disorder , Discontinued in Phase 1
15409,D0G6AB,Monocrotaline,Solid tumour/cancer , Approved
15410,D0G6BU,4pox,Virus infection , Investigative
15411,D0G6CF,B-701,Bladder cancer , Phase 2
15412,D0G6CF,B-701,Urothelial carcinoma , Phase 1
15413,D0G6CH,MD-990,Respiratory disease , Investigative
15414,D0G6DF,HMPL-004,Inflammatory bowel disease , Phase 3
15415,D0G6DR,Viltolarsen,Duchenne dystrophy , Approved
15416,D0G6EB,MDX-1097,Haematological malignancy , Phase 2
15417,D0G6EI,CP-533536,Osteoporosis , Phase 2
15418,D0G6EO,Hemoximer,Hypotension , Discontinued in Phase 3
15419,D0G6ES,TAK-218,Neurological disorder , Discontinued in Phase 2
15420,D0G6GB,Veglin,Renal cell carcinoma , Phase 1
15421,D0G6GB,Veglin,Kaposi sarcoma , Phase 1
15422,D0G6HA,Taliglucerase alfa,Metabolic disorder , Approved
15423,D0G6HI,Friulimicin,Bacterial infection , Phase 1
15424,D0G6IQ,PMID25666693-Compound-143,Osteoarthritis pain , Patented
15425,D0G6IQ,PMID25666693-Compound-143,Cancer related pain , Patented
15426,D0G6IQ,PMID25666693-Compound-143,Neuropathic pain , Patented
15427,D0G6IQ,PMID25666693-Compound-143,Inflammatory pain , Patented
15428,D0G6JE,SCH-C,Human immunodeficiency virus infection , Discontinued in Phase 1
15429,D0G6JU,Ibrutinib,Coronavirus Disease 2019 (COVID-19) , Phase 2
15430,D0G6KH,NOX-S91,Solid tumour/cancer , Investigative
15431,D0G6LR,PTI-721,Pain , Discontinued in Phase 1
15432,D0G6NA,REN-850,Multiple sclerosis , Discontinued in Phase 1
15433,D0G6OL,MVI-118,Prostate cancer , Phase 1
15434,D0G6PG,CPA-926,Arthritis , Discontinued in Phase 2
15435,D0G6PL,LG-2293,Prostate cancer , Terminated
15436,D0G6QF,Vandetanib,Solid tumour/cancer , Approved
15437,D0G6QV,Albaconazole,Fungal infection , Phase 2
15438,D0G6RB,Cintredekin besudotox,Brain cancer , Phase 3
15439,D0G6RK,ER-23006,Asthma , Investigative
15440,D0G6RU,NE-1530,Bronchitis , Discontinued in Phase 1
15441,D0G6SD,Delavirdine,Human immunodeficiency virus infection , Approved
15442,D0G6SE,ANGIOTENSIN II,Increase blood pressure , Approved
15443,D0G6SZ,GW873140,Human immunodeficiency virus-1 infection , Discontinued in Phase 3
15444,D0G6TL,DiaPep-277,Autoimmune diabetes , Phase 3
15445,D0G6TV,Recombinant human lubricin,Osteoarthritis , Investigative
15446,D0G6TX,PYC-38,Respiratory distress syndrome , Investigative
15447,D0G6UP,YM-75466,Thrombosis , Discontinued in Phase 1
15448,D0G6UQ,EP-42675,Thrombosis , Phase 1
15449,D0G6US,SLV-322,Heart arrhythmia , Terminated
15450,D0G6VC,Cx-501,Skin infection , Phase 2
15451,D0G6VL,Sarpogrelate,Diabetic complication , Approved
15452,D0G6WW,Morrhuate sodium,Hemorrhoids , Approved
15453,D0G6XC,SW-33377,Solid tumour/cancer , Discontinued in Phase 1
15454,D0G6XU,Melatonin,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
15455,D0G6ZG,Amediplase,Thrombosis , Phase 3
15456,D0G6ZG,Amediplase,Myocardial infarction , Phase 3
15457,D0G6ZS,DTwP-HepB prophylactic vaccine,Hepatitis B virus infection , Phase 3
15458,D0G6ZW,Panimun Bioral,Fungal infection , Discontinued in Phase 3
15459,D0G7BR,AMAP-102,Arthritis , Phase 1
15460,D0G7DJ,Etidocaine,Pain , Approved
15461,D0G7DP,RP-316,Hemorrhagic shock , Terminated
15462,D0G7FJ,Meloxicam,Arthritis , Approved
15463,D0G7HO,NS-649,Alzheimer disease , Terminated
15464,D0G7IF,VLX1570,Multiple myeloma , Phase 1
15465,D0G7IV,Premarin/Pravachol,Hyperlipidaemia , Phase 3
15466,D0G7IY,Cromolyn sodium,Atopic dermatitis , Approved
15467,D0G7KE,JX-2011,Prostate cancer , Investigative
15468,D0G7KJ,Diflorasone,Rosacea , Approved
15469,D0G7KY,Imidazopyridazine derivative 5,Pain , Patented
15470,D0G7KY,Imidazopyridazine derivative 5,Inflammation , Patented
15471,D0G7LC,PENNVAX-6,Human immunodeficiency virus infection , Phase 1
15472,D0G7LP,Pepticlere,Alzheimer disease , Preclinical
15473,D0G7LT,PD-AAV9,Parkinson disease , Investigative
15474,D0G7MM,TA-8995,Hyperlipidaemia , Phase 2
15475,D0G7MM,TA-8995,Cardiovascular disease , Phase 2
15476,D0G7MV,INCB24360,Urothelial carcinoma , Phase 3
15477,D0G7MV,INCB24360,Melanoma , Phase 2
15478,D0G7MV,INCB24360,Solid tumour/cancer , Phase 2
15479,D0G7MV,INCB24360,Recurrent glioblastoma , Phase 1
15480,D0G7MV,INCB24360,B-cell lymphoma , Phase 1
15481,D0G7MV,INCB24360,Colorectal cancer , Phase 1
15482,D0G7MV,INCB24360,Head and neck cancer , Phase 1
15483,D0G7MV,INCB24360,Lung cancer , Phase 1
15484,D0G7MV,INCB24360,Lymphoma , Phase 1
15485,D0G7MV,INCB24360,Merkel cell carcinoma , Phase 1
15486,D0G7MV,INCB24360,Ovarian cancer , Phase 1
15487,D0G7QH,NeisVac-C,Neisseria meningitis infection , Approved
15488,D0G7SM,AEA-35p,Influenza virus infection , Phase 1
15489,D0G7SP,SB-209247,Psoriasis vulgaris , Terminated
15490,D0G7SR,Zinforo,Bacterial infection , Approved
15491,D0G7UV,VI-0134,Premature ejaculation , Investigative
15492,D0G7UX,Cyclosporin A,Coronavirus Disease 2019 (COVID-19) , Phase 1
15493,D0G7WY,Epanova,Hypertriglyceridemia , Approved
15494,D0G7XA,NB-002,Onychomycosis , Phase 2
15495,D0G7XT,Modified PT1.2,Bacterial infection , Investigative
15496,D0G7XW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2",Albinism , Patented
15497,D0G7XW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2",Ephelides , Patented
15498,D0G7XW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2",Menkes disease , Patented
15499,D0G7XW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2",Senile lentigines , Patented
15500,D0G7XW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 2",Melasma , Patented
15501,D0G7YF,VX-467,Inflammation , Investigative
15502,D0G7YG,ABX-MA1,Melanoma , Discontinued in Phase 1
15503,D0G7YS,ONYX-015,Head and neck cancer , Phase 1
15504,D0G7YZ,BMS-189664,Myocardial infarction , Terminated
15505,D0G7ZT,Anti-PSCA mab,Pancreatic cancer , Phase 2
15506,D0G8BE,AMPPL,Diabetic complication , Investigative
15507,D0G8BM,Fedratinib,Myelofibrosis , Approved
15508,D0G8BV,Guggulsterone,Osteoarthritis , Approved
15509,D0G8CU,COTI-2,Cervical cancer , Phase 1
15510,D0G8CU,COTI-2,Endometrial cancer , Phase 1
15511,D0G8CU,COTI-2,Fallopian tube cancer , Phase 1
15512,D0G8CU,COTI-2,Head and neck cancer , Phase 1
15513,D0G8CU,COTI-2,Ovarian cancer , Phase 1
15514,D0G8CU,COTI-2,Peritoneal cavity cancer , Phase 1
15515,D0G8DV,Ad5CMV-NIS,Prostate cancer , Phase 1
15516,D0G8EI,HL-1020,Rheumatoid arthritis , Investigative
15517,D0G8LH,"Pyrazolo[1,5-a]pyrimidine derivative 8",Obesity , Patented
15518,D0G8LN,ISIS-SGLT2,Type-2 diabetes , Phase 1
15519,D0G8MW,BIOLUP,Systemic lupus erythematosus , Investigative
15520,D0G8MY,SIM-0710,Solid tumour/cancer , Investigative
15521,D0G8NJ,Rescinnamine,Hypertension , Approved
15522,D0G8NK,Axanum,Peptic ulcer , Phase 3
15523,D0G8NN,Pramipexole,Parkinson disease , Approved
15524,D0G8NP,CS-00028,Solid tumour/cancer , Preclinical
15525,D0G8OB,Alpha-arylamino hydroxamic acids,Bacillus anthracis infection , Investigative
15526,D0G8OC,Dihydrotachysterol,Hypocalcemia , Approved
15527,D0G8PA,MK-8228,Cytomegalovirus Disease , Approved
15528,D0G8PA,MK-8228,Cytomegalovirus infection , Phase 3
15529,D0G8QW,Delapril,Cardiovascular disease , Approved
15530,D0G8SQ,Levacecarnine hci,Nutritional deficiency , Approved
15531,D0G8SQ,Levacecarnine hci,Cognitive impairment , Approved
15532,D0G8UG,Sulukast,Asthma , Discontinued in Phase 2
15533,D0G8UL,Alferminogene tadenovec,Heart disease , Phase 3
15534,D0G8UL,Alferminogene tadenovec,Angina pectoris , Phase 3
15535,D0G8UY,PF-04958242,Schizophrenia , Phase 2
15536,D0G8YJ,CD19-TriCAR-T,Non-hodgkin lymphoma , Phase 1
15537,D0G8ZQ,G17DT,Gastric adenocarcinoma , Phase 3
15538,D0G9AP,E-2011,Anxiety disorder , Terminated
15539,D0G9AW,GS-9973,B-cell lymphoma , Phase 2
15540,D0G9AW,GS-9973,Acute myeloid leukaemia , Phase 2
15541,D0G9AW,GS-9973,Haematological malignancy , Phase 2
15542,D0G9BH,PC-8608,Solid tumour/cancer , Investigative
15543,D0G9CJ,X-082-NAB,Systemic lupus erythematosus , Investigative
15544,D0G9EI,Anti-IL-5 Receptor mab,Asthma , Phase 2
15545,D0G9EX,C5aR pepducins,Inflammation , Investigative
15546,D0G9FF,Nucleozin,Influenza virus infection , Investigative
15547,D0G9FL,CT-064,Osteoporosis , NDA filed
15548,D0G9FP,Rofleponide,Allergic rhinitis , Discontinued in Phase 2
15549,D0G9IU,Rifapentine,Tuberculosis , Approved
15550,D0G9IU,Rifapentine,Macular degeneration , Investigative
15551,D0G9JL,MTC-220,Solid tumour/cancer , Investigative
15552,D0G9JQ,PB1046,Heart failure , Phase 2
15553,D0G9JQ,PB1046,Pulmonary arterial hypertension , Phase 2
15554,D0G9JQ,PB1046,Hypertension , Phase 1
15555,D0G9JQ,PB1046,Cardiomyopathy , Phase 1
15556,D0G9JQ,PB1046,Duchenne dystrophy , Phase 1
15557,D0G9KS,Aryl mannoside derivative 2,Crohn disease , Patented
15558,D0G9KS,Aryl mannoside derivative 2,Ulcerative colitis , Patented
15559,D0G9KS,Aryl mannoside derivative 2,Urinary tract infection , Patented
15560,D0G9LP,Neutralase,Angiogenesis disorder , Discontinued in Phase 3
15561,D0G9MC,TLC178,Solid tumour/cancer , Phase 1/2
15562,D0G9ME,NAX-5055,Epileptic seizures , Investigative
15563,D0G9MY,CD33-specific gene-engineered T cells,Acute myeloid leukaemia , Phase 1/2
15564,D0G9NN,PEV-6A,Breast cancer , Phase 1
15565,D0G9OC,BMS-PCSK9,Coronary artery disease , Preclinical
15566,D0G9OH,VVZ-149,Arthritis , Phase 2
15567,D0G9PD,IChorcumab,Thrombosis , Phase 1
15568,D0G9RW,TAN-1496,Solid tumour/cancer , Terminated
15569,D0G9SD,EF-13,Solid tumour/cancer , Discontinued in Preregistration
15570,D0G9SH,SA-5845,Central nervous system disease , Phase 1
15571,D0G9SH,SA-5845,Psychotic disorder , Preclinical
15572,D0G9UO,HTRA-1 mabs,Age-related macular degeneration , Investigative
15573,D0G9XG,NBM-HD-1,Solid tumour/cancer , Investigative
15574,D0G9XP,LB80380,Hepatitis B virus infection , Phase 2b
15575,D0G9XS,ADS-0101,Chronic obstructive pulmonary disease , Investigative
15576,D0G9YH,Amsacrine,Acute lymphoblastic leukaemia , Approved
15577,D0G9ZJ,RG7458,Ovarian cancer , Discontinued in Phase 1
15578,D0G9ZU,ESBA-105,Ocular disease , Phase 2
15579,D0G9ZV,BMS-986177,Ischemic stroke , Phase 2
15580,D0G9ZW,Roquinimex,Rheumatoid arthritis , Discontinued in Phase 1
15581,D0G9ZY,"76Br-16alpha,17alpha-dioxolane progestin",Breast cancer , Investigative
15582,D0GA0A,Interferon alfacon-1,Hepatitis C , Approved
15583,D0GA1Q,H-345/52,Heart arrhythmia , Discontinued in Phase 2
15584,D0GA3M,BE-16627B,Inflammation , Terminated
15585,D0GA5T,Indiplon,Insomnia , Approved
15586,D0GA5T,Indiplon,Fibromyalgia , Approved
15587,D0GA7H,Grass peptide allergy desensitization agent,Allergy , Phase 2
15588,D0GA8I,ATLCAR.CD30 cells,Immune System disease , Phase 1
15589,D0GA8I,ATLCAR.CD30 cells,Immunoproliferative disorder , Phase 1
15590,D0GA8I,ATLCAR.CD30 cells,Lymphatic disease , Phase 1
15591,D0GA8I,ATLCAR.CD30 cells,Lymphoma , Phase 1
15592,D0GA8I,ATLCAR.CD30 cells,Neoplasm , Phase 1
15593,D0GB2L,SNN-0031,Brain injury , Phase 1/2
15594,D0GB3A,ABT-080,Asthma , Discontinued in Phase 1
15595,D0GB3Z,Dicoppcopper gluconate + disulfiram,Prostate cancer , Phase 1
15596,D0GB5X,Lulizumab pegol,Systemic lupus erythematosus , Phase 2
15597,D0GB6Y,PMID26651364-Compound-10a,Crohn disease , Patented
15598,D0GB6Y,PMID26651364-Compound-10a,Ulcerative colitis , Patented
15599,D0GB6Y,PMID26651364-Compound-10a,Urinary tract infection , Patented
15600,D0GB7F,ARX-AHD,Breast cancer , Investigative
15601,D0GC2M,Acamprosate,Alcohol dependence , Approved
15602,D0GC3U,CD19-directed CAR-T cells,Non-hodgkin lymphoma , Phase 1
15603,D0GC5H,Ramatroban,Perennial allergic rhinitis , Phase 2/3
15604,D0GC8F,MED-27,Inflammation , Discontinued in Phase 1
15605,D0GD4Q,Patidegib,Basal cell carcinoma , Phase 2
15606,D0GD4Q,Patidegib,Basal cell nevus syndrome , Phase 2
15607,D0GD4Q,Patidegib,Chondrosarcoma , Discontinued in Phase 2
15608,D0GD6J,TDI-0029,Motor neurone disease , Investigative
15609,D0GD9E,GAP T cells,Solid tumour/cancer , Phase 1
15610,D0GE2F,GSK-2485852,Hepatitis C virus infection , Terminated
15611,D0GE5B,RG-2833,Friedreich's ataxia , Phase 1
15612,D0GE6F,Thiazole carboxamide derivative 17,Solid tumour/cancer , Patented
15613,D0GE6F,Thiazole carboxamide derivative 17,Metastatic cancer , Patented
15614,D0GF2R,KN035,Solid tumour/cancer , Phase 2
15615,D0GF2R,KN035,Pleomorphic sarcoma , Phase 2
15616,D0GF2R,KN035,Advanced malignancy , Phase 1
15617,D0GG5I,Recombinant RGD-hirudin,Thrombosis , Phase 2
15618,D0GG7L,BMS-986104,Rheumatoid arthritis , Phase 1
15619,D0GG8N,LTX-200,Fungal infection , Investigative
15620,D0GG9P,Balixafortide,Metastatic breast cancer , Phase 3
15621,D0GH1C,CVT-1,Hypercholesterolaemia , Terminated
15622,D0GH3Q,ITF2357,Duchenne dystrophy , Phase 3
15623,D0GH3Q,ITF2357,Polycythemia vera , Phase 2
15624,D0GH3Q,ITF2357,Essential thrombocythemia , Phase 2
15625,D0GH3Q,ITF2357,Myelofibrosis , Phase 2
15626,D0GH4B,"Pyrazolo[1,5-a]pyrimidine derivative 13",Obesity , Patented
15627,D0GH7L,PRN1008,Pemphigus vulgaris , Phase 2
15628,D0GH8X,Pleo zinc,Coronavirus Disease 2019 (COVID-19) , Investigative
15629,D0GH9W,Heteroaryl-carboxamide derivative 6,Solid tumour/cancer , Patented
15630,D0GH9W,Heteroaryl-carboxamide derivative 6,Metastatic cancer , Patented
15631,D0GH9Z,GW-275175,Virus infection , Terminated
15632,D0GI6O,Iodine-124-labeled F-16 scFv antibody,Solid tumour/cancer , Phase 2
15633,D0GJ1U,C326,Crohn disease , Phase 1
15634,D0GJ2G,Anti-CD22 CAR-T cells,leukaemia , Phase 1
15635,D0GJ2G,Anti-CD22 CAR-T cells,Lymphoma , Phase 1
15636,D0GJ7B,NELOTANSERIN,Lewy body dementia , Phase 2
15637,D0GJ7B,NELOTANSERIN,Sleep-wake disorder , Discontinued in Phase 2
15638,D0GJ7N,Demcizumab,Pancreatic cancer , Phase 2
15639,D0GJ8R,Colestipol,Primary hypercholesterolemia , Approved
15640,D0GK1M,PNT-400,Solid tumour/cancer , Investigative
15641,D0GK4E,EMIVIRINE,Human immunodeficiency virus infection , Phase 2
15642,D0GK9J,ACVR2B,Muscle wasting disease , Investigative
15643,D0GL0J,TGFTX-2,Diabetic complication , Investigative
15644,D0GL0K,MRZ-8456,Movement disorder , Phase 1
15645,D0GL0Q,ICX-RHY,Skin infection , Phase 2
15646,D0GL7H,Talotrexin,Solid tumour/cancer , Phase 1/2
15647,D0GL7U,Norethindrone,Solid tumour/cancer , Approved
15648,D0GL9N,Ruconest,Coronavirus Disease 2019 (COVID-19) , Investigative
15649,D0GM0N,ENDG-6010,Dementia , Investigative
15650,D0GM4S,AG-1284,Human immunodeficiency virus infection , Terminated
15651,D0GM6E,Pegdinetanib,Non-small-cell lung cancer , Phase 1
15652,D0GM6O,Biphenyl mannoside derivative 9,Crohn disease , Patented
15653,D0GM6O,Biphenyl mannoside derivative 9,Ulcerative colitis , Patented
15654,D0GM6O,Biphenyl mannoside derivative 9,Urinary tract infection , Patented
15655,D0GM8E,Haemophilus recombinant vaccine,Chronic obstructive pulmonary disease , Phase 2
15656,D0GM9E,RQ-00310941,Irritable bowel syndrome , Investigative
15657,D0GMN2,JS004,Solid tumour/cancer , Phase 1
15658,D0GN7U,PMID25553724-Compound-US2011803494010,Immune System disease , Patented
15659,D0GN9J,Org-6632,Solid tumour/cancer , Terminated
15660,D0GNF7,OPS-2071,Crohn disease , Phase 2
15661,D0GO0R,Padeliporfin di-potassium,Prostate cancer , Phase 2
15662,D0GO4T,IPH4102,T-cell lymphoma , Phase 2
15663,D0GO7W,21-AMINOEPOTHILONE B,Solid tumour/cancer , Terminated
15664,D0GO9G,PC-mab,Artery stenosis , Investigative
15665,D0GP0H,VGX-100,Solid tumour/cancer , Phase 1
15666,D0GP1O,Emixustat,Age-related macular degeneration , Phase 2/3
15667,D0GP1O,Emixustat,Proliferative diabetic retinopathy , Phase 2
15668,D0GP4R,Picumeterol,Asthma , Discontinued in Phase 2
15669,D0GP7L,PMID26651364-Compound-115,Crohn disease , Patented
15670,D0GP7L,PMID26651364-Compound-115,Ulcerative colitis , Patented
15671,D0GP7L,PMID26651364-Compound-115,Urinary tract infection , Patented
15672,D0GP8N,MK-8808,Follicular lymphoma , Phase 3
15673,D0GP8N,MK-8808,Rheumatoid arthritis , Phase 1
15674,D0GP8P,GSK961081,Chronic obstructive pulmonary disease , Phase 2
15675,D0GP8Q,Risankizumab,Plaque psoriasis , Approved
15676,D0GP8Q,Risankizumab,Psoriatic arthritis , Phase 2
15677,D0GP9Q,TG100801,Macular degeneration , Phase 2
15678,D0GQ7K,Mefloquine,Malaria , Approved
15679,D0GR0I,CD19-targeted allogeneic T-cell therapy,Acute lymphoblastic leukaemia , Phase 2
15680,D0GR0T,Methadyl Acetate,Opioid dependence , Approved
15681,D0GR1Y,Minnelide,Solid tumour/cancer , Phase 1
15682,D0GR2J,Idoxifene,Breast cancer , Discontinued in Phase 3
15683,D0GR3C,Biphenyl mannoside derivative 22,Crohn disease , Patented
15684,D0GR3C,Biphenyl mannoside derivative 22,Ulcerative colitis , Patented
15685,D0GR3C,Biphenyl mannoside derivative 22,Urinary tract infection , Patented
15686,D0GR5X,Tolamba,Allergic rhinitis , Phase 2
15687,D0GR6I,Ganitumab,Ewing sarcoma , Clinical trial
15688,D0GR9H,CD22-specific CAR T-cells also expressing an EGFRt,leukaemia , Phase 1
15689,D0GS2W,W-198,Solid tumour/cancer , Phase 1
15690,D0GS7N,L-158809,Hypertension , Terminated
15691,D0GS9X,OMP-21M18,Solid tumour/cancer , Phase 1
15692,D0GT0Y,MN-246,Urinary incontinence , Discontinued in Phase 1
15693,D0GT3R,Anti-CD19 CAR-T cells,leukaemia , Phase 1/2
15694,D0GT3R,Anti-CD19 CAR-T cells,Lymphoma , Phase 1/2
15695,D0GT4N,BRL-55834,Chronic obstructive pulmonary disease , Discontinued in Phase 2
15696,D0GT5W,Elbasvir,Coronavirus Disease 2019 (COVID-19) , Investigative
15697,D0GT8W,BMS-587101,Psoriasis vulgaris , Discontinued in Phase 2
15698,D0GT9I,Mineral oil,Constipation , Approved
15699,D0GU1S,JNJ-55920839,Systemic lupus erythematosus , Phase 1
15700,D0GU4K,Aprepitant,Depression , Approved
15701,D0GU4K,Aprepitant,Nausea , Approved
15702,D0GU4K,Aprepitant,Solid tumour/cancer , Phase 3
15703,D0GU4Z,CLP-1004,Hypertension , Phase 1
15704,D0GU9J,Ad2/HIF-1alpha/VP16,Peripheral vascular disease , Phase 2
15705,D0GV0H,DPS-201,Atopic dermatitis , Investigative
15706,D0GV0O,Nephesh-1000,Lung cancer , Investigative
15707,D0GV0Q,BMY-43748,Bacterial infection , Phase 1
15708,D0GV5G,PMID25666693-Compound-66,Osteoarthritis pain , Patented
15709,D0GV5G,PMID25666693-Compound-66,Cancer related pain , Patented
15710,D0GV5G,PMID25666693-Compound-66,Neuropathic pain , Patented
15711,D0GV5G,PMID25666693-Compound-66,Inflammatory pain , Patented
15712,D0GV8J,Talazoparib,Breast cancer , Approved
15713,D0GV8J,Talazoparib,Psoriatic arthritis , Phase 3
15714,D0GV9F,Biaryl mannoside derivative 2,Crohn disease , Patented
15715,D0GV9F,Biaryl mannoside derivative 2,Ulcerative colitis , Patented
15716,D0GV9F,Biaryl mannoside derivative 2,Urinary tract infection , Patented
15717,D0GW1P,Actacel,Bordetella pertussis infection , Phase 3
15718,D0GW2L,AN-5973,Enterobacteriaceae infection , Investigative
15719,D0GW3R,PAV-612,Rabies , Investigative
15720,D0GW4K,Lopinavir + ritonavir + ribavirin + interferon beta-1b,Coronavirus Disease 2019 (COVID-19) , Phase 2
15721,D0GW5H,Polyhydroxy benzamide derivative 5,Albinism , Patented
15722,D0GW5H,Polyhydroxy benzamide derivative 5,Ephelides , Patented
15723,D0GW5H,Polyhydroxy benzamide derivative 5,Menkes disease , Patented
15724,D0GW5H,Polyhydroxy benzamide derivative 5,Senile lentigines , Patented
15725,D0GW5H,Polyhydroxy benzamide derivative 5,Melasma , Patented
15726,D0GW6K,ADX N05,Mood disorder , Phase 3
15727,D0GW6K,ADX N05,Excessive daytime sleepiness , Phase 2
15728,D0GW8L,Pyrrole derivative 2,Obesity , Patented
15729,D0GW8X,GDC-0077,Solid tumour/cancer , Phase 2
15730,D0GW8X,GDC-0077,Breast cancer , Phase 1
15731,D0GX0I,EDI200,X-linked hypophosphataemia , Phase 2
15732,D0GX2W,Nafithromycin,Community-acquired pneumonia , Phase 2
15733,D0GX3L,Arbaclofen placarbil,Fragile X syndrome , Phase 3
15734,D0GX3L,Arbaclofen placarbil,Alcohol dependence , Phase 2
15735,D0GX6V,Pyrazole derivative 1,Obesity , Patented
15736,D0GX8F,BN-82002,Solid tumour/cancer , Investigative
15737,D0GY0O,BAY-X-7195,Asthma , Phase 2
15738,D0GY0U,MultiGeneAngio cell therapy,Vascular systems peripheral arterial disorder , Phase 1/2
15739,D0GY1D,FP0011,Amyotrophic lateral sclerosis , Discontinued in Phase 2
15740,D0GY1Y,CS-8080,Arteriosclerosis , Phase 1
15741,D0GY3R,SERMs,Solid tumour/cancer , Investigative
15742,D0GY4H,Taberminogene vadenovec,Vascular restinosis , Phase 3
15743,D0GY4V,TY-11345,Peptic ulcer , Discontinued in Phase 2
15744,D0GY5T,Tuberculin,Mycobacterium infection , Approved
15745,D0GY5Z,Aspirin,Pain , Approved
15746,D0GY5Z,Aspirin,Myocardial infarction , Approved
15747,D0GY5Z,Aspirin,Cardiovascular disease , Phase 3
15748,D0GY8G,Thiazole carboxamide derivative 19,Solid tumour/cancer , Patented
15749,D0GY8G,Thiazole carboxamide derivative 19,Metastatic cancer , Patented
15750,D0GZ3A,L19-TNF-alpha,Colorectal cancer , Phase 2
15751,D0GZ3J,NAMI-A,Solid tumour/cancer , Discontinued in Phase 1
15752,D0GZ4G,PMID25666693-Compound-4,Osteoarthritis pain , Patented
15753,D0GZ4G,PMID25666693-Compound-4,Cancer related pain , Patented
15754,D0GZ4G,PMID25666693-Compound-4,Neuropathic pain , Patented
15755,D0GZ4G,PMID25666693-Compound-4,Inflammatory pain , Patented
15756,D0GZ5F,CX-1001,Solid tumour/cancer , Investigative
15757,D0GZ5M,Avobenzone + Ecamsule + Octocrylene,Discovery agent , Approved
15758,D0GZ7B,AG490,Multiple myeloma , Terminated
15759,D0GZ7B,AG490,Renal transplantation , Terminated
15760,D0GZ8Q,Toremifene,Coronavirus Disease 2019 (COVID-19) , Investigative
15761,D0H0AU,VER-155008,Alzheimer disease , Preclinical
15762,D0H0AU,VER-155008,Solid tumour/cancer , Investigative
15763,D0H0BF,Verdinexor,Coronavirus Disease 2019 (COVID-19) , Investigative
15764,D0H0BG,Sulbactam sodium,Bacterial infection , Approved
15765,D0H0BQ,NM-IL-12,Cutaneous T-cell lymphoma , Phase 2
15766,D0H0CH,PMID30107136-Compound-Example54,Solid tumour/cancer , Patented
15767,D0H0CH,PMID30107136-Compound-Example54,Infectious disease , Patented
15768,D0H0CH,PMID30107136-Compound-Example54,Human immunodeficiency virus infection , Patented
15769,D0H0CH,PMID30107136-Compound-Example54,Hepatitis , Patented
15770,D0H0EM,Dofequidar fumarate,Solid tumour/cancer , Discontinued in Phase 3
15771,D0H0EP,EDP-18,Major depressive disorder , Investigative
15772,D0H0EQ,Ponatinib,Acute lymphoblastic leukaemia , Approved
15773,D0H0FX,NCX-6560,Cardiovascular disease , Phase 1
15774,D0H0GY,HL-001,Diabetic complication , Approved
15775,D0H0HB,FAV-201,Lymphoma , Terminated
15776,D0H0HJ,Tranylcypromine,Major depressive disorder , Approved
15777,D0H0HJ,Tranylcypromine,Prostate cancer , Patented
15778,D0H0IA,WY-28342,Rheumatoid arthritis , Terminated
15779,D0H0KA,Macbecin,Solid tumour/cancer , Investigative
15780,D0H0KB,Riluzole,Amyotrophic lateral sclerosis , Approved
15781,D0H0KH,GS-4059,B-cell lymphoma , Phase 2
15782,D0H0KH,GS-4059,Rheumatoid arthritis , Phase 1
15783,D0H0KK,PD-155080,Hypertension , Terminated
15784,D0H0LK,IC9.GD2.CAR.IL-15 T-cells,Neuroblastoma , Phase 1
15785,D0H0MO,"1,3,4-oxadiazole derivative 5",Solid tumour/cancer , Patented
15786,D0H0MO,"1,3,4-oxadiazole derivative 5",Infectious disease , Patented
15787,D0H0MO,"1,3,4-oxadiazole derivative 5",Human immunodeficiency virus infection , Patented
15788,D0H0MO,"1,3,4-oxadiazole derivative 5",Hepatitis , Patented
15789,D0H0ND,Simvastatin,Hypercholesterolaemia , Approved
15790,D0H0SH,ATB-284,Irritable bowel syndrome , Investigative
15791,D0H0SJ,Neocarzinostatin,Solid tumour/cancer , Approved
15792,D0H0SL,Hemoglobin glutamer,Anemia , Approved
15793,D0H0UB,Darotropium + 642444,Chronic obstructive pulmonary disease , Phase 3
15794,D0H0UC,Resorcinol compound 12,Albinism , Patented
15795,D0H0UC,Resorcinol compound 12,Ephelides , Patented
15796,D0H0UC,Resorcinol compound 12,Menkes disease , Patented
15797,D0H0UC,Resorcinol compound 12,Senile lentigines , Patented
15798,D0H0UC,Resorcinol compound 12,Melasma , Patented
15799,D0H0VB,BC-822,Solid tumour/cancer , Investigative
15800,D0H0VI,Neo-GAA,Pompe disease , Phase 2/3
15801,D0H0VS,SBC-104,Genetic disease , Investigative
15802,D0H0VW,Oncolysin S,Nervous system cancer , Discontinued in Phase 2
15803,D0H0WK,Gadofosveset,Imaging , Approved
15804,D0H0YD,Impoyz,Plaque psoriasis , Phase 2
15805,D0H0YZ,GGF-2,Heart failure , Phase 1
15806,D0H0ZQ,Ad35.CS.01,Malaria , Phase 1/2
15807,D0H0ZU,MP-435,Rheumatoid arthritis , Discontinued in Phase 2
15808,D0H0ZV,MEDI7814,Chronic obstructive pulmonary disease , Phase 1
15809,D0H1AR,Methacycline,Bacterial infection , Approved
15810,D0H1AY,AQW-051,Alzheimer disease , Phase 2
15811,D0H1BZ,Biaryl mannoside derivative 19,Crohn disease , Patented
15812,D0H1BZ,Biaryl mannoside derivative 19,Ulcerative colitis , Patented
15813,D0H1BZ,Biaryl mannoside derivative 19,Urinary tract infection , Patented
15814,D0H1EA,TH-302,Soft tissue sarcoma , Phase 2
15815,D0H1EA,TH-302,Melanoma , Phase 1
15816,D0H1EA,TH-302,Prostate cancer , Phase 1
15817,D0H1EA,TH-302,Squamous cell carcinoma , Phase 1
15818,D0H1EA,TH-302,Pancreatic cancer , Phase 1
15819,D0H1FL,PF-514273,Obesity , Discontinued in Phase 1
15820,D0H1FN,AL-02,Amyotrophic lateral sclerosis , Phase 3
15821,D0H1FV,Selfotel,Cerebrovascular ischaemia , Discontinued in Phase 3
15822,D0H1GF,Sch-34826,Hypertension , Discontinued in Phase 2
15823,D0H1GJ,Sulfamerazine,Bacterial infection , Approved
15824,D0H1IX,Pyrazole derivative 5,Obesity , Patented
15825,D0H1JN,NsG-0501,Epilepsy , Investigative
15826,D0H1JS,Piperazine urea derivative 3,Inflammation , Patented
15827,D0H1JS,Piperazine urea derivative 3,Solid tumour/cancer , Patented
15828,D0H1LO,Lanthanum carbonate,Hypophosphatasia , Approved
15829,D0H1MK,INN-202,Coeliac disease , Phase 2
15830,D0H1MV,RLP-068,Fungal infection , Investigative
15831,D0H1NI,PINS,Breast cancer , Investigative
15832,D0H1NL,TESAGLITAZAR,Type-1 diabetes , Phase 3
15833,D0H1OO,AFT-EPO,Anemia , Investigative
15834,D0H1PK,MVA-BN,Ebola virus infection , Phase 3
15835,D0H1PN,ME-3277,Thrombosis , Discontinued in Phase 1
15836,D0H1QY,Camphor,Acute or chronic pain , Approved
15837,D0H1TA,EK-399,Inflammation , Terminated
15838,D0H1TG,ISIS-CRPRx,Coronary artery disease , Phase 2
15839,D0H1TL,ABT-874,Plaque psoriasis , Phase 3
15840,D0H1TL,ABT-874,Rheumatoid arthritis , Phase 1
15841,D0H1TL,ABT-874,Crohn disease , Discontinued in Phase 2
15842,D0H1UB,PanCyte,Anemia , Investigative
15843,D0H1UK,MK-8591,Human immunodeficiency virus infection , Phase 3
15844,D0H1UW,LATIN T1D,Type-1 diabetes , Phase 3
15845,D0H1UY,RQ-00000010,Gastric motility disorder , Investigative
15846,D0H1VG,DBET6,Coronavirus Disease 2019 (COVID-19) , Investigative
15847,D0H1WC,LY3023414,Solid tumour/cancer , Phase 2
15848,D0H1WC,LY3023414,Prostate cancer , Phase 2
15849,D0H1WT,Anti-SARS-CoV-2 REGN-COV2 vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
15850,D0H1WY,Pegademase bovine,Immune System disease , Approved
15851,D0H1XL,Fc-IFN alpha 2b,Solid tumour/cancer , Investigative
15852,D0H1YE,BE-22179,leukaemia , Terminated
15853,D0H1YQ,Xatral,Benign prostatic hyperplasia , Approved
15854,D0H1YZ,LymPro,Alzheimer disease , Phase 2
15855,D0H2AM,XR-3054,Solid tumour/cancer , Terminated
15856,D0H2AP,EDG-004,Generalized anxiety disorder , Phase 3
15857,D0H2CF,Anti-MUC1 mab,Pancreatic cancer , Phase 1
15858,D0H2CV,SDZ-SCV-106,Colorectal cancer , Phase 2
15859,D0H2DN,DE-310,Solid tumour/cancer , Discontinued in Phase 1
15860,D0H2DQ,Probucol,Coronary artery disease , Approved
15861,D0H2DS,PTH(7-34) liposomal cream,Alopecia , Phase 1
15862,D0H2EM,HIV-1 vaccine,Human immunodeficiency virus-1 infection , Phase 2
15863,D0H2GT,Pyrrole derivative 3,Obesity , Patented
15864,D0H2HZ,GSK2646264,Cutaneous lupus erythematosus , Phase 1
15865,D0H2HZ,GSK2646264,Urticaria , Phase 1
15866,D0H2IO,P32/98,Autism spectrum disorder , Phase 2
15867,D0H2IQ,BL-7010,Coeliac disease , Phase 1/2
15868,D0H2JP,Buprenorphine + naloxone,Opioid dependence , Approved
15869,D0H2JP,Buprenorphine + naloxone,Major depressive disorder , Phase 3
15870,D0H2JQ,NB-506,Solid tumour/cancer , Discontinued in Phase 2
15871,D0H2JS,Tin-117m-labeled annexin,Heart disease , Investigative
15872,D0H2KE,LN-040,leukaemia , Terminated
15873,D0H2KL,PMID29338548-Compound-13,Schizophrenia , Patented
15874,D0H2KV,ALS 2-0426,Type-2 diabetes , Discontinued in Phase 2
15875,D0H2LC,Anti-CD30 CAR-T cells,leukaemia , Phase 1
15876,D0H2LC,Anti-CD30 CAR-T cells,Lymphoma , Phase 1
15877,D0H2LE,"Gene therapy, Huntington's disease",Huntington disease , Investigative
15878,D0H2LJ,TDI-0105,Motor neurone disease , Investigative
15879,D0H2MA,Brilliant Blue G Ophthalmic Solution,Staining , Approved
15880,D0H2MF,PF-02367982,Endometriosis , Investigative
15881,D0H2MM,Influenza H3N2 vaccine,Influenza virus infection , Phase 1
15882,D0H2MO,Colforsin daropate hci,Asthma , Approved
15883,D0H2NH,BRIFENTANIL,Pain , Investigative
15884,D0H2NI,YM-543,Type-2 diabetes , Phase 2
15885,D0H2QL,WRSs2,Shigella infection , Phase 1
15886,D0H2QO,Tetrahydrofolic acid,Malnutrition , Approved
15887,D0H2RI,Fludeoxyglucose F 18,Solid tumour/cancer , Approved
15888,D0H2RJ,Clazosentan,Cerebral vasospasm , Phase 3
15889,D0H2RJ,Clazosentan,Vasospasm , Discontinued in Phase 3
15890,D0H2SY,Oxybuprocaine,Anaesthesia , Approved
15891,D0H2UB,Suramin,African trypanosomiasis , Phase 1
15892,D0H2UN,SC-108,Cardiovascular disease , Terminated
15893,D0H2UU,Entecavir+lamivudine+adefovir,Hepatitis B virus infection , Investigative
15894,D0H2VN,GRL-11097,Alzheimer disease , Investigative
15895,D0H2YX,Unoprostone isopropyl ester,Glaucoma/ocular hypertension , Approved
15896,D0H2YY,JX-929,Solid tumour/cancer , Phase 1
15897,D0H2ZN,ZP-005,Pharyngitis , Investigative
15898,D0H2ZQ,S-18326,Myocardial infarction , Discontinued in Phase 1
15899,D0H2ZW,Xipamide,Hypertension , Approved
15900,D0H3AB,Incobotulinum toxin A,Cervical cancer , Approved
15901,D0H3CV,Ro-48-8724,Multidrug resistant infection , Terminated
15902,D0H3FA,BB-101,Pain , Investigative
15903,D0H3FX,TGF alpha,Cerebrovascular ischaemia , Investigative
15904,D0H3GK,Autologous cell based gene therapy,Pulmonary hypertension , Phase 1
15905,D0H3HB,EG-011,Angina pectoris , Discontinued in Phase 1/2
15906,D0H3HM,Aripiprazole,Schizophrenia , Approved
15907,D0H3HM,Aripiprazole,Erythropoietic porphyrias , Approved
15908,D0H3HM,Aripiprazole,Major depressive disorder , Phase 3
15909,D0H3HM,Aripiprazole,Bipolar disorder , Application submitted
15910,D0H3HV,AP-1030,Metabolic disorder , Phase 1/2
15911,D0H3ID,Pfizer 10,Female sexual arousal dysfunction , Phase 1
15912,D0H3JC,Ragweed allergy immunotherapy vaccine,Seasonal allergic rhinitis , Phase 1
15913,D0H3JF,VTX-2337,Allergy , Discontinued in Phase 2
15914,D0H3JH,CGI-1316,Autoimmune diabetes , Investigative
15915,D0H3JR,MKC-121,Hyperlipidaemia , Discontinued in Phase 1
15916,D0H3KI,2-deoxyglucose,Solid tumour/cancer , Approved
15917,D0H3MG,Felypressin,Localisation , Approved
15918,D0H3ND,AGS62P1,Acute myeloid leukaemia , Phase 1
15919,D0H3NN,Chondrocyte tissue grafts,Back pain , Phase 3
15920,D0H3OZ,BIM-46187,Solid tumour/cancer , Investigative
15921,D0H3PC,Technetium Tc-99m Polyphosphate Kit,Radioactive tracer , Approved
15922,D0H3PV,Insulin + pramlintide,Type-1 diabetes , Phase 1
15923,D0H3ST,AKCEA-ANGPTL3-LRX,Cardiovascular disease , Phase 2
15924,D0H3TD,Imipenem,Bacterial infection , Approved
15925,D0H3UO,RGD-039,Thrombosis , Investigative
15926,D0H3UR,M3814,Locally advanced rectal cancer , Phase 1/2
15927,D0H3UR,M3814,Solid tumour/cancer , Phase 1
15928,D0H3VK,BIIB 028,Solid tumour/cancer , Phase 1
15929,D0H3WI,Ribavirin,Hepatitis C virus infection , Approved
15930,D0H3WU,Omega-3-acid ethyl esters 90,Hyperlipidaemia , Approved
15931,D0H3XB,TULOPAFANT,Cardiac arrhythmias , Terminated
15932,D0H3YC,EP-128504,Solid tumour/cancer , Preclinical
15933,D0H3ZG,Six-membered heterocyclic benzamide derivative 2,Pruritus , Patented
15934,D0H3ZG,Six-membered heterocyclic benzamide derivative 2,Solid tumour/cancer , Patented
15935,D0H3ZG,Six-membered heterocyclic benzamide derivative 2,Chronic pain , Patented
15936,D0H3ZG,Six-membered heterocyclic benzamide derivative 2,Neuropathic pain , Patented
15937,D0H3ZG,Six-membered heterocyclic benzamide derivative 2,Thymic cancer , Patented
15938,D0H3ZR,CytoGam,Cytomegalovirus infection , Approved
15939,D0H4BF,NS-11757,Atrial fibrillation , Investigative
15940,D0H4CB,Hemoglobin raffimer,Anemia , Phase 2/3
15941,D0H4CL,C-linked disaccharide biphenyl mannoside derivative 1,Crohn disease , Patented
15942,D0H4CL,C-linked disaccharide biphenyl mannoside derivative 1,Ulcerative colitis , Patented
15943,D0H4CL,C-linked disaccharide biphenyl mannoside derivative 1,Urinary tract infection , Patented
15944,D0H4DR,BMS-852927,Arteriosclerosis , Phase 1
15945,D0H4DU,KD-7332,Inflammation , Investigative
15946,D0H4EM,Tuberculosis recombinant subunit vaccine,Tuberculosis , Phase 2
15947,D0H4GB,"CB1 antagonist, Bayer",Obesity , Preclinical
15948,D0H4GE,MSI-469,Periodontal disease , Terminated
15949,D0H4GI,CEP-5214,Solid tumour/cancer , Terminated
15950,D0H4GN,Desflurane,Anaesthesia , Approved
15951,D0H4GT,131I-radretumab,Non-small-cell lung cancer , Phase 1/2
15952,D0H4GU,EPX-200,Dravet syndrome , Phase 2
15953,D0H4IM,PH-284,Cachexia , Phase 2
15954,D0H4IP,SL-052,Solid tumour/cancer , Phase 1
15955,D0H4IU,GPI-16072,Neuropathic pain , Phase 1
15956,D0H4JM,Yohimbine,Erectile dysfunction , Approved
15957,D0H4JN,RTI-113,Cocaine addiction , Terminated
15958,D0H4KF,EC-0565,Solid tumour/cancer , Investigative
15959,D0H4LI,H6N1 influenza vaccine,Influenza virus infection , Phase 1
15960,D0H4LK,Thiazoline derivative 1,Albinism , Patented
15961,D0H4LK,Thiazoline derivative 1,Ephelides , Patented
15962,D0H4LK,Thiazoline derivative 1,Menkes disease , Patented
15963,D0H4LK,Thiazoline derivative 1,Senile lentigines , Patented
15964,D0H4LK,Thiazoline derivative 1,Melasma , Patented
15965,D0H4NN,NB3322,Gram-positive bacterial infection , Investigative
15966,D0H4NQ,AWD-5239,Cognitive impairment , Discontinued in Phase 2
15967,D0H4RV,NDC-1022,Solid tumour/cancer , Investigative
15968,D0H4SE,Benzothiazine-carboxamide compound 6,Skin inflammation , Patented
15969,D0H4TC,Davalintide,Obesity , Discontinued in Phase 2
15970,D0H4TP,GSK189254A,Cognitive impairment , Investigative
15971,D0H4TQ,Thyrotropin Alfa,Thyroid cancer , Approved
15972,D0H4TR,PMID25666693-Compound-80,Osteoarthritis pain , Patented
15973,D0H4TR,PMID25666693-Compound-80,Cancer related pain , Patented
15974,D0H4TR,PMID25666693-Compound-80,Neuropathic pain , Patented
15975,D0H4TR,PMID25666693-Compound-80,Inflammatory pain , Patented
15976,D0H4TT,Sanglifehrin A,Coronavirus Disease 2019 (COVID-19) , Investigative
15977,D0H4UJ,INOGATRAN,Myocardial infarction , Discontinued in Phase 2
15978,D0H4UP,CAR-GPC3 T Cells,Lung squamous cell carcinoma , Phase 1
15979,D0H4XV,IM0-8400,Diffuse large B-cell lymphoma , Discontinued in Phase 1/2
15980,D0H4YD,AMG520,Alzheimer disease , Phase 2/3
15981,D0H4YL,Afluria Quadrivalent,Influenza virus infection , Phase 3
15982,D0H4ZD,GPI-2A,Human immunodeficiency virus infection , Discontinued in Phase 1
15983,D0H5BC,Tosagestin,Contraception , Phase 2
15984,D0H5CD,GI-129471,Inflammation , Terminated
15985,D0H5CV,ZK-119010,Carcinoma , Terminated
15986,D0H5DM,Viaskin Milk,Allergy , Phase 2
15987,D0H5DU,Oxyphencyclimine,Peptic ulcer , Approved
15988,D0H5ER,MLN-591RL,Prostate cancer , Phase 2
15989,D0H5ES,Rontalizumab,Systemic lupus erythematosus , Phase 2
15990,D0H5FW,PUR-118,Respiratory disease , Phase 1
15991,D0H5GU,GlucoStem,Insulin-dependent diabetes , Investigative
15992,D0H5HJ,ALN-PCS,Hypercholesterolaemia , Preclinical
15993,D0H5HS,HS-1183,Solid tumour/cancer , Investigative
15994,D0H5HT,PCAP-1,Central nervous system disease , Investigative
15995,D0H5HZ,Etamicastat,Heart failure , Phase 2
15996,D0H5IZ,Etirinotecan pegol,Breast cancer , Phase 3
15997,D0H5IZ,Etirinotecan pegol,Ovarian cancer , Phase 2
15998,D0H5JW,[3H](R)-(-)-baclofen,Multiple sclerosis , Phase 3
15999,D0H5KA,VRC-HIVDNA016-00-VP,Human immunodeficiency virus infection , Phase 2
16000,D0H5KG,AR-9273,Cardiovascular disease , Investigative
16001,D0H5KK,Garnocestim,Bone marrow transplantation , Discontinued in Phase 1
16002,D0H5KO,KW-3635,Thrombosis , Discontinued in Phase 1
16003,D0H5LC,CHPMPC,Virus infection , Discontinued in Phase 1
16004,D0H5LK,Dapoxetine,Premature ejaculation , Phase 4
16005,D0H5LY,STNM-04,Liver cirrhosis , Investigative
16006,D0H5MB,Bopindolol,Hypertension , Approved
16007,D0H5MS,CT84.66,Breast cancer , Phase 1/2
16008,D0H5MW,PHN-021,Motion sickness , Phase 2
16009,D0H5MX,TAFA-93,Transplant rejection , Discontinued in Phase 1
16010,D0H5NF,IFN-beta-CTP,Multiple sclerosis , Investigative
16011,D0H5NX,TOP-53,Metastatic lung cancer , Discontinued in Phase 1
16012,D0H5OX,HAL-MPE1,Allergy , Phase 1
16013,D0H5PD,CP-0597,Asthma , Terminated
16014,D0H5PG,CGS-22652,Angina pectoris , Discontinued in Phase 1
16015,D0H5TU,RQ-00000008,Inflammation , Investigative
16016,D0H5WM,S-0509,Ulcerative colitis , Phase 2
16017,D0H5XB,Asparaginase Erwinia chrysanthemi,Acute lymphoblastic leukaemia , Approved
16018,D0H5ZS,C31510,Squamous cell carcinoma , Phase 1
16019,D0H5ZS,C31510,Basal cell carcinoma , Phase 1
16020,D0H6AF,Thiazole carboxamide derivative 4,Solid tumour/cancer , Patented
16021,D0H6AF,Thiazole carboxamide derivative 4,Metastatic cancer , Patented
16022,D0H6AG,PMID23981898C11d ,Cardiovascular disease , Clinical trial
16023,D0H6AL,"1,3,4-oxadiazole derivative 4",Solid tumour/cancer , Patented
16024,D0H6AL,"1,3,4-oxadiazole derivative 4",Infectious disease , Patented
16025,D0H6AL,"1,3,4-oxadiazole derivative 4",Human immunodeficiency virus infection , Patented
16026,D0H6AL,"1,3,4-oxadiazole derivative 4",Hepatitis , Patented
16027,D0H6AT,SYM-005,Solid tumour/cancer , Investigative
16028,D0H6BL,APL-001,Leukopenia , Investigative
16029,D0H6BS,Rydaptmidostaurin,Acute myeloid leukaemia , Phase 3
16030,D0H6CA,Lenercept,Asthma , Discontinued in Phase 3
16031,D0H6CX,PMID25666693-Compound-72,Osteoarthritis pain , Patented
16032,D0H6CX,PMID25666693-Compound-72,Cancer related pain , Patented
16033,D0H6CX,PMID25666693-Compound-72,Neuropathic pain , Patented
16034,D0H6CX,PMID25666693-Compound-72,Inflammatory pain , Patented
16035,D0H6EF,MVA-BN HIV Multiantigen,Human immunodeficiency virus infection , Phase 1/2
16036,D0H6FY,Natural killer cell therapy,Multiple myeloma , Phase 1
16037,D0H6IG,EP-400,Solid tumour/cancer , Investigative
16038,D0H6LE,LP-20104,Solid tumour/cancer , Investigative
16039,D0H6PH,GSK-2231260A,Mycobacterium infection , Investigative
16040,D0H6PK,FKF02SC,Schizophrenia , Phase 2
16041,D0H6PN,LORECLEZOLE,Epileptic seizures , Discontinued in Phase 2
16042,D0H6PX,TAK-603,Inflammatory bowel disease , Discontinued in Phase 2
16043,D0H6QD,Eptinezumab,Migraine , Approved
16044,D0H6QU,Apomorphine,Parkinson disease , Approved
16045,D0H6QU,Apomorphine,Idiopathic parkinson disease , Phase 3
16046,D0H6QU,Apomorphine,Sexual dysfunction , Phase 2
16047,D0H6SH,MT203,Plaque psoriasis , Phase 2
16048,D0H6TP,Monobenzone,Vitiligo , Approved
16049,D0H6UK,HOO-IFOS,Solid tumour/cancer , Investigative
16050,D0H6UL,ICON-1,Melanoma , Phase 1
16051,D0H6VG,KF-15766,Allergy , Terminated
16052,D0H6VL,NCL-00016149,Solid tumour/cancer , Investigative
16053,D0H6VY,SM-101,Idiopathic thrombocytopenic purpura , Approved (orphan drug)
16054,D0H6VY,SM-101,Systemic lupus erythematosus , Phase 2
16055,D0H6VY,SM-101,Diabetic nephropathy , Preclinical
16056,D0H6VZ,REV-576,Autoimmune diabetes , Phase 1
16057,D0H6YK,MK-3614,Hypertension , Phase 1
16058,D0H6ZA,Pritumumab,Glioma , Phase 2
16059,D0H7AC,PF-03814735,Advanced solid tumour , Discontinued in Phase 1
16060,D0H7AM,MEDI1873,Solid tumour/cancer , Phase 1
16061,D0H7AR,MK-51,Dermatological disease , Phase 1
16062,D0H7AV,Pilsicainide,Heart arrhythmia , Approved
16063,D0H7AZ,Aminocandin,Fungal infection , Investigative
16064,D0H7BF,H3B-8800,Myelodysplastic syndrome , Phase 2
16065,D0H7BF,H3B-8800,Acute myeloid leukaemia , Phase 1
16066,D0H7BF,H3B-8800,Chronic myelogenous leukaemia , Phase 1
16067,D0H7DM,IMX-110,Solid tumour/cancer , Phase 1/2
16068,D0H7FW,YF-476,Stomach ulcer , Phase 2
16069,D0H7GH,ETH615,Dermatitis , Discontinued in Phase 2
16070,D0H7GQ,NS 1209,Neuropathic pain , Phase 2
16071,D0H7GQ,NS 1209,Epilepsy , Phase 2
16072,D0H7HR,Apilimod,Coronavirus Disease 2019 (COVID-19) , Preclinical
16073,D0H7JC,GL-2045,Autoimmune diabetes , Investigative
16074,D0H7JE,RS-100302,Atrial fibrillation , Investigative
16075,D0H7KF,Quetiapine,Schizophrenia , Approved
16076,D0H7KF,Quetiapine,Alcohol dependence , Phase 3
16077,D0H7KQ,ABBV-8E12,Alzheimer disease , Phase 2
16078,D0H7KQ,ABBV-8E12,Progressive supranuclear palsy , Phase 2
16079,D0H7LN,Lx-TB-PstS1,Bladder cancer , Phase 1/2
16080,D0H7MB,Nextomabs,Autoimmune diabetes , Investigative
16081,D0H7OO,PDS-0102,Melanoma , Investigative
16082,D0H7PS,MCT-175,Multiple sclerosis , Investigative
16083,D0H7PW,PIPERINE,Vitiligo , Phase 1/2
16084,D0H7QU,BMS 791325,Hepatitis C virus infection , Phase 2
16085,D0H7SG,PV-327,leukaemia , Investigative
16086,D0H7SO,Heteroaryl-carboxamide derivative 1,Solid tumour/cancer , Patented
16087,D0H7SO,Heteroaryl-carboxamide derivative 1,Metastatic cancer , Patented
16088,D0H7TB,18F labeled ethanolamine derivative,Solid tumour/cancer , Investigative
16089,D0H7TD,CK-2018509,Hypertension , Investigative
16090,D0H7TS,Mesenchymal stem cell therapy,Chronic heart failure , Phase 2
16091,D0H7TS,Mesenchymal stem cell therapy,Ischemic stroke , Phase 2
16092,D0H7UR,Mannoside derivative 11,Crohn disease , Patented
16093,D0H7UR,Mannoside derivative 11,Ulcerative colitis , Patented
16094,D0H7UR,Mannoside derivative 11,Urinary tract infection , Patented
16095,D0H7WA,FCP-3P1,Arteriosclerosis , Discontinued in Phase 2
16096,D0H7XJ,ASP-9521,Prostate cancer , Phase 1/2
16097,D0H7XL,OSI-027,Renal cell carcinoma , Phase 2
16098,D0H7YU,AviFlu,Influenza virus infection , Phase 1
16099,D0H7ZB,SX-013,Obesity , Discontinued in Phase 1
16100,D0H7ZN,VM-206,Solid tumour/cancer , Phase 1
16101,D0H8BD,PMA-101R,Autoimmune diabetes , Investigative
16102,D0H8DS,Tumor infiltrating lymphocyte,Melanoma , Phase 2
16103,D0H8FH,Indapamide,Hypertension , Approved
16104,D0H8FY,Firategrast,Multiple sclerosis , Phase 2
16105,D0H8GW,PS-938285,Chronic obstructive pulmonary disease , Phase 2
16106,D0H8JM,VT-214,Immune System disease , Investigative
16107,D0H8MH,HGH-CTP,Growth hormone deficiency , Phase 3
16108,D0H8MR,CAT-1902,Inflammatory bowel disease , Investigative
16109,D0H8OA,MK-5442,Osteoporosis , Phase 2
16110,D0H8OH,Palovarotene,Fibrodysplasia ossificans progressiva , Phase 3
16111,D0H8OH,Palovarotene,Emphysema , Phase 2
16112,D0H8PX,MORAb-066,Pancreatic cancer , Phase 1
16113,D0H8PX,MORAb-066,Solid tumour/cancer , Phase 1
16114,D0H8QL,Mazindol,Obesity , Approved
16115,D0H8UT,Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes,Acute myeloid leukaemia , Phase 0
16116,D0H8VM,UAI-201,Solid tumour/cancer , Investigative
16117,D0H8VY,BMS-201038,Familial hypercholesterolemia , Approved
16118,D0H8WF,Glucagon recombinant,Hypoglycemia , Approved
16119,D0H8WX,RSV/PIV-3 vaccine,Virus infection , Phase 1
16120,D0H8WZ,SR-43845,Glaucoma/ocular hypertension , Phase 2
16121,D0H8XB,Lancovutide,Chronic obstructive pulmonary disease , Phase 2
16122,D0H8ZI,PDS-0101,Human papillomavirus infection , Phase 1
16123,D0H8ZY,HEPLISAV-B,Hepatitis B virus infection , Application submitted
16124,D0H9AJ,MDL-28170,Coronavirus Disease 2019 (COVID-19) , Investigative
16125,D0H9DA,AZD6738,Small-cell lung cancer , Phase 2
16126,D0H9DA,AZD6738,Chronic lymphocytic leukaemia , Phase 1
16127,D0H9DA,AZD6738,Solid tumour/cancer , Phase 1
16128,D0H9DE,CS-722,Epilepsy , Discontinued in Phase 2
16129,D0H9FR,PRN1371,Solid tumour/cancer , Phase 1
16130,D0H9FX,HCV-371,Hepatitis C virus infection , Discontinued in Phase 1
16131,D0H9GH,31.1Chi,Solid tumour/cancer , Investigative
16132,D0H9GQ,DOV-216303,Mood disorder , Discontinued in Phase 2
16133,D0H9HO,ONO-5334,Coronavirus Disease 2019 (COVID-19) , Investigative
16134,D0H9HT,TAK-701,Advanced malignancy , Phase 1
16135,D0H9KW,Filaminast,Chronic obstructive pulmonary disease , Discontinued in Phase 2
16136,D0H9MA,COR-1,Heart failure , Phase 2
16137,D0H9MR,MP-PN-2,Solid tumour/cancer , Investigative
16138,D0H9OT,PfAMA-1,Malaria , Phase 1
16139,D0H9PT,RG3638,Non-small-cell lung cancer , Phase 3
16140,D0H9PT,RG3638,Gastric adenocarcinoma , Phase 3
16141,D0H9QC,S-474474,Metabolic syndrome x , Phase 3
16142,D0H9QN,AZ-TAK1,Mantle cell lymphoma , Investigative
16143,D0H9QX,FM-TP4000,Non-insulin dependent diabetes , Terminated
16144,D0H9RD,DZ-2640,Bacterial infection , Phase 1
16145,D0H9RN,NU-172,Thrombosis , Phase 2
16146,D0H9SD,PMID30280939-Compound-WO2013148426,Malaria , Patented
16147,D0H9SF,A-76202M,Acquired immune deficiency syndrome , Terminated
16148,D0H9SX,Daporinad,leukaemia , Phase 2
16149,D0H9VP,MP-4-CO,Sickle-cell anaemia , Phase 2
16150,D0H9WO,Gantofiban,Arteriosclerosis , Discontinued in Phase 2
16151,D0H9WR,LX-1031,Irritable bowel syndrome , Phase 2
16152,D0H9WY,PAZ-320,Type-2 diabetes , Phase 2
16153,D0H9XR,SC-435,Hypercholesterolaemia , Investigative
16154,D0H9YO,FLUASTERONE,Arthritis , Phase 2
16155,D0H9ZQ,Dexpanthenol,Wound healing , Approved
16156,D0HA2R,BBT-012,Solid tumour/cancer , Investigative
16157,D0HA7E,TD-Pur,Diphtheria , Approved
16158,D0HB0V,JX-594,Hepatocellular carcinoma , Phase 3
16159,D0HB0V,JX-594,Liver cancer , Phase 2
16160,D0HB0V,JX-594,Colorectal cancer , Phase 2
16161,D0HB2F,ABD-035,Solid tumour/cancer , Investigative
16162,D0HB4E,INCB47986,Rheumatoid arthritis , Discontinued in Phase 2
16163,D0HB5V,CN-2097,Neurological disorder , Investigative
16164,D0HC9K,PMID30107136-Compound-Example41,Solid tumour/cancer , Patented
16165,D0HC9K,PMID30107136-Compound-Example41,Infectious disease , Patented
16166,D0HC9K,PMID30107136-Compound-Example41,Human immunodeficiency virus infection , Patented
16167,D0HC9K,PMID30107136-Compound-Example41,Hepatitis , Patented
16168,D0HD0G,SB3,Breast cancer , Application submitted
16169,D0HD6C,"Tetra-hydro-1H-1,2,6-triazaazulene derivative 1",Obesity , Patented
16170,D0HD7C,PPA-904,Acne vulgaris , Phase 2
16171,D0HD7S,Pyrrole derivative 6,Obesity , Patented
16172,D0HD8X,ISF35,Small lymphocytic lymphoma , Phase 2
16173,D0HD8X,ISF35,Mantle cell lymphoma , Phase 2
16174,D0HD8X,ISF35,Chronic lymphocytic leukaemia , Phase 2
16175,D0HD9K,Acebutolol,Hypertension , Approved
16176,D0HE0Y,Amifampridine,LambertEaton myasthenic syndrome , Approved
16177,D0HE1P,BAY 60-6583,Myocardial ischemia , Preclinical
16178,D0HE3B,Biphenyl mannoside derivative 18,Crohn disease , Patented
16179,D0HE3B,Biphenyl mannoside derivative 18,Ulcerative colitis , Patented
16180,D0HE3B,Biphenyl mannoside derivative 18,Urinary tract infection , Patented
16181,D0HE7C,ORIC-101,Solid tumour/cancer , Phase 1
16182,D0HE7I,H1N1 influenza vaccine,Influenza virus infection , Phase 3
16183,D0HE7X,PMID25666693-Compound-11,Osteoarthritis pain , Patented
16184,D0HE7X,PMID25666693-Compound-11,Cancer related pain , Patented
16185,D0HE7X,PMID25666693-Compound-11,Neuropathic pain , Patented
16186,D0HE7X,PMID25666693-Compound-11,Inflammatory pain , Patented
16187,D0HE8M,"1,2,4-oxadiazole derivative 5",Solid tumour/cancer , Patented
16188,D0HE8M,"1,2,4-oxadiazole derivative 5",Infectious disease , Patented
16189,D0HE8M,"1,2,4-oxadiazole derivative 5",Human immunodeficiency virus infection , Patented
16190,D0HE8M,"1,2,4-oxadiazole derivative 5",Hepatitis , Patented
16191,D0HE9J,APN-201,Dermatitis , Phase 1/2
16192,D0HF0W,Levopropoxyphene Napsylate Anhydrous,Cough , Approved
16193,D0HF1A,Bicyclic heteroaryl benzamide derivative 1,Pruritus , Patented
16194,D0HF1A,Bicyclic heteroaryl benzamide derivative 1,Solid tumour/cancer , Patented
16195,D0HF1A,Bicyclic heteroaryl benzamide derivative 1,Chronic pain , Patented
16196,D0HF1A,Bicyclic heteroaryl benzamide derivative 1,Neuropathic pain , Patented
16197,D0HF1A,Bicyclic heteroaryl benzamide derivative 1,Thymic cancer , Patented
16198,D0HF2D,PBF-1129,Non-small-cell lung cancer , Phase 1
16199,D0HF7V,Peptide analog 3,Solid tumour/cancer , Patented
16200,D0HF7V,Peptide analog 3,Infectious disease , Patented
16201,D0HF7V,Peptide analog 3,Human immunodeficiency virus infection , Patented
16202,D0HF7V,Peptide analog 3,Hepatitis , Patented
16203,D0HFJ8,PfSPZ vaccine,Malaria , Phase 2
16204,D0HG5M,Apratastat,Rheumatoid arthritis , Phase 2
16205,D0HG9P,VentaProst,Pulmonary hypertension , Phase 2
16206,D0HH0G,ABT-767,Solid tumour/cancer , Phase 1
16207,D0HH0U,S-488410,Lung cancer , Phase 2
16208,D0HH2I,CV-9103,Solid tumour/cancer , Phase 1/2
16209,D0HH3W,VBY-825,Coronavirus Disease 2019 (COVID-19) , Investigative
16210,D0HH4L,Thiazolidine derivative 1,Albinism , Patented
16211,D0HH4L,Thiazolidine derivative 1,Ephelides , Patented
16212,D0HH4L,Thiazolidine derivative 1,Menkes disease , Patented
16213,D0HH4L,Thiazolidine derivative 1,Senile lentigines , Patented
16214,D0HH4L,Thiazolidine derivative 1,Melasma , Patented
16215,D0HH9P,NCE-401,Fibrosis , Investigative
16216,D0HI0L,HSV-1716,Solid tumour/cancer , Phase 1/2
16217,D0HI1K,GSK618334,Drug abuse , Phase 1
16218,D0HI1K,GSK618334,Nasopharyngeal carcinoma , Investigative
16219,D0HI1T,SAR440181,Acute heart failure , Phase 1
16220,D0HI5D,Naxitamab,Neuroblastoma , Approved
16221,D0HI5D,Naxitamab,Osteosarcoma , Phase 2
16222,D0HI8X,Heterocyclic derivative 13,Solid tumour/cancer , Patented
16223,D0HI8X,Heterocyclic derivative 13,Metastatic cancer , Patented
16224,D0HJ1R,INCB54707,Hidradenitis suppurativa , Phase 2
16225,D0HJ1Y,BW B70C,Asthma , Terminated
16226,D0HJ5H,BGC-20-1531,Migraine , Phase 2
16227,D0HJ5Y,ChronsVax,Crohn disease , Phase 1
16228,D0HJ7I,DA-727,Hypertension , Phase 1
16229,D0HJ9U,LAU-0901,Brain ischaemia , Investigative
16230,D0HK3N,Belnacasan,Epilepsy , Phase 2
16231,D0HK3U,AM-156,Allergic rhinitis , Investigative
16232,D0HK3X,ASF-1057,Erythema , Phase 3
16233,D0HK7G,DBT-1339,Alzheimer disease , Investigative
16234,D0HK7R,Midafotel,Cognitive impairment , Discontinued in Phase 3
16235,D0HL1X,ISIS-PKK,Amyloid cardiomyopathy , Phase 3
16236,D0HL5N,Trastuzumab duocarmazine,Breast cancer , Phase 3
16237,D0HM1S,FP-0230,Cardiovascular disease , Investigative
16238,D0HM1V,KYMRIAH,Acute lymphoblastic leukaemia , Phase 2
16239,D0HM2S,BTI-320,Type-2 diabetes , Phase 2
16240,D0HM5J,Brensocatib,Coronavirus Disease 2019 (COVID-19) , Preclinical
16241,D0HM5L,Breast cancer vaccine,Breast cancer , Phase 2
16242,D0HM5Q,ND-AMB,Leishmania infection , Investigative
16243,D0HM6B,T-121,Complex regional pain syndrome , Phase 3
16244,D0HM7G,SUVN-G1031,Metabolic disorder , Investigative
16245,D0HN6Q,RG-7348,Hepatitis C virus infection , Phase 1
16246,D0HN6X,SKYFlu,Influenza virus infection , Investigative
16247,D0HN7B,COR-001,Cardiovascular disease , Phase 1
16248,D0HN7I,Alacizumab pegol,Non-small-cell lung cancer , Phase 2
16249,D0HN8P,Leronlimab,Coronavirus Disease 2019 (COVID-19) , Phase 2
16250,D0HO0I,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12",Albinism , Patented
16251,D0HO0I,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12",Ephelides , Patented
16252,D0HO0I,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12",Menkes disease , Patented
16253,D0HO0I,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12",Senile lentigines , Patented
16254,D0HO0I,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 12",Melasma , Patented
16255,D0HO1A,CD19 CAR Gene Transduced T Lymphocytes,Non-hodgkin lymphoma , Phase 1/2
16256,D0HO2T,AZD7325,Anxiety disorder , Phase 2
16257,D0HO9M,AV-2,Ocular disease , Investigative
16258,D0HP3M,BILD-1263,Herpes simplex virus infection , Terminated
16259,D0HP8K,Thiazole carboxamide derivative 2,Solid tumour/cancer , Patented
16260,D0HP8K,Thiazole carboxamide derivative 2,Metastatic cancer , Patented
16261,D0HP8Q,SAR339375,Syndromic genetic deafness , Phase 1
16262,D0HQ1W,SKF-96365,Angina pectoris , Terminated
16263,D0HQ3A,ELGODIPINE HYDROCHLORIDE,Angina pectoris , Discontinued in Phase 3
16264,D0HQ6N,Benztropine,Parkinson disease , Approved
16265,D0HR5B,Apabetalone,Coronavirus Disease 2019 (COVID-19) , Investigative
16266,D0HR5H,Ambroxol,Coronavirus Disease 2019 (COVID-19) , Investigative
16267,D0HR5Q,CIP-137401,Solid tumour/cancer , Investigative
16268,D0HR7P,Amonafide,Prostate cancer , Phase 3
16269,D0HR7P,Amonafide,Ovarian cancer , Phase 3
16270,D0HR7P,Amonafide,Breast cancer , Phase 3
16271,D0HR7X,Riboflavin; ultraviolet-A (UVA) irradiation,Keratoconus , Application submitted
16272,D0HR7X,Riboflavin; ultraviolet-A (UVA) irradiation,Corneal deformity , Application submitted
16273,D0HR7Z,PF-05280014,Breast cancer , Phase 3
16274,D0HR8Z,Miglustat,Type 1 gaucher disease , Approved
16275,D0HS1D,PMID25666693-Compound-20,Osteoarthritis pain , Patented
16276,D0HS1D,PMID25666693-Compound-20,Cancer related pain , Patented
16277,D0HS1D,PMID25666693-Compound-20,Neuropathic pain , Patented
16278,D0HS1D,PMID25666693-Compound-20,Inflammatory pain , Patented
16279,D0HS2E,Rx-04,Bacterial infection , Investigative
16280,D0HS3X,BCH-2051,Solid tumour/cancer , Terminated
16281,D0HS4F,Oxytocin,Coronavirus Disease 2019 (COVID-19) , Phase 2
16282,D0HS5V,Brivanib,Liver cancer , Phase 3
16283,D0HS5V,Brivanib,Breast cancer , Phase 3
16284,D0HS9Y,CTCE-0501,Cerebrovascular ischaemia , Investigative
16285,D0HT2X,CNT0-1959,Rheumatoid arthritis , Phase 2
16286,D0HT4H,SOM-0009,Central nervous system disease , Investigative
16287,D0HT4Y,CC-92480,Multiple myeloma , Phase 1/2
16288,D0HU0A,TK216,Ewing sarcoma , Phase 1
16289,D0HU0W,Temocillin disodium,Sepsis , Approved
16290,D0HU9H,Panitumumab,Colorectal cancer , Approved
16291,D0HU9H,Panitumumab,Head and neck cancer , Phase 2
16292,D0HV4B,ADCT-402,Acute lymphoblastic leukaemia , Phase 1
16293,D0HV4B,ADCT-402,B-cell non-hodgkin lymphoma , Phase 1
16294,D0HV4B,ADCT-402,Burkitt cell leukaemia , Phase 1
16295,D0HV6O,AP-23588,Osteoporosis , Terminated
16296,D0HV6R,Mycophenolate mofetil,Middle East Respiratory Syndrome (MERS) , Investigative
16297,D0HV6X,TRK-130,Overactive bladder , Discontinued in Phase 2
16298,D0HV7A,Lintuzumab Ac-225,Acute myeloid leukaemia , Phase 1/2
16299,D0HV7K,Melacine,Melanoma , Approved
16300,D0HW1I,PAN-622-toxin conjugate,Cholangiocarcinoma , Investigative
16301,D0HW1L,HPN536,Solid tumour/cancer , Phase 1/2
16302,D0HX0P,INP-06,Pain , Investigative
16303,D0HX1T,DA-697b,Thrombosis , Phase 1
16304,D0HY3D,SY-1425,Acute myeloid leukaemia , Phase 1
16305,D0HY3D,SY-1425,Myelodysplastic syndrome , Phase 1
16306,D0HY3P,SGN-10,Solid tumour/cancer , Discontinued in Phase 1
16307,D0HY4Q,98mTc-CIM-ANT,Neuroendocrine cancer , Investigative
16308,D0HY5G,COVID-19 S-Trimer vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
16309,D0HY9S,BOS172722,Solid tumour/cancer , Phase 1
16310,D0HZ1V,KDM-1001,Gastritis , Investigative
16311,D0HZ2A,Recombinant factor VIIa PEGylated liposomal,Factor VII deficiency , Phase 1/2
16312,D0HZ2E,M100907,Sleep-wake disorder , Phase 3
16313,D0HZ4C,AvidinOx,Lymphoma , Phase 1
16314,D0HZ4C,AvidinOx,Solid tumour/cancer , Phase 1
16315,D0HZ8B,Brilacidin,Coronavirus Disease 2019 (COVID-19) , Investigative
16316,D0I0AW,elbasvir + grazoprevir,HCV-1 and HCV-4 infection , Approved
16317,D0I0BJ,Recombinant interleukin-2,Solid tumour/cancer , Investigative
16318,D0I0DL,Alpha 1-PI,Alpha-1 antitrypsin deficiency , Approved
16319,D0I0DL,Alpha 1-PI,Cancer related pain , Withdrawn from market
16320,D0I0DQ,Glisolamide,Diabetic complication , Approved
16321,D0I0DS,Theobromine,Asthma , Approved
16322,D0I0EG,Captopril,Hypertension , Approved
16323,D0I0FA,JCAR020,Ovarian cancer , Phase 1
16324,D0I0GM,Daxalipram,Multiple sclerosis , Discontinued in Phase 2
16325,D0I0JE,"1,3,4-thiadiazole derivative 1",Solid tumour/cancer , Patented
16326,D0I0JE,"1,3,4-thiadiazole derivative 1",Infectious disease , Patented
16327,D0I0JE,"1,3,4-thiadiazole derivative 1",Human immunodeficiency virus infection , Patented
16328,D0I0JE,"1,3,4-thiadiazole derivative 1",Hepatitis , Patented
16329,D0I0JG,[3H]fenobam,Allodynia , Phase 1
16330,D0I0KP,ISC-hpNSC,Parkinson disease , Phase 1/2
16331,D0I0LP,Parvovirus B19 vaccine,Parvovirus infection , Phase 1/2
16332,D0I0NJ,CART-19 cells,Multiple myeloma , Phase 2
16333,D0I0NJ,CART-19 cells,Acute lymphocytic leukaemia , Phase 1
16334,D0I0NP,SL125,Hyperaldosteronism , Investigative
16335,D0I0NP,SL125,Myocardial fibrosis , Investigative
16336,D0I0NP,SL125,Congestive heart failure , Investigative
16337,D0I0NU,NKP-2235,Solid tumour/cancer , Phase 1/2
16338,D0I0RB,Nadifloxacin,Acne vulgaris , Approved
16339,D0I0RF,BVT-142,Type-2 diabetes , Terminated
16340,D0I0RJ,Amiloride,Congestive heart failure , Approved
16341,D0I0SG,CLVax 1.0,Influenza virus infection , Investigative
16342,D0I0SH,KY-021,Diabetic complication , Investigative
16343,D0I0SY,MEDI-542,Solid tumour/cancer , Terminated
16344,D0I0TB,Emodin,Coronavirus Disease 2019 (COVID-19) , Investigative
16345,D0I0TD,AZM-134,Type-2 diabetes , Terminated
16346,D0I0UE,Lexipafant,Nerve injury , Phase 2
16347,D0I0UE,Lexipafant,Hepatovirus infection , Investigative
16348,D0I0UM,CTL019,Diffuse large B-cell lymphoma , Phase 2
16349,D0I0UM,CTL019,Chronic lymphocytic leukaemia , Phase 2
16350,D0I0UM,CTL019,Acute lymphoblastic leukaemia , Clinical trial
16351,D0I0VI,Albumin Human,Hypoalbuminemia , Approved
16352,D0I0VJ,Pyrazole derivative 3,Obesity , Patented
16353,D0I0VY,DA-7101,Gram-positive bacterial infection , Discontinued in Phase 3
16354,D0I0XF,IMO-8400,Rheumatoid arthritis , Phase 2
16355,D0I0XF,IMO-8400,Diffuse large B-cell lymphoma , Phase 1/2
16356,D0I0XF,IMO-8400,Waldenstrom macroglobulinemia , Phase 1/2
16357,D0I0XX,P2B-003,Solid tumour/cancer , Investigative
16358,D0I0YS,TTP-4000,Alzheimer disease , Phase 1
16359,D0I0ZO,Anti-CD45 mabs,Lymphoma , Phase 1
16360,D0I0ZP,Glyminox,Sexually transmitted infection , Phase 3
16361,D0I0ZY,ETN-001,Alzheimer disease , Investigative
16362,D0I1BQ,IL-18BP,Rheumatoid arthritis , Discontinued in Phase 1
16363,D0I1BQ,IL-18BP,B-cell non-hodgkin lymphoma , Discontinued in Phase 1
16364,D0I1BX,CGS-32359,Inflammation , Terminated
16365,D0I1CQ,BIIB067,Amyotrophic lateral sclerosis , Phase 3
16366,D0I1DH,Technetium Tc-99m Mertiatide Kit,Radioactive tracer , Approved
16367,D0I1DW,Edotecarin,Gastric adenocarcinoma , Phase 3
16368,D0I1DZ,DE-110,Xerophthalmia , Phase 2
16369,D0I1EX,DTI-0009,Atrial fibrillation , Phase 2
16370,D0I1FQ,Raltegravir,Human immunodeficiency virus infection , Approved
16371,D0I1FT,Lexgenleucel-T,Human immunodeficiency virus infection , Phase 2
16372,D0I1FU,GSK2830930A,Pneumococcal infection , Phase 2
16373,D0I1HM,CM-182,Neurological disorder , Investigative
16374,D0I1JG,ES-1,Osteoporosis , Phase 2
16375,D0I1KL,ACT-2,Wound healing , Phase 3
16376,D0I1LH,Aldosterone,Hypertension , Approved
16377,D0I1ML,AZD1222 vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
16378,D0I1OS,E-2212,Alzheimer disease , Phase 1
16379,D0I1OX,SPL-2101,Solid tumour/cancer , Investigative
16380,D0I1PF,LCAR-B4822M CAR-T Cell,Multiple myeloma , Phase 1
16381,D0I1PS,Dasatinib,Chronic myeloid leukaemia , Approved
16382,D0I1PS,Dasatinib,Severe acute respiratory syndrome (SARS) , Investigative
16383,D0I1PS,Dasatinib,Middle East Respiratory Syndrome (MERS) , Investigative
16384,D0I1PY,Insulin Susp Protamine Zinc Beef/Pork,Diabetic complication , Approved
16385,D0I1QI,Ganetespib,Non-small-cell lung cancer , Phase 3
16386,D0I1QJ,KP-100,Type-1 diabetes , Phase 1/2
16387,D0I1SK,Isosorbide Dinitrate,Anal fissure , Approved
16388,D0I1SK,Isosorbide Dinitrate,Angina pectoris , Approved
16389,D0I1TM,FP-1102,Vascular disease , Investigative
16390,D0I1VK,Heterocyclic-substituted 3-alkyl azetidine derivative 2,Obesity , Patented
16391,D0I1XE,Diphenyl purine derivative 3,Obesity , Patented
16392,D0I1XG,Salmon Calcitonin,Osteoporosis , Approved
16393,D0I1YQ,Pyrazolopyridines and imidazopyridine derivative 1,Solid tumour/cancer , Patented
16394,D0I1YQ,Pyrazolopyridines and imidazopyridine derivative 1,Metastatic cancer , Patented
16395,D0I1ZB,ENDG-4010,Solid tumour/cancer , Investigative
16396,D0I1ZT,ETV-002,Human immunodeficiency virus infection , Investigative
16397,D0I1ZY,Tralokinumab,Ulcerative colitis , Phase 3
16398,D0I1ZY,Tralokinumab,Atopic dermatitis , Phase 3
16399,D0I1ZY,Tralokinumab,Asthma , Phase 1/2
16400,D0I2AD,SF-113,Retinopathy , Investigative
16401,D0I2AV,Tositumomab,Non-hodgkin lymphoma , Approved
16402,D0I2FI,dequalinium,Myelopathy , Clinical trial
16403,D0I2GS,Contezolid,MRSA infection , Phase 2
16404,D0I2GS,Contezolid,Skin infection , Phase 2
16405,D0I2GT,TMX-30X,Autoimmune diabetes , Investigative
16406,D0I2HL,NLC-002,Obesity , Terminated
16407,D0I2HV,PF-05402536,Smoking dependence , Phase 1
16408,D0I2IY,ABT-700,Advanced solid tumour , Phase 1
16409,D0I2JY,R-1206,Human immunodeficiency virus infection , Investigative
16410,D0I2KE,MK-7684,Lung cancer , Phase 3
16411,D0I2KE,MK-7684,Solid tumour/cancer , Phase 1
16412,D0I2KZ,PC-2000,Hepatitis B virus infection , Investigative
16413,D0I2LX,RMG-40083,Schizophrenia , Preclinical
16414,D0I2MA,IO-21,Ulcer , Discontinued in Phase 2
16415,D0I2MD,RL-6A,Breast cancer , Investigative
16416,D0I2MK,Metoprolol,Hypertension , Approved
16417,D0I2MR,PMID26651364-Compound-9f,Crohn disease , Patented
16418,D0I2MR,PMID26651364-Compound-9f,Ulcerative colitis , Patented
16419,D0I2MR,PMID26651364-Compound-9f,Urinary tract infection , Patented
16420,D0I2NF,Intragam P,Immune System disease , Approved
16421,D0I2OO,PMID28270021-Compound-WO2013161919Example85-117,Pruritus , Patented
16422,D0I2OO,PMID28270021-Compound-WO2013161919Example85-117,Solid tumour/cancer , Patented
16423,D0I2OO,PMID28270021-Compound-WO2013161919Example85-117,Chronic pain , Patented
16424,D0I2OO,PMID28270021-Compound-WO2013161919Example85-117,Neuropathic pain , Patented
16425,D0I2OO,PMID28270021-Compound-WO2013161919Example85-117,Thymic cancer , Patented
16426,D0I2OP,Belaperidone,Schizophrenia , Terminated
16427,D0I2PS,CMET Avimer polypeptides,Solid tumour/cancer , Investigative
16428,D0I2RB,ONO-4641,Rheumatoid arthritis , Phase 2
16429,D0I2RS,PMID26936077-Compound-34,Type-2 diabetes , Patented
16430,D0I2RS,PMID26936077-Compound-34,Metabolic disorder , Patented
16431,D0I2RS,PMID26936077-Compound-34,Gastric ulcer , Patented
16432,D0I2SD,Medroxyprogesterone,Solid tumour/cancer , Approved
16433,D0I2TT,RMH-41,Bacterial infection , Investigative
16434,D0I2VK,Isocarboxazid,Depression , Approved
16435,D0I2VR,Choline magnesium trisalicylate,Osteoarthritis , Approved
16436,D0I2VT,ND7001,Mood disorder , Phase 1
16437,D0I2VW,GSK2838232,Human immunodeficiency virus-1 infection , Phase 2
16438,D0I2WV,Levamlodipine,Hypertension , Phase 4
16439,D0I2XM,L-796568,Obesity , Phase 1
16440,D0I2YV,BIBB-515,Arteriosclerosis , Terminated
16441,D0I3AS,CD-2475/101,Acne vulgaris , Phase 2
16442,D0I3BB,KW-7158,Urinary incontinence , Discontinued in Phase 2
16443,D0I3BS,KRL-401,Attention deficit hyperactivity disorder , Phase 1
16444,D0I3CP,SDX-7400,Solid tumour/cancer , Investigative
16445,D0I3CV,L-695256,Bacterial infection , Terminated
16446,D0I3EI,NK-1001,Atrial fibrillation , Discontinued in Phase 2
16447,D0I3GT,Live attenuated recombinant vaccine,Chikungunya virus infection , Phase 2
16448,D0I3GZ,TAK-003,Dengue fever , Phase 3
16449,D0I3HI,KP-413,Atopic dermatitis , Phase 1/2
16450,D0I3IG,Alseroxylon,Hypertension , Approved
16451,D0I3JZ,Peginesatide acetate,Anaemia , Approved
16452,D0I3KT,PMID26815044-Compound-64,Albinism , Patented
16453,D0I3KT,PMID26815044-Compound-64,Ephelides , Patented
16454,D0I3KT,PMID26815044-Compound-64,Menkes disease , Patented
16455,D0I3KT,PMID26815044-Compound-64,Senile lentigines , Patented
16456,D0I3KT,PMID26815044-Compound-64,Melasma , Patented
16457,D0I3LE,Insulin-aspart,Diabetic complication , Approved
16458,D0I3LO,IPI-549,Bladder cancer , Phase 2
16459,D0I3LO,IPI-549,Adrenocortical carcinoma , Phase 1
16460,D0I3LO,IPI-549,Breast cancer , Phase 1
16461,D0I3LO,IPI-549,Head and neck cancer , Phase 1
16462,D0I3LO,IPI-549,Melanoma , Phase 1
16463,D0I3LO,IPI-549,Mesothelioma , Phase 1
16464,D0I3LO,IPI-549,Solid tumour/cancer , Phase 1
16465,D0I3NA,Human-cl rhFVIII,Hypertension , Phase 3
16466,D0I3OS,Rebmab-100,Fallopian tube cancer , Phase 2
16467,D0I3OX,ESN-XX,Alzheimer disease , Investigative
16468,D0I3PG,SDZ-CPI-975,Diabetic complication , Discontinued in Phase 1
16469,D0I3QJ,HX-100,Diabetic neuropathy , Phase 1
16470,D0I3QU,ISIS 18078,Solid tumour/cancer , Investigative
16471,D0I3QX,Camrelizumab,Coronavirus Disease 2019 (COVID-19) , Investigative
16472,D0I3RD,TAK-733,Solid tumour/cancer , Phase 1
16473,D0I3RN,PGL-2,Endometriosis , Phase 2
16474,D0I3RO,Droxidopa,Neurogenic orthostatic hypotension , Approved
16475,D0I3TD,CRL-37212,Solid tumour/cancer , Investigative
16476,D0I3TJ,Fluvax,Influenza virus infection , Approved
16477,D0I3TS,GW-594884A,Obesity , Preclinical
16478,D0I3TU,MK-7246,Respiratory disease , Phase 1
16479,D0I3VP,SULOFENUR,Solid tumour/cancer , Discontinued in Phase 1
16480,D0I3VS,Autologous anti-gp100 T-cell receptor gene-engineered peripheral blood lymphocytes,Melanoma , Phase 2
16481,D0I3VT,CAD-106,Alzheimer disease , Phase 2/3
16482,D0I3VV,Telomelysin,Melanoma , Phase 2
16483,D0I3VV,Telomelysin,Merkel cell carcinoma , Phase 2
16484,D0I3WC,RO-4929097,Breast cancer , Phase 2
16485,D0I3XA,Ciproxifan,Obesity , Investigative
16486,D0I3XA,Ciproxifan,Dementia , Investigative
16487,D0I3XG,Verteporfin,Psoriasis vulgaris , Approved
16488,D0I3XR,Tefibazumab,Bacterial infection , Phase 2
16489,D0I3YX,Capadenoson,Atrial fibrillation , Phase 2
16490,D0I3ZW,PMID25666693-Compound-159,Osteoarthritis pain , Patented
16491,D0I3ZW,PMID25666693-Compound-159,Cancer related pain , Patented
16492,D0I3ZW,PMID25666693-Compound-159,Neuropathic pain , Patented
16493,D0I3ZW,PMID25666693-Compound-159,Inflammatory pain , Patented
16494,D0I4BK,XmAb14045,Acute myeloid leukaemia , Phase 1
16495,D0I4DQ,Alprostadil,Erectile dysfunction , Approved
16496,D0I4DQ,Alprostadil,Diabetic foot ulcer , Approved
16497,D0I4EI,NSL-105,Neuropathic pain , Preclinical
16498,D0I4EL,Odulimomab,Transplant rejection , Approved
16499,D0I4FL,N-1177-inh,Lymphoma , Discontinued in Phase 1
16500,D0I4GI,RO-26-9228,Urinary incontinence , Discontinued in Phase 2
16501,D0I4GT,Hexylcarbamoyl fluorouracil,Coronavirus Disease 2019 (COVID-19) , Investigative
16502,D0I4HG,4SCAR19 and 4SCAR38,B-cell lymphoma , Phase 1/2
16503,D0I4HS,PE0139,Type-2 diabetes , Phase 2
16504,D0I4LB,SM-16,Fibrosis , Terminated
16505,D0I4LM,ABIO-05/01,Chronic myeloid leukaemia , Phase 2
16506,D0I4LQ,RHIIP,Diabetic complication , Investigative
16507,D0I4MW,DWJ-425,Rheumatoid arthritis , Investigative
16508,D0I4OJ,Protectaid,Contraception , Investigative
16509,D0I4OX,SURADISTA,Solid tumour/cancer , Discontinued in Phase 1
16510,D0I4PB,MCT-485,Solid tumour/cancer , Investigative
16511,D0I4PL,DPC-543,Alzheimer disease , Discontinued in Phase 2
16512,D0I4PW,APD371,Crohn disease , Phase 2
16513,D0I4QA,Drug 2849330,Solid tumour/cancer , Phase 1
16514,D0I4RX,TJ-127,Allergy , Terminated
16515,D0I4TH,GDC-0068,Breast cancer , Phase 3
16516,D0I4TH,GDC-0068,Colorectal cancer , Phase 3
16517,D0I4TH,GDC-0068,Prostate cancer , Phase 3
16518,D0I4TH,GDC-0068,Gastric adenocarcinoma , Phase 2
16519,D0I4TH,GDC-0068,Solid tumour/cancer , Phase 2
16520,D0I4UY,GSK-1108167A,Non-insulin dependent diabetes , Investigative
16521,D0I4VX,DRP-049,Fibrosis , Investigative
16522,D0I4WH,NCX-434,Diabetic macular edema , Investigative
16523,D0I4XF,ALT 005,Ophthalmic infection , Phase 3
16524,D0I4YP,BIOO-5,Solid tumour/cancer , Investigative
16525,D0I4ZN,GSK2879552,Small-cell lung cancer , Phase 1
16526,D0I4ZQ,Collagenase clostridium histolyticum,Sarcoidosis , Approved
16527,D0I5BN,NV-196,Solid tumour/cancer , Phase 1
16528,D0I5CN,VRS-859,Type-2 diabetes , Phase 1
16529,D0I5CO,NNI-PD,Parkinson disease , Investigative
16530,D0I5DP,AMG 176,Multiple myeloma , Phase 1
16531,D0I5DP,AMG 176,Acute myeloid leukaemia , Phase 1
16532,D0I5DS,Meprednisone,Chronic obstructive pulmonary disease , Approved
16533,D0I5ED,Placental growth factor,Cerebrovascular ischaemia , Investigative
16534,D0I5EU,RG7421+RG7204,Melanoma , Phase 3
16535,D0I5FP,RHAMM-R3 peptide vaccine,Solid tumour/cancer , Phase 1
16536,D0I5GC,Dry-powder peptide YY(3-36),Obesity , Investigative
16537,D0I5GS,CAR.CD30 cells,Immune System disease , Phase 1/2
16538,D0I5GS,CAR.CD30 cells,Immunoproliferative disorder , Phase 1/2
16539,D0I5GS,CAR.CD30 cells,Lymphatic disease , Phase 1/2
16540,D0I5GS,CAR.CD30 cells,Lymphoma , Phase 1/2
16541,D0I5GS,CAR.CD30 cells,Neoplasm , Phase 1/2
16542,D0I5HE,NPY5RA-972,Obesity , Preclinical
16543,D0I5HF,Apixaban,Thrombosis , Approved
16544,D0I5HV,Articaine,Anaesthesia , Approved
16545,D0I5IM,LY-518674,Diabetic complication , Phase 2
16546,D0I5IS,MBS-103,Chronic obstructive pulmonary disease , Investigative
16547,D0I5JM,LC-350189,Gout , Phase 1
16548,D0I5KI,"Dibenzo [c,f]-[2,7]naphthyridine derivative 1",Solid tumour/cancer , Patented
16549,D0I5KI,"Dibenzo [c,f]-[2,7]naphthyridine derivative 1",Metastatic cancer , Patented
16550,D0I5KX,Thymalfasin,Hepatitis virus infection , Approved
16551,D0I5KX,Thymalfasin,Melanoma , Phase 2
16552,D0I5KX,Thymalfasin,Liver cancer , Phase 2
16553,D0I5LM,R-1065,Obesity , Discontinued in Phase 1
16554,D0I5ND,CNX-010,Non-insulin dependent diabetes , Investigative
16555,D0I5NN,Valtorim,Anthrax , Phase 1
16556,D0I5OM,Dextrin-2-sulphate,Human immunodeficiency virus infection , Discontinued in Phase 3
16557,D0I5OR,Tetrahydrouridine,Solid tumour/cancer , Phase 2
16558,D0I5PM,DW-908e,Allergy , Discontinued in Phase 1
16559,D0I5PQ,Interferon alpha-1b,Coronavirus Disease 2019 (COVID-19) , Phase 1
16560,D0I5QL,CRD-5,Hyperlipidaemia , Discontinued in Phase 2
16561,D0I5QV,VIR-201,Human immunodeficiency virus infection , Phase 1/2
16562,D0I5QX,Etanercept,Arthritis , Approved
16563,D0I5QX,Etanercept,Sciatica , Phase 3
16564,D0I5QX,Etanercept,Pemphigus vulgaris , Phase 2
16565,D0I5RR,V-503,Human papillomavirus infection , Phase 3
16566,D0I5SD,Azetidine derivative 1,Obesity , Patented
16567,D0I5TC,Cyanocobalamin Co-57,Vitamin B12 deficiency , Approved
16568,D0I5TL,ADX-48621,Parkinson disease , Phase 2/3
16569,D0I5TL,ADX-48621,Mood disorder , Phase 2
16570,D0I5TL,ADX-48621,Dyskinesia , Phase 2
16571,D0I5TT,EPI-2221,Solid tumour/cancer , Investigative
16572,D0I5US,UB-421,Human immunodeficiency virus-1 infection , Phase 2
16573,D0I5VA,CF502,Inflammation , Preclinical
16574,D0I5WB,Clomiphene Citrate,Female infertility , Approved
16575,D0I5WJ,Blisibimod,Systemic lupus erythematosus , Phase 3
16576,D0I5WO,"Lymphocyte immune globulin, anti-thymocyte globulin",Aplastic anemia , Approved
16577,D0I5XU,PF-3635659,Chronic obstructive pulmonary disease , Phase 2
16578,D0I5ZM,Remogli ozin-etabonate,Type-2 diabetes , Phase 2
16579,D0I5ZO,AS-1522489-00,Dementia , Investigative
16580,D0I5ZX,Recombinant novel coronavirus vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 2
16581,D0I6AU,BDD-10103,Pain , Phase 1
16582,D0I6EK,P10s-Padre/Montanide ISA 51 vaccine,Breast cancer , Phase 1/2
16583,D0I6FA,Hemoglobin crosfumaril,Hypotension , Approved
16584,D0I6FS,Rh-bmp-2/acs,Bone induction , Approved
16585,D0I6GC,NOGGIN,Multiple sclerosis , Investigative
16586,D0I6HJ,INC-106,Artery stenosis , Investigative
16587,D0I6IB,Tenoxicam,Rheumatoid arthritis , Approved
16588,D0I6IP,Candicidin,Bacterial infection , Approved
16589,D0I6IQ,Neihulizumab,Psoriatic arthritis , Phase 2
16590,D0I6JF,Sodium phosphate P 32,Bone metastases , Approved
16591,D0I6JG,Organon-3,Schizophrenia , Preclinical
16592,D0I6KC,HydroVAX,Dengue fever , Investigative
16593,D0I6LD,Monovalent oral polio vaccine 1,Poliovirus infection , Approved
16594,D0I6LH,Triptolide,Autoimmune diabetes , Phase 3
16595,D0I6LN,INP103,Parkinson disease , Phase 2
16596,D0I6LR,BL-6030,Bacterial infection , Investigative
16597,D0I6MR,NN1406,Type-1 diabetes , Phase 1
16598,D0I6MR,NN1406,Type-2 diabetes , Phase 1
16599,D0I6NH,Anti-PD-L1 mAb,Solid tumour/cancer , Phase 1
16600,D0I6OI,RG7601,Chronic lymphocytic leukaemia , Phase 3
16601,D0I6PP,VaxiGrip QIV IM,Influenza , Phase 3
16602,D0I6PP,VaxiGrip QIV IM,Influenza virus infection , Phase 3
16603,D0I6QN,K-454,Solid tumour/cancer , Investigative
16604,D0I6RC,Benzyl phenyl ether derivative 2,Solid tumour/cancer , Patented
16605,D0I6RC,Benzyl phenyl ether derivative 2,Infectious disease , Patented
16606,D0I6RC,Benzyl phenyl ether derivative 2,Human immunodeficiency virus infection , Patented
16607,D0I6RC,Benzyl phenyl ether derivative 2,Hepatitis , Patented
16608,D0I6RI,GRNVAC1,Acute myeloid leukaemia , Phase 2
16609,D0I6RV,HR1P peptide,Middle East Respiratory Syndrome (MERS) , Preclinical
16610,D0I6UE,STI-002,Rheumatoid arthritis , Phase 3
16611,D0I6UK,BO-0742,Solid tumour/cancer , Investigative
16612,D0I6UN,AbGn-150,Multiple myeloma , Investigative
16613,D0I6UU,UK-74505,Sepsis , Discontinued in Phase 2
16614,D0I6VU,Enzastaurin,Non-hodgkin lymphoma , Phase 3
16615,D0I6VU,Enzastaurin,Diffuse large B-cell lymphoma , Phase 3
16616,D0I6VU,Enzastaurin,Glioblastoma multiforme , Phase 2
16617,D0I6VU,Enzastaurin,Central nervous system disease , Phase 1
16618,D0I6XJ,AMP-X-0001,Epilepsy , Investigative
16619,D0I6YM,Ferroquine,Malaria , Phase 2
16620,D0I6ZO,AZD-5213,Alzheimer disease , Phase 2
16621,D0I7BD,CYT-006-AngQb,Hypertension , Phase 2
16622,D0I7BU,GSK1482160,Pain , Phase 1
16623,D0I7EU,SB-208651,Thrombosis , Terminated
16624,D0I7EX,Org-34116,Anxiety disorder , Terminated
16625,D0I7FH,PF-4859989,Schizophrenia , Investigative
16626,D0I7HB,NuroPro,Parkinson disease , Phase 1
16627,D0I7HG,RBT-401,Solid tumour/cancer , Investigative
16628,D0I7IB,Sodium butyrate,Refractory sickle cell ulcers , Phase 2
16629,D0I7IB,Sodium butyrate,Acute myeloid leukaemia , Phase 2
16630,D0I7LB,ZD-4953,Pain , Discontinued in Phase 2
16631,D0I7MF,SIM-0702,Solid tumour/cancer , Investigative
16632,D0I7MG,AG-707,Herpes simplex virus infection , Phase 1
16633,D0I7MK,DasKloster 0080-01,Lymphangioleiomyomatosis , Investigative
16634,D0I7MT,Puerarin,Alcohol dependence , Phase 2
16635,D0I7MX,LB-30870,Myocardial infarction , Phase 2
16636,D0I7NG,LOR-2040,Metastatic renal cancer , Phase 2
16637,D0I7NG,LOR-2040,Prostate cancer , Phase 2
16638,D0I7NG,LOR-2040,Metastatic colorectal cancer , Phase 2
16639,D0I7NG,LOR-2040,Breast cancer , Phase 2
16640,D0I7NG,LOR-2040,Acute myeloid leukaemia , Phase 2
16641,D0I7OE,CryptoGAM,Cryptosporidium infection , Discontinued in Phase 2
16642,D0I7OF,Hexamethylene amiloride,Severe acute respiratory syndrome (SARS) , Preclinical
16643,D0I7PO,Micardis telmisartan,Hypertension , Approved
16644,D0I7PU,Lirilumab,Acute myeloid leukaemia , Phase 2
16645,D0I7PU,Lirilumab,Chronic lymphocytic leukaemia , Phase 2
16646,D0I7PU,Lirilumab,Myelodysplastic syndrome , Phase 2
16647,D0I7PU,Lirilumab,Solid tumour/cancer , Phase 1/2
16648,D0I7RO,BPC-157,Inflammatory bowel disease , Discontinued in Phase 2
16649,D0I7SZ,Quinapril,Hypertension , Approved
16650,D0I7TN,3-DEAZAADENOSINE,Arthritis , Terminated
16651,D0I7UZ,Peptide analog 6,Solid tumour/cancer , Patented
16652,D0I7UZ,Peptide analog 6,Infectious disease , Patented
16653,D0I7UZ,Peptide analog 6,Human immunodeficiency virus infection , Patented
16654,D0I7UZ,Peptide analog 6,Hepatitis , Patented
16655,D0I7VI,EG-10,Inflammatory bowel disease , Investigative
16656,D0I7YR,AG-NCA805,Asthma , Investigative
16657,D0I7ZH,EGFR806-specific CAR T cell,Atypical teratoid/rhabdoid tumour , Phase 1
16658,D0I7ZH,EGFR806-specific CAR T cell,Choroid plexus carcinoma , Phase 1
16659,D0I7ZH,EGFR806-specific CAR T cell,Ependymoma , Phase 1
16660,D0I7ZH,EGFR806-specific CAR T cell,Germ cell tumour , Phase 1
16661,D0I7ZH,EGFR806-specific CAR T cell,Glioma , Phase 1
16662,D0I7ZH,EGFR806-specific CAR T cell,Medulloblastoma , Phase 1
16663,D0I7ZH,EGFR806-specific CAR T cell,Pineoblastoma , Phase 1
16664,D0I7ZH,EGFR806-specific CAR T cell,Gastric adenocarcinoma , Phase 1
16665,D0I8BC,S-100,Obesity , Investigative
16666,D0I8BH,Vx-001,Breast cancer , Phase 2
16667,D0I8CA,Isoxyl,Bacterial infection , Approved
16668,D0I8CK,IPL-512602,Asthma , Phase 2
16669,D0I8DD,Dantrolene,Hyperthermia , Approved
16670,D0I8DH,ONX-0801,Solid tumour/cancer , Phase 1
16671,D0I8DX,AMG 820,Solid tumour/cancer , Phase 1
16672,D0I8FI,Isoproterenol,Heart block , Approved
16673,D0I8FI,Isoproterenol,Melanoma , Phase 1
16674,D0I8FO,ABI-0043,Respiratory tract infection , Preclinical
16675,D0I8FS,BIIB092,Progressive supranuclear palsy , Phase 2
16676,D0I8FS,BIIB092,Alzheimer disease , Phase 1
16677,D0I8FV,SUN13834,Gram-positive bacterial infection , Phase 2
16678,D0I8GN,INK4a,Solid tumour/cancer , Investigative
16679,D0I8GU,LI 401,Gingivitis , Discontinued in Phase 2
16680,D0I8HJ,lormetazepam,Nasal polyp , Clinical trial
16681,D0I8KA,BLZ-100,Glioma , Phase 1/2
16682,D0I8KA,BLZ-100,Malignant primary brain tumour , Phase 1
16683,D0I8LL,XGP-310,Migraine , Investigative
16684,D0I8LS,Rubratin,Solid tumour/cancer , Discontinued in Preregistration
16685,D0I8LU,Zuclopenthixol,Schizophrenia , Approved
16686,D0I8NM,"Gene therapy, IFN-alpha",Head and neck cancer , Terminated
16687,D0I8OE,PcTx1,Pain , Investigative
16688,D0I8OY,XLCART001,B-cell lymphoma , Phase 2
16689,D0I8PA,MN-7105,Solid tumour/cancer , Investigative
16690,D0I8QC,Anti-GM-CSF human mabs,Autoimmune diabetes , Investigative
16691,D0I8QF,PU-2049,Psoriasis vulgaris , Investigative
16692,D0I8QJ,Ranpirnase,Lung cancer , Phase 2
16693,D0I8QS,BN82451,Parkinson disease , Phase 2
16694,D0I8QT,Pyridostigmine,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
16695,D0I8QY,P31-Protein,Solid tumour/cancer , Investigative
16696,D0I8RR,Streptozocin,Pancreatic cancer , Approved
16697,D0I8RY,SDZ-ICM-567,Anxiety disorder , Terminated
16698,D0I8SA,BO-110,Solid tumour/cancer , Investigative
16699,D0I8SC,WSB-290,Autoimmune diabetes , Investigative
16700,D0I8TF,EXO-226,Diabetic kidney disease , Discontinued in Phase 3
16701,D0I8TJ,CY-1788,Sepsis , Discontinued in Phase 1
16702,D0I8TV,DLX-0201,Vomiting , Preclinical
16703,D0I8TW,IBC-VS01,Type-1 diabetes , Phase 1
16704,D0I8YO,Hepatitis B vaccine,Hepatitis B virus infection , Approved
16705,D0I8YS,RO5520985,Colorectal cancer , Phase 2
16706,D0I8ZB,Ruthenium complexes,Autoimmune diabetes , Terminated
16707,D0I8ZM,CR-3294,Diarrhea , Phase 2
16708,D0I9AC,SM04554,Alopecia , Phase 2/3
16709,D0I9AR,BMS-185857,Solid tumour/cancer , Terminated
16710,D0I9FQ,XGP-125,Arthritis , Investigative
16711,D0I9FU,Bicyclic heteroaryl benzamide derivative 4,Pruritus , Patented
16712,D0I9FU,Bicyclic heteroaryl benzamide derivative 4,Solid tumour/cancer , Patented
16713,D0I9FU,Bicyclic heteroaryl benzamide derivative 4,Chronic pain , Patented
16714,D0I9FU,Bicyclic heteroaryl benzamide derivative 4,Neuropathic pain , Patented
16715,D0I9FU,Bicyclic heteroaryl benzamide derivative 4,Thymic cancer , Patented
16716,D0I9GA,AbGn-100,Solid tumour/cancer , Investigative
16717,D0I9GR,Plevitrexed,Gastric adenocarcinoma , Phase 2
16718,D0I9HF,Hesperidin,Vascular purpura , Approved
16719,D0I9HG,Amsilarotene,Solid tumour/cancer , Phase 2
16720,D0I9IF,AVN-492,Cognitive impairment , Investigative
16721,D0I9IL,OTL38,Ovarian cancer , Phase 2
16722,D0I9LH,PMI-001,Lupus , Discontinued in Phase 3
16723,D0I9LO,RWJ-416457,Bacterial infection , Preclinical
16724,D0I9MG,IMM-308,Multiple sclerosis , Discontinued in Phase 2
16725,D0I9NC,MDL-101002,Cerebrovascular ischaemia , Terminated
16726,D0I9QH,SR-58878,Irritable bowel syndrome , Terminated
16727,D0I9RB,SOM-0525,Chronic obstructive pulmonary disease , Investigative
16728,D0I9TV,DW-816,Hyperlipidaemia , Investigative
16729,D0I9UH,MOXIFETIN HYDROGEN MALEATE,Mood disorder , Terminated
16730,D0I9UP,HBX-41108,Solid tumour/cancer , Preclinical
16731,D0I9VO,Epratuzumab,Graft rejection in heart transplantation , Phase 3
16732,D0I9VO,Epratuzumab,Systemic lupus erythematosus , Phase 3
16733,D0I9VO,Epratuzumab,Acute lymphoblastic leukaemia , Phase 3
16734,D0I9VU,PMID28350212-Compound-20,Alzheimer disease , Patented
16735,D0I9WR,CNTO-3157,Asthma , Phase 1
16736,D0I9XH,Celastrol,Motor neurone disease , Preclinical
16737,D0I9YI,AZD-6942,Rheumatoid arthritis , Terminated
16738,D0I9YM,IMCnyeso,Melanoma , Phase 1/2
16739,D0I9YM,IMCnyeso,Merkel cell carcinoma , Phase 1/2
16740,D0I9ZQ,SB-104,Virus infection , Investigative
16741,D0I9ZV,Recombinant soluble PSMA protein vaccine,Prostate cancer , Phase 1
16742,D0IA0N,NRL-1,Acute repetitive seizure , Phase 3
16743,D0IA0N,NRL-1,Epilepsy , Phase 3
16744,D0IA1G,PAT-001,Non-syndromic ichthyosis , Phase 2
16745,D0IA1G,PAT-001,Autosomal recessive congenital ichthyosis , Phase 1
16746,D0IA5O,GSK-2241658A,Melanoma , Phase 1
16747,D0IA7K,MF-5137,Staphylococcus infection , Terminated
16748,D0IA8W,BMS-986156,Solid tumour/cancer , Phase 2
16749,D0IA9E,BTRX-246040,Major depressive disorder , Phase 2
16750,D0IA9Y,Vazegepant,Coronavirus Disease 2019 (COVID-19) , Phase 2
16751,D0IB3Z,Thiazolidine derivative 3,Albinism , Patented
16752,D0IB3Z,Thiazolidine derivative 3,Ephelides , Patented
16753,D0IB3Z,Thiazolidine derivative 3,Menkes disease , Patented
16754,D0IB3Z,Thiazolidine derivative 3,Senile lentigines , Patented
16755,D0IB3Z,Thiazolidine derivative 3,Melasma , Patented
16756,D0IB8D,PMID26651364-Compound-117a,Crohn disease , Patented
16757,D0IB8D,PMID26651364-Compound-117a,Ulcerative colitis , Patented
16758,D0IB8D,PMID26651364-Compound-117a,Urinary tract infection , Patented
16759,D0IC2O,Anti-miR-191 modified oligonucleotide,Hepatocellular carcinoma , Investigative
16760,D0IC3K,N-phenyl-5-phenyl-pyrazolin-3-yl amide derivative 1,Obesity , Patented
16761,D0IC6D,KM-133,Psoriasis vulgaris , Investigative
16762,D0IC7A,TZTX-001,Endometriosis , Phase 3
16763,D0IC8P,HL-026,Alzheimer disease , Investigative
16764,D0ID0R,LF-984,Fibrosis , Terminated
16765,D0ID2I,Typhella typhoid vaccine,Typhoid fever , Discontinued in Phase 2
16766,D0ID2I,Typhella typhoid vaccine,Salmonella infection , Discontinued in Phase 2
16767,D0ID3W,GW-813893,Thrombosis , Phase 2
16768,D0ID4Y,Gimsilumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
16769,D0ID4Z,Fomivirsen sodium,Cytomegalovirus retinitis , Approved
16770,D0ID9W,ATA188,Multiple sclerosis , Phase 1
16771,D0IE1E,Nitrofurazone,Skin burns , Approved
16772,D0IE1E,Nitrofurazone,Bacterial infection , Discontinued in Phase 3
16773,D0IE4H,TAZOMELINE,Cognitive impairment , Discontinued in Phase 1
16774,D0IE9L,M4344,Solid tumour/cancer , Phase 1
16775,D0IF4J,PMID26651364-Compound-110,Crohn disease , Patented
16776,D0IF4J,PMID26651364-Compound-110,Ulcerative colitis , Patented
16777,D0IF4J,PMID26651364-Compound-110,Urinary tract infection , Patented
16778,D0IG2Y,MVA p53 vaccine,Solid tumour/cancer , Phase 1
16779,D0IG4I,THIOCOLCHICOSIDE,Muscle spasm , Approved
16780,D0IG6J,Piperazine derivative 1,Obesity , Patented
16781,D0IG7W,BMS-986224,Chronic heart failure , Phase 1
16782,D0IH2I,13C-urea,Helicobacter infection , Approved
16783,D0IH3I,PMID28460551-Compound-1,Breast cancer , Patented
16784,D0IH3I,PMID28460551-Compound-1,Pancreatic cancer , Patented
16785,D0IH3I,PMID28460551-Compound-1,Lung cancer , Patented
16786,D0IH3I,PMID28460551-Compound-1,Gastric adenocarcinoma , Patented
16787,D0IH3I,PMID28460551-Compound-1,Colon cancer , Patented
16788,D0IH3I,PMID28460551-Compound-1,Colorectal cancer , Patented
16789,D0IH3I,PMID28460551-Compound-1,Prostate cancer , Patented
16790,D0IH6G,Resorcinol compound 26,Albinism , Patented
16791,D0IH6G,Resorcinol compound 26,Ephelides , Patented
16792,D0IH6G,Resorcinol compound 26,Menkes disease , Patented
16793,D0IH6G,Resorcinol compound 26,Senile lentigines , Patented
16794,D0IH6G,Resorcinol compound 26,Melasma , Patented
16795,D0IH8R,PMID30280939-Compound-WO2008009652,Malaria , Patented
16796,D0II5S,DMP-728,Thrombosis , Discontinued in Phase 1
16797,D0II7M,Modified adenovirus delta24-RGD,Glioblastoma multiforme , Phase 1
16798,D0II9K,Girisopam,Anxiety disorder , Terminated
16799,D0IJ0F,AG-013,Oral mucositis , Phase 2/3
16800,D0IJ0Q,ML-436,Solid tumour/cancer , Investigative
16801,D0IJ0U,TS-071,Type-2 diabetes , NDA filed
16802,D0IJ1D,HuM-195-Bi-213,Acute myeloid leukaemia , Discontinued in Phase 1/2
16803,D0IJ2H,FK-584,Central and peripheral nervous disease , Discontinued in Phase 2
16804,D0IJ3R,TRK-710,Solid tumour/cancer , Terminated
16805,D0IJ4G,VPM-2-001,Cytomegalovirus infection , Investigative
16806,D0IJ5I,Befiperide,Anxiety disorder , Terminated
16807,D0IJ7O,Metastat,Acne vulgaris , Phase 1
16808,D0IK1I,PHN-031,Diabetic nephropathy , Phase 2
16809,D0IK1S,PMID25666693-Compound-102,Osteoarthritis pain , Patented
16810,D0IK1S,PMID25666693-Compound-102,Cancer related pain , Patented
16811,D0IK1S,PMID25666693-Compound-102,Neuropathic pain , Patented
16812,D0IK1S,PMID25666693-Compound-102,Inflammatory pain , Patented
16813,D0IK1U,SEA-0400,Cerebrovascular ischaemia , Investigative
16814,D0IK5F,BSI-201,Solid tumour/cancer , Phase 3
16815,D0IK5R,ERY974,Solid tumour/cancer , Phase 1
16816,D0IL0C,SK-1306X,Arthritis , Approved
16817,D0IL0H,MaC46/M87o,Human immunodeficiency virus-1 infection , Phase 1/2
16818,D0IL1B,MCD-386/glycopyrrolate,Alzheimer disease , Investigative
16819,D0IL2B,VML-252,Hypophosphatasia , Discontinued in Phase 2
16820,D0IL3O,Strontium malonate,Metabolic bone disease , Phase 2
16821,D0IL4C,TgDCC-E1A,Breast cancer , Phase 2
16822,D0IL7L,Prednisone,Inflammation , Approved
16823,D0IL7L,Prednisone,Atopic dermatitis , Phase 1
16824,D0IL7L,Prednisone,Eczema , Phase 1
16825,D0IL7V,KRP-107,Autoimmune diabetes , Investigative
16826,D0IL8R,A-93178,Allergy , Terminated
16827,D0IM1B,MOv18IgE,Solid tumour/cancer , Phase 1
16828,D0IM6O,Talactoferrin,Diabetic foot ulcer , Phase 3
16829,D0IM6T,Tisagenlecleucel,Acute lymphoblastic leukaemia , Approved
16830,D0IM6T,Tisagenlecleucel,Diffuse large B-cell lymphoma , Phase 3
16831,D0IM6T,Tisagenlecleucel,Chronic lymphocytic leukaemia , Phase 3
16832,D0IM6T,Tisagenlecleucel,Follicular lymphoma , Phase 2
16833,D0IM6T,Tisagenlecleucel,Acute myeloid leukaemia , Application submitted
16834,D0IM7C,AE-9C90CB,Overactive bladder , Investigative
16835,D0IN2K,CD22 CAR-T,B-cell lymphoma , Phase 1/2
16836,D0IN5E,PMID25666693-Compound-48,Osteoarthritis pain , Patented
16837,D0IN5E,PMID25666693-Compound-48,Cancer related pain , Patented
16838,D0IN5E,PMID25666693-Compound-48,Neuropathic pain , Patented
16839,D0IN5E,PMID25666693-Compound-48,Inflammatory pain , Patented
16840,D0IN7I,Nemonapride,Schizophrenia , Approved
16841,D0IN7R,MUC-1 CART cell immunotherapy,Intrahepatic cholangiocarcinoma , Phase 1/2
16842,D0IN8Z,LY2928057,Anaemia , Phase 2
16843,D0IN9G,Liatermin,Lateral sclerosis , Phase 1/2
16844,D0IO2X,PMID25684022-Compound-WO2011137219 38(5-7),Solid tumour/cancer , Patented
16845,D0IO2X,PMID25684022-Compound-WO2011137219 38(5-7),Metastatic cancer , Patented
16846,D0IO9Z,Tafinlar + Mekinist,Glioma , Phase 2
16847,D0IP2J,ProQuad,Varicella zoster virus infection , Approved
16848,D0IP5E,PMID25666693-Compound-9,Osteoarthritis pain , Patented
16849,D0IP5E,PMID25666693-Compound-9,Cancer related pain , Patented
16850,D0IP5E,PMID25666693-Compound-9,Neuropathic pain , Patented
16851,D0IP5E,PMID25666693-Compound-9,Inflammatory pain , Patented
16852,D0IP6X,Osanetant,Schizoaffective disorder , Discontinued in Phase 2b
16853,D0IP6X,Osanetant,Schizophrenia , Discontinued in Phase 2b
16854,D0IP6X,Osanetant,Depression , Terminated
16855,D0IP7M,PAT-SM4,Solid tumour/cancer , Investigative
16856,D0IP9E,Hyqvia,Immunodeficiency , Approved
16857,D0IQ0Z,GSK1070916,Advanced solid tumour , Phase 1
16858,D0IQ1V,CIGB-300,Cervical cancer , Phase 3
16859,D0IQ2P,NexVax2,Type-1 diabetes , Phase 1
16860,D0IQ2P,NexVax2,Coeliac disease , Phase 1
16861,D0IQ3E,Muc1-specific gene-engineered T cells,Acute myeloid leukaemia , Phase 1/2
16862,D0IQ4V,Anti-GPC3 CAR T,Hepatocellular carcinoma , Phase 1
16863,D0IQ6O,S-1286,Solid tumour/cancer , Terminated
16864,D0IQ6P,Cabozantinib,Thyroid cancer , Approved
16865,D0IQ6P,Cabozantinib,Ovarian cancer , Phase 2
16866,D0IR2V,Prodarsan,Cockayne syndrome , Phase 1/2
16867,D0IR7H,PMID25666693-Compound-27,Osteoarthritis pain , Patented
16868,D0IR7H,PMID25666693-Compound-27,Cancer related pain , Patented
16869,D0IR7H,PMID25666693-Compound-27,Neuropathic pain , Patented
16870,D0IR7H,PMID25666693-Compound-27,Inflammatory pain , Patented
16871,D0IR8B,Benzonaphthyridine derivative 2,Solid tumour/cancer , Patented
16872,D0IR8B,Benzonaphthyridine derivative 2,Metastatic cancer , Patented
16873,D0IR8J,INDUS-815C,Retinopathy , Investigative
16874,D0IS5V,TC-34,Parkinson disease , Investigative
16875,D0IS5Z,Anti-CEA designer T cell therapy,Solid tumour/cancer , Phase 1
16876,D0IT1V,Zika virus vaccine,Semliki forest virus infection , Phase 1
16877,D0IT2G,Dexamethasone,Rheumatoid arthritis , Approved
16878,D0IT2X,Carprofen,Pain , Approved
16879,D0IT4N,PMID25666693-Compound-94,Osteoarthritis pain , Patented
16880,D0IT4N,PMID25666693-Compound-94,Cancer related pain , Patented
16881,D0IT4N,PMID25666693-Compound-94,Neuropathic pain , Patented
16882,D0IT4N,PMID25666693-Compound-94,Inflammatory pain , Patented
16883,D0IT6Q,Tandutinib,Anaplastic mixed oligoastrocytoma , Discontinued in Phase 2
16884,D0IT7F,Sitagliptin + metformin,Type-2 diabetes , Phase 3
16885,D0IU0W,Q-201,Mycobacterium infection , Investigative
16886,D0IU1H,PMID25666693-Compound-52,Osteoarthritis pain , Patented
16887,D0IU1H,PMID25666693-Compound-52,Cancer related pain , Patented
16888,D0IU1H,PMID25666693-Compound-52,Neuropathic pain , Patented
16889,D0IU1H,PMID25666693-Compound-52,Inflammatory pain , Patented
16890,D0IV3M,Polyethylene glycol,Constipation , Approved
16891,D0IV4C,WP-1066,Recurrent glioblastoma , Phase 1/2
16892,D0IV4C,WP-1066,Solid tumour/cancer , Phase 1
16893,D0IV4C,WP-1066,Brain cancer , Phase 1
16894,D0IV4E,Bromhexine + hydroxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
16895,D0IV7F,IDP-115,Rosacea , Phase 2
16896,D0IV7J,131I-COU-1,Colon cancer , Investigative
16897,D0IV7Z,AZD-8418,Schizophrenia , Phase 1
16898,D0IW0Y,MEN-10207,Pain , Terminated
16899,D0IW1Y,F-16915,Atrial fibrillation , Investigative
16900,D0IW4E,GALE-301 + GALE-302,Ovarian cancer , Phase 1/2
16901,D0IW4R,TREFENTANIL HYDROCHLORIDE,Pain , Discontinued in Phase 2
16902,D0IW6R,PD-L1 mAb + LY,Solid tumour/cancer , Phase 1
16903,D0IW8I,LipoNeu,Streptococcus infection , Investigative
16904,D0IW9Q,MDX-1147,Prostate cancer , Investigative
16905,D0IX1A,Pentolinium,Hypotension , Approved
16906,D0IX1I,NBI-98854,Movement disorder , Phase 3
16907,D0IX1I,NBI-98854,Tourette syndrome , Phase 2
16908,D0IX4B,AG-024322,Solid tumour/cancer , Phase 1
16909,D0IX6I,cortisone,Atopic dermatitis , Approved
16910,D0IX7G,FR-76830,Angina pectoris , Terminated
16911,D0IX9E,NIZ985,Solid tumour/cancer , Phase 1
16912,D0IX9O,Q-Derp1,Various major chronic disease , Phase 1
16913,D0IY0R,Viquidacin,Bacterial infection , Preclinical
16914,D0IY2B,Hairpin RNA,Psoriasis vulgaris , Investigative
16915,D0IY2M,AF-11,Solid tumour/cancer , Investigative
16916,D0IY3Z,Bivigam,Immune System disease , Approved
16917,D0IZ1A,LY309887,Solid tumour/cancer , Phase 1
16918,D0IZ1D,Brofaromine,Anxiety disorder , Discontinued in Phase 2
16919,D0IZ1I,SD-726,Pain , Preclinical
16920,D0IZ7T,YM-17E,Hyperlipidaemia , Discontinued in Phase 1
16921,D0IZ8X,BPN14770,Alzheimer disease , Phase 2
16922,D0J0AE,CP-945598,Obesity , Discontinued in Phase 3
16923,D0J0AH,GP-668,Angina pectoris , Discontinued in Phase 1
16924,D0J0AN,Polymer-tubulysin A prodrug conjugate,Solid tumour/cancer , Investigative
16925,D0J0BB,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11",Albinism , Patented
16926,D0J0BB,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11",Ephelides , Patented
16927,D0J0BB,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11",Menkes disease , Patented
16928,D0J0BB,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11",Senile lentigines , Patented
16929,D0J0BB,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 11",Melasma , Patented
16930,D0J0BI,NG-049,Dyspepsia , Investigative
16931,D0J0BN,TAK-079,Pheumatoid arthritis , Phase 1
16932,D0J0BU,BETRIXABAN,Venous thromboembolism , Approved
16933,D0J0BU,BETRIXABAN,Cerebrovascular ischaemia , Phase 3
16934,D0J0EL,"1,8-dihydroxy-anthraquinone",Laxative , Withdrawn from market
16935,D0J0EM,Virexxa,Endometrial cancer , Phase 2
16936,D0J0FD,MACI,leukaemia , Phase 3
16937,D0J0FD,MACI,Articular cartilage disorder , Phase 3
16938,D0J0GJ,P-1116,Anemia , Investigative
16939,D0J0GR,Rocapuldencel-T,Renal cell carcinoma , Phase 3
16940,D0J0HE,MK-8150,Hypertension , Phase 1
16941,D0J0HV,VBY- 285,Neuropathic pain , Investigative
16942,D0J0IJ,RG7636,Melanoma , Discontinued in Phase 1
16943,D0J0JC,FRG-8701,Stomach ulcer , Terminated
16944,D0J0JT,CC-11006,Solid tumour/cancer , Phase 1
16945,D0J0KD,Fibrinolysin,Wound healing , Approved
16946,D0J0KT,RhuDex,Rheumatoid arthritis , Phase 2a
16947,D0J0KX,PF-275366,Acne vulgaris , Discontinued in Phase 2
16948,D0J0LC,PMID26651364-Compound-4,Crohn disease , Patented
16949,D0J0LC,PMID26651364-Compound-4,Ulcerative colitis , Patented
16950,D0J0LC,PMID26651364-Compound-4,Urinary tract infection , Patented
16951,D0J0LI,Chorionic Gonadotropin,Fertility problem , Approved
16952,D0J0MK,JTT-608,Diabetic complication , Terminated
16953,D0J0OF,Choroid plexus cell-derived factors,Wound healing , Investigative
16954,D0J0PR,PIBROZELESIN HYDROCHLORIDE,Solid tumour/cancer , Discontinued in Phase 2
16955,D0J0RG,UK-66914,Cardiac arrhythmias , Phase 1
16956,D0J0RV,Larotaxel,Bladder cancer , Discontinued in Phase 3
16957,D0J0RV,Larotaxel,Pancreatic cancer , Discontinued in Phase 3
16958,D0J0WG,PMID27998201-Compound-1,Coronavirus infection , Patented
16959,D0J0WG,PMID27998201-Compound-1,Henipavirus Encephalitis , Patented
16960,D0J0WX,"(-)-3PPP, Maryland",Schizophrenia , Phase 1
16961,D0J0XN,OpRegen,Dry age-related macular degeneration , Phase 1/2
16962,D0J0YH,BI-187004,Type-2 diabetes , Phase 2
16963,D0J0ZM,RP-400C,Human immunodeficiency virus infection , Terminated
16964,D0J0ZS,Gabapentin,Complex partial seizure , Approved
16965,D0J0ZS,Gabapentin,Solid tumour/cancer , Phase 3
16966,D0J0ZU,KIN-3031,Pain , Investigative
16967,D0J1AU,CODA-001,Cornea epithelial defect , Phase 2
16968,D0J1AV,LAS 100977,Chronic obstructive pulmonary disease , Phase 2
16969,D0J1CF,Her2- and PSA-targeted TGX-D1,Prostate cancer , Investigative
16970,D0J1CL,EcoNail,Fungal infection , Phase 2
16971,D0J1DE,Heterologous liver-derived stem cells,Ornithine transcarbamylase deficiency , Investigative
16972,D0J1FB,GSK586529,Anxiety disorder , Phase 1
16973,D0J1FB,GSK586529,Depression , Phase 1
16974,D0J1FL,AZD-2098,Asthma , Terminated
16975,D0J1GA,GSK-1399686,Inflammatory bowel disease , Phase 2
16976,D0J1GR,CP-868596,Gastrointestinal cancer , Phase 3
16977,D0J1GR,CP-868596,Gastrointestinal stromal tumour , Phase 3
16978,D0J1GR,CP-868596,Acute myelogenous leukaemia , Phase 2
16979,D0J1GR,CP-868596,Acute myeloid leukaemia , Phase 2
16980,D0J1GR,CP-868596,Malignant glioma , Phase 1
16981,D0J1HB,PF-06840003,Glioma , Phase 1
16982,D0J1HG,HG-1338,Solid tumour/cancer , Investigative
16983,D0J1IT,Norovirus vaccine,Norovirus infection , Phase 1/2
16984,D0J1KG,PD-4048,Diabetic complication , Investigative
16985,D0J1KS,BMS-945429,Rheumatoid arthritis , Phase 2
16986,D0J1MI,Mebendazole,Worm infection , Approved
16987,D0J1ML,Mestranol,Contraception , Approved
16988,D0J1MO,TRX-518,Solid tumour/cancer , Phase 1/2
16989,D0J1MO,TRX-518,Melanoma , Phase 1
16990,D0J1NQ,Pinaverium bromide,Irritable bowel syndrome , Phase 3
16991,D0J1OG,Prolanta,Fallopian tube cancer , Phase 1
16992,D0J1OG,Prolanta,Ovarian cancer , Phase 1
16993,D0J1OG,Prolanta,Peritoneal cavity cancer , Phase 1
16994,D0J1PW,Orthokine,Arthritis , Approved
16995,D0J1QX,Carrimycin,Coronavirus Disease 2019 (COVID-19) , Phase 2
16996,D0J1RH,CY-1748,Deep vein thrombosis , Terminated
16997,D0J1RS,H5N1 pandemic influenza mab,Influenza virus infection , Investigative
16998,D0J1TN,ETEC vaccine,Escherichia coli infection , Phase 1
16999,D0J1TN,ETEC vaccine,Vibrio cholerae infection , Phase 1
17000,D0J1TS,AZD2207,Obesity , Discontinued in Phase 2
17001,D0J1TS,AZD2207,Diabetic complication , Discontinued in Phase 2
17002,D0J1TU,Technetium Tc-99m Sestamibi Kit,Radioactive tracer , Approved
17003,D0J1UA,Elosulfase alfa,Mucopolysaccharidosis , Approved
17004,D0J1VY,Entacapone,Parkinson disease , Approved
17005,D0J1WJ,ALS-769,Solid tumour/cancer , Terminated
17006,D0J1WO,ISIS 113715,Type-2 diabetes , Phase 2
17007,D0J1ZH,PH94B NS,Social anxiety disorder , Phase 3
17008,D0J2AJ,Nivolumab,Coronavirus Disease 2019 (COVID-19) , Phase 2
17009,D0J2BH,TA-GW,Human papillomavirus infection , Discontinued in Phase 2
17010,D0J2ES,BIO-300,Solid tumour/cancer , Phase 1/2
17011,D0J2ES,BIO-300,Rheumatoid arthritis , Phase 1
17012,D0J2GG,SR-3850,Solid tumour/cancer , Investigative
17013,D0J2HH,Cyclohexyl carbamate derivative 1,Albinism , Patented
17014,D0J2HH,Cyclohexyl carbamate derivative 1,Ephelides , Patented
17015,D0J2HH,Cyclohexyl carbamate derivative 1,Menkes disease , Patented
17016,D0J2HH,Cyclohexyl carbamate derivative 1,Senile lentigines , Patented
17017,D0J2HH,Cyclohexyl carbamate derivative 1,Melasma , Patented
17018,D0J2IB,ANG-3070,Scleroderma , Investigative
17019,D0J2IH,Avosentan,Diabetic nephropathy , Discontinued in Phase 2
17020,D0J2IN,CAR-T cells targeting GPC3,Hepatocellular carcinoma , Phase 1/2
17021,D0J2KV,Propafenone,Tachyarrhythmias , Approved
17022,D0J2LG,DCVax-001,Human immunodeficiency virus infection , Phase 1
17023,D0J2MJ,Selegiline Hydrochloride,Parkinson disease , Approved
17024,D0J2MJ,Selegiline Hydrochloride,Motor symptoms , Investigative
17025,D0J2NB,KRH-594,Hypertension , Discontinued in Phase 2
17026,D0J2NI,TDI-0010,Motor neurone disease , Investigative
17027,D0J2NK,Oxytetracycline,Bacterial infection , Approved
17028,D0J2NS,Anti-D,Idiopathic thrombocytopenic purpura , Investigative
17029,D0J2NX,LE-DT,Pancreatic cancer , Phase 2
17030,D0J2OC,MBX-700,Hepatitis C virus infection , Phase 1
17031,D0J2RV,XL-888,Solid tumour/cancer , Phase 1
17032,D0J2TN,Diphenoxylate,Diarrhea , Approved
17033,D0J2VB,Iboctadekin + rituximab,Follicular lymphoma , Phase 1
17034,D0J2VB,Iboctadekin + rituximab,Non-hodgkin lymphoma , Phase 1
17035,D0J2VB,Iboctadekin + rituximab,Atrial fibrillation , Investigative
17036,D0J2VS,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 2",Skin disease , Patented
17037,D0J2VS,"1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 2",Muscular wasting , Patented
17038,D0J2XP,BPI-713001,Diabetic complication , Investigative
17039,D0J2YR,PI-166,Liver cancer , Phase 1
17040,D0J3AN,HL-076,Hypertension , Investigative
17041,D0J3AV,PEG-LPA-2,Solid tumour/cancer , Investigative
17042,D0J3BU,Duteplase,Thrombin deficiency , Approved
17043,D0J3BY,Pimagedine HCl,Diabetic kidney disease , Phase 2/3
17044,D0J3CC,Latranal,Pain , Discontinued in Phase 2
17045,D0J3CT,FK-143,Prostate disease , Phase 2
17046,D0J3DC,VLP norovirus bivalent vaccine,Alzheimer disease , Phase 1/2
17047,D0J3DN,Anti-CD19-CAR PBL,Mantle cell lymphoma , Phase 1/2
17048,D0J3DN,Anti-CD19-CAR PBL,Primary mediastinal B-cell lymphoma , Phase 1/2
17049,D0J3DN,Anti-CD19-CAR PBL,Diffuse large B-cell lymphoma , Phase 1/2
17050,D0J3EA,Theliatinib,Solid tumour/cancer , Investigative
17051,D0J3EN,AB122,Solid tumour/cancer , Phase 1
17052,D0J3FK,DNX-2000,Autoimmune diabetes , Investigative
17053,D0J3HE,ACAM529,Herpes simplex virus infection , Phase 1
17054,D0J3KY,ReN-001,Cerebrovascular ischaemia , Phase 1
17055,D0J3MY,NPI-3114,Gram-positive bacterial infection , Investigative
17056,D0J3NJ,RP-69698,Inflammation , Terminated
17057,D0J3OV,PI-083,Solid tumour/cancer , Terminated
17058,D0J3PS,ASP-0265,Endometriosis , Terminated
17059,D0J3QN,CG-1255,Acute myeloid leukaemia , Investigative
17060,D0J3QU,ZD-7944,Asthma , Terminated
17061,D0J3RY,Denileukin diftitox,leukaemia , Approved
17062,D0J3RY,Denileukin diftitox,Non-small-cell lung cancer , Phase 2
17063,D0J3SU,isatin sulfonamide 34,Cystic fibrosis , Clinical trial
17064,D0J3TI,Rosmantuzumab,Colorectal cancer , Phase 1
17065,D0J3TI,Rosmantuzumab,Solid tumour/cancer , Phase 1
17066,D0J3TP,ZD-0870,Fungal infection , Discontinued in Phase 2
17067,D0J3VV,IPH-3201,Solid tumour/cancer , Terminated
17068,D0J3YX,BAY 86-6150,Hemophilia , Discontinued in Phase 2/3
17069,D0J3ZA,KBSA-302,Staphylococcus infection , Investigative
17070,D0J3ZT,PRT-201,Peripheral arterial disease , Phase 3
17071,D0J4BO,Norovirus monovalent vaccine,Norovirus infection , Phase 1/2
17072,D0J4CA,PMID28270021-Compound-WO2010077680 103,Pruritus , Patented
17073,D0J4CA,PMID28270021-Compound-WO2010077680 103,Solid tumour/cancer , Patented
17074,D0J4CA,PMID28270021-Compound-WO2010077680 103,Chronic pain , Patented
17075,D0J4CA,PMID28270021-Compound-WO2010077680 103,Neuropathic pain , Patented
17076,D0J4CA,PMID28270021-Compound-WO2010077680 103,Thymic cancer , Patented
17077,D0J4CV,AAV-sFLT gene therapy,Age-related macular degeneration , Phase 1
17078,D0J4EG,L-648051,Asthma , Terminated
17079,D0J4GO,Dichlorphenamide,Chronic glaucoma , Approved
17080,D0J4GQ,FR-152558,Alzheimer disease , Terminated
17081,D0J4IT,Cat peptide allergy desensitization agent,Allergy , Phase 3
17082,D0J4IX,Glaziovine,Depression , Approved
17083,D0J4JM,Reserpine,Hypertension , Approved
17084,D0J4KC,CETi-1,Arteriosclerosis , Discontinued in Phase 2
17085,D0J4LI,Thymoctonan,Immune System disease , Phase 2
17086,D0J4LV,PMID30107136-Compound-Example53,Solid tumour/cancer , Patented
17087,D0J4LV,PMID30107136-Compound-Example53,Infectious disease , Patented
17088,D0J4LV,PMID30107136-Compound-Example53,Human immunodeficiency virus infection , Patented
17089,D0J4LV,PMID30107136-Compound-Example53,Hepatitis , Patented
17090,D0J4MY,Tasidotin hydrochloride,Solid tumour/cancer , Phase 1
17091,D0J4NR,MC-4001,Ocular disease , Investigative
17092,D0J4PB,GW 597599,Mood disorder , Phase 2
17093,D0J4PB,GW 597599,Major depressive disorder , Phase 2
17094,D0J4PM,NNC-0151-0000-0000,Rheumatoid arthritis , Phase 2
17095,D0J4QE,Diazepinone derivative 5,Reflux disease , Patented
17096,D0J4QE,Diazepinone derivative 5,Parkinson disease , Patented
17097,D0J4TX,AVX-002,Rheumatoid arthritis , Investigative
17098,D0J4UO,Macrocycle derivative 3,Solid tumour/cancer , Patented
17099,D0J4UO,Macrocycle derivative 3,Infectious disease , Patented
17100,D0J4UO,Macrocycle derivative 3,Human immunodeficiency virus infection , Patented
17101,D0J4UO,Macrocycle derivative 3,Hepatitis , Patented
17102,D0J4WA,BAY1213790,Thrombosis , Phase 2
17103,D0J4WW,NIP-520,Asthma , Discontinued in Phase 1
17104,D0J4XV,AZD4635,Prostate cancer , Phase 2
17105,D0J4XV,AZD4635,Solid tumour/cancer , Phase 1
17106,D0J4YH,P-coumaric acid derivative 3,Albinism , Patented
17107,D0J4YH,P-coumaric acid derivative 3,Ephelides , Patented
17108,D0J4YH,P-coumaric acid derivative 3,Menkes disease , Patented
17109,D0J4YH,P-coumaric acid derivative 3,Senile lentigines , Patented
17110,D0J4YH,P-coumaric acid derivative 3,Melasma , Patented
17111,D0J4YV,AP-214,Candidiasis , Phase 2
17112,D0J5AD,FI-6,Influenza virus infection , Investigative
17113,D0J5CX,TAK-637,Depression , Discontinued in Phase 2
17114,D0J5DC,Clofibrate,Dysbetalipoproteinemia , Approved
17115,D0J5DL,L-4-OXALYSINE,Solid tumour/cancer , Discontinued in Phase 2
17116,D0J5ED,LTX-109,Bacterial infection , Phase 2
17117,D0J5EQ,Maclizumab,Inflammation , Investigative
17118,D0J5FU,MIV-701,Osteoporosis , Discontinued in Phase 1
17119,D0J5GT,ZANKIREN,Hypertension , Discontinued in Phase 2
17120,D0J5HG,ETS-6103,Major depressive disorder , Phase 2
17121,D0J5HR,LGK974,Solid tumour/cancer , Phase 1
17122,D0J5HU,Ro-46-2005,Hypertension , Terminated
17123,D0J5KF,Granisetron,Nausea and vomiting , Approved
17124,D0J5KZ,OBE-102,Weight loss , Investigative
17125,D0J5NA,INO-3106,Aerodigestive tract cancer , Phase 1
17126,D0J5NA,INO-3106,Malignant neoplasm , Phase 1
17127,D0J5NB,Pyrazole derivative 25,Obesity , Patented
17128,D0J5OS,Vasonex,Myocardial infarction , Investigative
17129,D0J5QA,GRNCM-1,Heart disease , Investigative
17130,D0J5QD,GL-4001,Inflammation , Investigative
17131,D0J5QW,ON-579,Asthma , Terminated
17132,D0J5RN,Armodafinil,Pediatric cancer , Approved
17133,D0J5SD,Gamma-secretase modulators,Alzheimer disease , Investigative
17134,D0J5TN,CEP-751,Neurodegenerative disorder , Terminated
17135,D0J5TS,Carzinophilin,Solid tumour/cancer , Approved
17136,D0J5UC,SDZ-ISQ-844,Asthma , Terminated
17137,D0J5UK,IRT-102,Pancreatic cancer , Phase 2
17138,D0J5VR,Idelalisib,Chronic lymphocytic leukaemia , Approved
17139,D0J5WI,FK-518,Bacterial infection , Discontinued in Phase 1
17140,D0J5XM,"Pyrido[2,3-d]pyrimidine derivative 1",Obesity , Patented
17141,D0J5XS,TV-1380,Cocaine addiction , Phase 2
17142,D0J5XZ,VP004,Substance use disorder , Discontinued in Phase 1
17143,D0J5YC,Fosphenytoin,Epilepsy , Approved
17144,D0J5YU,TSR-022,Solid tumour/cancer , Phase 1
17145,D0J6AB,MK-5108,Solid tumour/cancer , Phase 1
17146,D0J6AE,CYAD-01,Haematological malignancy , Phase 1
17147,D0J6AE,CYAD-01,Solid tumour/cancer , Phase 1
17148,D0J6AJ,JTCR016,Acute myeloid leukaemia , Phase 1/2
17149,D0J6AJ,JTCR016,Chronic myelogenous leukaemia , Phase 1/2
17150,D0J6AU,Odanacatib,Osteoporosis , Phase 3
17151,D0J6BR,Pentastarch,Bleeding disorder , Approved
17152,D0J6DQ,Tremelimumab,Solid tumour/cancer , Phase 3
17153,D0J6DQ,Tremelimumab,Malignant mesothelioma , Phase 3
17154,D0J6DS,Thiazolidine derivative 2,Albinism , Patented
17155,D0J6DS,Thiazolidine derivative 2,Ephelides , Patented
17156,D0J6DS,Thiazolidine derivative 2,Menkes disease , Patented
17157,D0J6DS,Thiazolidine derivative 2,Senile lentigines , Patented
17158,D0J6DS,Thiazolidine derivative 2,Melasma , Patented
17159,D0J6DU,VLP-based influenza vaccine,Influenza virus infection , Phase 2
17160,D0J6EQ,M-512101,Acne vulgaris , Discontinued in Phase 1
17161,D0J6FE,AVI-4557,Anxiety disorder , Phase 2
17162,D0J6FF,PENNVAX-GP/MVA-CMDR HIV vaccine regime,Human immunodeficiency virus infection , Phase 1/2
17163,D0J6GJ,SPI-1005,Meniere disease , Phase 2b
17164,D0J6GJ,SPI-1005,Coronavirus Disease 2019 (COVID-19) , Investigative
17165,D0J6GO,NRP409,Hormone deficiency , Discontinued in Phase 3
17166,D0J6II,Azimilide,Atrial fibrillation , Phase 3
17167,D0J6JC,PTL-101,Pulmonary fibrosis , Investigative
17168,D0J6JZ,MINALRESTAT,Diabetic complication , Discontinued in Phase 3
17169,D0J6KZ,S-777469,Atopic dermatitis , Phase 2
17170,D0J6LN,Etazolate,Neurodegenerative disorder , Phase 2
17171,D0J6LP,Colchiceine amide,Solid tumour/cancer , Approved
17172,D0J6LU,Cryopreserved human liver cells,Liver disease , Phase 1
17173,D0J6MS,BIBU-251,Thrombosis , Terminated
17174,D0J6NG,OPA-6566,Glaucoma/ocular hypertension , Phase 1/2
17175,D0J6NV,GI-5005,Hepatitis C virus infection , Phase 2
17176,D0J6NV,GI-5005,Chronic HCV-1 infection , Phase 2
17177,D0J6NW,Shigella vaccine,Shigella infection , Phase 2
17178,D0J6OV,(R)-PFI-2,Breast cancer , Preclinical
17179,D0J6PR,AC-100,Arthritis , Discontinued in Phase 1
17180,D0J6PY,Taxol/Paraplatin/Herceptin,Breast cancer , Phase 3
17181,D0J6RV,BAY1161909,Solid tumour/cancer , Phase 1
17182,D0J6TN,2085-P,Otitis media , Discontinued in Phase 3
17183,D0J6UA,CTP-499,Diabetic nephropathy , Phase 2
17184,D0J6UV,IBI-20089,Diabetic macular edema , Phase 1
17185,D0J6VE,Ad-IFNg,Lymphoma , Phase 2
17186,D0J6VN,Indol-3-carbinol,Fungal infection , Preclinical
17187,D0J6VU,CVS-995,Myocardial infarction , Terminated
17188,D0J6VW,CUV-9900,Dermatological disease , Investigative
17189,D0J6WA,HS-10296,Non-small-cell lung cancer , Phase 1/2
17190,D0J6WE,CD19-CAR-T Cells,Acute lymphoblastic leukaemia , Phase 1
17191,D0J6WJ,Modified vitamin A,Age-related macular degeneration , Investigative
17192,D0J6WV,WRR605,Amoebiasis , Investigative
17193,D0J6WW,Proquazone,Osteoarthritis , Approved
17194,D0J6WX,Flutropium bromide,Cough , Approved
17195,D0J6XC,tiratricol,Wound healing , Clinical trial
17196,D0J6XO,A-331440,Obesity , Investigative
17197,D0J6YZ,Very small embryonic-like stem cells,Glaucoma/ocular hypertension , Investigative
17198,D0J6ZA,SRD-441,Atopic dermatitis , Phase 2
17199,D0J7AI,BN-80245,Solid tumour/cancer , Terminated
17200,D0J7CD,Poly IC-poly arginine,Keratosis , Investigative
17201,D0J7CE,CDE-6960,Inflammation , Terminated
17202,D0J7CH,QGE-031,Chronic idiopathic urticaria , Phase 3
17203,D0J7CH,QGE-031,Thyroid cancer , Phase 2
17204,D0J7CP,OctreoScan,Solid tumour/cancer , Approved
17205,D0J7EH,ACCLAIM,Coronary artery disease , Phase 2
17206,D0J7EH,ACCLAIM,Angina pectoris , Phase 2
17207,D0J7EP,AVN 397,Anxiety disorder , Discontinued in Phase 2
17208,D0J7EP,AVN 397,Alzheimer disease , Discontinued in Phase 2
17209,D0J7HV,HER2.taNK,Recurrent glioblastoma , Phase 1
17210,D0J7HV,HER2.taNK,Recurring respiratory infection , Phase 1
17211,D0J7KR,Lenalidomide,Coronavirus Disease 2019 (COVID-19) , Phase 3
17212,D0J7LV,VLP vaccine,Influenza A virus infection , Phase 2
17213,D0J7ML,D-20133,Solid tumour/cancer , Phase 1
17214,D0J7MQ,MKC-1106-MT,Melanoma , Phase 2
17215,D0J7OG,Midecamycin,Bacterial infection , Approved
17216,D0J7OU,C-CAR088,Multiple myeloma , Phase 1
17217,D0J7QC,124I-8H9,Glioblastoma multiforme , Phase 1
17218,D0J7QU,E-913,Human immunodeficiency virus infection , Phase 3
17219,D0J7QX,AT-012,Solid tumour/cancer , Investigative
17220,D0J7RK,Dobutamine,Heart failure , Approved
17221,D0J7RP,RP-AAV8,Retinitis pigmentosa , Investigative
17222,D0J7TM,Benzylpenicilloyl Polylysine,Bacterial infection , Approved
17223,D0J7UI,ICI-198615,Asthma , Terminated
17224,D0J7UL,ALX148,Myelodysplastic syndrome , Phase 1/2
17225,D0J7UL,ALX148,Non-hodgkin lymphoma , Phase 1
17226,D0J7UL,ALX148,Solid tumour/cancer , Phase 1
17227,D0J7VH,4SCAR19 and 4SCAR22,B-cell lymphoma , Phase 1/2
17228,D0J7WO,BSF-78438,Schizophrenia , Preclinical
17229,D0J7XL,Gramicidin D,Bacterial infection , Approved
17230,D0J7XN,UR-5269,Rheumatoid arthritis , Investigative
17231,D0J8AE,OMN-54,Solid tumour/cancer , Phase 1
17232,D0J8BZ,BIIB 2024,Gastrointestinal stromal tumour , Phase 2
17233,D0J8BZ,BIIB 2024,Breast cancer , Phase 2
17234,D0J8DD,TAK-653,Depression , Phase 2
17235,D0J8EC,ACT-280778,Essential hypertension , Phase 2
17236,D0J8ED,JP-1201,Solid tumour/cancer , Investigative
17237,D0J8GO,Aminoazetidine derivative 4,Obesity , Patented
17238,D0J8HJ,PMID26651364-Compound-127,Crohn disease , Patented
17239,D0J8HJ,PMID26651364-Compound-127,Ulcerative colitis , Patented
17240,D0J8HJ,PMID26651364-Compound-127,Urinary tract infection , Patented
17241,D0J8IJ,Eliglustat tartrate,Metabolic disorder , Approved
17242,D0J8JF,RG-4934,Arthritis , Discontinued in Phase 1
17243,D0J8JP,Pimavanserin,Parkinson disease , Approved
17244,D0J8MA,KA2237,B-cell lymphoma , Phase 1
17245,D0J8NC,ASP-8370,Neuropathic pain , Investigative
17246,D0J8OC,Scriptaid,Solid tumour/cancer , Preclinical
17247,D0J8OV,BNT162b1 SARS-CoV-2 vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
17248,D0J8PI,Edotreotide,Acromegaly , Phase 2
17249,D0J8PR,LY03003,Parkinson disease , Phase 1
17250,D0J8RM,Posatirelin,Neurodegenerative disorder , Discontinued in Phase 3
17251,D0J8RR,Dextromethorphan+quinidine,Diabetic neuropathy , Phase 2
17252,D0J8RS,PD-146176,Arteriosclerosis , Terminated
17253,D0J8RV,SMT-A07,Solid tumour/cancer , Investigative
17254,D0J8SE,DFD-07,Actinic keratosis , Phase 2/3
17255,D0J8TH,CEB-925,Hypercholesterolaemia , Terminated
17256,D0J8UV,AC-260584,Schizophrenia , Terminated
17257,D0J8VV,PRO-055,Duchenne dystrophy , Investigative
17258,D0J8WE,CRYPTOPHYCIN 52,Solid tumour/cancer , Phase 2
17259,D0J8WJ,AKL-0707,Lipodystrophy , Discontinued in Phase 2
17260,D0J8WO,TAK-428,Diabetic neuropathy , Discontinued in Phase 2
17261,D0J8XO,BCH-150,Gastrointestinal disease , Terminated
17262,D0J8YA,PentaLyte,Blood transfusion , Phase 2
17263,D0J8ZA,Quinethazone,Hypertension , Approved
17264,D0J9AK,MK-944a,Human immunodeficiency virus infection , Discontinued in Phase 2
17265,D0J9CF,IDDBCP-150101,Sexual dysfunction , Preclinical
17266,D0J9CF,IDDBCP-150101,Obesity , Preclinical
17267,D0J9CG,NmVac,Meningococcal infection , Phase 1
17268,D0J9CS,PMID25666693-Compound-59,Osteoarthritis pain , Patented
17269,D0J9CS,PMID25666693-Compound-59,Cancer related pain , Patented
17270,D0J9CS,PMID25666693-Compound-59,Neuropathic pain , Patented
17271,D0J9CS,PMID25666693-Compound-59,Inflammatory pain , Patented
17272,D0J9DI,Heterocyclic derivative 5,Solid tumour/cancer , Patented
17273,D0J9DI,Heterocyclic derivative 5,Metastatic cancer , Patented
17274,D0J9EI,Lopinavir + ritonavir,Human immunodeficiency virus infection , Approved
17275,D0J9EI,Lopinavir + ritonavir,Coronavirus Disease 2019 (COVID-19) , Phase 3
17276,D0J9GR,OX-27,Cancer related pain , Phase 1
17277,D0J9HO,Single Tablet Regimen of sofosbuvir and ledipasvir,Chronic HCV-1 infection , Phase 3
17278,D0J9HW,Olaparib,Ovarian cancer , Approved
17279,D0J9HW,Olaparib,Pancreatic cancer , Phase 3
17280,D0J9HW,Olaparib,Prostate cancer , Phase 3
17281,D0J9IH,PELITREXOL,Solid tumour/cancer , Phase 2
17282,D0J9JQ,XR-5082,Thrombosis , Terminated
17283,D0J9KC,IGN-101,Colorectal cancer , Discontinued in Phase 2
17284,D0J9NJ,CLX-0901,Type-2 diabetes , Discontinued in Phase 2
17285,D0J9PD,STP-206,Necrotizing enterocolitis of newborn , Phase 2
17286,D0J9PD,STP-206,Enterocolitis , Phase 1/2
17287,D0J9PK,OXA-01,Solid tumour/cancer , Investigative
17288,D0J9PS,MEDI1841,Alzheimer disease , Phase 1
17289,D0J9PT,BMS-820836,Major depressive disorder , Phase 2
17290,D0J9QS,BTRC4017A,Solid tumour/cancer , Phase 1
17291,D0J9SB,Derlotuximan biotin,Recurrent glioblastoma , Phase 2
17292,D0J9TA,Sensor linked micelle,Solid tumour/cancer , Investigative
17293,D0J9TO,HG-1076,Solid tumour/cancer , Investigative
17294,D0J9UA,hESC-derived RPE (PF-05206388),Wet age-related macular degeneration , Phase 1
17295,D0J9UB,RG7593,Haematological malignancy , Discontinued in Phase 2
17296,D0J9UN,Uracil mustard,Acute myeloid leukaemia , Approved
17297,D0J9UY,V505,Human papillomavirus infection , Phase 2
17298,D0J9UY,V505,Cervical cancer , Phase 2
17299,D0J9VG,NSI-566,Lateral sclerosis , Phase 2
17300,D0J9VG,NSI-566,Amyotrophic lateral sclerosis , Phase 2
17301,D0J9VG,NSI-566,Cerebrovascular ischaemia , Phase 2
17302,D0J9VG,NSI-566,Spinal cord injury , Phase 1
17303,D0J9VK,CM-156,Drug abuse , Investigative
17304,D0J9VL,MC2-01 PAD cream,Plaque psoriasis , Phase 3
17305,D0J9XZ,Torasemide,Congestive heart failure , Approved
17306,D0J9YS,DFRF4539A,Multiple myeloma , Phase 1
17307,D0J9ZR,Niclosamide,Cestodes infection , Approved
17308,D0JA1Z,TA-6666,Type-2 diabetes , Discontinued in Phase 2
17309,D0JA3Y,MEDI-578,Pain , Phase 1
17310,D0JA7V,PRX-105,Poison intoxication , Phase 1
17311,D0JA8R,HLA-DQ2 peptide vaccine,Coeliac disease , Phase 1
17312,D0JB0D,Influenza subunit vaccines,Influenza virus infection , Phase 1
17313,D0JB0N,BLV-0704,Pain , Investigative
17314,D0JB2J,Isatuximab,Multiple myeloma , Approved
17315,D0JB2J,Isatuximab,Plasma cell myeloma , Phase 3
17316,D0JB3H,Omaveloxolone,Friedreich's ataxia , Phase 2
17317,D0JB3H,Omaveloxolone,Melanoma , Phase 1/2
17318,D0JB3H,Omaveloxolone,Psychiatric disorder , Clinical trial
17319,D0JB4V,XEN-403,Pain , Phase 1
17320,D0JB4W,CHIR-29498,Bacterial infection , Terminated
17321,D0JB7Z,AIT-034,Dementia , Discontinued in Phase 3
17322,D0JB9C,PF-06688992,Solid tumour/cancer , Phase 1
17323,D0JB9C,PF-06688992,Multiple myeloma , Phase 1
17324,D0JC3U,Resorcinol compound 11,Albinism , Patented
17325,D0JC3U,Resorcinol compound 11,Ephelides , Patented
17326,D0JC3U,Resorcinol compound 11,Menkes disease , Patented
17327,D0JC3U,Resorcinol compound 11,Senile lentigines , Patented
17328,D0JC3U,Resorcinol compound 11,Melasma , Patented
17329,D0JC4J,SARMs,Solid tumour/cancer , Investigative
17330,D0JC7A,NP-50501,Solid tumour/cancer , Preclinical
17331,D0JC8G,PL2100,Stroke , Terminated
17332,D0JC8L,PMID25666693-Compound-31,Osteoarthritis pain , Patented
17333,D0JC8L,PMID25666693-Compound-31,Cancer related pain , Patented
17334,D0JC8L,PMID25666693-Compound-31,Neuropathic pain , Patented
17335,D0JC8L,PMID25666693-Compound-31,Inflammatory pain , Patented
17336,D0JC9K,VI7734,Rheumatoid arthritis , Phase 1
17337,D0JC9K,VI7734,Systemic sclerosis , Phase 1
17338,D0JC9N,Adapalene,Acne vulgaris , Approved
17339,D0JD1R,Zn-DPA-G,Glioma , Investigative
17340,D0JD4S,CU-906,Solid tumour/cancer , Investigative
17341,D0JD4T,Anti-CD19 CAR transduced T cells,Acute lymphocytic leukaemia , Phase 1/2
17342,D0JD4T,Anti-CD19 CAR transduced T cells,Chronic lymphocytic leukaemia , Phase 1/2
17343,D0JD4T,Anti-CD19 CAR transduced T cells,Lymphoma , Phase 1/2
17344,D0JD5W,PMID27998201-Compound-7,Abdominal aortic aneurysm , Patented
17345,D0JD6Y,CD19 CAR T,Acute lymphoblastic leukaemia , Phase 1
17346,D0JD6Y,CD19 CAR T,B-cell lymphoma , Phase 1
17347,D0JE2E,Rosuvastatin,Hypercholesterolaemia , Approved
17348,D0JE2E,Rosuvastatin,Elevated C-reactive protein , Phase 3
17349,D0JE4D,Dornase Alfa,Cystic fibrosis , Approved
17350,D0JE8O,BNT162b2 SARS-CoV-2 vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
17351,D0JF2I,BNT162c2 SARS-CoV-2 vaccine,Coronavirus Disease 2019 (COVID-19) , Investigative
17352,D0JF3M,P-144,Ulcer , Phase 2
17353,D0JF3M,P-144,Age-related macular degeneration , Investigative
17354,D0JF6C,Eltanexor oral,Colorectal cancer , Phase 1/2
17355,D0JF6C,Eltanexor oral,Myelodysplastic syndrome , Phase 1/2
17356,D0JF6C,Eltanexor oral,Prostate cancer , Phase 1/2
17357,D0JF6O,Eltenac,Arthritis , Discontinued in Phase 1
17358,D0JF9Z,CSL-362,Acute myeloid leukaemia , Phase 1
17359,D0JG2X,JCAR018,Acute lymphoblastic leukaemia , Phase 1
17360,D0JG2X,JCAR018,Non-hodgkin lymphoma , Phase 1
17361,D0JG6T,XEN-401,Pain , Investigative
17362,D0JH5K,TVI-Kidney-1,Renal cell carcinoma , Phase 2
17363,D0JH6W,DX-9065a,Angina pectoris , Discontinued in Phase 2
17364,D0JH9T,ACE-393,Diarrhea , Phase 2
17365,D0JI1J,GP-683,Pain , Terminated
17366,D0JI1S,RDEA-640,Human immunodeficiency virus infection , Terminated
17367,D0JI2E,Aleplasinin,Alzheimer disease , Phase 1
17368,D0JI4J,BMS-986179,Solid tumour/cancer , Phase 1
17369,D0JI4M,CAR-T cells targeting HER2,Solid tumour/cancer , Phase 1
17370,D0JI5G,PCNU,Brain cancer , Terminated
17371,D0JI8B,Milataxel,Solid tumour/cancer , Phase 2
17372,D0JJ1B,Artilide,Cardiac arrhythmias , Discontinued in Phase 1
17373,D0JJ7S,Valbenazine Tosylate,Tardive dyskinesia , Approved
17374,D0JK2N,PMID25666693-Compound-22,Osteoarthritis pain , Patented
17375,D0JK2N,PMID25666693-Compound-22,Cancer related pain , Patented
17376,D0JK2N,PMID25666693-Compound-22,Neuropathic pain , Patented
17377,D0JK2N,PMID25666693-Compound-22,Inflammatory pain , Patented
17378,D0JK2R,RMJH-111b,Essential hypertension , Phase 1/2
17379,D0JK3V,Imidazole derivative 4,Obesity , Patented
17380,D0JL0C,LEAF-4L6715,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
17381,D0JL1M,Thiethylperazine,Middle East Respiratory Syndrome (MERS) , Investigative
17382,D0JL2K,Grepafloxacin,Chronic bronchitis , Approved
17383,D0JL2K,Grepafloxacin,Bacterial infection , Withdrawn from market
17384,D0JL3Y,HuGAL-F2,Solid tumour/cancer , Investigative
17385,D0JL4D,CBT-101 + CBT-501,Solid tumour/cancer , Phase 1
17386,D0JM0G,Non-Hodgkin's lymphoma vaccine,Haemophilus influenza , Phase 2
17387,D0JM7Z,ASP8062,Fibromyalgia , Phase 2
17388,D0JN3M,ITAMELINE,Cognitive impairment , Discontinued in Phase 1
17389,D0JN5H,Trunkamide,Solid tumour/cancer , Investigative
17390,D0JN5N,Laquinimod,Lupus , Phase 3
17391,D0JN5N,Laquinimod,Multiple sclerosis , Phase 3
17392,D0JN5N,Laquinimod,Huntington disease , Phase 2
17393,D0JN5N,Laquinimod,Primary progressive multiple sclerosis , Phase 2
17394,D0JN6P,PEPIDH1M,Recurrent glioblastoma , Phase 1/2
17395,D0JN8C,mRNA-1325,Semliki forest virus infection , Phase 1/2
17396,D0JN9Z,DB103,Schizophrenia , Phase 1
17397,D0JO0I,VBY- 825,Solid tumour/cancer , Investigative
17398,D0JO3U,Elliptinium acetate,Solid tumour/cancer , Approved
17399,D0JO3X,AG-SDT102,Genitourinary disease , Investigative
17400,D0JO4O,LEAF-4L7520,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
17401,D0JO7Y,Fulvestrant,Breast cancer , Approved
17402,D0JO8T,ACER-003,Systemic sclerosis , Phase 2
17403,D0JO8Z,Fosfestrol,Solid tumour/cancer , Approved
17404,D0JO9M,Anti-hCD70 CAR transduced PBL,Ovarian cancer , Phase 1
17405,D0JO9M,Anti-hCD70 CAR transduced PBL,Pancreatic cancer , Phase 1
17406,D0JO9M,Anti-hCD70 CAR transduced PBL,Renal cell carcinoma , Phase 1
17407,D0JP4A,OsteoCel,Injury , Approved
17408,D0JP4H,Bethanidine,Heart arrhythmia , Withdrawn from market
17409,D0JP8D,GSK249320,Stroke , Phase 2
17410,D0JQ2W,GBM-Lamp-Vax,Recurrent glioblastoma , Phase 2
17411,D0JQ4R,AA-10022,Pain , Investigative
17412,D0JQ4S,Xmab-7195,Asthma , Phase 1
17413,D0JQ7Y,Ximelagatran,Coagulation defect , Withdrawn from market
17414,D0JR0F,Thiazole carboxamide derivative 25,Solid tumour/cancer , Patented
17415,D0JR0F,Thiazole carboxamide derivative 25,Metastatic cancer , Patented
17416,D0JR0P,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4",Albinism , Patented
17417,D0JR0P,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4",Ephelides , Patented
17418,D0JR0P,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4",Menkes disease , Patented
17419,D0JR0P,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4",Senile lentigines , Patented
17420,D0JR0P,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 4",Melasma , Patented
17421,D0JR9V,JBP-1,Solid tumour/cancer , Investigative
17422,D0JR9Y,MAS825,Coronavirus Disease 2019 (COVID-19) , Phase 2
17423,D0JS0W,PF-05230907,Nontraumatic intracerebral hemorrhage , Phase 1
17424,D0JS2A,Somatotropin rdna,Growth hormone deficiency , Approved
17425,D0JS2L,Anti-RSV mab,Respiratory syncytial virus infection , Investigative
17426,D0JS4E,ICM-3,Graft-versus-host disease , Terminated
17427,D0JS7E,LMS-611,Asthma , Investigative
17428,D0JS8H,ME1111,Onychomycosis , Phase 2
17429,D0JS9U,GSK-2231395A,Streptococcus infection , Phase 1
17430,D0JT0B,Amidine compound 5,Inflammation , Patented
17431,D0JT0U,CAR-T cells targeting CD33,Acute myeloid leukaemia , Preclinical
17432,D0JT1P,Brain tumor vaccine,Brain cancer , Discontinued in Phase 1
17433,D0JT5I,PF-04457845,Liver disease , Phase 2
17434,D0JT6Q,IC14,Coronavirus Disease 2019 (COVID-19) , Phase 2
17435,D0JT8B,PMID25666693-Compound-147,Osteoarthritis pain , Patented
17436,D0JT8B,PMID25666693-Compound-147,Cancer related pain , Patented
17437,D0JT8B,PMID25666693-Compound-147,Neuropathic pain , Patented
17438,D0JT8B,PMID25666693-Compound-147,Inflammatory pain , Patented
17439,D0JU3A,U-Strip Diabetes,Type-1 diabetes , Phase 2
17440,D0JU3A,U-Strip Diabetes,Type-2 diabetes , Phase 2
17441,D0JU5X,Bardoxolone methyl,Mixed connective tissue disease , Phase 3
17442,D0JU5X,Bardoxolone methyl,Pulmonary arterial hypertension , Phase 2
17443,D0JU5X,Bardoxolone methyl,Pulmonary hypertension , Phase 2
17444,D0JV0O,GM608,Parkinson disease , Phase 2
17445,D0JV4A,PA08140,Cardiovascular disease , Investigative
17446,D0JV4Q,Lanoconazole,Dermatological disease , Approved
17447,D0JV4R,TriCAR-T-CD19,Non-hodgkin lymphoma , Phase 1/2
17448,D0JV8Q,XB-05,Solid tumour/cancer , Investigative
17449,D0JV8Z,HIV recombinant proteins vaccine,Human immunodeficiency virus infection , Phase 2
17450,D0JW0V,GCS-100,Chronic kidney disease , Phase 2
17451,D0JW1S,Meglumine gadoterate,Blood brain barrier , Approved
17452,D0JW2O,Anti-HER3/EGFR DAF,Metastatic epithelial tumour , Phase 1
17453,D0JW2Y,Anti-Clostridium difficile mabs,Clostridium infection , Investigative
17454,D0JW6R,LAM-002,Non-hodgkin lymphoma , Phase 2
17455,D0JW6R,LAM-002,Chronic lymphocytic leukaemia , Phase 2
17456,D0JW6R,LAM-002,B-cell non-hodgkin lymphoma , Phase 1
17457,D0JW7D,Omiganan,Bacterial infection , Phase 3
17458,D0JW7D,Omiganan,Rosacea , Phase 3
17459,D0JW7D,Omiganan,Acne vulgaris , Phase 2
17460,D0JW7D,Omiganan,Atopic dermatitis , Phase 2
17461,D0JW7D,Omiganan,External genital and perianal wart , Phase 2
17462,D0JW7D,Omiganan,Vulvar intraepithelial neoplasia , Phase 2
17463,D0JW7T,Amide derivative 1,Obesity , Patented
17464,D0JW9E,CAR-T cells targeting Mucl,Acute myeloid leukaemia , Preclinical
17465,D0JX4I,PMID25666693-Compound-62,Osteoarthritis pain , Patented
17466,D0JX4I,PMID25666693-Compound-62,Cancer related pain , Patented
17467,D0JX4I,PMID25666693-Compound-62,Neuropathic pain , Patented
17468,D0JX4I,PMID25666693-Compound-62,Inflammatory pain , Patented
17469,D0JX7M,CD123CAR-41BB-CD3zeta-EGFRt-expressing T cells,Acute myeloid leukaemia , Phase 1
17470,D0JY0M,CD28 and CD137 CAR-T Cells,Acute lymphoblastic leukaemia , Phase 1
17471,D0JY2K,NS-1643,Heart arrhythmia , Investigative
17472,D0JY2X,Neu-2000,Cardiac arrest , Phase 1
17473,D0JY3V,Racecadotril,Diarrhea , Approved
17474,D0JY4Y,E-3040,Thrombosis , Discontinued in Phase 2
17475,D0JY5S,Methantheline,Gastritis , Approved
17476,D0JY5S,Methantheline,Pancreatitis , Approved
17477,D0JY5S,Methantheline,Irritable bowel syndrome , Approved
17478,D0JY5S,Methantheline,Peptic ulcer , Approved
17479,D0JY6R,MTL-101,Infectious disease , Investigative
17480,D0JY8T,Bazedoxifene,Osteopetrosis , Approved
17481,D0JZ4C,Px563L,Anthrax , Phase 1
17482,D0JZ5Y,Gp75 DNA vaccine,Solid tumour/cancer , Phase 1
17483,D0JZ7P,Thymosin alpha-1,Coronavirus Disease 2019 (COVID-19) , Phase 2
17484,D0JZ8X,HGTV43,Human immunodeficiency virus-1 infection , Phase 2
17485,D0JZ8X,HGTV43,Human immunodeficiency virus infection , Phase 1/2
17486,D0K0AT,SARALASIN,Hypertension , Approved
17487,D0K0CK,AZ-17,Psoriasis vulgaris , Investigative
17488,D0K0DB,RO-25-6981,Cancer related pain , Terminated
17489,D0K0DV,N-phenyl-5-phenyl-pyrazolin-3-yl amide derivative 2,Obesity , Patented
17490,D0K0DY,Zinc hyaluronate,Acne vulgaris , Approved
17491,D0K0EK,Prasterone,Chronic obstructive pulmonary disease , Approved
17492,D0K0EK,Prasterone,Cardiovascular disease , Phase 4
17493,D0K0FV,QR-334,Salivary gland dysfunction , Discontinued in Phase 2
17494,D0K0GF,SSR-181507,Schizophrenia , Phase 1
17495,D0K0GN,LDI-200,leukaemia , Discontinued in Phase 3
17496,D0K0IM,MK-8666,Type-2 diabetes , Phase 1
17497,D0K0IN,KBSA-301,Staphylococcus infection , Phase 1
17498,D0K0IS,Polyglutamate camptothecin,Solid tumour/cancer , Phase 2
17499,D0K0IW,CRA-028129,Psoriatic disorder , Terminated
17500,D0K0JQ,Dilmapimod,Acute lung injury , Phase 2
17501,D0K0KG,Heterodimeric IL-15,Solid tumour/cancer , Phase 1
17502,D0K0KH,Tropisetron,Fibromyalgia , Approved
17503,D0K0KJ,LF-521,Pain , Terminated
17504,D0K0KP,GE-68,Heart arrhythmia , Terminated
17505,D0K0KQ,BC-819,Pancreatic cancer , Phase 2
17506,D0K0KQ,BC-819,Bladder cancer , Phase 2
17507,D0K0LA,LC34AD3,Non-insulin dependent diabetes , Investigative
17508,D0K0LG,CPG23NEUR,Neurological disorder , Investigative
17509,D0K0MB,LP-10218,Solid tumour/cancer , Investigative
17510,D0K0MI,Sulphur hexafluoride microbubble ultrasound agent,Cardiovascular disease , Approved
17511,D0K0MW,Lofexidine,Opioid dependence , Approved
17512,D0K0MW,Lofexidine,Heroin and opiate withdrawal , Approved
17513,D0K0OB,AL-18,leukaemia , Investigative
17514,D0K0OU,MBX-1684,Pseudomonas infection , Investigative
17515,D0K0OX,PMID30074795-compound-2,Coronavirus Disease 2019 (COVID-19) , Investigative
17516,D0K0OZ,Famotidine,Peptic ulcer , Approved
17517,D0K0SB,NKM,Influenza virus infection , Approved
17518,D0K0SW,VLST-002,Autoimmune diabetes , Investigative
17519,D0K0TC,Sertraline,Depression , Approved
17520,D0K0TZ,Multimeric-001,Influenza virus infection , Phase 2
17521,D0K0VH,S-5751,Rhinitis , Discontinued in Phase 2
17522,D0K0VO,Urapidil,Hypertension , Approved
17523,D0K0VO,Urapidil,Inflammation , Phase 1/2
17524,D0K0WA,CNTO-5825,Allergic asthma , Phase 1
17525,D0K0XG,MF-8615,Alzheimer disease , Terminated
17526,D0K0XW,C-9138,Alzheimer disease , Discontinued in Phase 1
17527,D0K0YC,PD-0325901,Breast cancer , Phase 2
17528,D0K0ZB,Tresperimus,Autoimmune diabetes , Discontinued in Phase 3
17529,D0K0ZI,PMID25666693-Compound-141,Osteoarthritis pain , Patented
17530,D0K0ZI,PMID25666693-Compound-141,Cancer related pain , Patented
17531,D0K0ZI,PMID25666693-Compound-141,Neuropathic pain , Patented
17532,D0K0ZI,PMID25666693-Compound-141,Inflammatory pain , Patented
17533,D0K0ZK,ADX-63365,Central nervous system disease , Investigative
17534,D0K1AF,A-74273,Hypertension , Terminated
17535,D0K1AI,Sch-58500,Breast cancer , Phase 1
17536,D0K1AK,LCAR-B38M CAR-T Cell,Multiple myeloma , Phase 2
17537,D0K1AP,NSL-101,Facial pain , Phase 2
17538,D0K1BR,NLP-61,Neurodegenerative disorder , Investigative
17539,D0K1CL,SDZ-224-015,Rheumatoid arthritis , Terminated
17540,D0K1DC,Romergoline,Anxiety disorder , Discontinued in Phase 2
17541,D0K1EG,QAV-680,Allergic rhinitis , Phase 2
17542,D0K1EO,Picroliv,Liver disease , Phase 2
17543,D0K1HO,Acifran,Arteriosclerosis , Discontinued in Phase 3
17544,D0K1LJ,Ad5-TRAIL,Prostate cancer , Phase 1
17545,D0K1LO,R-873,Erectile dysfunction , Discontinued in Phase 2
17546,D0K1OA,D-4418,Cutaneous T-cell lymphoma , Discontinued in Phase 1
17547,D0K1OK,CCR5 mab,Human immunodeficiency virus infection , Phase 1
17548,D0K1OM,Remdesivir + chloroquine,Coronavirus Disease 2019 (COVID-19) , Investigative
17549,D0K1OR,IB-06F259,Solid tumour/cancer , Investigative
17550,D0K1PR,B-428,Solid tumour/cancer , Terminated
17551,D0K1QD,Sulfamylon,Bacterial infection , Approved
17552,D0K1QO,CEFETECOL,Bacterial infection , Discontinued in Phase 3
17553,D0K1SR,PH-794428,Growth hormone deficiency , Phase 2
17554,D0K1ST,Revefenacin,Chronic obstructive pulmonary disease , Approved
17555,D0K1SZ,Norcisapride,Gastroesophageal reflux disease , Discontinued in Phase 2
17556,D0K1TM,AMP-423,Solid tumour/cancer , Investigative
17557,D0K1UD,MMV00/0053,Malaria , Terminated
17558,D0K1UF,Saliphenylhalamide,Solid tumour/cancer , Preclinical
17559,D0K1UO,Resorcinol compound 30,Albinism , Patented
17560,D0K1UO,Resorcinol compound 30,Ephelides , Patented
17561,D0K1UO,Resorcinol compound 30,Menkes disease , Patented
17562,D0K1UO,Resorcinol compound 30,Senile lentigines , Patented
17563,D0K1UO,Resorcinol compound 30,Melasma , Patented
17564,D0K1VK,AZD8055,Solid tumour/cancer , Discontinued in Phase 1/2
17565,D0K1VV,SR8278,Myocardial disease , Preclinical
17566,D0K1XK,Hydralazine,Hypertension , Approved
17567,D0K1XV,RemUnity,Pulmonary arterial hypertension , Phase 3
17568,D0K1YQ,SP-10,Human immunodeficiency virus infection , Investigative
17569,D0K1ZD,Edobacomab,Endotoxic shock , Discontinued in Preregistration
17570,D0K2AA,Biaryl mannoside derivative 11,Crohn disease , Patented
17571,D0K2AA,Biaryl mannoside derivative 11,Ulcerative colitis , Patented
17572,D0K2AA,Biaryl mannoside derivative 11,Urinary tract infection , Patented
17573,D0K2AR,Pyridocarbazole,Solid tumour/cancer , Investigative
17574,D0K2BQ,BRL-61063,Allergy , Discontinued in Phase 2
17575,D0K2CR,Nemorubicin,Solid tumour/cancer , Preclinical
17576,D0K2CV,HOE-694,Heart arrhythmia , Terminated
17577,D0K2EC,MEDI-77,Central nervous system disease , Investigative
17578,D0K2ER,MK-886,Asthma , Discontinued in Phase 2
17579,D0K2FH,Serenoa repens extract,Benign prostatic hyperplasia , Approved
17580,D0K2GA,Silteplase,Thrombin deficiency , Approved
17581,D0K2GV,HIV vaccine,Human immunodeficiency virus infection , Phase 1
17582,D0K2HA,PF-2413873,Endometriosis , Phase 1
17583,D0K2HU,PF-06444752,Asthma , Phase 1
17584,D0K2ID,NKTR-181,Neuropathic pain , Phase 3
17585,D0K2ID,NKTR-181,Chronic low back pain , Phase 3
17586,D0K2ID,NKTR-181,Pain , Phase 3
17587,D0K2KD,PB-6,Bacterial infection , Phase 1
17588,D0K2KR,Eplerenone,Coronavirus Disease 2019 (COVID-19) , Investigative
17589,D0K2KS,HuCNS-SC,Central nervous system disease , Phase 2
17590,D0K2LR,LG-611,Influenza virus infection , Investigative
17591,D0K2MT,ADC-7828,Chronic obstructive pulmonary disease , Investigative
17592,D0K2NA,YM-57158,Allergic rhinitis , Phase 1
17593,D0K2OV,Oxytrex,Pain , Phase 2
17594,D0K2PH,Elvucitabine,Human immunodeficiency virus infection , Discontinued in Phase 2
17595,D0K2PS,Carmoxirole,Hypertension , Phase 1
17596,D0K2QG,DASANTAFIL,Erectile dysfunction , Discontinued in Phase 2
17597,D0K2RV,Timothy grass extract,Allergic rhinitis , Phase 1
17598,D0K2RY,Itriglumide,Anxiety disorder , Phase 2
17599,D0K2TB,Docarpamine,Hypertension , Approved
17600,D0K2UJ,MUT-11931,Bacterial infection , Investigative
17601,D0K2WK,Cicletanine,Pulmonary arterial hypertension , Phase 2
17602,D0K2XB,GX-51,Solid tumour/cancer , Investigative
17603,D0K2XK,PMID26815044-Compound-I,Albinism , Patented
17604,D0K2XK,PMID26815044-Compound-I,Ephelides , Patented
17605,D0K2XK,PMID26815044-Compound-I,Menkes disease , Patented
17606,D0K2XK,PMID26815044-Compound-I,Senile lentigines , Patented
17607,D0K2XK,PMID26815044-Compound-I,Melasma , Patented
17608,D0K2ZF,PH-797804,Chronic obstructive pulmonary disease , Phase 2
17609,D0K2ZG,"5-LO (pain/neuro-inflammation), St Charles Pharmaceuticals",Nervous system inflammation , Investigative
17610,D0K3DA,PMID26651364-Compound-112,Crohn disease , Patented
17611,D0K3DA,PMID26651364-Compound-112,Ulcerative colitis , Patented
17612,D0K3DA,PMID26651364-Compound-112,Urinary tract infection , Patented
17613,D0K3DQ,Cefotiam,Respiratory tract infection , Approved
17614,D0K3FG,EDP-13,Solid tumour/cancer , Investigative
17615,D0K3FJ,Imidazole derivative 6,Obesity , Patented
17616,D0K3FX,NT-503,Age-related macular degeneration , Phase 1/2
17617,D0K3GB,99mTc-MIP-1340,Prostate cancer , Investigative
17618,D0K3GU,PF-3185043,Arteriosclerosis , Discontinued in Phase 1
17619,D0K3JQ,RPI-MN,Amyotrophic lateral sclerosis , Phase 1
17620,D0K3JQ,RPI-MN,Human immunodeficiency virus infection , Phase 1
17621,D0K3JZ,PT-00311,Neurological disorder , Investigative
17622,D0K3KE,PMID25666693-Compound-155,Osteoarthritis pain , Patented
17623,D0K3KE,PMID25666693-Compound-155,Cancer related pain , Patented
17624,D0K3KE,PMID25666693-Compound-155,Neuropathic pain , Patented
17625,D0K3KE,PMID25666693-Compound-155,Inflammatory pain , Patented
17626,D0K3KM,PMID25666693-Compound-148,Osteoarthritis pain , Patented
17627,D0K3KM,PMID25666693-Compound-148,Cancer related pain , Patented
17628,D0K3KM,PMID25666693-Compound-148,Neuropathic pain , Patented
17629,D0K3KM,PMID25666693-Compound-148,Inflammatory pain , Patented
17630,D0K3LO,Romosozumab,Postmenopausal osteoporosis , Approved
17631,D0K3LW,Malathion,Pediculus capitis infestation , Approved
17632,D0K3LX,RNAPc2,Colorectal cancer , Discontinued in Phase 2
17633,D0K3MC,Lofepramine,Major depressive disorder , Approved
17634,D0K3MU,NRL-0301,Non-alcoholic steatohepatitis , Investigative
17635,D0K3OK,Difelikefalin,Pruritus , Phase 3
17636,D0K3QS,Everolimus,Renal cell carcinoma , Approved
17637,D0K3QS,Everolimus,Kidney cancer , Phase 3
17638,D0K3QW,REC-0436,Overactive bladder , Investigative
17639,D0K3RP,NRI-1013,Pain , Investigative
17640,D0K3SM,MALP-2S,Pancreatic cancer , Phase 1/2
17641,D0K3SV,PF-05236812,Alzheimer disease , Discontinued in Phase 1
17642,D0K3UQ,Vercirnon,Crohn disease , Phase 3
17643,D0K3VA,Erdosteine,Bronchitis , Approved
17644,D0K3WN,DNP-004089,Alzheimer disease , Terminated
17645,D0K3WO,MK-08887A,Chronic obstructive pulmonary disease , Approved
17646,D0K3XB,JCAR015,B-cell lymphoma , Phase 2
17647,D0K3XB,JCAR015,Acute lymphoblastic leukaemia , Phase 2
17648,D0K3XP,Methoxy polyethylene glycol-epoetin beta,Kidney transplant rejection , Approved
17649,D0K3XS,Custirsen,Lung cancer , Phase 3
17650,D0K3XS,Custirsen,Breast cancer , Phase 3
17651,D0K3XS,Custirsen,Prostate cancer , Phase 3
17652,D0K3YG,ANX-201,Cytomegalovirus infection , Terminated
17653,D0K3ZL,MA09-hRPE cells,Ocular disease , Phase 1/2
17654,D0K3ZL,MA09-hRPE cells,Stargardt disease , Phase 1/2
17655,D0K3ZR,Bisoprolol,Hypertension , Approved
17656,D0K4CD,ASP-8477,Neuropathic pain , Phase 2
17657,D0K4CH,IMGN-009,Solid tumour/cancer , Investigative
17658,D0K4CQ,Indecainide,Dysrhythmias , Approved
17659,D0K4DI,Anistreplase,Acute coronary syndrome , Approved
17660,D0K4ED,Ro-23-9424,Bacterial infection , Discontinued in Phase 2
17661,D0K4FP,AZD-8165,Thrombosis , Phase 1
17662,D0K4GG,STP-902,Respiratory syncytial virus infection , Investigative
17663,D0K4GI,Affinitak + Gemcitabine,Non-small-cell lung cancer , Investigative
17664,D0K4GW,INL-002,Diabetic foot ulcer , Phase 3
17665,D0K4HW,N-DESMETHYLCLOZAPINE,Schizoaffective disorder , Phase 2
17666,D0K4HW,N-DESMETHYLCLOZAPINE,Schizophrenia , Phase 2
17667,D0K4IS,PF-06293620,Type-2 diabetes , Phase 1
17668,D0K4IV,TD-1439,Heart failure , Phase 1
17669,D0K4JI,JOT106,Alzheimer disease , Phase 2
17670,D0K4JQ,GSK2336805,Hepatitis C virus infection , Phase 2
17671,D0K4JS,ATX-3105,Inflammation , Investigative
17672,D0K4MH,Tapentadol hydrochloride,Acute pain , Approved
17673,D0K4MU,Crobenetine,Pain , Phase 2
17674,D0K4MW,LP-30171,Solid tumour/cancer , Investigative
17675,D0K4NZ,Velneperit,Obesity , Discontinued in Phase 2
17676,D0K4OC,DI-VAL-L-DC,Solid tumour/cancer , Phase 2
17677,D0K4OF,PlaMavax,Malaria , Phase 2
17678,D0K4OL,LOR-2501,Solid tumour/cancer , Discontinued in Phase 1
17679,D0K4OS,TS-121,Major depressive disorder , Phase 2
17680,D0K4OS,TS-121,Depression , Phase 1
17681,D0K4PN,AZD-1134,Anxiety disorder , Terminated
17682,D0K4QT,BAY-Y-5959,Cardiovascular disease , Phase 2
17683,D0K4RK,Blinatumomab,Acute lymphoblastic leukaemia , Approved
17684,D0K4RK,Blinatumomab,Diffuse large B-cell lymphoma , Phase 2/3
17685,D0K4RU,AF-130,Hypertension , Phase 1
17686,D0K4SZ,PMID25666693-Compound-46,Osteoarthritis pain , Patented
17687,D0K4SZ,PMID25666693-Compound-46,Cancer related pain , Patented
17688,D0K4SZ,PMID25666693-Compound-46,Neuropathic pain , Patented
17689,D0K4SZ,PMID25666693-Compound-46,Inflammatory pain , Patented
17690,D0K4UT,DNA-2401,Recurrent glioblastoma , Phase 2
17691,D0K4UT,DNA-2401,Glioma , Phase 1
17692,D0K4UV,KU-5039,Type-2 diabetes , Phase 1
17693,D0K4UW,Imitrodast,Asthma , Discontinued in Phase 2
17694,D0K4VN,Molecule 21,Pain , Investigative
17695,D0K4VW,Cenersen,Acute myeloid leukaemia , Phase 2
17696,D0K4WT,S-1033,Glaucoma/ocular hypertension , Discontinued in Phase 2
17697,D0K4WW,11A1,Alzheimer disease , Investigative
17698,D0K4YE,PMID32198291-compound11r,Coronavirus Disease 2019 (COVID-19) , Investigative
17699,D0K5BP,HSP-990,Solid tumour/cancer , Phase 1
17700,D0K5BY,MIM-3Ae,Ocular disease , Investigative
17701,D0K5CB,Salbutamol,Acute asthma , Approved
17702,D0K5CJ,DAVLB-HYDRAZIDE,Solid tumour/cancer , Phase 1
17703,D0K5CX,Celacade,Chronic heart failure , Approved
17704,D0K5EE,S-33084,Psychotic disorder , Preclinical
17705,D0K5ER,Rosiglitazone XR,Type-2 diabetes , Approved
17706,D0K5ER,Rosiglitazone XR,Alzheimer disease , Phase 3
17707,D0K5ET,M207,Migraine , Phase 3
17708,D0K5HD,LY-315902,Type-2 diabetes , Discontinued in Phase 1
17709,D0K5HI,Talnetant,Schizophrenia , Phase 2
17710,D0K5HI,Talnetant,Schizoaffective disorder , Discontinued in Phase 2
17711,D0K5HI,Talnetant,Irritable bowel syndrome , Discontinued in Phase 2
17712,D0K5HO,PMID32198291-compound13b,Coronavirus Disease 2019 (COVID-19) , Investigative
17713,D0K5IP,Palonosetron + fosnetupitant,Chemotherapy-induced nausea , Approved
17714,D0K5IQ,DAA-1097,Anxiety disorder , Terminated
17715,D0K5JE,HD-0701,Gastrointestinal disease , Investigative
17716,D0K5JG,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5",Albinism , Patented
17717,D0K5JG,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5",Ephelides , Patented
17718,D0K5JG,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5",Menkes disease , Patented
17719,D0K5JG,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5",Senile lentigines , Patented
17720,D0K5JG,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 5",Melasma , Patented
17721,D0K5KS,Adalimumab,Rheumatoid arthritis , Approved
17722,D0K5LQ,Pemirolast,Allergic conjunctivitis , Approved
17723,D0K5LT,Adult stem cell therapy,Stroke , Discontinued in Phase 2
17724,D0K5MC,SNK-01,Non-small-cell lung cancer , Phase 1/2
17725,D0K5NG,HLD200,Attention deficit hyperactivity disorder , Application submitted
17726,D0K5NN,GFP-bacterial methioninase/selenomethionine GDEPT,Solid tumour/cancer , Investigative
17727,D0K5OT,Penicillin G Sodium,Bacterial infection , Approved
17728,D0K5QY,AP-101,Ischemia , Investigative
17729,D0K5RX,KYS-05050,Solid tumour/cancer , Investigative
17730,D0K5SN,Dosmalfate,Stomach ulcer , Approved
17731,D0K5TE,BMS-955176,Human immunodeficiency virus-1 infection , Phase 2
17732,D0K5UK,HuMax-Wnt,Solid tumour/cancer , Investigative
17733,D0K5WM,CS-3030,Thrombosis , Preclinical
17734,D0K5WS,Cholecalciferol,Vitamin D deficiency , Approved
17735,D0K6AL,PM1183,Ovarian cancer , Phase 3
17736,D0K6CG,DRA-161,Diabetic complication , Investigative
17737,D0K6CW,CEN-109,Solid tumour/cancer , Phase 2
17738,D0K6DG,ONO-8130,Pollakiuria , Terminated
17739,D0K6ES,CRT-0004592,Solid tumour/cancer , Investigative
17740,D0K6GI,Benzimidazole derivative 2,Obesity , Patented
17741,D0K6GZ,Sparfloxacin,Bacterial infection , Approved
17742,D0K6HE,PRO-001,Retinitis pigmentosa , Phase 2
17743,D0K6HG,V116517,Osteoarthritis , Phase 2
17744,D0K6IM,PMID28270021-Compound-WO2010077680 495,Pruritus , Patented
17745,D0K6IM,PMID28270021-Compound-WO2010077680 495,Solid tumour/cancer , Patented
17746,D0K6IM,PMID28270021-Compound-WO2010077680 495,Chronic pain , Patented
17747,D0K6IM,PMID28270021-Compound-WO2010077680 495,Neuropathic pain , Patented
17748,D0K6IM,PMID28270021-Compound-WO2010077680 495,Thymic cancer , Patented
17749,D0K6JQ,INO-3401,Influenza A virus H5N1 infection , Phase 1
17750,D0K6JZ,DCLL9718S,Acute myeloid leukaemia , Phase 1
17751,D0K6KU,AFX-9901,Solid tumour/cancer , Phase 1
17752,D0K6LA,OPC-22575,Ulcerative colitis , Investigative
17753,D0K6LX,MK-5823,Type-2 diabetes , Phase 1
17754,D0K6MW,Teicoplanin,Bacterial infection , Approved
17755,D0K6NS,T-226293,Obesity , Preclinical
17756,D0K6NW,REC-02,Congestive heart failure , Phase 1
17757,D0K6PP,AG-NPP709,Bronchitis , Phase 3
17758,D0K6QU,IT-141,Solid tumour/cancer , Phase 1
17759,D0K6SM,Ilepatril,Diabetic nephropathy , Discontinued in Phase 2/3
17760,D0K6SM,Ilepatril,Heart failure , Discontinued in Phase 2/3
17761,D0K6SM,Ilepatril,Renal failure , Discontinued in Phase 2/3
17762,D0K6SM,Ilepatril,Hypertension , Discontinued in Phase 2/3
17763,D0K6TN,Resorcinol compound 25,Albinism , Patented
17764,D0K6TN,Resorcinol compound 25,Ephelides , Patented
17765,D0K6TN,Resorcinol compound 25,Menkes disease , Patented
17766,D0K6TN,Resorcinol compound 25,Senile lentigines , Patented
17767,D0K6TN,Resorcinol compound 25,Melasma , Patented
17768,D0K6UG,RhH1.3,Acute myeloid leukaemia , Phase 1/2
17769,D0K6UO,NK-101,Brain injury , Investigative
17770,D0K6UQ,HLA-A*2402-restricted KIF20A and VEGFR-1 epitope peptide vaccine,Pancreatic cancer , Phase 1
17771,D0K6UV,DNL201,Parkinson disease , Phase 1
17772,D0K6VD,Juniper tar,Eczema , Approved
17773,D0K6XI,Griffithsin,Human immunodeficiency virus infection , Phase 1
17774,D0K6XI,Griffithsin,Severe acute respiratory syndrome (SARS) , Preclinical
17775,D0K6ZH,PSI-661,Hepatitis C virus infection , Terminated
17776,D0K6ZI,H2N2 live attenuated influenza vaccine,Influenza virus infection , Phase 1
17777,D0K7BF,NX-201,Autism spectrum disorder , Investigative
17778,D0K7DV,Kevetrin,Ovarian cancer , Phase 2
17779,D0K7DV,Kevetrin,Solid tumour/cancer , Phase 1
17780,D0K7FT,AG-221,Acute myelogenous leukaemia , Phase 3
17781,D0K7FT,AG-221,Acute myeloid leukaemia , Phase 1/2
17782,D0K7FY,EGF816,Non-small-cell lung cancer , Phase 3
17783,D0K7HU,Ciclesonide,Obstructive airway disease , Approved
17784,D0K7HU,Ciclesonide,Asthma , Approved
17785,D0K7JC,ZP-001,Contracture , Investigative
17786,D0K7KV,ORP-100,Respiratory disease , Investigative
17787,D0K7LA,Low molecular weight dextran sulphate,Bone marrow transplantation , Phase 2
17788,D0K7LI,Resorcinol compound 31,Albinism , Patented
17789,D0K7LI,Resorcinol compound 31,Ephelides , Patented
17790,D0K7LI,Resorcinol compound 31,Menkes disease , Patented
17791,D0K7LI,Resorcinol compound 31,Senile lentigines , Patented
17792,D0K7LI,Resorcinol compound 31,Melasma , Patented
17793,D0K7LU,Santonin,Parasitic infection , Approved
17794,D0K7MY,ESI-014,Diabetic complication , Investigative
17795,D0K7NC,PMID30107136-Compound-Example16,Solid tumour/cancer , Patented
17796,D0K7NC,PMID30107136-Compound-Example16,Infectious disease , Patented
17797,D0K7NC,PMID30107136-Compound-Example16,Human immunodeficiency virus infection , Patented
17798,D0K7NC,PMID30107136-Compound-Example16,Hepatitis , Patented
17799,D0K7NI,ABT-RTA-408,Non-small-cell lung cancer , Phase 2
17800,D0K7NJ,Recombinant coagulation factors,Hemophilia , Investigative
17801,D0K7NQ,Colistin,Pseudomonas infection , Approved
17802,D0K7OO,SA-14-14-2,Japanese encephalitis virus infection , Approved
17803,D0K7OW,GSK-1360707,Major depressive disorder , Phase 1
17804,D0K7PD,Cat hair allergen extract,Allergy , Phase 1
17805,D0K7PQ,ST-570,Inflammation , Terminated
17806,D0K7QQ,TS-134,Schizophrenia , Phase 1
17807,D0K7SX,Avelumab,Merkel cell carcinoma , Approved
17808,D0K7SX,Avelumab,Solid tumour/cancer , Approved
17809,D0K7SX,Avelumab,Ovarian cancer , Phase 3
17810,D0K7SX,Avelumab,Renal cell carcinoma , Phase 3
17811,D0K7SX,Avelumab,Melanoma , Phase 2
17812,D0K7TE,Biaryl mannoside derivative 27,Crohn disease , Patented
17813,D0K7TE,Biaryl mannoside derivative 27,Ulcerative colitis , Patented
17814,D0K7TE,Biaryl mannoside derivative 27,Urinary tract infection , Patented
17815,D0K7TX,HOE-065,Cognitive impairment , Discontinued in Phase 1
17816,D0K7UL,S-2678,Immune System disease , Investigative
17817,D0K7VM,ARI-1778,Arteriosclerosis , Investigative
17818,D0K7WK,Ondansetron,Chemotherapy-induced nausea , Approved
17819,D0K7WK,Ondansetron,Alcohol dependence , Phase 2
17820,D0K7WQ,GS-441524,Coronavirus Disease 2019 (COVID-19) , Investigative
17821,D0K7XA,Pyrazole derivative 21,Obesity , Patented
17822,D0K7XR,KSB-304,Ulcerative colitis , Terminated
17823,D0K7ZH,PF-06649751,Parkinson disease , Phase 1
17824,D0K8AA,Zinc salts,Arthritis , Approved
17825,D0K8AL,OG-232,Solid tumour/cancer , Investigative
17826,D0K8BJ,MNK-010,Solid tumour/cancer , Phase 1
17827,D0K8BO,TX-RAD,Rheumatoid arthritis , Investigative
17828,D0K8CI,Otilonium bromide,Gastric motility disorder , Approved
17829,D0K8CP,HO/02/10,Dermatological disease , Investigative
17830,D0K8DI,SQ-109,Bacterial infection , Phase 2
17831,D0K8DI,SQ-109,Tuberculosis , Phase 2
17832,D0K8FI,Pegmusirudin,Angina pectoris , Phase 2
17833,D0K8GD,AR20,Mental disease , Phase 3
17834,D0K8HA,LL-6531,Diabetic complication , Investigative
17835,D0K8HF,PLD-147,Solid tumour/cancer , Discontinued in Phase 1
17836,D0K8IX,Thiazolidinedione,Alzheimer disease , Approved
17837,D0K8JE,TT-123,Coagulation defect , Investigative
17838,D0K8KA,DOX-PSASP-BBN-RGD prodrugs,Prostate cancer , Investigative
17839,D0K8KJ,DuP-129,Hypercholesterolaemia , Terminated
17840,D0K8KX,Quercetin,Obesity , Approved
17841,D0K8LB,PI-88/Taxotere,Solid tumour/cancer , Phase 2
17842,D0K8MP,Permethrin,Sarcoptes scabiei infection , Approved
17843,D0K8MQ,FP-1096,Endometriosis , Discontinued in Phase 3
17844,D0K8NR,AMG 386,Neuropathic pain , Phase 3
17845,D0K8NR,AMG 386,Breast cancer , Phase 3
17846,D0K8NR,AMG 386,Alzheimer disease , Phase 2
17847,D0K8NR,AMG 386,Asthma , Discontinued in Phase 2
17848,D0K8NR,AMG 386,Sexual dysfunction , Preclinical
17849,D0K8NW,Ritanserin,Anxiety disorder , Discontinued in Phase 3
17850,D0K8PH,SUVN-504,Vomiting , Investigative
17851,D0K8RK,Alisporivir,Hepatitis C virus infection , Phase 3
17852,D0K8RK,Alisporivir,Severe acute respiratory syndrome (SARS) , Investigative
17853,D0K8RK,Alisporivir,Middle East Respiratory Syndrome (MERS) , Investigative
17854,D0K8SH,GX-137,Hepatitis C virus infection , Investigative
17855,D0K8TI,Ranirestat,Diabetic neuropathy , Phase 3
17856,D0K8TO,AP1903,Transplant rejection , Phase 1/2
17857,D0K8UN,SCIB-2,Solid tumour/cancer , Investigative
17858,D0K8WE,Anti-CD33 CAR-T cells,Myeloid leukaemia , Phase 1/2
17859,D0K8WJ,Sf-1019,Diabetic complication , Phase 3
17860,D0K8XT,Thiazole carboxamide derivative 10,Solid tumour/cancer , Patented
17861,D0K8XT,Thiazole carboxamide derivative 10,Metastatic cancer , Patented
17862,D0K8YG,ISA-HPV-01,Cervical cancer , Phase 2
17863,D0K8YK,DVD-Ig,Solid tumour/cancer , Investigative
17864,D0K8YX,4SCAR19 and 4SCAR30,B-cell lymphoma , Phase 1/2
17865,D0K9BV,TVB-2640,Astrocytoma , Phase 2
17866,D0K9BV,TVB-2640,Colon cancer , Phase 2
17867,D0K9BV,TVB-2640,Advanced solid tumour , Phase 1
17868,D0K9CZ,VPM-1-002,Mycobacterium infection , Phase 2
17869,D0K9DI,GSK-356278,Huntington disease , Phase 1
17870,D0K9ES,Suprofenac,Ocular inflammation , Investigative
17871,D0K9FA,Dolutegravir + lamivudine,Human immunodeficiency virus infection , Phase 3
17872,D0K9HF,BLX-301,Non-hodgkin lymphoma , Investigative
17873,D0K9IB,Vonapanitase,Arterial thrombosis , Phase 3
17874,D0K9IB,Vonapanitase,Peripheral arterial disease , Phase 3
17875,D0K9IF,PF-06305591,Chronic pain , Phase 1
17876,D0K9JO,AskBio009,Haemophilia B , Phase 1/2
17877,D0K9KN,JNJ-26113100,Atopic dermatitis , Phase 2
17878,D0K9KS,Draculin,Thrombosis , Terminated
17879,D0K9MB,CX-1030,Immune System disease , Investigative
17880,D0K9MC,CetuGEX,Solid tumour/cancer , Phase 2
17881,D0K9MN,ZP-EPO,Anemia , Investigative
17882,D0K9MY,Saxagliptin,Type-2 diabetes , Approved
17883,D0K9NJ,F18-ML-10,Brain cancer , Phase 2
17884,D0K9OL,SCH 50911,Absence seizure , Terminated
17885,D0K9OU,MBX400,Cytomegalovirus infection , Phase 1
17886,D0K9PC,AG-881,Glioma , Phase 3
17887,D0K9PC,AG-881,Acute myeloid leukaemia , Phase 1
17888,D0K9PG,NXD-30001,Solid tumour/cancer , Investigative
17889,D0K9PS,CHF-5480,Chronic obstructive pulmonary disease , Investigative
17890,D0K9QH,Benzothiazine-carboxamide compound 3,Skin inflammation , Patented
17891,D0K9QQ,Pyrvinium pamoate,Middle East Respiratory Syndrome (MERS) , Investigative
17892,D0K9RR,LF-943,Ischemia , Terminated
17893,D0K9SS,GP2015,Ankylosing spondylitis , Application submitted
17894,D0K9SS,GP2015,Juvenile idiopathic arthritis , Application submitted
17895,D0K9SS,GP2015,Plaque psoriasis , Application submitted
17896,D0K9SS,GP2015,Psoriatic arthritis , Application submitted
17897,D0K9SS,GP2015,Rheumatoid arthritis , Application submitted
17898,D0K9TC,Sameridine,Pain , Terminated
17899,D0K9UK,E-6700,Asthma , Phase 2
17900,D0K9UT,Epi-13,Insulin-dependent diabetes , Investigative
17901,D0K9WL,Glucagon injection,Hypoglycemia , Phase 2
17902,D0K9WP,131I-TM-601,Glioma , Phase 2
17903,D0K9XI,DHF-18,Solid tumour/cancer , Investigative
17904,D0K9YJ,JNJ-3534,Psoriasis vulgaris , Phase 1
17905,D0K9ZU,CD45RB,Glioma , Investigative
17906,D0KA4R,NNZ-2591,Neurodegenerative disorder , Investigative
17907,D0KA7I,PMID30107136-Compound-Example7,Solid tumour/cancer , Patented
17908,D0KA7I,PMID30107136-Compound-Example7,Infectious disease , Patented
17909,D0KA7I,PMID30107136-Compound-Example7,Human immunodeficiency virus infection , Patented
17910,D0KA7I,PMID30107136-Compound-Example7,Hepatitis , Patented
17911,D0KA9L,AME-133v,Non-hodgkin lymphoma , Phase 2
17912,D0KB0Y,Pegargiminase,Hepatocellular carcinoma , Phase 3
17913,D0KB0Y,Pegargiminase,Mesothelioma , Phase 2/3
17914,D0KB0Y,Pegargiminase,Melanoma , Phase 2
17915,D0KB0Y,Pegargiminase,Gastrointestinal cancer , Phase 1/2
17916,D0KB0Y,Pegargiminase,Solid tumour/cancer , Phase 1
17917,D0KB0Y,Pegargiminase,Argininosuccinate synthase deficiency , Phase 1
17918,D0KB2E,FR167356,Osteoporosis , Preclinical
17919,D0KB2Z,PMID25666693-Compound-1,Osteoarthritis pain , Patented
17920,D0KB2Z,PMID25666693-Compound-1,Cancer related pain , Patented
17921,D0KB2Z,PMID25666693-Compound-1,Neuropathic pain , Patented
17922,D0KB2Z,PMID25666693-Compound-1,Inflammatory pain , Patented
17923,D0KB6S,MVA-mBN85B,Measles , Phase 2
17924,D0KC1H,Infliximab,Coronavirus Disease 2019 (COVID-19) , Investigative
17925,D0KC1N,Adalimumab,Coronavirus Disease 2019 (COVID-19) , Investigative
17926,D0KC2S,CAR-T cells targeting mesothelin,Pancreatic cancer , Phase 1/2
17927,D0KC5X,S-18616,Pain , Terminated
17928,D0KC7H,NCX-1236,Neuropathic pain , Investigative
17929,D0KC7K,EC-154,Solid tumour/cancer , Terminated
17930,D0KC8X,Bicyclic heteroaryl benzamide derivative 5,Pruritus , Patented
17931,D0KC8X,Bicyclic heteroaryl benzamide derivative 5,Solid tumour/cancer , Patented
17932,D0KC8X,Bicyclic heteroaryl benzamide derivative 5,Chronic pain , Patented
17933,D0KC8X,Bicyclic heteroaryl benzamide derivative 5,Neuropathic pain , Patented
17934,D0KC8X,Bicyclic heteroaryl benzamide derivative 5,Thymic cancer , Patented
17935,D0KC9U,Stage IV melanoma vaccine,Melanoma , Phase 2
17936,D0KC9V,AD10-1025,Hypercholesterolaemia , Investigative
17937,D0KD1A,HF-0699,Cerebrovascular ischaemia , Terminated
17938,D0KD1U,Practolol,Cardiac arrhythmias , Approved
17939,D0KD4U,FK-355,Asthma , Terminated
17940,D0KD4X,Rapacuronium bromide,Muscle spasm , Approved
17941,D0KD5P,Nefiracetam,Alzheimer disease , Phase 2
17942,D0KD5X,Pyrazole derivative 31,Obesity , Patented
17943,D0KD7E,XEL-003FP,Onychomycosis , Investigative
17944,D0KD9F,Equilin,Coronavirus Disease 2019 (COVID-19) , Investigative
17945,D0KE0C,STP-805,Spinal cord injury , Investigative
17946,D0KE1F,DFP-10917,Acute myeloid leukaemia , Phase 3
17947,D0KE1F,DFP-10917,Solid tumour/cancer , Phase 2
17948,D0KE1F,DFP-10917,Acute lymphoblastic leukaemia , Phase 1/2
17949,D0KE1V,SDZ-249482,Pain , Terminated
17950,D0KE4C,HG-1071,Solid tumour/cancer , Investigative
17951,D0KE4Q,DFD-29,Rosacea , Phase 2
17952,D0KE4Z,ARL-67085,Thrombosis , Phase 1
17953,D0KE7K,URG-302,Overactive bladder , Preclinical
17954,D0KE8Q,PMID26651364-Compound-46,Crohn disease , Patented
17955,D0KE8Q,PMID26651364-Compound-46,Ulcerative colitis , Patented
17956,D0KE8Q,PMID26651364-Compound-46,Urinary tract infection , Patented
17957,D0KE9G,hESC-derived oligodendrocyte progenitors (AST-OPC1),Spinal cord injury , Phase 1/2
17958,D0KF3A,PMID25666693-Compound-98,Osteoarthritis pain , Patented
17959,D0KF3A,PMID25666693-Compound-98,Cancer related pain , Patented
17960,D0KF3A,PMID25666693-Compound-98,Neuropathic pain , Patented
17961,D0KF3A,PMID25666693-Compound-98,Inflammatory pain , Patented
17962,D0KF3O,CardioPET,Coronary artery disease , Phase 2
17963,D0KF6X,MLN3897,Rheumatoid arthritis , Discontinued in Phase 2
17964,D0KF9Q,Rigosertib,Solid tumour/cancer , Phase 3
17965,D0KF9Q,Rigosertib,Myelodysplastic syndrome , Phase 3
17966,D0KF9T,Anti-CD19 CAR-T,Haematopoietic/lymphoid cancer , Phase 1/2
17967,D0KG1U,BXCL702,Haematological malignancy , Phase 1
17968,D0KG3R,Rivaroxaban,Deep vein thrombosis , Approved
17969,D0KG3Y,Imatinib,Chronic myeloid leukaemia , Approved
17970,D0KG3Y,Imatinib,Coronavirus Disease 2019 (COVID-19) , Phase 3
17971,D0KG3Y,Imatinib,Severe acute respiratory syndrome (SARS) , Investigative
17972,D0KG3Y,Imatinib,Middle East Respiratory Syndrome (MERS) , Investigative
17973,D0KG4B,Cefbuperazone sodium,Bacterial infection , Approved
17974,D0KG4Q,Cemiplimab,Cutaneous squamous cell carcinoma , Approved
17975,D0KG5D,Mapatumumab,Non-small-cell lung cancer , Phase 2
17976,D0KG5U,PMID26651364-Compound-9b,Crohn disease , Patented
17977,D0KG5U,PMID26651364-Compound-9b,Ulcerative colitis , Patented
17978,D0KG5U,PMID26651364-Compound-9b,Urinary tract infection , Patented
17979,D0KG9M,PMID27998201-Compound-22,Neurodegenerative disorder , Patented
17980,D0KG9M,PMID27998201-Compound-22,Pancreatitis , Patented
17981,D0KG9M,PMID27998201-Compound-22,Alzheimer disease , Patented
17982,D0KG9M,PMID27998201-Compound-22,Osteoarthritis , Patented
17983,D0KH8Q,Ruxolitinib,Myelofibrosis , Approved
17984,D0KH8Q,Ruxolitinib,Coronavirus Disease 2019 (COVID-19) , Phase 3
17985,D0KI3U,NXB-5886,Bacterial infection , Investigative
17986,D0KI5R,Dabigatran etexilate,Venous thromboembolism , Phase 3
17987,D0KI9N,Antimicrobial LL-37 cathelicidin,Infectious disease , Investigative
17988,D0KJ0U,AZD-7928,Chronic obstructive pulmonary disease , Preclinical
17989,D0KJ2J,BAY 1082439,Solid tumour/cancer , Phase 1
17990,D0KJ4S,ADS-4101,Epilepsy , Phase 1
17991,D0KJ4U,ACEA-1011,Cerebral infarction , Terminated
17992,D0KK1I,MVA E2 vaccine,Solid tumour/cancer , Phase 2
17993,D0KK2E,Eribulin,Breast cancer , Approved
17994,D0KK4N,ISA-P53-01,Colorectal cancer , Phase 1/2
17995,D0KK4U,CB-1267,Prostate cancer , Terminated
17996,D0KK9D,CA-011,Chronic pain , Phase 1
17997,D0KK9E,Exherin,Solid tumour/cancer , Phase 2
17998,D0KK9V,GI-4000 + gemcitabine,Pancreatic cancer , Phase 2
17999,D0KL3K,YM-440,Type-1 diabetes , Discontinued in Phase 2
18000,D0KL3U,AR9281,Hypertension , Phase 2
18001,D0KL4E,SAR422459,Stargardt disease , Phase 1/2
18002,D0KL4J,Rabeprazole,Bacterial infection , Approved
18003,D0KL4T,Ensitiximab,Pancreatic cancer , Phase 2
18004,D0KL5U,SYM-008,Infectious disease , Investigative
18005,D0KL7C,Aviptadil,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
18006,D0KL7C,Aviptadil,Acute lung injury , Investigative
18007,D0KL7G,MCL-1-specific antisense oligonucleotide + midostaurin(PKC412),Systemic mastocytosis , Investigative
18008,D0KL9X,"Krypton, Kr-81m",Asthma , Approved
18009,D0KM0W,PMID25666693-Compound-137,Osteoarthritis pain , Patented
18010,D0KM0W,PMID25666693-Compound-137,Cancer related pain , Patented
18011,D0KM0W,PMID25666693-Compound-137,Neuropathic pain , Patented
18012,D0KM0W,PMID25666693-Compound-137,Inflammatory pain , Patented
18013,D0KM1B,Follicle stimulating hormone,Infertility , Phase 2
18014,D0KM1F,PT-00114,Anxiety disorder , Investigative
18015,D0KM3P,NOStentin,Artery stenosis , Discontinued in Phase 1
18016,D0KM4T,UAI-101,Diabetic complication , Investigative
18017,D0KM7O,Otamixaban,Coronavirus Disease 2019 (COVID-19) , Preclinical
18018,D0KN0I,Valetizumab,Multiple sclerosis , Phase 2
18019,D0KN1U,Myo-inositol hexaphosphate,Cardiovascular disease , Phase 2/3
18020,D0KN1U,Myo-inositol hexaphosphate,Gastroesophageal reflux disease , Investigative
18021,D0KN2C,Insulin long-acting iv,Type-2 diabetes , Phase 3
18022,D0KN2M,Cynarin,Vibrio cholerae infection , Approved
18023,D0KN5B,CYT107,Human immunodeficiency virus infection , Phase 2
18024,D0KN7H,Mitoflaxone,Solid tumour/cancer , Terminated
18025,D0KN7T,Thiazole carboxamide derivative 22,Solid tumour/cancer , Patented
18026,D0KN7T,Thiazole carboxamide derivative 22,Metastatic cancer , Patented
18027,D0KN7Y,NPT088,Alzheimer disease , Phase 1
18028,D0KN7Y,NPT088,Psychotic disorder , Phase 1
18029,D0KP0L,SE-ET-TP020d,Thrombocytopenia , Investigative
18030,D0KP0W,Valproic Acid,Coronavirus Disease 2019 (COVID-19) , Investigative
18031,D0KP2R,ID-12,Hepatitis C virus infection , Investigative
18032,D0KP9A,Anti-PD-L1,Solid tumour/cancer , Phase 1
18033,D0KP9A,Anti-PD-L1,Human immunodeficiency virus-1 infection , Phase 1
18034,D0KQ0C,Danegaptide,Atrial fibrillation , Phase 2
18035,D0KQ2D,RVX-297,Multiple sclerosis , Investigative
18036,D0KQ7M,ARQ 531,Hematologic tumour , Phase 2
18037,D0KQ8H,PMID21925774-compound-5e,Severe acute respiratory syndrome (SARS) , Preclinical
18038,D0KQ8W,SurVaxM,Glioblastoma of brain , Phase 2
18039,D0KQ8W,SurVaxM,Multiple myeloma , Phase 1
18040,D0KQ8X,Entresto,Acute myocardial infarction , Phase 3
18041,D0KQ8X,Entresto,Heart failure , Phase 3
18042,D0KR1N,PPI-2458,Autoimmune diabetes , Phase 1
18043,D0KR2J,Entecavir,Hepatitis B virus infection , Approved
18044,D0KR3X,CGS-30440,Hypertension , Terminated
18045,D0KR5B,Hydrocortisone,Inflammation , Approved
18046,D0KR5B,Hydrocortisone,Congenital adrenal hyperplasia , Phase 2
18047,D0KR5K,Capravirine,Human immunodeficiency virus infection , Phase 1
18048,D0KR6E,SER-207,Solid tumour/cancer , Investigative
18049,D0KR9E,PMID26815044-Compound-122,Albinism , Patented
18050,D0KR9E,PMID26815044-Compound-122,Ephelides , Patented
18051,D0KR9E,PMID26815044-Compound-122,Menkes disease , Patented
18052,D0KR9E,PMID26815044-Compound-122,Senile lentigines , Patented
18053,D0KR9E,PMID26815044-Compound-122,Melasma , Patented
18054,D0KR9U,Picrotoxin,Respiratory distress syndrome , Approved
18055,D0KS0I,WAY-256805,Pain , Investigative
18056,D0KS6F,IRX-2,Head and neck cancer , Phase 2
18057,D0KS6F,IRX-2,Acute myeloid leukaemia , Phase 2
18058,D0KS6F,IRX-2,Squamous cell carcinoma , Phase 2
18059,D0KS6F,IRX-2,Breast cancer , Phase 1
18060,D0KS6F,IRX-2,leukaemia , Investigative
18061,D0KS6W,Phenyltoloxamine,Allergy , Approved
18062,D0KT1Q,Pyrazole derivative 11,Obesity , Patented
18063,D0KT3X,Thrombin/fibrinogen matrix patch,Bleeding disorder , Approved
18064,D0KT4B,CLP-1002,Congestive heart failure , Investigative
18065,D0KT8D,AC0058TA,Autoimmune disease , Phase 1
18066,D0KT8U,Semotiadil,Hypertension , Discontinued in Preregistration
18067,D0KU4M,MB07803,Type-2 diabetes , Phase 2
18068,D0KU5J,Resorcinol compound 5,Albinism , Patented
18069,D0KU5J,Resorcinol compound 5,Ephelides , Patented
18070,D0KU5J,Resorcinol compound 5,Menkes disease , Patented
18071,D0KU5J,Resorcinol compound 5,Senile lentigines , Patented
18072,D0KU5J,Resorcinol compound 5,Melasma , Patented
18073,D0KV1I,GC-1113,Anemia , Phase 1
18074,D0KV1Q,Trafermin,Periodontitis , Phase 3
18075,D0KV1Z,ImmunoVEX HSV2,Herpes simplex virus infection , Phase 1
18076,D0KV2E,Sonepcizumab,Macular degeneration , Phase 1
18077,D0KV3M,Varlilumab,Colorectal cancer , Phase 2
18078,D0KV3M,Varlilumab,Head and neck cancer , Phase 2
18079,D0KV3M,Varlilumab,Ovarian cancer , Phase 2
18080,D0KV3M,Varlilumab,Recurrent glioblastoma , Phase 2
18081,D0KV3M,Varlilumab,Renal cell carcinoma , Phase 2
18082,D0KV4Z,CI-949,Asthma , Discontinued in Phase 2
18083,D0KV6C,RG3039,Spinal muscular atrophy , Phase 1
18084,D0KW2A,BN50739,Cerebral infarction , Terminated
18085,D0KW2M,Relacatib,Coronavirus Disease 2019 (COVID-19) , Investigative
18086,D0KW3Z,GORALATIDE,Constitutional neutropenia , Phase 2
18087,D0KW8U,PTS-508a,Inflammation , Investigative
18088,D0KW9T,RSIFN-co,Solid tumour/cancer , Phase 1
18089,D0KX1A,Aryl mannoside derivative 6,Crohn disease , Patented
18090,D0KX1A,Aryl mannoside derivative 6,Ulcerative colitis , Patented
18091,D0KX1A,Aryl mannoside derivative 6,Urinary tract infection , Patented
18092,D0KX1E,CEP-2563,Solid tumour/cancer , Discontinued in Phase 1
18093,D0KX1Y,Erenumab,Hyperprolactinaemia , Approved
18094,D0KX2W,"1,2,4,5-tetra-substituted imidazole derivative 1",Obesity , Patented
18095,D0KX3A,PF-4194471,Human immunodeficiency virus infection , Terminated
18096,D0KX6E,DI-Leu16-IL2,Non-hodgkin lymphoma , Phase 2
18097,D0KX6E,DI-Leu16-IL2,B-cell lymphoma , Phase 1/2
18098,D0KX7A,CR-4174,Inflammation , Investigative
18099,D0KX7I,Ensartinib,Non-small-cell lung cancer , Phase 3
18100,D0KX8B,GNE Lipoplex,Myopathy , Phase 1
18101,D0KX8N,Diaryl morpholine derivative 1,Obesity , Patented
18102,D0KX9B,EP-101,Chronic obstructive pulmonary disease , Phase 2
18103,D0KX9B,EP-101,Breast cancer , Phase 1
18104,D0KX9Z,S-12363,Solid tumour/cancer , Discontinued in Phase 2
18105,D0KY3W,INO-4800 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
18106,D0KY4O,ASF-1075,Psoriatic disorder , Discontinued in Phase 2
18107,D0KY7S,ISIS-FXI,Coagulation defect , Phase 2
18108,D0KZ0V,CD19 CAR T Cells,Acute lymphocytic leukaemia , Phase 1
18109,D0KZ0V,CD19 CAR T Cells,Chronic lymphocytic leukaemia , Phase 1
18110,D0KZ0V,CD19 CAR T Cells,Non-hodgkin lymphoma , Phase 1
18111,D0KZ3Q,Omnitram,Chronic pain , Phase 2
18112,D0L0AU,DMPDDF,Solid tumour/cancer , Terminated
18113,D0L0BX,ICARITIN,Breast cancer , Phase 2
18114,D0L0CL,CP-471358,Solid tumour/cancer , Terminated
18115,D0L0CV,Diamine derivative 2,Albinism , Patented
18116,D0L0CV,Diamine derivative 2,Ephelides , Patented
18117,D0L0CV,Diamine derivative 2,Menkes disease , Patented
18118,D0L0CV,Diamine derivative 2,Senile lentigines , Patented
18119,D0L0CV,Diamine derivative 2,Melasma , Patented
18120,D0L0DA,PRX003,Psoriasis vulgaris , Phase 1
18121,D0L0DO,ETR-002,Diabetic complication , Investigative
18122,D0L0DZ,XL-041,Arteriosclerosis , Phase 1
18123,D0L0GM,Vilanterol,Chronic obstructive pulmonary disease , Approved
18124,D0L0HV,VX-916,Hepatitis C virus infection , Phase 1
18125,D0L0JM,Igiv-hb,Hepatitis B virus infection , Approved
18126,D0L0KI,NB-401,Respiratory tract infection , Investigative
18127,D0L0LR,UCL-67022,Multiple myeloma , Investigative
18128,D0L0MB,Acetophenazine,Bipolar disorder , Approved
18129,D0L0MK,Pachycarpine,Postpartum haemorrhage , Approved
18130,D0L0MO,Satigrel,Thrombosis , Discontinued in Preregistration
18131,D0L0NE,DPC-A78277,Human immunodeficiency virus infection , Terminated
18132,D0L0OU,CLT-005,Angiogenesis disorder , Investigative
18133,D0L0RO,AE37 peptide vaccine,Breast cancer , Phase 2
18134,D0L0RX,ABX-101,Solid tumour/cancer , Investigative
18135,D0L0SI,Galectin 2,Inflammatory bowel disease , Investigative
18136,D0L0SW,Bentiromide,Pancreatic cancer , Approved
18137,D0L0UF,MEN-11467,Respiratory tract inflammation , Terminated
18138,D0L0VV,GUT-70,Solid tumour/cancer , Investigative
18139,D0L0XV,NP-05,Osteoporosis , Investigative
18140,D0L0ZC,GSK1059615,Lymphoma , Discontinued in Phase 1
18141,D0L0ZC,GSK1059615,Endometrial cancer , Discontinued in Phase 1
18142,D0L0ZC,GSK1059615,Breast cancer , Discontinued in Phase 1
18143,D0L0ZF,VESNARINONE,Cardiac failure , Approved
18144,D0L1BS,PF-454583,Major depressive disorder , Investigative
18145,D0L1CO,MAGE-A10 TCR,Bladder cancer , Phase 1/2
18146,D0L1CO,MAGE-A10 TCR,Head and neck cancer , Phase 1/2
18147,D0L1CO,MAGE-A10 TCR,Melanoma , Phase 1/2
18148,D0L1CO,MAGE-A10 TCR,Merkel cell carcinoma , Phase 1/2
18149,D0L1DP,ABT-089,Dementia , Discontinued in Phase 2
18150,D0L1DP,ABT-089,Anxiety disorder , Discontinued in Phase 2
18151,D0L1DP,ABT-089,Schizophrenia , Discontinued in Phase 2
18152,D0L1DP,ABT-089,Attention deficit hyperactivity disorder , Discontinued in Phase 2
18153,D0L1DR,Recombinant human iduronate-2-sulfatase,Hunter syndrome , Phase 3
18154,D0L1DU,HIF-1 alpha gene therapy,Occlusive arterial disease , Discontinued in Phase 2
18155,D0L1EX,M2del11 HAavir H5N1,Influenza virus infection , Investigative
18156,D0L1FN,Emfilermin,Infertility , Phase 1/2
18157,D0L1GD,MK-8353,Solid tumour/cancer , Phase 1
18158,D0L1HK,TCN-032,Influenza virus infection , Phase 2
18159,D0L1IH,A-79175,Asthma , Terminated
18160,D0L1JE,CJC-1131,Type-1 diabetes , Discontinued in Phase 2
18161,D0L1JW,Hydrastine,Haemostatic astringent , Approved
18162,D0L1KX,CR-665,Pain , Phase 2
18163,D0L1LJ,Bervastatin,Thrombosis , Discontinued in Phase 2
18164,D0L1LV,TGFK07AD,Major depressive disorder , Phase 3
18165,D0L1NF,D-420720,Diabetic complication , Investigative
18166,D0L1NU,PHA-666859,Diabetic retinopathy , Investigative
18167,D0L1OC,Anti-LT alpha,Rheumatoid arthritis , Phase 2
18168,D0L1OF,HE-33,Graft-versus-host disease , Investigative
18169,D0L1OT,TroVax,Prostate cancer , Phase 3
18170,D0L1OY,ALCURONIUM,Anaesthesia , Approved
18171,D0L1PH,CB-5300,Hepatitis C virus infection , Phase 2
18172,D0L1PO,Alkyl mannoside derivative 4,Crohn disease , Patented
18173,D0L1PO,Alkyl mannoside derivative 4,Ulcerative colitis , Patented
18174,D0L1PO,Alkyl mannoside derivative 4,Urinary tract infection , Patented
18175,D0L1PP,PMID27998201-Compound-13,Hepatic fibrosis , Patented
18176,D0L1PW,R112,Allergic rhinitis , Investigative
18177,D0L1QF,Corifollitropin alfa,Infertility , Approved
18178,D0L1SV,Cyclohexyl carbamate derivative 4,Albinism , Patented
18179,D0L1SV,Cyclohexyl carbamate derivative 4,Ephelides , Patented
18180,D0L1SV,Cyclohexyl carbamate derivative 4,Menkes disease , Patented
18181,D0L1SV,Cyclohexyl carbamate derivative 4,Senile lentigines , Patented
18182,D0L1SV,Cyclohexyl carbamate derivative 4,Melasma , Patented
18183,D0L1TB,NPS-4,Dermatitis , Investigative
18184,D0L1UH,ASP-0777,Alzheimer disease , Phase 1
18185,D0L1VF,PH-10,Psoriasis vulgaris , Phase 2
18186,D0L1VI,AQ-13,Malaria , Phase 2
18187,D0L1VP,NX-CP105,Cerebrovascular ischaemia , Phase 1
18188,D0L1VR,ALT-946,Diabetic complication , Terminated
18189,D0L1VT,Cyprodine,Parkinson disease , Investigative
18190,D0L1WV,Kawain,Cardiovascular disease , Approved
18191,D0L1YM,McN3377,Fragile X syndrome , Phase 1/2
18192,D0L1YR,Ara-LAMP-vax,Allergy , Investigative
18193,D0L1YS,NE-033,Psychotic disorder , Terminated
18194,D0L1ZK,MDCO-216,Arteriosclerosis , Phase 1
18195,D0L1ZK,MDCO-216,Acute coronary syndrome , Preclinical
18196,D0L1ZM,HF-0299,Pain , Phase 1
18197,D0L2BC,MEDI-534,Respiratory syncytial virus infection , Phase 2
18198,D0L2BH,S-34109,Staphylococcus infection , Terminated
18199,D0L2BT,DMARDs,Rheumatoid arthritis , Investigative
18200,D0L2CI,Insulin degludec,Type-1/2 diabetes , Approved
18201,D0L2CN,Fibroblast growth factor-18,Cartilage lesions , Phase 2
18202,D0L2FR,KU-135,Solid tumour/cancer , Investigative
18203,D0L2GX,RG7342,Schizophrenia , Phase 1
18204,D0L2IQ,Fasidotril,Hypotension , Discontinued in Phase 2
18205,D0L2JE,XmAb13676,B-cell lymphoma , Phase 1
18206,D0L2JE,XmAb13676,Non-hodgkin lymphoma , Phase 1
18207,D0L2JM,Levomequitazine,Seasonal allergic rhinitis , Phase 3
18208,D0L2KL,DNA/MVA HIV vaccine,Human immunodeficiency virus infection , Phase 1
18209,D0L2LG,WC-3018,Acne vulgaris , Phase 2
18210,D0L2LS,Fluoxymesterone,Breast cancer , Approved
18211,D0L2MA,"Pyrazolo[1,5-a]pyrimidine derivative 12",Obesity , Patented
18212,D0L2MX,Benzthiazide,High blood pressure , Approved
18213,D0L2NV,U-89854,Anxiety disorder , Investigative
18214,D0L2OS,REG-3,Thrombosis , Investigative
18215,D0L2OT,Lipovaxin-MM,Melanoma , Phase 1
18216,D0L2PV,MOR-105,Inflammation , Investigative
18217,D0L2QC,OPT-88,Osteoarthritis , Terminated
18218,D0L2QJ,UC-84,Human immunodeficiency virus infection , Terminated
18219,D0L2QZ,Biphenyl mannoside derivative 27,Crohn disease , Patented
18220,D0L2QZ,Biphenyl mannoside derivative 27,Ulcerative colitis , Patented
18221,D0L2QZ,Biphenyl mannoside derivative 27,Urinary tract infection , Patented
18222,D0L2RV,PF-4325667,Diabetic complication , Discontinued in Phase 1
18223,D0L2TT,DasKloster 0028-01,Pulmonary fibrosis , Investigative
18224,D0L2UN,Auranofin,Inflammatory arthritis , Approved
18225,D0L2UQ,Pracinostat,Acute myeloid leukaemia , Phase 3
18226,D0L2UQ,Pracinostat,Myelofibrosis , Phase 2
18227,D0L2UQ,Pracinostat,Myelodysplastic syndrome , Phase 2
18228,D0L2VB,FE-203799,Gastrointestinal disease , Investigative
18229,D0L2VT,PV-10,Melanoma , Phase 3
18230,D0L2VT,PV-10,Cutaneous melanoma , Phase 3
18231,D0L2VT,PV-10,Hepatocellular carcinoma , Phase 1
18232,D0L2VT,PV-10,Metastatic liver cancer , Phase 1
18233,D0L2VT,PV-10,Neuroendocrine cancer , Phase 1
18234,D0L2VV,Typhim Vi,Salmonella infection , Approved
18235,D0L2WJ,Ryzodeg,Type-1/2 diabetes , Approved
18236,D0L2WK,CAM2043,Pulmonary arterial hypertension , Phase 1/2
18237,D0L2WW,RGel-Adnectin,Solid tumour/cancer , Investigative
18238,D0L2XO,BAY11-7082,Multiple myeloma , Investigative
18239,D0L2XU,Solulin,Thrombosis , Phase 1
18240,D0L2YF,Pc4,Psoriasis vulgaris , Phase 1
18241,D0L2YR,DT-1687,Parkinson disease , Phase 2
18242,D0L2YR,DT-1687,Neurological disorder , Investigative
18243,D0L2ZY,X-82,Age-related macular degeneration , Phase 2
18244,D0L2ZY,X-82,Macular degeneration , Phase 1
18245,D0L2ZY,X-82,Solid tumour/cancer , Phase 1
18246,D0L3CQ,Dexpirronium,Chronic obstructive pulmonary disease , Phase 1
18247,D0L3DC,HMR-1031,Arthritis , Phase 1
18248,D0L3DK,Vildagliptin,Type-2 diabetes , Approved
18249,D0L3EO,Cinitapride,Functional dyspepsia , Phase 3
18250,D0L3EW,ICI-D-6888,Hypertension , Discontinued in Phase 1
18251,D0L3GG,GEM-132,Cytomegalovirus retinitis , Terminated
18252,D0L3GH,CTCE-0324,Peripheral vascular disease , Investigative
18253,D0L3HG,I-432,Coronavirus Disease 2019 (COVID-19) , Investigative
18254,D0L3HU,BAY 86-5044,Breast cancer , Phase 2
18255,D0L3IL,ASM8,Allergic asthma , Phase 2
18256,D0L3JI,NGD 94-1,Schizophrenia , Phase 1
18257,D0L3JL,Aryl mannoside derivative 8,Crohn disease , Patented
18258,D0L3JL,Aryl mannoside derivative 8,Ulcerative colitis , Patented
18259,D0L3JL,Aryl mannoside derivative 8,Urinary tract infection , Patented
18260,D0L3KA,BP-100-1-01,Myelodysplastic syndrome , Phase 2
18261,D0L3KA,BP-100-1-01,Hematologic tumour , Phase 2
18262,D0L3KA,BP-100-1-01,Chronic myelogenous leukaemia , Phase 2
18263,D0L3KA,BP-100-1-01,Acute myeloid leukaemia , Phase 2
18264,D0L3KA,BP-100-1-01,Acute lymphoblastic leukaemia , Phase 2
18265,D0L3KN,NeurArrest,Multiple sclerosis , Investigative
18266,D0L3LO,ET-006,Ovarian cancer , Investigative
18267,D0L3MP,VRX496,Acquired immune deficiency syndrome , Approved
18268,D0L3MP,VRX496,Coronavirus infection , Approved
18269,D0L3MZ,Heptazyme,Hepatitis C virus infection , Discontinued in Phase 2
18270,D0L3OE,SRSS-021,Vomiting , Terminated
18271,D0L3RO,TAS-119,Solid tumour/cancer , Phase 1
18272,D0L3RZ,SBC-103,Mucopolysaccharidosis , Phase 1/2
18273,D0L3SP,MVA-BN Filo,Ebola virus infection , Phase 3
18274,D0L3TR,Estetrol,Autoimmune diabetes , Phase 2
18275,D0L3UI,Rabies VRVg,Rabies , Phase 3
18276,D0L3VA,QAN-747,Chronic obstructive pulmonary disease , Discontinued in Phase 1
18277,D0L3VC,DG-8,Osteosarcoma , Investigative
18278,D0L3VT,Myoblast cell transplantation therapy,Congestive heart failure , Phase 1
18279,D0L3VU,Pumactant,Asthma , Phase 3
18280,D0L3VY,Karomab,Solid tumour/cancer , Investigative
18281,D0L3WJ,IRT-103,Human immunodeficiency virus infection , Approved
18282,D0L3XE,Short ragweed pollen extracts,Allergy , Phase 2
18283,D0L3XV,SMART anti-E/P selectin,Asthma , Discontinued in Phase 1
18284,D0L3YX,T-62,Neuropathic pain , Discontinued in Phase 1
18285,D0L4AL,NTx-265,Stroke , Phase 2
18286,D0L4BR,HuCD40L,Solid tumour/cancer , Terminated
18287,D0L4BU,Sanaria PfSPZ Vaccine,Malaria , Phase 1
18288,D0L4CN,MTIG7192A,Solid tumour/cancer , Phase 1
18289,D0L4CW,Growth hormone releasing factor peptides,Growth hormone deficiency , Investigative
18290,D0L4EG,Mentat,Cognitive impairment , Approved
18291,D0L4ET,Hepatect CP,Hepatitis B virus infection , Approved
18292,D0L4FS,Genistein,Menopause symptom , Phase 2/3
18293,D0L4FS,Genistein,Prostate cancer , Phase 2
18294,D0L4GF,AG-3296,Solid tumour/cancer , Terminated
18295,D0L4GH,HBN-3,Sepsis , Investigative
18296,D0L4GX,JTT-252,Type-2 diabetes , Phase 1
18297,D0L4HK,TVX-002,Influenza virus infection , Investigative
18298,D0L4HL,RG7314,Autism spectrum disorder , Phase 2
18299,D0L4HY,Guanabenz,High blood pressure , Approved
18300,D0L4JT,Sulfanilamide,Bacterial infection , Approved
18301,D0L4LX,Atorvastatin/ ezetimibe,Hypercholesterolaemia , Phase 3
18302,D0L4PM,AVE-3247,Thrombosis , Discontinued in Phase 1
18303,D0L4PY,KB-5492,Peptic ulcer , Discontinued in Phase 2
18304,D0L4SB,Oncolysin CD6,Arthritis , Discontinued in Phase 1
18305,D0L4SD,Alpha-acetyldigoxin,Cardiovascular disease , Approved
18306,D0L4SL,TA-270,Asthma , Phase 2
18307,D0L4UN,HIV-IG,Human immunodeficiency virus infection , Discontinued in Phase 3
18308,D0L4US,BMS-770767,Hypercholesterolaemia , Phase 2
18309,D0L4VD,RG6058,Non-small cell lung cancer , Phase 3
18310,D0L4VI,L-cysteine,Non-small-cell lung cancer , Clinical trial
18311,D0L4VZ,SPP-1148,Hypertension , Discontinued in Phase 1
18312,D0L4WO,SGN-19A,Haematological malignancy , Preclinical
18313,D0L4XW,Nimenrix,Neisseria meningitis infection , Approved
18314,D0L4YD,Solifenacin,Overactive bladder , Approved
18315,D0L4ZK,RG-7351,Major depressive disorder , Phase 1
18316,D0L5AH,CELIKALIM,Hypertension , Phase 2
18317,D0L5AK,TTI-1612,Interstitial cystitis , Investigative
18318,D0L5AP,Gitalin,Cardiovascular disease , Approved
18319,D0L5BK,KW-2149,Solid tumour/cancer , Discontinued in Phase 3
18320,D0L5CZ,Rocuronium,Muscle spasm , Approved
18321,D0L5DK,99mTc-CYT-379,Diagnostic imaging , Phase 1
18322,D0L5DZ,4SC-202,Solid tumour/cancer , Preclinical
18323,D0L5EA,REC-200,Autoimmune diabetes , Investigative
18324,D0L5FB,TAK-329,Diabetic complication , Phase 1
18325,D0L5FY,Metipranolol,Open-angle glaucoma , Approved
18326,D0L5GH,Olcegepant,Migraine , Phase 2
18327,D0L5HM,CD19 CAR T cells,B-cell chronic lymphocytic leukaemia , Phase 2
18328,D0L5HM,CD19 CAR T cells,Diffuse large B-cell lymphoma , Phase 2
18329,D0L5HM,CD19 CAR T cells,Non-hodgkin lymphoma , Phase 2
18330,D0L5IA,PEGylated hyaluronidase (human recombinant),Pancreatic cancer , Phase 1/2
18331,D0L5IL,Betamarc,Cachexia , Phase 2
18332,D0L5JA,ETS-2101,Solid tumour/cancer , Phase 1
18333,D0L5KF,RU-58841,Acne vulgaris , Discontinued in Phase 1
18334,D0L5KK,ROR1R-CAR-T Cell,leukaemia , Phase 1
18335,D0L5KU,Remimazolam,Procedural sedation , Approved
18336,D0L5KU,Remimazolam,Anaesthesia , Phase 3
18337,D0L5MF,PYRAZOLOACRIDINE,Colorectal cancer , Phase 2
18338,D0L5NU,Human Factor XIII,Blood forming organ disorder , Phase 1
18339,D0L5OP,PMID26651364-Compound-6c,Crohn disease , Patented
18340,D0L5OP,PMID26651364-Compound-6c,Ulcerative colitis , Patented
18341,D0L5OP,PMID26651364-Compound-6c,Urinary tract infection , Patented
18342,D0L5PO,Phenyl Aminosalicylate,Pulmonary tuberculosis , Approved
18343,D0L5QT,Pentetate zinc trisodium,Acute radiation syndrome , Approved
18344,D0L5RW,Plerixafor,Non-hodgkin lymphoma , Approved
18345,D0L5UO,Darapladib,Arteriosclerosis , Discontinued in Phase 3
18346,D0L5VS,KF-17837,Parkinson disease , Phase 1
18347,D0L5VX,MNK-1411,Duchenne dystrophy , Phase 2
18348,D0L5WA,SR-46559A,Cognitive impairment , Phase 2
18349,D0L5WD,Ularitide,Heart failure , Phase 3
18350,D0L5WD,Ularitide,Acute heart failure , Phase 3
18351,D0L5WF,Somavaratan,Growth hormone deficiency , Phase 3
18352,D0L5WM,Amiodarone,Tachyarrhythmias , Approved
18353,D0L5XG,PF-4191834,Asthma , Phase 2
18354,D0L5XI,AMG-517,Chronic pain , Discontinued in Phase 1
18355,D0L5YF,ZD-4190,Solid tumour/cancer , Terminated
18356,D0L5YV,Salmeterol,Chronic obstructive pulmonary disease , Approved
18357,D0L5ZH,CC-90006,Psoriasis vulgaris , Phase 1
18358,D0L6AF,AEZS-112,Lymphoma , Phase 1
18359,D0L6BH,NN9068,Type-2 diabetes , Phase 3
18360,D0L6BI,Glucagon rdna,Hormone deficiency , Approved
18361,D0L6BU,CKD-10101,Solid tumour/cancer , Investigative
18362,D0L6DA,Valdecoxib,Osteoarthritis , Approved
18363,D0L6DO,Fosfluconazole,Fungal infection , Approved
18364,D0L6FF,NanoDTPA,Iron overload disease , Investigative
18365,D0L6GO,Emtricitabine + tenofovir ,Coronavirus Disease 2019 (COVID-19) , Investigative
18366,D0L6HF,MDX-1459,Solid tumour/cancer , Investigative
18367,D0L6HU,CAR-T Cells targeting CEA,Pancreatic cancer , Phase 1
18368,D0L6IF,AGT-0031,Neurodegenerative disorder , Investigative
18369,D0L6IJ,HG-1143,Solid tumour/cancer , Investigative
18370,D0L6JE,Insulin-lispro,Diabetic complication , Approved
18371,D0L6JX,CGP-50068,Cognitive impairment , Discontinued in Phase 1
18372,D0L6KC,BILR-355,Human immunodeficiency virus infection , Phase 2
18373,D0L6KK,TF2,Colorectal cancer , Phase 1
18374,D0L6LD,AZD-3199,Asthma , Phase 2
18375,D0L6NW,LY2605541,Type-1/2 diabetes , Phase 3
18376,D0L6OA,BL-1020,Schizophrenia , Phase 2
18377,D0L6OY,GSK-2590066A,Influenza virus infection , Phase 1
18378,D0L6PZ,PT-401,Anemia , Investigative
18379,D0L6QI,Rokitamycin,Bacterial infection , Approved
18380,D0L6RF,BAY1179470,Solid tumour/cancer , Phase 1
18381,D0L6RR,Transplant acceptance inducing cells,Transplant rejection , Phase 1/2
18382,D0L6SS,BPX-101,Prostate cancer , Phase 1
18383,D0L6UZ,"L-374,087",Thrombosis , Terminated
18384,D0L6VH,BF-389,Rheumatoid arthritis , Phase 1
18385,D0L6WT,MD-921,Wound healing , Investigative
18386,D0L6XO,AZD1390,Recurrent glioblastoma , Phase 1
18387,D0L6XQ,RWJ-676070,Congestive heart failure , Phase 1
18388,D0L7AS,NABILONE,Insomnia , Approved
18389,D0L7BV,Gevotroline,Psychotic disorder , Discontinued in Phase 1
18390,D0L7FB,T1-IR,Solid tumour/cancer , Investigative
18391,D0L7FM,Probenecid,Hyperuricaemia , Approved
18392,D0L7FM,Probenecid,Gout , Approved
18393,D0L7JE,OC104-26,Solid tumour/cancer , Terminated
18394,D0L7JR,Lenogastrim,Constitutional neutropenia , Approved
18395,D0L7LC,Romidepsin,Cutaneous T-cell lymphoma , Approved
18396,D0L7LC,Romidepsin,Renal cell carcinoma , Phase 3
18397,D0L7LC,Romidepsin,Peripheral T-cell lymphoma , Phase 3
18398,D0L7LH,Anti-IP10,Ulcerative colitis , Phase 2
18399,D0L7LH,Anti-IP10,Crohn disease , Phase 2
18400,D0L7LT,DCVax-Pancreas,Pancreatic cancer , Phase 1/2
18401,D0L7MA,NP-1998,Diabetic nephropathy , Discontinued in Phase 2
18402,D0L7MK,TR-4,Solid tumour/cancer , Investigative
18403,D0L7MO,F-80002-RR,Solid tumour/cancer , Investigative
18404,D0L7OJ,CAR-T Cells targeting Mesothelin,Pancreatic cancer , Phase 1
18405,D0L7OY,D-7193,Immune System disease , Discontinued in Phase 2
18406,D0L7PG,CKD-406,Anemia , Investigative
18407,D0L7PK,V-0191,Cognitive impairment , Phase 2
18408,D0L7QB,Alfaferone,Hairy cell leukaemia , Approved
18409,D0L7QR,VL-01,Solid tumour/cancer , Investigative
18410,D0L7RJ,DP-109,Neurodegenerative disorder , Investigative
18411,D0L7SY,Delequamine hydrochloride,Male sexual disorder , Discontinued in Phase 3
18412,D0L7TA,MIN-101,Schizophrenia , Phase 3
18413,D0L7TN,GSK3003891A,Respiratory syncytial virus infection , Phase 2
18414,D0L7UQ,Prothionamide,Tuberculosis , Approved
18415,D0L7UT,IMX-MSP3,Malaria , Investigative
18416,D0L7VC,GI-6207,Thyroid cancer , Phase 2
18417,D0L7VL,LIDOFLAZINE,Angina pectoris , Approved
18418,D0L7WS,RX-3117,Bladder cancer , Phase 2
18419,D0L7WS,RX-3117,Pancreatic cancer , Phase 2
18420,D0L7WS,RX-3117,Solid tumour/cancer , Phase 1
18421,D0L7YL,Rhuph20,Reproduction , Approved
18422,D0L7ZX,BAY-17-1998,Asthma , Terminated
18423,D0L8CJ,MV-9411,Keratosis , Discontinued in Phase 2
18424,D0L8EO,Anti-TLR3 mabs,Autoimmune diabetes , Investigative
18425,D0L8EQ,CB-182804,Bacterial infection , Discontinued in Phase 1
18426,D0L8GO,RK-28,Solid tumour/cancer , Discontinued in Phase 2
18427,D0L8HB,MEDI9197,Solid tumour/cancer , Phase 1
18428,D0L8IH,IMA-910,Colorectal cancer , Phase 1/2
18429,D0L8IO,AVN 322,Cognitive impairment , Phase 2
18430,D0L8IO,AVN 322,Alzheimer disease , Phase 1
18431,D0L8KJ,Oglemilast,Asthma , Phase 2
18432,D0L8KK,ALB-137391(a),Irritable bowel syndrome , Investigative
18433,D0L8MO,ME-3407,Duodenal ulcer , Phase 2
18434,D0L8OE,AC3056,Arteriosclerosis , Discontinued in Phase 1
18435,D0L8ON,Rx-101,Radiation syndrome , Investigative
18436,D0L8OP,AVP-21D9,Bacillus anthracis infection , Phase 1
18437,D0L8OZ,EG-013,Fetal growth restriction , Investigative
18438,D0L8PG,SK-126,Inflammation , Investigative
18439,D0L8PH,Biferonex,Multiple sclerosis , Phase 3
18440,D0L8PO,YC-12,Bacterial infection , Investigative
18441,D0L8PZ,ARQ 751,Solid tumour/cancer , Phase 1
18442,D0L8QQ,VELNACRINE,Cognitive impairment , Discontinued in Phase 3
18443,D0L8RD,INT-0003/2005,Nicotine dependence , Phase 1
18444,D0L8RG,CI-986,Rheumatoid arthritis , Terminated
18445,D0L8SP,MTL-004,Solid tumour/cancer , Investigative
18446,D0L8TL,YP-008,Psoriasis vulgaris , Terminated
18447,D0L8TN,BU-4514N,Alzheimer disease , Terminated
18448,D0L8TP,Ektomun,Melanoma , Investigative
18449,D0L8UQ,FKB327,Rheumatoid arthritis , Investigative
18450,D0L8US,PG-11144,Solid tumour/cancer , Investigative
18451,D0L8VA,CSL-112,Arteriosclerosis , Phase 2
18452,D0L8VA,CSL-112,Cardiovascular disease , Phase 2
18453,D0L8WA,AVAC,Atopic dermatitis , Discontinued in Phase 2
18454,D0L8WA,AVAC,Asthma , Discontinued in Phase 2
18455,D0L8YH,AntiHer2-XTEN-Docetaxel,Breast cancer , Investigative
18456,D0L8YY,SR-14136,Pain , Investigative
18457,D0L8ZX,OX-NLA,Allergic rhinitis , Discontinued in Phase 3
18458,D0L9AJ,Seletracetam,Epilepsy , Discontinued in Phase 3
18459,D0L9BV,TDM-621,Bleeding disorder , Phase 1
18460,D0L9BW,JNJ-1136,Obesity , Investigative
18461,D0L9CD,AZD-2115,Chronic obstructive pulmonary disease , Phase 2
18462,D0L9GG,Alprazolam,Anxiety disorder , Approved
18463,D0L9GG,Alprazolam,Epilepsy , Phase 2
18464,D0L9GR,Very low dose (VLD) cyclobenzaprine,Fibromyalgia , Investigative
18465,D0L9HG,Rotavirus vaccine I321,Rotavirus infection (Diarrhoea) , Phase 3
18466,D0L9HX,Voclosporin,Lupus nephritis , Approved
18467,D0L9HX,Voclosporin,Psoriasis vulgaris , Phase 3
18468,D0L9HX,Voclosporin,Kidney disease , Phase 2
18469,D0L9HZ,EP1090,Human immunodeficiency virus-1 infection , Phase 1
18470,D0L9IA,Glufosfamide,Pancreatic cancer , Phase 3
18471,D0L9IA,Glufosfamide,Ovarian cancer , Discontinued in Phase 2
18472,D0L9KH,APD-334,Ulcerative colitis , Phase 3
18473,D0L9KH,APD-334,Autoimmune diabetes , Phase 2
18474,D0L9KH,APD-334,Pyoderma gangrenosum , Phase 2
18475,D0L9MM,Split virion H1N1 influenza vaccine,Influenza virus infection , Approved
18476,D0L9NX,Satavaptan,Acute and chronic heart failure , Phase 3
18477,D0L9PA,X-396,Advanced solid tumour , Phase 1/2
18478,D0L9PL,UC-38,Human immunodeficiency virus infection , Terminated
18479,D0L9PX,F10,Influenza virus infection , Investigative
18480,D0L9PY,CP-66948,Gastric ulcer , Discontinued in Phase 1
18481,D0L9QM,MK-7145,Hypertension , Phase 1
18482,D0L9TD,HIV vaccine,Human immunodeficiency virus infection , Phase 1/2
18483,D0L9TQ,PRD_002214,Coronavirus Disease 2019 (COVID-19) , Investigative
18484,D0L9UU,Gentamicin,Bacterial infection , Approved
18485,D0L9WF,ARH-1,Malaria , Approved
18486,D0L9XF,BBI503,Ovarian cancer , Phase 2
18487,D0L9XF,BBI503,Hepatocellular carcinoma , Phase 2
18488,D0L9XF,BBI503,Cholangiocarcinoma , Phase 2
18489,D0L9XF,BBI503,Solid tumour/cancer , Phase 2
18490,D0L9XL,NPS-2,Solid tumour/cancer , Investigative
18491,D0L9XS,Plasmin,Occlusive disease , Phase 2
18492,D0L9XS,Plasmin,Peripheral arterial disease , Phase 2
18493,D0L9YS,Octopamine,Thrombosis , Discontinued in Phase 2a
18494,D0L9YX,Dihydroxyaluminium,Skin inflammation , Approved
18495,D0L9ZF,OsteoStem,Bone injury , Investigative
18496,D0L9ZK,R-1068,Vomiting , Discontinued in Phase 1
18497,D0L9ZR,Praziquantel,Flatworm infection , Approved
18498,D0LA0Q,PMID25666693-Compound-162,Osteoarthritis pain , Patented
18499,D0LA0Q,PMID25666693-Compound-162,Cancer related pain , Patented
18500,D0LA0Q,PMID25666693-Compound-162,Neuropathic pain , Patented
18501,D0LA0Q,PMID25666693-Compound-162,Inflammatory pain , Patented
18502,D0LA1R,AEB07,Transplant rejection , Phase 2
18503,D0LA2R,Dihydroxyfumaric acid derivative 1,Albinism , Patented
18504,D0LA2R,Dihydroxyfumaric acid derivative 1,Ephelides , Patented
18505,D0LA2R,Dihydroxyfumaric acid derivative 1,Menkes disease , Patented
18506,D0LA2R,Dihydroxyfumaric acid derivative 1,Senile lentigines , Patented
18507,D0LA2R,Dihydroxyfumaric acid derivative 1,Melasma , Patented
18508,D0LA5G,Evernimicin,Bacterial infection , Discontinued in Phase 3
18509,D0LA6Z,Beraprost 314d,Pulmonary arterial hypertension , Phase 3
18510,D0LA9K,REGN4018,Ovarian cancer , Phase 1/2
18511,D0LB0X,KH064,Breast cancer , Clinical trial
18512,D0LB2L,MS201408-0005A,Solid tumour/cancer , Phase 1
18513,D0LB3Z,ABL 001,Chronic myeloid leukaemia , Phase 3
18514,D0LB3Z,ABL 001,Promyelocytic leukaemia , Phase 2
18515,D0LB3Z,ABL 001,leukaemia , Phase 1
18516,D0LB4T,AD-5075,Type-2 diabetes , Terminated
18517,D0LB6D,RG7203,Schizophrenia , Phase 1
18518,D0LB8B,Sialyl Lea-KLH conjugate vaccine,Breast cancer , Phase 1
18519,D0LB8Z,TPIV200,Breast cancer , Phase 2
18520,D0LB8Z,TPIV200,Ovarian cancer , Phase 2
18521,D0LB8Z,TPIV200,Triple negative breast cancer , Phase 2
18522,D0LC0Q,Brincidofovir,Coronavirus Disease 2019 (COVID-19) , Investigative
18523,D0LC2B,NSP-805,Heart failure , Discontinued in Phase 2
18524,D0LC2G,Cyclohexyl carbamate derivative 7,Albinism , Patented
18525,D0LC2G,Cyclohexyl carbamate derivative 7,Ephelides , Patented
18526,D0LC2G,Cyclohexyl carbamate derivative 7,Menkes disease , Patented
18527,D0LC2G,Cyclohexyl carbamate derivative 7,Senile lentigines , Patented
18528,D0LC2G,Cyclohexyl carbamate derivative 7,Melasma , Patented
18529,D0LC3C,ARD-3150,Bronchiectasis , Phase 3
18530,D0LC4L,KI-0806,Insomnia , Approved
18531,D0LC5L,PF-06747143,Acute myeloid leukaemia , Phase 1
18532,D0LC6K,Fluticasone,Allergic rhinitis , Approved
18533,D0LC8F,EDP-15,Myocardial infarction , Investigative
18534,D0LD5B,Ribavirin + lopinavir + ritonavir + interferon alfa-2a,Middle East Respiratory Syndrome (MERS) , Investigative
18535,D0LD8U,TG-3003,Solid tumour/cancer , Investigative
18536,D0LD9P,CST-104,Solid tumour/cancer , Investigative
18537,D0LE3O,CEP-37248,Inflammation , Investigative
18538,D0LE4M,mab-338,Metapneumovirus infection , Investigative
18539,D0LE5N,CTL119,Acute lymphocytic leukaemia , Phase 1
18540,D0LE6F,CC-11050,Cutaneous lupus erythematosus , Phase 2
18541,D0LE6K,BL-Angiostatin,Solid tumour/cancer , Investigative
18542,D0LE7P,SDZ-GLC-756,Glaucoma/ocular hypertension , Discontinued in Phase 1
18543,D0LE8H,Chloromethylpyrrolindolines,Solid tumour/cancer , Investigative
18544,D0LF0O,BMS-695735,Solid tumour/cancer , Preclinical
18545,D0LF1E,AQST-117,Amyotrophic lateral sclerosis , Phase 3
18546,D0LF1U,Flavopiridol,Acute myeloid leukaemia , Phase 2
18547,D0LF1U,Flavopiridol,Chronic lymphocytic leukaemia , Discontinued in Phase 3
18548,D0LF3K,A/Anhui/05,Influenza virus infection , Phase 1
18549,D0LF5B,KN-38-7271,Ischemia , Discontinued in Phase 2
18550,D0LF5Q,ABT-267,Hepatitis C virus infection , Phase 3
18551,D0LF6M,Chimeric Antigen Receptor Modified T cells Targeting CD19,leukaemia , Phase 1/2
18552,D0LF6M,Chimeric Antigen Receptor Modified T cells Targeting CD19,Lymphoma , Phase 1/2
18553,D0LF8Z,Pentasa Sachet,Ulcerative colitis , Phase 3
18554,D0LG1H,NPL-2003,Obsessive compulsive disorder , Phase 2
18555,D0LG1K,TAR-1,Solid tumour/cancer , Terminated
18556,D0LG3Q,PLX-PAD cell therapy,Critical limb ischemia , Phase 3
18557,D0LG3Q,PLX-PAD cell therapy,Peripheral vascular disease , Phase 2
18558,D0LG4V,SR-47063,Cardiac arrhythmias , Discontinued in Phase 1
18559,D0LG6A,Budesonide,Coronavirus Disease 2019 (COVID-19) , Phase 3
18560,D0LG7X,RP6530,Chronic lymphocytic leukaemia , Phase 2
18561,D0LG7X,RP6530,Cutaneous T-cell lymphoma , Phase 1
18562,D0LG8E,Ephedrine,Asthma , Approved
18563,D0LG8T,DS-3201,Acute lymphoblastic leukaemia , Phase 1
18564,D0LG8T,DS-3201,Acute myeloid leukaemia , Phase 1
18565,D0LH4J,Aliskiren/valsartan,Acute coronary syndrome , Phase 2
18566,D0LH4P,CX-1846,Parkinson disease , Investigative
18567,D0LH9E,"Imidazolidine-2,4-dione derivative 2",Obesity , Patented
18568,D0LI1C,NITD609,Malaria , Phase 2
18569,D0LI3A,GS-326,Pancreatic cancer , Investigative
18570,D0LI3H,BMS-633,Hepatitis C virus infection , Investigative
18571,D0LI5N,IONIS-PTP1BRX,Type-2 diabetes , Phase 2
18572,D0LI7L,CC-0101,Solid tumour/cancer , Investigative
18573,D0LI9I,Sinopharms inactivated vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 3
18574,D0LJ0L,Lu-AA47070,Parkinson disease , Discontinued in Phase 1
18575,D0LJ1B,Reparixin,Pancreatic islet transplantation failure , Phase 3
18576,D0LJ1B,Reparixin,Graft rejection in heart transplantation , Phase 2
18577,D0LJ1B,Reparixin,lung transplantation , Phase 2
18578,D0LJ1B,Reparixin,Ischemia-reperfusion injury , Phase 2
18579,D0LJ1Z,CZ-MD001,Diabetic complication , Investigative
18580,D0LJ2S,Anti-NY-ESO-1 CAR-T cells,Esophageal cancer , Phase 1/2
18581,D0LJ2S,Anti-NY-ESO-1 CAR-T cells,Lung cancer , Phase 1/2
18582,D0LJ2S,Anti-NY-ESO-1 CAR-T cells,Multiple myeloma , Phase 1/2
18583,D0LJ2S,Anti-NY-ESO-1 CAR-T cells,Synovial sarcoma , Phase 1/2
18584,D0LJ4E,NIR178,Non-hodgkin lymphoma , Phase 2
18585,D0LJ4E,NIR178,Solid tumour/cancer , Phase 2
18586,D0LJ4J,DB104,Depression , Phase 2
18587,D0LJ5Q,GSK2340274A,Influenza A virus H1N1/H5N1 infection , Phase 4
18588,D0LJ6P,Etanidazole,Solid tumour/cancer , Approved
18589,D0LJ7R,M5,Cerebrovascular ischaemia , Investigative
18590,D0LJ8C,LCZ696,Heart failure , Approved
18591,D0LK4X,Carebastine,Ocular allergy , Phase 3
18592,D0LK8E,PMID28270021-Compound-WO2016054807Example112,Pruritus , Patented
18593,D0LK8E,PMID28270021-Compound-WO2016054807Example112,Solid tumour/cancer , Patented
18594,D0LK8E,PMID28270021-Compound-WO2016054807Example112,Chronic pain , Patented
18595,D0LK8E,PMID28270021-Compound-WO2016054807Example112,Neuropathic pain , Patented
18596,D0LK8E,PMID28270021-Compound-WO2016054807Example112,Thymic cancer , Patented
18597,D0LK8O,Lifarizine,Nerve injury , Discontinued in Phase 2
18598,D0LK8U,CG-1521,Solid tumour/cancer , Investigative
18599,D0LK9L,Adsorbed COVID-19 (inactivated) vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 3
18600,D0LK9N,Fradafiban,Thrombosis , Terminated
18601,D0LL1N,ADCT-301,Hodgkin lymphoma , Phase 2
18602,D0LL1N,ADCT-301,Acute lymphoblastic leukaemia , Phase 1
18603,D0LL1N,ADCT-301,Acute myeloid leukaemia , Phase 1
18604,D0LL1N,ADCT-301,Lymphoma , Phase 1
18605,D0LL4Y,TAK-931,Solid tumour/cancer , Phase 1
18606,D0LL6K,TRX-585,Solid tumour/cancer , Investigative
18607,D0LL7C,3C23K,Solid tumour/cancer , Investigative
18608,D0LL9K,L-771688,Prostate disease , Discontinued in Phase 2
18609,D0LL9W,VBI-1901,Glioblastoma of brain , Phase 1/2
18610,D0LM0X,Ceramide,Solid tumour/cancer , Phase 1/2
18611,D0LM3T,G3139 + Fludarabine,Acute leukaemia , Investigative
18612,D0LM4A,Varenicline,Smoking dependence , Approved
18613,D0LM4U,ATR-01,Adrenocortical carcinoma , Phase 1
18614,D0LM6D,"1,3,4-oxadiazole derivative 1",Solid tumour/cancer , Patented
18615,D0LM6D,"1,3,4-oxadiazole derivative 1",Infectious disease , Patented
18616,D0LM6D,"1,3,4-oxadiazole derivative 1",Human immunodeficiency virus infection , Patented
18617,D0LM6D,"1,3,4-oxadiazole derivative 1",Hepatitis , Patented
18618,D0LM6O,Gam-COVID-Vac vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 3
18619,D0LN1Z,Methylprednisolone,Rheumatoid arthritis , Approved
18620,D0LN1Z,Methylprednisolone,Coronavirus Disease 2019 (COVID-19) , Phase 3
18621,D0LN9P,TELUDIPINE HYDROCHLORIDE,Hypertension , Investigative
18622,D0LO2G,HSRx-888,Alzheimer disease , Phase 2
18623,D0LO3F,NG-348,Solid tumour/cancer , Phase 1
18624,D0LO5B,THZ1,Nasopharyngeal carcinoma , Investigative
18625,D0LO5N,SAR-103168,Acute myeloid leukaemia , Phase 1
18626,D0LP1L,CAR-T cells targeting BCMA,Multiple myeloma , Clinical trial
18627,D0LP2P,Nu-3,Diabetic foot ulcer , Phase 1/2
18628,D0LP4Q,RBPI-21,Bacterial infection , Approved
18629,D0LP4X,Aganirsen,Genitourinary tract cancer , Investigative
18630,D0LP7U,AMV564,Acute myeloid leukaemia , Phase 1
18631,D0LP7W,GSK-2210875,Anxiety disorder , Investigative
18632,D0LQ2Y,2CVV,Cystic fibrosis , Investigative
18633,D0LQ3L,GSK2982772,Plaque psoriasis , Phase 2
18634,D0LQ3L,GSK2982772,Psoriasis vulgaris , Phase 1
18635,D0LQ3L,GSK2982772,Rheumatoid arthritis , Phase 1
18636,D0LQ3L,GSK2982772,Ulcerative colitis , Phase 1
18637,D0LQ7V,HIVAX,Human immunodeficiency virus infection , Phase 1
18638,D0LR0R,Methdilazine,Allergic rhinitis , Approved
18639,D0LR1M,LY-444711,Growth hormone deficiency , Discontinued in Phase 1
18640,D0LR1W,Influenza virus vaccine quadrivalent,Seasonal influenza infection , Phase 3
18641,D0LR1W,Influenza virus vaccine quadrivalent,Influenza virus infection , Phase 3
18642,D0LR1Z,MK-2640,Type-1 diabetes , Phase 1
18643,D0LR2Q,LXR-015-2,Ischemia , Terminated
18644,D0LR4B,Loxoprofen gel,Inflammation , Approved
18645,D0LR4M,ETN-002,Motor neurone disease , Investigative
18646,D0LS3U,KD-332,Bordetella pertussis infection , Phase 2
18647,D0LS4U,Etrabamine,Parkinson disease , Terminated
18648,D0LS6W,KI-0803,Solid tumour/cancer , Investigative
18649,D0LS8H,MTX110,Glioma , Phase 1/2
18650,D0LS9E,Durvalumab,Urothelial carcinoma , Approved
18651,D0LS9E,Durvalumab,Hepatocellular carcinoma , Phase 3
18652,D0LS9E,Durvalumab,Pancreatic ductal carcinoma , Phase 2
18653,D0LS9E,Durvalumab,Solid tumour/cancer , Phase 2
18654,D0LS9E,Durvalumab,Biliary tract cancer , Phase 2
18655,D0LS9E,Durvalumab,Melanoma , Phase 2
18656,D0LS9E,Durvalumab,Diffuse large B-cell lymphoma , Phase 1
18657,D0LT0U,ORG-25935,Psychotic disorder , Phase 2
18658,D0LT2Z,Vaccimel,Melanoma , Phase 1
18659,D0LT4D,NI-1401,Autoimmune diabetes , Investigative
18660,D0LT5Y,Piperazine derivative 5,Atopic dermatitis , Patented
18661,D0LT6Z,PMID25553724-Compound-US2012810604610,Immune System disease , Patented
18662,D0LU1O,FAZ053,Solid tumour/cancer , Phase 1
18663,D0LU1O,FAZ053,Advanced cancer , Phase 1
18664,D0LU4N,EGFRvIII CAR,Glioblastoma multiforme , Phase 1/2
18665,D0LU5Q,TPM-1/Morphine,Pain , Phase 2
18666,D0LU6N,SPD-473,Mood disorder , Discontinued in Phase 2
18667,D0LU7K,"Pyrazolo[1,5-a]pyrimidine derivative 6",Obesity , Patented
18668,D0LV0R,Barixibat,Arteriosclerosis , Terminated
18669,D0LV4B,Gam-COVID-Vac Lyo vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
18670,D0LV7F,NCX-1047,Dermatitis , Investigative
18671,D0LW0T,Savolitinib,Renal cell carcinoma , Phase 3
18672,D0LW0T,Savolitinib,Solid tumour/cancer , Phase 2
18673,D0LW1Y,GFT-505,Non-alcoholic steatohepatitis , Phase 3
18674,D0LW1Y,GFT-505,Type-2 diabetes , Phase 2
18675,D0LW4A,Anti-DR5 cells,Hepatocellular carcinoma , Phase 1/2
18676,D0LW4O,PLEGRIDY,Multiple sclerosis , Approved
18677,D0LW9U,Polidocanol - BioForm Medical/Chemische Fabrik Kreussler & Co,Varicose veins , Approved
18678,D0LX2Y,Aminoazetidine derivative 8,Obesity , Patented
18679,D0LX4K,TDI-0066,Motor neurone disease , Investigative
18680,D0LX8D,AZD6918,Advanced solid tumour , Discontinued in Phase 1
18681,D0LX8Z,OCV-101,Pancreatic cancer , Phase 2
18682,D0LX9H,Tysuberprost,Pulmonary arterial hypertension , Phase 3
18683,D0LY0C,Radiolabelled-huA33,Colorectal cancer , Phase 1
18684,D0LY3A,Azithromycin + hydroxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
18685,D0LZ1W,PMID26651364-Compound-122,Crohn disease , Patented
18686,D0LZ1W,PMID26651364-Compound-122,Ulcerative colitis , Patented
18687,D0LZ1W,PMID26651364-Compound-122,Urinary tract infection , Patented
18688,D0LZ1Z,"Pyrazolo[1,5-a]pyrimidine derivative 7",Obesity , Patented
18689,D0LZ7E,TP-434,Intra-abdominal infection , Approved
18690,D0LZ7E,TP-434,Influenza virus infection , Phase 2
18691,D0LZ7G,ACTR707,Non-hodgkin lymphoma , Phase 1
18692,D0LZ7Z,RG6264,HER2-positive breast cancer , Phase 1
18693,D0M0AA,MenHibrix,Neisseria meningitis infection , Approved
18694,D0M0AM,Glycopyrrolate,Anaesthesia , Approved
18695,D0M0AM,Glycopyrrolate,Chronic obstructive pulmonary disease , Approved
18696,D0M0CO,PCAR-019,Acute lymphocytic leukaemia , Phase 1/2
18697,D0M0CO,PCAR-019,B-cell prolymphocytic leukaemia , Phase 1/2
18698,D0M0CO,PCAR-019,Chronic lymphocytic leukaemia , Phase 1/2
18699,D0M0CO,PCAR-019,Diffuse large B-cell lymphoma , Phase 1/2
18700,D0M0CO,PCAR-019,Follicular lymphoma , Phase 1/2
18701,D0M0CO,PCAR-019,Mantle cell lymphoma , Phase 1/2
18702,D0M0CU,ADE-DERM,Sarcoidosis , Investigative
18703,D0M0FY,Recombinant human hepatocyte growth factor,Renal failure , Phase 1
18704,D0M0GJ,SPV-30,Chronic fatigue syndrome , Terminated
18705,D0M0HJ,S-18986,Alzheimer disease , Discontinued in Phase 2
18706,D0M0JR,NsG-33,Motor neurone disease , Investigative
18707,D0M0KB,MK-6592,Solid tumour/cancer , Discontinued in Phase 1
18708,D0M0KJ,X-081-NAB,Hypereosinophilic syndrome , Investigative
18709,D0M0MX,CIGB-247,Solid tumour/cancer , Investigative
18710,D0M0NF,Tobacco-based vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
18711,D0M0NT,PF-04620110,Type-2 diabetes , Terminated
18712,D0M0OT,Leukemia cancer vaccine,Acute myeloid leukaemia , Phase 2
18713,D0M0PY,DX-890,Acute lung injury , Phase 2
18714,D0M0QX,MK-591,Asthma , Discontinued in Phase 2
18715,D0M0RN,SCH-42495,Hypotension , Discontinued in Phase 2
18716,D0M0SS,FARGLITAZAR,Type-1 diabetes , Phase 3
18717,D0M0SV,PRS-110,Solid tumour/cancer , Investigative
18718,D0M0TV,BIIB059,Systemic lupus erythematosus , Phase 3
18719,D0M0TV,BIIB059,Cutaneous lupus erythematosus , Phase 2
18720,D0M0UB,AZD2184,Alzheimer disease , Phase 1
18721,D0M0UJ,GS-9148,Human immunodeficiency virus infection , Terminated
18722,D0M0UT,Procysteine,Amyotrophic lateral sclerosis , Phase 2
18723,D0M0UU,ZYGK-1,Diabetic complication , Phase 1
18724,D0M0UV,INXC-ICAM1,Transplant rejection , Terminated
18725,D0M0VN,BISNAFIDE MESILATE,Solid tumour/cancer , Discontinued in Phase 2
18726,D0M0WM,ATI-355,Nerve injury , Phase 1
18727,D0M0WV,Fasiglifam hemihydrate,Type-2 diabetes , Phase 3
18728,D0M0WY,KSB-307,Osteoarthritis , Terminated
18729,D0M0XB,Saracatinib,Solid tumour/cancer , Phase 2
18730,D0M0XB,Saracatinib,Hematologic tumour , Phase 2
18731,D0M0XB,Saracatinib,Osteosarcoma , Phase 2
18732,D0M0XU,Ebola/Marburg vaccine,Ebola virus infection , Phase 1
18733,D0M0YB,BAY 11-42524,Left ventricular dysfunction , Phase 2
18734,D0M0YB,BAY 11-42524,Heart failure , Phase 1
18735,D0M0YE,HCV-specific STAR fusions,Hepatitis C virus infection , Investigative
18736,D0M1CZ,Rh-alphaglucosidase,Pompe disease , Approved
18737,D0M1DE,PMA-109R,Solid tumour/cancer , Investigative
18738,D0M1DG,RTL-1000,Multiple sclerosis , Phase 1
18739,D0M1EP,WNV DNA vaccine,Influenza virus infection , Phase 1
18740,D0M1II,HS-25,Hyperbilirubinemia , Phase 2
18741,D0M1IN,acelarin,Biliary tract cancer , Phase 3
18742,D0M1IN,acelarin,Ovarian cancer , Phase 2
18743,D0M1IN,acelarin,Alzheimer disease , Phase 1
18744,D0M1IO,Bacitracin,Skin infection , Approved
18745,D0M1KH,PM-181104,Bacterial infection , Investigative
18746,D0M1KK,PNB-03,Parkinson disease , Investigative
18747,D0M1MB,NESS-200P,Psychotic disorder , Investigative
18748,D0M1MN,AFP TCR,Hepatocellular carcinoma , Phase 1
18749,D0M1MZ,Reviroc,B-cell lymphoma , Phase 2
18750,D0M1NS,CTT-54,Solid tumour/cancer , Investigative
18751,D0M1OU,XEN-907,Pain , Investigative
18752,D0M1OX,COP1-LNP,Hepatocellular carcinoma , Investigative
18753,D0M1PL,Gadoteridol,Brain disease , Approved
18754,D0M1PQ,Mobenakin,Solid tumour/cancer , Approved
18755,D0M1PR,Prevnar,Otitis media , Approved
18756,D0M1RD,ICT-107,Brain cancer , Phase 3
18757,D0M1RD,ICT-107,Recurrent glioblastoma , Phase 3
18758,D0M1RD,ICT-107,Glioblastoma multiforme , Phase 2
18759,D0M1UE,IDD-5,Colorectal cancer , Terminated
18760,D0M1VC,Amdinocillin,Bacterial infection , Approved
18761,D0M1WF,SR-13654,Breast cancer , Investigative
18762,D0M1WN,L-701324,Cerebrovascular ischaemia , Terminated
18763,D0M1WU,AJM-300,Crohn disease , Phase 3
18764,D0M1WU,AJM-300,Ulcerative colitis , Phase 3
18765,D0M1WW,TDENV,Dengue fever , Phase 1/2
18766,D0M1XY,DYB-186,Hypercholesterolaemia , Investigative
18767,D0M1YN,ATI-17000,Irritable bowel syndrome , Preclinical
18768,D0M1YS,32-P BioSilicon,Liver cancer , Phase 2
18769,D0M1YW,ANG-3407,Prostate cancer , Investigative
18770,D0M1ZH,M4112,Solid tumour/cancer , Phase 2
18771,D0M2AN,AD-412,Autoimmune diabetes , Investigative
18772,D0M2BR,Factor 8,Hemophilia , Approved
18773,D0M2DM,BBI-3000,Cutaneous T-cell lymphoma , Phase 1
18774,D0M2DP,REACTA,Solid tumour/cancer , Investigative
18775,D0M2EG,Nasal glucagon,Hypoglycemia , Phase 3
18776,D0M2EH,Non-PEGylated butyrylcholinesterase,Toxicity , Investigative
18777,D0M2FH,Influenza A virus vaccine H1N1,Influenza A virus H1N1 infection , Phase 1
18778,D0M2FH,Influenza A virus vaccine H1N1,Influenza virus infection , Phase 1
18779,D0M2GE,Ad26-COV2-S vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 3
18780,D0M2GI,CI-1002,Alzheimer disease , Terminated
18781,D0M2GQ,ISS-1018,Lymphoma , Phase 3
18782,D0M2IS,Hebergel,Virus infection , Phase 3
18783,D0M2JA,ACP-106,Central nervous system disease , Investigative
18784,D0M2LD,BQCA,Neurological disorder , Investigative
18785,D0M2LI,NNC-0123-0000-0338,Diabetic complication , Phase 2
18786,D0M2MC,Phenmetrazine,Obesity , Approved
18787,D0M2ME,INDUSCA-1,Inflammatory bowel disease , Investigative
18788,D0M2MR,Gliclazide,Diabetic complication , Approved
18789,D0M2OW,Plasmodium falciparum LSA-NRC vaccine,Malaria , Terminated
18790,D0M2QH,Convallatoxin,Cardiovascular disease , Approved
18791,D0M2QR,TOL-3021,leukaemia , Phase 2
18792,D0M2RT,Pyrazole derivative 2,Obesity , Patented
18793,D0M2RZ,EDP-MRSA-1,MRSA infection , Investigative
18794,D0M2SR,R-803,Hepatitis C virus infection , Discontinued in Phase 1/2
18795,D0M2TC,SLC-022,Neuropathic pain , Phase 2
18796,D0M2TG,PYM-50028,Neurological disorder , Phase 2
18797,D0M2TS,Mivebresib,Acute myeloid leukaemia , Phase 1
18798,D0M2TS,Mivebresib,Multiple myeloma , Phase 1
18799,D0M2TS,Mivebresib,Solid tumour/cancer , Phase 1
18800,D0M2UT,NANT squamous cell carcinoma vaccine,Squamous cell carcinoma , Phase 1/2
18801,D0M2WF,Technetium Tc-99m Albumin Microspheres Kit,Radioactive tracer , Approved
18802,D0M2WQ,CAP-7.1,Solid tumour/cancer , Phase 2
18803,D0M2WZ,NS-2710,Anxiety disorder , Phase 2
18804,D0M2XE,Insulin-glulisine,Diabetic complication , Approved
18805,D0M2XK,CIK-CAR.CD19,Acute myeloid leukaemia , Phase 1/2
18806,D0M2YE,Lanreotide acetate,Acromegaly , Approved
18807,D0M2YX,CIGB-228,Human papillomavirus infection , Phase 1
18808,D0M2ZG,PHA-647A,Solid tumour/cancer , Investigative
18809,D0M3AH,TachoComb,Wound healing , Approved
18810,D0M3AR,L-168049,Diabetic complication , Investigative
18811,D0M3BB,Synthetic hypericin,Virus infection , Phase 3
18812,D0M3CV,Solriamfetol,Excessive daytime sleepiness , Approved
18813,D0M3CV,Solriamfetol,Narcolepsy , Phase 3
18814,D0M3FJ,Oxytocin,Autism spectrum disorder , Approved
18815,D0M3FJ,Oxytocin,Lactation failure , Phase 3
18816,D0M3FZ,NOD factors,Solid tumour/cancer , Investigative
18817,D0M3GK,RG7813,Solid tumour/cancer , Phase 1
18818,D0M3GQ,BL-22,Acute lymphoblastic leukaemia , Phase 2
18819,D0M3GW,E-1210,Fungal infection , Investigative
18820,D0M3HV,Nitric oxide synthase gene therapy,Pulmonary arterial hypertension , Phase 1/2
18821,D0M3IE,VVZ-140,Pain , Investigative
18822,D0M3IN,Xanthine,Apnea , Phase 1
18823,D0M3JI,SM-19712,Hypertension , Terminated
18824,D0M3KK,Perfluorochemical emulsion,Myocardial infarction , Approved
18825,D0M3MN,Leucovorin/5-fluorouracil,Colon cancer , Approved
18826,D0M3NF,DZ-13,Solid tumour/cancer , Investigative
18827,D0M3ON,Euro-Celtique 4,Pain , Investigative
18828,D0M3OR,KW-2450,Breast cancer , Discontinued in Phase 1/2
18829,D0M3QP,Digitoxin,Heart failure , Approved
18830,D0M3QP,Digitoxin,Arrhythmia , Approved
18831,D0M3QP,Digitoxin,Congestive cardiac insufficiency , Approved
18832,D0M3QT,VAL-201,Solid tumour/cancer , Phase 1/2
18833,D0M3RI,CART-138 cells,Multiple myeloma , Phase 1/2
18834,D0M3SS,GTU-based DNA vaccine,Human immunodeficiency virus infection , Phase 2
18835,D0M3TD,Org-43902,Infertility , Phase 1
18836,D0M3TM,Prussian blue,Thllium and radioactive isotopes of caesium poisoning , Approved
18837,D0M3TM,Prussian blue,Metal intoxication , Approved
18838,D0M3TZ,Mefloquine,Malaria , Approved
18839,D0M3TZ,Mefloquine,Coronavirus Disease 2019 (COVID-19) , Phase 2
18840,D0M3TZ,Mefloquine,Severe acute respiratory syndrome (SARS) , Preclinical
18841,D0M3TZ,Mefloquine,Middle East Respiratory Syndrome (MERS) , Preclinical
18842,D0M3VU,EQ-318,Hepatitis C virus infection , Investigative
18843,D0M3XE,PF-06826647,Plaque psoriasis , Phase 1
18844,D0M3XR,MK-3102,Type-2 diabetes , Phase 3
18845,D0M3YC,FT-201,Insulin-dependent diabetes , Investigative
18846,D0M3YX,NPC-09,Myopathy , Phase 1
18847,D0M3ZB,CanSino COVID-19 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 3
18848,D0M4AH,GX-19 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
18849,D0M4AV,CO-1686,Lung cancer , Phase 3
18850,D0M4AV,CO-1686,Non-small-cell lung cancer , Phase 3
18851,D0M4BB,Chi Lob 7/4,B-cell lymphoma , Phase 1
18852,D0M4DE,NP-184,Angiogenesis disorder , Investigative
18853,D0M4EQ,PMID26815044-Compound-48,Albinism , Patented
18854,D0M4EQ,PMID26815044-Compound-48,Ephelides , Patented
18855,D0M4EQ,PMID26815044-Compound-48,Menkes disease , Patented
18856,D0M4EQ,PMID26815044-Compound-48,Senile lentigines , Patented
18857,D0M4EQ,PMID26815044-Compound-48,Melasma , Patented
18858,D0M4FO,PA-1093,Multiple sclerosis , Terminated
18859,D0M4GX,Digoxin immune Fab,Eclampsia , Phase 2/3
18860,D0M4HC,L-757464,Prostate hyperplasia , Terminated
18861,D0M4HL,P-7435,Diabetic complication , Phase 1
18862,D0M4HM,MEN-10880,Human immunodeficiency virus-1 infection , Terminated
18863,D0M4JK,UCB-2892,Cognitive impairment , Investigative
18864,D0M4LC,EPTALOPROST,Solid tumour/cancer , Terminated
18865,D0M4LF,AZD-1283,Thrombosis , Terminated
18866,D0M4LW,BIM-23268,Acromegaly , Discontinued in Phase 2
18867,D0M4MG,Resten-NG,Coronary artery disease , Phase 2
18868,D0M4MG,Resten-NG,Solid tumour/cancer , Phase 2
18869,D0M4MH,ATR-107,Crohn disease , Phase 1
18870,D0M4MW,PPI-1301,Hepatitis C virus infection , Investigative
18871,D0M4OC,Venofer,Fatigue , Approved
18872,D0M4OG,SCB-2019 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
18873,D0M4PV,AAV5-hFIXco,Haemophilia B , Phase 1/2
18874,D0M4PY,GTP-0125,Hypertension , Investigative
18875,D0M4QA,SIM-010603,Solid tumour/cancer , Investigative
18876,D0M4RX,RG7685,Type-2 diabetes , Discontinued in Phase 2
18877,D0M4SV,BPI-3006,Hypoglycemia , Investigative
18878,D0M4TF,Canvaxin,Melanoma , Phase 3
18879,D0M4TJ,Ralinepag,Pulmonary hypertension , Phase 2
18880,D0M4TJ,Ralinepag,Pulmonary arterial hypertension , Phase 2
18881,D0M4TN,BCP-1071,Upper respiratory infection , Investigative
18882,D0M4TO,MVA-BN RSV vaccine,Respiratory syncytial virus infection , Phase 2
18883,D0M4UE,Herzyme,Breast cancer , Terminated
18884,D0M4UR,ZyCoV-D vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
18885,D0M4UX,NT-KO-009,Neurodegenerative disorder , Investigative
18886,D0M4UY,MBI-853NL,Staphylococcus infection , Discontinued in Phase 1
18887,D0M4UZ,JNJ-39758979,Asthma , Phase 2
18888,D0M4VM,Sulfacetamide,Acne vulgaris , Approved
18889,D0M4WA,obeticholic acid,Primary biliary cholangitis , Approved
18890,D0M4WA,obeticholic acid,Insomnia , Clinical trial
18891,D0M4WU,Lisocabtagene maraleucel,Large B-cell lymphoma , Approved
18892,D0M4WU,Lisocabtagene maraleucel,Central nervous system lymphoma , Phase 2
18893,D0M4WU,Lisocabtagene maraleucel,Follicular lymphoma , Phase 2
18894,D0M4WU,Lisocabtagene maraleucel,Richter syndrome , Phase 2
18895,D0M4WU,Lisocabtagene maraleucel,Non-hodgkin lymphoma , Phase 2
18896,D0M4WU,Lisocabtagene maraleucel,Precursor B-lymphoblastic neoplasm , Phase 1/2
18897,D0M4WY,PMID25666693-Compound-29,Osteoarthritis pain , Patented
18898,D0M4WY,PMID25666693-Compound-29,Cancer related pain , Patented
18899,D0M4WY,PMID25666693-Compound-29,Neuropathic pain , Patented
18900,D0M4WY,PMID25666693-Compound-29,Inflammatory pain , Patented
18901,D0M4XY,Omacetaxine mepesuccinate,Chronic myeloid leukaemia , Approved
18902,D0M4YC,Disopyramide,Ventricular arrhythmias , Approved
18903,D0M4YC,Disopyramide,Urinary incontinence , Withdrawn from market
18904,D0M4YK,Decorin-like collagen-binding peptidoglycan,Sarcoidosis , Investigative
18905,D0M5BI,Ampion,Bronchiectasis , Phase 3
18906,D0M5BS,ONO-6126,Chronic obstructive pulmonary disease , Phase 2
18907,D0M5CD,Doxorubicin-eluting beads,Liver cancer , Phase 2
18908,D0M5CU,YM-337,Angiogenesis disorder , Discontinued in Phase 2
18909,D0M5CW,CP-741952,Obesity , Phase 2
18910,D0M5DH,CRA1000,Anxiety disorder , Preclinical
18911,D0M5DP,KBP-COVID-19 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
18912,D0M5EN,Trigriluzole,Hereditary spinocerebellar ataxia , Phase 3
18913,D0M5FO,ML323,Solid tumour/cancer , Preclinical
18914,D0M5GX,Priorix,Varicella zoster virus infection , Approved
18915,D0M5GX,Priorix,Measles , Approved
18916,D0M5HV,Montelukast/mometasone,Asthma , Phase 2
18917,D0M5II,CART-19 autologous T-cells,Lymphoma , Phase 1
18918,D0M5JA,Lumiliximab,leukaemia , Phase 2
18919,D0M5JC,BrevaRex,Pancreatic cancer , Phase 1/2
18920,D0M5JI,Luvox,Anxiety disorder , Approved
18921,D0M5KQ,Edurant LA,Human immunodeficiency virus infection , Phase 1
18922,D0M5NK,SDZ-PGU-693,Non-insulin dependent diabetes , Terminated
18923,D0M5OC,Trandolapril,Hypertension , Approved
18924,D0M5OG,Hydroxyethyl starch,Haemorrhage , Approved
18925,D0M5OI,CD40L,Systemic lupus erythematosus , Discontinued in Phase 1
18926,D0M5PD,Recombinant new coronavirus vaccine (CHO cell),Coronavirus Disease 2019 (COVID-19) , Phase 2
18927,D0M5PH,PF-04937319,Type-2 diabetes , Phase 2
18928,D0M5QD,COU-1,Colon cancer , Investigative
18929,D0M5QU,IkT-014,Polyomavirus infection , Investigative
18930,D0M5RF,Gestrinone,Breast cancer , Approved
18931,D0M5UL,"1,5-Benzodiazepines series",Hepatitis C virus infection , Investigative
18932,D0M5VS,Aerugen,Pseudomonas infection , Discontinued in Phase 3
18933,D0M5VV,177Lu-DOTATATE,Hepatitis C virus infection , Phase 2
18934,D0M5WS,JNJ-16269110,Type-2 diabetes , Phase 2
18935,D0M5XE,PP-9706642,Herpes simplex virus infection , Discontinued in Phase 2
18936,D0M5XJ,DCC-3014,Haematological malignancy , Phase 1
18937,D0M5XJ,DCC-3014,Solid tumour/cancer , Phase 1
18938,D0M5XN,BGB-283,Solid tumour/cancer , Phase 1/2
18939,D0M5YS,Cupric Chloride,Fungal infection , Approved
18940,D0M6AR,Mesenchymal stem cell therapy,Ischemic stroke , Phase 2
18941,D0M6AR,Mesenchymal stem cell therapy,Alzheimer disease , Phase 1
18942,D0M6AR,Mesenchymal stem cell therapy,Skin photoaging , Phase 1
18943,D0M6BA,AR-67,Myelodysplastic syndrome , Phase 2
18944,D0M6BA,AR-67,Glioblastoma multiforme , Phase 2
18945,D0M6BD,RO-5126766,Ovarian cancer , Phase 2
18946,D0M6BD,RO-5126766,Non-small cell lung cancer , Phase 2
18947,D0M6BD,RO-5126766,Solid tumour/cancer , Phase 1
18948,D0M6DO,Aminoglutethimide,Cushing disease , Approved
18949,D0M6EG,Bisplatinum complexes,Solid tumour/cancer , Investigative
18950,D0M6ER,Golodirsen,Duchenne dystrophy , Approved
18951,D0M6GC,TRU-015,Lymphoma , Phase 2
18952,D0M6GP,IMC-HIV,Human immunodeficiency virus infection , Investigative
18953,D0M6HE,Simplirix,Genital herpes , Phase 3
18954,D0M6IG,Prostaganin,Prostate cancer , Investigative
18955,D0M6JP,S-14080,Inflammation , Terminated
18956,D0M6LN,L-ornithine L-aspartate,Hepatic encephalopathy , Approved
18957,D0M6OW,ANAVEX 1007,Pancreatic cancer , Preclinical
18958,D0M6OW,ANAVEX 1007,Prostate cancer , Preclinical
18959,D0M6OW,ANAVEX 1007,Melanoma , Preclinical
18960,D0M6PA,BCT-197,Chronic obstructive pulmonary disease , Phase 2
18961,D0M6PB,Pyrrole derivative 1,Obesity , Patented
18962,D0M6QJ,Lopinavir + ritonavir + interferon apha + traditional chinese medicines granules,Coronavirus Disease 2019 (COVID-19) , Phase 1
18963,D0M6SB,Inactivated SARS-CoV-2 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
18964,D0M6TA,LK-157,Bacterial infection , Investigative
18965,D0M6TX,T-109,Pain , Investigative
18966,D0M6VK,Methylscopolamine,Peptic ulcer , Approved
18967,D0M6WW,PMID30107136-Compound-Example11,Solid tumour/cancer , Patented
18968,D0M6WW,PMID30107136-Compound-Example11,Infectious disease , Patented
18969,D0M6WW,PMID30107136-Compound-Example11,Human immunodeficiency virus infection , Patented
18970,D0M6WW,PMID30107136-Compound-Example11,Hepatitis , Patented
18971,D0M6XE,ZP-003,Chronic obstructive pulmonary disease , Investigative
18972,D0M6XK,ANG1005,Brain metastases , Phase 2
18973,D0M6XK,ANG1005,Glioblastoma multiforme , Phase 2
18974,D0M6XK,ANG1005,Breast cancer , Phase 2
18975,D0M6XK,ANG1005,Recurrent glioblastoma , Phase 2
18976,D0M6XY,SYM-006,Bacterial infection , Investigative
18977,D0M6YE,SKF-106760,Thrombosis , Terminated
18978,D0M6YW,GYKI-12743,Hypertension , Discontinued in Phase 1
18979,D0M6ZA,Fsn-0306,Solid tumour/cancer , Investigative
18980,D0M7BL,BAY 1067197,Heart failure , Phase 2
18981,D0M7BT,Doxapram,Respiratory disease , Approved
18982,D0M7BW,GR-89696,Neurodegenerative disorder , Terminated
18983,D0M7CB,MK-0873,Psoriasis vulgaris , Phase 2
18984,D0M7DS,Valomaciclovir stearate,Varicella zoster virus infection , Phase 2
18985,D0M7DU,Radiolabeled onartuzumab,Solid tumour/cancer , Investigative
18986,D0M7EP,CD79-targeted immunotoxins,Non-hodgkin lymphoma , Investigative
18987,D0M7FX,KD-247,Human immunodeficiency virus-1 infection , Phase 1
18988,D0M7HO,SQ-33800,Hypertension , Terminated
18989,D0M7HZ,ISIS-SMNRx,Spinal muscular atrophy , Phase 3
18990,D0M7IG,RO-4920506,Solid tumour/cancer , Investigative
18991,D0M7IH,Abobotulinum toxin A,Cervical cancer , Approved
18992,D0M7IJ,DM-PIT-1,Solid tumour/cancer , Investigative
18993,D0M7JT,Dabigatran,Stroke , Approved
18994,D0M7LQ,CBD cannabis derivative,Schizophrenia , Discontinued in Phase 1
18995,D0M7LV,LYSERGIC ACID DIETHYLAMIDE,Addictive disorder , Withdrawn from market
18996,D0M7MB,ERC-124,Heart failure , Phase 2
18997,D0M7MH,NAChR alpha 7 APLs,Alzheimer disease , Investigative
18998,D0M7MR,Multivalent carbohydrate-based vaccine,Solid tumour/cancer , Phase 2
18999,D0M7NA,A-993610,Pain , Investigative
19000,D0M7OU,CP-461,Inflammatory bowel disease , Phase 2
19001,D0M7PS,E-4177,Hypertension , Discontinued in Phase 2
19002,D0M7PU,PM-00104,Solid tumour/cancer , Phase 2
19003,D0M7SG,IDP-118,Plaque psoriasis , Phase 2
19004,D0M7SZ,CAT-4000,Inflammation , Investigative
19005,D0M7TO,Tasosartan,Hypertension , Approved
19006,D0M7TT,IP-1200,Erectile dysfunction , Investigative
19007,D0M7TW,PF-3900422,Central nervous system disease , Investigative
19008,D0M7VB,AV-1013,Nervous system inflammation , Investigative
19009,D0M7VE,RO-4905417,Acute coronary syndrome , Phase 2
19010,D0M7VW,GR-65630,Vomiting , Terminated
19011,D0M7XB,Beta-cyclodextrin conjugate derivative 1,Crohn disease , Patented
19012,D0M7XB,Beta-cyclodextrin conjugate derivative 1,Ulcerative colitis , Patented
19013,D0M7XB,Beta-cyclodextrin conjugate derivative 1,Urinary tract infection , Patented
19014,D0M7XS,Antithymocyte globulin,Aplastic anemia , Approved
19015,D0M7YU,Folate binding protein vaccine,Ovarian cancer , Phase 2
19016,D0M7YU,Folate binding protein vaccine,Endometrial cancer , Phase 2
19017,D0M8AB,Glycine,Malnutrition , Approved
19018,D0M8AI,ARRY-380,Solid tumour/cancer , Phase 1
19019,D0M8CL,A-0001,Friedreich's ataxia , Phase 2
19020,D0M8EF,CD38 CAR-T Cell,Acute lymphoblastic leukaemia , Phase 1/2
19021,D0M8FD,SNDX-275,Breast cancer , Phase 3
19022,D0M8FD,SNDX-275,Colorectal cancer , Phase 2
19023,D0M8FD,SNDX-275,Melanoma , Phase 2
19024,D0M8FD,SNDX-275,Ovarian cancer , Phase 2
19025,D0M8FD,SNDX-275,Non-small-cell lung cancer , Phase 2
19026,D0M8FF,OSL-95II,Virus infection , Investigative
19027,D0M8HH,PUMAPRAZOLE,Duodenal ulcer , Discontinued in Phase 3
19028,D0M8HV,AZD-4451,Bipolar disorder , Phase 1
19029,D0M8JF,MOR-102,Psoriasis vulgaris , Terminated
19030,D0M8KY,(S)-DRF-1042,Bladder cancer , Clinical trial
19031,D0M8LN,A-690344,Schizophrenia , Investigative
19032,D0M8OC,Bavisant,Attention deficit hyperactivity disorder , Phase 2
19033,D0M8PD,Estrogen,Menopause symptom , Approved
19034,D0M8PL,Angiozyme,Solid tumour/cancer , Discontinued in Phase 2
19035,D0M8PM,IRX-4,Prostate cancer , Preclinical
19036,D0M8PW,Levocetirizine dihydrochloride,Allergic rhinitis , Approved
19037,D0M8QG,SAN-18,Rheumatoid arthritis , Terminated
19038,D0M8RC,Terbutaline,Asthma , Approved
19039,D0M8RW,FluCell,Colorectal cancer , Phase 1
19040,D0M8UO,"Imidazo[1,2-b]pyridazine derivative 2",Solid tumour/cancer , Patented
19041,D0M8VE,Iloperidone,Schizophrenia , Approved
19042,D0M8VL,GW-870086-X,Asthma , Phase 2
19043,D0M8VS,PMID28270021-Compound-WO2015042088Example4,Pruritus , Patented
19044,D0M8VS,PMID28270021-Compound-WO2015042088Example4,Solid tumour/cancer , Patented
19045,D0M8VS,PMID28270021-Compound-WO2015042088Example4,Chronic pain , Patented
19046,D0M8VS,PMID28270021-Compound-WO2015042088Example4,Neuropathic pain , Patented
19047,D0M8VS,PMID28270021-Compound-WO2015042088Example4,Thymic cancer , Patented
19048,D0M8XX,ATI-1123,Solid tumour/cancer , Phase 1
19049,D0M8YM,Pyrotinib,Solid tumour/cancer , Phase 1
19050,D0M8YQ,HIVAX-2,Human immunodeficiency virus infection , Investigative
19051,D0M9BW,Artemether,Malaria , Approved
19052,D0M9CV,TA-993,Arteriosclerosis , Terminated
19053,D0M9DC,Oxaprozin,Rheumatoid arthritis , Approved
19054,D0M9ER,EHT-1864,Alzheimer disease , Terminated
19055,D0M9EV,NBTX-001,Post-traumatic stress disorder , Phase 2/3
19056,D0M9EV,NBTX-001,Panic disorder , Phase 1
19057,D0M9FA,TCR-transduced T-cell immunotherapy,Solid tumour/cancer , Investigative
19058,D0M9FF,ReN-1820,Cystitis , Terminated
19059,D0M9FQ,PF-489791,Raynaud disease , Phase 2
19060,D0M9FQ,PF-489791,Chronic obstructive pulmonary disease , Phase 2
19061,D0M9FT,Omniferon,Solid tumour/cancer , Terminated
19062,D0M9FZ,Pyrazole derivative 6,Obesity , Patented
19063,D0M9GE,Rimcazole,Schizophrenia , Terminated
19064,D0M9JJ,DOV-216419,Attention deficit hyperactivity disorder , Phase 3
19065,D0M9JJ,DOV-216419,Major depressive disorder , Investigative
19066,D0M9KZ,Pyridine derivative 4,Solid tumour/cancer , Patented
19067,D0M9LB,NS-2389,Major depressive disorder , Discontinued in Phase 2
19068,D0M9NI,ARCT-021 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
19069,D0M9NJ,SOM-0005,Virus infection , Investigative
19070,D0M9OO,Galinpepimut-S,Acute myeloid leukaemia , Phase 3
19071,D0M9OO,Galinpepimut-S,Malignant pleural mesothelioma , Phase 2
19072,D0M9OO,Galinpepimut-S,Multiple myeloma , Phase 2
19073,D0M9OO,Galinpepimut-S,Ovarian cancer , Phase 2
19074,D0M9OO,Galinpepimut-S,Chronic myeloid leukaemia , Phase 2
19075,D0M9OO,Galinpepimut-S,Mesothelioma , Phase 2
19076,D0M9OO,Galinpepimut-S,Chronic myelogenous leukaemia , Phase 1/2
19077,D0M9PD,PP-200,Solid tumour/cancer , Investigative
19078,D0M9PI,SLP-1003,MRSA infection , Investigative
19079,D0M9QK,Beta-acetyldigoxin,Cardiovascular disease , Approved
19080,D0M9QZ,ABT-869,Solid tumour/cancer , Phase 3
19081,D0M9RE,ARI-809,Diabetic complication , Preclinical
19082,D0M9RI,SUVN-D4010,Alzheimer disease , Phase 1
19083,D0M9RM,[3H]CGS8216,Inflammation , Investigative
19084,D0M9RQ,MK-0249,Insulin-resistant disorder , Clinical trial
19085,D0M9SD,VA-119930,Inflammatory bowel disease , Investigative
19086,D0M9SL,DSP-7238,Diabetic complication , Terminated
19087,D0M9TD,MiR-34a mimics,Liver cancer , Investigative
19088,D0M9TO,JCAR023,Neuroblastoma , Phase 1
19089,D0M9VE,EXISULIND,Colorectal cancer , Phase 3
19090,D0M9VZ,Navuridine,Human immunodeficiency virus infection , Terminated
19091,D0M9WM,Chlorothiazide,Congestive heart failure , Approved
19092,D0M9WX,AMT-030,Hyperoxaluria , Terminated
19093,D0M9XH,XP-21510,Menorrhagia , Investigative
19094,D0M9XT,NB-003,Acne vulgaris , Phase 1
19095,D0M9ZL,TPO gene plasmid,Thrombocytopenia , Investigative
19096,D0M9ZT,TJ-960,Epilepsy , Discontinued in Phase 3
19097,D0MA0F,WF-11605,Bacterial infection , Phase 1
19098,D0MA2E,GLYCAR T cells,Hepatocellular carcinoma , Phase 1
19099,D0MA2J,POL-443,Hypertension , Terminated
19100,D0MA4F,GD2-CART01,Neuroblastoma , Phase 1/2
19101,D0MA4O,Anti-CD20 CAR-T cells,Diffuse large B-cell lymphoma , Phase 1/2
19102,D0MA7A,3-(phenoxymethyl) benzylamine derivative 4,Albinism , Patented
19103,D0MA7A,3-(phenoxymethyl) benzylamine derivative 4,Ephelides , Patented
19104,D0MA7A,3-(phenoxymethyl) benzylamine derivative 4,Menkes disease , Patented
19105,D0MA7A,3-(phenoxymethyl) benzylamine derivative 4,Senile lentigines , Patented
19106,D0MA7A,3-(phenoxymethyl) benzylamine derivative 4,Melasma , Patented
19107,D0MA7C,Sodium nitrite,Myocardial infarction , Approved
19108,D0MA7C,Sodium nitrite,Hypertension , Phase 2
19109,D0MA9N,Dapsone,Pneumocystis pneumonia , Approved
19110,D0MB2Z,ATR-101,Malignant adrenal gland cancer , Phase 1
19111,D0MB2Z,ATR-101,Arteriosclerosis , Terminated
19112,D0MB8I,Oxacillin,Bacterial infection , Approved
19113,D0MC0O,AZD-1080,Alzheimer disease , Discontinued in Phase 1
19114,D0MC2E,MOR-203,Solid tumour/cancer , Preclinical
19115,D0MC2S,NIC-002,Nicotine dependence , Phase 2
19116,D0MC3K,CID755673,Solid tumour/cancer , Investigative
19117,D0MC3R,Goxalapladib,Arteriosclerosis , Discontinued in Phase 1
19118,D0MC5O,CAP-1002,Duchenne dystrophy , Phase 2
19119,D0MC5O,CAP-1002,Myocardial infarction , Phase 1/2
19120,D0MC6Y,LTX-04,Pain , Phase 1
19121,D0MD0T,Satralizumab,Neuromyelitis optica spectrum disorder , Approved
19122,D0MD2L,Rufinamide,Seizure disorder , Approved
19123,D0MD2L,Rufinamide,Pediatric lennox-gastaut syndrome , Approved
19124,D0MD2L,Rufinamide,Epilepsy , Approved (orphan drug)
19125,D0MD5M,G100,Non-hodgkin lymphoma , Phase 2
19126,D0MD6C,Sernivo,Plaque psoriasis , Phase 3
19127,D0MD7Y,Ragweed mix vaccine,Allergic conjunctivitis , Phase 1
19128,D0MD7Y,Ragweed mix vaccine,Seasonal allergic rhinitis , Phase 1
19129,D0MD8D,Tecovirimat ,Smallpox , Approved
19130,D0MD8D,Tecovirimat ,Virus infection , Phase 3
19131,D0MD8O,Adacel,Bordetella pertussis infection , Approved
19132,D0MD8S,CARTmeso/19,Pancreatic cancer , Phase 1
19133,D0ME1L,Digibind,Eclampsia , Phase 2b
19134,D0ME1L,Digibind,Pre-eclampsia , Phase 2
19135,D0ME2T,RTA-901,Diabetic neuropathy , Phase 1
19136,D0ME7Q,MP0250,Non-small-cell lung cancer , Phase 1/2
19137,D0MF3C,WAY-123641,Asthma , Discontinued in Phase 2
19138,D0MF3F,AAV8-773,Achromatopsia , Investigative
19139,D0MF7U,PF-3052334,Arteriosclerosis , Discontinued in Phase 1
19140,D0MF9G,Potassium Perchlorate,Hyperthyroidism , Approved
19141,D0MF9H,Delucemine,Depression , Discontinued in Phase 1
19142,D0MG0F,IW-001,Idiopathic pulmonary fibrosis , Phase 1
19143,D0MG0H,NVC-612,Influenza virus infection , Investigative
19144,D0MG0O,BBV152 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
19145,D0MG1Y,Belladonna,Colitis , Approved
19146,D0MG2R,ALX-0141,Osteoporosis , Phase 1
19147,D0MG3Z,CAR-T cells targeting PSCA,Solid tumour/cancer , Phase 1
19148,D0MG4D,Heteroaryl-carboxamide derivative 5,Solid tumour/cancer , Patented
19149,D0MG4D,Heteroaryl-carboxamide derivative 5,Metastatic cancer , Patented
19150,D0MG6V,"3-substituted-1,2,4-oxadiazole derivative 2",Solid tumour/cancer , Patented
19151,D0MG6V,"3-substituted-1,2,4-oxadiazole derivative 2",Infectious disease , Patented
19152,D0MG6V,"3-substituted-1,2,4-oxadiazole derivative 2",Human immunodeficiency virus infection , Patented
19153,D0MG6V,"3-substituted-1,2,4-oxadiazole derivative 2",Hepatitis , Patented
19154,D0MH1F,MEDI3726,Prostate cancer , Phase 1
19155,D0MH1R,RG7418,Arteriosclerosis , Discontinued in Phase 1
19156,D0MH8K,LPO-1010CSR,Retinopathy , Investigative
19157,D0MH8O,Angiotensin-(1-7),Sarcoma , Phase 3
19158,D0MH8O,Angiotensin-(1-7),Lymphoma , Phase 2
19159,D0MH8O,Angiotensin-(1-7),Chemotherapy-induced nausea , Phase 2
19160,D0MH8O,Angiotensin-(1-7),Duchenne dystrophy , Phase 2
19161,D0MH8O,Angiotensin-(1-7),Muscular dystrophy , Phase 1
19162,D0MI0Q,Amarylline,Middle East Respiratory Syndrome (MERS) , Investigative
19163,D0MI0S,Antigen-pulsed dendritic cell vaccine,Melanoma , Phase 2
19164,D0MI1N,CR-5259,Osteoarthritis , Investigative
19165,D0MI3E,PMID25684022-Compound-WO2008107444,Solid tumour/cancer , Patented
19166,D0MI3E,PMID25684022-Compound-WO2008107444,Metastatic cancer , Patented
19167,D0MI5G,RG2077,Graft-versus-host disease , Phase 1/2
19168,D0MI8F,IdeS,Autoimmune diabetes , Investigative
19169,D0MI8Z,ONS-3010,Crohn disease , Phase 1
19170,D0MI8Z,ONS-3010,Plaque psoriasis , Phase 1
19171,D0MI8Z,ONS-3010,Psoriasis vulgaris , Phase 1
19172,D0MI8Z,ONS-3010,Rheumatoid arthritis , Phase 1
19173,D0MI8Z,ONS-3010,Ulcerative colitis , Phase 1
19174,D0MI9F,PTX-001,Solid tumour/cancer , Investigative
19175,D0MJ2H,KD-7040,Pain , Phase 2
19176,D0MJ5E,DMB mabs,Solid tumour/cancer , Investigative
19177,D0MJ7W,BRX-1002,Solid tumour/cancer , Investigative
19178,D0MJ9L,PB-102,Solid tumour/cancer , Investigative
19179,D0MK2C,SR-31742A,Schizophrenia , Terminated
19180,D0MK2F,Macrocyclic peptide analog 3,Solid tumour/cancer , Patented
19181,D0MK2F,Macrocyclic peptide analog 3,Infectious disease , Patented
19182,D0MK2F,Macrocyclic peptide analog 3,Human immunodeficiency virus infection , Patented
19183,D0MK2F,Macrocyclic peptide analog 3,Hepatitis , Patented
19184,D0MK2Y,Rotavax,Type-2 diabetes , Phase 1/2
19185,D0MK7H,Anti-BCMA CAR-T cells,Multiple myeloma , Phase 1/2
19186,D0ML0L,ARRY-614,Myelodysplastic syndrome , Discontinued in Phase 1
19187,D0ML0L,ARRY-614,Arthritis , Discontinued in Phase 1
19188,D0ML0R,SKF-105685,Autoimmune diabetes , Terminated
19189,D0ML1F,Adefovir Dipivoxil,Hepatitis B virus infection , Approved
19190,D0ML1G,Covax-19 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
19191,D0ML2V,RALURIDINE,Human immunodeficiency virus infection , Phase 2
19192,D0ML5T,EUR-1066,Exocrine pancreatic insufficiency , Phase 1
19193,D0ML8G,Turoctocog alfa,Haemophilia A , Phase 3
19194,D0ML9K,T-506,Solid tumour/cancer , Discontinued in Phase 2
19195,D0MM0N,MPC-300-IV,Diabetic nephropathy , Phase 2
19196,D0MM0N,MPC-300-IV,Rheumatoid arthritis , Phase 2
19197,D0MM1Y,Polyhydroxy benzamide derivative 2,Albinism , Patented
19198,D0MM1Y,Polyhydroxy benzamide derivative 2,Ephelides , Patented
19199,D0MM1Y,Polyhydroxy benzamide derivative 2,Menkes disease , Patented
19200,D0MM1Y,Polyhydroxy benzamide derivative 2,Senile lentigines , Patented
19201,D0MM1Y,Polyhydroxy benzamide derivative 2,Melasma , Patented
19202,D0MM2K,CP-195543,Rheumatoid arthritis , Discontinued in Phase 2
19203,D0MM2L,Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate,Human immunodeficiency virus infection , Approved
19204,D0MM2L,Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate,Human immunodeficiency virus-1 infection , Phase 2
19205,D0MM3A,BIIB104,Cognitive impairment , Phase 2a
19206,D0MM4H,GSK1795091,Solid tumour/cancer , Phase 1
19207,D0MM4X,MIV-710,Bone metastases , Investigative
19208,D0MM5P,Subcutaneous furosemide,Acute decompensated heart failure , Phase 2/3
19209,D0MM5P,Subcutaneous furosemide,Chronic heart failure , Application submitted
19210,D0MM6A,Coenzyme Q10 analog,Huntington disease , Phase 2
19211,D0MM6A,Coenzyme Q10 analog,Leigh syndrome , Phase 2
19212,D0MM6A,Coenzyme Q10 analog,Mitochondrial respiratory chain disease , Phase 2
19213,D0MM6A,Coenzyme Q10 analog,Rett syndrome , Phase 2
19214,D0MM6Q,MM-POD1,Autoimmune diabetes , Investigative
19215,D0MM8M,Diazepinone derivative 2,Reflux disease , Patented
19216,D0MM8M,Diazepinone derivative 2,Parkinson disease , Patented
19217,D0MM8N,Idebenone,Cognitive impairment , Approved
19218,D0MM8N,Idebenone,Friedreich's ataxia , Approved
19219,D0MN9K,Meclofenamate Sodium,Arthritis , Approved
19220,D0MO0J,MEDI0382,Type-2 diabetes , Phase 2
19221,D0MO0Z,Alkyl mannoside derivative 5,Crohn disease , Patented
19222,D0MO0Z,Alkyl mannoside derivative 5,Ulcerative colitis , Patented
19223,D0MO0Z,Alkyl mannoside derivative 5,Urinary tract infection , Patented
19224,D0MO7Y,MF59 adjuvanted SARS-CoV-2 Sclamp vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
19225,D0MP0X,AZD1480,Myeloproliferative syndrome , Phase 2
19226,D0MP1C,Flosequinan,Cardiovascular disease , Terminated
19227,D0MP1M,CERE-110,Alzheimer disease , Phase 2
19228,D0MP2S,Centanamycin,Solid tumour/cancer , Investigative
19229,D0MP2U,AN-9,Melanoma , Discontinued in Phase 2
19230,D0MP5H,Debrisoquin,Hypertension , Approved
19231,D0MQ6B,CVnCoV vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
19232,D0MR0B,TEW-7197,Myeloproliferative neoplasm , Phase 2
19233,D0MR0B,TEW-7197,Urothelial carcinoma , Phase 2
19234,D0MR0B,TEW-7197,Myelodysplastic syndrome , Phase 1/2
19235,D0MR0B,TEW-7197,Solid tumour/cancer , Phase 1
19236,D0MR2D,ARCoV vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
19237,D0MR4Q,CCX-168,Anca-associated vasculitis , Phase 3
19238,D0MR4Q,CCX-168,Eosinophilic granulomatosis with polyangiitis , Phase 2
19239,D0MR4Q,CCX-168,Hereditary haemolytic anemia , Phase 2
19240,D0MR9V,PMID27998201-Compound-15,Pain , Patented
19241,D0MS1D,FCE-25876,Major depressive disorder , Terminated
19242,D0MS1G,Fish oil triglycerides,Cholestasis of parenteral nutrition , Approved
19243,D0MS2T,BCMA-specific CAR-expressing T Lymphocytes,Plasma cell myeloma , Phase 1
19244,D0MS3Z,GSK690693,Haematological malignancy , Phase 1
19245,D0MS6B,LOR 253,Metastatic cancer , Phase 1
19246,D0MT0A,CCX915,Multiple sclerosis , Discontinued in Phase 1
19247,D0MT0M,Apraclonidine,Intra ocular pressure reduction , Approved
19248,D0MT1Q,K-201,Atopic dermatitis , Phase 2
19249,D0MT3A,Human retinal progenitor cells,Retinitis pigmentosa , Phase 1/2
19250,D0MT3J,Benzimidazole derivative 4,Albinism , Patented
19251,D0MT3J,Benzimidazole derivative 4,Ephelides , Patented
19252,D0MT3J,Benzimidazole derivative 4,Menkes disease , Patented
19253,D0MT3J,Benzimidazole derivative 4,Senile lentigines , Patented
19254,D0MT3J,Benzimidazole derivative 4,Melasma , Patented
19255,D0MT5C,L-742791,Obesity , Preclinical
19256,D0MT5U,DopaFuse,Parkinson disease , Phase 2
19257,D0MT6W,MVC-COV1901 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
19258,D0MT7W,NN8210,Rheumatoid arthritis , Discontinued in Phase 1
19259,D0MT9G,RO-48-8684,Anxiety disorder , Discontinued in Phase 1
19260,D0MT9X,Calcium dobesilate,Diabetic retinopathy , Approved
19261,D0MU0S,EM-800,Estrogen deficiency , Discontinued in Phase 3
19262,D0MU1F,XTL-6865,Hepatitis C virus infection , Phase 1
19263,D0MU3S,PMID25666693-Compound-47,Osteoarthritis pain , Patented
19264,D0MU3S,PMID25666693-Compound-47,Cancer related pain , Patented
19265,D0MU3S,PMID25666693-Compound-47,Neuropathic pain , Patented
19266,D0MU3S,PMID25666693-Compound-47,Inflammatory pain , Patented
19267,D0MU7N,123I-MNI-330,Alzheimer disease , Phase 1
19268,D0MU9L,Migalastat,Fabry disease , Approved
19269,D0MV3Q,Axovan-3,Obesity , Discontinued in Phase 1
19270,D0MV3Q,Axovan-3,Eating disorder , Discontinued in Phase 1
19271,D0MV4T,CD19.CAR T Cells,Acute lymphoblastic leukaemia , Phase 1/2
19272,D0MV4T,CD19.CAR T Cells,Chronic lymphocytic leukaemia , Phase 1/2
19273,D0MV4T,CD19.CAR T Cells,Follicular lymphoma , Phase 1/2
19274,D0MV4T,CD19.CAR T Cells,Mantle cell lymphoma , Phase 1/2
19275,D0MV4W,RUBOXISTAURIN HYDROCHLORIDE,Lymphoma , Phase 3
19276,D0MW0N,Masitinib,Amyotrophic lateral sclerosis , Phase 3
19277,D0MW0N,Masitinib,Metastatic gastric or gastroesophageal junction cancer , Phase 3
19278,D0MW0N,Masitinib,Multiple sclerosis , Phase 3
19279,D0MW0N,Masitinib,Gastrointestinal stromal tumour , Phase 3
19280,D0MW0N,Masitinib,Ovarian cancer , Phase 3
19281,D0MW0N,Masitinib,Pancreatic cancer , Phase 3
19282,D0MW3H,CIPEMASTAT,Rheumatoid arthritis , Phase 3
19283,D0MW7B,PF-4494700,Dementia , Phase 3
19284,D0MW7B,PF-4494700,Alzheimer disease , Phase 3
19285,D0MW7L,Heteroaryl-carboxamide derivative 7,Solid tumour/cancer , Patented
19286,D0MW7L,Heteroaryl-carboxamide derivative 7,Metastatic cancer , Patented
19287,D0MW7S,Lexatumumab,Solid tumour/cancer , Phase 2
19288,D0MWS2,YTB323,Diffuse large B-cell lymphoma , Phase 1
19289,D0MWS2,YTB323,Chronic lymphocytic leukaemia , Phase 1
19290,D0MWS2,YTB323,Small lymphocytic lymphoma , Phase 1
19291,D0MX5N,ASCT01,Critical limb ischemia , Phase 1/2
19292,D0MX6K,Crysvita,Complex epidermal hamartoma , Phase 2
19293,D0MY0F,MGD013,Hepatocellular carcinoma , Phase 1/2
19294,D0MY0F,MGD013,Solid tumour/cancer , Phase 1
19295,D0MY0F,MGD013,Hematologic tumour , Phase 1
19296,D0MY1U,Intanza,Influenza virus infection , Approved
19297,D0MY3C,AR08,Attention deficit hyperactivity disorder , Phase 2
19298,D0MY3K,PMID25666693-Compound-109,Osteoarthritis pain , Patented
19299,D0MY3K,PMID25666693-Compound-109,Cancer related pain , Patented
19300,D0MY3K,PMID25666693-Compound-109,Neuropathic pain , Patented
19301,D0MY3K,PMID25666693-Compound-109,Inflammatory pain , Patented
19302,D0MY6Q,Vibrilase,Burn and burn infection , Discontinued in Phase 1
19303,D0MY7F,BB3,Congestive heart failure , Phase 3
19304,D0MY7F,BB3,Cerebrovascular ischaemia , Phase 3
19305,D0MY7F,BB3,Graft-versus-host disease , Phase 3
19306,D0MY7X,Esonarimod,Arthritis , Phase 3
19307,D0MY8N,Beta-carotene,Vitamin deficiency , Approved
19308,D0MZ2B,IODOSTEARIC ACID,Solid tumour/cancer , Phase 2
19309,D0MZ4V,"1,2,4-oxadiazole derivative 1",Solid tumour/cancer , Patented
19310,D0MZ4V,"1,2,4-oxadiazole derivative 1",Infectious disease , Patented
19311,D0MZ4V,"1,2,4-oxadiazole derivative 1",Human immunodeficiency virus infection , Patented
19312,D0MZ4V,"1,2,4-oxadiazole derivative 1",Hepatitis , Patented
19313,D0MZ7K,"Triazolo[4,3-b]pyridazine derivative 2",Pruritus , Patented
19314,D0MZ7K,"Triazolo[4,3-b]pyridazine derivative 2",Solid tumour/cancer , Patented
19315,D0MZ7K,"Triazolo[4,3-b]pyridazine derivative 2",Chronic pain , Patented
19316,D0MZ7K,"Triazolo[4,3-b]pyridazine derivative 2",Neuropathic pain , Patented
19317,D0MZ7K,"Triazolo[4,3-b]pyridazine derivative 2",Thymic cancer , Patented
19318,D0MZ8J,PMID26651364-Compound-10d,Crohn disease , Patented
19319,D0MZ8J,PMID26651364-Compound-10d,Ulcerative colitis , Patented
19320,D0MZ8J,PMID26651364-Compound-10d,Urinary tract infection , Patented
19321,D0MZ9A,Suronacrine maleate,Cognitive impairment , Phase 3
19322,D0N0AJ,Double mutant heat-labile toxin,Escherichia coli infection , Phase 1
19323,D0N0AR,GPI-1485,Parkinson disease , Phase 2
19324,D0N0BI,SIBRAFIBAN,Angina pectoris , Discontinued in Phase 3
19325,D0N0BI,SIBRAFIBAN,Cardiovascular disease , Discontinued in Phase 3
19326,D0N0BW,ALD-518,Rheumatoid arthritis , Phase 2
19327,D0N0BW,ALD-518,Psoriatic arthritis , Phase 2
19328,D0N0DP,FB-1811,Salmonella infection , Investigative
19329,D0N0DU,DS-6051,Solid tumour/cancer , Phase 1
19330,D0N0EB,P-17,Bone metastases , Investigative
19331,D0N0EQ,Streptomycin,Bacterial infection , Approved
19332,D0N0ES,Vitamin B3,Lipid metabolism disorder , Approved
19333,D0N0HO,SX-RDS1,Solid tumour/cancer , Investigative
19334,D0N0IQ,Ro-27-3225,Obesity , Preclinical
19335,D0N0JE,UP-275-22,Hypertension , Terminated
19336,D0N0KG,CDRI-85/92,Stomach ulcer , Investigative
19337,D0N0KR,Emakalim,Angina pectoris , Discontinued in Phase 1
19338,D0N0LB,zoxazolamine,Multiple myeloma , Terminated
19339,D0N0MZ,ITL-1636,Breast cancer , Investigative
19340,D0N0OG,TAK-361S,Diphtheria , Discontinued in Phase 2
19341,D0N0OU,Deferiprone,Thalassemia , Approved
19342,D0N0OV,Retroviral vector-transduced autologous T cells to express anti-GPC3 CARs,Hepatocellular carcinoma , Phase 1/2
19343,D0N0PU,LTB 019,Asthma , Discontinued in Phase 2
19344,D0N0PW,IDP-113,Tinea pedis , Phase 2
19345,D0N0QC,GV1001,Pancreatic cancer , Phase 3
19346,D0N0QN,PMID25666693-Compound-146,Osteoarthritis pain , Patented
19347,D0N0QN,PMID25666693-Compound-146,Cancer related pain , Patented
19348,D0N0QN,PMID25666693-Compound-146,Neuropathic pain , Patented
19349,D0N0QN,PMID25666693-Compound-146,Inflammatory pain , Patented
19350,D0N0RN,Marizomib,Glioblastoma of brain , Phase 3
19351,D0N0RN,Marizomib,Solid tumour/cancer , Phase 1
19352,D0N0RN,Marizomib,Malignant glioma , Phase 1
19353,D0N0RN,Marizomib,Multiple myeloma , Phase 1
19354,D0N0RU,Bexarotene,Cutaneous T-cell lymphoma , Approved
19355,D0N0SB,BOF-12013,Bacterial infection , Terminated
19356,D0N0SC,AIKb2,Alzheimer disease , Investigative
19357,D0N0SO,Autosomal dominant retinitis pigmentosa,Retinitis pigmentosa , Investigative
19358,D0N0TF,PMID25666693-Compound-156,Osteoarthritis pain , Patented
19359,D0N0TF,PMID25666693-Compound-156,Cancer related pain , Patented
19360,D0N0TF,PMID25666693-Compound-156,Neuropathic pain , Patented
19361,D0N0TF,PMID25666693-Compound-156,Inflammatory pain , Patented
19362,D0N0TZ,Clopidogrel,Thrombosis , Approved
19363,D0N0UY,AZD1704,Pain , Discontinued in Phase 1
19364,D0N0VW,IDN-5174,Solid tumour/cancer , Investigative
19365,D0N0XU,Pyrazole derivative 29,Obesity , Patented
19366,D0N0YT,AP-10295,Solid tumour/cancer , Investigative
19367,D0N1AS,NGD-4715,Obesity , Discontinued in Phase 1
19368,D0N1AT,BIOO-1,Solid tumour/cancer , Investigative
19369,D0N1AY,Metallothionein,Brain injury , Investigative
19370,D0N1BF,LY-2811376,Alzheimer disease , Phase 1
19371,D0N1CF,"Imidazo[1,2-b]pyridazine derivative 3",Solid tumour/cancer , Patented
19372,D0N1CH,Arverapamil,Irritable bowel syndrome , Phase 2
19373,D0N1DG,F61F12,Solid tumour/cancer , Investigative
19374,D0N1DQ,ANQ-9040,Paralysis , Discontinued in Phase 1
19375,D0N1EC,WY-47766,Osteoporosis , Discontinued in Phase 2
19376,D0N1EF,DARGLITAZONE,Diabetic complication , Terminated
19377,D0N1EW,DuP-532,Hypertension , Discontinued in Phase 1
19378,D0N1EZ,SPC-3,Human immunodeficiency virus infection , Phase 1
19379,D0N1FR,BECATECARIN,Solid tumour/cancer , Discontinued in Phase 3
19380,D0N1GB,APD-916,Sleep-wake disorder , Phase 1
19381,D0N1HL,Frakefamide,Pain , Discontinued in Phase 2
19382,D0N1HW,"L-745,870",Psychotic disorder , Phase 2
19383,D0N1IL,HG-1246,Solid tumour/cancer , Investigative
19384,D0N1KC,B-type natriuretic peptide,Heart disease , Discontinued in Phase 3
19385,D0N1MC,Cefatrizine,Bacterial infection , Approved
19386,D0N1NE,Xp-828l,Psoriasis vulgaris , Approved
19387,D0N1NL,Recombinant Wolinella (rWS) asparaginase,Solid tumour/cancer , Investigative
19388,D0N1PA,CGP-49823,Pain , Discontinued in Phase 2
19389,D0N1PZ,S-tenatoprazole,Peptic ulcer , Phase 2
19390,D0N1QH,HuMax-CD38b,Solid tumour/cancer , Investigative
19391,D0N1QX,ImmStat,Human immunodeficiency virus infection , Terminated
19392,D0N1RE,BIBF100,Multiple myeloma , Investigative
19393,D0N1RG,SoRI-9409,Alcohol dependence , Preclinical
19394,D0N1RH,AMZ-0026,Human immunodeficiency virus infection , Phase 1/2
19395,D0N1RM,JR-101,Gaucher disease , Investigative
19396,D0N1SH,VX-15,Huntington disease , Phase 2
19397,D0N1SH,VX-15,Multiple sclerosis , Phase 1
19398,D0N1SH,VX-15,Non-small-cell lung cancer , Phase 1
19399,D0N1SL,KI-0801,Neurological disorder , Investigative
19400,D0N1ST,AFC-5128,Autoimmune diabetes , Investigative
19401,D0N1SU,Licofelone,Osteoarthritis , Discontinued in Phase 1
19402,D0N1TH,ATI-2042,Atrial fibrillation , Phase 2
19403,D0N1TP,Paricalcitol,Hyperparathyroidism , Approved
19404,D0N1UH,VTT-301,Prostate hyperplasia , Investigative
19405,D0N1VG,DeNVax,Dengue fever , Phase 2
19406,D0N1WG,GSK-1137585,Malaria , Investigative
19407,D0N1WM,A-68930,Hypertension , Terminated
19408,D0N1WU,Etodolac,Pain , Approved
19409,D0N1XJ,SCID-X stem cell therapy,Immune System disease , Phase 1/2
19410,D0N1YF,Beperminogene perplasmid,Heart disease , Phase 3
19411,D0N1YF,Beperminogene perplasmid,Critical limb ischemia , Phase 3
19412,D0N1YG,CureXcell,Diabetic foot ulcer , Phase 3
19413,D0N2AI,Biphenyl mannoside derivative 19,Crohn disease , Patented
19414,D0N2AI,Biphenyl mannoside derivative 19,Ulcerative colitis , Patented
19415,D0N2AI,Biphenyl mannoside derivative 19,Urinary tract infection , Patented
19416,D0N2AM,CAR CD30 T cells,Non-hodgkin lymphoma , Phase 1
19417,D0N2AM,CAR CD30 T cells,Hodgkin lymphoma , Phase 1
19418,D0N2AY,Stapled peptides,Autoimmune diabetes , Investigative
19419,D0N2BX,Nadroparin calcium,Coagulation defect , Approved
19420,D0N2CG,Carlecortemcel-L,Lung infection , Phase 2/3
19421,D0N2CG,Carlecortemcel-L,Hematologic tumour , Phase 2/3
19422,D0N2CS,RP-4000,Dementia , Investigative
19423,D0N2DD,PDL-241,Immune System disease , Investigative
19424,D0N2FI,GW-766994,Asthma , Discontinued in Phase 2
19425,D0N2GC,BMS-753493,Solid tumour/cancer , Phase 1/2
19426,D0N2GQ,ATI-0917,Human immunodeficiency virus infection , Phase 1
19427,D0N2GS,NDC-KM,Solid tumour/cancer , Investigative
19428,D0N2HF,Vanoxerine,Cocaine addiction , Discontinued in Phase 1
19429,D0N2HU,VRC-EBODNA023-00-VP,Ebola virus infection , Phase 1
19430,D0N2IE,VB-201,Psoriasis vulgaris , Phase 2
19431,D0N2IE,VB-201,Arteriosclerosis , Phase 2
19432,D0N2JI,VAS-203,Brain injury , Phase 2
19433,D0N2KU,PF-3409409,Attention deficit hyperactivity disorder , Investigative
19434,D0N2LY,NN-2501,Type-2 diabetes , Discontinued in Phase 1
19435,D0N2QI,TA-CD cocaine abuse vaccine,Cocaine addiction , Phase 2
19436,D0N2QW,Patritumab,Non-small-cell lung cancer , Phase 1
19437,D0N2RF,SMART ABL-364,Breast cancer , Discontinued in Phase 2
19438,D0N2SR,Selexipag,Pulmonary arterial hypertension , Approved
19439,D0N2UQ,PMID25666693-Compound-24,Osteoarthritis pain , Patented
19440,D0N2UQ,PMID25666693-Compound-24,Cancer related pain , Patented
19441,D0N2UQ,PMID25666693-Compound-24,Neuropathic pain , Patented
19442,D0N2UQ,PMID25666693-Compound-24,Inflammatory pain , Patented
19443,D0N2YN,Spirogermanium hydrochloride,Solid tumour/cancer , Discontinued in Phase 2
19444,D0N2YY,OSPC-rDT vaccine,Shigella infection , Phase 1
19445,D0N3AF,Imidazopyridazine derivative 7,Pain , Patented
19446,D0N3AF,Imidazopyridazine derivative 7,Inflammation , Patented
19447,D0N3BB,CBX-129801,Diabetic complication , Phase 2
19448,D0N3EJ,RGH-896,Peripheral neuropathy , Phase 2
19449,D0N3EJ,RGH-896,Epilepsy , Phase 1
19450,D0N3FJ,BL-1889,Pruritus , Terminated
19451,D0N3GE,CD19 CART,Acute lymphoblastic leukaemia , Phase 1/2
19452,D0N3IA,HE3235,Breast cancer , Phase 2
19453,D0N3IP,Campestanol ascorbyl phosphate,Hyperlipidaemia , Investigative
19454,D0N3IT,SNX-1012,Mucositis , Discontinued in Phase 1
19455,D0N3JT,Cantuzumab mertansine,Non-small-cell lung cancer , Phase 2
19456,D0N3NI,Deuteroporphyrin,Solid tumour/cancer , Investigative
19457,D0N3NL,Acriflavine,Human immunodeficiency virus infection , Phase 1
19458,D0N3NO,Limaprost,Spinal stenosis , Approved
19459,D0N3NZ,Somatomedin-1,Hormone deficiency , Approved
19460,D0N3OH,A-317920,Attention deficit hyperactivity disorder , Investigative
19461,D0N3PC,MR1-1,Brain cancer , Phase 1
19462,D0N3PE,Guanethidine,Moderate and severe hypertension , Approved
19463,D0N3QF,AZD-5122,Chronic obstructive pulmonary disease , Phase 1
19464,D0N3RC,TZP-301,Metabolic disorder , Preclinical
19465,D0N3RK,CYSTEMUSTINE,Solid tumour/cancer , Phase 2
19466,D0N3RU,"Stem cell therapy, heart disease",Heart disease , Investigative
19467,D0N3SA,IR-201,Arthritis , Phase 3
19468,D0N3SH,Pyroxamide,Solid tumour/cancer , Discontinued in Phase 1
19469,D0N3SP,Butoconazole,Candidiasis , Approved
19470,D0N3SR,Cilnidipine,High blood pressure , Phase 3
19471,D0N3TO,TRM-115,Gastric ulcer , Discontinued in Phase 1
19472,D0N3UG,Hylenex,Solid tumour/cancer , Approved
19473,D0N3UL,Fosfosal,Pain , Approved
19474,D0N3UQ,123I-MNI-168,Alzheimer disease , Phase 1
19475,D0N3US,FA-613,Severe acute respiratory syndrome (SARS) , Preclinical
19476,D0N3US,FA-613,Middle East Respiratory Syndrome (MERS) , Preclinical
19477,D0N3VR,Voriconazole,Invasive aspergillosis , Approved
19478,D0N3WN,ABT-308,Eosinophilic esophagitis , Phase 2
19479,D0N3WN,ABT-308,Asthma , Phase 1
19480,D0N3XT,BREQUINAR,Coronavirus Disease 2019 (COVID-19) , Phase 2
19481,D0N3XT,BREQUINAR,Acute myeloid leukaemia , Phase 1/2
19482,D0N3YL,ASC-201,Bone marrow transplantation , Investigative
19483,D0N3YT,GLPG-0555,Osteoarthritis , Phase 1
19484,D0N3ZJ,LOMERIZINE,Migraine , Approved
19485,D0N3ZN,MEDI-8662,Influenza virus infection , Phase 3
19486,D0N3ZY,DPC-681,Human immunodeficiency virus infection , Discontinued in Phase 1
19487,D0N4AB,Rx-01,Bacterial infection , Preclinical
19488,D0N4DF,ALKS-37,Constipation , Phase 2
19489,D0N4DO,Troponin-I,Ocular disease , Terminated
19490,D0N4EC,Taltirelin,Central nervous system disease , Approved
19491,D0N4EO,GMI-1070,Asthma , Phase 3
19492,D0N4EO,GMI-1070,Vaso-occlusive crisis , Phase 3
19493,D0N4HB,Belatacept,Kidney transplant rejection , Approved
19494,D0N4HB,Belatacept,Heart transplant rejection , NDA filed
19495,D0N4HQ,OXi4503,Acute myeloid leukaemia , Phase 1/2
19496,D0N4HQ,OXi4503,Acute myelogenous leukaemia , Phase 1/2
19497,D0N4HQ,OXi4503,Myelodysplastic malignancy , Phase 1/2
19498,D0N4IU,CDNF/MANF,Parkinson disease , Investigative
19499,D0N4IV,S-3304,Solid tumour/cancer , Phase 1/2
19500,D0N4JA,CLT-008,Blood transfusion , Phase 2
19501,D0N4JG,Eladem,Prostate cancer , Discontinued in Phase 2
19502,D0N4JI,APG-101,Cerebrovascular ischaemia , Phase 2
19503,D0N4KK,NB-1008,Seasonal influenza infection , Phase 1
19504,D0N4LW,Human Alpha Antitrypsin,Genetic disease , Investigative
19505,D0N4MK,IB-07A037,Bacterial infection , Investigative
19506,D0N4MR,CDE-5498,Heart arrhythmia , Terminated
19507,D0N4ND,Fontolizumab,Rheumatoid arthritis , Discontinued in Phase 2
19508,D0N4ND,Fontolizumab,Inflammatory bowel disease , Discontinued in Phase 2
19509,D0N4NH,Anti-CD45 mAb 131I-BC8,Acute myeloid leukaemia , Phase 2
19510,D0N4NJ,YKP-1358,Schizoaffective disorder , Phase 1
19511,D0N4NJ,YKP-1358,Schizophrenia , Phase 1
19512,D0N4OW,Vasopressin,Diabetes insipidus , Approved
19513,D0N4OW,Vasopressin,Polyuria , Approved
19514,D0N4OW,Vasopressin,Enuresis , Approved
19515,D0N4OZ,Epothilone D,Breast cancer , Discontinued in Phase 2
19516,D0N4PC,RU-46556,Endometrial cancer , Terminated
19517,D0N4PW,iOWH032,Diarrhea , Phase 2
19518,D0N4PZ,Incadronate,Hypercalcaemia , Approved
19519,D0N4SF,GI-4000,Colorectal cancer , Phase 2
19520,D0N4SF,GI-4000,Pancreatic cancer , Phase 2
19521,D0N4SU,Pegorgotein,Head injury , Terminated
19522,D0N4TO,Biphenyl mannoside derivative 11,Crohn disease , Patented
19523,D0N4TO,Biphenyl mannoside derivative 11,Ulcerative colitis , Patented
19524,D0N4TO,Biphenyl mannoside derivative 11,Urinary tract infection , Patented
19525,D0N4TZ,Macrocycle derivative 8,Solid tumour/cancer , Patented
19526,D0N4TZ,Macrocycle derivative 8,Infectious disease , Patented
19527,D0N4TZ,Macrocycle derivative 8,Human immunodeficiency virus infection , Patented
19528,D0N4TZ,Macrocycle derivative 8,Hepatitis , Patented
19529,D0N4VB,NLG802,Solid tumour/cancer , Phase 1
19530,D0N4VG,CAR-T cells targeting CD123,Acute myeloid leukaemia , Preclinical
19531,D0N4VN,INGAP peptide,Type-1/2 diabetes , Phase 2
19532,D0N4WW,PMID26651364-Compound-106,Crohn disease , Patented
19533,D0N4WW,PMID26651364-Compound-106,Ulcerative colitis , Patented
19534,D0N4WW,PMID26651364-Compound-106,Urinary tract infection , Patented
19535,D0N4YU,Enterococcus faecalis conjugate vaccine,Enterococcus faecium infection , Terminated
19536,D0N4YX,EAA-090,Diabetic neuropathy , Discontinued in Phase 2
19537,D0N4ZS,ST-4206,Parkinson disease , Investigative
19538,D0N4ZX,MK-1029,Asthma , Phase 2
19539,D0N5AS,ITI-014,Hot flushes , Investigative
19540,D0N5AY,Ranagengliotucel-T,Brain cancer , Discontinued in Phase 3
19541,D0N5BC,Autolymphocyte therapy,Hepatitis B virus infection , Discontinued in Phase 3
19542,D0N5BL,AJA-777,Dyspepsia , Discontinued in Phase 2
19543,D0N5CT,BIBS-222,Hypertension , Terminated
19544,D0N5CW,Oleoyl-estrone,Obesity , Phase 2
19545,D0N5CW,Oleoyl-estrone,Alzheimer disease , Phase 2
19546,D0N5CW,Oleoyl-estrone,Psychotic disorder , Phase 2
19547,D0N5DW,CG-023132,Inflammation , Investigative
19548,D0N5DZ,CBI-009,Human immunodeficiency virus infection , Investigative
19549,D0N5GV,Nivolumab + ipilimumab,Head and neck cancer , Phase 3
19550,D0N5GV,Nivolumab + ipilimumab,Mesothelioma , Phase 3
19551,D0N5GV,Nivolumab + ipilimumab,Renal cell carcinoma , Phase 3
19552,D0N5GV,Nivolumab + ipilimumab,Small-cell lung cancer , Phase 3
19553,D0N5GV,Nivolumab + ipilimumab,Solid tumour/cancer , Phase 1/2
19554,D0N5HJ,Enalaprilat,Hypertension , Approved
19555,D0N5HN,M-100240,Hypotension , Discontinued in Phase 2
19556,D0N5HO,SQ-32709,Arteriosclerosis , Discontinued in Phase 2
19557,D0N5JJ,ADROGOLIDE HYDROCHLORIDE,Cognitive impairment , Discontinued in Phase 2
19558,D0N5JZ,PF-04691502,Endometrial cancer , Phase 2
19559,D0N5KF,Meropenem + vaborbactam,Urinary tract infection , Approved
19560,D0N5KF,Meropenem + vaborbactam,Intra-abdominal infection , Approved
19561,D0N5KS,Pumosetrag,Irritable bowel syndrome , Phase 2
19562,D0N5KS,Pumosetrag,Gastro-oesophageal reflux , Phase 1
19563,D0N5LJ,Igmesine,Major depressive disorder , Phase 2
19564,D0N5LJ,Igmesine,Cystic fibrosis , Phase 1
19565,D0N5LJ,Igmesine,Chronic obstructive pulmonary disease , Phase 1
19566,D0N5MH,Risdiplam,Spinal muscular atrophy , Approved
19567,D0N5NC,TAS3681,Prostate cancer , Phase 1
19568,D0N5NI,Benlysta + Rituxan,Sjogren syndrome , Phase 2
19569,D0N5NM,Org-23366,Schizophrenia , Preclinical
19570,D0N5NV,Biaryl compound 2,Solid tumour/cancer , Patented
19571,D0N5NV,Biaryl compound 2,Infectious disease , Patented
19572,D0N5NV,Biaryl compound 2,Human immunodeficiency virus infection , Patented
19573,D0N5NV,Biaryl compound 2,Hepatitis , Patented
19574,D0N5OL,STD-052,Constipation , Investigative
19575,D0N5OV,Cetuximab,Colorectal cancer , Approved
19576,D0N5SC,UK-369003,Erectile dysfunction , Discontinued in Phase 1/2
19577,D0N5SS,AZD1175,Obesity , Discontinued in Phase 1
19578,D0N5SS,AZD1175,Diabetic complication , Discontinued in Phase 1
19579,D0N5SS,AZD1175,Hypertension , Discontinued in Phase 1
19580,D0N5SW,Sulochrin,Asthma , Investigative
19581,D0N5TB,ITRI-305,Thyroid cancer , Investigative
19582,D0N5UA,Dianicline+rimonabant,Tobacco dependence , Terminated
19583,D0N5UU,NRT-100,Pain , Investigative
19584,D0N5VK,TSR-042,Solid tumour/cancer , Phase 1
19585,D0N5VK,TSR-042,Advanced malignancy , Phase 1
19586,D0N5VK,TSR-042,Metastatic cancer , Phase 1
19587,D0N5VL,Saccharomyces boulardii,Diarrhea , Approved
19588,D0N5XI,DP-001,Osteoporosis , Phase 2
19589,D0N5YA,Repaglinide,Diabetic complication , Approved
19590,D0N5YD,Nepicastat oral,Post-traumatic stress disorder , Phase 2
19591,D0N5YX,PD-158473,Cerebrovascular ischaemia , Terminated
19592,D0N5ZS,Vedolizmab,Crohn disease , Approved
19593,D0N5ZS,Vedolizmab,Ulcerative colitis , Approved
19594,D0N6AC,SHAPE,Cutaneous T-cell lymphoma , Phase 2
19595,D0N6AC,SHAPE,Lymphoma , Phase 1
19596,D0N6CC,AFX-300,Inflammatory bowel disease , Investigative
19597,D0N6CR,Propoxycaine,Pain , Approved
19598,D0N6CS,FG-2216,Kidney disease , Phase 2
19599,D0N6DD,SF-109,Glaucoma/ocular hypertension , Investigative
19600,D0N6EA,Odiparcil,Cardiovascular disease , Phase 2
19601,D0N6EL,SX-AZD1,Alzheimer disease , Investigative
19602,D0N6FH,Dihydroartemisinin,Malaria , Approved
19603,D0N6FI,ChimeriVax-JE,Japanese encephalitis virus infection , Phase 4
19604,D0N6FZ,WS-50030,Schizophrenia , Investigative
19605,D0N6GL,Pyrazoline derivative 10,Obesity , Patented
19606,D0N6GW,NASPANVAC,Influenza virus infection , Phase 1
19607,D0N6HA,COL-2401,Bacterial infection , Investigative
19608,D0N6IY,TZ101,Graft-versus-host disease , Phase 3
19609,D0N6IY,TZ101,Haematological malignancy , Phase 1/2
19610,D0N6KO,THIQ,Erectile dysfunction , Investigative
19611,D0N6MX,Gamunex-C,Diabetic neuropathy , Phase 2
19612,D0N6MX,Gamunex-C,Myasthenia gravis , Phase 2
19613,D0N6NA,"1,3,4-thiadiazole derivative 2",Solid tumour/cancer , Patented
19614,D0N6NA,"1,3,4-thiadiazole derivative 2",Infectious disease , Patented
19615,D0N6NA,"1,3,4-thiadiazole derivative 2",Human immunodeficiency virus infection , Patented
19616,D0N6NA,"1,3,4-thiadiazole derivative 2",Hepatitis , Patented
19617,D0N6NG,Bicyclic heteroaryl benzamide derivative 7,Pruritus , Patented
19618,D0N6NG,Bicyclic heteroaryl benzamide derivative 7,Solid tumour/cancer , Patented
19619,D0N6NG,Bicyclic heteroaryl benzamide derivative 7,Chronic pain , Patented
19620,D0N6NG,Bicyclic heteroaryl benzamide derivative 7,Neuropathic pain , Patented
19621,D0N6NG,Bicyclic heteroaryl benzamide derivative 7,Thymic cancer , Patented
19622,D0N6NM,CEP-37440,Solid tumour/cancer , Phase 1
19623,D0N6OE,Benafentrine dimaleate,Sepsis , Terminated
19624,D0N6PB,VM-106,Chronic granulomatous disease , Discontinued in Phase 1/2
19625,D0N6PE,CART-123 cells,Acute myeloid leukaemia , Phase 1/2
19626,D0N6PV,MK-852,Thrombosis , Discontinued in Phase 2
19627,D0N6QB,MT-112,Solid tumour/cancer , Phase 1
19628,D0N6QO,RP-1040,Solid tumour/cancer , Investigative
19629,D0N6RF,Telmisartan,Hypertension , Approved
19630,D0N6SO,SYR-472,Metabolic disorder , Phase 3
19631,D0N6SO,SYR-472,Non-insulin dependent diabetes , Investigative
19632,D0N6TD,BIW-8962,Multiple myeloma , Phase 1/2
19633,D0N6UA,Leukemia DNA vaccine,Acute myeloid leukaemia , Phase 2
19634,D0N6UJ,Diacol,Gastrointestinal infection , Approved
19635,D0N6UP,ETHIMIZOL,Cognitive impairment , Phase 3
19636,D0N6VK,Hepapoietin,Liver disease , Phase 1
19637,D0N6VS,ADU-S100,Head and neck cancer , Phase 2
19638,D0N6VS,ADU-S100,Solid tumour/cancer , Phase 1
19639,D0N6WX,AI-128,Asthma , Phase 1
19640,D0N6YN,BN-DF-037,Osteoporosis , Preclinical
19641,D0N6YV,Cenestin,Menopause symptom , Approved
19642,D0N6YV,Cenestin,Osteoporosis , Approved
19643,D0N6ZK,CGP-20376,Parasitic infection , Investigative
19644,D0N6ZP,SKF-105494,Diuretic vasodilator , Phase 1
19645,D0N7AD,Azatadine,Allergic rhinitis , Approved
19646,D0N7AU,Nifurzide,Bacterial infection , Approved
19647,D0N7BL,UK-240455,Nerve injury , Phase 1
19648,D0N7BW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1",Albinism , Patented
19649,D0N7BW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1",Ephelides , Patented
19650,D0N7BW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1",Menkes disease , Patented
19651,D0N7BW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1",Senile lentigines , Patented
19652,D0N7BW,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 1",Melasma , Patented
19653,D0N7CU,HG-1182,Solid tumour/cancer , Investigative
19654,D0N7CY,VLI-27,Pancreatic cancer , Investigative
19655,D0N7DQ,APC-100,Prostate cancer , Phase 1/2
19656,D0N7DW,Needle-free influenza vaccine,Influenza virus infection , Discontinued in Phase 2
19657,D0N7FD,Multi-epitope tyrosinase/gp100 vaccine,Melanoma , Phase 2
19658,D0N7GN,Aerucin,Pneumocystis pneumonia , Phase 2
19659,D0N7GN,Aerucin,Pseudomonas infection , Phase 1
19660,D0N7HS,ASP-3258,Respiratory tract inflammation , Investigative
19661,D0N7HT,PRO-135,Myotonic dystrophy , Investigative
19662,D0N7JP,TEM,Postherpetic neuralgia , Phase 2
19663,D0N7JS,PG11047,Lymphoma , Phase 1
19664,D0N7JZ,SAND-26,Autoimmune diabetes , Phase 3
19665,D0N7KV,Reniale,Renal cell carcinoma , Approved
19666,D0N7LA,BIBH 1,Solid tumour/cancer , Phase 2
19667,D0N7ML,PV-707,Skin burns , Discontinued in Phase 2
19668,D0N7SG,R-84760,Pain , Discontinued in Phase 2
19669,D0N7WB,CLR-151,Psychotic disorder , Investigative
19670,D0N7WG,AM-111,Neurological disorder , Phase 3
19671,D0N7WR,Sepimostat mesylate,Solid tumour/cancer , Discontinued in Phase 3
19672,D0N7WW,RVX-208,Alzheimer disease , Phase 1/2
19673,D0N7XI,Tremetinib,Cutaneous melanoma , Approved
19674,D0N7XW,Human enterovirus 71 vaccine,Enterovirus infection , Phase 2
19675,D0N7XY,"111In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide (melanoma), NuView/University of New Mexico",Melanoma , Investigative
19676,D0N7YK,YPEG-EPO,Anemia , Investigative
19677,D0N8AB,PF-4629991,Rheumatoid arthritis , Discontinued in Phase 1
19678,D0N8CM,PAV-616,Influenza virus infection , Investigative
19679,D0N8CN,BVB-808,Solid tumour/cancer , Investigative
19680,D0N8DP,Bentazepam,Anxiety disorder , Approved
19681,D0N8FQ,Reboxetine,Depression , Approved
19682,D0N8GC,MRX-4TZT,Spastic paralysis , Phase 1
19683,D0N8GR,CZ-775,Solid tumour/cancer , Investigative
19684,D0N8IG,PdpSC18,Hepatitis virus infection , Phase 1
19685,D0N8IL,PF-06425090,Clostridium infection , Phase 3
19686,D0N8JA,Theradigm-HBV,Virus infection , Discontinued in Phase 2
19687,D0N8JB,JTT-552,Hyperuricaemia , Discontinued in Phase 2
19688,D0N8JG,FolateImmune,Renal cell carcinoma , Phase 2
19689,D0N8JG,FolateImmune,Solid tumour/cancer , Phase 2
19690,D0N8JJ,MDDR 217769,Arthritis , Investigative
19691,D0N8JP,JTV-803,Thrombosis , Discontinued in Phase 1
19692,D0N8MQ,GSK-159797,Chronic obstructive pulmonary disease , Discontinued in Phase 2
19693,D0N8NC,SAVOXEPIN MESYLATE,Psychotic disorder , Discontinued in Phase 2
19694,D0N8NK,AZD-6605,Osteoarthritis , Terminated
19695,D0N8NN,CT-12441,Diabetic complication , Investigative
19696,D0N8NT,BCMA-UCART,Multiple myeloma , Clinical trial
19697,D0N8PV,Bovine alkaline phosphatase,Renal failure , Phase 2
19698,D0N8QK,ABT-288,Alzheimer disease , Phase 2
19699,D0N8QQ,CARIPORIDE,Angina pectoris , Discontinued in Phase 2
19700,D0N8QR,GRF6019,Alzheimer disease , Phase 1
19701,D0N8RA,GS-5829,Solid tumour/cancer , Phase 1
19702,D0N8RV,OSI-930,Solid tumour/cancer , Phase 1
19703,D0N8TM,XGP-110,Arthritis , Investigative
19704,D0N8UQ,IMD-026259,Central nervous system disease , Investigative
19705,D0N8UU,ADX415,Hypertension , Terminated
19706,D0N8UY,LY-686017,Atopic dermatitis , Phase 3
19707,D0N8UY,LY-686017,Alcohol dependence , Phase 2
19708,D0N8XL,BMS-605339,Hepatitis C virus infection , Terminated
19709,D0N8YJ,PMID28270010-Compound-Figure21-b,Brain metastases , Patented
19710,D0N9AD,RNS-60,Asthma , Phase 2
19711,D0N9AD,RNS-60,Multiple sclerosis , Phase 2
19712,D0N9AD,RNS-60,Amyotrophic lateral sclerosis , Phase 1
19713,D0N9AS,GW-549771,Bacterial infection , Discontinued in Phase 1
19714,D0N9BU,SSR-97225,Solid tumour/cancer , Discontinued in Phase 1
19715,D0N9DZ,Elmustine,Solid tumour/cancer , Terminated
19716,D0N9ET,MRSAid,Bacterial infection , Investigative
19717,D0N9FJ,PMID25666693-Compound-7,Osteoarthritis pain , Patented
19718,D0N9FJ,PMID25666693-Compound-7,Cancer related pain , Patented
19719,D0N9FJ,PMID25666693-Compound-7,Neuropathic pain , Patented
19720,D0N9FJ,PMID25666693-Compound-7,Inflammatory pain , Patented
19721,D0N9GC,Neorphine,Pain , Investigative
19722,D0N9IN,MTX-25251,Solid tumour/cancer , Investigative
19723,D0N9JB,SAR228810,Alzheimer disease , Phase 1
19724,D0N9KZ,TN-871,Cognitive impairment , Phase 2
19725,D0N9PL,ACE-041,Age-related macular degeneration , Phase 1
19726,D0N9PQ,Aimspro,Multiple sclerosis , Phase 2
19727,D0N9SJ,ALTU-237,Hyperoxaluria , Discontinued in Phase 1
19728,D0N9TK,AR-mTOR-26,Solid tumour/cancer , Investigative
19729,D0N9TY,AZD-7295,Hepatitis C virus infection , Phase 1
19730,D0N9UP,PR-21,Spinal cord injury , Investigative
19731,D0N9VZ,ADL-5747,Pain , Phase 2
19732,D0N9WB,APC-366,Asthma , Discontinued in Phase 2
19733,D0N9WY,NPT-CLN,Asthma , Investigative
19734,D0NA4J,CAR-T cells targeting MAGE-A1,Lung cancer , Phase 1/2
19735,D0NA5L,AAV2-REP1,Choroidal dystrophy , Phase 2
19736,D0NA8B,Rubraca rucaparib,Prostate cancer , Phase 3
19737,D0NA8B,Rubraca rucaparib,Ovarian cancer , Phase 3
19738,D0NA8U,Dexamethasone sodium phosphate,Ataxia-telangiectasia , Approved
19739,D0NA8W,LTA,Pain , Discontinued in Phase 2
19740,D0NB2K,Pyrrole derivative 4,Obesity , Patented
19741,D0NB5M,PMID25666693-Compound-35,Osteoarthritis pain , Patented
19742,D0NB5M,PMID25666693-Compound-35,Cancer related pain , Patented
19743,D0NB5M,PMID25666693-Compound-35,Neuropathic pain , Patented
19744,D0NB5M,PMID25666693-Compound-35,Inflammatory pain , Patented
19745,D0NB5P,Biphenyl mannoside derivative 8,Crohn disease , Patented
19746,D0NB5P,Biphenyl mannoside derivative 8,Ulcerative colitis , Patented
19747,D0NB5P,Biphenyl mannoside derivative 8,Urinary tract infection , Patented
19748,D0NB9T,KD018,Liver cancer , Phase 2
19749,D0NC0G,RQ-00203066,Pain , Investigative
19750,D0NC1D,MX-6120,Heart disease , Terminated
19751,D0NC1Q,AMG 172,Renal cell carcinoma , Phase 1
19752,D0NC8H,GMI-1051,Pseudomonas infection , Investigative
19753,D0NC9E,SGX301,Cutaneous T-cell lymphoma , Phase 3
19754,D0NC9M,CM-CS1 T-cell,Multiple myeloma , Phase 1
19755,D0NC9M,CM-CS1 T-cell,Myelodysplastic syndrome , Phase 1
19756,D0NC9M,CM-CS1 T-cell,Acute myeloid leukaemia , Phase 1
19757,D0NC9Y,ISIS 2105,Human papillomavirus infection , Discontinued in Phase 2
19758,D0ND2J,Flavoxate,Suprapubic pain , Approved
19759,D0ND2J,Flavoxate,Nocturia , Approved
19760,D0ND2J,Flavoxate,Urgency , Approved
19761,D0ND2J,Flavoxate,Dysuria , Approved
19762,D0ND3F,LM-030,Congenital ichthyosiform erythroderma , Phase 2
19763,D0ND8N,Textilinin,Bleeding disorder , Investigative
19764,D0ND9T,CRLX101,Solid tumour/cancer , Phase 2
19765,D0ND9T,CRLX101,Renal cell carcinoma , Phase 2
19766,D0ND9T,CRLX101,Ovarian cancer , Phase 2
19767,D0ND9T,CRLX101,Non-small-cell lung cancer , Phase 2
19768,D0NE3C,AZD3409,Solid tumour/cancer , Terminated
19769,D0NE3W,GTx-024,Muscle atrophy , Phase 3
19770,D0NE3W,GTx-024,Breast cancer , Phase 2
19771,D0NE5B,Rintatolimid,Solid tumour/cancer , Phase 1/2
19772,D0NE5B,Rintatolimid,Chronic fatigue syndrome , Application submitted
19773,D0NE8F,EDS-EP,Ataxia-telangiectasia , Phase 3
19774,D0NE9T,Fondaparinux sodium,Venous thrombosis , Approved
19775,D0NE9W,CX-1020,Immune System disease , Investigative
19776,D0NF0P,ELS-130,Raynaud disease , Investigative
19777,D0NF0Q,ZD-0947,Overactive bladder , Discontinued in Phase 2
19778,D0NF0W,Metixene,Parkinson disease , Approved
19779,D0NF1D,BAY-1817080,Endometriosis , Phase 1
19780,D0NF1U,FENOFIBRIC ACID,Cardiovascular disease , Approved
19781,D0NF1Z,UBX0101,Knee osteoarthritis , Phase 2
19782,D0NF5J,EZN-2968,Solid tumour/cancer , Phase 1
19783,D0NF6F,Trichostatin A,Solid tumour/cancer , Investigative
19784,D0NF7S,R-59494,Ischemia , Terminated
19785,D0NG1C,S. aureus type 336 vaccine,Bacterial infection , Phase 1
19786,D0NG3T,BCMA CAR-T Cells,Multiple myeloma , Phase 1
19787,D0NG7O,Zolmitriptan,Migraine , Approved
19788,D0NH0U,HYG-440,Dermatological disease , Investigative
19789,D0NH1E,Org-231295,Anxiety disorder , Investigative
19790,D0NH1V,EDP-08,Solid tumour/cancer , Investigative
19791,D0NH2M,PMID25666693-Compound-142,Osteoarthritis pain , Patented
19792,D0NH2M,PMID25666693-Compound-142,Cancer related pain , Patented
19793,D0NH2M,PMID25666693-Compound-142,Neuropathic pain , Patented
19794,D0NH2M,PMID25666693-Compound-142,Inflammatory pain , Patented
19795,D0NH3R,ASTX727,Chronic myelogenous leukaemia , Phase 3
19796,D0NH3R,ASTX727,Myelodysplastic syndrome , Phase 3
19797,D0NH5E,Autologous dendritic cell therapy,Solid tumour/cancer , Discontinued in Phase 1
19798,D0NH6F,VUF-8929,Heart failure , Terminated
19799,D0NI0C,Vidarabine,Herpes simplex virus infection , Approved
19800,D0NI0X,SCH-721015,Mesothelioma , Phase 1
19801,D0NI2B,Macrocycle derivative 5,Solid tumour/cancer , Patented
19802,D0NI2B,Macrocycle derivative 5,Infectious disease , Patented
19803,D0NI2B,Macrocycle derivative 5,Human immunodeficiency virus infection , Patented
19804,D0NI2B,Macrocycle derivative 5,Hepatitis , Patented
19805,D0NI9X,Autologous stem cell therapy,Spinal cord injury , Phase 3
19806,D0NI9X,Autologous stem cell therapy,Ischemia , Clinical trial
19807,D0NJ0S,Pyrazole derivative 34,Obesity , Patented
19808,D0NJ1A,Aloxistatin,Neurological disorder , Discontinued in Phase 3
19809,D0NJ1A,Aloxistatin,Coronavirus infection , Preclinical
19810,D0NJ2R,DFD-05,Common wart , Phase 2
19811,D0NJ3Q,WZ-3146,Lung cancer , Investigative
19812,D0NJ3T,CART-19 cells,Acute lymphoblastic leukaemia , Phase 1/2
19813,D0NJ3V,Papaverine,Spasm , Approved
19814,D0NJ5H,Alogliptin,Type-2 diabetes , Approved
19815,D0NJ9W,Nfu-PA-D4-RNP,Bacillus anthracis infection , Investigative
19816,D0NK2U,FK-973,Solid tumour/cancer , Discontinued in Phase 1
19817,D0NK6K,P-BCMA-101 CAR-T cells,Multiple myeloma , Phase 1
19818,D0NK6Z,Beta LT,Lymphoma , Discontinued in Phase 1/2
19819,D0NK7X,Nordimmun,Coagulation defect , Approved
19820,D0NK8D,SC-53228,Asthma , Terminated
19821,D0NK8M,Human heterologous liver cells,Urea cycle disorder , Phase 2
19822,D0NL5M,Mycobacterial cell wall-DNA complex,Solid tumour/cancer , Phase 3
19823,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,Acute lymphoblastic leukaemia , Clinical trial
19824,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,B-cell chronic lymphocytic leukaemia , Clinical trial
19825,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,Chronic lymphocytic leukaemia , Clinical trial
19826,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,Diffuse large B-cell lymphoma , Clinical trial
19827,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,Follicular lymphoma , Clinical trial
19828,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,Mantle cell lymphoma , Clinical trial
19829,D0NL9N,Anti-CD19/20-CAR vector-transduced T cells,Prolymphocytic leukaemia , Clinical trial
19830,D0NM3D,PMID25666693-Compound-19,Osteoarthritis pain , Patented
19831,D0NM3D,PMID25666693-Compound-19,Cancer related pain , Patented
19832,D0NM3D,PMID25666693-Compound-19,Neuropathic pain , Patented
19833,D0NM3D,PMID25666693-Compound-19,Inflammatory pain , Patented
19834,D0NN0I,APC-8020,Amyloidosis , Discontinued in Phase 2
19835,D0NN5A,MK-6096,Diabetic neuropathy , Phase 2
19836,D0NN5A,MK-6096,Insomnia , Phase 2
19837,D0NN5B,FR-172357,Inflammation , Terminated
19838,D0NN5H,PF-4523655,Age-related macular degeneration , Phase 2
19839,D0NN5H,PF-4523655,Diabetic macular degeneration , Phase 2
19840,D0NN7L,AC 165198,Diabetic complication , Phase 1
19841,D0NN7P,CART-HER-2,Solid tumour/cancer , Phase 1/2
19842,D0NN7Q,HP-802-247,Duchenne dystrophy , Phase 3
19843,D0NN7W,Cu64-CNND1-L,Lung cancer , Investigative
19844,D0NN8N,TNX-102,Fibromyalgia , Phase 3
19845,D0NN8N,TNX-102,Post-traumatic stress disorder , Phase 3
19846,D0NN9I,IMU-200,Epilepsy , Investigative
19847,D0NO0K,RBT-101,Respiratory tract infection , Phase 3
19848,D0NO0K,RBT-101,Heart failure , Phase 2
19849,D0NO0K,RBT-101,Influenza virus infection , Investigative
19850,D0NO1A,AT001/r84,Solid tumour/cancer , Phase 1
19851,D0NO1L,Pascolizumab,Asthma , Phase 2
19852,D0NO6E,Mteron-F1,Mucositis , Preclinical
19853,D0NO7L,PRO-289,Huntington disease , Investigative
19854,D0NO8S,MVA3000,Virus infection , Discontinued in Phase 2
19855,D0NP1J,Bucladesine sodium,Skin ulcer , Approved
19856,D0NP8B,ERIC-1,Solid tumour/cancer , Terminated
19857,D0NP8M,209-342,Solid tumour/cancer , Investigative
19858,D0NP8P,APG-1387,Haematological malignancy , Phase 1
19859,D0NP8P,APG-1387,Solid tumour/cancer , Phase 1
19860,D0NP8P,APG-1387,Nasopharyngeal carcinoma , Investigative
19861,D0NQ0V,BT-061,Asthma , Phase 2
19862,D0NQ0V,BT-061,Psoriasis vulgaris , Phase 2
19863,D0NQ0W,SB-101,Solid tumour/cancer , Investigative
19864,D0NQ5R,AZD-4750,Multiple sclerosis , Discontinued in Phase 1
19865,D0NR2A,Resorcinol compound 6,Albinism , Patented
19866,D0NR2A,Resorcinol compound 6,Ephelides , Patented
19867,D0NR2A,Resorcinol compound 6,Menkes disease , Patented
19868,D0NR2A,Resorcinol compound 6,Senile lentigines , Patented
19869,D0NR2A,Resorcinol compound 6,Melasma , Patented
19870,D0NR3V,Zatebradine,Angina pectoris , Terminated
19871,D0NR6S,Maraviroc,Human immunodeficiency virus infection , Approved
19872,D0NR6S,Maraviroc,Chronic obstructive pulmonary disease , Phase 3
19873,D0NR6T,UB-311,Alzheimer disease , Phase 2
19874,D0NR7H,A-837093,Hepatitis C virus infection , Phase 1
19875,D0NR9E,Omeprazole + lansoprazole,Ulcer , Phase 1
19876,D0NS0S,Vinconate,Amnesia , Discontinued in Preregistration
19877,D0NS1X,SAR-650984,Haematological malignancy , Phase 1/2
19878,D0NS2U,LLL-12,Solid tumour/cancer , Investigative
19879,D0NS3O,TT10,Nasopharyngeal carcinoma , Phase 3
19880,D0NS6H,Donepezil,Alzheimer disease , Approved
19881,D0NS6Z,COH29,Solid tumour/cancer , Phase 1
19882,D0NS7A,APN-301,Melanoma , Phase 2
19883,D0NS7A,APN-301,Neuroblastoma , Phase 2
19884,D0NS8T,13-DEOXYADRIAMYCIN HYDROCHLORIDE,Solid tumour/cancer , Phase 2
19885,D0NS9C,BIIB-513,Myocardial infarction , Investigative
19886,D0NT1S,CB-10-01,Melanoma , Phase 2
19887,D0NT4H,BEL-0218,Gaucher disease , Phase 1
19888,D0NT6P,MK8242,Acute myeloid leukaemia , Phase 2
19889,D0NT6P,MK8242,Solid tumour/cancer , Phase 1
19890,D0NT8Q,DW-514,Dementia , Investigative
19891,D0NU0U,AZD4547,Solid tumour/cancer , Phase 2/3
19892,D0NU2H,Propyliodone,Pulmonary disease , Approved
19893,D0NU6Y,192C86,Thrombosis , Phase 1
19894,D0NU8J,PT2977,Renal cell carcinoma , Phase 3
19895,D0NU8J,PT2977,Von hippel-lindau disease , Phase 2
19896,D0NU8J,PT2977,Solid tumour/cancer , Phase 1
19897,D0NU9L,CAR-20/19-T Cells,B-cell non-hodgkin lymphoma , Phase 1
19898,D0NU9L,CAR-20/19-T Cells,Chronic lymphocytic leukaemia , Phase 1
19899,D0NU9L,CAR-20/19-T Cells,Pancreatic cancer , Phase 1
19900,D0NU9N,CAR-T cells targeting MUC1,Solid tumour/cancer , Phase 1
19901,D0NV2M,PMID25666693-Compound-157,Osteoarthritis pain , Patented
19902,D0NV2M,PMID25666693-Compound-157,Cancer related pain , Patented
19903,D0NV2M,PMID25666693-Compound-157,Neuropathic pain , Patented
19904,D0NV2M,PMID25666693-Compound-157,Inflammatory pain , Patented
19905,D0NV5O,Finerenone,Diabetic nephropathy , Phase 3
19906,D0NV6I,Anti-CD19 CAR-T cells,leukaemia , Phase 1
19907,D0NV6I,Anti-CD19 CAR-T cells,Lymphoma , Phase 1
19908,D0NV9O,BAY 10-00394,Small-cell lung cancer , Discontinued in Phase 2
19909,D0NW0T,Erdafitinib,Bladder cancer , Approved
19910,D0NW0T,Erdafitinib,Urothelial carcinoma , Phase 2
19911,D0NW0T,Erdafitinib,Solid tumour/cancer , Phase 2
19912,D0NW0T,Erdafitinib,Lymphoma , Phase 1/2
19913,D0NW2H,BG-777,Human immunodeficiency virus infection , Phase 1
19914,D0NW3X,Dofetilide,Sinus rhythm disorder , Approved
19915,D0NW7Y,Ravulizumab,Paroxysmal nocturnal haemoglobinuria , Approved
19916,D0NW8C,M3541,Solid tumour/cancer , Phase 1
19917,D0NW8L,"Anti-CD19 ""armored"" CAR-Tcell therapy",Chronic lymphocytic leukaemia , Phase 1
19918,D0NX0S,PTX-100,Solid tumour/cancer , Phase 1
19919,D0NX6F,BAY-85-3474,Solid tumour/cancer , Investigative
19920,D0NX8G,Pre-pandemic Avian influenza vaccine,Influenza A virus H5N1 infection , Phase 1
19921,D0NY1R,AC-3174,Non-alcoholic steatohepatitis , Investigative
19922,D0NY1Y,CART-34 cells,Myelodysplastic syndrome , Phase 1
19923,D0NY1Y,CART-34 cells,Acute myeloid leukaemia , Phase 1
19924,D0NY2E,E-64D,Severe acute respiratory syndrome (SARS) , Preclinical
19925,D0NY2E,E-64D,Middle East Respiratory Syndrome (MERS) , Preclinical
19926,D0NY4H,ReN-005,Huntington disease , Investigative
19927,D0NY5Y,IMA-026,Asthma , Phase 1
19928,D0NY7A,S-19528,Eating disorder , Investigative
19929,D0NZ2D,SERCA 2a gene therapy,Heart failure , Phase 2
19930,D0NZ3C,TTC-352,Breast cancer , Phase 1
19931,D0O0AF,Sodium sulfide sulfur,Ischemia , Approved
19932,D0O0AH,MIRFENTANIL HYDROCHLORIDE,Pain , Discontinued in Phase 2
19933,D0O0BM,PF-3463275,Schizophrenia , Phase 2
19934,D0O0BR,Poly-ICR,Keratosis , Investigative
19935,D0O0DF,Lirequinil,Anxiety disorder , Discontinued in Phase 2
19936,D0O0EX,SAR-110894,Alzheimer disease , Phase 2
19937,D0O0FF,GW 468816,Tobacco dependence , Discontinued in Phase 2
19938,D0O0GX,MedChew-1401,Muscle spasm , Phase 1
19939,D0O0GZ,Bicyclic heteroaryl benzamide derivative 3,Pruritus , Patented
19940,D0O0GZ,Bicyclic heteroaryl benzamide derivative 3,Solid tumour/cancer , Patented
19941,D0O0GZ,Bicyclic heteroaryl benzamide derivative 3,Chronic pain , Patented
19942,D0O0GZ,Bicyclic heteroaryl benzamide derivative 3,Neuropathic pain , Patented
19943,D0O0GZ,Bicyclic heteroaryl benzamide derivative 3,Thymic cancer , Patented
19944,D0O0HK,CRL-1018,Mycobacterium infection , Terminated
19945,D0O0HU,LAS-41007,Keratosis , Phase 3
19946,D0O0II,ASC-JMZ1,Bladder cancer , Investigative
19947,D0O0JB,PSMA-targeted tubulysin B conjugates,Prostate cancer , Phase 1
19948,D0O0JH,F-12509A,Arteriosclerosis , Terminated
19949,D0O0JP,EMA-401,Postherpetic neuralgia , Phase 2
19950,D0O0JP,EMA-401,Peripheral neuropathy , Phase 2
19951,D0O0LC,MER-101,Bone metastases , Phase 2
19952,D0O0LF,F-18 exendin-4 derivative PET tracers,Diabetic complication , Investigative
19953,D0O0LQ,BI 2536,Acute myeloid leukaemia , Phase 2
19954,D0O0LS,Entrectinib,Non-small cell lung cancer , Approved
19955,D0O0LS,Entrectinib,Colorectal cancer , Phase 2
19956,D0O0LS,Entrectinib,Solid tumour/cancer , Phase 2
19957,D0O0LS,Entrectinib,Neuroblastoma , Phase 1
19958,D0O0LS,Entrectinib,Mammary analogue secretory carcinoma , Phase 1
19959,D0O0NY,Sutilains,Skin burns , Approved
19960,D0O0PY,Pagoclone,Anxiety disorder , Phase 2/3
19961,D0O0QB,ATG-Fresenius S,Transplant rejection , Phase 3
19962,D0O0QG,SC-51316,Hypertension , Terminated
19963,D0O0QM,Modified hepatocyte growth factor gene therapy,Diabetic nephropathy , Phase 2
19964,D0O0RG,MUC-1 dendritic cancer vaccine,Solid tumour/cancer , Phase 1
19965,D0O0RK,A-81282,Hypertension , Terminated
19966,D0O0RY,JB-1,Multiple myeloma , Investigative
19967,D0O0UG,PMID25666693-Compound-86,Osteoarthritis pain , Patented
19968,D0O0UG,PMID25666693-Compound-86,Cancer related pain , Patented
19969,D0O0UG,PMID25666693-Compound-86,Neuropathic pain , Patented
19970,D0O0UG,PMID25666693-Compound-86,Inflammatory pain , Patented
19971,D0O0VE,Oncoquest-L,Follicular lymphoma , Phase 1
19972,D0O0VE,Oncoquest-L,Non-hodgkin lymphoma , Phase 1
19973,D0O0VW,HGP-30W,Human immunodeficiency virus infection , Discontinued in Phase 2
19974,D0O0YA,SPIO-Stasix nanoparticles,Prostate cancer , Investigative
19975,D0O0ZG,Micrurus fulvius antivenin,Poison intoxication , Approved
19976,D0O1AN,Hydroxypropyl methylcellulose,Hypercholesterolaemia , Approved
19977,D0O1AV,Squalestatin 1,Arteriosclerosis , Terminated
19978,D0O1BL,BMN053,Duchenne dystrophy , Phase 2
19979,D0O1CJ,AdVac tuberculosis vaccine,Tuberculosis , Phase 2
19980,D0O1DS,[123I] iodobenzoyl 12-Ex4,Diabetic complication , Investigative
19981,D0O1EH,KP415,Attention deficit hyperactivity disorder , Phase 3
19982,D0O1EI,PMX-500,Solid tumour/cancer , Investigative
19983,D0O1GS,Fulranumab,Cancer related pain , Phase 3
19984,D0O1GS,Fulranumab,Back pain , Phase 3
19985,D0O1GS,Fulranumab,Arthralgia , Phase 3
19986,D0O1HL,SC-49483,Acquired immune deficiency syndrome , Phase 2
19987,D0O1IM,CC-115,Non-hodgkin lymphoma , Phase 1
19988,D0O1IM,CC-115,Multiple myeloma , Phase 1
19989,D0O1KX,Avasimibe,Peripheral vascular disease , Discontinued in Phase 3
19990,D0O1LD,ZSTK474,Solid tumour/cancer , Phase 1
19991,D0O1LU,EP-51389,Eating disorder , Phase 1
19992,D0O1MP,CARZELESIN,Solid tumour/cancer , Discontinued in Phase 2
19993,D0O1OL,Polymyxins,Gram-positive bacterial infection , Investigative
19994,D0O1OX,GA-FSH,Female infertility , Terminated
19995,D0O1PH,Ethanolamine oleate,Bleeding disorder , Approved
19996,D0O1PU,BAY-39-9624,Osteoporosis , Terminated
19997,D0O1RH,KYN-54,Solid tumour/cancer , Terminated
19998,D0O1TC,Gamma-Homolinolenic acid,Malnutrition , Approved
19999,D0O1TJ,SAR439859,Breast cancer , Phase 2
20000,D0O1TJ,SAR439859,Solid tumour/cancer , Phase 1
20001,D0O1UC,NTC-801,Atrial flutter , Discontinued in Phase 1
20002,D0O1UC,NTC-801,Atrial fibrillation , Discontinued in Phase 1
20003,D0O1UT,ICX-PRO,Diabetic foot ulcer , Phase 3
20004,D0O1UX,Peanut allergy desensitization vaccine,Allergy , Phase 3
20005,D0O1UX,Peanut allergy desensitization vaccine,Hypersensitivity , Phase 2
20006,D0O1UZ,Cannabidiol,LennoxGastaut syndrome , Approved
20007,D0O1UZ,Cannabidiol,Dravet syndrome , Approved
20008,D0O1UZ,Cannabidiol,Infantile spasm , Phase 3
20009,D0O1UZ,Cannabidiol,Epilepsy , Phase 2
20010,D0O1VU,EB-001,Musculoskeletal pain , Phase 2
20011,D0O1WJ,SR-1001,Diabetic retinopathy , Preclinical
20012,D0O1WJ,SR-1001,Multiple sclerosis , Investigative
20013,D0O1WR,GMZ-2,Malaria , Phase 1
20014,D0O1WX,Ciprofloxacin XR,Bacterial infection , Approved
20015,D0O1WX,Ciprofloxacin XR,Gram-positive bacterial infection , Approved
20016,D0O1WX,Ciprofloxacin XR,Cystic fibrosis , Phase 2
20017,D0O1WX,Ciprofloxacin XR,Biliary cancer , Phase 1
20018,D0O1XO,SYM-007,Solid tumour/cancer , Investigative
20019,D0O1XU,XR-3005,Colorectal cancer , Terminated
20020,D0O1XV,GSK2374697,Obesity , Phase 1
20021,D0O1YF,RhLT28-171,Solid tumour/cancer , Discontinued in Phase 2
20022,D0O1ZI,AZD8329,Obesity , Phase 1
20023,D0O1ZI,AZD8329,Diabetic complication , Phase 1
20024,D0O2AC,FR-145237,Arteriosclerosis , Terminated
20025,D0O2AG,Pirsidomine,Angina pectoris , Phase 2
20026,D0O2EB,F-11105,Asthma , Discontinued in Phase 1
20027,D0O2EM,Nevirapine,Human immunodeficiency virus infection , Approved
20028,D0O2ET,AD-5467,Diabetic complication , Discontinued in Phase 2
20029,D0O2FF,Epstein-Barr vaccine,Virus infection , Discontinued in Phase 2
20030,D0O2HQ,Iopamidol,Cardiovascular disease , Approved
20031,D0O2IE,Phenacetin,Analgesia , Withdrawn from market
20032,D0O2JI,Ertumaxomab,Breast cancer , Phase 2
20033,D0O2JT,MyVax,leukaemia , Phase 1/2
20034,D0O2MO,CRX-675,Hepatitis virus infection , Phase 1
20035,D0O2MW,APN-501,Solid tumour/cancer , Investigative
20036,D0O2NQ,Eraxis/Vfend,Fungal infection , Phase 3
20037,D0O2OU,HIV vaccines,Human immunodeficiency virus infection , Phase 1
20038,D0O2PK,PV-802,Gastrointestinal disease , Terminated
20039,D0O2PV,Carumonam,Bacterial infection , Approved
20040,D0O2QB,Zolimomab aritox,Arthritis , Discontinued in Phase 2
20041,D0O2SR,Nicorandil,Angina pectoris , Approved
20042,D0O2TG,LCA-AAV7,Visual disturbance , Investigative
20043,D0O2UF,Griffithsin,Human immunodeficiency virus infection , Investigative
20044,D0O2VZ,Otelixizumab,Type-1 diabetes , Phase 2
20045,D0O2WB,Pyridostigmine,Myasthenia gravis , Approved
20046,D0O2WJ,Losartan,Hypertension , Approved
20047,D0O2WJ,Losartan,Coronavirus Disease 2019 (COVID-19) , Phase 3
20048,D0O2XI,Enterotoxigenic E Coli vaccine,Escherichia coli infection , Terminated
20049,D0O2XJ,NXN-188,Migraine , Phase 2
20050,D0O2XK,Mesothelin-targeted T cells,Breast cancer , Phase 1
20051,D0O2XQ,AMD-070,Whim syndrome , Phase 3
20052,D0O2XQ,AMD-070,Human immunodeficiency virus infection , Phase 1/2
20053,D0O2XQ,AMD-070,Renal cell carcinoma , Phase 1/2
20054,D0O2XQ,AMD-070,Melanoma , Phase 1/2
20055,D0O2XQ,AMD-070,Merkel cell carcinoma , Phase 1/2
20056,D0O2XQ,AMD-070,Solid tumour/cancer , Phase 1/2
20057,D0O2XW,VT-111a,Acute coronary syndrome , Phase 2
20058,D0O2YE,HTF 919,Constipation , Approved
20059,D0O2ZI,90Y-labeled humanized anti-Tac mab,Non-hodgkin lymphoma , Phase 1/2
20060,D0O3AB,Butethal,Insomnia , Approved
20061,D0O3CV,Ridaforolimus,Sarcoma , Phase 3
20062,D0O3CX,BMS-906024,Breast cancer , Phase 2
20063,D0O3CX,BMS-906024,T-cell acute lymphocytic leukaemia , Phase 1
20064,D0O3CX,BMS-906024,Lymphoma , Phase 1
20065,D0O3DK,GTP-010,Dyspepsia , Phase 2
20066,D0O3DK,GTP-010,Irritable bowel syndrome , Phase 2
20067,D0O3DW,"Meningococcal meningitis polysaccharide serogroups A,C,Y and W-135 vaccine",Neisseria meningitis infection , Phase 2
20068,D0O3EP,SRT2379,Type-2 diabetes , Phase 1
20069,D0O3EX,LIQ861,Pulmonary arterial hypertension , Phase 3
20070,D0O3FG,Desvenlafaxine,Major depressive disorder , Approved
20071,D0O3FG,Desvenlafaxine,Menopause symptom , Phase 3
20072,D0O3FS,OBR-5-340,Coxsackie virus infection , Investigative
20073,D0O3JR,P-coumaric acid derivative 1,Albinism , Patented
20074,D0O3JR,P-coumaric acid derivative 1,Ephelides , Patented
20075,D0O3JR,P-coumaric acid derivative 1,Menkes disease , Patented
20076,D0O3JR,P-coumaric acid derivative 1,Senile lentigines , Patented
20077,D0O3JR,P-coumaric acid derivative 1,Melasma , Patented
20078,D0O3KA,RG7602,Lymphoma , Discontinued in Phase 1
20079,D0O3LC,AD-519,Human immunodeficiency virus infection , Terminated
20080,D0O3OI,AVL-3288,Cognitive impairment , Phase 1
20081,D0O3OI,AVL-3288,Complete androgen insensitivity syndrome , Phase 1
20082,D0O3OI,AVL-3288,Immune dysregulation , Phase 1
20083,D0O3OK,Motavizumab,Respiratory syncytial virus infection , Phase 3
20084,D0O3OS,SR141716A,Obesity , Approved
20085,D0O3PP,ARGENT,Prostate cancer , Terminated
20086,D0O3QW,Trodusquemine,Obesity , Phase 1
20087,D0O3QW,Trodusquemine,Breast cancer , Phase 1
20088,D0O3SA,ATL-801,Non-insulin dependent diabetes , Investigative
20089,D0O3TC,FK-962,Alzheimer disease , Phase 2
20090,D0O3TE,NRG-101,Schizophrenia , Investigative
20091,D0O3TG,PMID25666693-Compound-136,Osteoarthritis pain , Patented
20092,D0O3TG,PMID25666693-Compound-136,Cancer related pain , Patented
20093,D0O3TG,PMID25666693-Compound-136,Neuropathic pain , Patented
20094,D0O3TG,PMID25666693-Compound-136,Inflammatory pain , Patented
20095,D0O3TW,PT4.0,Gram-positive bacterial infection , Investigative
20096,D0O3VK,CEP-37249,Solid tumour/cancer , Investigative
20097,D0O3VP,BMS-914392,Atrial fibrillation , Phase 2
20098,D0O3XS,GSK311739,Rhinovirus infection , Phase 1
20099,D0O3XU,HO/03/03,Diabetic foot ulcer , Phase 2
20100,D0O3YA,OPRX,Allergic conjunctivitis , Investigative
20101,D0O3YF,Ciclosporin,Psoriasis vulgaris , Approved
20102,D0O3YF,Ciclosporin,Brain injury , Phase 4
20103,D0O3YF,Ciclosporin,Xerophthalmia , Investigative
20104,D0O3ZI,OpsoVac,Solid tumour/cancer , Investigative
20105,D0O4CH,CLR1404-I-131,Non-small-cell lung cancer , Phase 1/2
20106,D0O4EU,Acrivastine,Allergic rhinitis , Approved
20107,D0O4EV,ADI,Liver cancer , Discontinued in Phase 3
20108,D0O4FF,Debrase,Skin burns , Phase 3
20109,D0O4FF,Debrase,Diabetic retinopathy , Phase 2
20110,D0O4GY,Aminolevulinic Acid Hydrochloride,Actinic keratosis , Approved
20111,D0O4IN,MOR-202,Multiple myeloma , Phase 1/2
20112,D0O4JH,ACEA-1328,Cancer related pain , Terminated
20113,D0O4KT,Bioadhesive berry gel therapy,Dysplasia , Phase 1
20114,D0O4LG,HIV vaccine,Human immunodeficiency virus infection , Phase 1
20115,D0O4LU,SK-896,Gastric motility disorder , Discontinued in Phase 2
20116,D0O4MW,NV.BC.04,Inflammatory bowel disease , Investigative
20117,D0O4NJ,Z-100,Human immunodeficiency virus infection , Phase 1
20118,D0O4NR,LTB4,Human immunodeficiency virus infection , Phase 2
20119,D0O4QR,Cefodizime sodium,Bacterial infection , Approved
20120,D0O4QS,WX-554,Solid tumour/cancer , Phase 1/2
20121,D0O4RB,"DdRNAi therapy rHIV7-shl-TAR-CCR5RZ, stem cells",Human immunodeficiency virus infection , Phase 1/2
20122,D0O4RG,ADE-HYPT,Hypertension , Investigative
20123,D0O4RN,Sulfonylated piperazine derivative 5,Obesity , Patented
20124,D0O4RQ,Focetria A(H1N1),Influenza virus infection , Approved
20125,D0O4SE,Tindamax,Bacterial infection , Approved
20126,D0O4SH,SAR-156597,Pulmonary fibrosis , Phase 2
20127,D0O4SH,SAR-156597,Idiopathic pulmonary fibrosis , Phase 2
20128,D0O4SH,SAR-156597,Systemic sclerosis , Phase 2
20129,D0O4SZ,EDP-09,Ischemia , Investigative
20130,D0O4TC,PMID26651364-Compound-10b,Crohn disease , Patented
20131,D0O4TC,PMID26651364-Compound-10b,Ulcerative colitis , Patented
20132,D0O4TC,PMID26651364-Compound-10b,Urinary tract infection , Patented
20133,D0O4UZ,Gp41 HIV-1 vaccine,Human immunodeficiency virus infection , Phase 1
20134,D0O4VW,TAL-0500018,Peripheral arterial occlusive disorder , Phase 2
20135,D0O4VW,TAL-0500018,Peripheral arterial disease , Phase 2
20136,D0O4VW,TAL-0500018,Stroke , Phase 1/2
20137,D0O4WB,OBP-601,Human immunodeficiency virus-1 infection , Phase 2
20138,D0O4XW,ONO-4819,Fracture , Discontinued in Phase 2
20139,D0O4YE,Anti-CD19,leukaemia , Phase 1
20140,D0O5AG,Baloxavir marboxil,Influenza virus infection , Approved
20141,D0O5CL,ARO 087,Solid tumour/cancer , Investigative
20142,D0O5CV,MEDI4212,Asthma , Phase 1
20143,D0O5ER,Catumaxomab,Malignant pleural effusion , Approved
20144,D0O5ER,Catumaxomab,Ovarian cancer , Phase 2
20145,D0O5FY,Meropenem,Bacterial infection , Approved
20146,D0O5GK,R-phenserine,Cognitive impairment , Phase 2
20147,D0O5GK,R-phenserine,Alzheimer disease , Phase 2
20148,D0O5GK,R-phenserine,Dementia , Phase 1/2
20149,D0O5HB,ATX-MS3,Multiple sclerosis , Investigative
20150,D0O5KH,Altrakincept,Asthma , Phase 2
20151,D0O5KY,Recombinant human neuregulin-1 beta,Chronic heart failure , Phase 3
20152,D0O5LA,Progabide,Depression , Approved
20153,D0O5LL,GT-2342,Neurodegenerative disorder , Terminated
20154,D0O5LU,Latamoxef,Bacterial infection , Approved
20155,D0O5NK,Oseltamivir,Influenza virus infection , Approved
20156,D0O5OF,SDZ-281-240,Pruritus , Phase 2
20157,D0O5QL,HT-1067,Parkinson disease , Discontinued in Phase 1
20158,D0O5QT,PD-0805,Parkinson disease , Investigative
20159,D0O5SZ,Homatropine Methylbromide,Uveitis , Approved
20160,D0O5SZ,Homatropine Methylbromide,Peptic ulcer , Approved
20161,D0O5TQ,Pentagastrin,Diagnostic imaging , Approved
20162,D0O5TR,RBP-7000,Non-small-cell lung cancer , Phase 3
20163,D0O5TR,RBP-7000,Schizophrenia , Application submitted
20164,D0O5UF,CNX-011,Non-insulin dependent diabetes , Investigative
20165,D0O5VR,TP-2758,Bacterial infection , Investigative
20166,D0O5WD,Lactoferrin,Solid tumour/cancer , Approved
20167,D0O5WP,Docetaxel,Solid tumour/cancer , Approved
20168,D0O5XF,CeaVac,Colorectal cancer , Phase 2
20169,D0O5XJ,XL652/XL014,Metabolic disorder , Phase 1
20170,D0O5XJ,XL652/XL014,Cardiovascular disease , Phase 1
20171,D0O5XQ,AL-60371,Small-cell lung cancer , Phase 3
20172,D0O5YZ,Mepindolol,Angina pectoris , Approved
20173,D0O5ZB,Ilodecakin,Sarcoidosis , Phase 2
20174,D0O5ZT,Organon-2,Schizophrenia , Preclinical
20175,D0O6AQ,Gavestinel,Nerve injury , Discontinued in Phase 2
20176,D0O6BJ,MP40X,Solid tumour/cancer , Phase 2
20177,D0O6BW,Encepur,Pediatric cancer , Phase 3
20178,D0O6BW,Encepur,Flavivirus infection , Phase 3
20179,D0O6DC,LY-2463665,Type-2 diabetes , Preclinical
20180,D0O6DE,RG-101,Hepatitis C virus infection , Phase 2
20181,D0O6EQ,mRNA-1388,Chikungunya virus infection , Phase 1
20182,D0O6GC,Methysergide,Migraine , Approved
20183,D0O6GN,"Mdl 101,146",Inflammation , Terminated
20184,D0O6HP,KAI-9803,Acute myocardial infarction , Phase 1/2
20185,D0O6IU,Phenylephrine,Fecal incontinence , Approved
20186,D0O6IU,Phenylephrine,Ophthalmic graves disease , Approved
20187,D0O6IZ,Naphazoline,Itching , Approved
20188,D0O6IZ,Naphazoline,Hyperaemia , Approved
20189,D0O6JE,Multiform PI3K inhibitors,Inflammation , Investigative
20190,D0O6KE,Repirinast,Asthma , Approved
20191,D0O6LR,Autologous CD19-targeting CAR T cells,leukaemia , Phase 1/2
20192,D0O6LY,MAT-304,Autoimmune diabetes , Investigative
20193,D0O6NA,JNJ-10229570,Acne vulgaris , Phase 2
20194,D0O6OK,LY3074828,Ulcerative colitis , Phase 2
20195,D0O6OM,CGEN-15001,Autoimmune diabetes , Investigative
20196,D0O6OZ,Sodium iodide I 131,Hyperthyroidism , Approved
20197,D0O6QW,Manifaxine,Major depressive disorder , Discontinued in Phase 2
20198,D0O6RK,MD-0727,Hypercholesterolaemia , Phase 2
20199,D0O6RU,Cepacidine A,Fungal infection , Terminated
20200,D0O6SA,KA2507,Solid tumour/cancer , Phase 1
20201,D0O6SQ,Ro-25-4835,Bacterial infection , Terminated
20202,D0O6SX,Hydroxyzine,Anxiety disorder , Approved
20203,D0O6TD,BBT-021,Anemia , Investigative
20204,D0O6UF,403U76,Major depressive disorder , Terminated
20205,D0O6UY,Pemigatinib,Cholangiocarcinoma , Approved
20206,D0O6UY,Pemigatinib,Bladder cancer , Phase 2
20207,D0O6UY,Pemigatinib,Myeloproliferative syndrome , Phase 2
20208,D0O6UZ,Sertaconazole,Fungal infection , Approved
20209,D0O6VU,PMID25666693-Compound-92,Osteoarthritis pain , Patented
20210,D0O6VU,PMID25666693-Compound-92,Cancer related pain , Patented
20211,D0O6VU,PMID25666693-Compound-92,Neuropathic pain , Patented
20212,D0O6VU,PMID25666693-Compound-92,Inflammatory pain , Patented
20213,D0O6VZ,GDC-0980/RG7422,Non-hodgkin lymphoma , Phase 2
20214,D0O6VZ,GDC-0980/RG7422,Solid tumour/cancer , Phase 1
20215,D0O6WJ,Ecalcidene,Acne vulgaris , Terminated
20216,D0O6WS,APC-004,Solid tumour/cancer , Investigative
20217,D0O6WZ,OcuNex,Wound healing , Discontinued in Phase 2
20218,D0O6YE,RG7450,Prostate cancer , Phase 1
20219,D0O6ZO,TAK-715,Rheumatoid arthritis , Phase 2
20220,D0O7AK,SF-107,Allergy , Investigative
20221,D0O7BW,SC-102,Solid tumour/cancer , Terminated
20222,D0O7CO,MyoCell,Congestive heart failure , Phase 2/3
20223,D0O7CO,MyoCell,Heart injury , Phase 2/3
20224,D0O7DB,A-204176,Stress urinary incontinence , Terminated
20225,D0O7DG,Histrelin,Polycystic ovarian syndrome , Approved
20226,D0O7DG,Histrelin,Endometriosis , Approved
20227,D0O7DG,Histrelin,Central precocious puberty , Approved
20228,D0O7DN,CEP-427,Alzheimer disease , Terminated
20229,D0O7DP,CVT-12012,Diabetic complication , Investigative
20230,D0O7DU,CT-1746,Colorectal cancer , Terminated
20231,D0O7DZ,R-61837,Virus infection , Discontinued in Phase 2
20232,D0O7EC,ADCON-I,Wound healing , Terminated
20233,D0O7ES,Heberpenta L,Hepatitis B virus infection , Approved
20234,D0O7GB,SPK-RPE65,Retinitis pigmentosa , Phase 3
20235,D0O7GU,Palifermin,Oral mucositis , Approved
20236,D0O7HP,example 98 (WO2011020806),Focal segmental glomerulosclerosis , Clinical trial
20237,D0O7IQ,PMID25666693-Compound-6,Osteoarthritis pain , Patented
20238,D0O7IQ,PMID25666693-Compound-6,Cancer related pain , Patented
20239,D0O7IQ,PMID25666693-Compound-6,Neuropathic pain , Patented
20240,D0O7IQ,PMID25666693-Compound-6,Inflammatory pain , Patented
20241,D0O7IZ,Anti-MIF antibodies,Autoimmune diabetes , Phase 4
20242,D0O7JK,ISG15-LNP01,Hepatitis C virus infection , Investigative
20243,D0O7JW,Alcaftadine,Allergic conjunctivitis , Approved
20244,D0O7KV,P1201-07,Metabolic disorder , Phase 1
20245,D0O7NF,MCP-205,Ischemic heart disease , Investigative
20246,D0O7NV,DOV-51892,Panic disorder , Investigative
20247,D0O7PS,AERAS-402,Mycobacterium infection , Phase 2
20248,D0O7QA,PF-05089771,Chronic pain , Phase 2
20249,D0O7QQ,BIIB 022,Non-small-cell lung cancer , Phase 1
20250,D0O7QQ,BIIB 022,Hepatocellular carcinoma , Phase 1
20251,D0O7RY,IDR-1018,Bacterial infection , Phase 1
20252,D0O7SC,D-11B,Solid tumour/cancer , Investigative
20253,D0O7SP,Bamifylline,Chronic obstructive pulmonary disease , Approved
20254,D0O7UU,GEM-SP,Multiple sclerosis , Phase 2
20255,D0O7VZ,AntiCD19 CART,Non-hodgkin lymphoma , Phase 1
20256,D0O7XA,Anti-BCMA CAR-T cell therapy,Multiple myeloma , Phase 1
20257,D0O7XG,SEM-606,Neurological disorder , Investigative
20258,D0O7XO,AOD-9604,Obesity , Discontinued in Phase 2
20259,D0O7ZR,NZ-4,Hepatitis B virus infection , Investigative
20260,D0O8AR,AZ-23,Solid tumour/cancer , Investigative
20261,D0O8AY,Combined PR1/WT1 vaccine,Myeloid leukaemia , Phase 2
20262,D0O8BP,ISIS 13920,Solid tumour/cancer , Investigative
20263,D0O8BQ,NT-KO-012,Neurodegenerative disorder , Investigative
20264,D0O8BS,AZD1656,Diabetic complication , Phase 2
20265,D0O8DI,Nitrous oxide,Anxiety disorder , Approved
20266,D0O8EH,NKTT-320,Solid tumour/cancer , Investigative
20267,D0O8EK,A-54145,Bacterial infection , Preclinical
20268,D0O8EX,PMID26651364-Compound-8c,Crohn disease , Patented
20269,D0O8EX,PMID26651364-Compound-8c,Ulcerative colitis , Patented
20270,D0O8EX,PMID26651364-Compound-8c,Urinary tract infection , Patented
20271,D0O8FI,"1,3-dihydroxy phenyl derivative 1",Solid tumour/cancer , Patented
20272,D0O8FI,"1,3-dihydroxy phenyl derivative 1",Infectious disease , Patented
20273,D0O8FI,"1,3-dihydroxy phenyl derivative 1",Human immunodeficiency virus infection , Patented
20274,D0O8FI,"1,3-dihydroxy phenyl derivative 1",Hepatitis , Patented
20275,D0O8FN,INDUS-815B,Kidney disease , Investigative
20276,D0O8GK,Osimertinib,Non-small-cell lung cancer , Approved
20277,D0O8GK,Osimertinib,Melanoma , Phase 3
20278,D0O8GZ,KI-0904,Solid tumour/cancer , Investigative
20279,D0O8HK,BCL-003,Glioma , Investigative
20280,D0O8HL,EML-16257,Non-insulin dependent diabetes , Discontinued in Phase 2
20281,D0O8IS,Cloperastine,Cough , Approved
20282,D0O8JB,Secretin,Pancreatic exocrine dysfunction , Approved
20283,D0O8JB,Secretin,Gastrinoma , Approved
20284,D0O8JM,NX-210,Spinal cord injury , Investigative
20285,D0O8JW,Ronomilast,Chronic obstructive pulmonary disease , Phase 1
20286,D0O8KI,AL-43546,Xerophthalmia , Phase 2
20287,D0O8KX,Reslizumab,Severe asthma , Approved
20288,D0O8KX,Reslizumab,Eosinophilic asthma , Phase 3
20289,D0O8KX,Reslizumab,Asthma , Phase 2
20290,D0O8LW,CYANIDIN CHLORIDE MONOHYDRATE,Ulcer , Discontinued in Phase 2
20291,D0O8OB,Isoxsuprine,Cerebrovascular disease , Withdrawn from market
20292,D0O8QU,B7-2/GM-CSF cancer gene therapy vaccine,Solid tumour/cancer , Phase 1
20293,D0O8RL,EQ-1280,Diabetic complication , Investigative
20294,D0O8SB,OPK-0018,Asthma , Phase 1
20295,D0O8SJ,Umbralisib,Follicular lymphoma , Approved
20296,D0O8SJ,Umbralisib,Marginal zone lymphoma , Approved
20297,D0O8SJ,Umbralisib,Diffuse large B-cell lymphoma , Phase 2/3
20298,D0O8SJ,Umbralisib,Chronic lymphocytic leukaemia , Phase 2
20299,D0O8SJ,Umbralisib,Non-hodgkin lymphoma , Phase 2
20300,D0O8SS,SX8,Staphylococcus infection , Investigative
20301,D0O8SX,"Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1",Malignant thymoma , Patented
20302,D0O8SX,"Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1",Pruritus , Patented
20303,D0O8SX,"Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1",Chronic pain , Patented
20304,D0O8SX,"Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1",Neuropathic pain , Patented
20305,D0O8SX,"Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1",Thymic cancer , Patented
20306,D0O8SY,GI-197111,Alopecia , Terminated
20307,D0O8TE,LASSBio-1524,Inflammation , Investigative
20308,D0O8TJ,AR101,Allergy , Phase 3
20309,D0O8UB,RG7129,Alzheimer disease , Phase 1
20310,D0O8UF,SRSS-023,Migraine , Terminated
20311,D0O8UM,XEL-002BG,Pain , Investigative
20312,D0O8WM,SP-003,Asthma , Investigative
20313,D0O8YO,Technetium Tc-99m Exametazime Kit,Radioactive tracer , Approved
20314,D0O9AF,TKM-Ebola,Ebola virus infection , Phase 1
20315,D0O9AZ,CCR5Qb,Human immunodeficiency virus infection , Terminated
20316,D0O9DK,PF-05280586,Cluster headache , Phase 3
20317,D0O9DK,PF-05280586,Follicular lymphoma , Phase 3
20318,D0O9EM,Eptapirone,Anxiety disorder , Discontinued in Phase 1
20319,D0O9EQ,VX-210,Spinal cord injury , Phase 2/3
20320,D0O9EX,NANT merkel cell cancer vaccine,Merkel cell carcinoma , Phase 2
20321,D0O9FH,PUMVC3-hIGFBP-2,Ovarian cancer , Phase 1
20322,D0O9GI,PMID25666693-Compound-63,Osteoarthritis pain , Patented
20323,D0O9GI,PMID25666693-Compound-63,Cancer related pain , Patented
20324,D0O9GI,PMID25666693-Compound-63,Neuropathic pain , Patented
20325,D0O9GI,PMID25666693-Compound-63,Inflammatory pain , Patented
20326,D0O9HF,TrasGEX,Solid tumour/cancer , Phase 1
20327,D0O9HG,BAY-1006578,Alzheimer disease , Phase 1
20328,D0O9IB,CI-933,Cognitive impairment , Terminated
20329,D0O9JI,Transferrin CRM-107,Solid tumour/cancer , Discontinued in Phase 3
20330,D0O9KY,KI-0401,Infectious disease , Approved
20331,D0O9LN,ME-143,Solid tumour/cancer , Phase 1
20332,D0O9MX,Influenza vaccine,Influenza virus infection , Approved
20333,D0O9OC,AZD5658,Diabetic complication , Phase 1
20334,D0O9OC,AZD5658,Obesity , Phase 1
20335,D0O9PQ,AP26113,Solid tumour/cancer , Phase 2
20336,D0O9RJ,CDX-011,Lymphoma , Approved
20337,D0O9RV,MOD-5023,Hemophilia , Investigative
20338,D0O9UC,Tak-220,Human immunodeficiency virus-1 infection , Phase 1
20339,D0O9UG,ZD-0490,Colorectal cancer , Discontinued in Phase 1
20340,D0O9UN,SAR231893,Atopic dermatitis , Phase 3
20341,D0O9UN,SAR231893,Asthma , Phase 3
20342,D0O9UZ,Alfimeprase,Peripheral vascular disease , Phase 3
20343,D0O9VW,Lanperisone,Musculoskeletal disorder , Phase 3
20344,D0O9XN,APD-597,Type-2 diabetes , Phase 1
20345,D0O9XO,KH-902,Diabetic macular edema , Phase 3
20346,D0O9YG,Cycloguanil,Malaria , Investigative
20347,D0O9ZT,Ebola vaccine,Ebola virus infection , Phase 1
20348,D0OA0H,INO-3112,Head and neck cancer , Phase 1/2
20349,D0OA0H,INO-3112,Cervical cancer , Phase 1/2
20350,D0OA1P,PMID25666693-Compound-53,Osteoarthritis pain , Patented
20351,D0OA1P,PMID25666693-Compound-53,Cancer related pain , Patented
20352,D0OA1P,PMID25666693-Compound-53,Neuropathic pain , Patented
20353,D0OA1P,PMID25666693-Compound-53,Inflammatory pain , Patented
20354,D0OA5G,SNS-314,Solid tumour/cancer , Phase 1
20355,D0OA7W,HG-1141,Solid tumour/cancer , Investigative
20356,D0OB0F,Bosutinib,Breast cancer , Approved
20357,D0OB1J,Diltiazem,Hypertension , Approved
20358,D0OB2M,Mivacurium,Anaesthesia , Approved
20359,D0OB4R,EVP-0962,Alzheimer disease , Phase 2
20360,D0OB7J,NPC-15669,Inflammation , Discontinued in Phase 1
20361,D0OB9V,Ginkgo biloba extract,Alzheimer disease , Investigative
20362,D0OC0W,AVID100,Solid tumour/cancer , Phase 1/2
20363,D0OC3J,Flupenthixol,Schizophrenia , Withdrawn from market
20364,D0OC4O,RG7388,Solid tumour/cancer , Phase 3
20365,D0OC4O,RG7388,Acute myeloid leukaemia , Phase 3
20366,D0OC4O,RG7388,Polycythemia vera , Phase 2
20367,D0OC4O,RG7388,Haematological malignancy , Phase 1
20368,D0OC5C,ICAR19 CAR-T cells,B-cell lymphoma , Phase 1
20369,D0OC5C,ICAR19 CAR-T cells,leukaemia , Phase 1
20370,D0OC5T,ANX005,Neurodegenerative disorder , Phase 1
20371,D0OC6A,PMID25666693-Compound-75,Osteoarthritis pain , Patented
20372,D0OC6A,PMID25666693-Compound-75,Cancer related pain , Patented
20373,D0OC6A,PMID25666693-Compound-75,Neuropathic pain , Patented
20374,D0OC6A,PMID25666693-Compound-75,Inflammatory pain , Patented
20375,D0OC6H,S-024,Solid tumour/cancer , Investigative
20376,D0OD2I,Pralsetinib,Non-small-cell lung cancer , Approved
20377,D0OD2I,Pralsetinib,Solid tumour/cancer , Phase 1
20378,D0OD3T,Meningococcal ACYW-135 vaccine,Neisseria meningitis infection , Phase 3
20379,D0OD8T,CD19 CAR T cells,Acute lymphoblastic leukaemia , Phase 1
20380,D0OD8T,CD19 CAR T cells,B-cell non-hodgkin lymphoma , Phase 1
20381,D0OE2G,Fsn-1006,Breast cancer , Investigative
20382,D0OE2Z,ONO-8809,Thrombosis , Investigative
20383,D0OE4F,Imatinib and nilotinib derivative 1,Cas mediated disorder , Patented
20384,D0OE5S,UE-2343,Alzheimer disease , Phase 2
20385,D0OF1R,Oportuzumab monatox,Bladder cancer , Phase 3
20386,D0OF1R,Oportuzumab monatox,Head and neck cancer , Phase 2
20387,D0OF2K,Rh-thrombomodulin,Stroke , Approved
20388,D0OF4A,SART3 peptide cancer vaccine,Colorectal cancer , Phase 1
20389,D0OF9D,Hepatitis delta antigen,Hepatitis D virus infection , Terminated
20390,D0OG0X,GLS-5300,Coronavirus infection , Phase 1
20391,D0OG0X,GLS-5300,Respiratory syndrome coronavirus infection , Phase 1
20392,D0OG1V,MDX-066,Diarrhea , Phase 3
20393,D0OG3K,Lodoxamide,Asthma , Approved
20394,D0OG4A,Kirromycin,Bacterial infection , Clinical trial
20395,D0OG5K,Bismuth,Diarrhea , Approved
20396,D0OG6N,LM-1507.NA,Asthma , Phase 2
20397,D0OG8A,Sultamicillin tosilate,Bacterial infection , Approved
20398,D0OH1O,VULM-1457,Arteriosclerosis , Investigative
20399,D0OH2H,BR-4628,Heart failure , Phase 2
20400,D0OH2W,PF-02545920,Schizophrenia , Phase 2
20401,D0OH2W,PF-02545920,Huntington disease , Phase 2
20402,D0OH4N,Oraqix,Anaesthesia , Approved
20403,D0OH5E,Cartistem,Rheumatoid arthritis , Phase 3
20404,D0OH5V,PIROXANTRONE,Solid tumour/cancer , Terminated
20405,D0OH8O,E coli EPVaccine,Escherichia coli infection , Investigative
20406,D0OH8W,Visilizumab,Graft-versus-host disease , Phase 3
20407,D0OH9B,WS-070117,Hyperlipidaemia , Investigative
20408,D0OI5Y,Human serum albumin,Anemia , Investigative
20409,D0OI7B,AZD-5745,Gastrointestinal disease , Terminated
20410,D0OI8M,UISH-001,Urinary incontinence , Phase 1/2
20411,D0OJ4L,Hydroxychloroquine,Malaria , Approved
20412,D0OJ5M,OLPADRONIC ACID SODIUM SALT,Bone resorption , Investigative
20413,D0OK1N,Domagrozumab,Duchenne dystrophy , Phase 2
20414,D0OK1S,PMID30107136-Compound-Example2,Solid tumour/cancer , Patented
20415,D0OK1S,PMID30107136-Compound-Example2,Infectious disease , Patented
20416,D0OK1S,PMID30107136-Compound-Example2,Human immunodeficiency virus infection , Patented
20417,D0OK1S,PMID30107136-Compound-Example2,Hepatitis , Patented
20418,D0OK2N,AMG 208,Solid tumour/cancer , Phase 2
20419,D0OK3O,Cenderitide,Heart disease , Phase 2
20420,D0OK3O,Cenderitide,Heart failure , Phase 1
20421,D0OK4O,Dalazatide,Inclusion body myositis , Phase 1b/2a
20422,D0OK4O,Dalazatide,Psoriasis vulgaris , Phase 1b/2a
20423,D0OK4O,Dalazatide,Plaque psoriasis , Phase 1
20424,D0OK5I,Tridihexethyl,Acquired nystagmus , Approved
20425,D0OK5Q,Diphemanil Methylsulfate,Peptic ulcer , Approved
20426,D0OK5R,OP-R003,Haematological malignancy , Phase 1
20427,D0OK6F,TRV734,Chronic pain , Phase 1
20428,D0OK8M,TEI-6522,Arteriosclerosis , Terminated
20429,D0OK9X,AZD6765,Major depressive disorder , Discontinued in Phase 2
20430,D0OL4S,GLY-515n,Cerebrovascular ischaemia , Terminated
20431,D0OL6O,Methyl aminolevulinate,Acne vulgaris , Approved
20432,D0OL7F,Uridine triacetate,Pancreatic cancer , Approved
20433,D0OL7F,Uridine triacetate,Diabetic complication , Approved
20434,D0OL9V,CGS-24565,Arteriosclerosis , Terminated
20435,D0OM0M,AVE1625,Psychotic disorder , Discontinued in Phase 2
20436,D0OM0X,IB-201,Bacillus anthracis infection , Investigative
20437,D0OM3A,Follitropin beta,Female infertility , Approved
20438,D0OM5L,VC-01,Type-1 diabetes , Phase 1/2
20439,D0OM5M,Ro-48-1220,Bacterial infection , Terminated
20440,D0OMC3,2E9IgA1,Mycobacterium infection , Preclinical
20441,D0ON4J,Muscle wasting protein therapeutics,Muscle wasting disease , Investigative
20442,D0ON4M,PMID25666693-Compound-8,Osteoarthritis pain , Patented
20443,D0ON4M,PMID25666693-Compound-8,Cancer related pain , Patented
20444,D0ON4M,PMID25666693-Compound-8,Neuropathic pain , Patented
20445,D0ON4M,PMID25666693-Compound-8,Inflammatory pain , Patented
20446,D0OO1S,Anti-CD38 CAR-T cells,Multiple myeloma , Phase 1/2
20447,D0OO3J,FluGEM,Influenza virus infection , Phase 1
20448,D0OO6A,Isbogrel,Angina pectoris , Discontinued in Preregistration
20449,D0OO8M,MAA868,Stroke , Phase 2
20450,D0OP1L,Anti-CEA CAR-T therapy,Liver metastasis , Phase 1
20451,D0OP1L,Anti-CEA CAR-T therapy,Metastatic liver cancer , Phase 1
20452,D0OP2E,D-81050,Solid tumour/cancer , Investigative
20453,D0OP7B,LY-210073,Asthma , Terminated
20454,D0OP7I,CARCIK-CD19,Acute lymphocytic leukaemia , Phase 1/2
20455,D0OP8W,Zalospirone,Anxiety disorder , Phase 2
20456,D0OQ1A,JNJ-55308942,Anhedonia , Phase 1
20457,D0OQ1A,JNJ-55308942,Mood disorder , Phase 1
20458,D0OQ1A,JNJ-55308942,Neuroinflammation , Phase 1
20459,D0OQ1I,Narciclasine,Melanoma , Investigative
20460,D0OQ2R,Mannoside derivative 1,Crohn disease , Patented
20461,D0OQ2R,Mannoside derivative 1,Ulcerative colitis , Patented
20462,D0OQ2R,Mannoside derivative 1,Urinary tract infection , Patented
20463,D0OQ3L,SL65.0472,Cardiovascular disease , Discontinued in Phase 2
20464,D0OQ4H,A-69024,Psychotic disorder , Terminated
20465,D0OQ5H,"6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)",Ovarian cancer , Investigative
20466,D0OQ5R,IGN523,Acute myeloid leukaemia , Phase 1
20467,D0OQ5W,Meninge ACYW,Rheumatoid arthritis , Phase 2
20468,D0OQ5W,Meninge ACYW,Meningococcal infection , Phase 2
20469,D0OQ8Q,Vatiquinone,Friedreich's ataxia , Phase 2
20470,D0OQ9V,BMN-110,Morquio syndrome , Phase 3
20471,D0OR2L,Cholic Acid,Synthesis disorder , Approved
20472,D0OR2L,Cholic Acid,Peroxisomal disorder , Approved
20473,D0OR2S,Broxaterol,Asthma , Discontinued in Phase 3
20474,D0OR3G,Bexagliflozin,Type-2 diabetes , Phase 3
20475,D0OR5P,TAS-106,Head and neck cancer , Phase 2
20476,D0OR6A,Melinamide,Hypocholesterolemia , Approved
20477,D0OR6L,CAR-T cells targeting CD20,Non-hodgkin lymphoma , Phase 2
20478,D0OR7P,DARPins,Autoimmune diabetes , Investigative
20479,D0OR8W,ETIPREDNOL DICLOACETATE,Rhinitis , Phase 2
20480,D0OS3C,PF-05230901,Cachexia , Phase 1
20481,D0OS6O,Sertindole,Schizophrenia , Withdrawn from market
20482,D0OS6P,XBIO-101,Endometrial cancer , Phase 2
20483,D0OS6P,XBIO-101,Malignant uterine tumour , Phase 2
20484,D0OS7K,EGEN-001,Ovarian cancer , Phase 2
20485,D0OS7K,EGEN-001,Peritoneal cancer , Phase 2
20486,D0OS7K,EGEN-001,Fallopian tube cancer , Phase 2
20487,D0OS8C,NCX-1015,Rheumatoid arthritis , Phase 1
20488,D0OT0O,Foscavir,Cytomegalovirus retinitis , Approved
20489,D0OT1Q,Axalimogene filolisbac,Cervical cancer , Phase 3
20490,D0OT1Q,Axalimogene filolisbac,Anal cancer , Phase 2
20491,D0OT1Q,Axalimogene filolisbac,Head and neck cancer , Phase 2
20492,D0OT1S,CP-4200,Solid tumour/cancer , Investigative
20493,D0OT3G,"Pyrazolo[1,5-a]pyrimidine derivative 10",Obesity , Patented
20494,D0OT3L,Folate binding protein-E39,Endometrial cancer , Phase 1/2
20495,D0OT3Y,Sebriplatin,Solid tumour/cancer , Terminated
20496,D0OT8O,STP-601,Ocular disease , Investigative
20497,D0OT9S,Vinflunine,Solid tumour/cancer , Approved
20498,D0OU0S,FP-0110,Gastrointestinal disease , Phase 2
20499,D0OU1V,PD-155392,Bacterial infection , Terminated
20500,D0OU3Q,TAK-058,Schizophrenia , Phase 1
20501,D0OU3Q,TAK-058,XY disorder of sex development due to androgen resistance , Phase 1
20502,D0OU6W,GSK2696275,Wiskott-Aldrich syndrome , Phase 2
20503,D0OU7P,SKF 38393,Type-2 diabetes , Terminated
20504,D0OV2F,212Pb-labelled DOTAMTATE,Neuroendocrine cancer , Phase 1
20505,D0OV4A,Cystic fibrosis therapeutics,Cystic fibrosis , Investigative
20506,D0OW1R,YM-43611,Psychotic disorder , Terminated
20507,D0OW1V,Biaryl mannoside derivative 25,Crohn disease , Patented
20508,D0OW1V,Biaryl mannoside derivative 25,Ulcerative colitis , Patented
20509,D0OW1V,Biaryl mannoside derivative 25,Urinary tract infection , Patented
20510,D0OW2S,AMG 145,Hypercholesterolaemia , Phase 3
20511,D0OW4A,PD-145065,Hypertension , Phase 2
20512,D0OW5Y,NW-1772,Neurodegenerative disorder , Investigative
20513,D0OW6O,PMID26651364-Compound-11c,Crohn disease , Patented
20514,D0OW6O,PMID26651364-Compound-11c,Ulcerative colitis , Patented
20515,D0OW6O,PMID26651364-Compound-11c,Urinary tract infection , Patented
20516,D0OW6V,AZM-1,Neuropathic pain , Investigative
20517,D0OW6Z,Sipoglitazar,Diabetic complication , Terminated
20518,D0OW9L,MK-3134,Dementia , Phase 1
20519,D0OX1Y,Ad5-ENVA-48,Human immunodeficiency virus-1 infection , Phase 1
20520,D0OX5H,ABT-122,Rheumatoid arthritis , Phase 2
20521,D0OX5H,ABT-122,Psoriatic arthritis , Phase 2
20522,D0OX6I,KB-9520,Solid tumour/cancer , Investigative
20523,D0OX9F,BIIB074,Lumbosacral radiculopathy , Phase 2
20524,D0OX9F,BIIB074,Trigeminal neuralgia , Phase 2
20525,D0OX9F,BIIB074,Bipolar disorder , Phase 2
20526,D0OX9Q,NOX-200,Rheumatoid arthritis , Terminated
20527,D0OX9W,Inolimomab,Heart transplant rejection , Phase 3
20528,D0OY0Q,Tihotungstate derivative 1,Nervous system disease , Patented
20529,D0OY0Q,Tihotungstate derivative 1,Neurodegenerative disorder , Patented
20530,D0OY0Q,Tihotungstate derivative 1,Copper metabolism disorder , Patented
20531,D0OY0Q,Tihotungstate derivative 1,Aberrant vascularization , Patented
20532,D0OY1V,NS-1608,Cerebrovascular ischaemia , Terminated
20533,D0OY4K,Vestronidase alfa,Mucopolysaccharidosis , Approved
20534,D0OY5G,Brostallicin,Breast cancer , Phase 2
20535,D0OY5X,DermaGraft,Diabetic complication , Approved
20536,D0OY7A,RBx-343E48F0,Chronic obstructive pulmonary disease , Investigative
20537,D0OY9L,ALXN6000,Acute myeloid leukaemia , Phase 2
20538,D0OY9L,ALXN6000,Chronic lymphocytic leukaemia , Phase 1/2
20539,D0OY9L,ALXN6000,Solid tumour/cancer , Phase 1
20540,D0OY9S,Rose Bengal Sodium I-131,Ophthalmic disease , Approved
20541,D0OZ0Z,Elenagen,Solid tumour/cancer , Phase 1/2
20542,D0OZ3S,RJM-0035-K002,Hypertension , Investigative
20543,D0OZ4F,Ordopidine,Psychotic disorder , Discontinued in Phase 1
20544,D0OZ4J,RG-7446,Urothelial carcinoma , Approved
20545,D0OZ4J,RG-7446,Bladder cancer , Phase 3
20546,D0OZ5H,CD19-CAR T cell,Acute lymphoblastic leukaemia , Phase 1/2
20547,D0OZ5H,CD19-CAR T cell,Non-hodgkin lymphoma , Phase 1/2
20548,D0OZ6W,STAGR320,Allergic rhinitis , Phase 3
20549,D0OZ7P,BILN-2061,Hepatitis virus infection , Phase 2
20550,D0P0BY,Codrituzumab,Hepatic metastasis , Phase 2
20551,D0P0DA,BM-162115,Inflammation , Investigative
20552,D0P0DT,TAK-044,Renal failure , Discontinued in Phase 2
20553,D0P0EI,PRLX93936,Solid tumour/cancer , Phase 1/2
20554,D0P0FQ,Relenza,Erectile dysfunction , Phase 3
20555,D0P0HB,Ethionamide,Tuberculosis , Approved
20556,D0P0HI,AZD8330,Solid tumour/cancer , Discontinued in Phase 1
20557,D0P0HT,Fluorometholone,Chronic obstructive pulmonary disease , Approved
20558,D0P0HU,GSK1070916A,Solid tumour/cancer , Phase 1
20559,D0P0KN,TG02,Anaplastic astrocytoma , Phase 1/2
20560,D0P0KN,TG02,Recurrent glioblastoma , Phase 1/2
20561,D0P0KN,TG02,Solid tumour/cancer , Phase 1
20562,D0P0LD,Efgartigimod,Myasthenia gravis , Phase 2
20563,D0P0LT,GSK3052230,Solid tumour/cancer , Phase 1
20564,D0P0MR,PMID25666693-Compound-57,Osteoarthritis pain , Patented
20565,D0P0MR,PMID25666693-Compound-57,Cancer related pain , Patented
20566,D0P0MR,PMID25666693-Compound-57,Neuropathic pain , Patented
20567,D0P0MR,PMID25666693-Compound-57,Inflammatory pain , Patented
20568,D0P0NH,HZ-08,Solid tumour/cancer , Investigative
20569,D0P0NS,CD22-Targeted CAR-T cells,leukaemia , Phase 1/2
20570,D0P0NS,CD22-Targeted CAR-T cells,Lymphoma , Phase 1/2
20571,D0P0OE,Cefuzonam sodium,Bacterial infection , Approved
20572,D0P0OU,OPC-34712,Major depressive disorder , Approved
20573,D0P0PC,S-265744 LAP,Human immunodeficiency virus infection , Phase 1
20574,D0P0PT,Aromatic hydrazine carboxyimidoamide derivative 3,Albinism , Patented
20575,D0P0PT,Aromatic hydrazine carboxyimidoamide derivative 3,Ephelides , Patented
20576,D0P0PT,Aromatic hydrazine carboxyimidoamide derivative 3,Menkes disease , Patented
20577,D0P0PT,Aromatic hydrazine carboxyimidoamide derivative 3,Senile lentigines , Patented
20578,D0P0PT,Aromatic hydrazine carboxyimidoamide derivative 3,Melasma , Patented
20579,D0P0QG,HuMV833,Solid tumour/cancer , Discontinued in Phase 1
20580,D0P0QK,Cysteine Hydrochloride,Adverse reactions to acetaminophen or acetaminophen overdose , Approved
20581,D0P0RP,P113D,Cystic fibrosis , Discontinued in Phase 2
20582,D0P0RX,Nemonoxacin,Community-acquired pneumonia , Approved
20583,D0P0RX,Nemonoxacin,infection associated with diabetic foot ulcers , Phase 3
20584,D0P0SD,Eryaspase,Acute myeloid leukaemia , Phase 2
20585,D0P0SM,Almogran,Migraine , Approved
20586,D0P0SZ,Piperaquine,Malaria , Approved
20587,D0P0TA,GC-1008,Idiopathic pulmonary fibrosis , Phase 1
20588,D0P0TA,GC-1008,Pleural disease , Investigative
20589,D0P0TR,Meluadrine,Premature ejaculation , Discontinued in Preregistration
20590,D0P0VD,Co-trimoxazole,Diarrhea , Approved
20591,D0P0WF,PMID25684022-Compound-WO2011137219 35(1-11),Solid tumour/cancer , Patented
20592,D0P0WF,PMID25684022-Compound-WO2011137219 35(1-11),Metastatic cancer , Patented
20593,D0P0WV,Interferon Alfa-2b,Melanoma , Approved
20594,D0P0XX,Avermectins,Pest attack , Investigative
20595,D0P0YU,human allogeneic NK cell,Solid tumour/cancer , Phase 1
20596,D0P0ZY,Pomaglumetad,Schizophrenia , Phase 1
20597,D0P1AS,Rexin-G,Solid tumour/cancer , Approved
20598,D0P1BK,NC1153,Renal transplantation , Investigative
20599,D0P1BM,CAR-GPC3 T cells,Hepatocellular carcinoma , Clinical trial
20600,D0P1BR,VII-87-B,Hypertension , Investigative
20601,D0P1BZ,Daclizumab,Multiple sclerosis , Approved
20602,D0P1CE,CYT 99007,Acquired immune deficiency syndrome , Phase 2
20603,D0P1CV,PHA-793887,Solid tumour/cancer , Phase 1
20604,D0P1DI,MCLA-128,Breast cancer , Phase 2
20605,D0P1DP,NK-2210,Neurological disorder , Investigative
20606,D0P1EB,NIS215,Type-2 diabetes , Investigative
20607,D0P1FO,Marinol,Anorexia nervosa cachexia , Approved
20608,D0P1FO,Marinol,Chemotherapy-induced nausea , Phase 2/3
20609,D0P1FZ,Osteoblast cell therapy,Osteonecrosis , Phase 2
20610,D0P1HZ,CHAP1,Solid tumour/cancer , Investigative
20611,D0P1ID,MTRX-1011A,Autoimmune diabetes , Phase 1
20612,D0P1IJ,CytoCor,Wound healing , Investigative
20613,D0P1IX,OT-551,Ocular inflammation , Phase 2
20614,D0P1IZ,Gadobutrol,Blood brain barrier , Approved
20615,D0P1JA,LETRAZURIL,Isosporiasis , Phase 1
20616,D0P1JI,Wortmannin,Haematological malignancy , Terminated
20617,D0P1JL,Avaxim,Hepatitis A virus infection , Approved
20618,D0P1JV,Bio-Flow,Arteriosclerosis , Terminated
20619,D0P1KJ,SOM1201,Adrenoleukodystrophy , Phase 1
20620,D0P1LR,Pemedolac,Pain , Discontinued in Phase 2
20621,D0P1ME,MK-3222,Psoriasis vulgaris , Phase 3
20622,D0P1ME,MK-3222,Hairy cell leukaemia , Phase 3
20623,D0P1ME,MK-3222,Plaque psoriasis , Phase 3
20624,D0P1MI,MDDR 347017,Virus infection , Investigative
20625,D0P1QN,ND-701,Mycobacterium infection , Investigative
20626,D0P1QW,Becampanel,Epilepsy , Discontinued in Phase 2
20627,D0P1RC,BMP-655,Tendon injuries , Phase 1
20628,D0P1RL,Iodofiltic acid I-123,Myocardial disease , Approved
20629,D0P1RV,ATX-GD,Graves disease , Investigative
20630,D0P1SA,Autologous endothelial progenitor cell therapy,Ischemic heart disease , Phase 2/3
20631,D0P1TZ,MLN-977,Chronic obstructive pulmonary disease , Discontinued in Phase 2
20632,D0P1UX,Venlafaxine,Depression , Approved
20633,D0P1VT,Pyrimidinone derivative 1,Solid tumour/cancer , Patented
20634,D0P1VT,Pyrimidinone derivative 1,Metastatic cancer , Patented
20635,D0P1WA,Tiotropium,Chronic obstructive pulmonary disease , Approved
20636,D0P1WB,EVT-301,Alzheimer disease , Discontinued in Phase 1
20637,D0P1WR,ZP-004,Cough , Investigative
20638,D0P1XQ,SEL-73,Psychiatric disorder , Investigative
20639,D0P1YE,Orvepitant,Anxiety disorder , Phase 2
20640,D0P1YE,Orvepitant,Depression , Phase 2
20641,D0P1YH,S-1746,Cerebrovascular ischaemia , Discontinued in Phase 1
20642,D0P1YO,MOL-218,Asthma , Terminated
20643,D0P1ZR,Molecule 25,Human immunodeficiency virus-1 infection , Investigative
20644,D0P2AC,CH-4938056,Solid tumour/cancer , Investigative
20645,D0P2AG,Formoterol/budesonide,Asthma , Approved
20646,D0P2AL,YJP-40101,Gram-positive bacterial infection , Investigative
20647,D0P2BD,SAFIRONIL,Transplant rejection , Phase 1
20648,D0P2BJ,Quinazoline derivative 13,Multiple sclerosis , Patented
20649,D0P2BJ,Quinazoline derivative 13,Gastrointestinal disease , Patented
20650,D0P2BJ,Quinazoline derivative 13,Atopic dermatitis , Patented
20651,D0P2BJ,Quinazoline derivative 13,Arteriosclerosis , Patented
20652,D0P2BV,Human thrombin,Bleeding disorder , Approved
20653,D0P2CK,Estazolam,Insomnia , Approved
20654,D0P2CS,EVANS BLUE,Abdominal aortic aneurysm , Approved
20655,D0P2CZ,SPH-260-4,Bacterial infection , Investigative
20656,D0P2ED,GRC-17536,Pain , Phase 2
20657,D0P2EH,A-196,Discovery agent , Preclinical
20658,D0P2EX,M-enoxaparin,Acute coronary syndrome , Approved
20659,D0P2FC,ADMDD-15,Solid tumour/cancer , Investigative
20660,D0P2GA,CART-meso cells,Pancreatic cancer , Phase 1
20661,D0P2GK,Sodium phenylbutyrate,Spinal muscular atrophy , Approved
20662,D0P2GU,CSL-362-AML,leukaemia , Phase 1
20663,D0P2IT,Asiaticoside,Vulnerary , Approved
20664,D0P2IW,Peramivir,Influenza virus infection , Approved
20665,D0P2JH,Sulfur hexafluoride lipid-type a microspheres,Cardiovascular disease , Approved
20666,D0P2KG,GSK1144814,Schizophrenia , Phase 1
20667,D0P2KG,GSK1144814,Alcohol dependence , Phase 1
20668,D0P2LR,Leprovac,Mycobacterium infection , Approved
20669,D0P2MD,AMB-8LK,Liver cancer , Investigative
20670,D0P2ME,INO-5401,Bladder cancer , Phase 2
20671,D0P2ME,INO-5401,Recurrent glioblastoma , Phase 2
20672,D0P2ME,INO-5401,Glioblastoma of brain , Phase 1/2
20673,D0P2MF,N91115,Cystic fibrosis , Phase 2
20674,D0P2MH,BTS-67582,Diabetic complication , Discontinued in Phase 2
20675,D0P2OK,HPP404,Allergic rhinitis , Phase 1
20676,D0P2OW,IR208,Hepatitis C virus infection , Phase 2/3
20677,D0P2OW,IR208,Multiple sclerosis , Phase 2
20678,D0P2QO,S-15535,Anxiety disorder , Phase 2
20679,D0P2RO,SSR-126517E,Thrombosis , Phase 3
20680,D0P2SI,Galiximab,Lymphoma , Phase 2
20681,D0P2TD,ElCams,Infectious disease , Investigative
20682,D0P2YD,Isosulfan blue,Investigative surgical procedure , Approved
20683,D0P2YP,AGT-181,Mucopolysaccharidosis , Phase 1/2
20684,D0P2YS,A 77636,Parkinson disease , Terminated
20685,D0P2YU,Mitiglinide,Diabetic complication , Approved
20686,D0P2ZM,SLX-1016,Breast cancer , Investigative
20687,D0P2ZY,INNO-305,Lung cancer , Phase 1
20688,D0P2ZY,INNO-305,Acute myeloid leukaemia , Phase 1
20689,D0P3BS,TUTI-16,Human immunodeficiency virus-1 infection , Phase 1/2
20690,D0P3CF,AZD-4407,Chronic obstructive pulmonary disease , Discontinued in Phase 1
20691,D0P3DC,LP-10,Cystitis , Investigative
20692,D0P3DM,Fencamfamine,Depressive fatigue , Withdrawn from market
20693,D0P3EG,"1,3,4-oxadiazole derivative 2",Solid tumour/cancer , Patented
20694,D0P3EG,"1,3,4-oxadiazole derivative 2",Infectious disease , Patented
20695,D0P3EG,"1,3,4-oxadiazole derivative 2",Human immunodeficiency virus infection , Patented
20696,D0P3EG,"1,3,4-oxadiazole derivative 2",Hepatitis , Patented
20697,D0P3IE,ZK-93426,Alzheimer disease , Terminated
20698,D0P3IZ,E-2040,Schizophrenia , Terminated
20699,D0P3JF,SCH-900978,Cough , Phase 2
20700,D0P3JU,Clorazepate,Anxiety disorder , Approved
20701,D0P3KA,TEBUFELONE,Pain , Discontinued in Phase 2
20702,D0P3KH,PMUC5AC,Xerophthalmia , Investigative
20703,D0P3LQ,SIL-187,Metabolic disorder , Investigative
20704,D0P3NZ,CMP-1,Allergic rhinitis , Phase 1/2
20705,D0P3PB,RX-10045,Ocular disease , Phase 2
20706,D0P3PF,AMX-256,Short bowel syndrome , Investigative
20707,D0P3QR,Carbapenem antibacterials,Bacterial infection , Investigative
20708,D0P3SH,ReN-1826,Central nervous system disease , Terminated
20709,D0P3SJ,XP-21279,Parkinson disease , Phase 2
20710,D0P3SL,PMID26651364-Compound-8d,Crohn disease , Patented
20711,D0P3SL,PMID26651364-Compound-8d,Ulcerative colitis , Patented
20712,D0P3SL,PMID26651364-Compound-8d,Urinary tract infection , Patented
20713,D0P3SY,Danaparoid,Deep venous clot , Approved
20714,D0P3TF,TU-2100,Psoriasis vulgaris , Discontinued in Phase 2
20715,D0P3TT,IDR-90104,Male sexual disorder , Discontinued in Phase 2
20716,D0P3TX,Abciximab,Angina pectoris , Approved
20717,D0P3UZ,CNJ-H01,Hepatitis virus infection , Investigative
20718,D0P3VP,JKB-119,Liver disease , Investigative
20719,D0P3WH,Anti-CD27 agonist,Solid tumour/cancer , Phase 1
20720,D0P3ZA,AB-3001,Syndrome X , Investigative
20721,D0P3ZF,IGF-MTX,Chronic myelogenous leukaemia , Phase 1/2
20722,D0P3ZF,IGF-MTX,Myelodysplastic syndrome , Phase 1/2
20723,D0P3ZF,IGF-MTX,Solid tumour/cancer , Phase 1
20724,D0P3ZN,RDEA3170,Hyperuricaemia , Phase 2
20725,D0P4BC,Disulfiram,Alcohol dependence , Approved
20726,D0P4BC,Disulfiram,Severe acute respiratory syndrome (SARS) , Investigative
20727,D0P4BC,Disulfiram,Middle East Respiratory Syndrome (MERS) , Investigative
20728,D0P4BC,Disulfiram,Coronavirus Disease 2019 (COVID-19) , Investigative
20729,D0P4BQ,LY-544344,Anxiety disorder , Discontinued in Phase 3
20730,D0P4DG,S-070,Solid tumour/cancer , Investigative
20731,D0P4DJ,Somatropin recombinant,Growth hormone deficiency , Approved
20732,D0P4EC,Surfactant ta,Respiratory distress syndrome , Approved
20733,D0P4FK,TB-010,Breast cancer , Investigative
20734,D0P4FT,ART-123,Disseminated intravascular coagulation , Preclinical
20735,D0P4IK,FK-706,Pulmonary emphysema , Discontinued in Phase 2
20736,D0P4IL,REGN-728,Cardiovascular disease , Phase 1
20737,D0P4JJ,Adoptive T-cell therapy,Melanoma , Phase 1
20738,D0P4KP,CART19 cells,Hodgkin lymphoma , Phase 0
20739,D0P4KU,ABI-011,Solid tumour/cancer , Phase 1
20740,D0P4KU,ABI-011,Lymphoma , Phase 1
20741,D0P4KV,MesoStem,Insulin-dependent diabetes , Investigative
20742,D0P4MA,2-MOE phosphorothioate gapmers,Myotonic dystrophy , Investigative
20743,D0P4MN,ALO 212,Critical limb ischemia , Phase 1
20744,D0P4MT,Oxamniquine,Schistosomiasis , Approved
20745,D0P4PS,Antimalarial peroxides,Malaria , Investigative
20746,D0P4PZ,Glucarpidase,Delayed methotrexate clearance , Approved
20747,D0P4QX,LPG-1030S,Irritable bowel syndrome , Investigative
20748,D0P4RA,Repifermin,Oral mucositis , Discontinued in Phase 2
20749,D0P4RC,Sitostanol ascorbyl phosphate,Hyperlipidaemia , Phase 2
20750,D0P4TH,Trastuzumab-DM1,Breast cancer , Phase 3
20751,D0P4VX,Terlipressin,Hypertension , Approved
20752,D0P4WI,Recombinant human TNF receptor,Arthritis , Investigative
20753,D0P4WO,ADX10059,Anxiety disorder , Phase 2
20754,D0P4XW,Tremfya,Psoriatic arthritis , Phase 3
20755,D0P4ZA,EM-2198,Diabetic complication , Investigative
20756,D0P4ZR,Istiratumab,Pancreatic cancer , Phase 2
20757,D0P5AA,Oratecan,Solid tumour/cancer , Phase 1
20758,D0P5AE,Ecallantide,Retina venous occlusion , Approved
20759,D0P5AL,Profezyme,Wound healing , Approved
20760,D0P5AP,Recombinant factor viii,Hemophilia , Approved
20761,D0P5BQ,IkT-051,Influenza virus infection , Investigative
20762,D0P5CD,Iocetamic acid,Bladder disease , Approved
20763,D0P5CM,AZD-3161,Peripheral neuropathy , Phase 1
20764,D0P5DG,Temoporfin,Bone metastases , Approved
20765,D0P5DW,Ach-02,Analgesia , Approved
20766,D0P5DZ,V920,Ebola virus infection , Phase 3
20767,D0P5FA,Galnobax,Diabetic foot ulcer , Phase 1/2
20768,D0P5GE,Dibucaine,Anaesthesia , Approved
20769,D0P5IZ,BI-811283,Acute myeloid leukaemia , Phase 1
20770,D0P5JH,ABBV-368,Solid tumour/cancer , Phase 1
20771,D0P5LH,APL-2,Paroxysmal nocturnal haemoglobinuria , Phase 3
20772,D0P5LX,N-6060,Asthma , Investigative
20773,D0P5MG,BAY 94-9343,Solid tumour/cancer , Phase 1
20774,D0P5NU,BN-AA-003-NY,Estrogen deficiency , Preclinical
20775,D0P5NW,SB-236049,Bacterial infection , Terminated
20776,D0P5NY,SPD 535,Thrombosis , Discontinued in Phase 2
20777,D0P5PD,IMMU-114,leukaemia , Phase 1
20778,D0P5PD,IMMU-114,Haematological malignancy , Phase 1
20779,D0P5PJ,MK-1972,Human immunodeficiency virus-1 infection , Phase 1
20780,D0P5QB,Cadherin-11,Rheumatoid arthritis , Phase 1
20781,D0P5QR,KAC-776,Malaria , Investigative
20782,D0P5RD,PentaStaph,Staphylococcus infection , Phase 1/2
20783,D0P5RJ,BF/PC-18,Inflammation , Investigative
20784,D0P5SA,Fluphenazine,Psychotic disorder , Approved
20785,D0P5SB,PMID25666693-Compound-49,Osteoarthritis pain , Patented
20786,D0P5SB,PMID25666693-Compound-49,Cancer related pain , Patented
20787,D0P5SB,PMID25666693-Compound-49,Neuropathic pain , Patented
20788,D0P5SB,PMID25666693-Compound-49,Inflammatory pain , Patented
20789,D0P5SC,GTU-TB vaccine,Mycobacterium infection , Phase 1/2
20790,D0P5SU,CHS-131,Multiple sclerosis , Phase 2
20791,D0P5TC,BURKE-103,Verruca vulgaris , Investigative
20792,D0P5TG,Multi-epitope peptide melanoma vaccine,Melanoma , Phase 3
20793,D0P5TI,CNX-1351,Solid tumour/cancer , Investigative
20794,D0P5TR,CGP-28014,Major depressive disorder , Phase 2
20795,D0P5UE,50-235,Hypertension , Terminated
20796,D0P5UQ,Tissue repair stem cell therapy,Peripheral ischemia , Phase 1/2
20797,D0P5UQ,Tissue repair stem cell therapy,Dilated cardiomyopathy , Phase 1/2
20798,D0P5VC,Mirimostim,Constitutional neutropenia , Approved
20799,D0P5VH,VennVax,Virus infection , Investigative
20800,D0P5VX,Hormone-independent vaccine,Prostate hyperplasia , Terminated
20801,D0P5VZ,Tenecrin,Sepsis , Terminated
20802,D0P5XM,SM04755,Liver cancer , Phase 1
20803,D0P5XM,SM04755,Plaque psoriasis , Phase 1
20804,D0P5ZG,EradicAide,Human immunodeficiency virus infection , Investigative
20805,D0P5ZJ,GP-1100,Neuropathic pain , Investigative
20806,D0P6AL,VPX-595,Pain , Investigative
20807,D0P6CF,Ozanezumab,Lateral sclerosis , Phase 2
20808,D0P6CN,XR-368,Anxiety disorder , Terminated
20809,D0P6CQ,ADS-NPTMZ-1,Melanoma , Investigative
20810,D0P6DF,PD-153103,Human immunodeficiency virus-1 infection , Terminated
20811,D0P6DJ,VATALANIB,Solid tumour/cancer , Phase 2
20812,D0P6EL,Cordil,Heart arrhythmia , Terminated
20813,D0P6GT,Cipro Inhale,Lung infection , Phase 3
20814,D0P6GX,CZ-2645,Lung inflammation , Investigative
20815,D0P6IK,Lanatoside b,Cardiovascular disease , Approved
20816,D0P6JD,RGN-259,Vaginal infection , Phase 2
20817,D0P6LE,GSK2696274,Metachromatic leukodystrophy , Phase 2
20818,D0P6LP,CB-01-16,Constipation , Preclinical
20819,D0P6MB,Pexelizumab,Cardiovascular disease , Discontinued in Phase 3
20820,D0P6MW,Imprime PGG,Non-hodgkin lymphoma , Phase 2/3
20821,D0P6MW,Imprime PGG,Breast cancer , Phase 2
20822,D0P6MW,Imprime PGG,Head and neck cancer , Phase 2
20823,D0P6MW,Imprime PGG,Colorectal cancer , Phase 1/2
20824,D0P6MW,Imprime PGG,Melanoma , Phase 1/2
20825,D0P6NL,Technetium Tc-99m Pyrophosphate Kit,Radioactive tracer , Approved
20826,D0P6NP,EDP-239,Hepatitis C virus infection , Phase 1
20827,D0P6OS,TT-235,Miscarriage , Discontinued in Phase 1
20828,D0P6PT,Thiazole carboxamide derivative 21,Solid tumour/cancer , Patented
20829,D0P6PT,Thiazole carboxamide derivative 21,Metastatic cancer , Patented
20830,D0P6UB,Methamphetamine,Pain , Approved
20831,D0P6UB,Methamphetamine,Attention deficit hyperactivity disorder , Approved
20832,D0P6UK,Citrofen,Arthritis , Approved
20833,D0P6VV,Dezocine,Pain , Approved
20834,D0P6YD,MK-7252,Solid tumour/cancer , Phase 1
20835,D0P6YL,MX-35,Ovarian cancer , Investigative
20836,D0P6YN,CART-33 cells,Myelodysplastic syndrome , Phase 1
20837,D0P6YN,CART-33 cells,Acute myeloid leukaemia , Phase 1
20838,D0P6YO,NSD-721,Anxiety disorder , Terminated
20839,D0P6ZB,Resorcinol compound 14,Albinism , Patented
20840,D0P6ZB,Resorcinol compound 14,Ephelides , Patented
20841,D0P6ZB,Resorcinol compound 14,Menkes disease , Patented
20842,D0P6ZB,Resorcinol compound 14,Senile lentigines , Patented
20843,D0P6ZB,Resorcinol compound 14,Melasma , Patented
20844,D0P6ZH,Lercanidipine,Hypertension , Approved
20845,D0P7BA,INP102,Alzheimer disease , Phase 0
20846,D0P7BQ,Atpenin B,Solid tumour/cancer , Investigative
20847,D0P7EK,Mannitol,Bronchiectasis , Approved
20848,D0P7EK,Mannitol,Renal failure , Approved
20849,D0P7FM,INCB57643,Advanced malignancy , Phase 1/2
20850,D0P7GV,Annexin A5,Myocardial infarction , Investigative
20851,D0P7HI,AC-8632,Parkinson disease , Investigative
20852,D0P7HM,Aom-0821,Cardiovascular disease , Investigative
20853,D0P7HQ,Pyrazole derivative 13,Obesity , Patented
20854,D0P7IL,GLG-801,Chronic lymphocytic leukaemia , Phase 1/2
20855,D0P7JZ,Carbidopa,Parkinson disease , Approved
20856,D0P7KI,Anti-CD3 and anti-Her2/neu bispecific antibody-armed activated T cells,Breast cancer , Phase 2
20857,D0P7KS,N-3601,Heart disease , Terminated
20858,D0P7KU,TGF-BR2 mab,Solid tumour/cancer , Phase 1
20859,D0P7LP,Azetidine derivative 3,Obesity , Patented
20860,D0P7MF,CMLVAX100,leukaemia , Terminated
20861,D0P7MO,SFV IL-12 gene therapy,Breast cancer , Phase 2
20862,D0P7PD,Empagliflozin/linagliptin,Type-2 diabetes , Approved
20863,D0P7PY,Cirmtuzumab,Chronic lymphocytic leukaemia , Phase 2
20864,D0P7PY,Cirmtuzumab,Mantle cell lymphoma , Phase 1/2
20865,D0P7QA,Pyrazole derivative 14,Obesity , Patented
20866,D0P7QG,CNM-Au8,Neurodegenerative disorder , Phase 1
20867,D0P7RV,AVL-181,Hepatitis C virus infection , Investigative
20868,D0P7SO,ADMVA,Diabetic complication , Phase 2
20869,D0P7TK,Ebola virus vaccine + Matrix-M,Ebola virus infection , Phase 1
20870,D0P7UB,Benzothiazine-carboxamide compound 1,Skin inflammation , Patented
20871,D0P7VJ,Pramiracetam,Brain disease , Approved (orphan drug)
20872,D0P7VQ,BCTC,Pain , Investigative
20873,D0P7WJ,PSN357,Type-2 diabetes , Discontinued in Phase 2
20874,D0P7WW,ET-001,Influenza virus infection , Investigative
20875,D0P8AY,Dibenzepin,Anxiety disorder , Approved
20876,D0P8ED,Oncoquest-CLL,Chronic lymphocytic leukaemia , Phase 2
20877,D0P8ED,Oncoquest-CLL,leukaemia , Phase 1
20878,D0P8EU,Thymocartin,Hodgkin lymphoma , Discontinued in Phase 3
20879,D0P8HU,CCX-721,Multiple myeloma , Investigative
20880,D0P8IU,AE37/GP2 peptide vaccine,Breast cancer , Phase 2
20881,D0P8IV,Dactinomycin,Solid tumour/cancer , Approved
20882,D0P8JC,ANG-1007,Solid tumour/cancer , Investigative
20883,D0P8JX,L-734217,Thrombosis , Discontinued in Phase 1
20884,D0P8LR,HC3-1496,Autoimmune diabetes , Investigative
20885,D0P8MB,AIGIV,Diabetic neuropathy , Phase 1/2
20886,D0P8ME,LG-889,Factor VIII deficiency , Investigative
20887,D0P8MG,KDS-2000,Postherpetic neuralgia , Discontinued in Phase 2
20888,D0P8MI,Suplatast tosilate,Allergy , Approved
20889,D0P8NR,PRB-6014,Lipid metabolism disorder , Investigative
20890,D0P8NV,BCI-952,Major depressive disorder , Phase 2
20891,D0P8QC,CEN-209,Solid tumour/cancer , Investigative
20892,D0P8QN,Recombinant Factor IX,Bleeding disorder , Approved
20893,D0P8QN,Recombinant Factor IX,Factor IX deficiency , Terminated
20894,D0P8RS,Proguanil,Malaria , Approved
20895,D0P8SR,"Pyrrolo[2,3-b]pyridine derivative 1",Pruritus , Patented
20896,D0P8SR,"Pyrrolo[2,3-b]pyridine derivative 1",Solid tumour/cancer , Patented
20897,D0P8SR,"Pyrrolo[2,3-b]pyridine derivative 1",Chronic pain , Patented
20898,D0P8SR,"Pyrrolo[2,3-b]pyridine derivative 1",Neuropathic pain , Patented
20899,D0P8SR,"Pyrrolo[2,3-b]pyridine derivative 1",Thymic cancer , Patented
20900,D0P8TS,Eperisone,Muscle spasm , Phase 3
20901,D0P8UN,INV103,Systemic lupus erythematosus , Phase 2
20902,D0P8VT,PMID30280939-Compound-US20170128558,Malaria , Patented
20903,D0P8VZ,ACS-14,Cardiovascular disease , Investigative
20904,D0P8YC,Batimastat,Idiopathic pulmonary fibrosis , Preclinical
20905,D0P8YJ,PTI-80,Alzheimer disease , Phase 1
20906,D0P9AC,Phenelzine,Depression , Approved
20907,D0P9AC,Phenelzine,Skin imperfections , Patented
20908,D0P9AK,CPI-003,Myocardial infarction , Phase 1
20909,D0P9BT,Alicaforsen,Lleum inflammation , Phase 3
20910,D0P9BT,Alicaforsen,Ulcerative colitis , Phase 2
20911,D0P9BT,Alicaforsen,Crohn disease , Phase 2
20912,D0P9CB,LG631,Glioblastoma multiforme , Phase 1
20913,D0P9DL,HBV vaccine,Hepatitis B virus infection , Terminated
20914,D0P9EA,Paraldehyde,Insomnia , Approved
20915,D0P9EL,AS-601811,Acne vulgaris , Discontinued in Phase 1
20916,D0P9FT,REC-15-2739,Prostate disease , Discontinued in Phase 2
20917,D0P9JE,Yuganning,Influenza virus infection , Approved
20918,D0P9JW,Emeriamine,Diabetic complication , Terminated
20919,D0P9KA,YM-16151-4,Hypertension , Phase 1
20920,D0P9KD,PF-3732010,Solid tumour/cancer , Phase 1
20921,D0P9KJ,PMID25666693-Compound-43,Osteoarthritis pain , Patented
20922,D0P9KJ,PMID25666693-Compound-43,Cancer related pain , Patented
20923,D0P9KJ,PMID25666693-Compound-43,Neuropathic pain , Patented
20924,D0P9KJ,PMID25666693-Compound-43,Inflammatory pain , Patented
20925,D0P9KL,TAK-683,Prostate cancer , Discontinued in Phase 1
20926,D0P9KL,TAK-683,Allergy , Terminated
20927,D0P9LO,BP-2.94,Pain , Discontinued in Phase 2
20928,D0P9MW,IMP-321,Allergy , Phase 1/2
20929,D0P9NT,Sodium thiosulfate,Poison intoxication , Approved
20930,D0P9OU,Cat allergy vaccine,Non-cystic fibrosis bronchiectasis , Approved
20931,D0P9OW,PL-225B,Solid tumour/cancer , Phase 1
20932,D0P9QR,JNJ-61187165,Respiratory syncytial virus infection , Phase 1
20933,D0P9QW,Tipapkinogene sovacivec,Cervical Intraepithelial neoplasia , Phase 2
20934,D0P9RF,Terazosin,Benign prostatic hyperplasia , Approved
20935,D0P9TS,MNX-160,Cachexia , Terminated
20936,D0P9UP,Civacir,Pancreatic cancer , Phase 3
20937,D0P9UP,Civacir,Hepatitis C virus infection , Phase 3
20938,D0P9UX,AMG 211,Solid tumour/cancer , Phase 1
20939,D0P9WF,MTL-003,Solid tumour/cancer , Investigative
20940,D0P9XE,Rx-101005,Bacterial infection , Investigative
20941,D0P9XM,Cobomarsen,Cutaneous T-cell lymphoma , Phase 2
20942,D0P9XM,Cobomarsen,Chronic lymphocytic leukaemia , Phase 1
20943,D0P9XM,Cobomarsen,Diffuse large B-cell lymphoma , Phase 1
20944,D0P9XW,VR465,Respiratory syncytial virus infection , Phase 2
20945,D0P9YP,AVP-13358,Rhinitis , Phase 1
20946,D0P9YQ,Avotermin,Sarcoidosis , Phase 3
20947,D0PA0S,LJP-920,Transplant rejection , Terminated
20948,D0PA1B,DCDS-4501A,Diffuse large B-cell lymphoma , Phase 2
20949,D0PA1B,DCDS-4501A,Non-hodgkin lymphoma , Phase 2
20950,D0PA2N,Azlocillin,Pseudomonas infection , Approved
20951,D0PA2R,JD-4000,Inflammatory bowel disease , Investigative
20952,D0PA5S,Risedronate,Paget's disease , Approved
20953,D0PB0D,SRX-251,Dysmenorrhea , Phase 1
20954,D0PB0U,RG7893,Pain , Phase 1
20955,D0PB1C,TPM-02/Insulin,Diabetic complication , Discontinued in Phase 2
20956,D0PB3X,Vinylsulphones,Infection of P. falciparum , Investigative
20957,D0PB4P,XM-323,Human immunodeficiency virus infection , Discontinued in Phase 1
20958,D0PB6P,Org-9935,Asthma , Terminated
20959,D0PC1A,PAV-617,Ebola virus infection , Investigative
20960,D0PC1V,T-82,Cognitive impairment , Phase 2
20961,D0PC5A,VER-156084,Neuropathic pain , Investigative
20962,D0PC7I,L-742728,Bacterial infection , Terminated
20963,D0PC8Q,MCF,Cystic fibrosis , Investigative
20964,D0PD0F,Paeoniflorin,Parkinson disease , Investigative
20965,D0PD2I,Thiazole carboxamide derivative 8,Solid tumour/cancer , Patented
20966,D0PD2I,Thiazole carboxamide derivative 8,Metastatic cancer , Patented
20967,D0PD4C,CAR-T cells targeting CD22,leukaemia , Phase 1/2
20968,D0PD4C,CAR-T cells targeting CD22,Lymphoma , Phase 1/2
20969,D0PD4C,CAR-T cells targeting CD22,Multiple myeloma , Phase 1/2
20970,D0PE0D,Nuleusin,Melanoma , Discontinued in Phase 3
20971,D0PE1A,DBO-11,Cancer related pain , Terminated
20972,D0PE2L,GSK2402968,Duchenne dystrophy , Phase 3
20973,D0PE3J,CAR-T Cells targeting CD19,Acute lymphoblastic leukaemia , Phase 1
20974,D0PE3Z,JNJ-61610588,Solid tumour/cancer , Phase 1
20975,D0PE8P,PD173212,Pain , Investigative
20976,D0PE9T,GS-438,Solid tumour/cancer , Terminated
20977,D0PF1A,CAR-BCMA T cell,Multiple myeloma , Clinical trial
20978,D0PF3J,DOLASTATIN-10,Solid tumour/cancer , Phase 2
20979,D0PF8B,PEDF gene therapy,Macular degeneration , Phase 1
20980,D0PF9G,NN-4201,Non-insulin dependent diabetes , Discontinued in Phase 1
20981,D0PG0F,Mitumprotimut-t,Lymphoma , Phase 2
20982,D0PG0G,Drotrecogin alfa,Cerebrovascular ischaemia , Approved
20983,D0PG0G,Drotrecogin alfa,Severe sepsis , Approved
20984,D0PG0S,CI-999,Arteriosclerosis , Terminated
20985,D0PG2W,Biomin Peptide-II,Bone injury , Investigative
20986,D0PG5G,Infliximab,Plaque psoriasis , Approved
20987,D0PG5G,Infliximab,Asthma , Phase 3
20988,D0PG5G,Infliximab,Rheumatoid arthritis , Phase 2
20989,D0PG5J,ZD-4927,Thrombosis , Discontinued in Phase 1
20990,D0PG5O,MGA012,Non-small-cell lung cancer , Phase 3
20991,D0PG5O,MGA012,Metastatic colorectal cancer , Phase 2
20992,D0PG5O,MGA012,Merkel cell carcinoma , Phase 2
20993,D0PG5O,MGA012,Solid tumour/cancer , Phase 1
20994,D0PG5O,MGA012,Penile squamous cancer , Phase 1
20995,D0PG7V,Acocantherin,Middle East Respiratory Syndrome (MERS) , Investigative
20996,D0PG8O,Naltrexone,Alcohol dependence , Approved
20997,D0PG8O,Naltrexone,Human immunodeficiency virus infection , Phase 4
20998,D0PH0G,NKTR-171,Neuropathic pain , Investigative
20999,D0PH0M,IDD-3,Melanoma , Discontinued in Phase 2
21000,D0PH0U,TDI-0042,Motor neurone disease , Investigative
21001,D0PH4R,RG7842,Solid tumour/cancer , Phase 1
21002,D0PH5J,IN0-8000,Hepatitis C virus infection , Phase 1
21003,D0PH5Z,Ceftazidime,Bacterial infection , Approved
21004,D0PH6Z,CD19+ CAR T Cells,leukaemia , Phase 1
21005,D0PH6Z,CD19+ CAR T Cells,Lymphoma , Phase 1
21006,D0PH9I,AZD5153,Solid tumour/cancer , Phase 1
21007,D0PI1Z,Resorcinol compound 13,Albinism , Patented
21008,D0PI1Z,Resorcinol compound 13,Ephelides , Patented
21009,D0PI1Z,Resorcinol compound 13,Menkes disease , Patented
21010,D0PI1Z,Resorcinol compound 13,Senile lentigines , Patented
21011,D0PI1Z,Resorcinol compound 13,Melasma , Patented
21012,D0PI2E,Sulfoxone,Dermatitis herpetiformis , Approved
21013,D0PI3Z,Isepamicin,Bacterial infection , Approved
21014,D0PI4T,BW-42,Breast cancer , Investigative
21015,D0PJ4K,Calcium,Osteoporosis , Approved
21016,D0PJ7M,"1,2-dihydroindazolo[4,3-bc][1,5]benzoxazepine derivative 1",Solid tumour/cancer , Patented
21017,D0PJ7M,"1,2-dihydroindazolo[4,3-bc][1,5]benzoxazepine derivative 1",Metastatic cancer , Patented
21018,D0PJ8O,PMID25666693-Compound-129,Osteoarthritis pain , Patented
21019,D0PJ8O,PMID25666693-Compound-129,Cancer related pain , Patented
21020,D0PJ8O,PMID25666693-Compound-129,Neuropathic pain , Patented
21021,D0PJ8O,PMID25666693-Compound-129,Inflammatory pain , Patented
21022,D0PK0R,Piperazine derivative 2,Obesity , Patented
21023,D0PK3W,Lotilibcin,Bacterial infection , Phase 1
21024,D0PK5M,MLN0002,Crohn disease , Approved
21025,D0PK7J,bis-triazole derivative 10,Otitis media , Clinical trial
21026,D0PL2Q,Cytoros,Solid tumour/cancer , Investigative
21027,D0PL3N,Gefapixant,Cough , Phase 3
21028,D0PL3N,Gefapixant,Overactive bladder , Phase 2
21029,D0PL4F,GW-3965,Major depressive disorder , Investigative
21030,D0PL5F,OT-4003,Asthma , Terminated
21031,D0PL7P,CYC065,Lymphoma , Phase 1
21032,D0PL7P,CYC065,Solid tumour/cancer , Phase 1
21033,D0PL8D,PLX73086,Solid tumour/cancer , Phase 1
21034,D0PM0Y,Lonsurf,Gastric adenocarcinoma , Phase 3
21035,D0PM1R,TZ-93,Solid tumour/cancer , Terminated
21036,D0PM3G,BC-RD-03,Raynaud disease , Investigative
21037,D0PM7Q,AZD7762,Solid tumour/cancer , Phase 1
21038,D0PM9D,Porfiromycin,Head and neck cancer , Phase 3
21039,D0PM9P,KB-5246,Bacterial infection , Terminated
21040,D0PN1F,Carbenicillin Indanyl Sodium,Bacterial infection , Approved
21041,D0PN3M,CD19-directed CAR-T cells,leukaemia , Phase 1/2
21042,D0PN3M,CD19-directed CAR-T cells,Lymphoma , Phase 1/2
21043,D0PN4D,CPC-201,Alzheimer disease , Phase 2
21044,D0PN6U,PMID26815044-Compound-52,Albinism , Patented
21045,D0PN6U,PMID26815044-Compound-52,Ephelides , Patented
21046,D0PN6U,PMID26815044-Compound-52,Menkes disease , Patented
21047,D0PN6U,PMID26815044-Compound-52,Senile lentigines , Patented
21048,D0PN6U,PMID26815044-Compound-52,Melasma , Patented
21049,D0PN8H,Pacritinib,Myelofibrosis , Phase 3
21050,D0PN9E,SK-951,Gastrointestinal disease , Terminated
21051,D0PO0B,Cilobradine,Cardiac arrhythmias , Phase 1
21052,D0PO0L,Retroviral vector-transduced autologous T cells to express CD22-specific CARs,Diffuse large B-cell lymphoma , Phase 1
21053,D0PO0L,Retroviral vector-transduced autologous T cells to express CD22-specific CARs,Follicular lymphoma , Phase 1
21054,D0PO0L,Retroviral vector-transduced autologous T cells to express CD22-specific CARs,Mantle cell lymphoma , Phase 1
21055,D0PO0T,BMS-986036,Type-2 diabetes , Phase 2
21056,D0PO5W,Tissuegene-Cs,Articular cartilage disorder , Investigative
21057,D0PO9P,EIDD-2801,Coronavirus Disease 2019 (COVID-19) , Investigative
21058,D0PP0Z,CAL-202,Parainfluenza virus infection , Investigative
21059,D0PP5M,BPH-652,Hypercholesterolaemia , Investigative
21060,D0PP6A,ABT-165,Solid tumour/cancer , Phase 1
21061,D0PP8G,ONO-5129,Diabetic complication , Phase 2
21062,D0PQ3G,Furosemide,Congestive heart failure , Approved
21063,D0PQ3V,SYN-1134,Cystic fibrosis , Terminated
21064,D0PQ8T,SB-436811,Asthma , Phase 1
21065,D0PR4O,Ilixadencel,Renal cell carcinoma , Phase 2
21066,D0PR5H,BIS-001,Epilepsy , Phase 1
21067,D0PR6H,PENCLOMEDINE,Solid tumour/cancer , Phase 1
21068,D0PS2W,TILNOPROFEN ARBAMEL,Inflammation , Discontinued in Phase 3
21069,D0PS2X,GEM-ALS,Motor neurone disease , Investigative
21070,D0PS4C,ANGX-1039,Intermittent claudication , Phase 1
21071,D0PS6X,Mega-3-acid ethyl esters,Hypertriglyceridemia , Approved
21072,D0PT0U,PMID25666693-Compound-112,Osteoarthritis pain , Patented
21073,D0PT0U,PMID25666693-Compound-112,Cancer related pain , Patented
21074,D0PT0U,PMID25666693-Compound-112,Neuropathic pain , Patented
21075,D0PT0U,PMID25666693-Compound-112,Inflammatory pain , Patented
21076,D0PT1Y,SAR-161271,Type-1 diabetes , Phase 1/2
21077,D0PT2M,EGFRvIII-CARs,Recurrent glioblastoma , Phase 1
21078,D0PT5D,Anti-mesothelin CAR T Cells,Tumour , Phase 1
21079,D0PT6W,PIN-2,Solid tumour/cancer , Phase 1
21080,D0PT9G,INT230-6,Solid tumour/cancer , Phase 1/2
21081,D0PU1O,GRN-510,Pulmonary fibrosis , Investigative
21082,D0PU1W,MKC-180,Obesity , Investigative
21083,D0PU5L,Adaprolol maleate-SME,Glaucoma/ocular hypertension , Discontinued in Phase 2
21084,D0PU8T,E5555,Acute coronary syndrome , Phase 2
21085,D0PU8Z,Dacetuzumab,Non-hodgkin lymphoma , Terminated
21086,D0PU8Z,Dacetuzumab,Diffuse large B-cell lymphoma , Terminated
21087,D0PU9C,TTP-448,Alzheimer disease , Phase 2
21088,D0PV0I,AKCEA-APO(a)-LRX,Hyperlipoproteinemia , Phase 2
21089,D0PV1U,FP-0210,Cardiovascular disease , Investigative
21090,D0PV3Y,ME-1036,Bacterial infection , Terminated
21091,D0PV4H,Legumain-cleavable doxorubicin prodrugs,Solid tumour/cancer , Phase 2/3
21092,D0PV9N,GC4419,Oral mucositis , Phase 2
21093,D0PV9N,GC4419,Pancreatic cancer , Phase 1/2
21094,D0PW0G,Valategrast,Asthma , Discontinued in Phase 2
21095,D0PW4C,Niravoline,Pain , Phase 2
21096,D0PW4N,Ispinesib,Solid tumour/cancer , Phase 2
21097,D0PW4N,Ispinesib,Ovarian cancer , Phase 2
21098,D0PW4N,Ispinesib,Renal cell carcinoma , Phase 2
21099,D0PW4N,Ispinesib,Head and neck cancer , Phase 2
21100,D0PW7C,Cefaclor,Bacterial infection , Approved
21101,D0PX0N,TF0023,Heart attack , Phase 2
21102,D0PX0N,TF0023,Ischemic stroke , Phase 2
21103,D0PX0N,TF0023,Type-2 diabetes , Phase 2
21104,D0PX5F,NU-1001-41,Solid tumour/cancer , Investigative
21105,D0PX7X,Re-188-P-2045,Lung cancer , Phase 1/2
21106,D0PX8I,TTP435,Obesity , Phase 2
21107,D0PX8L,Clothiapine,Schizophrenia , Approved
21108,D0PY0G,PMID28270021-Compound-WO2010077680 201,Pruritus , Patented
21109,D0PY0G,PMID28270021-Compound-WO2010077680 201,Solid tumour/cancer , Patented
21110,D0PY0G,PMID28270021-Compound-WO2010077680 201,Chronic pain , Patented
21111,D0PY0G,PMID28270021-Compound-WO2010077680 201,Neuropathic pain , Patented
21112,D0PY0G,PMID28270021-Compound-WO2010077680 201,Thymic cancer , Patented
21113,D0PY3L,MEDI-565,Gastrointestinal cancer , Phase 1
21114,D0PY5D,Elacytarabine,Late-stage acute myeloid leukaemia , Phase 3
21115,D0PY5I,IC9-CAR19 T cells,B-cell lymphoma , Phase 1
21116,D0PY5I,IC9-CAR19 T cells,Immune System disease , Phase 1
21117,D0PY5I,IC9-CAR19 T cells,Immunoproliferative disorder , Phase 1
21118,D0PY5I,IC9-CAR19 T cells,Lymphoma , Phase 1
21119,D0PY5R,MDA-106,Neurodegenerative disorder , Investigative
21120,D0PY7Z,Aflunov,Influenza A virus H5N1 infection , Phase 1/2
21121,D0PZ4Y,PF-3557156,Pain , Discontinued in Phase 1
21122,D0PZ5Q,MK-5160,Type-1/2 diabetes , Phase 1
21123,D0PZ5R,BVS-212,Influenza virus infection , Investigative
21124,D0Q0AJ,SM-8849,Arthritis , Discontinued in Phase 2
21125,D0Q0AP,BMS-582949,Psoriasis vulgaris , Phase 2
21126,D0Q0AP,BMS-582949,Atherosclerosis , Phase 2
21127,D0Q0EF,ITI-007,Insomnia , Phase 3
21128,D0Q0EF,ITI-007,Schizophrenia , Phase 3
21129,D0Q0EF,ITI-007,Depression , Phase 3
21130,D0Q0EF,ITI-007,Major depressive disorder , Phase 2
21131,D0Q0EX,Lincomycin,Gram-positive bacterial infection , Approved
21132,D0Q0FW,N1-methylnicotinamide,Hyperlipidemia , Phase 2/3
21133,D0Q0GY,IW-1221,Asthma , Investigative
21134,D0Q0HR,Y-931,Schizophrenia , Terminated
21135,D0Q0HZ,Elpamotide,Biliary cancer , Phase 1/2
21136,D0Q0IM,SNA-125,Atopic dermatitis , Phase 1
21137,D0Q0IM,SNA-125,Pruritus , Phase 1
21138,D0Q0IM,SNA-125,Psoriasis vulgaris , Phase 1
21139,D0Q0IX,BIOD-531,Type-2 diabetes , Phase 2
21140,D0Q0JG,Ispaghula,Irritable bowel syndrome , Approved
21141,D0Q0JI,ASP-4058,Multiple sclerosis , Phase 1
21142,D0Q0JJ,Streptococcal B vaccine,Bacterial infection , Discontinued in Phase 2
21143,D0Q0KX,Fluorapacin,Solid tumour/cancer , Phase 1
21144,D0Q0LF,Vitatropin,Growth failure , Phase 1
21145,D0Q0LI,SER-109,Clostridium infection , Phase 3
21146,D0Q0MH,CM-101,Solid tumour/cancer , Terminated
21147,D0Q0MI,Zn-DPA-I,Bacterial infection , Investigative
21148,D0Q0OD,Secukinumab,Plaque psoriasis , Approved
21149,D0Q0OD,Secukinumab,Atopic dermatitis , Phase 2
21150,D0Q0OD,Secukinumab,Alopecia , Phase 2
21151,D0Q0OD,Secukinumab,Type-1 diabetes , Phase 2
21152,D0Q0OD,Secukinumab,Psoriatic arthritis , Phase 2
21153,D0Q0OD,Secukinumab,Multiple sclerosis , Phase 2
21154,D0Q0OD,Secukinumab,Dry eye disease , Phase 2
21155,D0Q0OD,Secukinumab,Rheumatoid arthritis , Phase 2
21156,D0Q0OP,CAB-2,Coronary artery disease , Discontinued in Phase 1
21157,D0Q0OY,213Bi DOTA-PESIN,Solid tumour/cancer , Investigative
21158,D0Q0PO,LY2780301,Solid tumour/cancer , Phase 1
21159,D0Q0PR,Novobiocin,Bacterial infection , Approved
21160,D0Q0RC,Ethopropazine,Parkinson disease , Approved
21161,D0Q0RK,AZD4721,Chronic obstructive pulmonary disease , Phase 1
21162,D0Q0RX,CD20-Specific CAR T Cells,Chronic lymphocytic leukaemia , Phase 1/2
21163,D0Q0RX,CD20-Specific CAR T Cells,Follicular lymphoma , Phase 1/2
21164,D0Q0RX,CD20-Specific CAR T Cells,Large cell lymphoma , Phase 1/2
21165,D0Q0RX,CD20-Specific CAR T Cells,Lymphoma , Phase 1/2
21166,D0Q0RX,CD20-Specific CAR T Cells,Mantle cell lymphoma , Phase 1/2
21167,D0Q0RX,CD20-Specific CAR T Cells,Non-hodgkin lymphoma , Phase 1/2
21168,D0Q0SK,MAGE-3-transduced autologous T-cell vaccine,Melanoma , Phase 2
21169,D0Q0SZ,OLAMUFLOXACIN MESILATE,Bacterial infection , Discontinued in Phase 3
21170,D0Q0TI,NT-KO-003,Motor neurone disease , Phase 2
21171,D0Q0TK,RST100,Retinitis pigmentosa , Phase 1/2
21172,D0Q0UA,UFT/leucovorin calcium,Colorectal cancer , Phase 2
21173,D0Q0XC,PMID26651364-Compound-9c,Crohn disease , Patented
21174,D0Q0XC,PMID26651364-Compound-9c,Ulcerative colitis , Patented
21175,D0Q0XC,PMID26651364-Compound-9c,Urinary tract infection , Patented
21176,D0Q0XH,EP-342,Solid tumour/cancer , Investigative
21177,D0Q0YN,SORAPRAZAN,Peptic ulcer , Discontinued in Phase 2
21178,D0Q0ZY,PRI-724,Acute myeloid leukaemia , Phase 1/2
21179,D0Q1BT,Clidinium,Irritable bowel syndrome , Approved
21180,D0Q1BT,Clidinium,Abdominal stomach pain , Approved
21181,D0Q1CD,Tanomastat,Osteoarthritis , Discontinued in Phase 3
21182,D0Q1CD,Tanomastat,Ovarian cancer , Discontinued in Phase 3
21183,D0Q1CD,Tanomastat,Lung cancer , Discontinued in Phase 3
21184,D0Q1CD,Tanomastat,Pancreatic cancer , Discontinued in Phase 3
21185,D0Q1EC,STAT-3 DECOY (NSC-741763),Solid tumour/cancer , Investigative
21186,D0Q1ER,CGS-12066B,Anxiety disorder , Terminated
21187,D0Q1GL,CT-200,Solid tumour/cancer , Phase 1
21188,D0Q1HD,TRV250,Migraine , Phase 1
21189,D0Q1HG,PA-1806,Bacterial infection , Discontinued in Phase 2
21190,D0Q1HU,Resorcinol compound 28,Albinism , Patented
21191,D0Q1HU,Resorcinol compound 28,Ephelides , Patented
21192,D0Q1HU,Resorcinol compound 28,Menkes disease , Patented
21193,D0Q1HU,Resorcinol compound 28,Senile lentigines , Patented
21194,D0Q1HU,Resorcinol compound 28,Melasma , Patented
21195,D0Q1IH,ATX-201,Actinic keratosis , Discontinued in Phase 2
21196,D0Q1IT,Aclidinium/formoterol,Chronic obstructive pulmonary disease , Phase 4
21197,D0Q1JW,Hirufaxin,Thrombosis , Terminated
21198,D0Q1JZ,Anti-OX40 monoclonal antibody,Prostate cancer , Phase 1/2
21199,D0Q1KN,SRP 299,Asthma , Discontinued in Phase 2
21200,D0Q1KP,R-18893,Human immunodeficiency virus infection , Discontinued in Phase 2
21201,D0Q1LH,Micacides,Virus infection , Investigative
21202,D0Q1LO,Sitamaquine,Infectious disease , Phase 2
21203,D0Q1MS,Ertapenem,Bacterial infection , Approved
21204,D0Q1MX,ImmunoPulse IL-12,Breast cancer , Phase 2
21205,D0Q1NF,3-(phenoxymethyl) benzylamine derivative 6,Albinism , Patented
21206,D0Q1NF,3-(phenoxymethyl) benzylamine derivative 6,Ephelides , Patented
21207,D0Q1NF,3-(phenoxymethyl) benzylamine derivative 6,Menkes disease , Patented
21208,D0Q1NF,3-(phenoxymethyl) benzylamine derivative 6,Senile lentigines , Patented
21209,D0Q1NF,3-(phenoxymethyl) benzylamine derivative 6,Melasma , Patented
21210,D0Q1NI,TBC-Thai,Human immunodeficiency virus infection , Discontinued in Phase 1
21211,D0Q1PR,Atracurium,Anaesthesia , Approved
21212,D0Q1PS,VR096,Inflammation , Phase 2
21213,D0Q1RN,IL22-Fc,Diabetic foot ulcer , Phase 2
21214,D0Q1RZ,ATA190,Multiple sclerosis , Phase 1
21215,D0Q1SA,Rosaramicin,Neisseria gonorrhoeae infection , Approved
21216,D0Q1SQ,EDO-S101,Solid tumour/cancer , Phase 1/2
21217,D0Q1SQ,EDO-S101,Haematological malignancy , Phase 1
21218,D0Q1SX,PMID26651364-Compound-7e,Crohn disease , Patented
21219,D0Q1SX,PMID26651364-Compound-7e,Ulcerative colitis , Patented
21220,D0Q1SX,PMID26651364-Compound-7e,Urinary tract infection , Patented
21221,D0Q1TX,Fusopin,Hepatitis C virus infection , Investigative
21222,D0Q1UB,GZ402666,Pompe disease , Phase 1
21223,D0Q1UB,GZ402666,Type 2 glycogen storage disease , Phase 1
21224,D0Q1UR,TIAPAFANT,Sepsis , Terminated
21225,D0Q1VD,SB206,Molluscum contagiosum infection , Phase 3
21226,D0Q1VD,SB206,External genital and perianal wart , Phase 2
21227,D0Q1WI,RG7745,Infectious disease , Phase 2
21228,D0Q1XV,HBV vaccine,Hepatitis B virus infection , Phase 2
21229,D0Q1YX,SMNT-1,Solid tumour/cancer , Investigative
21230,D0Q1YZ,Teceleukin,Solid tumour/cancer , Approved
21231,D0Q1ZD,HO-4038,Myocardial infarction , Investigative
21232,D0Q2AS,Etozolin,Congestive heart failure , Approved
21233,D0Q2AT,Flucloxacillin,Bacterial infection , Approved
21234,D0Q2BB,AVE1701,Rheumatoid arthritis , Phase 1
21235,D0Q2BG,CU-2010,Bleeding disorder , Discontinued in Phase 2
21236,D0Q2BM,CB-001,leukaemia , Discontinued in Phase 1/2
21237,D0Q2CM,CRB-0016,Osteoarthritis , Investigative
21238,D0Q2EH,Brutieridin,Hypercholesterolaemia , Investigative
21239,D0Q2EJ,CPH-106,Central nervous system disease , Phase 1
21240,D0Q2ES,Benzonatate,Cough , Approved
21241,D0Q2GX,Strada,Major depressive disorder , Phase 2
21242,D0Q2HM,EDD7H9,Breast cancer , Preclinical
21243,D0Q2HO,Naldemedine Tosylate,Opioid-induced constipation , Approved
21244,D0Q2IV,ALVAC-CEA/hB7.1,Ovarian cancer , Investigative
21245,D0Q2JB,CP-640922,Dermatomycosis , Discontinued in Phase 2
21246,D0Q2JS,SB-282241,Inflammation , Terminated
21247,D0Q2KM,MM-111,Gastric adenocarcinoma , Phase 2
21248,D0Q2KM,MM-111,Breast cancer , Phase 2
21249,D0Q2MH,Hexafluronium bromide,Spasm , Approved
21250,D0Q2MN,Dothiepin,Major depressive disorder , Approved
21251,D0Q2PE,Norfloxacin,Bacterial infection , Approved
21252,D0Q2PF,LY-293284,Anxiety disorder , Terminated
21253,D0Q2QU,Inosine pranobex,Virus infection , Approved
21254,D0Q2QU,Inosine pranobex,Rheumatoid arthritis , Approved
21255,D0Q2RF,AP-1101,Cognitive impairment , Discontinued in Phase 2
21256,D0Q2RJ,CR-5542,Anxiety disorder , Investigative
21257,D0Q2UW,DIMS-9054,Infectious disease , Investigative
21258,D0Q2VA,EP-37,Cerebrovascular ischaemia , Investigative
21259,D0Q2VL,PD-157533,Schizophrenia , Preclinical
21260,D0Q2VU,mRNA MRK-1777,Infectious disease , Phase 1
21261,D0Q2WE,DFD-04,Rosacea , Phase 2
21262,D0Q2WS,Terbutyline,Hypertension , Approved
21263,D0Q2XF,Bimatoprost,Alopecia , Approved
21264,D0Q2XF,Bimatoprost,Glaucoma/ocular hypertension , Phase 3
21265,D0Q2XN,Turmeric extracts,Alzheimer disease , Investigative
21266,D0Q2ZQ,PAR-401,Influenza virus infection , Investigative
21267,D0Q2ZT,Kaolin/pectin,Diarrhea , Approved
21268,D0Q2ZV,OLANEXIDINE HYDROCHLORIDE,Bacterial infection , Registered
21269,D0Q3BG,"Gene therapy, IFN-b",Glioblastoma multiforme , Phase 1
21270,D0Q3BV,Colistimethate,Respiratory tract infection , Approved
21271,D0Q3ER,CVBT-141B,Diabetic foot ulcer , Phase 2
21272,D0Q3ES,APD668,Type-2 diabetes , Discontinued in Phase 1
21273,D0Q3GV,S32504,Parkinson disease , Preclinical
21274,D0Q3GV,S32504,Major depressive disorder , Terminated
21275,D0Q3IS,VB4-845,Head and neck cancer , Phase 2/3
21276,D0Q3OM,SKL-19014,Non-insulin dependent diabetes , Investigative
21277,D0Q3PB,CCX872,Pancreatic tumour , Phase 2
21278,D0Q3PB,CCX872,Diabetic nephropathy , Phase 1
21279,D0Q3PD,S-297995,Opioid dependence , Phase 2
21280,D0Q3QS,4-aminosalicylate sodium,Inflammatory bowel disease , Phase 1
21281,D0Q3RC,Taxotere-mab,Solid tumour/cancer , Investigative
21282,D0Q3SP,NPS-1392,Cerebrovascular ischaemia , Terminated
21283,D0Q3TF,Staphylocide,Bacterial infection , Investigative
21284,D0Q3UL,PD-160170,Heart disease , Preclinical
21285,D0Q3UL,PD-160170,Obesity , Preclinical
21286,D0Q3UL,PD-160170,Hypertension , Preclinical
21287,D0Q3UQ,LC16m8,Virus infection , Approved
21288,D0Q3VE,PF-04971729,Type-2 diabetes , Approved
21289,D0Q3WB,BK-PIFA,Influenza virus infection , Phase 3
21290,D0Q3WN,Napsagatran,Myocardial infarction , Discontinued in Phase 2
21291,D0Q3WP,MEDI-553,Autoimmune diabetes , Investigative
21292,D0Q3WW,BB-15600,Solid tumour/cancer , Investigative
21293,D0Q3XN,KR-31360,Nervous system inflammation , Investigative
21294,D0Q3YO,Cinnarizine,Vertigo meniere disease , Approved
21295,D0Q3ZN,GS-3435,Influenza virus infection , Terminated
21296,D0Q4AR,Glucagon-like peptide-1 analog,Non-insulin dependent diabetes , Investigative
21297,D0Q4BI,T-2,Malaria , Investigative
21298,D0Q4BQ,SA-20896,Musculoskeletal disorder , Investigative
21299,D0Q4BX,TA-111,Neurological disorder , Investigative
21300,D0Q4CQ,Viagenpumatucel-L,Non-small-cell lung cancer , Phase 2
21301,D0Q4CS,Cevimeline,Sjogren syndrome , Approved
21302,D0Q4CX,MLN-3126,Sjogren syndrome , Phase 1
21303,D0Q4DS,AC vaccine,Lung cancer , Phase 1/2
21304,D0Q4DT,HuMax-TAC,Autoimmune diabetes , Terminated
21305,D0Q4EJ,Anti-EGFR V III CAR-T cells,Glioma , Phase 1/2
21306,D0Q4EJ,Anti-EGFR V III CAR-T cells,Hepatocellular carcinoma , Phase 1/2
21307,D0Q4EJ,Anti-EGFR V III CAR-T cells,Lung cancer , Phase 1/2
21308,D0Q4EQ,JNJ-38158471,Angiogenesis disorder , Investigative
21309,D0Q4EW,Lithium Citrate,Bipolar disorder , Approved
21310,D0Q4FA,PR-P,Glioblastoma multiforme , Investigative
21311,D0Q4GL,RAVAX,Psoriasis vulgaris , Phase 3
21312,D0Q4GL,RAVAX,Rheumatoid arthritis , Phase 3
21313,D0Q4GT,PM-181108,Infectious disease , Investigative
21314,D0Q4HA,EDG-007,Estrogen deficiency , Investigative
21315,D0Q4IE,ARX-618,Metabolic disorder , Investigative
21316,D0Q4IX,GDC-0994,Solid tumour/cancer , Phase 1
21317,D0Q4JM,TAK-441,Solid tumour/cancer , Phase 1
21318,D0Q4LG,IT-139,Solid tumour/cancer , Phase 1
21319,D0Q4MO,ONX-0914,Autoimmune diabetes , Investigative
21320,D0Q4NX,FANG vaccine,Ovarian cancer , Phase 3
21321,D0Q4NX,FANG vaccine,Melanoma , Phase 2/3
21322,D0Q4NX,FANG vaccine,Ewing sarcoma , Phase 2/3
21323,D0Q4NX,FANG vaccine,Adjuvant ovarian cancer , Phase 2
21324,D0Q4NX,FANG vaccine,Solid tumour/cancer , Phase 2
21325,D0Q4NX,FANG vaccine,Breast cancer , Phase 1
21326,D0Q4OV,PF530,Multiple sclerosis , Phase 1
21327,D0Q4OW,Pixantrone,Multiple sclerosis , Phase 3
21328,D0Q4OW,Pixantrone,Follicular lymphoma , Phase 3
21329,D0Q4OW,Pixantrone,Diffuse large B-cell lymphoma , Phase 3
21330,D0Q4OW,Pixantrone,Pediatric cancer , Phase 1
21331,D0Q4QV,TPIV100,HER2-positive breast cancer , Phase 2
21332,D0Q4SD,Eplerenone,Heart failure , Approved
21333,D0Q4ST,Diazepinone derivative 3,Reflux disease , Patented
21334,D0Q4ST,Diazepinone derivative 3,Parkinson disease , Patented
21335,D0Q4TK,Morantel tartrate,Mature gastrointestinal nematode infection , Approved
21336,D0Q4TW,SCY-644,Human immunodeficiency virus infection , Investigative
21337,D0Q4US,FR-144420,Angina pectoris , Terminated
21338,D0Q4UY,CFC-222,Bacterial infection , Discontinued in Phase 2
21339,D0Q4WG,ACT-1,Diabetic foot ulcer , Phase 2
21340,D0Q4WR,Angiotensin therapeutic vaccine,Hypertension , Phase 2
21341,D0Q4XG,MOD-3012,Factor IX deficiency , Investigative
21342,D0Q4XQ,Ethosuximide,Epilepsy , Approved
21343,D0Q4YI,Trimetazidine,Angina pectoris , Approved
21344,D0Q4YK,Piracetam,Cognitive impairment , Approved
21345,D0Q4YP,TAK-100,Diabetic complication , Discontinued in Phase 1
21346,D0Q5AS,DUP-860,Fungal infection , Discontinued in Phase 1
21347,D0Q5AT,QVA-149,Chronic obstructive pulmonary disease , Phase 3
21348,D0Q5BK,HGT-1410,Sanfilippo syndrome , Phase 2
21349,D0Q5BU,MSH-1001,Ocular hypertension , Phase 2
21350,D0Q5CH,AP-301-IH,Pneumonia , Phase 2
21351,D0Q5DT,IM156,Solid tumour/cancer , Phase 1
21352,D0Q5EH,Anti-CD19 CAR-T cells,Acute lymphoblastic leukaemia , Phase 1/2
21353,D0Q5EH,Anti-CD19 CAR-T cells,B-cell lymphoma , Phase 1/2
21354,D0Q5FS,Pyrazole derivative 18,Obesity , Patented
21355,D0Q5FT,Fibroblast growth factor,Ear disease , Investigative
21356,D0Q5GK,MG7-CART,Acute myeloid leukaemia , Phase 1/2
21357,D0Q5II,G009,Immune System disease , Investigative
21358,D0Q5IN,Lindane,Infestations of lice and scabies , Approved
21359,D0Q5KL,Coagulation Factor IX,Haemophilia B , Approved
21360,D0Q5KZ,SGI110,Acute myeloid leukaemia , Phase 3
21361,D0Q5LF,BIO-1211,Asthma , Phase 2
21362,D0Q5MC,PCI-34051,Solid tumour/cancer , Investigative
21363,D0Q5MQ,Tasimelteon,Insomnia , Approved
21364,D0Q5MU,R-7025,Hepatitis B virus infection , Terminated
21365,D0Q5NX,Lenalidomide,Multiple myeloma , Approved
21366,D0Q5NZ,BP-100-1.02,Lymphoma , Investigative
21367,D0Q5OC,AGS-003,Migraine , Phase 2
21368,D0Q5OC,AGS-003,Renal cell carcinoma , Phase 2
21369,D0Q5PL,INDOPROFEN,Gout , Withdrawn from market
21370,D0Q5QC,EMD-534085,Haematological malignancy , Phase 1
21371,D0Q5QE,AN-10,Alopecia , Terminated
21372,D0Q5QF,Desferrithiocin,Metal intoxication , Terminated
21373,D0Q5QV,MVT-5873,Colorectal cancer , Phase 1
21374,D0Q5QV,MVT-5873,Pancreatic cancer , Phase 1
21375,D0Q5QV,MVT-5873,Prostate cancer , Phase 1
21376,D0Q5QV,MVT-5873,Solid tumour/cancer , Phase 1
21377,D0Q5RA,CVP S aureus vaccine,Staphylococcus infection , Terminated
21378,D0Q5SI,SHP611,Metachromatic leukodystrophy , Phase 2
21379,D0Q5SP,Sodium phenylacetate/sodium benzoate,Hepatic encephalopathy , Approved
21380,D0Q5SX,HMaxi-K,Overactive bladder , Phase 1
21381,D0Q5TH,XR-5944,Gastric adenocarcinoma , Phase 1
21382,D0Q5TP,Anti-sortase mab,Bacterial infection , Investigative
21383,D0Q5TW,TT-112,Bleeding disorder , Investigative
21384,D0Q5UQ,Exjade,Iron overload disease , Approved
21385,D0Q5VC,BAN-2203,Alzheimer disease , Investigative
21386,D0Q5VW,L-778123,Lymphoma , Phase 1
21387,D0Q5XX,Eicosapentaenoic acid/docosa-hexaenoic acid,Hypertriglyceridemia , Approved
21388,D0Q5XX,Eicosapentaenoic acid/docosa-hexaenoic acid,Alzheimer disease , Phase 3
21389,D0Q5YF,Cipralisant,Attention deficit hyperactivity disorder , Discontinued in Phase 2
21390,D0Q5YH,NGD-94-4,Schizophrenia , Discontinued in Phase 1
21391,D0Q5YJ,PMID25553724-Compound-US2012819831110,Immune System disease , Patented
21392,D0Q5ZN,Seprilose,Arthritis , Terminated
21393,D0Q6AE,EPI-288,Solid tumour/cancer , Investigative
21394,D0Q6AU,NEO-PV-01,Bladder cancer , Phase 1
21395,D0Q6AU,NEO-PV-01,Melanoma , Phase 1
21396,D0Q6BH,Agriflu,Influenza virus infection , Approved
21397,D0Q6DV,Metallo-SAHA,Solid tumour/cancer , Investigative
21398,D0Q6DX,Triacetin,Onychomycosis , Approved
21399,D0Q6EA,SCH-1450206,Solid tumour/cancer , Investigative
21400,D0Q6ED,ASP8497,Type-2 diabetes , Preclinical
21401,D0Q6EH,SBT-20,Huntington disease , Phase 1/2
21402,D0Q6EN,AHR-16303B,Hypertension , Terminated
21403,D0Q6FV,TJN-135,Osteoporosis , Discontinued in Phase 2
21404,D0Q6GD,WCK-1152,Respiratory tract inflammation , Phase 1
21405,D0Q6GK,EphB4-131,Solid tumour/cancer , Investigative
21406,D0Q6IF,Vmab + Y-90 Emab,Diffuse large B-cell lymphoma , Phase 1b
21407,D0Q6IW,Rosiglitazone + simvastatin,Type-2 diabetes , Phase 3
21408,D0Q6JY,A-003,Cardiovascular disease , Investigative
21409,D0Q6KV,SG-2274,Solid tumour/cancer , Investigative
21410,D0Q6LA,Levoleucovorin,Anemia , Approved
21411,D0Q6MA,Gamma-sarcoglycan gene-containing recombinant AAV1 vector based therapy,Duchenne dystrophy , Phase 2
21412,D0Q6MQ,CGEN-913,Inflammation , Investigative
21413,D0Q6MY,Nafamostat,Coronavirus Disease 2019 (COVID-19) , Phase 2/3
21414,D0Q6MY,Nafamostat,Middle East Respiratory Syndrome (MERS) , Preclinical
21415,D0Q6NN,TAK-070,Solid tumour/cancer , Clinical trial
21416,D0Q6NZ,Oxymetholone,Aplastic anemia , Approved
21417,D0Q6OL,KM-011,Arteriosclerosis , Investigative
21418,D0Q6OS,Macrolides,Bacterial infection , Approved
21419,D0Q6QU,MEDI6469,Solid tumour/cancer , Phase 1/2
21420,D0Q6RC,Thiazole carboxamide derivative 1,Solid tumour/cancer , Patented
21421,D0Q6RC,Thiazole carboxamide derivative 1,Metastatic cancer , Patented
21422,D0Q6RG,TD-1792,Skin infection , Phase 3
21423,D0Q6RG,TD-1792,Gram-positive bacterial infection , Phase 2
21424,D0Q6RX,Oravax-PX,Virus infection , Investigative
21425,D0Q6SD,Lamectacin,Bacterial infection , Discontinued in Phase 3
21426,D0Q6SF,APO-010,Multiple myeloma , Phase 1
21427,D0Q6YT,Poloxafuse-I,Injury , Investigative
21428,D0Q6ZQ,ELND-007,Alzheimer disease , Investigative
21429,D0Q7AG,CGM097,Solid tumour/cancer , Phase 1
21430,D0Q7AH,EP-1043,Human immunodeficiency virus-1 infection , Phase 1
21431,D0Q7AW,IMIRESTAT,Diabetic complication , Discontinued in Phase 3
21432,D0Q7AZ,Plant-derived antibacterials,Bacterial infection , Investigative
21433,D0Q7CR,MX-76629,Solid tumour/cancer , Preclinical
21434,D0Q7FC,Lurtotecan,Ovarian cancer , Discontinued in Phase 2
21435,D0Q7FC,Lurtotecan,Lung cancer , Discontinued in Phase 1
21436,D0Q7HO,PD-153035,Psoriasis vulgaris , Discontinued in Phase 1
21437,D0Q7IX,PF-06342674,Type-1 diabetes , Phase 1
21438,D0Q7IX,PF-06342674,Type-2 diabetes , Phase 1
21439,D0Q7JC,P-552-02,Cystic fibrosis , Phase 1/2
21440,D0Q7JJ,NA-808,Hepatitis C virus infection , Preclinical
21441,D0Q7MA,Cefiderocol,Urinary tract infection , Approved
21442,D0Q7MA,Cefiderocol,Ventilator-associated pneumonia , Approved
21443,D0Q7MA,Cefiderocol,Hospital-acquired pneumonia , Approved
21444,D0Q7MA,Cefiderocol,Healthcare-associated pneumonia , Phase 3
21445,D0Q7MI,KPE-00001113,Hepatitis C virus infection , Investigative
21446,D0Q7MQ,CP-100263,Vomiting , Investigative
21447,D0Q7NB,842166X,Pain , Phase 2
21448,D0Q7OA,HydrocoDex,Pain , Terminated
21449,D0Q7OB,RP-656,Solid tumour/cancer , Investigative
21450,D0Q7OE,BI-505,Multiple myeloma , Phase 2
21451,D0Q7OR,AdHu5-ZGP,Ebola virus infection , Investigative
21452,D0Q7QA,PT001 GP,Chronic obstructive pulmonary disease , Phase 3
21453,D0Q7QK,Mannoside derivative 13,Crohn disease , Patented
21454,D0Q7QK,Mannoside derivative 13,Ulcerative colitis , Patented
21455,D0Q7QK,Mannoside derivative 13,Urinary tract infection , Patented
21456,D0Q7QY,SSR-125047,Schizophrenia , Phase 1
21457,D0Q7QY,SSR-125047,Diabetic cataract , Withdrawn from market
21458,D0Q7RA,Epoietin delta,Constitutional neutropenia , Approved
21459,D0Q7RE,AZD-1152-HQPA,Solid tumour/cancer , Phase 1
21460,D0Q7RJ,SLP-1004,Gram-positive bacterial infection , Investigative
21461,D0Q7SO,RS-66252,Alzheimer disease , Terminated
21462,D0Q7SR,Cervarix,Human papillomavirus infection , Approved
21463,D0Q7TH,BMS-181885,Migraine , Terminated
21464,D0Q7TI,HG-1078,Solid tumour/cancer , Investigative
21465,D0Q7UD,ABT-888,Breast cancer , Phase 3
21466,D0Q7UD,ABT-888,Epithelial ovarian cancer , Phase 3
21467,D0Q7UD,ABT-888,Ovarian cancer , Phase 3
21468,D0Q7UD,ABT-888,Non-small-cell lung cancer , Phase 3
21469,D0Q7UD,ABT-888,Melanoma , Phase 2
21470,D0Q7UG,Tipelukast,Asthma , Phase 2
21471,D0Q7UG,Tipelukast,Idiopathic pulmonary fibrosis , Phase 2
21472,D0Q7VI,Siguazodan,Allergy , Terminated
21473,D0Q7WW,UR-8328,Asthma , Terminated
21474,D0Q7XA,LG-888,Factor VIII deficiency , Investigative
21475,D0Q7XS,LP-0067,Autoimmune diabetes , Investigative
21476,D0Q7YI,Alogliptin/pioglitazone,Type-2 diabetes , Approved
21477,D0Q7YZ,Gantenerumab,Alzheimer disease , Phase 3
21478,D0Q7ZG,Proparacaine,Anaesthesia , Approved
21479,D0Q7ZQ,Succinylcholine,Spasm , Approved
21480,D0Q8CA,GD2-lm,Herpes simplex virus infection , Investigative
21481,D0Q8CS,Tiludronic acid,Osteoporosis , Approved
21482,D0Q8CV,CDX-301,Hematopoietic stem cell transplantation , Phase 2
21483,D0Q8CV,CDX-301,Solid tumour/cancer , Phase 2
21484,D0Q8CV,CDX-301,Multiple myeloma , Phase 1
21485,D0Q8CW,PF-738502,Fibromyalgia , Discontinued in Phase 1
21486,D0Q8DM,BIM-26226,Solid tumour/cancer , Discontinued in Phase 1
21487,D0Q8DZ,EX-404,Polycystic ovarian syndrome , Phase 2/3
21488,D0Q8FE,UR-9660,Fungal infection , Terminated
21489,D0Q8GV,Prostate cancer vaccine,Prostate cancer , Phase 1/2
21490,D0Q8GX,SYM-011,Solid tumour/cancer , Investigative
21491,D0Q8JK,Thiazole carboxamide derivative 15,Solid tumour/cancer , Patented
21492,D0Q8JK,Thiazole carboxamide derivative 15,Metastatic cancer , Patented
21493,D0Q8LL,SYL-040012,Ocular hypertension , Phase 2
21494,D0Q8MI,Lintopride,Nausea , Phase 2
21495,D0Q8ML,ROR1 CAR-specific Autologous T-Lymphocytes,Acute lymphoblastic leukaemia , Phase 1
21496,D0Q8ML,ROR1 CAR-specific Autologous T-Lymphocytes,Chronic lymphocytic leukaemia , Phase 1
21497,D0Q8ML,ROR1 CAR-specific Autologous T-Lymphocytes,Mantle cell lymphoma , Phase 1
21498,D0Q8MQ,Benzothiazine-carboxamide compound 5,Skin inflammation , Patented
21499,D0Q8NJ,Viomycin sulfate,Bacterial infection , Approved
21500,D0Q8OW,AnergiX.MS,Multiple sclerosis , Discontinued in Phase 2
21501,D0Q8PF,Ad5f35-LMPd1-2-transduced autologous dendritic cells,Nasopharyngeal carcinoma , Investigative
21502,D0Q8PJ,NLP-91,Thrombosis , Investigative
21503,D0Q8QR,I-387,Solid tumour/cancer , Investigative
21504,D0Q8RX,L-368899,Miscarriage , Discontinued in Phase 1
21505,D0Q8SI,SOM-0777,Solid tumour/cancer , Investigative
21506,D0Q8SN,ET-003,Colon cancer , Investigative
21507,D0Q8TI,FX-141L,Inflammation , Investigative
21508,D0Q8TX,Ajinomoto 1,Pain , Investigative
21509,D0Q8UU,BM-17.0744,Type-1 diabetes , Discontinued in Phase 2
21510,D0Q8VM,TT-401,Type-2 diabetes , Phase 2
21511,D0Q8WG,Tedalinab,Pain , Phase 1
21512,D0Q8WX,AM-101,Tinnitus , Phase 3
21513,D0Q8XH,Cefsoludin sodium,Bacterial infection , Approved
21514,D0Q8XO,CART-19,Acute lymphoblastic leukaemia , Phase 1
21515,D0Q8YI,VEGF kinoid,Solid tumour/cancer , Investigative
21516,D0Q8YN,Sch-40338,Allergy , Terminated
21517,D0Q8YU,OX-ESI,Respiratory tract inflammation , Investigative
21518,D0Q8YZ,DW-286,Respiratory tract infection , Investigative
21519,D0Q8ZP,TDI-0033,Motor neurone disease , Investigative
21520,D0Q8ZX,Benzocaine,Anaesthesia , Approved
21521,D0Q9AD,Pyrazole derivative 59,Obesity , Patented
21522,D0Q9BV,JIN-2019,Solid tumour/cancer , Investigative
21523,D0Q9CY,HKI-272,Breast cancer , Phase 3
21524,D0Q9DK,Nizatidine,Acid-reflux disorder , Approved
21525,D0Q9DL,PB-108,Infectious disease , Investigative
21526,D0Q9EH,NV-18,Solid tumour/cancer , Discontinued in Phase 1
21527,D0Q9EV,lifitegrast,Dry eye disease , Approved
21528,D0Q9EV,lifitegrast,Allergic conjunctivitis , Phase 3
21529,D0Q9GJ,BP-C2,Radiation syndrome , Investigative
21530,D0Q9HF,Acetylcholine,Cataract , Approved
21531,D0Q9HM,CM-AT,Autism spectrum disorder , Phase 3
21532,D0Q9HM,CM-AT,Attention deficit hyperactivity disorder , Phase 3
21533,D0Q9HT,LY-307161,Type-2 diabetes , Discontinued in Phase 2
21534,D0Q9IE,BMS-707035,Human immunodeficiency virus infection , Investigative
21535,D0Q9IK,CEP-9722,Non-small-cell lung cancer , Phase 1/2
21536,D0Q9IK,CEP-9722,Cerebrovascular ischaemia , Phase 1/2
21537,D0Q9IY,PNU-142731A,Asthma , Phase 2
21538,D0Q9JT,Metyrapone,Cushing disease , Approved
21539,D0Q9KR,Seviteronel,Breast cancer , Phase 2
21540,D0Q9KR,Seviteronel,Prostate cancer , Phase 2
21541,D0Q9MN,COL-204,Sleep-wake disorder , Investigative
21542,D0Q9NJ,AC-625,Hypertension , Discontinued in Phase 1
21543,D0Q9ON,Denopamine,Cardiac disease , Approved
21544,D0Q9PP,Recombinant Slit-2-D1-D2-Fc,Acute lung injury , Investigative
21545,D0Q9PT,Synflorix,Streptococcus infection , Phase 4
21546,D0Q9QC,DMD-02,Duchenne dystrophy , Phase 2
21547,D0Q9RP,CBLC137,Haematological malignancy , Phase 1
21548,D0Q9RP,CBLC137,Solid tumour/cancer , Phase 1
21549,D0Q9RR,AZD0328,Alzheimer disease , Discontinued in Phase 2
21550,D0Q9RW,HL-135,Arteriosclerosis , Investigative
21551,D0Q9TB,White blood cell therapy,Diabetic foot ulcer , Phase 3
21552,D0Q9TC,Hexaxim,Haemophilus influenza , Approved
21553,D0Q9UL,IATX-FVIII,Factor VIII deficiency , Investigative
21554,D0Q9UX,PHA848125,Thymic cancer , Phase 2
21555,D0Q9VA,Tritanrix HB,Hepatitis B virus infection , Approved
21556,D0Q9VS,Phosphatonin,Hypophosphatasia , Investigative
21557,D0Q9VW,Beta-Gly,Multiple sclerosis , Investigative
21558,D0Q9WN,FC EPO,Anemia , Discontinued in Phase 1
21559,D0Q9WO,Cinolazepam,Muscle spasm , Approved
21560,D0Q9XE,MEDI4893,Ventilator-associated pneumonia , Phase 2b
21561,D0Q9XE,MEDI4893,Hospital-acquired pneumonia , Phase 1
21562,D0Q9YT,Tetrahydrobiopterin,Malnutrition , Approved
21563,D0Q9ZD,Camobucol,Rheumatoid arthritis , Discontinued in Phase 2
21564,D0Q9ZU,HepTcell,Hepatitis B virus infection , Phase 1
21565,D0QA0B,RDX-008,Hypernatremia , Investigative
21566,D0QA1M,MCP-203,Major depressive disorder , Investigative
21567,D0QA3C,OMB157,Multiple sclerosis , Clinical trial
21568,D0QA6Q,CGP-55847,Solid tumour/cancer , Discontinued in Phase 1
21569,D0QA7X,APG-103,Inflammation , Investigative
21570,D0QB1O,CD19 and CD20 CAR-T Cells,B-cell lymphoma , Phase 1/2
21571,D0QB1O,CD19 and CD20 CAR-T Cells,leukaemia , Phase 1/2
21572,D0QB6M,ND-901,Malaria , Investigative
21573,D0QB7K,Yunaoning,Neisseria meningitis infection , Approved
21574,D0QB7N,GD2 T cells,Neuroblastoma , Phase 1
21575,D0QB7N,GD2 T cells,Osteosarcoma , Phase 1
21576,D0QB8Q,EP-2167,Solid tumour/cancer , Preclinical
21577,D0QC2V,AEVI-1,Attention deficit hyperactivity disorder , Phase 2
21578,D0QC3M,Amorolfine,Onychomycosis , Approved
21579,D0QC5D,Gallium Citrate Ga-67,Hodgkin lymphoma , Approved
21580,D0QC6Z,GALL-200,Obstructive sleep apnea , Investigative
21581,D0QC9I,Benzoic acid linked peptide analog 1,Albinism , Patented
21582,D0QC9I,Benzoic acid linked peptide analog 1,Ephelides , Patented
21583,D0QC9I,Benzoic acid linked peptide analog 1,Menkes disease , Patented
21584,D0QC9I,Benzoic acid linked peptide analog 1,Senile lentigines , Patented
21585,D0QC9I,Benzoic acid linked peptide analog 1,Melasma , Patented
21586,D0QD1G,Elvitegravir,Human immunodeficiency virus infection , Approved
21587,D0QD4A,ABBV-428,Solid tumour/cancer , Phase 1
21588,D0QD6R,Lactobacillus,Diarrhea , Approved
21589,D0QD9R,Thyroglobulin,Hypothyroidism , Approved
21590,D0QE1Y,ViperaTAb,Poison intoxication , Approved
21591,D0QE4F,CD19-CAR and CD28-CAR T Cells,Acute lymphoblastic leukaemia , Phase 1
21592,D0QE5B,Tagorizine,Allergy , Discontinued in Phase 3
21593,D0QE5U,Insulin-detemir,Type-1/2 diabetes , Approved
21594,D0QE8K,PM-72G,Solid tumour/cancer , Investigative
21595,D0QE9F,P-6915,Solid tumour/cancer , Investigative
21596,D0QF0L,CD19 CAR-T Cells,Acute lymphoblastic leukaemia , Phase 1/2
21597,D0QF2W,AGTC-0106,Alpha-1 antitrypsin deficiency , Phase 2
21598,D0QF4W,Macrocycle derivative 7,Solid tumour/cancer , Patented
21599,D0QF4W,Macrocycle derivative 7,Infectious disease , Patented
21600,D0QF4W,Macrocycle derivative 7,Human immunodeficiency virus infection , Patented
21601,D0QF4W,Macrocycle derivative 7,Hepatitis , Patented
21602,D0QF4Z,MT-500,Migraine , Discontinued in Phase 1
21603,D0QF6E,Tridegin,Thrombosis , Terminated
21604,D0QF7Z,HER2/neu peptide vaccine,Breast cancer , Phase 2
21605,D0QF9P,GSK-208108,Haemophilus influenza , Approved
21606,D0QG1B,Aprocitentan,Hypertension , Phase 2
21607,D0QG2D,Amelubant,Pulmonary disease , Phase 2
21608,D0QG2D,Amelubant,Cystic fibrosis , Discontinued in Phase 2
21609,D0QG3E,CIGB-598a,Solid tumour/cancer , Investigative
21610,D0QG6A,NIP-142,Atrial fibrillation , Investigative
21611,D0QG8F,DNCB,Immune System disease , Phase 2
21612,D0QG9A,Apadenoson,Coronary artery disease , Phase 3
21613,D0QH0B,EPI-2010,Asthma , Discontinued in Phase 2
21614,D0QH0R,SB-206343,Human immunodeficiency virus-1 infection , Terminated
21615,D0QH3H,DCVax-Prostate cancer vaccine,Prostate cancer , Phase 2
21616,D0QH3H,DCVax-Prostate cancer vaccine,Diabetic neuropathy , Discontinued in Phase 3
21617,D0QH5I,N-phenyl-5-phenyl-pyrazolin-3-yl amide derivative 3,Obesity , Patented
21618,D0QH5K,AK-106-001616,Rheumatoid arthritis , Phase 2
21619,D0QH7G,RG-7432,Hepatitis C virus infection , Discontinued in Phase 1
21620,D0QH7H,AMP-579,Hyperlipidaemia , Phase 2
21621,D0QI0Z,IG-MD-009,Cardiovascular disease , Investigative
21622,D0QI1K,HuMax-AXL-ADC,Solid tumour/cancer , Phase 1/2
21623,D0QI1O,SL-601,Bladder cancer , Investigative
21624,D0QI4Z,KP484,Attention deficit hyperactivity disorder , Phase 3
21625,D0QI6W,Non-peptide TPO mimics,Thrombocytopenia , Investigative
21626,D0QI9N,BN-CB-045,Female sexual arousal dysfunction , Preclinical
21627,D0QJ2K,LEO-27989,Psoriasis vulgaris , Phase 1
21628,D0QJ4Y,TGF-beta Shield,Solid tumour/cancer , Investigative
21629,D0QJ6L,Demogastrin,Thyroid cancer , Phase 1
21630,D0QJ8J,mRNA-1273 vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 1
21631,D0QJ9Z,MGN-6114,Peripheral vascular disease , Investigative
21632,D0QK2E,SCH-205831,Thrombosis , Investigative
21633,D0QK5C,ALAMIFOVIR,Virus infection , Phase 1/2
21634,D0QK5X,Enzalutamide,Prostate cancer , Approved
21635,D0QL0D,SPIF,Autoimmune hepatitis , Phase 1
21636,D0QL0X,Biaryl mannoside derivative 23,Crohn disease , Patented
21637,D0QL0X,Biaryl mannoside derivative 23,Ulcerative colitis , Patented
21638,D0QL0X,Biaryl mannoside derivative 23,Urinary tract infection , Patented
21639,D0QL1U,DeOvo,Pediculus capitis infestation , Phase 2
21640,D0QL3P,Oxcarbazepine,Epilepsy , Approved
21641,D0QL3T,K-42,Human immunodeficiency virus-1 infection , Terminated
21642,D0QL4N,Darunavir + ritonavir + favipiravir + hydroxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
21643,D0QL4X,SOT-107,Brain cancer , Phase 3
21644,D0QL9W,Quadrivalent pediatric combination vaccine,Bordetella pertussis infection , Registered
21645,D0QM0D,Oxotetrahydro-2-H-furo[3.2-b]pyrrol-4(5-H)-yl derivative 1,Pain , Patented
21646,D0QM0N,BILD-733,Herpes simplex virus infection , Terminated
21647,D0QM1T,Finazosin,Prostate hyperplasia , Phase 3
21648,D0QM2O,PMID26651364-Compound-5f,Crohn disease , Patented
21649,D0QM2O,PMID26651364-Compound-5f,Ulcerative colitis , Patented
21650,D0QM2O,PMID26651364-Compound-5f,Urinary tract infection , Patented
21651,D0QM3Q,EP-102,Chronic obstructive pulmonary disease , Investigative
21652,D0QM4O,UV1 vaccine,Metastatic melanoma , Phase 2
21653,D0QM4U,Isoarnebin 4,Coronavirus Disease 2019 (COVID-19) , Investigative
21654,D0QM6Y,IkT-004,Polyomavirus infection , Investigative
21655,D0QM9P,INfluenza A virus H5N8 vaccine,Influenza virus infection , Phase 1
21656,D0QN3Q,LNA anti-miR-155,Chronic lymphocytic leukaemia , Investigative
21657,D0QN5M,LAM-001,Lymphangioleiomyomatosis , Phase 1
21658,D0QN6U,L-790070,Autoimmune diabetes , Investigative
21659,D0QN9U,GS-156 mab,Solid tumour/cancer , Investigative
21660,D0QNS3,REL-1017,Major depressive disorder , Phase 3
21661,D0QNS3,REL-1017,Neuropathic pain , Phase 1
21662,D0QO0D,H5N1 influenza vaccine,Influenza virus infection , Phase 3
21663,D0QO6N,MGD010,Autoimmune disease , Phase 1
21664,D0QO7H,Dithranol,Psoriasis vulgaris , Approved
21665,D0QP1X,HIV vaccine Ad4-mGag,Human immunodeficiency virus infection , Phase 1
21666,D0QP4N,PMID25666693-Compound-81,Osteoarthritis pain , Patented
21667,D0QP4N,PMID25666693-Compound-81,Cancer related pain , Patented
21668,D0QP4N,PMID25666693-Compound-81,Neuropathic pain , Patented
21669,D0QP4N,PMID25666693-Compound-81,Inflammatory pain , Patented
21670,D0QP8X,ONO-7579,Solid tumour/cancer , Phase 1/2
21671,D0QP9A,KI-1001,Solid tumour/cancer , Phase 3
21672,D0QQ0W,Selicrelumab,Solid tumour/cancer , Phase 1
21673,D0QQ1J,BITHIONOL,Trematode infection , Withdrawn from market
21674,D0QQ5W,Beta-cyclodextrin conjugate derivative 2,Crohn disease , Patented
21675,D0QQ5W,Beta-cyclodextrin conjugate derivative 2,Ulcerative colitis , Patented
21676,D0QQ5W,Beta-cyclodextrin conjugate derivative 2,Urinary tract infection , Patented
21677,D0QQ6Q,Enprostil,Ulcer , Approved
21678,D0QQ7D,Tazobactam,Bacterial infection , Approved
21679,D0QQ7I,BAY1834845,Psoriasis vulgaris , Phase 1
21680,D0QQ7N,TH-9229,Reperfusion injury , Terminated
21681,D0QR0E,Resorcinol compound 27,Albinism , Patented
21682,D0QR0E,Resorcinol compound 27,Ephelides , Patented
21683,D0QR0E,Resorcinol compound 27,Menkes disease , Patented
21684,D0QR0E,Resorcinol compound 27,Senile lentigines , Patented
21685,D0QR0E,Resorcinol compound 27,Melasma , Patented
21686,D0QR2K,NKR-2 cells,Acute myeloid leukaemia , Phase 1
21687,D0QR3J,GC-2107,Thrombosis , Investigative
21688,D0QR3X,Edasalonexent,Duchenne dystrophy , Phase 3
21689,D0QR4F,Sirolimus,Uveitis , Phase 3
21690,D0QR4H,D-21151,Inflammation , Terminated
21691,D0QR5G,5-methoxypsoralen,Psoriasis vulgaris , Phase 3
21692,D0QR8B,STP-432,Crohn disease , Investigative
21693,D0QS1U,Dihydralazine,Hypertension , Approved
21694,D0QS6G,Prevecon,Contraception , Preclinical
21695,D0QT8L,PMID28270021-Compound-WO2014129431Example8-1,Pruritus , Patented
21696,D0QT8L,PMID28270021-Compound-WO2014129431Example8-1,Solid tumour/cancer , Patented
21697,D0QT8L,PMID28270021-Compound-WO2014129431Example8-1,Chronic pain , Patented
21698,D0QT8L,PMID28270021-Compound-WO2014129431Example8-1,Neuropathic pain , Patented
21699,D0QT8L,PMID28270021-Compound-WO2014129431Example8-1,Thymic cancer , Patented
21700,D0QT9B,LPCN-1002,Testosterone deficiency , Investigative
21701,D0QU0H,OMS721,Atypical hemolytic uremic syndrome , Phase 3
21702,D0QU0H,OMS721,Thrombotic microangiopathy , Phase 2
21703,D0QU0H,OMS721,Glomerulonephritis , Phase 2
21704,D0QU0H,OMS721,Lupus , Phase 2
21705,D0QU3G,Diamine derivative 3,Albinism , Patented
21706,D0QU3G,Diamine derivative 3,Ephelides , Patented
21707,D0QU3G,Diamine derivative 3,Menkes disease , Patented
21708,D0QU3G,Diamine derivative 3,Senile lentigines , Patented
21709,D0QU3G,Diamine derivative 3,Melasma , Patented
21710,D0QU6N,PMID26651364-Compound-47,Crohn disease , Patented
21711,D0QU6N,PMID26651364-Compound-47,Ulcerative colitis , Patented
21712,D0QU6N,PMID26651364-Compound-47,Urinary tract infection , Patented
21713,D0QU8H,(S)-amisulpride,Schizophrenia , Discontinued in Phase 4
21714,D0QU8I,PF-06482077,Pneumococcal infection , Phase 3
21715,D0QV1E,Thiazole carboxamide derivative 28,Solid tumour/cancer , Patented
21716,D0QV1E,Thiazole carboxamide derivative 28,Metastatic cancer , Patented
21717,D0QV3O,OCID-4681,Solid tumour/cancer , Investigative
21718,D0QV4A,NI-0501,Autoimmune diabetes , Phase 2
21719,D0QV4A,NI-0501,Primary haemophagocytic lymphohistiocytosis , Phase 2
21720,D0QV5T,Phenprocoumon,Thrombosis , Approved
21721,D0QV9Q,CART22 cells,Acute lymphoblastic leukaemia , Phase 1
21722,D0QW0E,HBV infection vaccine,Hepatitis B virus infection , Phase 2
21723,D0QW1V,MAD-001,Cardiac failure , Investigative
21724,D0QW7D,DK-507k,Bacterial infection , Discontinued in Phase 1
21725,D0QW9H,Imiglucerase,Gaucher disease , Approved
21726,D0QX0H,GTx-134,Solid tumour/cancer , Investigative
21727,D0QX0K,FT-105,Diabetic complication , Discontinued in Phase 1
21728,D0QX8X,M2951,Multiple sclerosis , Phase 2
21729,D0QX8X,M2951,Rheumatoid arthritis , Phase 2
21730,D0QX8X,M2951,Systemic lupus erythematosus , Phase 1
21731,D0QX9K,AMG 986,Heart failure , Phase 1
21732,D0QX9U,BN-GU-005-DHP,Arthralgia , Preclinical
21733,D0QY1M,GS-5806,Respiratory syncytial virus infection , Phase 2
21734,D0QY4L,Nitroimidazole,Trypanosomiasis , Investigative
21735,D0QZ1Z,PVS-10200,Artery stenosis , Phase 1/2
21736,D0QZ3P,QAL964,Rheumatoid arthritis , Phase 2
21737,D0QZ4S,LEMINOPRAZOLE,Ulcerative colitis , Discontinued in Preregistration
21738,D0QZ7V,RXI-SCP,Cutaneous wart , Phase 2
21739,D0QZ9D,GRNIC-1,Insulin-dependent diabetes , Investigative
21740,D0R0AO,MOR-205,Solid tumour/cancer , Investigative
21741,D0R0BI,CT-1,Diabetic complication , Phase 2
21742,D0R0BJ,Cirrhosis,Liver disease , Investigative
21743,D0R0BX,Nitrofurantoin,Urinary tract infection , Approved
21744,D0R0EF,AZD-7268,Anxiety disorder , Phase 2
21745,D0R0EV,E-6123,Asthma , Discontinued in Phase 2
21746,D0R0FE,Verapamil,Hypertension , Approved
21747,D0R0FO,Lenvatinib,Thyroid cancer , Approved
21748,D0R0FO,Lenvatinib,Hepatocellular carcinoma , Phase 3
21749,D0R0FO,Lenvatinib,Renal cell carcinoma , Phase 3
21750,D0R0FO,Lenvatinib,Melanoma , Phase 2
21751,D0R0FO,Lenvatinib,Solid tumour/cancer , Phase 1/2
21752,D0R0FO,Lenvatinib,Ovarian cancer , Phase 1
21753,D0R0FO,Lenvatinib,Non-small-cell lung cancer , Application submitted
21754,D0R0FU,PXS-4159,Asthma , Investigative
21755,D0R0GK,NU300,Influenza virus infection , Phase 2
21756,D0R0HY,IONIS-DMPK-2.5RX,Myotonic dystrophy , Phase 2
21757,D0R0JN,PRAX-330,Epilepsy , Phase 1
21758,D0R0LB,PF-06747775,Solid tumour/cancer , Phase 1
21759,D0R0MB,Ropeginterferon alfa-2b,Polycythemia vera , Phase 3
21760,D0R0ME,IDP-204040,Bacterial infection , Phase 1
21761,D0R0MM,Anti-GP88 mabs,Solid tumour/cancer , Investigative
21762,D0R0MW,Sunitinib,Gastrointestinal stromal tumour , Approved
21763,D0R0MW,Sunitinib,Gastrointestinal cancer , Approved
21764,D0R0NX,AU-011,Melanoma , Phase 1/2
21765,D0R0OC,U-104067F,Neurological disorder , Discontinued in Phase 1
21766,D0R0PC,HM 401,Sepsis , Investigative
21767,D0R0RW,1D05,Coronary artery disease , Investigative
21768,D0R0SJ,PMID25684022-Compound-WO2012135799 43(1.5),Solid tumour/cancer , Patented
21769,D0R0SJ,PMID25684022-Compound-WO2012135799 43(1.5),Metastatic cancer , Patented
21770,D0R0SP,LIPO-5,Human immunodeficiency virus infection , Phase 2
21771,D0R0TF,BN50727,Inflammatory bowel disease , Discontinued in Phase 2
21772,D0R0TS,MK-1439,Human immunodeficiency virus infection , Approved
21773,D0R0UJ,Pargyline,Hypertension , Approved
21774,D0R0UJ,Pargyline,Skin imperfections , Patented
21775,D0R0UJ,Pargyline,Muscular dystrophy , Patented
21776,D0R0UW,INKP-102,Gastrointestinal infection , Investigative
21777,D0R0WZ,KX01 + paclitaxel,Solid tumour/cancer , Phase 1/2
21778,D0R0YW,HM-5016504,Solid tumour/cancer , Phase 2
21779,D0R0ZL,Clindamycin,Acne vulgaris , Approved
21780,D0R0ZP,VXA-RSV-f,Respiratory syncytial virus infection , Phase 1
21781,D0R1BA,CAR-T cells targeting Muc1,Cervical cancer , Phase 1/2
21782,D0R1BD,Penicillin,Bacterial infection , Approved
21783,D0R1CG,ASG-22ME,Solid tumour/cancer , Phase 1
21784,D0R1CR,L-Phenylalanine,Malnutrition , Approved
21785,D0R1DH,Oxybutynin hydrochloride,Urinary incontinence , Approved
21786,D0R1DP,A-74283,Hypertension , Terminated
21787,D0R1DX,Adiponectin mimetics,Arteriosclerosis , Investigative
21788,D0R1GD,Aryl mannoside derivative 16,Crohn disease , Patented
21789,D0R1GD,Aryl mannoside derivative 16,Ulcerative colitis , Patented
21790,D0R1GD,Aryl mannoside derivative 16,Urinary tract infection , Patented
21791,D0R1GJ,Casimersen,Duchenne dystrophy , Approved
21792,D0R1HK,T-9001,Central nervous system disease , Investigative
21793,D0R1JB,Acellular pertussis vaccine,Allergy , Approved
21794,D0R1JI,Rottlerin,Parkinson disease , Preclinical
21795,D0R1JO,SHP607,Retinopathy , Phase 2
21796,D0R1JV,Ziprasidone,Schizophrenia , Approved
21797,D0R1LT,E047/1,Cardiac arrhythmias , Discontinued in Phase 2
21798,D0R1PX,"Pyrano[2,3-b]pyridine derivative 1",Obesity , Patented
21799,D0R1PZ,F-15063,Schizophrenia , Preclinical
21800,D0R1QE,Ibuprofen,Pain , Approved
21801,D0R1QH,99mTc-tropantiol,Brain disease , Phase 2/3
21802,D0R1QJ,D-22888,Allergy , Terminated
21803,D0R1QX,EC-708,Prostate cancer , Terminated
21804,D0R1RK,EpiCept,Neuropathic pain , Investigative
21805,D0R1RQ,BJ-B11,Herpes simplex virus infection , Investigative
21806,D0R1RS,Indomethacin,Rheumatoid arthritis , Approved
21807,D0R1RV,ZP-008,Pharyngitis , Investigative
21808,D0R1SQ,Biaryl mannoside derivative 1,Crohn disease , Patented
21809,D0R1SQ,Biaryl mannoside derivative 1,Ulcerative colitis , Patented
21810,D0R1SQ,Biaryl mannoside derivative 1,Urinary tract infection , Patented
21811,D0R1UE,CLR325,Chronic heart failure , Phase 2
21812,D0R1VL,BIBN-99,Alzheimer disease , Terminated
21813,D0R1VR,Fluphenazine,Severe acute respiratory syndrome (SARS) , Investigative
21814,D0R1VR,Fluphenazine,Middle East Respiratory Syndrome (MERS) , Investigative
21815,D0R1VU,Perifosine,Solid tumour/cancer , Phase 1
21816,D0R1WQ,Thallous Chloride Tl-201,Diagnostic radiopharmaceutical , Approved
21817,D0R1WR,Procyclidine,Parkinson disease , Approved
21818,D0R1XF,212Pb-TCMC-trastuzumab,Solid tumour/cancer , Phase 1
21819,D0R1XI,TRK-851,Cough , Discontinued in Phase 1
21820,D0R1YJ,HCGRP8-37,Pain , Investigative
21821,D0R1YL,NGX-267,Schizophrenia , Phase 2
21822,D0R2CI,GI-264879A,Obesity , Preclinical
21823,D0R2CM,TA-383,Arthritis , Discontinued in Phase 2
21824,D0R2CZ,Rsv Immune Globulin,Bronchopulmonary dysplasia , Approved
21825,D0R2EY,SKF-97574,Peptic ulcer , Discontinued in Phase 1
21826,D0R2GA,Biaryl mannoside derivative 29,Crohn disease , Patented
21827,D0R2GA,Biaryl mannoside derivative 29,Ulcerative colitis , Patented
21828,D0R2GA,Biaryl mannoside derivative 29,Urinary tract infection , Patented
21829,D0R2GU,XRX-001,Yellow fever virus infection , Phase 1
21830,D0R2HZ,ETHOXY-IDAZOXAN,Poison intoxication , Investigative
21831,D0R2JS,Droloxifene,Breast cancer , Discontinued in Phase 2
21832,D0R2KF,Epervudine,Virus infection , Approved
21833,D0R2KJ,Dicloxacillin,Bacterial infection , Approved
21834,D0R2KO,CAF-01,Vaccination , Phase 1
21835,D0R2KR,Human Cytomegalovirus vaccine,Cytomegalovirus infection , Terminated
21836,D0R2KV,"CP-316,311",Mood disorder , Discontinued in Phase 2
21837,D0R2KV,"CP-316,311",Major depressive disorder , Discontinued in Phase 2
21838,D0R2KY,Ethynodiol Diacetate,Contraception , Approved
21839,D0R2LR,GR-108359,Bacterial infection , Discontinued in Phase 1
21840,D0R2LY,Multipeptide vaccine combination,Melanoma , Phase 1
21841,D0R2MG,HB-1275,Skin infection , Investigative
21842,D0R2MQ,BW-858C,Asthma , Investigative
21843,D0R2NE,Entacapone+levodopa+carbidopa,Restless legs syndrome , Phase 3
21844,D0R2NE,Entacapone+levodopa+carbidopa,Parkinson disease , Phase 3
21845,D0R2OA,Ipriflavone,Osteoporosis , Approved
21846,D0R2OU,Irdabisant,Cognitive impairment , Phase 1
21847,D0R2PR,Zn-DPA-P,Prostate cancer , Investigative
21848,D0R2QB,MT-7716,Alcohol dependence , Discontinued in Phase 1
21849,D0R2QG,TMI-358,Onychomycosis , Phase 2
21850,D0R2QV,PMID25666693-Compound-122,Osteoarthritis pain , Patented
21851,D0R2QV,PMID25666693-Compound-122,Cancer related pain , Patented
21852,D0R2QV,PMID25666693-Compound-122,Neuropathic pain , Patented
21853,D0R2QV,PMID25666693-Compound-122,Inflammatory pain , Patented
21854,D0R2RR,Typhoid vaccine,Mycobacterium infection , Approved
21855,D0R2RV,Anti-EGFR humanized mabs,Solid tumour/cancer , Investigative
21856,D0R2SK,Erteberel,Prostate hyperplasia , Phase 2
21857,D0R2SW,FSA2,Fungal infection , Preclinical
21858,D0R2VB,PMID25666693-Compound-106,Osteoarthritis pain , Patented
21859,D0R2VB,PMID25666693-Compound-106,Cancer related pain , Patented
21860,D0R2VB,PMID25666693-Compound-106,Neuropathic pain , Patented
21861,D0R2VB,PMID25666693-Compound-106,Inflammatory pain , Patented
21862,D0R2WK,NVP-TAE684,Lymphoma , Investigative
21863,D0R2YD,Lm Melanoma,Melanoma , Investigative
21864,D0R3BC,153Sm-EDTMP,Bone metastases , Approved
21865,D0R3BV,Inotersen,Hereditary amyloidosis , Approved
21866,D0R3DQ,SYL-040003,Ocular hypertension , Investigative
21867,D0R3DT,AT-006,Solid tumour/cancer , Investigative
21868,D0R3EL,GSK184072,Type-2 diabetes , Discontinued in Phase 2
21869,D0R3EL,GSK184072,Hematologic tumour , Discontinued in Phase 2
21870,D0R3EL,GSK184072,Colon cancer , Discontinued in Phase 2
21871,D0R3FP,Tenofovir disoproxil fumarate,Discovery agent , Approved
21872,D0R3GE,ANG-2010,Pain , Investigative
21873,D0R3HX,RB-6145,Solid tumour/cancer , Discontinued in Phase 1
21874,D0R3IG,SJCAR19,Acute lymphoblastic leukaemia , Phase 1/2
21875,D0R3IK,EPI-0030,Solid tumour/cancer , Investigative
21876,D0R3JB,Mitoxantrone,Solid tumour/cancer , Approved
21877,D0R3JB,Mitoxantrone,Non-hodgkin lymphoma , Phase 1/2
21878,D0R3JE,GS-2992,Human immunodeficiency virus infection , Terminated
21879,D0R3JO,PEG-EPO,Anemia , Investigative
21880,D0R3KL,RRV-TV rotavirus vaccine,Type-2 diabetes , Phase 2
21881,D0R3KN,MN-462,Thrombosis , Investigative
21882,D0R3KS,DX-2500,Ischemic heart disease , Investigative
21883,D0R3LH,UMN-01,Solid tumour/cancer , Investigative
21884,D0R3LQ,EXC 001,Fibrosis , Phase 2
21885,D0R3MA,Recombinant mab-biocide fusion proteins,Cryptosporidium infection , Investigative
21886,D0R3ML,PC-213,Human immunodeficiency virus infection , Phase 3
21887,D0R3MT,Acadesine,Diabetic complication , Phase 3
21888,D0R3NR,GATA-3-specific DNAzyme,Asthma , Investigative
21889,D0R3OQ,BNV-222,Diabetic neuropathy , Investigative
21890,D0R3OR,SR-27950,Eating disorder , Terminated
21891,D0R3PY,Tafasitamab,Diffuse large B-cell lymphoma , Approved
21892,D0R3PY,Tafasitamab,Chronic lymphocytic leukaemia , Phase 2
21893,D0R3QY,Vigabatrin,Complex partial seizure , Approved
21894,D0R3QY,Vigabatrin,Infantile spasm , Approved
21895,D0R3QY,Vigabatrin,Epilepsy , Approved
21896,D0R3RG,GZ402663,Macular degeneration , Phase 1
21897,D0R3RO,AZD-5455,Anxiety disorder , Discontinued in Phase 2
21898,D0R3SI,NNC-09-0026,Cerebrovascular ischaemia , Terminated
21899,D0R3VG,Thiazole carboxamide derivative 3,Solid tumour/cancer , Patented
21900,D0R3VG,Thiazole carboxamide derivative 3,Metastatic cancer , Patented
21901,D0R3VK,GDC-0623,Solid tumour/cancer , Phase 1
21902,D0R3VQ,BAL-27862,Solid tumour/cancer , Investigative
21903,D0R3WG,SILPERISONE HYDROCHLORIDE,Spasm , Discontinued in Phase 2
21904,D0R3XI,CDRI-97/78,Malaria , Phase 1
21905,D0R3YO,HKT288,Solid tumour/cancer , Phase 1
21906,D0R3YT,LPCN-1090,Cough , Investigative
21907,D0R3ZE,MEDI-551,Encephalopathy , Phase 2
21908,D0R3ZE,MEDI-551,Neuromyelitis optica , Phase 2
21909,D0R3ZE,MEDI-551,Chronic lymphocytic leukaemia , Phase 1
21910,D0R4AE,MT-7117,Erythropoietic porphyrias , Phase 2
21911,D0R4DN,NTC-121,Glioma , Discontinued in Phase 2
21912,D0R4DP,Clotiazepam,Anxiety disorder , Approved
21913,D0R4EN,LXR 623,Arteriosclerosis , Phase 1
21914,D0R4EY,Boscalid,Plant grey mould disease , Investigative
21915,D0R4GM,MDX-33,Thrombocytopenia , Discontinued in Phase 2
21916,D0R4HQ,Corticotropin,Diabetic nephropathy , Approved
21917,D0R4HQ,Corticotropin,Cushing disease , Approved
21918,D0R4IZ,Timothy grass pollen extracts,Allergy , Phase 1
21919,D0R4KK,verubecestat,Alzheimer disease , Phase 3
21920,D0R4ML,P1A,Toxicity , Discontinued in Phase 2
21921,D0R4MT,Gemcabene,Hypertriglyceridemia , Phase 2
21922,D0R4NJ,DW-908,Arthritis , Investigative
21923,D0R4NR,Prednisone/ dipyridamole,Rheumatoid arthritis , Phase 2
21924,D0R4NY,DTaP-IPV,Bordetella pertussis infection , Approved
21925,D0R4OD,Anti-IFN gamma,Alopecia , Terminated
21926,D0R4OI,K-103-IP,Pain , Phase 3
21927,D0R4OM,Trifluoperazine,Schizophrenia , Approved
21928,D0R4PW,Zalutumumab,Head and neck cancer , Phase 3
21929,D0R4RL,MYO-102,Limb girdle muscular dystrophy , Phase 1/2
21930,D0R4SE,FX-87L,Inflammation , Investigative
21931,D0R4UA,Hu3F8 mAb,Neuroblastoma , Phase 2
21932,D0R4UA,Hu3F8 mAb,Osteosarcoma , Phase 2
21933,D0R4UW,Roflumilast,Asthma , Approved
21934,D0R4UW,Roflumilast,Type-2 diabetes , Phase 1
21935,D0R4UW,Roflumilast,Chronic obstructive pulmonary disease , Withdrawn from market
21936,D0R4UW,Roflumilast,Atopic dermatitis , Discontinued in Phase 2
21937,D0R4WT,NB-325,Human immunodeficiency virus infection , Investigative
21938,D0R4YQ,CB-813,Hemophilia , Phase 1
21939,D0R4ZT,Gallium nitrate,Hypercalcaemia , Approved
21940,D0R5AU,LASINAVIR,Human immunodeficiency virus infection , Discontinued in Phase 1
21941,D0R5ER,BPX-01,Acne vulgaris , Phase 2
21942,D0R5GF,MRKAd5/ALVAC,Human immunodeficiency virus infection , Phase 1
21943,D0R5GS,Gepirone,Depression , Terminated
21944,D0R5HA,Tobacco plant-derived anti-idiotype vaccine,Non-hodgkin lymphoma , Phase 1
21945,D0R5HH,ACE-083,Charcot marie tooth disease , Phase 2
21946,D0R5HH,ACE-083,Muscular dystrophy , Phase 2
21947,D0R5IS,Flufenoxina,Major depressive disorder , Investigative
21948,D0R5JL,Polio IPV,Poliovirus infection , Approved
21949,D0R5JP,Pleuromutilins,Gram-positive bacterial infection , Investigative
21950,D0R5LL,Cancer vaccine,Sarcoma , Phase 2
21951,D0R5LL,Cancer vaccine,Glioblastoma multiforme , Phase 2
21952,D0R5NB,4SC-302,Flavivirus infection , Investigative
21953,D0R5NU,CART123 cells,Acute myeloid leukaemia , Phase 1
21954,D0R5OS,Apalcillin sodium,Bacterial infection , Approved
21955,D0R5PP,PRS-190,Autoimmune diabetes , Investigative
21956,D0R5QQ,AVE-8134,Heart failure , Discontinued in Phase 2
21957,D0R5RR,Clofarabine,Acute lymphoblastic leukaemia , Approved
21958,D0R5RR,Clofarabine,Myelodysplastic syndrome , Approved
21959,D0R5TT,FR-123826,Rheumatoid arthritis , Terminated
21960,D0R5TV,HD-0801,Parkinson disease , Phase 2/3
21961,D0R5TZ,SIM-071201,Cerebrovascular disease , Investigative
21962,D0R5UR,ALL-4,Non-insulin dependent diabetes , Investigative
21963,D0R5UZ,Caracemide,Solid tumour/cancer , Discontinued in Phase 2
21964,D0R5VO,Avicin D,Solid tumour/cancer , Investigative
21965,D0R5XK,ONO-1714,Sepsis , Discontinued in Phase 1
21966,D0R5XL,CAPTAT-414,Non-small-cell lung cancer , Investigative
21967,D0R5ZJ,SU-740,Stomach ulcer , Terminated
21968,D0R6AB,Droxicam,Inflammation , Withdrawn from market
21969,D0R6AI,TPX-100,Osteoarthritis , Phase 2
21970,D0R6BI,Fenoldopam,Hypertension , Approved
21971,D0R6BR,Amobarbital,Insomnia , Approved
21972,D0R6CD,Insulin,Diabetic complication , Approved
21973,D0R6EC,BC-7013,Skin infection , Phase 2
21974,D0R6EL,ETC-1001,Hyperlipidaemia , Discontinued in Phase 1
21975,D0R6EQ,Bivatuzumab mertansine,Solid tumour/cancer , Terminated
21976,D0R6FO,Aryl mannoside derivative 10,Crohn disease , Patented
21977,D0R6FO,Aryl mannoside derivative 10,Ulcerative colitis , Patented
21978,D0R6FO,Aryl mannoside derivative 10,Urinary tract infection , Patented
21979,D0R6GB,AG-SFT103,Hypertension , Investigative
21980,D0R6HN,Strontium Chloride Sr-89,Cancer related pain , Approved
21981,D0R6IF,EF-4,Diabetic complication , Discontinued in Preregistration
21982,D0R6IM,Empagliflozin/metformin,Type-2 diabetes , Registered
21983,D0R6JV,CX-1739,Attention deficit hyperactivity disorder , Phase 2
21984,D0R6MH,Cadrofloxacin,Bacterial infection , Discontinued in Phase 2
21985,D0R6MJ,MORAb-009,Mesothelioma , Phase 2
21986,D0R6OD,AnergiX-IDDM,Insulin-dependent diabetes , Terminated
21987,D0R6OM,ACTB-1003,Solid tumour/cancer , Investigative
21988,D0R6RB,PSD-597,Interstitial cystitis , Discontinued in Phase 2
21989,D0R6RC,Chlortetracycline,Pseudomonas infection , Approved
21990,D0R6RE,Esterified estrogens,Breast cancer , Approved
21991,D0R6RM,CP-118,Allergic rhinitis , Discontinued in Phase 2
21992,D0R6RO,Mianserin,Depression , Approved
21993,D0R6TI,Inamrinone Lactate,Congestive heart failure , Approved
21994,D0R6TI,Inamrinone Lactate,Cardiac disease , Approved
21995,D0R6TY,Noribogaine,Opioid dependence , Phase 2
21996,D0R6UR,ACI-24,Alzheimer disease , Phase 1/2
21997,D0R6UV,BMS-690514,Chronic pain , Phase 2
21998,D0R6VH,HI-1640V,Asthma , Phase 2
21999,D0R6VV,INO-5150,Prostate cancer , Phase 1
22000,D0R6WL,TAu mAb,Alzheimer disease , Phase 1
22001,D0R6YZ,Xultophy,Type-2 diabetes , Application submitted
22002,D0R6ZB,EDP-10,Insulin-dependent diabetes , Investigative
22003,D0R7AK,CP-601927,Gastrointestinal disease , Phase 2
22004,D0R7BB,GSK3359609,Squamous head and neck cell carcinom , Phase 2/3
22005,D0R7BB,GSK3359609,Solid tumour/cancer , Phase 1
22006,D0R7CD,INCB59872,Acute myeloid leukaemia , Phase 1/2
22007,D0R7CD,INCB59872,Small-cell lung cancer , Phase 1/2
22008,D0R7CP,Bromo benzyl ether derivative 2,Solid tumour/cancer , Patented
22009,D0R7CP,Bromo benzyl ether derivative 2,Infectious disease , Patented
22010,D0R7CP,Bromo benzyl ether derivative 2,Human immunodeficiency virus infection , Patented
22011,D0R7CP,Bromo benzyl ether derivative 2,Hepatitis , Patented
22012,D0R7DW,Thiomarinols,Bacterial infection , Terminated
22013,D0R7EA,"methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1,2,4-triazole-3-carboxylate",Alzheimer disease , Clinical trial
22014,D0R7EQ,Crenezumab,Alzheimer disease , Phase 3
22015,D0R7FS,BPI-704001,Solid tumour/cancer , Investigative
22016,D0R7GH,CS-526,Gastroesophageal reflux disease , Discontinued in Phase 1
22017,D0R7GL,BW-A502U,Solid tumour/cancer , Terminated
22018,D0R7HL,LXS196,Solid tumour/cancer , Phase 1/2
22019,D0R7HL,LXS196,Melanoma , Phase 1
22020,D0R7HO,Bumetanide,Congestive heart failure , Approved
22021,D0R7ID,HMN-214,Prostate cancer , Discontinued in Phase 1
22022,D0R7ID,HMN-214,Pancreatic cancer , Discontinued in Phase 1
22023,D0R7IU,NPSP-795,Osteoporosis , Phase 2
22024,D0R7JT,Fludrocortisone,Cerebral salt-wasting syndrome , Approved
22025,D0R7JW,Macrocycle derivative 4,Solid tumour/cancer , Patented
22026,D0R7JW,Macrocycle derivative 4,Infectious disease , Patented
22027,D0R7JW,Macrocycle derivative 4,Human immunodeficiency virus infection , Patented
22028,D0R7JW,Macrocycle derivative 4,Hepatitis , Patented
22029,D0R7KX,Rotarix,Rotavirus infection (Diarrhoea) , Approved
22030,D0R7LD,Sotorasib,Non-small-cell lung cancer , Phase 3
22031,D0R7LX,EU-C-002,Reperfusion injury , Investigative
22032,D0R7NI,Tagraxofusp,Blastic plasmacytoid dendritic cell neoplasm , Approved
22033,D0R7NI,Tagraxofusp,Acute myeloid leukaemia , Approved
22034,D0R7NP,INP-04,Solid tumour/cancer , Investigative
22035,D0R7OZ,BGC-20-0166,Obstructive sleep apnea , Discontinued in Phase 2
22036,D0R7QW,SR-2566,Eczema , Terminated
22037,D0R7UK,UR-8308,Asthma , Terminated
22038,D0R7UL,MD1003,Multiple sclerosis , Phase 3
22039,D0R7US,Interferon gamma-1a,Solid tumour/cancer , Approved
22040,D0R7WU,ACECLIDINE,Glaucoma/ocular hypertension , Approved
22041,D0R7XD,GSK1325756,Chronic obstructive pulmonary disease , Phase 2
22042,D0R7YH,SQZ-PBMC-HPV,Solid tumour/cancer , Phase 1
22043,D0R7YI,PMID30107136-Compound-Example13,Solid tumour/cancer , Patented
22044,D0R7YI,PMID30107136-Compound-Example13,Infectious disease , Patented
22045,D0R7YI,PMID30107136-Compound-Example13,Human immunodeficiency virus infection , Patented
22046,D0R7YI,PMID30107136-Compound-Example13,Hepatitis , Patented
22047,D0R7YN,Mannoside derivative 3,Crohn disease , Patented
22048,D0R7YN,Mannoside derivative 3,Ulcerative colitis , Patented
22049,D0R7YN,Mannoside derivative 3,Urinary tract infection , Patented
22050,D0R7YY,Darusentan,Hypotension , Phase 3
22051,D0R8AG,Prophage cancer vaccine,Glioblastoma multiforme , Phase 2
22052,D0R8AG,Prophage cancer vaccine,Recurrent glioblastoma , Phase 2
22053,D0R8AG,Prophage cancer vaccine,Glioma , Phase 2
22054,D0R8CE,M-114,Virus infection , Discontinued in Phase 2
22055,D0R8CN,Glycolipids,Parkinson disease , Investigative
22056,D0R8ER,Enoxacin,Urinary tract infection , Approved
22057,D0R8EW,SL-017,Acne vulgaris , Phase 1
22058,D0R8FL,Egalet-002,Chronic pain , Phase 3
22059,D0R8FM,Ebrotidine,Duodenal ulcer , Withdrawn from market
22060,D0R8GA,PMID25666693-Compound-14,Osteoarthritis pain , Patented
22061,D0R8GA,PMID25666693-Compound-14,Cancer related pain , Patented
22062,D0R8GA,PMID25666693-Compound-14,Neuropathic pain , Patented
22063,D0R8GA,PMID25666693-Compound-14,Inflammatory pain , Patented
22064,D0R8GR,OPC-14523,Mood disorder , Phase 2
22065,D0R8GR,OPC-14523,Bulimia nervosa , Phase 2
22066,D0R8GR,OPC-14523,Female sexual arousal dysfunction , Phase 1
22067,D0R8HY,DCCCyB,Schizophrenia , Phase 1
22068,D0R8ID,P-7170,Solid tumour/cancer , Phase 1
22069,D0R8IE,Inecalcitol oral,Prostate cancer , Phase 2
22070,D0R8IE,Inecalcitol oral,Acute myeloid leukaemia , Phase 2
22071,D0R8IU,AZD-4017,Ocular hypertension , Phase 2
22072,D0R8JN,AF-3485,Inflammation , Investigative
22073,D0R8KF,STP-322,Liver cancer , Investigative
22074,D0R8LQ,AQST-203,Acute repetitive seizure , Phase 3
22075,D0R8LV,NI-0401,Autoimmune diabetes , Phase 1/2
22076,D0R8LW,ORG-34167,Depression , Discontinued in Phase 1
22077,D0R8PE,Pivagabine,Depression , Phase 1
22078,D0R8PE,Pivagabine,Anxiety disorder , Phase 1
22079,D0R8PX,Vasicine,Postpartum haemorrhage , Approved
22080,D0R8QG,Tepotinib,Non-small cell lung cancer , Approved
22081,D0R8QG,Tepotinib,Hepatocellular carcinoma , Phase 2
22082,D0R8QG,Tepotinib,Solid tumour/cancer , Phase 1/2
22083,D0R8QX,HMGB-1 protein and its fragments,Bone disease , Phase 3
22084,D0R8RK,Ro-25-0534,Bacterial infection , Terminated
22085,D0R8RO,SAR-21609,Asthma , Phase 1
22086,D0R8SY,Limtop,Keratosis , Phase 2
22087,D0R8TB,ERA-923,Breast cancer , Discontinued in Phase 2
22088,D0R8VU,MyeloXen,Multiple sclerosis , Investigative
22089,D0R8WT,Tocilizumab,Giant cell arteritis , Approved
22090,D0R8WT,Tocilizumab,Coronavirus Disease 2019 (COVID-19) , Phase 3
22091,D0R8YO,CEDO-8956,Hypertension , Terminated
22092,D0R9BG,Acetohydroxamic Acid,Urinary tract infection , Approved
22093,D0R9DP,CEM-102,Joint infection , Phase 2/3
22094,D0R9DX,GsMTx4,Duchenne dystrophy , Investigative
22095,D0R9EQ,Ropinirole,Parkinson disease , Approved
22096,D0R9FM,SentoClone,Melanoma , Phase 2
22097,D0R9GF,GALGT2 gene therapy,Duchenne dystrophy , Phase 1/2
22098,D0R9HE,BI 113823,Osteoarthritis , Phase 1
22099,D0R9HI,SB-742457,Alzheimer disease , Phase 3
22100,D0R9HL,Vildagliptin/metformin,Type-2 diabetes , Phase 3
22101,D0R9IH,SAR-339658,Inflammatory bowel disease , Phase 2
22102,D0R9IL,CK-2066260,Neuromuscular disease , Investigative
22103,D0R9IU,PRT-062607,Chronic lymphocytic leukaemia , Phase 1
22104,D0R9JC,H5N1 influenza mab therapy,Influenza virus infection , Investigative
22105,D0R9KG,Temanogrel,Cardiovascular disease , Phase 1
22106,D0R9MN,Danoprevir,Hepatitis C virus infection , Phase 2
22107,D0R9NB,Lprivask,Thrombosis , Approved
22108,D0R9NQ,Bi-51013,Transplant rejection , Terminated
22109,D0R9OH,Sulfamethoxazole,Bacterial infection , Approved
22110,D0R9OH,Sulfamethoxazole,Infection of P. falciparum , Investigative
22111,D0R9ON,MR-889,Phlegmy cough , Discontinued in Phase 3
22112,D0R9PD,Hydrazide derivative 1,Obesity , Patented
22113,D0R9PL,RWJ-25730,Psychotic disorder , Terminated
22114,D0R9PS,Aviscumine,Solid tumour/cancer , Phase 2
22115,D0R9RP,PMID25666693-Compound-32,Osteoarthritis pain , Patented
22116,D0R9RP,PMID25666693-Compound-32,Cancer related pain , Patented
22117,D0R9RP,PMID25666693-Compound-32,Neuropathic pain , Patented
22118,D0R9RP,PMID25666693-Compound-32,Inflammatory pain , Patented
22119,D0R9UO,PAN-622,Solid tumour/cancer , Investigative
22120,D0R9UQ,Long-acting Factor VII conjugate,Bleeding disorder , Investigative
22121,D0R9US,GSK2140944,Urinary tract infection , Phase 3
22122,D0R9US,GSK2140944,Neisseria gonorrhoeae infection , Phase 3
22123,D0R9US,GSK2140944,Acute bacterial skin infection , Phase 2
22124,D0R9VC,GnRH,Female infertility , Phase 3
22125,D0R9VR,Galantamine,Alzheimer disease , Approved
22126,D0R9VX,DS-3078,Lymphoma , Phase 1
22127,D0R9VX,DS-3078,Solid tumour/cancer , Phase 1
22128,D0R9WD,Egalet-004,Chronic pain , Phase 1
22129,D0R9WI,F-16242,Major depressive disorder , Preclinical
22130,D0R9WP,Demeclocycline,Bronchitis , Approved
22131,D0R9WP,Demeclocycline,Acne vulgaris , Approved
22132,D0R9WP,Demeclocycline,Lyme disease , Approved
22133,D0R9XX,TG-N,Bone disease , Investigative
22134,D0R9YR,BETULINIC ACID,Melanoma , Phase 1
22135,D0R9ZB,Propiomazine,Insomnia , Approved
22136,D0RA1R,CD19-targeting CAR T cells,B-cell lymphoma , Phase 2
22137,D0RA1R,CD19-targeting CAR T cells,leukaemia , Phase 2
22138,D0RA5E,MK-8835B,Type-2 diabetes , Phase 3
22139,D0RA5Q,Bestatin,Acute myeloid leukaemia , Approved
22140,D0RA7L,Anti-BCMA CART Cells,Multiple myeloma , Phase 1
22141,D0RA9C,CCT301-38 (targeting ROR2),Renal cell carcinoma , Phase 1/2
22142,D0RA9E,Ramosetron,Nausea and vomiting , Approved
22143,D0RA9E,Ramosetron,Irritable bowel syndrome , Phase 4
22144,D0RB2H,PBI-1308,Atopic dermatitis , Investigative
22145,D0RB6L,rhACE2,Coronavirus Disease 2019 (COVID-19) , Phase 2
22146,D0RC0J,ABT-436,Anxiety disorder , Phase 2
22147,D0RC0P,EBV-targeted autologous T-cell therapy,Lymphoma , Phase 1/2
22148,D0RC1R,Dendritic cell-based exosome vaccine,Lung cancer , Phase 1
22149,D0RC2V,Albuvirtide,Human immunodeficiency virus infection , Phase 3
22150,D0RC5I,Azetidine derivative 4,Obesity , Patented
22151,D0RC7L,PMID25666693-Compound-139,Osteoarthritis pain , Patented
22152,D0RC7L,PMID25666693-Compound-139,Cancer related pain , Patented
22153,D0RC7L,PMID25666693-Compound-139,Neuropathic pain , Patented
22154,D0RC7L,PMID25666693-Compound-139,Inflammatory pain , Patented
22155,D0RC7R,Resorcinol compound 9,Albinism , Patented
22156,D0RC7R,Resorcinol compound 9,Ephelides , Patented
22157,D0RC7R,Resorcinol compound 9,Menkes disease , Patented
22158,D0RC7R,Resorcinol compound 9,Senile lentigines , Patented
22159,D0RC7R,Resorcinol compound 9,Melasma , Patented
22160,D0RD0D,BCMA CART,Multiple myeloma , Phase 1
22161,D0RD0Y,RetinoStat,Macular degeneration , Phase 2
22162,D0RD1I,XOMA-3AB,Clostridium infection , Phase 1
22163,D0RD1Z,Exebryl-1,Alzheimer disease , Phase 1
22164,D0RD5W,Hyoscyamine,Gastrointestinal disease , Approved
22165,D0RD6X,CLDC,Hepatocellular carcinoma , Investigative
22166,D0RE0F,Biphenyl mannoside derivative 13,Crohn disease , Patented
22167,D0RE0F,Biphenyl mannoside derivative 13,Ulcerative colitis , Patented
22168,D0RE0F,Biphenyl mannoside derivative 13,Urinary tract infection , Patented
22169,D0RE0K,PF-05161704,Non-insulin dependent diabetes , Phase 1
22170,D0RE3R,PMID25684022-Compound-US20120277229 44(1.4),Solid tumour/cancer , Patented
22171,D0RE3R,PMID25684022-Compound-US20120277229 44(1.4),Metastatic cancer , Patented
22172,D0RE4L,KX2-361,Brain cancer , Phase 1
22173,D0RE4L,KX2-361,Glioblastoma multiforme , Phase 1
22174,D0RE6T,Telotristat ethyl,Carcinoid syndrome diarrhea , Approved
22175,D0RE6T,Telotristat ethyl,Carcinoid syndrome , Approved
22176,D0RE8R,SF-101,Infectious disease , Investigative
22177,D0RE9C,Lucerastat,Fabry disease , Phase 3
22178,D0RE9H,NR-LU-13,Colon cancer , Terminated
22179,D0RF3F,MGCD-290,Rheumatoid arthritis , Phase 2
22180,D0RF4J,CLL1 CAR-T Cell,Acute myeloid leukaemia , Phase 2/3
22181,D0RF9T,Lexacalcitol,Solid tumour/cancer , Discontinued in Phase 2
22182,D0RG1Z,Biaryl mannoside derivative 22,Crohn disease , Patented
22183,D0RG1Z,Biaryl mannoside derivative 22,Ulcerative colitis , Patented
22184,D0RG1Z,Biaryl mannoside derivative 22,Urinary tract infection , Patented
22185,D0RG3O,Atropine,Organophosphate poisoning , Approved
22186,D0RG3O,Atropine,Poison intoxication , Phase 1
22187,D0RG8Z,FPI-01,Acute myeloid leukaemia , Phase 2
22188,D0RG9A,Monensin sodium,Middle East Respiratory Syndrome (MERS) , Investigative
22189,D0RH0J,LAM-111,Muscular dystrophy , Investigative
22190,D0RH3S,DC/I540/KLH vaccine,Brain cancer , Phase 1
22191,D0RH6G,Heterocyclic derivative 16,Solid tumour/cancer , Patented
22192,D0RH6G,Heterocyclic derivative 16,Metastatic cancer , Patented
22193,D0RI4I,BioE-743,Leigh syndrome , Phase 2
22194,D0RI4I,BioE-743,Pontocerebellar hypoplasia type 6 , Phase 2
22195,D0RI6L,M-3000,Autoimmune diabetes , Investigative
22196,D0RI6Q,Monalizumab,Chronic lymphocytic leukaemia , Phase 1/2
22197,D0RI6Q,Monalizumab,Head and neck cancer , Phase 1/2
22198,D0RI6Q,Monalizumab,Solid tumour/cancer , Phase 1
22199,D0RI7N,Mesenchymal bone marrow-derived stem cell therapy,Cerebrovascular ischaemia , Phase 1
22200,D0RI8E,GD2-targeted CAR-T cells,Neuroblastoma , Clinical trial
22201,D0RI9A,LFX453,Actinic keratosis , Phase 2
22202,D0RI9A,LFX453,External genital and perianal wart , Phase 2
22203,D0RJ0J,M-5010,Arthritis , Discontinued in Phase 3
22204,D0RJ0V,GFT14,Hyperlipidaemia , Phase 2
22205,D0RJ1W,OX-914,Asthma , Phase 2
22206,D0RJ2P,BB-2983,Inflammatory bowel disease , Discontinued in Phase 1
22207,D0RJ2V,LMP1-CAR-T cells,Nasopharyngeal carcinoma , Phase 1/2
22208,D0RJ6R,Du-123015,Anxiety disorder , Terminated
22209,D0RK4B,IONIS-MAPTRx,Alzheimer disease , Phase 1/2
22210,D0RK4I,Empagliflozin + linagliptin + metformin,Diabetic complication , Phase 1
22211,D0RK4V,Aromatic acetylene derivative 1,Solid tumour/cancer , Patented
22212,D0RK4V,Aromatic acetylene derivative 1,Infectious disease , Patented
22213,D0RK4V,Aromatic acetylene derivative 1,Human immunodeficiency virus infection , Patented
22214,D0RK4V,Aromatic acetylene derivative 1,Hepatitis , Patented
22215,D0RK6W,"Pyrazolo[4,3-c]pyridine derivative 1",Pruritus , Patented
22216,D0RK6W,"Pyrazolo[4,3-c]pyridine derivative 1",Solid tumour/cancer , Patented
22217,D0RK6W,"Pyrazolo[4,3-c]pyridine derivative 1",Chronic pain , Patented
22218,D0RK6W,"Pyrazolo[4,3-c]pyridine derivative 1",Neuropathic pain , Patented
22219,D0RK6W,"Pyrazolo[4,3-c]pyridine derivative 1",Thymic cancer , Patented
22220,D0RK8E,NI-202,Parkinson disease , Investigative
22221,D0RK8U,JKB-122,Hepatitis virus infection , Phase 2
22222,D0RL4M,Pranazepide,Pancreatic malfunction , Discontinued in Phase 2
22223,D0RL4T,Gadolinium based C60 fullerene-paclitaxel-ZME-018 conjugates,Solid tumour/cancer , Investigative
22224,D0RL4X,AP-761,Asthma , Phase 2
22225,D0RL5B,VLB-01,Epilepsy , Phase 3
22226,D0RM2O,S. sonnei-rEPA,Shigella infection , Phase 3
22227,D0RM5W,MX2/120,Asthma , Terminated
22228,D0RM5Z,Sofosbuvir + velpatasvir + voxilaprevir,Hepatitis C virus infection , Approved
22229,D0RM6A,RST-001,Retinopathy , Phase 1/2
22230,D0RM9Q,Budipine,Migraine , Approved
22231,D0RN2W,Potassium,Hypokalemia , Approved
22232,D0RN3S,GS-4997,Diabetic nephropathy , Phase 2
22233,D0RN3S,GS-4997,Pulmonary arterial hypertension , Phase 2
22234,D0RN6V,BRL-52656,Pain , Phase 1
22235,D0RO0T,MKC-1313,Solid tumour/cancer , Terminated
22236,D0RO2L,CAR-T cells targeting PSMA,Cervical cancer , Phase 1/2
22237,D0RO7R,BhCG vaccine,Solid tumour/cancer , Terminated
22238,D0RO8H,AC-262271,Glaucoma/ocular hypertension , Phase 1
22239,D0RP2W,Mirvetuximab soravtansine,Ovarian cancer , Phase 3
22240,D0RP2W,Mirvetuximab soravtansine,Endometrial cancer , Phase 1
22241,D0RP4U,PMID25684022-Compound-WO2006015124,Solid tumour/cancer , Patented
22242,D0RP4U,PMID25684022-Compound-WO2006015124,Metastatic cancer , Patented
22243,D0RP5T,RG6206,Duchenne dystrophy , Phase 2/3
22244,D0RQ2W,Gadopentetate dimeglumine,Carcinoma , Approved
22245,D0RQ5Z,Shan 6,Pertussis , Phase 3
22246,D0RQ5Z,Shan 6,Poliomyelitis , Phase 2
22247,D0RQ5Z,Shan 6,Tetanus , Phase 2
22248,D0RQ5Z,Shan 6,Diphtheria , Phase 2
22249,D0RQ5Z,Shan 6,Haemophilus influenza , Phase 2
22250,D0RQ5Z,Shan 6,Hepatitis B virus infection , Phase 2
22251,D0RQ5Z,Shan 6,Poliovirus infection , Phase 2
22252,D0RR2E,IDP-122,Plaque psoriasis , Phase 3
22253,D0RR4T,GI-270384X,Inflammatory bowel disease , Terminated
22254,D0RR8O,"Pyrido[3,2-d]pyrimidine derivative 2",Pruritus , Patented
22255,D0RR8O,"Pyrido[3,2-d]pyrimidine derivative 2",Solid tumour/cancer , Patented
22256,D0RR8O,"Pyrido[3,2-d]pyrimidine derivative 2",Chronic pain , Patented
22257,D0RR8O,"Pyrido[3,2-d]pyrimidine derivative 2",Neuropathic pain , Patented
22258,D0RR8O,"Pyrido[3,2-d]pyrimidine derivative 2",Thymic cancer , Patented
22259,D0RR9O,EDP-24,Solid tumour/cancer , Investigative
22260,D0RS0Q,Ad-VirRx 007,Solid tumour/cancer , Phase 1
22261,D0RS1Q,E-1413,Major depressive disorder , Investigative
22262,D0RS4X,PEN-866,Solid tumour/cancer , Phase 1/2
22263,D0RT2E,RG-83852,Solid tumour/cancer , Terminated
22264,D0RT5T,ARANOSE,Solid tumour/cancer , Discontinued in Phase 3
22265,D0RU0O,IPI-145,Small lymphocytic lymphoma , Approved
22266,D0RU0O,IPI-145,Follicular lymphoma , Approved
22267,D0RU0O,IPI-145,Arthritis , Phase 3
22268,D0RU5R,NEV-801,Solid tumour/cancer , Phase 1
22269,D0RU6U,Dixyrazine,Anxiety disorder , Approved
22270,D0RU7T,G-619,Thrombosis , Phase 1
22271,D0RV0O,PMID29334795-Compound-23,Schizophrenia , Patented
22272,D0RV2E,Pyrazole derivative 17,Obesity , Patented
22273,D0RV4P,Daratumumab,Multiple myeloma , Approved
22274,D0RV6F,MK-0773,Osteoporosis , Phase 2
22275,D0RV6U,ADU-623,Glioblastoma multiforme , Phase 1
22276,D0RV7J,RG-7256,Melanoma , Discontinued in Phase 1
22277,D0RV8L,PAV-667,Ebola virus infection , Investigative
22278,D0RV9C,GRL-001,Severe acute respiratory syndrome (SARS) , Preclinical
22279,D0RV9C,GRL-001,Middle East Respiratory Syndrome (MERS) , Preclinical
22280,D0RW4F,CereCRIB,Pain , Discontinued in Phase 2
22281,D0RW5O,DPX-0907,Breast cancer , Phase 1
22282,D0RW9P,HiviCides I and II,Human immunodeficiency virus infection , Investigative
22283,D0RX3C,Piritramide,Pain , Approved
22284,D0RX6F,CLR-131,Haematological malignancy , Phase 2
22285,D0RX6F,CLR-131,Multiple myeloma , Phase 2
22286,D0RX6F,CLR-131,Pediatric cancer , Phase 1
22287,D0RX7Z,DEOXYCYTIDINE,Acute myeloid leukaemia , Approved
22288,D0RY4N,Human and mouse PSMA DNA vaccines,Prostate cancer , Phase 1
22289,D0RY6M,Heterocyclic-carboxamide derivative 1,Solid tumour/cancer , Patented
22290,D0RY6M,Heterocyclic-carboxamide derivative 1,Metastatic cancer , Patented
22291,D0RZ0N,FR-62765,Diabetic complication , Terminated
22292,D0RZ5E,Biphenyl mannoside derivative 17,Crohn disease , Patented
22293,D0RZ5E,Biphenyl mannoside derivative 17,Ulcerative colitis , Patented
22294,D0RZ5E,Biphenyl mannoside derivative 17,Urinary tract infection , Patented
22295,D0RZ9V,IDH305,Advanced malignancy , Phase 1
22296,D0S0AF,Bunazosin,Glaucoma/ocular hypertension , Approved
22297,D0S0AS,Ipratropium,Obstructive lung disease , Approved
22298,D0S0BJ,IMCgp100,Melanoma , Phase 2
22299,D0S0BJ,IMCgp100,Cutaneous melanoma , Phase 2
22300,D0S0CW,AcALY-18,Immune System disease , Investigative
22301,D0S0DU,KSB-303,Colorectal cancer , Discontinued in Phase 1/2
22302,D0S0DY,OP-04,Pancreatic cancer , Investigative
22303,D0S0EQ,AZD-0865,Gastrointestinal disease , Phase 2
22304,D0S0ES,Imidapril,Cardiovascular disease , Approved
22305,D0S0FD,E2027,Parkinson disease , Phase 2
22306,D0S0FD,E2027,Lewy body dementia , Phase 2
22307,D0S0FD,E2027,Alzheimer disease , Phase 1
22308,D0S0FZ,Carisbamate,Seizure disorder , Phase 3
22309,D0S0FZ,Carisbamate,Focal dystonia , Phase 3
22310,D0S0FZ,Carisbamate,Epilepsy , Phase 3
22311,D0S0GM,ADX-10061,Psychotic disorder , Discontinued in Phase 2
22312,D0S0GO,DLYE-5953A,Solid tumour/cancer , Phase 1
22313,D0S0HA,O6-Benzylguanine alkylade,Sarcoma , Phase 3
22314,D0S0II,"Pyrrolo[2,3-d]pyrimidine derivative 3",Pruritus , Patented
22315,D0S0II,"Pyrrolo[2,3-d]pyrimidine derivative 3",Solid tumour/cancer , Patented
22316,D0S0II,"Pyrrolo[2,3-d]pyrimidine derivative 3",Chronic pain , Patented
22317,D0S0II,"Pyrrolo[2,3-d]pyrimidine derivative 3",Neuropathic pain , Patented
22318,D0S0II,"Pyrrolo[2,3-d]pyrimidine derivative 3",Thymic cancer , Patented
22319,D0S0IW,PJ-3505,Solid tumour/cancer , Terminated
22320,D0S0KP,CVX-045,Solid tumour/cancer , Phase 2
22321,D0S0LD,DTwP-HBV vaccine,Hepatitis B virus infection , Phase 3
22322,D0S0LZ,Doxycycline,Chronic periodontitis , Approved
22323,D0S0LZ,Doxycycline,Advanced gum disease , Approved
22324,D0S0LZ,Doxycycline,Diabetic foot ulcer , Phase 2
22325,D0S0MP,SGN-30,Solid tumour/cancer , Phase 2
22326,D0S0MR,NVB-333,Gram-positive bacterial infection , Preclinical
22327,D0S0NK,Neoandrographolide,Bacillary dysentery , Approved
22328,D0S0NX,Peginterferon beta,Multiple sclerosis , Phase 1
22329,D0S0OF,Macrocyclic peptide analog 1,Solid tumour/cancer , Patented
22330,D0S0OF,Macrocyclic peptide analog 1,Infectious disease , Patented
22331,D0S0OF,Macrocyclic peptide analog 1,Human immunodeficiency virus infection , Patented
22332,D0S0OF,Macrocyclic peptide analog 1,Hepatitis , Patented
22333,D0S0OI,ATEVIRDINE,Human immunodeficiency virus infection , Phase 1
22334,D0S0RE,HuMax-CD74,Solid tumour/cancer , Investigative
22335,D0S0RS,MK-8245,Type-2 diabetes , Phase 2
22336,D0S0RX,ATGC-OP0359,Prostate cancer , Investigative
22337,D0S0SE,Rupintrivir,Virus infection , Phase 2
22338,D0S0ST,NPS-31807,Psoriasis vulgaris , Phase 4
22339,D0S0TR,NeurTriptin,Neurodegenerative disorder , Investigative
22340,D0S0VR,PF-5230894,Bacterial infection , Phase 1/2
22341,D0S0VZ,IDRA-21,Alzheimer disease , Terminated
22342,D0S0WN,Biomed 101,Kidney cancer , Phase 1
22343,D0S0WN,Biomed 101,Inflammatory bowel disease , Discontinued in Phase 2
22344,D0S0WN,Biomed 101,Renal cell carcinoma , Discontinued in Phase 1
22345,D0S0WR,Luspatercept,Anaemia , Approved
22346,D0S0WR,Luspatercept,Beta thalassemia , Phase 3
22347,D0S0WR,Luspatercept,Myelodysplastic syndrome , Phase 3
22348,D0S0XS,SR-271425,Solid tumour/cancer , Discontinued in Phase 1
22349,D0S0ZQ,Vesimune,Non-muscle invasive bladder cancer , Phase 2
22350,D0S0ZQ,Vesimune,Bladder cancer , Phase 1
22351,D0S1AD,Tridolgosir,Solid tumour/cancer , Discontinued in Phase 2
22352,D0S1BF,AD02 vaccine,Alzheimer disease , Phase 2
22353,D0S1BN,Iptakalim,Hypertension , Phase 1
22354,D0S1CR,Anti-CD123-CAR-transduced T cells,leukaemia , Phase 1/2
22355,D0S1FM,G3139 + Paclitaxel,Small-cell lung cancer , Investigative
22356,D0S1HE,Rhenium-186 etidronate,Bone metastases , Approved
22357,D0S1HI,Azoles,Trypanosomiasis , Investigative
22358,D0S1HX,TAS-203,Respiratory tract inflammation , Investigative
22359,D0S1JV,AM-260,Osteoarthritis , Investigative
22360,D0S1KP,PT003,Chronic obstructive pulmonary disease , Phase 3
22361,D0S1KR,RVT-103+RVT-104,Alzheimer disease , Phase 1
22362,D0S1LE,Lintuzumab Bi-213,Acute myeloid leukaemia , Discontinued in Phase 1/2
22363,D0S1NZ,Acipimox,Arteriosclerosis , Approved
22364,D0S1OE,Chlormezanone,Anxiety disorder , Approved
22365,D0S1PM,RBx-2258,Prostate hyperplasia , Discontinued in Phase 2
22366,D0S1QN,Anti-CEA-CAR T,Colorectal cancer , Phase 1
22367,D0S1QN,Anti-CEA-CAR T,Gastric adenocarcinoma , Phase 1
22368,D0S1QN,Anti-CEA-CAR T,Lung cancer , Phase 1
22369,D0S1QN,Anti-CEA-CAR T,Pancreatic cancer , Phase 1
22370,D0S1QY,SHP620,Cytomegalovirus infection , Phase 3
22371,D0S1RT,UK-290795,Urinary incontinence , Terminated
22372,D0S1TI,RX-5902,Triple negative breast cancer , Phase 2
22373,D0S1TI,RX-5902,Solid tumour/cancer , Phase 1
22374,D0S1UW,Premarin/Trimegestone,Menopause symptom , Approved
22375,D0S1UZ,PD-360324,Rheumatoid arthritis , Phase 2
22376,D0S1WV,Enoblituzumab,Solid tumour/cancer , Phase 2
22377,D0S1WV,Enoblituzumab,Prostate cancer , Phase 2
22378,D0S1XO,BIBX-79,Arteriosclerosis , Terminated
22379,D0S1XX,BMS-986165,Plaque psoriasis , Phase 3
22380,D0S1XX,BMS-986165,Psoriasis vulgaris , Phase 3
22381,D0S1YN,MYK-491,Dilated cardiomyopathy , Phase 1
22382,D0S1YX,S-PRAnt,Uterine fibroids , Phase 2
22383,D0S1ZB,Fotemustine,Solid tumour/cancer , Approved
22384,D0S1ZY,RSLV-125,Systemic lupus erythematosus , Investigative
22385,D0S2BL,CRTX-074,Cough , Investigative
22386,D0S2BT,Potassium Aminosalicylate,Pulmonary tuberculosis , Approved
22387,D0S2BU,BA-058,Osteoporosis , Phase 3
22388,D0S2DU,Eligen insulin,Diabetic complication , Phase 2
22389,D0S2GT,CDP571,Crohn disease , Discontinued in Phase 3
22390,D0S2HO,Perillyl alcohol,Solid tumour/cancer , Discontinued in Phase 2
22391,D0S2IQ,Sapropterin hydrochloride,Hyperphenylalaninemia , Approved
22392,D0S2JI,Clopamide,Edema , Approved
22393,D0S2KX,PLR-15,Diabetic foot ulcer , Terminated
22394,D0S2LQ,PYY3-36,Obesity , Discontinued in Phase 2
22395,D0S2ME,Pyrazoline derivative 5,Obesity , Patented
22396,D0S2MG,Ambrisentan + tadalafil,Pulmonary arterial hypertension , Phase 1
22397,D0S2MQ,SD-102,Pneumonia , Investigative
22398,D0S2NI,Rhpth,Osteoporosis , Approved
22399,D0S2PD,BMS-823778,Hypercholesterolaemia , Phase 2
22400,D0S2PY,MK-866,Discovery agent , Phase 2
22401,D0S2QP,COG-248,Alzheimer disease , Investigative
22402,D0S2RZ,XEL-007DO,Cardiovascular disease , Investigative
22403,D0S2UG,Selegiline,Major depressive disorder , Approved
22404,D0S2UG,Selegiline,Skin imperfections , Patented
22405,D0S2UG,Selegiline,Chemotherapy-induced nausea , Discontinued in Phase 3
22406,D0S2UR,PIRODOMAST,Asthma , Phase 2
22407,D0S2WC,Nerisopam,Anxiety disorder , Discontinued in Phase 1
22408,D0S2YX,Mofarotene,Solid tumour/cancer , Discontinued in Phase 1
22409,D0S3AE,Anti-MUC1 AR20.5 mab,Pancreatic cancer , Phase 1
22410,D0S3AQ,CAT-2003,Hypertriglyceridemia , Phase 2
22411,D0S3BF,Pegadricase,Gout , Phase 1
22412,D0S3BK,GS010,Leber hereditary optic neuropathy , Phase 3
22413,D0S3BR,RG7598,Multiple myeloma , Discontinued in Phase 1
22414,D0S3CX,Necuparanib,Pancreatic cancer , Phase 2
22415,D0S3EF,CT-400P,Bone metastases , Investigative
22416,D0S3EK,EVT100,Major depressive disorder , Phase 1
22417,D0S3EM,CAZ AVI,Serious infection , Phase 3
22418,D0S3HR,ARA-04,Entamoeba histolytica infection , Investigative
22419,D0S3IG,SCH-10363,Hepatitis C virus infection , Investigative
22420,D0S3LF,MFH-244,Ischemia , Investigative
22421,D0S3MY,ET-642,Arteriosclerosis , Discontinued in Phase 2
22422,D0S3NU,Delamanid,Multi-drug resistant tuberculosis , Approved
22423,D0S3NU,Delamanid,Mycobacterium infection , Phase 3
22424,D0S3PO,Pelitinib,Lymphoma , Phase 2
22425,D0S3PX,Intra-oral lozenge,Fungal infection , Investigative
22426,D0S3QH,AP-CDLD,Parkinson disease , Phase 3
22427,D0S3QK,CW-343,Gastroesophageal reflux disease , Investigative
22428,D0S3RB,ELAROFIBAN,Thrombosis , Discontinued in Phase 2
22429,D0S3RX,"1,2,3-triazole derivative 1",Obesity , Patented
22430,D0S3UH,SUVN-507,Neurological disorder , Investigative
22431,D0S3WH,Artemisinin,Malaria , Approved
22432,D0S3WK,HRC-302,Chronic myelogenous leukaemia , Discontinued in Phase 1
22433,D0S3XA,HRG-214,Human immunodeficiency virus infection , Discontinued in Phase 2
22434,D0S3XE,Turosteride,Prostate disease , Phase 2
22435,D0S3YG,SNX-9,Solid tumour/cancer , Investigative
22436,D0S3YN,FE-202158,Sepsis , Phase 2
22437,D0S3YV,CD30 CAR T Cells,Non-hodgkin lymphoma , Phase 1
22438,D0S3YV,CD30 CAR T Cells,Hodgkin lymphoma , Phase 1
22439,D0S3ZP,Dorolac,Migraine , Phase 2
22440,D0S4AR,MX-68,Obesity , Discontinued in Phase 1
22441,D0S4BP,DP-802,Inflammation , Investigative
22442,D0S4BR,Methimazole,Hyperthyroidism , Approved
22443,D0S4FQ,Insulin glargine biosimilar,Type-1 diabetes , Phase 3
22444,D0S4FQ,Insulin glargine biosimilar,Type-2 diabetes , Phase 3
22445,D0S4GR,ETV-004,Toxicity , Investigative
22446,D0S4GT,CAR-T cells targeting GD2,Lung cancer , Phase 1/2
22447,D0S4GT,CAR-T cells targeting GD2,Glioblastoma multiforme , Phase 1
22448,D0S4II,GSK1292263,Type-2 diabetes , Phase 2
22449,D0S4II,GSK1292263,Gastric adenocarcinoma , Phase 2
22450,D0S4IK,PMI-016,Muscle wasting disease , Investigative
22451,D0S4IR,PBCAR0191,Acute lymphoblastic leukaemia , Phase 1/2
22452,D0S4IR,PBCAR0191,Non-hodgkin lymphoma , Phase 1/2
22453,D0S4JK,MLN8237,Solid tumour/cancer , Phase 3
22454,D0S4JK,MLN8237,Small-cell lung cancer , Phase 2
22455,D0S4JL,Simtuzumab,Colorectal cancer , Phase 2
22456,D0S4JL,Simtuzumab,Primary sclerosing cholangitis , Phase 2
22457,D0S4JY,Ro-24-4736,Sepsis , Discontinued in Phase 2
22458,D0S4KI,Menitorix,Haemophilus influenza , Approved
22459,D0S4KJ,KHK-2866,Ovarian cancer , Phase 1
22460,D0S4LL,Sanfetrinem,Bacterial infection , Discontinued in Phase 3
22461,D0S4LP,VLI-03A,Hepatitis virus infection , Phase 2
22462,D0S4LV,VB-111,Malignant glioma , Phase 3
22463,D0S4LV,VB-111,Ovarian cancer , Phase 3
22464,D0S4LV,VB-111,Recurrent glioblastoma , Phase 3
22465,D0S4LV,VB-111,Glioblastoma multiforme , Phase 2
22466,D0S4MX,MGN-1374,Myocardial infarction , Investigative
22467,D0S4NZ,AVN-458,Cognitive impairment , Investigative
22468,D0S4OH,Anti-CD20 engineered toxin bodies,Lymphoma , Investigative
22469,D0S4PN,C-1205,Urinary tract infection , Phase 1
22470,D0S4PZ,SWT-01113,Atopic dermatitis , Investigative
22471,D0S4QZ,Lobaplatin,Breast cancer , Approved
22472,D0S4RB,ITX-7650,Hepatitis C virus infection , Investigative
22473,D0S4RK,Recombinant factor VIII-Fc,Diarrhea , Phase 3
22474,D0S4RR,ProTarg,Prostate cancer , Investigative
22475,D0S4SX,K-134,Arteriosclerosis , Phase 2
22476,D0S4WA,ASP0113,Cytomegalovirus infection , Phase 3
22477,D0S4XX,INOC-003,Solid tumour/cancer , Discontinued in Phase 1
22478,D0S4XZ,GE-1170A,Bacterial infection , Phase 1
22479,D0S4YT,Plasminogen,Alzheimer disease , Phase 2/3
22480,D0S4ZZ,Anti-HER2 bi-specific mabs,Solid tumour/cancer , Investigative
22481,D0S5AL,XTL-2125,Hepatitis C virus infection , Discontinued in Phase 1
22482,D0S5BC,CART-19 cells,Acute lymphoblastic leukaemia , Phase 1
22483,D0S5BV,ABT-652,Musculoskeletal pain , Phase 2
22484,D0S5BV,ABT-652,Diabetic neuropathy , Phase 2
22485,D0S5CH,Metaxalone,Pain , Approved
22486,D0S5CU,Nisoldipine,Hypertension , Approved
22487,D0S5CY,SGN-CD48A,Multiple myeloma , Phase 1
22488,D0S5EB,Adoniside,Cardiovascular disease , Approved
22489,D0S5EF,PF-4418948,Endometriosis , Phase 1
22490,D0S5FF,BYM338,Inclusion body myositis , Phase 3
22491,D0S5FF,BYM338,Acute myeloid leukaemia , Phase 2/3
22492,D0S5FF,BYM338,Muscle atrophy , Phase 2
22493,D0S5FQ,MCPP,Mood disorder , Discontinued in Phase 2
22494,D0S5IR,SAGE-217,Postpartum depression , Phase 3
22495,D0S5IR,SAGE-217,Essential tremor or related tremors , Phase 2
22496,D0S5IR,SAGE-217,Major depressive disorder , Phase 2
22497,D0S5IR,SAGE-217,Parkinson disease , Phase 2
22498,D0S5IV,Anti-Marburg virus mabs,Marburg virus infection , Investigative
22499,D0S5LD,BAY 80-6946,Follicular lymphoma , Approved
22500,D0S5LD,BAY 80-6946,Non-hodgkin lymphoma , Approved
22501,D0S5LH,Edrophonium,Myasthenia gravis , Approved
22502,D0S5LO,PF-04449913,Chronic myelomonocytic leukaemia , Approved
22503,D0S5LO,PF-04449913,Solid tumour/cancer , Approved
22504,D0S5LT,Deoxynojirimycin,Pompe disease , Phase 3
22505,D0S5MJ,HDL-based therapeutics,Cardiovascular disease , Investigative
22506,D0S5NG,Cetiedil,Sickle-cell anaemia , Approved
22507,D0S5NN,ABI-010,Solid tumour/cancer , Investigative
22508,D0S5NS,Pyrazole derivative 24,Obesity , Patented
22509,D0S5RC,SNS-032,Solid tumour/cancer , Phase 1
22510,D0S5RZ,Amtolmetin guacil,Inflammation , Approved
22511,D0S5TT,ACE-435,Cachexia , Investigative
22512,D0S5UB,PS522501,Metabolic disorder , Discontinued in Phase 1
22513,D0S5UH,Clofazimine,Crohn disease , Approved
22514,D0S5UH,Clofazimine,Mycobacterium infection , Investigative
22515,D0S5VU,Herbicide amitrole,Bacterial infection , Investigative
22516,D0S5WG,Flucytosine,Endocarditis , Approved
22517,D0S5WP,Trametinib + 2141795,Solid tumour/cancer , Phase 2
22518,D0S5XO,NasoVAX,Seasonal influenza infection , Phase 2
22519,D0S5XO,NasoVAX,Bacillus anthracis infection , Investigative
22520,D0S5YC,MEPTAZINOL,Pain , Approved
22521,D0S5ZJ,SERGOLEXOLE MALEATE,Migraine , Discontinued in Phase 2
22522,D0S6AE,Diquafosol,Dry eye disease , Phase 3
22523,D0S6AH,Adiptin,Obesity , Investigative
22524,D0S6AQ,Ramorelix,Esophageal cancer , Discontinued in Phase 1
22525,D0S6CD,NPS-P156,Central nervous system disease , Investigative
22526,D0S6FE,PTX-008,Solid tumour/cancer , Investigative
22527,D0S6GJ,KC-764,Platelet aggregation disorder , Discontinued in Phase 3
22528,D0S6GY,SER-101,Congestive heart failure , Phase 1
22529,D0S6HR,KI-0802,Gastrointestinal ulcer , Phase 3
22530,D0S6IA,PMID25623274-Compound-WO2014132220C2,Pulmonary arterial hypertension , Patented
22531,D0S6JG,Liothyronine,Hypothyroidism , Approved
22532,D0S6JG,Liothyronine,Congestive heart failure , Phase 3
22533,D0S6JV,Nepadutant,Postoperative ileus , Phase 1/2
22534,D0S6JV,Nepadutant,Infantile colics , Phase 1/2
22535,D0S6KA,CALANOLIDE A,Mycobacterium infection , Phase 1
22536,D0S6KI,AT-101,Hemorrhagic shock , Phase 2
22537,D0S6KX,GSK-677954,Non-alcoholic fatty liver disease , Discontinued in Phase 2
22538,D0S6MA,OCID-2987,Inflammation , Investigative
22539,D0S6NH,ZAMI-633,Urinary tract disease , Investigative
22540,D0S6NJ,AC-03-636,Solid tumour/cancer , Investigative
22541,D0S6OH,Relaxin,Cardiac failure , Phase 3
22542,D0S6OY,FabOvar,Ovarian cancer , Investigative
22543,D0S6QJ,C10-1040,Bacterial infection , Investigative
22544,D0S6QR,BMS-204352,Nerve injury , Discontinued in Phase 3
22545,D0S6RY,OPC 108459,Atrial fibrillation , Phase 1
22546,D0S6SJ,Piperidine derivative 3,Inflammation , Patented
22547,D0S6SJ,Piperidine derivative 3,Solid tumour/cancer , Patented
22548,D0S6SP,BPL-002,Bacterial infection , Investigative
22549,D0S6SQ,Odelepran,Alcohol dependence , Phase 2
22550,D0S6SU,KRN-2391,Angina pectoris , Discontinued in Phase 2
22551,D0S6TK,tamatinib,Solid tumour/cancer , Clinical trial
22552,D0S6UH,BC-6213,Osteoporosis , Investigative
22553,D0S6VB,DG031,Asthma , Discontinued in Phase 3
22554,D0S6VX,CGP-40215A,Pneumocystis pneumonia , Terminated
22555,D0S6WW,E12/DP3-117,Solid tumour/cancer , Investigative
22556,D0S6XJ,GS-522,Thrombosis , Terminated
22557,D0S6YO,Ajinomoto 3,Pain , Investigative
22558,D0S7AR,Papillomavirus vaccine,Human papillomavirus infection , Terminated
22559,D0S7AW,KD020,Kidney disease , Phase 1/2
22560,D0S7BQ,GSK1322322,Bacterial infection , Phase 2
22561,D0S7CM,HDL-100,Attention deficit hyperactivity disorder , Phase 1/2
22562,D0S7CP,VK-12,Solid tumour/cancer , Investigative
22563,D0S7DS,SPD-756,Human immunodeficiency virus infection , Terminated
22564,D0S7DV,Tiazofurin,Solid tumour/cancer , Approved
22565,D0S7EQ,PEN-203,Gynecological disease , Discontinued in Phase 2
22566,D0S7FR,Ostabolin-C,Osteoporosis , Phase 2
22567,D0S7HM,ENMD-2076,Acute myeloid leukaemia , Phase 2
22568,D0S7HM,ENMD-2076,Fibrolamellar liver cancer , Phase 2
22569,D0S7HM,ENMD-2076,Triple negative breast cancer , Phase 2
22570,D0S7HM,ENMD-2076,Hepatocellular carcinoma , Phase 1
22571,D0S7HW,Anti-miR-199a oligonucleotides,Ischemic heart disease , Investigative
22572,D0S7IQ,Anti-VEGF human mabs,Solid tumour/cancer , Investigative
22573,D0S7IZ,Apricoxib,Rheumatoid arthritis , Discontinued in Phase 2
22574,D0S7IZ,Apricoxib,Pancreatic cancer , Discontinued in Phase 2
22575,D0S7IZ,Apricoxib,Non-small-cell lung cancer , Discontinued in Phase 2
22576,D0S7JH,Macitentan,Cardiovascular disease , Approved
22577,D0S7JN,GP-2017,Plaque psoriasis , Phase 3
22578,D0S7JN,GP-2017,Rheumatoid arthritis , Phase 3
22579,D0S7JN,GP-2017,Psoriatic arthritis , Application submitted
22580,D0S7KA,(-)-deprenyl,Alopecia , Patented
22581,D0S7KQ,Hematide,Anemia , Phase 3
22582,D0S7LG,ARN-509,Acute myeloid leukaemia , Approved
22583,D0S7LG,ARN-509,Prostate cancer , Phase 3
22584,D0S7LN,GS-9132,Hepatitis C virus infection , Discontinued in Phase 1/2
22585,D0S7NS,MMI-0100,Airway inflammation , Phase 1
22586,D0S7NS,MMI-0100,Fibrosis , Investigative
22587,D0S7QB,JNJ-28165722,Diabetic complication , Investigative
22588,D0S7UH,ALX-0171,Respiratory syncytial virus infection , Phase 1
22589,D0S7UQ,RG-7103,Chronic obstructive pulmonary disease , Phase 1
22590,D0S7UU,PF-06260414,Cachexia , Discontinued in Phase 1
22591,D0S7UU,PF-06260414,Pain , Investigative
22592,D0S7VI,AXT-914,Osteoporosis , Phase 1
22593,D0S7VN,MRL-953,Immune System disease , Terminated
22594,D0S7VO,Tiaprofenic acid,Pain , Approved
22595,D0S7VZ,WAY-100289,Anxiety disorder , Discontinued in Phase 1
22596,D0S7WX,Vitamin A,Night blindness , Approved
22597,D0S7WX,Vitamin A,Kinetoplastids , Investigative
22598,D0S7XR,TKP-1002,Schizophrenia , Investigative
22599,D0S7XV,Tetanus immune globulin,Clostridium infection , Approved
22600,D0S7YU,ALD-601,Lysosomal storage disease , Discontinued in Phase 1
22601,D0S8AF,Visceral leishmaniasis vaccine,Visceral leishmaniasis , Phase 1
22602,D0S8BG,EMD 55900,Glioma , Phase 1/2
22603,D0S8BU,SE RNA,Human immunodeficiency virus infection , Investigative
22604,D0S8CI,ELIPRODIL,Multiple sclerosis , Phase 2
22605,D0S8DB,Org-9731,Heart failure , Discontinued in Phase 2
22606,D0S8DU,TGWOOAA,Social phobia , Phase 2
22607,D0S8DU,TGWOOAA,Generalized anxiety disorder , Phase 2
22608,D0S8FU,Resultz,Head and body lice , Approved
22609,D0S8HD,PEP-223/CoVaccine HT,Prostate cancer , Phase 1/2
22610,D0S8KE,NS-2979,Pain , Terminated
22611,D0S8LJ,S-1,Gastric adenocarcinoma , Phase 3
22612,D0S8LV,Panipenem,Bacterial infection , Approved
22613,D0S8MG,Genz-668764,Malaria , Investigative
22614,D0S8MN,AAV-miApoB,Hypercholesterolaemia , Investigative
22615,D0S8RG,Nasalflu Berna,Influenza virus infection , Terminated
22616,D0S8RN,IPN-100,Respiratory syncytial virus infection , Investigative
22617,D0S8RY,GP-531,Myocardial ischemia , Discontinued in Phase 2
22618,D0S8TD,Methohexital,Anaesthesia , Approved
22619,D0S8VG,PGL-3001,Female infertility , Discontinued in Phase 2
22620,D0S8WA,Obinutuzumab,Chronic lymphocytic leukaemia , Approved
22621,D0S8WA,Obinutuzumab,Haematological malignancy , Phase 1
22622,D0S8XP,Canagliflozin/metformin,Type-2 diabetes , Phase 1
22623,D0S8YL,Tomelukast,Asthma , Terminated
22624,D0S8YV,HGP-30,Acquired immune deficiency syndrome , Discontinued in Phase 2
22625,D0S9AW,Rifamycin b,Bacterial infection , Approved
22626,D0S9BH,Ozarelix,Prostate disease , Phase 2
22627,D0S9CB,Flibanserin,Mood disorder , Approved
22628,D0S9CB,Flibanserin,Female sexual arousal dysfunction , Phase 3
22629,D0S9EK,LIlotomab satetraxetan,Diffuse large B-cell lymphoma , Phase 1
22630,D0S9ET,Pirprofen,Dysmenorrhea , Approved
22631,D0S9FI,ICasp9M28z T cell,Lung cancer , Phase 1
22632,D0S9FI,ICasp9M28z T cell,Malignant pleural effusion , Phase 1
22633,D0S9FI,ICasp9M28z T cell,Mesothelioma , Phase 1
22634,D0S9FI,ICasp9M28z T cell,Metastatic malignant neoplasm , Phase 1
22635,D0S9FU,Simotinib,Solid tumour/cancer , Phase 1
22636,D0S9GJ,AE-443p,Influenza virus infection , Phase 1
22637,D0S9HV,MitoAscorbate,Non-alcoholic steatohepatitis , Investigative
22638,D0S9IE,BAY1125976,Solid tumour/cancer , Phase 1
22639,D0S9KM,NGD 91-3,Anxiety disorder , Discontinued in Phase 2
22640,D0S9LK,GSK-2584786A,Influenza virus infection , Phase 2
22641,D0S9LR,Beclomethasone dispropionate,Acute radiation syndrome , Phase 1
22642,D0S9MC,Clobazam - Lundbeck,Anxiety disorder , Approved
22643,D0S9MC,Clobazam - Lundbeck,Epilepsy , Approved
22644,D0S9MD,DFP-11207,Solid tumour/cancer , Phase 1
22645,D0S9MO,Modified BCG vaccine,Mycobacterium infection , Terminated
22646,D0S9MU,Rizatriptan,Migraine , Approved
22647,D0S9OH,L-MDAM,Solid tumour/cancer , Phase 1
22648,D0S9PV,Type VII collagen,Epidermolysis bullosa , Investigative
22649,D0S9QA,Ivabradine,Angina pectoris , Approved
22650,D0S9SD,Emtricitabine,Human immunodeficiency virus infection , Approved
22651,D0S9SD,Emtricitabine,Hepatitis virus infection , Approved
22652,D0S9SD,Emtricitabine,Hepatitis B virus infection , Phase 3
22653,D0S9UO,SPI-3608,Spinal disease , Phase 1
22654,D0S9VG,C4X-101,Endocrine disease , Investigative
22655,D0S9WB,Lumacaftor + ivacaftor,Cystic fibrosis , Approved
22656,D0S9WB,Lumacaftor + ivacaftor,Acute lung injury , Approved
22657,D0S9WW,GI-6301,Chordoma , Phase 2
22658,D0S9WW,GI-6301,Solid tumour/cancer , Phase 1
22659,D0S9WW,GI-6301,Advanced cancer , Phase 1
22660,D0S9XR,TRx-0037,Alzheimer disease , Discontinued in Phase 1
22661,D0S9XV,A-134974,Epilepsy , Terminated
22662,D0S9YP,ZP-103,Metastatic malignant neoplasm , Investigative
22663,D0SA3J,Ibrolipim,Hyperlipidaemia , Phase 2
22664,D0SB0X,CX-1040,Immune System disease , Investigative
22665,D0SB1B,CPX-351,Acute myeloid leukaemia , Phase 3
22666,D0SB1B,CPX-351,Myelodysplastic syndrome , Phase 2
22667,D0SB2G,EP-1300,Malaria , Phase 1
22668,D0SB2U,MVA-BN brachyury vaccine,Solid tumour/cancer , Phase 1
22669,D0SB4A,PMID25684022-Compound-US20130053382 35(1-11),Solid tumour/cancer , Patented
22670,D0SB4A,PMID25684022-Compound-US20130053382 35(1-11),Metastatic cancer , Patented
22671,D0SB5K,SAR164877,Pain , Phase 2/3
22672,D0SB6K,DAT-582,Nausea , Discontinued in Phase 2
22673,D0SB8E,UTL-5g,Toxicity , Investigative
22674,D0SB8X,FluNhance,Adenosine deaminase defciency , Phase 3
22675,D0SB8X,FluNhance,Influenza virus infection , Phase 2
22676,D0SC1I,S. pneumoniae paediatric next generation,Streptococcus infection , Phase 2
22677,D0SC2J,Tanespimycin,Breast cancer , Phase 2
22678,D0SC2J,Tanespimycin,Multiple myeloma , Discontinued in Phase 3
22679,D0SC6I,Sodium benzoate,Schizophrenia , Phase 2/3
22680,D0SC8F,Ethylestrenol,Testosterone deficiency , Approved
22681,D0SD1L,Mercaptopurine,Acute lymphocytic leukaemia , Approved
22682,D0SD1L,Mercaptopurine,Severe acute respiratory syndrome (SARS) , Preclinical
22683,D0SD1L,Mercaptopurine,Middle East Respiratory Syndrome (MERS) , Preclinical
22684,D0SD2J,INP104,Migraine , Phase 1
22685,D0SD3E,PF-05186462,Pain , Phase 1
22686,D0SD3Q,GIDAZEPAM,Anxiety disorder , Investigative
22687,D0SD4G,PMID25666693-Compound-16,Osteoarthritis pain , Patented
22688,D0SD4G,PMID25666693-Compound-16,Cancer related pain , Patented
22689,D0SD4G,PMID25666693-Compound-16,Neuropathic pain , Patented
22690,D0SD4G,PMID25666693-Compound-16,Inflammatory pain , Patented
22691,D0SD4Q,Aryl mannoside derivative 11,Crohn disease , Patented
22692,D0SD4Q,Aryl mannoside derivative 11,Ulcerative colitis , Patented
22693,D0SD4Q,Aryl mannoside derivative 11,Urinary tract infection , Patented
22694,D0SD6V,CFZ533,Rheumatoid arthritis , Phase 2
22695,D0SD6V,CFZ533,Graves disease , Phase 2
22696,D0SD6V,CFZ533,Myasthenia gravis , Phase 2
22697,D0SD6V,CFZ533,Sjogren syndrome , Phase 2
22698,D0SD7G,LY3002813,Alzheimer disease , Phase 2
22699,D0SD8V,TDI-0047,Motor neurone disease , Investigative
22700,D0SD9L,Monoamine derivative 5,Albinism , Patented
22701,D0SD9L,Monoamine derivative 5,Ephelides , Patented
22702,D0SD9L,Monoamine derivative 5,Menkes disease , Patented
22703,D0SD9L,Monoamine derivative 5,Senile lentigines , Patented
22704,D0SD9L,Monoamine derivative 5,Melasma , Patented
22705,D0SD9R,ARI-0001 cells,leukaemia , Phase 1
22706,D0SD9R,ARI-0001 cells,Lymphoma , Phase 1
22707,D0SD9V,Flupirtine,Fibromyalgia , Phase 2
22708,D0SD9V,Flupirtine,Cancer related pain , Phase 2
22709,D0SD9Z,TRC-253,Prostate cancer , Phase 1/2
22710,D0SE4D,Org-20599,Anaesthesia , Terminated
22711,D0SE7V,Alkyl mannoside derivative 3,Crohn disease , Patented
22712,D0SE7V,Alkyl mannoside derivative 3,Ulcerative colitis , Patented
22713,D0SE7V,Alkyl mannoside derivative 3,Urinary tract infection , Patented
22714,D0SE9S,SCH-221510,Anxiety disorder , Investigative
22715,D0SF0U,HS-7,Solid tumour/cancer , Investigative
22716,D0SF2R,GVX-3322,Cytomegalovirus infection , Terminated
22717,D0SF5F,Org-34092,Thrombosis , Terminated
22718,D0SF5Q,Pennvax-B,Human immunodeficiency virus infection , Phase 1
22719,D0SF6C,P-coumaric acid derivative 2,Albinism , Patented
22720,D0SF6C,P-coumaric acid derivative 2,Ephelides , Patented
22721,D0SF6C,P-coumaric acid derivative 2,Menkes disease , Patented
22722,D0SF6C,P-coumaric acid derivative 2,Senile lentigines , Patented
22723,D0SF6C,P-coumaric acid derivative 2,Melasma , Patented
22724,D0SF8V,RO7082859,Non-hodgkin lymphoma , Phase 1
22725,D0SG0J,ASC09 + ritonavir + oseltamivir,Coronavirus Disease 2019 (COVID-19) , Phase 3
22726,D0SG0N,DB-200,Psoriasis vulgaris , Terminated
22727,D0SG4W,Oral insulin,Type-1 diabetes , Terminated
22728,D0SG7B,GLPG-0634,Rheumatoid arthritis , Phase 2
22729,D0SG7B,GLPG-0634,Crohn disease , Phase 2
22730,D0SG7B,GLPG-0634,Cutaneous lupus erythematosus , Phase 2
22731,D0SG8X,PMID30124346-Compound-LDT66,Benign prostatic hyperplasia , Patented
22732,D0SH2X,Amocarzine,Helminth infection , Phase 3
22733,D0SH3I,Bortezomib,Multiple myeloma , Approved
22734,D0SH3I,Bortezomib,Mantle cell lymphoma , Approved
22735,D0SH3I,Bortezomib,Non-hodgkin lymphoma , Phase 3
22736,D0SH5O,FK-317,Solid tumour/cancer , Discontinued in Phase 2
22737,D0SH7J,INO-4212,Ebola virus infection , Phase 1
22738,D0SI1Z,SCLERON,Motor neurone disease , Investigative
22739,D0SI4C,KF-17625,Asthma , Terminated
22740,D0SI9L,Nicotinamide riboside,Mitochondrial myopathy , Phase 1
22741,D0SJ1U,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8",Albinism , Patented
22742,D0SJ1U,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8",Ephelides , Patented
22743,D0SJ1U,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8",Menkes disease , Patented
22744,D0SJ1U,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8",Senile lentigines , Patented
22745,D0SJ1U,"Beta-phenyl-alpha,beta-unsaturated carbonyl derivative 8",Melasma , Patented
22746,D0SJ4S,P-coumaric acid derivative 5,Albinism , Patented
22747,D0SJ4S,P-coumaric acid derivative 5,Ephelides , Patented
22748,D0SJ4S,P-coumaric acid derivative 5,Menkes disease , Patented
22749,D0SJ4S,P-coumaric acid derivative 5,Senile lentigines , Patented
22750,D0SJ4S,P-coumaric acid derivative 5,Melasma , Patented
22751,D0SJ8Q,ERITORAN,Sepsis , Phase 3
22752,D0SK1W,AS-602305,Androgen deficiency , Terminated
22753,D0SK2J,Palux,Intermittent claudication , Discontinued in Phase 2
22754,D0SK9J,AN-3661,Malaria , Investigative
22755,D0SL2V,Lanatoside c,Cardiovascular disease , Approved
22756,D0SL4P,Sharon-4000,Acne vulgaris , Investigative
22757,D0SL8J,Ascrolimus,Psoriasis vulgaris , Phase 2
22758,D0SL8T,ISIS-FGFR4,Obesity , Phase 2
22759,D0SL8X,Edoxaban tosylate,Stroke , Approved
22760,D0SL8X,Edoxaban tosylate,Venous thromboembolism , Approved
22761,D0SL8X,Edoxaban tosylate,Embolism , Approved
22762,D0SM4E,CD101 IV,Candidiasis , Phase 1
22763,D0SM6N,ISIS-PTP1Brx,Type-2 diabetes , Phase 2
22764,D0SM6Y,MNT-02-07,Clostridium infection , Investigative
22765,D0SM8S,Lebrikizumab,Severe asthma , Phase 3
22766,D0SM8S,Lebrikizumab,Chronic obstructive pulmonary disease , Phase 2
22767,D0SM8S,Lebrikizumab,Atopic dermatitis , Phase 2
22768,D0SM8S,Lebrikizumab,Idiopathic pulmonary fibrosis , Phase 2
22769,D0SN0U,Alpha-C-galactosyl ceramide,Solid tumour/cancer , Investigative
22770,D0SN1T,Nikkomycin Z,Candidiasis , Phase 1/2
22771,D0SN2I,ABT-555,Multiple sclerosis , Phase 1
22772,D0SN2Q,AZD-6714,Type-2 diabetes , Discontinued in Phase 1
22773,D0SN4Y,Trospium,Neurogenic detrusor overactivity , Phase 1
22774,D0SN7I,SB-656933,Chronic obstructive pulmonary disease , Phase 2
22775,D0SN7I,SB-656933,Cystic fibrosis , Phase 2
22776,D0SN9T,Nilutamide,Prostate cancer , Approved
22777,D0SO0U,AG-122005,Solid tumour/cancer , Investigative
22778,D0SO1Z,PN-203,Solid tumour/cancer , Investigative
22779,D0SO4Z,ASP1585,Hypophosphatasia , Phase 3
22780,D0SOG8,NBM-BMX,Solid tumour/cancer , Phase 1
22781,D0SP3D,Dihydroergotoxine,Alzheimer disease , Approved
22782,D0SP5Q,PRT-064445,Bleeding disorder , Investigative
22783,D0SP5V,Setipiprant,Asthma , Phase 3
22784,D0SP6A,SL-801,Solid tumour/cancer , Phase 1
22785,D0SP7S,Androgen,Prostate cancer , Investigative
22786,D0SQ1O,XmAb5981,Autoimmune disease , Phase 1
22787,D0SQ1W,Sterile Water,Solid tumour/cancer , Approved
22788,D0SQ2K,Miravirsen,Hepatitis C virus infection , Phase 2
22789,D0SQ2Z,Ridaforolimus eluting coronary stent,Coronary artery disease , Phase 3
22790,D0SQ6A,FKW00GA,Social phobia , Phase 2
22791,D0SQ8R,V-710,Staphylococcus infection , Phase 2/3
22792,D0SQ9O,Herpes simplex vaccine,Herpes simplex virus infection , Phase 1/2
22793,D0SR3J,Loperamide,Diarrhea , Approved
22794,D0SR3J,Loperamide,Severe acute respiratory syndrome (SARS) , Preclinical
22795,D0SR3J,Loperamide,Middle East Respiratory Syndrome (MERS) , Preclinical
22796,D0SR3T,JN-711,Central nervous system disease , Investigative
22797,D0SR4G,ONT-093,Solid tumour/cancer , Discontinued in Phase 1
22798,D0SR4T,PHENSERINE TARTRATE,Parkinson disease , Preclinical
22799,D0SR6S,PandyFlu,Influenza virus infection , Registered
22800,D0SR8I,PMID26651364-Compound-124,Crohn disease , Patented
22801,D0SR8I,PMID26651364-Compound-124,Ulcerative colitis , Patented
22802,D0SR8I,PMID26651364-Compound-124,Urinary tract infection , Patented
22803,D0SS1J,SAR399063,Pre-sarcopenia , Phase 3
22804,D0SS1Q,Influenza vaccine patch,Influenza virus infection , Phase 1/2
22805,D0SS2E,AZD-8450,Lipid metabolism disorder , Preclinical
22806,D0SS4I,ASP-2905,Schizophrenia , Discontinued in Phase 1
22807,D0SS4P,Pirbuterol,Asthma , Approved
22808,D0SS6J,GR-328713,Arteriosclerosis , Discontinued in Phase 1
22809,D0ST5P,TA-5538,Overactive bladder , Discontinued in Phase 2
22810,D0SU0E,Biphenyl mannoside derivative 1,Crohn disease , Patented
22811,D0SU0E,Biphenyl mannoside derivative 1,Ulcerative colitis , Patented
22812,D0SU0E,Biphenyl mannoside derivative 1,Urinary tract infection , Patented
22813,D0SU1F,CP-122288,Migraine , Discontinued in Phase 2
22814,D0SU1G,Zomepirac,Pain , Withdrawn from market
22815,D0SU4D,Aflibercept + nesvacumab,Diabetic macular edema , Phase 2
22816,D0SU5N,PMID28624700-compound-3-31,Severe acute respiratory syndrome (SARS) , Preclinical
22817,D0SV4A,CD19 targeted chimeric antigen receptor T cells,B-cell lymphoma , Phase 1/2
22818,D0SV6D,Heterocyclic-substituted 3-alkyl azetidine derivative 1,Obesity , Patented
22819,D0SV6V,PP-303,Alopecia , Investigative
22820,D0SV7D,LOTRAFIBAN,Cardiovascular disease , Discontinued in Phase 3
22821,D0SV8E,Methotrexate,leukaemia , Approved
22822,D0SV8E,Methotrexate,Solid tumour/cancer , Phase 3
22823,D0SV8E,Methotrexate,Proliferative vitreoretinopathy , Phase 3
22824,D0SV8E,Methotrexate,Rheumatoid arthritis , Phase 1
22825,D0SV8E,Methotrexate,Prostate cancer , Investigative
22826,D0SW1D,Cellspan esophageal implant,Esophageal cancer , Clinical trial
22827,D0SW2H,TAK-778,Osteoporosis , Discontinued in Phase 2
22828,D0SW2Q,"Tetra-hydro-1H-1,2,6-triazaazulene derivative 2",Obesity , Patented
22829,D0SW8L,LC-280126,Ischemia , Investigative
22830,D0SX3X,TEI-6122,Diabetic complication , Discontinued in Phase 2
22831,D0SX4D,KD-295,Influenza A virus H5N1 infection , Registered
22832,D0SX4K,HR325,Rheumatoid arthritis , Discontinued in Phase 2
22833,D0SX6O,Meninvact,Neisseria meningitis infection , Approved
22834,D0SX7F,AZALANSTAT,Hyperlipidaemia , Discontinued in Phase 2
22835,D0SX9C,Alfa-interferon,Endometriosis , Phase 1
22836,D0SY0W,ASC09 + ritonavir,Coronavirus Disease 2019 (COVID-19) , Phase 1
22837,D0SY2O,ANG-3067,Fibrosis , Investigative
22838,D0SY7H,IDX-184,Hepatitis C virus infection , Phase 1/2
22839,D0SY9B,SSR149415,Anxiety disorder , Phase 2
22840,D0SY9B,SSR149415,Major depressive disorder , Phase 2
22841,D0SZ1G,AZD9567,Rheumatoid arthritis , Phase 1
22842,D0SZ2E,Acetohydroxamic,Urinary tract infection , Approved
22843,D0SZ2G,SC-003,Ovarian cancer , Phase 1
22844,D0SZ2G,SC-003,Solid tumour/cancer , Phase 1
22845,D0SZ3B,ER-34122,Inflammation , Terminated
22846,D0SZ5G,ANX-042,Chronic heart failure , Phase 1
22847,D0SZ6E,YN-968D1,Breast cancer , Approved
22848,D0SZ8Q,CSC-500297,Obesity , Investigative
22849,D0SZ9R,2X-121,Breast cancer , Phase 2
22850,D0SZT3,NEXI-001,Acute myeloid leukaemia , Phase 1/2
22851,D0SZT3,NEXI-001,Myelodysplastic syndrome , Phase 1/2
22852,D0T0BA,CX-1010,Epilepsy , Investigative
22853,D0T0BF,EBV CTLs,Lymphoma , Phase 1/2
22854,D0T0BP,MenBioVax,Neisseria meningitis infection , Investigative
22855,D0T0BS,CGS-18102A,Anxiety disorder , Terminated
22856,D0T0FT,AutoSynVax,Advanced cancer , Phase 1
22857,D0T0FT,AutoSynVax,Solid tumour/cancer , Phase 1
22858,D0T0HM,PMID28270021-Compound-WO2010077680 109,Pruritus , Patented
22859,D0T0HM,PMID28270021-Compound-WO2010077680 109,Solid tumour/cancer , Patented
22860,D0T0HM,PMID28270021-Compound-WO2010077680 109,Chronic pain , Patented
22861,D0T0HM,PMID28270021-Compound-WO2010077680 109,Neuropathic pain , Patented
22862,D0T0HM,PMID28270021-Compound-WO2010077680 109,Thymic cancer , Patented
22863,D0T0IE,ISV-215,Glaucoma/ocular hypertension , Investigative
22864,D0T0JF,PseudIgY,Pseudomonas infection , Phase 3
22865,D0T0KA,Nicardipine,High blood pressure , Approved
22866,D0T0KQ,SEL-100130,Inflammation , Investigative
22867,D0T0KT,Briciclib,Solid tumour/cancer , Phase 1
22868,D0T0LE,IRX-4310,Psoriasis vulgaris , Discontinued in Phase 3
22869,D0T0LM,Pirenzepine,Peptic ulcer , Approved
22870,D0T0LO,RP-54745,Rheumatoid arthritis , Terminated
22871,D0T0LR,Debio-0929,Solid tumour/cancer , Investigative
22872,D0T0LU,Conjugated Estrogens,Menopause symptom , Approved
22873,D0T0LU,Conjugated Estrogens,Vasomotor symptom , Approved
22874,D0T0MY,DT-330,Solid tumour/cancer , Investigative
22875,D0T0NG,Arofylline,Chronic obstructive pulmonary disease , Phase 3
22876,D0T0NL,ARC031,Alzheimer disease , Phase 1
22877,D0T0OQ,Furopyridine derivative 2,Obesity , Patented
22878,D0T0PN,CP-122721,Major depressive disorder , Phase 2
22879,D0T0PU,CME-548,Solid tumour/cancer , Investigative
22880,D0T0QU,MEDI-559,Respiratory syncytial virus infection , Phase 2
22881,D0T0RU,AC-8,Herpetic keratitis , Investigative
22882,D0T0SE,Anti-EGFR CAR T,Glioma , Phase 1
22883,D0T0SK,ST-2987,Solid tumour/cancer , Investigative
22884,D0T0SO,BI-K0376,Acne vulgaris , Discontinued in Phase 1
22885,D0T0TZ,Ticrynafen,Congestive heart failure , Withdrawn from market
22886,D0T0UC,ANAVEX 1-41,Alzheimer disease , Preclinical
22887,D0T0UM,EM-6110a,Solid tumour/cancer , Investigative
22888,D0T0VA,B-4474,Gram-positive bacterial infection , Investigative
22889,D0T0VZ,XEN-D0104,Atrial fibrillation , Investigative
22890,D0T0YB,Cotrimazine,Urinary tract infection , Approved
22891,D0T0YG,Pixuvripixantrone,Non-hodgkin lymphoma , Phase 3
22892,D0T0ZW,ALKS33,Alcohol dependence , Phase 2
22893,D0T1AO,MystiTrip,Migraine , Investigative
22894,D0T1DZ,EPI-001,Prostate cancer , Investigative
22895,D0T1EO,Sulfonamides,Bacterial infection , Approved
22896,D0T1EU,Ndx-Peptide,Diabetic complication , Investigative
22897,D0T1FC,PF-4878691,Melanoma , Phase 2
22898,D0T1FC,PF-4878691,Hepatitis C virus infection , Phase 1
22899,D0T1GF,MP470,Solid tumour/cancer , Phase 2
22900,D0T1GG,3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivative 1,Cell proliferative disorder , Patented
22901,D0T1GG,3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivative 1,Metabolic disorder , Patented
22902,D0T1GG,3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivative 1,Blood vessel proliferative disorder , Patented
22903,D0T1GT,Sulfacytine,Cystitis , Approved
22904,D0T1GT,Sulfacytine,Urinary tract infection , Approved
22905,D0T1GV,ADD-17014,Epileptic seizures , Discontinued in Phase 1
22906,D0T1HE,APD-403,Vomiting , Phase 2
22907,D0T1IJ,Oprelvekin,Thrombocytopenia , Approved
22908,D0T1KL,Pankomab-GEX,Solid tumour/cancer , Phase 2
22909,D0T1LK,Primaquine,Malaria , Approved
22910,D0T1LX,BC-ONY-01,Onychomycosis , Investigative
22911,D0T1MI,INP-01,Pain , Investigative
22912,D0T1MP,Lurosetron,Vomiting , Discontinued in Phase 2
22913,D0T1MT,OTK18 TF mabs,Viral encephalitis , Investigative
22914,D0T1OR,BRX-3,Bone disease , Investigative
22915,D0T1QY,Technetium Tc-99m Gluceptate Kit,Radioactive tracer , Approved
22916,D0T1RG,Sitaxsentan,Pulmonary arterial hypertension , Withdrawn from market
22917,D0T1RJ,MDT-012,Autoimmune diabetes , Investigative
22918,D0T1SF,PNU-109291,Migraine , Terminated
22919,D0T1TC,C-5304,Solid tumour/cancer , Investigative
22920,D0T1UH,REC-0467,Gastroesophageal reflux disease , Investigative
22921,D0T1UJ,Reteplase,Heart attack , Approved
22922,D0T1VK,CJ-30002,Non-insulin dependent diabetes , Phase 3
22923,D0T1WN,Zolpidem,Insomnia , Approved
22924,D0T1WY,Clevudine,Hepatitis B virus infection , Phase 3
22925,D0T1XW,Meclizine,Dizziness , Approved
22926,D0T1YH,ALD-806,Solid tumour/cancer , Investigative
22927,D0T1YN,Tiqueside,Hyperlipidaemia , Discontinued in Phase 2
22928,D0T1ZJ,Naked DNA (B-cell lymphoma),B-cell lymphoma , Discontinued in Phase 2
22929,D0T2AE,V-0251,Labyrinthitis , Phase 2
22930,D0T2DL,GM-7050,Inflammation , Terminated
22931,D0T2EO,MAXY-4,Autoimmune diabetes , Phase 1
22932,D0T2EP,CLOTURIN,Solid tumour/cancer , Discontinued in Phase 2
22933,D0T2ER,TAK-593,Solid tumour/cancer , Phase 1
22934,D0T2FC,NPC-1C,Colorectal cancer , Phase 2
22935,D0T2FC,NPC-1C,Pancreatic tumour , Phase 2
22936,D0T2FC,NPC-1C,Pancreatic cancer , Phase 2
22937,D0T2FP,JNJ-54861911,Alzheimer disease , Phase 2/3
22938,D0T2GP,DP-5599,Autoimmune diabetes , Investigative
22939,D0T2IA,Dapiprazole,Glaucoma/ocular hypertension , Approved
22940,D0T2IF,DPX-survivac cancer vaccine,Ovarian cancer , Phase 1/2
22941,D0T2IF,DPX-survivac cancer vaccine,Fallopian tube cancer , Phase 1
22942,D0T2IF,DPX-survivac cancer vaccine,Peritoneal cavity cancer , Phase 1
22943,D0T2LP,ARM036,Heart failure , Discontinued in Phase 2
22944,D0T2LR,PMX-30063,Oral mucositis , Phase 2
22945,D0T2MN,Z-300,Gastric ulcer , Discontinued in Phase 1
22946,D0T2MS,ZX002,Back pain , Phase 3
22947,D0T2MV,AS-9705,Gastric motility disorder , Investigative
22948,D0T2MV,AS-9705,Vomiting , Investigative
22949,D0T2NG,SOM-1025,Bacterial infection , Investigative
22950,D0T2NV,LAMP-Vax + pp65 DC,Recurrent glioblastoma , Phase 1/2
22951,D0T2OT,GW-278884,Colorectal cancer , Terminated
22952,D0T2PL,Calcitriol,Congenital alopecia , Approved
22953,D0T2PT,MTbuVax,Mycobacterium infection , Investigative
22954,D0T2QI,MPV-1743,Obesity , Terminated
22955,D0T2QN,PF-2393296,Neuropathic pain , Discontinued in Phase 1
22956,D0T2RU,PF-277343,Alopecia , Phase 1
22957,D0T2RZ,Moroctocog alfa,Hemophilia , Approved
22958,D0T2SK,AmZaar,Hypertension , Investigative
22959,D0T2ST,Azotropin,Growth failure , Investigative
22960,D0T2TK,ZD6416,Pain , Discontinued in Phase 2
22961,D0T2UB,APCK-110,Solid tumour/cancer , Investigative
22962,D0T2XU,Promethazine,Nausea , Approved
22963,D0T2YQ,N-chlorotaurine,Bacterial infection , Phase 2
22964,D0T3AD,Pentostatin,Hairy cell leukaemia , Approved
22965,D0T3AW,Antroquinonol,Non-small-cell lung cancer , Phase 2
22966,D0T3AW,Antroquinonol,Pancreatic cancer , Phase 2
22967,D0T3BX,IFN-beta,Solid tumour/cancer , Investigative
22968,D0T3CB,Ono 1,Pain , Investigative
22969,D0T3CE,SUPER-LEU-DOX,Solid tumour/cancer , Discontinued in Phase 2
22970,D0T3CH,RGI-2001,Graft-versus-host disease , Phase 2
22971,D0T3DG,BCI-632,Major depressive disorder , Phase 1
22972,D0T3DG,BCI-632,Alzheimer disease , Phase 1
22973,D0T3DO,IRX-5183,Solid tumour/cancer , Phase 1
22974,D0T3EV,SR-146131,Obesity , Discontinued in Phase 1
22975,D0T3FN,RLX030,Acute heart failure , Approval submitted
22976,D0T3HL,Cx-611,Rheumatoid arthritis , Phase 1/2
22977,D0T3HY,Levorphanol,Pain , Approved
22978,D0T3HY,Levorphanol,Ischemic stroke , Terminated
22979,D0T3JF,GliAtak,Brain cancer , Phase 3
22980,D0T3JF,GliAtak,Prostate cancer , Phase 3
22981,D0T3JW,U-99194A,Schizophrenia , Preclinical
22982,D0T3JZ,ABBV-085,Solid tumour/cancer , Phase 1
22983,D0T3KI,Naratriptan,Migraine , Approved
22984,D0T3KW,AS-337,Human immunodeficiency virus-1 infection , Investigative
22985,D0T3KZ,TENOSAL,Rheumatoid arthritis , Investigative
22986,D0T3LF,Dextroamphetamine,Narcolepsy , Approved
22987,D0T3LF,Dextroamphetamine,Attention deficit hyperactivity disorder , Approved
22988,D0T3NB,Sanguinarine,Dental plaque , Approved
22989,D0T3NH,MBS-105,Bacterial infection , Investigative
22990,D0T3NY,Crotamiton,Pruritus , Approved
22991,D0T3QR,GSK679586,Asthma , Phase 2
22992,D0T3QU,MBL-HCV1,Hepatitis C virus infection , Phase 2
22993,D0T3RR,ISIS-ANGPTL3,Hyperlipidaemia , Phase 1
22994,D0T3TZ,Benzimidazole derivative 6,Solid tumour/cancer , Patented
22995,D0T3VF,GSK3050002,Psoriatic arthritis , Phase 1
22996,D0T3VO,DX-619,Bacterial infection , Discontinued in Phase 2
22997,D0T3VY,RBT-201,Human papillomavirus infection , Investigative
22998,D0T3ZL,RC-552,Neurological disorder , Discontinued in Phase 2
22999,D0T4BL,Neovastat,Renal cell carcinoma , Phase 1
23000,D0T4BL,Neovastat,Non-small-cell lung cancer , Phase 1
23001,D0T4CD,NGN-9077,Multiple system atrophy , Investigative
23002,D0T4CF,Five membered heterocyclic benzamide derivative 1,Pruritus , Patented
23003,D0T4CF,Five membered heterocyclic benzamide derivative 1,Solid tumour/cancer , Patented
23004,D0T4CF,Five membered heterocyclic benzamide derivative 1,Chronic pain , Patented
23005,D0T4CF,Five membered heterocyclic benzamide derivative 1,Neuropathic pain , Patented
23006,D0T4CF,Five membered heterocyclic benzamide derivative 1,Thymic cancer , Patented
23007,D0T4EA,GD2 ganglioside peptide mimics,Solid tumour/cancer , Investigative
23008,D0T4EL,A-80263,Inflammation , Terminated
23009,D0T4FY,CAR-T cells targeting CD30,Non-hodgkin lymphoma , Phase 2
23010,D0T4GA,INTEGRA Artificial Skin,Skin burns , Approved
23011,D0T4GG,NANT,Pancreatic cancer , Phase 1/2
23012,D0T4GX,Clade C HIV vaccine,Human immunodeficiency virus infection , Phase 1
23013,D0T4GZ,MPL-S,Endotoxic shock , Phase 3
23014,D0T4HS,GR-95168,Virus infection , Terminated
23015,D0T4IQ,MEN-11149,Asthma , Terminated
23016,D0T4IW,8H9 I-131 mab,Leptomeningeal sarcoma , Phase 2
23017,D0T4IW,8H9 I-131 mab,Small round cell desmoplastic tumour , Phase 1/2
23018,D0T4IW,8H9 I-131 mab,Soft tissue sarcoma , Phase 1
23019,D0T4IW,8H9 I-131 mab,Peritoneal cancer , Phase 1
23020,D0T4KG,F-8-IL-10 fusion protein,Endometriosis , Phase 2
23021,D0T4KG,F-8-IL-10 fusion protein,Rheumatoid arthritis , Phase 2
23022,D0T4KG,F-8-IL-10 fusion protein,Inflammatory bowel disease , Phase 1
23023,D0T4LT,GSK-1842799C,Cardiovascular disease , Investigative
23024,D0T4ME,V930,Solid tumour/cancer , Phase 1
23025,D0T4MK,Andexanet alfa,Bleeding disorder , Application submitted
23026,D0T4MK,Andexanet alfa,"Harmful effects of drugs, medicaments or biological substances ", Application submitted
23027,D0T4NV,CDX-1135,Macular degeneration , Phase 1
23028,D0T4OE,Palinavir,Human immunodeficiency virus infection , Terminated
23029,D0T4OT,Zilascorb (2H),Solid tumour/cancer , Discontinued in Phase 2
23030,D0T4PA,TAK-243,Solid tumour/cancer , Phase 1
23031,D0T4QA,LXH254,Non-small-cell lung cancer , Phase 1
23032,D0T4QX,CTEP,Fragile X syndrome , Investigative
23033,D0T4SG,AZD1981,Chronic obstructive pulmonary disease , Phase 2
23034,D0T4SJ,SCH-546909,Solid tumour/cancer , Investigative
23035,D0T4SO,PRO-367,Human immunodeficiency virus infection , Discontinued in Phase 1
23036,D0T4TN,Vasoactive intestinal peptide,Pulmonary arterial hypertension , Phase 2
23037,D0T4TN,Vasoactive intestinal peptide,Chronic obstructive pulmonary disease , Phase 2
23038,D0T4UL,PD-348292,Thrombosis , Discontinued in Phase 2
23039,D0T4WA,Trimazosin,Congestive heart failure , Approved
23040,D0T4WK,AAV2 GDNF,Parkinson disease , Phase 1
23041,D0T4XQ,SEP-227162,Major depressive disorder , Discontinued in Phase 2
23042,D0T4XV,SL-18.1616,Insomnia , Terminated
23043,D0T4YH,PF-03716539,Human immunodeficiency virus infection , Phase 1
23044,D0T4YZ,CNSB-004,Pain , Preclinical
23045,D0T4ZW,MP-RM-1,Solid tumour/cancer , Investigative
23046,D0T5AH,PHA-690509,Solid tumour/cancer , Investigative
23047,D0T5AW,Desoxypeganine,Alcohol dependence , Phase 1
23048,D0T5BC,Lactulose,Constipation , Approved
23049,D0T5CH,HSC835,Haematological malignancy , Phase 1/2
23050,D0T5DC,CAR-T cells targeting CEA,Colorectal cancer , Phase 1/2
23051,D0T5DE,Barium sulfate,Gastrointestinal disease , Approved
23052,D0T5DP,Selumetinib,Melanoma , Phase 3
23053,D0T5DP,Selumetinib,Thyroid cancer , Phase 3
23054,D0T5DP,Selumetinib,Non-small-cell lung cancer , Phase 2
23055,D0T5DP,Selumetinib,Solid tumour/cancer , Investigative
23056,D0T5ES,MUC-1 cancer vaccine,Ovarian cancer , Phase 2
23057,D0T5FO,CVA-21 DAF,Solid tumour/cancer , Investigative
23058,D0T5FU,DS-3801,Constipation , Phase 1
23059,D0T5GO,Erythropoietin gene therapy,Anemia , Phase 2
23060,D0T5GT,CE-1037,Chronic obstructive pulmonary disease , Discontinued in Phase 2
23061,D0T5HO,Vaxfectin plasmid DNA pandemic influenza vaccine,Influenza virus infection , Phase 1
23062,D0T5IN,PX-867,Cardiovascular disease , Terminated
23063,D0T5JG,TDI-0114,Motor neurone disease , Investigative
23064,D0T5JS,TT-100,Non-small-cell lung cancer , Phase 2
23065,D0T5LQ,123-Iodine-labeled MFE-23,Solid tumour/cancer , Phase 1
23066,D0T5MB,Lu-35138,Psychotic disorder , Discontinued in Phase 2
23067,D0T5NB,GS-4774,Hepatitis C virus infection , Phase 2
23068,D0T5NI,Saperconazole,Fungal infection , Discontinued in Phase 2
23069,D0T5OX,Remifentanil,Anaesthesia , Approved
23070,D0T5PH,Relacatib,Bone metastases , Discontinued in Phase 2
23071,D0T5PH,Relacatib,Osteoporosis , Discontinued in Phase 1
23072,D0T5QC,AAV1-FS344,Macular degeneration , Phase 1/2
23073,D0T5QC,AAV1-FS344,Duchenne dystrophy , Phase 1/2
23074,D0T5QC,AAV1-FS344,Inclusion body myositis , Phase 1/2
23075,D0T5QT,Becaplermin,Diabetic complication , Approved
23076,D0T5SG,ME-3221,Hypertension , Terminated
23077,D0T5SZ,PNU-142721,Human immunodeficiency virus infection , Discontinued in Phase 1
23078,D0T5TN,CJM112,Acne vulgaris , Phase 2
23079,D0T5TN,CJM112,Chronic plaque psoriasis , Phase 1/2
23080,D0T5TN,CJM112,Multiple myeloma , Phase 1
23081,D0T5TN,CJM112,Plaque psoriasis , Phase 1
23082,D0T5TN,CJM112,Solid tumour/cancer , Phase 1
23083,D0T5TU,TPI-1020,Chronic obstructive pulmonary disease , Phase 2
23084,D0T5UL,Benzphetamine,Obesity , Approved
23085,D0T5VD,EVK-001,Diabetic gastroparesis , Phase 3
23086,D0T5VQ,Mearubik,Measles , Approved
23087,D0T5WA,Healive,Hepatitis A virus infection , Approved
23088,D0T5WK,Nitrazepam,Epilepsy , Approved
23089,D0T5WK,Nitrazepam,Insomnia , Approved
23090,D0T5XN,LEURUBICIN,Solid tumour/cancer , Approved
23091,D0T5YB,MEDI6012,Coronary artery disease , Phase 2
23092,D0T5YB,MEDI6012,Acute coronary syndrome , Phase 1
23093,D0T5YX,DM-71,Type-2 diabetes , Phase 2
23094,D0T5ZC,BAY-50-9062,Osteoporosis , Terminated
23095,D0T5ZM,NAChR APLs,Alzheimer disease , Investigative
23096,D0T6AY,WX-04554,Bone disease , Investigative
23097,D0T6BA,S-16924,Anxiety disorder , Phase 2
23098,D0T6CN,BL-8040,Multiple myeloma , Phase 3
23099,D0T6CN,BL-8040,Acute myeloid leukaemia , Phase 2
23100,D0T6CN,BL-8040,Pancreatic cancer , Phase 2
23101,D0T6CN,BL-8040,Myelodysplastic syndrome , Phase 2
23102,D0T6EE,ACE-031,Duchenne dystrophy , Phase 2
23103,D0T6EI,Sarecycline ,Acne vulgaris , Approved
23104,D0T6ES,SSR-125329A,Immune System disease , Phase 1
23105,D0T6FY,KD-901,Alzheimer disease , Investigative
23106,D0T6IM,Tetomilast,Chronic obstructive pulmonary disease , Phase 2
23107,D0T6IN,Peginterferon lambda-1a,Acute myeloid leukaemia , Phase 3
23108,D0T6IP,Cefetamet pivoxil hcl,Bacterial infection , Approved
23109,D0T6KI,CAR-T cells targeting CD80/86,Solid tumour/cancer , Phase 1
23110,D0T6KV,GSK933776A,Macular degeneration , Phase 2
23111,D0T6KV,GSK933776A,Alzheimer disease , Phase 2
23112,D0T6LF,PF-3823863,Solid tumour/cancer , Investigative
23113,D0T6LU,H1N1 influenza vaccine,Influenza virus infection , Phase 1
23114,D0T6MM,AM-94,Rotavirus infection (Diarrhoea) , Discontinued in Phase 2
23115,D0T6MU,FR-113680,Asthma , Terminated
23116,D0T6NG,CAR-T cells targeting CD138,Multiple myeloma , Clinical trial
23117,D0T6NS,ACPC,Neurological disorder , Investigative
23118,D0T6NX,Biphenyl mannoside derivative 29,Crohn disease , Patented
23119,D0T6NX,Biphenyl mannoside derivative 29,Ulcerative colitis , Patented
23120,D0T6NX,Biphenyl mannoside derivative 29,Urinary tract infection , Patented
23121,D0T6PF,IMX-MEL1,Melanoma , Investigative
23122,D0T6PV,DV-7751A,Bacterial infection , Discontinued in Phase 1
23123,D0T6QX,ZOTEPINE,Anxiety disorder , Approved
23124,D0T6RC,Dihydrocodeine,Cancer related pain , Phase 4
23125,D0T6RG,SAR113244,Systemic lupus erythematosus , Phase 1
23126,D0T6SU,Phendimetrazine,Obesity , Approved
23127,D0T6TH,EVT-501,Sleep-wake disorder , Investigative
23128,D0T6TQ,IS-0402,Autoimmune diabetes , Investigative
23129,D0T6TW,GSK642444,Chronic obstructive pulmonary disease , Phase 3
23130,D0T6UW,Tetraoxane derivatives,Malaria , Investigative
23131,D0T6VD,Meglumine antimoniate,Leishmania braziliensis infection , Approved
23132,D0T6VU,ED-110,Solid tumour/cancer , Terminated
23133,D0T6WN,Rilpivirine,Human immunodeficiency virus infection , Approved
23134,D0T6WN,Rilpivirine,Pain , Investigative
23135,D0T6WT,Heroin diacetylmorphine,Neurological disorder , Approved
23136,D0T6XU,Myelopid,Immune System disease , Approved
23137,D0T6XX,Pantoprazole,Gastroesophageal reflux disease , Approved
23138,D0T7AE,OMS-182410,Schizophrenia , Investigative
23139,D0T7BD,PF-06669571,Cognitive impairment , Phase 1
23140,D0T7BH,Resorcinol compound 34,Albinism , Patented
23141,D0T7BH,Resorcinol compound 34,Ephelides , Patented
23142,D0T7BH,Resorcinol compound 34,Menkes disease , Patented
23143,D0T7BH,Resorcinol compound 34,Senile lentigines , Patented
23144,D0T7BH,Resorcinol compound 34,Melasma , Patented
23145,D0T7BI,V160,Cytomegalovirus infection , Phase 2
23146,D0T7BV,PMID22911925C2,Diabetic complication , Clinical trial
23147,D0T7CM,UCL-2000; butabindide,Obesity , Discontinued in Phase 1
23148,D0T7CR,MOv19-BBz CAR T cells,Fallopian tube cancer , Phase 1
23149,D0T7CR,MOv19-BBz CAR T cells,Ovarian cancer , Phase 1
23150,D0T7CR,MOv19-BBz CAR T cells,Pancreatic cancer , Phase 1
23151,D0T7EZ,CL-387626,Virus infection , Terminated
23152,D0T7FO,MOD-7023,Anemia , Investigative
23153,D0T7GQ,APETX2,Pain , Investigative
23154,D0T7GV,Picoplatin,Small-cell lung cancer , Phase 3
23155,D0T7GV,Picoplatin,Prostate cancer , Phase 3
23156,D0T7GV,Picoplatin,Ovarian cancer , Phase 3
23157,D0T7GV,Picoplatin,Colorectal cancer , Phase 3
23158,D0T7LV,LIPO-4,Human immunodeficiency virus infection , Phase 1
23159,D0T7MJ,PF-06412562,Cognitive impairment , Phase 1
23160,D0T7MN,ZYH-1,Lipid metabolism disorder , Phase 3
23161,D0T7MZ,GALE-302,Ovarian cancer , Phase 1/2
23162,D0T7OE,NEO100,Glioblastoma multiforme , Phase 1/2
23163,D0T7OE,NEO100,Malignant glioma , Phase 1/2
23164,D0T7OE,NEO100,Recurrent malignant glioma , Phase 1/2
23165,D0T7OI,Anti-LAG3,Gastric adenocarcinoma , Phase 2
23166,D0T7OI,Anti-LAG3,Renal cell carcinoma , Phase 2
23167,D0T7OI,Anti-LAG3,Non-small-cell lung cancer , Phase 2
23168,D0T7OS,AL-6802,Solid tumour/cancer , Investigative
23169,D0T7OW,Dopamine,Parkinson disease , Approved
23170,D0T7OW,Dopamine,Hypotension , Phase 1
23171,D0T7PZ,NAI-107,Bacterial infection , Investigative
23172,D0T7QC,TRU-016,Chronic lymphocytic leukaemia , Phase 1/2
23173,D0T7QN,SPN-811,Attention deficit hyperactivity disorder , Phase 1
23174,D0T7QY,Pyrazole derivative 38,Obesity , Patented
23175,D0T7US,Eprosartan,Hypertension , Approved
23176,D0T7VN,Aryl mannoside derivative 20,Crohn disease , Patented
23177,D0T7VN,Aryl mannoside derivative 20,Ulcerative colitis , Patented
23178,D0T7VN,Aryl mannoside derivative 20,Urinary tract infection , Patented
23179,D0T7WL,Pirmenol,Heart arrhythmia , Approved
23180,D0T7WQ,Datelliptium chloride,Breast cancer , Terminated
23181,D0T7XI,Methaqualone,Insomnia , Withdrawn from market
23182,D0T7XN,E-2070,Neuropathic pain , Terminated
23183,D0T7XO,IGEL1.2,Allergy , Investigative
23184,D0T7YE,LYC-55716,Solid tumour/cancer , Phase 2
23185,D0T7YE,LYC-55716,Non-small-cell lung cancer , Phase 2
23186,D0T7ZQ,Estradiol Acetate,Hormone replacement therapy , Approved
23187,D0T8AI,Y-90 Clivatuzumab,Pancreatic cancer , Phase 3
23188,D0T8BP,AH-9700,Pollakiuria , Terminated
23189,D0T8CE,AMG888/U3-1287,Non-small-cell lung cancer , Phase 1/2
23190,D0T8CQ,CP-70949,Diabetic complication , Investigative
23191,D0T8DD,EPCAM-targeted CAR-T cells,Liver cancer , Clinical trial
23192,D0T8DD,EPCAM-targeted CAR-T cells,Gastric adenocarcinoma , Clinical trial
23193,D0T8EH,Pirarubicin,Breast cancer , Approved
23194,D0T8EL,AHL,Hearing disorder , Investigative
23195,D0T8GD,Nicotine,Nicotine dependence , Approved
23196,D0T8GD,Nicotine,Tobacco dependence , Clinical trial
23197,D0T8HR,Naptumomab estafenatox,Solid tumour/cancer , Phase 2/3
23198,D0T8HU,LU-29252,Anxiety disorder , Terminated
23199,D0T8HZ,Pegvaliase,Phenylketonuria , Approved
23200,D0T8IW,Ultimab IgG1 antibody,Solid tumour/cancer , Phase 3
23201,D0T8JY,BMS-986277,Carcinoma , Phase 1/2
23202,D0T8KA,JNJ-18038683,Major depressive disorder , Phase 2
23203,D0T8KD,Eberconazole,Fungal infection , Approved
23204,D0T8KF,SUN-8399,Anxiety disorder , Discontinued in Phase 1
23205,D0T8LF,Ragweed pollen extract,Allergy , Phase 3
23206,D0T8MA,ATN-224,Solid tumour/cancer , Phase 2
23207,D0T8NS,AZD-8677,Diabetic complication , Discontinued in Phase 1
23208,D0T8QB,GLYCYRRHIZIN,Influenza virus infection , Phase 3
23209,D0T8QE,FMX102,Impetigo , Phase 2
23210,D0T8QM,MQX-3016,Keratosis , Investigative
23211,D0T8QY,PMI-008,Obesity , Investigative
23212,D0T8RQ,166Ho-phytate,Arthropathy , Investigative
23213,D0T8RV,BCMA CART and huCART19,Multiple myeloma , Phase 1
23214,D0T8TC,VPC-8,Solid tumour/cancer , Investigative
23215,D0T8VE,Aminoazetidine derivative 5,Obesity , Patented
23216,D0T8VV,FLM-5011,Inflammation , Discontinued in Phase 1
23217,D0T8VY,Aceclofenac,Inflammation , Approved
23218,D0T8XB,Anagliptin,Type-2 diabetes , Approved
23219,D0T8XD,"Imidazo[1,2-b]pyridazine derivative 1",Solid tumour/cancer , Patented
23220,D0T8XY,PMID30280939-Compound-WO2015091734,Malaria , Patented
23221,D0T8YK,EP-01492,Obesity , Preclinical
23222,D0T8YV,LymphoRad-131,Lymphoma , Discontinued in Phase 1
23223,D0T8ZA,Zohydro ER,Pain , Approved
23224,D0T9CD,Cobacan,Peritoneal cavity cancer , Investigative
23225,D0T9CE,BCMA nanobody CAR-T cells,Multiple myeloma , Phase 1
23226,D0T9CO,MelCancerVac,Colorectal cancer , Phase 2/3
23227,D0T9DA,NGF-hTNF,Multiple sclerosis , Phase 3
23228,D0T9DN,Dimiracetam,Neuropathic pain , Phase 2
23229,D0T9DT,Diatrizoate,Urinary tract disease , Approved
23230,D0T9DV,PMID28621580-Compound-WO2013036866C66,Solid tumour/cancer , Patented
23231,D0T9FD,YKP-3089,Epilepsy , Phase 3
23232,D0T9FU,BC-3205,Respiratory tract infection , Phase 1
23233,D0T9GM,Nanoflu,Seasonal influenza infection , Phase 3
23234,D0T9GQ,ASB-010,Dengue fever , Investigative
23235,D0T9HG,GM6001,Corneal ulcer , Discontinued in Phase 2
23236,D0T9JK,VER-82160,Solid tumour/cancer , Investigative
23237,D0T9JW,AU101,Osteosarcoma , Phase 1/2
23238,D0T9JW,AU101,Recurrent glioblastoma , Phase 1/2
23239,D0T9JW,AU101,Recurring respiratory infection , Phase 1/2
23240,D0T9JW,AU101,Sarcoma , Phase 1/2
23241,D0T9KF,RDEA-427,Human immunodeficiency virus infection , Terminated
23242,D0T9LH,MM-131,Solid tumour/cancer , Investigative
23243,D0T9LR,Liprotamase,Cystic fibrosis , Phase 3
23244,D0T9MQ,KN-203,Urinary incontinence , Discontinued in Phase 1
23245,D0T9OC,TL-118,Pancreatic cancer , Phase 2
23246,D0T9PL,BLV-0703,Central nervous system disease , Investigative
23247,D0T9SJ,CEP-4186,Acute myeloid leukaemia , Terminated
23248,D0T9TE,Ombitasvir + paritaprevir + ritonavir,Hepatitis C virus infection , Approved
23249,D0T9TJ,Orlistat,Obesity , Approved
23250,D0T9TR,HR2P-M1 peptide,Middle East Respiratory Syndrome (MERS) , Preclinical
23251,D0T9YF,A-74187,Peripheral vascular disease , Discontinued in Phase 3
23252,D0T9YU,Imino sugars,Dengue fever , Investigative
23253,D0T9YV,STD-06,Dermatological disease , Investigative
23254,D0T9ZG,PLD-180,Motor neurone disease , Terminated
23255,D0TA3V,ADC-5510,Movement disorder , Investigative
23256,D0TA4A,GLPG0974,Abortion , Phase 2
23257,D0TA8O,LTT462,Solid tumour/cancer , Phase 1
23258,D0TB1L,Indium In-111 Chloride,Diagnostic radiopharmaceutical , Approved
23259,D0TB1X,AL-0671,Arteriosclerosis , Terminated
23260,D0TB2H,Heteroaryl-carboxamide derivative 10,Solid tumour/cancer , Patented
23261,D0TB2H,Heteroaryl-carboxamide derivative 10,Metastatic cancer , Patented
23262,D0TB8C,Nadrolone phenylpropionate,Solid tumour/cancer , Approved
23263,D0TC1T,Ro-40-1641,Cognitive impairment , Terminated
23264,D0TC4R,Desmoteplase,Ischemic stroke , Phase 3
23265,D0TC6X,Anti-CD30-CAR T cells,Hodgkin lymphoma , Phase 1
23266,D0TC6X,Anti-CD30-CAR T cells,Large cell lymphoma , Phase 1
23267,D0TC6X,Anti-CD30-CAR T cells,Lymphoma , Phase 1
23268,D0TC7C,Hidrosmin,Cardiovascular disease , Approved
23269,D0TC7X,Isoquinoline derivative 1,Neuropathic pain , Patented
23270,D0TD0O,Anti-CD19 CAR-T,Acute lymphoblastic leukaemia , Phase 1
23271,D0TD0O,Anti-CD19 CAR-T,B-cell chronic lymphocytic leukaemia , Phase 1
23272,D0TD0O,Anti-CD19 CAR-T,Haematopoietic/lymphoid cancer , Phase 1
23273,D0TD1R,Lusutrombopag,Thrombocytopenia , Approved
23274,D0TD1R,Lusutrombopag,Liver disease , Phase 2
23275,D0TD2F,ES-6864,Hypertension , Investigative
23276,D0TD2G,Canakinumab,Rheumatoid arthritis , Approved
23277,D0TD2G,Canakinumab,Cryopyrin-associated periodic syndromes , Approved
23278,D0TD2G,Canakinumab,Vasculitis , Phase 2
23279,D0TD2G,Canakinumab,Urticaria , Phase 2
23280,D0TD7J,ALKS 8700,Multiple sclerosis , Phase 3
23281,D0TE0L,4SCAR19 cells,B-cell lymphoma , Phase 1/2
23282,D0TE8W,NSD-801,Ataxia , Investigative
23283,D0TE9G,PF-4957325-00,Inflammation , Investigative
23284,D0TF1E,A-366833,Pain , Preclinical
23285,D0TF2D,CDX-301 + CDX-1401,Solid tumour/cancer , Phase 2
23286,D0TG1H,Diclofenac,Osteoarthritis , Approved
23287,D0TG4K,Oxycyte,Traumatic brain injury , Preclinical
23288,D0TG4S,ASN002,Eczema , Phase 2
23289,D0TG4S,ASN002,Lymphoma , Phase 1/2
23290,D0TG4S,ASN002,Solid tumour/cancer , Phase 1/2
23291,D0TG7I,Erythromycin/sulfisoxazole,Gram-positive bacterial infection , Approved
23292,D0TG9Q,MK-0812,Multiple sclerosis , Phase 2
23293,D0TH1Z,Naxagolide,Parkinson disease , Discontinued in Phase 2
23294,D0TH5H,Dapansutrile,Acute gout flare , Phase 2
23295,D0TH5H,Dapansutrile,Musculoskeletal pain , Phase 2
23296,D0TH6O,AR-132,Cytomegalovirus infection , Terminated
23297,D0TI3Q,"1,2,4,5-tetra-substituted imidazole derivative 2",Obesity , Patented
23298,D0TI3R,FLX-787,Amyotrophic lateral sclerosis , Phase 2
23299,D0TI3R,FLX-787,Multiple sclerosis , Phase 2
23300,D0TI3R,FLX-787,Muscle spasm , Phase 2
23301,D0TI4C,AK002,Urticaria , Phase 2
23302,D0TI4U,EGFR/IGFR tandem adnectin,Solid tumour/cancer , Preclinical
23303,D0TJ0R,TA-CIN,Cervical cancer , Phase 2
23304,D0TJ3M,NSC-281612,Solid tumour/cancer , Phase 1
23305,D0TJ4D,PMID30107136-Compound-Example58,Solid tumour/cancer , Patented
23306,D0TJ4D,PMID30107136-Compound-Example58,Infectious disease , Patented
23307,D0TJ4D,PMID30107136-Compound-Example58,Human immunodeficiency virus infection , Patented
23308,D0TJ4D,PMID30107136-Compound-Example58,Hepatitis , Patented
23309,D0TJ7S,PDC-41,Dysmenorrhea , Phase 1
23310,D0TJ9I,HSB-13,Neurodegenerative disorder , Investigative
23311,D0TJ9S,N-methanocarbathymidine,Zoster , Phase 1
23312,D0TJ9S,N-methanocarbathymidine,Virus infection , Investigative
23313,D0TK0W,Ro-46-5934,Alzheimer disease , Terminated
23314,D0TK2J,BN-AM-206,Solid tumour/cancer , Preclinical
23315,D0TK7R,LGX818,Melanoma , Approved
23316,D0TL1L,Fendrix,Hepatitis B virus infection , Approved
23317,D0TL2C,Resorcinol compound 18,Albinism , Patented
23318,D0TL2C,Resorcinol compound 18,Ephelides , Patented
23319,D0TL2C,Resorcinol compound 18,Menkes disease , Patented
23320,D0TL2C,Resorcinol compound 18,Senile lentigines , Patented
23321,D0TL2C,Resorcinol compound 18,Melasma , Patented
23322,D0TL7L,Dexloxiglumide,Pancreatic malfunction , Phase 2
23323,D0TM0C,LIMAZOCIC,Liver disease , Discontinued in Phase 2
23324,D0TM0Y,FT-1101,Haematological malignancy , Phase 1
23325,D0TM7Q,Ritonavir + oseltamivir,Coronavirus Disease 2019 (COVID-19) , Phase 3
23326,D0TMF3,JNJ-64417184,Respiratory syncytial virus infection , Phase 1
23327,D0TN0O,PRTT-300,Pain , Investigative
23328,D0TN1J,MENK ,Pancreatic tumour , Phase 2
23329,D0TN1N,NY-ESO-TCR,Melanoma , Phase 1/2
23330,D0TN1N,NY-ESO-TCR,Multiple myeloma , Phase 1/2
23331,D0TN1N,NY-ESO-TCR,Myxoid round cell liposarcoma , Phase 1/2
23332,D0TN1N,NY-ESO-TCR,Ovarian cancer , Phase 1/2
23333,D0TN1N,NY-ESO-TCR,Synovial sarcoma , Phase 1/2
23334,D0TN3D,AZD-7140,Rheumatoid arthritis , Discontinued in Phase 1
23335,D0TN3D,AZD-7140,Chronic obstructive pulmonary disease , Discontinued in Phase 1
23336,D0TN3Q,LY3214996,Solid tumour/cancer , Phase 1
23337,D0TN4M,8H9 I-124 mAb,Glioma , Phase 1/2
23338,D0TN5W,HER2-CAR T Cells,Malignant neoplasm , Phase 1
23339,D0TN5W,HER2-CAR T Cells,Metastatic malignant neoplasm , Phase 1
23340,D0TN6K,LSZ102,Breast cancer , Phase 1
23341,D0TN7S,BAY-1075553,Prostate cancer , Phase 1
23342,D0TO0C,FPA150,Solid tumour/cancer , Phase 1
23343,D0TO0F,VLDM-01,Prostate hyperplasia , Investigative
23344,D0TO2R,Fludarabine phosphate,Solid tumour/cancer , Phase 1
23345,D0TP1P,CPP -15,Infantile spasm , Phase 1
23346,D0TP2W,Thymopentin,Immune System disease , Approved
23347,D0TP5H,Esketamine,Depression , Phase 3
23348,D0TP7T,SCY-641,Ocular inflammation , Preclinical
23349,D0TP8R,Iobenguane Sulfate I-131,Pheochromocytoma , Approved
23350,D0TP8T,PMID26651364-Compound-113,Crohn disease , Patented
23351,D0TP8T,PMID26651364-Compound-113,Ulcerative colitis , Patented
23352,D0TP8T,PMID26651364-Compound-113,Urinary tract infection , Patented
23353,D0TP9A,CB-30865,Solid tumour/cancer , Terminated
23354,D0TQ1G,Rimantadine,Influenza A virus infection , Approved
23355,D0TQ4Y,PF-06648671,Alzheimer disease , Phase 1
23356,D0TR0Z,MOGUISTEINE,Cough , Discontinued in Preregistration
23357,D0TR3Y,Ovapuldencel-T,Ovarian cancer , Phase 2
23358,D0TR3Y,Ovapuldencel-T,Peritoneal cavity cancer , Phase 2
23359,D0TR4Y,LN-145,Cervical cancer , Phase 2
23360,D0TR4Y,LN-145,Squamous cell carcinoma , Phase 2
23361,D0TR4Z,Zindoxifene,Breast cancer , Terminated
23362,D0TR5X,Fluoxetine,Depression , Approved
23363,D0TS0R,CD19xCD3 DART,Solid tumour/cancer , Investigative
23364,D0TS1Z,Floxuridine,Solid tumour/cancer , Approved
23365,D0TS1Z,Floxuridine,Colorectal cancer , Approved
23366,D0TS2B,CAR-T cells targeting CD117,Acute myeloid leukaemia , Preclinical
23367,D0TS3S,Heterocyclic-substituted 3-alkyl azetidine derivative 3,Obesity , Patented
23368,D0TS8E,ADX71149,Epilepsy , Phase 1
23369,D0TS8E,ADX71149,Anxiety disorder , Discontinued in Phase 2
23370,D0TS8E,ADX71149,Psychiatric disorder , Discontinued in Phase 2
23371,D0TT0B,"1,2,4-triazole derivative 2",Obesity , Patented
23372,D0TT4H,E6005,Atopic dermatitis , Phase 2
23373,D0TT5I,FAS-20013,Mycobacterium infection , Investigative
23374,D0TT5K,MDL-27531,Epilepsy , Phase 1
23375,D0TT6L,SF0166,Diabetic macular edema , Phase 1/2
23376,D0TU0F,LAP-001,Lipid metabolism disorder , Investigative
23377,D0TU1E,EB-101,Dystrophic epidermolysis bullosa , Phase 1/2
23378,D0TU1E,EB-101,Alzheimer disease , Investigative
23379,D0TU7B,PQR309,Squamous head and neck cell carcinom , Phase 2
23380,D0TU7B,PQR309,Pain , Phase 1
23381,D0TU7G,SUVN-1004028,Neurodegenerative disorder , Investigative
23382,D0TU7V,MB-12066,Obesity , Phase 2
23383,D0TU9W,BIIB054,Parkinson disease , Phase 2
23384,D0TV0C,Pasireotide,Cushing disease , Approved
23385,D0TV0E,JNJ-64457107,Solid tumour/cancer , Phase 1
23386,D0TV4N,T-226296,Obesity , Preclinical
23387,D0TV4N,T-226296,Atrial fibrillation , Investigative
23388,D0TV6H,HuM-195-Ac-225,Acute myeloid leukaemia , Phase 1/2
23389,D0TV6H,HuM-195-Ac-225,Acute myelogenous leukaemia , Phase 1/2
23390,D0TV6I,Safinamide,Parkinson disease , Approved
23391,D0TV6I,Safinamide,Idiopathic parkinson disease , Phase 3
23392,D0TV9K,Propiverine,Urinary incontinence , Approved
23393,D0TW1Q,DP-3005,Angina pectoris , Investigative
23394,D0TW2J,CMX-020,Neuropathic pain , Phase 2
23395,D0TW3L,CD20Bi aATC,Non-hodgkin lymphoma , Phase 1
23396,D0TX5P,ITX-5061,Human immunodeficiency virus-1 infection , Phase 1
23397,D0TX7T,Sulglycotide,Active duodenal ulcer , Approved
23398,D0TX8Z,FLOSATIDIL,Angina pectoris , Discontinued in Phase 2
23399,D0TY0G,Mumps skin test antigen,Allergy , Approved
23400,D0TY0P,G-573,Solid tumour/cancer , Investigative
23401,D0TY1Q,Mannoside derivative 9,Crohn disease , Patented
23402,D0TY1Q,Mannoside derivative 9,Ulcerative colitis , Patented
23403,D0TY1Q,Mannoside derivative 9,Urinary tract infection , Patented
23404,D0TY1U,TDI-0103,Motor neurone disease , Investigative
23405,D0TY1Y,PfSPZ-Cvac,Malaria , Phase 2
23406,D0TY3L,KX-01,Actinic keratosis , Phase 3
23407,D0TY5K,NWP-09,Attention deficit hyperactivity disorder , Phase 3
23408,D0TY5N,Cotinine,Insecticide , Approved
23409,D0TY6U,BPX-601,Gastric adenocarcinoma , Phase 1/2
23410,D0TY6U,BPX-601,Pancreatic cancer , Phase 1/2
23411,D0TY6U,BPX-601,Prostate cancer , Phase 1/2
23412,D0TY6Y,Avicine,Colorectal cancer , Discontinued in Phase 1
23413,D0TY8B,PGGA-PTX,Solid tumour/cancer , Investigative
23414,D0TZ1C,Curemisinin,Malaria , Approved
23415,D0TZ1G,Procaine,Anaesthesia , Approved
23416,D0TZ2W,PMID25666693-Compound-38,Osteoarthritis pain , Patented
23417,D0TZ2W,PMID25666693-Compound-38,Cancer related pain , Patented
23418,D0TZ2W,PMID25666693-Compound-38,Neuropathic pain , Patented
23419,D0TZ2W,PMID25666693-Compound-38,Inflammatory pain , Patented
23420,D0TZ6M,Phenazopyridine,Middle East Respiratory Syndrome (MERS) , Investigative
23421,D0TZ8J,Clade A HIV vaccine,Human immunodeficiency virus infection , Phase 1
23422,D0U0AM,VGV-1,Human immunodeficiency virus infection , Discontinued in Phase 3
23423,D0U0AU,AZD-9819,Chronic obstructive pulmonary disease , Phase 1
23424,D0U0AY,AV-101,Neuropathic pain , Phase 2
23425,D0U0AY,AV-101,Major depressive disorder , Phase 2
23426,D0U0BA,AERAS-407 rBCG,Mycobacterium infection , Phase 1
23427,D0U0BN,JCAR014,Non-hodgkin lymphoma , Phase 1/2
23428,D0U0BN,JCAR014,B-cell lymphoma , Phase 1
23429,D0U0BN,JCAR014,Mediastinal large B-cell lymphoma , Phase 1
23430,D0U0BN,JCAR014,Diffuse large B-cell lymphoma , Phase 1
23431,D0U0BN,JCAR014,B-cell non-hodgkin lymphoma , Phase 1
23432,D0U0BP,DFP 13318,Solid tumour/cancer , Phase 1
23433,D0U0BU,TOK-001,Prostate cancer , Phase 2
23434,D0U0CF,CNTX-0290,Chronic pain , Phase 1
23435,D0U0DD,Phleum pratense-containing vaccine,Allergic conjunctivitis , Phase 2
23436,D0U0EC,TRemelimumab + MEDI0562,Solid tumour/cancer , Phase 1
23437,D0U0FH,Amitivir,Virus infection , Terminated
23438,D0U0GC,ZP-012,Urinary tract infection , Investigative
23439,D0U0GZ,Filibuvir,Hepatitis C virus infection , Phase 2
23440,D0U0HX,Molgramostim,Autoimmune pulmonary alveolar proteinosis , Phase 3
23441,D0U0HX,Molgramostim,Wound healing , Phase 1
23442,D0U0IS,NP-02,Heart disease , Investigative
23443,D0U0JL,Neo-1507,Osteoarthritis , Investigative
23444,D0U0KR,CF102,Hepatocellular carcinoma , Phase 2
23445,D0U0KR,CF102,Hepatitis C virus infection , Phase 1/2
23446,D0U0KW,Ramelteon,Insomnia , Approved
23447,D0U0KW,Ramelteon,Circadian rhythm sleep disorder , Terminated
23448,D0U0NS,Myeloma cancer vaccine,Multiple myeloma , Phase 2
23449,D0U0OF,TPI-273,Solid tumour/cancer , Terminated
23450,D0U0OT,Melevodopa,Parkinson disease , Approved
23451,D0U0PV,M-40401,Cerebrovascular ischaemia , Terminated
23452,D0U0QC,ABBV-2737,Cystic fibrosis , Phase 1
23453,D0U0QI,GYKI-16084,Prostate disease , Discontinued in Phase 2
23454,D0U0RJ,Leukocyte interleukin,Human immunodeficiency virus infection , Phase 1
23455,D0U0RJ,Leukocyte interleukin,Head and neck cancer , Phase 1
23456,D0U0RZ,Phentermine,Obesity , Approved
23457,D0U0SD,RG-125,Non-alcoholic fatty liver disease , Phase 1
23458,D0U0SK,GZ402668,Multiple sclerosis , Phase 1
23459,D0U0TD,Gedocarnil,Anxiety disorder , Discontinued in Phase 1
23460,D0U0VU,SILODOSIN,Benign prostatic hyperplasia , Approved
23461,D0U0VY,CNTO-2476,Retinitis pigmentosa , Phase 1/2
23462,D0U0XD,Estradiol Cypionate,Hormone replacement therapy , Approved
23463,D0U0XL,NN-7415,Factor IX deficiency , Phase 1
23464,D0U0YR,SNAP-7941,Depression , Preclinical
23465,D0U0YR,SNAP-7941,Anxiety disorder , Preclinical
23466,D0U0YR,SNAP-7941,Obesity , Preclinical
23467,D0U1BR,Herpes simplex DNA vaccine,Herpes simplex virus infection , Phase 1
23468,D0U1BU,HPP-851,Metabolic disorder , Preclinical
23469,D0U1BW,SIVIG,Autoimmune diabetes , Investigative
23470,D0U1CL,PGX-200097,Schizophrenia , Preclinical
23471,D0U1DD,KiroVAX-003,Solid tumour/cancer , Phase 1/2
23472,D0U1DU,NVX-207,Solid tumour/cancer , Investigative
23473,D0U1FR,PBI-1393,Solid tumour/cancer , Preclinical
23474,D0U1FZ,EUK-207,Neurodegenerative disorder , Terminated
23475,D0U1GM,NexVas VI,Vasculitis , Investigative
23476,D0U1GP,CD56 CAR T cells,Multiple myeloma , Phase 1/2
23477,D0U1HE,PEGylated PYY-3-36,Metabolic disorder , Investigative
23478,D0U1HN,AM-211,Asthma , Phase 1
23479,D0U1HP,Org-24461,Schizophrenia , Preclinical
23480,D0U1HR,Donor-derived CD19/22 bispecific CAR-T cells,leukaemia , Phase 1
23481,D0U1HX,DIMS-0150,Ulcerative colitis , Phase 3
23482,D0U1IR,AP-5346,Head and neck cancer , Discontinued in Phase 2
23483,D0U1KE,FF-10502-01,Lymphoma , Phase 1
23484,D0U1KE,FF-10502-01,Solid tumour/cancer , Phase 1
23485,D0U1LQ,Rotavirus vaccine,Pediatric cancer , Phase 3
23486,D0U1LQ,Rotavirus vaccine,Type-2 diabetes , Phase 1
23487,D0U1MO,CERE-120,Parkinson disease , Phase 2
23488,D0U1NA,Fadolmidine,Neuropathic pain , Phase 2
23489,D0U1NA,Fadolmidine,Pain , Discontinued in Phase 2
23490,D0U1OE,Thioridazine,Schizophrenia , Approved
23491,D0U1OM,Bromfenac,Postoperative inflammation , Approved
23492,D0U1OM,Bromfenac,Inflammation , Withdrawn from market
23493,D0U1OO,ARM210,Duchenne dystrophy , Phase 1
23494,D0U1QE,VR736,Influenza virus infection , Phase 2
23495,D0U1SA,KTP-001,Intervertebral disc displacement , Phase 1/2
23496,D0U1SI,Bimoclomol,Diabetic complication , Discontinued in Phase 2
23497,D0U1TA,RHuEPO,Solid tumour/cancer , Approved
23498,D0U1TJ,NKTR-194,Pain , Investigative
23499,D0U1UN,DWP-10292,Retinitis pigmentosa , Phase 1
23500,D0U1US,18F-FEDAA-1106,Alzheimer disease , Phase 1
23501,D0U1VR,AFX-9154,leukaemia , Phase 1/2
23502,D0U1VZ,Flurpiridaz F 18,Myocardial disease , Phase 3
23503,D0U1WP,MV-CEA,Glioblastoma multiforme , Phase 1
23504,D0U1WU,ETBX-011 cancer vaccine,Solid tumour/cancer , Phase 1/2
23505,D0U1WU,ETBX-011 cancer vaccine,Colorectal cancer , Phase 1/2
23506,D0U1WU,ETBX-011 cancer vaccine,Pancreatic cancer , Phase 1/2
23507,D0U1WU,ETBX-011 cancer vaccine,Metastatic cancer , Phase 1
23508,D0U1XG,Long-acting hGH conjugate,Growth hormone deficiency , Phase 2
23509,D0U1ZD,Ioversol,Cardiovascular disease , Approved
23510,D0U1ZV,NERATINIB MALEATE,HER2/NEU overexpressing breast cancer , Approved
23511,D0U2BH,Epigallocatechin gallate,Hepatic fibrosis , Phase 3
23512,D0U2CB,Ibuproxam,Respiratory disease , Withdrawn from market
23513,D0U2CE,RM-131,Gastroparesis , Phase 3
23514,D0U2CE,RM-131,Cachexia , Phase 2
23515,D0U2CE,RM-131,Diabetic gastroparesis , Phase 2
23516,D0U2CT,EMITEFUR,Solid tumour/cancer , Discontinued in Preregistration
23517,D0U2CV,Trapidil,Coronary artery disease , Phase 4
23518,D0U2CV,Trapidil,Acute coronary syndrome , Phase 4
23519,D0U2CV,Trapidil,Multiple myeloma , Investigative
23520,D0U2DA,BNC-210,Anxiety disorder , Phase 2
23521,D0U2DH,CC-1088,Crohn disease , Phase 2
23522,D0U2DO,FP-1039,Endometrial cancer , Phase 2
23523,D0U2DO,FP-1039,Solid tumour/cancer , Phase 1b
23524,D0U2DY,Recombinant TSH superagonists,Thyroid cancer , Investigative
23525,D0U2EF,ACN-1052,Glaucoma/ocular hypertension , Investigative
23526,D0U2FD,HIV-PV,Human immunodeficiency virus infection , Investigative
23527,D0U2FN,Romazarit,Rheumatoid arthritis , Preclinical
23528,D0U2GT,SA3C,Solid tumour/cancer , Investigative
23529,D0U2JP,Sitagliptin,Type-2 diabetes , Approved
23530,D0U2JP,Sitagliptin,Peripheral arterial disease , Phase 1/2
23531,D0U2KX,Aloradine,Glioma , Phase 2
23532,D0U2MP,BP-Inter-014,Hepatitis B virus infection , Investigative
23533,D0U2OO,Buspirone,Anxiety disorder , Approved
23534,D0U2OQ,X-071-NAB,Arthritis , Investigative
23535,D0U2OS,GNE-652,Multiple myeloma , Investigative
23536,D0U2PS,HER2p63-71 peptide vaccine,Solid tumour/cancer , Phase 1
23537,D0U2PU,Anti-BCMA CAR T cells,Multiple myeloma , Phase 1
23538,D0U2PY,UTI vaccine,Urinary tract infection , Phase 1
23539,D0U2QI,METH-mab,Methamphetamine dependence , Phase 1
23540,D0U2QX,4-ethynyl-2-fluoro-deoxyadenosine,Human immunodeficiency virus-1 infection , Investigative
23541,D0U2RR,NLP-83,Solid tumour/cancer , Investigative
23542,D0U2TQ,CGP-60474,Solid tumour/cancer , Terminated
23543,D0U2TZ,NYX-2925,Peripheral neuropathy , Phase 2
23544,D0U2TZ,NYX-2925,Fibromyalgia , Phase 2
23545,D0U2WO,ONO-2231,Cerebrovascular ischaemia , Discontinued in Phase 1
23546,D0U2XB,PGC GLP-1,Diabetic complication , Investigative
23547,D0U2XU,XEN-2174,Cancer related pain , Phase 2
23548,D0U3AL,Interleukin-12 gene therapy,Merkel cell carcinoma , Phase 2
23549,D0U3AL,Interleukin-12 gene therapy,Melanoma , Phase 2
23550,D0U3AL,Interleukin-12 gene therapy,Cutaneous T-cell lymphoma , Phase 2
23551,D0U3CR,Guanadrel Sulfate,Hypertension , Approved
23552,D0U3DE,NT-FV-007,Motor neurone disease , Investigative
23553,D0U3DP,VS-5584,Solid tumour/cancer , Phase 1
23554,D0U3DP,VS-5584,Malignant mesothelioma , Phase 1
23555,D0U3DU,Dexmedetomidine,Irritability , Approved
23556,D0U3DX,Mannose phosphate,Lesion , Discontinued in Phase 2
23557,D0U3EA,BVT 933,Obesity , Investigative
23558,D0U3EC,Benazepril,Hypertension , Approved
23559,D0U3ED,E-2007,Diabetic neuropathy , Approved
23560,D0U3ED,E-2007,Parkinson disease , Discontinued in Phase 3
23561,D0U3EP,Resveratrol,Giant cell arteritis , Phase 3
23562,D0U3EP,Resveratrol,Rheumatoid arthritis , Phase 3
23563,D0U3EP,Resveratrol,Systemic sclerosis , Phase 3
23564,D0U3EP,Resveratrol,Colorectal cancer , Discontinued in Phase 2
23565,D0U3FP,Her-2/neu vaccine,Ovarian cancer , Phase 1/2
23566,D0U3GA,SPC5001,Hyperlipidaemia , Phase 1
23567,D0U3GB,LIQ-001,Influenza virus infection , Phase 2
23568,D0U3GL,Oxandrolone,Alcoholic hepatitis , Approved
23569,D0U3GT,MK-8342B,Contraception , Phase 2
23570,D0U3GW,PXVX0047,Adenovirus infection , Phase 1
23571,D0U3IG,Cetrimide,Skin infection , Approved
23572,D0U3IS,Benzonaphthyridine derivative 1,Solid tumour/cancer , Patented
23573,D0U3IS,Benzonaphthyridine derivative 1,Metastatic cancer , Patented
23574,D0U3JZ,PMX-30024,Mycobacterium infection , Investigative
23575,D0U3KP,HT-100,Duchenne dystrophy , Phase 2
23576,D0U3LK,Metformin glycinate,Type-2 diabetes , Phase 2/3
23577,D0U3LS,Triazolam,Insomnia , Approved
23578,D0U3MQ,UX001 sialic acid,Hereditary inclusion body myositis , Phase 2
23579,D0U3OY,Rovelizumab,Cerebrovascular disease , Terminated
23580,D0U3QK,OMS824,Huntington disease , Phase 2
23581,D0U3RD,"Pyrido[3,2-d]pyrimidine derivative 3",Pruritus , Patented
23582,D0U3RD,"Pyrido[3,2-d]pyrimidine derivative 3",Solid tumour/cancer , Patented
23583,D0U3RD,"Pyrido[3,2-d]pyrimidine derivative 3",Chronic pain , Patented
23584,D0U3RD,"Pyrido[3,2-d]pyrimidine derivative 3",Neuropathic pain , Patented
23585,D0U3RD,"Pyrido[3,2-d]pyrimidine derivative 3",Thymic cancer , Patented
23586,D0U3RM,AL-508,Central nervous system disease , Investigative
23587,D0U3RU,MK-1107,Human immunodeficiency virus infection , Investigative
23588,D0U3RV,Motexafin lutetium,Artery stenosis , Phase 3
23589,D0U3SK,Tiapamil,Cardiovascular disease , Investigative
23590,D0U3SY,Alectinib,Lung cancer , Approved
23591,D0U3SY,Alectinib,Non-small-cell lung cancer , Phase 2
23592,D0U3TE,J-555Y,Atopic dermatitis , Investigative
23593,D0U3UJ,CHT-25,Hodgkin lymphoma , Phase 1
23594,D0U3VH,STEBVax,Endotoxic shock , Phase 1
23595,D0U3VH,STEBVax,Toxic shock syndrome , Phase 1
23596,D0U3VU,Aminoazetidine derivative 9,Obesity , Patented
23597,D0U3XI,FT-061,Fibrosis , Investigative
23598,D0U3XL,JNJ-26483327,Solid tumour/cancer , Phase 1
23599,D0U3YB,Masoprocol,Prostate cancer , Approved
23600,D0U3YU,Ademetionine,Hepatic fibrosis , Approved
23601,D0U3YU,Ademetionine,Cerebrovascular ischaemia , Phase 4
23602,D0U3YW,ADC-9971,Allergic rhinitis , Investigative
23603,D0U3YY,"Pyrano[2,3-b]pyridine derivative 2",Obesity , Patented
23604,D0U4CE,Bosentan,Pulmonary arterial hypertension , Approved
23605,D0U4EU,SB-743921,Solid tumour/cancer , Phase 2
23606,D0U4FF,BMS-599626,Solid tumour/cancer , Phase 2
23607,D0U4FW,DU 125530,Mood disorder , Discontinued in Phase 2
23608,D0U4GL,GLWL-01,Type-2 diabetes , Phase 1
23609,D0U4HZ,Bilive,Hepatitis B virus infection , Approved
23610,D0U4IG,AVP-4,Solid tumour/cancer , Investigative
23611,D0U4IV,Elfamycin,Enterocolitis , Investigative
23612,D0U4JX,Padoporfin photodynamic therapy,Prostate cancer , Phase 1/2
23613,D0U4JY,Protease activated prodrug,Solid tumour/cancer , Investigative
23614,D0U4KJ,MTV273,Multiple myeloma , Phase 1
23615,D0U4LP,Curcumin-ND,Mantle cell lymphoma , Investigative
23616,D0U4PG,AEOL-11207,Asthma , Investigative
23617,D0U4QQ,TNFcept,Rheumatoid arthritis , Investigative
23618,D0U4QZ,EU-517,Solid tumour/cancer , Investigative
23619,D0U4SM,NASVAC,Hepatitis B virus infection , Phase 3
23620,D0U4SS,CD-160130,Chronic lymphocytic leukaemia , Investigative
23621,D0U4UQ,Hydrochlorothiazide,Hypertension , Approved
23622,D0U4VT,Trimethadione,Pancreatic cancer , Approved
23623,D0U4VT,Trimethadione,Epilepsy , Approved
23624,D0U4WB,TLC-C-53,Respiratory distress syndrome , Terminated
23625,D0U4WF,HCG contraceptive vaccine,Contraception , Terminated
23626,D0U4WG,SLV-307,Parkinson disease , Terminated
23627,D0U4WY,BILD-1357,Herpes simplex virus infection , Terminated
23628,D0U4XC,Carticel,Articular cartilage disorder , Approved
23629,D0U4XJ,Luliconazole,Tinea pedis , Approved
23630,D0U4XJ,Luliconazole,Dry eye disease , Phase 2/3
23631,D0U4YD,YKP10461,Parkinson disease , Phase 1
23632,D0U4YG,Penicillin G Benzathine,Bacterial infection , Approved
23633,D0U5AN,ImmuFact IMP321,Melanoma , Phase 1/2
23634,D0U5AQ,ATLCAR.CD30.CCR4 cells,Immune System disease , Phase 1
23635,D0U5AQ,ATLCAR.CD30.CCR4 cells,Immunoproliferative disorder , Phase 1
23636,D0U5AQ,ATLCAR.CD30.CCR4 cells,Lymphatic disease , Phase 1
23637,D0U5AQ,ATLCAR.CD30.CCR4 cells,Lymphoma , Phase 1
23638,D0U5AQ,ATLCAR.CD30.CCR4 cells,Neoplasm , Phase 1
23639,D0U5BF,ALPHA-FMH,Pruritus , Phase 1
23640,D0U5BV,AKT-10082,Vibrio cholerae infection , Investigative
23641,D0U5CE,Capsaicin,Neuropathic pain , Approved
23642,D0U5CQ,PMID25666693-Compound-54,Osteoarthritis pain , Patented
23643,D0U5CQ,PMID25666693-Compound-54,Cancer related pain , Patented
23644,D0U5CQ,PMID25666693-Compound-54,Neuropathic pain , Patented
23645,D0U5CQ,PMID25666693-Compound-54,Inflammatory pain , Patented
23646,D0U5CS,LY354740,Anxiety disorder , Discontinued in Phase 2
23647,D0U5EU,SC-45662,Asthma , Discontinued in Phase 2
23648,D0U5EY,Org-37684,Anxiety disorder , Terminated
23649,D0U5FF,Leuprolide,Prostate cancer , Approved
23650,D0U5FS,Fluspirilene,Schizophrenia , Approved
23651,D0U5GB,Lopinavir,Human immunodeficiency virus infection , Approved
23652,D0U5GI,RP-66784,Angina pectoris , Terminated
23653,D0U5GU,PMID26815044-Compound-125,Albinism , Patented
23654,D0U5GU,PMID26815044-Compound-125,Ephelides , Patented
23655,D0U5GU,PMID26815044-Compound-125,Menkes disease , Patented
23656,D0U5GU,PMID26815044-Compound-125,Senile lentigines , Patented
23657,D0U5GU,PMID26815044-Compound-125,Melasma , Patented
23658,D0U5GX,CXB-724,Anxiety disorder , Investigative
23659,D0U5GZ,Zadaxin/transarterial chemoembolization(TACE) (cisplatin),Hepatitis virus infection , Phase 3
23660,D0U5HB,Thiazole carboxamide derivative 5,Solid tumour/cancer , Patented
23661,D0U5HB,Thiazole carboxamide derivative 5,Metastatic cancer , Patented
23662,D0U5HU,Cisplatin,Solid tumour/cancer , Approved
23663,D0U5HU,Cisplatin,Osteosarcoma , Phase 2
23664,D0U5HY,Anti-TAG-72 antibody,Solid tumour/cancer , Investigative
23665,D0U5JJ,KT-105,Solid tumour/cancer , Investigative
23666,D0U5JP,MEM-3454,Schizophrenia , Phase 2
23667,D0U5JR,H7N3 avian influenza virus live attenuated vaccine,Influenza virus infection , Phase 1
23668,D0U5NO,CAR-CD19 T cell,B-cell lymphoma , Clinical trial
23669,D0U5NO,CAR-CD19 T cell,leukaemia , Clinical trial
23670,D0U5NU,GLENVASTATIN,Hyperlipidaemia , Discontinued in Phase 2
23671,D0U5NW,BVT-24834,Obesity , Terminated
23672,D0U5NY,JTT-553,Obesity , Discontinued in Phase 1
23673,D0U5OB,Charybdotoxin,Scorpion envenoming syndrome , Approved
23674,D0U5OE,Loxapine,Schizophrenia , Approved
23675,D0U5ON,PMID25666693-Compound-125,Osteoarthritis pain , Patented
23676,D0U5ON,PMID25666693-Compound-125,Cancer related pain , Patented
23677,D0U5ON,PMID25666693-Compound-125,Neuropathic pain , Patented
23678,D0U5ON,PMID25666693-Compound-125,Inflammatory pain , Patented
23679,D0U5OU,Naproxcinod,Inflammation , Phase 3
23680,D0U5PR,Seridopidine,Neurological disorder , Terminated
23681,D0U5PT,GS-9901,Haematological malignancy , Phase 1
23682,D0U5QK,Acetaminophen,Pain , Approved
23683,D0U5RT,Primidone,Epilepsy , Approved
23684,D0U5SC,CT-102,Diabetic foot ulcer , Approved
23685,D0U5SI,Procainamide,Ventricular arrhythmias , Approved
23686,D0U5SU,FM-301,Psoriasis vulgaris , Investigative
23687,D0U5UC,KD025,Rheumatoid arthritis , Phase 2
23688,D0U5UC,KD025,Psoriasis vulgaris , Phase 2
23689,D0U5UC,KD025,Psoriatic arthritis , Phase 1
23690,D0U5UC,KD025,Scleroderma , Phase 1
23691,D0U5UC,KD025,Systemic lupus erythematosus , Phase 1
23692,D0U5VM,HBN-1,Neurological disorder , Investigative
23693,D0U5VX,Human AM/AMBP-1,Ischemia , Investigative
23694,D0U5VZ,Bepotastine,Allergic rhinitis , Approved
23695,D0U5WB,Alpha-type-1 polarized dendritic cells,Chronic lymphocytic leukaemia , Investigative
23696,D0U5XI,PMID28270021-Compound-WO2015042088Example11,Pruritus , Patented
23697,D0U5XI,PMID28270021-Compound-WO2015042088Example11,Solid tumour/cancer , Patented
23698,D0U5XI,PMID28270021-Compound-WO2015042088Example11,Chronic pain , Patented
23699,D0U5XI,PMID28270021-Compound-WO2015042088Example11,Neuropathic pain , Patented
23700,D0U5XI,PMID28270021-Compound-WO2015042088Example11,Thymic cancer , Patented
23701,D0U5YJ,14F7 humanized mab,Solid tumour/cancer , Investigative
23702,D0U5YM,ONO-6950,Asthma , Phase 2
23703,D0U5YW,Travoprost punctal plug,Glaucoma/ocular hypertension , Phase 2
23704,D0U5ZV,AT-3375,Parkinson disease , Investigative
23705,D0U6AI,I-A09,Mycobacterium infection , Investigative
23706,D0U6AL,BI-L-357,Asthma , Terminated
23707,D0U6BB,L-703014,Thrombosis , Terminated
23708,D0U6BJ,Desoxyribonuclease,Female genital tract inflammation , Approved
23709,D0U6BQ,Anti-VEGFR2 CD8 cell therapy,Solid tumour/cancer , Phase 1/2
23710,D0U6CL,CC-10015,Systemic sclerosis , Phase 1
23711,D0U6DC,PF-4967544,Renal failure , Discontinued in Phase 1
23712,D0U6DZ,L-erythro-3-hydroxyaspartate,Neurodegenerative disorder , Investigative
23713,D0U6EX,Quadracel,leukaemia , Approved
23714,D0U6FT,GSI-136,Alzheimer disease , Phase 1
23715,D0U6KH,Figitumumab,Malignant adrenal gland cancer , Discontinued in Phase 1
23716,D0U6LM,Midazolam,Irritability , Approved
23717,D0U6LM,Midazolam,Epilepsy , Phase 3
23718,D0U6ML,CKD602,Solid tumour/cancer , Phase 2
23719,D0U6NC,PJ-016,Psychotic disorder , Investigative
23720,D0U6NV,ISIS-1082,Virus infection , Terminated
23721,D0U6PA,"Pyrazolo[1,5-a]pyrimidine derivative 9",Obesity , Patented
23722,D0U6PJ,PC-SOD,Interstitial lung disease , Phase 2
23723,D0U6PK,ACY-001,Coronary ischemia , Phase 1
23724,D0U6PZ,VS1-011,Solid tumour/cancer , Investigative
23725,D0U6QN,ACH-3102,Hepatitis C virus infection , Phase 2
23726,D0U6RP,AL-072,Legionella infection , Terminated
23727,D0U6TV,UltraGITRL,Solid tumour/cancer , Investigative
23728,D0U6UK,Tabalumab,Multiple myeloma , Phase 3
23729,D0U6WC,RM-4864,Hepatitis C virus infection , Investigative
23730,D0U6WQ,PRALNACASAN,Rheumatoid arthritis , Phase 2
23731,D0U6XE,PAN-90806,Solid tumour/cancer , Phase 1
23732,D0U6XE,PAN-90806,Diabetic retinopathy , Phase 1
23733,D0U7AH,NurOwn,Amyotrophic lateral sclerosis , Phase 3
23734,D0U7BW,Carbachol,Glaucoma/ocular hypertension , Approved
23735,D0U7CO,CRE-319M2,Ischemic heart disease , Discontinued in Phase 1
23736,D0U7CP,KX-03,Autoimmune diabetes , Investigative
23737,D0U7DI,SM-10661,Sepsis , Discontinued in Phase 2
23738,D0U7GA,Recombinant human fibrinogen,Wound healing , Investigative
23739,D0U7GE,KUR-116,Spinal disease , Investigative
23740,D0U7GK,Thalidomide,Multiple myeloma , Approved
23741,D0U7GP,RAUWOLFIA SERPENTINA ROOT,Discovery agent , Approved
23742,D0U7GW,PF-431499,Obesity , Discontinued in Phase 1
23743,D0U7HD,SQ-33961,Thrombosis , Terminated
23744,D0U7HJ,Certoparin sodium,Deep vein thrombosis , Approved
23745,D0U7HL,N-5984,Type-2 diabetes , Phase 2
23746,D0U7HL,N-5984,Obesity , Phase 2
23747,D0U7IG,SD-281,Inflammation , Investigative
23748,D0U7IL,LX-4211,Type-2 diabetes , Phase 3
23749,D0U7IL,LX-4211,Cardiovascular disease , Phase 3
23750,D0U7IL,LX-4211,Type-1 diabetes , Phase 3
23751,D0U7KM,Boostrix,Bordetella pertussis infection , Approved
23752,D0U7KR,FR-118487,Solid tumour/cancer , Terminated
23753,D0U7LW,Thiazole carboxamide derivative 26,Solid tumour/cancer , Patented
23754,D0U7LW,Thiazole carboxamide derivative 26,Metastatic cancer , Patented
23755,D0U7NG,BAY 86-8050,Heart failure , Phase 1
23756,D0U7OS,CARD-024,Cardiovascular disease , Phase 1
23757,D0U7PM,OPL-CCL2-LPM,Arthritis , Phase 1
23758,D0U7PS,GSK256066,Asthma , Discontinued in Phase 2
23759,D0U7SH,Desmopressin,Diabetic complication , Approved
23760,D0U7SR,RO-4998452,Type-2 diabetes , Phase 2
23761,D0U7SU,Interferon-alpha lozenge,Fibromyalgia , Phase 2
23762,D0U7SU,Interferon-alpha lozenge,Chronic obstructive pulmonary disease , Phase 2
23763,D0U7SU,Interferon-alpha lozenge,Behcet disease , Phase 2
23764,D0U7VO,CNS-1307,Schizophrenia , Terminated
23765,D0U7VS,CAR-T cells targeting CD19,Lymphoma , Phase 1
23766,D0U7VU,MLN0264,Gastrointestinal cancer , Phase 2
23767,D0U7VZ,TD-2749,Gastrointestinal disease , Discontinued in Phase 1
23768,D0U7WF,"16,16-dimethyl-PGE2",Stem cell engraftment , Phase 2
23769,D0U7WN,A-80987,Human immunodeficiency virus infection , Discontinued in Phase 1
23770,D0U7WY,Anti-CD19/BCMA CAR-T cells,Multiple myeloma , Phase 1
23771,D0U7XJ,BCA101,Solid tumour/cancer , Phase 1
23772,D0U7ZY,SP-MET-1,Breast cancer , Preclinical
23773,D0U8AD,TLV-1,Erectile dysfunction , Investigative
23774,D0U8AR,DMP-851,Human immunodeficiency virus infection , Discontinued in Phase 1
23775,D0U8AS,Telapristone,Endometriosis , Phase 2
23776,D0U8AT,Echothiophate Iodide,Chronic glaucoma , Approved
23777,D0U8CR,S-06911,Osteoporosis , Phase 3
23778,D0U8EA,S-41744,Major depressive disorder , Investigative
23779,D0U8FG,APS-001,Solid tumour/cancer , Phase 1/2
23780,D0U8GH,LPCN-1056,Asthma , Investigative
23781,D0U8IJ,SDZ-PCO-400,Asthma , Discontinued in Phase 1
23782,D0U8IU,PerioPatch,Periodontal disease , Phase 2
23783,D0U8JN,Pegaspargase,Solid tumour/cancer , Approved
23784,D0U8KA,CGP-43371,Arteriosclerosis , Terminated
23785,D0U8LD,MGN-1706,Solid tumour/cancer , Phase 1
23786,D0U8MF,Theradigm-HPV,Carcinoma , Discontinued in Phase 2
23787,D0U8OD,CIMICOXIB,Pain , Phase 2
23788,D0U8PE,CAR19 T cells carrying cytoplasmic activated PD-1,Non-hodgkin lymphoma , Phase 1
23789,D0U8PR,HPP-593,Dyslipidemia , Phase 1
23790,D0U8PR,HPP-593,Diabetic complication , Phase 1
23791,D0U8QB,JTT-851,Type-2 diabetes , Phase 2
23792,D0U8QC,AS-210,Psoriasis vulgaris , Phase 1/2
23793,D0U8QH,GDC-0349,Non-hodgkin lymphoma , Phase 1
23794,D0U8TW,APV-001,Virus infection , Investigative
23795,D0U8US,Interferon gamma-1b,Chronic granulomatous disease , Approved
23796,D0U8UV,Dimenhydrinate,Nausea , Approved
23797,D0U8VO,Lopinavir + ritonavir + interferon beta-1b,Middle East Respiratory Syndrome (MERS) , Phase 2/3
23798,D0U8WW,NLCQ-1,Solid tumour/cancer , Investigative
23799,D0U8XD,KIN-806,Solid tumour/cancer , Terminated
23800,D0U8XE,Bemcentinib,Non-small-cell lung cancer , Phase 2
23801,D0U8XE,Bemcentinib,Myelodysplastic syndrome , Phase 2
23802,D0U8XE,Bemcentinib,Triple negative breast cancer , Phase 2
23803,D0U8XW,APX-3330,Solid tumour/cancer , Phase 1
23804,D0U8XW,APX-3330,Ocular cancer , Discontinued in Phase 2
23805,D0U8YK,NN5401,Diabetic complication , Phase 3
23806,D0U8YZ,PMID25666693-Compound-45,Osteoarthritis pain , Patented
23807,D0U8YZ,PMID25666693-Compound-45,Cancer related pain , Patented
23808,D0U8YZ,PMID25666693-Compound-45,Neuropathic pain , Patented
23809,D0U8YZ,PMID25666693-Compound-45,Inflammatory pain , Patented
23810,D0U8ZD,OPT-822/OPT-821,Breast cancer , Phase 3
23811,D0U9AE,AIKa1,Osteoarthritis , Investigative
23812,D0U9EN,Actimmune,Idiopathic pulmonary fibrosis , Approved
23813,D0U9EN,Actimmune,Cystic fibrosis , Approved
23814,D0U9EN,Actimmune,Hepatic fibrosis , Approved
23815,D0U9EN,Actimmune,Friedreich's ataxia , Phase 3
23816,D0U9EN,Actimmune,Solid tumour/cancer , Phase 1
23817,D0U9FD,Trospium chloride,Discovery agent , Approved
23818,D0U9FJ,KA-40X,Solid tumour/cancer , Investigative
23819,D0U9GZ,"Recombinant protein subunit vaccine, Emergent",Infectious disease , Preclinical
23820,D0U9HM,GSK-1322888,Gastroparesis , Phase 1
23821,D0U9IQ,PF-477736,Advanced solid tumour , Discontinued in Phase 1
23822,D0U9IZ,Alkaline Phosphatase,Ulcerative colitis , Phase 2
23823,D0U9JL,LY-223982,Asthma , Discontinued in Phase 2
23824,D0U9LL,NKS-01,Bladder cancer , Discontinued in Phase 2
23825,D0U9LT,Y-39983,Glaucoma/ocular hypertension , Phase 1/2
23826,D0U9LV,LY-2428757,Type-2 diabetes , Phase 2
23827,D0U9MJ,Melanoma vaccine,Melanoma , Phase 3
23828,D0U9MN,ACAM-Cdiff,Traveler's diarrhea , Phase 2
23829,D0U9MN,ACAM-Cdiff,Clostridium infection , Phase 2
23830,D0U9MR,Tilidine,Pain , Approved
23831,D0U9NN,OG987SC,Type-2 diabetes , Phase 1
23832,D0U9OC,ASP8374,Solid tumour/cancer , Phase 1
23833,D0U9OD,CreaVax-RA,Rheumatoid arthritis , Phase 2a
23834,D0U9OJ,GSK-326416,Gastroparesis , Preclinical
23835,D0U9PV,CXB-909,Neurodegenerative disorder , Phase 1/2
23836,D0U9QT,UMN-03,Metabolic disorder , Investigative
23837,D0U9QU,Ibopamine hci,Cardiac disease , Approved
23838,D0U9RR,Quinoxaline,Arteriosclerosis , Preclinical
23839,D0U9SM,OX-641,Migraine , Terminated
23840,D0U9TM,Ponalrestat,Gout , Discontinued in Phase 3
23841,D0U9TM,Ponalrestat,Diabetic complication , Investigative
23842,D0U9UF,A-967079,Pain , Investigative
23843,D0U9VO,PF-2575799,Diabetic complication , Discontinued in Phase 1
23844,D0U9WS,LEO-32731,Plaque psoriasis , Phase 2
23845,D0U9WS,LEO-32731,Psoriasis vulgaris , Phase 1
23846,D0U9YV,PAT-PM-1,Pancreatic cancer , Investigative
23847,D0UA0I,Metergolin,Hyperprolactinaemia , Approved
23848,D0UA0U,CAR-T cells targeting CD30,leukaemia , Phase 1/2
23849,D0UA0U,CAR-T cells targeting CD30,Lymphoma , Phase 1/2
23850,D0UA0U,CAR-T cells targeting CD30,Multiple myeloma , Phase 1/2
23851,D0UA0Y,HKI-46F08,Solid tumour/cancer , Investigative
23852,D0UA2Z,Epicillin,Bacterial infection , Approved
23853,D0UA6W,Pyrazole derivative 33,Obesity , Patented
23854,D0UA9J,VT-1129,Onchocerciasis , Phase 2
23855,D0UA9J,VT-1129,Onychomycosis , Phase 2
23856,D0UA9J,VT-1129,Cryptococcal meningitis infection , Phase 1
23857,D0UB0T,PD176078,Pain , Investigative
23858,D0UB1J,BRL-44385,Virus infection , Terminated
23859,D0UB5A,IC14,Sepsis , Phase 2
23860,D0UB8U,Alkyl mannoside derivative 6,Crohn disease , Patented
23861,D0UB8U,Alkyl mannoside derivative 6,Ulcerative colitis , Patented
23862,D0UB8U,Alkyl mannoside derivative 6,Urinary tract infection , Patented
23863,D0UC5C,DP-1038,Neuroendocrine cancer , Phase 1
23864,D0UC5G,MBN-101,Diabetic foot ulcer , Phase 2
23865,D0UC6H,Chlamydocin,Solid tumour/cancer , Preclinical
23866,D0UD1J,EDP1066,Atopic dermatitis , Phase 1
23867,D0UD1J,EDP1066,Psoriasis vulgaris , Phase 1
23868,D0UD1Y,Neladenoson bialanate,Chronic heart failure , Phase 2
23869,D0UD4Y,PQ-912,Dementia , Phase 2
23870,D0UD5P,BPR-DC-2,Solid tumour/cancer , Investigative
23871,D0UD6S,NY-ESO-1/LAGE-1-specific T-cells,Sarcoma , Phase 1/2
23872,D0UD6X,Imidazopyridazine derivative 3,Pain , Patented
23873,D0UD6X,Imidazopyridazine derivative 3,Inflammation , Patented
23874,D0UE3F,Biphenyl mannoside derivative 28,Crohn disease , Patented
23875,D0UE3F,Biphenyl mannoside derivative 28,Ulcerative colitis , Patented
23876,D0UE3F,Biphenyl mannoside derivative 28,Urinary tract infection , Patented
23877,D0UE8P,Recombinant grass pollen allergens,Allergic rhinitis , Phase 3
23878,D0UE9K,PMID25666693-Compound-83,Osteoarthritis pain , Patented
23879,D0UE9K,PMID25666693-Compound-83,Cancer related pain , Patented
23880,D0UE9K,PMID25666693-Compound-83,Neuropathic pain , Patented
23881,D0UE9K,PMID25666693-Compound-83,Inflammatory pain , Patented
23882,D0UE9X,Gamolenic acid,Allergy , Approved
23883,D0UF0N,ACP-319,Chronic lymphocytic leukaemia , Phase 1/2
23884,D0UF1D,RG7986,Non-hodgkin lymphoma , Phase 1
23885,D0UF2N,DIADENOSINE TETRAPHOSPHATE,Cardiac arrhythmias , Phase 2
23886,D0UF5I,MPC-0920,Thrombosis , Discontinued in Phase 1
23887,D0UF6M,Thiacetazone,Mycobacterium infection , Approved
23888,D0UF8E,XOMA-629,Acne vulgaris , Phase 2
23889,D0UF8M,IMO-9200,Autoimmune disease , Phase 1
23890,D0UF9W,Pegaptanib,Neovascular age-related macular degeneration , Approved
23891,D0UG0K,Trastuzumab emtansine,HER2-positive breast cancer , Phase 3
23892,D0UG0K,Trastuzumab emtansine,Breast cancer , Phase 2
23893,D0UG3Q,VBP-245,Molluscum contagiosum infection , Phase 2
23894,D0UG4P,Egaptivon pegol,Thrombosis , Discontinued in Phase 2
23895,D0UG4T,CDP840,Chronic obstructive pulmonary disease , Discontinued in Phase 2
23896,D0UG9S,Biphenyl mannoside derivative 7,Crohn disease , Patented
23897,D0UG9S,Biphenyl mannoside derivative 7,Ulcerative colitis , Patented
23898,D0UG9S,Biphenyl mannoside derivative 7,Urinary tract infection , Patented
23899,D0UH0S,H1N1 influenza vaccine,Influenza virus infection , Approved
23900,D0UH4P,Vasculan,Systemic sclerosis , Phase 2
23901,D0UH4T,GW-493838,Neuropathic pain , Discontinued in Phase 2
23902,D0UH7R,Etrolizumab,Crohn disease , Phase 3
23903,D0UH7R,Etrolizumab,Ulcerative colitis , Phase 3
23904,D0UI0B,VTX-763,Autoimmune diabetes , Investigative
23905,D0UI0I,BL-3010,Pain , Phase 1/2
23906,D0UI3T,Elagolix,Uterine fibroids , Phase 3
23907,D0UI3Z,H1N1 influenza A inactivated split virion vaccine,Influenza virus infection , Phase 3
23908,D0UI4K,VB4-847,Squamous cell carcinoma , Phase 2
23909,D0UI4L,ND-0801,Attention deficit hyperactivity disorder , Phase 1/2
23910,D0UI4S,PF-3475952,Solid tumour/cancer , Investigative
23911,D0UI7K,Emapalumab,Primary haemophagocytic lymphohistiocytosis , Approved
23912,D0UI8K,Apogen MS,Multiple sclerosis , Discontinued in Phase 1
23913,D0UI8Y,Encapsulated human islet allografts,Type-1 diabetes , Phase 1/2
23914,D0UJ3C,CD38-specific gene-engineered T cells,Acute myeloid leukaemia , Phase 1/2
23915,D0UJ8E,Sch-49209,Solid tumour/cancer , Terminated
23916,D0UJ9N,Promethazine,Severe acute respiratory syndrome (SARS) , Investigative
23917,D0UJ9N,Promethazine,Middle East Respiratory Syndrome (MERS) , Investigative
23918,D0UK1L,EP-217609,Thrombosis , Phase 2
23919,D0UK1Q,Prosaptide TX14(A),Neuropathic pain , Phase 2
23920,D0UK1S,PMID26651364-Compound-126a,Crohn disease , Patented
23921,D0UK1S,PMID26651364-Compound-126a,Ulcerative colitis , Patented
23922,D0UK1S,PMID26651364-Compound-126a,Urinary tract infection , Patented
23923,D0UK2N,CMT-02,Charcot marie tooth disease , Phase 3
23924,D0UK2Z,Vitespen,Renal cell carcinoma , Phase 3
23925,D0UK2Z,Vitespen,Recurrent glioblastoma , Phase 2
23926,D0UK3A,Hydroxychloroquine,Malaria , Approved
23927,D0UK3A,Hydroxychloroquine,Coronavirus Disease 2019 (COVID-19) , Phase 3
23928,D0UK7B,REGN1400,Solid tumour/cancer , Phase 1
23929,D0UK7Z,Emetine hydrochloride,Middle East Respiratory Syndrome (MERS) , Investigative
23930,D0UL0R,BK-C-0701,Diabetic neuropathy , Phase 3
23931,D0UL2I,PF-06427878,Hyperlipidaemia , Phase 1
23932,D0UL2I,PF-06427878,Cardiovascular disease , Phase 1
23933,D0UL2L,Lornoxicam,Migraine , Approved
23934,D0UL2X,CC-90010,Non-hodgkin lymphoma , Phase 1
23935,D0UL2X,CC-90010,Solid tumour/cancer , Phase 1
23936,D0UL5X,SK-7041,Solid tumour/cancer , Preclinical
23937,D0UL7L,Recombinant human Erbb3 fragment therapeutic tumor vaccine,Solid tumour/cancer , Phase 1
23938,D0UL9R,Tesamorelin,HIV-associated lipodystrophy , Approved
23939,D0UM1Y,SNX-2,Human immunodeficiency virus infection , Investigative
23940,D0UM3M,AQST-120,LennoxGastaut syndrome , Application submitted
23941,D0UM4S,ASG-15ME,Bladder cancer , Phase 1
23942,D0UM4S,ASG-15ME,Urothelial carcinoma , Phase 1
23943,D0UM7H,BIA-12,Cardiovascular disease , Investigative
23944,D0UM7O,Ketamine,Anaesthesia , Approved
23945,D0UM8Q,UCART019,B-cell lymphoma , Phase 1/2
23946,D0UM8Q,UCART019,leukaemia , Phase 1/2
23947,D0UN1S,Tigapotide,Prostate cancer , Phase 1
23948,D0UN4M,Six-membered heterocyclic benzamide derivative 5,Pruritus , Patented
23949,D0UN4M,Six-membered heterocyclic benzamide derivative 5,Solid tumour/cancer , Patented
23950,D0UN4M,Six-membered heterocyclic benzamide derivative 5,Chronic pain , Patented
23951,D0UN4M,Six-membered heterocyclic benzamide derivative 5,Neuropathic pain , Patented
23952,D0UN4M,Six-membered heterocyclic benzamide derivative 5,Thymic cancer , Patented
23953,D0UN8H,IC261,Pancreatic cancer , Preclinical
23954,D0UN9X,Imidazopyridazine derivative 4,Pain , Patented
23955,D0UN9X,Imidazopyridazine derivative 4,Inflammation , Patented
23956,D0UO0C,MAK683,Diffuse large B-cell lymphoma , Phase 1/2
23957,D0UO2H,NMS-P715,Solid tumour/cancer , Investigative
23958,D0UO2N,BUTIXOCORT,Asthma , Discontinued in Phase 2
23959,D0UO2P,Avapritinib,Gastrointestinal stromal tumour , Approved
23960,D0UO2P,Avapritinib,Mast cell leukaemia , Phase 1
23961,D0UO2P,Avapritinib,Systemic mastocytosis , Phase 1
23962,D0UO4B,RQ-00000005,Frailty , Phase 2
23963,D0UO6M,ReN-004,Alzheimer disease , Investigative
23964,D0UO7V,DW-800,Mucositis , Investigative
23965,D0UO9R,RGX-202,Gastrointestinal cancer , Phase 1
23966,D0UO9T,VR-147,Migraine , Terminated
23967,D0UP0A,CAL-201,Metapneumovirus infection , Investigative
23968,D0UP1U,Recombinant plasmin,Cerebrovascular ischaemia , Investigative
23969,D0UP1Z,GDC-0032,Breast cancer , Phase 3
23970,D0UP1Z,GDC-0032,Solid tumour/cancer , Phase 2/3
23971,D0UP2Y,RVEc,Intoxication , Phase 1
23972,D0UP5N,PN-2107,Gout , Investigative
23973,D0UP9M,Gusperimus trihydrochloride,Immune System disease , Approved
23974,D0UQ1R,Eloctate,Haemophilia A , Approved
23975,D0UQ2G,Tri-substituted urea derivative 1,Pruritus , Patented
23976,D0UQ2G,Tri-substituted urea derivative 1,Solid tumour/cancer , Patented
23977,D0UQ2G,Tri-substituted urea derivative 1,Chronic pain , Patented
23978,D0UQ2G,Tri-substituted urea derivative 1,Neuropathic pain , Patented
23979,D0UQ2G,Tri-substituted urea derivative 1,Thymic cancer , Patented
23980,D0UQ5B,GSK-1437173A,Malaria , Phase 3
23981,D0UQ5I,Botulinum toxin vaccine,Yersinia infection , Phase 2
23982,D0UR1Z,OncoVAX,Melanoma , Preregistration
23983,D0UR1Z,OncoVAX,Colorectal cancer , Phase 3
23984,D0UR4K,Cenerimod,Systemic lupus erythematosus , Phase 2
23985,D0UR4L,SF-110,Inflammation , Investigative
23986,D0US1X,OCT-1547,Osteoporosis , Preclinical
23987,D0US3C,ZK-90695,Arthritis , Terminated
23988,D0US5I,C-linked disaccharide biphenyl mannoside derivative 2,Crohn disease , Patented
23989,D0US5I,C-linked disaccharide biphenyl mannoside derivative 2,Ulcerative colitis , Patented
23990,D0US5I,C-linked disaccharide biphenyl mannoside derivative 2,Urinary tract infection , Patented
23991,D0US8M,OX-CLI,Respiratory tract inflammation , Investigative
23992,D0UT0X,Aromatic hydrazine carboxyimidoamide derivative 2,Albinism , Patented
23993,D0UT0X,Aromatic hydrazine carboxyimidoamide derivative 2,Ephelides , Patented
23994,D0UT0X,Aromatic hydrazine carboxyimidoamide derivative 2,Menkes disease , Patented
23995,D0UT0X,Aromatic hydrazine carboxyimidoamide derivative 2,Senile lentigines , Patented
23996,D0UT0X,Aromatic hydrazine carboxyimidoamide derivative 2,Melasma , Patented
23997,D0UT3F,Nolpitantium besilate,Asthma , Discontinued in Phase 2
23998,D0UT4W,Zanubrutinib,Mantle cell lymphoma , Approved
23999,D0UT4W,Zanubrutinib,Chronic lymphocytic leukaemia , Phase 3
24000,D0UT4W,Zanubrutinib,Small lymphocytic lymphoma , Phase 3
24001,D0UT4W,Zanubrutinib,Waldenstrom macroglobulinemia , Phase 3
24002,D0UT4W,Zanubrutinib,B-cell lymphoma , Phase 1
24003,D0UT5A,SGN-CD19A,Diffuse large B-cell lymphoma , Phase 2
24004,D0UT5A,SGN-CD19A,Non-hodgkin lymphoma , Phase 1
24005,D0UT5A,SGN-CD19A,Acute lymphoblastic leukaemia , Phase 1
24006,D0UT7E,Lopinavir + ritonavir + favipiravir,Coronavirus Disease 2019 (COVID-19) , Phase 3
24007,D0UT7F,3K3A-APC,Cerebrovascular ischaemia , Phase 2
24008,D0UT7F,3K3A-APC,Ischemic stroke , Phase 2
24009,D0UT7X,Tideglusib,Osteosarcoma , Phase 2
24010,D0UT9H,Cyclohexyl carbamate derivative 5,Albinism , Patented
24011,D0UT9H,Cyclohexyl carbamate derivative 5,Ephelides , Patented
24012,D0UT9H,Cyclohexyl carbamate derivative 5,Menkes disease , Patented
24013,D0UT9H,Cyclohexyl carbamate derivative 5,Senile lentigines , Patented
24014,D0UT9H,Cyclohexyl carbamate derivative 5,Melasma , Patented
24015,D0UU1E,CC-100,Motor neurone disease , Phase 1
24016,D0UU1E,CC-100,Amyotrophic lateral sclerosis , Phase 1
24017,D0UU3J,RWJ-37868,Epilepsy , Terminated
24018,D0UU4B,CLS006,Verruca vulgaris , Phase 3
24019,D0UU4D,Peniel-5000,Autoimmune diabetes , Investigative
24020,D0UU9Y,Propentofylline propionate,Alzheimer disease , Approved
24021,D0UV2E,VOLT02,Traumatic brain injury , Phase 2
24022,D0UV4H,GSK-706769,Human immunodeficiency virus infection , Phase 2
24023,D0UV9F,GSK-894281,Gastric motility disorder , Investigative
24024,D0UW4A,Benzimate,Solid tumour/cancer , Phase 1
24025,D0UW7D,Varicella zoster virus vaccine live,Zoster , Approved
24026,D0UX0T,Milameline,Cognitive impairment , Discontinued in Phase 3
24027,D0UX2H,HG-1109,Solid tumour/cancer , Investigative
24028,D0UX2V,BMS-817399,Rheumatoid arthritis , Phase 2
24029,D0UX4A,HU-433,Osteoporosis , Investigative
24030,D0UX4J,Dimethoxybenzylidene-2-thio-imidazole-4-one derivative 1,Cerebral ischemia , Patented
24031,D0UX6Z,Heparin Sodium,Deep vein thrombosis , Approved
24032,D0UX6Z,Heparin Sodium,Coagulation defect , Approved
24033,D0UXJ2,Omidubicel,Hematologic tumour , Phase 3
24034,D0UY8U,SNX-002,Neurodegenerative disorder , Investigative
24035,D0UZ0X,ACH-2892,Infectious disease , Investigative
24036,D0UZ1I,S-33138,Psychotic disorder , Discontinued in Phase 1
24037,D0UZ2S,PMID26651364-Compound-6d,Crohn disease , Patented
24038,D0UZ2S,PMID26651364-Compound-6d,Ulcerative colitis , Patented
24039,D0UZ2S,PMID26651364-Compound-6d,Urinary tract infection , Patented
24040,D0UZ4G,99mTc-rBitistatin,Embolism , Phase 1/2
24041,D0V0AF,Seviprotimut-L,Melanoma , Phase 3
24042,D0V0AF,Seviprotimut-L,Merkel cell carcinoma , Phase 3
24043,D0V0AR,"HLA-A, B7.1-transfected adenocarcinoma vaccine",Solid tumour/cancer , Phase 2
24044,D0V0BD,GFT-1229,Diabetic complication , Investigative
24045,D0V0BO,Anti-FGFR3,Multiple myeloma , Phase 1
24046,D0V0CJ,CO-101,Pancreatic cancer , Phase 2
24047,D0V0DI,CT-2584,Solid tumour/cancer , Phase 3
24048,D0V0FQ,Brain derived neurotrophic factor,Amyotrophic lateral sclerosis , Discontinued in Phase 2
24049,D0V0HU,IFN alpha kinoid,Human immunodeficiency virus infection , Phase 1/2
24050,D0V0IO,NN9223,Type-2 diabetes , Discontinued in Phase 1
24051,D0V0IX,Epoprostenol,Pulmonary hypertension , Approved
24052,D0V0JQ,CHF 5407,Chronic obstructive pulmonary disease , Phase 1
24053,D0V0JR,Cadi-05,Prostate cancer , Phase 3
24054,D0V0JV,mabionHER2,Breast cancer , Investigative
24055,D0V0KJ,IDDBCP161883,Type-2 diabetes , Phase 3
24056,D0V0LB,Cysteamine,Nephropathic cystinosis , Approved
24057,D0V0NL,Aminoguanidine,Diabetic retinopathy , Phase 1
24058,D0V0NL,Aminoguanidine,Rheumatoid arthritis , Discontinued in Phase 2
24059,D0V0NL,Aminoguanidine,Insulin-resistant disorder , Discontinued in Phase 2
24060,D0V0OP,Polyphenon e,Perianal wart , Approved
24061,D0V0RW,BB-1433,Arthritis , Terminated
24062,D0V0RY,Factor ix human,Hemophilia , Approved
24063,D0V0SE,Alpha-Helical lipopeptides FFS,Middle East Respiratory Syndrome (MERS) , Preclinical
24064,D0V0SL,Abexinostat,Follicular lymphoma , Phase 3
24065,D0V0SL,Abexinostat,Renal cell carcinoma , Phase 3
24066,D0V0SL,Abexinostat,Acute myeloid leukaemia , Phase 2
24067,D0V0SL,Abexinostat,Breast cancer , Phase 2
24068,D0V0SL,Abexinostat,Diffuse large B-cell lymphoma , Phase 2
24069,D0V0SL,Abexinostat,Gynecologic cancer , Phase 2
24070,D0V0SL,Abexinostat,Peripheral T-cell lymphoma , Phase 2
24071,D0V0SL,Abexinostat,Solid tumour/cancer , Phase 2
24072,D0V0TT,CS-204,Metabolic disorder , Terminated
24073,D0V0UH,AMG 557,Systemic lupus erythematosus , Phase 2
24074,D0V0UH,AMG 557,Sjogren syndrome , Phase 2
24075,D0V0UW,Pyridotriazolopyrimidine derivative 2,Obesity , Patented
24076,D0V0UX,RVLYSIN,Solid tumour/cancer , Investigative
24077,D0V0VI,11C-AZD-2184,Alzheimer disease , Phase 1
24078,D0V0VR,CMVpp65-A0201,Cytomegalovirus infection , Phase 2
24079,D0V0WE,NIA-114,Plaque psoriasis , Clinical trial
24080,D0V0XV,FLU-v,Influenza virus infection , Phase 1
24081,D0V0YA,Veltuzumab/epratuzumab Y-90,Diffuse large B-cell lymphoma , Phase 1
24082,D0V0YH,Flu vaccine,Seasonal influenza infection , Approved
24083,D0V0YM,MK-5596,Obesity , Investigative
24084,D0V1AV,JNJ-61186372,Non-small-cell lung cancer , Phase 1
24085,D0V1BY,EPI-6,Gastrointestinal disease , Investigative
24086,D0V1CG,MLI-1018,Otitis media , Terminated
24087,D0V1DG,EG-Decorin,Ulcer , Investigative
24088,D0V1ES,ALM-301,Solid tumour/cancer , Investigative
24089,D0V1FF,Davunetide,Cognitive impairment , Phase 3
24090,D0V1FF,Davunetide,Alzheimer disease , Discontinued in Phase 2
24091,D0V1FP,RHB-104,Crohn disease , Phase 3
24092,D0V1GK,KB-5359,Lipid metabolism disorder , Terminated
24093,D0V1HK,Berlafenone,Heart arrhythmia , Terminated
24094,D0V1KA,MTL-104,Solid tumour/cancer , Investigative
24095,D0V1KD,ALT-022,Glaucoma/ocular hypertension , Investigative
24096,D0V1KP,N-acetylardeemin,Solid tumour/cancer , Investigative
24097,D0V1KS,AZD-2836,Hepatitis C virus infection , Phase 1/2
24098,D0V1NI,AM-66,Pain , Terminated
24099,D0V1NK,VER-54505,Solid tumour/cancer , Investigative
24100,D0V1OC,DA-3880,Anemia , Phase 1
24101,D0V1OG,Glycosaminoglycans,Inflammation , Investigative
24102,D0V1OY,BC-DU-04,Ulcer , Investigative
24103,D0V1QC,Ethacrynic,Edema , Approved
24104,D0V1QX,Axogenesis Factor-1,Cerebrovascular ischaemia , Investigative
24105,D0V1RX,Mivazerol,Angina pectoris , Discontinued in Phase 3
24106,D0V1SD,BP4.879a,Schizophrenia , Terminated
24107,D0V1TV,CGEN-991,Ovarian cancer , Investigative
24108,D0V1UQ,FT-101,Heart disease , Investigative
24109,D0V1UV,N-885,Solid tumour/cancer , Investigative
24110,D0V1UW,Nitisinone,Hereditary tyrosinemia type 1 , Approved
24111,D0V1UZ,BF/PC-21,Inflammation , Investigative
24112,D0V1VG,AMRS-001,Brain injury , Investigative
24113,D0V1WL,Debio-0826,Solid tumour/cancer , Investigative
24114,D0V1WQ,TAK-875,Type-2 diabetes , Phase 3
24115,D0V2CN,LAS-37779,Psoriasis vulgaris , Discontinued in Phase 2
24116,D0V2CO,ML SA1,Human immunodeficiency virus infection , Preclinical
24117,D0V2DC,ST-0703,Cardiovascular disease , Investigative
24118,D0V2DV,Sodium phosphate dibasic/sodium phosphate monobasic,Multiple sclerosis , Approved
24119,D0V2FZ,111In-hEGF,Breast cancer , Preclinical
24120,D0V2GH,Nicergoline,Brain ischaemia , Approved
24121,D0V2GH,Nicergoline,Senile dementia , Approved
24122,D0V2GT,BIBP 3226,Hypertension , Terminated
24123,D0V2GZ,BioVant,Vaccination , Investigative
24124,D0V2JK,Nomegestrol acetate,Breast cancer , Approved
24125,D0V2KD,CAT-3000,Cardiovascular disease , Investigative
24126,D0V2KE,Oralgen,Type-2 diabetes , Approved
24127,D0V2KR,Yttrium (90Y) clivatuzumab tetraxetan,Pancreatic cancer , Phase 3
24128,D0V2LL,PF-06873600,Breast cancer , Phase 1
24129,D0V2MB,GRNCHND-1,Arthropathy , Investigative
24130,D0V2NJ,Somatropin biosimilar,Growth hormone deficiency , Approved
24131,D0V2NK,Clade B HIV vaccine,Human immunodeficiency virus infection , Phase 1
24132,D0V2OL,NN1841,Hemophilia , Phase 3
24133,D0V2OS,DX-9065,Coagulation defect , Discontinued in Phase 2
24134,D0V2OX,Afamelanotide,Erythropoietic porphyrias , Approved
24135,D0V2OX,Afamelanotide,Vitiligo , Phase 2
24136,D0V2PG,ALD-701,Inflammation , Investigative
24137,D0V2PK,PHY-808,Solid tumour/cancer , Investigative
24138,D0V2QU,Anti-CD22/CD19 mab-toxin conjugate,Acute lymphoblastic leukaemia , Investigative
24139,D0V2RF,Shigella conjugated and outer membrane vaccine,Diarrhea , Phase 2
24140,D0V2RK,NKP-46,Solid tumour/cancer , Preclinical
24141,D0V2SP,INGN-225,Head and neck cancer , Phase 2
24142,D0V2WK,A-70826,Bacterial infection , Terminated
24143,D0V2WO,PC-DAC:Insulin,Type-1 diabetes , Phase 3
24144,D0V2WO,PC-DAC:Insulin,Type-2 diabetes , Phase 2
24145,D0V2YC,OC42-92,Solid tumour/cancer , Terminated
24146,D0V2YE,Vivia-009,Solid tumour/cancer , Investigative
24147,D0V2YJ,MK-0731,Solid tumour/cancer , Phase 1
24148,D0V2ZC,SEL24,Acute myeloid leukaemia , Phase 1/2
24149,D0V2ZH,PAV-611,Human immunodeficiency virus infection , Investigative
24150,D0V2ZJ,BCX-25,Arthritis , Terminated
24151,D0V3BI,Aom-0890,Erectile dysfunction , Investigative
24152,D0V3BS,AT-002,Autoimmune diabetes , Investigative
24153,D0V3BZ,ME-1071,Bacterial infection , Phase 1
24154,D0V3CK,IMD-1041,Alzheimer disease , Phase 2
24155,D0V3CM,Opaviraline,Human immunodeficiency virus infection , Discontinued in Phase 2
24156,D0V3EQ,AD03 vaccine,Alzheimer disease , Phase 1
24157,D0V3FM,Delpazolid,Pulmonary tuberculosis , Phase 2
24158,D0V3GA,Acetyldigitoxin,Congestive heart failure , Approved
24159,D0V3HC,Anti-CD40-XTEN,Rheumatoid arthritis , Investigative
24160,D0V3HP,MP-0112,Macular degeneration , Phase 1
24161,D0V3HZ,BSP-C728,Gram-positive bacterial infection , Investigative
24162,D0V3LD,DIO-901,Type-1 diabetes , Terminated
24163,D0V3LF,ECCS-50,Scleroderma , Phase 3
24164,D0V3LM,P54,Solid tumour/cancer , Phase 2
24165,D0V3PI,PMID25666693-Compound-36,Osteoarthritis pain , Patented
24166,D0V3PI,PMID25666693-Compound-36,Cancer related pain , Patented
24167,D0V3PI,PMID25666693-Compound-36,Neuropathic pain , Patented
24168,D0V3PI,PMID25666693-Compound-36,Inflammatory pain , Patented
24169,D0V3PN,Withaferin A,Melanoma , Terminated
24170,D0V3QE,NSL-036,Neuropathic pain , Terminated
24171,D0V3RZ,Crisnatol,Solid tumour/cancer , Discontinued in Phase 3
24172,D0V3SB,Prolastin,Alpha-1 antitrypsin deficiency , Approved
24173,D0V3UN,CP-80794,Hypertension , Phase 2
24174,D0V3WE,Pseudomonas aeruginosa protein vaccine,Pseudomonas infection , Phase 3
24175,D0V3WN,BMN-103,Pompe disease , Investigative
24176,D0V3WQ,Sch-207758,Solid tumour/cancer , Terminated
24177,D0V3XK,SWT-02.100,Wound healing , Terminated
24178,D0V3YT,BOCEPREVIR,Hepatitis C virus infection , Approved
24179,D0V3YY,NN9828,Type-1 diabetes , Phase 2
24180,D0V3ZA,Dihydroergotamine,Migraine , Approved
24181,D0V3ZK,GX-H9,Dwarfism , Investigative
24182,D0V3ZN,AG-SPT201,Ulcerative colitis , Phase 3
24183,D0V3ZX,DA-3607,Brain cancer , Phase 1
24184,D0V4AS,Cellulose Sodium Phosphate,Hypercalciuria , Approved
24185,D0V4CL,GN-1140,Liver cancer , Discontinued in Phase 2
24186,D0V4DH,Estriol E3,Multiple sclerosis , Investigative
24187,D0V4DX,PF-06700841,Asthma , Phase 2
24188,D0V4DX,PF-06700841,Plaque psoriasis , Phase 2
24189,D0V4DX,PF-06700841,Psoriasis vulgaris , Phase 1
24190,D0V4EX,AC-710,Autoimmune diabetes , Investigative
24191,D0V4FK,SM 11044,Asthma , Terminated
24192,D0V4FP,OX-30,Pain , Terminated
24193,D0V4GT,CMI-206,Inflammation , Terminated
24194,D0V4GY,Chlorhexidine,Bacterial infection , Approved
24195,D0V4HO,Avoralstat,Hereditary angioedema , Phase 2/3
24196,D0V4IB,Itraconazole,Fungal infection , Approved
24197,D0V4IJ,AKCEA-APOCIII-LRX,Hypertriglyceridemia , Phase 2
24198,D0V4IQ,RhGDF-5,Periodontal disease , Phase 2
24199,D0V4JO,AMPEROZIDE,Alcohol dependence , Terminated
24200,D0V4JQ,Interferon beta-1a,Multiple sclerosis , Approved
24201,D0V4JR,Fibrinogen,Pulmonary embolism , Approved
24202,D0V4JR,Fibrinogen,Deep vein thrombosis , Approved
24203,D0V4JW,SRPIN-340,Choroidal neovascularization , Investigative
24204,D0V4KL,VAR-10200,Neurodegenerative disorder , Investigative
24205,D0V4LG,RS-8891,Hypertension , Discontinued in Phase 1
24206,D0V4MB,Remogliflozin etabonate,Type-1/2 diabetes , Phase 2
24207,D0V4MB,Remogliflozin etabonate,Type-2 diabetes , Phase 2
24208,D0V4PH,Tolerimab,Transplant rejection , Terminated
24209,D0V4QE,BN-58705,Inflammation , Terminated
24210,D0V4QS,Olanzapine,Schizophrenia , Approved
24211,D0V4RH,Lobucavir,Virus infection , Discontinued in Phase 3
24212,D0V4TV,CBLB-502,Acute radiation syndrome , Phase 2
24213,D0V4TY,Oxidized glutathione,Breast cancer , Approved
24214,D0V4TY,Oxidized glutathione,Bacterial infection , Investigative
24215,D0V4UF,Pramoxine,Anal fistula , Approved
24216,D0V4UO,M-16209,Diabetic complication , Phase 2
24217,D0V4UR,NS-1546,Major depressive disorder , Terminated
24218,D0V4VQ,WASP gene therapy,Wiskott-Aldrich syndrome , Phase 1/2
24219,D0V4WD,Ulipristal,Contraception , Approved
24220,D0V4WG,VR-909,Transplant rejection , Investigative
24221,D0V4XA,ATH-90879,Obesity , Investigative
24222,D0V4XG,GSK2793660,Bronchiectasis , Phase 1
24223,D0V4XL,BMEC-1217B,Allergic rhinitis , Phase 1
24224,D0V4XY,S-222611,Malignant solid tumour , Phase 1b
24225,D0V4YA,KHK4083,Ulcerative colitis , Phase 2
24226,D0V4YE,Technetium Tc-99m Pyro/Trimeta Phosphates Kit,Radioactive tracer , Approved
24227,D0V4YO,ROCICLOVIR,Virus infection , Phase 1
24228,D0V4YT,CytoRet,Retinopathy , Investigative
24229,D0V4YW,Hepcidin mab,Anemia , Phase 1
24230,D0V4ZN,Cobicistat/darunavir,Human immunodeficiency virus infection , Approved
24231,D0V4ZQ,SAM-531,Alzheimer disease , Phase 2
24232,D0V5AJ,Antithrombin iii,Coagulation defect , Approved
24233,D0V5AL,LC-1,Acute myeloid leukaemia , Phase 1
24234,D0V5BJ,T-2000,Cerebrovascular ischaemia , Discontinued in Phase 1
24235,D0V5BV,Benzimidazole derivative 1,Obesity , Patented
24236,D0V5DD,CART-meso-19 T cells,Pancreatic cancer , Phase 1
24237,D0V5DX,GR-79236,Diabetic complication , Discontinued in Phase 1
24238,D0V5FQ,Axitirome,Hyperlipidaemia , Phase 1
24239,D0V5GO,Allox,Wound healing , Discontinued in Phase 2
24240,D0V5HA,VX-128,Pain , Phase 1
24241,D0V5IW,Secnidazole,Bacterial vaginosis , Approved
24242,D0V5IW,Secnidazole,Amoebiasis , Approved
24243,D0V5JH,ALT-801,Acute myeloid leukaemia , Phase 2
24244,D0V5JH,ALT-801,Bladder cancer , Phase 2
24245,D0V5JH,ALT-801,Non-muscle invasive bladder cancer , Phase 1/2
24246,D0V5JO,T-0128,Solid tumour/cancer , Phase 1
24247,D0V5JQ,COL-172,Pain , Phase 1
24248,D0V5KJ,Interferon beta 1a,Discovery agent , Phase 2
24249,D0V5LG,ChronVac-C hepatitis C DNA vaccine,Hepatitis C virus infection , Phase 1/2
24250,D0V5LJ,JNJ-10329670,Autoimmune diabetes , Investigative
24251,D0V5OG,BE-14106,Solid tumour/cancer , Investigative
24252,D0V5QH,ONO-9054,Glaucoma/ocular hypertension , Phase 2
24253,D0V5QY,StaphTAME,Bacterial infection , Phase 1/2
24254,D0V5TP,Adipose-derived stem cell therapy,Cardiovascular disease , Phase 1
24255,D0V5VA,CIGB-814,Rheumatoid arthritis , Investigative
24256,D0V5VR,LEO 90100,Psoriasis vulgaris , Phase 2
24257,D0V5WL,Met-enkephalin,Pain , Phase 2
24258,D0V5XJ,AG-AFZ709,Genitourinary disease , Approved
24259,D0V5XL,KRI-1314,Hypertension , Terminated
24260,D0V5YA,TA-381,Cerebral infarction , Investigative
24261,D0V5YQ,TS antisense + raltitrexed,Solid tumour/cancer , Investigative
24262,D0V5ZG,TCN-202,Cytomegalovirus infection , Phase 1
24263,D0V5ZZ,Propantheline,Stomach ulcer , Approved
24264,D0V5ZZ,Propantheline,Excessive sweating , Approved
24265,D0V6AB,XR-1500,Solid tumour/cancer , Phase 3
24266,D0V6AH,Endostatin,Solid tumour/cancer , Phase 2
24267,D0V6AN,Encapsulated islet cell transplantation therapy,Type-1 diabetes , Phase 1/2
24268,D0V6BE,ALC-919,Verruca vulgaris , Phase 2
24269,D0V6BS,Jemdel,Plaque psoriasis , Application submitted
24270,D0V6CE,GBT-009,Skin fibrosis , Phase 2
24271,D0V6CE,GBT-009,Scar conditions , Phase 2
24272,D0V6CY,ET-005,Acquired haemolytic anemia , Investigative
24273,D0V6CZ,XG-5XX,Virus infection , Investigative
24274,D0V6DF,LJP-1207,Cerebrovascular ischaemia , Investigative
24275,D0V6EC,INOmax nitric oxide,Congestive heart failure , Phase 3
24276,D0V6EY,Pumiliotoxin 251D,Bacterial infection , Investigative
24277,D0V6FV,OcuXan,Age-related macular degeneration , Investigative
24278,D0V6GN,Chlorpromazine,Coronavirus Disease 2019 (COVID-19) , Phase 3
24279,D0V6GN,Chlorpromazine,Schizophrenia , Withdrawn from market
24280,D0V6GN,Chlorpromazine,Severe acute respiratory syndrome (SARS) , Investigative
24281,D0V6GN,Chlorpromazine,Middle East Respiratory Syndrome (MERS) , Investigative
24282,D0V6GT,IDN-6439,Solid tumour/cancer , Investigative
24283,D0V6HS,R-82913,Human immunodeficiency virus infection , Discontinued in Phase 1
24284,D0V6IM,SBG,Breast cancer , Phase 3
24285,D0V6IN,PV-267,Multiple sclerosis , Investigative
24286,D0V6JF,SAR-104772,Cerebrovascular ischaemia , Phase 1
24287,D0V6JJ,LP-1810,Hypercholesterolaemia , Investigative
24288,D0V6JP,Endixaprine,Anxiety disorder , Terminated
24289,D0V6KF,LHRH,Endometriosis , Investigative
24290,D0V6KL,CLP-635,Epilepsy , Investigative
24291,D0V6KU,CMV glycoprotein B subunit vaccine,Cytomegalovirus infection , Phase 1
24292,D0V6KV,HL-2353,Hemophilia , Investigative
24293,D0V6LF,NN9928,Type-2 diabetes , Discontinued in Phase 1
24294,D0V6LH,PBI-1101,Inflammation , Terminated
24295,D0V6MX,IMA 203,Solid tumour/cancer , Phase 1
24296,D0V6MX,IMA 203,Hematologic tumour , Phase 1
24297,D0V6OA,Lurbinectedin,Small-cell lung cancer , Approved
24298,D0V6OA,Lurbinectedin,leukaemia , Phase 3
24299,D0V6OA,Lurbinectedin,Ovarian cancer , Phase 3
24300,D0V6OA,Lurbinectedin,Solid tumour/cancer , Phase 2
24301,D0V6OA,Lurbinectedin,Endometrial cancer , Phase 2
24302,D0V6OZ,CN-105,Nontraumatic intracerebral hemorrhage , Phase 2
24303,D0V6RC,Satumomab Pendetide,Breast cancer , Approved
24304,D0V6RE,BCH-371,Human immunodeficiency virus infection , Terminated
24305,D0V6RL,Stempeucel,Cerebrovascular ischaemia , Preregistration
24306,D0V6SI,RESP-4000,Solid tumour/cancer , Investigative
24307,D0V6SV,PG-201,Arthralgia , Phase 3
24308,D0V6TP,Humanized SMART Anti-IL-12 Antibody,Autoimmune diabetes , Phase 1
24309,D0V6TY,MYO-201,Limb girdle muscular dystrophy , Phase 1
24310,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,Acute lymphoblastic leukaemia , Phase 1/2
24311,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,B-cell chronic lymphocytic leukaemia , Phase 1/2
24312,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,Diffuse large B-cell lymphoma , Phase 1/2
24313,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,Follicular lymphoma , Phase 1/2
24314,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,Haematopoietic/lymphoid cancer , Phase 1/2
24315,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,Mantle cell lymphoma , Phase 1/2
24316,D0V6VD,Anti-CD20-CAR vector-transduced autologous T cells,Prolymphocytic leukaemia , Phase 1/2
24317,D0V6VL,Cilofungin,Candidiasis , Terminated
24318,D0V6VQ,PF-956980,Inflammation , Investigative
24319,D0V6WU,CAR-T cells targeting CD38,Multiple myeloma , Clinical trial
24320,D0V6WU,CAR-T cells targeting CD38,Acute myeloid leukaemia , Preclinical
24321,D0V6WW,CAR-T cells targeting CD56,Multiple myeloma , Clinical trial
24322,D0V6WW,CAR-T cells targeting CD56,Acute myeloid leukaemia , Preclinical
24323,D0V6WZ,PN-201,Herpes simplex virus infection , Investigative
24324,D0V6XJ,Hemsleyadin,Bacillary dysentery , Approved
24325,D0V6XW,Teglarinad,Lymphoma , Phase 1
24326,D0V6YT,SR-33805A,Hypertension , Investigative
24327,D0V6ZC,Aurograb,Staphylococcus infection , Phase 3
24328,D0V6ZQ,VG-LC,Lung cancer , Investigative
24329,D0V7BD,HuCART19,leukaemia , Phase 1
24330,D0V7BD,HuCART19,Lymphoma , Phase 1
24331,D0V7BH,FG-4497,Cerebrovascular ischaemia , Investigative
24332,D0V7CF,Indinavir,Human immunodeficiency virus infection , Approved
24333,D0V7DQ,CD40LGVAX,Non-small-cell lung cancer , Phase 2
24334,D0V7DW,"Meningococcal groups A, C, Y and W-135 conjugate vaccine",Meningococcal infection , Approved
24335,D0V7ES,DKC-215,Hypertension , Investigative
24336,D0V7FG,SPH-1285,Alzheimer disease , Preclinical
24337,D0V7FX,RLP-073,Pseudomonas infection , Investigative
24338,D0V7GC,Rolafagrel,Nephritis , Discontinued in Phase 2
24339,D0V7GS,RG7461,Solid tumour/cancer , Phase 1
24340,D0V7HB,Modified CCR5-transduced autologous hematopoietic stem cells,Human immunodeficiency virus infection , Investigative
24341,D0V7HD,BN-50726,Nerve injury , Terminated
24342,D0V7HI,PRINOMIDE TROMETHAMINE,Inflammation , Discontinued in Phase 3
24343,D0V7HQ,ANA-02,Pain , Investigative
24344,D0V7IE,Pamiteplase,Thrombin deficiency , Approved
24345,D0V7IS,Pumafentrine,Asthma , Discontinued in Phase 2
24346,D0V7KJ,Recombinant Clostridium botulinum A/B vaccine,Clostridium infection , Phase 2
24347,D0V7MA,AMESERGIDE,Mood disorder , Discontinued in Phase 2
24348,D0V7OF,Pyrimidine derivative 6,Neurodegenerative disorder , Patented
24349,D0V7OF,Pyrimidine derivative 6,Fibrosis , Patented
24350,D0V7OF,Pyrimidine derivative 6,Blood vessel proliferative disorder , Patented
24351,D0V7OH,Ceftiofur,Bacterial infection , Approved
24352,D0V7PL,Lefradafiban,Angina pectoris , Phase 1
24353,D0V7PX,Apogossypol,Solid tumour/cancer , Investigative
24354,D0V7PY,Giracodazole,Solid tumour/cancer , Discontinued in Phase 1
24355,D0V7QO,BI-836880,Solid tumour/cancer , Phase 1
24356,D0V7QT,AMI-121,Gastrointestinal disease , Approved
24357,D0V7QW,RG7882,Ovarian cancer , Phase 1
24358,D0V7QW,RG7882,Pancreatic cancer , Phase 1
24359,D0V7RH,Calcium levofolinate,Anemia , Approved
24360,D0V7RN,CDR-134D123,Diabetic complication , Phase 1
24361,D0V7SO,PF-06291874,Type-2 diabetes , Phase 2
24362,D0V7SU,DD-20207,Neuropathic pain , Investigative
24363,D0V7SY,Neuronal transplant cells,Stroke , Phase 2
24364,D0V7US,NKP 608,Mood disorder , Phase 2
24365,D0V7VX,ALN-HTT,Huntington disease , Preclinical
24366,D0V7WS,Zotarolimus,Solid tumour/cancer , Approved
24367,D0V7XC,R-1518,Hepatitis C virus infection , Discontinued in Phase 1
24368,D0V7XF,Dopexamine,Cardiac failure , Approved
24369,D0V7YA,GMX1777,Solid tumour/cancer , Phase 1
24370,D0V7YG,EHT/AGN-0003,Neurodegenerative disorder , Investigative
24371,D0V7YK,ImBryon,Solid tumour/cancer , Investigative
24372,D0V8AG,Poly-ICLC,Glioblastoma multiforme , Phase 2
24373,D0V8AG,Poly-ICLC,Solid tumour/cancer , Phase 2
24374,D0V8AG,Poly-ICLC,Recurrent glioblastoma , Phase 1/2
24375,D0V8AP,TRC-4186,Diabetic complication , Phase 2
24376,D0V8AR,Candin,Verruca vulgaris , Phase 2
24377,D0V8BU,P-2202,Syndrome X , Phase 2
24378,D0V8GT,E-0116,Psoriasis vulgaris , Phase 3
24379,D0V8HA,Mecamylamine,Essential hypertension , Approved
24380,D0V8HB,Food allergy epicutaneous immunotherapy,Peanut hypersensitivity , Phase 2
24381,D0V8HF,GS-9160,Human immunodeficiency virus infection , Terminated
24382,D0V8HJ,Fostamatinib,Immune thrombocytopenic purpura , Approved
24383,D0V8HJ,Fostamatinib,Rheumatoid arthritis , Phase 3
24384,D0V8HK,H-NOX proteins,Hypoxia , Investigative
24385,D0V8JZ,"Pyrrolo[2,3-d]pyrimidine derivative 17",Solid tumour/cancer , Patented
24386,D0V8JZ,"Pyrrolo[2,3-d]pyrimidine derivative 17",Autoimmune disease , Patented
24387,D0V8KB,CM-4612,Attention deficit hyperactivity disorder , Investigative
24388,D0V8KD,P-1101,Hepatitis B virus infection , Phase 3
24389,D0V8KD,P-1101,Essential thrombocythemia , Phase 3
24390,D0V8KD,P-1101,Myelofibrosis , Phase 2
24391,D0V8KI,Fenspiride hydrochloride,Asthma , Terminated
24392,D0V8PA,NERIDRONIC ACID,Bone disease , Approved
24393,D0V8PA,NERIDRONIC ACID,Complex regional pain syndrome , Phase 3
24394,D0V8PN,Droxinavir hydrochloride,Human immunodeficiency virus infection , Terminated
24395,D0V8PQ,NGN-9078,Cerebrovascular ischaemia , Investigative
24396,D0V8QT,Chlorambucil,Chronic lymphocytic leukaemia , Approved
24397,D0V8RV,Rotavin,Type-2 diabetes , Phase 1
24398,D0V8RY,KR-30450,Hypertension , Discontinued in Phase 1
24399,D0V8TQ,Aluminium,Hyperhidrosis , Approved
24400,D0V8UJ,PEP-6409,Human immunodeficiency virus infection , Phase 1
24401,D0V9AL,MCAF5352A,Autoimmune diabetes , Phase 1
24402,D0V9BD,Bicalutamide,Prostate cancer , Approved
24403,D0V9BU,ABT-492,Bacterial infection , Phase 3
24404,D0V9BX,TD-6989,Bladder cancer , Investigative
24405,D0V9DZ,Fluprednisolone,Asthma , Approved
24406,D0V9EN,"3,4-Dihydroxycinnamic Acid",Thrombocytopenia , Phase 4
24407,D0V9EX,Mirvetuximab soratansine,Ovarian cancer , Phase 2
24408,D0V9FU,WST11,Non-small-cell lung cancer , Phase 2
24409,D0V9HC,Darunavir + cobicistat,Coronavirus Disease 2019 (COVID-19) , Phase 3
24410,D0V9HH,Taprizosin,Prostate hyperplasia , Discontinued in Phase 2
24411,D0V9HI,Irindalone,Inflammation , Terminated
24412,D0V9HL,BMS-241027,Tauopathy , Phase 1
24413,D0V9HL,BMS-241027,Alzheimer disease , Phase 1
24414,D0V9IE,ZD2079,Diabetic complication , Phase 2
24415,D0V9JR,Viloxazine,Major depressive disorder , Approved
24416,D0V9LF,Anti-CD28,Immune System disease , Investigative
24417,D0V9LJ,Flufirvitide-3,Influenza virus infection , Phase 1
24418,D0V9LY,Bertilimumab,Ocular allergy , Phase 2
24419,D0V9LY,Bertilimumab,Bullous pemphigoid , Phase 2
24420,D0V9LY,Bertilimumab,Psoriasis vulgaris , Phase 2
24421,D0V9LY,Bertilimumab,Ulcerative colitis , Phase 2
24422,D0V9ME,VT-111,Graft rejection in heart transplantation , Preclinical
24423,D0V9MG,KY-382,Arteriosclerosis , Investigative
24424,D0V9MO,Ono 3,Pain , Investigative
24425,D0V9MR,XL888,Gastrointestinal cancer , Phase 1
24426,D0V9MT,PU-AD,Encephalopathy , Phase 1
24427,D0V9MT,PU-AD,Alzheimer disease , Phase 0
24428,D0V9MV,IDDBCP226234,Inflammation , Investigative
24429,D0V9NB,Non-Hodgkin lymphoma vaccine,B-cell lymphoma , Terminated
24430,D0V9ND,MCP-1,Rheumatoid arthritis , Preclinical
24431,D0V9NE,Tanaproget,Estrogen deficiency , Investigative
24432,D0V9OL,534U87,Epileptic seizures , Discontinued in Phase 2
24433,D0V9PB,Gilotrifafatinib,Lung squamous cell carcinoma , Phase 2
24434,D0V9PB,Gilotrifafatinib,Rhabdomyosarcoma , Phase 1/2
24435,D0V9QR,Apricitabine,Human immunodeficiency virus infection , Phase 3
24436,D0V9RM,PMID25666693-Compound-89,Osteoarthritis pain , Patented
24437,D0V9RM,PMID25666693-Compound-89,Cancer related pain , Patented
24438,D0V9RM,PMID25666693-Compound-89,Neuropathic pain , Patented
24439,D0V9RM,PMID25666693-Compound-89,Inflammatory pain , Patented
24440,D0V9RU,ENIPORIDE,Cardiac arrhythmias , Discontinued in Phase 2
24441,D0V9TE,GPI-2138,Cocaine addiction , Terminated
24442,D0V9UA,OligoG CF-5/20,Cystic fibrosis , Phase 2
24443,D0V9UY,Technetium Tc-99m Sulfur Colloid Kit,Radioactive tracer , Approved
24444,D0V9VG,Rimegepant,Migraine , Approved
24445,D0V9WE,TS23,Thrombosis , Phase 1
24446,D0V9WF,Lestaurtinib,Acute myeloid leukaemia , Approved (orphan drug)
24447,D0V9WF,Lestaurtinib,Myeloid leukaemia , Phase 3
24448,D0V9WF,Lestaurtinib,Psoriasis vulgaris , Phase 2/3
24449,D0V9WX,KarXT,Schizophrenia , Phase 3
24450,D0V9YR,Sulfamethazine,Bacterial infection , Approved
24451,D0V9YW,GYKI-47261,Parkinson disease , Preclinical
24452,D0V9ZG,Cetraxate,Peptic ulcer , Approved
24453,D0V9ZJ,"Pyrazolo[1,5-a]pyridine derivative 2",Pruritus , Patented
24454,D0V9ZJ,"Pyrazolo[1,5-a]pyridine derivative 2",Solid tumour/cancer , Patented
24455,D0V9ZJ,"Pyrazolo[1,5-a]pyridine derivative 2",Chronic pain , Patented
24456,D0V9ZJ,"Pyrazolo[1,5-a]pyridine derivative 2",Neuropathic pain , Patented
24457,D0V9ZJ,"Pyrazolo[1,5-a]pyridine derivative 2",Thymic cancer , Patented
24458,D0V9ZL,FCE-28161,Solid tumour/cancer , Discontinued in Phase 1
24459,D0V9ZR,GNI-105,Human papillomavirus infection , Terminated
24460,D0VA0I,Vorapaxar,Myocardial infarction , Approved
24461,D0VA1D,Alkyl mannoside derivative 1,Crohn disease , Patented
24462,D0VA1D,Alkyl mannoside derivative 1,Ulcerative colitis , Patented
24463,D0VA1D,Alkyl mannoside derivative 1,Urinary tract infection , Patented
24464,D0VA2I,CRx-191,Psoriatic disorder , Discontinued in Phase 2
24465,D0VA4Y,Phentermine+topiramate,Obesity , Phase 3
24466,D0VA9Z,ND0612,Parkinson disease , Phase 2
24467,D0VB0U,Chlorphenesin,Muscular pain , Approved
24468,D0VB0U,Chlorphenesin,Injury , Approved
24469,D0VB0U,Chlorphenesin,Fungal infection , Withdrawn from market
24470,D0VB2K,SPX-601,Arthritis , Investigative
24471,D0VB2M,"1,5-diphenylpyrrolidin-2-one derivative 1",Obesity , Patented
24472,D0VB3Y,Manganese Sulfate,Overactive bladder , Approved
24473,D0VB4T,Aryl mannoside derivative 9,Crohn disease , Patented
24474,D0VB4T,Aryl mannoside derivative 9,Ulcerative colitis , Patented
24475,D0VB4T,Aryl mannoside derivative 9,Urinary tract infection , Patented
24476,D0VB4X,VTP-43742,Psoriasis vulgaris , Phase 2
24477,D0VB4X,VTP-43742,Autoimmune disease , Phase 1
24478,D0VB9J,ISIS 14803,Hepatitis C virus infection , Discontinued in Phase 2
24479,D0VB9M,Peptide analog 1,Solid tumour/cancer , Patented
24480,D0VB9M,Peptide analog 1,Infectious disease , Patented
24481,D0VB9M,Peptide analog 1,Human immunodeficiency virus infection , Patented
24482,D0VB9M,Peptide analog 1,Hepatitis , Patented
24483,D0VC0I,Oxindole 94,Pain , Investigative
24484,D0VC3H,BT-V003,Influenza virus infection , Investigative
24485,D0VC4F,HG-1226,Solid tumour/cancer , Investigative
24486,D0VC8H,KI-0003,Solid tumour/cancer , Investigative
24487,D0VC8T,AZ-05,Solid tumour/cancer , Investigative
24488,D0VC8Y,SAR428926,Solid tumour/cancer , Phase 1
24489,D0VC8Z,Trehalose,Muscular dystrophy , Phase 2
24490,D0VC8Z,Trehalose,Oculopharyngeal muscular dystrophy , Phase 2
24491,D0VC8Z,Trehalose,Spinal cerebellar ataxia type 3 , Phase 2
24492,D0VD1R,Suramin,African trypanosomiasis , Phase 1
24493,D0VD1R,Suramin,Coronavirus Disease 2019 (COVID-19) , Investigative
24494,D0VD5J,PMID28270021-Compound-WO2015042088Example12,Pruritus , Patented
24495,D0VD5J,PMID28270021-Compound-WO2015042088Example12,Solid tumour/cancer , Patented
24496,D0VD5J,PMID28270021-Compound-WO2015042088Example12,Chronic pain , Patented
24497,D0VD5J,PMID28270021-Compound-WO2015042088Example12,Neuropathic pain , Patented
24498,D0VD5J,PMID28270021-Compound-WO2015042088Example12,Thymic cancer , Patented
24499,D0VD5X,KI-0001,Solid tumour/cancer , Investigative
24500,D0VD6Q,RP103,Huntington disease , Phase 2/3
24501,D0VD7H,CL-5343,Solid tumour/cancer , Investigative
24502,D0VD8S,Oral-lyn,Type-1 diabetes , Phase 3
24503,D0VD9X,AstroStem,Alzheimer disease , Phase 1/2
24504,D0VE1W,SB-623,Cerebrovascular ischaemia , Phase 2
24505,D0VE1W,SB-623,Ischemic stroke , Phase 2
24506,D0VE1W,SB-623,Stroke , Phase 2
24507,D0VE1W,SB-623,Traumatic brain injury , Phase 2
24508,D0VE3U,JT02,Inflammatory bowel disease , Phase 2
24509,D0VE4O,EVP-4473,Alzheimer disease , Investigative
24510,D0VE6X,R1549,Ovarian cancer , Discontinued in Phase 3
24511,D0VE7B,DSP-2230,Neuropathic pain , Phase 1
24512,D0VE9F,SBP-101,Pancreatic cancer , Phase 1
24513,D0VE9F,SBP-101,Pancreatic ductal carcinoma , Phase 1
24514,D0VF3C,NPC-01,Dysmenorrhea , Phase 3
24515,D0VF4H,Hydroxocobalamin,Vitamin B12 deficiency , Approved
24516,D0VF4H,Hydroxocobalamin,Lung injury , Phase 2
24517,D0VF5B,PMID26651364-Compound-107,Crohn disease , Patented
24518,D0VF5B,PMID26651364-Compound-107,Ulcerative colitis , Patented
24519,D0VF5B,PMID26651364-Compound-107,Urinary tract infection , Patented
24520,D0VF6E,PD173074,Nasopharyngeal carcinoma , Investigative
24521,D0VF8Z,SRD-326,Raynaud disease , Preclinical
24522,D0VG0D,BEZ235,Solid tumour/cancer , Phase 2
24523,D0VG0F,Biphenyl mannoside derivative 23,Crohn disease , Patented
24524,D0VG0F,Biphenyl mannoside derivative 23,Ulcerative colitis , Patented
24525,D0VG0F,Biphenyl mannoside derivative 23,Urinary tract infection , Patented
24526,D0VG0G,PeproStat,Bleeding disorder , Investigative
24527,D0VG7I,MENK,Pancreatic cancer , Phase 2
24528,D0VG7Y,Elagolix sodium,Endometriosis , Approved
24529,D0VH0X,Tuberculosis vaccine,Tuberculosis , Phase 2
24530,D0VH0X,Tuberculosis vaccine,Mycobacterium infection , Phase 1
24531,D0VH3D,SC-599,Shigella infection , Phase 2
24532,D0VH3H,TM38837,Metabolic disorder , Phase 1
24533,D0VH3H,TM38837,Obesity , Phase 1
24534,D0VH4T,ONO-7475,Acute myeloid leukaemia , Phase 1
24535,D0VH4V,Teplizumab,Type-1 diabetes , Phase 3
24536,D0VH4V,Teplizumab,Melanoma , Phase 3
24537,D0VH6V,P53 cell pentrating peptide,Central nervous system disease , Phase 1
24538,D0VH9C,Synuclere,Parkinson disease , Investigative
24539,D0VI4N,JNJ-54175446,Major depressive disorder , Phase 1
24540,D0VI7R,Selinexor oral,Recurrent glioblastoma , Phase 2
24541,D0VI8H,Ribavirin,Hepatitis C virus infection , Approved
24542,D0VI8H,Ribavirin,Severe acute respiratory syndrome (SARS) , Investigative
24543,D0VI8H,Ribavirin,Middle East Respiratory Syndrome (MERS) , Investigative
24544,D0VI8H,Ribavirin,Coronavirus Disease 2019 (COVID-19) , Investigative
24545,D0VI8T,4SCAR-PSMA,Bladder cancer , Phase 1/2
24546,D0VI9P,OPN-305,Myelodysplastic syndrome , Phase 2
24547,D0VIG4,LY3405105,Solid tumour/cancer , Phase 1
24548,D0VJ0Q,MuStDO 5,Malaria , Phase 1/2
24549,D0VJ4N,CIGB-230,Hepatitis C virus infection , Phase 2
24550,D0VJ5N,SB-705498,Rhinitis , Phase 2
24551,D0VJ5N,SB-705498,Migraine , Discontinued in Phase 1
24552,D0VJ7G,TECHNETIUM-99M-MRP20,Diagnostic imaging , Phase 1
24553,D0VJ9X,AXS-06,Pain , Phase 1
24554,D0VJ9X,AXS-06,Osteoarthritis , Phase 1
24555,D0VJ9X,AXS-06,Rheumatoid arthritis , Phase 1
24556,D0VK9O,Sofpironium bromide,Primary axillary hyperhidrosis , Phase 3
24557,D0VL3L,DFD-03,Acne vulgaris , Phase 3
24558,D0VL4M,AMG0103,Chronic back pain , Phase 1
24559,D0VL4V,SR-123781A,Venous thrombosis , Phase 2/3
24560,D0VL5E,Aminoazetidine derivative 3,Obesity , Patented
24561,D0VL8Q,Tiropramide,Pain , Approved
24562,D0VM2L,Zoledronate,Hypercalcaemia , Approved
24563,D0VM8B,NTP-2014,Epilepsy , Investigative
24564,D0VM8K,Sodium ferric gluconate complex,Iron-deficiency anemia , Approved
24565,D0VN2N,Recombinant opticin,Solid tumour/cancer , Investigative
24566,D0VN2U,Amidine compound 1,Inflammation , Patented
24567,D0VN2Y,BL-1825,Parkinson disease , Terminated
24568,D0VN3O,Lmprime P66,leukaemia , Phase 3
24569,D0VN6O,N-65 lacritin,Xerophthalmia , Investigative
24570,D0VO0A,INV-21,"Hand, foot and mouth disease ", Phase 1
24571,D0VO0T,Delanzomib,Multiple myeloma , Phase 2
24572,D0VO3H,CG7060,Prostate cancer , Discontinued in Phase 2
24573,D0VO5S,LY-2584702,Solid tumour/cancer , Phase 1
24574,D0VO5V,NNZ-4945,Motor neurone disease , Investigative
24575,D0VO6J,FAD-104,Solid tumour/cancer , Phase 2
24576,D0VO7K,Capzola,Bladder cancer , Application submitted
24577,D0VO7R,AjvW2,Thrombosis , Phase 1
24578,D0VO9O,Talizumab,Allergy , Discontinued in Phase 2
24579,D0VP1V,Aclidinium,Chronic obstructive pulmonary disease , Approved
24580,D0VP2T,KU-2285,Solid tumour/cancer , Discontinued in Phase 1
24581,D0VP7D,HR-004-1,Bone disease , Investigative
24582,D0VP9E,Cyrtominetin,Phlegmy cough , Phase 3
24583,D0VQ7Y,SPK-CHM,Choroidal dystrophy , Phase 1/2
24584,D0VQ8Q,Ladiratuzumab vedotin,Breast cancer , Phase 2
24585,D0VR5T,BEPH,Solid tumour/cancer , Discontinued in Phase 1
24586,D0VR7F,CNTX-6970,Inflammatory pain , Phase 1
24587,D0VR7W,Gemifloxacin,Bacterial infection , Approved
24588,D0VS1P,DRL-21995,Lipid metabolism disorder , Investigative
24589,D0VS2M,ALS-886,Respiratory distress syndrome , Terminated
24590,D0VS2R,Tovaxin,Multiple sclerosis , Phase 2
24591,D0VS2W,YSIL6,Crohn disease , Phase 2
24592,D0VS3J,BM-17.0249.2NA,Diabetic complication , Discontinued in Phase 2
24593,D0VS3U,TAK-020,Rheumatoid arthritis , Phase 1
24594,D0VS3W,KAR5585,Pulmonary arterial hypertension , Phase 1
24595,D0VS9E,GDC-5573,Solid tumour/cancer , Phase 1
24596,D0VT0T,NLX-P101,Parkinson disease , Discontinued in Phase 2
24597,D0VT1S,TTP889,Blood forming organ disorder , Phase 2
24598,D0VT1S,TTP889,Respiratory syncytial virus infection , Terminated
24599,D0VT2B,ALS-8176,Respiratory syncytial virus infection , Phase 2
24600,D0VT2C,FK-505,Hyperuricaemia , Phase 2
24601,D0VT6X,ABBV-2451,Cystic fibrosis , Phase 1
24602,D0VT8P,Famciclovir,Virus infection , Approved
24603,D0VT9O,AR28,Skin disease , Phase 2
24604,D0VU2M,TA-2005,Chronic obstructive pulmonary disease , Phase 2
24605,D0VU2X,Conivaptan,Euvolemic hyponatremia , Approved
24606,D0VU5M,Imiglitazar,Type-2 diabetes , Phase 3
24607,D0VU8K,REIC gene therapy vaccine,Prostate cancer , Phase 1/2
24608,D0VU8Q,Mebeverine,Irritable bowel syndrome , Approved
24609,D0VV2D,B-06,Solid tumour/cancer , Investigative
24610,D0VV3O,GNI-104,Hepatitis C virus infection , Terminated
24611,D0VV5X,EZN-3920,Solid tumour/cancer , Investigative
24612,D0VV6V,Reovirus,Head and neck cancer , Phase 2
24613,D0VW0A,Dermacyn,Diabetic foot ulcer , Phase 2
24614,D0VW0I,Cyclopentenylcytosine,Solid tumour/cancer , Phase 1
24615,D0VW1I,GLS-5700,Semliki forest virus infection , Phase 1
24616,D0VW2Z,Nerelimomab,Rheumatoid arthritis , Discontinued in Phase 3
24617,D0VW4J,NT0102,Cardiovascular disease , Phase 3
24618,D0VW7E,TPR-100-Rx,Pain , Investigative
24619,D0VX5O,Neboglamine,Cocaine addiction , Phase 2
24620,D0VY5O,A-620223,Solid tumour/cancer , Investigative
24621,D0VY9O,3-(phenoxymethyl) benzylamine derivative 2,Albinism , Patented
24622,D0VY9O,3-(phenoxymethyl) benzylamine derivative 2,Ephelides , Patented
24623,D0VY9O,3-(phenoxymethyl) benzylamine derivative 2,Menkes disease , Patented
24624,D0VY9O,3-(phenoxymethyl) benzylamine derivative 2,Senile lentigines , Patented
24625,D0VY9O,3-(phenoxymethyl) benzylamine derivative 2,Melasma , Patented
24626,D0VZ0U,H5N1 pandemic influenza vaccine,Influenza virus infection , Phase 1
24627,D0VZ1C,H-103,Metastatic malignant neoplasm , Phase 1
24628,D0VZ2A,SQ-609,Virus infection , Investigative
24629,D0VZ3D,AQ-RA-741,Cardiovascular disease , Terminated
24630,D0VZ4N,Guadecitabine,Myelodysplastic syndrome , Phase 3
24631,D0VZ5B,Bempedoic acid + ezetimibe,High blood cholesterol level , Phase 3
24632,D0VZ5X,BI-44370,Migraine , Phase 2
24633,D0VZ8S,KA-398,Asthma , Terminated
24634,D0VZ9S,CROMOGLYCATE LISETIL HYDROCHLORIDE,Asthma , Phase 2
24635,D0W0AM,SB 235699,Psoriasis vulgaris , Discontinued in Phase 1
24636,D0W0BF,Anastrozole,Breast cancer , Approved
24637,D0W0BN,NM-2014,Rheumatoid arthritis , Investigative
24638,D0W0DY,Agrippal S1/MF-59 influenza vaccine,Influenza virus infection , Approved
24639,D0W0ED,Eflucimibe,Hyperlipidaemia , Discontinued in Phase 2
24640,D0W0GE,CR-002,Cystic fibrosis , Phase 1
24641,D0W0HZ,TZ-101sm,Osteoporosis , Investigative
24642,D0W0IN,NN-9925,Non-insulin dependent diabetes , Discontinued in Phase 1
24643,D0W0JJ,AKB-9788,Edema , Investigative
24644,D0W0JP,OMS405,Nicotine dependence , Phase 2
24645,D0W0JP,OMS405,Opioid dependence , Phase 2
24646,D0W0KW,Ro-24-8138,Bacterial infection , Terminated
24647,D0W0LS,TAK-779,Transplant rejection , Terminated
24648,D0W0MD,MBX2329,Influenza virus infection , Investigative
24649,D0W0MF,Talbutal,Irritability , Approved
24650,D0W0MT,PMID30107136-Compound-Example51,Solid tumour/cancer , Patented
24651,D0W0MT,PMID30107136-Compound-Example51,Infectious disease , Patented
24652,D0W0MT,PMID30107136-Compound-Example51,Human immunodeficiency virus infection , Patented
24653,D0W0MT,PMID30107136-Compound-Example51,Hepatitis , Patented
24654,D0W0NU,NIC5-15,Alzheimer disease , Phase 2
24655,D0W0PC,"1,2,4-oxadiazole derivative 7",Solid tumour/cancer , Patented
24656,D0W0PC,"1,2,4-oxadiazole derivative 7",Infectious disease , Patented
24657,D0W0PC,"1,2,4-oxadiazole derivative 7",Human immunodeficiency virus infection , Patented
24658,D0W0PC,"1,2,4-oxadiazole derivative 7",Hepatitis , Patented
24659,D0W0RT,PTX-008313,Bacterial infection , Terminated
24660,D0W0SL,LY2940680,Solid tumour/cancer , Phase 1/2
24661,D0W0SL,LY2940680,Ovarian cancer , Phase 1
24662,D0W0SM,CRL-8131,Bacterial infection , Phase 3
24663,D0W0SM,CRL-8131,Sickle-cell disorder , Phase 3
24664,D0W0SM,CRL-8131,Non-small-cell lung cancer , Phase 3
24665,D0W0TH,R 80122,Cardiovascular disease , Discontinued in Phase 1
24666,D0W0UU,CPG23DIAB,Insulin-dependent diabetes , Investigative
24667,D0W0UW,CLT-002,Diabetic nephropathy , Investigative
24668,D0W0VD,Beta-Lapachone,Solid tumour/cancer , Phase 2
24669,D0W0VR,PFK-158,Solid tumour/cancer , Phase 1
24670,D0W0WP,LL-3858,Mycobacterium infection , Phase 2
24671,D0W0WU,Diethylnorspermine,Solid tumour/cancer , Phase 2
24672,D0W0XM,NPS-2390,Cerebrovascular ischaemia , Preclinical
24673,D0W0XS,PolyPEPI1018,Colorectal cancer , Phase 1/2
24674,D0W0YI,BI-54903 + olodaterol,Asthma , Phase 2
24675,D0W1AR,ERC-1671,Lymphoma , Phase 2
24676,D0W1AR,ERC-1671,Glioma , Phase 2
24677,D0W1AR,ERC-1671,Recurrent glioblastoma , Phase 2
24678,D0W1BV,Acel-Immune,Bordetella pertussis infection , Approved
24679,D0W1DI,AS-1670542,Thrombocytopenia , Approved
24680,D0W1DI,AS-1670542,Idiopathic thrombocytopenic purpura , Phase 3
24681,D0W1GP,Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143,Plasma cell myeloma , Phase 1
24682,D0W1HB,BAY-61-2116,Solid tumour/cancer , Discontinued in Phase 1
24683,D0W1JJ,GS-9669,Chronic HCV-1 infection , Phase 2
24684,D0W1JY,NAPQI,Autoimmune disease , Investigative
24685,D0W1MU,TBC-M4,Human immunodeficiency virus infection , Phase 1
24686,D0W1MX,BMS-187745,Hyperlipidaemia , Discontinued in Phase 2
24687,D0W1NH,Thiophene sulfonamide,Malaria , Investigative
24688,D0W1PV,Apicidin,Solid tumour/cancer , Investigative
24689,D0W1QA,GC-1102,Hepatitis B virus infection , Phase 2
24690,D0W1QI,Butizide,Congestive heart failure , Approved
24691,D0W1RQ,PMID30107136-Compound-Example44,Solid tumour/cancer , Patented
24692,D0W1RQ,PMID30107136-Compound-Example44,Infectious disease , Patented
24693,D0W1RQ,PMID30107136-Compound-Example44,Human immunodeficiency virus infection , Patented
24694,D0W1RQ,PMID30107136-Compound-Example44,Hepatitis , Patented
24695,D0W1RY,Hydroxyamphetamine Hydrobromide,Horner syndrome , Approved
24696,D0W1SD,124I-labeled 11-1F4,Amyloidosis , Phase 1
24697,D0W1SE,PMID26651364-Compound-5b,Crohn disease , Patented
24698,D0W1SE,PMID26651364-Compound-5b,Ulcerative colitis , Patented
24699,D0W1SE,PMID26651364-Compound-5b,Urinary tract infection , Patented
24700,D0W1TK,NKTR-105,Solid tumour/cancer , Phase 1
24701,D0W1TL,BB-MPI-03,Acute myeloid leukaemia , Phase 1
24702,D0W1TL,BB-MPI-03,Multiple myeloma , Phase 1
24703,D0W1TL,BB-MPI-03,Myelodysplastic syndrome , Phase 1
24704,D0W1US,PLECONARIL,Virus infection , Phase 2
24705,D0W1WF,4-iodo-6-phenylpyrimidine,Solid tumour/cancer , Investigative
24706,D0W1YM,AS-1406,Solid tumour/cancer , Terminated
24707,D0W1YV,PLX-5622,Autoimmune diabetes , Phase 1
24708,D0W1YX,BBT-031,Growth failure , Investigative
24709,D0W1YZ,TSERaM,Menopause symptom , Investigative
24710,D0W2AN,Emepronium,Urinary incontinence , Approved
24711,D0W2BF,Vadastuximab talirine,Acute myeloid leukaemia , Phase 3
24712,D0W2BF,Vadastuximab talirine,Myelodysplastic syndrome , Phase 2
24713,D0W2BK,ICo-007,Diabetic retinopathy , Phase 1
24714,D0W2BK,ICo-007,Diabetic macular edema , Phase 1
24715,D0W2CX,CG-100649,Arthritis , Phase 3
24716,D0W2DV,BM-13677,Diabetic complication , Terminated
24717,D0W2EA,Theradigm-Melanoma,Solid tumour/cancer , Discontinued in Phase 2
24718,D0W2ED,L-731735,Solid tumour/cancer , Terminated
24719,D0W2EG,ATL-1222,Diabetic nephropathy , Investigative
24720,D0W2EK,Ixabepilone,Breast cancer , Approved
24721,D0W2FG,OPHD-001,Clostridium infection , Discontinued in Phase 1
24722,D0W2FN,BBT-018,Neutropenia , Investigative
24723,D0W2FZ,Solithromycin,Bacillus anthracis infection , Phase 3
24724,D0W2HD,Mogamulizumab,Sezary syndrome , Approved
24725,D0W2HD,Mogamulizumab,Mycosis fungoides , Approved
24726,D0W2HD,Mogamulizumab,Cutaneous T-cell lymphoma , Phase 3
24727,D0W2HD,Mogamulizumab,T-cell leukaemia , Phase 2
24728,D0W2HD,Mogamulizumab,Solid tumour/cancer , Phase 1/2
24729,D0W2HG,Urocortin 2,Congestive heart failure , Phase 2
24730,D0W2IU,AVE-0847,Hyperlipidaemia , Discontinued in Phase 2
24731,D0W2JT,LXR-017,Myocardial infarction , Terminated
24732,D0W2JY,IC-47,Streptococcus infection , Discontinued in Phase 1
24733,D0W2KA,ANTI-TWEAK,Lupus , Phase 2
24734,D0W2KG,NT-69-L,Alcohol dependence , Investigative
24735,D0W2KR,CS-0240,Immune System disease , Investigative
24736,D0W2LR,Influenza virus vaccine,Influenza virus infection , Approved
24737,D0W2LW,NOX-151,Cerebrovascular ischaemia , Terminated
24738,D0W2MI,Anti-CD30-CAR-transduced T cells,leukaemia , Phase 1/2
24739,D0W2MI,Anti-CD30-CAR-transduced T cells,Lymphoma , Phase 1/2
24740,D0W2NM,Flunitrazepam,Insomnia , Approved
24741,D0W2NZ,VLI-04A,Bacillus anthracis infection , Investigative
24742,D0W2PK,Beloxepin,Depression , Discontinued in Phase 1
24743,D0W2PZ,Parasin I,Bacterial infection , Investigative
24744,D0W2RI,JTE-451,Plaque psoriasis , Phase 1
24745,D0W2RY,G530L,Obesity , Phase 1
24746,D0W2SO,Orazipone,Inflammatory bowel disease , Discontinued in Phase 1
24747,D0W2SX,NP-0336,Cognitive impairment , Investigative
24748,D0W2UY,E-5050,Hyperuricaemia , Discontinued in Phase 2
24749,D0W2VS,RGI-4100,Multiple sclerosis , Investigative
24750,D0W2ZX,UK-387618,Inflammation , Investigative
24751,D0W3AX,SB-281832,Asthma , Discontinued in Phase 1
24752,D0W3BA,Methanesulfonyl fluoride,Alzheimer disease , Phase 2
24753,D0W3BC,ATL1103,Acromegaly , Phase 1
24754,D0W3DV,Sotatercept,Myelodysplastic syndrome , Phase 2
24755,D0W3GE,Plague vaccine,Yersinia infection , Phase 2
24756,D0W3GE,Plague vaccine,leukaemia , Phase 2
24757,D0W3GL,SR-147778,Obesity , Phase 2
24758,D0W3GR,Prexigebersen,Acute myeloid leukaemia , Phase 2
24759,D0W3GR,Prexigebersen,Chronic myelogenous leukaemia , Phase 2
24760,D0W3JA,LA-8045,Acute coronary syndrome , Investigative
24761,D0W3JC,Heterocyclic derivative 7,Solid tumour/cancer , Patented
24762,D0W3JC,Heterocyclic derivative 7,Metastatic cancer , Patented
24763,D0W3JH,CM2489,Psoriasis vulgaris , Phase 1
24764,D0W3LI,LY333531,Solid tumour/cancer , Phase 2
24765,D0W3MH,BAY-94-9392,Solid tumour/cancer , Phase 2
24766,D0W3NN,Polygeline,Blood transfusion , Approved
24767,D0W3NR,BetaGRAFT,Diabetic complication , Investigative
24768,D0W3OQ,BMS-182566,Solid tumour/cancer , Terminated
24769,D0W3OS,Tibolone,Anabolic metabolism , Approved
24770,D0W3RA,Phenylsulfonyl derivative 1,Central nervous system disease , Patented
24771,D0W3RW,MK-2206,Rectal adenocarcinoma , Phase 2
24772,D0W3RW,MK-2206,Nasopharyngeal carcinoma , Investigative
24773,D0W3SQ,H-101,Solid tumour/cancer , Approved
24774,D0W3SX,FSHR NAM,Contraception , Investigative
24775,D0W3TC,ITV-3,Human immunodeficiency virus infection , Investigative
24776,D0W3TZ,Tgth-0100,Diabetic complication , Investigative
24777,D0W3UH,QLT-091568,Glaucoma/ocular hypertension , Phase 1/2
24778,D0W3UV,ABI-009,Solid tumour/cancer , Phase 2
24779,D0W3UV,ABI-009,Malignant perivascular epithelioid cell tumour , Phase 2
24780,D0W3UV,ABI-009,Non-muscle invasive bladder cancer , Phase 1/2
24781,D0W3UV,ABI-009,Pulmonary arterial hypertension , Phase 1
24782,D0W3WB,CWF-0808,Transplant rejection , Investigative
24783,D0W3WD,VRC-HIVADV027-00-VP,Human immunodeficiency virus infection , Phase 1
24784,D0W3YL,Bentoquatam,Contact dermatitis , Approved
24785,D0W3YW,DRF 10945,Hyperlipidaemia , Discontinued in Phase 1
24786,D0W4AA,PMID25666693-Compound-33,Osteoarthritis pain , Patented
24787,D0W4AA,PMID25666693-Compound-33,Cancer related pain , Patented
24788,D0W4AA,PMID25666693-Compound-33,Neuropathic pain , Patented
24789,D0W4AA,PMID25666693-Compound-33,Inflammatory pain , Patented
24790,D0W4AR,KUR-211,Ulcer , Phase 2
24791,D0W4CC,CPI-005,Cardiac failure , Investigative
24792,D0W4EB,Endoxifen,Breast cancer , Phase 2
24793,D0W4HA,MDX-018,Autoimmune diabetes , Phase 1
24794,D0W4HA,MDX-018,Solid tumour/cancer , Phase 1
24795,D0W4HJ,MSX-3,Parkinson disease , Investigative
24796,D0W4HO,IMT-504,Solid tumour/cancer , Investigative
24797,D0W4HW,SB-9000,Hepatitis B virus infection , Investigative
24798,D0W4HZ,Lonafarnib,Hutchinson-Gilford progeria syndrome , Approved
24799,D0W4HZ,Lonafarnib,Myelodysplastic syndrome , Phase 3
24800,D0W4HZ,Lonafarnib,Hepatitis D virus infection , Phase 2
24801,D0W4HZ,Lonafarnib,Non-small-cell lung cancer , Discontinued in Phase 3
24802,D0W4JI,INS-50589,Cardiovascular disease , Phase 2
24803,D0W4JY,CPZEN-45,Mycobacterium infection , Investigative
24804,D0W4NM,Oltipraz,Solid tumour/cancer , Phase 3
24805,D0W4OL,FK-633,Artery stenosis , Discontinued in Phase 2
24806,D0W4OZ,GG-8573,Obesity , Preclinical
24807,D0W4RB,BIOO-3,Solid tumour/cancer , Investigative
24808,D0W4SM,CD19 and CD22 CAR-T Cells,Lymphoma , Phase 1/2
24809,D0W4SS,Interferon beta,Solid tumour/cancer , Investigative
24810,D0W4TG,Recombinant botulinum neurotoxin vaccine,Migraine , Phase 3
24811,D0W4VH,Peptide-T,Neurodegenerative disorder , Phase 2
24812,D0W4WN,BT-101,Osteoporosis , Investigative
24813,D0W4WP,CVT-10216,Alcohol dependence , Investigative
24814,D0W4XY,PRX-08066,Pulmonary arterial hypertension , Phase 2
24815,D0W4YO,NOCICEPTIN,Headache , Phase 1
24816,D0W5BS,FerriSeltz,Gastrointestinal disease , Approved
24817,D0W5CI,DWJ-209,Alzheimer disease , Investigative
24818,D0W5EH,Sarizotan,Rett syndrome , Phase 2/3
24819,D0W5EH,Sarizotan,Parkinson disease , Discontinued in Phase 2
24820,D0W5EY,LpxCi-4,Multidrug resistant infection , Investigative
24821,D0W5GP,LN-020,Solid tumour/cancer , Terminated
24822,D0W5HA,XEP-018,Pain , Investigative
24823,D0W5HK,Sorafenib,Renal cell carcinoma , Approved
24824,D0W5HK,Sorafenib,Hepatocellular carcinoma , Phase 3
24825,D0W5HK,Sorafenib,Myelodysplastic syndrome , Phase 2
24826,D0W5IC,SF-103,Glaucoma/ocular hypertension , Investigative
24827,D0W5IF,CH-4933468,Prostate cancer , Investigative
24828,D0W5KA,Cefpiroxime,Bacterial infection , Discontinued in Phase 2
24829,D0W5KO,MesoTarg,Pancreatic cancer , Investigative
24830,D0W5LC,Forigerimod,Systemic lupus erythematosus , Phase 3
24831,D0W5LS,Desoxycorticosterone Pivalate,Addison disease , Approved
24832,D0W5MX,DTP vaccine,Bordetella pertussis infection , Approved
24833,D0W5NP,Anatumomab mafenatox,Breast cancer , Terminated
24834,D0W5NW,CMX-001,Solid tumour/cancer , Phase 3
24835,D0W5OV,DF-1111301,Allergy , Discontinued in Phase 1
24836,D0W5PN,Radezolid,Pneumonia , Phase 2
24837,D0W5PN,Radezolid,Acne vulgaris , Phase 2
24838,D0W5QJ,Anti-HIV ribozyme therapy,Human immunodeficiency virus infection , Phase 1/2
24839,D0W5RE,SUN-13837,Cerebrovascular ischaemia , Phase 2
24840,D0W5RL,Asoprisnil,Endometriosis , Discontinued in Phase 3
24841,D0W5UD,Adipose stem cell therapy,Myocardial infarction , Phase 1
24842,D0W5UV,Ethacrynate Sodium,High blood pressure , Approved
24843,D0W5VV,NVXT,Onychomycosis , Phase 2
24844,D0W5WH,ET-004,Human immunodeficiency virus infection , Investigative
24845,D0W5WZ,Tideglusib,Alzheimer disease , Phase 2
24846,D0W5WZ,Tideglusib,Coronavirus Disease 2019 (COVID-19) , Investigative
24847,D0W5XT,ARC-183,Blood forming organ disorder , Discontinued in Phase 1
24848,D0W5YC,Vacc-5q,Human immunodeficiency virus infection , Phase 1/2
24849,D0W5YP,WVE-120101,Huntington disease , Phase 1/2
24850,D0W5YY,PM-060184,Solid tumour/cancer , Phase 1
24851,D0W5ZU,Antova,Thrombocytopenia , Terminated
24852,D0W6AB,NC-100150,Cardiovascular disease , Discontinued in Phase 2
24853,D0W6AF,YM-264,Sepsis , Phase 2
24854,D0W6AQ,TZP-201,Diarrhea , Investigative
24855,D0W6BS,PRO-2000,Human immunodeficiency virus infection , Phase 3
24856,D0W6CA,Cefpodoxime,Bacterial infection , Approved
24857,D0W6DG,Pentazocine,Pain , Approved
24858,D0W6DY,Diphenylpyraline,Allergic rhinitis , Approved
24859,D0W6EP,AMG-889436,Parkinson disease , Investigative
24860,D0W6EV,ICGD,Solid tumour/cancer , Investigative
24861,D0W6GR,H1N1 influenza vaccine,Influenza virus infection , Approved
24862,D0W6HO,IMO-2055,Solid tumour/cancer , Phase 2
24863,D0W6HO,IMO-2055,Renal cell carcinoma , Phase 2
24864,D0W6KM,Dasotraline,Attention deficit hyperactivity disorder , Approved
24865,D0W6KM,Dasotraline,Mood disorder , Phase 3
24866,D0W6KM,Dasotraline,Eating disorder , Phase 3
24867,D0W6LI,Cosyntropin,Adrenocortical insufficiency , Approved
24868,D0W6LW,BIT225,Hepatitis C virus infection , Phase 1
24869,D0W6MA,E-2050,Cerebrovascular ischaemia , Terminated
24870,D0W6NW,SD-118,Inflammation , Phase 1
24871,D0W6PM,CNV-NT,Solid tumour/cancer , Phase 1
24872,D0W6QN,Choroid plexus cell therapy,Neurodegenerative disorder , Phase 1/2
24873,D0W6SS,Choriogonadotropin alfa,Female infertility , Approved
24874,D0W6TB,MK-7285,Inflammation , Investigative
24875,D0W6UV,FP-289,Autoimmune diabetes , Investigative
24876,D0W6WC,Apolizumab,Solid tumour/cancer , Phase 2
24877,D0W6WD,KP106,Attention deficit hyperactivity disorder , Discontinued in Phase 1
24878,D0W6XL,SB-209670,Arrhythmia , Discontinued in Phase 2
24879,D0W6XV,AbGn-7,Solid tumour/cancer , Phase 1
24880,D0W6YQ,SB therapeutics induced gene therapy,Ischemia , Investigative
24881,D0W6YR,PF-06817024,Atopic dermatitis , Phase 1
24882,D0W6ZF,Sevoflurane,Anaesthesia , Approved
24883,D0W6ZO,PMID26815044-Compound-30,Albinism , Patented
24884,D0W6ZO,PMID26815044-Compound-30,Ephelides , Patented
24885,D0W6ZO,PMID26815044-Compound-30,Menkes disease , Patented
24886,D0W6ZO,PMID26815044-Compound-30,Senile lentigines , Patented
24887,D0W6ZO,PMID26815044-Compound-30,Melasma , Patented
24888,D0W6ZV,HF-0420,Dementia , Investigative
24889,D0W7AB,Anti-BCMA CAR T cells,Multiple myeloma , Phase 1
24890,D0W7AE,HL-018,Diabetic complication , Phase 1
24891,D0W7CR,EZN-3889,Solid tumour/cancer , Investigative
24892,D0W7DD,BAY-44-3428,Asthma , Terminated
24893,D0W7DP,TDI-0107,Motor neurone disease , Investigative
24894,D0W7FC,MLN-2704,Prostate cancer , Phase 1/2
24895,D0W7FG,ALF-421,Acute liver failure , Investigative
24896,D0W7FS,PMID29338548-Compound-21,Schizophrenia , Patented
24897,D0W7GH,IC-747,Psoriasis vulgaris , Discontinued in Phase 2
24898,D0W7HE,Alpelisib,Breast cancer , Approved
24899,D0W7HE,Alpelisib,Solid tumour/cancer , Phase 2
24900,D0W7IR,DMP-543,Parkinson disease , Discontinued in Phase 2
24901,D0W7JZ,Tivozanib,Renal cell carcinoma , Approved
24902,D0W7KD,FANDOFLOXACIN HYDROCHLORIDE,Bacterial infection , Discontinued in Phase 2
24903,D0W7LO,PF9601N,Parkinson disease , Phase 1
24904,D0W7NL,PF-06647263,Solid tumour/cancer , Phase 1
24905,D0W7NV,TDI-0043,Motor neurone disease , Investigative
24906,D0W7OE,Aprindine,Cardiac arrhythmias , Approved
24907,D0W7OF,PMID20527968-compound-6577871,Severe acute respiratory syndrome (SARS) , Investigative
24908,D0W7OG,HPMA-gemcitabine conjugate,Solid tumour/cancer , Investigative
24909,D0W7PP,ST-0701,Cardiovascular disease , Investigative
24910,D0W7PQ,Glufosfomide,Pancreatic cancer , Phase 3
24911,D0W7RJ,Hetacillin,Bacterial infection , Approved
24912,D0W7RZ,ST-05,Spinal disease , Investigative
24913,D0W7SX,CNTO-3649,Type-2 diabetes , Phase 1
24914,D0W7TK,P-1118,Growth hormone deficiency , Investigative
24915,D0W7TQ,IDX-719,Hepatitis C virus infection , Phase 1/2
24916,D0W7TU,NSC-73306,Solid tumour/cancer , Investigative
24917,D0W7UC,VAL-101,Solid tumour/cancer , Investigative
24918,D0W7UD,Anti-PD-L1 CSR T cells,Glioblastoma multiforme , Phase 1
24919,D0W7UN,BI-409306,Psychiatric disorder , Phase 2
24920,D0W7UN,BI-409306,Alzheimer disease , Phase 2
24921,D0W7UN,BI-409306,Schizophrenia , Phase 2
24922,D0W7UO,CGP71683A,Obesity , Discontinued in Phase 3
24923,D0W7VE,Biphenyl mannoside derivative 20,Crohn disease , Patented
24924,D0W7VE,Biphenyl mannoside derivative 20,Ulcerative colitis , Patented
24925,D0W7VE,Biphenyl mannoside derivative 20,Urinary tract infection , Patented
24926,D0W7VG,AMG 108,Rheumatoid arthritis , Discontinued in Phase 2
24927,D0W7VQ,Imab-468,Solid tumour/cancer , Investigative
24928,D0W7VX,Statin,Hypercholesterolaemia , Investigative
24929,D0W7WC,Ivacaftor,Cystic fibrosis , Approved
24930,D0W7WG,Hormone-dependent vaccine,Prostate cancer , Terminated
24931,D0W7XH,DR2313,Stroke , Investigative
24932,D0W7XX,HS-HCV,Hepatitis C virus infection , Investigative
24933,D0W7YA,PP-202,Liver disease , Investigative
24934,D0W7ZN,SIM-916,Gynecological disease , Discontinued in Phase 1
24935,D0W7ZS,Del 60 tetramer,Solid tumour/cancer , Investigative
24936,D0W8AG,TPIV 100/110 vaccine,Breast cancer , Phase 1
24937,D0W8AI,Andromustine,Prostate cancer , Investigative
24938,D0W8BO,RA101495,Myasthenia gravis , Phase 3
24939,D0W8BO,RA101495,Paroxysmal nocturnal haemoglobinuria , Phase 2
24940,D0W8CA,Genz-667348,Malaria , Investigative
24941,D0W8CW,D-5519,Asthma , Phase 3
24942,D0W8DA,BI-54903,Asthma , Phase 2
24943,D0W8DG,L-19-PDT,Age-related macular degeneration , Investigative
24944,D0W8FE,CV-301,Breast cancer , Phase 2
24945,D0W8FE,CV-301,Diabetic neuropathy , Phase 2
24946,D0W8FE,CV-301,Bladder cancer , Phase 2
24947,D0W8FE,CV-301,Non-small-cell lung cancer , Phase 2
24948,D0W8FU,Autologous cartilage system,Cartilage lesions , Approved
24949,D0W8GP,DP-3590,Solid tumour/cancer , Investigative
24950,D0W8GT,SP160412,Sunburn , Phase 2
24951,D0W8HN,Bavencio,Merkel cell carcinoma , Approved
24952,D0W8HN,Bavencio,Gastric adenocarcinoma , Phase 3
24953,D0W8HN,Bavencio,Head and neck cancer , Phase 3
24954,D0W8HN,Bavencio,Urothelial carcinoma , Phase 3
24955,D0W8HN,Bavencio,Colon cancer , Phase 3
24956,D0W8HN,Bavencio,Melanoma , Phase 2
24957,D0W8HN,Bavencio,Breast cancer , Phase 2
24958,D0W8HN,Bavencio,Squamous cell carcinoma , Phase 2
24959,D0W8HN,Bavencio,Testicular cancer , Phase 2
24960,D0W8HN,Bavencio,Haematological malignancy , Phase 1
24961,D0W8HP,MEDI-543,Solid tumour/cancer , Preclinical
24962,D0W8HW,CAL-301,Klebsiella infection , Investigative
24963,D0W8IY,P-276,Breast cancer , Phase 2
24964,D0W8JE,Depudecin,Solid tumour/cancer , Preclinical
24965,D0W8JY,IL-4,Immune System disease , Investigative
24966,D0W8KT,AVI-4065,Hepatitis virus infection , Discontinued in Phase 1/2
24967,D0W8MS,Injectable MPL allergy vaccine,Seasonal allergic rhinitis , Phase 3
24968,D0W8NB,SC-005,Triple negative breast cancer , Phase 1
24969,D0W8NP,SAR-115740,Pain , Phase 1
24970,D0W8NZ,SC-112,Alcohol dependence , Terminated
24971,D0W8OH,SKF-96231,Asthma , Terminated
24972,D0W8OJ,A-348441,Type-2 diabetes , Phase 1
24973,D0W8PU,Prohibitin targeting peptide-1,Obesity , Phase 1
24974,D0W8QG,FR-229934,Erectile dysfunction , Terminated
24975,D0W8QH,ONO-4817,Inflammatory bowel disease , Discontinued in Phase 1
24976,D0W8QV,FK-613,Asthma , Discontinued in Phase 2
24977,D0W8RV,PMID26815044-Compound-116,Albinism , Patented
24978,D0W8RV,PMID26815044-Compound-116,Ephelides , Patented
24979,D0W8RV,PMID26815044-Compound-116,Menkes disease , Patented
24980,D0W8RV,PMID26815044-Compound-116,Senile lentigines , Patented
24981,D0W8RV,PMID26815044-Compound-116,Melasma , Patented
24982,D0W8RX,Sitimagene ceradenovec,Brain cancer , Discontinued in Phase 3
24983,D0W8SB,Penbutolol,Hypertension , Approved
24984,D0W8SJ,Minaprine,Depression , Approved
24985,D0W8TQ,SL-701,Glioblastoma of brain , Phase 2
24986,D0W8UV,NP-313,Thrombosis , Investigative
24987,D0W8UW,AMG-628,Pain , Investigative
24988,D0W8VC,PA-1637,Neurological disorder , Investigative
24989,D0W8VI,Co-122739,Anxiety disorder , Terminated
24990,D0W8VY,A-86719.1,Bacterial infection , Discontinued in Phase 2
24991,D0W8WG,CD19-targeting CAR T Cells,B-cell lymphoma , Phase 1/2
24992,D0W8XH,PI-103,Haematological malignancy , Investigative
24993,D0W8XT,Mibefradil,Glioblastoma multiforme , Phase 1
24994,D0W8XT,Mibefradil,Ovarian cancer , Withdrawn from market
24995,D0W8YY,HI-con1,Solid tumour/cancer , Phase 2
24996,D0W8YZ,IPZ-010,Allergy , Investigative
24997,D0W8ZE,G3139 + Dexamethasone,Multiple myeloma , Investigative
24998,D0W8ZW,PA-342,Mycobacterium infection , Terminated
24999,D0W9AB,Imidazopyridazine derivative 6,Pain , Patented
25000,D0W9AB,Imidazopyridazine derivative 6,Inflammation , Patented
25001,D0W9AI,MTC-DOX,Liver cancer , Phase 2/3
25002,D0W9CU,HLM-008182,Solid tumour/cancer , Investigative
25003,D0W9GA,Levormeloxifene,Breast cancer , Approved
25004,D0W9IH,Ad35-GRIN,Human immunodeficiency virus infection , Phase 1/2
25005,D0W9IT,NXN-462,Headache , Phase 2
25006,D0W9JH,BMY-30123,Acne vulgaris , Discontinued in Phase 2
25007,D0W9JM,KNI-272,Human immunodeficiency virus infection , Phase 2
25008,D0W9JP,Anti-Clostridium perfringens toxin mabs,Clostridium infection , Investigative
25009,D0W9KE,AS-1708727,Hypertriglyceridemia , Investigative
25010,D0W9LP,LC-9018,Solid tumour/cancer , Terminated
25011,D0W9LS,ACI-35,Alzheimer disease , Phase 1
25012,D0W9LX,Carvedilol,Congestive heart failure , Approved
25013,D0W9MJ,TPIV 110,Breast cancer , Phase 1
25014,D0W9MM,Vinblastine,Solid tumour/cancer , Approved
25015,D0W9NH,Tacedinaline,Solid tumour/cancer , Discontinued in Phase 2
25016,D0W9NO,YT-146,Hypertension , Phase 2
25017,D0W9OR,OspA lipoprotein,Lyme disease , Approved
25018,D0W9OW,RAP-310,Alzheimer disease , Investigative
25019,D0W9PG,Pyrazinoylguanidine,Diabetic complication , Discontinued in Phase 2
25020,D0W9QG,SBI-087,Rheumatoid arthritis , Phase 2
25021,D0W9QG,SBI-087,Multiple sclerosis , Phase 2
25022,D0W9QI,LErafAON,Solid tumour/cancer , Phase 1
25023,D0W9SL,LY2523355,Acute myeloid leukaemia , Phase 2
25024,D0W9SN,Pertuzumab + trastuzumab,Breast cancer , Phase 2
25025,D0W9SZ,T611,Virus infection , Discontinued in Phase 2
25026,D0W9TE,Pentaerythritol tetranitrate,Angina pectoris , Approved
25027,D0W9VB,Diphenidol,Nausea , Approved
25028,D0W9VW,TZP-101,Gastrointestinal disease , Phase 2b
25029,D0W9VW,TZP-101,Gastroparesis , Phase 2b
25030,D0W9VW,TZP-101,Ileus , Phase 2b
25031,D0W9WF,Ketoprofen,Musculoskeletal pain , Approved
25032,D0W9WF,Ketoprofen,Pain , Phase 3
25033,D0W9WF,Ketoprofen,Migraine , Phase 2
25034,D0W9WF,Ketoprofen,Osteoarthritis , Phase 1
25035,D0W9XF,LRN-281,Xerophthalmia , Investigative
25036,D0W9YW,BI-655130,Plaque psoriasis , Phase 2
25037,D0W9YW,BI-655130,Palmoplantar pustulosis , Phase 2
25038,D0W9ZF,Quinagolide,Hyperprolactinaemia , Approved
25039,D0W9ZS,Zn-DPA-H,Ischemic heart disease , Investigative
25040,D0W9ZT,ADL-5859,Rheumatoid arthritis , Phase 2
25041,D0W9ZY,CE-326597,Obesity , Discontinued in Phase 2
25042,D0WA1R,Keratinocyte growth factor,Solid tumour/cancer , Phase 1
25043,D0WA3T,CBNU-06,Alzheimer disease , Investigative
25044,D0WB0R,KPP203,Subacute cutaneous lupus erythematosus , Phase 2
25045,D0WB8J,PF-06647020 ,Solid tumour/cancer , Phase 1
25046,D0WB9V,Barbiturate,Depression , Approved
25047,D0WB9V,Barbiturate,Anaesthesia , Approved
25048,D0WC4Y,FCX-007,Dystrophic epidermolysis bullosa , Phase 1/2
25049,D0WC7S,Unsaturated long chain fatty acids,Multiple sclerosis , Investigative
25050,D0WD6K,VPM-4-001,Prostate cancer , Preclinical
25051,D0WD8M,Connexyn,Attention deficit hyperactivity disorder , Approved
25052,D0WD8R,MDP-01,Solid tumour/cancer , Investigative
25053,D0WE3O,Morphine,Chronic pain , Approved
25054,D0WF1S,Tomeglovir,Virus infection , Discontinued in Phase 2
25055,D0WF7H,ICT-111,Solid tumour/cancer , Investigative
25056,D0WF7K,Candoxatril,Hypertension , Phase 3
25057,D0WF7L,Brilinta,Thrombosis , Approved
25058,D0WF7L,Brilinta,Myocardial infarction , Phase 3
25059,D0WF7L,Brilinta,Arterial thrombosis , Phase 3
25060,D0WG1T,IC 1001,Non-small-cell lung cancer , Phase 1
25061,D0WG2R,Doravirine + lamivudine + tenofovir disoproxil fumarate,Human immunodeficiency virus-1 infection , Phase 3
25062,D0WG3X,HAC-1 vaccine,Influenza virus infection , Phase 1
25063,D0WG8A,Long-actingloop diuretic,Congestive heart failure , Phase 2
25064,D0WH1K,Amidine compound 2,Inflammation , Patented
25065,D0WH4L,AVN 211,Schizophrenia , Phase 2/3
25066,D0WH4P,ENASIDENIB MESYLATE,Acute myeloid leukaemia , Approved
25067,D0WH9U,FK-070,Angina pectoris , Phase 2
25068,D0WI1L,Arthromir,Rheumatoid arthritis , Investigative
25069,D0WI3T,Saquinavir,Human immunodeficiency virus infection , Approved
25070,D0WI7N,Imidazo pyridine derivative 1,Pruritus , Patented
25071,D0WI7N,Imidazo pyridine derivative 1,Solid tumour/cancer , Patented
25072,D0WI7N,Imidazo pyridine derivative 1,Chronic pain , Patented
25073,D0WI7N,Imidazo pyridine derivative 1,Neuropathic pain , Patented
25074,D0WI7N,Imidazo pyridine derivative 1,Thymic cancer , Patented
25075,D0WI9W,CPC-250,Alzheimer disease , Phase 1
25076,D0WJ1H,Replication-defective HIV vaccine,Human immunodeficiency virus-1 infection , Phase 1
25077,D0WJ3C,Hepatitis B prophylactic vaccine,Hepatitis B virus infection , Phase 1
25078,D0WJ3F,"N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 2",Osteoporosis , Patented
25079,D0WJ5M,Bimekizumab,Plaque psoriasis , Phase 3
25080,D0WJ5M,Bimekizumab,Psoriatic arthritis , Phase 2
25081,D0WJ7H,AGEN2034,Solid tumour/cancer , Phase 2
25082,D0WJ7H,AGEN2034,Cervical cancer , Phase 2
25083,D0WJ8M,U3-1402,Colorectal cancer , Phase 2
25084,D0WJ8M,U3-1402,Non-small-cell lung cancer , Phase 1
25085,D0WJ8R,PMID25666693-Compound-91,Osteoarthritis pain , Patented
25086,D0WJ8R,PMID25666693-Compound-91,Cancer related pain , Patented
25087,D0WJ8R,PMID25666693-Compound-91,Neuropathic pain , Patented
25088,D0WJ8R,PMID25666693-Compound-91,Inflammatory pain , Patented
25089,D0WK0P,Topiroxostat,Gout , Phase 2
25090,D0WK1M,Baltaleucel-T,Diffuse large B-cell lymphoma , Phase 2
25091,D0WK1M,Baltaleucel-T,Hodgkin lymphoma , Phase 2
25092,D0WK1M,Baltaleucel-T,Lymphoma , Phase 2
25093,D0WK1M,Baltaleucel-T,Post-transplant lymphoproliferative disorder , Phase 2
25094,D0WK6V,PF-05231023,Type-2 diabetes , Phase 1
25095,D0WK7B,FP-0220,Cardiovascular disease , Investigative
25096,D0WK7Y,Men ABCWY vaccine,Neisseria meningitis infection , Phase 2
25097,D0WK8I,Sulfonylated piperazine derivative 2,Obesity , Patented
25098,D0WL0G,PYN-17,Hepatitis C virus infection , Discontinued in Phase 2
25099,D0WL0Q,GS-5745,Gastric adenocarcinoma , Phase 3
25100,D0WL0Q,GS-5745,Ulcerative colitis , Phase 3
25101,D0WL0Q,GS-5745,Solid tumour/cancer , Phase 2
25102,D0WL0Q,GS-5745,Crohn disease , Phase 2
25103,D0WL0Q,GS-5745,Rheumatoid arthritis , Phase 1
25104,D0WL1C,Hementin,Thrombosis , Terminated
25105,D0WL1U,PMID25656651-Compound-5,Chronic myeloid leukaemia , Patented
25106,D0WL2E,PMID30940566-compound-6,Middle East Respiratory Syndrome (MERS) , Preclinical
25107,D0WL3H,LY03005,Depression , Phase 3
25108,D0WL4D,STX-100,Idiopathic pulmonary fibrosis , Phase 2
25109,D0WL5F,Grazax,Allergic rhinitis , Approved
25110,D0WL5P,Antibodie derivative 9,Corneal neovascularization , Patented
25111,D0WL5P,Antibodie derivative 9,Carotid artery disease , Patented
25112,D0WL5P,Antibodie derivative 9,Macular degeneration , Patented
25113,D0WL5P,Antibodie derivative 9,Solid tumour/cancer , Patented
25114,D0WL5T,BIIB076,Alzheimer disease , Phase 1
25115,D0WL5V,LAROPIPRANT,Coronary heart disease , Phase 4
25116,D0WL5V,LAROPIPRANT,Arteriosclerosis , Discontinued in Phase 3
25117,D0WL7V,ME-3738,Hepatitis virus infection , Discontinued in Phase 2
25118,D0WL8I,CJ-30001,Non-insulin dependent diabetes , Phase 3
25119,D0WM3D,TAR-200,Bladder cancer , Phase 1
25120,D0WM3E,INP-341,Skin burns , Preclinical
25121,D0WM3Z,TI-061,Solid tumour/cancer , Phase 1/2
25122,D0WM5H,OP-06,Solid tumour/cancer , Investigative
25123,D0WM5O,G1,Lymphoma , Phase 1/2
25124,D0WM5O,G1,Solid tumour/cancer , Phase 1/2
25125,D0WM6E,"3,5-diiodothyropropionic acid",Cardiovascular disease , Phase 2
25126,D0WM6E,"3,5-diiodothyropropionic acid",Congestive heart failure , Phase 2
25127,D0WM6I,Analatro,Poison intoxication , Phase 3
25128,D0WM7M,Anti-CD19 CAR-T cell therapy,B-cell lymphoma , Phase 1
25129,D0WM7M,Anti-CD19 CAR-T cell therapy,Haematological malignancy , Phase 1
25130,D0WM7M,Anti-CD19 CAR-T cell therapy,Lymphoma , Phase 1
25131,D0WM8D,CAD-1833,Essential tremor or related tremors , Phase 1
25132,D0WM8D,CAD-1833,Spinocerebellar ataxia , Phase 1
25133,D0WN0U,Felodipine,Hypertension , Approved
25134,D0WN1N,DM-204,Solid tumour/cancer , Investigative
25135,D0WN1T,99mTc-labelled adrenomedullin,Pulmonary hypertension , Phase 2
25136,D0WN2Y,CAR-T cells targeting Glypican-3 (GPC3),Hepatocellular carcinoma , Phase 1/2
25137,D0WN7T,MFH-147,Sepsis , Investigative
25138,D0WO2I,PMID26651364-Compound-111,Crohn disease , Patented
25139,D0WO2I,PMID26651364-Compound-111,Ulcerative colitis , Patented
25140,D0WO2I,PMID26651364-Compound-111,Urinary tract infection , Patented
25141,D0WO4T,PMID27998201-Compound-24,Meningioma tumour , Patented
25142,D0WO4T,PMID27998201-Compound-24,Glioma , Patented
25143,D0WO6C,PMID26651364-Compound-49,Crohn disease , Patented
25144,D0WO6C,PMID26651364-Compound-49,Ulcerative colitis , Patented
25145,D0WO6C,PMID26651364-Compound-49,Urinary tract infection , Patented
25146,D0WO7R,ABBV-181,Solid tumour/cancer , Phase 1
25147,D0WO8I,PD-2015,Alzheimer disease , Investigative
25148,D0WO8W,Mepivacaine,Analgesia , Approved
25149,D0WP0B,Acemannan,Human immunodeficiency virus infection , Approved
25150,D0WP0B,Acemannan,Canine and feline spontaneous neoplasm , Approved
25151,D0WP0U,CMB305,Soft tissue sarcoma , Phase 2
25152,D0WP0U,CMB305,Solid tumour/cancer , Phase 2
25153,D0WP1L,NPS-3,Dermatitis , Investigative
25154,D0WP2R,AC-201,Type-2 diabetes , Phase 2
25155,D0WP4E,RO-5271983,Asthma , Phase 1
25156,D0WP7P,NNC-55-0118,Insulin-dependent diabetes , Terminated
25157,D0WP9A,BIIB068,Systemic lupus erythematosus , Phase 1
25158,D0WQ0R,Anti-T-lymphocyte immune globulin,Graft-versus-host disease , Phase 3
25159,D0WQ5S,U-99363E,Schizophrenia , Preclinical
25160,D0WQ5U,MTR107,Intradialytic hypotension , Phase 2
25161,D0WQ9X,PMID30107136-Compound-Example1,Solid tumour/cancer , Patented
25162,D0WQ9X,PMID30107136-Compound-Example1,Infectious disease , Patented
25163,D0WQ9X,PMID30107136-Compound-Example1,Human immunodeficiency virus infection , Patented
25164,D0WQ9X,PMID30107136-Compound-Example1,Hepatitis , Patented
25165,D0WR3D,Abetimus sodium,Lupus , Discontinued in Phase 3
25166,D0WR7C,PH-94B,Anxiety disorder , Phase 2
25167,D0WR7U,REN-1053,Ischemic heart disease , Terminated
25168,D0WR9U,MEDI7352,Diabetic neuropathy , Phase 2
25169,D0WR9U,MEDI7352,Pain , Phase 1
25170,D0WR9U,MEDI7352,Osteoarthritis , Phase 1
25171,D0WS1V,L-751250,Obesity , Preclinical
25172,D0WS1X,Cefdinir,Bacterial infection , Approved
25173,D0WS4E,COR-388,Alzheimer disease , Phase 1
25174,D0WS5L,BIA-13,Respiratory disease , Investigative
25175,D0WS8K,Ilatreotide,Duodenal ulcer , Investigative
25176,D0WT0E,VasoPET,Coronary artery disease , Investigative
25177,D0WT1C,Benzothiazole analog 2,Albinism , Patented
25178,D0WT1C,Benzothiazole analog 2,Ephelides , Patented
25179,D0WT1C,Benzothiazole analog 2,Menkes disease , Patented
25180,D0WT1C,Benzothiazole analog 2,Senile lentigines , Patented
25181,D0WT1C,Benzothiazole analog 2,Melasma , Patented
25182,D0WT1W,PMID25666693-Compound-132,Osteoarthritis pain , Patented
25183,D0WT1W,PMID25666693-Compound-132,Cancer related pain , Patented
25184,D0WT1W,PMID25666693-Compound-132,Neuropathic pain , Patented
25185,D0WT1W,PMID25666693-Compound-132,Inflammatory pain , Patented
25186,D0WT6A,Ethylene diamine,Tuberculosis , Investigative
25187,D0WT8Z,TDI-0115,Motor neurone disease , Investigative
25188,D0WT9A,Vero-cell H5N1 vaccine,Influenza virus infection , Phase 1/2
25189,D0WT9J,Heteroaryl-carboxamide derivative 8,Solid tumour/cancer , Patented
25190,D0WT9J,Heteroaryl-carboxamide derivative 8,Metastatic cancer , Patented
25191,D0WU0K,Sporeamicins,Bacterial infection , Terminated
25192,D0WU1O,G1T38,Breast cancer , Phase 2
25193,D0WU1O,G1T38,Non-small-cell lung cancer , Phase 2
25194,D0WU2Y,ImmuStem,Graft-versus-host disease , Investigative
25195,D0WU3G,99mTc-RP-527,Breast cancer , Discontinued in Phase 2
25196,D0WU7X,EMB-001,Cocaine addiction , Phase 1
25197,D0WU8Z,BB-476,Arteriosclerosis , Terminated
25198,D0WV3U,Prazosin,Congestive heart failure , Approved
25199,D0WV3U,Prazosin,Benign prostatic hyperplasia , Approved
25200,D0WV3U,Prazosin,Hypertension , Approved
25201,D0WV4H,Hemomex I,Solid tumour/cancer , Phase 3
25202,D0WV4M,Propicillin,Bacterial infection , Approved
25203,D0WV4N,AHR-14042,Anxiety disorder , Terminated
25204,D0WV8Z,MEDI4166,Type-2 diabetes , Phase 2
25205,D0WV9J,Beta-cyclodextrin conjugate derivative 5,Crohn disease , Patented
25206,D0WV9J,Beta-cyclodextrin conjugate derivative 5,Ulcerative colitis , Patented
25207,D0WV9J,Beta-cyclodextrin conjugate derivative 5,Urinary tract infection , Patented
25208,D0WW1V,MM-310,Solid tumour/cancer , Phase 1
25209,D0WW3O,XEN1101,Epilepsy , Phase 1
25210,D0WW7U,BFPT-12603,Asthma , Investigative
25211,D0WW9B,Aryl mannoside derivative 18,Crohn disease , Patented
25212,D0WW9B,Aryl mannoside derivative 18,Ulcerative colitis , Patented
25213,D0WW9B,Aryl mannoside derivative 18,Urinary tract infection , Patented
25214,D0WX1I,ProVax,Human immunodeficiency virus infection , Investigative
25215,D0WX1N,Ensemblin macrocycle,Immune System disease , Investigative
25216,D0WX3N,KRP-110,Constipation , Investigative
25217,D0WX4H,Heterocyclic derivative 19,Solid tumour/cancer , Patented
25218,D0WX4H,Heterocyclic derivative 19,Metastatic cancer , Patented
25219,D0WX4W,PMID25666693-Compound-120,Osteoarthritis pain , Patented
25220,D0WX4W,PMID25666693-Compound-120,Cancer related pain , Patented
25221,D0WX4W,PMID25666693-Compound-120,Neuropathic pain , Patented
25222,D0WX4W,PMID25666693-Compound-120,Inflammatory pain , Patented
25223,D0WX5V,LP-205A1,Solid tumour/cancer , Investigative
25224,D0WY0N,ALKASAR-18,Solid tumour/cancer , Discontinued in Phase 1/2
25225,D0WY1E,MB-106,B-cell non-hodgkin lymphoma , Phase 1/2
25226,D0WY2L,GSK1018921,Schizophrenia , Discontinued in Phase 1
25227,D0WY3J,Pfizer 4,Female sexual arousal dysfunction , Phase 1
25228,D0WY5Q,Rivastigmine,Alzheimer disease , Approved
25229,D0WY9F,MenAfriVac,Neisseria meningitis infection , Approved
25230,D0WY9H,ZD-0892,Chronic obstructive pulmonary disease , Discontinued in Phase 1
25231,D0WY9N,Agrimophol,Parasitic infection , Approved
25232,D0WZ0E,TV-Kidney-1,Renal cell carcinoma , Phase 2
25233,D0WZ0X,ABP 980,Breast cancer , Phase 3
25234,D0WZ0X,ABP 980,Gastric adenocarcinoma , Phase 3
25235,D0WZ3G,Entolimod,Solid tumour/cancer , Phase 1
25236,D0WZ3G,Entolimod,Colorectal cancer , Phase 1
25237,D0WZ3G,Entolimod,Radiation syndrome , Phase 1
25238,D0WZ4J,CYC-800,Solid tumour/cancer , Preclinical
25239,D0WZ9R,PRS-343,Solid tumour/cancer , Phase 1
25240,D0WZ9T,CGP-44532,Drug abuse , Investigative
25241,D0WZC1,JNJ-61393215,Major depressive disorder , Phase 2
25242,D0WZX4,AB-205,Non-hodgkin lymphoma , Phase 1/2
25243,D0X0CB,Lumacaftor,Cystic fibrosis , Phase 2
25244,D0X0CH,Ganaxolone,Complex partial seizure , Phase 3
25245,D0X0CH,Ganaxolone,Postpartum depression , Phase 2
25246,D0X0EF,XGP-210,Solid tumour/cancer , Investigative
25247,D0X0EU,E-5531,Sepsis , Discontinued in Phase 2
25248,D0X0FU,KP-1461,Pneumococcal infection , Phase 2
25249,D0X0FU,KP-1461,Human immunodeficiency virus infection , Phase 2
25250,D0X0FW,B1-655075,Coagulation defect , Phase 1
25251,D0X0GB,LetibotulinumtoxinA,Glabellar frown line , Phase 3
25252,D0X0GI,Gadoversetamide,Myocardial infarction , Approved
25253,D0X0IQ,Modified GDNF,Parkinson disease , Investigative
25254,D0X0IU,LMB-2,Chronic lymphocytic leukaemia , Phase 2
25255,D0X0IY,Rolofylline,Heart failure , Phase 3
25256,D0X0KJ,Chlorotrianisene,Menopause symptom , Withdrawn from market
25257,D0X0KM,Tasisulam,Acute myeloid leukaemia , Phase 3
25258,D0X0NA,R-524,Graft-versus-host disease , Investigative
25259,D0X0OF,Pennvax-G,Human immunodeficiency virus infection , Phase 1
25260,D0X0OT,Needle-free ETEC vaccine,Diarrhea , Discontinued in Phase 3
25261,D0X0PP,AMG 579,Schizophrenia , Phase 1
25262,D0X0PQ,NHS-IL2-LT,Solid tumour/cancer , Phase 2
25263,D0X0PW,Revamilast,Asthma , Phase 2
25264,D0X0QC,DES-6,Cytomegalovirus infection , Terminated
25265,D0X0RI,Mexiletine,Ventricular tachycardia , Approved
25266,D0X0RV,PMID26815044-Compound-47,Albinism , Patented
25267,D0X0RV,PMID26815044-Compound-47,Ephelides , Patented
25268,D0X0RV,PMID26815044-Compound-47,Menkes disease , Patented
25269,D0X0RV,PMID26815044-Compound-47,Senile lentigines , Patented
25270,D0X0RV,PMID26815044-Compound-47,Melasma , Patented
25271,D0X0SK,GSK-2302025A,Melanoma , Phase 2
25272,D0X0TM,Trichuris suis ova,Allergic rhinitis , Phase 2
25273,D0X0WQ,SHP680,Neurologic conditions associated with aminoacylase 1 deficiency , Phase 1
25274,D0X0WU,Tolperisone,Muscle spasm , Approved
25275,D0X0ZD,EXRD-4605,Hypertension , Investigative
25276,D0X0ZK,HG-1343,Solid tumour/cancer , Investigative
25277,D0X1BJ,Denibulin,Solid tumour/cancer , Discontinued in Phase 1
25278,D0X1BR,MEDI-550,Human immunodeficiency virus infection , Phase 1
25279,D0X1BX,hESC-derived pancreatic endoderm (VC-01),Type-1 diabetes , Phase 1/2
25280,D0X1EV,TNT009,Bullous pemphigoid , Phase 1
25281,D0X1EV,TNT009,Cold type autoimmune haemolytic anemia , Phase 1
25282,D0X1EX,TIBENELAST,Asthma , Discontinued in Phase 2
25283,D0X1EZ,Cyclofenil,Infertility , Approved
25284,D0X1HE,Ozenoxacin,Impetigo , Approved
25285,D0X1HE,Ozenoxacin,Bacterial infection , Phase 3
25286,D0X1IB,"111In-labeled LFA-1 targeted imaging agent (lymphoma/leukemia), NuView/University of New Mexico",leukaemia , Investigative
25287,D0X1IL,SPC4955,High blood cholesterol level , Phase 1
25288,D0X1LE,ST-383,Ebola virus infection , Investigative
25289,D0X1LO,EMR-62203,Erectile dysfunction , Discontinued in Phase 2
25290,D0X1LP,N-acylpiperidine ether derivative 3,Pruritus , Patented
25291,D0X1LP,N-acylpiperidine ether derivative 3,Solid tumour/cancer , Patented
25292,D0X1LP,N-acylpiperidine ether derivative 3,Chronic pain , Patented
25293,D0X1LP,N-acylpiperidine ether derivative 3,Neuropathic pain , Patented
25294,D0X1LP,N-acylpiperidine ether derivative 3,Thymic cancer , Patented
25295,D0X1LW,Ragweed pollen allergen sublingual immunotherapy,Allergy , Phase 1
25296,D0X1NX,ACE-920,Escherichia coli infection , Investigative
25297,D0X1OO,PMID25666693-Compound-39,Osteoarthritis pain , Patented
25298,D0X1OO,PMID25666693-Compound-39,Cancer related pain , Patented
25299,D0X1OO,PMID25666693-Compound-39,Neuropathic pain , Patented
25300,D0X1OO,PMID25666693-Compound-39,Inflammatory pain , Patented
25301,D0X1OV,HO/07/09,Wound healing , Investigative
25302,D0X1OW,AZD9496,Breast cancer , Phase 1
25303,D0X1QM,AT-001,Solid tumour/cancer , Phase 1
25304,D0X1QN,Neurotrophic factor-producing stem cells,Multiple sclerosis , Investigative
25305,D0X1RQ,MTR105,Hypotension , Phase 2
25306,D0X1RR,Coccidioidin,Dermatomycosis , Approved
25307,D0X1ST,ESR0114,Plaque psoriasis , Phase 1/2
25308,D0X1SV,Epratuzumab Y-90,Non-hodgkin lymphoma , Phase 1/2
25309,D0X1TD,RemeStim-CEA,Solid tumour/cancer , Terminated
25310,D0X1VJ,AGI-1067,Artery stenosis , Phase 3
25311,D0X1WJ,Josamycin,Bacterial infection , Approved
25312,D0X1XA,62Cu-ETS,Kidney disease , Phase 2
25313,D0X1XK,CPC-212,Alzheimer disease , Phase 1
25314,D0X1YF,T-1095,Diabetic complication , Discontinued in Phase 2
25315,D0X1YZ,KM-4056,Solid tumour/cancer , Investigative
25316,D0X1ZV,Trimidox,Solid tumour/cancer , Preclinical
25317,D0X2DK,Phenoxybenzamine,Malignant essential hypertension , Approved
25318,D0X2EM,UNI-PH (1-34),Osteoporosis , Phase 2
25319,D0X2FT,Gadoxetate disodium,Imaging , Approved
25320,D0X2GM,PRX-12256,Neurological disorder , Investigative
25321,D0X2HD,ELS-120,Herpes simplex virus infection , Investigative
25322,D0X2HE,GlycoPEG-GCSF,Solid tumour/cancer , Approved
25323,D0X2HJ,PTI-125,Alzheimer disease , Phase 1
25324,D0X2IE,Dimercaprol,Poison intoxication , Approved
25325,D0X2JM,XL418,Solid tumour/cancer , Phase 1
25326,D0X2JY,Multiclade DNA recombinant adenovirus-5 (rAd5) vaccine,Human immunodeficiency virus-1 infection , Phase 1/2
25327,D0X2KY,99mTc-Hynic-Annexin V,Solid tumour/cancer , Discontinued in Phase 2
25328,D0X2LB,IDP-120,Acne vulgaris , Phase 2
25329,D0X2LQ,LY03004,Schizophrenia , Phase 3
25330,D0X2LV,Betamethasone butyrate propion,Inflammation , Approved
25331,D0X2LW,DPT/Hib vaccine,Infectious disease , Phase 3
25332,D0X2MB,Oxprenolol,Hypertension , Approved
25333,D0X2MZ,Syn-1020,Pain , Investigative
25334,D0X2NB,AZD-6319,Alzheimer disease , Investigative
25335,D0X2NE,PAT-SM3,Solid tumour/cancer , Investigative
25336,D0X2NN,BIBT986,Thrombosis , Phase 1
25337,D0X2OV,ONO-8711,Pain , Terminated
25338,D0X2PQ,IX207-887,Rheumatoid arthritis , Discontinued in Phase 2
25339,D0X2PR,MEDI-541,Inflammation , Investigative
25340,D0X2QH,PBI-1402,Anemia , Phase 1/2
25341,D0X2RJ,Technetium TC 99M votumumab,Colorectal cancer , Approved
25342,D0X2RL,LY3012212,Bladder cancer , Phase 2
25343,D0X2RL,LY3012212,Arteriosclerosis , Phase 2
25344,D0X2SY,CR-3663,Osteoarthritis , Investigative
25345,D0X2TO,Adatanserin,Mood disorder , Discontinued in Phase 2
25346,D0X2TZ,Streptococcus pneumoniae vaccine,Pneumonia , Phase 1
25347,D0X2TZ,Streptococcus pneumoniae vaccine,Meningitis , Phase 1
25348,D0X2TZ,Streptococcus pneumoniae vaccine,Streptococcus infection , Phase 1
25349,D0X2UE,Sulprostone,Medical abortion , Approved
25350,D0X2UI,LIK-066,Type-2 diabetes , Phase 2
25351,D0X2UI,LIK-066,Heart failure , Phase 2
25352,D0X2UK,Affitope AD-01,Alzheimer disease , Phase 1
25353,D0X2XF,Piboserod,Atrial fibrillation , Phase 2
25354,D0X2XZ,CFI-400945,Breast cancer , Phase 2
25355,D0X2YI,IPLl576092,Asthma , Discontinued in Phase 1
25356,D0X3AK,GL-438,Hepatitis E virus infection , Phase 4
25357,D0X3BG,Acid sphingomyelinase,Niemann-pick disease , Phase 1
25358,D0X3CD,Thiarabine,Solid tumour/cancer , Phase 1
25359,D0X3ER,OP-145,Otitis media , Phase 2
25360,D0X3ER,OP-145,Chronic suppurative otitis media , Phase 2
25361,D0X3ER,OP-145,Bronchitis , Discontinued in Phase 2
25362,D0X3FX,Naloxone,Narcotic depression , Approved
25363,D0X3FX,Naloxone,Respiratory depression , Phase 3
25364,D0X3FX,Naloxone,Pruritus , Phase 3
25365,D0X3FX,Naloxone,Opioid dependence , Phase 1
25366,D0X3GA,NN8717,Graft-versus-host disease , Phase 3
25367,D0X3GD,LPCVD,Cardiovascular disease , Investigative
25368,D0X3HV,BI-695500,Follicular lymphoma , Phase 3
25369,D0X3HV,BI-695500,Rheumatoid arthritis , Phase 3
25370,D0X3HV,BI-695500,Chronic lymphocytic leukaemia , Phase 3
25371,D0X3HV,BI-695500,Non-hodgkin lymphoma , Phase 3
25372,D0X3HV,BI-695500,Solid tumour/cancer , Clinical trial
25373,D0X3HV,BI-695500,Diffuse large B-cell lymphoma , Application submitted
25374,D0X3JK,V120083,Chronic pain , Phase 2
25375,D0X3JV,MalariVax,Malaria , Phase 1
25376,D0X3JY,NTX-010,Small-cell lung cancer , Phase 2
25377,D0X3KX,U-80816,Amnesia , Terminated
25378,D0X3LD,Valtorcitabine,Hepatitis virus infection , Discontinued in Phase 2
25379,D0X3NK,MP-PN-1,Solid tumour/cancer , Investigative
25380,D0X3OF,NPT-1162,Non-insulin dependent diabetes , Investigative
25381,D0X3OI,TAK-700,Prostate cancer , Phase 3
25382,D0X3PN,DR-5/DR-4 cross reactive mabs,Solid tumour/cancer , Investigative
25383,D0X3QL,PD-3766,Chronic obstructive pulmonary disease , Investigative
25384,D0X3QR,AVA-101,Age-related macular degeneration , Phase 2
25385,D0X3RK,LLY-507,Solid tumour/cancer , Preclinical
25386,D0X3TI,SRT3025,Type-2 diabetes , Phase 1
25387,D0X3UW,Saurestat,Staphylococcus infection , Investigative
25388,D0X3XV,AdCMV-PR8.ha,Influenza virus infection , Phase 1
25389,D0X3YY,OMP-52M51,Solid tumour/cancer , Phase 1
25390,D0X4AN,CGEN-791,Melanoma , Investigative
25391,D0X4AV,GV-150013,Anxiety disorder , Discontinued in Phase 2
25392,D0X4BZ,Virulizin,Breast cancer , Approved
25393,D0X4CE,NMK-36,Solid tumour/cancer , Phase 2
25394,D0X4CS,Cefroxadine,Bacterial infection , Approved
25395,D0X4DB,Drisapersen,Duchenne dystrophy , Phase 3
25396,D0X4DJ,Tumor-associated macrophage immunotherapy,Solid tumour/cancer , Investigative
25397,D0X4EC,Benzoic acid linked peptide analog 5,Albinism , Patented
25398,D0X4EC,Benzoic acid linked peptide analog 5,Ephelides , Patented
25399,D0X4EC,Benzoic acid linked peptide analog 5,Menkes disease , Patented
25400,D0X4EC,Benzoic acid linked peptide analog 5,Senile lentigines , Patented
25401,D0X4EC,Benzoic acid linked peptide analog 5,Melasma , Patented
25402,D0X4FM,Docusate,Constipation , Approved
25403,D0X4FW,AT9183,leukaemia , Phase 1/2
25404,D0X4FY,Cis-tetracosenoyl sulfatide,Motor neurone disease , Investigative
25405,D0X4IA,FK778,Kidney/heart transplant rejection , Discontinued in Phase 2
25406,D0X4IH,Fluciclatide F-18,Solid tumour/cancer , Phase 2
25407,D0X4IO,Sulforaphane,Solid tumour/cancer , Investigative
25408,D0X4IO,Sulforaphane,Skin disease , Investigative
25409,D0X4IV,PSD-508,Dysmenorrhea , Discontinued in Phase 2
25410,D0X4JN,Pelubiprofen,Back pain , Approved
25411,D0X4JO,EncorStat,Corneal abrasion , Investigative
25412,D0X4KN,BI-836845,Solid tumour/cancer , Phase 1
25413,D0X4LA,N-acylpyrrolidine ether derivative 1,Pruritus , Patented
25414,D0X4LA,N-acylpyrrolidine ether derivative 1,Solid tumour/cancer , Patented
25415,D0X4LA,N-acylpyrrolidine ether derivative 1,Chronic pain , Patented
25416,D0X4LA,N-acylpyrrolidine ether derivative 1,Neuropathic pain , Patented
25417,D0X4LA,N-acylpyrrolidine ether derivative 1,Thymic cancer , Patented
25418,D0X4MC,AMG 076,Obesity , Discontinued in Phase 1
25419,D0X4MN,CC-930,Discoid lupus erythematosus , Phase 2
25420,D0X4MN,CC-930,Idiopathic pulmonary fibrosis , Phase 2
25421,D0X4MO,SPVF-2801-30,Solid tumour/cancer , Investigative
25422,D0X4NF,Radiosensitizer gene therapy,Pancreatic cancer , Phase 3
25423,D0X4OJ,AdipoCell,Heart failure , Phase 1/2
25424,D0X4OJ,AdipoCell,Congestive heart failure , Phase 1/2
25425,D0X4OM,SPD-701,Influenza virus infection , Discontinued in Phase 1
25426,D0X4RN,Lidocaine,Anaesthesia , Approved
25427,D0X4RN,Lidocaine,Dysmenorrhea , Phase 2
25428,D0X4RS,Cortisone Acetate,Solid tumour/cancer , Approved
25429,D0X4RT,DS-7423,Solid tumour/cancer , Phase 1
25430,D0X4SI,RS-504393,Chronic obstructive pulmonary disease , Preclinical
25431,D0X4TK,Nadofaragene firadenovec,Bladder cancer , Phase 3
25432,D0X4TV,PMID26651364-Compound-118,Crohn disease , Patented
25433,D0X4TV,PMID26651364-Compound-118,Ulcerative colitis , Patented
25434,D0X4TV,PMID26651364-Compound-118,Urinary tract infection , Patented
25435,D0X4UA,DISC GM-CSF,Melanoma , Terminated
25436,D0X4UH,S-8184,Ovarian cancer , Preclinical
25437,D0X4UP,Liposomal amikacin,Mycobacterium infection , Phase 3
25438,D0X4UP,Liposomal amikacin,Bronchiectasis , Phase 2
25439,D0X4VA,Imlygictalimogene laherparepvec,Peripheral nervous system tumour , Phase 1
25440,D0X4VG,Anti-Notch-1 receptor mabs,Solid tumour/cancer , Investigative
25441,D0X4WV,IDV-007,Glaucoma/ocular hypertension , Investigative
25442,D0X4YJ,ImCOOH,Acne vulgaris , Phase 2
25443,D0X4ZL,AN-1792,Alzheimer disease , Phase 2
25444,D0X4ZR,Bupropion,Smoking dependence , Approved
25445,D0X4ZV,BAX-499,Factor IX deficiency , Phase 1
25446,D0X5AN,U300,Type-2 diabetes , Phase 3
25447,D0X5BC,DT-320,Solid tumour/cancer , Investigative
25448,D0X5CU,AM-491,Hepatitis B virus infection , Terminated
25449,D0X5ES,NCX 950,Asthma , Discontinued in Phase 1/2
25450,D0X5GF,K22,Severe acute respiratory syndrome (SARS) , Preclinical
25451,D0X5GF,K22,Middle East Respiratory Syndrome (MERS) , Preclinical
25452,D0X5IV,"1,2,4-oxadiazole derivative 6",Solid tumour/cancer , Patented
25453,D0X5IV,"1,2,4-oxadiazole derivative 6",Infectious disease , Patented
25454,D0X5IV,"1,2,4-oxadiazole derivative 6",Human immunodeficiency virus infection , Patented
25455,D0X5IV,"1,2,4-oxadiazole derivative 6",Hepatitis , Patented
25456,D0X5JF,AR-H050642,Heart arrhythmia , Terminated
25457,D0X5KF,Hydrocodone,Pain , Approved
25458,D0X5LG,ABJ-879,Solid tumour/cancer , Discontinued in Phase 1
25459,D0X5LL,WBI-2000,Solid tumour/cancer , Investigative
25460,D0X5NX,Clenbuterol,Chronic breathing disorder , Approved
25461,D0X5OV,TTA-A8,Insomnia , Preclinical
25462,D0X5SD,Disulfiram,Alcohol dependence , Approved
25463,D0X5SI,Carbocisteine,Chronic obstructive pulmonary disease , Approved
25464,D0X5SJ,Alacepril,Cardiovascular disease , Approved
25465,D0X5UH,ADOZELESIN,Solid tumour/cancer , Discontinued in Phase 2
25466,D0X5UL,Salmonella typhi vaccine,Salmonella infection , Approved
25467,D0X5UN,Mirabegron,Overactive bladder , Approved
25468,D0X5UY,HL-146,Solid tumour/cancer , Investigative
25469,D0X5VH,Monoamine derivative 4,Albinism , Patented
25470,D0X5VH,Monoamine derivative 4,Ephelides , Patented
25471,D0X5VH,Monoamine derivative 4,Menkes disease , Patented
25472,D0X5VH,Monoamine derivative 4,Senile lentigines , Patented
25473,D0X5VH,Monoamine derivative 4,Melasma , Patented
25474,D0X5WJ,Levodropropizine,Cough , Approved
25475,D0X5XU,Decitabine,Myelodysplastic syndrome , Approved
25476,D0X5YN,CHS-1420,Plaque psoriasis , Phase 3
25477,D0X5YU,KOS-2484,Solid tumour/cancer , Preclinical
25478,D0X5ZH,LC-445,Solid tumour/cancer , Investigative
25479,D0X5ZI,Ambrisentan,Pulmonary arterial hypertension , Approved
25480,D0X5ZO,SSR-162369,Type-2 diabetes , Discontinued in Phase 1
25481,D0X5ZU,ET-01,Facial wrinkles , Phase 2
25482,D0X6AU,FAS-031,Solid tumour/cancer , Investigative
25483,D0X6BV,Vilazodone,Major depressive disorder , Approved
25484,D0X6BX,ABC294640,Advanced solid tumour , Phase 3
25485,D0X6BX,ABC294640,Hepatocellular carcinoma , Phase 2
25486,D0X6BX,ABC294640,Cholangiocarcinoma , Phase 2
25487,D0X6BX,ABC294640,Multiple myeloma , Phase 1/2
25488,D0X6DC,STM 434,Ovarian cancer , Phase 1
25489,D0X6DE,FemiVac,Bacterial infection , Phase 3
25490,D0X6DK,TDI-0098,Motor neurone disease , Investigative
25491,D0X6EM,T2c-001,Congestive heart failure , Phase 2
25492,D0X6EX,OX-MPI,Inflammation , Investigative
25493,D0X6FB,KI-0903,Immune System disease , Investigative
25494,D0X6FF,SPPI-339,Attention deficit hyperactivity disorder , Terminated
25495,D0X6FU,C-CAR011,Non-hodgkin lymphoma , Phase 1
25496,D0X6GN,Loteprednol Etabonate,Eye inflammation , Approved
25497,D0X6GP,PF-04577806,Diabetic neuropathy , Investigative
25498,D0X6HD,Anileridine,Pain , Approved
25499,D0X6IU,Chloramphenicol,Bacterial infection , Approved
25500,D0X6LC,Monteplase,Thrombin deficiency , Approved
25501,D0X6LG,MC-1002,Diabetic complication , Preclinical
25502,D0X6MO,Ralitoline,Epilepsy , Terminated
25503,D0X6NU,Debio-1142,Solid tumour/cancer , Investigative
25504,D0X6NZ,AFN-1720,Bacterial infection , Phase 2
25505,D0X6OW,Cefminox sodium,Bacterial infection , Approved
25506,D0X6OX,CAB-051,Solid tumour/cancer , Investigative
25507,D0X6PG,LY-274614,Dementia , Terminated
25508,D0X6QL,KGP94,Coagulation defect , Clinical trial
25509,D0X6SZ,GNTI,Obesity , Preclinical
25510,D0X6TZ,RCD-1,Stress urinary incontinence , Preclinical
25511,D0X6VC,HIV vaccine,Human immunodeficiency virus infection , Phase 1
25512,D0X6XC,Lm Ft,Tularemia , Investigative
25513,D0X6XF,VTP-201227,Psoriatic disorder , Discontinued in Phase 2
25514,D0X6XH,CM-2395,Schizophrenia , Phase 3
25515,D0X6XP,JIN-2011,Solid tumour/cancer , Investigative
25516,D0X6ZG,XEN-D0101,Atrial fibrillation , Phase 1
25517,D0X7BN,AP32788,Non-small-cell lung cancer , Phase 1
25518,D0X7CV,PTX-200,Parkinson disease , Phase 2
25519,D0X7CV,PTX-200,Breast cancer , Phase 2
25520,D0X7CV,PTX-200,Acute myeloid leukaemia , Phase 1
25521,D0X7CV,PTX-200,Ovarian cancer , Phase 1
25522,D0X7DE,Nefazodone,Major depressive disorder , Approved
25523,D0X7DE,Nefazodone,Depression , Withdrawn from market
25524,D0X7DZ,"Pyrazolo[1,5-a]pyrimidine derivative 1",Obesity , Patented
25525,D0X7EG,OC-000459,Allergy , Phase 2
25526,D0X7EQ,Resorcinol compound 19,Albinism , Patented
25527,D0X7EQ,Resorcinol compound 19,Ephelides , Patented
25528,D0X7EQ,Resorcinol compound 19,Menkes disease , Patented
25529,D0X7EQ,Resorcinol compound 19,Senile lentigines , Patented
25530,D0X7EQ,Resorcinol compound 19,Melasma , Patented
25531,D0X7GA,RO-6036,Obesity , Investigative
25532,D0X7GL,Retigabine,Behcet disease , Approved
25533,D0X7GL,Retigabine,Epilepsy , Withdrawn from market
25534,D0X7GU,Rizaport,Migraine , Application submitted
25535,D0X7GX,Dendritic cancer vaccine,Solid tumour/cancer , Phase 1/2
25536,D0X7HM,Carboplatin,Ovarian cancer , Approved
25537,D0X7HN,PMID26651364-Compound-50,Crohn disease , Patented
25538,D0X7HN,PMID26651364-Compound-50,Ulcerative colitis , Patented
25539,D0X7HN,PMID26651364-Compound-50,Urinary tract infection , Patented
25540,D0X7HQ,NitroSense PA6,Neuropathic pain , Phase 1
25541,D0X7HV,ZD-6169,Urinary incontinence , Discontinued in Phase 2
25542,D0X7IN,BGT226,Solid tumour/cancer , Phase 1/2
25543,D0X7IT,Ioxaglate,Cardiovascular disease , Approved
25544,D0X7IW,Tolerizing peptide,Allergic rhinitis , Discontinued in Phase 2
25545,D0X7JC,BAY-86-4367,Solid tumour/cancer , Phase 1
25546,D0X7JN,Clavulanate,Bacterial infection , Approved
25547,D0X7JR,Eflornithine,African trypanosomiasis , Approved
25548,D0X7JR,Eflornithine,Trypanosomiasis , Phase 2
25549,D0X7KB,Lisuride,Parkinson disease , Approved
25550,D0X7KB,Lisuride,Fibrosis , Phase 3
25551,D0X7KZ,Strontium ranelate,Osteoporosis , Approved
25552,D0X7LY,CT-100,Kidney disease , Investigative
25553,D0X7MY,AGS-16 mab,Renal cell carcinoma , Phase 1
25554,D0X7NT,SAF-312,Pain , Discontinued in Phase 2
25555,D0X7NU,Pralidoxime Chloride,Poisoning due to pesticides and chemicals , Approved
25556,D0X7OE,PMID32321856-compound-11a,Coronavirus Disease 2019 (COVID-19) , Investigative
25557,D0X7OH,EPZ028862,Solid tumour/cancer , Preclinical
25558,D0X7QQ,Benperidol,Schizophrenia , Approved
25559,D0X7VB,MBX-102,Gout , Phase 2/3
25560,D0X7WK,AZD-6553,Chronic obstructive pulmonary disease , Discontinued in Phase 1
25561,D0X7XG,Fusidic Acid,Bacterial infection , Approved
25562,D0X7XG,Fusidic Acid,MRSA infection , Phase 3
25563,D0X7YC,IGE-026,Allergic rhinitis , Terminated
25564,D0X7YR,PGCvax,Pneumonia , Terminated
25565,D0X7ZE,AdVac Malaria Vaccine,Malaria , Phase 1
25566,D0X7ZG,Ledgins,Human immunodeficiency virus infection , Investigative
25567,D0X7ZH,PAT-CM-1,Solid tumour/cancer , Investigative
25568,D0X7ZL,Sodium salicylate,Pain , Approved
25569,D0X7ZS,MAT-303,Autoimmune diabetes , Investigative
25570,D0X8AB,Mannoside derivative 4,Crohn disease , Patented
25571,D0X8AB,Mannoside derivative 4,Ulcerative colitis , Patented
25572,D0X8AB,Mannoside derivative 4,Urinary tract infection , Patented
25573,D0X8AU,KNI-764,Human immunodeficiency virus infection , Discontinued in Phase 1
25574,D0X8CH,GSK2330672,Type-2 diabetes , Phase 2
25575,D0X8CH,GSK2330672,Pruritus , Phase 2
25576,D0X8DU,Clinprost,Asthma , Discontinued in Preregistration
25577,D0X8EE,VitiGam,Melanoma , Investigative
25578,D0X8GJ,TMA-230,Bacterial infection , Discontinued in Phase 2
25579,D0X8HB,NAV5001,Dementia , Phase 3
25580,D0X8HP,TRIDMAC,Mood disorder , Phase 2
25581,D0X8ID,SEL-24,Acute myeloid leukaemia , Phase 1/2
25582,D0X8ID,SEL-24,Solid tumour/cancer , Investigative
25583,D0X8JN,GFC-003,Solid tumour/cancer , Investigative
25584,D0X8KY,Fosinopril,Hypertension , Approved
25585,D0X8MI,Berupipam,Psychotic disorder , Discontinued in Phase 1
25586,D0X8MZ,Alvameline,Alzheimer disease , Terminated
25587,D0X8NK,Tripropeptin C,Gram-positive bacterial infection , Investigative
25588,D0X8OW,QBX258,Asthma , Phase 2
25589,D0X8PD,XGP-510,Allergy , Investigative
25590,D0X8PU,Leukozene,Chronic lymphocytic leukaemia , Investigative
25591,D0X8QI,UP-116-77,Thrombosis , Terminated
25592,D0X8QO,PL-3994,Hypertension , Phase 2
25593,D0X8QO,PL-3994,Congestive heart failure , Phase 2
25594,D0X8QO,PL-3994,Asthma , Phase 2
25595,D0X8QP,FOSOPAMINE,Hypertension , Discontinued in Phase 2
25596,D0X8RA,Anti-BCR mabs,Non-hodgkin lymphoma , Investigative
25597,D0X8RS,RG6125,Rheumatoid arthritis , Phase 1
25598,D0X8SM,Anti-TNF human mabs,Autoimmune diabetes , Investigative
25599,D0X8SY,Oxazyme,Hyperoxaluria , Phase 1/2
25600,D0X8TK,IMC-F106C,Solid tumour/cancer , Phase 1/2
25601,D0X8TS,RRx-001,Small-cell lung cancer , Phase 3
25602,D0X8TS,RRx-001,Lymphoma , Phase 2
25603,D0X8TS,RRx-001,Neuroendocrine cancer , Phase 2
25604,D0X8TS,RRx-001,Ovarian epithelial cancer , Phase 2
25605,D0X8TS,RRx-001,Non-small-cell lung cancer , Phase 2
25606,D0X8TS,RRx-001,Anaplastic glioma , Phase 1
25607,D0X8TS,RRx-001,Solid tumour/cancer , Phase 1
25608,D0X8UW,TRN-101,Chronic obstructive pulmonary disease , Investigative
25609,D0X8VV,Flobufen,Rheumatoid arthritis , Phase 3
25610,D0X8VX,DV281,Non-small-cell lung cancer , Phase 1
25611,D0X8XA,Sulconazole,Fungal infection , Approved
25612,D0X8XT,CS-0777,Multiple sclerosis , Phase 1
25613,D0X8ZY,BIA-10,Pain , Investigative
25614,D0X9CH,Telaprevir,Hepatitis C virus infection , Approved
25615,D0X9FO,KC-399,Alopecia , Terminated
25616,D0X9GE,CIGB-500,Cerebrovascular ischaemia , Phase 1
25617,D0X9GV,ANA-012,Muscle wasting disease , Investigative
25618,D0X9HB,MKT-077,Solid tumour/cancer , Phase 2
25619,D0X9HF,ABT-354,Alzheimer disease , Phase 1
25620,D0X9IQ,BND-002,Solid tumour/cancer , Investigative
25621,D0X9IS,FGI-102,Virus infection , Investigative
25622,D0X9JR,QR-313,Epidermolysis bullosa , Phase 1/2
25623,D0X9KB,ACER-002,Ehlers-Danlos syndrome , Phase 3
25624,D0X9KE,A-78773,Asthma , Terminated
25625,D0X9KI,Technetium Tc-99m Disofenin Kit,Radioactive tracer , Approved
25626,D0X9LC,IC-41,Hepatitis virus infection , Phase 2
25627,D0X9LK,Iralukast,Asthma , Phase 2
25628,D0X9MP,Zipeprol,Cough , Approved
25629,D0X9NG,M2del11 H1N1,Influenza virus infection , Investigative
25630,D0X9PB,HO/04/09,Acne vulgaris , Investigative
25631,D0X9PF,Bremelanotide,Hypoactive sexual desire dysfunction , Approved
25632,D0X9PF,Bremelanotide,Erectile dysfunction , Phase 3
25633,D0X9PW,Tesmilifene,Breast cancer , Discontinued in Phase 2
25634,D0X9RG,Butorphanol,Pain , Approved
25635,D0X9RN,Robatumumab,Sarcoma , Discontinued in Phase 2
25636,D0X9RN,Robatumumab,Osteosarcoma , Discontinued in Phase 2
25637,D0X9RN,Robatumumab,Colorectal cancer , Discontinued in Phase 2
25638,D0X9RY,Benzoic Acid,Fungal infection , Approved
25639,D0X9TM,LPMD,Metabolic disorder , Investigative
25640,D0X9UA,Vatelizumab,Multiple sclerosis , Phase 2
25641,D0X9VP,Furnidipine,Nerve injury , Discontinued in Phase 3
25642,D0X9VR,BGB-324,Breast cancer , Phase 2
25643,D0X9VR,BGB-324,Acute myeloid leukaemia , Phase 1/2
25644,D0X9VR,BGB-324,Myelodysplastic syndrome , Phase 1/2
25645,D0X9VR,BGB-324,Metastatic malignant neoplasm , Investigative
25646,D0X9WC,ISIS-DMPK,Myotonic dystrophy , Phase 1/2
25647,D0X9XP,Diosmin,Hemorrhoids , Approved
25648,D0X9YB,OCV-105,Pancreatic cancer , Phase 1
25649,D0X9YP,AZD7594,Chronic obstructive pulmonary disease , Phase 2
25650,D0X9ZC,Cefadroxil,Bacterial infection , Approved
25651,D0XA1B,RTA-301,Solid tumour/cancer , Investigative
25652,D0XA2G,INDUS-860,Major depressive disorder , Investigative
25653,D0XA4U,Ebola recombinant viral vector vaccine,Ebola virus infection , Phase 2
25654,D0XA5N,NVP-LDE276,Solid tumour/cancer , Investigative
25655,D0XB0T,Acolbifene,Breast cancer , Phase 3
25656,D0XB1M,MSH-372,Human immunodeficiency virus infection , Phase 1
25657,D0XB4D,NTC-100,Cerebrovascular ischaemia , Preclinical
25658,D0XB8P,Betaine,Inborn error of metabolism , Approved
25659,D0XB8Y,COL-195,Chronic pain , Phase 1/2
25660,D0XC1F,CX-9051,Solid tumour/cancer , Investigative
25661,D0XD0N,REL-1028,Chronic pain , Phase 1
25662,D0XD0N,REL-1028,Opioid dependence , Phase 1
25663,D0XD4I,AZD0156,Solid tumour/cancer , Phase 1
25664,D0XD4N,ERB-002,Inflammation , Investigative
25665,D0XD5A,E-101,Infectious disease , Phase 3
25666,D0XD5N,LY3202626,Alzheimer disease , Phase 2
25667,D0XD7V,FLX475,Solid tumour/cancer , Phase 1/2
25668,D0XE0U,14C-urea,Diagnostic imaging , Approved
25669,D0XE0U,14C-urea,Helicobacter infection , Approved
25670,D0XE0X,Aplindore fumarate,Schizophrenia , Phase 2
25671,D0XE1C,Regadenoson,Radionuclide imaging , Approved
25672,D0XE2O,BIIB063,Sjogren syndrome , Phase 1
25673,D0XE4G,Mesenchymal stromal cells secreting neurotrophic factors,Amyotrophic lateral sclerosis , Phase 2
25674,D0XE4W,Actimab-M,Multiple myeloma , Phase 1
25675,D0XE5L,Rispenzepine,Chronic obstructive pulmonary disease , Discontinued in Phase 2
25676,D0XE5M,SAR247799,Cardiovascular disease , Phase 1
25677,D0XE8H,Von willebrand factor,Hemophilia , Approved
25678,D0XF4B,RIGS CC49,Colorectal cancer , Phase 3
25679,D0XF8W,Pyrazinamide,Mycobacterium infection , Approved
25680,D0XG0L,Anti-CD19 CAR T cells,B-cell lymphoma , Phase 1/2
25681,D0XG0Z,A-82186,Hypertension , Investigative
25682,D0XG3Y,TZP-102,Diabetic gastroparesis , Phase 2
25683,D0XG4K,KI-0804,Solid tumour/cancer , Investigative
25684,D0XG7H,IB-09A149,Bacterial infection , Investigative
25685,D0XG8I,PSI-879,Hepatitis C virus infection , Investigative
25686,D0XH0K,Mitemcinal fumarate,Pain , Phase 2
25687,D0XH1H,DBO-17,Cancer related pain , Terminated
25688,D0XH1P,CRx-102,Inflammation , Discontinued in Phase 2
25689,D0XH2N,RS-1748,Asthma , Investigative
25690,D0XH3V,Inebilizumab,Neuromyelitis optica spectrum disorder , Approved
25691,D0XH4K,C-linked disaccharide biphenyl mannoside derivative 3,Crohn disease , Patented
25692,D0XH4K,C-linked disaccharide biphenyl mannoside derivative 3,Ulcerative colitis , Patented
25693,D0XH4K,C-linked disaccharide biphenyl mannoside derivative 3,Urinary tract infection , Patented
25694,D0XH8X,APC-8015F,Prostate cancer , Phase 2
25695,D0XH9B,Tabimorelin,Growth hormone deficiency , Phase 2
25696,D0XI1B,NBI-18,Cerebrovascular disease , Investigative
25697,D0XI3E,INCB01158,Solid tumour/cancer , Phase 1/2
25698,D0XI4P,BMS-932481,Alzheimer disease , Phase 1
25699,D0XI9O,RWJ-46458,Hypertension , Terminated
25700,D0XJ0P,BCX-140,Influenza virus infection , Terminated
25701,D0XJ0S,PD-134308,Anxiety disorder , Discontinued in Phase 2
25702,D0XJ4G,PF-3049423,Ischemic stroke , Discontinued in Phase 2
25703,D0XJ5I,DNA-C,Human immunodeficiency virus infection , Phase 1/2
25704,D0XJ6C,DIAPLASININ,Thrombosis , Phase 1
25705,D0XJ8K,Recombinant soluble human CD5,Sepsis , Investigative
25706,D0XJ9U,BMS-986242,Solid tumour/cancer , Phase 1
25707,D0XK1F,S-16961,Hyperlipidaemia , Discontinued in Phase 1
25708,D0XK2N,Sinbaro,Osteoarthritis , Phase 3
25709,D0XK4R,EFLETIRIZINE,Rhinitis , Discontinued in Phase 2
25710,D0XK6O,SMaRT FVIII,Hemophilia , Investigative
25711,D0XK6P,HS-210,Ovarian cancer , Investigative
25712,D0XL0E,NVX-272,Solid tumour/cancer , Investigative
25713,D0XL1T,PDT with Photofrin,Brain cancer , Phase 2
25714,D0XL1T,PDT with Photofrin,Non-small-cell lung cancer , Phase 1
25715,D0XL4I,ER-319711-15,Type-2 diabetes , Preclinical
25716,D0XL6C,SB-M00026,Hepatitis B virus infection , Approved
25717,D0XL8W,ASN003,Solid tumour/cancer , Phase 1
25718,D0XM1A,Safinamide mesylate,Parkinson disease , Approved
25719,D0XM3S,CX-1501,Alzheimer disease , Preclinical
25720,D0XM3W,HRA-072033,Endocrine disease , Investigative
25721,D0XM4G,Bindarit,Nephritis , Phase 3
25722,D0XM6L,OT-010,Chronic obstructive pulmonary disease , Investigative
25723,D0XM9E,Human plasminogen,Ligneous conjunctivitis , Phase 2/3
25724,D0XM9M,Methyl-piperidine compound 1,Neoplasm , Patented
25725,D0XM9M,Methyl-piperidine compound 1,Angiogenesis disorder , Patented
25726,D0XM9Y,Pinazepam,Anxiety disorder , Approved
25727,D0XN1F,Nimodipine,Cerebral vasospasm , Approved
25728,D0XN5L,Albutropin,Growth failure , Phase 3
25729,D0XN8C,Rosaprostol,Ulcer , Approved
25730,D0XN8W,LB-101,Memory loss , Investigative
25731,D0XO1O,CC8464,Neuropathic pain , Phase 1
25732,D0XO1O,CC8464,Pain , Phase 1
25733,D0XO3E,"Gene therapy, neurodegenerative diseases",Neurodegenerative disorder , Investigative
25734,D0XO4I,3-(phenoxymethyl) benzylamine derivative 3,Albinism , Patented
25735,D0XO4I,3-(phenoxymethyl) benzylamine derivative 3,Ephelides , Patented
25736,D0XO4I,3-(phenoxymethyl) benzylamine derivative 3,Menkes disease , Patented
25737,D0XO4I,3-(phenoxymethyl) benzylamine derivative 3,Senile lentigines , Patented
25738,D0XO4I,3-(phenoxymethyl) benzylamine derivative 3,Melasma , Patented
25739,D0XO4K,TA-HPV,Cervical cancer , Phase 1
25740,D0XO7I,PF-06753512,Prostate cancer , Phase 1
25741,D0XO7Q,Alequel,Crohn disease , Phase 2
25742,D0XO7Q,Alequel,Inflammatory bowel disease , Phase 1/2
25743,D0XO8D,PJJ-34,Solid tumour/cancer , Investigative
25744,D0XO9F,FS118,Advanced malignancy , Phase 1
25745,D0XO9F,FS118,Advanced cancer , Phase 1
25746,D0XP0Q,FCE-24265,Thrombosis , Terminated
25747,D0XP3A,BFPT-16864,Rheumatoid arthritis , Investigative
25748,D0XP3W,Ro-24-7429,Human immunodeficiency virus infection , Phase 2
25749,D0XP4A,Labetuzumab I-131,Colorectal cancer , Phase 2
25750,D0XP5X,Mannoside derivative 5,Crohn disease , Patented
25751,D0XP5X,Mannoside derivative 5,Ulcerative colitis , Patented
25752,D0XP5X,Mannoside derivative 5,Urinary tract infection , Patented
25753,D0XP7T,NEOD001,Amyloidosis , Phase 3
25754,D0XP7V,TWIN,Acne vulgaris , Phase 2
25755,D0XQ0Q,Cefsulodin,Pseudomonas infection , Approved
25756,D0XQ0V,DC-9703,Non-insulin dependent diabetes , Investigative
25757,D0XQ1W,SDZ-62-434,Solid tumour/cancer , Discontinued in Phase 1
25758,D0XQ2X,Calcium Chloride,Magnesium intoxication , Approved
25759,D0XQ5X,Halaven,Breast cancer , Approved
25760,D0XQ5X,Halaven,Bladder cancer , Phase 1/2
25761,D0XQ6J,99mTc-NC-100668,Thrombosis , Discontinued in Phase 2
25762,D0XQ6V,APD-515,Xerostomia , Phase 2
25763,D0XQ8A,TPN-729,Erectile dysfunction , Investigative
25764,D0XR0B,SPI-205,Parkinson disease , Phase 2
25765,D0XR0V,DWP-451,Lung cancer , Investigative
25766,D0XR1B,Vyndaqel,Amyloid cardiomyopathy , Phase 3
25767,D0XR1B,Vyndaqel,Familial amyloid polyneuropathy , Application submitted
25768,D0XR1C,Biaryl mannoside derivative 28,Crohn disease , Patented
25769,D0XR1C,Biaryl mannoside derivative 28,Ulcerative colitis , Patented
25770,D0XR1C,Biaryl mannoside derivative 28,Urinary tract infection , Patented
25771,D0XR6B,ACH-2881,Bacterial infection , Investigative
25772,D0XR6I,TDI-0113,Motor neurone disease , Investigative
25773,D0XR7C,YM-598,Prostate cancer , Phase 2
25774,D0XR7R,RG7386,Solid tumour/cancer , Phase 1
25775,D0XR7V,TG-B,Osteoporosis , Investigative
25776,D0XS1W,Lisinopril,Hypertension , Approved
25777,D0XS1W,Lisinopril,Coronavirus Disease 2019 (COVID-19) , Investigative
25778,D0XS3T,Vagonixen,Asthma , Investigative
25779,D0XS4X,Ibodutant,Irritable bowel syndrome , Phase 3
25780,D0XS7I,PF-06939926,Duchenne dystrophy , Phase 1
25781,D0XT0I,BIA,Non-insulin dependent diabetes , Investigative
25782,D0XT0W,Debio 1347,Solid tumour/cancer , Phase 2
25783,D0XT0W,Debio 1347,Breast cancer , Phase 1/2
25784,D0XT1M,Valrocemide,Epilepsy , Discontinued in Phase 2
25785,D0XT3G,ET-009,Bladder cancer , Investigative
25786,D0XT5F,Onyvax-O,Ovarian cancer , Discontinued in Phase 1
25787,D0XT5Q,AGS-16C3F,Renal cell carcinoma , Phase 2
25788,D0XT5Y,Sargramostim,Bone marrow transplantation , Approved
25789,D0XT6W,PDX-101,Solid tumour/cancer , Phase 2
25790,D0XT6W,PDX-101,Haematological malignancy , Phase 1
25791,D0XT6W,PDX-101,Peripheral T-cell lymphoma , Phase 1
25792,D0XT8V,Calcium nanoparticles,Solid tumour/cancer , Investigative
25793,D0XT8W,SOM3355,Huntington disease , Phase 2
25794,D0XT8W,SOM3355,Tardive dyskinesia , Phase 1
25795,D0XU1I,G3139 + Dacarbazine,Melanoma , Investigative
25796,D0XU3D,IDP-124,Atopic dermatitis , Phase 3
25797,D0XU4O,NVX-412,Melanoma , Investigative
25798,D0XU5Y,HL-025,Allergy , Investigative
25799,D0XU9F,G3139 + cytarabine (ARA-C),Acute leukaemia , Investigative
25800,D0XV0Y,CT-P6,Breast cancer , Phase 1
25801,D0XV2U,BIIB093,Cerebral edema , Phase 3
25802,D0XV3Z,Allervax Ragweed,Allergy , Discontinued in Phase 3
25803,D0XV5B,Human insulin zinc suspension,Diabetic complication , Approved
25804,D0XV6L,Kanglaite,Cachexia , Phase 1
25805,D0XV7Y,"1,3-dihydroxy phenyl derivative 2",Solid tumour/cancer , Patented
25806,D0XV7Y,"1,3-dihydroxy phenyl derivative 2",Infectious disease , Patented
25807,D0XV7Y,"1,3-dihydroxy phenyl derivative 2",Human immunodeficiency virus infection , Patented
25808,D0XV7Y,"1,3-dihydroxy phenyl derivative 2",Hepatitis , Patented
25809,D0XV8M,CVT-012000,Coronary artery disease , Investigative
25810,D0XW2H,Mometasone furoate/ formoterol fumarate,Asthma , Approved
25811,D0XW4W,SEP-227900,Cognitive impairment , Terminated
25812,D0XW6B,Autologous dendritic cell vaccine,Human immunodeficiency virus-1 infection , Phase 2
25813,D0XW6Y,S-38093,Alzheimer disease , Phase 2
25814,D0XW8R,11C-R-129144,Major depressive disorder , Investigative
25815,D0XW8Y,CNTX-4975,Pain , Phase 3
25816,D0XW8Y,CNTX-4975,Knee osteoarthritis , Phase 3
25817,D0XW8Y,CNTX-4975,Morton neuroma , Phase 2
25818,D0XW9L,Rifalazil,Bacterial infection , Phase 3
25819,D0XX2I,NPH-30907,Fungal infection , Phase 2
25820,D0XX6Y,Pipecuronium,Spasm , Approved
25821,D0XX7E,RNA-144101,Age-related macular degeneration , Investigative
25822,D0XX8R,PMID25666693-Compound-161,Osteoarthritis pain , Patented
25823,D0XX8R,PMID25666693-Compound-161,Cancer related pain , Patented
25824,D0XX8R,PMID25666693-Compound-161,Neuropathic pain , Patented
25825,D0XX8R,PMID25666693-Compound-161,Inflammatory pain , Patented
25826,D0XY4A,BPS-804,Metabolic bone disease , Phase 2
25827,D0XY4Q,Cholazol,Arteriosclerosis , Terminated
25828,D0XY6T,Humanized CD19 CAR-T cells,Acute lymphoblastic leukaemia , Phase 1/2
25829,D0XY8C,Encapsulated cell therapy,Prostate cancer , Phase 1/2
25830,D0XY8C,Encapsulated cell therapy,Pancreatic cancer , Phase 1/2
25831,D0XY8C,Encapsulated cell therapy,Metastatic colorectal cancer , Phase 1/2
25832,D0XY8K,ZP-007,Pharyngitis , Investigative
25833,D0XZ1D,BLU-554,Hepatocellular carcinoma , Phase 1
25834,D0XZ2S,CAR-T cells targeting MAGE-A4,Lung cancer , Phase 1/2
25835,D0XZ3W,SEL-120,Solid tumour/cancer , Investigative
25836,D0XZ9H,LY2951742,Migraine , Phase 4
25837,D0Y0AP,GR-144053,Thrombosis , Terminated
25838,D0Y0BC,XL-541,Solid tumour/cancer , Terminated
25839,D0Y0BZ,PUP-1,Chronic obstructive pulmonary disease , Investigative
25840,D0Y0EP,Lanabecestat,Alzheimer disease , Phase 3
25841,D0Y0ER,Thiethylperazine,Nausea , Approved
25842,D0Y0FE,PWT-33597,Solid tumour/cancer , Phase 1
25843,D0Y0FZ,PF-05230905,Rheumatoid arthritis , Phase 1
25844,D0Y0GG,Epanolol,Angina pectoris , Discontinued in Preregistration
25845,D0Y0GH,Mitomycin,Breast cancer , Approved
25846,D0Y0GH,Mitomycin,Gastrointestinal cancer , Approved
25847,D0Y0GH,Mitomycin,Solid tumour/cancer , Approved
25848,D0Y0GS,PMA-406,Solid tumour/cancer , Investigative
25849,D0Y0HC,PF-06671008,Solid tumour/cancer , Phase 1
25850,D0Y0HR,XOMA 358,Congenital hyperinsulinism , Phase 2
25851,D0Y0ID,6-azacytidine,Solid tumour/cancer , Investigative
25852,D0Y0JH,Salsalate,Rheumatoid arthritis , Approved
25853,D0Y0KV,RS-118641,Bacterial infection , Investigative
25854,D0Y0KY,ISIS-APO(a),Coronary artery disease , Phase 2
25855,D0Y0LA,PG2-2000,Thrombocytopenia , Investigative
25856,D0Y0PY,PI-2301,Multiple sclerosis , Phase 2
25857,D0Y0QB,PF-4522625,Influenza virus infection , Discontinued in Phase 1
25858,D0Y0RF,Dendritic cancer cell vaccine,Melanoma , Phase 1
25859,D0Y0RG,PMID25684022-Compound-US20130053382 37(4-6),Solid tumour/cancer , Patented
25860,D0Y0RG,PMID25684022-Compound-US20130053382 37(4-6),Metastatic cancer , Patented
25861,D0Y0RW,Alniditan,Migraine , Discontinued in Phase 3
25862,D0Y0SI,Aryl mannoside derivative 7,Crohn disease , Patented
25863,D0Y0SI,Aryl mannoside derivative 7,Ulcerative colitis , Patented
25864,D0Y0SI,Aryl mannoside derivative 7,Urinary tract infection , Patented
25865,D0Y0SW,Flutamide,Prostate cancer , Approved
25866,D0Y0SY,E-3620,Gastric motility disorder , Discontinued in Phase 2
25867,D0Y0TQ,AGX-1053,Solid tumour/cancer , Investigative
25868,D0Y0UK,MX-6,Cervical cancer , Discontinued in Phase 3
25869,D0Y0VC,NLS-1,Attention deficit hyperactivity disorder , Phase 2
25870,D0Y0WW,FM-303,Inflammatory bowel disease , Investigative
25871,D0Y0XJ,PMID28270021-Compound-WO2013009582Example76,Pruritus , Patented
25872,D0Y0XJ,PMID28270021-Compound-WO2013009582Example76,Solid tumour/cancer , Patented
25873,D0Y0XJ,PMID28270021-Compound-WO2013009582Example76,Chronic pain , Patented
25874,D0Y0XJ,PMID28270021-Compound-WO2013009582Example76,Neuropathic pain , Patented
25875,D0Y0XJ,PMID28270021-Compound-WO2013009582Example76,Thymic cancer , Patented
25876,D0Y0ZB,SB-219825,Pain , Terminated
25877,D0Y0ZQ,Ecabapide,Peptic ulcer , Discontinued in Preregistration
25878,D0Y1AA,Chymopapain,Musculoskeletal disorder , Approved
25879,D0Y1BF,APG-201,Solid tumour/cancer , Investigative
25880,D0Y1BI,TT-124,Coagulation defect , Investigative
25881,D0Y1BS,TGFTX-3,Central nervous system disease , Investigative
25882,D0Y1FG,HSV-Tk,leukaemia , Phase 3
25883,D0Y1FI,SP-03,Human immunodeficiency virus infection , Investigative
25884,D0Y1FO,Rubitecan,Human immunodeficiency virus infection , Phase 3
25885,D0Y1FP,RO-5310074,Autoimmune diabetes , Phase 1
25886,D0Y1FU,GDC0134,Amyotrophic lateral sclerosis , Phase 1
25887,D0Y1GJ,MLN-576,Acute lymphoblastic leukaemia , Phase 1
25888,D0Y1HZ,IMD-026260,Solid tumour/cancer , Investigative
25889,D0Y1IO,Galectin-3C,Solid tumour/cancer , Investigative
25890,D0Y1IT,Sodium thiosalicylate,Gout , Approved
25891,D0Y1KF,Feraheme/Rienso,Iron-deficiency anemia , Approved
25892,D0Y1LD,RX-1792,Solid tumour/cancer , Investigative
25893,D0Y1MK,99mTc-nitrocade,Diagnostic imaging , Discontinued in Phase 3
25894,D0Y1NC,CHS-828,Solid tumour/cancer , Phase 1/2
25895,D0Y1NH,Azaindazole amide derivative 1,Pruritus , Patented
25896,D0Y1NH,Azaindazole amide derivative 1,Chronic pain , Patented
25897,D0Y1NH,Azaindazole amide derivative 1,Neuropathic pain , Patented
25898,D0Y1NH,Azaindazole amide derivative 1,Thymic cancer , Patented
25899,D0Y1OF,VA-045,Cerebrovascular ischaemia , Terminated
25900,D0Y1RN,AC-1204,Alzheimer disease , Phase 3
25901,D0Y1RN,AC-1204,Pancreatic cancer , Phase 2/3
25902,D0Y1RU,CAL-102-R,Herpes simplex virus infection , Investigative
25903,D0Y1SI,PMID25666693-Compound-100,Osteoarthritis pain , Patented
25904,D0Y1SI,PMID25666693-Compound-100,Cancer related pain , Patented
25905,D0Y1SI,PMID25666693-Compound-100,Neuropathic pain , Patented
25906,D0Y1SI,PMID25666693-Compound-100,Inflammatory pain , Patented
25907,D0Y1UC,Trofosfamide,Non-hodgkin lymphoma , Approved
25908,D0Y1UO,VS-6063,Ovarian cancer , Phase 2
25909,D0Y1UO,VS-6063,Mesothelioma , Phase 2
25910,D0Y1UO,VS-6063,Solid tumour/cancer , Phase 1
25911,D0Y1UO,VS-6063,Pancreatic cancer , Phase 1
25912,D0Y1VI,SJ-3249,Solid tumour/cancer , Investigative
25913,D0Y1VZ,GT-389255,Obesity , Discontinued in Phase 2
25914,D0Y1XD,ProCord,Spinal cord injury , Phase 2
25915,D0Y1XR,CY-403,Staphylococcus infection , Investigative
25916,D0Y1YA,Human embryonic stem cell-derived hepatocytes,Liver disease , Investigative
25917,D0Y1YP,Doqualast,Hyperuricaemia , Discontinued in Phase 2
25918,D0Y1YX,AZD-9935,Solid tumour/cancer , Terminated
25919,D0Y1ZU,SA-237,Rheumatoid arthritis , Phase 3
25920,D0Y1ZU,SA-237,Encephalopathy , Phase 3
25921,D0Y1ZU,SA-237,Neuromyelitis optica , Phase 3
25922,D0Y2CJ,Minoxidil,Hypertension , Approved
25923,D0Y2DI,Chlorproguanil,Malaria , Approved
25924,D0Y2DW,CHAP31,Solid tumour/cancer , Investigative
25925,D0Y2EN,IB-09A133,Angiogenesis disorder , Investigative
25926,D0Y2ES,Bepafant,Sepsis , Terminated
25927,D0Y2FY,Pediarix Vaccine,Diphtheria , Approved
25928,D0Y2GJ,DSP-1053,Major depressive disorder , Phase 1
25929,D0Y2HA,Pramiconazole,Dermatological disease , Phase 2
25930,D0Y2HH,KC706,Psoriasis vulgaris , Discontinued in Phase 2
25931,D0Y2HH,KC706,Cardiovascular disease , Discontinued in Phase 2
25932,D0Y2HH,KC706,Rheumatoid arthritis , Discontinued in Phase 2
25933,D0Y2HH,KC706,Inflammatory bowel disease , Discontinued in Phase 2
25934,D0Y2HR,Astemizole,Allergic rhinitis , Withdrawn from market
25935,D0Y2IE,Cefuroxime,Acute bronchitis , Approved
25936,D0Y2IF,AZD-6357,Osteoarthritis , Terminated
25937,D0Y2IH,LY-255283,Asthma , Terminated
25938,D0Y2IN,Doranidazole,Solid tumour/cancer , Phase 3
25939,D0Y2IP,HLA-B7.75-84,Immune System disease , Discontinued in Phase 2
25940,D0Y2IZ,Trichlormethiazide,Hypertension , Approved
25941,D0Y2JM,Soluble ferric pyrophosphate,Iron-deficiency anemia , Phase 3
25942,D0Y2KX,COL-1777,Uterine fibroids , Investigative
25943,D0Y2LR,Doxylamine,Morning sickness , Approved
25944,D0Y2MC,Alkavervir,High blood pressure , Approved
25945,D0Y2MP,E-5110,Inflammation , Terminated
25946,D0Y2NE,Diethylstilbestrol,Gonorrheal vaginitis , Approved
25947,D0Y2NN,Replication-defective HIV-1 vaccine,Human immunodeficiency virus-1 infection , Phase 1
25948,D0Y2NS,MLN1117,Solid tumour/cancer , Phase 1/2
25949,D0Y2NU,ALX-40-4C,Human immunodeficiency virus infection , Phase 2
25950,D0Y2OG,YM-511,Breast cancer , Discontinued in Phase 2
25951,D0Y2RF,Lnfluvac TC,Influenza virus infection , Phase 3
25952,D0Y2RN,PMID25553724-Compound-US2011788838110,Immune System disease , Patented
25953,D0Y2SE,Alpha-glucosidase,Muscle disease , Phase 3
25954,D0Y2SW,Ixazomib,Multiple myeloma , Approved
25955,D0Y2TI,Glionitrin A,Solid tumour/cancer , Investigative
25956,D0Y2TK,Tetanus toxoid,Clostridium infection , Approved
25957,D0Y2VA,Nefecon,IgA nephropathy , Phase 2
25958,D0Y2XQ,PF-3526299,Asthma , Discontinued in Phase 1
25959,D0Y2XZ,MK-4166,Solid tumour/cancer , Phase 1
25960,D0Y2YP,Flurandrenolide,Inflammation , Approved
25961,D0Y2YV,BECIPARCIL,Coagulation defect , Discontinued in Phase 1
25962,D0Y3AG,VIR-576,Human immunodeficiency virus infection , Phase 1/2
25963,D0Y3AR,RhASM enzyme replacement therapy (acid sphingomyelinase deficiency),Niemann-pick disease , Phase 1
25964,D0Y3AZ,MK-2637,Schizophrenia , Phase 1
25965,D0Y3BU,VAK-694,Allergic rhinitis , Phase 2
25966,D0Y3HP,CD20 CAR T cells,B-cell chronic lymphocytic leukaemia , Phase 2
25967,D0Y3HP,CD20 CAR T cells,Diffuse large B-cell lymphoma , Phase 2
25968,D0Y3HP,CD20 CAR T cells,Non-hodgkin lymphoma , Phase 2
25969,D0Y3JI,DG-17,Human immunodeficiency virus infection , Phase 2
25970,D0Y3JR,ISIS 16507,Solid tumour/cancer , Investigative
25971,D0Y3KG,Valproate,Epilepsy , Approved
25972,D0Y3KG,Valproate,Alcohol dependence , Phase 2
25973,D0Y3KR,GSK-2302024A,Breast cancer , Investigative
25974,D0Y3LJ,AZD5904,Multiple sclerosis , Discontinued in Phase 1
25975,D0Y3LJ,AZD5904,Chronic obstructive pulmonary disease , Discontinued in Phase 1
25976,D0Y3LL,Taprenepag,Glaucoma/ocular hypertension , Phase 2
25977,D0Y3ME,Oxaliplatin,Colorectal cancer , Approved
25978,D0Y3MO,Amikacin,Bacterial infection , Approved
25979,D0Y3MO,Amikacin,Tuberculosis , Investigative
25980,D0Y3MW,Tolecine,Herpes simplex virus infection , Investigative
25981,D0Y3OQ,AZM-145,Diabetic complication , Terminated
25982,D0Y3OR,SQ-33600,Hyperlipidaemia , Terminated
25983,D0Y3OX,TN-14003,Acute lymphoblastic leukaemia , Investigative
25984,D0Y3QR,BQS-481,Solid tumour/cancer , Investigative
25985,D0Y3RN,BAY-Y-1015,Inflammation , Discontinued in Phase 1
25986,D0Y3RY,R-1578,Mood disorder , Discontinued in Phase 2
25987,D0Y3TB,ALGRX 2872,Cluster headache , Investigative
25988,D0Y3TB,ALGRX 2872,Migraine , Investigative
25989,D0Y3TM,Iron,Iron-deficiency anemia , Approved
25990,D0Y3TX,Apovasc,Arteriosclerosis , Investigative
25991,D0Y3TY,NAB-001,Onychomycosis , Phase 3
25992,D0Y3UB,PMID26651364-Compound-7d,Crohn disease , Patented
25993,D0Y3UB,PMID26651364-Compound-7d,Ulcerative colitis , Patented
25994,D0Y3UB,PMID26651364-Compound-7d,Urinary tract infection , Patented
25995,D0Y3VN,Ii-key/MHC class II epitope hybrid peptides,Allergy , Investigative
25996,D0Y3VQ,Ryzodeq,Type-2 diabetes , Approved
25997,D0Y3VT,ORB-101,Solid tumour/cancer , Phase 1
25998,D0Y3WY,RG7841,Solid tumour/cancer , Phase 1
25999,D0Y3XA,Ge2270a,Bacterial infection , Phase 1
26000,D0Y3XF,Stem cell-derived astrocytes,Motor neurone disease , Investigative
26001,D0Y3ZC,CBT-501,Solid tumour/cancer , Phase 1
26002,D0Y3ZP,Terodiline,Urinary incontinence , Phase 3
26003,D0Y3ZX,D-21775,Solid tumour/cancer , Terminated
26004,D0Y4AW,Meprobamate,Malaria , Approved
26005,D0Y4AW,Meprobamate,Anxiety disorder , Approved
26006,D0Y4AW,Meprobamate,Ischemic reperfusion injury , Discontinued in Phase 1
26007,D0Y4AZ,Galocitabine,Solid tumour/cancer , Discontinued in Phase 3
26008,D0Y4BF,Pentraxin 2/analog,Fibrosis , Investigative
26009,D0Y4BO,ABI-013,Solid tumour/cancer , Preclinical
26010,D0Y4CN,IMC-TR1,Solid tumour/cancer , Phase 1
26011,D0Y4DY,Xylometazoline,Allergic rhinitis , Phase 4
26012,D0Y4EM,Thrombomodulin,Disseminated intravascular coagulation , Discontinued in Phase 3
26013,D0Y4EU,PMID25656651-Compound-11a,Chronic myeloid leukaemia , Patented
26014,D0Y4FL,Roxithromycin,Bacterial infection , Withdrawn from market
26015,D0Y4GJ,AVE-5883,Asthma , Discontinued in Phase 1/2
26016,D0Y4GO,Pemetrexed,Malignant pleural mesothelioma , Approved
26017,D0Y4HO,LMV-601,Herpes simplex virus infection , Phase 1
26018,D0Y4IR,UBC1967,Ophthalmic graves disease , Phase 1
26019,D0Y4IX,XEL-002BI,Pain , Investigative
26020,D0Y4JJ,Bepridil,Chronic/stable angina , Approved
26021,D0Y4KE,Collagenase,Skin burns , Approved
26022,D0Y4KE,Collagenase,Dermal ulcers , Approved
26023,D0Y4LI,PF-4708671,Ulcerative colitis , Clinical trial
26024,D0Y4LX,Favipiravir,Influenza virus infection , Registered
26025,D0Y4MA,CART-138 cells,Multiple myeloma , Phase 1/2
26026,D0Y4MJ,KQ-791,Type-2 diabetes , Phase 1
26027,D0Y4OI,SKF-105809,Pain , Phase 1
26028,D0Y4PL,QAP-642,Allergic rhinitis , Terminated
26029,D0Y4QG,Bedaquiline,Multi-drug resistant tuberculosis , Approved
26030,D0Y4QY,Long-acting IL-11 analog,Thrombocytopenia , Investigative
26031,D0Y4SI,Ponesimod,Multiple sclerosis , Approved
26032,D0Y4SI,Ponesimod,Psoriasis vulgaris , Phase 2
26033,D0Y4TQ,VK-11,Alzheimer disease , Investigative
26034,D0Y4WR,R-1,Irritable bowel syndrome , Investigative
26035,D0Y4XN,AGX-1009,Human immunodeficiency virus-1 infection , Investigative
26036,D0Y4YG,Iodixanol,Cardiovascular disease , Approved
26037,D0Y4ZE,BGC-20-0582,Pediculus capitis infestation , Phase 2
26038,D0Y4ZI,Silicon-modified indomethacin,Arthritis , Investigative
26039,D0Y4ZS,Endovion,Solid tumour/cancer , Terminated
26040,D0Y5AM,Darifenacin,Overactive bladder , Approved
26041,D0Y5BR,Phylomers,Brain injury , Investigative
26042,D0Y5BV,AXImab,Sepsis , Investigative
26043,D0Y5DC,ZJM-289,Reperfusion injury , Investigative
26044,D0Y5DO,Citalopram,Depression , Approved
26045,D0Y5ED,AV-203,Solid tumour/cancer , Phase 1
26046,D0Y5EX,DuP 714,Thrombosis , Terminated
26047,D0Y5GK,Bromodiphenhydramine,Hay fever , Approved
26048,D0Y5IH,MPDL-3280A,Melanoma , Phase 3
26049,D0Y5JC,Avanafil,Erectile dysfunction , Approved
26050,D0Y5JZ,JB991,Skin infection , Phase 2
26051,D0Y5JZ,JB991,Sarcoidosis , Discontinued in Phase 2
26052,D0Y5KL,RI-001,Respiratory syncytial virus infection , Phase 2
26053,D0Y5LR,AEN-100,Motor neurone disease , Phase 4
26054,D0Y5MF,BND-001,Central nervous system disease , Investigative
26055,D0Y5MY,GRN1005,Brain metastases , Phase 2
26056,D0Y5NA,PF-06751979,Alzheimer disease , Phase 1
26057,D0Y5NT,VT-224,Inflammation , Investigative
26058,D0Y5OP,18F-fluoromethylallylcholine,Solid tumour/cancer , Investigative
26059,D0Y5OY,MK-3641,Allergy , Approved
26060,D0Y5QA,AVB-S6-500,Acute myeloid leukaemia , Phase 1
26061,D0Y5QA,AVB-S6-500,Solid tumour/cancer , Phase 1
26062,D0Y5QD,ENMD-1198,Solid tumour/cancer , Phase 1
26063,D0Y5QO,GK-128,Vomiting , Terminated
26064,D0Y5RZ,Brovincamine fumarate,Cerebral vasodilator , Approved
26065,D0Y5UC,PC-24,Solid tumour/cancer , Investigative
26066,D0Y5UG,Amitriptyline,Depression , Approved
26067,D0Y5VR,H5N1 influenza vaccine,Influenza virus infection , Phase 2
26068,D0Y5WL,TTL-1177,Solid tumour/cancer , Investigative
26069,D0Y5WX,GBR 310,Chronic idiopathic urticaria , Phase 1
26070,D0Y5ZA,Arteether,Malaria , Approved
26071,D0Y5ZG,Theradigm-HIV,Virus infection , Terminated
26072,D0Y5ZT,KRP-203,Cutaneous lupus erythematosus , Phase 2
26073,D0Y6BO,Milatuzumab-doxorubicin conjugate,Multiple myeloma , Phase 1/2
26074,D0Y6CE,Metocurine Iodide,Anaesthesia , Approved
26075,D0Y6DO,Streptokinase rectal suppository,Hemorrhoids , Phase 3
26076,D0Y6HA,CYC-103,Solid tumour/cancer , Terminated
26077,D0Y6HV,EMD-53998,Cardiovascular disease , Discontinued in Phase 1
26078,D0Y6HW,Ecopipam,Cocaine addiction , Phase 3
26079,D0Y6HW,Ecopipam,Tourette syndrome , Phase 2
26080,D0Y6HY,A-364,Bacterial infection , Terminated
26081,D0Y6IJ,Ro-48-5545,Bacterial infection , Terminated
26082,D0Y6KO,Methyldopate Hydrochloride,Hypertension , Approved
26083,D0Y6KY,Optiquel,Uveitis , Phase 1
26084,D0Y6LO,NNC-13-8119,Anxiety disorder , Terminated
26085,D0Y6MD,NRC-2694,Solid tumour/cancer , Investigative
26086,D0Y6MH,Tebipenem,Urinary tract infection , Phase 3
26087,D0Y6MH,Tebipenem,Obesity , Phase 2
26088,D0Y6MH,Tebipenem,Nicotine dependence , Phase 2
26089,D0Y6NL,Arepanrix,Influenza virus infection , Approved
26090,D0Y6NO,Anti-CD326 humanized mab,Solid tumour/cancer , Investigative
26091,D0Y6OA,Coumate,Breast cancer , Phase 2
26092,D0Y6OC,REC-1819,Overactive bladder , Investigative
26093,D0Y6QC,Dapagliflozin Propanediol; Saxagliptin Hydrochloride,Type-2 diabetes , Approved
26094,D0Y6QO,Antipruritic agents,Pruritus , Investigative
26095,D0Y6QX,FOLIGO 002,Ovarian cancer , Investigative
26096,D0Y6SN,SB-277011,Schizophrenia , Terminated
26097,D0Y6SQ,Camostat,Cystic fibrosis , Phase 2
26098,D0Y6TI,YM-355179,Asthma , Preclinical
26099,D0Y6UU,Atrasentan,Diabetic nephropathy , Phase 3
26100,D0Y6UU,Atrasentan,Prostate cancer , Withdrawn from market
26101,D0Y6VW,Fingolimod,Multiple sclerosis , Approved
26102,D0Y6VW,Fingolimod,Coronavirus Disease 2019 (COVID-19) , Phase 2
26103,D0Y6XD,B-247,Wound healing , Investigative
26104,D0Y6XG,Atu-195,Solid tumour/cancer , Investigative
26105,D0Y6ZK,IB-MECA,Solid tumour/cancer , Phase 3
26106,D0Y6ZK,IB-MECA,Psoriasis vulgaris , Phase 3
26107,D0Y6ZK,IB-MECA,Plaque psoriasis , Phase 2/3
26108,D0Y6ZK,IB-MECA,Rheumatoid arthritis , Phase 2
26109,D0Y6ZS,Esterom,Pain , Discontinued in Phase 2
26110,D0Y7BD,Ceftizoxime,Bacterial infection , Approved
26111,D0Y7BV,Florifenine,Inflammation , Terminated
26112,D0Y7CO,ABT-072,Hepatitis C virus infection , Phase 1
26113,D0Y7DP,Uridine,Depression , Approved
26114,D0Y7EM,Felbinac,Arthritis , Approved
26115,D0Y7HW,Clomet,Solid tumour/cancer , Discontinued in Phase 1
26116,D0Y7IC,Baricitinib,Rheumatoid arthritis , Approved
26117,D0Y7IU,Budesonide,Asthma , Approved
26118,D0Y7JU,GW685698X,Asthma , Approved
26119,D0Y7KH,Degarelix,Prostate cancer , Approved
26120,D0Y7LD,Sitosterol,Hyperlipidaemia , Approved
26121,D0Y7LV,Anti-CD38 CAR-T cell therapy,Multiple myeloma , Phase 1
26122,D0Y7NA,INCB9471,Infectious disease , Phase 2a
26123,D0Y7NA,INCB9471,Human immunodeficiency virus infection , Phase 2
26124,D0Y7OI,vialinin A,Inflammation , Preclinical
26125,D0Y7OJ,LU302146,Pulmonary hypertension , Approved
26126,D0Y7PG,Tolcapone,Parkinson disease , Approved
26127,D0Y7PJ,ELS-110,Migraine , Investigative
26128,D0Y7RR,XGP-515,Allergy , Investigative
26129,D0Y7RW,Phenobarbital,Seizure disorder , Approved
26130,D0Y7SN,PTI-188,Melanoma , Phase 1
26131,D0Y7TC,Cancer vaccine,Melanoma , Phase 2
26132,D0Y7TO,Doxacurium,Spasm , Approved
26133,D0Y7TS,Trimetrexate,Toxoplasmosis , Approved
26134,D0Y7VM,Forskolin,Solid tumour/cancer , Investigative
26135,D0Y7VP,VRS-317,Growth hormone deficiency , Phase 3
26136,D0Y7WA,SYN-1003,Pain , Investigative
26137,D0Y7WL,Lorglumide,Pancreatic malfunction , Terminated
26138,D0Y7XG,Ocriplasmin,Symptomatic vitreomacular adhesion , Approved
26139,D0Y7YB,HIV recombinant vaccine,Human immunodeficiency virus infection , Phase 2
26140,D0Y7YD,SMT-C1100,Duchenne dystrophy , Phase 2
26141,D0Y7YH,TK-54,Graft-versus-host disease , Phase 1/2
26142,D0Y7YR,CAT-1920,Inflammatory bowel disease , Investigative
26143,D0Y7ZD,Aminolevulinic acid hci,Acne vulgaris , Approved
26144,D0Y7ZD,Aminolevulinic acid hci,Actinic keratosis , Approved
26145,D0Y7ZU,Dacarbazine,Melanoma , Approved
26146,D0Y8AW,CB3304,Solid tumour/cancer , Phase 1/2
26147,D0Y8BJ,CT-112,Inflammation , Investigative
26148,D0Y8BW,TMC-647055,Hepatitis C virus infection , Phase 1
26149,D0Y8DP,Rorifone,Cough , Approved
26150,D0Y8GL,APF-580,Pain , Terminated
26151,D0Y8IE,AR-13165,Glaucoma/ocular hypertension , Phase 3
26152,D0Y8IF,MX-781,Breast cancer , Terminated
26153,D0Y8IS,VP-025,Alzheimer disease , Discontinued in Phase 1
26154,D0Y8KM,STP-900,Organ transplant rejection , Investigative
26155,D0Y8KN,Ilaris canakinumab,Osteoarthritis , Approved
26156,D0Y8KZ,AIM-501,Artery stenosis , Investigative
26157,D0Y8LT,AstaFactor,Solid tumour/cancer , Terminated
26158,D0Y8ND,VERED,Rosacea , Phase 3
26159,D0Y8NZ,Efatutazone,Non-small-cell lung cancer , Phase 2
26160,D0Y8NZ,Efatutazone,Metastatic colorectal cancer , Phase 2
26161,D0Y8OK,Peginterferon alfa-2a,Hairy cell leukaemia , Approved
26162,D0Y8PH,CI-996,Hypertension , Terminated
26163,D0Y8PM,LJP-1082,Hughes syndrome , Discontinued in Phase 1
26164,D0Y8PT,UFT,Solid tumour/cancer , Approved
26165,D0Y8RS,DSP-6745,Parkinson disease , Phase 1
26166,D0Y8SS,MufroSyn,Bacterial infection , Investigative
26167,D0Y8TZ,PF-06410293,Rheumatoid arthritis , Phase 3
26168,D0Y8UB,Agomelatine,Major depressive disorder , Withdrawn from market
26169,D0Y8UV,EMD-1204831,Solid tumour/cancer , Phase 1
26170,D0Y8VC,M-5200,Skin allergy , Investigative
26171,D0Y8ZN,Ofatumumab,Chronic lymphocytic leukaemia , Approved
26172,D0Y8ZN,Ofatumumab,Diffuse large B-cell lymphoma , Phase 3
26173,D0Y8ZN,Ofatumumab,Non-hodgkin lymphoma , Phase 3
26174,D0Y8ZN,Ofatumumab,Rheumatoid arthritis , Phase 2
26175,D0Y8ZZ,GI-10001,Chronic myelogenous leukaemia , Investigative
26176,D0Y9BX,Peptide p277,Type-1 diabetes , Phase 3
26177,D0Y9BX,Peptide p277,Grass pollen hypersensitivity , Phase 3
26178,D0Y9CC,TM-31,Rheumatoid arthritis , Terminated
26179,D0Y9CV,Ketolides,Bacterial infection , Terminated
26180,D0Y9ES,AD-0802,Alzheimer disease , Investigative
26181,D0Y9EW,Vemurafenib,Melanoma , Approved
26182,D0Y9FF,Human factor viii,Hemophilia , Approved
26183,D0Y9FX,example 7 [US8664233],Bladder cancer , Clinical trial
26184,D0Y9GA,Dehydroxymethylepoxyquinomicin,Cachexia , Investigative
26185,D0Y9GF,Entyvio,Crohn disease , Phase 3
26186,D0Y9GF,Entyvio,Ulcerative colitis , Phase 3
26187,D0Y9GM,Pexiganan,Diabetic foot ulcer , Approved
26188,D0Y9HH,SIB-1508Y,Parkinson disease , Terminated
26189,D0Y9HW,ISIS-TTR,Amyloidosis , Phase 3
26190,D0Y9JY,XGP-410,Acne vulgaris , Investigative
26191,D0Y9KR,SSR-103800,Schizophrenia , Preclinical
26192,D0Y9LL,Lorcainide,Heart arrhythmia , Approved
26193,D0Y9NA,MN-2011,Age-related macular degeneration , Investigative
26194,D0Y9NE,NWP-08,Central nervous system disease , Discontinued in Phase 2
26195,D0Y9OS,Euro-Celtique 1,Pain , Investigative
26196,D0Y9PQ,AM-1101,Arteriosclerosis , Investigative
26197,D0Y9PZ,Efungumab,Breast cancer , Phase 2
26198,D0Y9RN,Salinosporamide B,Solid tumour/cancer , Investigative
26199,D0Y9RO,Dexanabinol,Traumatic brain injury , Phase 3
26200,D0Y9SB,RG7444,Refractory metastatic multiple myeloma , Phase 1
26201,D0Y9ST,PMID25666693-Compound-64,Osteoarthritis pain , Patented
26202,D0Y9ST,PMID25666693-Compound-64,Cancer related pain , Patented
26203,D0Y9ST,PMID25666693-Compound-64,Neuropathic pain , Patented
26204,D0Y9ST,PMID25666693-Compound-64,Inflammatory pain , Patented
26205,D0Y9TQ,Cytotect CP,Cytomegalovirus infection , Phase 3
26206,D0Y9TS,Ceruletide,Caerulein stimulated gastric and pancreatic secretion , Approved
26207,D0Y9TS,Ceruletide,Solid tumour/cancer , Phase 3
26208,D0Y9VC,IMT-1012 immunotherapeutic vaccine,Ovarian cancer , Phase 1
26209,D0Y9VC,IMT-1012 immunotherapeutic vaccine,Breast cancer , Phase 1
26210,D0Y9XD,Dalvastatin,Hyperlipidaemia , Discontinued in Phase 3
26211,D0Y9XO,SDZ-FOX-988,Diabetic complication , Phase 1
26212,D0Y9XU,Turgenpumatucel-L,Non-small-cell lung cancer , Phase 2/3
26213,D0Y9YG,SLV-342,Arteriosclerosis , Phase 1
26214,D0Y9YN,Velimogene aliplasmid,Melanoma , Phase 3
26215,D0Y9ZE,Milrinone,Congestive heart failure , Approved
26216,D0YA0N,BR3-Fc,Idiopathic thrombocytopenic purpura , Discontinued in Phase 2
26217,D0YA0N,BR3-Fc,Rheumatoid arthritis , Discontinued in Phase 2
26218,D0YA1B,Flotetuzumab,Acute myeloid leukaemia , Phase 2
26219,D0YA1B,Flotetuzumab,Acute biphenotypic leukaemia , Phase 2
26220,D0YA1B,Flotetuzumab,Myelodysplastic syndrome , Phase 1
26221,D0YA2L,Teriparatide,Osteogenesis imperfecta , Approved
26222,D0YA2L,Teriparatide,Psoriatic disorder , Discontinued in Phase 2
26223,D0YA6U,ELN-864709,Central nervous system injury , Investigative
26224,D0YA9Z,Ampicillin,Bacterial infection , Approved
26225,D0YB1G,Fentiazac,Dysmenorrhea , Approved
26226,D0YB2Y,AMG 853,Asthma , Phase 2
26227,D0YB3D,CytoregUNO,Skin cancer , Investigative
26228,D0YB3N,HTNV + PUUV DNA vaccine,Hemorrhagic fever , Phase 2
26229,D0YB3W,CI-1033,Lymphoma , Phase 2
26230,D0YB4D,Eldacimibe,Hyperlipidaemia , Phase 2
26231,D0YB5G,Sodium cellulose po4,Hypercalciuria , Approved
26232,D0YB5Z,ARX-Trail,Colon cancer , Investigative
26233,D0YB6P,YP-004,Solid tumour/cancer , Terminated
26234,D0YB7F,MT-II,Female sexual arousal dysfunction , Investigative
26235,D0YB7P,IFN-Kinoid,Systemic lupus erythematosus , Phase 2
26236,D0YC1R,BMS-520,Immune System disease , Investigative
26237,D0YC1Z,Doxorubicin-hemoglobin conjugate,Bacterial infection , Preclinical
26238,D0YC4F,K-828-AB,Dementia , Phase 2
26239,D0YC7U,Eptaplatin,Solid tumour/cancer , Approved
26240,D0YC8W,Folotynpralatrexate,Peripheral T-cell lymphoma , Phase 2
26241,D0YC9M,AllerT,Allergy , Phase 2
26242,D0YD1Q,PMID25684022-Compound-EP20041486488,Solid tumour/cancer , Patented
26243,D0YD1Q,PMID25684022-Compound-EP20041486488,Metastatic cancer , Patented
26244,D0YD6K,APC-200,Prostate cancer , Investigative
26245,D0YD9E,PF-00212062,Solid tumour/cancer , Investigative
26246,D0YE2N,Eperezolid,Bacterial infection , Discontinued in Phase 3
26247,D0YE6C,BN-brachyury cancer vaccine,Solid tumour/cancer , Phase 1
26248,D0YF2T,HepaVaxx C,Hepatitis C virus infection , Investigative
26249,D0YF3X,Ethamsylate,Menorrhagia , Approved
26250,D0YF4I,MN-221,Exacerbation of acute asthma , Phase 2
26251,D0YF4I,MN-221,Aging skin , Phase 2
26252,D0YF6K,HER2-specific CAR T cell,Atypical teratoid/rhabdoid tumour , Phase 1
26253,D0YF6K,HER2-specific CAR T cell,Choroid plexus carcinoma , Phase 1
26254,D0YF6K,HER2-specific CAR T cell,Ependymoma , Phase 1
26255,D0YF6K,HER2-specific CAR T cell,Germ cell tumour , Phase 1
26256,D0YF6K,HER2-specific CAR T cell,Glioma , Phase 1
26257,D0YF6K,HER2-specific CAR T cell,Medulloblastoma , Phase 1
26258,D0YF6K,HER2-specific CAR T cell,Pineoblastoma , Phase 1
26259,D0YF6K,HER2-specific CAR T cell,Gastric adenocarcinoma , Phase 1
26260,D0YF6L,KST-5468,Pain , Investigative
26261,D0YF9W,FST-200,Otitis externa , Investigative
26262,D0YG3K,Soluble insulin,Diabetic complication , Approved
26263,D0YG4I,Bevasiranib,Exudative age-related macular degeneration , Discontinued in Phase 3
26264,D0YG4P,Anti-OX40 mab,Prostate cancer , Phase 1
26265,D0YG4Q,OG-9,Solid tumour/cancer , Investigative
26266,D0YG7H,CM-2359,Nervous system disease , Terminated
26267,D0YG7M,Ketotifen,Allergic conjunctivitis , Approved
26268,D0YH0I,EP HIV-1090 vaccine,Human immunodeficiency virus-1 infection , Phase 1
26269,D0YH0I,EP HIV-1090 vaccine,Human immunodeficiency virus infection , Phase 1
26270,D0YH0N,Metadoxine,Multiple myeloma , Approved
26271,D0YH5F,Ridostin,Virus infection , Approved
26272,D0YH5L,CART-56 cells,Myelodysplastic syndrome , Phase 1
26273,D0YH5L,CART-56 cells,Acute myeloid leukaemia , Phase 1
26274,D0YH5V,MK-8189,Schizophrenia , Phase 2
26275,D0YH8F,RG7347,Solid tumour/cancer , Phase 1
26276,D0YH8T,MI-09018,Schizophrenia , Investigative
26277,D0YH9A,TPT-43,Alzheimer disease , Preclinical
26278,D0YI4F,Vecabrutinib,B-cell lymphoma , Phase 1/2
26279,D0YI6W,SPN-805,Anxiety disorder , Phase 1
26280,D0YJ2G,ADXS11-001,Human papillomavirus infection , Phase 2
26281,D0YJ5F,PT-112,Multiple myeloma , Phase 1
26282,D0YJ5H,EX-1311,Metabolic disorder , Investigative
26283,D0YJ9T,DU-6681,Bacterial infection , Discontinued in Phase 1
26284,D0YK4L,PAC-10649,Arthritis , Investigative
26285,D0YK7C,XR-5118,Solid tumour/cancer , Terminated
26286,D0YK7J,CDP-492,Vomiting , Terminated
26287,D0YK8M,"1,3,4-oxadiazole derivative 3",Solid tumour/cancer , Patented
26288,D0YK8M,"1,3,4-oxadiazole derivative 3",Infectious disease , Patented
26289,D0YK8M,"1,3,4-oxadiazole derivative 3",Human immunodeficiency virus infection , Patented
26290,D0YK8M,"1,3,4-oxadiazole derivative 3",Hepatitis , Patented
26291,D0YK9D,CHIR-99021,Graft rejection , Patented
26292,D0YK9D,CHIR-99021,Allergic inflammation , Patented
26293,D0YL0L,G-256,Cardiac arrhythmias , Investigative
26294,D0YL3E,GSK159802,Asthma , Discontinued in Phase 2
26295,D0YL8U,Omecamtiv mecarbil,Heart failure , Phase 3
26296,D0YL9G,TS-091,Hypersomnia , Phase 2
26297,D0YM1M,PMID25666693-Compound-67,Osteoarthritis pain , Patented
26298,D0YM1M,PMID25666693-Compound-67,Cancer related pain , Patented
26299,D0YM1M,PMID25666693-Compound-67,Neuropathic pain , Patented
26300,D0YM1M,PMID25666693-Compound-67,Inflammatory pain , Patented
26301,D0YM2K,Atezolizumab,Non-small cell lung cancer , Approved
26302,D0YM2K,Atezolizumab,Breast cancer , Phase 3
26303,D0YM2K,Atezolizumab,Bladder cancer , Phase 3
26304,D0YM2K,Atezolizumab,Renal cell carcinoma , Phase 3
26305,D0YM2K,Atezolizumab,Squamous cell carcinoma , Phase 3
26306,D0YM2K,Atezolizumab,Urothelial carcinoma , Phase 3
26307,D0YM2K,Atezolizumab,Hepatocellular carcinoma , Phase 3
26308,D0YM2K,Atezolizumab,Ovarian cancer , Phase 3
26309,D0YM2K,Atezolizumab,Prostate cancer , Phase 3
26310,D0YM2K,Atezolizumab,Small-cell lung cancer , Phase 3
26311,D0YM2K,Atezolizumab,Melanoma , Phase 1
26312,D0YM2K,Atezolizumab,Colorectal cancer , Phase 1
26313,D0YM2K,Atezolizumab,Haematological malignancy , Phase 1
26314,D0YM2K,Atezolizumab,Myelodysplastic syndrome , Phase 1
26315,D0YM2K,Atezolizumab,Acute myeloid leukaemia , Phase 1
26316,D0YM2K,Atezolizumab,Follicular lymphoma , Phase 1
26317,D0YM2K,Atezolizumab,Gastric adenocarcinoma , Phase 1
26318,D0YM2K,Atezolizumab,Multiple myeloma , Phase 1
26319,D0YM2K,Atezolizumab,Pancreatic cancer , Phase 1
26320,D0YM2K,Atezolizumab,Solid tumour/cancer , Phase 1
26321,D0YM2K,Atezolizumab,Bronchioalveolar carcinoma , Phase 0
26322,D0YM2K,Atezolizumab,Ulcer , Phase 0
26323,D0YM4F,ACC-002,Alzheimer disease , Phase 0
26324,D0YM7U,Rituximab,Non-hodgkin lymphoma , Approved
26325,D0YM7U,Rituximab,Pemphigus vulgaris , Phase 3
26326,D0YM8K,[99mTc]Met,Solid tumour/cancer , Investigative
26327,D0YN0I,PMID28270021-Compound-WO2014078408Example26,Pruritus , Patented
26328,D0YN0I,PMID28270021-Compound-WO2014078408Example26,Solid tumour/cancer , Patented
26329,D0YN0I,PMID28270021-Compound-WO2014078408Example26,Chronic pain , Patented
26330,D0YN0I,PMID28270021-Compound-WO2014078408Example26,Neuropathic pain , Patented
26331,D0YN0I,PMID28270021-Compound-WO2014078408Example26,Thymic cancer , Patented
26332,D0YN2F,HG-1209,Solid tumour/cancer , Investigative
26333,D0YN2I,Pyrazole derivative 54,Obesity , Patented
26334,D0YN3T,Tamiphosphor,Influenza virus infection , Investigative
26335,D0YN4S,BI 754111,Solid tumour/cancer , Phase 1
26336,D0YN4Y,PTI-202,Pain , Phase 1
26337,D0YN5T,Selumetinib,Neurofibromatosis type 1 , Approved
26338,D0YN5T,Selumetinib,Severe acute respiratory syndrome (SARS) , Investigative
26339,D0YN5T,Selumetinib,Middle East Respiratory Syndrome (MERS) , Investigative
26340,D0YN9H,VVP-100X,Non-insulin dependent diabetes , Investigative
26341,D0YN9Y,MB-101,Recurrent glioblastoma , Phase 1
26342,D0YO0Z,IB-08A099,Bacterial infection , Investigative
26343,D0YO2N,MP-0260,Ocular disease , Investigative
26344,D0YO4B,Cabiralizumab,Solid tumour/cancer , Phase 2
26345,D0YO4B,Cabiralizumab,Pancreatic cancer , Phase 2
26346,D0YO4C,Xilonix,Influenza virus infection , Phase 3
26347,D0YO4C,Xilonix,Colorectal cancer , Phase 3
26348,D0YO4C,Xilonix,Non-small-cell lung cancer , Phase 2
26349,D0YO4D,LG100268,Acquired immune deficiency syndrome , Discontinued in Phase 1
26350,D0YO5Z,UshStat,Deafness , Phase 1/2
26351,D0YO5Z,UshStat,Retinitis pigmentosa , Phase 1
26352,D0YO6R,ADXS-DUAL,Cervical cancer , Phase 3
26353,D0YO7Y,DAS-181,Influenza virus infection , Phase 2
26354,D0YP0C,DT-TX-30,Angina pectoris , Phase 1
26355,D0YP2R,99mTc-teboroxime,Myocardial disease , Approved
26356,D0YP5Z,"Streptococcus pneumoniae vaccine, Cytovax",Streptococcus infection , Terminated
26357,D0YP6F,AZD-4121,Lipid metabolism disorder , Discontinued in Phase 1
26358,D0YP7B,Setmelanotide,Obesity , Approved
26359,D0YP7B,Setmelanotide,Bardet biedl syndrome , Phase 3
26360,D0YP7B,Setmelanotide,Prader-Willi syndrome , Phase 2
26361,D0YP7B,Setmelanotide,Diabetic complication , Preclinical
26362,D0YP7L,SB-269970,Sleep-wake disorder , Terminated
26363,D0YP8F,Glypican3-ADC,Solid tumour/cancer , Phase 1
26364,D0YQ0V,Cefpirome sulfate,Bacterial infection , Approved
26365,D0YQ2K,YS110 mAb clone,Middle East Respiratory Syndrome (MERS) , Investigative
26366,D0YQ3M,EP-2104R,Cardiovascular disease , Discontinued in Phase 2
26367,D0YQ7U,Cenicriviroc,Human immunodeficiency virus infection , Phase 2
26368,D0YQ7U,Cenicriviroc,Human immunodeficiency virus-1 infection , Phase 2
26369,D0YQ9G,GT-16-239,Arteriosclerosis , Terminated
26370,D0YQ9I,FF-10101-01,Acute myeloid leukaemia , Phase 1
26371,D0YQ9P,Amodiaquine,Malaria , Withdrawn from market
26372,D0YQ9P,Amodiaquine,Severe acute respiratory syndrome (SARS) , Preclinical
26373,D0YQ9P,Amodiaquine,Middle East Respiratory Syndrome (MERS) , Preclinical
26374,D0YR4E,PMID25666693-Compound-21,Osteoarthritis pain , Patented
26375,D0YR4E,PMID25666693-Compound-21,Cancer related pain , Patented
26376,D0YR4E,PMID25666693-Compound-21,Neuropathic pain , Patented
26377,D0YR4E,PMID25666693-Compound-21,Inflammatory pain , Patented
26378,D0YS0B,DF-1012,Cough , Discontinued in Phase 2
26379,D0YS1U,sparsentan,Focal segmental glomerulosclerosis , Phase 3
26380,D0YS1U,sparsentan,Myocardial infarction , Phase 2
26381,D0YS1U,sparsentan,Hypertension , Phase 2
26382,D0YS2W,PT005,Chronic obstructive pulmonary disease , Phase 3
26383,D0YS3H,Debio-0617,Solid tumour/cancer , Investigative
26384,D0YS7D,Isosorbide Mononitrate,Hydrocephalus , Approved
26385,D0YS8C,BTA-188,Rhinovirus infection , Terminated
26386,D0YT3Z,AR-7947,Non-insulin dependent diabetes , Investigative
26387,D0YT6Z,Mirisetron maleate,Anxiety disorder , Discontinued in Phase 1
26388,D0YT8P,JNJ-38877605,Solid tumour/cancer , Phase 1
26389,D0YU0L,GPA-TriMAR-T cells,Melanoma , Phase 1
26390,D0YU1L,MP-124,Ischemic stroke , Phase 1
26391,D0YU1L,MP-124,Stroke , Phase 1
26392,D0YU1M,G-207 virus construct,Glioma , Phase 1/2
26393,D0YU9B,PMID25666693-Compound-151,Osteoarthritis pain , Patented
26394,D0YU9B,PMID25666693-Compound-151,Cancer related pain , Patented
26395,D0YU9B,PMID25666693-Compound-151,Neuropathic pain , Patented
26396,D0YU9B,PMID25666693-Compound-151,Inflammatory pain , Patented
26397,D0YV0N,GSK2857916,Multiple myeloma , Phase 2
26398,D0YV1Q,Kanamycin,Bacterial infection , Approved
26399,D0YV4F,Ocrelizumab,Multiple sclerosis , Approved
26400,D0YV4F,Ocrelizumab,Diffuse large B-cell lymphoma , Approved
26401,D0YW3K,Pyrazole derivative 16,Obesity , Patented
26402,D0YW4R,IDM-2,Bladder cancer , Discontinued in Phase 2/3
26403,D0YW6B,AM-679,Ocular inflammation , Investigative
26404,D0YW6P,RU-101,Xerophthalmia , Phase 1/2
26405,D0YX1C,Thiazole derivative 1,Albinism , Patented
26406,D0YX1C,Thiazole derivative 1,Ephelides , Patented
26407,D0YX1C,Thiazole derivative 1,Menkes disease , Patented
26408,D0YX1C,Thiazole derivative 1,Senile lentigines , Patented
26409,D0YX1C,Thiazole derivative 1,Melasma , Patented
26410,D0YX3D,Olipudase alfa,Sphingolipidosis , Phase 2
26411,D0YX4L,PMID26651364-Compound-126b,Crohn disease , Patented
26412,D0YX4L,PMID26651364-Compound-126b,Ulcerative colitis , Patented
26413,D0YX4L,PMID26651364-Compound-126b,Urinary tract infection , Patented
26414,D0YX4S,Cefprozil,Bacterial infection , Approved
26415,D0YX4Z,IC-43,Rotavirus infection (Diarrhoea) , Phase 2/3
26416,D0YX7E,Ortataxel,Solid tumour/cancer , Phase 2
26417,D0YX7E,Ortataxel,Heart transplant rejection , Preclinical
26418,D0YX8X,MG-1104,Factor IX deficiency , Investigative
26419,D0YY6O,CLIC-1901,Acute lymphoblastic leukaemia , Phase 1/2
26420,D0YY6O,CLIC-1901,Non-hodgkin lymphoma , Phase 1/2
26421,D0YY8N,PMID25470667-Compound-GO-CoA-Tat,Type-2 diabetes , Patented
26422,D0YY8N,PMID25470667-Compound-GO-CoA-Tat,Obesity , Patented
26423,D0YZ0B,HT-2678,Cognitive impairment , Investigative
26424,D0YZ1J,APG-2305,Autoimmune diabetes , Investigative
26425,D0YZ1Q,RGX-104,Non-small-cell lung cancer , Phase 1/2
26426,D0YZ1Q,RGX-104,Lymphoma , Phase 1
26427,D0YZ1Q,RGX-104,Solid tumour/cancer , Phase 1
26428,D0YZ4T,SFLT-01,Macular degeneration , Phase 1
26429,D0YZ5T,NT-345,Sarcopenia , Investigative
26430,D0YZ8I,JWH-015,Organ transplant rejection , Patented
26431,D0Z0AM,PSI-697,Thrombosis , Phase 1
26432,D0Z0AM,PSI-697,Atherosclerosis , Phase 1
26433,D0Z0AS,CDRI-93/478,Hypertension , Investigative
26434,D0Z0CH,Almokalant,Cardiac arrhythmias , Discontinued in Phase 3
26435,D0Z0CU,Cx-621,Autoimmune diabetes , Phase 1
26436,D0Z0DW,Folic Acid,Vitamin deficiency , Approved
26437,D0Z0DW,Folic Acid,Folate-deficiency anemia , Approved
26438,D0Z0DX,Benzothiazole analog 5,Albinism , Patented
26439,D0Z0DX,Benzothiazole analog 5,Ephelides , Patented
26440,D0Z0DX,Benzothiazole analog 5,Menkes disease , Patented
26441,D0Z0DX,Benzothiazole analog 5,Senile lentigines , Patented
26442,D0Z0DX,Benzothiazole analog 5,Melasma , Patented
26443,D0Z0EH,PheTQS,Central nervous system disease , Investigative
26444,D0Z0EP,CIGB-M3,Colorectal cancer , Phase 1
26445,D0Z0FA,MLN7243,Solid tumour/cancer , Phase 1
26446,D0Z0GH,AZD-2563,Bacterial infection , Phase 2
26447,D0Z0GX,SUVN-502,Neurological disorder , Phase 2
26448,D0Z0GX,SUVN-502,Alzheimer disease , Phase 2
26449,D0Z0HH,Gossypol,Prostate cancer , Phase 2
26450,D0Z0HL,Lixisenatide + Lantus,Type-2 diabetes , Phase 3
26451,D0Z0HS,Hu Dreg 55,Psoriasis vulgaris , Terminated
26452,D0Z0JA,TDI-0046,Motor neurone disease , Investigative
26453,D0Z0JC,NS-640,Neurodegenerative disorder , Investigative
26454,D0Z0KD,PD-0183812,Retinoblastoma , Terminated
26455,D0Z0KE,BX-044,Thrombosis , Terminated
26456,D0Z0KH,Azole,Solid tumour/cancer , Investigative
26457,D0Z0KH,Azole,Candidiasis , Investigative
26458,D0Z0KL,"1,3,4-oxadiazole derivative 6",Solid tumour/cancer , Patented
26459,D0Z0KL,"1,3,4-oxadiazole derivative 6",Infectious disease , Patented
26460,D0Z0KL,"1,3,4-oxadiazole derivative 6",Human immunodeficiency virus infection , Patented
26461,D0Z0KL,"1,3,4-oxadiazole derivative 6",Hepatitis , Patented
26462,D0Z0LJ,ABT-107,Attention deficit hyperactivity disorder , Discontinued in Phase 1
26463,D0Z0LZ,IT-121,Colorectal cancer , Investigative
26464,D0Z0MG,Carglumic acid,Acute hyperammonaemia , Approved
26465,D0Z0MI,Iomab-B CD45,Acute myeloid leukaemia , Phase 3
26466,D0Z0NX,AR-06,Heart failure , Phase 3
26467,D0Z0OT,ONO-4057,Inflammatory bowel disease , Discontinued in Phase 2
26468,D0Z0PB,NGD-8243,Acute or chronic pain , Discontinued in Phase 2
26469,D0Z0PR,L-006235-1,Osteoarthritis , Preclinical
26470,D0Z0QO,SX-PCK9,Hypercholesterolaemia , Investigative
26471,D0Z0RR,VGV-X,Human immunodeficiency virus infection , Investigative
26472,D0Z0RU,APC-6336,Hepatitis C virus infection , Terminated
26473,D0Z0SI,TBD-2,Mycobacterium infection , Investigative
26474,D0Z0TU,ITCA-638,Hepatitis C virus infection , Phase 2
26475,D0Z0XM,CBL0137,Advanced solid tumour , Phase 1
26476,D0Z0ZJ,M-108101,Acne vulgaris , Investigative
26477,D0Z0ZT,CTX-4430,Cystic fibrosis , Phase 2
26478,D0Z1AB,ABBV-927,Solid tumour/cancer , Phase 1
26479,D0Z1BQ,Cefluprenam,Bacterial infection , Phase 3
26480,D0Z1CQ,HumaRAD-OV,Ovarian cancer , Investigative
26481,D0Z1CS,Recombinant glucocerebrosidase enzyme,Gaucher disease , Investigative
26482,D0Z1CZ,IR502,Psoriatic disorder , Phase 2
26483,D0Z1CZ,IR502,Plaque psoriasis , Phase 2
26484,D0Z1CZ,IR502,Psoriasis vulgaris , Phase 2
26485,D0Z1DH,LY2090314,Acute myeloid leukaemia , Phase 2
26486,D0Z1EN,CIGB-166,Solid tumour/cancer , Investigative
26487,D0Z1FX,Estriol,Hormone deficiency , Approved
26488,D0Z1FX,Estriol,Multiple sclerosis , Phase 2
26489,D0Z1GP,FT-1050-treated umbilical cord stem cell therapy,Thrombocytopenia , Phase 1
26490,D0Z1HA,TDI-0020,Motor neurone disease , Investigative
26491,D0Z1HQ,PNU156804,Renal transplantation , Terminated
26492,D0Z1KC,Interferon gamma,Inflammation , Approved
26493,D0Z1LJ,3-(phenoxymethyl) benzylamine derivative 1,Albinism , Patented
26494,D0Z1LJ,3-(phenoxymethyl) benzylamine derivative 1,Ephelides , Patented
26495,D0Z1LJ,3-(phenoxymethyl) benzylamine derivative 1,Menkes disease , Patented
26496,D0Z1LJ,3-(phenoxymethyl) benzylamine derivative 1,Senile lentigines , Patented
26497,D0Z1LJ,3-(phenoxymethyl) benzylamine derivative 1,Melasma , Patented
26498,D0Z1MM,KP-9928,Hypercholesterolaemia , Investigative
26499,D0Z1NF,BFPET,Coronary artery disease , Phase 1
26500,D0Z1NY,BMS214662,Non-small-cell lung cancer , Phase 1
26501,D0Z1OR,IPP-204106,Solid tumour/cancer , Phase 1/2
26502,D0Z1OS,ARI-2243,Type-2 diabetes , Phase 1
26503,D0Z1OT,ALD-403,Migraine , Phase 2
26504,D0Z1PA,GG-818,Prostate disease , Investigative
26505,D0Z1QC,Monoctanoin,Gallstone , Approved
26506,D0Z1QR,TD-1473,Ulcerative colitis , Phase 1
26507,D0Z1RJ,Adaphostin,Chronic myelogenous leukaemia , Phase 1
26508,D0Z1RQ,L-365260,Anxiety disorder , Discontinued in Phase 2
26509,D0Z1RV,Clozapine,Schizophrenia , Approved
26510,D0Z1SL,Bazedoxifene/ conjugated estrogens,Postmenopausal osteoporosis , Phase 3
26511,D0Z1TF,Ro-25-4094,Inflammation , Terminated
26512,D0Z1UA,Nebivolol,Hypertension , Approved
26513,D0Z1UB,NAI-acne,Acne vulgaris , Phase 2
26514,D0Z1UW,TTPABC,Diabetic nephropathy , Phase 1
26515,D0Z1VE,SER-203,Solid tumour/cancer , Investigative
26516,D0Z1VS,RN6G,Age-related macular degeneration , Discontinued in Phase 2
26517,D0Z1VU,Second generation therapeutics,Obesity , Phase 3
26518,D0Z1WA,Procaterol,Asthma , Approved
26519,D0Z1WH,CRAM 1-2,Central nervous system disease , Investigative
26520,D0Z1XD,Methyltestosterone,Solid tumour/cancer , Approved
26521,D0Z1YF,Biphenyl mannoside derivative 16,Crohn disease , Patented
26522,D0Z1YF,Biphenyl mannoside derivative 16,Ulcerative colitis , Patented
26523,D0Z1YF,Biphenyl mannoside derivative 16,Urinary tract infection , Patented
26524,D0Z1YK,EM-703,Inflammation , Investigative
26525,D0Z1ZA,Mannoside derivative 2,Crohn disease , Patented
26526,D0Z1ZA,Mannoside derivative 2,Ulcerative colitis , Patented
26527,D0Z1ZA,Mannoside derivative 2,Urinary tract infection , Patented
26528,D0Z1ZM,Clarithromycin,Bacterial infection , Approved
26529,D0Z2AY,RLIP76 protein,Sunburn , Investigative
26530,D0Z2BI,mRNA-1851,Influenza virus infection , Phase 1
26531,D0Z2BO,CX-072,Solid tumour/cancer , Phase 2
26532,D0Z2BO,CX-072,Advanced malignancy , Phase 2
26533,D0Z2BO,CX-072,Medulloblastoma , Phase 2
26534,D0Z2BO,CX-072,Lymphoma , Phase 1/2
26535,D0Z2BT,DP-266,Solid tumour/cancer , Investigative
26536,D0Z2CM,Lutropin alfa,Female infertility , Approved
26537,D0Z2FB,Piclamilast,Rheumatoid arthritis , Phase 2
26538,D0Z2FD,BMS-908662,Solid tumour/cancer , Phase 1
26539,D0Z2FX,AL-209,Central nervous system disease , Investigative
26540,D0Z2GF,NI-101,Alzheimer disease , Phase 3
26541,D0Z2GH,AS-1387392,Immune System disease , Investigative
26542,D0Z2GQ,DV-601,Hepatitis B virus infection , Phase 1
26543,D0Z2HG,V950 vaccine,Alzheimer disease , Phase 1
26544,D0Z2IY,TMX-201,Autoimmune diabetes , Investigative
26545,D0Z2JF,Nivocasan,Fibrosis , Phase 2
26546,D0Z2JP,Vi-CRM197,Salmonella infection , Phase 2
26547,D0Z2JR,LG-911,Solid tumour/cancer , Investigative
26548,D0Z2KU,S-288310,Bladder cancer , Discontinued in Phase 1/2
26549,D0Z2LG,Sennoside a,Cardiovascular disease , Approved
26550,D0Z2MB,Cilansetron,Irritable bowel syndrome , Phase 3
26551,D0Z2NA,AT-005,Inflammatory bowel disease , Preclinical
26552,D0Z2NJ,ASN100,Ventilator-associated pneumonia , Phase 2
26553,D0Z2NJ,ASN100,Hospital-acquired pneumonia , Phase 2
26554,D0Z2NY,Aom-0763,Gout , Investigative
26555,D0Z2QR,DS-7250,Diabetic complication , Discontinued in Phase 1
26556,D0Z2RA,Cantharidin,Molluscum contagiosum infection , Approved
26557,D0Z2TH,IMD-015213,Solid tumour/cancer , Investigative
26558,D0Z2UD,RS-100975,Prostate disease , Discontinued in Phase 1
26559,D0Z2UQ,AZD2014,Solid tumour/cancer , Phase 2
26560,D0Z2UT,BNP-FIX,Factor IX deficiency , Investigative
26561,D0Z2UW,Nicaraven,Cerebrovascular disease , Phase 3
26562,D0Z2UY,Antigen-specific melanoma vaccine,Melanoma , Phase 1/2
26563,D0Z2WQ,Quinelorane,Male sexual disorder , Discontinued in Phase 3
26564,D0Z2WV,ASP6981,Complete androgen insensitivity syndrome , Phase 1
26565,D0Z2WV,ASP6981,Immune dysregulation , Phase 1
26566,D0Z2YQ,Patiromer calcium,Hyperkalemia , Approved
26567,D0Z2ZY,SL-401,Blastic plasmacytoid dendritic cell neoplasm , Phase 1/2
26568,D0Z2ZY,SL-401,Acute myeloid leukaemia , Phase 1/2
26569,D0Z2ZY,SL-401,Multiple myeloma , Phase 1/2
26570,D0Z2ZY,SL-401,Myeloproliferative neoplasm , Phase 1/2
26571,D0Z3AB,Anti-PSA mabs,Prostate cancer , Investigative
26572,D0Z3AK,NPC-17923,Rheumatoid arthritis , Terminated
26573,D0Z3BU,Drug 2878175,Hepatitis virus infection , Phase 1
26574,D0Z3DY,Benzbromarone,Gout , Approved
26575,D0Z3EI,Quinolones,Bacterial infection , Approved
26576,D0Z3EI,Quinolones,Tuberculosis , Approved
26577,D0Z3ES,"Melanoma vaccine, University of Virginia",Melanoma , Phase 3
26578,D0Z3FV,MPL-containing Pollinex allergy desensitization vaccine,Allergy , Approved
26579,D0Z3HF,AE-IG,Genetic disease , Phase 1
26580,D0Z3HW,Thiazole carboxamide derivative 30,Solid tumour/cancer , Patented
26581,D0Z3HW,Thiazole carboxamide derivative 30,Metastatic cancer , Patented
26582,D0Z3KK,PMID32321856-compound-11b,Coronavirus Disease 2019 (COVID-19) , Investigative
26583,D0Z3LC,SR-4554,Diagnostic imaging , Phase 1
26584,D0Z3LN,LT-1945,Graft-versus-host disease , Investigative
26585,D0Z3LY,SOM-0010,Virus infection , Investigative
26586,D0Z3OO,PneuGEM,Streptococcus infection , Investigative
26587,D0Z3PD,Purified secretory immunoglobulin,Enterocolitis , Investigative
26588,D0Z3PO,BIIB014,Parkinson disease , Phase 2
26589,D0Z3RF,UCB-11056,Cognitive impairment , Phase 2
26590,D0Z3RZ,EISO,Virus infection , Phase 2
26591,D0Z3UP,Dabuzalgron,Urinary incontinence , Discontinued in Phase 2
26592,D0Z3XO,MP-136,Lipid metabolism disorder , Discontinued in Phase 1
26593,D0Z3YP,ALGRX-1207,Pain , Discontinued in Phase 1
26594,D0Z3ZF,TOCA-621,Melanoma , Investigative
26595,D0Z4BH,Celtura,Influenza virus infection , Approved
26596,D0Z4BP,Human liver-engrafting cells,Liver disease , Investigative
26597,D0Z4BV,Oxiracetam,Dementia , Approved
26598,D0Z4CY,PEN-221,Neuroendocrine cancer , Phase 1/2
26599,D0Z4CY,PEN-221,Small-cell lung cancer , Phase 1/2
26600,D0Z4EI,Mifepristone,Cushing disease , Approved
26601,D0Z4FE,MIN-117,Major depressive disorder , Phase 2
26602,D0Z4KX,Farampator,Schizophrenia , Discontinued in Phase 1
26603,D0Z4KX,Farampator,Major depressive disorder , Discontinued in Phase 1
26604,D0Z4NA,EG-P119,Attention deficit hyperactivity disorder , Preclinical
26605,D0Z4NI,Zinc Acetate,Wilson disease , Approved
26606,D0Z4NI,Zinc Acetate,Human immunodeficiency virus infection , Investigative
26607,D0Z4NX,FR-171113,Thrombosis , Terminated
26608,D0Z4OQ,TAK-783,Rheumatoid arthritis , Phase 2
26609,D0Z4PE,Zinostatin stimalamer,Brain cancer , Approved
26610,D0Z4QC,SDZ-SER-082,Neurological disorder , Terminated
26611,D0Z4QJ,PMID25623274-Compound-WO2014132220C1,Pulmonary arterial hypertension , Patented
26612,D0Z4QQ,PMID25666693-Compound-160,Osteoarthritis pain , Patented
26613,D0Z4QQ,PMID25666693-Compound-160,Cancer related pain , Patented
26614,D0Z4QQ,PMID25666693-Compound-160,Neuropathic pain , Patented
26615,D0Z4QQ,PMID25666693-Compound-160,Inflammatory pain , Patented
26616,D0Z4QT,"3-substituted-1,2,4-oxadiazole derivative 1",Solid tumour/cancer , Patented
26617,D0Z4QT,"3-substituted-1,2,4-oxadiazole derivative 1",Infectious disease , Patented
26618,D0Z4QT,"3-substituted-1,2,4-oxadiazole derivative 1",Human immunodeficiency virus infection , Patented
26619,D0Z4QT,"3-substituted-1,2,4-oxadiazole derivative 1",Hepatitis , Patented
26620,D0Z4QV,DUP-734,Psychotic disorder , Discontinued in Phase 1
26621,D0Z4RC,CUDC-101,Solid tumour/cancer , Phase 1
26622,D0Z4RX,HuMax-cMet,Solid tumour/cancer , Investigative
26623,D0Z4SB,Glipizide,Diabetic complication , Approved
26624,D0Z4SP,RG7426,Type-1 diabetes , Phase 2
26625,D0Z4UN,Pimecrolimus,Atopic dermatitis , Approved
26626,D0Z4UY,Sodium Acetate Anhydrous,Hyponatraemia , Approved
26627,D0Z4VA,UD-CG-212,Heart failure , Terminated
26628,D0Z4VG,HG-1092,Immune System disease , Investigative
26629,D0Z4VX,BI 695501,Rheumatoid arthritis , Phase 3
26630,D0Z4XW,Topetecan,Small-cell lung cancer , Approved
26631,D0Z4YF,Ad5-nCoV vaccine,Coronavirus Disease 2019 (COVID-19) , Phase 2
26632,D0Z4YK,SMT-C2100,Melanoma , Investigative
26633,D0Z4ZT,Drospirenone,Contraception , Approved
26634,D0Z5AC,Gonadimmune,Prostate cancer , Discontinued in Phase 2
26635,D0Z5BC,Undecylenic acid,Dermatitis , Approved
26636,D0Z5BD,CER-627,Dyslipidemia , Discontinued in Phase 1
26637,D0Z5DJ,Long-acting oxyntomodulin,Obesity , Investigative
26638,D0Z5DM,IMD-0354,Acne vulgaris , Phase 1
26639,D0Z5EJ,PSMA-617,Prostate cancer , Phase 2
26640,D0Z5EM,Cephalexin,Bacterial infection , Approved
26641,D0Z5FC,Allogeneic cytotoxic T-cell therapy,Epstein barr virus infection , Phase 2
26642,D0Z5HA,VLTS-934,Peripheral vascular disease , Phase 2
26643,D0Z5HB,FH-510,Psychotic disorder , Terminated
26644,D0Z5HH,PMID25666693-Compound-144,Osteoarthritis pain , Patented
26645,D0Z5HH,PMID25666693-Compound-144,Cancer related pain , Patented
26646,D0Z5HH,PMID25666693-Compound-144,Neuropathic pain , Patented
26647,D0Z5HH,PMID25666693-Compound-144,Inflammatory pain , Patented
26648,D0Z5HL,Thiazole carboxamide derivative 6,Solid tumour/cancer , Patented
26649,D0Z5HL,Thiazole carboxamide derivative 6,Metastatic cancer , Patented
26650,D0Z5HR,VX-661,Cystic fibrosis , Phase 3
26651,D0Z5IP,Ixiaro,Japanese encephalitis virus infection , Approved
26652,D0Z5IU,Sulindac,Rheumatoid arthritis , Approved
26653,D0Z5LB,AT1022,Pain , Discontinued in Phase 2
26654,D0Z5LI,MEDI9447,Solid tumour/cancer , Phase 1
26655,D0Z5LZ,Tilmacoxib,Colon polyp , Discontinued in Phase 2
26656,D0Z5OE,Mitotane,Adrenocortical carcinoma , Approved
26657,D0Z5OJ,NMI-150,Pain , Terminated
26658,D0Z5OV,Delorazepam,Anxiety disorder , Approved
26659,D0Z5QI,Fentanyl/droperidol,Anaesthesia , Approved
26660,D0Z5SC,Dengue fever vaccine,Dengue fever , Phase 3
26661,D0Z5SM,Sodium Tetradecyl Sulfate,Hemangioma , Approved
26662,D0Z5SM,Sodium Tetradecyl Sulfate,Varicose and spider veins of leg , Approved
26663,D0Z5SR,Fosfructose,Asthma , Discontinued in Phase 3
26664,D0Z5TS,KI-0503,Arthropathy , Phase 2
26665,D0Z5TW,Parietaria Judaica-containing vaccine,Allergic conjunctivitis , Phase 3
26666,D0Z5UB,CX-2076,Attention deficit hyperactivity disorder , Investigative
26667,D0Z5UD,MIP-1375,Prostate cancer , Investigative
26668,D0Z5UT,INOpulse,Pulmonary arterial hypertension , Phase 3
26669,D0Z5VG,CZ-48,Solid tumour/cancer , Phase 1
26670,D0Z5VG,CZ-48,Lymphoma , Phase 1
26671,D0Z5VL,PPMX-2017,Solid tumour/cancer , Investigative
26672,D0Z5VQ,Terutroban sodium,Thrombosis , Discontinued in Phase 3
26673,D0Z5VW,H3B-6545,Breast cancer , Phase 1/2
26674,D0Z5XT,Imexon,Non-hodgkin lymphoma , Phase 2
26675,D0Z5YI,AVI-5038,Duchenne dystrophy , Investigative
26676,D0Z6AM,Ipafricept,Ovarian cancer , Phase 1
26677,D0Z6AR,Descartes-08,Multiple myeloma , Phase 2
26678,D0Z6AX,BAY-27-9955,Type-2 diabetes , Discontinued in Phase 1
26679,D0Z6BF,Grastek,Allergic rhinitis , Approved
26680,D0Z6DE,RPSGL-Ig,Delayed graft function , Phase 2
26681,D0Z6EQ,ZP-009,Pharyngitis , Investigative
26682,D0Z6GW,TMC649128,Hepatitis C virus infection , Phase 1
26683,D0Z6IB,AVP-786,Alzheimer disease , Phase 3
26684,D0Z6IB,AVP-786,Neurobehavioral disorder , Phase 2
26685,D0Z6IB,AVP-786,Schizophrenia , Phase 2
26686,D0Z6IB,AVP-786,Pain , Phase 1
26687,D0Z6KF,TAS-114,Non-small-cell lung cancer , Phase 2
26688,D0Z6KF,TAS-114,Solid tumour/cancer , Phase 1
26689,D0Z6KK,AZD-5847,Mycobacterium infection , Phase 2
26690,D0Z6MT,Famitinib,Solid tumour/cancer , Phase 2
26691,D0Z6MW,ODS-656,Osteopetrosis , Investigative
26692,D0Z6NK,CHB-111,Hepatitis B virus infection , Discontinued in Phase 1
26693,D0Z6OI,DS-6930,Diabetic complication , Discontinued in Phase 1
26694,D0Z6OW,Staphylococcus aureus vaccine,Bacterial infection , Phase 2/3
26695,D0Z6OW,Staphylococcus aureus vaccine,Staphylococcus infection , Phase 1
26696,D0Z6PF,Alkyl mannoside derivative 2,Crohn disease , Patented
26697,D0Z6PF,Alkyl mannoside derivative 2,Ulcerative colitis , Patented
26698,D0Z6PF,Alkyl mannoside derivative 2,Urinary tract infection , Patented
26699,D0Z6QG,Pipotiazine,Schizophrenia , Approved
26700,D0Z6RW,LMP-1/LMP-2 CTLs,Lymphoma , Phase 1
26701,D0Z6SP,Andecaliximab,Gastric adenocarcinoma , Phase 3
26702,D0Z6SP,Andecaliximab,Solid tumour/cancer , Phase 1
26703,D0Z6ST,Buflomedil,Peripheral vascular disease , Approved
26704,D0Z6UC,Sumatriptan,Migraine , Approved
26705,D0Z6VR,Buthionine sulfoximine,Malaria , Investigative
26706,D0Z6VR,Buthionine sulfoximine,Solid tumour/cancer , Investigative
26707,D0Z6WI,EP-51216,Eating disorder , Phase 1
26708,D0Z6WN,NDM-10107,Obesity , Investigative
26709,D0Z6XQ,Recombinant human zinc alpha-2 glycoprotein (ZAG),Diabetic complication , Investigative
26710,D0Z7AB,Olodaterol/tiotropium bromide,Chronic obstructive pulmonary disease , Phase 3
26711,D0Z7AM,Ether lipid,Solid tumour/cancer , Discontinued in Phase 1
26712,D0Z7AN,Ro-19-8022,Anxiety disorder , Terminated
26713,D0Z7BE,H-100,Bacterial infection , Phase 1
26714,D0Z7BX,GSK3145095,Pancreatic cancer , Phase 1/2
26715,D0Z7EV,Carboxamide derivative 1,Obesity , Patented
26716,D0Z7FK,XMT-1001,Solid tumour/cancer , Phase 1
26717,D0Z7FU,INS 316,Lung cancer , Discontinued in Phase 3
26718,D0Z7FY,CEM-301,Gastric motility disorder , Investigative
26719,D0Z7FZ,VN-180,Herpes simplex virus infection , Investigative
26720,D0Z7GJ,EUK-418,Radiation syndrome , Terminated
26721,D0Z7GX,BBT-032,Multiple sclerosis , Investigative
26722,D0Z7IW,JI-101,Solid tumour/cancer , Phase 2
26723,D0Z7KB,HPMA-docetaxel conjugate,Solid tumour/cancer , Investigative
26724,D0Z7KE,Isradipine,Hypertension , Approved
26725,D0Z7KE,Isradipine,Herpes simplex virus infection , Phase 3
26726,D0Z7LK,GSC-1,Hyperglycemia , Investigative
26727,D0Z7MJ,Prednisolone sodium metazoate,Inflammatory bowel disease , Discontinued in Phase 2
26728,D0Z7PI,GR-233548,Thrombosis , Terminated
26729,D0Z7QK,UCART123,Acute myeloid leukaemia , Phase 1
26730,D0Z7QK,UCART123,Blastic plasmacytoid dendritic cell neoplasm , Phase 1
26731,D0Z7RA,GLY-220,Diabetic angiopathy , Investigative
26732,D0Z7RR,ARRY-770,Solid tumour/cancer , Investigative
26733,D0Z7TR,ACP-01,Critical limb ischemia , Phase 2
26734,D0Z7UN,H5N1 influenza vaccine,Influenza virus infection , Phase 3
26735,D0Z7ZM,Rhucin,Hereditary angioedema , Approved
26736,D0Z7ZM,Rhucin,Erectile dysfunction , Approved
26737,D0Z8AA,Propiolactone,Sterilant , Approved
26738,D0Z8AE,Chromic Chloride,Virus infection , Approved
26739,D0Z8BI,IMGN-007,Solid tumour/cancer , Investigative
26740,D0Z8CQ,Sarilumab,Rheumatoid arthritis , Approved
26741,D0Z8DO,SPD-556,Heart failure , Phase 2
26742,D0Z8EA,FMX104,Chronic post cancer treatment pain , Phase 2
26743,D0Z8EJ,KOS-1815,Solid tumour/cancer , Preclinical
26744,D0Z8EV,Mycophenolic acid,Crohn disease , Approved
26745,D0Z8EV,Mycophenolic acid,Middle East Respiratory Syndrome (MERS) , Investigative
26746,D0Z8EV,Mycophenolic acid,Coronavirus Disease 2019 (COVID-19) , Investigative
26747,D0Z8EX,Stavudine,Human immunodeficiency virus infection , Approved
26748,D0Z8GD,CD19 CAR T Cells,Acute lymphoblastic leukaemia , Phase 1/2
26749,D0Z8GD,CD19 CAR T Cells,Chronic lymphocytic leukaemia , Phase 1/2
26750,D0Z8GD,CD19 CAR T Cells,Diffuse large B-cell lymphoma , Phase 1/2
26751,D0Z8GD,CD19 CAR T Cells,Large cell lymphoma , Phase 1/2
26752,D0Z8GD,CD19 CAR T Cells,Mantle cell lymphoma , Phase 1/2
26753,D0Z8HG,Vecuronium,Spasm , Approved
26754,D0Z8JR,BMS-936564,B-cell chronic lymphocytic leukaemia , Phase 1
26755,D0Z8JR,BMS-936564,Acute myeloid leukaemia , Phase 1
26756,D0Z8KS,Zanolimumab,Lymphoma , Phase 3
26757,D0Z8KU,SGN-2FF,Solid tumour/cancer , Phase 1
26758,D0Z8LA,Cyclocreatine,Virus infection , Discontinued in Phase 1
26759,D0Z8LN,Ebola virus vaccine,Ebola virus infection , Phase 3
26760,D0Z8MC,Botulinum toxin type A gel,Solid tumour/cancer , Phase 3
26761,D0Z8PO,KPE-06001,Arthritis , Phase 1
26762,D0Z8SF,Sarkomycin,Solid tumour/cancer , Approved
26763,D0Z8UJ,TDI-0111,Motor neurone disease , Investigative
26764,D0Z8UQ,DM-83,Type-2 diabetes , Discontinued in Phase 2
26765,D0Z8WF,Pyridotriazolopyrimidine derivative 3,Obesity , Patented
26766,D0Z8XI,HG-1077,Solid tumour/cancer , Investigative
26767,D0Z8ZW,EGF-SLiP fusion protein,Breast cancer , Investigative
26768,D0Z9AV,H5N1 vaccine,Influenza virus infection , Phase 2
26769,D0Z9BN,NBRI-16716a,Solid tumour/cancer , Investigative
26770,D0Z9BU,99mTc-EC-0652,Prostate cancer , Investigative
26771,D0Z9EO,Metreleptin,Diabetic complication , Approved
26772,D0Z9GM,LY-2940094,Major depressive disorder , Phase 2
26773,D0Z9HW,AZD6280,Schizophrenia , Discontinued in Phase 1
26774,D0Z9HW,AZD6280,Anxiety disorder , Discontinued in Phase 1
26775,D0Z9LD,SC-49992,Arterial thrombosis , Terminated
26776,D0Z9LP,RP101,Pancreatic cancer , Phase 2/3
26777,D0Z9LP,RP101,Infectious disease , Phase 2/3
26778,D0Z9MR,TG-1042,B-cell lymphoma , Discontinued in Phase 2
26779,D0Z9NY,API-023,Gastroesophageal reflux disease , Phase 1
26780,D0Z9NZ,Glutethimide,Insomnia , Approved
26781,D0Z9OS,BT-VACC,Yersinia infection , Discontinued in Phase 2
26782,D0Z9PX,Isopropamide iodide,Allergic rhinitis , Approved
26783,D0Z9QR,Zalcitabine,Human immunodeficiency virus infection , Approved
26784,D0Z9QX,CTX-1301,Attention deficit hyperactivity disorder , Phase 1
26785,D0Z9RJ,GS 9667,Hypertriglyceridemia , Phase 1
26786,D0Z9UJ,Peptide analog 4,Solid tumour/cancer , Patented
26787,D0Z9UJ,Peptide analog 4,Infectious disease , Patented
26788,D0Z9UJ,Peptide analog 4,Human immunodeficiency virus infection , Patented
26789,D0Z9UJ,Peptide analog 4,Hepatitis , Patented
26790,D0Z9VB,Halazepam,Anxiety disorder , Approved
26791,D0Z9VY,UCN-01,Non-small-cell lung cancer , Phase 2
26792,D0Z9WP,ZP-3022,Diabetic complication , Investigative
26793,D0Z9WV,Sharon-1000,Mycobacterium infection , Investigative
26794,D0Z9YF,Recombinant Bet v 1 immunotherapy,Allergic rhinitis , Phase 2/3
26795,D0Z9YV,BT-D005,Solid tumour/cancer , Investigative
26796,D0Z9YW,FK-3311,Rheumatoid arthritis , Phase 2
26797,D0Z9ZT,MDNA55,Glioblastoma of brain , Phase 2
26798,D0ZA0W,PSA/IL-2/GM-CSF vaccine,Prostate cancer , Phase 1
26799,D0ZA1K,BPX-701,Acute myeloid leukaemia , Phase 1
26800,D0ZA1K,BPX-701,Myelodysplastic syndrome , Phase 1
26801,D0ZA2L,ER-35786,Bacterial infection , Discontinued in Phase 1
26802,D0ZA4G,Varicella-zoster immune globulin,Varicella zoster virus infection , Approved
26803,D0ZA6P,CBT-501 + CBT-502,Solid tumour/cancer , Phase 1
26804,D0ZA6V,MNPR-201,Soft tissue sarcoma , Phase 2
26805,D0ZB2E,NV-07a,Inflammatory bowel disease , Investigative
26806,D0ZB7K,Zopiclone,Insomnia , Approved
26807,D0ZB9D,ER-21036,Hypercholesterolaemia , Investigative
26808,D0ZB9U,Lopinavir + ritonavir + oseltamivir,Coronavirus Disease 2019 (COVID-19) , Phase 3
26809,D0ZC0M,GSK561679,Major depressive disorder , Phase 2
26810,D0ZC0M,GSK561679,Alcohol dependence , Phase 2
26811,D0ZC3C,GTS-21,Parkinson disease , Phase 2
26812,D0ZC3K,Anti-ricin mabs,Poison intoxication , Investigative
26813,D0ZC6X,PRTX-100,Arthritis , Phase 1/2
26814,D0ZC6X,PRTX-100,Behcet disease , Phase 1/2
26815,D0ZC6X,PRTX-100,Rheumatoid arthritis , Phase 1/2
26816,D0ZC6X,PRTX-100,Thrombocytopenia , Phase 1/2
26817,D0ZC7P,Bamaquimast,Asthma , Discontinued in Phase 2
26818,D0ZC7W,Phenylsulfonyl derivative 4,Central nervous system disease , Patented
26819,D0ZD2M,MLN4924,Myelodysplastic syndrome , Phase 3
26820,D0ZD2M,MLN4924,Acute myelogenous leukaemia , Phase 2
26821,D0ZD2M,MLN4924,Advanced malignancy , Phase 1
26822,D0ZD2M,MLN4924,Nasopharyngeal carcinoma , Investigative
26823,D0ZD3C,Gemigliptin,Diabetic complication , Phase 3
26824,D0ZD3C,Gemigliptin,Type-2 diabetes , Phase 3
26825,D0ZD6N,Biaryl mannoside derivative 3,Crohn disease , Patented
26826,D0ZD6N,Biaryl mannoside derivative 3,Ulcerative colitis , Patented
26827,D0ZD6N,Biaryl mannoside derivative 3,Urinary tract infection , Patented
26828,D0ZD6Y,RUS 3108,Arteriosclerosis , Discontinued in Phase 1
26829,D0ZDP2,TAK-573,Refractory multiple myeloma , Phase 1
26830,D0ZDP2,TAK-573,Multiple myeloma , Phase 1
26831,D0ZE0S,BMS-986183,Hepatocellular carcinoma , Phase 1/2
26832,D0ZE0S,BMS-986183,Angiogenesis disorder , Patented
26833,D0ZE1M,PMID25666693-Compound-107,Osteoarthritis pain , Patented
26834,D0ZE1M,PMID25666693-Compound-107,Cancer related pain , Patented
26835,D0ZE1M,PMID25666693-Compound-107,Neuropathic pain , Patented
26836,D0ZE1M,PMID25666693-Compound-107,Inflammatory pain , Patented
26837,D0ZE1O,Plinabulin,Non-small-cell lung cancer , Phase 3
26838,D0ZE2J,"Oxetane 3,3-dicarboxamide compound 2",Virus infection , Patented
26839,D0ZE3S,RESP-6000,Atopic dermatitis , Investigative
26840,D0ZE5U,Indolinone derivative 1,Solid tumour/cancer , Patented
26841,D0ZE5U,Indolinone derivative 1,Metastatic cancer , Patented
26842,D0ZE5V,FPL-55712,Asthma , Terminated
26843,D0ZE6H,Six-membered heterocyclic benzamide derivative 1,Pruritus , Patented
26844,D0ZE6H,Six-membered heterocyclic benzamide derivative 1,Solid tumour/cancer , Patented
26845,D0ZE6H,Six-membered heterocyclic benzamide derivative 1,Chronic pain , Patented
26846,D0ZE6H,Six-membered heterocyclic benzamide derivative 1,Neuropathic pain , Patented
26847,D0ZE6H,Six-membered heterocyclic benzamide derivative 1,Thymic cancer , Patented
26848,D0ZE7B,VLD-631,Melanoma , Investigative
26849,D0ZE8B,Azetidine-1-carboxamide derivative 2,Obesity , Patented
26850,D0ZE9C,Pazinaclone,Anxiety disorder , Discontinued in Phase 3
26851,D0ZE9T,DA-3811,Gaucher disease , Investigative
26852,D0ZF1D,Ambasilide,Cardiac arrhythmias , Discontinued in Phase 2
26853,D0ZF8F,HIP-2B,Type-1/2 diabetes , Phase 1
26854,D0ZF8F,HIP-2B,Type-2 diabetes , Phase 1
26855,D0ZF9J,HuCART-meso cells,Lymphatic disease , Phase 1
26856,D0ZF9J,HuCART-meso cells,Pancreatic cancer , Phase 1
26857,D0ZF9J,HuCART-meso cells,Pediatric cancer , Phase 1
26858,D0ZG0K,Thiazole carboxamide derivative 13,Solid tumour/cancer , Patented
26859,D0ZG0K,Thiazole carboxamide derivative 13,Metastatic cancer , Patented
26860,D0ZG1Y,RG-7167,Solid tumour/cancer , Discontinued in Phase 1
26861,D0ZG3S,Reproxalap,Sjogren-Larsson syndrome , Phase 3
26862,D0ZG5K,Kiacta,Amyloidosis , Phase 3
26863,D0ZG7S,BXL-01-0029,Heart transplant rejection , Investigative
26864,D0ZG9N,SC-53116,Gastric motility disorder , Terminated
26865,D0ZH0X,IPH-24,Autoimmune diabetes , Investigative
26866,D0ZH2L,Autologous fat-derived stem cell therapy,Solid tumour/cancer , Phase 1/2
26867,D0ZH4J,MOB015B,Onychomycosis , Phase 3
26868,D0ZI0C,Dersalazine,Inflammatory bowel disease , Phase 2
26869,D0ZI0K,NMI-870,Sexual dysfunction , Discontinued in Phase 2
26870,D0ZI1F,Tivantinib,Solid tumour/cancer , Phase 3
26871,D0ZI1F,Tivantinib,Hepatocellular carcinoma , Phase 3
26872,D0ZI4H,Ornoprostil,Ulcer , Approved
26873,D0ZI4H,Ornoprostil,Gastritis , Approved
26874,D0ZI4L,CX-01,Acute myeloid leukaemia , Phase 2
26875,D0ZI4L,CX-01,Myelodysplastic syndrome , Phase 2
26876,D0ZI5A,PF-00337210,Solid tumour/cancer , Phase 1
26877,D0ZI5U,XeriJect,Acute repetitive seizure , Phase 1
26878,D0ZI7Q,Miboplatin,Prostate cancer , Discontinued in Phase 3
26879,D0ZJ0A,2164U90,Arteriosclerosis , Terminated
26880,D0ZJ0R,PDC-APB,Contact dermatitis , Phase 1
26881,D0ZJ1C,(S)-(+)-Dimethindene maleate,Pruritus , Approved
26882,D0ZJ4M,Resorcinol compound 3,Albinism , Patented
26883,D0ZJ4M,Resorcinol compound 3,Ephelides , Patented
26884,D0ZJ4M,Resorcinol compound 3,Menkes disease , Patented
26885,D0ZJ4M,Resorcinol compound 3,Senile lentigines , Patented
26886,D0ZJ4M,Resorcinol compound 3,Melasma , Patented
26887,D0ZJ6W,Ragweed peptide allergy desensitization,Allergy , Phase 2
26888,D0ZJ8G,FM-501,Autoimmune diabetes , Investigative
26889,D0ZK0N,BMS-931699,Systemic lupus erythematosus , Phase 2
26890,D0ZK3X,BBI-2000,Allergic contact dermatitis , Phase 2
26891,D0ZK5H,PW-4156,Muscle hypertonia , Investigative
26892,D0ZK7B,Tesofensine,Pain , Phase 2
26893,D0ZK8H,Gardasil,Human papillomavirus infection , Approved
26894,D0ZL1T,SK-NBP601,Hemophilia , Preregistration
26895,D0ZL3U,Allogeneic CART-33,Myeloid leukaemia , Phase 1
26896,D0ZL5J,XCUR17,Psoriasis vulgaris , Phase 1
26897,D0ZL9B,Diaspirin crosslinked hemoglobin,Cerebrovascular ischaemia , Terminated
26898,D0ZM1H,Isoquinoline derivative 3,Neuropathic pain , Patented
26899,D0ZM2S,R1204,Depression , Discontinued in Phase 1
26900,D0ZM5B,AG-021541,Hepatitis C virus infection , Discontinued in Phase 1
26901,D0ZM5E,VCL-1M01,Melanoma , Phase 1
26902,D0ZM5O,Pexacerfont,Anxiety disorder , Phase 2/3
26903,D0ZM5W,Esuprone,Major depressive disorder , Discontinued in Phase 2
26904,D0ZM8B,FK-409,Angina pectoris , Phase 2
26905,D0ZM8F,ASP7374,Seasonal influenza infection , Phase 3
26906,D0ZM8H,PMID25666693-Compound-18,Osteoarthritis pain , Patented
26907,D0ZM8H,PMID25666693-Compound-18,Cancer related pain , Patented
26908,D0ZM8H,PMID25666693-Compound-18,Neuropathic pain , Patented
26909,D0ZM8H,PMID25666693-Compound-18,Inflammatory pain , Patented
26910,D0ZN1R,Delphinidin,Cardiovascular disease , Phase 2
26911,D0ZN3M,PMID27998201-Compound-19,Solid tumour/cancer , Patented
26912,D0ZO2Z,Lingliptin + pioglitazone,Type-2 diabetes , Phase 3
26913,D0ZO5K,MEDI0562,Solid tumour/cancer , Phase 1
26914,D0ZO7A,Dorgenmeltucel-L,Melanoma , Phase 2
26915,D0ZP2C,PMID25666693-Compound-105,Osteoarthritis pain , Patented
26916,D0ZP2C,PMID25666693-Compound-105,Cancer related pain , Patented
26917,D0ZP2C,PMID25666693-Compound-105,Neuropathic pain , Patented
26918,D0ZP2C,PMID25666693-Compound-105,Inflammatory pain , Patented
26919,D0ZP2E,HinsBet,Insulin-dependent diabetes , Phase 2
26920,D0ZP3Q,Multikine,Head and neck cancer , Phase 3
26921,D0ZP4B,RP-3035,Non-small-cell lung cancer , Investigative
26922,D0ZP7D,GenePro,Human immunodeficiency virus infection , Investigative
26923,D0ZP8Z,CART22-65s cells,Acute lymphoblastic leukaemia , Phase 1
26924,D0ZQ2W,PMID25666693-Compound-96,Osteoarthritis pain , Patented
26925,D0ZQ2W,PMID25666693-Compound-96,Cancer related pain , Patented
26926,D0ZQ2W,PMID25666693-Compound-96,Neuropathic pain , Patented
26927,D0ZQ2W,PMID25666693-Compound-96,Inflammatory pain , Patented
26928,D0ZQ3K,Anti-CD22 CAR-T cells,leukaemia , Phase 1/2
26929,D0ZQ3K,Anti-CD22 CAR-T cells,Lymphoma , Phase 1/2
26930,D0ZQ6N,CAR-T Cells targeting EGFRvIII,Pancreatic cancer , Phase 1
26931,D0ZQ7P,Sch-49210,Solid tumour/cancer , Terminated
26932,D0ZR1Z,IMGN779,Acute myeloid leukaemia , Phase 1
26933,D0ZR2O,Biaryl mannoside derivative 6,Crohn disease , Patented
26934,D0ZR2O,Biaryl mannoside derivative 6,Ulcerative colitis , Patented
26935,D0ZR2O,Biaryl mannoside derivative 6,Urinary tract infection , Patented
26936,D0ZR2W,S-47445,Cognitive impairment , Investigative
26937,D0ZR3N,Pro 542,Human immunodeficiency virus infection , Discontinued in Phase 2
26938,D0ZR4Q,SSS-08,Cervical cancer , Investigative
26939,D0ZR4W,Nuedexta,Alzheimer disease , Phase 2
26940,D0ZR4W,Nuedexta,Parkinson disease , Phase 2
26941,D0ZR6E,TVI-Brain-1 cancer vaccine,Pneumococcal infection , Phase 2
26942,D0ZR6E,TVI-Brain-1 cancer vaccine,Glioma , Phase 2
26943,D0ZR6E,TVI-Brain-1 cancer vaccine,Astrocytoma , Phase 2
26944,D0ZR6E,TVI-Brain-1 cancer vaccine,Brain cancer , Phase 2
26945,D0ZR6E,TVI-Brain-1 cancer vaccine,Recurrent glioblastoma , Phase 2
26946,D0ZR8T,MSB 11022,Chronic plaque psoriasis , Phase 3
26947,D0ZS3E,PMID25666693-Compound-152,Osteoarthritis pain , Patented
26948,D0ZS3E,PMID25666693-Compound-152,Cancer related pain , Patented
26949,D0ZS3E,PMID25666693-Compound-152,Neuropathic pain , Patented
26950,D0ZS3E,PMID25666693-Compound-152,Inflammatory pain , Patented
26951,D0ZS5X,SHP610,Sanfilippo syndrome , Phase 2
26952,D0ZS6R,Technetium Tc-99m Apcitide,Radioactive tracer , Approved
26953,D0ZS8P,Clomipramine,Depression , Approved
26954,D0ZS8S,CT-750,Pain , Investigative
26955,D0ZT0G,Cinaciguat,Acute decompensated heart failure , Phase 2
26956,D0ZT1L,AP33,Hepatitis C virus infection , Phase 2
26957,D0ZT3U,Resorcinol compound 29,Albinism , Patented
26958,D0ZT3U,Resorcinol compound 29,Ephelides , Patented
26959,D0ZT3U,Resorcinol compound 29,Menkes disease , Patented
26960,D0ZT3U,Resorcinol compound 29,Senile lentigines , Patented
26961,D0ZT3U,Resorcinol compound 29,Melasma , Patented
26962,D0ZT4J,JSM 6427,Macular degeneration , Phase 1
26963,D0ZT5T,NTHi-Pneumo vaccine,Haemophilus influenza , Phase 2
26964,D0ZT8A,T3D-959,Alzheimer disease , Phase 1/2
26965,D0ZU2X,K-510,Malaria , Investigative
26966,D0ZU4U,MLR-1023,Obesity , Phase 2
26967,D0ZU4U,MLR-1023,Type-2 diabetes , Phase 2
26968,D0ZU5F,SGX523,Solid tumour/cancer , Phase 1
26969,D0ZU6O,T-1106,Virus infection , Investigative
26970,D0ZU9P,Napirimus,Immune System disease , Investigative
26971,D0ZU9R,Ritonavir,Human immunodeficiency virus infection , Approved
26972,D0ZU9T,NSC-134754,Solid tumour/cancer , Investigative
26973,D0ZV0R,F-200,Ocular disease , Terminated
26974,D0ZV0Z,Moxifloxacin,Bacterial infection , Approved
26975,D0ZV1F,Ro-09-1227,Bacterial infection , Terminated
26976,D0ZV4I,HL-020,Solid tumour/cancer , Investigative
26977,D0ZV6W,Albupoietin,Anemia , Terminated
26978,D0ZV7Y,MorphPlus,Pain , Investigative
26979,D0ZV9P,"Pyrido[4,3-d]pyrimidin-5(6H)-one derivative 1",Solid tumour/cancer , Patented
26980,D0ZV9P,"Pyrido[4,3-d]pyrimidin-5(6H)-one derivative 1",Metastatic cancer , Patented
26981,D0ZVM5,177-Lu-NeoB,Solid tumour/cancer , Phase 1/2
26982,D0ZW1W,SoluMatrix naproxen,Pain , Phase 2
26983,D0ZW1W,SoluMatrix naproxen,Osteoarthritis , Phase 2
26984,D0ZW2F,NSC-119910,Cardiac failure , Investigative
26985,D0ZW2I,RVT-104,Alzheimer disease , Phase 1
26986,D0ZW2I,RVT-104,Lewy body dementia , Phase 1
26987,D0ZW3R,TG-4010,Bipolar disorder , Phase 2/3
26988,D0ZW3R,TG-4010,Non-small-cell lung cancer , Phase 2/3
26989,D0ZW4W,(+)-JQ1,Testicular cancer , Phase 1
26990,D0ZW5D,LY-2409021,Type-2 diabetes , Phase 2
26991,D0ZW5Y,Recombinant pox virus vaccine,Breast cancer , Discontinued in Phase 2
26992,D0ZW6X,Anti-GITR antibody,Solid tumour/cancer , Phase 1
26993,D0ZW8B,Human anti-rabies mab,Rabies , Phase 2
26994,D0ZX0C,Tetanus vaccine,Clostridium infection , Terminated
26995,D0ZX1E,CNT0-5825,Allergic asthma , Phase 1
26996,D0ZX1P,FADROZOLE,Breast cancer , Approved
26997,D0ZX2D,11C-6-Me-BTA-1,Alzheimer disease , Phase 1
26998,D0ZX2G,Hexachlorophene,Bacterial infection , Approved
26999,D0ZX2L,GSK2831781,Autoimmune disease , Phase 1
27000,D0ZX2L,GSK2831781,Plaque psoriasis , Phase 1
27001,D0ZX7I,SR-57227,Major depressive disorder , Discontinued in Phase 2
27002,D0ZY0Z,ABT-560,Cognitive impairment , Discontinued in Phase 1
27003,D0ZY3E,INO-1001,Brain cancer , Phase 3
27004,D0ZY3R,MEDI8111,Bleeding disorder , Phase 1
27005,D0ZY6C,Diaryl piperazine derivative 1,Obesity , Patented
27006,D0ZY9U,SLV-305,Gastric motility disorder , Discontinued in Phase 2
27007,D0ZZ3Q,AOB101,Acne vulgaris , Phase 2
27008,D0ZZ6C,EB-001A,Glabellar frown line , Phase 2
27009,D0ZZ6C,EB-001A,Keloidal surgical scar , Phase 2
27010,D0ZZ8F,PMID25666693-Compound-68,Osteoarthritis pain , Patented
27011,D0ZZ8F,PMID25666693-Compound-68,Cancer related pain , Patented
27012,D0ZZ8F,PMID25666693-Compound-68,Neuropathic pain , Patented
27013,D0ZZ8F,PMID25666693-Compound-68,Inflammatory pain , Patented
27014,D10GPJ,STRO-002,Ovarian cancer , Phase 1
27015,D10LNV,MRX-2843,Solid tumour/cancer , Phase 1
27016,D12AIV,PRGN-3005,Refractory hematologic malignancy , Phase 1
27017,D12DYT,HPN217,Multiple myeloma , Phase 1
27018,D12EFM,RG7854,Hepatitis B virus infection , Phase 1
27019,D12QYO,JNJ-64300535,Hepatitis B virus infection , Phase 1
27020,D12THW,AGN-241751,Major depressive disorder , Phase 2
27021,D14NDZ,Deguelin,Esophageal squamous cell carcinoma , Investigative
27022,D14SKB,MGTA-456,Metabolic disorder , Phase 2
27023,D15ZUR,RO6870810,Multiple myeloma , Phase 1
27024,D16JNF,3-Oxo-C12-(2-amino-cyclohexanone),Pseudomonas infection , Preclinical
27025,D17TRG,2-Amino-4-[3-hydroxyphenyl]-4-hydroxybutanoic acid,Breast cancer , Preclinical
27026,D17URP,Cosibelimab,Non-small cell lung cancer , Phase 1
27027,D18QIB,MSC110,Pigmented villonodular synovitis , Phase 1
27028,D18SHN,Tecartus,Mantle cell lymphoma , Approved
27029,D19OMU,PF-06741086,Hemophilia , Phase 3
27030,D1A5GK,DSTA-4637S,Bacteremia , Phase 1
27031,D1A8NU,NG-641,Solid tumour/cancer , Phase 1
27032,D1AD6L,NPS-1034,Solid tumour/cancer , Preclinical
27033,D1AVT5,SEA-TGT,Solid tumour/cancer , Phase 1
27034,D1B2US,BTI-410,Type-1 diabetes , Phase 1
27035,D1B2US,BTI-410,Type-2 diabetes , Phase 1
27036,D1BCW8,APY29,Solid tumour/cancer , Investigative
27037,D1BG7C,BOS172738,Solid tumour/cancer , Phase 1
27038,D1BT2M,NJA-730,Graft-versus-host disease , Phase 1
27039,D1C0WB,DZD1516,HER2-positive breast cancer , Phase 1
27040,D1CG5M,VLS-101,Solid tumour/cancer , Phase 2
27041,D1CWL0,lumateperone tosylate,Schizophrenia , Approved
27042,D1CZ8K,177-Lu-PSMA-R2,Prostate cancer , Phase 1/2
27043,D1EW3O,IN10018,Metastatic melanoma , Phase 1
27044,D1FO9C,GNX102,Solid tumour/cancer , Phase 1
27045,D1FR3T,Mitoquinone,Hepatitis C virus infection , Phase 2
27046,D1FUQ2,ASP9801,Solid tumour/cancer , Phase 1
27047,D1G7XU,SPYK04,Solid tumour/cancer , Phase 1
27048,D1GWL7,PLG-0206,Joint infection , Phase 2
27049,D1HEN2,Ga-68-DOTATOC,Diagnostic imaging , Approved
27050,D1J4GS,BT595,Idiopathic thrombocytopenic purpura , Phase 3
27051,D1JS9X,ABTAA,Sepsis , Investigative
27052,D1KC8H,AB-4166,Parkinson disease , Clinical Trial
27053,D1KIY9,HH2710,Solid tumour/cancer , Phase 1/2
27054,D1KO3P,SXC-2023,Trichotillomania , Phase 2
27055,D1L7DE,GEM3PSCA,Non-small cell lung cancer , Phase 1
27056,D1LEU5,JAB-3312,Solid tumour/cancer , Phase 1/2
27057,D1LU7W,NP001,Amyotrophic lateral sclerosis , Phase 2
27058,D1LU7W,NP001,Alzheimer disease , Phase 1
27059,D1M5NW,Exebacase,Bacteremia , Phase 3
27060,D1M8GC,PRO 140,Human immunodeficiency virus-1 infection , Phase 2/3
27061,D1MEH5,Enmetazobactam,Urinary tract infection , Phase 3
27062,D1MK7G,AR-501,Cystic fibrosis , Phase 1/2
27063,D1N2BO,GSK'963,Myeloid leukaemia , Investigative
27064,D1NC2O,Ifx-Hu2.0,Merkel cell carcinoma , Phase 1
27065,D1NC2O,Ifx-Hu2.0,Cutaneous squamous cell carcinoma , Phase 1
27066,D1O9XQ,SKY59,Haemolytic uraemic syndrome , Phase 3
27067,D1ONZ8,AVID200,Solid tumour/cancer , Phase 1
27068,D1PC9J,CX2009,Neoplasm , Phase 2
27069,D1PC9J,CX2009,Solid tumour/cancer , Phase 1/2
27070,D1PYC8,MGD019,Solid tumour/cancer , Phase 1
27071,D1RIW2,APN401,Solid tumour/cancer , Phase 2
27072,D1RMS5,OTL-300,Beta thalassemia , Phase 1/2
27073,D1S7EP,SI-B003,Solid tumour/cancer , Phase 1
27074,D1SL2W,PRT811,Glioma , Phase 1
27075,D1SWN3,Afegostat,Gaucher disease , Discontinued in Phase 2
27076,D1TED8,Reloxaliase,Hyperoxaluria , Phase 3
27077,D1TNJ2,XL092,Solid tumour/cancer , Phase 1
27078,D1U3EG,MAb114,Ebola virus infection , Phase 2/3
27079,D1U4BC,BIIB-087,X-linked retinoschisis , Phase 1/2
27080,D1U5BA,Remestemcel-L,Crohn disease , Phase 3
27081,D1U5BA,Remestemcel-L,Graft-versus-host disease , Phase 3
27082,D1UA2E,AM001,Actinic keratosis , Phase 2
27083,D1W2DS,GEN3009,B-cell non-hodgkin lymphoma , Phase 1/2
27084,D1WB6Z,DSP-107,Solid tumour/cancer , Phase 1/2
27085,D1WOX4,CT053,Multiple myeloma , Phase 1
27086,D1X2VT,JNJ-56136379,Hepatitis B , Phase 2
27087,D1XI9E,BDC-1001,Solid tumour/cancer , Phase 1/2
27088,D1Y6RQ,NTU281,Renal fibrosis , Preclinical
27089,D1YZ5O,CPI-818,T-cell lymphoma , Phase 1
27090,D1Z0IM,IMR-687,Sickle-cell disorder , Phase 2
27091,D1Z6TS,ONCR-177,Solid tumour/cancer , Phase 1
27092,D1ZD0N,VMD-928,Lymphoma , Phase 1
27093,D1ZD0N,VMD-928,Solid tumour/cancer , Phase 1
27094,D1ZG5E,OTSA-101-DTPA-90Y,Synovial sarcoma , Phase 1
27095,D20IMG,LAM-003,Acute myeloid leukaemia , Phase 1
27096,D20IMG,LAM-003,Non-hodgkin lymphoma , Phase 1
27097,D20OCB,VAC52416,Escherichia coli infection , Phase 1/2
27098,D21OLD,BW-1010,Anthrax , Phase 1
27099,D23FRK,F26G3,Anthrax , Preclinical
27100,D24EPJ,CAT4001,Alpha-1 antitrypsin deficiency , Preclinical
27101,D24EPJ,CAT4001,Friedreich's ataxia , Preclinical
27102,D24GYL,GS-6207,Human immunodeficiency virus infection , Phase 2/3
27103,D26DCA,RP2-001-18,Solid tumour/cancer , Phase 1
27104,D27SXO,FMX-8,Anaemia , Phase 2
27105,D28EMJ,IW001,Idiopathic pulmonary fibrosis , Phase 1
27106,D28HJI,FF-10101,Acute myeloid leukaemia , Phase 1/2
27107,D28JEC,ATA3219,B-cell lymphoma , Preclinical
27108,D28MNU,CDX-527,Solid tumour/cancer , Phase 1
27109,D28VIO,DNX-2440,Liver metastasis , Phase 1
27110,D2AYS0,PF-06473871,Hypertrophic scars , Phase 2
27111,D2B7WM,Torin2,T-cell leukaemia , Investigative
27112,D2C0DY,SPL-108,Ovarian epithelial cancer , Phase 2
27113,D2C0DY,SPL-108,Ovarian cancer , Phase 2
27114,D2CZR3,YE-NEO-001,Solid tumour/cancer , Phase 1
27115,D2D9CN,Z-VAD-fmk,Pulmonary fibrosis , Preclinical
27116,D2DB5T,TBX-3400,Melanoma , Phase 1
27117,D2DLN9,"5N,6S-(N'-butyliminomethylidene)-6-thio-1-deoxygalactonojirimycin",GM1 gangliosidosis , Preclinical
27118,D2F7JC,PZ-128,Peripheral arterial occlusive disorder , Phase 2
27119,D2FCM4,VB 1953,Acne vulgaris , Phase 2
27120,D2G4HB,Bulevirtide,Hepatitis D virus infection , Approved
27121,D2GJ4P,TP-1287,Solid tumour/cancer , Phase 1
27122,D2GV9Q,Salvianolic acid B,Vascular dementia , Phase 2
27123,D2GY5C,APVO436,Acute myeloid leukaemia , Phase 1
27124,D2GY5C,APVO436,Myelodysplastic syndrome , Phase 1
27125,D2H4RZ,BMS-986263,Hepatic fibrosis , Phase 2
27126,D2H5CI,RBX7455,Clostridium infection , Phase 1
27127,D2H6NI,OBI-999,Solid tumour/cancer , Phase 1/2
27128,D2HDB8,Mosunetuzumab,Follicular lymphoma , Phase 3
27129,D2HE9I,TAK-169,Multiple myeloma , Phase 1
27130,D2ITJ1,FPT155,Solid tumour/cancer , Phase 1
27131,D2J4YT,211At-labelled aLAT-1,Multiple myeloma , Preclinical
27132,D2K6DU,P22077,Inflammation , Preclinical
27133,D2KA0W,GS-2872,Human immunodeficiency virus infection , Phase 1
27134,D2KB3W,ALLO-501,Non-hodgkin lymphoma , Phase 1
27135,D2KOX5,BMS-986301,Solid tumour/cancer , Phase 1
27136,D2KV8B,AB-106,Non-small cell lung cancer , Phase 2
27137,D2L8NT,TBR-760,Pituitary adenoma , Phase 2
27138,D2LUK7,PF-06936308,Triple negative breast cancer , Phase 1
27139,D2LUK7,PF-06936308,Non-small cell lung cancer , Phase 1
27140,D2MA0E,IONIS-TMPRSS6-LRx,Beta thalassemia , Phase 2
27141,D2MZF8,TAK-102,Solid tumour/cancer , Phase 1
27142,D2NU0H,MAb173,Kaposi sarcoma , Preclinical
27143,D2OZ9D,CodaVax-H1N1,Influenza virus infection , Phase 1
27144,D2P8LR,AGEN1181,Solid tumour/cancer , Phase 1
27145,D2PFY3,AMG 562,Diffuse large B-cell lymphoma , Phase 1
27146,D2PFY3,AMG 562,Follicular lymphoma , Phase 1
27147,D2PFY3,AMG 562,Mantle cell lymphoma , Phase 1
27148,D2Q0OI,CLBS14,Myocardial ischemia , Phase 2
27149,D2Q3VY,Tepoditamab,Acute myelogenous leukaemia , Phase 1
27150,D2QO5J,BMS-986012,Small-cell lung cancer , Phase 2
27151,D2QO5J,BMS-986012,Solid tumour/cancer , Phase 2
27152,D2QY0Z,MCLA-145,Lymphoma , Phase 1
27153,D2QY0Z,MCLA-145,Solid tumour/cancer , Phase 1
27154,D2R0UM,Naratuximab emtansine,Diffuse large B-cell lymphoma , Phase 2
27155,D2R0UM,Naratuximab emtansine,Non-hodgkin lymphoma , Phase 2
27156,D2RTQ0,SB12,Paroxysmal nocturnal haemoglobinuria , Phase 3
27157,D2SJZ9,EAPB0203,T-cell leukaemia , Investigative
27158,D2SPH4,IW-1701,Sickle-cell disorder , Phase 2
27159,D2TH1E,NasoShield,Anthrax , Phase 1
27160,D2U4RX,S109,Solid tumour/cancer , Investigative
27161,D2U5CW,GSK3228836,Hepatitis B , Phase 2
27162,D2V4YI,BI 891065,Solid tumour/cancer , Phase 1
27163,D2V6BI,AV-1 mAb,Dengue , Phase 1
27164,D2V6MO,VXA-G1.1-NN,Norovirus infection , Phase 1
27165,D2VRE1,NGM120,Solid tumour/cancer , Phase 1
27166,D2WT8Y,V212,Herpes zoster , Phase 3
27167,D2Y7ZG,APG-2575,Chronic lymphocytic leukaemia , Phase 1/2
27168,D2Y7ZG,APG-2575,Small lymphocytic lymphoma , Phase 1/2
27169,D2Y9IG,JNJ-63898081,Solid tumour/cancer , Phase 1
27170,D2YN1W,NKTR-255,Colorectal cancer , Phase 1/2
27171,D2YN1W,NKTR-255,Head and neck cancer , Phase 1/2
27172,D2YT5I,ADP-A2M4,Synovial sarcoma , Phase 2
27173,D2YT5I,ADP-A2M4,Solid tumour/cancer , Phase 1
27174,D2Z6WF,CA-170,Lymphoma , Phase 1
27175,D2Z6WF,CA-170,Solid tumour/cancer , Phase 1
27176,D2Z7EL,CYAD-02,Acute myeloid leukaemia , Phase 1
27177,D2Z7EL,CYAD-02,Myelodysplastic syndrome , Phase 1
27178,D2ZI3H,BNC-102,Solid tumour/cancer , Preclinical
27179,D30EUC,GSK3844766A,Respiratory syncytial virus infection , Phase 2
27180,D31NIC,PDS0101,Head and neck cancer , Phase 2
27181,D31ZLD,pbi-shRNA EWS-FLI-Type 1,Ewing sarcoma , Phase 1
27182,D32PZT,LY2382770,Diabetic nephropathy , Phase 2
27183,D32PZT,LY2382770,Diabetic kidney disease , Phase 2
27184,D32XRQ,BAY 853934,Anaemia , Phase 3
27185,D34CWV,EP-301,Breast cancer , Phase 1
27186,D34SXJ,Avalglucosidase alfa,Pompe disease , Phase 3
27187,D35SKV,EPZ032597,Solid tumour/cancer , Preclinical
27188,D37JBX,MK-0482,Solid tumour/cancer , Phase 1
27189,D39VXL,JNJ-32729463,Community-acquired pneumonia , Phase 2
27190,D3AIE0,BMS-986141,Thrombosis , Phase 2
27191,D3B1MS,ONC-392,Non-small-cell lung cancer , Phase 1
27192,D3B1MS,ONC-392,Solid tumour/cancer , Phase 1
27193,D3C9MX,JNJ-63682918,Human papillomavirus infection , Phase 1/2
27194,D3CG6E,MB-66,Human immunodeficiency virus infection , Phase 1
27195,D3CG6E,MB-66,Herpes simplex virus infection , Phase 1
27196,D3DPR8,Sleeping Beauty CAR-TCR,leukaemia , Phase 1
27197,D3FYE1,M802,Solid tumour/cancer , Phase 1
27198,D3G2BO,VIR-2482,Influenza A virus infection , Phase 1
27199,D3GD1L,Octahydrocurcumin,Solid tumour/cancer , Investigative
27200,D3GIQ9,JNJ-67856633,Non-hodgkin lymphoma , Phase 1
27201,D3GIQ9,JNJ-67856633,Chronic lymphocytic leukaemia , Phase 1
27202,D3HBJ1,GEN1046,Solid tumour/cancer , Phase 1
27203,D3HBL2,MEDI7219,Type 2 diabetes , Phase 1
27204,D3HL1R,NT-I7,Progressive multifocal leukoencephalopathy , Phase 1
27205,D3IK7O,NYX-783,Post-traumatic stress disorder , Phase 2
27206,D3J9XC,Cemdisiran,Paroxysmal nocturnal haemoglobinuria , Phase 2
27207,D3J9XC,Cemdisiran,Haemolytic uraemic syndrome , Phase 2
27208,D3JN6C,GRN 1201,Non-small-cell lung cancer , Phase 2
27209,D3JN6C,GRN 1201,Melanoma , Phase 1
27210,D3JP7R,VE416,Food allergy , Phase 1/2
27211,D3KMC9,Elipovimab,Human immunodeficiency virus infection , Phase 1
27212,D3KZ4Y,OG2023SC,Type 2 diabetes , Phase 1
27213,D3KZ6M,LY2624587,Solid tumour/cancer , Phase 1
27214,D3KZ6M,LY2624587,Metastatic cancer , Phase 1
27215,D3LT5W,ASP3772,Pneumococcal infection , Phase 2
27216,D3LW8A,HXP124,Onychomycosis , Phase 2
27217,D3M6SN,ACHM-CNGA3,Achromatopsia , Phase 1/2
27218,D3M7FK,CNSA-001,Gastroparesis , Phase 2
27219,D3M7FK,CNSA-001,Hyperphenylalaninemia , Phase 1/2
27220,D3MG8L,PLX-R18,Acute radiation syndrome , Phase 3
27221,D3MP1S,CS1001,Non-small cell lung cancer , Phase 3
27222,D3N5TB,Apraglutide,Short bowel syndrome , Phase 3
27223,D3NLJ9,Dusquetide,Oral cavity squamous cell carcinoma , Phase 3
27224,D3NLJ9,Dusquetide,Oral mucositis , Phase 3
27225,D3NTA9,MK-8504,Human immunodeficiency virus-1 infection , Phase 1
27226,D3OUH0,RX108,Solid tumour/cancer , Phase 1
27227,D3OWG9,M1774,Solid tumour/cancer , Phase 1
27228,D3P8JK,GC4711,Pancreatic cancer , Phase 2
27229,D3PD8C,AXS-05,Depression , Phase 3
27230,D3PD8C,AXS-05,Alzheimer disease , Phase 2/3
27231,D3Q1OL,Debio1453,Neisseria gonorrhoeae infection , Preclinical
27232,D3Q4SZ,DTRMWXHS-12,B-cell lymphoma , Phase 1
27233,D3Q4SZ,DTRMWXHS-12,Chronic lymphocytic leukaemia , Phase 1
27234,D3QEZ2,LY3295668,Solid tumour/cancer , Phase 1/2
27235,D3RT4A,SRP-9003,Limb girdle muscular dystrophy , Phase 1/2
27236,D3S2UY,GS-1156,Human immunodeficiency virus infection , Phase 1
27237,D3SPE5,BAY 1905254,Solid tumour/cancer , Phase 1
27238,D3T7NY,CART-ddBCMA,Multiple myeloma , Phase 1
27239,D3TW6X,ZEN003694,Prostate cancer , Phase 1
27240,D3U1LH,V158411,Triple negative breast cancer , Investigative
27241,D3U2QM,AST-VAC2,Non-small-cell lung cancer , Phase 1
27242,D3U8YR,WP1220,Cutaneous T-cell lymphoma , Phase 1
27243,D3UG0T,90Y-loaded glass microspheres,Hepatocellular carcinoma , Approved
27244,D3W5TL,ABO-102,Mucopolysaccharidosis , Phase 1/2
27245,D3X1TS,BAY 1902607,Cough , Phase 1/2
27246,D3X2TH,TPI-287,Glioblastoma multiforme , Phase 2
27247,D3X2TH,TPI-287,Breast cancer , Phase 2
27248,D3X2TH,TPI-287,Progressive supranuclear palsy , Phase 1
27249,D3X2TH,TPI-287,Alzheimer disease , Phase 1
27250,D3XYK2,VAC52150,Ebola virus infection , Phase 3
27251,D3ZN5U,Axatilamab,Solid tumour/cancer , Phase 1
27252,D3ZY1K,ARV-110,Prostate cancer , Phase 1/2
27253,D40DVS,SR9009,Solid tumour/cancer , Preclinical
27254,D41OJE,BTL-TML,Coronavirus Disease 2019 (COVID-19) , Phase 2
27255,D42TUS,Telisotuzumab vedotin,Non-small-cell lung cancer , Phase 2
27256,D43ADF,P-007,Pulmonary fibrosis , Preclinical
27257,D43ADF,P-007,Renal fibrosis , Preclinical
27258,D43GZX,SAR566658,Solid tumour/cancer , Phase 2
27259,D46EBX,VCB101,Multiple sclerosis , Preclinical
27260,D46RKC,Fitusiran,Hemophilia , Phase 3
27261,D47MOS,Alofanib,Gastric adenocarcinoma , Phase 1
27262,D47RIS,OTL-101,Severe combined immunodeficiency , Phase 3
27263,D48MDS,HPN424,Prostate cancer , Phase 1
27264,D48UEV,IGM-8444,Solid tumour/cancer , Phase 1
27265,D48UEV,IGM-8444,Hematologic tumour , Phase 1
27266,D48ZBO,FOR46,Multiple myeloma , Phase 1
27267,D49AGF,CB7993113,Solid tumour/cancer , Preclinical
27268,D49YEO,ABI-H3733,Hepatitis B , Phase 1
27269,D4A2DQ,SAGE-324,Essential tremor or related tremors , Phase 2
27270,D4A2DQ,SAGE-324,Parkinson disease , Phase 1
27271,D4AGB6,Voyager-V1,Melanoma , Phase 2
27272,D4AGB6,Voyager-V1,Hepatocellular carcinoma , Phase 2
27273,D4AGB6,Voyager-V1,Non-small cell lung cancer , Phase 2
27274,D4AY6B,SUVN 911,Major depressive disorder , Phase 1
27275,D4BC6I,RG7827,Solid tumour/cancer , Phase 1
27276,D4CGN3,RG6139,Solid tumour/cancer , Phase 1
27277,D4D0XY,M2SR,Influenza A virus H3N2 infection , Phase 2
27278,D4DK2R,DBI-001,Tinea pedis , Phase 2
27279,D4H2CP,Ceftobiprole medocaril,Skin and skin-structure infection , Phase 3
27280,D4HDR2,LVGN6051,Solid tumour/cancer , Phase 1
27281,D4HQ1F,Zolbetuximab,Gastric adenocarcinoma , Phase 3
27282,D4HQ1F,Zolbetuximab,Esophagogastric junction neoplasm , Phase 3
27283,D4HQ1F,Zolbetuximab,Pancreatic cancer , Phase 2
27284,D4IS0G,GLR2007,Non-small-cell lung cancer , Phase 1/2
27285,D4IS0G,GLR2007,Glioblastoma of brain , Phase 1/2
27286,D4IWF1,AAV-AQP1,Xerostomia , Phase 1/2
27287,D4J9HV,ABBV-011,Small-cell lung cancer , Phase 1
27288,D4JPV8,MER5101,Alzheimer disease , Phase 1
27289,D4JS3A,Cu-anti-hAXL,Breast cancer , Preclinical
27290,D4JU8H,MK-2118,Lymphoma , Phase 1
27291,D4JU8H,MK-2118,Solid tumour/cancer , Phase 1
27292,D4JV0H,ASP1948,Solid tumour/cancer , Phase 1
27293,D4JYH3,FPI-1434,Solid tumour/cancer , Phase 1
27294,D4K2CQ,DP-3975,Mesothelioma , Preclinical
27295,D4K7BI,DPK 060,Otitis externa , Phase 2
27296,D4KTA9,INCAGN2385,Melanoma , Phase 1
27297,D4L3IZ,Sym022,Lymphoma , Phase 1
27298,D4L3IZ,Sym022,Solid tumour/cancer , Phase 1
27299,D4LJO1,RGN-137,Epidermolysis bullosa , Phase 2
27300,D4LJO9,CLG561,Geographic retinal atrophy , Phase 2
27301,D4LOR2,Tebipenem pivoxil,Respiratory tract infection , Approved
27302,D4M0GR,CNX-011-67,Type 2 diabetes , Preclinical
27303,D4M8RS,TNP-2092,Skin and skin-structure infection , Phase 2
27304,D4M8RS,TNP-2092,Joint infection , Phase 1
27305,D4MO2K,Granexin,Diabetic foot ulcer , Phase 3
27306,D4MW3O,MK-8776,Hodgkin lymphoma , Phase 1
27307,D4N2JV,PRX002,Parkinson disease , Phase 2
27308,D4N7TE,mRNA-1944,Chikungunya virus infection , Phase 1
27309,D4ON2Y,mRNA-1893,Zika virus infection , Phase 1
27310,D4OU6H,Rivo-cel,Acute myeloid leukaemia , Phase 2/3
27311,D4OU6H,Rivo-cel,Myelodysplastic syndrome , Phase 2/3
27312,D4OZC7,Suvodirsen,Duchenne dystrophy , Phase 2/3
27313,D4P8YO,AB023,End-stage renal disease , Phase 1
27314,D4PG6A,Nobiletin,Atherosclerosis , Preclinical
27315,D4PL6G,BNV-222,Diabetic neuropathy , Phase 2/3
27316,D4PV0B,AGN-242266,Non-alcoholic steatohepatitis , Phase 1
27317,D4Q5AW,Beraprost,Pulmonary hypertension , Phase 4
27318,D4RD0C,Bamosiran,Glaucoma/ocular hypertension , Phase 2
27319,D4RGV9,2-Ethoxypropanoic acid,Breast cancer , Preclinical
27320,D4RMB0,3PO,Pulmonary fibrosis , Investigative
27321,D4TI9A,JNJ-69086420,Prostate cancer , Phase 1
27322,D4UFT5,2-D08,Acute myeloid leukaemia , Preclinical
27323,D4USX5,9-ING-41,Myelofibrosis , Phase 2
27324,D4USX5,9-ING-41,Solid tumour/cancer , Phase 1
27325,D4V0SI,MS2177,Solid tumour/cancer , Preclinical
27326,D4VBY6,Bafilomycin A1,B-cell acute lymphoblastic leukaemia , Investigative
27327,D4VZ2A,TT-00420,Solid tumour/cancer , Phase 1
27328,D4WN2M,APG-1252,Small-cell lung cancer , Phase 1/2
27329,D4WN2M,APG-1252,Solid tumour/cancer , Phase 1
27330,D4X9MD,"9-(Ethoxyimino)-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile",Solid tumour/cancer , Preclinical
27331,D4XBR9,Pozelimab,Paroxysmal nocturnal haemoglobinuria , Phase 2
27332,D4Y0IM,INCB054329,Solid tumour/cancer , Phase 1/2
27333,D4Y0IM,INCB054329,Refractory hematologic malignancy , Phase 1/2
27334,D4Y0SB,Vonvendi,Von willebrand disease , Approved
27335,D4Z5CU,M710,Diabetic macular edema , Phase 3
27336,D4ZLC2,RXI-109,Fibrosis , Phase 2
27337,D4ZLC2,RXI-109,Hypertrophic scars , Phase 2
27338,D50CXM,PRT1419,Melanoma , Phase 1
27339,D50ESV,Polivy,Mantle cell lymphoma , Phase 2
27340,D50NHR,YW327.6S2,Non-small-cell lung cancer , Preclinical
27341,D50NHR,YW327.6S2,Breast cancer , Preclinical
27342,D50OLM,INCB00928,Multiple myeloma , Phase 2
27343,D50OLM,INCB00928,Myelodysplastic syndrome , Phase 2
27344,D50OLM,INCB00928,Anemia , Phase 2
27345,D51HBQ,CD20-CD19 cCAR,B-cell lymphoma , Phase 1
27346,D51VYQ,514G3,Staphylococcus infection , Phase 1/2
27347,D52NOH,BNT411,Small-cell lung cancer , Phase 1/2
27348,D52NZX,Belantamab mafodotin,Multiple myeloma , Approved
27349,D53CGK,PC14586,Solid tumour/cancer , Phase 1/2
27350,D53CMU,Methylselenocysteine,Breast cancer , Clinical Trial
27351,D53CMU,Methylselenocysteine,Prostate cancer , Clinical Trial
27352,D53QMP,Beta-caryophyllene,Pain , Phase 2
27353,D54FYW,TPST-1495,Solid tumour/cancer , Phase 1
27354,D56ERU,INBRX-109,Solid tumour/cancer , Phase 1
27355,D56WJV,AAV-CNGB3,Achromatopsia , Phase 1/2
27356,D58AMF,ABBV-CX-2029,Hematologic tumour , Phase 1
27357,D59BZJ,177Lu-labelled RM2,Solid tumour/cancer , Investigative
27358,D59OTG,OBI-888,Solid tumour/cancer , Phase 1/2
27359,D5AV3Q,AT-527,Coronavirus Disease 2019 (COVID-19) , Phase 2
27360,D5BMY9,TMX-049,Diabetic nephropathy , Phase 2
27361,D5CP3S,SV-BR-1-GM cancer vaccine,Breast cancer , Phase 1/2
27362,D5CP3S,SV-BR-1-GM cancer vaccine,Solid tumour/cancer , Investigative
27363,D5D6ZM,IK-175,Urothelial carcinoma , Phase 1
27364,D5DAR1,LYS-SAF302,Mucopolysaccharidosis , Phase 2/3
27365,D5DBU7,CarVAC,B-cell lymphoma , Phase 1
27366,D5DO9L,Brolucizumab,Wet age-related macular degeneration , Approved
27367,D5DO9L,Brolucizumab,Diabetic macular edema , Phase 3
27368,D5EOV9,ABBV-CLS-579,Solid tumour/cancer , Phase 1
27369,D5FCP1,TTI-622,Lymphoma , Phase 1
27370,D5FCP1,TTI-622,Myeloma , Phase 1
27371,D5FSV8,TRx0237,Alzheimer disease , Phase 3
27372,D5GI0O,VIMO-001,Breast cancer , Phase 1
27373,D5I3MF,GRL0617,Coronavirus infection , Preclinical
27374,D5IS6V,Abametapir,Head and body lice , Approved
27375,D5ISZ1,NKTR-214,Melanoma , Phase 3
27376,D5IZ1S,BI 685509,Diabetic nephropathy , Phase 2
27377,D5J3BL,Bintrafusp alfa,Non-small cell lung cancer , Phase 2
27378,D5JVD6,ALLO-ASC-DFU,Diabetic foot ulcer , Phase 3
27379,D5KIL8,RG6290,Solid tumour/cancer , Phase 1
27380,D5LB7Y,RG6346,Hepatitis B virus infection , Phase 1
27381,D5MF8Y,Lithium,Fragile X syndrome , Phase 2
27382,D5OEL4,212Pb-labelled aTEM1,Solid tumour/cancer , Preclinical
27383,D5ON9Z,ASP9831,Steatohepatitis , Phase 2
27384,D5ON9Z,ASP9831,Non-alcoholic steatohepatitis , Phase 2
27385,D5P3SI,STP1002,Solid tumour/cancer , Phase 1
27386,D5Q6FS,MPC-25-IC,Acute cardiac ischemia , Phase 2
27387,D5R6AG,ATI-2173,Hepatitis B , Phase 2
27388,D5R7AE,Piperlongumine,Solid tumour/cancer , Preclinical
27389,D5S7JL,ODN-1411,Rheumatoid arthritis , Investigative
27390,D5T1RN,BAY 1834942,Solid tumour/cancer , Phase 1
27391,D5T3OY,DPX Survivac,Diffuse large B-cell lymphoma , Phase 2
27392,D5T6DY,AMG 404,Solid tumour/cancer , Phase 1
27393,D5T7QW,LX2761,Type 2 diabetes , Phase 1
27394,D5T9GZ,CLL1-CD33 cCART cell therapy,Acute myeloid leukaemia , Phase 1
27395,D5TH2B,PF-07104091,Triple negative breast cancer , Phase 1
27396,D5TH2B,PF-07104091,Small-cell lung cancer , Phase 1
27397,D5TH2B,PF-07104091,Non-small cell lung cancer , Phase 1
27398,D5V2HR,IBI188,Myelodysplastic syndrome , Phase 1
27399,D5VE7C,SAR442085,Plasma cell myeloma , Phase 1
27400,D5VMP4,BTX-A51,Non-hodgkin lymphoma , Phase 1
27401,D5VMP4,BTX-A51,Advanced solid tumour , Phase 1
27402,D5VRX2,Dociparstat sodium,Acute myeloid leukaemia , Phase 3
27403,D5W7BG,M012,Myelodysplastic syndrome , Phase 1
27404,D5W7BG,M012,Polycythemia vera , Phase 1
27405,D5W7BG,M012,Thalassemia , Phase 1
27406,D5WAG1,DTX401,Pompe disease , Phase 1
27407,D5WB0F,RG6279,Solid tumour/cancer , Phase 1
27408,D5WU7B,CEND-1,Pancreatic cancer , Phase 1
27409,D5XV9K,PF-06882961,Type 2 diabetes , Phase 2
27410,D5Y3NP,Donislecel,Type-1 diabetes , Phase 3
27411,D5YN8U,ALLO-715,Multiple myeloma , Phase 1
27412,D60SWR,VAC89220,Human immunodeficiency virus infection , Phase 3
27413,D61LJZ,RiMO-301,Solid tumour/cancer , Phase 1
27414,D62FLA,BHQ880,Multiple myeloma , Phase 2
27415,D62LKT,BI 836880,Neoplasm , Phase 1
27416,D62LKT,BI 836880,Wet age-related macular degeneration , Phase 1
27417,D63QIY,ABBV-467,Multiple myeloma , Phase 1
27418,D63WMQ,Ingrezza,Tardive dyskinesia , Phase 4
27419,D63WMQ,Ingrezza,Tourette syndrome , Phase 2
27420,D64FNH,SAR441236,Human immunodeficiency virus infection , Phase 1
27421,D65IMT,MS1943,Breast cancer , Investigative
27422,D67AKN,PXL-770,Non-alcoholic fatty liver disease , Phase 2
27423,D67IRW,DF6002,Solid tumour/cancer , Phase 1/2
27424,D67ZDJ,PHE885,Multiple myeloma , Phase 1
27425,D68DPH,IOV-2001,Chronic lymphocytic leukaemia , Phase 1/2
27426,D68DPH,IOV-2001,Small lymphocytic lymphoma , Phase 1/2
27427,D68PVB,PD01A,Parkinson disease , Phase 1
27428,D68RMI,CLN-081,Non-small-cell lung cancer , Phase 1
27429,D69KBS,ASP7317,Age-related macular degeneration , Phase 1
27430,D6AHO2,LY3410738,Solid tumour/cancer , Phase 1
27431,D6CV1Q,TG4050,Ovarian cancer , Phase 1
27432,D6CZ0T,CPL207-280CA,Type 2 diabetes , Phase 1
27433,D6DPI4,ABI-H2158,Hepatitis B , Phase 2
27434,D6DR8F,INO-4201,Ebola virus infection , Phase 1
27435,D6DT3X,Sitafloxacin,Escherichia coli infection , Phase 2
27436,D6EI9F,NEXI-002,Multiple myeloma , Phase 1/2
27437,D6EQ3X,MV-CHIK,Chikungunya virus infection , Phase 2
27438,D6ETD2,PTI-125,Alzheimer disease , Phase 2
27439,D6EU7R,HH2853,Non-hodgkin lymphoma , Phase 1
27440,D6EU7R,HH2853,Solid tumour/cancer , Phase 1
27441,D6FNV9,IXT-m200,Methamphetamine use disorder , Phase 2
27442,D6FTN1,ABSK021,Solid tumour/cancer , Phase 1
27443,D6FX2G,VIC-1911,Solid tumour/cancer , Phase 1
27444,D6H9TE,SEA-CD70,Acute myeloid leukaemia , Phase 1
27445,D6H9TE,SEA-CD70,Myelodysplastic syndrome , Phase 1
27446,D6INZ9,ATI-501,Alopecia , Phase 2
27447,D6IOB5,BAY 2701439,Solid tumour/cancer , Phase 1
27448,D6JM8Z,SI-B001,Metastatic epithelial tumour , Phase 1
27449,D6MEX0,ALN-TMP,Beta thalassemia , Preclinical
27450,D6N5UC,ATI-502,Atopic dermatitis , Phase 2
27451,D6N5UC,ATI-502,Alopecia , Phase 2
27452,D6N8UJ,NAM-NK cells,Multiple myeloma , Phase 1
27453,D6N8UJ,NAM-NK cells,Non-hodgkin lymphoma , Phase 1
27454,D6O2PN,ATIR101,Acute myeloid leukaemia , Phase 3
27455,D6O2PN,ATIR101,Myelodysplastic syndrome , Phase 3
27456,D6O2PN,ATIR101,Acute lymphoblastic leukaemia , Phase 3
27457,D6ONY2,KUR-502,B-cell lymphoma , Phase 1
27458,D6P9OU,ONC206,Brain and central nervous system tumour , Phase 1
27459,D6PRE7,GRL001,Coronavirus infection , Preclinical
27460,D6Q4TS,JNJ-66684657,Zika virus infection , Phase 1
27461,D6Q5MG,JNJ-74494550,Myelodysplastic syndrome , Phase 2
27462,D6QA4N,"S-(2-Aminophenyl)-L-cysteine S,S-dioxide",Bacterial infection , Preclinical
27463,D6QO5V,CPI-100,Solid tumour/cancer , Phase 1
27464,D6QRJ2,RG6115,Hepatocellular carcinoma , Phase 1
27465,D6SL3N,Zenocutuzomab,Solid tumour/cancer , Phase 1/2
27466,D6VLX2,JNJ-42905343,Anaemia , Preclinical
27467,D6VLX2,JNJ-42905343,Iron deficiency , Preclinical
27468,D6W2MF,ST-400,Beta thalassemia , Phase 1/2
27469,D6X7KR,SR-T100,Actinic keratosis , Phase 3
27470,D6XMS1,DTX301,Ornithine transcarbamylase deficiency , Phase 1/2
27471,D6XS7L,BMS-986315,Solid tumour/cancer , Phase 1/2
27472,D6YB1E,CDK-002,Solid tumour/cancer , Phase 1/2
27473,D6YD0X,Tilsotolimod,Melanoma , Phase 3
27474,D6Z3HR,MV-012-968,Respiratory syncytial virus infection , Phase 2
27475,D70HIN,CCT251545,Colorectal cancer , Preclinical
27476,D70SHJ,mRNA-2416,Lymphoma , Phase 1
27477,D70SHJ,mRNA-2416,Solid tumour/cancer , Phase 1
27478,D70SHJ,mRNA-2416,Ovarian cancer , Phase 1
27479,D72HXF,EB8018,Crohn disease , Phase 2
27480,D72UDH,OXB-102,Parkinson disease , Phase 1/2
27481,D73ZML,T3011,Solid tumour/cancer , Phase 1
27482,D74BRK,BGB-11417,Acute myeloid leukaemia , Phase 1
27483,D74BRK,BGB-11417,Myelodysplastic syndrome , Phase 1
27484,D74ZUI,GSK3903133A,Rabies , Phase 1
27485,D75LNO,BMS-986299,Solid tumour/cancer , Phase 1
27486,D76INB,Tesidolumab,Age-related macular degeneration , Phase 2
27487,D76PDV,BI 425809,Schizophrenia , Phase 3
27488,D79HBK,NBE-002,Solid tumour/cancer , Phase 1/2
27489,D79JZU,FT538,Multiple myeloma , Phase 1
27490,D79JZU,FT538,Acute myeloid leukaemia , Phase 1
27491,D7AFK9,KUR-501,Neuroblastoma , Phase 1
27492,D7AOL8,BNT321,Pancreatic cancer , Phase 2
27493,D7BF8Y,BMS-986288,Solid tumour/cancer , Phase 1/2
27494,D7C3JA,UCART-22,B-cell acute lymphoblastic leukaemia , Phase 1
27495,D7CE6N,AB680,Pancreatic cancer , Phase 1
27496,D7CI5F,C-178,Aicardi-Goutieres syndrome , Investigative
27497,D7CWQ0,RG6286,Colorectal cancer , Phase 1
27498,D7EZ0H,CG0070,Non-muscle invasive bladder cancer , Phase 3
27499,D7EZ0H,CG0070,Bladder cancer , Phase 2
27500,D7FJQ3,INCB057643,Solid tumour/cancer , Phase 1/2
27501,D7FPZ4,A-337,Non-small-cell lung cancer , Phase 1
27502,D7GQR3,CPK850,Retinitis pigmentosa , Phase 1/2
27503,D7HLI1,Valoctocogene roxaparvovec,Haemophilia A , Phase 3
27504,D7HZ3T,RXDX-106,Solid tumour/cancer , Phase 1
27505,D7I9JH,Dichloroacetate,Insulin-resistant disorder , Phase 4
27506,D7I9JH,Dichloroacetate,Pyruvate dehydrogenase complex deficiency , Phase 3
27507,D7I9JH,Dichloroacetate,Pulmonary fibrosis , Phase 1
27508,D7IA0N,AMG 757,Small-cell lung cancer , Phase 1
27509,D7IA0N,AMG 757,Neuroendocrine cancer , Phase 1
27510,D7J2NK,TTX-080,Solid tumour/cancer , Phase 1
27511,D7K0GP,PT630,Lung cancer , Preclinical
27512,D7K0GP,PT630,Colon cancer , Preclinical
27513,D7K3FB,CPX-POM,Bladder cancer , Phase 2
27514,D7K3FB,CPX-POM,Solid tumour/cancer , Phase 1
27515,D7K5XP,NEO-201,Solid tumour/cancer , Phase 1
27516,D7L1MP,MEDI5752,Solid tumour/cancer , Phase 1
27517,D7L1MP,MEDI5752,Non-small cell lung cancer , Phase 1
27518,D7L8JC,DpC,Solid tumour/cancer , Phase 1
27519,D7LC8N,MIK665,Acute myeloid leukaemia , Phase 1
27520,D7LN0E,TNB-486,B-cell lymphoma , Phase 1
27521,D7LQJ8,PX-102,Hepatic fibrosis , Phase 1
27522,D7LU8R,PBCAR269A,Multiple myeloma , Phase 1/2
27523,D7M3JN,Disufenton,Recurrent glioblastoma , Phase 2
27524,D7M8LI,TPX-0022,Solid tumour/cancer , Phase 1
27525,D7NEV4,PXL01,Scar tissue , Phase 2
27526,D7PVH4,LPN023,IgA nephropathy , Phase 2
27527,D7QHV6,ABBV-184,Non-small-cell lung cancer , Phase 1
27528,D7QHV6,ABBV-184,Acute myeloid leukaemia , Phase 1
27529,D7RK2M,THZ531,Solid tumour/cancer , Investigative
27530,D7S9LP,Somapacitan,Growth hormone deficiency , Approved
27531,D7SJE2,MVA-BN WEV vaccine,Encephalitis virus infection , Phase 1
27532,D7T5AN,CMP-001,Melanoma , Phase 1
27533,D7T5AN,CMP-001,Non-small-cell lung cancer , Phase 1
27534,D7TA4P,PF-06826647,Plaque psoriasis , Phase 2
27535,D7TB6I,ZIKV-IG,Zika virus infection , Phase 1
27536,D7TIB0,RS2-1G9,Pseudomonas infection , Preclinical
27537,D7TV5I,MK-4280,Solid tumour/cancer , Phase 1
27538,D7TV5I,MK-4280,Neoplasm , Phase 1
27539,D7UIZ1,BGB-A425,Solid tumour/cancer , Phase 1/2
27540,D7UIZ1,BGB-A425,Non-small cell lung cancer , Phase 1/2
27541,D7W6SO,IMT1012,Breast cancer , Phase 1
27542,D7W6SO,IMT1012,Ovarian cancer , Phase 1
27543,D7WOL5,COM701,Solid tumour/cancer , Phase 1
27544,D7X8AQ,M3258,Multiple myeloma , Phase 1
27545,D7XB0Q,SEP-378614,Depression , Phase 1
27546,D7XE8J,VLA84,Clostridium infection , Phase 2
27547,D7XNQ1,Exeporfinium chloride,Staphylococcus infection , Phase 2
27548,D7Z1CR,TP-3654,Solid tumour/cancer , Phase 1
27549,D7ZXE5,Beta-aminopropionitrile,Cardiac arrest , Preclinical
27550,D80OLH,CPI-200,Solid tumour/cancer , Phase 1
27551,D81AQG,AMG 890,Cardiac fibrosis , Phase 2
27552,D81KMY,Neupro,Restless legs syndrome , Phase 4
27553,D81KMY,Neupro,Parkinson disease , Phase 3
27554,D81YIK,WVT078,Multiple myeloma , Phase 1
27555,D81YNE,CFI-402257,Solid tumour/cancer , Phase 1
27556,D82COK,FLU-IGIV,Influenza A virus infection , Phase 2
27557,D82DGN,JT08,Solid tumour/cancer , Preclinical
27558,D82DMK,LM11A-31,Alzheimer disease , Phase 1/2
27559,D82GST,JNJ-65195208,Human papillomavirus infection , Phase 1/2
27560,D82UVG,ALPN-202,Solid tumour/cancer , Phase 1
27561,D83YSR,680C91,Solid tumour/cancer , Preclinical
27562,D84EGX,AT-342,Crigler-Najjar syndrome , Phase 1/2
27563,D85NEG,BAY 2253651,Obstructive sleep apnea , Phase 2
27564,D86ALC,SBX-101,Intestinal toxicities from therapy , Preclinical
27565,D86ILE,SPHINX31,Wet age-related macular degeneration , Preclinical
27566,D87KMZ,ISA101,Squamous cell carcinoma , Phase 2
27567,D87PWZ,IPH5201,Solid tumour/cancer , Phase 1
27568,D87TMY,OT-58,Homocystinuria , Phase 1/2
27569,D89XBL,STMC-103H,Allergic rhinitis , Phase 1
27570,D89XBL,STMC-103H,Atopic dermatitis , Phase 1
27571,D8AF1M,OPC-167832,Tuberculosis , Phase 1/2
27572,D8AG3S,Vorolanib,Non-small cell lung cancer , Phase 2
27573,D8AI0N,ATA3271,Solid tumour/cancer , Preclinical
27574,D8AI0N,ATA3271,Mesothelioma , Preclinical
27575,D8AOC1,AMG 330,Acute myeloid leukaemia , Phase 1
27576,D8B9KJ,Jivi,Haemophilia A , Approved
27577,D8BJX5,TAEK-VAC-HerBy,Solid tumour/cancer , Phase 1/2
27578,D8CFX3,REGN6569,Squamous head and neck cell carcinom , Phase 1
27579,D8CJE9,Norketotifen,Influenza virus infection , Phase 2
27580,D8D1MI,MDR-101,Kidney transplant rejection , Phase 3
27581,D8DJX0,OBT076,Breast cancer , Phase 1
27582,D8EB7G,eFT226,Solid tumour/cancer , Phase 1/2
27583,D8EIB7,MCY-M11,Ovarian cancer , Phase 1
27584,D8EIB7,MCY-M11,Peritoneal cancer , Phase 1
27585,D8EIB7,MCY-M11,Fallopian tube cancer , Phase 1
27586,D8EIB7,MCY-M11,Peritoneal mesothelioma , Phase 1
27587,D8F6PB,FKB238,Non-small-cell lung cancer , Phase 3
27588,D8FJ9K,XmAb23104,Solid tumour/cancer , Phase 1
27589,D8GN2C,TRN-148,Central nervous system disease , Clinical Trial
27590,D8IQ0D,ME-401,Follicular lymphoma , Phase 2
27591,D8JN5H,NKTR-262,Solid tumour/cancer , Phase 1/2
27592,D8JN5H,NKTR-262,Melanoma , Phase 1
27593,D8L5PA,Loncastuximab tesirine,Diffuse large B-cell lymphoma , Approved
27594,D8L5PA,Loncastuximab tesirine,Follicular lymphoma , Phase 2
27595,D8MS6C,BGB-15025,Solid tumour/cancer , Phase 1
27596,D8OJX6,SO-C101,Solid tumour/cancer , Phase 1
27597,D8PE7D,AVB-500,IgA nephropathy , Phase 2
27598,D8RN3B,JNJ-63682931,Human papillomavirus infection , Phase 1/2
27599,D8SO5T,RNS60,Amyotrophic lateral sclerosis , Phase 2
27600,D8SO5T,RNS60,Multiple sclerosis , Phase 2
27601,D8SV9R,DNX-2401,Brain cancer , Phase 2
27602,D8SV9R,DNX-2401,Recurrent glioblastoma , Phase 2
27603,D8TE4F,AMXI 5001,Solid tumour/cancer , Phase 1/2
27604,D8U2EM,PVX-2,Human papillomavirus infection , Phase 2
27605,D8UNG2,TG-1801,B-cell lymphoma , Phase 1
27606,D8UZ5R,NBF-006,Colorectal cancer , Phase 1
27607,D8UZ5R,NBF-006,Non-small-cell lung cancer , Phase 1
27608,D8UZ5R,NBF-006,Pancreatic cancer , Phase 1
27609,D8UZM7,REGN5678,Prostate cancer , Phase 1/2
27610,D8VH5Q,ML209,Autoimmune disease , Preclinical
27611,D8VJT5,ZEN-3694,Prostate cancer , Phase 2
27612,D8W1DJ,[153Sm]CycloSam,Osteosarcoma , Phase 1
27613,D8WBZ2,PMID25197057-Compound6e,Staphylococcus infection , Preclinical
27614,D8XHT1,RGX-111,Mucopolysaccharidosis , Phase 1
27615,D8XK7F,RGLS4326,Autosomal dominant polycystic kidney disease , Phase 1
27616,D8ZNW0,MDR-102,Kidney transplant rejection , Phase 2
27617,D8ZV2Q,FCN-437,Breast cancer , Phase 1/2
27618,D90GKY,PrabotulinumtoxinA,Glabellar frown line , Approved
27619,D90UZW,Ad-RTS-hIL-12,Melanoma , Phase 2
27620,D90UZW,Ad-RTS-hIL-12,Recurrent glioblastoma , Phase 2
27621,D90UZW,Ad-RTS-hIL-12,Glioblastoma of brain , Phase 2
27622,D90UZW,Ad-RTS-hIL-12,Malignant glioma , Phase 1
27623,D91CMX,AMG 427,Acute myeloid leukaemia , Phase 1
27624,D92KBX,RG6217,Hepatitis B virus infection , Phase 1
27625,D92KUQ,ARN-6039,Multiple sclerosis , Phase 1
27626,D93JXG,Somatrogon,Growth hormone deficiency , Phase 3
27627,D93TWL,GSK3389245A,Respiratory syncytial virus infection , Phase 2
27628,D94NTP,GSK3277511A,Respiratory tract disease , Phase 2
27629,D95GKC,BCL11a shRNA,Sickle-cell disorder , Phase 1
27630,D95KWS,KL001,Glioblastoma of brain , Preclinical
27631,D95YSW,BPI-9016 M,Solid tumour/cancer , Phase 1
27632,D96DPA,ECT-001,Hematologic tumour , Phase 2
27633,D96XNU,3VM1001,Postherpetic neuralgia , Phase 1/2
27634,D96XNU,3VM1001,Knee osteoarthritis , Phase 1/2
27635,D97YGW,SNDX-5613,T lymphoblastic leukaemia , Phase 1/2
27636,D98FBH,DN1508052,Solid tumour/cancer , Phase 1
27637,D98UXE,NNZ-2256,Fragile X syndrome , Phase 2
27638,D98VPM,MS-553,Chronic lymphocytic leukaemia , Phase 1
27639,D98VPM,MS-553,Small lymphocytic lymphoma , Phase 1
27640,D9CI7V,Donaperminogene seltoplasmid,Diabetic foot ulcer , Phase 3
27641,D9CI7V,Donaperminogene seltoplasmid,Diabetic neuropathy , Phase 3
27642,D9CI7V,Donaperminogene seltoplasmid,Amyotrophic lateral sclerosis , Phase 1/2
27643,D9D6QN,SR1078,Liver cancer , Preclinical
27644,D9DN5J,RG6076,Hematologic tumour , Phase 1
27645,D9DQ1I,BI 905681,Solid tumour/cancer , Phase 1
27646,D9DS8O,NDV-3A,Vulvovaginal Candidiasis , Phase 2
27647,D9DS8O,NDV-3A,Staphylococcus infection , Phase 2
27648,D9DS8O,NDV-3A,Candidiasis , Phase 1/2
27649,D9E6KQ,Copper dotatate Cu-64,Diagnostic imaging , Approved
27650,D9EC0G,Zemaira,Emphysema , Approved
27651,D9EGS5,ITI-1000,Glioblastoma of brain , Phase 2
27652,D9FGB3,AMG 119,Small-cell lung cancer , Phase 1
27653,D9FJ5V,BDTX-189,Solid tumour/cancer , Phase 1/2
27654,D9FT0A,R552,Nervous system paraneoplastic or autoimmune disorders , Phase 1
27655,D9FZN0,SG-2-0776,Inflammatory bowel disease , Preclinical
27656,D9HY7D,SVV-001,Lung cancer , Phase 2
27657,D9HYU8,Reltecimod,Necrotizing soft tissue infection , Phase 3
27658,D9I3WE,SYN120,Parkinson disease , Phase 2
27659,D9ILC1,PD98059,Cardiac arrest , Investigative
27660,D9IQ6N,TJ4309,Solid tumour/cancer , Phase 1
27661,D9J4ZI,JNJ-64213175,Respiratory syncytial virus infection , Phase 1/2
27662,D9J6XV,Vobarilizumab,Rheumatoid arthritis , Phase 2
27663,D9J6XV,Vobarilizumab,Systemic lupus erythematosus , Phase 2
27664,D9JHN4,INV-1120,Solid tumour/cancer , Phase 1
27665,D9L2WN,PEP-CMV,Medulloblastoma , Phase 1
27666,D9L2WN,PEP-CMV,Malignant glioma , Phase 1
27667,D9LA6Q,COM902,Solid tumour/cancer , Phase 1
27668,D9LT5G,CV301,Metastatic colorectal cancer , Phase 2
27669,D9M0KJ,SRF617,Solid tumour/cancer , Phase 1
27670,D9M8FK,SRP-9001,Duchenne dystrophy , Phase 2
27671,D9MT4S,CA-074Me,Cardiac arrest , Preclinical
27672,D9MT4S,CA-074Me,Pulmonary fibrosis , Preclinical
27673,D9MT4S,CA-074Me,Cystic fibrosis , Preclinical
27674,D9MWL4,Faricimab,Diabetic macular edema , Phase 3
27675,D9NJS5,INO-5151,Prostate cancer , Phase 2
27676,D9NL3R,Trebananib,Ovarian cancer , Phase 3
27677,D9NL3R,Trebananib,Renal cell carcinoma , Phase 2
27678,D9NL3R,Trebananib,Solid tumour/cancer , Phase 1
27679,D9O7GC,GTB-3550,Myelodysplastic syndrome , Phase 1/2
27680,D9O7GC,GTB-3550,Systemic mastocytosis , Phase 1/2
27681,D9O7GC,GTB-3550,Acute myelogenous leukaemia , Phase 1/2
27682,D9O7GC,GTB-3550,Mast cell leukaemia , Phase 1/2
27683,D9OMQ3,GEN3013,Diffuse large B-cell lymphoma , Phase 1/2
27684,D9OMQ3,GEN3013,Follicular lymphoma , Phase 1/2
27685,D9OMQ3,GEN3013,Mantle cell lymphoma , Phase 1/2
27686,D9OQ6R,VAX014,Urothelial carcinoma , Phase 1
27687,D9OS5I,SB623,Ischemic stroke , Phase 2
27688,D9OS5I,SB623,Traumatic brain injury , Phase 2
27689,D9OZ3B,JNJ-67571244,Acute myeloid leukaemia , Phase 1
27690,D9OZ3B,JNJ-67571244,Myelodysplastic syndrome , Phase 1
27691,D9P8LE,RG70099,Solid tumour/cancer , Preclinical
27692,D9PBQ8,PF-04859989,Cognitive impairment , Preclinical
27693,D9PBQ8,PF-04859989,Schizophrenia , Preclinical
27694,D9Q5UP,TBA-354,Tuberculosis , Phase 1
27695,D9RH0V,DCC-3014,Solid tumour/cancer , Phase 1/2
27696,D9S1KL,TS-161,Depression , Phase 2
27697,D9S7XO,DN1406131,Solid tumour/cancer , Phase 1
27698,D9SL1N,TAK-252,Solid tumour/cancer , Phase 1
27699,D9SMC5,C30,Pseudomonas infection , Preclinical
27700,D9SMF2,KVD824,Diabetic macular edema , Phase 2
27701,D9TG4H,JNJ-63709178,Acute myeloid leukaemia , Phase 1
27702,D9U5LY,REGN3051,Coronavirus infection , Phase 1
27703,D9UDT8,ASP2397,Invasive pulmonary aspergillosis , Phase 2
27704,D9UGX7,Encequidar,Metastatic breast cancer , Phase 2
27705,D9UZ5Q,NC318,Non-small cell lung cancer , Phase 2
27706,D9WQD2,V114,Pneumococcal infection , Phase 3
27707,D9WQD2,V114,Myelodysplastic syndrome , Phase 2
27708,D9Y2KA,"4-(4-fluoropyrazol-1-yl)-1,2-oxazol-5-amine",Solid tumour/cancer , Preclinical
27709,D9Y8OG,CEVA101,Traumatic brain injury , Phase 2
27710,D9Y8ZU,BI 905711,Solid tumour/cancer , Phase 1
27711,D9YG4P,APX3330,Diabetic retinopathy , Phase 2
27712,D9YG4P,APX3330,Solid tumour/cancer , Phase 1
27713,D9ZEM7,HPP971,Non-alcoholic steatohepatitis , Phase 1
27714,D9ZQ7T,VYR 006,Toxoplasmosis , Phase 1
27715,DA01IB,MTL-CEPBA,Hepatocellular carcinoma , Phase 1/2
27716,DA02DE,BGB-10188,Solid tumour/cancer , Phase 1
27717,DA02DE,BGB-10188,B-cell lymphoma , Phase 1
27718,DA08WU,EDP-938,Respiratory syncytial virus infection , Phase 2
27719,DA0OZ2,HBX19818,Solid tumour/cancer , Preclinical
27720,DA1L7V,AADvac-1,Alzheimer disease , Phase 2
27721,DA1MG8,ONO-7475,Myelodysplastic syndrome , Phase 1/2
27722,DA1MG8,ONO-7475,Acute leukaemia , Phase 1/2
27723,DA1X5W,INBRX-105,Solid tumour/cancer , Phase 1
27724,DA37BQ,Jynneos,Monkeypox virus infection , Phase 3
27725,DA3F2X,TP-6076,Enterobacteriaceae infection , Phase 1
27726,DA3F2X,TP-6076,Multidrug resistant infection , Phase 1
27727,DA3GL5,ZGN-1061,Type 2 diabetes , Phase 2
27728,DA4O8C,IMGC936,Solid tumour/cancer , Phase 1
27729,DA4W1I,AO-176,Solid tumour/cancer , Phase 1/2
27730,DA5RC6,BC-1215,Inflammation , Preclinical
27731,DA69JF,Tirzepatide,Type 2 diabetes , Phase 3
27732,DA6C8N,LXE408,Visceral leishmaniasis , Phase 2
27733,DA6F1D,MERS-4,Coronavirus infection , Preclinical
27734,DA6NG5,Nimacimab,Diabetic nephropathy , Phase 2
27735,DA6OU0,GL-ONC1,Solid tumour/cancer , Phase 2
27736,DA6OU0,GL-ONC1,Peritoneal carcinomatosis , Phase 1/2
27737,DA6OU0,GL-ONC1,Ovarian cancer , Phase 1/2
27738,DA6OU0,GL-ONC1,Peritoneal cavity cancer , Phase 1
27739,DA6T3R,VLA1553,Chikungunya virus infection , Phase 3
27740,DA74SC,P1101,Polycythemia vera , Phase 3
27741,DA78ZH,MEDI5395,Solid tumour/cancer , Phase 1
27742,DA79HM,SB 11285,Melanoma , Phase 1
27743,DA79HM,SB 11285,Head-neck squamous cell carcinoma , Phase 1
27744,DA85KQ,M102,Amyotrophic lateral sclerosis , Preclinical
27745,DA85NC,60P002,Dengue , Phase 2
27746,DA8MK6,M6223,Solid tumour/cancer , Phase 1
27747,DA8W3Q,THR-149,Diabetic macular edema , Phase 2
27748,DA91HS,ODM-207,Solid tumour/cancer , Phase 1/2
27749,DA9N4O,BJ-001,Solid tumour/cancer , Phase 1
27750,DAD65R,RP-3500,Solid tumour/cancer , Phase 1/2
27751,DAD95G,VX-371,Cystic fibrosis , Phase 2
27752,DAD95G,VX-371,Primary ciliary dyskinesia , Phase 2
27753,DAD9V4,GSK2643943A,Solid tumour/cancer , Preclinical
27754,DAJ3D2,SMI-4a,Non-small cell lung cancer , Investigative
27755,DAL5C7,Eftilagimod alpha,Non-small-cell lung cancer , Phase 2
27756,DAL5C7,Eftilagimod alpha,Squamous head and neck cell carcinom , Phase 2
27757,DALG29,KY1044,Solid tumour/cancer , Phase 1/2
27758,DAOT46,LY2787106,Anemia , Phase 1
27759,DAPZ09,PSMA VRP,Prostate cancer , Phase 1
27760,DAQ31P,2-aminophenoxazine-3-one,T-cell leukaemia , Investigative
27761,DAQ4G0,NC043,Neurodegenerative disorder , Preclinical
27762,DARV32,GP-2250,Pancreatic cancer , Phase 1/2
27763,DAS4D6,PSMA CAR-T cell therapy,Prostate cancer , Phase 1
27764,DAT0U5,NV-5138,Major depressive disorder , Phase 1
27765,DATO92,AZD9833,ER-positive breast cancer , Phase 2
27766,DAW86K,AV7909,Anthrax , Phase 3
27767,DAX06Q,AMG 509,Prostate cancer , Phase 1
27768,DAY4L1,SX-682,Melanoma , Phase 1
27769,DAY4L1,SX-682,Myelodysplastic syndrome , Phase 1
27770,DB0V3R,Spautin 1,Inflammation , Preclinical
27771,DB18SE,SAGE-718,Parkinson disease , Phase 2
27772,DB18SE,SAGE-718,Schizophrenia , Phase 1
27773,DB1P9T,LpxC-1,Acinetobacter baumannii infection , Preclinical
27774,DB1U9N,S-Phenyl-L-cysteine sulfoxide,Bacterial infection , Preclinical
27775,DB26FH,EO2401,Adrenocortical carcinoma , Phase 1/2
27776,DB26FH,EO2401,Pheochromocytoma , Phase 1/2
27777,DB26FH,EO2401,Paraganglioma , Phase 1/2
27778,DB29TN,MER4101,Influenza virus infection , Phase 1
27779,DB29TN,MER4101,Influenza , Phase 1
27780,DB2U3O,GSK3640254,Human immunodeficiency virus infection , Phase 2
27781,DB35WK,Fresolimumab,Brain cancer , Phase 2
27782,DB4C5H,CD123-CD33 Ccar,Acute myeloid leukaemia , Phase 1
27783,DB4C5H,CD123-CD33 Ccar,Myelodysplastic syndrome , Phase 1
27784,DB4D2N,UNC0379,Hepatocellular carcinoma , Preclinical
27785,DB4M9J,Epcoritamab,Diffuse large B-cell lymphoma , Phase 3
27786,DB53NH,HTI-1090,Solid tumour/cancer , Phase 1
27787,DB58KR,RT001,Friedreich's ataxia , Phase 3
27788,DB58KR,RT001,Iron overload disease , Phase 2/3
27789,DB5O1U,H3B-8800,Myelodysplastic syndrome , Phase 1
27790,DB5O1U,H3B-8800,Chronic myelomonocytic leukaemia , Phase 1
27791,DB5O1U,H3B-8800,Acute myeloid leukaemia , Phase 1
27792,DB5UA2,CC-90011,Lymphoma , Phase 2
27793,DB5UA2,CC-90011,Non-hodgkin lymphoma , Phase 2
27794,DB5UO0,CAN04,Non-small-cell lung cancer , Phase 1
27795,DB5YU0,DMT210,Atopic dermatitis , Phase 2
27796,DB5YU0,DMT210,Rosacea , Phase 2
27797,DB6GK4,DS-1055,Solid tumour/cancer , Phase 1
27798,DB6XD8,BMS-986177,Cerebral ischemia , Phase 2
27799,DB6XD8,BMS-986177,Thrombosis , Phase 1
27800,DB82TO,Tofisopam,Irritable bowel syndrome , Phase 2
27801,DB82TO,Tofisopam,Hyperuricaemia , Phase 2
27802,DB8J2U,KPG-818,Systemic lupus erythematosus , Phase 1
27803,DB8MR6,OS2966,Glioblastoma of brain , Phase 1
27804,DB91HQ,ADG106,Non-hodgkin lymphoma , Phase 1/2
27805,DB91HQ,ADG106,Solid tumour/cancer , Phase 1/2
27806,DBA40S,Recifercept,Achondroplasia , Phase 2
27807,DBA5M7,PMX205,Central nervous system disease , Preclinical
27808,DBDW09,GMI-1359,Solid tumour/cancer , Phase 1
27809,DBDW09,GMI-1359,Breast cancer , Phase 1
27810,DBE26P,ADXS-NEO,Colon cancer , Phase 1
27811,DBE26P,ADXS-NEO,Head and neck cancer , Phase 1
27812,DBE26P,ADXS-NEO,Non-small-cell lung cancer , Phase 1
27813,DBE26P,ADXS-NEO,Colorectal cancer , Phase 1
27814,DBE87X,MRG-110,Heart failure , Phase 1
27815,DBG46D,PSMA-11 Ga-68,Diagnostic imaging , Approved
27816,DBGD91,PTX-35,Solid tumour/cancer , Phase 1
27817,DBHO19,AMT-061,Haemophilia B , Phase 3
27818,DBI81F,AMG 397,Refractory hematologic malignancy , Phase 1
27819,DBJ36R,JT07,Solid tumour/cancer , Preclinical
27820,DBJ5Z0,N-Octyl-4-epi-beta-valienamine,GM1 gangliosidosis , Preclinical
27821,DBL5H8,MK-8527,Human immunodeficiency virus-1 infection , Phase 1
27822,DBND71,GS-9674,Primary sclerosing cholangitis , Phase 3
27823,DBND71,GS-9674,Non-alcoholic steatohepatitis , Phase 2
27824,DBO39X,JNJ-64264681,Non-hodgkin lymphoma , Phase 1
27825,DBO39X,JNJ-64264681,Chronic lymphocytic leukaemia , Phase 1
27826,DBP9Q5,SAR442257,Malignant neoplasm , Phase 1
27827,DBPV74,BP1002,Haematopoietic/lymphoid cancer , Phase 1
27828,DBT1H4,CC100,Amyotrophic lateral sclerosis , Phase 1
27829,DBU13L,Cavrotolimod,Solid tumour/cancer , Phase 1
27830,DBU16T,JSI-1187,Solid tumour/cancer , Phase 1
27831,DBU2W3,EYP001,Non-alcoholic steatohepatitis , Phase 2
27832,DBY42T,LP-108,Acute myeloid leukaemia , Phase 1
27833,DBY42T,LP-108,Myelodysplastic syndrome , Phase 1
27834,DBY42T,LP-108,Chronic myelomonocytic leukaemia , Phase 1
27835,DBZ87Q,BGB-A445,Solid tumour/cancer , Phase 1
27836,DC0P6U,AT-752,Dengue , Phase 1
27837,DC19UI,SQX770,Herpes simplex virus infection , Phase 2
27838,DC1AV3,DNL758,Cutaneous lupus erythematosus , Phase 2
27839,DC29HL,Lu AF11167,Schizophrenia , Phase 2
27840,DC2DO5,PDC-1421,Attention deficit hyperactivity disorder , Phase 2
27841,DC37YW,IMSA101,Solid tumour/cancer , Phase 1/2
27842,DC3Y7O,RG6296,Multiple myeloma , Phase 1
27843,DC3ZD5,DRP-104,Solid tumour/cancer , Phase 1/2
27844,DC4AT7,MERS-27,Coronavirus infection , Preclinical
27845,DC4U0L,ADPS,Acne vulgaris , Phase 2
27846,DC52UD,CTP-692,Schizophrenia , Phase 2
27847,DC57TE,BT8009,Solid tumour/cancer , Phase 1/2
27848,DC5A9Q,mRNA-2752,Solid tumour/cancer , Phase 1
27849,DC5VW9,BGB-A333,Solid tumour/cancer , Phase 1/2
27850,DC6IR4,INO-4700,Middle East Respiratory Syndrome (MERS) , Phase 2
27851,DC6LS1,AB-110,Acute myeloid leukaemia , Phase 1
27852,DC6LS1,AB-110,Myelodysplastic syndrome , Phase 1
27853,DC6UG5,PRT543,Solid tumour/cancer , Phase 1
27854,DC6UG5,PRT543,Hematologic tumour , Phase 1
27855,DC72LG,RMJH-111b,Essential hypertension , Phase 1/2
27856,DC7UF3,Remlarsen,Keloid , Phase 2
27857,DC8EN0,131I-labelled aCD45,Acute myeloid leukaemia , Phase 3
27858,DC8HR6,LY3415244,Solid tumour/cancer , Phase 1
27859,DC9FD4,RC-01,Gram-negative bacterial infection , Terminated
27860,DC9J1Y,RO5461111,Systemic lupus erythematosus , Preclinical
27861,DCA5M2,Padsevonil,Epilepsy , Phase 2/3
27862,DCD1M8,ABBV-621,Haematological malignancy , Phase 1
27863,DCD1M8,ABBV-621,Solid tumour/cancer , Phase 1
27864,DCD1M8,ABBV-621,Hematologic tumour , Phase 1
27865,DCE09U,GSK3437949A,Malaria , Phase 2
27866,DCI8V2,GEN-009,Solid tumour/cancer , Phase 1/2
27867,DCIP24,LDN-57444,Solid tumour/cancer , Preclinical
27868,DCIX20,ADU- S100,Head and neck cancer , Phase 2
27869,DCJ75Y,CUTX-101,Menkes disease , Phase 3
27870,DCJX65,UNC2025,Glioblastoma of brain , Investigative
27871,DCL84J,VLA1601,Zika virus infection , Phase 1
27872,DCL8J5,WZB-117,Skin fibrosis , Preclinical
27873,DCMG03,TTX-030,Lymphoma , Phase 1
27874,DCMG03,TTX-030,Solid tumour/cancer , Phase 1
27875,DCN2U9,BC-7013,Skin and skin-structure infection , Phase 1
27876,DCT2Q3,Annamycin,Acute myeloid leukaemia , Phase 1/2
27877,DCU94X,NmVac-4 A/C/Y/W-135 DT,Meningococcal infection , Phase 2
27878,DCVO04,OSU-53,Triple negative breast cancer , Investigative
27879,DCWS23,166Ho microspheres,Neuroendocrine cancer , Phase 2
27880,DCWT40,Seclidemstat,Ewing sarcoma , Phase 1
27881,DCXB47,QBS10072S,Solid tumour/cancer , Phase 1
27882,DCYV91,TBA-7371,Tuberculosis , Phase 2
27883,DCZ16N,SD1002,Alzheimer disease , Preclinical
27884,DCZ28G,Ibezapolstat,Clostridium infection , Phase 2
27885,DD1GK8,Lumasiran,Hyperoxaluria , Approved
27886,DD1TJ8,XmAb20717,Solid tumour/cancer , Phase 1
27887,DD1TJ8,XmAb20717,Advanced malignancy , Phase 1
27888,DD1TJ8,XmAb20717,Melanoma , Phase 1
27889,DD1TJ8,XmAb20717,Breast cancer , Phase 1
27890,DD1ZV6,BI 1358894,Depression , Phase 2
27891,DD25UM,177Lu-labelled NeoBOMB1,Solid tumour/cancer , Phase 2
27892,DD2C5E,IONIS-416858,Thrombosis , Phase 2
27893,DD36YG,OP-0595,Bacterial infection , Phase 1
27894,DD39ET,NVX-CoV2373,Coronavirus Disease 2019 (COVID-19) , Phase 3
27895,DD3IE7,ENERGI-F701,Alopecia , Phase 2
27896,DD3MB0,IDR-1002,Asthma , Investigative
27897,DD3XO8,SSYA10-001,Coronavirus infection , Preclinical
27898,DD4H6V,BI 1206,Chronic lymphocytic leukaemia , Phase 1/2
27899,DD4H6V,BI 1206,B-cell lymphoma , Phase 1/2
27900,DD4H6V,BI 1206,leukaemia , Phase 1/2
27901,DD4XR3,MB-105,Prostate cancer , Phase 1
27902,DD5NX2,AT-777,Hepatitis C , Phase 1/2
27903,DD5VO3,TAK-906,Diabetic gastroparesis , Phase 2
27904,DD6AZ5,BNC-101,Metastatic colorectal cancer , Phase 1
27905,DD76ER,RV001V,Prostate cancer , Phase 2
27906,DD76HZ,SNF472,Calciphylaxis , Phase 3
27907,DD76HZ,SNF472,Calcific uremic arteriolopathy , Phase 3
27908,DD8QK9,Bexsero,Meningococcal infection , Approved
27909,DD94ZN,A166,Solid tumour/cancer , Phase 1/2
27910,DD9J4X,SNS-301,Myelodysplastic syndrome , Phase 2
27911,DD9NG5,SHP-627,Cardiac arrest , Preclinical
27912,DD9VR3,MIJ821,Major depressive disorder , Phase 2
27913,DDC63W,EPZ033294,Solid tumour/cancer , Preclinical
27914,DDE3Z4,HMPL-689,Lymphoma , Phase 1
27915,DDE82F,ABBV-155,Solid tumour/cancer , Phase 1
27916,DDG8W9,SGN-CD30C,Lymphoma , Phase 1
27917,DDH8L6,Almonertinib,Non-small-cell lung cancer , Phase 3
27918,DDI6B0,Nuplazid,Alzheimer disease , Phase 2
27919,DDK1I4,AT-GAA,Pompe disease , Phase 3
27920,DDK53C,BTRX-335140,Major depressive disorder , Phase 2
27921,DDKF39,Evenamide,Schizophrenia , Phase 2
27922,DDKY53,BI 754091,Neoplasm , Phase 1
27923,DDL79K,XMT-1592,Non-small-cell lung cancer , Phase 1/2
27924,DDL79K,XMT-1592,Ovarian cancer , Phase 1/2
27925,DDL86V,MGTA-145,Hematologic tumour , Phase 2
27926,DDN3B1,BIVV-003,Sickle-cell disorder , Phase 1/2
27927,DDNL40,KB174,Cirrhosis , Clinical Trial
27928,DDP27A,JNJ-64152348,Poliomyelitis , Phase 2
27929,DDP74J,MGC018,Solid tumour/cancer , Phase 1/2
27930,DDU2Y0,Vupanorsen,Hypertriglyceridemia , Phase 2
27931,DDU2Y0,Vupanorsen,Non-alcoholic fatty liver disease , Phase 2
27932,DDU2Y0,Vupanorsen,Type 2 diabetes , Phase 2
27933,DDV09U,DS-1558,Type 2 diabetes , Preclinical
27934,DDV8H5,AlphaMedix,Neuroendocrine cancer , Phase 1
27935,DDV9M0,SB209762,Measles , Phase 3
27936,DDV9M0,SB209762,Mumps virus infection , Phase 3
27937,DDV9M0,SB209762,Rubella prophylaxis , Phase 3
27938,DDX95P,AAV-RPE65,Leber congenital amaurosis , Phase 1/2
27939,DDXH71,LMP744,Solid tumour/cancer , Phase 1
27940,DDY51F,EDP-514,Chronic HBV infection , Phase 1
27941,DDZ6B0,RG6330,Solid tumour/cancer , Phase 1
27942,DE09IO,BNZ-1,Cutaneous T-cell lymphoma , Phase 2
27943,DE09IO,BNZ-1,T-cell leukaemia , Phase 2
27944,DE09IO,BNZ-1,Large granular lymphocytic leukemia , Phase 1/2
27945,DE0L6O,ISB 1342,Multiple myeloma , Phase 1/2
27946,DE0TD1,"CP-870,893",Solid tumour/cancer , Phase 1
27947,DE2U5N,TVB-2640,Non-alcoholic fatty liver disease , Phase 2
27948,DE2V3Y,Inodiftagene vixteplasmid,Bladder cancer , Phase 2
27949,DE2Z7V,BT1718,Solid tumour/cancer , Phase 1/2a
27950,DE49RW,CTX120,Multiple myeloma , Phase 1
27951,DE4AO8,HC-1119,Prostate cancer , Phase 3
27952,DE53JQ,Camsirubicin,Soft tissue sarcoma , Phase 2
27953,DE58RZ,CUE-101,Oropharyngeal squamous cell carcinoma , Phase 2
27954,DE5L6B,DSP-7888,Glioblastoma of brain , Phase 3
27955,DE5L6B,DSP-7888,Acute myeloid leukaemia , Phase 2
27956,DE5L6B,DSP-7888,Haematological malignancy , Phase 1
27957,DE5L6B,DSP-7888,Solid tumour/cancer , Phase 1
27958,DE5N3K,Dasiglucagon,Hypoglycemia , Approved
27959,DE5N3K,Dasiglucagon,Hyperinsulinemia , Phase 2
27960,DE6GF4,ZYH7,Lipid metabolism disorder , Phase 2
27961,DE6GF4,ZYH7,Dyslipidemia , Phase 2
27962,DE7BZ4,SR2211,Autoimmune disease , Preclinical
27963,DE7N6F,ASTX295,Solid tumour/cancer , Phase 1/2
27964,DE8H1W,Aglatimagene besadenovec,Prostate cancer , Phase 3
27965,DE8H1W,Aglatimagene besadenovec,Hepatocellular carcinoma , Phase 3
27966,DE8H1W,Aglatimagene besadenovec,Pediatric glioma , Phase 2
27967,DE8H1W,Aglatimagene besadenovec,Malignant glioma , Phase 2
27968,DE8H1W,Aglatimagene besadenovec,Pancreatic cancer , Phase 1/2
27969,DE8H1W,Aglatimagene besadenovec,Malignant pleural effusion , Phase 1
27970,DE8OJ0,ZYAN1,Anaemia , Phase 1
27971,DE8S2F,DFP-14927,Solid tumour/cancer , Phase 1
27972,DE8V1R,ARO-HIF2,Renal cell carcinoma , Phase 1
27973,DEC8O3,CT 868,Type 2 diabetes , Phase 1
27974,DEDP81,AMG 910,Gastric adenocarcinoma , Phase 1
27975,DEDP81,AMG 910,Esophagogastric junction neoplasm , Phase 1
27976,DEI07S,AIP-303,Breast cancer , Phase 1
27977,DEI4U0,HMR59,Wet age-related macular degeneration , Phase 2
27978,DEI4U0,HMR59,Dry age-related macular degeneration , Phase 2
27979,DEI4U0,HMR59,Geographic retinal atrophy , Phase 2
27980,DEKM09,GWP42006,Epilepsy , Phase 2
27981,DELC48,A-893,Lung cancer , Preclinical
27982,DENA17,CD24Fc,Coronavirus Disease 2019 (COVID-19) , Phase 3
27983,DENO49,RV521,Respiratory syncytial virus infection , Phase 2
27984,DEP3Z8,AMG 199,Gastric adenocarcinoma , Phase 1
27985,DEP3Z8,AMG 199,Esophagogastric junction neoplasm , Phase 1
27986,DES36M,Q301,Atopic dermatitis , Phase 2
27987,DEU08Q,GS-5423,Human immunodeficiency virus infection , Phase 1
27988,DEU8O6,Sym023,Lymphoma , Phase 1
27989,DEU8O6,Sym023,Solid tumour/cancer , Phase 1
27990,DEUC70,TJC4,Lymphoma , Phase 1
27991,DEUC70,TJC4,Solid tumour/cancer , Phase 1
27992,DEV97R,PK68,Inflammation , Investigative
27993,DEWC27,Odevixibat,Alagille syndrome , Phase 3
27994,DEX8D5,NJH395,HER2-positive metastatic breast cancer , Phase 1
27995,DEXM29,LY3499446,Solid tumour/cancer , Phase 1/2
27996,DEZ3D7,Fucoxanthin,Metabolic syndrome x , Phase 2
27997,DEZV54,SPR206,Multidrug resistant infection , Phase 1
27998,DF04YM,AIC499,Bacterial infection , Phase 2
27999,DF0DN4,EDP-788,Bacterial infection , Phase 1
28000,DF0L3G,INCB99280,Solid tumour/cancer , Phase 1
28001,DF0PI8,BAY 1817080,Endometriosis , Phase 1
28002,DF0PI8,BAY 1817080,Cough , Phase 1
28003,DF0PR6,ZN-e4,Non-small-cell lung cancer , Phase 1/2
28004,DF0R5I,ASP0819,Fibromyalgia , Phase 2
28005,DF14RB,CRV-101,Varicella zoster virus infection , Phase 1
28006,DF14RB,CRV-101,Herpes zoster , Phase 1
28007,DF1JO7,CXA10,Pulmonary arterial hypertension , Phase 2
28008,DF1JO7,CXA10,Focal segmental glomerulosclerosis , Phase 2
28009,DF1S3A,GSK180,Neurodegenerative disorder , Preclinical
28010,DF1S3A,GSK180,Pancreatitis , Preclinical
28011,DF2E5G,VXA-G2.4-NS,Norovirus infection , Phase 1
28012,DF36DY,Givosiran,Acute intermittent hepatic porphyria , Approved
28013,DF37QR,VE800,Solid tumour/cancer , Phase 1/2
28014,DF3QH8,IMM-529,Clostridium infection , Phase 1/2
28015,DF3UN2,CAD106,Alzheimer disease , Phase 2/3
28016,DF43EH,AMG 701,Multiple myeloma , Phase 1
28017,DF5C2I,RIPA-56,Non-alcoholic fatty liver disease , Investigative
28018,DF5LB8,NSC 19630,T-cell leukaemia , Investigative
28019,DF5R7E,Romilkimab,Idiopathic pulmonary fibrosis , Phase 2
28020,DF6UP7,Tadekinig alfa,XIAP deficiency , Phase 3
28021,DF6Y1J,MK-8583,Human immunodeficiency virus-1 infection , Phase 1
28022,DF8M1T,TPST-1120,Solid tumour/cancer , Phase 1
28023,DF8M3V,KB109,Coronavirus Disease 2019 (COVID-19) , Clinical Trial
28024,DF90DS,SIS-3,Renal fibrosis , Preclinical
28025,DF9S1L,ATA2271,Mesothelioma , Phase 1
28026,DFBJ28,"6-Formylindolo[3,2-b]carbazole",Dermatitis , Investigative
28027,DFC0V4,CB-5339,Acute myeloid leukaemia , Phase 1
28028,DFC0V4,CB-5339,Myelodysplastic syndrome , Phase 1
28029,DFDT39,Anti-RAS-G12V mTCR-transduced PBL,Solid tumour/cancer , Phase 1/2
28030,DFHC16,ARNAX,Solid tumour/cancer , Investigative
28031,DFLK16,Sintilimab,Hodgkin lymphoma , Approved
28032,DFO5W3,MK-4621,Solid tumour/cancer , Phase 1
28033,DFPS93,Pravibismane,Respiratory tract infection , Phase 2
28034,DFQ17Y,TMB-365,Human immunodeficiency virus-1 infection , Phase 1
28035,DFU4B0,RO7040547,Asthma , Discontinued in Phase 1
28036,DFV71O,AAV2/8-LSPhGAA,Pompe disease , Phase 1
28037,DFW5P7,DermaVir,Human immunodeficiency virus-1 infection , Phase 2
28038,DFX7K1,BPZE1,Pertussis , Phase 2
28039,DFY58O,RTB101,Respiratory tract infection , Phase 3
28040,DFY58O,RTB101,Coronavirus Disease 2019 (COVID-19) , Phase 2
28041,DFYL51,Ociperlimab,Non-small-cell lung cancer , Phase 3
28042,DFYL51,Ociperlimab,Cervical cancer , Phase 2
28043,DFZ0V3,JNJ-64619178,Myelodysplastic syndrome , Phase 1
28044,DFZ0V3,JNJ-64619178,Solid tumour/cancer , Phase 1
28045,DFZJ79,SRK-181,Solid tumour/cancer , Phase 1
28046,DG07UD,VCB102,Psoriasis vulgaris , Preclinical
28047,DG07WN,RGX-314,Wet age-related macular degeneration , Phase 2
28048,DG0NA1,MEDI1191,Solid tumour/cancer , Phase 1
28049,DG17UJ,AMG 228,Solid tumour/cancer , Phase 1
28050,DG1CX7,ABO-101,Mucopolysaccharidosis , Phase 1/2
28051,DG1ED2,Pepinemab,Squamous head and neck cell carcinom , Phase 1/2
28052,DG38QS,G1T-48,Breast cancer , Phase 1
28053,DG4A0Y,Cefilavancin,Skin and skin-structure infection , Phase 3
28054,DG4YF6,SYN125,Solid tumour/cancer , Phase 1
28055,DG4YF6,SYN125,Uterine serous carcinoma , Phase 1
28056,DG5K6D,APN301,Neuroblastoma , Phase 2
28057,DG5T9Q,RTL1000,Multiple sclerosis , Phase 1
28058,DG61OC,MGCD290,Vulvovaginal Candidiasis , Phase 2
28059,DG68CL,TTP399,Type 2 diabetes , Phase 2
28060,DG68CL,TTP399,Type-1 diabetes , Phase 1/2
28061,DG6V7E,GS-1423,Solid tumour/cancer , Phase 1
28062,DG80IS,MEDI2228,Multiple myeloma , Phase 1
28063,DG90VQ,SHP656,Glioblastoma of brain , Preclinical
28064,DG9LF8,DKY709,Solid tumour/cancer , Phase 1
28065,DG9QY7,Brivoligide,Postoperative pain , Phase 2
28066,DGCQ13,MK-7162,Solid tumour/cancer , Phase 1
28067,DGD72N,BAY 1142524,Myocardial infarction , Phase 2
28068,DGH83L,DNL747,Alzheimer disease , Phase 1
28069,DGH83L,DNL747,Amyotrophic lateral sclerosis , Phase 1
28070,DGJD82,Ravidasvir,Hepatitis C , Phase 2/3
28071,DGN26L,BST-236,Acute myeloid leukaemia , Phase 2
28072,DGO2C1,Leniolisib,Sjogren syndrome , Phase 2
28073,DGP6V3,BAP-15,Solid tumour/cancer , Preclinical
28074,DGQU43,Dostarlimab,Endometrial cancer , Approved
28075,DGQU43,Dostarlimab,Neoplasm , Phase 3
28076,DGQU43,Dostarlimab,Multiple myeloma , Phase 2
28077,DGQU43,Dostarlimab,Breast cancer , Phase 2
28078,DGQW52,177Lu-labelled PSMA-617,Prostate cancer , Phase 3
28079,DGU51Y,Benapenem,Urinary tract infection , Phase 2/3
28080,DGU51Y,Benapenem,Acute pyelonephritis , Phase 2/3
28081,DGV5Z3,MK-1092,Type-1 diabetes , Phase 1
28082,DGV8K5,GSK065,Pancreatitis , Phase 1
28083,DGWE36,90Y-loaded resin microspheres,Liver cancer , Approved
28084,DGZ38L,NK314,T-cell leukaemia , Investigative
28085,DH09QZ,ZW49,Solid tumour/cancer , Phase 1
28086,DH0M2P,131I-labelled CLR 131,Waldenstrom macroglobulinemia , Phase 2
28087,DH17JI,DS-8273,Solid tumour/cancer , Phase 1
28088,DH17JI,DS-8273,Colorectal cancer , Phase 1
28089,DH19QJ,CTX-101,Non-hodgkin lymphoma , Phase 1
28090,DH19QJ,CTX-101,B-cell lymphoma , Phase 1
28091,DH1D5R,Nerofe,Myelodysplastic syndrome , Phase 2
28092,DH1D5R,Nerofe,Acute myelogenous leukaemia , Phase 2
28093,DH1OY4,OMS527,Substance use disorder , Phase 1
28094,DH1W0G,VY-AADC,Parkinson disease , Phase 2
28095,DH2S8X,GT103,Non-small-cell lung cancer , Phase 1
28096,DH3YK4,Zimura,Macular degeneration , Phase 3
28097,DH40QT,SB-FIX,Haemophilia B , Phase 1/2
28098,DH42RF,PD-L1 t-haNK,Solid tumour/cancer , Phase 1
28099,DH4Y3O,LY3484356,Breast cancer , Phase 1
28100,DH5BX2,CC-99712,Multiple myeloma , Phase 1
28101,DH5RN1,HQP1351,Chronic myeloid leukaemia , Phase 2
28102,DH5S6Z,CTT1403,Prostate cancer , Phase 1
28103,DH67XF,LJ001,Coronavirus infection , Preclinical
28104,DH6GK7,ADG116,Solid tumour/cancer , Phase 1
28105,DH7F9S,Fevipiprant,Asthma , Phase 3
28106,DH82BG,ARQ-154,Plaque psoriasis , Phase 2
28107,DH8FY6,ARC1779,Intracranial embolism , Phase 2
28108,DHB2K8,OLX10010,Hypertrophic scars , Phase 2
28109,DHD2S9,DNL104,Alzheimer disease , Phase 1
28110,DHD79B,SMER3,Solid tumour/cancer , Preclinical
28111,DHG2O3,OT551,Age-related macular degeneration , Phase 2
28112,DHG36S,ETP-45658,Breast cancer , Investigative
28113,DHLU46,GSK2904545A,Clostridium infection , Phase 1
28114,DHMO41,KITE-439,Cervical cancer , Phase 1
28115,DHMO41,KITE-439,Solid tumour/cancer , Phase 1
28116,DHQ9S3,AMG 256,Solid tumour/cancer , Phase 1
28117,DHS3X7,GSK3901961,Solid tumour/cancer , Phase 1
28118,DHTN76,ALN-CC5,Haemolytic uraemic syndrome , Phase 2
28119,DHV2L8,Rexlemestrocel-L,Intervertebral disc degeneration , Phase 3
28120,DHY3Q9,ABI-H0731,Hepatitis B , Phase 2
28121,DHY6S0,Arfolitixorin,Colorectal cancer , Phase 3
28122,DHYZ53,GSK3368715,Solid tumour/cancer , Phase 1
28123,DI0ZA3,Enapotamab vedotin,Solid tumour/cancer , Phase 1/2
28124,DI10NU,AMG 650,Solid tumour/cancer , Phase 1
28125,DI17KH,TAS-1440,Acute myeloid leukaemia , Phase 1
28126,DI1L7M,PF-06821497,Small-cell lung cancer , Phase 1
28127,DI1L7M,PF-06821497,Follicular lymphoma , Phase 1
28128,DI1L7M,PF-06821497,Prostate cancer , Phase 1
28129,DI1L7M,PF-06821497,Diffuse large B-cell lymphoma , Phase 1
28130,DI1S4K,GSK3888550A,Respiratory syncytial virus infection , Phase 2
28131,DI1VM3,HM43239,Acute myeloid leukaemia , Phase 1/2
28132,DI29VD,mRNA-1653,Metapneumovirus infection , Phase 1
28133,DI29VD,mRNA-1653,Parainfluenza virus infection , Phase 1
28134,DI2X8V,ATA2321,Acute myeloid leukaemia , Preclinical
28135,DI37UY,Viralym-M,Virus infection , Phase 2
28136,DI4HA7,Mobocertinib,Non-small cell lung cancer , Phase 3
28137,DI4SM3,MT-1621,Thymidine kinase 2 deficiency , Phase 3
28138,DI57MF,Nivatrotamab,Small-cell lung cancer , Phase 2
28139,DI57MF,Nivatrotamab,Solid tumour/cancer , Phase 1
28140,DI6G5U,KB001A,Infectious disease , Phase 2
28141,DI6G5U,KB001A,Cystic fibrosis , Phase 2
28142,DI7SP5,L1-79,Autism spectrum disorder , Phase 2
28143,DI81LW,UNC569,Acute lymphoblastic leukaemia , Investigative
28144,DI8WC4,CC-90002,Acute myeloid leukaemia , Phase 1
28145,DI8WC4,CC-90002,Myelodysplastic syndrome , Phase 1
28146,DI8WC4,CC-90002,Non-hodgkin lymphoma , Phase 1
28147,DI8WC4,CC-90002,Solid tumour/cancer , Phase 1
28148,DI8WC4,CC-90002,leukaemia , Phase 1
28149,DI8ZG7,VIS513,Dengue , Preclinical
28150,DI9ZQ6,212Pb-labelled aCD37,leukaemia , Preclinical
28151,DIA08F,SKI-G-801,Acute myeloid leukaemia , Phase 1
28152,DIAM05,Aerosurf,Respiratory distress syndrome , Phase 2
28153,DIB8G5,KBP-V001,Influenza , Phase 1
28154,DIC20P,HB-AdMSC,Coronavirus Disease 2019 (COVID-19) , Phase 2
28155,DIE75V,AR201,Food allergy , Phase 2
28156,DIK8W5,MGB-BP-3,Clostridium infection , Phase 2
28157,DILV59,HB-101,Cytomegalovirus Disease , Phase 2
28158,DILZ67,HB-202,Squamous cell carcinoma , Phase 1/2
28159,DIPY14,NOV1501,Solid tumour/cancer , Phase 1
28160,DIQ9G6,VBI-2601,Hepatitis B virus infection , Phase 2
28161,DIQE54,XmAB24306,Solid tumour/cancer , Phase 1
28162,DIS4N5,ABM-1310,Solid tumour/cancer , Phase 1
28163,DIW37N,NPT200-11,Multiple system atrophy , Phase 1
28164,DIW37N,NPT200-11,Parkinson disease , Phase 1
28165,DIW58H,UCART-CLL1,Multiple myeloma , Preclinical
28166,DIWL76,PVSRIPO,Glioblastoma of brain , Phase 2
28167,DIWL76,PVSRIPO,Melanoma , Phase 2
28168,DIX61C,CC-90010,Glioblastoma of brain , Phase 1
28169,DIX61C,CC-90010,Astrocytoma , Phase 1
28170,DIY4C2,CCS1477,Solid tumour/cancer , Phase 1/2
28171,DJ0E7P,ALN-TTR01,Amyloidosis , Phase 1
28172,DJ0E7P,ALN-TTR01,Transthyretin familial amyloid cardiomyopathy , Phase 1
28173,DJ0L4K,Sutimlimab,Cold type autoimmune haemolytic anemia , Phase 3
28174,DJ0P6A,PBF-999,Solid tumour/cancer , Phase 1
28175,DJ0P6A,PBF-999,Huntington disease , Phase 1
28176,DJ1Q9B,MS012,Inflammation , Preclinical
28177,DJ1W5R,ZN-c5,Breast cancer , Phase 1/2
28178,DJ25DI,227Th-labelled MSLN-TTC,Epithelioid mesothelioma , Phase 1
28179,DJ29KW,FSI-189,Non-hodgkin lymphoma , Phase 1
28180,DJ2N3L,BMS-986253,Coronavirus Disease 2019 (COVID-19) , Phase 2
28181,DJ2N3L,BMS-986253,Solid tumour/cancer , Phase 2
28182,DJ48HT,LNP023,IgA nephropathy , Phase 3
28183,DJ48HT,LNP023,Paroxysmal nocturnal haemoglobinuria , Phase 3
28184,DJ4GE9,INO-4500,Lassa fever , Phase 1
28185,DJ4X7D,DS-6157,Gastrointestinal stromal tumour , Phase 1
28186,DJ51FH,REGN3048,Coronavirus infection , Phase 1
28187,DJ5D4G,NA-831,Coronavirus Disease 2019 (COVID-19) , Phase 3
28188,DJ5D4G,NA-831,Cognitive impairment , Phase 2
28189,DJ5E7O,SAIT101,Follicular lymphoma , Phase 3
28190,DJ5I6L,SPK-8016,Haemophilia A , Phase 1/2
28191,DJ5XY8,SLN124,Beta thalassemia , Phase 1
28192,DJ6NE2,TRX518,Solid tumour/cancer , Phase 1
28193,DJ7K9G,RBN-2397,Solid tumour/cancer , Phase 1
28194,DJ7Z5W,Ro 61-8048,Neurodegenerative disorder , Preclinical
28195,DJ81QF,VE303,Clostridium infection , Phase 2
28196,DJ8CY4,F901318,Fungal infection , Phase 2
28197,DJ8TN2,HL-085,Melanoma , Phase 1/2
28198,DJ9WC4,SY-5609,Solid tumour/cancer , Phase 1
28199,DJCN38,REGN1193,Type-2 diabetes , Phase 1
28200,DJH9P4,BI 695502,Non-small-cell lung cancer , Phase 3
28201,DJK0W9,NCGC607,Gaucher disease , Preclinical
28202,DJN3E2,mRNA-3704,Methylmalonic acidemia , Phase 1/2
28203,DJNY65,GSK3528869A,Hepatitis B virus infection , Phase 1
28204,DJR94F,PMD-026,Triple negative breast cancer , Phase 1
28205,DJR94F,PMD-026,Metastatic breast cancer , Phase 1
28206,DJVH04,CC-97540,Non-hodgkin lymphoma , Phase 1
28207,DJVR06,KD033,Solid tumour/cancer , Phase 1
28208,DJX7K9,RG6084,Hepatitis B virus infection , Phase 1
28209,DJYD13,SGN-B6A,Solid tumour/cancer , Phase 1
28210,DK1CU4,SGT-94,Solid tumour/cancer , Phase 1
28211,DK1MX0,GMA102,Type-2 diabetes , Phase 3
28212,DK1MX0,GMA102,Obesity , Phase 3
28213,DK1PA2,225Ac-labelled aCD38,Multiple myeloma , Phase 1
28214,DK26FL,CYC140,Acute myeloid leukaemia , Phase 1
28215,DK26FL,CYC140,Myelodysplastic syndrome , Phase 1
28216,DK28GS,NOUS-209,Solid tumour/cancer , Phase 1
28217,DK28NV,ION 224,Non-alcoholic steatohepatitis , Phase 1
28218,DK3QD9,ORIN1001,Metastatic breast cancer , Phase 1/2
28219,DK4I9R,MK-4830,Solid tumour/cancer , Phase 1
28220,DK52QX,RG6292,Solid tumour/cancer , Phase 1
28221,DK5JP3,GZ17-6.02,Lymphoma , Phase 1
28222,DK5JP3,GZ17-6.02,Solid tumour/cancer , Phase 1
28223,DK65RJ,IDCT,Intervertebral disc degeneration , Phase 1/2
28224,DK6J7M,NC410,Solid tumour/cancer , Phase 1/2
28225,DK6P5A,VDA-1102,Actinic keratosis , Phase 2
28226,DK6S3G,CTX-471,Solid tumour/cancer , Phase 1
28227,DK87UQ,PF-07062119,Solid tumour/cancer , Phase 1
28228,DK8QG3,AFM24,Solid tumour/cancer , Phase 1/2
28229,DKB8X2,MDR-103,Kidney transplant rejection , Phase 2
28230,DKCI94,ABBV-151,Solid tumour/cancer , Phase 1
28231,DKCU40,FN-1501,Solid tumour/cancer , Phase 1
28232,DKF7G0,RG6062,Follicular lymphoma , Phase 1
28233,DKF9I3,GRANITE,Gastric adenocarcinoma , Phase 3
28234,DKGB36,TnMUC-1 CAR-T cell therapy,Solid tumour/cancer , Phase 1
28235,DKH94Z,BIIB-088,Retinitis pigmentosa , Phase 2/3
28236,DKJ93L,131 I-omburtamab,Neuroblastoma , Phase 2/3
28237,DKJ93L,131 I-omburtamab,Brain and central nervous system tumour , Phase 2/3
28238,DKL13E,CPI-006,Advanced cancer , Phase 1
28239,DKL13E,CPI-006,Solid tumour/cancer , Phase 1
28240,DKL3Z7,CC-95251,Solid tumour/cancer , Phase 1
28241,DKM79E,INCB86550,Solid tumour/cancer , Phase 2
28242,DKM7S3,CDX-1140,Solid tumour/cancer , Phase 1
28243,DKM7S3,CDX-1140,Melanoma , Phase 1
28244,DKM90C,SP0173,Diphtheria , Phase 1/2
28245,DKM90C,SP0173,Tetanus , Phase 1/2
28246,DKM90C,SP0173,Pertussis , Phase 1/2
28247,DKS3G5,Neuprex,Burn and burn infection , Phase 2
28248,DKUF26,SL-172154,Ovarian cancer , Phase 1
28249,DL07ZP,GSK4074386,Solid tumour/cancer , Phase 1
28250,DL0C5E,VLPM01,Falciparum malaria , Phase 1
28251,DL1E6F,212Pb-labelled PLEa,Solid tumour/cancer , Preclinical
28252,DL1FG3,SAR440234,Acute myeloid leukaemia , Phase 1/2
28253,DL1FG3,SAR440234,leukaemia , Phase 1/2
28254,DL1XC2,609A,Solid tumour/cancer , Phase 1
28255,DL2AD7,ERC1671,Glioblastoma of brain , Phase 2
28256,DL30JC,FF-10502,Solid tumour/cancer , Phase 1/2
28257,DL36FJ,CH-223191,Solid tumour/cancer , Investigative
28258,DL4WG9,ALVAC-HIV,Human immunodeficiency virus infection , Phase 2/3
28259,DL51QK,EA-230,Acute kidney injury , Phase 2
28260,DL5C1W,Lifileucel,Melanoma , Phase 2
28261,DL5UR0,BI 3011441,Solid tumour/cancer , Phase 1
28262,DL6EZ5,AG019,Type-1 diabetes , Phase 1/2
28263,DL74RO,Virstatin,Acinetobacter baumannii infection , Preclinical
28264,DL76CW,EP-100,Ovarian cancer , Phase 2
28265,DL76CW,EP-100,Solid tumour/cancer , Phase 1
28266,DL7HD5,RP-L102,Fanconi's anemia , Phase 2
28267,DL7J8B,RAPA-201,Multiple myeloma , Phase 2
28268,DL8T4I,SCO-088,Chronic myeloid leukaemia , Phase 1
28269,DL9F3C,O-304,Type 2 diabetes , Phase 2
28270,DL9ZT4,Utomilumab,Solid tumour/cancer , Phase 1
28271,DLCB65,IONIS-DNM2-2.5Rx,Centronuclear myopathy , Phase 2
28272,DLG95A,NYX-2925,Diabetic neuropathy , Phase 2
28273,DLG95A,NYX-2925,Fibromyalgia , Phase 2
28274,DLJN17,DSP-0337,Solid tumour/cancer , Phase 1
28275,DLJQ42,MB-107,Severe combined immunodeficiency , Phase 1/2
28276,DLKQ59,LH846,Mood disorder , Preclinical
28277,DLN0P8,TP-1454,Solid tumour/cancer , Phase 1
28278,DLO18H,CB-103,Breast cancer , Phase 2
28279,DLOQ25,KN046,Non-small-cell lung cancer , Phase 3
28280,DLPD74,NT-501 ECT,Glaucoma/ocular hypertension , Phase 2
28281,DLQ4N0,REGN-COV2,Coronavirus Disease 2019 (COVID-19) , Phase 2
28282,DLV0Z8,REMD 477,Type-1 diabetes , Phase 2
28283,DLV0Z8,REMD 477,Type-2 diabetes , Phase 1/2
28284,DLV0Z8,REMD 477,Type 2 diabetes , Phase 1/2
28285,DLW69V,"1,2,3,4,5,6-hexabromocyclohexane",Liver cancer , Investigative
28286,DLXO91,MB-108,Glioblastoma of brain , Phase 1
28287,DLY65X,AMG 424,Multiple myeloma , Phase 1
28288,DLY89F,SRF388,Solid tumour/cancer , Phase 1
28289,DLY89F,SRF388,Liver cancer , Phase 1
28290,DM04QU,AVN-101,Cognitive impairment , Phase 2
28291,DM14CQ,HPN328,Small-cell lung cancer , Phase 1/2
28292,DM16HS,JAB-3068,Solid tumour/cancer , Phase 1
28293,DM16YT,VX-166,Hepatic fibrosis , Preclinical
28294,DM1FD5,ASTX029,Solid tumour/cancer , Phase 1/2
28295,DM1VE5,PF-06939999,Solid tumour/cancer , Phase 1
28296,DM2Y8T,GSK2820151,Solid tumour/cancer , Phase 1
28297,DM3J5I,BI 1467335,Diabetic retinopathy , Discontinued in Phase 2
28298,DM4K9V,EDP-305,Non-alcoholic steatohepatitis , Phase 2
28299,DM4K9V,EDP-305,Primary biliary cholangitis , Phase 2
28300,DM5T2B,Mical,Attention deficit hyperactivity disorder , Phase 2
28301,DM5X0L,SHR2554,Prostate cancer , Phase 1/2
28302,DM5X0L,SHR2554,Haematopoietic/lymphoid cancer , Phase 1
28303,DM69TL,Z-Phe-Ala-diazomethylketone,Alzheimer disease , Preclinical
28304,DM6CE2,177Lu-labelled CTT-1403,Prostate cancer , Phase 1
28305,DM6KV2,TEV-48125,Migraine , Phase 3
28306,DM7WY2,MRG002,Urothelial carcinoma , Phase 2
28307,DM7Z6Y,Lampalizumab,Geographic retinal atrophy , Phase 3
28308,DM8BN1,Otesaconazole,Vulvovaginal Candidiasis , Phase 3
28309,DM8BN1,Otesaconazole,Onychomycosis , Phase 2
28310,DM8Y2N,DZD9008,Non-small cell lung cancer , Phase 1/2
28311,DM90BJ,AAV-CNGA3,Achromatopsia , Phase 1/2
28312,DM9GO4,IO-202,Acute myeloid leukaemia , Phase 1
28313,DM9GO4,IO-202,Chronic myelomonocytic leukaemia , Phase 1
28314,DMAU56,mRNA-5671,Non-small-cell lung cancer , Phase 1
28315,DMBG04,ATP128,Colorectal cancer , Phase 1/2
28316,DMD26W,CRV431,Non-alcoholic steatohepatitis , Phase 2
28317,DMD9W8,AB-2004,Autism spectrum disorder , Phase 1
28318,DMDS20,LY2922470,Type 2 diabetes , Phase 1
28319,DMEQ73,ADPT01,Breast cancer , Phase 1
28320,DMEV15,Dilpacimab,Solid tumour/cancer , Phase 2
28321,DMF73Z,DKN-01,Endometrial cancer , Phase 2
28322,DMF73Z,DKN-01,Ovarian cancer , Phase 2
28323,DMF73Z,DKN-01,Esophageal cancer , Phase 2
28324,DMF73Z,DKN-01,Biliary tract cancer , Phase 2
28325,DMF73Z,DKN-01,Multiple myeloma , Phase 1/2
28326,DMF73Z,DKN-01,Cholangiocarcinoma , Phase 1/2
28327,DMF73Z,DKN-01,Oesophagogastric junction cancer , Phase 1/2
28328,DMF73Z,DKN-01,Prostate cancer , Phase 1/2
28329,DMF82G,Glepaglutide,Short bowel syndrome , Phase 3
28330,DMK65T,Longeveron Mesenchymal Stem Cells,Frailty , Phase 1/2
28331,DMK65T,Longeveron Mesenchymal Stem Cells,Hypoplastic left heart syndrome , Phase 1/2
28332,DMK6W0,Emodepside,Filarial disease , Phase 1
28333,DMN03O,IMM-124E,Non-alcoholic fatty liver disease , Phase 2
28334,DMOF95,Tezepelumab,Severe asthma , Phase 3
28335,DMP6A9,INXN 2001,Melanoma , Phase 1
28336,DMR72A,JNJ-70218902,Solid tumour/cancer , Phase 1
28337,DMS5N4,Adagloxad simolenin,Triple negative breast cancer , Phase 3
28338,DMS5N4,Adagloxad simolenin,Breast cancer , Phase 2/3
28339,DMV0H7,GSK3536819A,Meningococcal infection , Phase 3
28340,DMVR61,BAY 2416964,Solid tumour/cancer , Phase 1
28341,DMXD02,mRNA-1172,Respiratory syncytial virus infection , Phase 1
28342,DMYS25,BGB-3245,Solid tumour/cancer , Phase 2
28343,DN18SP,MB-110,Hepatitis C virus infection , Phase 1
28344,DN28KM,GEN1042,Solid tumour/cancer , Phase 1
28345,DN28SH,Descartes-11,Multiple myeloma , Phase 2
28346,DN2F9A,AMG 506,Solid tumour/cancer , Phase 1
28347,DN2MC5,AUTO1,Acute lymphoblastic leukaemia , Phase 1/2
28348,DN3B5E,KPG-121,Prostate cancer , Phase 1
28349,DN3U0I,Polyvalent pneumococcal conjugate vaccine,Pneumococcal infection , Phase 3
28350,DN3Z5D,L-DOS47,Non-small-cell lung cancer , Phase 2
28351,DN3Z5D,L-DOS47,Lung cancer , Phase 1/2
28352,DN3Z5D,L-DOS47,Non-small cell lung cancer , Phase 1/2
28353,DN46RL,KITE-718,Solid tumour/cancer , Phase 1
28354,DN5CM6,Magrolimab,Acute myeloid leukaemia , Phase 3
28355,DN5CM6,Magrolimab,Myelodysplastic syndrome , Phase 3
28356,DN5F7C,BNT131,Solid tumour/cancer , Phase 1
28357,DN5J9R,SRK-015,Spinal muscular atrophy , Phase 2
28358,DN62DG,I3C,Breast cancer , Phase 3
28359,DN62IU,AG-270,Lymphoma , Phase 1
28360,DN62IU,AG-270,Solid tumour/cancer , Phase 1
28361,DN65GW,LY3475070,Solid tumour/cancer , Phase 1
28362,DN68MW,P-PSMA-101,Prostate cancer , Phase 1
28363,DN6MT7,OT-82,Lymphoma , Phase 1
28364,DN6YE0,PRGN-2009,Solid tumour/cancer , Phase 1/2
28365,DN71VY,TAK-007,Hematologic tumour , Phase 1/2
28366,DN7M4T,BBP-398,Solid tumour/cancer , Phase 1
28367,DN81JB,OPB-111077,Hepatocellular carcinoma , Phase 1
28368,DN81JB,OPB-111077,Haematological malignancy , Phase 1
28369,DN81JB,OPB-111077,Solid tumour/cancer , Phase 1
28370,DN87BL,Fidanacogene elaparvovec,Haemophilia B , Phase 3
28371,DN8F1Z,AR-301,Ventilator-associated pneumonia , Phase 3
28372,DN8F1Z,AR-301,Hospital-acquired pneumonia , Phase 2
28373,DN8F1Z,AR-301,Pneumonia , Phase 1/2
28374,DN8VS3,AEF0117,Marijuana use disorder , Phase 2
28375,DN91RC,IGM-2323,Non-hodgkin lymphoma , Phase 1
28376,DN9IC4,GSK3186899,Leishmaniasis , Phase 1
28377,DNA7I1,OPT-302,Diabetic macular edema , Phase 2
28378,DNC79U,ISB 1302,HER2-positive breast cancer , Phase 1/2
28379,DNC97Y,BI 690517,Diabetic nephropathy , Phase 1
28380,DNCA54,CLR 131,Waldenstrom macroglobulinemia , Phase 2
28381,DNCA54,CLR 131,Multiple myeloma , Phase 1
28382,DNCA54,CLR 131,Head and neck cancer , Phase 1
28383,DNE4B9,ZBzl-YAA5911,Enterococcus faecium infection , Preclinical
28384,DNE73Q,F26G4,Anthrax , Preclinical
28385,DNET17,GSK3810109,Human immunodeficiency virus-1 infection , Phase 2
28386,DNF95E,Nirsevimab,Respiratory syncytial virus infection , Phase 2
28387,DNF9L1,Fluorodopa F 18,Diagnostic imaging , Approved
28388,DNH67V,SiG12D-LODER,Pancreatic cancer , Phase 2
28389,DNI28K,TP-0184,Solid tumour/cancer , Phase 1
28390,DNI61P,CP101,Autism spectrum disorder , Phase 2
28391,DNI61P,CP101,Clostridium infection , Phase 2
28392,DNL2F1,MK6-83,Discovery agent , Preclinical
28393,DNM79H,DS-3201b,T-cell leukaemia , Phase 2
28394,DNM79H,DS-3201b,Small-cell lung cancer , Phase 1/2
28395,DNM79H,DS-3201b,Acute myeloid leukaemia , Phase 1
28396,DNM79H,DS-3201b,Acute lymphoblastic leukaemia , Phase 1
28397,DNM79H,DS-3201b,Urothelial carcinoma , Phase 1
28398,DNM79H,DS-3201b,Renal cell carcinoma , Phase 1
28399,DNM9C4,ALN-RSV01,Respiratory infection , Phase 2
28400,DNM9C4,ALN-RSV01,Respiratory syncytial virus infection , Phase 2
28401,DNML54,Lumoxiti,Hairy cell leukaemia , Phase 1
28402,DNS2P1,AMG 673,Acute myeloid leukaemia , Phase 1
28403,DNS4D6,KB195,Urea cycle disorder , Phase 2
28404,DNS58L,SRX246,Huntington disease , Phase 2
28405,DNS58L,SRX246,Post-traumatic stress disorder , Phase 2
28406,DNS58L,SRX246,Intermittent explosive disorder , Phase 1/2
28407,DNS58L,SRX246,Fear-related disorder , Phase 1
28408,DNS58L,SRX246,Anxiety disorder , Phase 1
28409,DNTW18,SCO-120,Breast cancer , Phase 1
28410,DNV17I,LY3113593,Anaemia , Phase 2
28411,DNXH76,Eptacog beta,Non-hodgkin lymphoma , Phase 1/2
28412,DNXH76,Eptacog beta,Chronic lymphocytic leukaemia , Phase 1/2
28413,DNXH76,Eptacog beta,Mantle cell lymphoma , Phase 1/2
28414,DNY16U,MI-219,Triple negative breast cancer , Investigative
28415,DNY63Z,CC-94676,Prostate cancer , Phase 1
28416,DNY63Z,CC-94676,Invasive prostate cancer , Phase 1
28417,DNYC95,LBP-EC01,Urinary tract infection , Phase 1
28418,DNZ96J,INT-767,Hepatic fibrosis , Preclinical
28419,DO0GJ1,LKA651,Diabetic macular edema , Phase 2
28420,DO0LP3,NMS-03305293,Solid tumour/cancer , Phase 1
28421,DO20LT,ATRC-101,Solid tumour/cancer , Phase 1
28422,DO2LE6,CC-31244,Hepatitis C virus infection , Phase 1
28423,DO2P5G,CVN058,Schizophrenia , Phase 1
28424,DO3E7R,PF-06940434,Solid tumour/cancer , Phase 1
28425,DO3XB8,KAZ954,Solid tumour/cancer , Phase 1
28426,DO5H6K,OT-101,Melanoma , Phase 2/3
28427,DO5H6K,OT-101,Merkel cell carcinoma , Phase 2/3
28428,DO5H6K,OT-101,Pancreatic cancer , Phase 2/3
28429,DO5H6K,OT-101,Recurrent glioblastoma , Phase 2/3
28430,DO5H6K,OT-101,Coronavirus Disease 2019 (COVID-19) , Phase 2
28431,DO61WZ,Combinectin,Human immunodeficiency virus infection , Phase 1
28432,DO6UE8,227Th-labelled HER2-TTC,Solid tumour/cancer , Preclinical
28433,DO75VX,LYS228,Urinary tract infection , Phase 2
28434,DO76YM,AGTC-501,Retinitis pigmentosa , Phase 1/2
28435,DO78YZ,GMA105,Type-2 diabetes , Phase 3
28436,DO78YZ,GMA105,Obesity , Phase 3
28437,DO7D1L,E7766,Solid tumour/cancer , Phase 1
28438,DO7HS1,FAP5-DM1,Solid tumour/cancer , Preclinical
28439,DO7MC9,CD4CAR,T-cell leukaemia , Phase 1
28440,DO7PX4,VerorabVax,Rabies , Phase 3
28441,DO7QK1,KSI-301,Diabetic macular edema , Phase 3
28442,DO8W9E,M9241,Pancreatic cancer , Phase 1
28443,DO9B3Y,AB-729,Hepatitis B virus infection , Phase 2
28444,DOA3J0,AGEN2373,Solid tumour/cancer , Phase 1
28445,DOBZ63,NKX101,Acute myeloid leukaemia , Phase 1
28446,DOBZ63,NKX101,Myelodysplastic syndrome , Phase 1
28447,DOD24G,Isunakinra,Solid tumour/cancer , Phase 1/2
28448,DODG42,HMPL-523,Non-hodgkin lymphoma , Phase 1
28449,DOE7C4,GSK3389404,Hepatitis B , Phase 2
28450,DOHM41,7HP349,Solid tumour/cancer , Phase 1
28451,DOI7H2,INCAGN01876,Solid tumour/cancer , Phase 2
28452,DOJ6D9,COR-D,T-cell leukaemia , Preclinical
28453,DOJ6E8,AMG 596,Recurrent glioblastoma , Phase 1
28454,DOJ6E8,AMG 596,Glioblastoma multiforme , Phase 1
28455,DOJG79,SEL120,Acute myeloid leukaemia , Phase 1
28456,DOJG79,SEL120,Myelodysplastic syndrome , Phase 1
28457,DOL04T,CPCB-RPE1,Dry age-related macular degeneration , Phase 1/2
28458,DOMC56,SYMB-104,Inflammatory bowel disease , Preclinical
28459,DONA19,CKI-7,Mood disorder , Preclinical
28460,DOQ13X,CC-93269,Multiple myeloma , Phase 1
28461,DOR1I0,ETP-46321,Rheumatoid arthritis , Investigative
28462,DORB45,Enfortumab,Urothelial carcinoma , Approved
28463,DOS62C,SKB264,Solid tumour/cancer , Phase 1/2
28464,DOST52,MK-1654,Respiratory syncytial virus infection , Phase 2/3
28465,DOV7J4,Selgantolimod,Hepatitis B , Phase 2
28466,DOY1D6,HTI-2088,Type 2 diabetes , Phase 1
28467,DOY4E6,AMG 160,Non-small cell lung cancer , Phase 1
28468,DOYP92,V937,Melanoma , Phase 2
28469,DOZQ70,TH301,Glioblastoma of brain , Preclinical
28470,DP07NC,Zolgensma,Spinal muscular atrophy , Approved
28471,DP0G9N,Anti-CD19 EBV CTL therapy,Acute lymphoblastic leukaemia , Phase 1
28472,DP0NU9,AIC100,Thyroid cancer , Phase 1
28473,DP17AI,Palomid-529,Macular degeneration , Phase 1
28474,DP1SE6,Parsaclisib,Follicular lymphoma , Phase 2
28475,DP2F6W,C-176,Aicardi-Goutieres syndrome , Investigative
28476,DP2Z0X,Sasanlimab,Non-muscle invasive bladder cancer , Phase 3
28477,DP3J2W,UPF-648,Neurodegenerative disorder , Preclinical
28478,DP3Q0C,Flucelvax Quadrivalent,Hepatitis B virus infection , Approved
28479,DP3Q0C,Flucelvax Quadrivalent,Influenza virus infection , Approved
28480,DP3S1J,IMU-201,Non-small-cell lung cancer , Phase 1
28481,DP48WE,Stenoparib,Ovarian cancer , Phase 2
28482,DP4J2K,MRx0518,Non-small cell lung cancer , Phase 1/2
28483,DP4KH3,PF-07265807,Solid tumour/cancer , Phase 1
28484,DP63FS,VOB560,Multiple myeloma , Phase 1
28485,DP63FS,VOB560,Acute myeloid leukaemia , Phase 1
28486,DP63FS,VOB560,Non-hodgkin lymphoma , Phase 1
28487,DP6GC3,NZV930,Solid tumour/cancer , Phase 1
28488,DP6J5K,177Lu-labelled PSMA-R2,Prostate cancer , Phase 1/2
28489,DP6Y5N,MK-8719,Progressive supranuclear palsy , Phase 1
28490,DP7GK8,ABBV-951,Parkinson disease , Phase 3
28491,DP7J0Z,MEDI3617,Solid tumour/cancer , Phase 1
28492,DP7J0Z,MEDI3617,Ovarian cancer , Phase 1
28493,DP7Z9Q,Nesvacumab,Solid tumour/cancer , Phase 1
28494,DP85ES,177Lu-labelled DOTA-JR11,Neuroendocrine cancer , Phase 1/2
28495,DP8T7K,KP3,Pneumonia due to Klebsiella pneumoniae , Preclinical
28496,DP9SF6,THR-184,Renal fibrosis , Phase 2
28497,DPAS02,AGEN1223,Solid tumour/cancer , Phase 1
28498,DPB04G,GLS-1200,Coronavirus Disease 2019 (COVID-19) , Phase 2
28499,DPBE75,NSC-207895,Solid tumour/cancer , Preclinical
28500,DPG5T9,ACT017,Cerebral ischemia , Phase 1/2
28501,DPIR35,OMP-131R10,Solid tumour/cancer , Phase 1
28502,DPJ01T,ABV3,Bacterial vaginosis , Phase 2
28503,DPJ05C,TFM735,Multiple sclerosis , Preclinical
28504,DPJ70I,SAR444245,Solid tumour/cancer , Phase 1
28505,DPJM92,225Ac-labelled FPX-01,Solid tumour/cancer , Phase 1
28506,DPN1F0,ADXS-503,Non-small-cell lung cancer , Phase 1/2
28507,DPN2R7,YM-201636,Discovery agent , Preclinical
28508,DPNT63,AZD7648,Solid tumour/cancer , Phase 1/2
28509,DPQ4U3,BFF-122,Cognitive impairment , Preclinical
28510,DPQ4U3,BFF-122,Schizophrenia , Preclinical
28511,DPQ6Y9,PF-06928316,Respiratory syncytial virus infection , Phase 1
28512,DPS6V0,SPK-7001,Choroidal dystrophy , Phase 1/2
28513,DPTM94,MAU868,Epstein barr virus infection , Phase 1
28514,DPUF69,N-Octyl-beta-valienamine,Gaucher disease , Preclinical
28515,DQ04FJ,MBS301,Solid tumour/cancer , Phase 1
28516,DQ0I4N,RP-L201,Leukocyte adhesion deficiency type 1 , Phase 1/2
28517,DQ12XP,BXQ-350,Recurrent glioblastoma , Phase 1
28518,DQ12XP,BXQ-350,Solid tumour/cancer , Phase 1
28519,DQ15HJ,GEN1044,Solid tumour/cancer , Phase 1
28520,DQ18VG,BOS-228,Bacterial infection , Phase 2
28521,DQ1OJ4,VIR-2218,Hepatitis B virus infection , Phase 2
28522,DQ1P6X,AZD0466,Hematologic tumour , Phase 1/2
28523,DQ1S0B,Berotralstat,Hereditary angioedema , Approved
28524,DQ21NM,TG-1701,Non-hodgkin lymphoma , Phase 1
28525,DQ21NM,TG-1701,Chronic lymphocytic leukaemia , Phase 1
28526,DQ2T3S,HB-201,Squamous cell carcinoma , Phase 1/2
28527,DQ2XP5,Viralym-C,Cytomegalovirus Disease , Phase 1
28528,DQ2Y7L,IONIS-FB-LRx,IgA nephropathy , Phase 2
28529,DQ3AM0,PTG-300,Hemochromatosis , Phase 2
28530,DQ3AM0,PTG-300,Polycythemia vera , Phase 2
28531,DQ3NC4,"2-(1H-indole-3,-carbonyl)-thiazole-4-carboxylic acid methyl ester",Glioma , Preclinical
28532,DQ43PA,Cetrelimab,Solid tumour/cancer , Phase 1/2
28533,DQ45GY,VIS410,Influenza A virus infection , Phase 2
28534,DQ4OU8,MK-1454,Squamous head and neck cell carcinom , Phase 2
28535,DQ4OU8,MK-1454,Lymphoma , Phase 1
28536,DQ4OU8,MK-1454,Solid tumour/cancer , Phase 1
28537,DQ4TO3,OTL-200,Metachromatic leukodystrophy , Approved
28538,DQ5V7F,MEDI0457,Oropharyngeal squamous cell carcinoma , Phase 1/2
28539,DQ5X1Z,Amivantamab,Non-small-cell lung cancer , Phase 3
28540,DQ5Y6Z,PF-06952229,Solid tumour/cancer , Phase 1
28541,DQ62VF,SOBI003,Sanfilippo syndrome , Phase 1/2
28542,DQ6J0W,GSK3745417,Solid tumour/cancer , Phase 1
28543,DQ7PB1,IONIS-C9Rx,Amyotrophic lateral sclerosis , Phase 2
28544,DQ83JW,INVAC-1,Chronic lymphocytic leukaemia , Phase 2
28545,DQ9B8C,NUC-3373,Solid tumour/cancer , Phase 1
28546,DQ9OL5,OBI-3424,Acute lymphoblastic leukaemia , Phase 2
28547,DQ9OL5,OBI-3424,Hepatocellular carcinoma , Phase 1/2
28548,DQ9OL5,OBI-3424,Prostate cancer , Phase 1/2
28549,DQ9OL5,OBI-3424,Solid tumour/cancer , Phase 1/2
28550,DQ9T7I,Viralym-A,Adenovirus infection , Phase 1
28551,DQC80I,TRPH-222,Non-hodgkin lymphoma , Phase 1
28552,DQC80I,TRPH-222,B-cell lymphoma , Phase 1
28553,DQD1T2,GEM333,Acute myeloid leukaemia , Phase 1
28554,DQGF20,ALKS 4230,Solid tumour/cancer , Phase 2
28555,DQJX34,JS016,Coronavirus Disease 2019 (COVID-19) , Phase 1/2
28556,DQM0X1,BIO-11006,Non-small-cell lung cancer , Phase 2
28557,DQM48O,RO7121661,Esophageal squamous cell carcinoma , Phase 2
28558,DQN76R,CardiAMP,Heart failure , Phase 3
28559,DQP87H,177-Lu-oxodotreotide,Neuroendocrine cancer , Phase 3
28560,DQVR30,JBH492,Chronic lymphocytic leukaemia , Phase 1
28561,DQVR30,JBH492,Non-hodgkin lymphoma , Phase 1
28562,DQX83Z,INCB81776,Solid tumour/cancer , Phase 1
28563,DQY14Z,CSL 112,Acute myocardial infarction , Phase 2
28564,DR03FL,INO-4600,Zika virus infection , Phase 1
28565,DR0M3F,CEA CAR-T,Ascites , Phase 1
28566,DR0M3F,CEA CAR-T,Peritoneal metastasis , Phase 1
28567,DR15DO,FT-819,Chronic lymphocytic leukaemia , Phase 1
28568,DR1YQ7,GEN-011,Melanoma , Phase 1
28569,DR1YQ7,GEN-011,Non-small cell lung cancer , Phase 1
28570,DR1YQ7,GEN-011,Squamous head and neck cell carcinom , Phase 1
28571,DR36YB,Prulifloxacin,Urinary tract infection , Approved
28572,DR3FA8,JNJ-73841937,Non-small-cell lung cancer , Phase 1
28573,DR49KB,CSL312,Hereditary angioedema , Phase 3
28574,DR4K0V,BI 1701963,Solid tumour/cancer , Phase 1
28575,DR4ND6,D2C7,Glioblastoma of brain , Phase 1
28576,DR5LW8,INB03,Solid tumour/cancer , Phase 1
28577,DR5VQ1,CYT-0851,Solid tumour/cancer , Phase 1/2
28578,DR5VQ1,CYT-0851,B-cell lymphoma , Phase 1/2
28579,DR6BU1,Vaborbactam,Urinary tract infection , Phase 3
28580,DR7EV6,ARO-AAT,Alopecia , Phase 2
28581,DR7EV6,ARO-AAT,Alpha-1 antitrypsin deficiency , Phase 1
28582,DR7Q5N,REGN5458,Multiple myeloma , Phase 1/2
28583,DR7ZU0,GBT-101,Epidermolysis bullosa , Phase 2
28584,DR7ZU0,GBT-101,Pressure ulcers , Phase 2
28585,DRA84P,Tivanisiran,Dry eye disease , Phase 3
28586,DRD0M5,SYMB-202,Inflammatory bowel disease , Preclinical
28587,DRF94Z,AIV001,Basal cell carcinoma , Phase 1/2
28588,DRFT15,CLBS12,Critical limb ischemia , Phase 2
28589,DRG3B4,TAK-648,Type 2 diabetes , Phase 1
28590,DRGC82,VRC07-523LS,Human immunodeficiency virus-1 infection , Phase 1
28591,DRGZ61,S-648414,Human immunodeficiency virus infection , Phase 1
28592,DRH80V,JNJ-53718678,Respiratory syncytial virus infection , Phase 2
28593,DRI23U,ARQ-751,Solid tumour/cancer , Phase 1
28594,DRI97M,MGD014,Human immunodeficiency virus-1 infection , Phase 1
28595,DRJU35,ADC-01,Solid tumour/cancer , Preclinical
28596,DRK7Q1,BAY 1238097,Neoplasm , Phase 1
28597,DRL5Y7,SPN-812,Attention deficit hyperactivity disorder , Phase 4
28598,DRL76S,AMXT1501,Solid tumour/cancer , Phase 1
28599,DRM1X5,Ansuvimab,Ebola virus infection , Approved
28600,DRN30U,BMS-986118,Type 2 diabetes , Preclinical
28601,DRO7H6,FOXO4-DRI,Hypogonadism , Preclinical
28602,DRP4Q9,Vicineum,Bladder cancer , Phase 3
28603,DRQ18X,ABP959,Paroxysmal nocturnal haemoglobinuria , Phase 3
28604,DRQN21,ZN-c3,Uterine serous carcinoma , Phase 2
28605,DRT2P7,GEN-1,Ovarian cancer , Phase 2
28606,DRT90B,NSC632839,Solid tumour/cancer , Preclinical
28607,DRU0M6,MB-104,Multiple myeloma , Phase 1
28608,DRV14M,GSK3902986A,Bacillary dysentery , Phase 2
28609,DRZ1J4,HuMNC2-CAR44 T cells,Breast cancer , Phase 1
28610,DS01GZ,Dilanubicel,Acute myeloid leukaemia , Phase 2
28611,DS14FO,Sepofarsen,Leber congenital amaurosis , Phase 2/3
28612,DS15QG,Romyelocel-L,Neutropenia , Phase 2
28613,DS19UZ,Savirin,Staphylococcus infection , Preclinical
28614,DS1BJ7,RPTR-147,Lymphoma , Phase 1
28615,DS1BJ7,RPTR-147,Solid tumour/cancer , Phase 1
28616,DS2J7Q,EOS100850,Solid tumour/cancer , Phase 1
28617,DS31JZ,SEP--4199,Bipolar disorder , Phase 2
28618,DS39MT,GSK3845097,Solid tumour/cancer , Phase 1
28619,DS40LF,GD2-GD3 vaccine,Neuroblastoma , Phase 2
28620,DS41PJ,ARV-471,Breast cancer , Phase 1/2
28621,DS4JE8,KO-539,Acute myeloid leukaemia , Phase 1/2
28622,DS4M1A,SM09419,Hematologic tumour , Phase 1
28623,DS4U1W,Ligelizumab,Chronic idiopathic urticaria , Phase 3
28624,DS53MJ,TC-110,Non-hodgkin lymphoma , Phase 1/2
28625,DS53MJ,TC-110,Acute lymphoblastic leukaemia , Phase 1/2
28626,DS58AE,M64,Pseudomonas infection , Preclinical
28627,DS5C0K,BT5528,Solid tumour/cancer , Phase 1/2
28628,DS5LI8,LL-37,Venous leg ulcer , Phase 2
28629,DS5UH0,VBI-1501,Cytomegalovirus Disease , Phase 1
28630,DS60CK,MT-5111,Solid tumour/cancer , Phase 1
28631,DS68GD,REGN910-3,Neovascular age-related macular degeneration , Phase 2
28632,DS6B1L,SGN-LIV1A,Small-cell lung cancer , Phase 2
28633,DS6B1L,SGN-LIV1A,Non-small cell lung cancer , Phase 2
28634,DS6BE2,SGN-CD228A,Solid tumour/cancer , Phase 1
28635,DS6C1Y,CybroCell,Intervertebral disc degeneration , Phase 1/2
28636,DS6OV9,THR-687,Diabetic macular edema , Phase 1
28637,DS6OV9,THR-687,Diabetic retinopathy , Phase 1
28638,DS6VD0,GS-4224,Solid tumour/cancer , Phase 1/2
28639,DS6W8Z,UCARTCS1,Multiple myeloma , Phase 1
28640,DS70MP,DM199,Ischemic stroke , Phase 2
28641,DS70MP,DM199,Cerebral ischemia , Phase 2
28642,DS70MP,DM199,Autoimmune diabetes , Phase 1/2
28643,DS70MP,DM199,Diabetic nephropathy , Phase 1/2
28644,DS79KP,TNX-1300,Cocaine addiction , Phase 2
28645,DS7CY4,TPX-0046,Solid tumour/cancer , Phase 1/2
28646,DS9R3G,SAR442720,Solid tumour/cancer , Phase 1
28647,DSC90Z,AZD-1222,Coronavirus Disease 2019 (COVID-19) , Phase 3
28648,DSE59Z,pbi-shRNA STMN1,Solid tumour/cancer , Phase 1
28649,DSE59Z,pbi-shRNA STMN1,Breast cancer , Investigative
28650,DSEF47,KBP-7072,Community-acquired pneumonia , Phase 1
28651,DSEF47,KBP-7072,Ventilator-associated pneumonia , Phase 1
28652,DSEF47,KBP-7072,Hospital-acquired pneumonia , Phase 1
28653,DSHE52,EPZ031686,Solid tumour/cancer , Preclinical
28654,DSHT18,ABL001,Chronic myeloid leukaemia , Phase 3
28655,DSI31T,AMY-101,Gingivitis , Phase 2
28656,DSI4G9,225Ac-labelled aCD33,Acute myeloid leukaemia , Phase 1
28657,DSIW85,OPC-64005,Attention deficit hyperactivity disorder , Phase 2
28658,DSK7I5,MP-101,Alzheimer disease , Phase 2
28659,DSK96I,IBP-9414,Necrotizing enterocolitis of newborn , Phase 3
28660,DSM03D,SD1003,Alzheimer disease , Preclinical
28661,DSM5X9,177-Lu-PSMA-617,Prostate cancer , Phase 3
28662,DSOE74,GQ1001,Solid tumour/cancer , Phase 1
28663,DST04F,ARQ-151,Atopic dermatitis , Phase 3
28664,DST04F,ARQ-151,Psoriasis vulgaris , Phase 2
28665,DST04F,ARQ-151,Plaque psoriasis , Phase 1/2
28666,DSU7K2,Tosyl-l-arginine methyl ester,Solid tumour/cancer , Preclinical
28667,DSWZ60,CD38 CAR-T,Multiple myeloma , Phase 1
28668,DSYM73,FT500,Acute myeloid leukaemia , Phase 1
28669,DSYM73,FT500,B-cell lymphoma , Phase 1
28670,DT1FS0,AB154,Non-small cell lung cancer , Phase 3
28671,DT1FS0,AB154,Solid tumour/cancer , Phase 1
28672,DT1Z9I,HS-130,Solid tumour/cancer , Phase 1
28673,DT28NV,AVR-RD-01,Fabry disease , Phase 1/2
28674,DT29OQ,SMITB14,Mycobacterium infection , Preclinical
28675,DT2B6G,SER-401,Metastatic melanoma , Phase 1
28676,DT30FV,VNRX-5133,Bacterial infection , Phase 1
28677,DT3BA1,CG-806,Acute myeloid leukaemia , Phase 1/2
28678,DT3OE6,AL102,Desmoid tumour , Phase 2
28679,DT41EO,CB-06-01,Acne vulgaris , Phase 2
28680,DT45OV,TAK-831,Friedreich's ataxia , Phase 2
28681,DT4WU3,TTC-352,Metastatic melanoma , Phase 1
28682,DT52FI,MYK-491,Dilated cardiomyopathy , Phase 2
28683,DT56YX,PBI-4050,Idiopathic pulmonary fibrosis , Phase 2
28684,DT6EN8,PBCAR20A,Non-hodgkin lymphoma , Phase 1/2
28685,DT6EN8,PBCAR20A,Chronic lymphocytic leukaemia , Phase 1/2
28686,DT6EN8,PBCAR20A,Small lymphocytic lymphoma , Phase 1/2
28687,DT6N0O,ODN-2088,Spinal cord injury , Investigative
28688,DT6P8M,BAY 598,Discovery agent , Preclinical
28689,DT6ZE3,ASP0892,Allergy , Phase 1
28690,DT6ZE3,ASP0892,Food allergy , Phase 1
28691,DT7I5A,N-803,Human immunodeficiency virus infection , Phase 1
28692,DT7O8R,Tavokinogene telseplasmid,Melanoma , Phase 2
28693,DT7O8R,Tavokinogene telseplasmid,Triple negative breast cancer , Phase 2
28694,DT7SN5,Air polymer-type A,Diagnostic imaging , Approved
28695,DT8IL6,FT-7051,Prostate cancer , Phase 1
28696,DT8R1L,DS-7300,Solid tumour/cancer , Phase 1/2
28697,DTB43H,BI 905677,Solid tumour/cancer , Phase 1
28698,DTF20P,HM71224,Rheumatoid arthritis , Phase 1
28699,DTHR46,IMC-002,Lymphoma , Phase 1
28700,DTHR46,IMC-002,Solid tumour/cancer , Phase 1
28701,DTJ5W8,HeV-sG-V,Henipavirus Encephalitis , Phase 1
28702,DTM8B0,NG-350A,Solid tumour/cancer , Phase 1
28703,DTO06Y,Macozinone,Mycobacterium infection , Phase 1
28704,DTP85B,Hippuristanol,T-cell leukaemia , Investigative
28705,DTQ3Z8,Dectrekumab,Idiopathic pulmonary fibrosis , Phase 2
28706,DTR05Z,BCMA-CD19 cCAR,Multiple myeloma , Phase 1
28707,DTU7W2,K-NK002,Acute myeloid leukaemia , Phase 2
28708,DTU7W2,K-NK002,Myelodysplastic syndrome , Phase 2
28709,DTV6Q7,Tonogenchoncel-L,Knee osteoarthritis , Phase 3
28710,DTY5W0,mRNA-4157,Melanoma , Phase 2
28711,DTY5W0,mRNA-4157,Solid tumour/cancer , Phase 1
28712,DTYP21,CA102N,Solid tumour/cancer , Phase 1
28713,DTYQ45,TAK-676,Solid tumour/cancer , Phase 1
28714,DU04SO,RGN-352,Acute myocardial infarction , Phase 2
28715,DU04SO,RGN-352,Myocardial infarction , Phase 2
28716,DU04SO,RGN-352,Peripheral neuropathy , Phase 1
28717,DU04SO,RGN-352,Stroke , Phase 1
28718,DU0K2R,Livoletide,Prader-Willi syndrome , Phase 2/3
28719,DU0K2R,Livoletide,Hyperphagia , Phase 2/3
28720,DU10JI,CTP-543,Alopecia , Phase 2
28721,DU1DL0,RLY-4008,Solid tumour/cancer , Phase 1
28722,DU2G0C,LHC165,Solid tumour/cancer , Phase 1
28723,DU3GQ9,TP-271,Respiratory tract infection , Phase 1
28724,DU3GQ9,TP-271,Pneumonia , Phase 1
28725,DU47SF,Crizanlizumab,Vaso-occlusive crisis , Approved
28726,DU47SF,Crizanlizumab,Sickle-cell disorder , Phase 4
28727,DU54BA,MB-103,Glioblastoma multiforme , Phase 1
28728,DU60ND,Ofranergene obadenovec,Ovarian cancer , Phase 3
28729,DU60ND,Ofranergene obadenovec,Glioblastoma of brain , Phase 2
28730,DU6H8Z,TR1801-ADC,Solid tumour/cancer , Phase 1
28731,DU8CF6,Cenobamate,Complex partial seizure , Approved
28732,DU98JH,Belvarafenib,Solid tumour/cancer , Phase 1
28733,DU9RB1,GL21.T,Non-small-cell lung cancer , Preclinical
28734,DUA7N4,SNX281,Lymphoma , Phase 1
28735,DUA7N4,SNX281,Solid tumour/cancer , Phase 1
28736,DUA7P2,SBT6050,Solid tumour/cancer , Phase 1
28737,DUAO82,Evt201,Sleep-wake disorder , Phase 2
28738,DUBW95,Omburtamab,Neuroblastoma , Phase 2/3
28739,DUCA08,Caplacizumab,Thrombotic thrombocytopenic purpura , Approved
28740,DUDT78,RVT-1801,Sickle-cell disorder , Phase 1/2
28741,DUF26L,SEP-378608,Bipolar disorder , Phase 1
28742,DUI1N7,TP 6076,Multidrug resistant infection , Phase 1
28743,DUI59O,NT219,Solid tumour/cancer , Phase 1/2
28744,DUIA46,SRP-9004,Limb girdle muscular dystrophy , Phase 1/2
28745,DUK2V4,LP-300,Non-small-cell lung cancer , Phase 1
28746,DUM25X,BMS-986120,Thrombosis , Phase 1
28747,DUO7Y0,V938,Solid tumour/cancer , Phase 1
28748,DUP48T,SPR741,Acinetobacter baumannii infection , Phase 1
28749,DUQV41,MRTX849,Non-small-cell lung cancer , Phase 3
28750,DUR0F6,SYNB1891,Lymphoma , Phase 1
28751,DUR0F6,SYNB1891,Neoplasm , Phase 1
28752,DURD59,SPR720,Mycobacterium infection , Phase 1/2
28753,DUSB35,GSK3036656,Tuberculosis , Phase 2
28754,DUTJ12,ICP-022,Chronic lymphocytic leukaemia , Phase 3
28755,DUTJ12,ICP-022,Small lymphocytic lymphoma , Phase 3
28756,DUTJ12,ICP-022,Diffuse large B-cell lymphoma , Phase 2
28757,DUVH60,NM21-1480,Advanced solid tumour , Phase 1/2
28758,DUVH60,NM21-1480,Non-small cell lung cancer , Phase 1/2
28759,DUW81M,Tarloxotinib,Non-small-cell lung cancer , Phase 2
28760,DUZ0F7,AMG 420,Multiple myeloma , Phase 1
28761,DUZ35W,PF-06842433,Pneumococcal infection , Phase 2
28762,DV19IS,mAb926,Urinary tract infection , Preclinical
28763,DV1R0X,CC-95775,Non-hodgkin lymphoma , Phase 1
28764,DV25QN,Cadazolid,Clostridium difficile associated diarrhea , Phase 3
28765,DV2CR7,AMG 570,Systemic lupus erythematosus , Phase 2
28766,DV2N5P,KN026,Breast cancer , Phase 2
28767,DV3H6T,Arabaclofen,Fragile X syndrome , Phase 3
28768,DV3KC5,P5091,Solid tumour/cancer , Preclinical
28769,DV3WF1,LMP400,Lymphoma , Phase 1
28770,DV3WF1,LMP400,Neoplasm , Phase 1
28771,DV3Y7F,APL-101,Non-small cell lung cancer , Phase 2
28772,DV3ZI0,CD19t-haNK,Diffuse large B-cell lymphoma , Phase 1
28773,DV59ZT,PR-619,Esophageal squamous cell carcinoma , Preclinical
28774,DV74TF,EPZ0330456,Colon cancer , Preclinical
28775,DV7O1M,ProTmune,Refractory hematologic malignancy , Phase 1/2
28776,DV8A1L,CHDI-340246,Huntington disease , Preclinical
28777,DV8I4Q,MCLA-158,Solid tumour/cancer , Phase 1
28778,DV9M0Y,GPRC5D CAR-T cell therapy,Multiple myeloma , Phase 1
28779,DVA36E,INCAGN2390,Solid tumour/cancer , Phase 1
28780,DVA7X9,DARE-BV1,Bacterial vaginosis , Phase 3
28781,DVCN93,INCAGN01949,Advanced malignancy , Phase 2
28782,DVCN93,INCAGN01949,Metastatic malignant neoplasm , Phase 2
28783,DVD0E9,Quaratusugene ozeplasmid,Non-small-cell lung cancer , Phase 1/2
28784,DVI8T3,SEP-380135,Agitation , Phase 1
28785,DVIY25,CTX130,T-cell lymphoma , Phase 1
28786,DVO4H2,APL-501,Solid tumour/cancer , Phase 1
28787,DVOB28,AFM11,Non-hodgkin lymphoma , Phase 1
28788,DVOB28,AFM11,B-cell non-hodgkin lymphoma , Phase 1
28789,DVOB28,AFM11,leukaemia , Phase 1
28790,DVQ37G,(S)-4-(Ethylsulfonyl)benzoylalanine,Cognitive impairment , Preclinical
28791,DVQ37G,(S)-4-(Ethylsulfonyl)benzoylalanine,Schizophrenia , Preclinical
28792,DVR84A,131I-labelled CLR1404,Multiple myeloma , Phase 1
28793,DVS81T,DTRM-555,Chronic lymphocytic leukaemia , Phase 2
28794,DVS91L,MCC1 TCR,Merkel cell carcinoma , Phase 1
28795,DVT3F8,BBI-5000,Alopecia , Phase 2
28796,DVU2H8,CV8102,Melanoma , Phase 1
28797,DVU2H8,CV8102,Squamous cell carcinoma , Phase 1
28798,DVU2Y5,CTX001,Sickle-cell disorder , Phase 1/2
28799,DVU2Y5,CTX001,Beta thalassemia , Phase 1/2
28800,DVX3H0,Sibrotuzumab,Metastatic colorectal cancer , Phase 2
28801,DVX4P3,GEN1029,Solid tumour/cancer , Phase 1
28802,DVY5D9,TXA709,MRSA infection , Phase 1
28803,DVZ6M1,BI 7273,Acute myeloid leukaemia , Investigative
28804,DVZN13,INB-200,Glioblastoma of brain , Phase 1
28805,DW01LJ,CLT030,Acute myeloid leukaemia , Phase 1
28806,DW08BG,mRNA-1647,Cytomegalovirus Disease , Phase 2
28807,DW0D7G,GNE684,Inflammation , Preclinical
28808,DW0Z1Y,IU1,Neurodegenerative disorder , Preclinical
28809,DW18LK,SR9011,Solid tumour/cancer , Preclinical
28810,DW1H9O,TNB-383B,Multiple myeloma , Phase 1
28811,DW24LQ,CLIK-148,Rheumatoid arthritis , Preclinical
28812,DW3AX4,BI 907828,Solid tumour/cancer , Phase 1
28813,DW3J9N,DACRA 089,Type 2 diabetes , Phase 1
28814,DW43DG,Bimagrumab,Type 2 diabetes , Phase 2
28815,DW4J6M,GM602,Ischemic stroke , Phase 2
28816,DW56QV,Calmidazolium,Huntington disease , Investigative
28817,DW5R6Y,SR1555,Rheumatoid arthritis , Preclinical
28818,DW5Z1R,RG7907,Hepatitis B , Phase 1
28819,DW68KF,5-(4-(4-Acetylphenyl)piperazin-1-ylsulfonyl)-6-chloroindolin-2-one,Pompe disease , Preclinical
28820,DW7PT6,SPK-8011,Haemophilia A , Phase 1/2
28821,DW7XC5,IONIS-GCGR-Rx,Type-2 diabetes , Phase 2
28822,DW7XC5,IONIS-GCGR-Rx,Type 2 diabetes , Phase 2
28823,DW9ML8,LMB763,Non-alcoholic steatohepatitis , Phase 2
28824,DW9ML8,LMB763,Diabetic nephropathy , Phase 2
28825,DWB8C5,VLA15,Lyme disease , Phase 2
28826,DWD06K,AVN-322,Alzheimer disease , Phase 1
28827,DWF98V,GSK2807,Solid tumour/cancer , Preclinical
28828,DWH79Q,LY-CoV555,Coronavirus Disease 2019 (COVID-19) , Phase 3
28829,DWJ3A7,DS-2969,Clostridium infection , Phase 1
28830,DWK5H3,C16G2,Dental caries , Phase 2
28831,DWK96T,ASP1929,Head and neck cancer , Phase 3
28832,DWK96T,ASP1929,Solid tumour/cancer , Phase 1/2
28833,DWOY01,RTA 901,Diabetic neuropathy , Phase 1
28834,DWQ6J1,EMB-01,Neoplasm , Phase 1/2
28835,DWQ6J1,EMB-01,Non-small cell lung cancer , Phase 1/2
28836,DWR6A9,ML364,Inflammation , Preclinical
28837,DWS08I,BPL-HRIG,Rabies , Phase 2/3
28838,DWS5G1,ARO-HBV,Hepatitis B , Phase 1/2
28839,DWSO57,SAB-176,Influenza A virus H1N1 infection , Phase 2
28840,DWX4A0,ZM-H1505R,Hepatitis B , Phase 1
28841,DX06ZU,AV-MEL-1,Melanoma , Phase 1
28842,DX1LD3,BCMA-CS1 cCAR,Multiple myeloma , Phase 1
28843,DX1U3C,BI 456906,Type 2 diabetes , Phase 2
28844,DX1U8I,F24F2,Anthrax , Preclinical
28845,DX2B8E,TG4010,Non-small-cell lung cancer , Phase 2/3
28846,DX2J9R,Ad/PNP,Head and neck cancer , Phase 1/2
28847,DX30BA,IBI318,Non-small cell lung cancer , Phase 1
28848,DX36OY,RP-A501,Type 2 glycogen storage disease , Phase 1
28849,DX45IW,COV08-0064,Parkinson disease , Investigative
28850,DX4A3Q,DA-1241,Type 2 diabetes , Phase 1
28851,DX56JK,MET409,Non-alcoholic steatohepatitis , Phase 2
28852,DX5T9B,MSC-1,Solid tumour/cancer , Phase 1
28853,DX6J8M,CC-98633,Multiple myeloma , Phase 1
28854,DX6O9V,TC-210,Ovarian cancer , Phase 1/2
28855,DX6O9V,TC-210,Cholangiocarcinoma , Phase 1/2
28856,DX6O9V,TC-210,Peritoneal mesothelioma , Phase 1/2
28857,DX6O9V,TC-210,Non-small cell lung cancer , Phase 1/2
28858,DX6RV3,IVA337,Non-alcoholic steatohepatitis , Phase 2
28859,DX7M4S,Perchlozone,Multi-drug resistant tuberculosis , Approved
28860,DX8QZ3,CK0801,Hematologic disease , Phase 1
28861,DX9KC2,GT-AADC,Aromatic L-amino acid decarboxylase deficiency , Phase 2
28862,DX9T0N,AZD8701,Solid tumour/cancer , Phase 1
28863,DXC94O,HCVax,Hepatitis C virus infection , Phase 1
28864,DXCR87,OKG-0301,Acute adenoviral conjunctivitis , Phase 2
28865,DXD69J,AZD2811,Small-cell lung cancer , Phase 2
28866,DXF93J,CI-8993,Solid tumour/cancer , Phase 1
28867,DXJ4B7,LY2880070,Solid tumour/cancer , Phase 1/2
28868,DXJH93,AK104,Cervical cancer , Phase 2
28869,DXJH93,AK104,Hepatocellular carcinoma , Phase 2
28870,DXK49H,CFI-402411,Solid tumour/cancer , Phase 1/2
28871,DXL38G,CPI-0209,Solid tumour/cancer , Phase 1/2
28872,DXM30Y,LJPC-401,Hemochromatosis , Phase 2
28873,DXM30Y,LJPC-401,Beta thalassemia , Phase 2
28874,DXNT71,DecRVKRCMK,Coronavirus infection , Preclinical
28875,DXO1V4,AT-787,Hepatitis C , Phase 1
28876,DXP04H,Pirtobrutinib,Chronic lymphocytic leukaemia , Phase 3
28877,DXP04H,Pirtobrutinib,Small lymphocytic lymphoma , Phase 3
28878,DXR7G0,Next Gen PCV,Pneumococcal infection , Phase 2
28879,DXRP68,Vutrisiran,Transthyretin familial amyloid cardiomyopathy , Phase 3
28880,DXV06E,Ciltacabtagene autoleucel,Multiple myeloma , Phase 3
28881,DXV67Q,227Th-labelled PSMA-TTC,Prostate cancer , Phase 1
28882,DXWP72,SEphB4-HSA,Kaposi sarcoma , Phase 2
28883,DXWP72,SEphB4-HSA,Solid tumour/cancer , Phase 1
28884,DY03KH,LHF-535,Lassa fever , Phase 1
28885,DY0HV9,GSK366,Pancreatitis , Preclinical
28886,DY13WU,TAS-0728,Solid tumour/cancer , Phase 1/2
28887,DY1H2Z,NCO-48,Hepatitis B virus infection , Phase 1
28888,DY21QW,RGX-121,Mucopolysaccharidosis , Phase 1/2
28889,DY2EJ1,ATA2431,B-cell lymphoma , Preclinical
28890,DY2UG0,DF1001,Solid tumour/cancer , Phase 1/2
28891,DY2WH5,OTL-103,Wiskott-Aldrich syndrome , Phase 3
28892,DY36LD,GSK6097608,Solid tumour/cancer , Phase 1
28893,DY38JR,Astodrimer,Bacterial vaginosis , Approved
28894,DY46GM,Lefitolimod,Human immunodeficiency virus-1 infection , Phase 2
28895,DY4OZ6,Thymoquinone,Polycystic ovarian syndrome , Phase 2/3
28896,DY4Q6M,Tabelecleucel,Post-transplant lymphoproliferative disorder , Phase 3
28897,DY4Q6M,Tabelecleucel,Nasopharyngeal carcinoma , Phase 2
28898,DY4X5W,CCW702,Prostate cancer , Phase 1
28899,DY5KS2,m337,Coronavirus infection , Preclinical
28900,DY7D9A,ZL-1201,Solid tumour/cancer , Phase 1
28901,DY7IP9,12B9m,Anaemia , Preclinical
28902,DY7MH5,Balovaptan,Autism spectrum disorder , Phase 3
28903,DY7Q1O,EPI-7386,Prostate cancer , Phase 1
28904,DY9CM8,BRD1240,Solid tumour/cancer , Investigative
28905,DY9CP0,TAK-426,Zika virus infection , Phase 1
28906,DY9DX8,SB-913,Mucopolysaccharidosis , Phase 1/2
28907,DY9G1D,REGN5459,Multiple myeloma , Phase 1/2
28908,DYCI37,TST001,Solid tumour/cancer , Phase 1
28909,DYF2N4,HHCYH33,Breast cancer , Phase 1
28910,DYG0W5,Coversin,Paroxysmal nocturnal haemoglobinuria , Phase 3
28911,DYH42L,INXN 4001,Heart failure , Phase 1
28912,DYIA63,CVM-1118,Neuroendocrine cancer , Phase 2
28913,DYJ0V9,Anti-RAS-G12D mTCR-transduced PBL,Solid tumour/cancer , Phase 1/2
28914,DYJ0Z1,NeoTCR-P1,Solid tumour/cancer , Phase 1
28915,DYK5U6,EI1071,Solid tumour/cancer , Phase 1
28916,DYM1J4,ASP7517,Acute myeloid leukaemia , Phase 1/2
28917,DYM1J4,ASP7517,Myelodysplastic syndrome , Phase 1/2
28918,DYNT08,KM-819,Parkinson disease , Phase 1
28919,DYP56K,VXA-A1.1-H1,Influenza , Phase 2
28920,DYQZ38,RLY-1971,Solid tumour/cancer , Phase 1
28921,DYRC18,ACHM-CNGB3,Achromatopsia , Phase 1/2
28922,DYS56C,SB218078,Triple negative breast cancer , Investigative
28923,DYSA16,RT-400,Acute decompensated heart failure , Phase 2
28924,DYSI03,ASP1951,Solid tumour/cancer , Phase 1
28925,DYU37E,EDP-1503,Melanoma , Phase 2
28926,DYU3I8,CLIK-181,Rheumatoid arthritis , Preclinical
28927,DYWK46,SB-318,Mucopolysaccharidosis , Phase 1/2
28928,DZ0DT2,Generx,Angina pectoris , Phase 3
28929,DZ0LJ5,ABBV-4083,Filarial disease , Phase 1
28930,DZ1IL2,MK-1308,Solid tumour/cancer , Phase 1/2
28931,DZ27CY,INB-100,leukaemia , Phase 1
28932,DZ28EB,SR3335,Type-2 diabetes , Preclinical
28933,DZ38PI,INP1855,Pseudomonas infection , Preclinical
28934,DZ4A1W,HF10,Solid tumour/cancer , Phase 2
28935,DZ4A1W,HF10,Melanoma , Phase 2
28936,DZ5K6F,GB1275,Pancreatic cancer , Phase 1/2
28937,DZ68IC,MK-8558,Human immunodeficiency virus-1 infection , Phase 1
28938,DZ76PB,PF-06648671,Alzheimer disease , Phase 1
28939,DZ7OC3,Iomab-ACT,Diffuse large B-cell lymphoma , Phase 1
28940,DZ7OC3,Iomab-ACT,B-cell acute lymphoblastic leukaemia , Phase 1
28941,DZ8DF0,DCR-PHXC,Hyperoxaluria , Phase 2
28942,DZ8FV2,AAV-RPGR,Retinitis pigmentosa , Phase 1/2
28943,DZ8UP4,LM10,Solid tumour/cancer , Preclinical
28944,DZ91HE,OP-1250,Breast cancer , Phase 1/2
28945,DZ9AJ3,PF-07055480,Haemophilia A , Phase 3
28946,DZ9BD3,CHIKV VLP,Chikungunya virus infection , Phase 2
28947,DZA98D,ARGX-113,Myasthenia gravis , Phase 3
28948,DZB84T,Maralixibat,Progressive familial intrahepatic cholestasis , Phase 3
28949,DZB84T,Maralixibat,Alagille syndrome , Phase 2
28950,DZBV67,BI 765063,Solid tumour/cancer , Phase 1
28951,DZEF27,HCB1019,Diabetic macular edema , Phase 2
28952,DZJ3D5,PF-07220060,Prostate cancer , Phase 1
28953,DZJ3D5,PF-07220060,Liposarcoma , Phase 1
28954,DZK24C,EPL-1410,Solid tumour/cancer , Preclinical
28955,DZK7E0,PF-670462,Chronic lymphocytic leukaemia , Preclinical
28956,DZL3F8,VTR-297,Hematologic tumour , Phase 1
28957,DZL8S6,DSP-0509,Solid tumour/cancer , Phase 1/2
28958,DZLM72,SHR0534,Type 2 diabetes , Phase 1
28959,DZM2L1,AFM13,Hodgkin lymphoma , Phase 2
28960,DZM2L1,AFM13,Peripheral T-cell lymphoma , Phase 2
28961,DZM2L1,AFM13,Mycosis fungoides , Phase 2
28962,DZM2L1,AFM13,Lymphoma , Phase 1/2
28963,DZM65T,ICP-192,Bladder cancer , Phase 2
28964,DZMO76,JTX-4014,Non-small-cell lung cancer , Phase 2
28965,DZNH43,MT-3724,Diffuse large B-cell lymphoma , Phase 2
28966,DZNH43,MT-3724,Non-hodgkin lymphoma , Phase 2
28967,DZNH43,MT-3724,B-cell chronic lymphocytic leukaemia , Phase 1
28968,DZNH43,MT-3724,B-cell lymphoma , Phase 1
28969,DZNH43,MT-3724,B-cell non-hodgkin lymphoma , Phase 1
28970,DZQ32M,TAPA-pulsed dendritic cell vaccine,Solid tumour/cancer , Phase 1/2
28971,DZTL59,INO-A002,Zika virus infection , Phase 1
28972,DZTX12,ASC-J9,Thrombosis , Phase 2
28973,DZTX12,ASC-J9,End-stage renal disease , Phase 2
28974,DZU72C,OKI 179,Solid tumour/cancer , Phase 1
28975,DZVF15,TRN-110,Attention deficit hyperactivity disorder , Clinical Trial
28976,DZW53X,GSK4069889,Non-small cell lung cancer , Phase 2
28977,DZY4R2,JNJ-74699157,Solid tumour/cancer , Phase 1
